<SEC-DOCUMENT>0001104659-25-060762.txt : 20250620
<SEC-HEADER>0001104659-25-060762.hdr.sgml : 20250620
<ACCEPTANCE-DATETIME>20250618212145
ACCESSION NUMBER:		0001104659-25-060762
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		35
FILED AS OF DATE:		20250620
DATE AS OF CHANGE:		20250618

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Caris Life Sciences, Inc.
		CENTRAL INDEX KEY:			0002019410
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				852077369
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287551
		FILM NUMBER:		251058828

	BUSINESS ADDRESS:	
		STREET 1:		750 W JOHN CARPENTER FREEWAY
		STREET 2:		SUITE 800
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		(866) 771-8946

	MAIL ADDRESS:	
		STREET 1:		750 W JOHN CARPENTER FREEWAY
		STREET 2:		SUITE 800
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>tm2415719-25_424b4.htm
<DESCRIPTION>424B4
<TEXT>
<html>
  <head>
    <title>tm2415719-25_424b4 - none - 52.1510394s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">&#8202;Filed Pursuant to Rule 424(b)(4)</font>&#8203;</div>
        <div style="margin-top:1.9pt; text-align:right; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">&#8202;Registration No. 333-287551</font>&#8203;</div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">P R O S P E C T U S</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">23,529,412 Shares</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="position:relative;margin-top:5pt; text-align:center; width:456pt;">
          <img src="lg_carislifesciences-pn.jpg" alt="[MISSING IMAGE: lg_carislifesciences-pn.jpg]" height="96" width="116" >
        </div>
        <div style="margin-top:8.8pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Caris Life Sciences, Inc.</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Common Stock</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:6.167pt; text-align:center; width:456pt;">
          <div style="margin-left: 40.132%; margin-right: 40.132%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:36pt; margin-top:7.9pt; width:420pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">This is Caris Life Sciences, Inc.&#8217;s initial public offering. We are selling 23,529,412 shares of our common stock. </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">The public offering price is $21.00 per share. Currently, no public market exists for shares of our common stock. Our common stock has been approved for listing on the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;CAI.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">Immediately following the completion of this offering, David D. Halbert, our Founder, Chairman, and Chief Executive Officer, will beneficially own approximately 44.6% of our outstanding shares of common stock, and our existing executive officers (including Mr.&#160;Halbert), directors, holders of more than 5% of our outstanding capital stock, and their respective affiliates will collectively beneficially own approximately 66.2% of our outstanding shares of common stock, in each case, based on the initial public offering price of $21.00 per share and assuming no exercise by the underwriters of their option to purchase additional shares of our common stock. As a result, Mr. Halbert as well as our other existing executive officers, directors, and principal shareholders, if acting together, will be able to control all matters submitted to our shareholders for approval, including the election of directors, amendments to our certificate of formation and bylaws, and the approval of significant corporate transactions. See &#8220;Principal Shareholders&#8221; for additional information. </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">At our request, the underwriters have reserved up to 5% of the shares of common stock offered by this prospectus, excluding the additional shares that the underwriters have a 30-day option to purchase, for sale, at the initial public offering price, to certain individuals identified by management, including certain of our directors, officers, employees, and certain other parties related to us. See &#8220;Underwriting&#8212;Reserved Share Program.&#8221;</font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">We are an &#8220;emerging growth company&#8221; as defined under the federal securities laws and, as such, have elected to comply with certain reduced reporting requirements for this prospectus and may elect to do so in future filings. See &#8220;Prospectus Summary&#8212;</font>&#8203;<font style="letter-spacing:-0.17pt;">Implications of Being an Emerging Growth Company.&#8221;</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font></div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:12.5pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">Investing in our common stock involves risks that are described in the &#8220;Risk Factors&#8221; section beginning on page <a href="#tRIFA">21</a> of this prospectus.</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:5.733pt; text-align:center; width:456pt;">
          <div style="margin-left: 40.132%; margin-right: 40.132%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:456pt;height:41.5pt;margin-top:0.400000000000034pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:331.06pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1pt 0pt 0.5pt 0pt; width:331.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Public offering price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">21.00 </td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">494,117,652.00 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:331.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Underwriting discount</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.47 </td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">34,588,235.64 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:331.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Proceeds, before expenses, to us </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">19.53 </td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">459,529,416.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">We refer you to &#8220;Underwriting&#8221; for additional information regarding underwriting compensation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">The underwriters may also exercise their option to purchase up to an additional 3,529,411 shares of common stock from us, at the public offering price, less the underwriting discount, for 30&#160;days after the date of this prospectus. </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">Certain entities affiliated with Neuberger Berman Investment Advisers LLC (collectively, &#8220;Neuberger Berman&#8221;) have indicated an interest in purchasing up to $75.0 million of shares of our common stock being offered in this offering at the initial public offering price and on the same terms as the other purchasers in this offering. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters could determine to sell more, fewer, or no shares to Neuberger Berman, and Neuberger Berman could determine to purchase more, fewer, or no shares in this offering. The underwriters will receive the same underwriting discounts and commissions on any of our shares of common stock purchased by Neuberger Berman as they will from any other shares of common stock sold to the public in this offering. </font>
        </div>
        <div style="margin-left:36pt; margin-top:4pt; width:420pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">The shares will be ready for delivery on or about June&#160;20, 2025. </font>
        </div>
        <div style="margin-top:7.233pt; text-align:center; width:456pt;">
          <div style="margin-left: 40.132%; margin-right: 40.132%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.39pt; width:456pt; line-height:12.5pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">BofA Securities</font><font style="margin-left:43.45pt;letter-spacing:-0.24pt;">J.P. Morgan</font><font style="margin-left:43.45pt;letter-spacing:-0.24pt;">Goldman Sachs &amp; Co. LLC</font><font style="float:right;"><font style="letter-spacing:-0.24pt;">Citigroup</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
          </font>
        </div>
        <table style="width:456pt;height:25pt;margin-top:4.89999999999998pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:44.76pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">TD Cowen </font>
              </div>
            </td>
            <td style="padding:0pt; width:64.07pt;">&#8203;</td>
            <td style="padding:0pt; width:64.07pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:52.41pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.2pt;">Evercore ISI </font>
              </div>
            </td>
            <td style="padding:0pt; width:64.07pt;">&#8203;</td>
            <td style="padding:0pt; width:64.07pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:102.55pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:-0.2pt;">Guggenheim Securities</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; width:44.76pt;">
              <font style="letter-spacing:-0.2pt;">BTIG </font>
            </td>
            <td style="padding:0pt; width:64.07pt;">&#8203;</td>
            <td style="padding:0pt; width:64.07pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:52.41pt;">&#8203;</td>
            <td style="padding:0pt; width:64.07pt;">&#8203;</td>
            <td style="padding:0pt; width:64.07pt;">&#8203;</td>
            <td style="padding:5.5pt 0.5pt 0.5pt 0pt; width:102.55pt;text-align:right;">
              <div style="white-space:nowrap; text-align:right;">
                <font style="letter-spacing:-0.2pt;">Wolfe | Nomura Alliance</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:8.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 40.132%; margin-right: 40.132%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4.4pt; text-align:center; width:456pt; line-height:9pt;">
          <font style="letter-spacing:0.17pt;">The date of this prospectus is June&#160;17, 2025.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="min-height:759.71pt;page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-26pt;margin-left:-18pt;width:631.31pt;">
        <div style="width:631.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">&#8202;Where Molecular Science Meets Artificial Intelligence Arizona blood lab; the entrance lobby of Caris&#8217; Phoenix, Arizona tissue lab; tissue sample storage in Caris&#8217; Phoenix, Arizona tissue lab; a Caris laboratory technician preparing a centrifuge for Caris Assure&#8482; profiling of patient blood samples; a Caris laboratory technician preparing patient blood samples for Caris Assure&#8482; profiling; a Caris laboratory technician microdissecting a patient tissue sample in preparation for MI Profile&#8482; analysis; Caris laboratory technicians in our Phoenix, Arizona blood lab; sequencing machines in Caris&#8217; Phoenix, Arizona blood lab. </font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
        <div style="position:relative;z-index:-1;z-index:-1;z-index:-1;margin-top:7.71pt; text-align:center; width:613.31pt; overflow:hidden;">
          <img src="pg_carislifesciences-4c.jpg" alt="[MISSING IMAGE: pg_carislifesciences-4c.jpg]" height="1056" width="816" >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-26pt;margin-left:-18pt;width:631.31pt;">
        <div style="margin-top:34.36pt; width:631.31pt; line-height:3pt;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">&#8202; </font><font style="color:#FFFFFF;letter-spacing:0.02pt;">By the Numbers Profiling, Data &amp; Technology 849,000+ Unique Cases Profiled 6.5+ Million Total Tests Completed 13+ Quadrillion Datapoints Generated 38+ Billion Molecular Markers Measured 220+ AI-Powered Tools Utilized 51+Petabytes of Genomic Data 4.4+ Million Digitized Slides for Interpretation &amp; AI Training 580,000+ Matched Molecular &amp; Clinical Outcomes Database 23,000+ Genes Analyzed per Order (WES/WTS) Commercial Reach 5,550+ Regularly Ordering Oncologists (4+ orders in the last 12 months) 100+ Biopharma Partners 270+ Commercial Sales Team Members 96 Caris Precision Oncology Alliance Members 90+ Payer Reimbursement Contracts ~60% Cases Ordered Electronically Publications, Patents &amp; People 1,050+ Publications 200+ Patents Granted (100+ additional pending) 1,700+ Employees Data points are as of March 31, 2025.</font><font style="letter-spacing:0.02pt;"> </font>
        </div>
        <div style="position:relative;z-index:-1;z-index:-1;margin-top:10pt; text-align:center; width:613.31pt; overflow:hidden;">
          <img src="pg_bynumbers-4c.jpg" alt="[MISSING IMAGE: pg_bynumbers-4c.jpg]" height="960" width="720" >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-26pt;margin-left:-18pt;width:631.31pt;">
        <div style="margin-top:77.55pt; width:631.31pt; line-height:3pt;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">&#8202; </font><font style="color:#FFFFFF;letter-spacing:0.02pt;">Case Volume Growth (Thousands*) Clinical Cases Biopharma &amp; External Research Cases 172.6 31% CAGR 136.9 2019-2024 103.4 162.9 77.5 30% Year-Over-Year Growth Rate 128.8 61.5 97.3 47.3 45.1 36.5 75.3 59.9 45.9 34.9 42.8 2019 2020 2021 2022 2023 2024 Q1 2024 Q1 2025 *Figures reflect case volume for the periods presented. Figures may not sum precisely due to rounding. </font><font style="letter-spacing:0.02pt;"> </font>
        </div>
        <div style="position:relative;z-index:-1;margin-top:10pt; text-align:center; width:613.31pt; overflow:hidden;">
          <img src="pg_casevaluegrowth-4c.jpg" alt="[MISSING IMAGE: pg_casevaluegrowth-4c.jpg]" height="845" width="634" >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-26pt;margin-left:-18pt;width:631.31pt;">
        <div style="margin-top:37.95pt; width:631.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">&#8202;Revenue Growth($ Millions*) Molecular Profiling Services Pharma Research &amp; Development Services $412.3 28% CAGR 2019-2024 $306.1 $258.5 $120.5 $114.1 $163.9 $155.3 $192.3 $181.5 $238.6 $278.7 $349.1 50% Year-Over-Year Growth Rate $120.9 $80.7 $114.1 $73.2 $6.4 2019 $8.6 2020 $10.8 2021 $19.9 2022 2023 2024 $7.4 $6.8 Q1 2024 Q1 2025 ($79.1) ($175.8) ($324.0) ($320.8) ($341.4) ($281.9) ($111.0) ($102.6) NET (LOSS) *Figures reflect revenue for the periods presented. Figures may not sum precisely due to rounding. </font>
        </div>
        <div style="position:relative;z-index:-1;z-index:-1;margin-top:10pt; text-align:center; width:613.31pt; overflow:hidden;">
          <img src="pg_revenuegrowth-4c.jpg" alt="[MISSING IMAGE: pg_revenuegrowth-4c.jpg]" height="950" width="714" >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:14.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:392.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:422.72pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">PAGE </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLFDD"><font style="letter-spacing:0.2pt;">LETTER FROM DAVID DEAN HALBERT, FOUNDER, CHAIRMAN, AND CEO </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLFDD">iii</a></font> <a href="#tLFDD"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSU"><font style="letter-spacing:0.2pt;">PROSPECTUS SUMMARY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRSU">1</a></font> <a href="#tPRSU"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRIFA">21</a></font> <a href="#tRIFA"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSNRF"><font style="letter-spacing:0.2pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSNRF">99</a></font> <a href="#tSNRF"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMAID"><font style="letter-spacing:0.2pt;">MARKET AND INDUSTRY DATA </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMAID">101</a></font> <a href="#tMAID"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP"><font style="letter-spacing:0.2pt;">USE OF PROCEEDS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUOP">102</a></font> <a href="#tUOP"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIPO"><font style="letter-spacing:0.2pt;">DIVIDEND POLICY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDIPO">103</a></font> <a href="#tDIPO"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCAP"><font style="letter-spacing:0.2pt;">CAPITALIZATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCAP">104</a></font> <a href="#tCAP"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIL"><font style="letter-spacing:0.2pt;">DILUTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDIL">106</a></font> <a href="#tDIL"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:422.72pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tMDAA"><font style="letter-spacing:0.2pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMDAA">108</a></font> <a href="#tMDAA"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tBUS"><font style="letter-spacing:0.2pt;">BUSINESS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tBUS">135</a></font> <a href="#tBUS"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMAN"><font style="letter-spacing:0.2pt;">MANAGEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMAN">210</a></font> <a href="#tMAN"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXCO"><font style="letter-spacing:0.2pt;">EXECUTIVE COMPENSATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEXCO">220</a></font> <a href="#tEXCO"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCRAR"><font style="letter-spacing:0.2pt;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCRAR">230</a></font> <a href="#tCRAR"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSH"><font style="letter-spacing:0.2pt;">PRINCIPAL SHAREHOLDERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRSH">234</a></font> <a href="#tPRSH"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOCS"><font style="letter-spacing:0.2pt;">DESCRIPTION OF CAPITAL STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOCS">237</a></font> <a href="#tDOCS"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSEFF"><font style="letter-spacing:0.2pt;">SHARES ELIGIBLE FOR FUTURE SALE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEFF">245</a></font> <a href="#tSEFF"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:422.72pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tMUFI"><font style="letter-spacing:0.2pt;">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS OF </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">OUR COMMON STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMUFI">250</a></font> <a href="#tMUFI"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUND"><font style="letter-spacing:0.2pt;">UNDERWRITING </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUND">254</a></font> <a href="#tUND"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA"><font style="letter-spacing:0.2pt;">LEGAL MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLEMA">265</a></font> <a href="#tLEMA"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP"><font style="letter-spacing:0.2pt;">EXPERTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEXP">265</a></font> <a href="#tEXP"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCIRPAF"><font style="letter-spacing:0.2pt;">CHANGE IN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCIRPAF">266</a></font> <a href="#tCIRPAF"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF"><font style="letter-spacing:0.2pt;">WHERE YOU CAN FIND ADDITIONAL INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWYCF">267</a></font> <a href="#tWYCF"></a></td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tITFS"><font style="letter-spacing:0.2pt;">INDEX TO FINANCIAL STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tITFS">F-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:3.14pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neither we nor the underwriters have authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We and the underwriters take no responsibility for and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of common stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of shares of our common stock. Our business, financial condition, results of operations, and prospects may have changed since that date. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">For investors outside the United States:</font><font style="letter-spacing:0.2pt;"> Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus or any free writing prospectus we may provide to you in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus and any such free writing prospectus outside of the United States.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:360pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TRADEMARKS, TRADE NAMES AND SERVICE MARKS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus includes our trademarks and trade names, including, without limitation, Caris&#160;Life&#160;Sciences</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, Caris</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, Caris Discovery</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, Caris Assure</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, MI Profile</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, Molecular Intelligence</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, Caris&#160;Precision Oncology Alliance</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, MI Tumor Seek</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, MI Tumor Seek Hybrid</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, ABCDai</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, CODEai</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, ESPai</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, MI Cancer Seek</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, GPSai</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, FOLFIRSTai</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, Caris ChromoSeq</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, MGMTai</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;">, and our logo, which are protected under applicable intellectual property laws and are our property. This prospectus also contains trademarks, trade names, and service marks of other companies, which are the property of their respective owners. Solely for convenience, trademarks, trade names, and service marks referred to in this prospectus, including logos, artwork, and other visual displays, may appear without the </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> or </font><font style=" position:relative; bottom:6.25pt;font-weight:bold;text-transform:uppercase;font-size:4pt;letter-spacing:-0.08pt;">SM</font><font style="letter-spacing:0.2pt;"> symbols, but such references are not intended to indicate in any way that we or the applicable owner will not assert, to the fullest extent under applicable law, our or its rights or the rights of the applicable licensor to these trademarks, trade names, and service marks. We do not intend our use or display of other parties&#8217; trademarks, trade names or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other parties. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ROUNDING ADJUSTMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain&#160;monetary amounts, percentages, and other figures included elsewhere in this prospectus have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables or charts may not be the arithmetic aggregation of the figures that precede them, and figures expressed as&#160;percentages in the text may not total 100% or, as applicable, when aggregated may not be the arithmetic aggregation of the figures that precede them. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLFDD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LETTER FROM DAVID DEAN HALBERT, FOUNDER, CHAIRMAN, AND CEO</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Hello, my name is David Dean Halbert, and I am the Founder, Chairman, and CEO of Caris Life Sciences. Caris is the first and only company that I&#8217;ve founded without a business model. Our only purpose is to help patients live longer and have a better quality of life by applying personalized medicine to disease. We believe that precise, data-driven, and personalized molecular information is crucial to eradicating chronic health conditions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a science-focused company, Caris has been at the forefront of precision medicine from the beginning and has driven the industry forward through our focus on science and investments into technology, instrumentation, facilities, and people. When I started Caris, next-generation sequencing, and other technologies needed to realize the benefits of personalized medicine, did not exist. However, we have benefited from tremendous advances in sequencing technology, cloud computing, and AI technologies to power our expertise and insights in molecular biology. We believe that these advances provide an unmatched resource to develop the next generation of precision medicine solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our platform is built on the premise that more data enables us to answer questions about biology that could not be answered until now due to limited or narrow information. In the course of completing over 6.5&#160;million tests on over 849,000 cases, we have generated over 13 quadrillion molecular datapoints and measured over 38&#160;billion molecular markers. We measure billions of data points per clinical case using Caris Assure, our universal blood-based whole exome/whole transcriptome sequencing solution, that we have created based on our vast experience in tissue sequencing. We are utilizing this tremendous amount of molecular information to pioneer the transition from intuitive medicine, where decisions for cancer patients are made based on prior experience or intuition, to empirical medicine, where decisions are based on the genetic make-up of each person&#8217;s disease. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Driven by over 17&#160;years of innovation to help build a better world, we have gained vast expertise in sequencing and data interpretation. We believe we were the first to offer comprehensive molecular profiling as standard practice when we launched whole transcriptome sequencing in 2019, the first to offer whole exome sequencing as standard practice when we introduced our whole exome sequencing solution in 2020, and the first to offer whole exome and whole transcriptome sequencing in blood when we broadly launched Caris Assure in the first quarter of 2024. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have utilized AI and machine learning algorithms across our dataset to identify approximately 915,000 unique pathogenic mutations, of which only approximately 17,000 were previously identified, with approximately 130 novel pathogenic mutations found on average in each person. We can now identify a person&#8217;s circulating pathogenic mutations and enable the design of a customized individualized therapy to that specific set of mutations. So, it becomes an individualized, customized immunotherapy. We believe this is going to create the opportunity for physicians to use our solutions to effectively prevent various chronic diseases before they ever get started at the earliest of stages. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">It is a very exciting time because technology has finally advanced to the point where it enables this big idea. This is not something that could have been thought of in 2008 or even 2018 because the technologies were not available. Such as large sequencing capacity, AI, and the cloud, all of which have to be utilized to look at all of the different aberrations that are occurring at the molecular level with the outcomes. So over time, it&#8217;s just going to get better and better and better. We run the same assay in both blood and tissue on every eligible patient sample every day, so the only changes to the assay will be at the bioinformatic level utilizing specially-designed algorithms to provide new insights. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While we specialize in oncology today, we also believe that since we have designed the Caris Assure platform as a universal assay that runs on every coding gene in the blood, it can be utilized to identify alterations that drive other chronic disease states such as cardiovascular disease, neurological conditions, metabolic disorders, and many others. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We exist in a very exciting time of unprecedented technological disruption to benefit mankind and &#8220;go where no man has gone before&#8221;&#8212;something I have described as the molecular revolution&#8212;leading me to be bullish on humanity. Never before have we seen a convergence of molecular sequencing power, sophisticated AI technologies, and massive computer processing capabilities. We will continue to harness these and other advanced technologies, pushing the boundaries of what is possible and leading the precision medicine revolution in healthcare. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">iii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:542pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">We feel honored to have served hundreds of thousands of patients in their battle against cancer. I would like to thank our Caris Life Sciences family for their tireless work to help our patients and to build a company that is actively changing the practice of medicine. We are excited about our future and welcome new shareholders that share our vision and passion to improve the human condition. </font>
        </div>
        <div style="margin-top:14pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">David Dean Halbert, D.Sc. (h.c.)</font> <br ><font style="letter-spacing:0.2pt;">Founder, Chairman, and CEO</font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">iv</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">This summary highlights selected information contained elsewhere in this prospectus and is qualified in its entirety by the more detailed information and financial statements included elsewhere in this prospectus. It does not contain all of the information that may be important to you and your investment decision. You should carefully read this entire prospectus, including the sections titled &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and &#8220;Special Note Regarding Forward-Looking Statements&#8221; and our financial statements and related notes included elsewhere in this prospectus before making an investment decision. In this prospectus, unless context requires otherwise, references to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Caris,&#8221; or &#8220;the Company&#8221; refer to Caris Life Sciences, Inc. and its wholly owned subsidiaries.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We founded Caris in 2008 with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize the potential of precision medicine for patients. We have spent the last 17&#160;years developing and building our portfolio of comprehensive, proprietary molecular profiling solutions and generating what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology based on the more than 6.5 million tests we have run on over 849,000 cases, which have generated measurements of over 38 billion molecular markers. Our platform is purpose-built to leverage the convergence of next-generation sequencing (&#8220;NGS&#8221;), artificial intelligence (&#8220;AI&#8221;) and machine learning (&#8220;ML&#8221;) technologies, and high-performance computing. The power of our differentiated Caris platform has enabled us to develop the latest generation of advanced precision medicine diagnostic solutions designed to address the entire cancer care continuum, including early detection, minimal residual disease (&#8220;MRD&#8221;) tracking, therapy selection, and treatment monitoring, as well as to create molecular signatures and discover and develop novel precision medicine therapeutics. Our current commercial product portfolio is focused on oncology and consists of MI Profile, our tissue-based molecular profiling solution that has generated the majority of our revenue to date, and Caris Assure, our novel, universal blood-based molecular profiling solution that was broadly launched in the first quarter of 2024 for therapy selection. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Dysfunctionality at the molecular level underlies every chronic disease, and this dysfunction is now measurable using techniques such as NGS. Cells are embedded within highly complex biological networks that govern all aspects of life, including how these cells grow, divide, interact, and die. These biological networks and their inherent functions, as well as dysfunctions, are controlled and directed at the molecular level. The precise molecular origins or contributors to a given biological dysfunction, however, are often unknown, and a comprehensive molecular profile is necessary to determine these origins. The central dogma of molecular biology states that genetic information flows in one direction, from DNA, to RNA, to proteins. Our approach is designed to accurately capture the full breadth of the DNA and RNA coding information in cells as well as protein expression through immunohistochemical (&#8220;IHC&#8221;) tests, constructing a fulsome mosaic of disease, and ultimately unlocking the potential for precision medicine therapeutics to guide individualized patient diagnoses and treatment. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We believe we are well-positioned to realize the full potential of our vision and optimally leverage our vast datasets due to the recent convergence of several advancements in biology, medicine, and technology: (1)&#160;the medical community&#8217;s understanding and appreciation of the molecular nature of cancer has accelerated in recent&#160;years, resulting in a continued increase in molecular profiling of different cancer types and stages; (2)&#160;NGS costs have declined, making NGS more accessible to the healthcare ecosystem; (3)&#160;cloud-computing architecture has enabled massive scalability, distributed real-time collaboration, and greater cost efficiency for the analysis of previously unmanageable amounts of data; and (4) AI and ML computational capabilities have advanced to allow more effective interrogation of large biological datasets. We believe that our early foresight to generate comprehensive data at scale over the past many&#160;years and build a robust, foundational infrastructure have uniquely positioned Caris to leverage the benefits of these </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">biological and technological advances to deliver transformative and advanced innovations in precision medicine and patient care into the future. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. We provide whole exome sequencing (&#8220;WES&#8221;) (all 23,000 encoding DNA genes) and whole transcriptome sequencing (&#8220;WTS&#8221;) (all 61,000 RNA transcripts that encode proteins) on every eligible patient sample (a sample provided by ordering physicians that contains sufficient genetic material for profiling). Since launching our WTS solution in 2019 and WES solution in 2020, we have performed over 500,000 WES and WTS cases through May&#160;2025, which we believe is more than any other company. We sequence at a sector-leading depth of coverage, which directly correlates with increased accuracy and detection of low frequency molecular markers of relevance. MI Cancer Seek, our U.S. Food and Drug Administration (&#8216;&#8216;FDA&#8217;&#8217;)-approved companion diagnostic assay to identify cancer patients who may benefit from treatment with targeted therapies (a component of MI Profile), consistently reaches 1,500 times depth of coverage for clinically relevant DNA genes, which is a higher sequencing depth than other assays available in the marketplace based on reported depths of coverage, and 300 times depth of coverage for the whole exome. Caris Assure features a raw average sequencing depth of 8,000 times for clinically relevant genes, similarly a higher sequencing depth than other assays available in the marketplace based on reported depths of coverage. We generate tens of billions of datapoints per clinical case to reveal an individualized molecular blueprint of the patient&#8217;s disease. We believe this approach best positions us to provide actionable treatment pathways from targeted therapies to drive superior clinical outcomes for patients while also generating a rich dataset to power insights and innovation. To our knowledge, we remain the only genomic profiling company to consistently utilize WES and WTS as standard practice on every eligible patient sample. We also evaluate protein molecular markers through an extensive menu of IHC tests performed in a tumor-type specific manner, which in combination with WES and WTS, provide a comprehensive view of a patient&#8217;s disease. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our in-depth profiling of patient samples has led to the creation of what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology, including genomic data, clinical data, digitized slide images, and remnant tissue. As of March 31, 2025, we have run more than 6.5&#160;million tests on over 849,000 cases, which have generated measurements of over 38&#160;billion molecular markers. Leveraging high-powered computing and AI/ML algorithms, we, and our biopharma and research partners who use our data and bioinformatics services, analyze our datasets to determine the key molecular characteristics of a particular disease or dysfunction that drives disease, enabling signature identification and drug target discovery. As a leader in the transition to WES/WTS sequencing through our launch of a WTS solution in 2019 and a WES solution the following year, we believe we have more molecular data and information than any other company and are well-positioned to make precision medicine widely accessible. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our molecular profiling solutions and the data generated by our multi-omic technology platform provide value to our more than 100 biopharma partners, such as Moderna, AbbVie, Xencor, and Merck KGaA, through partnerships that aim to increase the probability of technical and regulatory success of their therapeutic pipelines. In addition to biopharma, we leverage our datasets to partner with outside academic centers and researchers to further advance precision oncology research. The Caris Precision Oncology Alliance (&#8220;Caris POA&#8221;), which we established in 2015, is a growing network of leading cancer centers and research consortia across the globe that collaborate to advance precision oncology and biomarker-driven research, with its members working together to establish and optimize standards of care for molecular testing through innovative research to improve clinical outcomes for cancer patients. As of March 31, 2025, the Caris POA was comprised of 96 members, including 45 National Cancer Institute (&#8220;NCI&#8221;)-designated comprehensive cancer centers. This academic-industry collaborative network has been exceptionally productive with over 145 peer-reviewed manuscripts published since the beginning of 2022. Close connectivity with this vast network of key opinion leaders (&#8220;KOLs&#8221;) in oncology clinical care, research, and drug development has enabled us to remain at the forefront of precision oncology and closely attuned to the key needs of the most sophisticated researchers. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our Caris platform is designed to create a virtuous cycle that can enable continued innovation and improved impact for patients and physicians. We believe our comprehensive approach to profiling will continue to drive demand for our genomic profiling capabilities, leading to further expansion of our clinico-genomic datasets, which provide additional valuable inputs to develop and enhance our solutions, with the </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">ultimate goal of contributing to improved patient results. This continuous feedback loop enabled us to develop Caris Assure, which utilized genomic data generated by MI Profile to inform our blood-based bioinformatics algorithms, allowing us to detect previously unknown features and signals in the blood that provide advanced insights into disease development. We believe we will be able to further leverage this process to continue meaningful innovation in precision oncology as well as other chronic disease states, including cardiology, neurology, and metabolic conditions. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our global annual clinical case volume has been growing rapidly, with year-over-year growth of 29% in 2022, 32% in 2023, 26% in 2024, and 31% in the first quarter of 2025, primarily driven by MI Profile. With our broad commercial launch of Caris Assure for therapy selection in the first quarter of 2024 and the FDA approval of MI Cancer Seek as a companion diagnostic in the fourth quarter of 2024 followed by the broad commercial launch of MI Cancer Seek in the first quarter of 2025 as the NGS component of MI Profile, we believe that increased profiling volumes will meaningfully contribute to our growth in 2025 and beyond. For the&#160;years ended December&#160;31, 2024 and 2023, we generated total revenue of $412.3&#160;million and $306.1&#160;million, respectively. For the three months ended March 31, 2025 and 2024, we generated total revenue of $120.9 million and $80.7 million, respectively. We have incurred net losses and negative cash flows from operations since inception. For the years ended December&#160;31, 2024 and 2023, we incurred net losses of $257.1&#160;million and $341.4&#160;million, respectively. For the three months ended March 31, 2025 and 2024, we incurred net losses of $102.6 million and $111.0 million, respectively. Our Adjusted EBITDA was $(189.6)&#160;million and $(255.3) million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Our Adjusted EBITDA was $(36.2) million and $(70.1) million for the three months ended March 31, 2025 and 2024, respectively. For additional information regarding Adjusted EBITDA, a non-GAAP financial measure, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Financial Measures.&#8221; We expect to incur additional net losses in the near future, and our expenses will increase as we continue to invest in developing new solutions, expand our organization, and increase our marketing efforts to continue to drive market adoption of our solutions. These investments, together with general and administrative expenses, have resulted in negative cash flows from operations of $245.2 million, $276.1 million, $31.3 million, and $73.9 million for the years ended December&#160;31, 2024 and 2023 and the three months ended March 31, 2025 and 2024, respectively. Our free cash flow was $(253.6)&#160;million and $(298.4) million for the years ended December 31, 2024 and 2023, respectively, and, $(34.0&#160;) million and $(75.7) million for the three months ended March&#160;31, 2025 and 2024, respectively. For additional information regarding free cash flow, a non-GAAP financial measure, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Financial Measures.&#8221; Additionally, as of March&#160;31, 2025, we had cash, cash equivalents, and short-term marketable securities of $33.4 million, and the aggregate principal amount of debt outstanding under our existing term loan was $400.0 million. For additional information regarding our liquidity and capital resources, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources.&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Industry Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Addressing the complexity of cancer remains a major challenge in healthcare and a critical area of unmet medical need, despite enormous investments in research and development (&#8220;R&amp;D&#8221;), and the introduction of new oncology therapeutics and treatments. The molecular revolution is upending the traditional paradigm of complex workflows of diagnosis, treatment, and monitoring of diseases, which largely uses a symptomatic, reactive approach to medicine. Over the last several decades, significant advances in genomics, proteomics, molecular technology, and computing power have enabled a comprehensive, multi-omic approach to the molecular profiling of diseases, both efficiently and at scale. The information provided by comprehensive molecular profiling is driving a revolution in medicine, where molecular information is used to guide individualized patient diagnoses and treatment. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Comprehensive molecular profiling entails evaluating thousands of potential biomarkers, including DNA, RNA, proteins, and other molecular and clinical information for characteristics unique to a particular patient&#8217;s disease. Given the complexity of a cancer&#8217;s origin and drivers, comprehensive molecular information incorporating DNA, RNA, and protein profiles can help provide the most robust picture of a patient&#8217;s disease and potential treatment pathways. WES/WTS streamlines the patient experience and clinical decision-making and offers increased value to patients, physicians, and payers. We believe WES/WTS </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">provides the most efficient and cost-effective way to obtain the maximum information on a patient&#8217;s cancer at the start of the patient journey. It enables accurate identification of a greater number of actionable genomic alterations that can be leveraged to match patients to the most effective treatments, yielding a higher probability of response and providing comprehensive predictive and prognostic information. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">While the molecular revolution has already changed the way cancer is being diagnosed and treated, we believe that molecular testing faces several major challenges in its current form, which have hindered broader adoption of precision oncology. These challenges include: (1)&#160;targeted panels are subject to missing information and significant variability; (2)&#160;lack of consistent RNA profiling; (3)&#160;lack of clonal hematopoiesis (&#8220;CH&#8221;) derived variant subtraction technology in current blood assays, contributing to the inability to identify false positive mutations that are not tumor-derived; (4)&#160;disparate data sets collected across testing modalities; (5)&#160;logistical drawbacks and sensitivity limitations of current MRD assays; and (6)&#160;false positives and a lack of early-stage sensitivity with current multi-cancer early detection (&#8220;MCED&#8221;) assays. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">As a result of these challenges, clinicians may make critical treatment decisions based on incomplete and/or inaccurate information and analytics, potentially resulting in suboptimal outcomes. We believe that our comprehensive molecular profiling solutions and the data generated by our multi-omic technology platform is well-suited to address the limitations and challenges of today&#8217;s molecular testing alternatives. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Caris Platform</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">We are leading a molecular revolution and developing the latest generation of advanced precision medicine information solutions that we believe have applicability across the care continuum for a broad range of conditions. The fundamental differentiation of the Caris platform and our business model is the depth, breadth, and scale of data, including how that data is integrated vertically and horizontally across our business, as well as the resulting innovation which it fuels. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Our multi-omic technology platform is built on the following pillars: (1)&#160;Caris Assure; (2)&#160;MI Profile; (3)&#160;Caris Discovery; (4)&#160;Caris Strategic Data; and (5)&#160;Caris Infrastructure. These five pillars are designed to work together to create a virtuous cycle that can enable continued innovation and improved impact for patients and physicians. We believe our comprehensive approach to profiling will continue to drive demand for our genomic profiling capabilities, leading to further expansion of our clinico-genomic datasets, which provide additional valuable inputs to develop and enhance our solutions, with the ultimate goal of contributing to improved patient results. We believe this continuing cycle will deepen our competitive advantage and allow us to achieve meaningful innovation and business success in precision oncology, while illuminating a path to precision medicine for other chronic disease states, including cardiology, neurology, and metabolic conditions. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:18pt;margin-left:12pt;width:456pt;">
          <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
            <img src="pc_platform-4c.jpg" alt="[MISSING IMAGE: pc_platform-4c.jpg]" height="451" width="602" >
          </div>
          <div style="text-indent:36pt; margin-top:13.2pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We believe our growth and competitive differentiation are driven by the five pillars of our platform, each of which are both a product of the upstream data and a foundation to further innovation and data generation across the platform: </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Assure.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our universal blood-based WES/WTS profiling solution is designed to deploy a single assay across the entire continuum of cancer care, including early detection, MRD tracking, therapy selection, and treatment monitoring, and generates over 42&#160;billion datapoints, spanning 168,000 molecular markers, per clinical case. We leveraged our experience and data from MI Profile to create Caris Assure, which enables us to understand how a patient&#8217;s disease started, what therapies the tumor may be sensitive to, how the tumor is transforming to resist therapies, and how best to control or cure the disease. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">MI Profile.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our tissue-based profiling solution for therapy selection includes MI Cancer Seek, our FDA-approved companion diagnostic WES/WTS profiling assay, and IHC protein expression testing. Our WES/WTS profiling solution generates over 28.8&#160;billion datapoints, spanning 84,000 molecular markers, per clinical case. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Discovery.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The combination of our data and our AI enables us to discover previously unknown drug targets for antibody-directed therapies (such as antibody drug conjugates, degrader-antibody conjugates, and T-cell engagers), small molecules, targeted protein degradation, synthetic lethal interactions, and cell therapy. In addition, we believe Caris Discovery is well-positioned for neoantigen discovery for personalized therapy development given our ability to detect variants, insertions, and deletions by WES and to assess gene expression and detect fusions by WTS on every patient&#8217;s tumor. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Strategic Data.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of March 31, 2025, we have run more than 6.5&#160;million tests that have measured over 38&#160;billion molecular markers from over 13 quadrillion datapoints. To assist us with analyzing the data we generate, we utilize over 220 AI and AI/ML tools across our </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:56pt; width:400pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">clinical testing, R&amp;D, and biopharma business. These tools include over 50 clinical sequencing automation and variant calling AIs, over 100 RNA expression AI signatures, approximately 20 multi-omic AI/ML therapy response predictors, two ADAPT target discovery AI/ML algorithms, 37 digital image AI/ML classifiers, and 12 AI/ML support tools. The breadth and depth of our data assets, along with our ability to create algorithms and discover signatures, represent a deep competitive moat for us. </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Infrastructure.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We have a well-developed laboratory, R&amp;D, and sales infrastructure that we believe is foundational to our business. Our infrastructure includes substantial testing capacity and a dedicated workforce to support our R&amp;D efforts, sales activity, and expansion. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Market Opportunity and Vision for Leveraging Molecular Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We believe we are well-positioned to initially pursue a total addressable market in U.S. oncology of approximately $150&#160;billion through the provision of precision medicine solutions across the entire cancer care continuum, as well as offerings to support biopharma drug discovery and development. While our tissue-based molecular profiling solution for cancer therapy has generated the majority of our revenue to date, we believe the launch of our blood-based profiling offering for therapy selection, our expansion of our blood-based profiling offering beyond therapy selection in particular, and further leveraging our platform to provide solutions to biopharma companies will enable us to benefit significantly from this large market opportunity. Our estimated total addressable U.S. oncology market, which is based on a market study by Nephron Research LLC that we commissioned, is comprised of opportunities in the following areas: </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Early detection:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;approximately $100&#160;billion. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Therapy selection:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;approximately $8&#160;billion. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">MRD tracking and treatment monitoring:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;approximately $28&#160;billion. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Core biopharma services:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;approximately $4&#160;billion. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Data services for biopharma:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;approximately $10&#160;billion. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We also believe there is a large market opportunity for our platform in other chronic disease states beyond oncology, including cardiology, neurology, and metabolic conditions, based on the fundamental premise that approaching blood-based disease detection with a comprehensive WES/WTS approach enables examination of biomarkers that go beyond oncology. For additional information, see &#8220;Business&#8212;Our Market Opportunity and Vision for Leveraging Molecular Information.&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Caris Advantage</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We believe our approach is differentiated and we have a competitive advantage because: </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">We purpose-built our Caris platform to put the patient first and make comprehensive precision medicine a reality.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">We are a leading provider of tissue-based molecular profiling, including through our FDA-approved companion diagnostic tissue-based profiling solution, MI Cancer Seek.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Our novel, universal blood-based profiling solution, Caris Assure, is unique in the market and poised for rapid adoption.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">We have built what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Our first mover advantage, specialized commercial channel, robust infrastructure, and deep research collaborations enable our leadership and provide us with the ability to scale for future growth.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">We are led by a founder with significant experience building and scaling businesses in the healthcare industry and a management team with scientific expertise.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Strategies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">To achieve our goal of leading a molecular revolution and developing the next generation of precision medicine information solutions for a broad range of conditions across the care continuum, we plan to: </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Drive the continued adoption and use of our tissue-based profiling and expand blood-based profiling offering into early detection, MRD, and monitoring.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Utilize the data generated by our existing solutions to develop new solutions with additional revenue using our existing sales channel.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Leverage our platform to provide solutions to biopharma companies to drive advances in personalized medicine and accelerate the development of novel therapeutics.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Continue to expand and enrich our clinico-genomic datasets to drive breakthrough science and develop new solutions.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Maximize market reach through our regulatory approval and reimbursement strategy.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;font-style:italic;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Capitalize on the ultimate potential of our novel, universal blood-based profiling solution, Caris Assure, and broader innovation platform in other chronic disease states beyond oncology, including in cardiology, neurology, and metabolic conditions.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Caris Assure&#8212;Our Universal Blood-Based Profiling Solution</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Caris Assure is our novel, universal blood-based solution that is purpose-built to extend across the entire continuum of cancer treatment, including early detection, monitoring of MRD and recurrent cancers, and precision selection of molecularly targeted therapies. Caris Assure also has applications in therapeutic discovery and development. We believe Caris Assure represents the most comprehensive blood-based solution on the market, featuring over 23,000 gene coverage at a raw average sequencing depth of coverage of 8,000 times for clinically relevant genes, as compared to other blood-based offerings in the market that only assess 500 to 1,000 genes from DNA. Caris Assure performs WES and WTS for every eligible patient blood sample. We integrate WES and WTS with sophisticated AI and ML technologies to offer diagnostic, prognostic, and predictive utility in a single test. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">For therapy selection, in addition to sequencing cell-free DNA and cell-free RNA isolated from the plasma to identify somatic tumor variants, Caris Assure also sequences genomic nucleic acid (gDNA and gRNA) isolated from the white blood cells, or buffy coat, from each sample. Sequencing the buffy coat in addition to the plasma allows Caris Assure to identify incidental germline mutations as well as CH mutations. CH mutations are age-related non-malignant mutations that occur in a substantial portion of the population, are not cancer-derived and are present in both the plasma and buffy coat and cannot be identified from sequencing plasma alone. Caris Assure &#8220;subtracts&#8221; CH mutations in the reporting of somatic tumor variants. This lessens the risk of incorrectly interpreting CH or germline mutations as tumor-derived and results in fewer false positive diagnoses and more accurate and effective treatment recommendations. We believe that CH subtraction is of critical importance to ensure optimal cancer care because of the prevalence of CH mutations. By identifying and distinguishing variants that are not from the tumor itself and, therefore not relevant to therapeutic decision-making, the CH subtraction feature of Caris Assure further separates our solution from other liquid biopsy tests currently on the market that do not sequence the white blood cells and therefore cannot definitively distinguish CH mutations from tumor-derived mutations. To our knowledge, Caris Assure is the only commercially available tissue-naive blood-based profiling assay that directly accounts for CH mutations instead of using algorithmic approximations, which we believe gives Caris Assure a differentiated ability to drive improved therapy selection. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Customers for Caris Assure include treating physicians as well as researchers and biopharma companies. The same benefits that blood-based WES, WTS, and CH subtraction bring to patients in the clinical setting also offer significant and previously unavailable advantages to biopharma companies. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We initiated a broad commercial launch of Caris Assure for therapy selection in the first quarter of 2024 and currently offer the solution as a laboratory developed test (&#8220;LDT&#8221;), which the FDA has historically considered a form of medical device, as an </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> diagnostic (&#8220;IVD&#8221;) test intended for clinical use and </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">designed, manufactured, and used within a single laboratory. The FDA has historically exercised enforcement discretion and not required marketing authorization for certain kinds of LDTs. Accordingly, we have not obtained FDA marketing authorization for Caris Assure. We may decide to seek FDA marketing authorization&#160;for certain of our solutions in the future, including Caris Assure for therapy selection, depending in part on the ultimate outcome of litigation over the FDA&#8217;s authority over LDTs. For additional information, see &#8220;Business&#8212;Government Regulation&#8212;U.S. Food and Drug Administration&#8221; and &#8220;Risk Factors&#8212;We have current solutions marketed as LDTs and plan to launch future solutions as LDTs. The regulation of LDT products in the United States remains subject to significant uncertainty, and if we fail to comply with any new or existing legal requirements governing our LDT solutions, our business, financial condition, and results of operations could be adversely affected.&#8221; We have Medicare reimbursement and various levels of commercial payer adoption and/or reimbursement coverage for Caris Assure for therapy selection across the United States. The current pricing of Caris Assure for therapy selection under Medicare&#8217;s Molecular Diagnostic Services Program (&#8220;MolDX&#8221;) is $3,649. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Caris Assure for therapy selection is available in all U.S. states (other than New York, where we intend to apply in 2025 for approval from New York State&#8217;s Clinical Laboratory Evaluation Program (&#8220;NY CLEP&#8221;)) and in Puerto Rico. We also offer Caris Assure for therapy selection internationally through distributors and direct contracts with hospital systems, where permitted by applicable regulations. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Differentiated Approach to Address the Entire Cancer Care Continuum Through a Single Blood Test</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our universal approach to blood-based profiling is unique. Liquid biopsies can be used across the care continuum, including for: therapy selection in the advanced/metastatic setting; MRD and monitoring in the curative/adjuvant setting; and early detection in the diagnosis setting. Because many of our competitors&#8217; liquid biopsy assays are designed to address only a single portion of this care continuum, in order to develop products for other portions of the care continuum, our competitors must invest in the development of new wet lab assays and generate disparate datasets across the patient journey for patients, oncologists, and researchers. In contrast, Caris Assure is designed as a single test applicable across the entire patient journey. To our knowledge, there is no other assay on the market that can be applied as broadly as Caris Assure. We believe that our approach will enable us to scale our R&amp;D infrastructure to analyze increasingly larger testing volumes, process expanding datasets, and reach economies of scale in liquid biopsy across the entire cancer care continuum. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We believe that one of the most promising uses for Caris Assure is for detection of cancer at very early stages, such as stage 1 or stage 2. Our detection of cancer at very early stages would enable clinicians to treat disease sooner, which could significantly improve patient outcomes. We believe that Caris Assure for early detection of cancers will initially be available for early detection of certain types of cancers, such as breast cancer and colon cancer, and then we intend to expand Caris Assure for full MCED indications. In an internal validation study conducted by us, the performance of our Assure Blood-based Cancer Detection ai (&#8220;ABCDai&#8221;) for MCED (&#8220;ABCDai-MCED&#8221;) demonstrated a high level of sensitivity at a specificity that reduces the burden of false positives. For additional information on the validation study, see &#8220;Business&#8212;</font>&#8203;<font style="letter-spacing:0.2pt;">Our Solutions&#8212;Caris Assure&#8212;Our Universal Blood-Based Profiling Solution&#8212;Caris Assure for Early Detection.&#8221;</font></div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">For MRD, our detection methodology based on ABCDai takes a tumor na&#239;ve approach, and therefore does not require a bespoke panel to be created to track the recurrence of a patient&#8217;s tumor. This approach means that our MRD assay can be used without the need for a tissue sample and enables faster turn-around-time, enabling patients to be informed of additional therapy sooner to combat their disease.</font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">MI Profile&#8212;Our Tissue-Based Profiling Solution</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">MI Profile is our tissue-based molecular profiling solution for cancer therapy selection, with over one&#160;million tests performed on approximately 146,500 clinical cases in 2024 and an additional approximately 40,000 clinical cases in the three months ended March 31, 2025. As of March 31, 2025, we have performed over 6.5 million tissue-based tests on over 790,000 clinical cases since inception. MI Profile includes MI Cancer Seek, our FDA-approved companion diagnostic WES/WTS NGS assay, and IHC protein expression testing. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-indent:36pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Customers for MI Profile include treating physicians as well as researchers and biopharma companies. The information generated from profiling the patient&#8217;s tissue is used to create an interpretative report based on our bioinformatics pipeline and recommend individualized therapies for cancer patients. Our goal is to maximize the information generated and corresponding clinical utility for patients from the limited available tumor tissue. Molecular profiling also has broad applications for our biopharma partners, including prospective screening, retrospective testing and deep translational analyses, stratification of patients for existing or future trials, and treatment monitoring. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have obtained Medicare and commercial reimbursement for MI Profile. We have also obtained a premarket approval (&#8220;PMA&#8221;) from the FDA for a companion diagnostic and tumor profiling designation for MI Cancer Seek, a WES/WTS NGS assay that uses the whole exome for tumor mutational burden (&#8220;TMB&#8221;) calling, and for which we have obtained a Proprietary Laboratory Analyses (&#8220;PLA&#8221;) code, Current Procedural Terminology (&#8216;&#8216;CPT&#8217;&#8217;) code 0211U, at a reimbursement rate of $8,455. In the first quarter of 2025, we began to market MI Cancer Seek as the WES/WTS NGS component of MI Profile. We have obtained Medicare coverage for MI Cancer Seek for CPT code 0211U under the NGS NCD. We currently offer MI Tumor Seek Hybrid, which is a WES/WTS NGS LDT assay, as an alternative assay if a specimen does not meet the eligibility requirements for MI Cancer Seek. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">MI Profile, including our MI Cancer Seek assay and proprietary clinical molecular signatures GPSai and FOLFIRSTai, is available in all U.S. states and in Puerto Rico. We also offer MI Profile internationally in over 40 countries through distributors and direct contracts with hospital systems, where permitted by applicable regulations. </font>
          </div>
          <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
            <img src="fc_clinicalmole-4c.jpg" alt="[MISSING IMAGE: fc_clinicalmole-4c.jpg]" height="453" width="603" >
          </div>
          <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Caris Discovery</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Caris Discovery is our drug target and therapeutic discovery business. Caris Discovery leverages our profiling solutions, multi-modal clinico-genomic datasets, wet lab facilities, proprietary Adaptive </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Dynamic Artificial Polyligand Targeting (&#8220;ADAPT&#8221;) platform, and AI/ML-enabled </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> analyses to identify potential drug targets and develop therapeutics. We launched Caris Discovery in 2022 to partner with biopharma partners to address the lack of novel cancer-specific targets and the herding of biopharma pipelines around a discrete number of lower-risk targets. Caris Discovery is disease- and modality-agnostic and can be applied to any therapeutic modality, including antibody-directed therapies (such as antibody drug conjugates, degrader-antibody conjugates, and T-cell engagers), small molecules, targeted protein degradation, synthetic lethal interactions, and cell therapy. We have achieved external validation of our Caris Discovery approach through strategic partnerships with established biopharma companies, such as Merck KGaA and Xencor, to develop therapeutics against novel targets that emanate from our molecular insights and proprietary technology. In addition, we believe Caris Discovery is well-positioned for neoantigen discovery for personalized therapy development given our ability to detect variants, insertions, and deletions by WES and to assess gene expression and detect fusions by WTS on every patient&#8217;s tumor. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our proprietary repositories of tissue and data, each of which we believe to be at an unmatched scale, are a resource that could not have been amassed without our underlying commercial profiling business, and as such are a significant differentiator and enabler of our discovery efforts. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Caris Strategic Data</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Data and molecular information are at the core of every aspect of our business. Our team of more than 60 data scientists deploy our proprietary advanced AI/ML algorithms to decipher unique features from our resulting clinico-genomic datasets, helping us decode and further unravel the molecular complexity of disease. Our 17-year history of utilizing AI and ML algorithms, together with the breadth and depth of our clinico-genomic datasets, provide us a significant advantage in sophisticated analysis of cancer, and a foundation that we believe will have applications in additional disease states. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The tremendous amount of data generated through our profiling solutions, which we have deidentified for research use, provides us a differentiated capability to advance precision oncology research through many business models. For example, we launched our data licensing business in late 2022, through which we license deidentified data that we have generated from our clinical profiling business to biopharma companies with the aim of generating insights directly responsible for superior clinical outcomes for patients. We have a rich pipeline of data opportunities that we believe will deliver new partnerships, as we continue to introduce biopharma companies to this unique data offering. Additionally, through the Caris POA, which is a growing network of leading cancer centers and research consortia across the globe, we support research partner engagement, collaboration opportunities, and the advancement of precision oncology research. Since its establishment in 2015, the Caris POA has grown to comprise 96 members as of March 31, 2025, including 45 NCI-designated comprehensive cancer centers that work collaboratively toward a common goal: to advance tumor profiling and establish and optimize standards of care for molecular testing through innovative research to improve clinical outcomes for cancer patients. We estimate that the members of the Caris POA have over 3,000 oncologists in over 650 locations that treat more than 650,000 new cancer patients annually.</font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Future Assays</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Caris aims to develop the next generation of precision medicine tools that will allow us to transition from intuitive medicine to empirical medicine. As a leader in the transition to WES/WTS sequencing through our launch of a WTS solution in 2019 and a WES solution the following year, we believe we have more molecular data and information than any other company and are well-positioned to make precision medicine widely accessible. For example, we are developing Caris ChromoSeq, an assay to detect and analyze hematological (blood) cancers using whole genome sequencing (&#8220;WGS&#8221;) and WTS. We are internally validating this assay and developing it for commercial launch. We are also working to develop and validate the plasma portion of our Caris Assure assay for full germline testing. Additionally, we are using our molecular data to develop ESPai, an AI/ML algorithm to predict the risk of recurrence of early-stage breast cancer. We have obtained the samples and clinical data from the National Surgical Adjuvant Breast and Bowel Project and the ECOG-ACRIN Cancer Research Group. We are currently in the process of creating two AI/ML&#160;models for ESPai using these samples and are working to obtain additional samples for external </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">validation studies. We are initially creating a model for late recurrence (five to 15 years following diagnosis), but we are also in the beginning stages of creating a model for early recurrence (zero to five years following diagnosis).</font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Caris Infrastructure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We believe our well-developed laboratory, R&amp;D, and sales infrastructure is foundational to our business. We have substantial testing capacity, including over 275,000 square feet of space across four precision medicine laboratories with throughput capabilities of over one trillion reads per day generated by 50 NovaSeq sequencing systems. We believe this capacity provides us with ample capability to manage our current operations and future growth. We also have a dedicated R&amp;D infrastructure, including a specialized laboratory and over 200 employees dedicated to R&amp;D efforts. In addition to our internal research, we regularly partner with outside academic centers and researchers, including through the Caris POA. Additionally, to support our sales activity and expansion, as of March 31, 2025, we have assembled a targeted sales organization in the United States of over 270 sales team members and nearly 50 highly trained Ph.D. or M.D. molecular science liaisons (&#8220;MSLs&#8221;) who focus on physician and provider education. We believe that our robust, foundational infrastructure, together with our expansive multi-modal clinico-genomic datasets, has uniquely positioned Caris to deliver transformative and advanced innovations in precision medicine and patient care into the future. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Summary Risk Factors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Participating in this offering involves substantial risk. Our ability to execute our strategy is also subject to certain risks. The risks described under the heading &#8220;Risk Factors&#8221; included elsewhere in this prospectus may cause us not to realize the full benefits of our strengths or may cause us to be unable to successfully execute all or part of our strategy. Some of the most significant challenges and risks we face include the following: </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The precision medicine industry is highly competitive and subject to rapid change. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We have incurred significant losses since inception, expect to incur losses in the future, and may not be able to generate sufficient revenue to achieve and maintain profitability. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our current or future solutions may not achieve or maintain sufficient commercial market acceptance. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our solutions may not perform as expected, and the results of our validation studies or our clinical trials may not support the launch or use of our solutions and may not comply with the requirements, or be replicated in later trials required, for any necessary or desirable marketing authorizations. This could adversely affect our business, financial condition, results of operations, and growth prospects. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our current revenue is primarily generated from the continued adoption and use of our tissue-based profiling solution. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our future success and growth will depend in part on market acceptance and commercial success of our MI Cancer Seek and Caris Assure solutions. We may be unsuccessful in continuing the commercialization of MI Cancer Seek or Caris Assure, which would adversely affect our business, financial condition, results of operations, and growth prospects. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If we are unable to support demand for MI Profile, Caris Assure, and any other solutions we develop, including ensuring that we have adequate capacity to meet increased demand, or if we are unable to successfully manage our anticipated growth, our business could suffer. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our results of operations may fluctuate significantly, which makes our future results of operations difficult to predict and could cause our results of operations to fall below expectations or any guidance we may provide. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If our solutions, or solutions we develop in the future, do not receive adequate coverage and reimbursement from third-party payers, including government and commercial payers, our </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:56pt; width:400pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">ability to expand access to our solutions beyond our existing sales channels, and thus our overall commercial success, will be limited. </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our billing, collections, and claims processing activities are complex and time-consuming, and any delay in transmitting and collecting claims or failure to comply with applicable billing requirements could have an adverse effect on our future revenue. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We rely on a limited number of third-party suppliers or, in many cases, sole suppliers, for some of our next-generation sequencers, lab materials, reagents, and supplies, and we may not be able to find replacements or immediately transition to alternative suppliers if necessary. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If we or our partners fail to comply with healthcare and other applicable laws and regulations, we could face substantial penalties and sanctions and our business, reputation, financial condition, and results of operations could be adversely affected. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If we are unable to obtain and maintain intellectual property protection for our technology, or if the scope of the intellectual property protection we obtain is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to our solutions, and our ability to successfully commercialize our solutions may be impaired. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We have incurred substantial indebtedness, and we may not generate sufficient cash flow from operations to meet our debt service requirements, continue our operations, and pursue our growth strategy, and we may be unable to raise capital when needed or on acceptable terms. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">After this offering, our executive officers, directors, and principal shareholders, including, in particular, David D. Halbert, our Founder, Chairman, and Chief Executive Officer, will continue to have the ability to control or significantly influence matters submitted to shareholders for approval, which could limit the ability of our other shareholders to affect the outcome of key corporate decisions and transactions, including a change of control. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Before you invest in our common stock, you should carefully consider all the information in this prospectus, including matters set forth in the section titled &#8220;Risk Factors.&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Corporate Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We were founded in 2008 when we entered the field of precision oncology through our acquisition of Molecular Profiling Institute, a Delaware-incorporated molecular life sciences company. We were incorporated under the laws of the Cayman Islands in October&#160;2011 as Caris Life Sciences, Ltd. and in July&#160;2020, we changed our name to Caris Life Sciences, Inc. and re-domiciled to be incorporated in Texas. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our principal executive offices are located at 750 West John Carpenter Freeway, Suite 800, Irving, Texas 75039, and our telephone number is (866) 771-8946. Our website address is </font><font style="font-style:italic;letter-spacing:0.2pt;">www.carislifesciences.com</font><font style="letter-spacing:0.2pt;">. The information on, or that can be accessed through, our website is not incorporated into this prospectus. You should not consider information contained on our website to be part of this prospectus in deciding whether to purchase shares of our common stock. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Implications of Being an Emerging Growth Company</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We qualify as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;). We will remain an emerging growth company until the earliest to occur of: (i)&#160;the last day of the fiscal year in which we have at least $1.235&#160;billion in total annual gross revenue; (ii)&#160;the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which would occur if the market value of our common stock held by non-affiliates exceeded $700&#160;million as of the last business day of the second fiscal quarter of such year; (iii)&#160;the date on which we have issued more than $1.0&#160;billion in non-convertible debt securities during the prior three-year period; and (iv)&#160;the last day of the fiscal year ending after the fifth anniversary of the date of the completion of this offering. An emerging growth company may take advantage of specified reduced reporting requirements and is relieved of certain other significant requirements that are otherwise generally applicable to public companies. As an emerging growth company: </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">we will present in this prospectus only two&#160;years of audited financial statements, plus any required unaudited financial statements, and related management&#8217;s discussion and analysis of financial condition and results of operations; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">we will avail ourselves of the exemption from the requirement to obtain an attestation and report from our auditors on the assessment of our internal control over financial reporting pursuant to Section&#160;404 of the Sarbanes-Oxley Act of 2002 (&#8220;SOX Section&#160;404&#8221;); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">we will provide less extensive disclosure about our executive compensation arrangements; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">we will not be required to hold shareholder non-binding advisory votes on executive compensation or golden parachute arrangements. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Accordingly, the information contained herein may be different than the information you receive from our competitors that are public companies or other public companies in which you hold stock. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In addition, the JOBS Act provides that an emerging growth company can delay the adoption of new or revised accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this extended transition period for complying with new or revised accounting standards and, as a result, our results of operations and financial statements may not be comparable to those of companies that have adopted the new or revised accounting standards. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">THE OFFERING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Common stock offered by us </font>
            </div>
          </div>
          <div style="margin-left:192pt; margin-top:-12pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">23,529,412 shares. </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Option to purchase additional shares of common stock </font>
            </div>
          </div>
          <div style="margin-left:192pt; margin-top:-12pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have granted the underwriters an option for a period of 30&#160;days to purchase up to 3,529,411 additional shares of our common stock. </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Common stock to be outstanding immediately after this offering </font>
            </div>
          </div>
          <div style="margin-left:192pt; margin-top:-12pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">277,932,779 shares (or 281,462,190 shares if the underwriters exercise their option to purchase additional shares of common stock in full). </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Reserved share program </font>
            </div>
          </div>
          <div style="margin-left:192pt; margin-top:-12pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">At our request, the underwriters have reserved up to 5% of the shares of common stock offered by this prospectus, excluding the additional shares that the underwriters have a 30-day option to purchase, for sale, at the initial public offering price, to certain individuals identified by management, including certain of our directors, officers, employees and certain other parties related to us. If these persons purchase reserved shares it will reduce the number of shares of common stock available for sale to the general public. Any reserved shares of common stock that are not so purchased will be offered by the underwriters to the general public on the same terms as the other shares of common stock offered by this prospectus. For more information, see &#8220;Underwriting&#8212;</font>&#8203;<font style="letter-spacing:0.2pt;">Reserved Share Program.&#8221; </font></div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Use of proceeds </font>
            </div>
          </div>
          <div style="margin-left:192pt; margin-top:-12pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We estimate that the net proceeds from this offering will be approximately $452.1 million (or $521.1 million if the underwriters exercise their option to purchase additional shares of common stock in full), based on the initial public offering price of $21.00 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</font>
          </div>
          <div style="margin-left:192pt; margin-top:8pt; width:264pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">We intend to use the net proceeds from this offering for general corporate purposes, including working capital, operating expenses, and capital expenditures. We also intend to use approximately $6.2 million of the net proceeds to satisfy our anticipated tax withholding and remittance obligations related to the RSU Net Settlement (as defined below). We will have broad discretion in the way that we use the net proceeds from this offering. See the section titled &#8220;Use of Proceeds&#8221; for additional information. </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Indication of interest </font>
            </div>
          </div>
          <div style="margin-left:192pt; margin-top:-12pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Neuberger Berman has indicated an interest in purchasing up to $75.0 million of shares of our common stock being offered in this offering at the initial public offering price and on the same terms as the other purchasers in this offering. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters could determine to sell more, fewer, or no shares to Neuberger Berman, and Neuberger Berman could determine to purchase more, fewer, or no shares in this offering. The underwriters will receive the same underwriting discounts and commissions on any of our shares of common stock purchased by Neuberger </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:6.5pt; margin-left:12pt;width:456pt;">
          <div style="margin-left:192pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Berman as they will from any other shares of common stock sold to the public in this offering. </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Risk factors </font>
            </div>
          </div>
          <div style="margin-left:192pt; margin-top:-12pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">See the section titled &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">21</a> and the other information included in this prospectus for a discussion of factors you should consider carefully before deciding to invest in our common stock. </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Nasdaq trading symbol </font>
            </div>
          </div>
          <div style="margin-left:192pt; margin-top:-12pt; width:264pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;CAI&#8221;</font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The number of shares of our common stock to be outstanding after this offering is based on 254,403,367 shares of our common stock outstanding as of March&#160;31, 2025, after giving effect to (i) the Warrant Net Exercises, (ii) the Series E and F Issuance, (iii) the Preferred Stock Conversion, (iv) the issuance of the 2025 Convertible Notes and the related Notes Conversion, and (v) the RSU Net Settlement (each as defined below), and excludes: </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">24,113,482 shares of our common stock issuable upon the exercise of options outstanding under our 2020 Incentive Plan, as amended and restated (the &#8220;2020 Plan&#8221;), as of March&#160;31, 2025, at a weighted-average exercise price of $10.18 per share; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">249,999 shares of our common stock issuable upon the exercise of options granted under our 2020 Plan subsequent to March 31, 2025, at an exercise price per share equal to the initial public offering price; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">236,290 shares of our common stock issuable upon the vesting and settlement of restricted stock units (&#8220;RSUs&#8221;) outstanding under our 2020 Plan as of March 31, 2025 that are subject to vesting conditions that are not satisfied in connection with this offering; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">15,125,002 shares of our common stock reserved for future issuance under our 2025 Incentive Award Plan (the &#8220;2025 Plan&#8221;), based on the initial public offering price of $21.00 per share, which 2025 Plan will become effective in connection with this offering, as well as shares of our common stock that may be issued pursuant to provisions of our 2025 Plan that automatically increase the share reserve under our 2025 Plan (see the section titled &#8220;Executive Compensation&#8221; for additional information); and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">2,571,250 shares of our common stock reserved for future issuance under our 2025 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), based on the initial public offering price of $21.00 per share, which ESPP will become effective in connection with this offering, as well as shares of our common stock that may be issued pursuant to provisions in our ESPP that automatically increase the share reserve under our ESPP. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Unless otherwise indicated, all information in this prospectus assumes:</font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">a one-for-four reverse stock split of our common stock effected as of June&#160;1, 2025; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the net issuance of 16,699,621 shares of our Series&#160;C preferred stock upon the cashless exercise, based on the initial public offering price of $21.00 per share, of warrants outstanding as of March&#160;31, 2025 at a weighted-average exercise price of $1.76 per share, which warrants are exercisable to purchase, at the holder&#8217;s election, shares of either our common stock or our Series&#160;C preferred stock and would have expired upon the completion of this offering unless earlier exercised (the &#8220;Series C Warrant Net Exercise&#8221;); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the net issuance of 784,231 shares of our common stock issuable upon the cashless exercise of warrants issued in April 2025 at an exercise price of $0.04 per share (the &#8220;2025 Warrants&#8221;), based on the initial public offering price of $21.00 per share (the &#8220;2025 Warrant Net Exercise&#8221; and together with the Series C Warrant Net Exercise, the &#8220;Warrant Net Exercises&#8221;); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the conversion of (i) all shares of our convertible preferred stock outstanding as of March&#160;31, 2025 (including the 16,699,621 shares of Series&#160;C preferred stock issued upon the Series C Warrant Net Exercise) and (ii) all shares of our Series E and Series F convertible preferred stock issued and sold in April 2025 (such issuance and sale, the &#8220;Series E and F Issuance&#8221;), into an </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:56pt; width:400pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">aggregate of 215,553,545 shares of our common stock, based on the initial public offering price of $21.00 per share, which conversion will occur immediately prior to and in connection with the completion of this offering (the &#8220;Preferred Stock Conversion&#8221;); </font>
          </div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the issuance of 2,076,596 shares of our common stock upon the conversion of senior convertible notes issued by us in April 2025 (the &#8220;2025 Convertible Notes&#8221;), based on the initial public offering price of $21.00 per share, which conversion will occur immediately prior to and in connection with the completion of this offering (the &#8220;Notes Conversion&#8221;); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the net issuance of 751,464 shares of our common stock underlying RSUs outstanding under our 2020 Plan that will vest in connection with this offering, after giving effect to the withholding of 296,786 shares of our common stock to satisfy the estimated tax withholding and remittance obligations (based on an assumed tax withholding rate of 28.3%) (the &#8220;RSU Net Settlement&#8221;); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the effectiveness of our amended and restated certificate of formation and the adoption of our amended and restated bylaws, each of which will occur immediately prior to the completion of this offering; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">no exercise by the underwriters of their option to purchase additional shares of common stock; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">no exercise of outstanding options or settlement of outstanding RSUs except as described above. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The assumed 28.3% tax withholding rate applicable to the RSU Net Settlement used in this prospectus is an estimated blended withholding rate for all of the RSUs that will vest in connection with this offering. The estimates in this prospectus relating to the RSU Net Settlement and related share withholding may differ from actual results due to, among other things, actual forfeitures through the date of this prospectus and actual tax withholding rates. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:26pt; margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">SUMMARY CONSOLIDATED FINANCIAL AND OTHER DATA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following tables set forth a summary of our historical consolidated financial and other data as of, and for the periods ended on, the dates indicated. The summary consolidated statements of operations data for the&#160;years ended December&#160;31, 2024 and 2023 and the summary consolidated balance sheet data as of December&#160;31, 2024 are derived from our audited consolidated financial statements and related notes included elsewhere in this prospectus. The summary consolidated statements of operations data for the three months ended March 31, 2025 and 2024 and the summary consolidated balance sheet data as of March&#160;31, 2025 are derived from our unaudited condensed consolidated financial statements and related notes included elsewhere in this prospectus. In our opinion, the unaudited interim financial statements have been prepared on a basis consistent with our audited financial statements and contain all adjustments, consisting only of normal and recurring adjustments, necessary for a fair presentation of such interim financial statements. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our historical results are not necessarily indicative of results that may be expected in the future. You should read these data together with our financial statements and related notes appearing elsewhere in this prospectus and the information in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; </font>
          </div>
          <table style="width:456pt;height:420pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:224.34pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Three Months Ended March 31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:224.34pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2025</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2024</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:224.34pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:2.083pt 0pt 1.667pt 0pt; width:0pt;text-align:center;" colspan="22">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in&#160;thousands, except share and </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">per share data) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Consolidated Statements of Operations Data</font><font style="font-weight:normal;letter-spacing:0.2pt;">:</font>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">Revenue:</font>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">114,081</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">73,233</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">349,115</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">278,748</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">6,834</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">7,444</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">63,145</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">27,380</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:20pt;">
                  <font style="letter-spacing:0.2pt;">Total revenue </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">120,915</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">80,677</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">412,260</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">306,128</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">Costs and operating expenses: </font>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td colspan="6">&#8203;</td>
              <td colspan="6">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Cost of services&#8211;Molecular profiling services </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">60,894</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,894</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">223,075</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">207,509</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.667pt 0pt 0.5pt 0pt; width:224.34pt;white-space:normal;text-align:left;">
                <div style="margin-left:20pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Cost of services&#8211;Pharma research and development services </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,958</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,669</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10,403</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">9,309</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">39,829</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">39,609</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">152,602</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">142,925</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">General and administrative expense </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,119</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">44,354</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">169,386</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">149,053</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Research and development expense </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">23,066</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">34,376</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">113,916</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">116,883</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:20pt;font-weight:normal;">
                  <font style="letter-spacing:0.2pt;">Total costs and operating expenses </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">178,867</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">172,902</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">669,382</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">625,679</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Loss from operations </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(57,952<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(92,225<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(257,122<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(319,551<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">Other income (expense), net: </font>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td colspan="6">&#8203;</td>
              <td colspan="6">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Interest income </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">503</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,768</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,122</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,258</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Interest expense </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(12,782<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(9,290<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(50,025<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(31,610<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(32,333<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(11,064<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">18,484</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,094</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Other expense, net </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(17<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(219<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(349<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(12,606<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:20pt;">
                  <font style="letter-spacing:0.2pt;">Total other expense, net </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(44,629<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(18,804<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(24,768<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(21,864<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.417pt 0pt 0.5pt 0pt; width:224.34pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Loss before income taxes and provision for income taxes </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(102,581<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(111,028<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(281,890<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:1.417pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(341,415<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:224.34pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Provision for income taxes </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">&#8212;</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">&#8212;</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">&#8212;</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">&#8212;</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 2.75pt 0pt; width:224.34pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:normal;">
                  <font style="letter-spacing:0.2pt;">Net loss </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:0.917pt 0pt 1.333pt 0pt; width:224.34pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Adjustments of redeemable convertible preferred stock to redemption value </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(24,262<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(23.113<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(96,367<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(121,112<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 2.75pt 0pt; width:224.34pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:normal;">
                  <font style="letter-spacing:0.2pt;">Net loss attributable to common shareholders </font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(127,043<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(134,141<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(378,257<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(462,527<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:6.99000000000001pt; margin-left:12pt;width:456pt;">
          <table style="width:456pt;height:176.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:224.34pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Three Months Ended March 31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:224.34pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2025</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2024</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:224.34pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:2.083pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="22">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in&#160;thousands, except share and </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">per share data) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.417pt 0pt 2.083pt 0pt; width:224.34pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Net loss per share attributable to common shareholders, basic and diluted</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">(3.57<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(3.80<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">(10.66<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(13.24<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.917pt 0pt 2.083pt 0pt; width:224.34pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted-average shares used to compute net loss per share attributable to common shareholders, basic and diluted</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">35,623,042</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">35,313,037</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">35,496,832</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">34,942,691</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.917pt 0pt 2.083pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma net loss per share attributable to common </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">shareholders, basic and diluted (unaudited)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(1)(2)</font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">(0.40<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">(2.70<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.917pt 0pt 2.083pt 0pt; width:224.34pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted-average shares used to compute pro&#160;forma </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">net loss per share attributable to common </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">shareholders, basic and diluted (unaudited)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(1)(2)</font>
                </div>
              </td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">254,788,878</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.917pt 0pt 1.333pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">254,662,668</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt; width:2.5pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="height:4.5pt;line-height:4.5pt;">
              <td style="padding:0pt;font-size:0pt;line-height:0pt;" colspan="26">&#8203;</td>
            </tr>
          </table>
          <div style="margin-top:9.9pt; width:456pt;">
            <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
          </div>
          <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
            <font style="letter-spacing:0.18pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.18pt;">See Note 12 to our consolidated financial statements included elsewhere in this prospectus for an explanation of the method used to calculate our historical basic and diluted net loss per share attributable to common shareholders and the weighted-average number of shares of common stock used in the computation of these per share amounts. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:11pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
            <font style="letter-spacing:0.18pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.18pt;">Gives effect to (i)&#160;the Warrant Net Exercises, (ii)&#160;the Series E and F Issuance, (iii) the Preferred Stock Conversion, (iv) the issuance of the 2025 Convertible Notes and the related Notes Conversion, (v) the RSU Net Settlement, and (vi) the reduction of the compound derivative liability bifurcated from the 2023 Term Loan. The following table sets forth the computation of our unaudited pro forma basic and diluted net loss per share, which does not include shares being offered in this offering: </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <table style="width:456pt;height:345.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:298.66pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">March&#160;31, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Year Ended </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">December&#160;31, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:298.66pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.583pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands, except share </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">and per share data) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:298.66pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Numerator:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Net loss attributable to common shareholders </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">(127,043<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">(378,257<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:298.66pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Pro forma adjustment related to deemed dividend from Series D redeemable convertible preferred stock from the triggering of conversion price adjustments</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(a)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">(384,436<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:298.66pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment to record stock-based compensation expense related to RSUs for which the performance-based vesting conditions will be satisfied in connection with this offering </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">(19,735<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Other miscellaneous pro&#160;forma adjustments</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(b)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">(1,295<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:298.66pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Pro forma adjustment to record the reduction of fair value of derivative liability associated with the 2023 Term Loan</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(c)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">17,451</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:298.66pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment to reverse the adjustments of Series&#160;C and D redeemable convertible preferred stock to redemption value </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">24,462</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">96,367</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:298.66pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Pro forma adjustment related to the reversal of the change in fair value of derivative liabilities </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">(11,393<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 0.5pt 0pt; width:298.66pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment related to the reversal of the change in fair value of warrant liabilities </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">(7,091<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma net loss </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">(688,388<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 0.5pt 0pt; width:298.66pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Denominator:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:298.66pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted-average shares used in computing net loss per share attributable to common shareholders, basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">35,623,042</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">35,496,832</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment to reflect the Preferred Stock Conversion </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">211,378,638 </td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">211,378,638 </td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <table style="width:456pt;height:144.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:298.66pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">March&#160;31, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Year Ended </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">December&#160;31, 2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:298.66pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.583pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands, except share </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">and per share data) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment to reflect the Series&#160;C Warrant Net Exercise </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">4,174,907 </td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">4,174,907 </td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro forma adjustment to reflect the 2025 Warrant Net Exercise </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">784,231 </td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">784,231 </td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment to reflect the Notes Conversion </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">2,076,596 </td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">2,076,596 </td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment to reflect the RSU Net Settlement </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">751,464</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">751,464</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.917pt 0pt 2.583pt 0pt; width:298.66pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted-average shares used in computing pro&#160;forma net loss per share, basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">254,788,878 </td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">254,662,668 </td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 3.25pt 0pt; width:298.66pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma net loss per share, basic and diluted</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">(0.40<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">(2.70<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="height:4pt;line-height:4pt;">
              <td style="padding:0pt;font-size:0pt;line-height:0pt;" colspan="14">&#8203;</td>
            </tr>
          </table>
          <div style="margin-top:10.4pt; width:456pt;">
            <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
          </div>
          <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(a)</font>
            <br >
          </div>
          <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Gives effect to conversion price adjustments for the Series D preferred stock based on the initial public offering price of $21.00 per share. The change in the fair value of the shares of preferred stock triggered by such conversion price adjustments is considered a deemed dividend and thus excluded from the computation of pro forma net loss per share attributable to common shareholders. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(b)</font>
            <br >
          </div>
          <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Gives effect to (i) the cash bonus payable upon a successful initial public offering, as further described in the section titled &#8220;Executive Compensation,&#8221; and (ii) expenses associated with the issuance of the 2025 Warrants. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.91pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(c)</font>
            <br >
          </div>
          <div style=" margin-top:3.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Gives effect to the reduction of the fair value of the compound derivative liability bifurcated from the 2023 Term Loan. The fair value is mainly driven by the prepayment amortization feature of the 2023 Term Loan, which, upon consummation of this offering, has a de minimis value. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <table style="width:456pt;height:149.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:274.14pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">As of March&#160;31, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:274.14pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Actual </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Pro Forma</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Pro Forma</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">As Adjusted</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)(3)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:274.14pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:274.14pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Consolidated Balance Sheet Data</font><font style="font-weight:normal;letter-spacing:0.2pt;">: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.14pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">32,704</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">185,531</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">632,589</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.14pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Working capital</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">8,679</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">156,283</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">603,993</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.14pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total assets </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">291,583</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">444,410</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">885,646 </td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.14pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total liabilities </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">645,335</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">520,525</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">509,631</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.14pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Redeemable convertible preferred stock </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">2,246,113</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.14pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total shareholders&#8217; (deficit) equity </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(2,599,865<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(76,115<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.715pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">376,014</td>
              <td style="padding:0pt;padding-left:8.135pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="margin-top:12.4pt; width:456pt;">
            <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
          </div>
          <div style=" float:left; margin-top:11.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
            <font style="letter-spacing:0.18pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:11.9pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.18pt;">Gives effect to (i)&#160;the Warrant Net Exercises, (ii)&#160;the Series E and F Issuance, (iii) the Preferred Stock Conversion, (iv) the issuance of the 2025 Convertible Notes and the related Notes Conversion, (v) the RSU Net Settlement, and (vi) the reduction of the compound derivative liability bifurcated from the 2023 Term Loan. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:11pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
            <font style="letter-spacing:0.18pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.18pt;">Gives effect to (i)&#160;the pro&#160;forma adjustments described in footnote (1)&#160;above, (ii)&#160;the sale by us of 23,529,412 shares of common stock in this offering at the initial public offering price of $21.00 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, net of $1.4 million of offering expenses paid as of March&#160;31, 2025 and (iii)&#160;the use of approximately $6.2 million of the net proceeds from this offering to satisfy our anticipated tax withholding and remittance obligations related to the RSU Net Settlement. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:11pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
            <font style="letter-spacing:0.18pt;">(3)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.18pt;">The pro forma as adjusted cash, cash equivalents, and restricted cash amount includes the employer portion of the withholding tax obligation of approximately $0.2 million related to the RSU Net Settlement at the initial public offering price of $21.00 per share. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:11pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
            <font style="letter-spacing:0.18pt;">(4)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.18pt;">We define working capital as current assets, less current liabilities. See our consolidated financial statements and related notes included elsewhere in this prospectus for further details regarding our current assets and current liabilities. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Non-GAAP Financial Measures</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <table style="width:384pt;height:65.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:159.68pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Three Months Ended March 31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:159.68pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2025</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2024 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2024</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:159.68pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="6">&#8203;</td>
              <td colspan="6">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:159.68pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Adjusted EBITDA </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(36,216<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(70,062<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(189,566<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(255,309<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:159.68pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Free cash flow</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(34,027<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(75,663<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(253,643<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(298,419<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We use Adjusted EBITDA and free cash flow, financial measures not calculated in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;) to supplement our consolidated financial statements, which are presented in accordance with GAAP. We believe the non-GAAP financial measures we use, Adjusted EBITDA and free cash flow, are useful in evaluating our performance and liquidity. Our non-GAAP financial measures have limitations as analytical tools, however, and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP. </font>
          </div>
          <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We define Adjusted EBITDA as net loss, adjusted to exclude interest income, interest expense, changes in fair value of financial instruments, other expense, net, the provision for (benefit from) income taxes, depreciation and amortization, and stock-based compensation expense. We use Adjusted EBITDA in conjunction with GAAP measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. We believe Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors. Adjusted EBITDA provides a useful measure for period-to-period comparisons of our business, as it removes the effect of certain non-cash expenses and certain variable charges. We define free cash flow as net cash used in operating activities less purchases of property and equipment. We believe free cash flow is a useful measure of liquidity that provides an additional basis for assessing our ability to generate cash. For additional information regarding Adjusted EBITDA and free cash flow, including a reconciliation of these measures to the most directly comparable financial measure calculated in accordance with GAAP, see the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Financial Measures.&#8221;</font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Investing in our common stock involves risk. You should carefully consider the risks described below, as well as the other information in this prospectus, including our financial statements and the related notes and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in this prospectus, before deciding whether to invest in our common stock. This prospectus also contains forward-looking statements that involve risks and uncertainties. See the section titled &#8220;Special Note Regarding Forward-Looking Statements.&#8221; The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations, and growth prospects. In such an event, the market price of our common stock could decline, and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Our Business and Industry</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The precision medicine industry is highly competitive and subject to rapid change.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our industry is highly competitive and characterized by rapid changes, including technological and scientific breakthroughs, frequent new product introductions and enhancements, and evolving industry standards. Our future success will depend on our ability to compete successfully and keep pace with the evolving needs of physicians, patients, and our biopharma partners on a timely and cost-effective basis and to pursue new market opportunities that develop as a result of technological and scientific advances. In recent&#160;years, there have been numerous advances in technologies relating to the diagnosis and treatment of cancer and advances in methods used to analyze large amounts of genomic information. We must continuously enhance our proprietary profiling and signature offerings and develop new solutions in a cost-effective way to achieve meaningful innovation in precision oncology and other chronic disease states. If we do not update our suite of solutions to reflect new scientific knowledge or technological advancements, including as they relate to precision medicine, therapeutic developments, or relevant validation studies or clinical trials, adoption and use of our current solutions and any new solutions we may develop could decline, which would adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, as an AI TechBio company that has experienced significant recent growth in the rapidly evolving field of precision medicine, our current business, our future success, and the risks and challenges we may encounter can be difficult to evaluate or accurately predict. If we fail to address the risks and difficulties that we face, including those described elsewhere in this &#8220;Risk Factors&#8221; section, our business, financial condition, and results of operations could be adversely affected. We have encountered in the past, and expect to encounter in the future, risks and difficulties frequently experienced by companies operating in rapidly evolving fields. If our assumptions regarding these risks and difficulties, which we use to plan and operate our business, are incorrect or change, or if we do not address these risks and difficulties, our results of operations could differ materially from our or your expectations, and our business, financial condition, and results of operations could be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have incurred significant losses since inception, expect to incur losses in the future, and may not be able to generate sufficient revenue to achieve and maintain profitability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have incurred significant losses since our inception. For the&#160;years ended December&#160;31, 2024 and 2023, we incurred net losses of $281.9&#160;million and $341.4&#160;million, respectively. For the three months ended March&#160;31, 2025 and 2024, we incurred net losses of $102.6 million and $111.0 million, respectively. As of March&#160;31, 2025, we had an accumulated deficit of $2.6&#160;billion. To date, we have financed our operations principally from the sale of convertible preferred stock, the incurrence of indebtedness, and revenue from molecular profiling and pharma R&amp;D services. Over the last 17&#160;years, we have devoted significant resources towards developing our current portfolio that consists of tissue- and blood-based profiling solutions, building our multi-modal clinico-genomic datasets, expanding our operational capacity, and strengthening our AI/ML-driven data analysis capabilities. We also devote significant resources to clinical and regulatory initiatives to obtain marketing authorization, sales and marketing activities, and R&amp;D activities. We anticipate incurring significant costs to continue developing and commercializing our solutions. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, because of the various risks and uncertainties associated with developing and commercializing our solutions, we are unable to predict the extent of future costs that may impact our prospects for profitability. Our future expenses will depend, in part, on the level of our expenditures and our ability to generate revenue at scale. We expect to continue to incur significant expenses and operating losses for the foreseeable future if and as we, among other things: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">attract, hire, and retain qualified personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">continue our R&amp;D activities and scale our R&amp;D infrastructure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expand our laboratory capacity and operating capabilities, including completing the build-out of our laboratory facility in Irving, Texas; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">further build our sales, marketing, and distribution infrastructure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">continue to invest in the expansion and enrichment of our clinico-genomic datasets and related analysis capabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">seek marketing authorization that may be necessary or desired for our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtain, maintain, protect, and enforce our intellectual property portfolio, including intellectual property obtained through license agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">meet the requirements and demands of being a public company; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">defend against any claims or other lawsuits related to our solutions or otherwise. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our expenses could increase beyond expectations if we are required by the FDA or other regulatory agencies to delay the launch of any new solutions, narrow or change our intended use or product claims, modify or expand our clinical trials or to perform additional clinical trials, either pre- or post-approval, in addition to those that we currently anticipate. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will also need to generate significant additional revenue to achieve and then sustain profitability, and even if we achieve profitability, we cannot be sure that we will remain profitable for any substantial period of time. While we have commercially launched MI Cancer Seek, a new WES/WTS NGS assay, in the United States and seek to drive its increased adoption, and also plan to capitalize on the potential of Caris Assure applications for early detection, MRD tracking, and treatment monitoring and in chronic disease states beyond oncology, we cannot assure you that we will successfully be able to do so as planned, if at all, and our failure to do so may prevent us from generating increased revenue. Our failure to achieve or maintain profitability could negatively impact the value of our common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our current or future solutions may not achieve or maintain sufficient commercial market acceptance.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The commercial success of any of our solutions, including MI Profile and Caris Assure, or solutions that are marketed in the future, will depend upon the degree of commercial market acceptance, including by government payers, insurance companies, integrated health systems, healthcare providers, patients, biopharma companies and other third-party payers. The degree of market acceptance of our solutions will depend on a number of factors, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the performance and clinical utility of such solutions as demonstrated in clinical trials and published in peer-reviewed journals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rate of adoption and/or endorsement of our solutions by clinicians, KOLs, advocacy groups, and biopharma companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability of our newer solutions, such as Caris Assure, and solutions that may be marketed in the future, to demonstrate the same performance in real-world intended use populations as in clinical trials or analytical or clinical validation studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the willingness of medical providers to utilize our solutions as they are commercially released; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the willingness of commercial third-party payers and government payers to cover and reimburse for our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the development or introduction of competing products, including the expansion of the capabilities of existing products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the market acceptance of existing competitive products, including tests that are currently reimbursed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">publicity concerning our solutions or competing products; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the strength of our marketing and sales support. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We cannot assure you that we will be successful in addressing each of these factors or other factors that might affect the market acceptance of our solutions. Failure to achieve broad market acceptance of our solutions, would harm our business, financial condition, and results of operations. For additional information, see &#8220;&#8212;Our current revenue is primarily generated from the continued adoption and use of our tissue-based profiling solution, and we are highly dependent on it for our success&#8221; and &#8220;&#8212;Our future&#160;success and growth will depend in part on market acceptance and commercial success of our MI Cancer&#160;Seek and Caris Assure solutions. We may be unsuccessful in continuing the commercialization of MI Cancer Seek or Caris Assure, which would adversely affect our business, financial condition, results of operations, and growth prospects.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our solutions may not perform as expected, and the results of our validation studies or our clinical trials may not support the launch or use of our solutions and may not comply with the requirements, or be replicated in later trials required, for any necessary or desirable marketing authorizations. This could adversely affect our business, financial condition, results of operations, and growth prospects.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our success depends on the market and the medical community&#8217;s confidence that we can provide reliable, high-quality solutions, as well as our ability to complete validation studies and clinical trials and comply with applicable regulatory requirements that would allow us to commercialize our solutions. Our solutions, including MI Cancer Seek, for which we have obtained PMA approval from the FDA, MI Tumor Seek Hybrid, and Caris Assure, may not perform as expected, and the results obtained from our ongoing or future studies and trials may be inconsistent with certain results obtained from our previous studies or trials. In addition, the application of Caris Assure in early detection, MRD tracking, and treatment monitoring, for which we are still collecting preliminary data to support, may not be as effective as we anticipate. If Caris Assure or our other solutions are ineffective or do not consistently perform as expected, either before or after launch, our business, financial condition, results of operations, and growth prospects would suffer. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our solutions require a number of complex and sophisticated biochemical and bioinformatics processes, many of which are highly sensitive to external factors. An operational or technological failure in one of these complex processes or fluctuations in external variables may result in sensitivity and specificity rates that are lower than we anticipate or that vary between test runs or in a higher than anticipated number of tests that fail to produce consistent results. In addition, we regularly evaluate and refine our AI/ML algorithms and other processes under development. These refinements may inadvertently result in unanticipated issues that may reduce our sensitivity and specificity rates or otherwise adversely affect the performance of our solutions and their results, such that supplemental submissions to the FDA may be required. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have obtained a PMA approval from the FDA for MI Cancer Seek and may decide to seek FDA approval for Caris Assure and additional solutions, though whether we will do so and the timing thereof is uncertain. The FDA and other regulators may request additional information or require that we generate additional clinical data to support such future approval applications, which could result in delays, increased costs, or other limitations on our ability to receive such approval. Additionally, the FDA included certain conditions of approval and limitations in the PMA approval letter for MI Cancer Seek, namely that we submit data evaluating the effects of interfering substances such as necrotic tissue, melanin, and fatty acids and also conduct a study and submit data regarding formalin-fixed paraffin-embedded block and slide stability duration claims. Our failure to comply with these limitations and conditions could result in the withdrawal of the PMA approval for MI Cancer Seek. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, we plan to enhance, iterate, and improve our solutions, scalability, and/or reduce our cost of goods. However, we may not be successful in transitioning our solutions to new or enhanced versions or iterations, or reducing our cost of goods. The improvement of our solutions involves a lengthy and complex process, may require regulatory approval, and we may be unable to commercialize, validate, or improve performance of any of our solutions on a timely basis, or at all. Our failure to successfully develop new and/or improved solutions (including new versions of existing solutions) on a timely basis could adversely affect our business, financial conditions, and results of operation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Finally, generating the clinical data necessary to validate and support the launch of our solutions and new versions of solutions and subsequently obtain marketing authorization or third-party reimbursement, is time-consuming and carries with it the risk of not yielding the desired results. The performance achieved in our analytical validation studies, clinical trials, or published studies may not be replicated in later studies that may be required to obtain or maintain marketing authorization. For example, limited results from earlier-stage analytical validation studies, such as our analytical validation studies on the use of Caris Assure for early detection, MRD tracking, and treatment monitoring, may not predict results from studies in larger numbers of participants drawn from more diverse populations over a longer period of time. Unfavorable results from ongoing analytical validation studies or clinical trials, or delays in publication of such results, could lead to delays, modifications, or abandonment of ongoing or future studies and trials, or abandonment of a solution development program, or may delay, limit, or prevent marketing authorizations or commercialization of our solutions. In addition, results from such studies and trials may not be consistent with the results from real-world application of our solutions, if commercialized, for a particular care setting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our current revenue is primarily generated from the continued adoption and use of our tissue-based profiling solution.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our ability to execute our growth strategy and become profitable is highly dependent on the continued adoption and use of MI Profile, our tissue-based profiling solution, which accounted for 78.2% and 91.0% of our revenue in the&#160;years ended December&#160;31, 2024 and 2023, respectively, and 83.9% and 87.9% of our revenue for the three months ended March 31, 2025 and 2024, respectively. Continued adoption and use of MI Profile will depend on several factors, including the prices we charge for our solution, the scope of coverage and amount of reimbursement available from government and third-party payers for our solution, the availability of clinical data that supports the value of MI Profile and the inclusion of MI Profile solutions in industry treatment guidelines. The commercial success of our tissue-based profiling solution depends significantly on its broad adoption and use by oncologists and other physicians. Many physicians and biopharma companies have existing relationships with companies that develop molecular diagnostic tests, including our competitors, and may continue to use their tests instead of MI Profile. Despite our business development efforts, it could be difficult, expensive, and/or time-consuming for physicians and/or biopharma companies to switch diagnostic tests for their products, and MI Profile may not be widely accepted, if at all, which could in turn hinder the rate of adoption and continued use of our solutions. We cannot assure you that MI Profile will continue to maintain or gain market acceptance, and any failure to do so would harm our business, financial condition, and results of operations. Moreover, as we have leveraged the data we have generated to date with MI Profile to develop Caris Assure and other solutions, if the adoption and use of MI Profile wanes or if reliability or other issues with the data we generate with MI Profile are discovered, the further development and future success and growth of Caris Assure and other solutions would be adversely impacted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our future success and growth will depend in part on market acceptance and commercial success of our MI Cancer Seek and Caris Assure solutions. We may be unsuccessful in continuing the commercialization of MI Cancer Seek or Caris Assure, which would adversely affect our business, financial condition, results of operations, and growth prospects.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">MI Cancer Seek, for which we obtained a PMA approval from the FDA in November 2024 and commercially launched in January 2025, is the new WES/WTS NGS assay component of MI Profile, our tissue-based molecular profiling solution for cancer therapy that has generated the majority of our revenue to date. Driving increased adoption among physicians of, and obtaining reimbursement for, MI Cancer Seek are key expected drivers of our growth, particular in the near and medium term. The success of MI </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cancer Seek will depend upon, among other things, the extent to which our recent FDA approval drives increased adoption and use of the solution by physicians as a companion diagnostic tool.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Caris Assure, for which we initiated the broad commercial launch for therapy selection in the first quarter of 2024, ultimately aims to address the entire continuum of cancer treatment. Realizing the potential of Caris Assure across disease states is a key component of our long-term business strategy. The commercial success of Caris Assure for therapy selection and in other applications across the cancer treatment continuum will depend upon, among other things, additional analytical validation studies and clinical trials that demonstrate the effectiveness of Caris Assure, particularly for early detection, MRD tracking, and treatment monitoring, the continued adoption of Caris Assure by physicians, the medical community, patients, and third-party payers, and our ability to successfully run and market Caris Assure in substantial quantities or to manage and expand the required infrastructure to do so, including large-scale laboratory and information technology systems. Maintaining and expanding market acceptance of our solutions, marketing, and laboratory capabilities are expensive and time-consuming. If MI Cancer Seek or Caris Assure is not successfully commercialized, we will not be able to recover the significant investment we have made in developing these solutions, and our business, prospects, financial condition, and results of operations would be harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we are unable to support demand for MI Profile, Caris Assure, and any other solutions we develop, including ensuring that we have adequate capacity to meet increased demand, or if we are unable to successfully manage our anticipated growth, our business could suffer.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As and to the extent the volumes of our current and new solutions continue to grow, we will need to simultaneously increase our capacity for sample intake, storage, and processing enhance our customer service, improve our billing and general processes, expand our internal quality assurance programs, incorporate new equipment, implement new technology systems and processes, expand laboratory capacity, and otherwise extend our operational capabilities to support comprehensive genomic analyses at a larger scale while retaining expected turnaround times. We will also need additional equipment and certified and licensed laboratory personnel to process higher volumes of solutions. We may face difficulties increasing the scale of our operations, including implementing changes in infrastructure or programs or acquiring additional equipment or personnel. As we refine our solutions and develop additional solutions, we may need to bring new equipment on-line, implement new systems, technology, controls and procedures, and hire personnel with different qualifications, licenses, or certifications. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are also in the process of constructing additional facilities in order to increase capacity, including our laboratory facility in Irving, Texas. We may not be able to complete construction of such facilities and obtain necessary certifications, permits, licenses, and accreditations in a timely or cost-effective manner, or at all. Therefore, we may be unable to support our development and commercial activities in a timely manner, if at all. There is no assurance that any of these increases in scale, expansion of personnel, equipment, software and computing capacities or process enhancements will be successfully implemented, or that we will have adequate resources and facilities to accommodate such required expansion. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The value of MI Profile, Caris Assure, and related solutions will depend, in part, on our ability to perform tests and return test results to providers on a timely basis and at an appropriate quality standard, and on our reputation for such timeliness and quality. If our business grows too quickly, our ability to meet demand for our solutions in a timely and efficient manner could be challenged, and our quality standards or turnaround time may be compromised. Failure to implement necessary procedures, to transition to new equipment or processes, or to hire the appropriate, qualified personnel could result in higher costs of processing, longer turnaround times, declining product quality, deteriorating customer service, an inability to meet market demand, or slower responses to competitive challenges, all of which could make it difficult for us to meet market expectations for our solutions and could damage our reputation and the prospects for our business. There can be no assurance that we will be able to perform tests on a timely basis at a level consistent with demand, that we will be able to maintain the quality of our test results as we scale our commercial operations, or that we will be successful in responding to the growing complexity of our laboratory operations, including the related data analysis requirements. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect to add new associates in our Phoenix and Tempe, Arizona and Irving, Texas facilities. We will need additional laboratory scientists, technicians, and other scientific and technical personnel with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">different qualifications, licenses, or certifications. As our development plans and strategies develop, and as we transition into operating as a public company, we must add a significant number of additional managerial, operational, financial, and other personnel. Future growth will impose significant added responsibilities on members of management, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">identifying, recruiting, integrating, retaining, and motivating employees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">managing our internal development and commercialization efforts effectively, including creating and maintaining compliant programs and processes, such as a laboratory and manufacturing quality system, and managing the regulatory requirements for our solutions, while adhering with our contractual obligations to contractors and other third parties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expanding our operational, human resources, financial and management controls, reporting systems, and procedures; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">managing the increasing complexity associated with a larger organization and expanded operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our growth may place a significant strain on our management, operating and financial systems, R&amp;D, and our sales, marketing, and administrative resources. As a result of our growth, our operating costs may escalate even faster than planned, and some of our internal systems may need to be enhanced or replaced. If we cannot effectively manage our expanding operations and our costs, we may not be able to successfully commercialize future solutions and grow successfully, and our business could be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our results of operations may fluctuate significantly, which makes our future results of operations difficult to predict and could cause our results of operations to fall below expectations or any guidance we may provide.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our quarterly and annual results of operations may fluctuate significantly, which makes it difficult for us to predict our future results of operations. These fluctuations may occur due to a variety of factors, many of which are outside of our control, including, but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the level of demand for our solutions, which may vary significantly; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing and cost of, and level of investment in, research, development, regulatory approval, or certification and commercialization activities relating to our solutions, which may change from time to time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the volume and customer mix of our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the introduction of new solutions or solution enhancements by us or others in our industry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">coverage and reimbursement policies with respect to our solutions and products that compete with our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expenditures that we may incur to acquire, develop, or commercialize additional solutions and technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in governmental regulations or in the status of our regulatory approvals or certifications or applications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">future accounting pronouncements or changes in our accounting policies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">developments or disruptions in the business and operations of physicians and our biopharma partners; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the impact of natural disasters, political instability, including wars, terrorism, and political unrest, epidemics or pandemics, boycotts, and curtailment of trade and other business restrictions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effects of high inflation or other general market and economic conditions and other factors, including factors unrelated to our operating performance or the operating performance of our competitors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, due to the inherent variability and unpredictability of the reimbursement landscape, including related to the amount that payers reimburse us for any of our solutions, when we recognize revenue we estimate the transaction price based on our historical collection experience and on the historical selling price of similar transactions, where applicable, and subsequent changes to the estimate of the transaction price are generally recorded as adjustments to revenue in the period where such changes occur. Both the estimate and any subsequent revision are uncertain and require the use of management&#8217;s judgment in the estimation of the variable consideration and application of the constraint for such variable consideration. Due to this variability and unpredictability, previously recorded revenue adjustments are not indicative of future revenue adjustments from actual cash collections, which may fluctuate significantly. Moreover, we receive a substantial portion of our revenue from a limited number of third-party commercial payers. If one or more of these payers were to significantly reduce or cease to pay the amount such payer reimburses us for our solutions, or if such payer does not reach or maintain favorable coverage and reimbursement decisions for our solutions, it could have an adverse effect on our business, financial condition, and results of operations. We have experienced situations where commercial payers proactively reduced the amounts they were willing to reimburse for our solutions, and in other situations, payers have determined that the amounts they previously paid were too high and have sought to recover those perceived excess payments by deducting such amounts from payments otherwise being made. For additional information regarding risks associated with the reimbursement landscape, see &#8220;&#8212;If our solutions, or solutions we develop in the future, do not receive adequate coverage and reimbursement from third-party payers, including government and commercial payers, our ability to expand access to our solutions beyond our existing sales channels, and thus our overall commercial success, will be limited.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The cumulative effects of factors discussed above could result in large fluctuations and unpredictability in our quarterly and annual results of operations. As a result, comparing our results of operations on a period-to-period basis may not be meaningful. Investors should not rely on our past results as an indication of our future performance. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our results of operations fall below the expectations of analysts or investors or below any guidance we may provide, or if the guidance we provide is below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated guidance we may provide, and which could harm our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we do not have the support of KOLs or if clinical data using our solutions is not published in peer-reviewed journals or is otherwise not well received, it may be difficult to drive adoption and use of our solutions and establish them as a component of the standard of care for patients with cancer.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of March 31, 2025, the Caris POA was comprised of 96 members, including 45 NCI-designated comprehensive cancer centers. If these KOLs or others within the broader precision oncology industry determine that our platform, our existing solutions, or other solutions that we develop are not clinically effective, that alternative technologies are more effective, or if they elect to use internally developed products or services, we may see lower demand for our solutions and face difficulty establishing our solutions as an integral component of the applicable standard of care, which would limit our revenue growth and our ability to achieve profitability. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The publication of clinical data using our solutions in peer-reviewed journals is also crucial to our success. We are unable to control when, if ever, results are published, which may delay or limit broad adoption and use of our solutions. Our ability to publish clinical data relating to our solutions in peer-reviewed publications may be limited by many factors, including increased difficulty in obtaining acceptance for publication from journals, conflicts of interest, lack of qualified experts willing to participate in the peer review process, delays in the completion of, poor design of, or lack of compelling data from, validation studies or clinical trials, as well as delays in the review, acceptance, and publication process. If our solutions do not receive sufficient favorable exposure in peer-reviewed publications or are not well received by clinicians, the rate of clinician adoption and use of our solutions and positive reimbursement coverage determinations for our solutions, even if approved with guideline inclusion, could be adversely affected. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If our solutions, or solutions we develop in the future, do not receive adequate coverage and reimbursement from third-party payers, including government and commercial payers, our ability to expand access to our solutions beyond our existing sales channels, and thus our overall commercial success, will be limited.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our revenue and commercial success depend on achieving coverage and reimbursement for assays that comprise MI Profile, Caris Assure, and any solutions we may offer in the future, from third-party payers, including both government and commercial payers. Obtaining approvals from third-party payers to cover our solutions and establishing adequate coding recognition and reimbursement levels is an unpredictable, challenging, time-consuming, and costly process, and we may not always be successful. Coverage determinations from third-party payers may depend on a number of factors, including a payer&#8217;s determination that a solution is appropriate, medically necessary, and cost-effective. Each payer will make its own decision as to whether to establish a policy or enter into a contract to cover our solutions and the amount it will reimburse for such solutions. In addition, determinations by a payer whether to cover and the amount it will reimburse for our solutions are often made on an indication-by-indication basis. If we are unable to provide payers with sufficient evidence of the clinical utility and validity of our solutions, they may not provide coverage, may provide limited coverage, or may terminate coverage for our solutions, which will adversely affect our revenues and our financial condition. In addition, the fact that one of our solutions has been approved for reimbursement in the past does not guarantee that such solution will remain approved for reimbursement, that the approved reimbursement amount will not be reduced in the future, or that similar or additional solutions will be approved in the future. Moreover, there can be no assurance that any new solutions we launch will be reimbursed at rates that are comparable to the rates that we historically obtained for our existing portfolio or rates that other industry participants receive. Third-party payers may not cover or provide adequate payment for our current or future molecular and other solutions to enable us to maintain past levels of revenue or profitability with respect to such solutions. Further, third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on investment in the development of our solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Healthcare providers may not order our solutions unless third-party payers cover and provide reimbursement rates for a substantial portion of the price of our solutions. If we are unable to obtain adequate coverage and an acceptable level of reimbursement for our solutions from third-party payers, patients could incur a greater co-insurance, co-payment, and/or deductible obligation. Uninsured patients or patients whose insurance does not cover our solutions may also be forced to pay for our solutions out-of-pocket. Such scenarios could dissuade physicians from ordering our solutions or, if ordered, could result in delay in or decreased likelihood of our collection of payment. We thus believe our revenue and revenue growth will depend on our success in achieving broad coverage and adequate reimbursement for our solutions from third-party payers. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the coding process used by third-party payers to identify various medical procedures during the billing process is complex, may not adapt well to the types of solutions we offer, and may not enable coverage and adequate reimbursement rates. Current Procedural Terminology (&#8220;CPT&#8221;) coding plays a significant role in how our solutions are reimbursed both from commercial and governmental payers. The CPT code set is maintained by the American Medical Association (&#8220;AMA&#8221;) and includes the Proprietary Laboratory Analyses (&#8220;PLA&#8221;) codes that are used to describe many molecular diagnostic tests. In cases where there is not a specific CPT code to describe a test, or when required by a commercial payer, we bill under an unlisted molecular pathology procedure code or through the use of a combination of single gene CPT codes, depending on the payer. In addition, the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) maintains the Healthcare Common Procedure Coding System (&#8220;HCPCS&#8221;) and may assign unique Level&#160;II HCPCS code to tests that are not already described by a unique CPT code. New CPT codes are issued annually and new HCPCS codes are issued as frequently as quarterly. In addition to CPT and HCPCS codes, Z-Code Identifiers are used by certain payers, including under MolDX, to supplement CPT codes for our solutions. Our MI Tumor Seek Hybrid solution is reported to Medicare and to some commercial payers using unlisted molecular pathology CPT code 81479 and unique test-specific identifier (&#8220;a DEX&#160;Z-Code&#8221;). Our MI Cancer Seek solution is reported to Medicare and to commercial payers using the 0211U CPT code and a unique DEX Z-Code identifier. Our Caris Assure solution is reported to Medicare and to non-contracted, commercial payers using the 0485U CPT code and a unique DEX Z-Code identifier. Commercial payers sometimes require other codes to be reported for our solutions, and we will bill in accordance with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the respective contract terms. Changes to the codes used to report our solutions to payers may result in significant changes in reimbursement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Third-party payers are increasingly attempting to contain healthcare costs by limiting both coverage of certain diagnostic tests and the amounts that they will pay for such tests. Payers may also create conditions for coverage or may contract with third-party vendors to manage laboratory benefits, in both cases creating administrative hurdles for ordering physicians and patients that may make our services more difficult to sell. U.S. and foreign governments continue to propose and pass legislation designed to reduce the cost of healthcare. In some foreign markets, the government controls the pricing of many healthcare products. In the United States, we expect that there will continue to be federal and state proposals to implement governmental controls or impose healthcare requirements, which may increase the pressure to reduce spending on genetic testing and comprehensive molecular profiling. In addition, the Medicare program and increasing emphasis on managed care in the United States will continue to put pressure on product pricing. Cost control initiatives could decrease the price that we would receive for any solutions in the future, which would limit our revenue and profitability. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Obtaining approvals from third-party payers to cover our existing and new solutions and establishing adequate coding recognition and reimbursement levels is an unpredictable, challenging, time-consuming, and costly process, and we may not always be successful. If third-party payers do not provide adequate coverage and reimbursement for our solutions, our ability to succeed commercially will be limited.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Medicare</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Medicare is the single largest U.S. payer and a particularly important payer for many cancer-related laboratory services given the demographics of the Medicare population. Medicare coverage is limited to items and services that are within the scope of a Medicare benefit category that are reasonable and necessary for the diagnosis or treatment of an illness or injury. Medicare coverage criteria that define when items and services are reasonable and necessary are defined in National Coverage Determinations (&#8220;NCDs&#8221;) made by&#160;CMS through an evidence-based process, with opportunities for public participation, and Local Coverage&#160;Determinations (&#8220;LCDs&#8221;) made by Medicare Administrative Contractors (&#8220;MACs&#8221;) that apply&#160;within the specific jurisdictions. Medicare&#8217;s NCD for NGS (NCD&#160;90.2), first established in 2018 and subsequently&#160;updated in 2020, provides national Medicare coverage for certain molecular diagnostic tests (1)&#160;performed in a laboratory certified by the Clinical Laboratory Improvement Amendments of 1988 (&#8220;CLIA&#8221;), (2)&#160;ordered by a treating physician, (3)&#160;the patient meets certain clinical and treatment criteria, including having recurrent, relapsed, refractory, metastatic, or advanced stages III or IV cancer, (4)&#160;the test is approved or cleared by the FDA as a companion IVD for an FDA-approved or -cleared therapeutic for use in that patient&#8217;s cancer, and (5)&#160;results are provided to the treating physician for management of the patient using a report template to specify treatment options. The NGS NCD also provides discretion to the MACs to provide local coverage of other NGS tests for cancer patients only when the test is performed by a CLIA-certified laboratory, ordered by a treating physician and the patient meets the same clinical and treatment criteria required of nationally covered NGS tests under the NGS NCD. Palmetto GBA is the MAC responsible for administering MolDX, which issues coverage determinations applicable to molecular diagnostic tests within the scope of the program, including for molecular assays that are LDTs. Our MAC for the Phoenix laboratory locations is Noridian, and Noridian relies on MolDX to make local coverage and pricing determinations relating to molecular testing. To achieve coverage under MolDX, laboratories must apply for and obtain a DEX Z-Code that is unique to the laboratory&#8217;s specific test and must also submit a technical assessment to demonstrate analytical and clinical validity, and clinical utility at a level that meets the Medicare reasonable and necessary requirement. Analytical validity relates to technical performance, such as that an assay accurately and reliably measures a specific feature. Clinical validity means whether a test can accurately identify, measure, or predict a clinical condition or characteristic in patients.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Diagnostic Tests: Tissue- and Blood-Based Solutions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have received DEX Z-Codes and MolDX technical assessments for our MI Cancer Seek, Caris Assure, and MI Tumor Seek Hybrid solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We received a PMA approval for MI Cancer Seek from the FDA in November 2024 and commercially launched the solution in January 2025. We have obtained Medicare coverage under the NGS NCD for MI Cancer Seek for CPT code 0211U at $8,455 under the CLFS. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our MI Tumor Seek Hybrid solution is covered for solid tumor testing as allowable under the NGS NCD and related LCD and are reported to Medicare with unlisted molecular pathology CPT code 81479 and the unique DEX Z-Code identifier issued by MolDX. MI Tumor Seek Hybrid is covered by Medicare as of August&#160;3, 2022, with current MolDX pricing of $3,500. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Caris Assure solution is currently reported to Medicare using a PLA code, CPT code 0485U, and a unique DEX Z-Code identifier issued by MolDX. Caris Assure is covered for therapy selection by Medicare as of December&#160;8, 2023 for Comprehensive Genomic Profiling from ctDNA of patients with recurrent, relapsed, refractory, metastatic, or advanced solid tumors who are seeking treatment, and for whom tissue-based, comprehensive genomic profiling (&#8220;CGP&#8221;) is infeasible (for example, quantity not sufficient for tissue-based CGP or invasive biopsy is medically contraindicated), with current MolDX pricing of $3,649. In November 2024, CMS determined to price Caris Assure for therapy selection using the &#8220;Gapfill&#8221; method. There is no certainty regarding the pricing that we will obtain for Caris Assure during the Gapfill process. For additional information, see &#8220;Business&#8212;Government Regulation&#8212;Coverage and Reimbursement&#8212;Coverage and Reimbursement in the United States.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Immunohistochemical Tests</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As part of our MI Profile solution, we perform certain third-party IHC tests. Medicare coverage and payment for these tests is under the Molecular Pathology Procedures Billing and Coding Article, with payment amounts assigned to specific HCPCS and CPT codes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Protecting Access to Medicare Act</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Medicare payment for clinical diagnostic laboratory tests (&#8220;CDLTs&#8221;) is generally made under the CLFS based on payment rates that are assigned to specific HCPCS or CPT codes. Under the Protecting Access to Medicare Act of 2014 (&#8220;PAMA&#8221;), laboratories that meet certain requirements related to volume and type of Medicare revenues are required to report to CMS, beginning in 2017 and every three&#160;years thereafter (or annually for &#8220;advanced diagnostic laboratory tests&#8221; &#8203;(&#8220;ADLTs&#8221;)), their private payer payment rates and volume for each test they perform that is reported with a specific HCPCS code (defined by PAMA to exclude miscellaneous or unlisted codes). ADLTs are subject to separate reporting and payment requirements under PAMA. New ADLTs are paid at a rate equal to their actual list charge during an initial period of three calendar quarters, after which CLFS payment is based on the weighted median of private payer rates, which must be reported annually for ADLTs. We are subject to these reporting requirements under PAMA for any solution we perform that is not reported with a miscellaneous HCPCS or CPT code, including the third-party IHC tests we perform, and for any profiling solutions that commercial payers currently require us to report using a HCPCS code that has been identified by CMS as subject to PAMA reporting requirements. In addition, MI Cancer Seek, which is reported with PLA code&#160;0211U, Caris Assure, which is reported using PLA Code 0485U, and any other solution for which we obtain a specific HCPCS or CPT code, will be subject to these reporting requirements in future PAMA reporting cycles, and that the Medicare CLFS payment rates for such solutions will be calculated in the future based on our private payer rates. While we do not currently have ADLT status for any of our solutions, we may seek ADLT status for one or more of our solutions in the future. If we are successful in obtaining such ADLT status, any solution for which we obtain ADLT status will be subject to the PAMA reporting requirements and pricing methodology as an ADLT. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Congress passed legislation that delayed data reporting requirements for CDLTs that are not ADLTs and further delayed the phase-in of payment reductions under the CLFS from private payer rate implementation. Any reductions to reimbursement rates resulting from the new methodology are limited to 0% in 2025 and 15% per test per year in each of 2026 through 2028. The subsequent data reporting periods for CDLTs that are not ADLTs will occur in three-year cycles, with the next cycle beginning in 2026. CLFS rates for CDLTs will be updated every three&#160;years, and for ADLTs will be updated annually. For many tests and/or laboratories, the result of the PAMA pricing methodology has been lower pricing and reimbursement. As a result, our Medicare CLFS pricing for any solutions that may be subject to PAMA reporting requirements in the future could be negatively impacted by PAMA. In addition, private payer payment levels have more significance in setting Medicare reimbursement and, therefore, future Medicare payments may fluctuate more often and become subject to the willingness of private payers to recognize </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the value of diagnostic tests generally and any given test individually. Given the many uncertainties built into PAMA&#8217;s price-setting process, we cannot predict how payments we receive under the CLFS, and thus our revenue, may change from year to year. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the reporting requirements and pricing methodology described above, PAMA codified Medicare coverage rules for laboratory tests by requiring any local coverage determination to be made following the local coverage determination process. PAMA also authorizes CMS to consolidate coverage policies for clinical laboratory tests among one to four laboratory specific MACs. These same contractors may also be designated to process claims if CMS determines that such a model is appropriate. It is unclear whether CMS will proceed with contractor consolidation under this authorization. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Signature Tests, and Screening and Early Detection Intended Uses for Our Solutions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our proprietary molecular signature tests, GPSai and FOLFIRSTai, as well as early detection indications for our blood and tissue-based profiling solutions, are not currently covered by Medicare. Obtaining Medicare coverage for these molecular signatures would require significant investments and may ultimately be unsuccessful or may take several&#160;years to achieve. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we are developing screening capabilities for Caris Assure for MRD tracking and treatment monitoring in colorectal cancer (&#8220;CRC&#8221;), breast cancer, lung cancer, and other indications. On January&#160;19, 2021, CMS released an NCD that covers future tests for CRC screening if and when such screening tests have FDA approval and meet pre-specified CMS criteria. In addition, MolDX LCDs provide coverage for MRD for CRC, breast cancer, lung cancer, and other indications when applicable coverage criteria are satisfied. While this NCD and applicable LCDs may provide a pathway to coverage of Caris Assure in CRC and other indications under Medicare if applicable coverage criteria are satisfied, there is no assurance that we will be successful in completing the required studies, trials, or publications or obtaining FDA approval, or obtaining Medicare coverage even if we are successful in obtaining FDA approval, and if we are not successful, our business, financial condition, and results of operations would be harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Commercial Payers and Other Payers</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our commercial success also depends on achieving acceptable coverage and reimbursement for our solutions from commercial payers. When we contract with a payer as a participating provider, reimbursements by the payer are generally made pursuant to a negotiated fee schedule and are limited to only covered indications, and in many cases require prior authorization. Becoming a participating provider can result in higher reimbursement amounts for covered uses of our solutions and, potentially, no reimbursement for non-covered uses identified under the payer&#8217;s medical policies or the contract. Although we are a participating provider with many commercial payers, certain payers may not cover based on existing medical policy and may treat our solutions or solutions that we develop in the future as experimental and investigational or import restrictive coverage criteria. If we are not successful in obtaining coverage from such payers, or if other payers issue non-coverage policies, our business, financial condition, and results of operations could be adversely affected. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because current codes applicable to our solutions are not always test-specific, each insurance claim will have different submission criteria, including appending our DEX Z-Code, and typically must be examined to determine what test was provided, whether the test was appropriate and medically necessary, and whether payment should be rendered, which may require progress notes, medical records, or a letter of medical necessity from the ordering physician. This process can result in a delay in processing the claim, a lower reimbursement amount or denial of the claim. As a result, obtaining approvals from third-party payers to cover our solutions and establishing adequate reimbursement levels is an unpredictable, challenging, time-consuming, and costly process, and we may never be successful in obtaining such approvals. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some payers have implemented, or are in the process of implementing, laboratory benefit management programs, often using third-party benefit managers to manage these programs. The stated goals of these programs are to help improve the quality of outpatient laboratory services, support evidence-based guidelines for patient care and lower costs. The impact on laboratories, such as ours, of active laboratory benefit management by third parties is unclear, and we expect that it would have a negative impact on our revenue in the short term. Payers may resist reimbursement for our solutions in favor of less </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">expensive tests, require pre-authorization for our solutions, or impose additional pricing pressure on and substantial administrative burden for reimbursement for our solutions. We expect to continue to focus substantial resources on increasing adoption of, and coverage and reimbursement for, our current solutions and any future solutions we may develop. We believe it may take several&#160;years to achieve broad coverage and adequate contracted reimbursement with a majority of payers for our solutions. However, we cannot predict whether, under what circumstances, or at what price levels payers will cover and reimburse our solutions. If we fail to establish and maintain broad adoption of, and coverage and reimbursement for, our solutions, our ability to generate revenue could be harmed and our business, financial condition, and results of operations could be adversely affected. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if we establish relationships with commercial payers to provide our future solutions at negotiated rates, such agreements would not obligate any healthcare providers to order our solutions or guarantee that we would receive reimbursement for our solutions from these or any other payers at adequate levels. Thus, these payer relationships, or any similar relationships, may not result in acceptable levels of coverage and reimbursement for our solutions, or meaningful increases in the number of billable tests we perform. We believe it may take several&#160;years to achieve coverage and adequate reimbursement for our solutions with a majority of third-party payers, including with those payers offering negotiated rates. In addition, we cannot predict whether, under what circumstances, or at what payment levels payers will cover and reimburse for our solutions. In addition to the available Medicare coverage, we plan to market Caris Assure for early detection, MRD tracking, and treatment monitoring, as well as other solutions that we are developing or may develop in the future, to large self-insured employers, commercial insurance plans, certain physician directed channels, concierge medicine and executive health programs, and innovative health systems. Additionally, a third-party payer&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained, less favorable coverage policies and reimbursement rates may be implemented in the future. If we fail to establish and maintain broad-based coverage and reimbursement for certain solutions, our ability to expand access to our solutions, generate increased revenue, and grow our clinical case volume and customer base for such solutions will be limited and our overall commercial success may be limited. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our billing, collections, and claims processing activities are complex and time-consuming, and any delay in transmitting and collecting claims or failure to comply with applicable billing requirements could have an adverse effect on our future revenue.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depending on the billing arrangement and applicable law, we bill and expect to bill various payers, such as governmental payers, insurance companies, hospitals, and patients, which may each have different billing requirements. We may face increased risk in our collection efforts, including long collection cycles and the risk that we never collect at all, either of which could adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our failure to timely submit claims for our solutions to payers or failure to comply with applicable billing requirements could have an adverse effect on our revenue and our business, and could result in our inability to receive payment for our services or in attempts by private payers and state and federal healthcare programs, such as Medicare and Medicaid, to recover payments already made. Submission of claims in violation of billing requirements and applicable laws and regulations can result in recoupment of payments already received, substantial civil monetary penalties, and exclusion from state and federal health care programs, and can subject us to liability under the federal False Claims Act (the &#8220;FCA&#8221;) and similar laws. For example, in March 2025, we received a Civil Investigative Demand (&#8220;CID&#8221;) from the DOJ in connection with an investigation under the False Claims Act regarding our compliance with Medicare&#39;s date of service rule (also referred to as the 14-day rule). For additional information, see &#8220; &#8212;We have been, are currently, and in the future may be the subject of government investigations, claims, audits, whistleblower and payer audits, overpayment and recoupment efforts and other litigation in the course of our business that could adversely affect our business and financial statements&#8221; and &#8220;Business&#8212;Legal Proceedings.&#8221; The failure to report and return an overpayment to the Medicare or Medicaid program within 60&#160;days of identifying its existence can also give rise to liability under the FCA. Further, a government agency could attempt to hold us liable for causing the improper submission of claims by another entity for services that we performed if we were found to have knowingly participated in the arrangement at issue. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, our claims for reimbursement may be denied and we may have to appeal such denials in order to get paid. Such appeals may not result in payment and can be time-consuming and costly. Moreover, payers often perform audits of historically paid claims and regularly attempt to recoup funds&#160;years after the funds were initially distributed if the payers believe the funds were paid in error or determine that our solutions were medically unnecessary. If a payer&#8217;s audit of our claims results in a negative finding, and we are unable to reverse the finding through appeal or subsequent litigation, any subsequent recoupment could have an adverse effect on our revenue. Additionally, in some cases commercial payers for whom we are not a participating provider may elect at any time to review claims previously paid and determine the amount they paid was excessive. In these situations, the payer typically notifies us of its decision and then offsets the amount it determines to be overpaid against amounts it owes us on current claims. We may not have a mechanism to dispute these retroactive adjustments, and we cannot predict when, or how often, a payer might engage in these reviews. We have been, are currently, and may in the future be, subject to overpayment demands, recoupment efforts, and related disputes from or with payers, managed care plans, and government healthcare programs relating to the billing and coding of our solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, we maintain financial assistance programs under which we assess patient financial need and offer to provide solutions at a discount, or at no cost, to certain eligible patients. These practices may result in scrutiny of our financial assistance programs by governmental and commercial payers and could result in recoupment actions or termination of coverage of our solutions, as well as scrutiny under health care fraud and abuse laws. For additional information, see &#8220;&#8212;We have been, are currently, and in the future may be the subject of government investigations, claims, audits, whistleblower and payer audits, overpayment and recoupment efforts and other litigation in the course of our business that could adversely affect our business and financial statements&#8221; and &#8220;Business&#8212;Legal Proceedings.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently handle our own billing and coding for our solutions but have initiated the process of transitioning certain of our billing and coding software and other operations to a vendor for revenue cycle management services. Our business, financial condition, and results of operations may be affected by our ability to successfully transition these functions and the ability of our vendor to timely, accurately, and appropriately code and bill claims and collect payments in compliance with the stringent billing, coding and documentation requirements imposed by government healthcare programs and other payers. Terminating or transitioning arrangements with revenue cycle management vendors could result in additional costs and a risk of operational problems, delays in collections from payers, potential errors and possible control issues during the termination and transition processes, any of which could adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We rely on a limited number of third-party suppliers or, in many cases, sole suppliers, for some of our next-generation sequencers, lab materials, reagents, and supplies, and we may not be able to find replacements or immediately transition to alternative suppliers if necessary.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We rely on Illumina, Inc. (&#8220;Illumina&#8221;) as the sole supplier of NGS instruments and the associated sequencing reagent kits for our solutions. Illumina is also the sole provider of maintenance and repair services for these sequencing instruments. Without access to these sequencers, we may be unable to run our solutions and commercialize our solutions. Additionally, we rely on several sole suppliers, including, among others, Roche Diagnostics Corporation (&#8220;Roche&#8221;), Matsunami Glass USA (&#8220;Matsunami Glass&#8221;), and Agilent Technologies, Inc. (&#8220;Agilent&#8221;), for certain lab materials, reagents, and supplies. If we do not have timely access or access to sufficient quantities of these lab materials, reagents, and supplies, we may be unable to run our solutions and commercialize our solutions. We also rely on several sole suppliers, or manufacturers, for blood collection tubes, including the cfDNA PAXgene tubes for use with liquid biopsy profiling, for total nucleic acid extraction kits, and for the NGS panels and library preparation kits we use. Given the specialized function of certain instruments and reagents, suitable replacements may not be available if a product is discontinued or the product specification undergoes substantial changes due to their own external competition or otherwise. This may significantly delay our ability to continue to develop and commercialize any other future commercial products. All changes to instruments, associated software and reagents will undergo a risk evaluation to determine the level of validation required per the product regulatory status and may require supplementary submissions to, and approval of, regulatory agencies such as the FDA. Whether transitioning to a new supplier, instrument or reagent, the process is likely to be time-consuming, expensive and could affect test performance metrics. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have obtained a PMA approval from the FDA for MI Cancer Seek and may decide to seek FDA approval for Caris Assure and additional solutions. We do not manufacture the instruments or reagents used with our solutions, nor do we control such process, and we rely on external suppliers to maintain development and commercialization activities. The molecular testing performed by us is highly complex and requires specialized instruments and reagents, some of which are considered critical and could not be substituted without significant impact to our operations. Any failures or delays in negotiating appropriate agreements with our suppliers on reasonable terms, or their inability to obtain any required marketing authorizations, may increase our costs or delay or prevent us from obtaining or maintaining FDA marketing authorization of the related solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our current suppliers may also discontinue or substantially change the specification of products that we use or intend to use in our solutions. We believe there are few other manufacturers that are currently capable of supplying and servicing the equipment and materials necessary for our laboratory operations, including certain instruments, components, consumables, and reagents. Transitioning to a new supplier for this equipment or these materials would be time-consuming and expensive, could result in interruptions in or otherwise affect the performance specifications of our laboratory operations and sample processing or could require that we revalidate our solutions and could require a new submission to the FDA and other regulatory bodies to authorize such changes for any of our solutions that have received FDA approval. We also cannot guarantee that we will appropriately prioritize or select alternative suppliers, where necessary. In addition, we do not have written supply agreements with certain of our suppliers, including Agilent, Matsunami Glass, and PAXgene, and instead purchase certain products on a purchase order basis, which exposes us to potential price increases and termination of supply without notice or recourse. We cannot guarantee a consistent source of supply and cannot assure you that any efforts to enter into written agreements with our suppliers will be successful. The use of equipment or materials provided by a replacement supplier could require us to alter our laboratory operations and sample collection and processing and related procedures. Moreover, replacement instruments and associated reagents, tubes, and panels that meet our quality control and performance requirements may not be available at all, or may not be available on reasonable terms or in a timely manner. If we encounter delays or difficulties in securing, reconfiguring, or revalidating the equipment, reagents, and other materials that we require for our solutions, laboratory operations and same collection and processing, in particular for those products that are sole sourced, we would likely face significant disruptions or delays in commercializing our solutions and our business, financial condition, results of operations, and growth prospects would be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to obtain additional financing, we may be unable to execute on our business strategies and our growth prospects could be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our operations have required substantial amounts of cash since our inception. The development of our solutions are expensive, and we expect to continue to spend substantial amounts as we continue to enhance our solutions, broaden the applications of our existing solutions, and develop new solutions. In addition, obtaining any necessary or desirable marketing authorizations for our solutions will require substantial additional funding. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may consider raising additional capital in the future to expand our business, meet existing obligations, pursue acquisitions or strategic investments, take advantage of financing opportunities, or for other reasons, including to: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">increase our sales and marketing efforts to drive market adoption of our current solutions and address competitive developments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fund development and marketing efforts of new solutions or any other future solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expand our technologies into other types of cancer management and detection solutions for other chronic disease states; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acquire, license, or invest in our existing and future technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acquire or invest in complementary businesses or assets; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">finance capital expenditures and general and administrative expenses. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025, we had $31.2&#160;million of cash and cash equivalents and $2.2&#160;million of short-term marketable securities. We could use our available capital resources sooner than we expect, including due to changing circumstances or those beyond our control that may cause us to increase our spending significantly faster than we anticipate, requiring us to raise additional funds sooner than we anticipate. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will require additional capital for the development and commercialization of MI Cancer Seek, Caris Assure, Caris ChromoSeq, and the development of additional solutions. Our future capital requirements depend on many additional factors, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost of development and commercialization activities, including marketing and sales, for our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to achieve revenue growth; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost related to scaling operating capabilities to support demand for our solutions, including the cost of completing the build-out of our laboratory in Irving, Texas; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing of, and the costs involved in, obtaining any required or desired marketing authorizations for our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing, scope, progress, results and costs of developing additional solutions, and of conducting validation studies, clinical trials, and other studies that may be required in order to market our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs involved in obtaining, maintaining, protecting, and enforcing patent and other intellectual property rights and claims, including litigation costs and the outcome of such litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing and amount of sales of our solutions, if any, and collection of related receivables; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which our solutions are eligible for coverage and reimbursement from third-party payers and government payers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the emergence of new technologies, scientific breakthroughs, or any competing tests, products, or services, and other adverse market developments; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">other potential adverse developments. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additional capital may not be available when we need it, on terms acceptable to us or at all. We have no committed source of additional capital, having borrowed the remaining principal amount of $200.0&#160;million under the delayed draw loan of the 2023 Term Loan (as defined below) in March&#160;2024. Furthermore, any additional capital raised through the sale of equity or equity-linked securities will dilute shareholders&#8217; ownership interests in us, may require shareholder approval, may have an adverse effect on the price of our common stock, and holders of these securities may have rights, preferences, or privileges senior to those of our then-existing shareholders. Debt financing, if available, may include restrictive covenants that could limit how we conduct our business. Our ability to incur additional indebtedness also is currently restricted by the terms of our 2023 Term Loan Agreement (as defined below). If adequate capital is not available to us on a timely basis, we may be required to significantly delay, scale back, or discontinue the commercialization of our solutions or R&amp;D programs, or be unable to continue or expand our operations or otherwise capitalize on our business opportunities, as desired, which could adversely impact our business, financial condition, and results of operations and cause the price of our common stock to decline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If our facilities or those of our third-party collaborators are insufficient or become inoperable, our ability to provide our solutions will be significantly impaired and our business will be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently perform all R&amp;D and commercial profiling in our multiple laboratories in Phoenix and Tempe, Arizona and are building out our newest facility in Irving, Texas. Any disruption to the operations of these facilities could compromise the integrity of our samples and impede our ability to accurately perform our profiling and ultimately adversely impact our reputation, business, financial condition, and results of operations. In addition, we may maintain samples for several&#160;years. It is possible that some, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">if not all, of these samples may degrade over time, which could negatively impact our ability to use such samples to validate future solutions and which could adversely impact our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">One or more of our facilities may be harmed, rendered inoperable by physical damage or otherwise become partially or completely unusable due to fire, floods, earthquakes, power loss, telecommunications failures, break-ins, accidents, water shortages, floods, tornadoes, hurricanes, fires, extreme weather conditions, health epidemics, pandemics, and similar events, which may render it difficult or impossible for us to provide our solutions for some period of time. Our laboratories and the equipment we use to perform our R&amp;D or commercialization work could be unavailable or costly and time-consuming to repair or replace. It would be difficult, time-consuming, and expensive to rebuild one of our facilities, particularly in light of the licensure, permits, and accreditation requirements for clinical laboratories like ours. Although we carry insurance for damage to our properties and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have started the process of constructing a new laboratory facility in Irving, Texas to increase product development and operational capacity. Such construction requires significant resources, and we may encounter difficulties and delays in construction, procuring laboratory equipment, obtaining necessary validation, permits, licenses, and certifications (including CLIA certification and College of American Pathologists (&#8220;CAP&#8221;) accreditation, or completing the technology implementation) for this new facility. If we are unable to complete construction and go-live in a timely and satisfactory manner, obtain the necessary permits, licenses, certificates, and accreditations within our currently anticipated timelines, or meet demand for our solutions at our Arizona facilities, on a timely basis or at all, our reputation and commercial activities would be negatively impacted. We may be unable to regain customers or repair our reputation in the future, which would negatively impact our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We also rely on our third-party collaborators, consultants, contractors, vendors, suppliers, and service providers. The facilities of these partners could be subject to fire, floods, earthquakes, power loss, telecommunications failures, break-ins, accidents, water shortages, floods, tornadoes, hurricanes, fires, extreme weather conditions, health epidemics, pandemics and other natural or man-made disasters or business interruptions. In addition, they may be affected by government shutdowns, changes to applicable laws, regulations, and policies, or withdrawn funding. The occurrence of any of these business disruptions could seriously harm their ability to complete their contracted services to us, which may adversely impact our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If our solutions result in direct or indirect patient harm or injury, we could be subject to significant reputational and liability risks, and our business, financial condition, and results of operations could suffer.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our success depends on the market&#8217;s confidence that our solutions, including MI Profile, MI Cancer Seek, Caris Assure, MI Tumor Seek Hybrid, and GPSai and other solutions that we may develop in the future, can provide reliable and high-quality results. We believe that patients, physicians, and regulators are likely to be particularly sensitive to errors in the use of our solutions or failure of our solutions to perform as described, and there can be no guarantee that our solutions will meet their expectations. Performance failures could establish a negative perception of our solutions among physicians, patients, and regulators, jeopardize our ability to successfully commercialize our solutions, impair our ability to obtain marketing authorizations or secure favorable coverage and reimbursement, or otherwise result in reputational harm. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins. Identifying the root cause of quality issues, particularly those affecting reagents and third-party components, may be difficult, which increases the time needed to address quality issues as they arise, and increases the risk that similar problems could recur. In addition, we may be subject to legal claims arising from any errors in the use, manufacture, design, labeling or performance of our solutions, including any false-positive or false-negative results. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our anticipated application of Caris Assure for early detection, MRD tracking, and treatment monitoring poses additional risks. Caris Assure is currently intended to be used to detect cancers in patients. A detection of cancer by Caris Assure would need to be followed up with a cancer diagnosis by a physician. Because Caris Assure is not currently able to detect all forms of cancer, a negative test would not rule out the presence of cancer. Additionally, an individual undergoing further diagnostic procedures on </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the basis of a false-positive result or an erroneous cancer lineage could expose us to significant liability and reputational risks, notwithstanding the emotional and mental health effects to which the patient may be exposed. Similarly, an individual who receives a cancer diagnosis shortly following an inaccurate result, such as a negative test or false negative result, may create adverse publicity about our solutions, which could damage our reputation and have a negative impact on our business, financial condition, and results of operations. Failure to accurately detect cancer and other performance failures could establish a negative perception of our solutions among physicians, patients, customers, and regulators, jeopardize our ability to successfully commercialize our solutions, impair our ability to obtain marketing authorizations or secure favorable coverage and reimbursement, or otherwise result in reputational harm or enforcement action or inquiry by a regulatory body. These risks may be more pronounced and could expose us to claims of injury or other adverse events under medical liability, product liability, or other liability laws if a provider uses our tests inaccurately or inappropriately for diagnosis purposes, as our solutions would be directly involved with the choice to use certain treatments. In addition, we may be subject to legal claims arising from any errors in the use, manufacture, design, labeling, marketing, or performance of our products, including from inaccurate results. If our solutions result in direct or indirect participant or patient harm or injury, we could be subject to significant reputational and liability risks, may be required to initiate corrective actions, recalls or suspend sales of our products, which may adversely impact our reputation, business, financial condition, and results of operations.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we were to be sued for product liability or professional liability, we could face substantial liabilities that exceed our resources, including any insurance coverage.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The marketing, adoption, and use of our solutions could lead to the filing of product liability claims if someone alleges that our solutions identified inaccurate or incomplete information regarding the genomic alterations of the tumor or malignancy analyzed, reported inaccurate or incomplete information concerning the available therapies for a certain type of cancer, or otherwise failed to perform as designed. We may also be subject to professional liability for errors in, a misunderstanding of, or inappropriate reliance upon, the information we provide in the ordinary course of our business activities. A product liability or professional liability claim could result in substantial damages and be costly and time-consuming for us to defend. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We maintain product and professional liability insurance, but this insurance may not fully protect us from the financial impact of defending against product liability or professional liability claims. Any product liability or professional liability claim brought against us, with or without merit, could increase our insurance rates or prevent us from securing insurance coverage in the future. Additionally, any product liability or professional liability lawsuit could damage our reputation or cause current clinical customers to terminate existing agreements with us and potential clinical customers to seek other partners, any of which could adversely impact our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business and results of operations will suffer if we fail to compete effectively.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The precision oncology industry, which is the focus of our current commercial portfolio, is intensely competitive. Our competitors include numerous companies offering or seeking to offer tissue-based molecular profiling, blood-based early detection, blood-based molecular profiling for therapy selection, MRD tracking, and/or treatment monitoring, core biopharma services, and genomic data and AI services to biopharma companies. For additional information, see &#8220;Business&#8212;Competition.&#8221; Our competitors have or may have substantially greater financial, technical, and other resources, such as larger R&amp;D staff and more well-established marketing and sales forces. Our competitors may succeed in developing, acquiring, or licensing, on an exclusive basis or otherwise, tests or services that are more effective or less costly than our solutions. In addition, established medical technology, biotechnology, or biopharma companies, some of whom may be our customers, may invest heavily to accelerate discovery and development of tests that could make our solutions less competitive than we anticipate. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our ability to compete successfully will depend largely on our ability to: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully commercialize and expand the features of our solutions and develop new solutions to achieve meaningful innovation in precision oncology and other chronic disease states; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">demonstrate compelling advantages in the performance and convenience of our solutions, including on a cost competitive basis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">achieve market acceptance of our solutions by patients and healthcare providers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rate of adoption and/or endorsement of our solutions by clinicians, KOLs, advocacy groups, and biopharma companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">achieve adequate coverage and reimbursement recognition from governmental payers, health insurance organizations, and other third-party payers for our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">address any technological, scientific, and market developments to differentiate our solutions from products and services offered by current and potential competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">attract qualified scientific, data science, clinical development, solution development, and commercial personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtain, maintain, defend, and enforce patent and other proprietary protection as necessary for our solutions and platform; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtain and maintain any necessary or desirable marketing authorizations from regulators in the United States and other jurisdictions for any versions of our current solutions and any future solutions that we may develop; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully collaborate with institutions in the discovery, development, and commercialization of our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establish and maintain supply and manufacturing relationships with third parties that can timely and consistently provide adequate, in both amount and quality, products and services to support clinical development and the market demand for our solutions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully expand our operations infrastructure and implement a successful sales and marketing strategy to support increased commercialization. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may not be able to compete effectively or keep pace with the rapid rate of change in our industry if we are unable to accomplish one or more of these or similar objectives. This could render our solutions obsolete or less attractive, result in significant price reductions, or substantially limit the volume of products that we offer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure of, or defects in, our AI/ML models and on-premise, co-located, and cloud-based computing infrastructure, including interruption of services through Amazon Web Services, or increased regulation in the AI/ML space, could impair our ability to process our data, develop solutions, or provide test results, and harm our business and results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The design, development, maintenance, and operation of our technology over time is expensive and complex, and may involve unforeseen difficulties including material performance problems, undetected defects, or errors. Overcoming technical obstacles and correcting defects or errors could prove to be impossible or impracticable, and the costs incurred may be substantial and adversely affect our business, financial condition, and results of operations. Additionally, regulation in the AI/ML space is constantly evolving. See &#8220;&#8212;Regulatory, social and ethical issues relating to our use of new and evolving technologies, such as AI and ML, may result in reputational harm and liability.&#8221; If our technology does not function reliably, fails to meet expectations in terms of performance, or cannot be fully utilized due to increasing regulation, including regulation by the FDA of AI or medical device software, we may be unable to provide, or our customers may stop using, our solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently host our data on, and conduct certain data analysis through, Amazon Web Services (&#8220;AWS&#8221;) cloud-based hosting facilities as well as on our own co-located or on-premise computing infrastructure. Any technical problems or outages that may arise in connection with AWS&#8217;s or our data center hosting facilities could result in operational disruption, loss of our data or delayed or ineffective data processing. A variety of factors, including infrastructure changes, human or software errors, viruses, malware, security attacks, fraud, denial of service or technical support issues could cause interruptions in our service. Such service interruptions may reduce or inhibit our ability to provide our solutions, delay our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">clinical trials, and damage our relationships with our customers. We could also be exposed to potential lawsuits, customer reputational impact, liability claims or regulatory actions, for example, if AWS or we experienced a privacy or data security breach. If we were required to transfer our data to an alternative hosting provider, the transfer and acclimation to the new provider could result in significant business delays and subject us to technological risks and require additional resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory, social, and ethical issues relating to our use of new and evolving technologies, such as AI and ML, may result in reputational harm, additional costs, and liability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We utilize AI/ML algorithms for data analysis of patient information and other data. As with many cutting-edge innovations, AI and ML present new risks and challenges, including social and ethical issues and a quickly evolving legal and regulatory environment, which may cause us to incur increased compliance or R&amp;D costs, or to divert resources from other development efforts. Regulation of AI/ML usage continues to evolve, and limitations placed on the use of data, including personal information, health data, or genetic/genomic data in such systems may make it difficult or more costly for us to continue using our ML algorithms. Existing laws and regulations may be interpreted to apply to us in new ways due to our use of AI and ML, the nature and extent of which are difficult to predict. The risks and challenges presented by AI and ML could undermine public confidence in AI and ML, which could slow its adoption, impact patients&#8217; and physicians&#8217; confidence in our solutions, and otherwise affect our business. Failure to adequately address ethical and social issues related to our use of AI/ML could adversely affect the adoption of our solutions and subject us to reputational harm, regulatory action, or legal liability, which may harm our financial condition and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Potential government regulation related to AI ethics or usage may also increase the burden and cost of R&amp;D in this area. Certain U.S. states have passed or are considering the passage of laws intended to regulate and/or require disclosures in connection with the usage of AI, including in interactions with customers or other market participants. For example, Colorado passed the Colorado Artificial Intelligence Act, which will require disclosures and compliance efforts associated with different uses of AI, and Utah passed the Utah Artificial Intelligence Policy Act, which requires certain disclosures to customers and confirms companies&#8217; responsibility for legal violations caused by their AI applications. It is possible that these or other states or the federal government could pass additional legislation or implement regulations impacting businesses&#8217; use of AI/ML, which could impact our operations and impose additional costs or liability on us. Additionally, employees or customers who are dissatisfied with our public statements, policies, practices, or solutions related to the development and use of AI and ML may express opinions that could introduce reputational or business harm, or legal liability. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We use AI/ML to assist us in making certain diagnostic and benefit prediction decisions, which AI/ML is regulated by certain privacy laws. Due to inaccuracies or flaws in the training, development, inputs, outputs, and logic of an AI/ML model, the model could be biased. Any bias in a model could result in limits on the applicability or accuracy of the model across patient populations or could lead us to make decisions that could disadvantage certain individuals (or classes of individuals) and adversely impact their rights, employment, and ability to obtain certain pricing, products, services, or benefits. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are highly dependent on our key personnel, and if we lose key members of our senior management, scientific or technical teams or are not successful in attracting, motivating, and retaining highly qualified personnel, we may not be successful.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our ability to compete in the competitive precision medicine industry depends upon our ability to attract, motivate, and retain highly qualified personnel. We are particularly dependent on key members of our senior management team, including David D. Halbert, our Founder, Chairman, and Chief Executive Officer. The loss or incapacity of existing members of our senior management team could adversely affect our operations if we experience difficulties in hiring qualified successors and could hamper or delay the development and commercialization of our solutions and harm our business, financial condition, and results of operations. We do not maintain &#8220;key person&#8221; insurance policies on the lives of these individuals or the lives of any of our other employees. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our R&amp;D programs and laboratory operations depend on our ability to attract and retain highly skilled scientists, technicians, and data scientists. We may not be able to attract or retain qualified scientists </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and technicians in the future due to the competition for qualified personnel among life science businesses. We also face competition from universities and public and private research institutions in recruiting and retaining highly qualified scientific personnel. In addition, we may have difficulties locating, recruiting, or retaining qualified sales representatives and business development managers. Recruiting and retention difficulties can limit our ability to support our R&amp;D and sales programs. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To induce valuable employees to remain at our company, in addition to salary and cash incentives, we provide stock option and RSU grants with vesting conditions. The value of these equity grants may be significantly affected by movements in our stock price that are beyond our control, and may at any time be insufficient to counteract more lucrative offers made to our employees from other companies. Although we have employment agreements with certain key employees, consistent with all of our employment arrangements, these employment agreements provide for at-will employment, which means that any of our employees could leave our employment at any time, with or without notice. If we are unable to attract and incentivize highly qualified personnel on acceptable terms, or at all, our business, financial condition, and results of operations may suffer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If our information technology systems or those of third parties with whom we work, or our data are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions, litigation, fines and penalties, disruptions of our business operations, reputational harm, loss of revenue or profits, and other adverse consequences.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the ordinary course of our business, we and the third-parties with whom we work collect, store, receive, process, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, transmit, and share (collectively, &#8220;Process&#8221;) personal information, including health-related information, individually identifiable health information and protected health information (&#8220;PHI&#8221;) as defined by the Health Insurance Portability and Accountability Act, as amended by the Health Information Technology for Economic and Clinical Health Act, and their implementing regulations (collectively, &#8220;HIPAA&#8221;), personally identifiable information, credit card and other financial information, and intellectual property and proprietary business information (collectively &#8220;Sensitive Information&#8221;). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a result, we and the third parties with whom we work face numerous and evolving cybersecurity risks that threaten the confidentiality, integrity, and availability of our information technology and telecommunications systems and Sensitive Information. Such threats are prevalent and continue to rise, are increasingly difficult to detect, and come from a variety of sources, including telecommunications or network failures, malicious human acts, and natural disasters. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and the third parties with whom we work are subject to threats from various threat actors, such as state-sponsored organizations, criminal threat actors, organized crime outfits, opportunistic hackers and &#8220;hacktivists,&#8221; as well as a variety of evolving threats, such as social engineering/phishing (including through deep fakes, which may be increasingly more difficult to identify as fake), malware (including ransomware and as a result of advanced persistent threat intrusions), network reconnaissance and intellectual property theft, use of illegitimate virtual private networks or anonymization tools, malfeasance by insiders (such as personnel misconduct or error), human or technological error, malicious code (such as viruses and worms), denial-of-service attacks, database compromises, business email compromises, credential stuffing, credential harvesting, credential theft, software &#8220;bugs,&#8221; misconfigurations, or other vulnerabilities in software that is integrated into our (or the third parties with whom we work) IT systems, misuse of company resources and software, lack of adherence to company policy, products or services, adware, attacks enhanced or facilitated by AI, physical or electronic break-ins, earthquakes, fires, floods, and similar disruptive threats. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some actors now engage and are expected to continue to engage in cyber-attacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities. During times of war and other major conflicts, we and the third parties with whom we work are vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our services. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Remote work has become more common and has increased risks to our information technology systems and data, as more of our employees utilize network connections, computers, and devices outside our premises or network, including working at home, while in transit and in public locations. Additionally, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">future or past business transactions (such as acquisitions or integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities&#8217; systems and technologies. Furthermore, we may discover security issues that were not found during due diligence of such acquired or integrated entities, and it may be difficult to integrate companies into our information technology environment and security program. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We depend on information technology and telecommunications systems, including those provided by third parties and their vendors (some of which are legacy systems developed internally and may carry additional information security vulnerabilities), for significant elements of our operations, such as our laboratory information management systems, including test validation, specimen tracking, and quality control; personal information collection, storage, maintenance, and transmission; our profiling report production systems; and our billing and reimbursement, R&amp;D, scientific and medical data analysis, and general administrative activities that collect, store and transmit large amounts of Sensitive Information, including intellectual property, proprietary business information, PHI, and other personal information of our customers, patients, business partners, employees, and contractors on such systems. In turn, the third parties and vendors with whom we work depend upon technology and telecommunications systems provided by outside vendors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. If the third parties with whom we work experience a security incident or other interruption, we could experience adverse consequences. While we may be entitled to damages if the third parties with whom we work fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. In addition, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties&#8217; infrastructure in our supply chain or that of the third parties with whom we work have not been compromised. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cyber-attacks, malicious internet-based activity, online and offline fraud, insider threats and other similar activities are increasing in their frequency, levels of persistence, sophistication, and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise. Furthermore, because the techniques used to obtain unauthorized access to, or to sabotage, systems change frequently and often are not recognized until launched against a target, we and the third parties with whom we work may be unable to anticipate these techniques or implement adequate preventative measures. We and the third parties with whom we work may also experience security incidents that may remain undetected for an extended period. There can also be no assurance that our cybersecurity risk management program and processes, including our policies, controls, or procedures, will be fully implemented, complied with or effective in protecting our information technology and telecommunications systems and Sensitive Information. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, severe ransomware attacks are becoming increasingly prevalent and can lead to significant interruptions in our operations, ability to provide our products or services, loss of Sensitive Information and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. Some of these attacks have also been coupled with attackers directly threatening executives with physical harm. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Applicable privacy and data security obligations may require us to notify relevant stakeholders, including affected individuals, customers, regulators, and investors, of security incidents, or to implement other requirements such as providing credit monitoring. Such disclosures and compliance with such requirements are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences. For example, a growing number of legislative and regulatory bodies around the world have adopted breach notification and other requirements in the event that information subject to such laws is accessed by unauthorized persons and additional regulations regarding the use, access, accuracy, and security of such data are possible. In particular, we are a &#8220;Covered Entity&#8221; as defined under HIPAA, and, in the event of a breach as defined by HIPAA, we have specific reporting requirements under HIPAA regulations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under HIPAA, in the event of a significant breach, the reporting requirements could include notification to the general public, in addition to affected individuals and certain governmental agencies. In </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">addition, in the United States, we are subject to state and other laws that require notification. Complying with such numerous and complex regulations in the event of unauthorized access would be expensive and difficult, and failure to comply with these regulations could subject us to regulatory scrutiny and additional liability, could harm our reputation and our ability to compete, and could adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We take steps designed to detect, mitigate, and remediate vulnerabilities in our information systems (such as our hardware and/or software, including that of third parties with whom we work). We may not, however, detect or remediate all such vulnerabilities including on a timely basis. By way of example, in the spring of 2024, a security researcher informed us of a previously unknown vulnerability in one of our systems, which we have remediated. Further, we may experience delays in developing and deploying remedial measures and patches designed to address identified vulnerabilities. Vulnerabilities could be exploited and result in a security incident. If attackers are able to exploit vulnerabilities before patches are installed or mitigating measures are implemented, compromises could impact our information technology systems and Sensitive Information. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any of the previously identified or similar threats could cause a security incident or other interruption that could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our Sensitive Information or our information technology systems, or those of the third parties with whom we work. A security incident or other interruption could disrupt our ability (and that of third parties with whom we work) to provide our services. If an attacker were to gain sufficient access to our systems, our data contained in those systems could be discovered by the attacker. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We, and the third parties with whom we work have been the target of cybersecurity attacks in the past and expect that such cybersecurity incidents will continue to occur in the future. For example, the February 2024 cybersecurity attack on Change Healthcare, who we used to process certain insurance claims, resulted in a delay in our ability to submit claims for payment and could require us to issue notifications to impacted individuals and various regulators if Change Healthcare determines that any PHI of our patients was impacted. While we may be entitled to damages as a result of this incident, any award may be insufficient to cover all such damages, or we may be unable to recover such award. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may expend significant resources or modify our business activities to try to protect against security incidents. Additionally, certain privacy and data security obligations may require us to implement and maintain specific security measures or industry-standard or reasonable security measures to protect our information technology systems and Sensitive Information. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Despite the precautionary measures we and the third parties with whom we work have taken to detect and prevent or solve problems that could affect our information technology and telecommunications systems and Sensitive Information, there is a risk that our security measures will not be fully effective in the future. Failures or significant downtime of these systems or those used by the third parties with whom we work could prevent us from conducting tests, preparing and providing reports to future customers, billing payers, conducting R&amp;D activities, maintaining our financial controls and other reporting functions, and managing the administrative aspects of our business. Any failure by us or the third parties with whom we work to prevent or mitigate security incidents, or other adverse impact to the availability, integrity, or confidentiality of our information technology systems or Sensitive Information, or improper access to, or use, acquisition, disclosure, alteration or destruction of, any such Sensitive Information, including loss of PHI or other data subject to privacy laws or proprietary business information, could result in operational or business delays, significant liability, regulatory action, a material loss of revenue resulting from the adverse impact on our reputation and brand, a diminished ability to retain or attract new customers, disruption to our business, and adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our existing cyber liability insurance policies may not cover, or may cover only a portion of, any potential claims related to security breaches to which we are exposed or may not be adequate to indemnify us for all or any portion of liabilities that may be imposed. We also cannot be certain that our existing insurance coverage will continue to be available on acceptable terms or in amounts sufficient to cover the potentially significant losses that may result from a security incident or breach or that the insurer will not deny coverage of any future claim. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to experiencing a security incident, third parties may gather, collect, or infer Sensitive Information about us from public sources, data brokers, or other means that reveals competitively sensitive details about our organization and could be used to undermine our competitive advantage or market position. Additionally, Sensitive Information of the Company or our customers could be leaked, disclosed, or revealed as a result of or in connection with our employees&#8217;, personnel&#8217;s, or vendors&#8217; use of AI/ML technologies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not be successful in developing and commercializing new solutions or new applications for our current solutions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We continue to expand our R&amp;D efforts to use our solutions and our multi-modal clinico-genomic datasets to develop enhanced versions of our solutions and create new solutions. These initiatives include expanding the application of Caris Assure to early detection, MRD tracking, and treatment monitoring, developing Caris ChromoSeq for hematological (blood) cancers, developing additional AI signatures using NGS or image data, and additional solutions, including for chronic disease states beyond cancer. The commercialization of any new solutions or new applications for our current solutions will require the completion of certain clinical development activities, validation studies and/or clinical trials, having guidelines or recommendations for healthcare providers, administrators, payers, and patient communities relating to such solutions, and receiving favorable exposure in peer-reviewed publications and from KOLs. We cannot assure you that we can successfully complete the clinical development or applicable subsequent requirements of any such solutions in order to commercialize such solutions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may fail to build a sustainable data licensing business, and our data licensing efforts may result in reputational harm that has an adverse effect on our business, financial condition, and results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We and our biopharma and academic partners leverage high-powered computing and AI/ML algorithms to analyze our data to find the key molecular characteristics of a particular disease or dysfunction that drives disease. As part of these efforts, we license data to our partners, and certain of our partners license data to us. We are in the early stages of these data licensing efforts and may not be able to grow these efforts into a sustainable business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The outbound licensing of data for research purposes is a novel business model without an established track record, which makes it difficult to evaluate our future prospects and the risks and challenges we may encounter in seeking to execute on this opportunity. Although we have negotiated data licensing agreements with several partners, these partners may have rights to terminate these agreements before the initial term has been completed, and these arrangements may not be renewed, or they may be renewed on less favorable terms. In addition, many of our data licensing agreements involve the use of third-party clinical data that is combined with our molecular data and then licensed to biopharma companies or other end users, and these third-party clinical data partners may not be willing to work with us in the future. We also depend on these third-party partners to provide access to data from their own data partners. We cannot guarantee that our third-party partners will enter into new data sharing arrangements with us, continue to provide their data, or that of their partners, to us, or include their data as part of combined data sets, and in the event that any of these arrangements terminate, we may not be able to find a replacement, or a replacement may not be available on reasonable terms or in a timely manner. Any of the foregoing could result in us losing access to real-world evidence, longitudinal patient data, and clinical outcomes that are key to maintaining, expanding, and enriching our datasets, which could have an adverse effect on our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The commercial market for licensing this type of data may not develop or may be limited by regulation or other factors, which could diminish the value of licensing this data over time and make it challenging to secure arrangements with these partners on similar terms, or at all, with any additional licensees. While our data licensing arrangements include protections against abuse and misuse of patient data, we may be unable to adequately control how our partners, or the commercial customers that they license our data to as part of a combined data set, use the data, and any abuse or misuse could adversely impact our reputation, which could have an adverse effect on our business, financial condition, and results of operations. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we cannot maintain our current relationships, or enter into new relationships, with biopharma companies, our development of solutions could be delayed or our business, financial condition, and results of operations could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We deploy our proprietary profiling and signature offerings to analyze tissue and blood samples provided by biopharma partners. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our success in the future depends in part on our ability to maintain and expand relationships with our biopharma partners. This can be difficult due to several factors, including internal and external constraints placed on these organizations that can limit the number and type of relationships with companies like us they can consider and consummate; that certain of our agreements governing our relationships are terminable at will by our biopharma partners; and that our biopharma partners may be dissatisfied with our services. Continued usage of our services by particular biopharma partners may also depend on whether the partner obtains positive data in its clinical trials, is able to successfully obtain regulatory approval and subsequently commercializes a therapy for which we have partnered with them to develop a companion diagnostic, or other administrative factors that are outside our control. Additionally, some of our biopharma partners have contracted with us to provide profiling for large numbers of samples, which could strain our testing capacity and restrict our ability to perform tests for other customers. If we fail to maintain these relationships or enter into new ones, our business could suffer. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, we expect to engage in discussions with biopharma companies regarding commercial opportunities. There is no assurance that any of these discussions will result in a commercial agreement, or if an agreement is reached, that the resulting engagement will be successful or that any clinical trials conducted as part of the engagement will produce successful outcomes. Speculation in the industry about our existing or potential engagements with biopharma companies can be a catalyst for adverse speculation about us, our services, and our technology, which can result in harm to our reputation and our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We rely on third-party services to collect, process, transport, and store our samples in a secure and cost-efficient manner. If these services were disrupted, our business would be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We rely on third-party providers to collect tissue and blood samples for our solutions. If third-party providers fail to adequately and properly obtain and collect viable blood and tissue samples from patients and to properly and timely package and ship the samples to us, our patients and their physicians may experience problems and delays in receiving test results, which could lead to dissatisfaction with our solutions, therefore harming our reputation and adversely affecting our business, financial condition, and results of operations. If our current third-party providers become unable to continue to collect samples for us or if our clients are unable to readily access a provider to collect a blood or tissue sample that we can analyze, we may be unable to compete effectively with other laboratories that have greater access to phlebotomy providers and our business, may be harmed. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we may maintain samples and extracted material for several&#160;years. It is possible that the long-term stability of these samples may not be maintained with the passage of time, which could negatively impact our ability to use such samples to validate our solutions. Further, interruptions in collection, processing, freezing, storing, or transportation of samples performed by third parties, whether due to labor disruptions, weather conditions, natural disaster, terrorist acts, threats, or for other reasons could adversely affect the samples and our ability to process the samples in a timely manner, which could negatively affect our ongoing research studies and harm our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The clinical trial process is lengthy and expensive with uncertain outcomes. We have encountered delays, and may encounter future substantial delays, in our clinical trials, and may therefore be unable to complete our clinical trials on the timelines we expect, if at all, which could adversely impact our ability to market our solutions or receive adequate reimbursement.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical testing is expensive, time-consuming, and subject to uncertainty. Initiating and completing validation studies and clinical trials necessary to validate and market our solutions, and to support any submissions to CMS, MolDX, or other payers for reimbursement, or the FDA for marketing authorization for our solutions, will be time-consuming and expensive and the outcomes are inherently uncertain. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Validation studies and clinical trials must be conducted in accordance with the laws and regulations of the FDA and other applicable regulatory authorities&#8217; legal requirements and regulations, and are subject to oversight by these governmental agencies and institutional review boards (&#8220;IRBs&#8221;). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The results of preclinical studies and clinical trials of our solutions conducted to date and ongoing or future studies and trials of our current, planned, or future solutions may not be predictive of the results of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. Our interpretation of data and results from our validation studies and clinical trials do not ensure that we will achieve similar results in future validation studies or clinical trials. In addition, preclinical and clinical data are often susceptible to various interpretations and analyses, and many companies that have believed their products performed satisfactorily in validation studies, preclinical studies and earlier clinical trials have nonetheless failed to replicate results in later validation studies or clinical trials. Products in later stages of validation studies or clinical trials may fail to show the desired analytical validity and clinical validity despite having progressed through validation studies, nonclinical studies, and earlier clinical trials. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, we cannot guarantee that any validation studies or clinical trials will be conducted as planned or completed on schedule, if at all. The timely completion of validation studies in accordance with their protocols depends, among other things, on our ability to locate and test a sufficient number of samples to demonstrate satisfaction of the validation study criteria. The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of participants who remain in the trial until its conclusion. Many of our validation studies and clinical trials require enrolling a large number of participants without cancer who may not see value in enrollment. Additionally, we may encounter delays as a result of the administrative complexities in managing and recruiting for validation studies and trials of this scope and size. If we are unable to recruit and enroll sufficient participants for our validation studies or clinical trials, or maintain sufficient participation of enrolled participants, our product development, commercialization activities and our ability to seek marketing authorization for our solutions could be delayed, modified, or prevented. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The initiation and completion of validation studies and clinical trials may be prevented, delayed, or halted for numerous reasons, including related to the following: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inability to generate sufficient </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> or </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> data to support the initiation or continuation of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the requirement to submit an IDE application to the FDA, which must become effective prior to commencing certain human clinical trials of significant risk medical devices, and which the FDA may disapprove; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">delays caused by participants withdrawing from clinical trials or failing to return for follow-up or by institutions failing to timely submit data, including follow-up data, if at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">delays or failure in reaching a consensus or agreement, if required, with regulatory agencies on trial design or feedback from regulatory agencies necessitating changes to ongoing or planned clinical trial design; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">delays or failure in reaching agreement on acceptable terms with prospective contract research organizations (&#8220;CROs&#8221;), service providers, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">delays or failure in obtaining any required IRB approvals or ethics committee (&#8220;EC&#8221;) approvals for our clinical trial sites; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">delays in amending, or the inability to amend, our IRB-approved protocols at clinical trial sites when necessary or desired; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">difficulty or delays in collaborating with sites, institutions, and investigators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure by us, investigators, sites, or participants to comply with the applicable trial protocol or applicable regulatory requirements and standards for data collection, reporting, records maintenance, or data integrity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure by us, investigators, sites or any CROs or other third parties to adhere to clinical trial requirements, including the applicable protocol; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to perform in accordance with good clinical practice (&#8220;GCP&#8221;) and good laboratory practice requirements, and/or other applicable regulations and requirements of the FDA or other applicable governmental authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to comply with applicable privacy and data security laws related to clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure of our solutions to achieve acceptable performance, and safety endpoints; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">unacceptable safety findings, including findings related to the risk of the false positive tests (which could lead to unnecessary biopsy or anxiety) or false negative tests (which could lead to a delay in diagnosis or disease progression); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">termination or suspension of a trial or site by us or the data safety monitoring board, suspension or termination of a trial or site by an IRB, EC, or institution, or clinical hold or termination of a trial or site by a regulatory authority, including the FDA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disqualification, termination, or suspension of a clinical investigator; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">adverse inspections of our clinical trial sites or results by any applicable regulatory authority, including the FDA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in statutory or regulatory requirements or guidance, or clinical guidelines, that require amending existing or designing new clinical protocols, obtaining new IRB or EC approvals, modifying our clinical trials, modifying our consent process or obtaining additional consent from trial participants, or altering the pathway to marketing authorization of our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in the standard of care on which a clinical development plan was based, which may require new or additional clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost of clinical trials of our solutions being greater than we anticipate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">destruction or compromise of, or other inability to access or receive, clinical trial samples processed, stored, or managed at a third-party site or otherwise in the control of a third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">clinical trials of our solutions producing negative or inconclusive results, which may result in our deciding, or regulators requiring us, to conduct additional clinical trials or abandon development programs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">lack of adequate funding. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any such delays could adversely affect the costs, timing, or successful completion of any future clinical trials. Moreover, we may depend on our collaborators and on medical institutions and CROs to conduct any future clinical trials in compliance with applicable GCP requirements, and while we may have agreements governing their committed activities, we may have limited influence over their actual performance. To the extent any future collaborators, the CROs, or clinical sites fail to enroll participants for our clinical trials, fail to conduct the trial to GCP requirements or are delayed for a significant time in the execution of trials, including achieving full enrollment, we may be affected by increased costs, program delays, and/or enforcement actions. In addition, any future clinical trials that are conducted in countries outside the United States may subject us to further delays and expenses. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any inability to initiate or complete clinical trials successfully could result in additional costs to us, slow down or prevent our product development and receipt of positive reimbursement and coverage decisions, or impair our ability to generate revenue. Delays in initiating or completing our planned clinical trials could also allow our competitors to bring competing products to market before we do or sooner than expected, which could impair our ability to successfully commercialize our solutions, if launched, and may harm our business, financial condition, and results of operations. In addition, many of the factors that may cause, or lead to, a delay in initiation or completion of clinical trials may also ultimately lead to the delay or the narrowing or denial of any marketing authorization we may seek with respect to our solutions. Delays in the initiation or completion of any clinical trial of our solutions, such as Caris Assure for early detection, MRD tracking, or treatment monitoring, or seeking coverage and reimbursement, will increase </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">our costs, slow down, or jeopardize our product development and marketing authorization process, and delay or potentially jeopardize broad adoption of our solutions and their ability to generate revenue. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Regulation and Legal Compliance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we or our partners fail to comply with healthcare and other applicable laws and regulations, we could face substantial penalties and sanctions and our business, reputation, financial condition, and results of operations could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our operations in the United States are subject to various U.S. federal and state laws and regulations that govern, among other things, the manner in which we provide and bill for tests and collect reimbursement from governmental programs, third-party payers and patients, our relationships with referral sources, and our marketing and advertising activities. In addition, the commercialization of our solutions outside the United States would also subject us to foreign equivalents of the healthcare laws described below, among other foreign laws. The laws that may impact our operations include: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal Anti-Kickback Statute (the &#8220;AKS&#8221;), which prohibits, among other things, knowingly and willfully soliciting, receiving, offering, or paying any remuneration (including any kickback, bribe, rebate, a provision of free or discounted goods, services or items), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the purchase, lease, order, recommendation, or arrangement of any good, facility, item, or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation, and many courts have interpreted the AKS as being violated if merely one purpose of any arrangement is to induce referrals or purchases. The AKS includes statutory exceptions and regulatory safe harbors that protect certain arrangements. Failure to meet the requirements of an exception or safe harbor, however, does not render an arrangement illegal. Rather, the government may evaluate arrangements that do not fit into an exception or safe harbor on a case-by-case basis, taking into account all facts and circumstances, including the parties&#8217; intent and the arrangement&#8217;s potential for abuse, and such arrangements may be subject to greater scrutiny by enforcement agencies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Eliminating Kickbacks in Recovery Act of 2018 (&#8220;EKRA&#8221;), which establishes an all-payer anti-kickback prohibition for, among other things, knowingly and willfully paying or offering any remuneration directly or indirectly to induce a referral of an individual to or in exchange for an individual using the services of a clinical laboratory. EKRA applies to all payers including commercial payers and government payers. EKRA adopted safe harbors that are not directly analogous to the safe harbors under the AKS, and certain conduct that is permissible under the AKS may violate EKRA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal physician self-referral prohibition, commonly known as the Stark Law, which, in the absence of an applicable exception, prohibits a physician from making a referral for certain designated health services covered by the Medicare or Medicaid program if the physician or an immediate family member of the physician has a financial relationship (including an ownership interest or a compensation arrangement) with the entity providing the designated health services. The Stark Law also prohibits the entity furnishing the designated health services from billing, presenting, or causing to be presented a claim for the designated health services furnished pursuant to the prohibited referral. The term &#8220;designated health services&#8221; includes, among other things, clinical laboratory services. Unlike the AKS, the Stark Law is violated if the financial arrangement does not meet an applicable exception, regardless of any intent by the parties to induce or reward referrals or the reasons for the financial relationship and the referral; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FCA, which imposes civil and criminal liability on individuals or entities that knowingly submit false or fraudulent claims for payment to the government or knowingly make, or cause to be made, a false statement in order to have a false claim paid. Actions under the FCA may be brought by the government or by a private person under a qui tam, or &#8220;whistleblower,&#8221; suit. There are many potential bases for liability under the FCA. For example, the government </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">has used the FCA to prosecute Medicare and other government healthcare program fraud such as coding errors, coding and billing for tests not compliant with coverage and reimbursement requirements, including MolDX reimbursement and coverage standards and requirements, waiver of patient copayments and deductibles, and performing tests that are not medically necessary or that are substandard in quality. In addition, a claim including items or services resulting from a violation of the AKS constitutes a false or fraudulent claim for purposes of the FCA, and courts have held that claims for services furnished pursuant to a referral prohibited by the Stark Law also are considered false for purposes of the FCA; </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the criminal healthcare fraud provisions of HIPAA and related rules that prohibit knowingly and willfully executing a scheme or artifice to defraud any healthcare benefit program or falsifying, concealing, or covering up a material fact or making any materially false, fictitious, or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items, or services. These criminal healthcare fraud provisions are not limited to benefits, items, or services that may be paid for by federal or state healthcare programs, and similar to the AKS, a person or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have committed a violation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal Civil Monetary Penalties Law, which provides civil penalties for a wide variety of conduct relating to federal and state healthcare programs, including, subject to certain exceptions, prohibiting, among other things, the offer or transfer of remuneration, including free services, discounts, or waivers of copayments and deductible amounts (or any part thereof), to a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner or supplier of services reimbursable by Medicare or a state healthcare program; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal Physician Payment Sunshine Act, created under the Affordable Care Act (the &#8220;ACA&#8221;), and its implementing regulations, which require manufacturers of drugs, devices, biologicals, and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program to report annually to the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) under the Open Payments Program, information related to payments or other transfers of value made to physicians (as defined by statute), teaching hospitals and other healthcare practitioners such as physician assistants and nurse practitioners, as well as ownership and investment interests held by such physicians and their immediate family members and similar state laws with various reporting requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">state self-referral, kickback, false claim, fraud, and abuse laws, some of which may apply to items or services reimbursed by any payer, including patients and commercial insurers, and include &#8220;whistleblower&#8221; provisions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">federal and state &#8220;Anti-Markup&#8221; rules, which, among other things, typically prohibit a physician or supplier billing for clinical or diagnostic tests (with certain exceptions) from marking up the price of a purchased test performed by another physician or supplier that does not &#8220;share a practice&#8221; with the billing physician or supplier; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">federal and state laws applicable to test ordering, documentation of tests ordered, consent requirements, billing practices and claims payment and laws that prohibit other specified practices, such as providing tests at no or discounted cost to induce adoption, which may apply to laboratories; waiving co-insurance, deductibles or other amounts owed by patients; and billing a state healthcare program at a price that is higher than what is charged to other payers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the &#8220;No Surprises Act,&#8221; which prohibits balance billing for certain non-emergency care, including for out-of-network clinical laboratory tests, and analogous state laws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">state corporate practice prohibitions and professional fee-splitting laws that prohibit employing, exercising control over, or splitting fees with licensed medical professionals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">federal and state consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, self-referral, false claims, consumer protection, and unfair competition laws that may apply to our business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services reimbursed by any third-party payer, including commercial insurers; state laws that require healthcare companies to comply with the medical device industry&#8217;s voluntary compliance guidelines, the relevant compliance guidance promulgated by the federal government that otherwise restricts payments that may be made to healthcare providers, and other potential referral sources or state-specific standards on financial interactions with healthcare providers; state laws that require healthcare companies to file reports with states regarding pricing and marketing information, such as the tracking and reporting of gifts, compensation, and other remuneration and items of value provided to healthcare professionals and entities; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These laws and regulations, among other things, constrain our business and limit the types of financial arrangements we have with providers, customers, patients, vendors and third-party payers, and our billing, coding, and collection practices, including our patient financial assistance programs and our practices relating to collection of co-payments and deductibles. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available and lack of clear guidance, our business activities could be subject to challenge under one or more of such laws. To enforce compliance, the Office of the Inspector General (&#8220;OIG&#8221;) and the DOJ recently have increased their scrutiny of interactions between healthcare companies, on the one hand, and healthcare providers and patients on the other, which has led to a number of investigations, prosecutions, convictions, and settlements in the healthcare industry. These investigations often are focused on billing and coding practices as well as financial arrangements with referral sources and patients. We expect that the federal government will continue to devote substantial resources to investigating healthcare providers&#8217; compliance with the FCA and other applicable fraud and abuse laws. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We also have been, are currently, and may be in the future, subject to actions or investigations relating to our arrangements and interactions with healthcare professionals and patients. For additional information, see &#8220;&#8212;We have been, are currently, and in the future may be the subject of government investigations, claims, audits, whistleblower and payer audits, overpayment and recoupment efforts and other litigation in the course of our business that could adversely affect our business and financial statements.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Efforts to ensure that our business arrangements will comply with applicable laws, including healthcare laws and regulations, may involve substantial costs. In addition, the healthcare and other laws applicable to our business may change or be amended, and, it is possible that governmental and enforcement authorities will conclude that our business practices do not comply with current or then-existing statutes, regulations, or case law interpreting applicable fraud and abuse or other healthcare or applicable laws and regulations. We may not properly interpret certain requirements or fail to timely report activities, when required. If any such actions are instituted against us, and we are not successful in defending ourselves, those actions could have a material impact on our business, including the imposition of significant civil, criminal, and administrative penalties, damages, disgorgement, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, imposition of forward-looking compliance obligations, and curtailment of our operations, any of which could adversely affect our business, financial condition, and our results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We and the third parties with whom we work are subject to stringent and evolving U.S. and foreign privacy and data security laws, regulations, and rules, contractual obligations, industry standards, policies and other obligations related to privacy and data security. Our actual or perceived failure to comply with privacy and data security obligations (or such failure by the third parties with whom we work) could result in significant liability, administrative or governmental penalties, reputational harm and/or, other adverse business consequences. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the ordinary course of business, we process Sensitive Information, including personal information, genetic information, and data about trial participants in connection with clinical trials. These data processing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">activities subject us to numerous federal, state, and foreign privacy and data security obligations, such as various laws, regulations, guidance, industry standards, external and internal privacy and security policies, contractual requirements, and other obligations, including AI/ML usage, relating to privacy and data security. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, numerous state and federal laws and regulations govern the privacy and security of personal information, including health-related information, such as data breach notification laws, personal information privacy laws, consumer protection laws (for example, Section&#160;5 of the Federal Trade Commission Act), and other similar laws (e.g., wiretapping laws). HIPAA establishes a set of national privacy and security standards for the protection of individually identifiable health information, by health plans, healthcare clearinghouses and certain healthcare providers (&#8220;Covered Entities&#8221;), as well as for entities that perform certain services for or on behalf of such Covered Entities that involve creating, receiving, maintaining, or transmitting PHI (&#8220;Business Associates&#8221;), and their covered subcontractors. We are a Covered Entity when performing our healthcare services for customers, and also act as a Business Associate when performing certain services for or on behalf of Covered Entities. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When we act as a Covered Entity, for example, through services provided by Caris MPI, Inc., we are subject to certain obligations such as notice of privacy practices and secure handling of protected health information. In addition, when we act as a Business Associate of Covered Entities, for example, through services provided by our other entities, we are subject to certain provisions of HIPAA and the terms of any business associate agreements we enter into with such other Covered Entities. In addition, we may obtain health information from third parties that are subject to privacy and security requirements under HIPAA. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under HIPAA, Covered Entities must report breaches of unsecured PHI to affected individuals without unreasonable delay, not to exceed 60&#160;days following discovery of the breach by a Covered Entity or its agents. Notification also must be made to the HHS Office for Civil Rights and, in certain circumstances involving large breaches, to the media. Business associates must report breaches of unsecured PHI to Covered Entities during the timeframe outlined in the operative Business Associate Agreement, but in no even longer than 60&#160;days of discovery of the breach by the Business Associate or its agents. A non-permitted use or disclosure of PHI is presumed to be a breach under HIPAA unless the Covered Entity or Business Associate establishes that there is a low probability the information has been compromised consistent with requirements enumerated in HIPAA. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Entities that are found to be in violation of HIPAA as the result of a breach of unsecured PHI, a complaint about privacy practices or an audit by HHS may be subject to significant civil, criminal, and administrative fines and penalties and/or additional reporting and oversight obligations if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance. HIPAA also authorizes state Attorneys General to file suit on behalf of their residents. Courts may award damages, costs and attorneys&#8217; fees related to violations of HIPAA in such cases. While HIPAA does not create a private right of action allowing individuals to sue us in civil court for violations of HIPAA, its standards have been used as the basis for duty of care in state civil suits such as those for negligence or recklessness in the misuse or breach of PHI. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain states have also implemented genetic testing and privacy laws imposing specific patient consent requirements and protecting test results by strictly limiting the disclosure of those results. In addition, in the past few&#160;years, more than a dozen U.S. states have enacted comprehensive privacy laws that impose certain obligations on covered businesses, including providing specific disclosures in privacy notices and affording residents with certain rights concerning their personal data; however, many of these laws have exceptions for entities subject to HIPAA or include exemptions for data subject to HIPAA, including clinical data protected under HIPAA and clinical trial data. For example, the California Consumer Privacy Act of 2018, as amended by the California Privacy Rights Act of 2020 (&#8220;CPRA&#8221;) (collectively, &#8220;CCPA&#8221;), applies to personal information of consumers, business representatives, and employees who are California residents, and gives California residents expanded rights regarding their personal information, including the right to opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for fines of up to $7,500 per intentional violation, as well as a private right of action for certain data breaches. Although the CCPA exempts some data processed in the context of clinical trials and information subject to HIPAA, the CCPA increases compliance costs and potential liability with respect to other personal information we maintain about California residents. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may also be subject to new laws governing the privacy of consumer health data, including genetic information. For example, Washington&#8217;s My Health My Data Act broadly defines consumer health data, imposes obligations and restrictions on processing consumer health data (including imposing stringent requirements for consents), provides consumers certain rights with respect to their health data, and creates a private right of action to allow individuals to sue for violations of the law. More than a dozen states have also adopted laws regarding the processing, privacy, and security of genetic information or expanded their comprehensive privacy laws to include additional restriction on companies with respect to processing of sensitive personal information, including genetic information; however, many of these laws have exceptions for entities subject to HIPAA or include exemptions for data subject to HIPAA, including clinical data protected under HIPAA and clinical trial data. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Similar laws are being considered in several other states, as well as at the federal and local levels, and we expect more states to pass similar laws in the future. While several of these laws exempt some data processed in the context of clinical trials or deidentified information under HIPAA, such laws could have potentially conflicting requirements and may increase our compliance costs and potential liability. We could be adversely affected if such laws and other state or federal legislation or regulations applicable to us require changes in our business practices (including our ability to license deidentified information to biopharma companies) or privacy policies, or if governing jurisdictions interpret or implement their legislation or regulations in ways that adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, violation of consumers&#8217; privacy rights or failure to take appropriate steps to keep consumers&#8217; personal information secure may constitute unfair and/or deceptive acts or practices in or affecting commerce in violation of Section&#160;5(a) of the Federal Trade Commission Act, including entities subject to HIPAA. The Federal Trade Commission (&#8220;FTC&#8221;) expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. Individually identifiable health information is considered sensitive data that merits particularly strong safeguards. We publish privacy policies, marketing materials, and other statements, such as compliance with certain certifications or self-regulatory principles, regarding privacy and data security. If these policies, materials, or statements are found to be deficient, lacking in transparency, deceptive, unfair, or misrepresentative of our practices, we may be subject to investigation, enforcement actions by regulators, or other adverse consequences. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, we seek to utilize biological samples and data from participants in our clinical trials and validation studies in accordance with applicable law, IRB requirements, and participant permissions (through consent forms and HIPAA authorizations). If we are unable or significantly restricted in using participant samples and data for secondary research purposes, our ability to develop additional solutions and/or improve or refine existing solutions will be limited, which may impact our business and prospects. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, we are subject to laws, regulations, and standards governing certain marketing, advertising, and other communications conducted by telephone, fax, or text. In particular, sending short message service text messages to participants and prospective participants in our clinical trials is governed by the Telephone Consumer Protection Act (&#8220;TCPA&#8221;) which imposes various consumer consent requirements and other restrictions on communications with consumers. Although we may be able to rely on certain exemptions for healthcare-related purposes, any actual or perceived violations of the TCPA can result in significant financial penalties, including penalties or criminal fines imposed by the Federal Communications Commission or fines of up to $1,500 per violation imposed through private litigation or by state authorities. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, because we accept debit and credit cards payments, we are subject to the Payment Card Industry Security Standard (&#8220;PCI-DSS&#8221;), issued by the Payment Card Industry Security Standards Council; however, we rely on third-party payment processors to process such payments who are also separately subject to PCI-DSS. Noncompliance with PCI-DSS can result in penalties ranging from $5,000 to $100,000 per month by credit card companies, litigation, damage to our reputation, and revenue losses. If we or our third-party payment processors are unable to comply with the PCI-DSS, we may be subject to fines, restrictions, expulsion from card acceptance programs, or other consequences which could affect our business. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, it is not guaranteed that PCI-DSS compliance will prevent illegal or improper use of our third-party payment processors&#8217; payment systems or the theft, loss or misuse of payment card data or transaction information. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our business also increasingly relies on AI to improve our services. However, the development and use of AI presents various privacy and data security risks that may impact our business and is subject to various laws. For example, several countries, states, and localities have proposed or enacted measures related to the use of AI in products and services, including the EU&#8217;s AI Act, which may limit our ability to utilize AI or make utilization of such technology more expensive. The effects of these regulations are difficult to predict, and we expect other jurisdictions will adopt similar laws. Additionally, certain privacy laws extend rights to consumers (such as the right to delete certain personal information) and regulate automated decision making, which may be incompatible with our use of artificial intelligence. These obligations may make it harder for us to conduct our business using artificial intelligence, lead to regulatory fines or penalties, require us to change our business practices, retrain our artificial intelligence, or prevent or limit our use of artificial intelligence. For example, the FTC has required other companies to turn over (or disgorge) valuable insights or trainings generated through the use of AI where they allege the company has violated privacy and consumer protection laws. If we cannot use AI or that use is restricted, our business may be less efficient, or we may be at a competitive disadvantage. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Outside the United States, an increasing number of laws, regulations, and industry standards may govern privacy and data security. For example, the European Union General Data Protection Regulation (the &#8220;EU GDPR&#8221;) and to the United Kingdom General Data Protection Regulation and Data Protection Act 2018 (collectively, the &#8220;UK GDPR&#8221;) (the EU GDPR and UK GDPR together referred to as the &#8220;GDPR&#8221;) impose strict requirements for processing personal data. The GDPR imposes stringent and comprehensive data protection requirements, and provides for greater penalties for noncompliance. The GDPR expands the rights that individuals have to request access, correction, and deletion of their personal data, although certain exceptions exist for scientific research, and makes notification of data breaches to supervisory authorities and data subjects mandatory in certain circumstances. In addition, the GDPR imposes additional compliance obligations and local law derogations in relation to the processing of special category or sensitive personal data under the GDPR (e.g., health data); we may be subject to diverging requirements under EU member state laws and the United Kingdom (&#8220;UK&#8221;) laws, such as whether consent can be used as a legal basis for processing. Where we rely on consent as a legal basis for processing, the validity of informed consent from patients may be challenged, which could force us to stop offering our services, which could hinder our business and operations. In addition, as laws develop, we may need to make operational changes to adapt to diverging rules, which could increase our costs and adversely affect our business. The GDPR also regulates cross-border transfers of personal data outside of the EEA (in the case of the EU GDPR) and UK (in the case of the UK GDPR) and recent case law and regulatory guidance have increased legal complexity and uncertainty regarding international personal data transfers, which we expect to continue. In particular, we expect international transfers to the United States and to other jurisdictions more generally to continue to be subject to enhanced scrutiny by regulators. As the regulatory guidance and enforcement landscape in relation to data transfers continue to develop, we could suffer additional costs, complaints and/or regulatory investigations or fines; we may have to stop using certain tools and vendors and make other operational changes. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Penalties and fines for failure to comply with the GDPR include fines of up to 20&#160;million euros under the EU GDPR, 17.5&#160;million pounds sterling under the UK GDPR or, in each case, 4% of annual global revenue, whichever is greater, and since we are subject to the supervision of relevant data protection authorities under both the EU GDPR and UK GDPR, we could be fined under each of those regimes independently in respect of the same breach. In addition to fines, a breach of the EU GDPR and/or UK GDPR may result in regulatory investigations, reputational damage, orders to cease/ change our data processing activities, enforcement notices, assessment notices (for a compulsory audit) and/ or civil claims (including class actions). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, we may be unable to transfer personal data from Europe and other jurisdictions to the United States or other countries due to data localization requirements or limitations on cross-border data flows. Europe and other jurisdictions have enacted laws requiring data to be localized or limiting the transfer of personal data to other countries. In particular, we expect the existing legal complexity and uncertainty </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">regarding international data transfers from the European Economic Area (&#8220;EEA&#8221;) and the UK to continue. Other jurisdictions may adopt similarly stringent interpretations of their data localization and cross-border data transfer laws. Although there are currently various mechanisms that may be used to transfer personal data from the EEA and UK to the United States in compliance with law, such as the EEA&#8217;s standard contractual clauses, the UK&#8217;s International Data Transfer Agreement/Addendum, and the EU-U.S. Data Privacy Framework and the UK extension thereto (which allows for transfers to relevant U.S.-based organizations who self-certify compliance and participate in the Framework), these mechanisms are subject to legal challenges. As the regulatory guidance and enforcement landscape in relation to data transfers continues to develop, there is no assurance that we can continue to satisfy or rely on these measures to lawfully transfer personal data to the United States. If there is no lawful manner for us to transfer personal data from the EEA, the UK, or other jurisdictions to the United States, or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our business or data processing activities to other jurisdictions (such as Europe) at significant expense, increased exposure to regulatory actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against our processing or transferring of personal data necessary to operate our business. Additionally, companies that transfer personal data out of the EEA and UK to other jurisdictions, particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and activist groups. Some European regulators have ordered certain companies to suspend or permanently cease certain transfers of personal data out of Europe for allegedly violating the GDPR&#8217;s cross-border data transfer limitations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We furnish to biopharma partners and academic researchers genomic information that has been de-identified in accordance with applicable laws, regulations, and the requirements governing the clinical trial. Any data transferred pursuant to international health information privacy regulations is transferred under relevant data protection agreements at the direction of the Data Controller. We may also furnish our biopharma partners and academic researchers with identifiable genomic information for research purposes, so long as such disclosure has been consented to by the patient and/or approved by an IRB or other ethical or privacy review board. The laws of certain states and countries may require specific consent from the individual either to retain or utilize certain genetic information for research or other purposes even if such information has been de-identified, or may require that we obtain a waiver of such consent from an ethical or privacy review board. Even where we furnish to biopharma partners and academic researchers genomic information that has been de-identified in accordance with applicable laws and regulations, biopharma partners or academic researchers may use technology or other methods to link that de-identified genomic information to the patient from whom it was obtained in contravention of one or more applicable laws and regulations. A finding that we have failed to comply with any such laws and any remedial activities required to ensure compliance with such laws could cause us to incur substantial costs, to be subject to unfavorable publicity or public opinion, to change our business practices, or to limit the retention or use of genetic information in a manner that, individually or collectively, could be adverse to our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Obligations related to privacy and data security (and consumers&#8217; data privacy expectations) are quickly changing, becoming increasingly stringent, and creating uncertainty. For example, HHS issued a notice of proposed rulemaking on January 6, 2025, clarifying existing requirements and imposing new security requirements for entities subject to HIPAA. The agency received thousands of proposed comments, and may adjust or clarify the rule as part of the rule making process. Under President Trump&#8217;s Regulatory Freeze Pending Review executive order, HHS cannot issue a final rule until a President-appointed department head has reviewed and approved the rule. It is uncertain whether the proposed rule will move forward in its current state and what the timing of a final rule will be. If adopted in a form similar to the proposed rule, we anticipate our compliance costs could increase substantially. We would need to invest in additional cybersecurity technologies, hire specialized personnel, and potentially redesign certain aspects of our systems and processes. These investments were not contemplated in our current business plan and could impact our profitability. If we are unable to comply with new requirements by any prescribed deadlines, we could face penalties, enforcement actions, reputational damage, and potential loss of business from customers. While we have begun assessing our current security posture against the proposed requirements, the uncertainty regarding the final rule makes comprehensive preparation difficult. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, these obligations may be subject to differing applications and interpretations, which may be inconsistent or conflict among jurisdictions. We also expect that there will continue to be new laws, regulations, and industry standards concerning privacy and data security proposed and enacted in various jurisdictions in which we do business. In addition to privacy and data security laws, we are also bound by other contractual obligations related to privacy and data security. Preparing for and complying with these obligations requires us to devote significant resources and may necessitate changes to our services, information technologies, systems, and practices and to those of any third parties that process personal data on our behalf. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Compliance with privacy and data security obligations could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business. We strive, and contractually obligate our vendors, to comply with applicable laws, regulations, policies, and other legal obligations relating to privacy and data security. However, the various regulatory frameworks for privacy and data protection are, and are likely to remain, uncertain, and it is possible that these or other actual or alleged obligations may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another and may conflict with other rules and subject our business practices to uncertainty. In addition, it is not guaranteed that regulators or consumers will agree with our interpretation of our obligations or our steps to comply with them. Any actual or perceived failure by us to comply with privacy and data security laws, rules, regulations, industry standards and other obligations could result in proceedings or actions against us by individuals, consumer rights groups, government agencies, or others, or orders to cease/ change our data processing activities. We could incur significant costs in investigating and defending such claims and, if found liable, pay significant damages or fines or be required to make changes to our business practices. Further, these proceedings and requires to any subsequent adverse outcomes may subject us to significant negative publicity and an erosion of trust. If any of these events were to occur, our business, financial condition, and results of operations could be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have current solutions marketed as LDTs and plan to launch future solutions as LDTs. The regulation of LDT products in the United States remains subject to significant uncertainty, and if we fail to comply with any new or existing legal requirements with respect to our LDT solutions, our business, financial condition, and results of operations could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have obtained PMA approval from the FDA for MI Cancer Seek as a companion diagnostic device. We have also contemplated seeking FDA approval for Caris Assure and additional solutions. Except for MI Cancer Seek, we currently offer our NGS solutions, MI Tumor Seek Hybrid and Caris Assure, and our AI solutions, such as GPSai and FOLFIRSTai, as LDTs. The FDA considers LDTs to be IVD tests that are intended for clinical use and are designed, manufactured, and used within a single laboratory, and the FDA has historically viewed LDTs as medical devices subject to FDA&#8217;s medical device authority. Notwithstanding this position, the FDA historically exercised enforcement discretion and did not enforce certain medical device requirements, including requirements for premarket review, with respect to LDTs, with certain exceptions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even under that enforcement discretion policy, the FDA has issued warning letters to, and published Medical Device Safety Communications about, manufacturers for commercializing laboratory tests that were purported to be LDTs but the FDA alleged failed to meet the definition of an LDT or that otherwise were not subject to the FDA&#8217;s enforcement discretion policy. If our current solutions fail to meet the definition of an LDT, our business, financial condition, and results of operations could be adversely affected. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, the FDA had for a number of&#160;years stated its intention to modify its enforcement discretion policy with respect to LDTs and enforce applicable medical device requirements to LDTs more broadly, and on May 6, 2024, the FDA issued a final rule in effort to clarify the FDA&#8217;s historical view that LDTs are medical devices subject to the requirements applicable to IVDs (the &#8220;LDT Final Rule&#8221;), and to phase out the FDA&#8217;s enforcement discretion policy over a period of four&#160;years from issuance of the LDT Final Rule. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the LDT Final Rule, the FDA sought to establish certain new and targeted enforcement discretion policies. Specifically, if the LDT Final Rule were implemented, the FDA planned to exercise enforcement discretion and not enforce certain medical device requirements (including the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">requirements for marketing authorization and compliance with certain elements of the Quality System Regulation (&#8220;QSR&#8221;) with respect to LDTs that were marketed as of the date of the LDT Final Rule&#8217;s publication, although such products would still be required to comply with certain other FDA requirements, such as registration and listing, relevant portions of the QSR, medical device reporting, labeling, and corrections and removals reporting. However, where these tests are modified in certain ways from the version of the test marketed as of the LDT Final Rule&#8217;s publication date, this enforcement discretion policy, if implemented, would no longer apply and the FDA would enforce all applicable FDA requirements (including premarket review and marketing authorization requirements) consistent with the stated phase-in policy. In addition, for LDTs that receive approval from NY CLEP, FDA planned to not enforce the proposed marketing authorization requirements at either three and a half or four&#160;years following the date of publication of the LDT Final Rule. However, these tests would still be subject to the remaining medical device requirements, including registration and listing, medical device reporting, and QSR requirements, at the time that such requirements would be phased in more generally.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, on March 31, 2025, the United States District Court for the Eastern District of Texas vacated the LDT Final Rule, reasoning that LDTs are not medical devices, and remanded the matter to the FDA for further consideration. The District Court&#8217;s decision remains subject to a potential appeal until June&#160;30, 2025, and it remains uncertain at this time whether such appeal will be sought and if such appeal would be successful, and even if an appeal is not sought, whether the District Court&#8217;s decision has the effect of eliminating the FDA&#8217;s authority over LDTs nationwide, as the holding in the case merely vacated the LDT Final Rule, which simply clarified FDA&#8217;s longstanding position on LDTs being classified as medical devices. Accordingly, it is unclear whether or when the FDA may be able to implement the LDT Final Rule, or otherwise exercise its medical device authority with respect to LDTs. This uncertainty could adversely affect the FDA&#8217;s ability to apply and enforce its medical device requirements with respect to diagnostic tests more broadly, including any LDTs for which we have obtained or plan to obtain PMAs. Such uncertainty, the final resolution of the litigation over the LDT Final Rule, and the FDA&#8217;s actions in response could have a material adverse effect on our business and operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In light of the uncertainty regarding the future status and potential implementation of the LDT Final Rule, the associated planned new enforcement discretion policies, and the FDA&#8217;s actions in response the District Court&#8217;s decision as it relates to LDTs, we do not know if or when our offerings could become or will remain subject to FDA medical device requirements, including the need to seek and obtain marketing authorization (in the case of our LDTs, at the time that those medical device requirements are phased in more generally if they are phased in at all). If we were unable to comply with any medical device requirements applicable to LDTs if and when such requirements become applicable, we could be required to cease marketing any solutions that we market as LDTs. In addition, further efforts by the FDA or Congress to impose more regulation on LDTs could create a negative public perception about the validity, safety, effectiveness, or performance of LDTs, including our solutions, which could adversely affect patient, provider, and customer perception about, and confidence in, our solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, the FDA may assert that we are improperly marketing our solutions as LDTs, or if FDA succeeds in maintaining asserted authority over LDTs as medical devices, the FDA may assert we do not comply with applicable requirements, and in such cases may take enforcement action against us and/or require premarket review and marketing authorization, which may require us to cease marketing any commercially marketed solutions that are marketed as LDTs until such marketing authorization is obtained or the applications are submitted. There can be no assurance that we will be able to obtain such marketing authorization or that any labeling claims would be consistent with the claims we have made or intend to make for such solutions when launched as LDTs, or that such claims will be adequate to support continued adoption of and reimbursement for our solutions. In the event we are required to seek FDA marketing authorization for any current or planned LDT solutions, the FDA may request that we provide additional analyses and information beyond that which we intend to produce based on the designs of our current and planned validation studies or clinical trials, or that we modify or narrow our intended use or product claims. It is possible that the FDA, among other things, could disagree with our interpretation of data we have relied on to support our LDT launches for our intended uses. If we are required to provide additional analyses or additional data or perform additional clinical trials beyond those we currently contemplate to support the intended uses of our solutions, our planned commercial launches may be delayed and we may be required to cease commercialization of any solutions we currently market as LDTs. Even if our solutions are allowed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to remain on the market prior to any required marketing authorization, demand or reimbursement for our solutions may decline if there is uncertainty about our solutions, if we are required by the FDA to label our solutions as RUO or IUO, or if the FDA limits the labeling claims we are permitted to make for our solutions. As a result, we could experience significantly increased development costs and a delay in generating additional revenue from our current or future solutions, which could reduce our revenues or increase our costs and adversely affect our business, financial condition, and results of operations. Additionally, an FDA enforcement action against us, a delay in the launch of our solutions, or significantly narrowing their intended uses, could negatively impact our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, Congress has, for over the past decade, considered a number of proposals, which if enacted, would subject LDTs to additional regulatory requirements. Any such legislation could substantially alter our marketing of LDTs and negatively impact our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our early detection and MRD tracking assays are intended to introduce new approaches to cancer detection, which present a number of novel and complex issues for FDA review. Because the FDA has never provided marketing authorization for an early detection test and has only granted marketing authorization in limited instances for MRD tests, it is difficult to predict what information we will need to submit to obtain approval of a PMA from the FDA for a proposed intended use of early detection or MRD tracking, or if we will be able to obtain such approval on a timely basis or at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA has never granted marketing authorization for a early detection test and has only granted marketing authorization in limited instances for MRD tests. Therefore, obtaining FDA approval for Caris Assure for early detection and/or MRD tracking presents a number of novel issues. For example, in November&#160;2023, the Molecular and Clinical Genetics Panel (the &#8220;Panel&#8221;) of the FDA&#8217;s Medical Devices Advisory Committee held a public meeting in which the Panel discussed and made recommendations on the design of MCED IVD devices as well as potential study designs and study outcomes of interest that could inform the assessment of the probable benefits and risks of MCED screening tests. The FDA may continue to modify its thinking on how to evaluate the performance of these types of tests, as well as its views around MRD tests. As such, we believe the FDA requirements that will govern any early detection or MRD tracking test we develop, as well as the breadth and nature of data we must provide the FDA, to support the proposed intended use, will remain subject to change. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Given the novel nature and complexity of our early detection and MRD tracking assays, we cannot be certain whether we will receive FDA marketing authorization for our screening tests and whether the trials we eventually conduct will be sufficient to provide the data that the FDA requires to support a proposed intended use. The FDA may require us to perform new analyses of future clinical data or perform additional clinical trials beyond any trials that we may conduct in the future. We may be required to undertake significant efforts to address the FDA requests, which could delay or prevent approval, lead to a more limited intended use statement than the broader intended use statement we plan to pursue, and/or lead to significant post-approval limitations or restrictions, if approval is obtained at all. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business could be adversely affected by legal challenges to our business model or by actions restricting our ability to provide the full range of our solutions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many states prohibit, by statute, regulation, guidance from professional licensing boards or state attorneys general or under common law, the unlicensed practice of medicine. Corporate practice restrictions are generally designed to prohibit a non-professional entity, such as us, from practicing medicine, employing physicians, or controlling or unduly influencing the professional practice and clinical decision making of physicians. The laws relating to corporate practice vary from state to state and are subject to change and to evolving interpretations by courts, state licensing boards and state attorneys general, among others. Further, changes to the membership or staff of state agencies, licensing boards or attorney general offices could lead to increased enforcement of these laws and regulations. In addition, many states also have laws that prohibit a non-professional entity or individual from sharing in or splitting profits or professional fees for patient care, often referred to as &#8220;fee-splitting.&#8221; Some states also prohibit entities from engaging in certain financial arrangements, such as fee-splitting, with physicians. The laws relating to fee-splitting also vary from state to state and are not fully developed or uniformly enforced. Generally, these laws restrict business </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">arrangements that involve a physician sharing professional fees with a non-professional source, but in some states, these laws have been interpreted to extend to other agreements between physicians and business entities under some circumstances. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our test reports delivered to physicians provide information regarding solutions that oncologists and other physicians may use in making treatment decisions for their patients. We also employ pathologists and other medical professionals that interpret results of our solutions and sign our profiling results. These pathologists, physicians and other medical professionals are employed through our subsidiary non-profit corporation, Caris Molecular Pathology, which we believe complies with state corporate practice prohibitions and professional fee-splitting prohibitions. A governmental authority or other parties could allege that the business practices and services we provide constitute the practice of medicine or violate professional fee-splitting prohibitions and that our structure and arrangements are not compliant. A state may seek to have us discontinue the related services we provide, or subject us to fines, penalties, or other sanctions. Any determination that we are practicing medicine without a license may result in significant liability to us, and our business and reputation would be harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Obtaining and maintaining regulatory authorization of our solutions in one jurisdiction does not mean that we will be successful in obtaining regulatory authorization of our solutions in other jurisdictions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Obtaining and maintaining regulatory authorization of solutions in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory authorization in any other jurisdiction, but a failure or delay in obtaining regulatory authorization in one jurisdiction may have a negative effect on the regulatory authorization process in others. For example, even if the FDA or a comparable foreign regulatory authority grants marketing authorization for our solutions, comparable regulatory authorities in foreign jurisdictions may also need to authorize the solutions in those countries. Premarket authorization processes vary among jurisdictions and can involve requirements and administrative review periods different from those in the United States, including additional clinical trials, because clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions or the data may not be considered applicable to the jurisdiction&#8217;s intended patient population. For example, while we have obtained a PMA approval from the FDA for MI Cancer Seek, we do not have any non-U.S. approvals for this solution, and there can be no assurance that we receive any such approvals in the future. In some cases, the price that we intend to charge for our solutions may also be subject to approval. In addition, NY CLEP approval is required in order to market LDTs in New York State. We have not received NY CLEP approval for Caris&#160;Assure. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Obtaining foreign regulatory authorization and maintaining compliance with foreign regulatory requirements could result in significant delays, difficulties, and costs for us and could delay or prevent the introduction of our solutions in certain countries. If we fail to comply with the regulatory requirements in other jurisdictions, or we fail to receive necessary or desirable marketing authorizations in other jurisdictions, our target market will be reduced and our ability to realize the full market potential of our solutions will be harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our employees, independent contractors, consultants, commercial partners, customers, and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are exposed to the risk of fraud, misconduct, or other illegal activity by our employees, independent contractors, consultants, commercial partners, customers, and vendors. Misconduct by these parties could include intentional, reckless and negligent conduct that fails to: comply with the rules and regulations of the CMS, the FDA, and other comparable foreign regulatory authorities; provide true, complete and accurate information to such regulatory authorities; comply with manufacturing and clinical laboratory standards; comply with healthcare fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws; or report financial information or data accurately or to disclose unauthorized activities to us. Since we began commercializing MI Profile, Caris Assure and our earlier solutions in the United States, our potential exposure under such laws has increased significantly, and our costs associated with compliance with such laws have, and will likely continue to, increase. In particular, research, sales, marketing, education, and other business arrangements in the healthcare industry are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing, and other abusive practices, as well as off-label product </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">promotion. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, educating, marketing and promotion, sales and commission, certain customer incentive programs, and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of participant recruitment for clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. We have adopted a Corporate Compliance Program, but it is not always possible to identify and deter misconduct by employees and third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions. Even if it is later determined after an action is instituted against us that we were not in violation of these laws, we may be faced with negative publicity, incur significant expenses defending our actions, and have to divert significant management resources from other matters. We expect our exposure to and costs associated with compliance with healthcare fraud and abuse laws to increase significantly if we commercialize additional solutions in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We use medical and hazardous materials that require considerable expertise and expense for handling, storage, or disposal and may result in claims against us.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and our facilities are subject on an ongoing basis to federal, state, and local laws and regulations governing the use, storage, handling, and disposal of regulated medical waste, hazardous waste, and biohazardous waste, including chemicals, biological agents and compounds and blood and other tissue specimens. We cannot eliminate the risk of accidental contamination or injury to employees, consultants, or third parties from the use, storage, handling, or disposal of these materials. Typically, we use licensed or otherwise qualified outside vendors to dispose of this waste. However, many of these laws and regulations provide for strict liability, holding a party potentially liable without regard to fault or negligence. As a result, we could be held liable for damages and fines if our, or others&#8217;, business operations or other actions result in contamination of the environment or personal injury due to exposure to hazardous materials. Our costs for complying with these laws and regulations cannot be estimated or predicted with accuracy and depends on a number of factors, including the amount and nature of waste we produce, which depends in part on the number of tests we perform, and the terms we negotiate with our waste disposal vendors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have been, are currently, and in the future may be the subject of government investigations, claims, audits, whistleblower and payer audits, overpayment and recoupment efforts and other litigation in the course of our business that could adversely affect our business and financial statements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Healthcare companies are subject to various criminal, civil, and administrative investigations and audits by governmental authorities. Both federal and state government agencies have heightened civil and criminal enforcement efforts in recent&#160;years and expanded collaborative program integrity initiatives. These efforts have led to a number of investigations, prosecutions, convictions, and settlements in the healthcare industry involving federal civil and criminal false claims laws, other healthcare fraud and abuse laws, and civil monetary penalties laws, including the FCA. Further, under the FCA, private parties may bring </font><font style="font-style:italic;letter-spacing:0.2pt;">qui tam</font><font style="letter-spacing:0.2pt;">, or &#8220;whistleblower,&#8221; lawsuits on behalf of the government in connection with alleged false claims for payments submitted to the government or improper retention of overpayments, and these types of actions can be &#8220;under seal&#8221; for a long period of time while regulatory authorities investigate. The private parties who bring FCA lawsuits are entitled to share in any amounts recovered by the government. When an entity is determined to have violated the FCA and other criminal healthcare fraud laws, the government may impose substantial civil and criminal fines and penalties for each false claim, plus up to treble damages, and exclude the entity from participation in Medicare, Medicaid, and other federal healthcare programs. In addition, a number of states have adopted their own false claims and whistleblower provisions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have been, are currently, and may in the future be subject to lawsuits, qui tam actions, CIDs, subpoenas, investigations, audits, and other inquiries related to our operations. We have also been, are currently, and may be in the future, subject to subpoenas, CIDs, actions, or investigations relating to our arrangements and interactions with third parties such as healthcare professionals, healthcare institutions, market participants, or patients. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For example, in March 2025, we received a CID from the DOJ in connection with an investigation under the False Claims Act regarding our compliance with Medicare&#39;s date of service rule (also referred to as the 14-day rule), particularly focused on patients of certain health care providers, and our policies, procedures, and training related to compliance with the 14-day rule. The related investigation continues to evolve and is in too early a stage to assess potential outcomes. We are cooperating with the investigation. We have implemented compliance policies, procedures, and training designed to foster compliance with the 14-day rule, but there can be no certainties regarding the outcome of the CID. In June 2022, we entered into a settlement agreement with the United States in connection with a previous investigation into our compliance with the 14-day day rule. Pursuant to this settlement agreement, under which we admitted no fault or liability, we paid approximately $2.9 million in restitution and penalties and we obtained a nationwide release from all 14-day rule claims prior to January 1, 2018. For additional information see &#8220;Business&#8212;</font>&#8203;<font style="letter-spacing:0.2pt;">Legal Proceedings.&#8221; These interactions could result in the government or other parties pursuing legal claims against us that may result in liabilities, including damages penalties, the potential for exclusion from participation in federal healthcare programs, or the imposition of additional compliance and reporting requirements as part of a corporate integrity agreement, any of which could have an adverse effect on our business, financial condition, reputation, and results of operations. </font></div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are subject to audits and investigations of the ordering, billing, and coding of our solutions, including whether these services were properly ordered, billed, and coded or otherwise compliant with requirements for coverage and payment. In particular, as a result of our participation in the Medicare and Medicaid programs, we face and are currently subject to various governmental reviews, audits, and investigations to verify our compliance with these program requirements and applicable laws and regulations. Government agencies and their agents, such as the MACs and Recovery Audit Contractors (&#8220;RACs&#8221;), as well as the OIG, CMS, and state Medicaid programs, conduct audits of post-payment reviews to detect and correct improper payments in the Medicare program. Private third-party payers conduct similar reviews, audits and pre-payment and post-payment audits. Government agencies and their contractors and other third-party payers regularly conduct audits and request documentation to support claims submitted for payment of services rendered and compliance with claim submission requirements. We are routinely subject to audits under various government programs and third-party payers, and any delays timely providing requested records, negative audit findings or allegations of fraud or abuse may subject us to liability, such as overpayment liability, refunds or recoupments of previously paid claims, payment suspension or the revocation of billing or payment privileges in governmental healthcare programs or other third-party payer programs. Such actions, if imposed on us or our subsidiaries, could adversely impact our business, financial condition, and results of operations. In addition, we perform internal audits and monitoring. Depending on the nature of the conduct uncovered in such audits, and whether the underlying conduct could be considered systemic, the resolution of these audits could have an adverse effect on our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Responding to government investigations, qui tam lawsuits, payer audits, subpoenas, CIDs, or other legal and administrative proceedings can be time- and resource-consuming and can divert management&#8217;s attention from the business. Even an unsuccessful challenge or investigation into our practices could cause unfavorable publicity and require us to incur significant costs, resulting in an adverse effect to our reputation and business. If our operations are found to be in violation of applicable laws or regulations, we may be subject to civil and criminal penalties, including significant fines or damages or other sanctions, including exclusion from government healthcare programs. Settlements of lawsuits involving Medicare and Medicaid issues routinely require both monetary payments and corporate integrity agreements that require the imposition of substantial compliance and reporting requirements, any of which could have an adverse effect on our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Healthcare reform measures or changes in policy or government spending could cause significant harm to our business, financial condition, and results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Healthcare systems are subject to ongoing reform in the United States and abroad. Federal and state governments have made, and continue to make, significant modifications to the Medicare and Medicaid programs through statutory and regulatory changes, administrative rulings and other interpretations and determinations. For example, in the United States, the&#160;ACA made a number of substantial changes to the way healthcare is financed both by government and private insurers. The ACA, among other things, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">included provisions governing enrollment in federal and state healthcare programs, reimbursement matters, and fraud and abuse. We expect these and other provisions will influence our industry and our operations in ways that we cannot currently predict. Since its enactment, there have been judicial and congressional challenges to certain aspects of the ACA. For example, on June&#160;17, 2021, the U.S. Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress. In addition, on August&#160;16, 2022, President Biden signed the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in ACA marketplaces through plan year 2025. The IRA also eliminates the &#8220;donut hole&#8221; under the Medicare Part&#160;D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and creating a new manufacturer discount program. It is possible that efforts to reform, modify, or repeal parts of the ACA may continue under the new presidential administration. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In recent&#160;years, legislative and regulatory changes have resulted in limitations and reductions in reimbursement levels and payments to healthcare providers for certain services under the Medicare program. For example, In April&#160;2014, Congress passed PAMA, which included substantial changes to the way in which clinical laboratory services are paid under Medicare. In addition, Congress established automatic spending reductions under the Budget Control Act of 2011 (the &#8220;BCA&#8221;), resulting in a 2% reduction in Medicare payments that began in 2013, and due to subsequent legislative amendments, will remain in effect until 2032, unless additional Congressional action is taken. In addition, as a result of the American Rescue Plan&#160;Act of 2021 (&#8220;ARPA&#8221;), an additional Medicare payment reduction of up to 4% was required to take effect in January&#160;2022; however, Congress has delayed implementation of this reduction until 2025. It is difficult to predict whether, when or what other deficit reduction initiatives may be proposed by Congress. We anticipate that the federal budget deficit will continue to place pressures on government healthcare programs and impose additional spending reductions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to changing federal policy and regulatory oversight, states and third-party payers may also introduce proposals and polices to reduce costs while expanding individual healthcare benefits. Certain of these proposals may limit the prices we will be able to charge for our solutions or limit coverage of or lower reimbursement for the procedures associated with the use of our solutions. Healthcare reform and pricing of prescription drugs and medical devices, including clinical laboratory tests, are and will remain a key bipartisan issue. Policies to be pursued in the future may be more aggressive, regardless of which party controls the White House or houses of Congress. Uncertainty surrounding future changes may adversely affect our operating environment and therefore our business, financial condition, results of operations, and growth prospects. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We cannot predict whether or when these or other recently enacted healthcare initiatives will be implemented at the federal or state level or in foreign jurisdictions, or the full impact of current or future healthcare reform measures on our business. For example, the payment reductions imposed by the ACA and the changes to the reimbursement amounts paid by Medicare for tests based on the procedures set forth in PAMA, could limit the prices we are able to charge or the amount, if any, of available reimbursement or coverage for our solutions, which would reduce our revenue. Additionally, these healthcare policy changes could be amended or additional healthcare initiatives could be implemented in the future. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, the impact on our business of the expansion of the federal and state governments&#8217; role in the U.S. healthcare industry generally, including the social, governmental, and other pressures to reduce healthcare costs while expanding individual benefits is uncertain. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Statutory, regulatory, and policy changes, or government budget and funding levels, may also impact the ability of the FDA, the Department of Health and Human Services (including CMS) and other regulatory authorities to perform their regulatory functions. Inadequate funding or staffing for such organizations and/or potentially shifting priorities, including under the new administration, could prevent or delay regulatory reviews and approval processes on which certain of our initiatives may rely, adversely affect agencies&#8217; ability to hire and retain key personnel, or otherwise prevent those agencies from timely performing normal business functions on which the operation of our business may rely, any of which could negatively impact our business. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The current Trump administration is pursuing policies to reduce regulations and expenditures across government including at HHS, the FDA, CMS, and related agencies. These actions, presently directed by executive orders or memoranda from the Office of Management and Budget, may propose policy changes that create additional uncertainty for our business. Further, in June 2024, the U.S. Supreme Court reversed its longstanding approach under the Chevron doctrine, which provided for judicial deference to regulatory agencies&#39; interpretation of statutes that are silent or ambiguous, including the FDA and CMS. As a result of this decision, we cannot be sure whether there will be increased challenges to existing agency regulations or how lower courts will apply the decision in the context of other regulatory schemes without more specific guidance from the U.S. Supreme Court. For example, this decision may result in more companies bringing lawsuits against the regulatory agencies to challenge current regulations and longstanding decisions and policies of the FDA or CMS, which could lead to uncertainties in the industry. We cannot predict the full impact of this decision, future judicial challenges brought against the FDA, CMS, or other regulatory agencies, or the nature or extent of government regulation that may arise from future legislation or administrative action.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The marketing authorization processes of the FDA and comparable foreign regulatory authorities are lengthy, time-consuming, and unpredictable. If we are ultimately unable to obtain any necessary or desirable marketing authorizations, or if such marketing authorizations are significantly delayed, our business will be substantially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except for MI Cancer Seek, for which we have obtained a PMA approval from the FDA, we currently offer our NGS solutions, MI Tumor Seek Hybrid and Caris Assure, and our AI solutions, such as GPSai and FOLFIRSTai, as LDTs. See &#8220;&#8212;We have current solutions marketed as LDTs and plan to launch future solutions as LDTs. The regulation of LDT products in the United States remains subject to significant uncertainty, and if we fail to comply with any new or existing legal requirements with respect to our LDT solutions, our business, financial condition, and results of operations could be adversely affected.&#8221; We currently anticipate eventually seeking FDA approval for Caris Assure and additional solutions. The time required and ability to obtain marketing authorization from the FDA and comparable foreign regulatory authorities is unpredictable and typically takes several&#160;years following the commencement of clinical trials, and depends upon numerous factors, including the type, complexity, and novelty of our solutions. In addition, policies, laws, regulations, or the type and amount of clinical data necessary to gain marketing authorization may change during the course of a test&#8217;s clinical development and may vary among jurisdictions, which may cause delays in the marketing authorization of, or the decision not to approve, an application. Regulatory authorities have substantial discretion in the premarket review process and may refuse to accept any application, decide that our data are insufficient for marketing authorization, require additional clinical or other data, or determine that our manufacturing and quality systems are insufficient or in violation of applicable requirements. Even if we believe our data are sufficient to support marketing authorization, regulatory authorities may disagree, or may require the generation and submission of additional data or analyses, which could significantly delay or preclude marketing authorization. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before a new medical device can be marketed in the United States, a company must first submit a premarket notification to FDA and receive clearance by FDA under Section&#160;510(k) of the FDCA, a PMA application and receive approval by FDA under Section&#160;515 of the FDCA, or a </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification request and receive a grant of the request from the FDA under section 513(f)(2) of the FDCA, unless an exemption applies. In the 510(k) clearance process, before a device may be marketed, the FDA must determine that a proposed device is &#8220;substantially equivalent&#8221; to a legally-marketed &#8220;predicate&#8221; device, which includes a device that has been previously cleared through the 510(k) process, a device that was legally marketed prior to May&#160;28, 1976 (pre-amendments device), a device that was originally on the U.S. market pursuant to an approved PMA and later down-classified, a device that was classified under the </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification pathway, or a 510(k)-exempt device. To be &#8220;substantially equivalent,&#8221; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different technological characteristics and not raise different questions of safety or effectiveness than the predicate device and performance data show that the proposed device is as safe and effective as the predicate device. Clinical data are sometimes required to support substantial equivalence. In the process of obtaining PMA approval, the FDA must determine that a proposed device is safe and effective (which means analytically valid and clinically valid in the case of tests) for its intended use based, in part, on extensive data, including, but not limited to, technical, pre-clinical, clinical trial, manufacturing and labeling data. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The PMA process is typically required for devices that are deemed to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices. In the </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification process, a manufacturer whose novel device under the FDCA would otherwise be automatically classified as Class&#160;III and require the submission and approval of a PMA prior to marketing is able to request down-classification of the device to Class&#160;I or Class&#160;II on the basis that the device presents a low or moderate risk. If Class&#160;II, new special controls will be required to provide reasonable assurance of safety and effectiveness of the device. If the FDA grants the </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification request, the applicant will receive authorization to market the device. This device type may be used subsequently as a predicate device for future 510(k) submissions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The PMA approval, 510(k) clearance and </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification processes can be expensive, lengthy, and uncertain. The FDA&#8217;s 510(k) clearance process usually takes from three to 12&#160;months, but can take longer. The process of obtaining a PMA approval or </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification is much more costly and uncertain than the 510(k) clearance process and the FDA has 180&#160;days from the day of filing under the FDC Act to complete its review of the PMA and FDA endeavors to review </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification requests within 150&#160;days, although, in practice, the FDA&#8217;s review often takes significantly longer. In addition, a PMA generally requires the performance of one or more clinical trials. Despite the time, effort and cost, a device may not obtain marketing authorization by the FDA. Any delay or failure to obtain necessary marketing authorizations could harm our business. Furthermore, even if we are granted such marketing authorizations, they may include significant limitations on the indicated uses for the solution, which may limit the potential commercial market for the solution. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, any modification to a product for which we receive marketing authorization may require us to submit a new 510(k) notification and obtain clearance, to submit a supplemental PMA and obtain FDA approval, or to submit a </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> request prior to implementing the change. For example, any modification to a 510(k)-cleared device that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, design, or manufacture, generally requires a new 510(k) clearance or other marketing authorization. The FDA requires every manufacturer to make such determinations in the first instance, but the FDA may review any manufacturer&#8217;s decision. The FDA may not agree with a manufacturer&#8217;s decisions regarding whether new marketing authorizations is necessary. If we obtain market authorizations from the FDA, we may make modifications or add additional features in the future that we believe do not require a new 510(k) clearance, </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> request or approval of a PMA or supplement. If the FDA disagrees with our determination and requires us to seek new marketing authorizations for the modifications for which we have concluded that new marketing authorizations are unnecessary, we may be required to cease marketing and/or to recall the modified product until we obtain such marketing authorization, and we may be subject to significant regulatory fines or penalties. If the FDA requires us to go through a lengthier, more rigorous examination for future solutions or modifications to existing solutions than we had expected, solution introductions or modifications could be delayed or canceled, which could adversely affect our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA or other regulators can delay, limit, or deny marketing authorization of a product for many reasons, including but not limited to the following: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA or comparable foreign regulatory authorities may disagree with the design, implementation, or results of, or interpretation of the data from, our clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA or comparable foreign regulatory authorities may determine that our solution has not been shown to be safe and effective or substantially equivalent to a predicate device, or has other characteristics that preclude us from obtaining marketing authorization or prevent or limit its commercial use (for example, a narrowed indication for use claim); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the population studied in the clinical program may not be sufficiently broad, generalizable, or representative of the intended target population of our solution to assure effectiveness and safety in the population for which we seek approval or clearance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from clinical trials or may fail to accept data from clinical trials (or clinical sites), including if we fail to establish the integrity of our data; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA or comparable foreign regulatory authorities may determine that our clinical trials otherwise fail to comply with applicable regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">serious or unexpected adverse effects or other performance issues are identified with our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA or comparable foreign regulatory authorities may determine that our manufacturing or quality system fails to comply with applicable regulations or otherwise fails to meet the standards necessary to support approval; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that our solutions for which we may seek marketing authorization will receive such marketing authorization from by the FDA or a comparable foreign regulatory authority on a timely basis, if at all, nor can there be assurance that labeling claims will be consistent with our anticipated claims or adequate to support continued adoption of, and reimbursement for, our solutions. If our solutions receive marketing authorization but there is uncertainty about such solutions among providers or payers, or if the approved or cleared indication or other labeling claims the FDA or a comparable foreign regulatory authority has authorized us to make are more limited than we expect, reimbursement may be adversely affected and we may not be able to sell our solutions. Compliance with FDA or comparable foreign regulatory authority regulations will require substantial costs, and subject us to heightened scrutiny by regulators and substantial penalties for failure to comply with such requirements or the inability to market our solutions, if authorized. The lengthy and unpredictable marketing authorization processes, as well as the unpredictability of the results of our clinical trials, may result in our failing to obtain marketing authorization to market our solutions, which would significantly harm our business, results of operations, reputation, and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ethical, legal, and social concerns related to the use of genomic information could reduce demand for our solutions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Genomic testing, like that conducted using our solutions, has raised ethical, legal, and social issues regarding privacy and the appropriate uses of the resulting information. Governmental authorities could, for social or other purposes, limit or regulate the use of genomic information or genomic testing or prohibit testing for genetic predisposition to certain conditions, particularly for those that have no known cure. Similarly, these concerns may lead patients to refuse to use genomic and somatic profiling tests even if permissible. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Ethical and social concerns may also influence U.S. and foreign patent offices and courts with regard to patent protection for technology relevant to our business. These and other ethical, legal, and social concerns may limit market acceptance of our solutions or reduce the potential markets for services enabled by our platform, either of which could have an adverse effect on our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If the validity of an informed consent from patients regarding our solution was challenged and proven invalid, unlawful, or otherwise inadequate for our purposes, we could be forced to stop offering our solutions or using our resources, our business, financial condition, and results of operations will be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We offer our solutions to physicians and to biopharma companies in connection with clinical trials. We generally rely on treating physicians to obtain required informed consent under applicable state laws, but we have also recently implemented measures to ensure that data and biological samples that we receive have been collected from subjects who have provided appropriate informed consent. We also conduct validation studies, or act as a sponsor of clinical trials in connection with the development and validation of our solutions, which are frequently conducted in collaboration with different parties. We submit for projects that meet the definition of &#8220;human subjects research,&#8221; to the IRB, or other reviewing body for review and approval of processes for subject informed consent and authorization for use of personal information or waivers thereof. We and our biopharma partners could conduct clinical trials in a number of different countries. When we are acting as a vendor in connection with a clinical trial sponsored by our biopharma partners, we rely upon them to comply with the requirements to obtain the subject&#8217;s informed consent and to comply with applicable laws and regulations. The collection of data and samples in many different countries results in complex legal questions regarding the adequacy of informed consent and the status of genetic material under a large number of different legal systems. Those informed consents could be challenged and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">proven invalid, unlawful, or otherwise inadequate for our purposes. Any such findings against us, or our biopharma partners, could force us to stop accessing or using data and samples or servicing or conducting clinical trials, which would hinder our product offerings or development. We could also become involved in legal actions, which could consume our management and financial resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to comply with applicable data interoperability and information blocking rules, our business, financial condition, and results of operations could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 21</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">st</font><font style="letter-spacing:0.2pt;"> Century Cures Act (the &#8220;Cures Act&#8221;), which was passed and signed into law in December&#160;2016, includes provisions related to data interoperability, information blocking and patient access. In March&#160;2020, the HHS Office of the National Coordinator for Health Information Technology (&#8220;ONC&#8221;) finalized and issued complementary rules that are intended to clarify provisions of the Cures Act regarding interoperability and information blocking, and include, among other things, requirements surrounding information blocking and changes to ONC&#8217;s health IT certification program. The companion rules will transform the way in which healthcare providers, health IT developers, health information exchanges/</font>&#8203;<font style="letter-spacing:0.2pt;">health information networks and health plans share patient information, and create significant new requirements for healthcare industry participants. For example, the ONC rule, which went into effect on April&#160;5, 2021, prohibits healthcare providers from engaging in practices that are likely to interfere with, prevent, materially discourage, or otherwise inhibit the access, exchange, or use of electronic health information (&#8220;EHI&#8221;), also known as &#8220;information blocking.&#8221; To further support access and exchange of EHI, the ONC rule identifies eight &#8220;reasonable and necessary activities&#8221; as exceptions to information blocking activities, as long as specific conditions are met. On July&#160;3, 2023, the HHS Office of the Inspector General (&#8220;HHS-OIG&#8221;) published its final rule implementing information blocking penalties for &#8220;actors,&#8221; which is supplemented by ONC&#8217;s January&#160;9, 2024 final rule enhancing certain information blocking requirements, under which HHS-OIG may impose penalties for information blocking that has occurred after September&#160;1, 2023. In addition, ONC and HHS proposed a rule on November&#160;1, 2023, listing &#8220;appropriate disincentives&#8221; for noncompliance by healthcare providers. If we fail to comply with the requirements, it may negatively impact our business operations. The goals of increased use of electronic health data and interoperability are improved quality of care and lower healthcare costs generally. However, increased use of electronic health data and interoperability inherently magnifies the risk of security breaches involving that data and information systems used to share it. For additional information, see &#8220;&#8212;Risks Related to Our Business and Industry&#8212;If our information technology systems or those of third parties with whom we work, or our data are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; and other adverse consequences.&#8221; Any failure to comply with these rules could adversely affect our business, financial condition, and results of operations. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we or our partners fail to comply with federal, state, and foreign laboratory and other applicable licensing and registration requirements, we could be prevented from performing our solutions or experience disruptions to our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">CLIA is a federal law that regulates clinical laboratories that perform testing on specimens derived from humans for the purpose of providing information for the diagnosis, prevention, or treatment of disease, or impairment of, or the assessment of the health of, human beings. CLIA regulations require, among other things, clinical laboratories to obtain a certificate and mandate specific standards in the areas of personnel qualifications, administration, participation in proficiency testing, test management, and quality assurance. CLIA certification is also required for us to be eligible to bill state and federal healthcare programs, if such reimbursement is otherwise available, as well as many private third-party payers, for our solutions. Certain product additions to our solution menu require notification to regulatory and accrediting bodies that regulate our laboratories. To renew these certifications, we are subject to routine surveys and inspections. Moreover, CLIA inspectors may make random or &#8220;for cause&#8221; inspections of our clinical laboratories. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently have two commercial clinical laboratory facilities in Phoenix, Arizona, and we are in the process of building out our newest clinical laboratory in Irving, Texas. Both of the Phoenix laboratory facilities hold independent CLIA Certificates of Accreditation. A CLIA Certificate of Accreditation is issued </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to a laboratory facility that performs moderate and/or high complexity testing after an accreditation organization conducts a survey and determines that the laboratory is in compliance with the CLIA regulations. Our laboratory facility in Irving, Texas will seek a CLIA Certificate of Registration from CMS, and upon required inspection, anticipate receiving a CLIA Certificate of Accreditation. The CLIA Certificate of Registration allows the laboratory facility to begin conducting moderate and/or high complexity testing, subject to a survey to determine compliance with the CLIA regulations. After a laboratory obtains a Certificate of Registration, CLIA begins scheduling regular, routine inspections. Once the inspection process for the laboratory facility is successfully completed, the facility qualifies for a CLIA Certificate of Accreditation and thereafter is inspected every two years.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Both of our Phoenix laboratories hold CAP accreditations upon which our CLIA Certificate of Accreditation are based. CAP typically conducts biannual surveys of each facility. Any failure to pass inspections, maintain our CAP accreditation, CLIA Certificate of Registration, CLIA Certificate of Accreditation, or state licenses, or add new validated solutions to our laboratory offerings could significantly harm our business, results of operations, and prospects. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to obtaining federal certification for a laboratory under CLIA, we are also required to obtain and maintain state licenses to conduct profiling in our laboratories. Neither Arizona (where we currently operate two clinical laboratories) nor Texas (where we are completing the build-out of our newest clinical laboratory) requires us to obtain and maintain state licenses to conduct profiling in our laboratories. However, some states require out-of-state licensure if we test specimens originating from those states and return patient-specific results. Our tissue-based Arizona facility has obtained licenses from California, Rhode Island, Maryland, New York, and Pennsylvania, and our blood-based Arizona facility has obtained licenses from California, Maryland, Pennsylvania, and Rhode Island. If we have a blood-based profiling solution approved by New York state, we will also obtain a New York license for our blood-based facility. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For example, to be able to receive specimens originating from New York, we must obtain and maintain a New York State Department of Health clinical laboratory permit. We have a New York State Department of Health clinical laboratory permit for our tissue-based Arizona facility, and we intend to apply for such a permit for our other commercial facilities. Research testing (which we conduct at our R&amp;D laboratory in Tempe, Arizona), however, does not require licensure if patient-specific results are not generated and/or returned for diagnostic purposes. As our blood-based Arizona facility does not currently operate in New York, we have not sought a New York laboratory permit. We cannot guarantee that the New York State Department of Health will issue a clinical laboratory permit for our Texas facility or our blood-based Arizona facility, and if we do not receive this permit, our business may be adversely impacted. In addition, New York laws and regulations establish rigorous standards for day-to-day operation of a clinical laboratory, including training and skill levels required of laboratory personnel, physical requirements of a facility, equipment, and validation and quality control, and we are required to abide by these laws and regulations as a permit holder. Failure to comply with these laws and regulations could result in various significant penalties, including loss of our New York permit, fines and other penalties, or limitations on our potential profiling population, which could adversely impact our business. New York also requires specific reporting for companies in the oncology space. Failure to comply with any established reporting requires could negatively impact our license. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The states that require us to hold an out-of-state license may change, and we are uncertain whether states will continue to grant or may require us to hold these licenses in the future. Any failure or inability on our part to obtain required state licensure may result in substantial penalties, including prohibition form billing certain payers and thus adversely affect our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with CLIA certification and state laboratory licensing and permitting, we remain subject to a number of risks in the event of noncompliance. Any sanction imposed under CLIA, its implementing regulations, or state or foreign laws or regulations governing licensure or permitting, or our failure to renew or maintain a CLIA certificate, a state license or permit, or accreditation (including CAP), could adversely affect our business and reputation. CMS also has the authority to impose a wide range of sanctions, including suspension, limitation, or revocation of the CLIA certification, termination of Medicare and Medicaid participation, civil money penalties, and a bar on the ownership or operation of a CLIA-certified laboratory by any owners or operators of the deficient laboratory. If we fail to obtain any required state licensure, or lose CLIA certification, CAP accreditation, or licensure once obtained, we </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">would not be able to operate our clinical laboratories and offer our solutions in full or in particular states, which would adversely impact our business, financial condition, and results of operations. Even if we were able to bring our laboratory back into compliance, we could incur significant expenses and potentially lose revenue in doing so. </font>
        </div>
        <div style="text-indent:36pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to state laboratory licensing laws, we may also be subject to foreign state registration and/or licensing requirements that apply to companies that manufacture medical devices. Certain states may require such registrations or licenses before the solutions are commercialized, including while manufacturers are evaluating the devices in clinical trials. Violations of these laws may result in a range of potential sanctions or penalties which could include the denial, suspension, limitation or revocation of the registration or license, as well as other fines and penalties, including imprisonment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, our pathologists are subject to individual medical licensure requirements and our pathologists, physicians, and geneticists could also be subject to in the future additional licensure requirements under state law. If the physicians and geneticists are not able to timely maintain, obtain or otherwise satisfy any new licensure requirements, this could have a negative impact on our operations. </font>
        </div>
        <div style="margin-top:9.63pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Data from our clinical trials that we announce or publish from time to time before our trials are complete may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, we may publicly disclose preliminary or topline data from our validation studies and clinical trials that we conduct ourselves or in partnership with other organizations, including on the application of Caris Assure in early detection, MRD tracking, and treatment monitoring, and Caris ChromoSeq, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular trial. We also make assumptions, estimations, calculations, and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline or preliminary results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results once additional data have been received and fully evaluated. Topline and preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the topline or preliminary data we previously published. As a result, topline and preliminary data should be viewed with caution until the final data are available. </font>
        </div>
        <div style="text-indent:36pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, we may also disclose interim data from our validation studies that we conduct or from our clinical trials. Interim data from these studies or trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as subject enrollment continues and more data become available. Adverse differences between interim data and top-line, preliminary, or final data could significantly harm our business prospects. Further, disclosure of interim data by us or by our competitors could result in volatility in the price of our common stock. </font>
        </div>
        <div style="text-indent:36pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions, or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, and our ability to receive coverage, marketing authorization or commercialize a particular solution and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is the material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding our business. If the data that we report differ from final results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to commercialize or obtain marketing authorization for, our solutions may be harmed, which could harm our reputation, business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="margin-top:9.62pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Any solution for which we obtain marketing authorization will be subject to extensive ongoing regulatory requirements, and we may be subject to penalties if we or our partners fail to comply with regulatory requirements or if we experience unanticipated problems with our solutions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Medical devices, along with the manufacturing processes, post-market surveillance, labeling, packaging, advertising, and promotion, distribution, storage, import, export, reporting, and recordkeeping </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">for such solutions, are subject to continued regulatory review, oversight, requirements, and periodic inspections by the FDA and comparable foreign regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports; registration and listing requirements; requirements relating to quality control, quality assurance, cyber security, and corresponding maintenance of records and documents; requirements relating to recalls, removals, and corrections; and requirements relating to product labeling, advertising and promotion, and recordkeeping. It is uncertain whether our currently-marketed LDTs will become subject to these or any other requirements. See &#8220;Risk Factors&#8212;We have current solutions marketed as LDTs and plan to launch future solutions as LDTs. The regulation of LDT products in the United States remains subject to significant uncertainty, and if we fail to comply with any new or existing legal requirements with respect to our LDT solutions, our business, financial condition, and results of operations could be adversely affected.&#8221; Regardless, the regulations to which we are subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales. The FDA enforces these regulatory requirements through, among other means, periodic unannounced inspections. We do not know whether we will be found compliant in connection with any future regulatory inspections. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Marketing authorization of a test or device may be subject to limitations by the regulatory body as to the indicated uses for which the product may be marketed or to other conditions of marketing authorization. In addition, marketing authorization may contain requirements for costly post-marketing testing and surveillance to monitor the safety or effectiveness of the test or device. Discovery of problems with our solutions, suppliers, vendors, contract manufacturers, manufacturing processes (including software validation), and/or failure to comply with regulatory requirements, may result in actions such as: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on operations of our laboratories; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on manufacturing processes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on marketing of a product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Untitled or Warning letters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withdrawal or recall of the product from the market or seizure of the product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal to approve applications or supplements to approved applications that we may submit; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fines, restitution or disgorgement of profits or revenue; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">suspension, limitation, or withdrawal of marketing authorization; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">exclusion from participation in U.S. federal or state healthcare programs, such as Medicare and Medicaid; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">safety communications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal to permit the import or export of our solution; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">injunctions; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">imposition of civil or criminal penalties. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any of these sanctions could result in higher than anticipated costs or lower than anticipated sales and adversely affect our reputation, business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the FDA may change its marketing authorization policies, adopt additional regulations or revise existing regulations, or take other actions. For example, in addition to the FDA&#8217;s LDT Final Rule, a few&#160;months earlier in February&#160;2024, the FDA issued a final rule to amend and replace the QSR, which sets forth the FDA&#8217;s current good manufacturing practice requirements for medical devices, to align more closely with the International Organization for Standardization standards. Specifically, this final rule, which the FDA expects to go into effect on February&#160;2, 2026, establishes the Quality Management System Regulation (&#8220;QMSR&#8221;), which among other things, incorporates by reference the quality management system requirements of ISO 13485:2016. Although the FDA has stated that the standards contained in ISO 13485:2016 are substantially similar to those set forth in the QSR, it is unclear the extent to which this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">final rule, once effective, could impose additional or different regulatory requirements on us that could increase the costs of compliance or otherwise adversely affect our business. If we are unable to comply with the QMSR, once effective, or with any other changes in the laws or regulations enforced by the FDA or comparable regulatory authorities, we may be subject to enforcement action, which could have an adverse effect on our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">For any solution we market that is or becomes subject to the FDA&#8217;s medical device authority, we are or may become subject to the FDA&#8217;s requirements to report to the FDA certain information about adverse medical events or malfunctions for any of our solutions, and if we fail to do so, we would be subject to sanctions that could harm our reputation, business, financial condition, and results of operations. The discovery of serious safety issues with our solutions, or a recall of our solutions either voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on us.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any solution we market that is or becomes subject to the FDA&#8217;s medical device authority and any solution for which we obtain FDA marketing authorization, including MI Cancer Seek, is or will become subject to the FDA&#8217;s medical device reporting regulations and similar foreign regulations, which require us to report to the FDA when we receive or become aware of information that reasonably suggests that one or more of these solutions may have caused or contributed to a death or serious injury or malfunctioned in a way that, if the malfunction were to recur, it could cause or contribute to a death or serious injury. Under the FDA&#8217;s LDT Final Rule issued on May&#160;6, 2024, and which was vacated by a federal District Court on March 31, 2025, any LDT that receives marketing authorization would be subject to these medical device reporting regulations, as applicable, if the rule is ultimately implemented. See &#8220;Risk Factors&#8212;&#8220;We have current solutions marketed as LDTs and plan to launch future solutions as LDTs. The regulation of LDT products in the United States remains subject to significant uncertainty, and if we fail to comply with any new or existing legal requirements with respect to our LDT solutions, our business, financial condition, and results of operations could be adversely affected.&#8221; The timing of our obligation to report is triggered by the date we become aware of the adverse event as well as the nature of the event. We may fail to report adverse events of which we become aware within the prescribed timeframe. We may also fail to recognize that we have become aware of a reportable adverse event, especially if it is not reported to us as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of the product. If we fail to comply with our reporting obligations, the FDA could take action, including warning letters, untitled letters, administrative actions, criminal prosecution, imposition of civil monetary penalties, revocation of our device marketing authorization, withdrawal of our solutions from the market, seizure of our solutions, or delay in marketing authorization of future solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA and foreign regulatory bodies have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture of a product or in the event that a product poses an unacceptable risk to health. The FDA&#8217;s authority to require a recall must be based on a finding that there is reasonable probability that the device could cause serious injury or death. We may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall by us could occur as a result of an unacceptable risk to health, component failures, malfunctions, manufacturing defects, labeling or design deficiencies, packaging defects or other deficiencies, or failures to comply with applicable regulations. Product defects or other errors may occur in the future. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Depending on the corrective action we take to redress a product&#8217;s deficiencies or defects, the FDA may require, or we may decide, that we will need to obtain new marketing authorizations for the device before we may market or distribute the corrected device. Seeking such marketing authorizations may delay our ability to replace the recalled devices in a timely manner. Moreover, if we do not adequately address problems associated with our devices, we may face additional regulatory enforcement action, including FDA warning letters, product seizure, injunctions, administrative penalties or civil or criminal fines. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Companies are required to maintain certain records of recalls and corrections, even if they are not reportable to the FDA. We may initiate voluntary withdrawals or corrections for our solutions in the future that we determine do not require notification of the FDA. If the FDA disagrees with our determinations, it could require us to report those actions as recalls and we may be subject to enforcement action. A future recall announcement could harm our reputation with customers, potentially lead to product </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">liability claims against us and negatively affect the adoption and use of our solutions. Any corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, will require the dedication of our time and capital, distract management from operating our business and may harm our reputation and financial results. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our solutions will need to be manufactured and offered in accordance with federal and state regulations, and we could be forced to recall our devices or terminate production or offering our LDTs if we or our partners fail to comply with these regulations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The methods used in, and the facilities used for, the manufacture of medical devices must comply with the FDA&#8217;s QSR requirements, which is a complex regulatory scheme that covers the procedures and documentation of the design, testing, production, process controls, quality assurance, labeling, packaging, handling, storage, distribution, installation, servicing, and shipping of medical devices. Furthermore, we are required to verify that our suppliers maintain facilities, procedures and operations that comply with our quality standards and applicable regulatory requirements. The FDA enforces the QSR requirements through periodic announced or unannounced inspections of medical device manufacturing facilities, which may include the facilities of subcontractors. Our solutions are also subject to similar state regulations and various laws and regulations of foreign countries governing manufacturing. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our third-party manufacturers may not take the necessary steps to comply with applicable regulations, which could cause delays in the delivery of our solutions. In addition, in February&#160;2024, the FDA issued a final rule to amend and replace the QSR, which sets forth the FDA&#8217;s current good manufacturing practice requirements for medical devices, to align more closely with the International Organization for Standardization standards. Specifically, this final rule, which the FDA expects to go into effect on February&#160;2, 2026, establishes the QMSR, which among other things, incorporates by reference the quality management system requirements of ISO 13485:2016. Although the FDA has stated that the standards contained in ISO 13485:2106 are substantially similar to those set forth in the QSR, it is unclear the extent to which this final rule, once effective, could impose additional or different regulatory requirements on us that could increase the costs of compliance or otherwise negatively affect our business. Failure to comply with applicable FDA requirements or later discovery of previously unknown problems with our solutions or manufacturing processes could result in, among other things: warning letters or untitled letters; fines, injunctions or civil penalties; suspension or withdrawal of approvals; seizures or recalls of our solutions; total or partial suspension of production or distribution; administrative or judicially imposed sanctions; FDA&#8217;s refusal to grant pending or future marketing authorizations for our solutions; clinical holds; refusal to permit the import or export of our solutions; and criminal prosecution of us, our suppliers, or our employees. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any of these actions could significantly and negatively affect supply of our solutions. If any of these events occurs, our reputation could be harmed, we could be exposed to product liability claims and we could lose customers, experience reduced sales, and increased costs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The misuse or off-label use of our solutions may harm our reputation in the marketplace, lead to product liability suits or result in costly investigations, fines, or sanctions by regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which could be costly to our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any marketing authorization we may receive for our solutions will be limited to specified indications for use. We train our marketing personnel and direct sales force to not promote our solutions for uses outside of FDA cleared or approved indications for use, known as &#8220;off-label uses.&#8221; We cannot, however, prevent a physician from using our solutions off-label, when in the physician&#8217;s independent professional medical judgment, he or she deems it appropriate. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the FDA or any foreign regulatory body determines that our promotional materials or training constitute promotion of an off-label use, it could request that we modify our training or promotional materials or subject us to regulatory or enforcement actions, including the issuance or imposition of an untitled letter, which is used for violators that do not necessitate a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action under other regulatory authority, such as false claims laws, if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">but not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs and the curtailment of our operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, physicians may misuse our solutions if they are not adequately trained, potentially leading to injury and an increased risk of product liability. If our solutions are misused, we may become subject to costly litigation by our customers or their patients. As described above, product liability claims could divert management&#8217;s attention from our core business, be expensive to defend and result in sizeable damage awards against us that may not be covered by insurance. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Misleading, untruthful, or unsubstantiated labeling, advertising, marketing, or promotional practices could adversely impact our business, financial condition, and results of operations. The FTC has instituted enforcement actions against certain healthcare testing companies for making false or misleading advertising claims and for failing to adequately substantiate claims made in advertising. These enforcement actions may result in warning letters, consent decrees, and the payment of civil penalties and/or restitution by the companies involved. Should the FTC determine that our claims are false or misleading or unsubstantiated, we could be subject to FTC enforcement action and may face significant penalties which may adversely impact our business, financial condition, and results of operations.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The labeling, advertising, marketing, and promotional practices related to our solutions is governed by numerous state and federal regulators, including the FDA and the FTC, as well as subject to third-party claims. Any statements related to our solutions that could be construed as misleading, untruthful, or unsubstantiated, could subject us to regulatory enforcement action, third-party lawsuits, or plaintiffs&#8217; complaints. Any of these actions could significantly and negatively affect our reputation, expose us to liability claims, and we could lose customers and experience reduced sales and increased costs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our &#8220;research use only&#8221; and any potential &#8220;investigational use only&#8221; products could become subject to more onerous regulation by the FDA or other regulatory authorities in the future, which could increase our costs and delay our commercialization efforts, thereby materially and adversely affecting our business, financial condition, and results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, some of our products are currently available, or may become available, for research use only (&#8220;RUO&#8221;), or for investigational use only (&#8220;IUO&#8221;), depending on the proposed application. We make our RUO and IUO products available to a variety of parties, including pharmaceutical and biotechnology companies and research institutes. Because RUO and IUO products are not intended for use in clinical practice and cannot be advertised or promoted for clinical or diagnostic claims, they are exempt from many regulatory requirements otherwise applicable to medical devices. In particular, FDA regulations require that RUO products be labeled &#8220;For Research Use Only. Not for use in diagnostic procedures,&#8221; and IUO products be labeled &#8220;For Investigational Use Only. The performance characteristics of this product have not been established,&#8221; and such products are not subject to the FDA&#8217;s pre- and post-market controls for medical devices. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A significant change in the laws governing RUO or IUO products or how they are enforced may require us to change our business model in order to maintain compliance. In addition, even under the current law and governmental policies, there is a risk that the FDA may disagree with our characterization of whether a product is appropriately considered an &#8220;RUO&#8221; product that is not subject to FDA&#8217;s premarket review or marketing authorization. For instance, in November 2013, the FDA issued a guidance document entitled &#8220;Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only&#8221; &#8203;(the &#8220;RUO/IUO Guidance&#8221;), which indicates that distribution of RUO or IUO products with written or verbal statements in any labeling, advertising or promotion suggesting that clinical laboratories can validate the test through their own procedures and subsequently offer it for clinical diagnostic use as an LDT would conflict with the RUO or IUO status. The RUO/IUO Guidance further indicates that any assistance offered in performing clinical validation or verification, or similar specialized technical support, to clinical laboratories, would conflict with the RUO or IUO status of the product. If we engage in any activities that the FDA deems to be in conflict with the RUO or IUO status held by any of our products so labeled, we may be subject to immediate, severe, and broad FDA enforcement action that would adversely affect our ability to continue operations. Accordingly, if the FDA finds that we are distributing our RUO or IUO products in a manner that is inconsistent with its RUO/IUO requirements and restrictions, we may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">be forced to stop distribution of our RUO/IUO tests until we are in compliance, which would reduce our revenue, increase our costs, and adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in funding or disruptions at the FDA and other government agencies caused by funding shortages, staffing limitations, or global health concerns could hinder their ability to hire and retain key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or at all, or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could adversely impact our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ability of the FDA to review and provide marketing authorization of new products or changes to existing products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory, and policy changes, the FDA&#8217;s ability to hire and retain key personnel and accept the payment of user fees, federal government shutdowns, and other events that may otherwise affect the FDA&#8217;s ability to perform routine functions. Average review times at the agency have fluctuated in recent&#160;years as a result. In addition, government funding of other government agencies that fund R&amp;D activities is subject to the political process, which is inherently fluid and unpredictable. Decreases in government funding of research and development, including termination of federal employees and any reductions in funding to the U.S. National Institutes of Health may impact our business, as could changes in government programs that provide funding to research institutions and companies, including changes in the amount of funds allocated to different areas of research or changes that have the effect of increasing the length of time of the funding process. Disruptions at the FDA and other government agencies may also slow the time necessary for new medical devices or modifications to FDA cleared or approved medical devices to be reviewed and/or approved by necessary government agencies, which could adversely affect our business. For example, in recent&#160;years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities. In addition, the current U.S. Presidential administration has issued certain policies and Executive Orders directed towards reducing the employee headcount and costs associated with U.S. administrative agencies, including the FDA, and it remains unclear the degree to which these efforts may limit or otherwise adversely affect the FDA&#8217;s ability to conduct routine activities. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, during the COVID-19 pandemic, the FDA postponed most inspections of domestic and foreign manufacturing facilities at various points. If a prolonged government shutdown occurs, or if funding shortages, staffing limitations or renewed global health concerns prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other routine activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could adversely affect our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Federal Policy for the Protection of Human Subjects or related state regulations may be revised or altered in a way that negatively impacts our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Federal Policy for the Protection of Human Subjects (typically referred to as the Common Rule) may be altered in a way that prevents or restricts us from using patient samples or clinical trial data to further develop or validate our solutions or future AI/ML algorithms which rely upon identifiable data. The revised Common Rule, effective as of July&#160;19, 2018, allows the use of prospective consent to unspecified future research (i.e., &#8220;broad consent&#8221;) from a human subject for the storage, maintenance, and secondary use of identifiable private information and identifiable biospecimens in research activities. We obtain both identifiable and de-identified data which we use to develop our solutions through biospecimen repositories and from our biopharma partners. If regulations allowing broad consent or the regulatory definition of &#8220;research&#8221; changes in a way that excludes our research activities, our business may be negatively impacted. State laws governing clinical research may complicate our compliance efforts and add costs and delay to our R&amp;D activities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business activities are subject to the FCPA and similar anti-bribery and anti-corruption laws, as well as export and import controls and economic sanctions laws and regulations of the United States and other jurisdictions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our business activities are subject to the Foreign Corrupt Practices Act of 1977, as amended (the &#8220;FCPA&#8221;), and similar anti-bribery or anti-corruption laws, regulations, or rules of other countries, such as </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the U.K. Bribery Act. The FCPA generally prohibits offering, promising, giving, or authorizing others to give anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action, or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and records that accurately and fairly reflect the transactions of the corporation and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments. Additionally, in many countries, the healthcare providers who administer diagnostic tests are employed by their government, and the purchasers of diagnostics tests are government entities; therefore, our dealings with these providers and purchasers are subject to regulation under the FCPA. The Securities and Exchange Commission (&#8220;SEC&#8221;) and DOJ have increased their FCPA enforcement activities with respect to life sciences companies. There is no certainty that all of our employees, agents, contractors, or collaborators, or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Filing of FCPA enforcement actions have been temporarily paused. Once enforcement resumes, companies may incur additional damage due to delayed prosecution. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our business is also subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. customs regulations, and various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control. Export controls and trade sanctions laws and regulations may restrict or prohibit altogether the provision, sale, or supply of our products to certain governments, persons, entities, countries, and territories, including those that are the target of comprehensive sanctions or an embargo. In particular, there is currently significant uncertainty about the future relationship between the United States and various other countries, including, without limitation, China, Mexico, and Canada, with respect to trade policies, treaties, tariffs, taxes, and other limitations on cross-border operations.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers, or our employees, the closing down of our facilities, requirements to obtain export licenses, cessation of business activities in sanctioned countries, implementation of compliance programs, and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our solutions in one or more countries and could harm our reputation, brand, international expansion efforts, and ability to attract and retain employees, which could have an adverse effect on our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we are unable to obtain and maintain intellectual property protection for our technology, or if the scope of the intellectual property protection we obtain is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to our solutions, and our ability to successfully commercialize our solutions may be impaired.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our success and ability to compete successfully will depend in part on our ability to obtain, maintain, and enforce issued patents, trademarks, and other intellectual property rights and proprietary technology protection for our solutions, preserve our trade secrets, and operate without infringing the intellectual property rights of third parties. Filing, prosecuting, enforcing, and defending patents on our solutions and other technologies in all countries throughout the world would be prohibitively expensive and time-consuming, and the laws of some foreign countries may not protect our rights to the same extent as the laws of the United States. We may not, and our exclusive licensors may not, be able to file, prosecute, maintain, enforce, or license all necessary or desirable patents or patent applications at a reasonable cost or in a timely manner, or in all jurisdictions, or at all, or may choose not to do any of the foregoing. Furthermore, in some cases, we have only filed provisional patent applications on certain aspects of our products and technologies and each of these provisional patent applications, or any future provisional patent application on certain aspects of our products and technologies, is not eligible to become an issued patent until, among other things, we file a non-provisional patent application within 12&#160;months of the filing date of the applicable provisional patent application. In cases where we have not obtained, or decided not to obtain, patent protection for certain of our inventions, we may not be able to prevent third parties from practicing our inventions or from selling or importing tests made using our inventions in and into the United States or other jurisdictions. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent positions of companies, including our patent position, may involve complex legal and factual questions that have been the subject of much litigation in recent&#160;years, and, therefore, the scope of any patent claims that we have or may obtain cannot be predicted with certainty. Accordingly, we cannot provide any assurances about which of our patent applications will issue, the breadth of any resulting patent, whether any of the issued patents will be found to be infringed, that any of our issued patents have, or that any of our currently pending or future patent applications that mature into issued patents will include, claims with a scope sufficient to protect our solutions and services. Our pending and future patent applications may not result in the issuance of patents or, if issued, may not issue in a form that will be advantageous to us. The coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. We cannot offer any assurances that the breadth of our granted patents will be sufficient to prevent a competitor from developing, manufacturing, and commercializing a solution or technologies in a non-infringing manner that would be competitive with one or more of our solutions or technologies, or otherwise provide us with any competitive advantage. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, although we have applied for patents covering aspects of our technology in the United States and several other countries, we cannot be certain that our owned and exclusively licensed patents will not be challenged, or that all patents for which we have applied, or that are covered by our exclusive in-licenses, will be issued on a timely basis or at all, or that such patents will protect our technology, in whole or in part, or be issued in a form that will provide us with meaningful protection, prevent competitors from competing with us, or otherwise provide us with any competitive advantage. As further described below, the enforceability of issued patents may be challenged on a number of fronts, including inventorship, scope, or validity, and certain of our owned or exclusively in-licensed patents have been, and others in the future may be, challenged in the courts or patent offices in the United States and abroad. As a result of such challenges, our issued patents may be held invalid or unenforceable and the scope of existing or future patents may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. For additional information, see &#8220;&#8212;Issued patents covering our solutions and other technologies could be found invalid or unenforceable if challenged in court or before administrative bodies in the United States and abroad.&#8221; We may fail to identify patentable technologies in a timely fashion, which could impair our ability to obtain patent protection on such technology at all. If we fail to timely file for patent protection in any jurisdiction, we may be precluded from doing so at a later date. Our competitors may be able to circumvent our owned or exclusively in-licensed patents by developing similar or alternative technologies or tests in a non-infringing manner. In addition, to the extent we have granted, or may grant in the future, licenses, or sublicenses of our intellectual property rights to third parties, we cannot be certain that such intellectual property rights will not be used by those third parties in a manner that could compete with our business or otherwise negatively impact any competitive advantage provided by such intellectual property rights. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Publications of discoveries in scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18&#160;months after filing, or in some cases not at all. Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in our owned or licensed patents or pending patent applications, or that we were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability, and commercial value of our patent rights are uncertain. Given the amount of time required for the development, testing, and regulatory review of biological tests, patents protecting or covering such tests might expire shortly after such solutions are commercialized. As a result, our owned or exclusively in-licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a third party obtains an issued patent on a technology we use in our solutions, that party may be able to prevent us from using those inventions, and we may not be able to design around the third party&#8217;s patents or obtain a license on commercially reasonable terms, if at all. Third-party patents or other intellectual property may exist that our current technology, manufacturing methods, solutions, platform, or future methods or tests will be alleged to infringe, which could result in litigation, the imposition of injunctions preventing our use of the foregoing, or require us to obtain licenses or pay royalties and/or other forms of compensation to third parties, which could be significant and could harm our results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some of our patents and patent applications may in the future be co-owned with third parties. If we are unable to obtain an exclusive license to any such third-party co-owners&#8217; interest in such patents or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">patent applications, such co-owners may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products, services, and technology. In addition, we may need the cooperation of any such co-owners of our patents in order to enforce such patents against third parties, and such cooperation may not be provided to us. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The degree of future protection for our proprietary rights is uncertain, and we cannot ensure that: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any of our patents, or any of our pending patent applications, if issued, will include claims having a scope sufficient to protect our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any of our pending patent applications will issue as patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we will be able to successfully manufacture and commercialize our solutions on a substantial scale, if approved, before relevant patents we may have expire; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we were the first to make the inventions covered by each of our patents and pending patent applications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we were the first to file patent applications for these inventions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">others will not independently develop, manufacture and/or commercialize similar or alternative or duplicative solutions of any of our technologies or products that do not infringe our patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any of our challenged patents will be found to ultimately be valid and enforceable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any patents issued to us will provide a basis for an exclusive market for our commercially viable solutions or technologies, and will provide us with any competitive advantages or will not be challenged by third parties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we will develop additional proprietary technologies or solutions that are separately patentable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our pending patent applications or those that we may own in the future will lead to issued patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our competitors will not conduct R&amp;D activities in countries where we do not have patent rights and then use the information learned from such activities to develop, manufacture, and commercialize competitive products for sale in our major commercial markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the patents of others will not harm our business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a third party does not subsequently file a patent covering trade secrets or know-how that we chose not to seek patent protection; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our commercial activities or solutions will not infringe upon the patents of others. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Third parties may allege that we infringe, misappropriate, or violate their intellectual property rights, and if they prevail, could block sales of our solutions and force us to pay damages and/or royalties, which could adversely affect the success of our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our commercial success in part depends upon our ability, and the ability of our relevant commercial partners, to market, sell, and distribute our solutions and use our proprietary technologies and platform without infringing, misappropriating, or otherwise violating the intellectual property rights of third parties. There is considerable intellectual property litigation in the medical technology, biotechnology, diagnostic, and pharmaceutical industries, and companies in these industries have used intellectual property litigation to gain a competitive advantage. In addition, there is ongoing intellectual property litigation involving the analysis of circulating nucleic acid, the outcome of which could also impact future litigation involving our intellectual property or our ability to commercialize our solutions. We may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights. Third parties may assert infringement claims against us based on existing patents or patents that issue in the future. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we are found to infringe, misappropriate, or otherwise violate a third party&#8217;s intellectual property rights, we could be required to obtain a license from such third party to continue developing, marketing, selling, and distributing our solutions or platform, or to cease using the infringing technology. However, we </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">may not be able to obtain any required license on commercially reasonable terms, if at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, we could be found liable for monetary damages, including treble damages if we are found to have willfully infringed a patent and attorneys&#8217; fees if the court finds the case to be exceptional. A finding of infringement, misappropriation, or other violation could prevent us from commercializing our solutions or force us to cease some of our operations or develop alternate technologies, which could materially harm our business, financial condition, results of operations, and prospects. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our reputation and business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can if they have greater financial resources and/or more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could adversely affect our ability to compete in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Issued patents covering our solutions and other technologies could be found invalid or unenforceable if challenged in court or before administrative bodies in the United States and abroad.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to allegations of infringement of a third party&#8217;s intellectual property rights, a third party may also challenge the validity or enforceability of our owned or in-licensed patents in court or before administrative bodies in the United States or abroad. If we or one of our licensors were to initiate legal proceedings against a third party to enforce a patent covering a solution or a solution candidate, the defendant could counterclaim that the asserted patent is invalid and/or unenforceable. Though an issued patent is presumed valid and enforceable, defendant counterclaims alleging invalidity or unenforceability are commonplace in patent litigation in the United States. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements for patentability, including lack of novelty, obviousness, lack of subject matter eligibility, lack of written description, and non-enablement. Non-statutory grounds for unenforceability include inequitable conduct in obtaining the patent, such as an allegation that someone connected with prosecution of the patent withheld relevant information from the United States Patent and Trademark Office (the &#8220;USPTO&#8221;), or made a material misleading statement. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to validity, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. In addition, the patent laws or interpretation thereof by the USPTO and courts could result in some of the claims of our patents to become invalidated. A court may decide that a patent or other intellectual property right of ours is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims or other intellectual property narrowly or refuse to stop a third party from using the technology at issue on the grounds that our patents or other intellectual property do not cover the technology in question and is therefore not infringed upon, violated, or misappropriated. For example, certain claims of five of our U.S. patents have previously been invalidated in </font><font style="font-style:italic;letter-spacing:0.2pt;">inter partes</font><font style="letter-spacing:0.2pt;"> review (&#8220;IPR&#8221;) proceedings, two of our European patents were challenged but ultimately upheld in their entirety in opposition proceedings, and one of our European patents was held unpatentable in an opposition that is currently under appeal. As a result of such challenges, our issued patents may be held invalid or unenforceable and the scope of existing or future patents may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a defendant were to prevail on its legal assertion of invalidity and/or unenforceability against our intellectual property related to a solution or a solution candidate, we could lose at least part, and perhaps all, of the patent protection on such solution or solution candidate. Such a loss of patent protection could adversely impact our business. Moreover, our competitors could counterclaim that we infringe their intellectual property, and some of our competitors have substantially greater intellectual property portfolios than we do. Even if our patents or other intellectual property rights are found to be valid and infringed, a court may refuse to grant injunctive relief against the infringer and instead grant us monetary damages and/or ongoing royalties. Such monetary compensation may be insufficient to adequately offset the damage to our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">business caused by the infringer&#8217;s competition in the market. An adverse result in any litigation or administrative proceeding could put one or more of our patents or other intellectual property rights at risk of being invalidated or interpreted narrowly, which could adversely affect our competitive business position, financial condition, and results of operations. Moreover, even if we are successful in any litigation, we may incur significant cost and expense in connection with such proceedings, and the amount of any monetary damages may be inadequate to compensate us for damage from the infringement and proceedings. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to infringement claims against us, third parties have raised, and in the future may raise, claims challenging the validity or enforceability of our owned or in-licensed patents before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms before the USPTO include re-examination, post grant review, IPR, derivation proceedings, interference proceedings, and equivalent proceedings in foreign jurisdictions (such as opposition proceedings in Europe). Such administrative proceedings could result in the revocation of, cancellation of, or amendment to our patents in such a way that they no longer cover our technologies or solutions. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we, our patent counsel, and the patent examiner were unaware during prosecution. If a third party were to prevail on a legal assertion of invalidity and/or unenforceability, we may lose at least part, and perhaps all, of the patent protection on our solutions or technologies. Such a loss of patent protection could adversely impact our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to comply with our obligations in the agreements under which we license or may license intellectual property rights from third parties or we otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important to our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have entered into, and may further need to enter into, certain licenses or other collaboration agreements pertaining to the in-license of intellectual property rights from others to advance our research or allow commercialization of our solutions and technologies. Some of these licenses are for a limited term and may include the right for the licensor to terminate upon notice. If any such arrangement is terminated by the licensor, or if we need to enter into any additional licensing arrangements, then we may be unable to obtain such licenses at a reasonable cost or on reasonable terms, if at all, and as a result, we may be required to expend significant time and resources to redesign our technology or to develop or license replacement technology, any of which may not be feasible on a technical or commercial basis. If we are unable to obtain or maintain applicable licenses, we may be unable to commercialize certain solutions or continue to use certain technology, which could harm our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our intellectual property in-licenses may impose various reporting, development, diligence, milestone payment, royalty, insurance, commercialization, and other obligations on us, and we expect that our future license or development agreements will contain similar types of obligations. If we fail to comply with any of these obligations, our licensor or collaboration partners may have the right to terminate the relevant license or collaboration agreement, in which event we would not be able to develop or market the solutions or technologies covered by such licensed intellectual property, or to pursue other reasonable or alternative arrangements. Despite our efforts, our licensors or collaborators might conclude that we have materially breached our obligations under such license agreements. If our licensors or collaborators were to terminate the license agreements or otherwise modify our rights under those agreements, our ability to develop and commercialize solutions and technology covered by these license agreements could be limited if not halted. This could adversely affect our competitive position, business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Agreements under which we license or otherwise obtain rights to intellectual property or technology from third parties may be complex, and certain provisions in such agreements may be susceptible to multiple interpretations, which could lead to disputes between us and our licensor, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope of rights granted under the license agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which our solution and technology are alleged to infringe the licensor&#8217;s intellectual property that is not subject to the license agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the right to sublicense patent and other rights under our collaborative development relationships; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our diligence and other obligations under the license agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the priority of invention of patented technology; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inventorship and ownership of inventions and know-how resulting from the collaboration with a licensor or joint invention of intellectual property by us and our licensors and our partners. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The resolution of any contract disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could adversely affect our business, financial condition, results of operations, and prospects. If we were required to engage in litigation to enforce or defend our rights under our license or development agreements, even if we were successful, such litigation could require significant financial resources, divert the attention of management, and harm our business. Moreover, if disputes over intellectual property rights that we have licensed or otherwise obtained rights to prevent or impair our ability to maintain our current arrangements on commercially acceptable terms, or at all, we may be unable to successfully commercialize the affected solution or technology, which could adversely affect our business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, we may have limited control over the maintenance and prosecution of in-licensed patents and patent applications, or any other intellectual property that may be related to our in-licensed intellectual property. For example, we cannot be certain that such activities by any future licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights. If any of our current or future licensors fail to obtain and maintain patent or other protection for the proprietary intellectual property we license from them, we could lose our rights to the intellectual property, or these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business and our competitors could market competing products using the intellectual property. In the event we breach any of our obligations related to such maintenance or prosecution, we may incur significant liability to our licensing partners, including loss of our right to the licensed patent applications or early termination of the license by our licensor. We also may have limited control over the manner in which our licensors initiate an infringement proceeding against a third-party infringer of the intellectual property rights, or defend certain of the intellectual property that is licensed to us. It is possible that the licensor&#8217;s infringement proceeding or defense activities may be less vigorous than had we conducted such activities ourselves. Our ability to enforce in-licensed patents may be in question if our licensors refuse to join in such activities initiated by us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our technology licensed from third parties may be subject to retained rights.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any license we may enter into could provide for the retention by the licensor of certain rights under their agreements with us, including for example, the right to use the underlying technology for noncommercial academic and research use, to publish general scientific findings from research related to the technology, and to make customary scientific and scholarly disclosures of information relating to the technology. It is difficult to monitor whether any future licensors will limit their use of the technology to these uses, and we may incur substantial expenses to enforce our rights to our licensed technology in the event of misuse. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the U.S. government retains certain rights in inventions produced with its financial assistance under the Patent and Trademark Law Amendments Act (the &#8220;Bayh-Dole Act&#8221;). The U.S. government retains a &#8220;nonexclusive, nontransferable, irrevocable, paid-up license&#8221; for its own benefit. The Bayh-Dole Act also provides federal agencies with &#8220;march-in rights.&#8221; March-in rights allow the government, in specified circumstances, to require the contractor or successors in title to the patent to grant a &#8220;nonexclusive, partially exclusive, or exclusive license&#8221; to a &#8220;responsible applicant or applicants.&#8221; If the patent owner refuses to do so, the government may grant the license itself. The Bayh-Dole Act also imposes other obligations, including the requirement that products covered by the government funded patents be manufactured in the United States. We sometimes collaborate with academic institutions to accelerate our R&amp;D efforts. In the future, we may own or license technology which is critical to our business that is developed in whole or in part with federal funds subject to the Bayh-Dole Act. If the federal government exercises its rights under the Bayh-Dole Act, our ability to enforce or otherwise exploit patents covering such technology may be adversely affected. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may become involved in lawsuits to protect or enforce or defend our patents or other intellectual property rights, which could be expensive, time-consuming, and unsuccessful.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Third parties, including our competitors, may currently, or in the future, infringe, misappropriate, or otherwise violate our issued patents or other intellectual property rights, and we may file lawsuits or initiate other proceedings to protect or enforce our patents or other intellectual property rights, which could be expensive, time-consuming, and unsuccessful. We monitor for unauthorized use of our intellectual property rights and, from time to time, analyze whether to seek enforce our rights against potential infringement, misappropriation, or violation of our intellectual property rights. However, the steps we have taken, and are taking, to protect our proprietary rights may not be adequate to enforce our rights as against such infringement, misappropriation, or violation of our intellectual property rights. In certain circumstances it may not be practicable or cost-effective for us to enforce our intellectual property rights fully, for example, in certain countries or where the initiation of a claim might harm our business relationships. We may also be hindered or prevented from enforcing our rights with respect to a government entity or instrumentality because of the doctrine of sovereign immunity. Our ability to enforce our patent or other intellectual property rights can depend on our ability to detect infringement. It may be difficult to detect infringers who do not advertise the components or methods that are used in connection with their products or technologies. Moreover, it may be difficult or impossible to obtain evidence of infringement in a competitor&#8217;s or potential competitor&#8217;s product or technologies. Thus, we may not be able to detect unauthorized use of, or take appropriate steps to enforce, our intellectual property rights. Any inability to meaningfully enforce our intellectual property rights could harm our ability to compete and reduce demand for our solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, these lawsuits or other proceedings could be costly and could affect our operations and divert the attention of our managerial, legal, and scientific personnel. There is a risk that a court or administrative body would decide that our owned or in-licensed patents are invalid or not infringed by a third party&#8217;s activities, or that the scope of certain claims is more limited than we believe. An adverse outcome in a litigation or other proceeding involving our owned or in-licensed patents could limit our ability to enforce our patents against competitors, affect our ability to receive royalties or other licensing consideration, and may curtail or preclude our ability to exclude third parties from making, using, and selling similar or competitive products. We may become more susceptible to these types of lawsuits and proceedings given the proliferation of organizations pursuing intellectual property protections in the biomarker testing space, particularly as relates to cell free nucleic acids. Any of these occurrences could adversely affect our business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property litigation may lead to public disclosures and unfavorable publicity that harms our reputation and causes the market price of our common stock to decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during litigation. Further, during the course of any intellectual property litigation, there could be public announcements of the initiation of the litigation as well as results of hearings, rulings on motions, and other interim proceedings in the litigation. If securities analysts or investors regard these announcements as negative, the perceived value of our existing solutions, programs or intellectual property could be diminished. Accordingly, the market price of shares of our common stock may decline. Such announcements could also harm our reputation or the market for our future solutions, which could adversely affect our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patent terms may be inadequate to protect our competitive position on our solutions for an adequate amount of time.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Patents have a limited lifespan in all jurisdictions around the world. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20&#160;years from its earliest U.S. non-provisional filing date. Various extensions may be available, but the protection offered by a patent remains time limited. Once a patent covering our solutions expires, we may be subject to additional competition. Given the amount of time required for the development, testing and regulatory review of new products, patents protecting such products might expire before or shortly after such products are commercialized or receive regulatory approval. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing solutions similar or identical to ours for a meaningful </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">amount of time, or at all. Such an inability to exclude competitors from commercializing similar or identical products could have adversely impact our reputation, business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we do not obtain patent term extension and data or regulatory exclusivity for any solutions we may develop, our business may be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Depending upon the timing, duration, and specifics of any FDA marketing approval of any therapeutic solutions we may develop, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Action of 1984 (the &#8220;Hatch-Waxman Amendments&#8221;). The Hatch-Waxman Amendments permit a patent extension term of up to five&#160;years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents, or otherwise failing to satisfy applicable legal requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or the term of any such extension is less than we request, the period during which we will have the right to exclusively market our solution will be shortened and our competitors may obtain approval of competing products following our patent expiration and may take advantage of our investment in development and clinical trials by referencing our clinical and preclinical data to launch their product earlier than might otherwise be the case. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, depending upon the timing, duration, and specifics of any FDA approval of biological products we may develop as part of Caris Discovery or otherwise, such products may be eligible for a period of regulatory exclusivity under the Biologics Price Competition and Innovation Act of 2009 (&#8220;BPCIA&#8221;), a subtitle of the Patient Protection and Affordable Care Act. The BPCIA created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed reference biological product. Under the BPCIA, an application for a highly similar or &#8220;biosimilar&#8221; product may not be submitted to the FDA until four years following the date that the reference product was first approved by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12&#160;years from the date on which the reference product was first approved. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full biologics license application for the competing product containing the sponsor&#8217;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of its product. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Biological products we may develop, if any and if approved, could be considered reference products entitled to 12-year exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider a product candidate to be reference products for competing products, potentially creating the opportunity for competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once approved, will be substituted for any reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing. The FDA only approved the first interchangeable biosimilar in July 2021, and the law is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. If competitors are able to obtain marketing approval for biosimilars referencing any biological products we may develop, our products may become subject to competition from such biosimilars, which could adversely impact our competitive position.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent application process to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">maintain patent applications and issued patents. In addition, periodic maintenance fees, renewal fees, annuity fees, and various other government fees on patents and applications must be paid to the USPTO and similar patent agencies outside of the United States over the lifetime of our owned and in-licensed patents and applications. In some cases, we rely on our licensing partners to pay such fees and to take the necessary actions to comply with other requirements to maintain such in-licensed patents during their term. While an unintentional lapse of a patent or patent application can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, in some cases non-compliance can result in abandonment or lapse of the patent or patent application, resulting in a partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. In such an event, potential competitors might be able to enter the market with similar or identical tests or technology, which could adversely affect our competitive position. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Developments in patent law could have a negative impact on our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the U.S. Supreme Court or other federal courts, the U.S. Congress, the USPTO, or similar governmental authorities in other jurisdictions may change the standards of patentability and any such changes could have a negative impact on our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Several decisions from the U.S. Supreme Court regarding patentable subject matter are of particular relevance in the medical diagnostics and computer-implemented applications space. The 2012 decision in </font><font style="font-style:italic;letter-spacing:0.2pt;">Mayo Collaborative v. Prometheus Laboratories</font><font style="letter-spacing:0.2pt;"> (&#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Mayo</font><font style="letter-spacing:0.2pt;">&#8221;) concerns patent claims directed to optimizing the amount of drug administered to a specific patient based on certain metabolite levels in blood. The Supreme Court held that the applicable patent&#8217;s claims were directed to a law of nature (i.e., a natural correlation between metabolite levels and efficacy or toxicity) and failed to incorporate a sufficiently inventive concept above and beyond routine and conventional method steps to allow the claimed methods of treatment to qualify as patent eligible. The 2014 decision in </font><font style="font-style:italic;letter-spacing:0.2pt;">Alice Corporation Pty. Ltd. v. CLS Bank International</font><font style="letter-spacing:0.2pt;"> (&#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Alice</font><font style="letter-spacing:0.2pt;">&#8221;) concerns a computer-implemented, electronic escrow service for facilitating financial transactions. The Supreme Court held that an abstract idea could not be patented just because it is implemented on a computer. It is generally believed that </font><font style="font-style:italic;letter-spacing:0.2pt;">Mayo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Alice</font><font style="letter-spacing:0.2pt;">, and subsequent cases interpreting these decisions, have made it more difficult to patent medical diagnostic and computer-implemented inventions. Our efforts to seek patent protection for such technologies and solutions may be negatively impacted by this jurisprudence, or guidance or procedures issued by the USPTO or authorities in other jurisdictions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot predict the impact of the changing landscape of patent eligible subject matter on our ability, or that of our competitors, to obtain or enforce patents relating to products and services involving genomic or biomarker related discoveries, or computer-implemented technologies, such as molecular tests that implement ML. Indeed, many believe that the contours of whether claims are patent eligible, or recite laws of nature, natural phenomena, natural products, or abstract ideas remain unclear despite a decade of interpretation at the USPTO and in the courts. Third parties holding patents issued prior to </font><font style="font-style:italic;letter-spacing:0.2pt;">Mayo</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">Myriad</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Alice</font><font style="letter-spacing:0.2pt;"> could allege that we infringe these patents, even if these patents are not likely enforceable under current U.S. laws. We could be forced to defend against claims of patent infringement or obtain license rights, if available on commercially reasonable terms or at all, under these patents. In jurisdictions other than the United States, gene- and computer-related patent claims may remain valid and may be enforceable against us. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The U.S. Congress has periodically sought to pass laws concerning subject matter eligibility for patent protection, aimed in large part at abrogating the holdings of </font><font style="font-style:italic;letter-spacing:0.2pt;">Mayo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Alice</font><font style="letter-spacing:0.2pt;">. To date, these efforts have been unsuccessful, but are ongoing. We cannot fully predict the impact that such new laws may have on our ability to obtain patent protection on our solutions and technologies, and our ability to operate in view of the patents controlled by third parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not be able to enforce our intellectual property rights throughout the world.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The laws of foreign countries may not protect intellectual property rights to the same extent as the laws of the United States. In some cases, companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. The legal systems of some countries, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">particularly developing countries, do not favor the enforcement of patents and other intellectual property protection, especially those relating to life sciences. This could make it difficult for us to stop the infringement of our patents or the misappropriation of our other intellectual property rights. For example, some foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;1, 2023, the European Union implemented a unitary patent system with the goal of providing a single pan-European Unitary Patent and a new European Unified Patent Court (&#8220;UPC&#8221;) for litigation involving European patents. As a result, all European patents, including those issued prior to ratification of the unitary patent system, now by default automatically fall under the jurisdiction of the UPC, although patent applicants and patent holders may elect to opt-out of the new system for a transitional period of at least seven&#160;years. It is uncertain how the UPC will impact European patents, including those in the biotechnology and pharmaceutical industries. If we do not opt-out, our European patents could be challenged in the UPC. Thus far, like many others, we have elected to opt-out of the UPC as it matures. We may continue to opt-out our future European patents, but doing so may preclude us from realizing its benefits. Moreover, if we do not meet all of the formalities and requirements for opt-out under the UPC, our future European patents could remain under the jurisdiction of the UPC. The UPC will provide our competitors with a new forum to centrally revoke our European patents, and allow for the possibility of a competitor to obtain a pan-European injunction. Such a loss of patent protection or injunction obtained by a competitor could adversely impact our business and our ability to commercialize our technology and solutions and, as a result, on our business, financial condition, prospects, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Proceedings to enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of our business. Furthermore, while we intend to protect our intellectual property rights in our expected significant markets, we cannot ensure that we will be able to initiate or maintain similar efforts in all jurisdictions in which we may wish to market our solutions. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain and enforce adequate intellectual property protection for our solutions and technology. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position could be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to seeking patents for certain of our solutions and other technologies, we rely on trade secrets and confidentiality agreements to protect our unpatented know-how, technology, data, and other proprietary information and to maintain our competitive position. Trade secrets and know-how can be difficult to protect. Our trade secrets and know-how may over time become known to others through various means such as independent development, personnel movement, collaborative efforts or other intentional or unintentional disclosure. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We seek to protect our trade secrets and other proprietary technology, in part, by entering into non-disclosure and confidentiality agreements with relevant parties, such as our employees, directors, corporate and scientific collaborators, contract research organizations, contract manufacturers, suppliers, service providers, consultants, advisors, and other third parties. We generally enter into confidentiality and invention assignment agreements with our employees and consultants upon their commencement of a relationship with us, and remind departing employees of their continuing confidentiality obligations. However, we may not be successful in entering into such agreements with all employees and consultants. Although we generally require all of our employees, consultants, advisors and any third parties who have access to our proprietary know-how, information, processes, or technology to enter into confidentiality agreements, we cannot provide any assurances that we have entered into confidentiality agreements with each person or party that had or may have had access to our proprietary know-how, information, processes, or technology. In addition, monitoring unauthorized use and disclosure of our proprietary know-how, information, processes or technology by employees, consultants and other third parties who have access can be difficult, and we cannot be certain whether the steps we have taken to protect our proprietary know-how, information, processes, or technology will be adequate. Therefore, we may not be able to prevent the unauthorized disclosure or use of our technical knowledge or other trade secrets by such employees, consultants, advisors or third parties, despite the existence of confidentiality restrictions. These agreements may also not provide meaningful </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">protection against the unauthorized use or disclosure of our trade secrets, know-how or other proprietary information in the event the unwanted use is outside the scope of the provisions of the contracts or in the event of any unauthorized use, misappropriation, or disclosure of such trade secrets, know-how, or other proprietary information. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Despite our efforts, any of these persons or parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a person or party illegally disclosed or misappropriated a trade secret can be difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, some courts outside the United States may be less willing or unwilling to protect trade secrets. Further, agreement terms that address non-competition are difficult to enforce in many jurisdictions and might not be enforceable in certain cases. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. We may enter into collaboration, license, contract research and/or manufacturing relationships with contract organizations that operate in certain countries that are at heightened risk of theft of technology, data, and intellectual property through direct intrusion by private parties or foreign actors, including those affiliated with or controlled by state actors. If any of our trade secrets were to be misappropriated by, disclosed to, or independently developed by a competitor or other third party, our competitive position could be adversely harmed. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to contractual measures, we try to protect the confidential nature of our proprietary information by maintaining physical security of our premises and electronic security of our information technology systems. Such security measures may not be adequate for all scenarios, for example, in the case of misappropriation of a trade secret by an employee, consultant, or other third party with authorized access. An employee, consultant or other third party who misappropriates our trade secrets may provide such information to a competitor, and any recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our solutions, platform, or services that we consider proprietary. Although we use commonly accepted security measures, trade secret violations are a matter of both federal and state law in the United States, and the criteria for protection of trade secrets can vary among different jurisdictions. If the steps we have taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse against third parties for misappropriating the trade secret. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. If any of our intellectual property rights or confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information was independently developed by a competitor, it could adversely affect our competitive position, business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, our efforts to protect and enforce our trade secrets, know-how and intellectual property rights around the world may be inadequate to obtain a significant commercial advantage, and we may be at heightened risk of losing our trade secrets, proprietary know-how and intellectual property rights around the world, to the extent such theft or intrusion destroys their secrecy or other proprietary nature. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be subject to claims by third parties asserting that we or our employees have infringed or misappropriated intellectual property rights, or to assertions by third parties or employees claiming ownership of what we regard as our own intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many of our former, current, and future employees, consultants and contractors have been previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors and strategic partners. Some of these employees, consultants and contractors may have executed proprietary rights, non-disclosure and non-competition agreements in connection with such previous employment or engagement. We train our employees, consultants, and contractors not to bring, or use in their work proprietary information or technology from former employers. Although we intend for such training and other measures to ensure that our employees do not use the proprietary information or know-how of others in their work for us, to the extent that our employees, consultants or contractors use intellectual property rights or proprietary information owned by others in their work for us, we may be subject to claims that an employee has used or disclosed intellectual property, including trade secrets or other proprietary information, of such employee&#8217;s former employer. Litigation, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">which would be expensive, time-consuming, a distraction to management, and uncertain of outcome, may be necessary to defend against these claims. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we may be subject to claims from third parties challenging ownership interest in or inventorship of intellectual property rights we regard as our own, based on claims that our agreements with employees or consultants obligating them to assign their intellectual property rights to us are ineffective or in conflict with prior or competing contractual obligations to assign inventions and intellectual property rights to another employer, to a former employer, or to another person or entity. We are not aware of any threatened or pending claims related to these matters, but, in the future, litigation may be necessary to defend against such claims should they arise, and it may be necessary or we may desire to obtain a license to such third party&#8217;s intellectual property rights to settle any such claim. However, there can be no assurance that we would be able to obtain such license on commercially reasonable terms, if at all. If we fail in defending any such claims, in addition to paying monetary damages or a settlement payment, we may lose valuable intellectual property rights or personnel, or access to consultants and contractors. A court could prohibit us from using technologies, features or other intellectual property rights that are essential to our solutions or technologies, if such technologies or features are found to incorporate or be derived from the trade secrets or other proprietary information of another person or entity, including another or former employers. An inability to incorporate technologies, features or other intellectual property rights that are important or essential to our solutions or technologies could adversely affect our business, financial condition, results of operations, and competitive position, and may prevent us from developing, manufacturing and/or commercializing our solutions or technologies. In addition, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and our employees. Any litigation or the threat of litigation may adversely affect our ability to hire employees or contract with independent sales representatives. A loss of key personnel or their work product could hamper or prevent our ability to develop, manufacture and/or commercialize our solutions or services, which could adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we may be subject to claims that our former employees, contractors or collaborators, or other third parties have an ownership interest in our current or future patents, patent applications, or other intellectual property rights, including as an inventor or co-inventor. We may be subject to ownership or inventorship disputes in the future arising, for example, from conflicting obligations of employees, consultants or others who were or are involved in developing our solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we fail to prevail on any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, or be required to obtain a license, which may not be available to us on commercially reasonable terms or at all. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to management, which could harm our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We currently hold and/or have applied for a number of trademarks, covering Caris, MI Profile, MI Tumor Seek Hybrid, MI Cancer Seek, Caris Assure, and other solutions and services in certain jurisdictions. However, our pending or future trademark applications may not be approved or our registered or unregistered trademarks or trade names may be challenged, invalidated, infringed, or declared generic or determined to be infringing on other marks. If any of the foregoing occurs, we could be forced to re-brand our solutions or technologies, and we may not be able to protect our rights to these trademarks and trade names, which we view as valuable to building name recognition among partners and customers in our markets of interest. At times, competitors or other third parties have adopted or may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion and/or litigation. In addition, there have been and could be trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. There can be no assurance that competitors will not infringe our trademarks or that we will have adequate resources to enforce our trademarks. Over the long term, if we are unable to establish name recognition based on our trademarks </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and trade names, we may be unable to compete effectively and our business may be adversely affected. Our efforts to enforce, protect, or defend our trademarks may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our competitive position, business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our use of open-source software could subject our proprietary technology to unwanted open-source license conditions that could negatively impact our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We use open-source software in some of our technologies and solutions, and we may incorporate open-source software into future technologies and solutions. From time to time, companies that use third-party open source software have faced claims challenging the use of such open source software and requesting compliance with the open source software license terms. Accordingly, we may be subject to suits by parties claiming ownership of what we believe to be open source software or claiming non-compliance with the applicable open source licensing terms. Some open source software licenses require end users, who use, distribute, or make available across a network software and services that include open source software, to make publicly available or to license all or part of such software (which in some circumstances could include valuable proprietary code, such as derivative works of the open source software) under the terms of the particular open source license. If a third party were to allege that we had not complied with the conditions of one or more of these licenses, we could be required to invest substantial time and resources to re-engineer some of our software or release certain portions of our proprietary source code, which could substantially help our competitors develop products that are similar to or improve upon ours and harm our business. We could also be required to incur significant legal expenses defending against such allegations. Further, the outcome of such litigation may be particularly uncertain because there are numerous open source software licenses which have not been tested in courts of law, and thus lack guidance regarding their proper legal interpretation. Any of the foregoing could disrupt and harm our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the use of third-party open source software typically exposes us to greater risks than the use of third-party commercial software because open source licensors generally do not provide warranties or controls on the functionality or origin of the software. Use of open source software may also present additional security risks because the public availability of such software may make it easier for hackers and other third parties to determine how to compromise platforms using such source code. Any of the foregoing could harm our business and could help our competitors develop products and services that are similar to or that improve upon ours. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The occurrence of any of these events could adversely affect our business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Our Indebtedness</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have incurred substantial indebtedness, and we may not generate sufficient cash flow from operations to meet our debt service requirements, continue our operations, and pursue our growth strategy, and we may be unable to raise capital when needed or on acceptable terms.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025, we and our subsidiaries had approximately $400.0&#160;million aggregate principal amount of debt outstanding under the 2023 Term Loan. Subsequent to March&#160;31, 2025, we issued $30.0 million aggregate principal amount of our 2025 Convertible Notes in April 2025, which will convert into shares of our common stock in connection with this offering, in accordance with their terms. Our substantial level of indebtedness increases the risk that we may be unable to generate cash sufficient to pay amounts due in respect of our indebtedness, pay dividends and to fund our general corporate and capital requirements. The substantial indebtedness of us and our subsidiaries could have important consequences to our shareholders, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a portion of our cash flow from operations must be dedicated to the payment of principal and interest on our debt, thereby reducing the funds available to us for other purposes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to satisfy our obligations under the 2023 Term Loan Agreement may be adversely affected; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to make loans and investments or engage in acquisitions without issuing additional equity or obtaining additional debt financing may be impaired in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to obtain additional financing for working capital, capital expenditures, acquisitions, debt service requirements or general corporate purposes may be impaired in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to pay dividends or engage in share repurchases may continue to be restricted; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our flexibility may be limited in planning for, or reacting to, changes or challenges relating to the business we conduct; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may be more vulnerable to general adverse economic and industry conditions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may be at a competitive disadvantage compared to our competitors who have less debt or comparable debt at more favorable interest rates or terms and who, as a result, may be better positioned to withstand economic downturns or to finance capital expenditures or acquisitions; our costs of borrowing may increase; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may be unable to refinance our debt on terms as favorable as our existing debt or at all. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The occurrence of any one of these events could have an adverse effect on our business, financial condition, results of operations, and ability to satisfy our obligations under the 2023 Term Loan Agreement. We may not be able to access capital on acceptable terms, raise additional capital in the future, or make effective capital allocation decisions, which could result in our inability to achieve operational objectives. Any disruption in access to capital could require us to take measures to conserve cash until alternative credit arrangements or other funding for business needs can be arranged. Such measures could include deferring capital expenditures, acquisitions or other discretionary uses of cash, or revising capital allocation decisions. Any of these risks could adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The agreements and instruments governing our debt contain restrictions and limitations that could significantly impact our management&#8217;s flexibility and our financial and operational flexibility to operate our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Restrictive covenants in the 2023 Term Loan Agreement place limits on our ability to conduct our business. Covenants in the 2023 Term Loan Agreement include those that, subject to certain exceptions, restrict our ability to: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">materially alter the business we conduct; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">incur certain additional indebtedness and guarantee indebtedness; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">create or incur liens; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">purchase, make, incur, assume, or permit to exist certain investments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make any dividends, distributions, and certain other payments to our shareholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sell, transfer, or otherwise dispose of assets, including capital stock of our subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">modify certain agreements that have an impact on our indebtedness; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">engage in certain transactions with our affiliates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into any restrictive agreements prohibiting (i)&#160;the creation of liens to secure our obligations under the 2023 Term Loan Agreement, (ii)&#160;our or our subsidiaries&#8217; modification of the 2023 Term Loan Agreement, or (iii)&#160;our or our subsidiaries&#8217; ability to pay dividends or make any other distributions on any capital securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into sale and leaseback transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make changes to name, location, executive office, executive management, or fiscal&#160;years without prior notice; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">incur any actual or potential liability on benefit plans or allow any employee benefit plans to cease to be tax qualified. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2023 Term Loan Agreement also imposes maintenance requirements on our liquidity and revenue base and restricts our ability to engage in certain mergers or consolidations. For additional </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">information, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8212;Indebtedness&#8221; and &#8220;&#8212;Risks Related to Our Business and Industry&#8212;Our business and results of operations will suffer if we fail to compete effectively.&#8221; These restrictions may prevent us from taking actions that we believe would be in the best interest of our business and may make it difficult for us to execute our business strategy successfully or compete effectively with companies that are not similarly restricted. We may also incur future debt obligations that might subject us to additional restrictive covenants that could affect our financial and operational flexibility. Our ability to comply with the covenants and restrictions contained in the 2023 Term Loan Agreement may be affected by economic, financial and industry conditions beyond our control. The breach of any of these covenants or restrictions could result in a default under the 2023 Term Loan Agreement that would permit the applicable lenders or noteholders, as the case may be, to declare all amounts outstanding thereunder to be due and payable, together with accrued and unpaid interest. In addition, such a default or acceleration may result in the acceleration of any other debt to which a cross-acceleration or cross-default provision applies. Our obligations under the 2023 Term Loan Agreement are secured by our intellectual property. If we are unable to repay debt, lenders having secured obligations under the 2023 Term Loan Agreement could proceed against the collateral securing the debt. This could have serious consequences to our business, financial condition, and results of operations and could cause us to become bankrupt or insolvent. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We rely on cash generated from our financing and operating activities as our primary source of liquidity. To support our operations, execute our growth strategy as planned and pay dividends, if declared, we will need to continue generating significant amounts of cash from operations, including funds required to pay our employees, related benefits and other operating expenses, finance future acquisitions, invest in the growth of our business and pay for the increased direct and indirect costs associated with operating as a public company. If our business does not generate sufficient cash flow from operations to fund these activities, we may need to seek additional capital, including by incurring additional debt or equity capital. Additional capital may not be available to us on acceptable terms or at all. In addition, incurring indebtedness requires that a portion of cash flow from operating activities be dedicated to interest and principal payments. Debt service requirements could reduce our ability to use our cash flow to fund operations and capital expenditures, to capitalize on future business opportunities, including additional acquisitions, or to pay dividends. Any of these risks could adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our variable rate debt subjects us to interest rate risk, which could cause our debt service obligations to increase significantly and affect our operating results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The indebtedness under the 2023 Term Loan is at variable rates of interest, which exposes us to interest rate risk. In addition, our 2023 Term Loan references the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) as the primary benchmark rate for our variable rate indebtedness. If benchmark interest rates, including SOFR, were to increase, our debt service obligations on our variable rate indebtedness would increase even if the amount borrowed remains the same, and our net income and cash flows, including cash available for servicing our indebtedness, will correspondingly decrease. In addition, while our 2023 Term Loan will continue to be subject to SOFR, other factors may impact SOFR, including factors causing SOFR to cease to exist, new methods of calculating SOFR to be established, or the use of an alternative reference rate. Such circumstances are not entirely predictable, but could have an adverse impact on our financing costs and results of operations. As of March&#160;31, 2025, we had $400.0&#160;million outstanding principal amount of variable rate debt subject to interest rate exposure. While we currently hedge the interest rate risk on $200.0&#160;million principal amount of this outstanding variable rate debt with a purchased interest rate cap derivative with a strike rate of 6.0% and a February&#160;2026 maturity, the remainder of the outstanding amount is not similarly hedged. Accordingly, a 1% increase in interest rates would increase annual interest expense by $4&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Despite our indebtedness level, we and our subsidiaries may incur substantially more debt, including secured debt. This could further exacerbate the risks associated with our substantial indebtedness.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and our subsidiaries may incur substantial additional indebtedness in the future. Although the terms of the 2023 Term Loan Agreement contain restrictions on the incurrence of additional indebtedness, such restrictions are subject to a number of significant exceptions and qualifications and any additional indebtedness incurred in compliance with such restrictions could be substantial. These restrictions also will </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">not prevent us from incurring obligations that do not constitute indebtedness. If we and our subsidiaries incur significant additional indebtedness or other obligations, the related risks that we face could increase, and we may not be able to meet all our debt obligations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to This Offering and Ownership of Our Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">An active, liquid, and orderly market for our common stock may not develop or be sustained. As a result, it may be difficult to sell shares of our common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our common stock has been approved for listing on Nasdaq. Prior to listing on Nasdaq, there has been no public trading market for our common stock. If an active, liquid, and orderly trading market for our common stock does not develop or is not sustained after this offering, it may be difficult to sell shares of our common stock at an attractive price, if at all. We cannot predict the prices at which our common stock will trade. It is possible that in one or more future periods our results of operations, regulatory approval process, and/or development of our platform and solutions may not meet the expectations of securities research analysts and investors. These and other factors could also significantly depress the market price of our common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The market price of our common stock may be volatile, which could result in substantial losses for investors purchasing shares in this offering.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The initial public offering price for our common stock will be determined by agreement among us and the representatives of the underwriters. This initial public offering price may differ from the market price of our common stock after this offering. As a result, if you purchase shares of our common stock in this offering, it may not be possible for you to sell those shares at or above the initial public offering price. Securities markets worldwide experience significant price and volume fluctuations. This market volatility, as well as general economic, market, or political conditions, could reduce the market price of our common stock regardless of our operating performance. Some of the factors that may cause the market price of our common stock to fluctuate include: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing or success of launch of our solutions, such as Caris Assure for early detection, MRD tracking, and treatment monitoring, as well as MI Cancer Seek or other solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the degree to which the launch and commercialization of our solutions meet the expectations of securities analysts and investors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in the structure of healthcare payment systems, including changes that would affect coverage and reimbursement by third-party or government payers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the success of, or perception of success of, our research and development efforts and our ability to develop new solutions and enhance our existing solutions, as well as our solutions&#8217; effectiveness or perceived effectiveness compared to those of our competitors;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing and results of validation studies and clinical trials for our solutions and solutions from our competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">commencement or termination of collaborations for our solution development and research programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure or discontinuation of any of our solution development and research programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the success of existing or new competitive tests, services, or technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">results of validation studies, clinical trials, or regulatory approvals of diagnostic or other cancer-related screening tests of our competitors, or announcements about new research programs or diagnostic or other cancer-related tests of our competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory or legal developments in the United States and other countries affecting our solutions or competing products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">developments or disputes concerning patent applications, issued patents, or other proprietary rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the impact of public health crises on our business and on global economic conditions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the recruitment or departure of key personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the level of expenses related to any of our research programs, clinical development programs or commercialization activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">actual or anticipated changes in our estimates as to our financial results or development timelines; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether our quarterly and annual financial results, forecasts, and development timelines meet the expectations of securities analysts or investors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">announcement or expectation of additional financing efforts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sales of our common stock by us, our insiders, or other shareholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expiration of lock-up agreements and market stand-off provisions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">variations in our quarterly and annual financial results or those of companies that are perceived to be similar to us; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in estimates or recommendations by securities analysts, if any, that cover our stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in accounting standards, policies, guidelines, interpretations, or principles; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">market conditions in the healthcare sector; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">general economic, industry, and market conditions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the other factors described in this &#8220;Risk Factors&#8221; section. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stock markets in general, and the market for healthcare companies in particular (including companies in the precision oncology industry and broader precision medicine industry), experience significant price and volume fluctuations that are often unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations. Broad market and industry factors may significantly affect the market price of our common stock, regardless of our actual operating performance. Following periods of such volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought against that company. Because of the potential volatility of our stock price, we may become the target of securities litigation in the future. Securities litigation could result in substantial costs and divert management&#8217;s attention and resources from our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If securities analysts do not publish research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The trading market for our common stock will rely in part on the research and reports that industry or securities analysts publish about us or our business. We do not currently have, and may never obtain, research coverage by industry or securities analysts. If no or few analysts commence coverage of us, the trading price of our common stock could decrease. Even if we do obtain analyst coverage, if one or more of the analysts covering our business downgrade their evaluations of our stock, the price of our common stock could decline. If one or more of these analysts cease to cover our stock, we could lose visibility in the market for our common stock, which in turn could cause the price of our common stock to decline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sales of a substantial number of shares of our common stock following the completion of this offering could cause the price of our common stock to decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sales of a substantial number of shares of our common stock in the public market following the completion of this offering, or the perception that these sales might occur, could depress the market price of our common stock, and could impair our ability to raise capital through the sale of additional equity securities. Many of our existing equity holders have substantial unrecognized gains on the value of the equity they hold based upon the price of this offering, and therefore, may take steps to sell their shares or otherwise secure the unrecognized gains on those shares. We are unable to predict the timing of or the effect that such sales may have on the prevailing market price of our common stock. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with this offering, we, our directors and executive officers, and holders of substantially all of our common stock and securities exercisable for or convertible into our common stock, have entered into lock-up agreements with the underwriters that restrict our and their ability to sell or transfer shares of our common stock, and securities convertible into or exercisable or exchangeable for shares of our common stock, for a period of 180 days from the date of this prospectus, subject to certain customary exceptions and a potential earlier termination. See the sections titled &#8220;Shares Eligible for Future Sale&#8221; and &#8220;Underwriting&#8221; for a discussion of such exceptions that may allow for sales during the lock-up period. In addition, upon providing prior written notice to BofA Securities, Inc., J.P. Morgan Securities LLC, and Goldman Sachs &amp; Co. LLC, BofA Securities, Inc. and either J.P. Morgan Securities LLC or Goldman Sachs&#160;&amp; Co. LLC may, in their sole discretion, release certain shareholders from the lock-up agreements prior to the end of the lock-up period. Additionally, at our request, the underwriters have reserved up to 5% of the shares of our common stock offered by this prospectus, excluding the additional shares that the underwriters have a 30-day option to purchase, for sale, at the initial public offering price, to certain individuals identified by management under the reserved share program, including certain of our directors, officers, employees, and certain other parties related to us. Except for any shares acquired by our directors and officers, shares purchased pursuant to the reserved share program will not be subject to lock-up restrictions with the underwriters. If not earlier released, all of our shares of common stock, other than those sold in this offering, which are freely tradable, will become eligible for sale upon expiration of the lock-up period, except for any shares held by our affiliates as defined in Rule&#160;144 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, after this offering, up to 24,599,771 shares of our common stock may be issued upon exercise of outstanding stock options or vesting and settlement of outstanding RSUs, and up to 17,696,252 shares of our common stock will initially be available for future issuance under our 2025 Plan and our ESPP, and will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, exercise limitations, the lock-up agreements, and Rule&#160;144 and Rule&#160;701 under the Securities Act. We intend to register all of the shares of common stock issuable upon exercise of outstanding options or other equity incentive awards we may grant in the future for public resale under the Securities Act. If any of these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, holders of approximately 245.9 million shares as of March&#160;31, 2025, or approximately 88.5% of our capital stock after the completion of this offering, will have rights, subject to some conditions and the lock-up agreements described above, to require us to file registration statements covering the sale of their shares or to include their shares in registration statements that we may file for ourselves or other shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investors in our common stock will incur immediate and substantial dilution as a result of this offering.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our common stock will incur immediate and substantial dilution of $19.72 per share, representing the difference between the initial public offering price of $21.00 per share, and our pro&#160;forma as adjusted net tangible book value per share after giving effect to this offering, the Warrant Net Exercises, the Series&#160;E and F Issuance, the Preferred Stock Conversion, the issuance of the 2025 Convertible Notes and the related Notes Conversion, the RSU Net Settlement, and the reduction of the compound derivative liability bifurcated from the 2023 Term Loan. As of March&#160;31, 2025, there were 24,113,482 shares of common stock issuable upon exercise of outstanding stock options with a weighted-average exercise price of $10.18 per share and 1,284,540&#160;shares of common stock issuable upon the vesting and settlement of outstanding RSUs. To the extent that these outstanding options or RSUs, or any other rights, are exercised, or we issue additional equity or convertible securities in the future, or the underwriters exercise their option to purchase additional shares of common stock, investors will incur further dilution. See the section titled &#8220;Dilution&#8221; for a further description of the dilution that will occur immediately after this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Raising additional capital may cause dilution to our existing shareholders, restrict our operations, or require us to relinquish rights to our technologies or our solutions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may need or determine to raise additional capital through a combination of public and private equity offerings, debt financings, strategic partnerships, and alliances and licensing arrangements. We, and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">indirectly, our shareholders, will bear the cost of issuing and servicing securities issued in any such transactions. Because our decision to issue debt or equity securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, or nature of any future offerings. If we incur debt, debt holders would have rights senior to holders of our common stock to make claims on our assets, and any debt financing we secure would result in increased fixed payment obligations and could involve restrictive and financial covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell, or license intellectual property rights, and other operating restrictions that could adversely impact our ability to conduct our business. If we issue additional equity securities, shareholders will experience dilution, and the new equity securities could have rights senior to those of our common stock. Additionally, any future collaborations we enter into with third parties may provide capital in the near term but limit our potential cash flow and revenue in the future. If we raise additional funds through strategic partnerships, alliances, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies or our solutions, or grant licenses on terms unfavorable to us.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">After this offering, our executive officers, directors, and principal shareholders, including, in particular, David&#160;D. Halbert, our Founder, Chairman, and Chief Executive Officer, will continue to have the ability to control or significantly influence matters submitted to shareholders for approval, which could limit the ability of our other shareholders to affect the outcome of key corporate decisions and transactions, including a change of control.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the completion of this offering, David D. Halbert, our Founder, Chairman, and Chief Executive Officer, will beneficially own approximately 44.6% of our outstanding common stock, based on the initial public offering price of $21.00 per share and assuming no exercise by the underwriters of their option to purchase additional shares of our common stock. As a result, Mr. Halbert will be able to significantly influence all matters submitted to our shareholders for approval, including the election of directors, amendments to our certificate of formation and bylaws, and the approval of significant corporate transactions, regardless of whether others believe that any such transaction is in our best interests. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, immediately following the completion of this offering, our executive officers (including Mr. Halbert), directors, holders of more than 5% of our outstanding capital stock, and their respective affiliates will collectively beneficially own shares representing approximately 66.2% of our outstanding common stock, based on the initial public offering price of $21.00 per share and assuming no exercise by the underwriters of their option to purchase additional shares of our common stock. If these shareholders act together, they will be able to influence our management and affairs and control all matters requiring shareholder approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may have the effect of delaying, deferring, or preventing a change in control, impeding a merger, consolidation, takeover, or other business combination involving us, or discouraging a potential acquiror from making a tender offer or otherwise attempting to obtain control of our business, even if such a transaction would benefit other shareholders. Moreover, it could deprive shareholders of an opportunity to receive a premium for their common stock as part of a sale of our company and may adversely affect the trading price for our common stock because some investors perceive disadvantages in owning shares in companies with concentrated equity ownership. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have identified a material weakness in our internal control over financial reporting. If our remediation of such material weakness is not effective, or if we experience additional material weaknesses in the future or otherwise fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, investors may lose confidence in our financial reporting, and the trading price of our common stock may decline. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with the audit of our consolidated financial statements for the year ended December&#160;31, 2024, we identified a material weakness in our internal control over financial reporting. A material weakness, as defined by Rule&#160;12b-2 under the Exchange Act, is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The material weakness identified pertained to a lack of sufficient qualified accounting resources, including those with technical expertise necessary to account for and disclose accounting transactions which require complex calculations or thorough evaluation of the accounting literature. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have taken and will continue to take action to remediate the material weakness, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">implementation of controls to enhance our review of significant accounting transactions and other new technical accounting and financial reporting issues and the preparation and review of accounting memoranda addressing these issues; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">implementation of controls to enable an effective and timely review of account analyses and account reconciliations; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">continued hiring of additional accounting and finance resources with public company experience and expanding the capabilities of the existing accounting and financial personnel through continuous training and education in the accounting and reporting requirements under GAAP and SEC rules and regulations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to SOX Section&#160;404, our management will be required to report upon the effectiveness of our internal control over financial reporting beginning with the second annual report following the completion of this offering. When we lose our status as an &#8220;emerging growth company&#8221; and do not otherwise qualify as a &#8220;smaller reporting company&#8221; with less than $100.0&#160;million in annual revenue, our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting. The rules governing the standards that must be met for our management to assess our internal control over financial reporting are complex and require significant documentation, testing and possible remediation. To comply with the requirements of being a reporting company under the Exchange Act, we may need to upgrade our information technology systems; implement additional financial and management controls, reporting systems and procedures; and hire additional accounting and finance staff. If we or, if required, our auditors are unable to conclude that our internal control over financial reporting is effective, investors may lose confidence in our financial reporting and the trading price of our common stock may decline. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will not be able to fully remediate the material weakness until the steps detailed above have been completed and such controls have been operating effectively for a sufficient period of time. Additionally, as stated above, we have not performed an evaluation of our internal control over financial reporting as permitted under the JOBS Act; accordingly, we cannot assure you that we have identified all, or that we will not in the future have additional, material weaknesses. Material weaknesses may still exist when we report on the effectiveness of our internal control over financial reporting as required under SOX Section&#160;404, beginning with our second annual report after the completion of this offering. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot assure you that additional material weaknesses in our internal control over financial reporting will not arise in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition, results of operations or cash flows. If we are unable to conclude that our internal control over financial reporting is effective, investors may lose confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and we could be subject to sanctions or investigations by Nasdaq, the SEC, or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are an emerging growth company and the reduced disclosure requirements applicable to emerging growth companies may make our common stock less attractive to investors.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are an emerging growth company and, for so long as we remain an emerging growth company, we are permitted by SEC rules and plan to rely on exemptions from certain disclosure requirements that are applicable to other SEC-registered public companies that are not emerging growth companies. Under these exemptions, we are not required to comply with the auditor attestation requirements of SOX Section&#160;404 or the auditor requirements to communicate critical audit matters in the auditor&#8217;s report on the financial statements, have reduced disclosure obligations regarding executive compensation, and have </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result, the information we provide shareholders will be different than the information that is available with respect to other public companies. We have taken advantage of reduced reporting burdens in this prospectus. In particular, in this prospectus, we have provided only two&#160;years of audited financial statements and we have not included all of the executive compensation related information that would be required if we were not an emerging growth company. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We could be an emerging growth company for up to five&#160;years following the completion of this offering. We will cease to be an emerging growth company upon the earliest of: (i)&#160;the end of the fiscal year following the fifth anniversary of this offering, (ii)&#160;the first fiscal year after our annual gross revenues are $1.235&#160;billion or more, (iii)&#160;the date on which we have, during the previous three-year period, issued more than $1.0&#160;billion in nonconvertible debt securities or (iv)&#160;the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700&#160;million as of the end of the second quarter of that fiscal year. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards, and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies, which may make comparison of our financials to those of other public companies more difficult. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives and corporate governance practices.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a public company, and particularly after we are no longer an emerging growth company, we will incur significant legal, accounting, and other expenses that we did not incur as a private company. SOX Section&#160;404, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of Nasdaq, and other applicable U.S. rules and regulations impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. We expect that we will need to hire additional accounting, finance, and other personnel in connection with our becoming, and our efforts to comply with the requirements of being, a public company, and our management and other personnel will need to devote a substantial amount of time towards maintaining compliance with these requirements. These requirements will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that the rules and regulations applicable to us as a public company may make it more difficult and more expensive for us to obtain director and officer liability insurance, which could make it more difficult for us to attract and retain qualified members of our board of directors. We cannot predict or estimate the amount of additional costs we may incur or the timing of such costs. These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the completion of this offering, we will become subject to the periodic reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to provide reasonable assurance that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC. Even if we are successful in remediating our material weaknesses, we believe that any disclosure controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our results of operations could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue, and expenses that are not readily apparent from other sources. For example, as we adopted and implemented the new revenue accounting standard, management made judgments and assumptions based on our interpretation of the new standard. The new revenue standard is principle-based and interpretation of those principles may vary from company to company based on their unique circumstances. It is possible that interpretation, industry practice and guidance may evolve as we continue to use these new accounting standards. If our assumptions change or if actual circumstances differ from our assumptions, our results of operations may be adversely affected and could fall below our publicly announced guidance or the expectations of analysts and investors, resulting in a decline in the market price of our common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have broad discretion in the use of the net proceeds from this offering and may not use them effectively.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our management will have broad discretion in the application of the net proceeds, including for any of the purposes described in the section titled &#8220;Use of Proceeds&#8221; in this prospectus. Our management may spend a portion or all of the net proceeds from this offering in ways that our shareholders may not desire or that may not yield a favorable return. The failure by our management to apply these funds effectively could harm our business, financial condition, and results of operations. Pending their use, we may invest the net proceeds from this offering in a manner that does not produce income or that loses value. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We do not intend to pay dividends for the foreseeable future. Investors in this offering may never obtain a return on their investment.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have never declared or paid any cash dividends on our capital stock, and we do not intend to pay any cash dividends in the foreseeable future. We expect to retain all available funds and future earnings, if any, to support our operations and to finance the growth and development of our business. Any future determination to pay dividends on our capital stock will be at the discretion of our board of directors subject to applicable laws and dependent on factors our board of directors deems relevant. In addition, our ability to pay dividends on our capital stock is limited by the terms of the 2023 Term Loan Agreement and may be further restricted under the terms of any future debt or preferred securities or future credit facility. Accordingly, you must rely on the sale of your common stock after price appreciation, which may never occur, as the only way to realize any future gain on your investment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Texas law and provisions in our amended and restated certificate of formation and bylaws that will be in effect prior to the completion of this offering might discourage, delay, or prevent a change in control of our company or changes in our management and, therefore, depress the trading price of our common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Provisions in our amended and restated certificate of formation and bylaws that will be in effect prior to the completion of this offering may discourage, delay, or prevent a merger, acquisition, or other change in control that shareholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares of our common stock. These provisions may also prevent or frustrate attempts by our shareholders to replace or remove our management. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our organizational documents will: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">authorize our board of directors to issue shares of preferred stock and determine the price and other terms of those shares, including preferences and voting rights, without shareholder approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that&#160;vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum, or by a sole remaining director, or by the affirmative vote of a majority of the voting power of our then-outstanding capital stock entitled to vote generally in the election of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that any action required or permitted to be taken at an annual or special meeting of shareholders may be taken by written consent in lieu of a meeting of shareholders only with the unanimous written consent of our shareholders entitled to vote on such action; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that the written request of the holders of at least 50% of the voting power of our outstanding capital stock entitled to be voted at a special meeting is required for our shareholders to call a special meeting of shareholders; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">require that shareholders give advance notice to nominate directors or submit proposals for consideration at shareholder meetings. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, as a Texas corporation, we are also subject to provisions of Texas law that may impair a takeover attempt that our shareholders may find beneficial. For additional information, see &#8220;Description of Capital Stock&#8212;Anti-Takeover Effects of Certain Provisions of Our Amended and Restated Certificate of Formation.&#8221; Any provision of our amended and restated certificate of formation, bylaws, or Texas law that has the effect of delaying or preventing a change in control could limit the opportunity for our shareholders to receive a premium for their shares of our capital stock and could also affect the price that some investors are willing to pay for our common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our amended and restated certificate of formation will provide that the Business Court in the First Business Court Division of the State of Texas will be the exclusive forum for substantially all disputes between us and our shareholders (excluding claims under the federal securities laws), which could limit our shareholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation will provide that, unless we consent in writing to the selection of an alternative forum, the Business Court in the First Business Court Division of the State of Texas will be the exclusive forum for the following types of actions or proceedings under Texas statutory or common law: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any derivative action or proceeding brought on our behalf; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees, or shareholders to us or our shareholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any action asserting a claim arising pursuant to any provision of the Texas Business Organizations Code (&#8220;TBOC&#8221;) or our amended and restated certificate of formation and bylaws; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any action asserting a claim governed by the internal affairs doctrine. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, this provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Furthermore, our amended and restated certificate of formation will also provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Any person purchasing or otherwise acquiring or holding any interest in shares of our capital stock is deemed to have received notice of and consented to the foregoing provisions. This choice of forum provision may limit a shareholder&#8217;s ability to bring a claim in a judicial forum that it finds more favorable for disputes with us or with our directors, officers, other employees or agents, or our other shareholders, may discourage such lawsuits against us and such other persons, and may result in increased costs for a shareholder to bring a claim. Alternatively, if a court were to find this choice of forum provision inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">associated with resolving such matters in other jurisdictions, which could adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General Risk Factors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The sizes of the markets for our current and future solutions have not been established with precision, and may be smaller than we estimate.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our estimates of the total addressable markets for our current or future solutions are based on a number of internal and third-party estimates, including, without limitation, the number of new cancer cases, the market size of oncology testing, and the number of patients with advanced stage cancer. While we believe the assumptions and the data underlying these estimates are reasonable, these assumptions and estimates may not be correct and the conditions supporting these assumptions or estimates may change at any time, thereby reducing the predictive accuracy of these underlying factors. As a result, these estimates of the total addressable market for our current or future solutions may prove to be incorrect. If the actual number of patients who would benefit from our solutions, the price at which we can sell our solutions, or the annual total addressable market for our solutions is smaller than estimated, it may impair our sales growth and have an adverse impact on our business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adverse economic or market conditions may harm our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Worsening economic conditions, including heightened inflation, increasing interest rates, decreasing economic activity, volatility in equity and credit markets, or other changes in the economic environment, may adversely affect our business, financial condition, and results of operations. For example, we depend on third-party manufacturers and suppliers for some of our solutions, or components and materials used in our solutions, and the suppliers of these inputs may seek to raise prices in the current inflationary economic environment. If our costs increase and we are unable to successfully pass along those increased costs to our partners and patients, our revenue and or operating profitability may be adversely affected. In addition, we may in the future raise additional debt or refinance existing debt. Our cost of borrowing in the future may be higher than it has been to date because interest rates have risen and may continue to increase. An increased cost of borrowing may adversely affect our financial condition and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business is subject to economic, political, regulatory, and other risks associated with international operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Some of our ordering physicians and biopharma partners are located outside of the United States. While we currently have limited international operations, international expansion could also become a key component of our future business strategy. Accordingly, our future results could be harmed by a variety of factors, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">challenges enforcing our contractual and intellectual property rights, especially in those foreign jurisdictions that do not respect and protect intellectual property rights to the same extent as the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">trade protection measures, import or export controls and licensing requirements (including possible restrictions on licensing intellectual property to certain non-U.S. persons) or other restrictive actions by U.S. or non-U.S. governments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in non-U.S. laws, regulations and customs, tariffs, and trade barriers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">exchange rate risk we may face from denominating a portion of our transactions in currencies other than the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in a specific country&#8217;s or region&#8217;s political or economic environment, including inflation, including the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">logistics and regulations associated with shipping samples, including infrastructure conditions and transportation delays; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">negative consequences from changes in tax laws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">negative consequences from changes in U.S. national security laws, including those governing non-U.S. investors&#8217; ownership of U.S. biotech and other technology companies and U.S. companies&#8217; ability to enter into joint ventures with non-U.S. entities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with tax, employment, immigration, and labor laws for employees living or traveling abroad; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance challenges relating to the complexity of multiple, conflicting, and changing data protection laws and international data sharing and transfer restrictions globally. For additional information, see &#8220;&#8212;Risks Related to Regulation and Legal Compliance&#8212;We are subject to stringent and evolving U.S. and foreign privacy and data security laws, regulations, and rules, contractual obligations, industry standards, policies and other obligations related to privacy and data security. Our actual or perceived failure to comply with privacy and data security obligations could result in significant liability, administrative or governmental penalties, reputational harm and/or, other adverse business consequences&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">workforce uncertainty in countries where labor unrest is more common than in the United States;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">adoption of new regulations, modification to existing regulations, or expiration of prior regulations that apply to the products we offer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">difficulties associated with staffing and managing international operations, including differing labor relations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulator and compliance risks that relate to maintaining and control over sales and distribution activities that may fall within the purview of the FCPA or comparable foreign laws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">difficulties associated with the interpretation of laws and regulations in non-English speaking jurisdictions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">business interruptions resulting from geo-political actions, including war and terrorism, pandemics, or natural disasters, including earthquakes, typhoons, floods, and fires. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These and other risks associated with current and future international operations may adversely affect our business and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business is subject to risks arising from public health crises.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Widespread public health crises may pose the risk that our company, our personnel, courier delivery services, and other partners may be prevented from conducting business activities for an indefinite period of time, including due to spread of the disease within these groups or due to shutdowns that may be requested or mandated by governmental authorities. For example, the COVID-19 pandemic and mitigation measures have had an adverse impact on global economic conditions. Comparable future public health crises could have similar adverse effects on our business, financial condition, and results of operations, including impairing the ability to raise capital when needed. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Government-imposed quarantines and restrictions as a result of future public health crises may also require us to temporarily terminate our clinical sites. Furthermore, if we determine that our trial participants may suffer from exposure to such diseases as a result of their participation in our clinical trials, we may voluntarily terminate certain clinical sites as a safety measure until we reasonably believe that the likelihood of exposure has subsided. As a result, our expected regulatory submissions and development timelines for our solutions may be negatively impacted. Future public health crises may materially disrupt or delay our business operations, further divert the attention and efforts of the medical community to coping with such epidemics, reduce the number of patients getting physicals and physicians potentially ordering our solutions, disrupt the clinical sites on which we depend, and/or adversely affect our operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our ability to utilize our net operating loss (&#8220;NOL&#8221;) and R&amp;D credit carryforwards is subject to certain conditions. For instance, we have experienced a history of losses and a lack of future taxable income </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">would adversely affect our ability to utilize our NOL and R&amp;D credit carryforwards. As of March&#160;31, 2025, we had NOL carryforwards of $1,150.7&#160;million for federal income tax purposes and $985.8&#160;million for state income tax purposes. In addition, our federal NOL carryforwards generated in taxable&#160;years beginning before January&#160;1, 2018, are permitted to be carried forward for only 20&#160;years. Although our federal NOL carryforwards generated in taxable&#160;years beginning after December&#160;31, 2017, may be carried forward indefinitely, they are permitted to be used in any taxable year to offset only up to 80% of taxable income, if any, in such year. For state income tax purposes, there may be periods during which the use of NOL carryforwards is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. We also had R&amp;D credit carryforwards of $2.8&#160;million that will begin to expire in 2031. Our ability to use our NOL and R&amp;D credit carryforwards also may be subject to certain limitations due to prior or future ownership changes, if any, as defined in Section&#160;382 of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) (generally a greater than 50% change, by value, in a corporation&#8217;s equity ownership over a three-year period). Under Sections&#160;382 and 383 of the Code, and corresponding provisions of state law, if a corporation undergoes an ownership change, the corporation&#8217;s ability to use its pre-change NOL and R&amp;D credit carryforwards to offset the corporation&#8217;s post-change income or taxes may be limited. Although we have not experienced ownership changes in the past, we may experience ownership changes as a result of this offering or subsequent shifts in our stock ownership, some of which may be outside our control. As such, there can be no assurance that we will be able to utilize our NOL and R&amp;D credit carryforwards, and we have established valuation allowances against our NOL and R&amp;D credit carryforwards due to the uncertainty surrounding the realization of such assets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in tax laws or regulations may have an adverse effect on our business, financial condition, and results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">New tax laws, statutes, rules, regulations, or ordinances could be enacted at any time. For example, the Tax Cuts and Jobs Act, the Coronavirus Aid, Relief, and Economic Security Act, and the Inflation Reduction Act made significant changes to U.S. tax laws. Further, existing tax laws, statutes, rules, regulations, or ordinances could be interpreted differently, changed, repealed, or modified at any time. Any such enactment, interpretation, change, repeal, or modification could adversely affect us, possibly with retroactive effect. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may seek acquisitions or other strategic transactions from time to time that could increase our capital requirements, dilute our shareholders, cause us to incur debt or assume contingent liabilities, and subject us to other risks.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may engage in various acquisitions and strategic partnerships in the future, including licensing or acquiring complementary intellectual property rights, technologies, or businesses. Any acquisition or strategic partnership may entail numerous risks, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">increased operating expenses and cash requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the assumption of indebtedness or contingent liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the issuance of our equity securities that would result in dilution to our shareholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">assimilation of operations, personnel, intellectual property, and products of an acquired company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to achieve any expected synergies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">retention of key employees, the loss of key personnel, and uncertainties in our ability to maintain key business relationships; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or candidates and regulatory approvals, and the validity and enforceability of their intellectual property. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, as our strategy evolves, we may opt to discontinue, deprioritize, or dispose of assets, technologies, or acquired businesses. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:312pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The increasing focus on environmental, social, and governance (&#8220;ESG&#8221;) initiatives could increase our costs, harm our reputation, and adversely impact our financial results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There has been increasing public focus by investors, patients, environmental activists, the media, and governmental and nongovernmental organizations on a variety of environmental, social, and other sustainability matters. We may experience pressure to make commitments relating to sustainability matters, including the design and implementation of specific risk mitigation strategic initiatives relating to sustainability. While we may in the future engage in various initiatives (including but not limited to voluntary disclosures, policies, or goals) to improve our ESG profile or respond to stakeholder expectations, we cannot guarantee that these initiatives will have the desired effect. If we are not effective in addressing environmental, social, and other sustainability matters affecting our business, or setting and meeting relevant sustainability goals, our reputation and financial results may suffer. In addition, even if we are effective at addressing such concerns, we may experience increased costs as a result of executing upon our sustainability goals that may not be offset by any benefit to our reputation, which could have an adverse impact on our business and financial condition. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, this emphasis on ESG matters has resulted and may result in the adoption of new laws and regulations, including new reporting requirements, including with respect to climate change. ESG and sustainability-related regulation and legislation, to the extent implemented, will require us to incur significant additional costs to comply, including the implementation of significant additional internal controls, processes and procedures regarding matters that have not been subject to such controls in the past, and impose increased oversight obligations on our management and board of directors as well as impose additional disclosure obligations on us. Additionally, our suppliers, customers or other business partners may require us to provide additional climate-related information if they are also subject to additional climate-related disclosure laws or regulations in other jurisdictions. If we fail to comply with new laws, regulations or reporting requirements, or we fail to provide complete and accurate information to our suppliers, customers or other business partners, our reputation and business could be adversely impacted.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSNRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains forward-looking statements. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations and financial condition, business strategy, information solutions, technology, R&amp;D costs, regulatory approvals, potential market opportunity, anticipated trends in our business, timing and likelihood of success, as well as plans and objectives of management for future operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties, and other important factors that are in some cases beyond our control and may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; or &#8220;would,&#8221; or the negative of these terms or other similar expressions, are intended to identify forward looking statements. Forward-looking statements contained in this prospectus include, but are not limited to, statements about: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">developments in the precision oncology industry, including our biopharma partners&#8217; use of molecular information and the market size for molecular information services; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our expectations as to our addressable U.S. market in oncology, future financial performance, results of operations, or other operational results or metrics; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability of the Caris platform to help our biopharma partners and physicians improve the efficiency and success of their therapeutic development, and clinical programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to scale the Caris platform and develop new solutions or enhancements to existing solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to capture, aggregate, analyze, or otherwise utilize molecular information in novel ways; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to compete with companies that are currently in, or may in the future enter, the industry in which we operate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">third-party payer reimbursement and coverage decisions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to establish, maintain, protect, and enforce our intellectual property rights of our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">federal, state, and foreign regulatory requirements, including FDA regulation of our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing, likelihood, or conditions of regulatory filings and approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to hire and retain key personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our anticipated cash needs and our estimates regarding our capital requirements and our needs for additional financing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our estimates regarding our expenses, future revenue, and capital requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our expectations related to the use of proceeds from this offering; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">remediating the material weakness in our internal control over financial reporting; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the volatility of the trading price of our common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described in the section titled &#8220;Risk Factors&#8221; and elsewhere in this prospectus. Moreover, we operate in a competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the forward-looking events and circumstances discussed in this prospectus may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:416pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, advancements, discoveries, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur. In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this prospectus, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and you are cautioned not to unduly rely upon these statements. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these statements to actual results or to changes in our expectations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should read this prospectus and the documents that we reference in this prospectus and have filed as exhibits to the registration statement of which this prospectus is a part with the understanding that our actual future results, levels of activity, performance, and events and circumstances may be materially different from what we expect. We qualify all of the forward-looking statements in this prospectus by these cautionary statements. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMAID">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:288pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MARKET AND INDUSTRY DATA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains estimates, projections, and other information concerning our industry, our business, and the markets for our precision medicine information solutions, including data regarding the estimated size of such markets. We obtained the industry, market, and similar data set forth in this prospectus from our internal estimates and research, including surveys and studies we have sponsored and/or conducted, and from academic and industry research, publications, surveys, and studies conducted by third parties, including governmental agencies. Information based on estimates, forecasts, projections, market research, or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Forecasts and other forward-looking information with respect to industry, business, market, and other data are subject to the same qualifications and additional uncertainties regarding the other forward-looking statements in this prospectus. See the section titled &#8220;Special Note Regarding Forward-Looking Statements.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The sources of certain industry, business, market, and other data contained in this prospectus include: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Nephron Research LLC, Oncology Testing TAM Analysis, March&#160;2024, which we commissioned; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Evaluate Pharma, World Preview 2023, Outlook to 2028, August 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Centers for Disease Control and Prevention; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The American Cancer Society; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The American Lung Association; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The International Agency for Research on Cancer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">National Center for Biotechnology Information; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The American Society of Clinical Oncology. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:304pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We estimate that the net proceeds from this offering will be approximately $452.1 million (or $521.1 million if the underwriters exercise their option to purchase additional shares of common stock in full), based on the initial public offering price of $21.00 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The principal purposes of this offering are to increase our capitalization and financial flexibility, create a public market for our common stock, and enable access to the public equity markets for us and our shareholders. As of the date of this prospectus, we have no specific plan for any significant portion of the net proceeds from this offering. However, we intend to use the net proceeds from this offering for general corporate purposes, including working capital, operating expenses, and capital expenditures. We also intend to use approximately $6.2&#160;million of the net proceeds to satisfy our anticipated tax withholding and remittance obligations related to the RSU Net Settlement, based on the initial public offering price of $21.00 per share and an assumed tax withholding rate of 28.3%. We may also use a portion of our net proceeds to co-develop, acquire, or invest in products, technologies, or businesses that are complementary to our business, although we do not have agreements or commitments for any material acquisitions or investments at this time. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will have broad discretion over the uses of the net proceeds from this offering. The expected use of net proceeds from this offering represents our intentions based upon our present plans and business conditions. We cannot predict with certainty all of the particular uses for the proceeds of this offering or the amounts that we will actually spend on the uses set forth above. The timing and amount of our actual expenditures will be based on many factors, including cash flows from operations and the anticipated growth of our business. Pending the uses described above, we plan to invest the net proceeds in a variety of capital preservation investments, including short-term interest-bearing investment-grade securities, certificates of deposit, or government securities. Investors will be relying on the judgment of our management regarding the application of the net proceeds from this offering. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIPO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:488pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DIVIDEND POLICY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have never declared or paid any cash dividends on our capital stock, and we do not currently intend to pay any cash dividends on our capital stock for the foreseeable future. We currently intend to retain all available funds and any future earnings to support operations and to finance the growth and development of our business. Any future determination to pay dividends will be made at the discretion of our board of directors subject to applicable laws and will depend upon, among other factors, our results of operations, financial condition, contractual, legal, tax, and regulatory restrictions, capital requirements, and such other factors as our board of directors may deem relevant. In addition, our ability to pay cash dividends is currently restricted by the terms of the 2023 Term Loan Agreement. Our future ability to pay cash dividends on our capital stock may also be limited by the terms of any future debt or preferred securities or future credit facility. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCAP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAPITALIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth our cash, cash equivalents, and restricted cash and capitalization as of March&#160;31, 2025, as follows: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.49pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.49pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">on an actual basis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">on a pro&#160;forma basis to give effect to (i)&#160;the Warrant Net Exercises, (ii)&#160;the Series E and F Issuance, (iii) the Preferred Stock Conversion, (iv) the issuance of the 2025 Convertible Notes and the related Notes Conversion, (v)&#160;the RSU Net Settlement, and (vi) the reduction of the compound derivative liability bifurcated from the 2023 Term Loan; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">on a pro&#160;forma as adjusted basis to give further effect to (i) our issuance and sale of 23,529,412 shares of common stock in this offering at the initial public offering price of $21.00 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, net of $1.4 million of offering expenses paid as of March 31, 2025 and (ii) the use of approximately $6.2 million of the net proceeds from this offering to satisfy our anticipated tax withholding and remittance obligations related to the RSU Net Settlement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">You should read this table in conjunction with the information contained in &#8220;Use of Proceeds&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; as well as the consolidated financial statements and the notes thereto included elsewhere in this prospectus. </font>
        </div>
        <table style="width:416pt;margin-bottom:7pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:245.77pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:245.77pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.083pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Actual </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.083pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro Forma </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.083pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro Forma</font>
                <br >
                <font style="letter-spacing:-0.16pt;">As Adjusted</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:245.77pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except share and per share data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:245.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:33pt; text-align:right; white-space:nowrap;">32,704</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:33pt; text-align:right; white-space:nowrap;">185,531</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">632,589 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 0.5pt 0pt; width:245.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Debt (including current portion of long-term debt)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">414,183</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">412,841</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">408,421</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.333pt 0pt 0.5pt 0pt; width:245.77pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Redeemable convertible preferred stock, par value $0.001 </font>
                <br >
                <font style="letter-spacing:0.2pt;">per share; 787,439,505 shares authorized, 734,142,041 </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares issued and outstanding, actual; and no shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">authorized, issued, or outstanding, pro&#160;forma and </font>
                <br >
                <font style="letter-spacing:0.2pt;">pro&#160;forma as adjusted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">2,246,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:245.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Warrants to purchase capital stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">128,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:245.77pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Shareholders&#8217; (deficit) equity: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.333pt 0pt 0.5pt 0pt; width:245.77pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Preferred stock, par value $0.001 per share; no shares authorized, issued and outstanding, actual; 100,000,000 shares authorized, no shares issued and outstanding, pro&#160;forma and pro forma as adjusted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.333pt 0pt 0.5pt 0pt; width:245.77pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Common stock, par value $0.001 per share; </font>
                <br >
                <font style="letter-spacing:0.2pt;">1,173,000,000 shares authorized, 35,237,531 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">issued and outstanding, actual; 2,800,000,000 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">authorized, 254,403,367 shares issued and </font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding, pro forma; and 2,800,000,000 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">authorized, 277,932,779 shares issued and </font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding, pro forma as adjusted</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">256</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">280 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.333pt 0pt 0.5pt 0pt; width:245.77pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Treasury stock&#8212;1,620,638 shares of common stock, par value $0.001 per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(16,917<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(16,917<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.333pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">(16,917<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:245.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">2,543,219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">2,995,325 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:245.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(2,583,231<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(2,602,919<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">(2,602,919<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2pt 0pt 1pt 0pt; width:245.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated other comprehensive income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:33pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:33pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:1.75pt 0pt 1pt 0pt; width:245.77pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total shareholders&#8217; (deficit) equity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:33pt; text-align:right; white-space:nowrap;">(2,599,865<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:33pt; text-align:right; white-space:nowrap;">(76,115<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">376,014</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:245.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total capitalization </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:33pt; text-align:right; white-space:nowrap;">189,122</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:33pt; text-align:right; white-space:nowrap;">336,726 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">784,436</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:6pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">The pro forma as adjusted cash, cash equivalents, and restricted cash amount includes the employer portion of the withholding tax obligation of approximately $0.2 million related to the RSU Net Settlement at the initial public offering price of $21.00 per share. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">104</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:229pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:11pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(2)</font>
          <br >
        </div>
        <div style=" line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Represents long-term indebtedness, net of debt discounts. Total&#160;debt as of March&#160;31, 2025 consisted of approximately $400.0 million of borrowings outstanding under the 2023 Term Loan Agreement. In April&#160;2025, we also issued 2025 Convertible Notes to certain investors in aggregate principal amount of $30.0 million. The 2025 Convertible Notes mature on January 1, 2026, accrue interest at a rate of 8% per annum (payable quarterly in cash), and will, immediately prior to and in connection with the completion of this offering, convert at a conversion price equal to 70% of the initial public offering price per share, or into 2,076,596 shares of our common stock, based on the initial public offering price of $21.00 per share. The pro forma as adjusted debt amount reflects payment of accrued offering costs of approximately $4.4 million. For a discussion of our long-term debt, see the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources.&#8221; Also, see our consolidated financial statements and related notes thereto included elsewhere in this prospectus, which include all recorded liabilities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The number of shares of common stock in the table above excludes: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">24,113,482 shares of our common stock issuable upon the exercise of options outstanding under our 2020 Plan as of March&#160;31, 2025, at a weighted-average exercise price of $10.18 per share; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">249,999 shares of our common stock issuable upon the exercise of options granted under our 2020 Plan subsequent to March&#160;31, 2025, at an exercise price per share equal to the initial public offering price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">236,290 shares of our common stock issuable upon the vesting and settlement of RSUs outstanding under our 2020 Plan as of March 31, 2025 that are subject to vesting conditions that are not satisfied in connection with this offering; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">15,125,002 shares of our common stock reserved for future issuance under our 2025 Plan, based on the initial public offering price of $21.00 per share, which 2025 Plan will become effective in connection with this offering, as well as shares of our common stock that may be issued pursuant to provisions of our 2025 Plan that automatically increase the share reserve under our 2025 Plan; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">2,571,250 shares of our common stock reserved for future issuance under our ESPP, based on the initial public offering price of $21.00 per share, which ESPP will become effective in connection with this offering, as well as shares of our common stock that may be issued pursuant to provisions in our ESPP that automatically increase the share reserve under the ESPP. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">105</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DILUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference between the initial public offering price per share and the pro&#160;forma as adjusted net tangible book value per share of our common stock immediately after this offering. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Historical net tangible book value (deficit) per share represents our total tangible assets less our liabilities and preferred stock that is not included in equity divided by the total number of shares of common stock outstanding. As of March&#160;31, 2025, our historical net tangible book value (deficit) was approximately $(2,625.03) million, or $(74.50) per share. Our pro&#160;forma net tangible book value (deficit) as of March&#160;31, 2025, was approximately $(101.28) million, or $(0.40) per share, after giving effect to (i) the Warrant Net Exercises, (ii) the Series E and F Issuance, (iii) the Preferred Stock Conversion, (iv)&#160;the issuance of the 2025 Convertible Notes and the related Notes Conversion, (v) the RSU Net Settlement, and (vi) the reduction of the compound derivative liability bifurcated from the 2023 Term Loan. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After giving further effect to receipt of the net proceeds of our sale of 23,529,412 shares of common stock at the initial public offering price of $21.00 per share, and after deducting underwriting discounts and commissions and estimated offering expenses, net of $1.4 million of offering expenses paid as of March&#160;31, 2025, our pro&#160;forma as adjusted net tangible book value as of March&#160;31, 2025 would have been approximately $356.7 million, or $1.28 per share. This represents an immediate increase in pro&#160;forma as adjusted net tangible book value of $74.10 per share to our existing shareholders and an immediate dilution of $19.72 per share to investors purchasing common stock in this offering. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table illustrates this dilution to new investors on a per share basis: </font>
        </div>
        <table style="width:456pt;height:113.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:385.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Initial public offering price per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;"> 21.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:385.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Historical net tangible book value (deficit) per share as of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(74.50<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:385.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Increase per share attributable to the pro&#160;forma adjustments described above </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">74.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:385.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Pro&#160;forma net tangible book value (deficit) per share as of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(0.40<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:385.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Increase in pro&#160;forma net tangible book value per share attributable to new investors in this offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1.68</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:385.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pro&#160;forma as adjusted net tangible book value per share immediately after this offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1.28</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:385.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dilution per share to new investors purchasing shares in this offering </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">19.72</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the underwriters&#8217; option to purchase additional shares of common stock in this offering is exercised in full, the pro&#160;forma as adjusted net tangible book value would be $1.51 per share, the increase in the pro&#160;forma net tangible book value per share for existing shareholders would be $0.23 per share, and the dilution to new investors participating in this offering would be $0.23 per share. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below summarizes, as of March&#160;31, 2025, on the pro&#160;forma basis described above, the number of shares of our common stock, the total consideration, and the average price per share (i)&#160;paid to us by our existing shareholders and (ii)&#160;to be paid by new investors participating in this offering at the initial public offering price of $21.00 per share, before deducting underwriting discounts and commissions and estimated offering expenses payable by us. </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:22.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:196.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Purchased </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total Consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="5" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price Per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:196.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:196.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Existing shareholders </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">254,403,367</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">91.5</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">1,541,910,812</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">75.7</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.06</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:196.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">New investors </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">23,529,412</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">8.5</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:44.25pt; text-align:right; white-space:nowrap;">494,117,652</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">24.3</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">21.00</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:196.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">277,932,779</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:44.25pt; text-align:right; white-space:nowrap;">2,036,028,464</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.33</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, if the underwriters&#8217; option to purchase additional shares of common stock is exercised in full, the number of shares held by existing shareholders will be reduced to 90.4% of the total number of shares of common stock to be outstanding upon the completion of this offering, and the number of shares of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">106</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:246pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">common stock held by new investors participating in this offering will be further increased to 9.6% of the total number of shares of common stock to be outstanding upon the completion of the offering. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The number of shares of our common stock to be outstanding after this offering is based on 254,403,367 shares of our common stock outstanding as of March&#160;31, 2025, after giving effect to (i) the Warrant Net Exercises, (ii) the Series E and F Issuance, (iii) the Preferred Stock Conversion, (iv) the issuance of the 2025 Convertible Notes and the related Notes Conversion, and (v)&#160;the RSU Net Settlement, and excludes: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">24,113,482 shares of our common stock issuable upon the exercise of options outstanding under our 2020 Plan as of March&#160;31, 2025, at a weighted-average exercise price of $10.18 per share; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">249,999 shares of our common stock issuable upon the exercise of options granted under our 2020 Plan subsequent to March 31, 2025, at an exercise price per share equal to the initial public offering price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">236,290 shares of our common stock issuable upon the vesting and settlement of RSUs outstanding under our 2020 Plan as of March 31, 2025 that are subject to vesting conditions that are not satisfied in connection with this offering; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">15,125,002 shares of our common stock reserved for future issuance under our 2025 Plan, based on the initial public offering price of $21.00 per share, which 2025 Plan will become effective in connection with this offering, as well as shares of our common stock that may be issued pursuant to provisions of our 2025 Plan that automatically increase the share reserve under our 2025 Plan; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">2,571,250 shares of our common stock reserved for future issuance under our ESPP, based on the initial public offering price of $21.00 per share, which ESPP will become effective in connection with this offering, as well as shares of our common stock that may be issued pursuant to provisions in our ESPP that automatically increase the share reserve under our ESPP. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent that any outstanding options are exercised, or new awards are granted and exercised or settled under our equity compensation plans, new investors will experience further dilution.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">107</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMDAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:72pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes and other financial information included elsewhere in this prospectus. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under the section titled &#8220;Risk Factors&#8221; and elsewhere in this prospectus. See the section titled &#8220;Special Note Regarding Forward-Looking Statements&#8221; elsewhere in this prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and AI/ML algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We founded Caris in 2008 with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize the potential of precision medicine for patients. We have spent the last 17&#160;years developing and building our portfolio of comprehensive, proprietary molecular profiling solutions and generating what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology based on the more than 6.5 million tests we have run on over 849,000 cases, which have generated measurements of over 38 billion molecular&#160;markers. Our platform is purpose-built to leverage the convergence of NGS, AI and ML technologies, and high-performance computing. The power of our differentiated Caris platform has enabled us to develop the latest generation of advanced precision medicine diagnostic solutions designed to address the entire cancer care continuum, including early detection, MRD tracking, therapy selection, and treatment monitoring, as well as to create molecular signatures and discover and develop novel precision medicine therapeutics. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our current commercial product portfolio consists of MI Profile, our tissue-based molecular profiling solution that has generated the majority of our revenue to date, and Caris Assure, our novel, universal blood-based molecular profiling solution that was broadly launched in the first quarter of 2024 for therapy selection. Our purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. We believe this approach best positions us to provide actionable treatment pathways from targeted therapies to drive superior clinical outcomes for patients while also generating a rich dataset to power insights and innovation. Our molecular profiling solutions and the data generated by our multi-omic technology platform also provide value to our more than 100 biopharma partners, such as Moderna, AbbVie, Xencor, and Merck KGaA, through partnerships that aim to increase the probability of technical and regulatory success of their therapeutic pipelines. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that our early foresight to generate comprehensive data at scale over the past many&#160;years and build a robust, foundational infrastructure have uniquely positioned Caris to leverage the benefits of biological and technological advances to deliver transformative and advanced innovations in precision medicine and patient care into the future. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">108</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:36pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since our founding, we have achieved the following significant milestones: </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="fc_keydevelop-4c.jpg" alt="[MISSING IMAGE: fc_keydevelop-4c.jpg]" height="199" width="600" >
        </div>
        <div style="text-indent:36pt; margin-top:9.61pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To our knowledge, we remain the only genomic profiling company to consistently utilize WES and WTS as standard practice on every eligible patient sample. Our in-depth profiling of patient samples has led to the creation of what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology. Our ever-expanding datasets include data generated from more than 6.5&#160;million tests that have generated measurements of over 38&#160;billion molecular markers from over 13 quadrillion datapoints as of March 31, 2025, as well as matched clinical outcomes for many of these patients. </font>
        </div>
        <div style="text-indent:36pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our global annual clinical case volume has been growing rapidly, with year-over-year growth of 29% in 2022, 32% in 2023, 26% in 2024, and 31% in the first quarter of 2025, primarily driven by MI Profile. With our broad commercial launch of Caris Assure for therapy selection in the first quarter of 2024 and the FDA approval of MI Cancer Seek as a companion diagnostic in the fourth quarter of 2024 followed by the broad commercial launch of MI Cancer Seek in the first quarter of 2025 as the NGS component of MI Profile, we believe that increased profiling volumes will meaningfully contribute to our growth in 2025 and beyond. </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="bc_casevolume-4c.jpg" alt="[MISSING IMAGE: bc_casevolume-4c.jpg]" height="434" width="578" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">109</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Caris platform is designed to create a virtuous cycle that can enable continued innovation and improved impact for patients and physicians. We believe our comprehensive approach to profiling will continue to drive demand for our genomic profiling capabilities, leading to further expansion of our clinico-genomic datasets, which provide additional valuable inputs to develop and enhance our solutions, with the ultimate goal of contributing to improved patient results. This continuous feedback loop enabled us to develop Caris Assure, which utilized genomic data generated by MI Profile to inform our blood-based bioinformatics algorithms, allowing us to detect previously unknown features and signals in the blood that provide advanced insights into disease development. We believe we will be able to further leverage this process to continue meaningful innovation in precision oncology as well as other chronic disease states, including cardiology, neurology, and metabolic conditions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have funded our operations to date principally from the sale of our stock, convertible and&#160;senior secured notes, and revenue from our molecular profiling solutions and services with biopharma companies. For the&#160;years ended December&#160;31, 2024 and 2023, we generated total revenue of $412.3&#160;million and $306.1&#160;million, respectively, and incurred net losses of $281.9&#160;million and $341.4&#160;million, respectively. For the three months ended March 31, 2025 and 2024, we generated total revenue of $120.9 million and $80.7 million, respectively, and incurred net losses of $102.6 million and $111.0 million, respectively. Our Adjusted EBITDA was $(189.6) million and $(255.3) million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Our Adjusted EBITDA was $(36.2) million and $(70.1) million for the three months ended March 31, 2025 and 2024, respectively. For additional information regarding Adjusted EBITDA, a non-GAAP financial&#160;measure, see &#8220;&#8212;Non-GAAP Financial Measures.&#8221; We expect to incur additional net losses in the near future, and our expenses will increase as we continue to invest in developing new solutions, expand our organization, and increase our marketing efforts to continue to drive market adoption of our solutions. These investments, together with general and administrative expenses, have resulted in negative cash flows from operations of $245.2 million, $276.1 million, $31.3 million, and $73.9 million for the years ended December 31, 2024 and 2023 and the three months ended March 31, 2025 and 2024, respectively. Our free cash flow was $(253.6)&#160;million and $(298.4)&#160;million for the years ended December 31, 2024 and 2023, respectively, and $(34.0)&#160;million and $(75.7)&#160;million for the three months ended March&#160;31, 2025 and 2024, respectively. For additional information regarding free cash flow, a non-GAAP financial measure, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Financial Measures.&#8221; Additionally, as of March&#160;31, 2025, we had cash, cash equivalents, and short-term marketable securities of $33.4&#160;million, and the aggregate principal amount of debt outstanding under our existing term loan was $400.0 million. For additional information regarding our liquidity and capital resources, see &#8220;&#8212;Liquidity and Capital Resources.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Business Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We generate revenue primarily from the provision of precision oncology solutions to ordering physicians utilizing MI Profile and Caris Assure. We have obtained Medicare and commercial reimbursement for MI Profile. We also have Medicare reimbursement and various levels of commercial payer adoption and/or reimbursement coverage for Caris Assure for therapy selection across the United States (other than New York State). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We also generate revenue utilizing our Caris platform to provide R&amp;D services for biopharma partners, who we partner with to help improve the efficiency and success of their therapeutic development and clinical programs. For our biopharma partners, our profiling solutions provide prospective and retrospective testing, companion diagnostics development, data licensing, and commercial services that include identification of patients for approved therapies. In addition, our multi-modal data creates a differentiated capability to advance precision oncology research through novel target identification and discovery, translational sciences, clinical trial design solutions and patient enrollment facilitated by our right-in-time trials network, post-market label expansion, and commercialization insights. Under the strategic partnerships, targets discovered by us using our proprietary wet lab, </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;">, ADAPT, proximity labeling, and surfacesome analysis can be pursued by our biopharma partners to conduct their own preclinical and clinical research, as well as the eventual development and commercialization of drug candidates. Our biopharma partners select drug targets based, among other things, on their prevalence and expression across cancer types, the uniqueness of the targets and efficacy of current treatments, and their therapeutic modality. Our biopharma partners are also able to combine their relevant technology and/or drug </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">110</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">development capabilities, such as data analysis, </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> studies, molecule design, and therapeutic modality, to design and manufacture potential therapies for the treatment of cancer. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe the market for our solutions is large and expanding. We have made significant investments in our scaled and state-of-the-art infrastructure to support our growth and our ability to address the needs of the U.S. oncology market through the provision of molecular information services across the full patient care continuum and to support biopharma drug development. We operate two precision medicine laboratories in Phoenix, Arizona, and one R&amp;D laboratory in Tempe, Arizona. Our Arizona laboratories all utilize state-of-the-art genomic sequencing technology, including 50 NovaSeq sequencing systems, with capacity to perform more than one trillion &#8220;reads&#8221; daily. Our newest laboratory facility in Irving, Texas, near our headquarters, is continuing to be built-out and will bring our total operational capacity to over 275,000 square feet. To support our sales activity and expansion, as of March&#160;31, 2025, we have assembled a targeted sales organization in the United States of over 270 sales team members and nearly 50&#160;highly trained Ph.D. or M.D. MSLs who focus on physician and provider education and consultation. In addition, the Caris POA, which we established in 2015, is a growing network of leading cancer centers and research consortia across the globe that supports our academic partner engagement and research and collaboration opportunities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Key Factors Affecting Our Performance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that our operating performance and future success depend on a number of factors that present significant opportunities for us and may pose risks and challenges, including those discussed below and in the &#8220;Risk Factors&#8221; section of this prospectus. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Market acceptance and commercial success of our solutions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our success and future growth will depend on maintaining and expanding market acceptance of our molecular profiling solutions along with commercial success of these solutions across existing and new customers. Our MI Profile and Caris Assure case volumes have continued to increase over time. Such changes in our case volumes and the pricing of our solutions, however, are not impacted by the cancer type. For the&#160;years ended December&#160;31, 2024 and 2023, the number of clinical cases was 162,862 and 128,831, respectively. For the three months ended March 31, 2025 and 2024, the number of clinical cases was 45,858 and 34,902, respectively. We commercially launched our MI Cancer Seek solution in January&#160;2025 as the WES/WTS NGS component of MI Profile. We initiated the broad commercial launch of Caris Assure for therapy selection in the first quarter of 2024, and realizing the potential of Caris Assure across the cancer treatment continuum is a key component of our business strategy. The commercial success of Caris Assure will depend upon, among other things, additional clinical trials that demonstrate the effectiveness of Caris Assure, particularly for early detection, MCED, MRD tracking, and treatment monitoring, and the continued adoption of Caris Assure by patients, the medical community, and third-party payers. In addition, we expect that our ability to maintain and expand our sales, marketing, and distribution capabilities to support the increased adoption of our molecular profiling solutions will play a key factor in our success. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Biopharma partners.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our revenue also depends on our ability to maintain and expand relationships with our biopharma partners and attract new biopharma partners. As we continue to develop these relationships, we expect to support a growing number of projects and&#160;continue to have opportunities to offer our platform to such customers for development and research services. For the&#160;years ended December&#160;31, 2024 and 2023, our year-over-year growth in pharma research and development services revenue has been 131% and 37%, respectively. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Development and introduction of new solutions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our business success will also depend on our ability to develop and commercialize new solutions. We plan to continue to invest in the enhancement of our molecular profiling solutions, the development of new solutions to achieve meaningful innovation in precision oncology and other disease states, and the expansion of our clinico-genomic datasets to drive breakthrough science. We intend to expand the application of Caris Assure to early detection, MCED, MRD tracking, and treatment monitoring. Our ability to develop and commercialize new solutions and services could face many challenges and thus impact our future performance and results of operations. Such challenges include, but </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">111</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:40pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">are not limited to, obtaining regulatory approvals; completing certain clinical development activities, validation studies, and/or clinical trials; having guidelines or recommendations for healthcare providers, administrators, payers, and patient communities relating to such solutions; and receiving favorable exposure in peer-reviewed publications and from KOLs. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Payer coverage and reimbursements.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our revenue and future revenue growth will depend on our success in achieving broad coverage and adequate reimbursement for our solutions from third-party payers. Coverage and reimbursement by third-party payers, including managed care organizations, private health insurers, and government healthcare programs for the types of solutions we offer can be limited and uncertain and may depend on a number of factors, including a payer&#8217;s determination that a product is appropriate, medically necessary, and cost-effective. Each payer will make its own decision as to whether to establish a policy or enter into a contract to cover our products and the amount it will reimburse for such products. In addition, Z-Code Identifiers are used by certain payers, including under MolDX, to supplement CPT codes for our molecular diagnostics solutions. Changes to the codes used to report to payers may result in significant changes in their reimbursement. We have obtained a PMA approval from the FDA for a companion diagnostic and tumor profiling designation for MI Cancer Seek, a WES/WTS NGS assay that uses the whole exome for tumor mutational burden (&#8220;TMB&#8221;) calling along with being designed to meet the stricter requirements applicable to companion diagnostic devices. We have obtained Medicare coverage for MI Cancer Seek for CPT code 0211U, at a reimbursement rate of $8,455, under the NGS NCD. We currently market MI Cancer Seek as the WES/WTS NGS component of MI Profile. The current MolDX pricings of MI Tumor Seek Hybrid, and Caris Assure are $3,500 and $3,649, respectively. In&#160;July 2024, the AMA issued a PLA code, CPT code&#160;0485U, for Caris Assure, with an effective date of October&#160;1, 2024. In November&#160;2024, CMS determined to price Caris Assure for therapy selection using the &#8220;Gapfill&#8221; method, a method used when there are no comparable existing&#160;codes available. There is no certainty regarding the pricing that we will obtain for Caris Assure&#160;during the Gapfill process. For additional information, </font><font style="letter-spacing:0.196pt;">see &#8220;&#8212;Government Regulation&#8212;</font>&#8203;<font style="letter-spacing:0.196pt;">Coverage and </font><font style="letter-spacing:0.2pt;">Reimbursement&#8212;Coverage and Reimbursement in the United States.&#8221; While the average selling prices (&#8220;ASPs&#8221;) for Caris Assure and MI Cancer Seek reimbursed by a particular payer are determined by our arrangements with that payer and do not materially differ by cancer type, any fluctuation or differences in coverage and reimbursement among our third-party payers may impact our ASPs and gross margins. Moreover, if we are unable to obtain and/or maintain broad coverage and adequate reimbursement for our solutions from third-party payers, we may not be able to effectively increase our clinical case volume and our revenue would be impacted. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Scaling infrastructure to meet increasing demand.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our financial results are also dependent upon our ability to support current and future levels of demand for our solutions, including MI Profile and Caris Assure. As and to the extent the volumes of our current and new molecular profiling solutions continue to grow, we will need to simultaneously increase our capacity for sample intake and storage, enhance our customer service, improve our billing and general processes, expand our internal quality assurance programs, incorporate new equipment, implement new technology systems and processes, expand laboratory capacity, and otherwise extend our operational capabilities to support comprehensive genomic analyses at a larger scale while retaining expected turnaround times. This may result in us purchasing additional equipment, constructing additional facilities, hiring additional qualified labor, and implementing new systems, technology, controls, and procedures. As such, our capital expenditures and cost of services may increase as we continue our efforts to expand capacity. In addition, revenue may be impacted in the event that we are not able to meet the increase in demand. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">112</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Components of Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Revenue consists primarily of the following: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Profiling Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Molecular profiling services revenue is generated from the provision of precision oncology solutions to ordering physicians utilizing MI Profile, MI Cancer Seek (NGS component of MI Profile), and Caris Assure. Revenue is recorded when performance obligations are satisfied, which is deemed to be when the results of the profiling services are provided to the ordering physicians, including certain hospitals, cancer centers, and institutions. Revenue is recorded at the amount that reflects the consideration to which we expect to be entitled from customers and third-party payers in exchange for providing such services. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pharma Research and Development Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pharma research and development services revenue is generated from the provision of research and development services for biopharma partners utilizing our Caris platform. Given the nature of these services, each contract may contain multiple performance obligations, such as molecular profiling solutions, developmental services, and strategic data services. Each performance obligation is analyzed, and revenue is recognized as or when such performance obligations are satisfied. The timing and extent of revenue recognized may vary from contract to contract. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Costs and Operating Expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We allocate certain overhead expenses, such as rent, utilities, and depreciation to cost of services and operating expense categories based on headcount and facility usage. As a result, an overhead expense allocation is reflected in cost of services and operating expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cost of Services&#8212;Molecular Profiling Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of molecular profiling services generally consists of cost of materials, direct labor (including bonus and stock-based compensation), equipment maintenance and depreciation expenses associated with processing cases (including accessioning, sequencing, quality control analyses, and shipping charges to transport samples), and freight. Costs associated with completing the molecular profiling services are recorded as the service is performed, regardless of whether revenue is recognized with respect to the service. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cost of Services&#8212;Pharma Research and Development Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of services for pharma research and development services generally consists of costs incurred for the performance of the services requested by our biopharma partners related to research and development services. For the development of new products, costs incurred before technological feasibility has been achieved are reported as research and development expenses, while costs incurred thereafter are reported as cost of services. Cost of services for pharma research and development services will vary depending on the nature, timing, and scope of customer projects. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect cost of services to increase in absolute dollars as our revenue grows. In the short term, increases to cost of services may outpace revenue growth as we invest in expanding our laboratory capacity and implementing new processes. However, over time, the cost per clinical case is expected to decrease due to economies of scale. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Selling and Marketing Expense</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our selling and marketing expense includes costs associated with our sales organization, including our direct sales force and sales management, marketing, and business development personnel. These expenses consist principally of salaries, incentive compensation, bonuses, employee benefits, travel, and stock-based compensation, as well as marketing and educational activities. We expense all selling and marketing expenses as incurred. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">113</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that our marketing activities continue to drive awareness and differentiate our existing solutions and future solutions. We expect our selling and marketing expenses to continue to increase in absolute dollars as we expand our sales force and continue to grow our presence within and outside of the United States. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative Expense</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our general and administrative expense includes costs for our executive, accounting and finance, legal, information technology, billing, and human resources functions. These expenses consist principally of salaries, bonuses, employee benefits, travel, and stock-based compensation, as well as professional services fees (such as audit and tax consulting), general corporate costs, and allocated overhead expenses. While we expect our general and administrative expenses will increase in absolute dollars as we continue to invest in our growth and operate as a public company, we expect them to decline as a&#160;percentage of revenue over time as we scale our business and leverage our investments already made. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We expect to incur additional expenses after we complete this offering, primarily due to the costs of operating as a public company, which are expected to include additional legal, accounting, corporate governance, and investor relations expenses, as well as higher directors&#8217; and officers&#8217; insurance premiums. In addition, as a public company, we also expect to incur increased stock-based compensation expense related to our long-term equity incentive plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development Expense</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our research and development expense consists of costs incurred in performing research and development activities. These expenses include direct costs for salaries and benefits, supplies used in research and development, contract services and other outside costs, costs to acquire in-process research and development projects and technologies that have no alternative future use, and allocated overhead expenses. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We expect that our overall research and development expenses will vary from period to period as a&#160;percentage of revenue, as projects and prospective trials are initiated and completed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Income (Expense), Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest Income</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Interest income consists primarily of interest earned on our cash and cash equivalents and marketable securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest Expense</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Interest expense consists primarily of contractual interest expense on our term loan, amortization of the debt discount related to our term loans, and interest expense on our finance leases. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Changes in Fair Value of Financial Instruments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments consists of changes in the fair value of the warrant liability and changes in the fair value of the derivative liability. Our warrants are classified as a liability on our consolidated balance sheets and re-measured to fair value at each balance sheet date with the corresponding changes in fair value recorded within changes in fair value of financial instruments, as the holders have the option to convert their warrants into shares of either our common stock or our Series&#160;C preferred stock. The warrants will expire upon the completion of this offering unless earlier exercised. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other Expense, Net</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other expense, net consists of items related to foreign currency gains and losses, and other immaterial items. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">114</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:52.5pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Three Months Ended March&#160;31, 2025 and 2024</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of our results of operations for the periods presented: </font>
        </div>
        <table style="width:416pt;height:315.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:309.93pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">114,081</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">73,233</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">6,834</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">7,444</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total revenue</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">120,915</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">80,677</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Costs and operating expenses</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font><font style="letter-spacing:0.2pt;">: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of Services&#8201;&#8211;&#8201;Molecular Profiling Services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">60,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of Services&#8201;&#8211;&#8201;Pharma Research and Development Services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,669</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">39,829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">39,609</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,119</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">44,354</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">23,066</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">34,376</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:20pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total costs and operating expenses</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">178,867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">172,902</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(57,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(92,225<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other income (expense), net: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">503</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(12,782<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(9,290<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(32,333<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(11,064<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(17<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(219<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:20pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total other expense, net</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(44,629<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(18,804<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Loss before income taxes and provision for income taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:309.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Provision for (benefit from) income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:309.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Costs and operating expenses contains the following stock-based compensation expense: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:135pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:331.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:331.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:331.59pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8201;&#8211;&#8201;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">466</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">427</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8201;&#8211;&#8201;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,243</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,118</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,945</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2,346</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">966</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">14,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">4,458</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">115</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth our results of operations as a&#160;percentage of revenue for the periods presented: </font>
        </div>
        <table style="width:416pt;height:348.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:334.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:334.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">94<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">91<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total revenue</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Costs and operating expenses</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font><font style="letter-spacing:0.2pt;">: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8201;&#8211;&#8201;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">50<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">66<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of Services&#8201;&#8211;&#8201;Pharma Research and Development Services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">33<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">49<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">43<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">55<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">19<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">43<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:20pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total costs and operating expenses</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">148<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">214<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(48<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(114<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other income (expense), net: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(11<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(12<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(27<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(14<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="margin-left:20pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total other expense, net</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(37<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(23<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Loss before income taxes and provision for income taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(85<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(138<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:334.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Provision for (benefit from) income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:334.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(85<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:6.355pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(138<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.79pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:90pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:287.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:287.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:287.17pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:287.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">114,081</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">73,233</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">40,848</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">55.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:287.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">6,834</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,444</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(610<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(8.2<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:287.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">120,915</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">80,677</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">40,238</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">49.9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:13.8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Total revenue was $120.9 million for the three&#160;months ended March&#160;31, 2025, compared to $80.7 million for the three&#160;months ended March&#160;31, 2024, an increase of $40.2 million, or 49.9%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Profiling Services Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Molecular profiling services revenue increased to $114.1 million for the three&#160;months ended March&#160;31, 2025, from $73.2 million for the three&#160;months ended March&#160;31, 2024, an increase of $40.8 million, or 55.8%. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This increase in revenue was primarily due to the increase in clinical cases associated with MI Profile and Caris Assure for therapy selection from 33,095 and 1,807 cases, respectively, for the three&#160;months ended March&#160;31, 2024, to 40,048 and 5,810 cases, respectively, for the three&#160;months ended March&#160;31, 2025, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">116</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">a total increase of 10,956 cases, or 31.4%. We believe the growth in MI Profile clinical case volume is driven by increased market acceptance and adoption of MI Profile by ordering physicians year over year, and increased market acceptance and adoption of Caris Assure following its broad commercial launch in the first quarter of 2024. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Revenue from clinical cases for patients covered by Medicare represented approximately 54.3% and 40.5% of our molecular profiling services revenue for the three&#160;months ended March&#160;31, 2025 and 2024, respectively due to mix. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the relative impacts of clinical volume and ASP on our increase in molecular profiling services revenue. </font>
        </div>
        <table style="width:416pt;height:84pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:356.78pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:356.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services revenue for the three&#160;months ended March&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">73,233</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MI Profile volume increase </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">14,894</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MI Profile ASP increase due to payer mix </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">15,704</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:356.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Caris Assure for therapy selection </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">10,250</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:356.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services revenue for the three&#160;months ended March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">114,081</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:15.41pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pharma Research and Development Services Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pharma research and development services revenue decreased to $6.8 million for the three&#160;months ended March&#160;31, 2025, from $7.4 million for the three&#160;months ended March&#160;31, 2024, a decrease of $0.6&#160;million, or 8.2%. The decrease is mainly driven by reduced research case volume. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cost of Services</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:74.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:297.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:297.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:297.17pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8201;&#8211;&#8201;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">60,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">15.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8201;&#8211;&#8201;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2,958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,669</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,289</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">77.2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.3pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cost of Services&#8212;Molecular Profiling Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of services&#8722;Molecular profiling services was $60.9 million for the three&#160;months ended March&#160;31, 2025, compared to $52.9 million for the three&#160;months ended March&#160;31, 2024, an increase of $8.0&#160;million, or 15.1%. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Caris Assure laboratory contributed to the majority of the $8.0 million increase. The Caris Assure increase was primarily driven by an increase in materials and related testing costs of $5.0 million, a $1.3 million increase in utilities, rent, and allocated overhead, and an increase in labor costs of $1.1 million, due to the increased volume from broad launch in the first quarter of 2024. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cost of Services&#8212;Pharma Research and Development Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of services&#8722;Pharma research and development services was $3.0 million for the three&#160;months ended March&#160;31, 2025, compared to $1.7 million for the three&#160;months ended March&#160;31, 2024, an increase of $1.3 million, or 77.2%. The increase was driven primarily by an increase within costs associated with the delivery of data licensing and target discovery services of $2.5 million, offset by a reduction in delivering research services of $1.2 million, driven by lower research volume. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Gross Profit</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Gross profit, calculated as total revenue less cost of services, was $57.1 million for the three&#160;months ended March&#160;31, 2025, compared to $26.1 million for the three&#160;months ended March&#160;31, 2024, an increase of $30.9 million, or 118.5%, primarily due to the increase in clinical revenue. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">117</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Selling and Marketing Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:59.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:309.88pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:309.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">39,829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">39,609</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">221</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8.8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Selling and marketing expenses were $39.8 million for the three&#160;months ended March&#160;31, 2025, compared to $39.6 million for the three&#160;months ended March&#160;31, 2024, an increase of $0.2 million, or 0.6%. This increase was primarily due to a $2.1 million increase in personnel costs to support existing solutions, offset by a $1.9 million decrease in travel and marketing expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General and Administrative Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:59.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:297.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:297.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:297.17pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,119</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">44,354</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7,765</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">17.5<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8.79pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses were $52.1 million for the three&#160;months ended March&#160;31, 2025, compared to $44.4 million for the three&#160;months ended March&#160;31, 2024, an increase of $7.8 million, or 17.5%. This increase was primarily due to an increase of $11.6 million in labor costs, benefits and stock-based compensation associated with an expansion of personnel, a $1.3 million increase in consulting, audit and legal professional fees, a $1.3 million increase related to utilities and cloud computing usages, offset by a $7.2 million decrease in depreciation expense.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:59.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:285.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:285.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:285.51pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:285.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">23,066</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">34,376</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(11,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(32.9<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8.8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses were $23.1 million for the three&#160;months ended March&#160;31, 2025, compared to $34.4 million for the three&#160;months ended March&#160;31, 2024, a decrease of $11.3 million, or 32.9%. The decrease was primarily driven by a reduction of $9.6 million in material and reference testing costs associated with the development of Caris Assure and FDA submission of MI Cancer Seek, a reduction of $0.8 million in labor costs, benefits and stock-based compensation, and a $0.8 million reduction in allocated overhead. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Income (Expense), Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:120pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:277.18pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:277.18pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:277.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:277.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">503</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,265<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(71.6<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:277.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,782<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(9,290<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,492<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">37.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:277.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(32,333<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(11,064<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(21,269<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">192.2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:277.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(219<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">202</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(92.2<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:277.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total other income (expense), net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,629<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(18,804<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(25,825<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">137.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">118</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:322.95pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest Income</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Interest income was $0.5 million for the three&#160;months ended March&#160;31, 2025, compared to $1.8 million for the three&#160;months ended March&#160;31, 2024, a decrease of $1.3 million, or 71.6%. This decrease was primarily due to reduced investments in marketable securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest Expense</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Interest expense was $12.8 million for the three&#160;months ended March&#160;31, 2025, compared to $9.3 million for the three months ended March&#160;31, 2024, an increase of $3.5 million, or 37.6%. This increase was primarily due to increased interest expense associated with $200.0&#160;million of additional borrowing under the 2023 Term Loan Agreement, which was drawn on March&#160;5, 2024. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Changes in Fair Value of Financial Instruments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments was $32.3 million for the three&#160;months ended March&#160;31, 2025, compared to $11.1 million for the three&#160;months ended March&#160;31, 2024, an increase of $21.3 million, or 192.2%. This increase is mainly driven by the increase in warrant and derivative fair values during the three&#160;months ended March&#160;31, 2025. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other Expense, Net</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Other expense, net was $17 thousand for the three&#160;months ended March&#160;31, 2025, compared to $0.2 million for the three&#160;months ended March&#160;31, 2024, a decrease of $0.2 million, or 92.2%. This decrease was primarily due to the undrawn fee of the 2023 Term Loan, incurred during the three months ended March&#160;31, 2024. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">119</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:54.7199999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Years Ended December&#160;31, 2024 and 2023</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of our results of operations for the periods presented: </font>
        </div>
        <table style="width:384pt;height:365.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:277.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:277.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:277.93pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">349,115</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">278,748</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">63,145</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">27,380</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">412,260</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">306,128</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Costs and operating expenses</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font><font style="letter-spacing:0.2pt;">: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">223,075</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">207,509</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Pharma research and development </font>
                <br >
                <font style="letter-spacing:0.2pt;">services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10,403</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9,309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">152,602</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">142,925</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">169,386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">149,053</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">113,916</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">116,883</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:20pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total costs and operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">669,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">625,679</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(257,122<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(319,551<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other income (expense), net: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,122</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11,258</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(50,025<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(31,610<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">18,484</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11,094</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(12,606<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="margin-left:20pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(24,768<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(21,864<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Loss before income taxes and provision for income taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:277.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Provision for (benefit from) income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:277.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:6.69pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Costs and operating expenses contains the following stock-based compensation expense:</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:384pt;height:121.7pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:282.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years&#160;Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:282.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:282.89pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.27pt 0pt 1.79pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Cost of services&#8211;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 1.79pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 1.79pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,669</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 1.79pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 1.79pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,504</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.52pt 0pt 1.79pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Cost of services&#8211;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.52pt 0pt 1.79pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 1.79pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.52pt 0pt 1.79pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 1.79pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.53pt 0pt 1.78pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 1.78pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 1.78pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4,301</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 1.78pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 1.78pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">3,400</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.53pt 0pt 1.78pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 1.78pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 1.78pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8,448</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 1.78pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 1.78pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">6,983</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.52pt 0pt 2.655pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.655pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.655pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">4,214</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.655pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.655pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">3,344</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.27pt 0pt 3.405pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.655pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.655pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">18,643</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.655pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.655pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">15,241</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">120</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth our results of operations as a&#160;percentage of revenue for the periods presented: </font>
        </div>
        <table style="width:384pt;height:339.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:282.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:282.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">85<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">91<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">15<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total revenue</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Costs and operating expenses</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font><font style="letter-spacing:0.2pt;">: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">54<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">68<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">37<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">47<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">41<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">49<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">28<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">38<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:20pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total costs and operating expenses</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">162<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">204<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(62<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(104<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other income (expense), net: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">4<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(12<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(10<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">4<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">4<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="margin-left:20pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total other expense, net</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(6<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(7<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Loss before income taxes and provision for income taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(68<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(112<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Provision for (benefit from) income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:282.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(68<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:11.195pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(112<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:10.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:14.42pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:262.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:262.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:262.25pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="26">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:262.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">349,115</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">278,748</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">70,367</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">25.2</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:262.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">63,145</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">27,380</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">35,765</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">130.6</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:262.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">412,260</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">306,128</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">106,132</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">34.7</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:11.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Total revenue was $412.3 million for the year ended December&#160;31, 2024, compared to $306.1&#160;million for the year ended December&#160;31, 2023, an increase of $106.1&#160;million, or 34.7%. </font>
        </div>
        <div style="margin-top:11.42pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Profiling Services Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Molecular profiling services revenue increased to $349.1 million for the year ended December&#160;31, 2024, from $278.7&#160;million for the year ended December&#160;31, 2023, an increase of $70.4&#160;million, or 25.2%. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This increase in revenue was primarily due to the increase in clinical cases associated with MI Profile and Caris Assure for therapy selection from 128,168 and 663 cases, respectively, for the year ended December&#160;31, 2023, to 146,580 and 16,282 cases, respectively, for the year ended December&#160;31, 2024, a total increase of 34,031 cases, or 26.4%. We believe the growth in MI Profile clinical case volume is driven by increased market acceptance and adoption of MI Profile by ordering physicians year over year, and increased market acceptance and adoption of Caris Assure following its broad commercial launch in the first quarter of 2024. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">121</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the year ended December 31, 2023, we recorded $4.4 million of revenue related to the transition of payers from &#8220;non-contract basis&#8221; to &#8216;&#8216;contract basis.&#8217;&#8217; Revenue from clinical cases for patients covered by Medicare represented approximately 39.0% and 39.3% of our molecular profiling services revenue for the&#160;years ended December&#160;31, 2024 and 2023, respectively. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the relative impacts of clinical volume and ASP on our increase in molecular profiling services revenue from 2023 to 2024. </font>
        </div>
        <table style="width:456pt;height:99pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:396.78pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:396.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services revenue for the year ended December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">278,748</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:396.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MI Profile volume increase </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">39,393</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:396.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MI Profile ASP increase due to payer mix </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">8,621</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:396.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Transition adjustments for MI Profile payers in 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(4,390)</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:396.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Caris Assure for therapy selection </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">26,743</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:396.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services revenue for the year ended December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">349,115</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:4.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.2pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pharma Research and Development Services Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Pharma research and development services revenue increased to $63.1 million for the year ended December&#160;31, 2024, from $27.4&#160;million for the year ended December&#160;31, 2023, an increase of $35.7 million, or 130.3%. This increase was primarily due to increased activity with our biopharma partners for our data licensing business of $35.6 million and an increase within pharma profiling services of $1.8 million. The increases were partially offset by a reduction in research revenue of $2.5 million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cost of Services</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:65.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:272.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:272.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:272.25pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="26">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:272.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">223,075</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">207,509</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">15,566</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.5</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:272.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,403</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">9,309</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,094</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">11.8</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.19pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cost of Services&#8212;Molecular Profiling Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of services&#8212;Molecular profiling services was $223.1 million for the year ended December&#160;31, 2024, compared to $207.5&#160;million for the year ended December&#160;31, 2023, an increase of $15.6 million, or 7.5%.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Caris Assure laboratory contributed a $20.2 million increase, which was offset by a $4.6 million decrease within the MI Profile tissue laboratory. The Caris Assure increase was primarily driven by an increase in materials and related testing costs of $15.7 million and an increase in labor costs of $2.7 million, due to the increased volume from broad launch in the first quarter of 2024. The MI Profile decrease was driven primarily by a reduction in labor costs of $2.9 million and reduced depreciation of $5.7 million, mainly from lab equipment that has been fully depreciated, offset by an increase in materials and related testing costs of $2.0 million, driven by increased case volume.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cost of Services&#8212;Pharma Research and Development Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of services&#8212;Pharma research and development services was $10.4 million for the year ended December&#160;31, 2024, compared to $9.3&#160;million for the year ended December&#160;31, 2023, an increase of $1.1 million, or 11.8%. The increase was driven primarily by an increase within costs associated with the delivery of data licensing and target discovery services, offset by a reduction in labor and materials used in pharma profiling services. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">122</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:81.5pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Gross Profit</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Gross profit, calculated as total revenue less cost of services, was $178.8 million for the year ended December&#160;31, 2024, compared to $89.3&#160;million for the year ended December&#160;31, 2023, an increase of $89.5 million, or 100.2%, primarily due to the increase in the number of clinical cases and pharma research and development services revenue.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Selling and Marketing Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:50.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:282.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:282.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:282.25pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="26">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:282.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">152,602</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">142,925</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9,677</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">6.8</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Selling and marketing expenses were $152.6 million for the year ended December&#160;31, 2024, compared to $142.9&#160;million for the year ended December&#160;31, 2023, an increase of $9.7&#160;million, or 6.8%. This increase was primarily due to a $5.7 million increase in personnel costs to support existing solutions, a $1.4 million increase in professional service costs from expanded EMR integrations and consulting, and a $2.4 million increase in travel and marketing expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General and Administrative Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:50.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:272.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:272.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:272.25pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="26">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:272.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">169,386</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">149,053</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,333</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">13.6</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses were $169.4&#160;million for the year ended December&#160;31, 2024, compared to $149.1&#160;million for the year ended December&#160;31, 2023, an increase of $20.3&#160;million, or 13.6%. This increase was primarily due to an increase of $6.9 million in labor costs, benefits and stock-based compensation associated with an expansion of personnel, a $4.3 million increase in consulting, audit and legal professional fees, and a $6.9 million increase related to utilities and cloud computing usages.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:50.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:268.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:268.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:268.93pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="26">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:268.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,916</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">116,883</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">(2,967)</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">(2.5)</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses were $113.9 million for the year ended December&#160;31, 2024, compared to $116.9&#160;million for the year ended December&#160;31, 2023, a decrease of $3.0 million, or 2.5%. The decrease was primarily driven by a reduction of $8.2 million in material and reference testing costs associated with the development of Caris Assure and FDA submission of MI Cancer Seek and a reduction&#160;of $2.6 million in consulting fees, offset by an $8.0 million increase in labor costs, benefits and stock-based compensation.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">123</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Income (Expense), Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:111pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:257.31pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="12">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:257.31pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="5">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:257.31pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="26">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Dollars in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:257.31pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">7,122</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">11,258</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(4,136)</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">(36.7)</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:257.31pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(50,025)</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(31,610)</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(18,415)</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">58.3</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:257.31pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">18,484</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">11,094</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">7,390</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">66.6</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:257.31pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(349)</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(12,606)</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">12,257</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:18pt; text-align:right; white-space:nowrap;">(97.2)</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:257.31pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total other income (expense), net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(24,768)</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(21,864)</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(2,904)</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:18pt; text-align:right; white-space:nowrap;">13.3</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0.01pt; text-align:left; ">%</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.2pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest Income</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Interest income was $7.1 million for the year ended December 31, 2024, compared to $11.3&#160;million for the year ended December&#160;31, 2023, a decrease of $4.1&#160;million, or 36.7%. This decrease was primarily due to reduced investments in marketable securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest Expense</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Interest expense was $50.0 million for the year ended December 31, 2024, compared to $31.6&#160;million for the year ended December&#160;31, 2023, an increase of $18.4&#160;million, or 58.3%. This increase was primarily due to increased interest expense associated with $200.0 million of additional borrowing under the 2023 Term Loan Agreement, which was drawn on March 5, 2024. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Changes in Fair Value of Financial Instruments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments was $18.5 million for the year ended December&#160;31, 2024, compared to $11.1&#160;million for the year ended December&#160;31, 2023, an increase of $7.4&#160;million, or 66.6%. This increase is mainly driven by the decrease in warrant and derivative fair values during the year ended December 31, 2024.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other Expense, Net</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other expense, net was $0.3 million for the year ended December 31, 2024, compared to $12.6&#160;million for the year ended December&#160;31, 2023, a net decrease of $12.3&#160;million, or 97.2%. This decrease was primarily due to a loss on debt extinguishment of $10.9 million in connection with our prior term loan that was recorded in January 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Non-GAAP Financial Measures</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We use certain non-GAAP financial measures to supplement our consolidated financial statements, which are presented in accordance with GAAP. We believe the non-GAAP financial measures we use, Adjusted EBITDA and free cash flow, are useful in evaluating our performance and liquidity. Our non-GAAP financial measures have limitations as analytical tools, however, and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adjusted EBITDA</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We define Adjusted EBITDA as net loss, adjusted to exclude interest income, interest expense, changes in fair value of financial instruments, other&#160;expense, net, the provision for (benefit from) income taxes, depreciation and amortization, and stock-based compensation expense. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We use Adjusted EBITDA in conjunction with GAAP measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. We believe that Adjusted EBITDA provides useful information to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">124</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors. In addition, it provides a useful measure for period-to-period comparisons of our business, as it removes the effect of certain non-cash expenses and certain variable charges. Some of the limitations related to the use of Adjusted EBITDA as an analytical tool include: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it does not reflect interest income, interest expense or other non-operating gains and losses, which may represent an increase to or reduction in cash available to us; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it does not reflect recurring, non-cash expenses of depreciation of property and equipment and amortization of right-of-use assets and intangible assets, and although these are non-cash expenses, the assets being depreciated and amortized may have to be replaced in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it does not reflect the impact of stock-based compensation expense, which has been, and will continue to be a part of our compensation strategy; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it may be calculated differently than similarly titled measures used by other companies, which reduces its usefulness as a comparative measure. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including net loss and our other GAAP results. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same as, or similar to, some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by the types of items excluded from the calculation of Adjusted EBITDA. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table provides a reconciliation of net loss, the most directly comparable financial measure presented in accordance with GAAP, to Adjusted EBITDA for the periods presented: </font>
        </div>
        <table style="width:396pt;height:177pt;margin-left:30pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:183.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ended March 31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:183.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:183.85pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:183.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:183.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(503<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(1,768<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(7,122<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(11,258<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:183.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">12,782</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9,290</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">50,025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">31,610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:183.85pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">32,333</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(18,484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(11,094<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:183.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">349</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">12,606</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:183.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Depreciation and amortization expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,045</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">17,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">48,913</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">49,001</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:183.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">14,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">4,458</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">18,643</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">15,241</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:183.85pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Adjusted EBITDA </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(36,216<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(70,062<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(189,566<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(255,309<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.71pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Free Cash Flow</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We define free cash flow as net cash used in operating activities less purchases of property and equipment. We believe free cash flow is a useful measure of liquidity that provides an additional basis for assessing our ability to generate cash. Some of the limitations related to the use of free cash flow as an analytical tool include:</font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it does not reflect our future contractual commitments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it does not represent our total residual cash flow for a given period; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it may be calculated differently than similarly titled measures used by other companies, which reduces its usefulness as a comparative measure. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because of these limitations, you should consider free cash flow alongside other financial performance measures, including net cash used in operating activities, capital expenditures, and our other GAAP results. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">125</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table provides a reconciliation of net cash used in operating activities, the most directly comparable financial measure presented in accordance with GAAP, to free cash flow for the periods presented: </font>
        </div>
        <table style="width:384pt;height:102pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:181.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:181.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:181.85pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:181.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(31,338<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(73,925<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(245,199<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(276,100<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 1.833pt 0pt; width:181.85pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Less: purchases of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,689<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,738<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(8,444<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(22,319<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:181.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Free cash flow </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(34,027<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(75,663<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(253,643<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(298,419<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.71pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sources of Liquidity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have incurred net losses and negative cash flows from operations since inception. We expect to incur additional net losses in the near future, and our expenses will increase as we continue to invest in developing new solutions, expand our organization, and increase our marketing efforts to continue to drive market adoption of our solutions. These investments, together with general and administrative expenses, have resulted in negative cash flows from operations of $245.2 million and $276.1&#160;million for the&#160;years ended December&#160;31, 2024 and 2023, respectively, and an accumulated deficit of $2.6&#160;billion as of March&#160;31, 2025. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To date, we have funded our operations principally from the issuance of stock, term loan borrowings and convertible debt, and through revenue from molecular profiling and pharma research and development services. As of March&#160;31, 2025, we had cash and cash equivalents of $31.2&#160;million and short-term marketable securities of $2.2&#160;million. We believe our existing cash and cash equivalents and anticipated cash flows from operations, together with the net proceeds from our 2025 Private Placement and this offering, will provide sufficient capital and liquidity to fund our operating expenses and capital expenditure requirements for at least the next 12&#160;months after the completion of this offering. We will, however, continue to require additional capital to meet our operational needs. See &#8220;&#8212;Indebtedness&#8221; and &#8220;&#8212;Cash Requirements&#8221; below for additional information regarding our cash requirements and various factors that may impact our liquidity and capital resources, including the Non-conversion Amortization Payments (as defined below) in respect of our existing indebtedness. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash Flows</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes our cash flows for the periods presented: </font>
        </div>
        <table style="width:384pt;height:89.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:180.18pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ended March 31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:180.18pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:180.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:180.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(31,338<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(73,925<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(245,199<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(276,100<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:180.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash provided by investing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,689<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">59,638</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,932</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">214,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:180.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,285</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,107</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">200,292</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10,132</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Operating Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in operating activities during the year ended December 31, 2024 was $245.2 million, which was primarily due to a net loss of $281.9 million and a net change in our operating assets and liabilities of $29.1 million, and offset by non-cash charges of $65.8 million. The net change in our operating assets and liabilities was primarily the result of a $33.8 million increase in accounts receivable, a $1.4 million increase in prepaid expenses and other current assets, offset by a $5.5 million decrease in supplies and a $0.1 million decrease in other assets. Net non-cash charges, primarily consisted of $48.9 million of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">126</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">depreciation and amortization expense, $18.6 million of stock-based compensation expense and $7.1 million in amortization of debt discount costs, offset by a $18.5 million gain within changes in the fair value of financial instruments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in operating activities during the year ended December&#160;31, 2023 was $276.1&#160;million, which was primarily due to a net loss of $341.4&#160;million and a net change in our operating assets and liabilities of $7.1&#160;million, and offset by non-cash charges, net of $72.4&#160;million. The net change in our operating assets and liabilities was primarily the result of a $15.1&#160;million increase in accounts receivable, and offset by a $7.2&#160;million increase in accounts payable and a $1.3 million increase in accrued expenses and other current liabilities. Net non-cash charges primarily consisted of $49.0&#160;million of depreciation and amortization, $15.2&#160;million of stock-based compensation expense, $10.9&#160;million of debt extinguishment expense, offset by a $11.1&#160;million gain within changes in the fair value of financial instruments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in operating activities during the three&#160;months ended March&#160;31, 2025 was $31.3 million, which was primarily due to a net loss of $102.6 million and a net change in our operating assets and liabilities of $13.3 million, offset by non-cash charges of $57.9 million. The net change in our operating assets and liabilities was primarily the result of a $1.7 million decrease in accounts payable, offset by a $7.9 million decrease in accounts receivable, a $2.5 million decrease in prepaid expenses and other current assets, a $2.1 million decrease in supplies, and a $2.6 million increase in accrued expenses and other liabilities. Net non-cash charges primarily consisted of $7.0 million of depreciation and amortization expense, $14.7 million of stock-based compensation expense and $1.9 million in amortization of debt discount costs, offset by a $32.3 million loss within changes in the fair value of financial instruments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in operating activities during the three&#160;months ended March&#160;31, 2024 was $73.9 million, which was primarily due to a net loss of $111.0 million and a net change in our operating assets and liabilities of $1.2 million, and offset by non-cash charges of $38.3 million. The net change in our operating assets and liabilities was primarily the result of a $2.4 million increase in accounts receivable, a $0.1 million increase in prepaid expenses and other current assets, a $2.8 million decrease in accounts payable, a $0.8 million decrease in accrued expenses and other liabilities, offset by a $4.0 million decrease in supplies and a $0.3 million decrease in other assets. Net non-cash charges, primarily consisted of $17.7 million of depreciation and amortization expense, $4.5 million of stock-based compensation expense and $1.6 million in amortization of debt discount costs, offset by a $11.1 million loss within changes in the fair value of financial instruments. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Investing Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by investing activities during the year ended December&#160;31, 2024 was $52.9&#160;million, which was primarily due to maturities of marketable securities of $61.4 million, offset by purchases of purchases of property and equipment of $8.4 million.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by investing activities during the year ended December&#160;31, 2023 was $214.8&#160;million, which was primarily due to maturities of marketable securities of $300.5&#160;million, offset by purchases of marketable securities of $63.4&#160;million and purchases of property and equipment of $22.3&#160;million. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in investing activities during the three&#160;months ended March&#160;31, 2025 was $2.7 million, which was primarily due to purchases of property and equipment of $2.7 million. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by investing activities during the three&#160;months ended March&#160;31, 2024 was $59.6 million, which was primarily due to maturities of marketable securities of $61.4 million, offset by purchases of property and equipment of $1.7 million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financing Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities during the year ended December&#160;31, 2024 was $200.3&#160;million, which was primarily due to proceeds from issuance of additional borrowings under the 2023 Term Loan Agreement (as defined below) on March 5, 2024, net of issuance costs, of $200.0 million. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">127</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities during the year ended December&#160;31, 2023 was $10.1&#160;million, which was primarily due to proceeds from issuance of the initial borrowing under the 2023 Term Loan Agreement, net of issuance costs, of $189.0&#160;million, offset by the repayment of the prior term loans of $180.0&#160;million. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities during the three&#160;months ended March&#160;31, 2025 was $1.3 million, which was primarily due to proceeds from exercises of stock options of $1.4 million, offset by the payment of deferred offering costs of $0.1 million. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities during the three&#160;months ended March&#160;31, 2024 was $200.1 million, which was primarily due to proceeds from issuance of additional borrowings under the 2023 Term Loan Agreement on March&#160;5, 2024, net of issuance costs, of $200.0 million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indebtedness</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2023, we entered into a term loan agreement, as amended (the &#8220;2023 Term Loan Agreement&#8221;) with OrbiMed Royalty &amp; Credit Opportunities III, LP, OrbiMed Royalty &amp; Credit Opportunities IV, LP, and Braidwell Transaction Holdings LLC (the &#8220;Lenders&#8221;), pursuant to which we issued senior, secured promissory notes and the Lenders agreed to lend us up to an aggregate principal amount of $400.0&#160;million (the &#8220;2023 Term Loan&#8221;), $200.0&#160;million of which was drawn down upon issuance of the notes. Net cash proceeds to us were $189.0&#160;million, after deducting customary debt discounts and debt issuance costs. The net proceeds were used to repay in full our then-outstanding term loans, including an aggregate principal amount of $175.0&#160;million, a prepayment premium of $5.0&#160;million, and accrued and unpaid interest of $1.0&#160;million. In March&#160;2024, we drew down the remaining $200.0&#160;million under the 2023 Term Loan Agreement. As of March 31, 2025, we had $400.0 million of borrowings outstanding under the 2023 Term Loan Agreement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The aggregate principal amount outstanding under the 2023 Term Loan Agreement is due and payable on January&#160;18, 2028. If an event of default occurs and is continuing, the lenders may declare all amounts outstanding under the 2023 Term Loan Agreement to be immediately due and payable. A final payment exit fee equal to 2.0% of the amount funded under the 2023 Term Loan Agreement is due upon prepayment or maturity. Amounts borrowed pursuant to the 2023 Term Loan Agreement may be prepaid at any time. Upon prepayment, we may be subject to a prepayment penalty based on the timing of repayment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, pursuant to the terms of the 2023 Term Loan Agreement, on the earlier to occur of (x)&#160;for dates prior to January&#160;1, 2026, any date that the redemption rights in respect of our Series&#160;C preferred stock, Series&#160;D preferred stock, or Series E preferred stock are or may become exercisable within 90&#160;days following such date, or (y)&#160;January&#160;1, 2026 or the first date thereafter if, as of such date, the redemption rights in respect of our Series&#160;C preferred stock, Series&#160;D preferred stock, or Series E preferred stock are or may become exercisable on or prior to the date that is six&#160;months after the maturity date, we will be required to make a one-time payment in an amount equal to 15% of the outstanding principal amount under the 2023 Term Loan Agreement together with any applicable repayment premium and exit fee as described in the 2023 Term Loan Agreement and, commencing with the first full fiscal quarter following such payment, we will be required to repay 2.5% of the outstanding principal amount in equal quarterly installments each quarter thereafter (such payments, the &#8220;Non-conversion Amortization Payments&#8221;). The Series&#160;C preferred stock redemption rights may be exercised on or after March&#160;31, 2026, and the Series&#160;D preferred stock and Series E preferred stock redemption rights may be exercised on or after May&#160;11, 2026. All outstanding shares of our Series&#160;C preferred stock, Series&#160;D preferred stock, and Series E preferred stock will convert into shares of common stock as part of the Preferred Stock Conversion and any redemption rights&#160;thereunder will terminate in connection with the completion of this offering and consequently, the Non-conversion Amortization Payments discussed above would not be applicable following the completion of this offering. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The aggregate principal amount under the 2023 Term Loan Agreement bears interest at a rate per annum equal to a fixed margin of 6.5% plus the greater of (a)&#160;forward-looking three-month secured overnight financing rate (&#8220;SOFR&#8221;) and (b)&#160;2.5%. In the event of default, the fixed margin shall increase by 3.0% per annum. As of December&#160;31, 2024, the interest rate was 11.1%. Regular quarterly payments are interest-only for the 60-month term of the 2023 Term Loan Agreement, with the principal due at maturity. The effective interest rate for the term loan is 17.0%. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">128</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our obligations under the 2023 Term Loan Agreement are secured by a first lien security interest in substantially all of our assets and our subsidiaries&#8217; assets. The 2023 Term Loan Agreement contains certain customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default applicable to us and our subsidiaries. Additional covenants include those restricting dispositions, fundamental changes to its business, mergers or acquisitions, indebtedness, encumbrances, distributions, investments, transactions with affiliates, and subordinated debt. As of March&#160;31, 2025, we were in compliance with all covenants under the 2023 Term Loan Agreement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On April 1, 2025, we closed a private financing in which we issued a combination of senior convertible notes (the &#8220;2025 Convertible Notes&#8221;), Series E convertible preferred stock and Series F convertible preferred stock, for an aggregate of $167.7 million. The 2025 Convertible Notes have an aggregate principal amount of $30.0 million. The 2025 Convertible Notes accrue interest at a rate of 8% per annum, payable quarterly in cash, and mature on January 1, 2026. In connection with this financing, we also issued warrants to acquire shares of common stock to the holders of the 2025 Convertible Notes. These warrants are not initially exercisable for any shares of common stock, but such warrants become exercisable for a specified dollar value of shares on a monthly basis commencing on June 1, 2025 if we have not completed an initial public offering by such date. Any exercisable portion of the warrants will be automatically exercised prior to the closing of the initial public offering and such warrants will terminate upon the closing of the offering.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Immediately prior to and in connection with the completion of the initial public offering, the 2025 Convertible Notes, Series E convertible preferred stock and Series F convertible preferred stock (plus accrued interest in connection with the 2025 Convertible Notes and an 8% accretion in connection with the preferred stocks) will convert into common stock at a price equal to 70% of the initial public offering price per share.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our primary use of cash is to fund operating expenses and capital expenditures (including leases of equipment and buildings), which consist of research and development expenditures, general and administrative expenditures, clinical and regulatory expenditures, purchases of testing equipment, and buildout of our laboratories. Cash used to fund such activities is impacted by the timing of when we pay or prepay these expenses. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes our material cash requirements as of December&#160;31, 2024: </font>
        </div>
        <table style="width:456pt;height:96pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:217.46pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Due by </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:217.46pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2026 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Thereafter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:217.46pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:217.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">69,312</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,718</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,071</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">41,441</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">387</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">117</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">118</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">117</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">35</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:217.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Term loans and interest</font><font style=" position:relative; bottom:4.25pt;line-height:6.5pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">516,813</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">97,360</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">36,819</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">36,819</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">345,816</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:217.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total material cash requirements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">586,512</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">108,195</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">47,008</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">44,018</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">387,292</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Excludes the Non-conversion Amortization Payments described above under &#8220;&#8212;Indebtedness,&#8221; as such payment will not be required if this offering is completed prior to December&#160;31, 2025 (the date that is 90&#160;days prior to March&#160;31, 2026, the first date the Series&#160;C preferred stock redemption rights may be exercised, if such rights are not earlier amended, waived, or terminated). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will continue to require additional capital to fund our operations and to continue to fund investments in the development and marketing of our solutions for the foreseeable future. We may need or determine to raise additional capital through private or public equity or debt financings, through collaborative or other arrangements with corporate sources, or through other sources of financing. Requirements for additional capital will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope, timing, rate of progress and costs of our research efforts, preclinical development activities, laboratory testing, and clinical trials for our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">129</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number and scope of clinical programs we decide to pursue; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost, timing, and outcome of preparing for and undergoing regulatory review of our solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope and costs of development and commercial manufacturing activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost and timing associated with commercializing our solutions if they receive marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which we acquire or in-license other complementary solutions or technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs of preparing, filing, and prosecuting patent applications, maintaining and enforcing our intellectual property rights, and defending intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to establish and maintain collaborations on favorable terms, if at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our efforts to enhance operational systems and our ability to attract, hire, and retain qualified personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our success in achieving broad coverage and adequate reimbursement for our solutions from third-party payers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our implementation of operational, financial, and management systems; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs associated with being a public company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A change in the outcome of any of these or other variables with respect to the development and commercialization of any of our solutions could significantly change the costs and timing associated with such development and commercialization. Furthermore, our operating plans may change in the future, and we will continue to require additional capital to meet operational needs and capital requirements associated with such operating plans. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may experience increased costs and be required to raise additional capital much sooner than anticipated. In April 2025, we issued the 2025 Convertible Notes and shares of our convertible Series E preferred stock and convertible Series F preferred stock. Further, if the Series&#160;C preferred stock redemption rights described above have not been amended, waived, or otherwise terminated prior to December&#160;31, 2025 (the date that is 90&#160;days prior to March&#160;31, 2026, the first date on which such redemption rights would become exercisable), we will be required to make the Non-conversion Amortization Payments following such date. See &#8220;&#8212;Indebtedness&#8221; above. If this offering is not completed by such date and such early repayment and the repayment on maturity of the 2025 Convertible Notes are required, based on our existing assumptions and expenditures, our existing cash resources and projected operating cash flows would not be sufficient to fund our operating expenses and capital expenditure requirements for at least the next 12&#160;months from the date of this prospectus. These conditions indicate the existence of a material uncertainty that raises substantial doubt as to our ability to continue as a going concern. See Note&#160;1 of our consolidated financial statements included elsewhere in this prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical Accounting Policies and Estimates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our consolidated financial statements have been prepared in conformity with GAAP. Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASUs&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). The preparation of the consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While our significant accounting policies are described in Note 2 to our consolidated financial statements included elsewhere in this prospectus, we believe that the following critical accounting policies are most important to understanding and evaluating our reported financial results. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We recognize revenue in accordance with ASC Topic 606, </font><font style="font-style:italic;letter-spacing:0.2pt;">Revenue from Contracts with Customers</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 606&#8221;). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">130</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ASC 606 provides a five-step framework through which revenue is recognized when control of promised goods or services is transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements that are within the scope of ASC 606, we perform the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract(s); (iii)&#160;determine the transaction price, including whether there are any constraints on variable consideration; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) we satisfy a performance obligation. At contract inception, once a contract is determined to be within the scope of ASC 606, we assess whether individual goods or services promised within each contract are distinct and, therefore, represent separate performance obligations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Profiling Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We recognize revenue from our molecular profiling services at the time when the results of the profiling services are delivered to ordering physicians, including certain hospitals, cancer centers, and institutions. We identify each sale of our profiling case as a single performance obligation. We estimate the transaction price based on our historical collection experience using a portfolio approach for third-party payers and patients with similar reimbursement characteristics. This includes analysis of an average reimbursement per case per portfolio and a percentage of cases reimbursed by considering the historical reimbursement data (including any refunds and recoupments) from such third-party payers and patients, current contractual and statutory requirements, patient insurance eligibility and payer reimbursement contracts, and any known or current or anticipated reimbursement trends not reflected in the historical data. We monitor the estimated amount to be collected in the portfolio at each reporting period. Subsequent changes to the estimate of the transaction price are generally recorded as adjustments to molecular profiling services in the period of change. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pharma Research and Development Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Contracts with biopharma partners may include multiple distinct performance obligations, such as provision of molecular profiling services, pharma research and development services, and strategic data services. For each of our contracts with biopharma partners, we evaluate the terms and conditions to identify distinct performance obligations. For each performance obligation determined, based on when and how it is delivered, we recognize revenue either when or as such obligation is delivered. Under contracts that include a performance obligation to provide molecular profiling services, to facilitate the development and regulatory approval of drugs, or to provide target discovery services, we receive payments upon the achievement of milestones, as well as provision of on-going support. We recognize pharma research and development services revenue over the period in which pharma research and development services are provided. Depending on the nature of the service, we recognize revenue using either the output or input method to measure progress, whichever provides a more faithful depiction of the transfer of goods or services. Use of an output method or input method to depict the transfer of services generally does not result in a material difference with respect to the timing of revenue recognition because most services commence and end within the same reporting period. We determine the transaction price of each performance obligation by considering the historical selling price of similar transactions, where applicable, as well as other factors, including, but not limited to, the price that customers in the market would be willing to pay, competitive pricing of our competitors, industry publications, and current pricing practices. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have granted stock-based awards consisting primarily of stock options and RSUs to employees, consultants, and members of our board of directors. We account for stock-based compensation in accordance with ASC Topic 718, </font><font style="font-style:italic;letter-spacing:0.2pt;">Compensation&#8212;Stock Compensation</font><font style="letter-spacing:0.2pt;">. Stock-based compensation expense is measured based on the fair value of the awards as of the grant date and is recognized as expense over the requisite service period, which is generally the vesting period. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of stock option awards as of the date of the grant is estimated by applying the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the use of highly </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">131</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">subjective and complex assumptions, which determine the fair value of stock-based awards. These assumptions include the following: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Fair value per share of the underlying stock.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As our common stock is not publicly traded, the fair value of the common stock underlying our stock options is determined by our board of directors, with input from management and valuation reports prepared by third-party valuation specialists as described below under &#8220;&#8212;Common Stock Valuations.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected price volatility.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As we are not a publicly traded company, the expected price volatility for our stock options is determined by using an average of historical volatilities of selected industry peers deemed to be comparable to our business and corresponding to the expected term of the awards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Risk-free interest rate.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for U.S. treasury notes with maturities corresponding to the expected term of the awards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected term.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The expected term of stock options represents the period of time over which the options granted are expected to remain outstanding and is based on our estimate, taking into consideration vesting terms, contractual terms, and historical actual lives. Options granted have a maximum term of 10&#160;years. Due to the lack of historical option exercise data, we utilize the simplified method for determining the expected term. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected dividend rate.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We have never declared or paid any cash dividends, and we do not intend to pay any cash dividends in the foreseeable future. Therefore, we use an expected dividend yield of zero&#160;percent. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected forfeitures.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Forfeitures are estimated at the time of grant and reduce compensation expense ratably over the vesting period. This estimate is based on historical forfeitures and is adjusted periodically based on the extent to which actual forfeitures differ, or are expected to differ, from the previous estimate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will continue to use judgment in evaluating the assumptions related to our stock-based compensation on a prospective basis. As we continue to accumulate additional data related to our common stock, we may refine our estimation process, which could materially impact our future stock-based compensation expense. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with this offering, we expect to incur approximately $28.9 million of stock-based compensation expense related to RSUs granted through March&#160;31, 2025, for which the performance-based vesting condition will be satisfied in connection with this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock Valuations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to this offering, given the absence of a public trading market for our common stock, and in accordance with the American Institute of Certified Public Accountants Accounting and Valuation Guide, </font><font style="font-style:italic;letter-spacing:0.2pt;">Valuation of Privately-Held Company Equity Securities Issued as Compensation</font><font style="letter-spacing:0.2pt;">, our board of directors exercised reasonable judgment and considered numerous objective and subjective factors to determine the best estimate of fair value of our common stock at each grant date, including: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">independent third-party valuations of our common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the prices of recent issuances of convertible preferred stock by us to investors in arm&#8217;s-length transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rights, preferences, and privileges of our convertible preferred stock relative to our common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our performance and market position relative to comparable publicly traded companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the likelihood and timing of achieving a liquidity event, such as an initial public offering or sale of our company, given prevailing market conditions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our developments and milestones; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">132</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our current business conditions and projections; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the lack of marketability inherent in our common stock; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the general economic outlook and global economic trends. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In valuing our common stock, the fair value of our business, or enterprise value, was determined using the market approach and/or income approach. The market approach estimates value based on a comparison of the subject company to comparable public companies in a similar line of business. From the comparable companies, a representative market value multiple is determined and then applied to the subject company&#8217;s financial results to estimate the value of the subject company. The precedent transaction method, a form of the market approach that derives the implied equity value from the recent issuance of stock by the subject company, was also utilized when appropriate. The income approach estimates value based on the expectation of future cash flows, which are then discounted to present value. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For each valuation, the equity value, which is calculated as the enterprise value, adjusted for cash and debt, was then allocated to the common stock using the option pricing method (&#8220;OPM&#8221;) and/or the probability-weighted expected return method (&#8220;PWERM&#8221;). The OPM allocates the equity value to the various share classes based on differences in liquidation preferences, participation rights, dividend policy, and conversion rights, using a series of call options. The call right is valued using a Black-Scholes option pricing model. The PWERM employs additional information not used in the OPM, including the likelihood and potential timing of various discrete future liquidity scenarios, such as an initial public offering. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Application of these approaches involves the use of estimates, judgment, and assumptions that are highly complex and subjective, such as those regarding our expected future revenues, expenses, cash flows, discount rates and market multiples, the selection of comparable companies, and the probability of possible future events. Changes in any or all of these estimates and assumptions, or the relationships between those assumptions, impact our valuations as of each valuation date and may have a material impact on the valuation of our common stock. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following this offering, it will not be necessary to estimate the fair value of our common stock, as our shares of common stock will be traded in the public market, and the fair value of our common stock will be based on the closing price of our common stock as reported by Nasdaq. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Emerging Growth Company Status</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The JOBS Act permits an &#8220;emerging growth company&#8221; such as us to delay the adoption of new or revised accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this extended transition period for complying with new or revised accounting standards and, as a result, our results of operations and financial statements may not be comparable to those of companies that have adopted the new or revised accounting standards. We will remain an emerging growth company until the earliest to occur of: (1)&#160;the last day of the fiscal year in which we have at least $1.235&#160;billion in total annual gross revenue; (2)&#160;the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700&#160;million as of the last business day of the second fiscal quarter of such year; (3)&#160;the date on which we have issued more than $1.0&#160;billion in non-convertible debt securities during the prior three-year period; and (4)&#160;the last day of the fiscal year ending after the fifth anniversary of the date of the completion of this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent Accounting Pronouncements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">See Note 2 of our consolidated financial statements included elsewhere in this prospectus for more information regarding recently issued accounting pronouncements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Quantitative and Qualitative Disclosures about Market Risk</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interest Rate Risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The market risk inherent in our financial instruments and in our financial position represents the potential loss arising from adverse changes in interest rates. As of March&#160;31, 2025, we had cash, cash </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">133</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:348pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">equivalents, and restricted cash of $35.3 million, and short-term marketable securities of $2.2 million, consisting of interest-bearing money market accounts, for which the fair market value would be affected by changes in the general level of United States interest rates. However, due to the short-term maturities and the low risk profile of our investments, an immediate 100 basis point change in interest rates would not have a material effect on the fair market value of our cash and investments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our borrowings under the 2023 Term Loan Agreement also subject us to market risk associated with movements in interest rates associated with forward-looking three-month SOFR. We had $400.0&#160;million in variable rate debt outstanding as of March&#160;31, 2025. A hypothetical 100 basis point adverse movement in the interest rate would increase our annual interest expense by $4.0&#160;million. We hedge interest rate risk on $200.0 million of this variable rate debt with a purchased interest rate cap derivative that has a strike rate of 6.0%. We did not receive any settlement payments from the counterparty to the interest rate cap for the year ended December&#160;31, 2024 or the three months ended March 31, 2025. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign Currency Risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Substantially all of our revenue is generated in the United States, and we do not believe we are currently subject to significant foreign currency risk. To date, foreign currency transaction gains and losses have not had a material impact on our operations, and we have not engaged in any foreign currency hedging transactions. As we expand our presence in the international market, our results of operations and cash flows are expected to increasingly be subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. We will continue to reassess our approach to manage risk relating to fluctuations in currency rates as our international operations grow.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">134</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tBUS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We founded Caris in 2008 with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize the potential of precision medicine for patients. We have spent the last 17&#160;years developing and building our portfolio of comprehensive, proprietary molecular profiling solutions and generating what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology based on the more than 6.5 million tests we have run on over 849,000 cases, which have generated measurements of over 38 billion molecular markers. Our platform is purpose-built to leverage the convergence of next-generation sequencing (&#8220;NGS&#8221;), artificial intelligence (&#8220;AI&#8221;) and machine learning (&#8220;ML&#8221;) technologies, and high-performance computing. The power of our differentiated Caris platform has enabled us to develop the latest generation of advanced precision medicine diagnostic solutions designed to address the entire cancer care continuum, including early detection, minimal residual disease (&#8220;MRD&#8221;) tracking, therapy selection, and treatment monitoring, as well as to create molecular signatures and discover and develop novel precision medicine therapeutics. Our current commercial product portfolio is focused on oncology and consists of MI Profile, our tissue-based molecular profiling solution that has generated the majority of our revenue to date, and Caris Assure, our novel, universal blood-based molecular profiling solution that was broadly launched in the first quarter of 2024 for therapy selection. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dysfunctionality at the molecular level underlies every chronic disease, and this dysfunction is now measurable using techniques such as NGS. Cells are embedded within highly complex biological networks that govern all aspects of life, including how these cells grow, divide, interact, and die. These biological networks and their inherent functions, as well as dysfunctions, are controlled and directed at the molecular level. The precise molecular origins or contributors to a given biological dysfunction, however, are often unknown, and a comprehensive molecular profile is necessary to determine these origins. The central dogma of molecular biology states that genetic information flows in one direction, from DNA, to RNA, to proteins. Our approach is designed to accurately capture the full breadth of the DNA and RNA coding information in cells as well as protein expression through immunohistochemical (&#8220;IHC&#8221;) tests, constructing a fulsome mosaic of disease, and ultimately unlocking the potential for precision medicine therapeutics to guide individualized patient diagnoses and treatment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe we are well-positioned to realize the full potential of our vision and optimally leverage our vast datasets due to the recent convergence of several advancements in biology, medicine, and technology: (1)&#160;the medical community&#8217;s understanding and appreciation of the molecular nature of cancer has accelerated in recent&#160;years, resulting in a continued increase in molecular profiling of different cancer types and stages; (2)&#160;NGS costs have declined, making NGS more accessible to the healthcare ecosystem; (3)&#160;cloud-computing architecture has enabled massive scalability, distributed real-time collaboration, and greater cost efficiency for the analysis of previously unmanageable amounts of data; and (4) AI and ML computational capabilities have advanced to allow more effective interrogation of large biological datasets. We believe that our early foresight to generate comprehensive data at scale over the past many&#160;years and build a robust, foundational infrastructure have uniquely positioned Caris to leverage the benefits of these biological and technological advances to deliver transformative and advanced innovations in precision medicine and patient care into the future. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. We provide whole exome sequencing (&#8220;WES&#8221;) (all 23,000 encoding DNA genes) and whole transcriptome sequencing (&#8220;WTS&#8221;) (all 61,000 RNA transcripts that encode proteins) on every eligible patient sample (a sample provided by ordering physicians that contains sufficient genetic material for profiling). Since launching our WTS solution in 2019 and WES solution in 2020, we have performed over 500,000 WES and WTS cases through May 2025, which we </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">135</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">believe is more than any other company. We sequence at a sector-leading depth of coverage, which directly correlates with increased accuracy and detection of low frequency molecular markers of relevance. MI Cancer Seek, our FDA-approved companion diagnostic assay to identify cancer patients who may benefit from treatment with targeted therapies (a component of MI Profile), consistently reaches 1,500 times depth of coverage for clinically relevant DNA genes, which is a higher sequencing depth than other assays available in the marketplace based on reported depths of coverage, and 300 times depth of coverage for the whole exome. Caris Assure features a raw average sequencing depth of 8,000 times for clinically relevant genes, similarly a higher sequencing depth than other assays available in the marketplace based on reported depths of coverage. We generate tens of billions of datapoints per clinical case to reveal an individualized molecular blueprint of the patient&#8217;s disease. We believe this approach best positions us to provide actionable treatment pathways from targeted therapies to drive superior clinical outcomes for patients while also generating a rich dataset to power insights and innovation. To our knowledge, we remain the only genomic profiling company to consistently utilize WES and WTS as standard practice on every eligible patient sample. We also evaluate protein molecular markers through an extensive menu of IHC tests performed in a tumor-type specific manner, which in combination with WES and WTS, provide a comprehensive view of a patient&#8217;s disease. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our in-depth profiling of patient samples has led to the creation of what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology, including genomic data, clinical data, digitized slide images, and remnant tissue. As of March 31, 2025, we have run more than 6.5&#160;million tests on over 849,000 cases, which have generated measurements of over 38&#160;billion molecular markers. Leveraging high-powered computing and AI/ML algorithms, we, and our biopharma and research partners who use our data and bioinformatics services, analyze our datasets to determine the key molecular characteristics of a particular disease or dysfunction that drives disease, enabling signature identification and drug target discovery. As a leader in the transition to WES/WTS sequencing through our launch of a WTS solution in 2019 and a WES solution the following year, we believe we have more molecular data and information than any other company and are well-positioned to make precision medicine widely accessible. In 2018, our clinical case volume was approximately 29,000 cases, increasing to approximately 43,000 cases in 2019, approximately 60,000 cases in 2020, approximately 75,000 cases in 2021, approximately 97,000 cases in 2022, approximately 129,000 cases in 2023 and approximately 163,000 cases in 2024. Our clinical case volume for the first quarter of 2025 was approximately 45,900 cases, representing 31% year-over-year growth from approximately 34,900 clinical cases in the first quarter of 2024. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our molecular profiling solutions and the data generated by our multi-omic technology platform provide value to our more than 100 biopharma partners, such as Moderna, AbbVie, Xencor, and Merck KGaA, through partnerships that aim to increase the probability of technical and regulatory success of their therapeutic pipelines. In addition to biopharma, we leverage our datasets to partner with outside academic centers and researchers to further advance precision oncology research. The Caris Precision Oncology Alliance (&#8220;Caris POA&#8221;), which we established in 2015, is a growing network of leading cancer centers and research consortia across the globe that collaborate to advance precision oncology and biomarker-driven research, with its members working together to establish and optimize standards of care for molecular testing through innovative research to improve clinical outcomes for cancer patients. As of March 31, 2025, the Caris POA was comprised of 96&#160;members, including 45&#160;National Cancer Institute (&#8220;NCI&#8221;)-designated comprehensive cancer centers. This academic-industry collaborative network has been exceptionally productive with over 145 peer-reviewed manuscripts published since the beginning of 2022. Close connectivity with this vast network of key opinion leaders (&#8220;KOLs&#8221;) in oncology clinical care, research, and drug development has enabled us to remain at the forefront of precision oncology and closely attuned to the key needs of the most sophisticated researchers. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Caris platform is designed to create a virtuous cycle that can enable continued innovation and improved impact for patients and physicians. We believe our comprehensive approach to profiling will continue to drive demand for our genomic profiling capabilities, leading to further expansion of our clinico-genomic datasets, which provide additional valuable inputs to develop and enhance our solutions, with the ultimate goal of contributing to improved patient results. This continuous feedback loop enabled us to develop Caris Assure, which utilized genomic data generated by MI Profile to inform our blood-based bioinformatics algorithms, allowing us to detect previously unknown features and signals in the blood that provide advanced insights into disease development. We believe we will be able to further leverage this process to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">136</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">continue meaningful innovation in precision oncology as well as other chronic disease states, including cardiology, neurology, and metabolic conditions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our global annual clinical case volume has been growing rapidly, with year-over-year growth of 29% in 2022, 32% in 2023, 26% in 2024, and 31% in the first quarter of 2025, primarily driven by MI Profile. With our broad commercial launch of Caris Assure for therapy selection in the first quarter of 2024 and the FDA approval of MI Cancer Seek as a companion diagnostic in the fourth quarter of 2024 followed by the broad commercial launch of MI Cancer Seek in the first quarter of 2025 as the NGS component of MI Profile, we believe that increased profiling volumes will meaningfully contribute to our growth in 2025 and beyond. For the&#160;years ended December&#160;31, 2024 and 2023, we generated total revenue of $412.3&#160;million and $306.1&#160;million, respectively. For the three months ended March&#160;31, 2025 and 2024, we generated total revenue of $120.9 million and $80.7 million, respectively. We have incurred net losses and negative cash flows from operations since inception. For the years ended December&#160;31, 2024 and 2023, we incurred net losses of $257.1&#160;million and $341.4&#160;million, respectively. For the three months ended March&#160;31, 2025 and 2024, we incurred net losses of $102.6 million and $111.0 million, respectively. Our Adjusted EBITDA was $(189.6)&#160;million and $(255.3) million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Our Adjusted EBITDA was $(36.2)&#160;million and $(70.1)&#160;million for the three months ended March 31, 2025 and 2024, respectively. For additional information regarding Adjusted EBITDA, a non-GAAP financial measure, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Financial Measures.&#8221; We expect to incur additional net losses in the near future, and our expenses will increase as we continue to invest in developing new solutions, expand our organization, and increase our marketing efforts to continue to drive market adoption of our solutions. These investments, together with general and administrative expenses, have resulted in negative cash flows from operations of $245.2 million, $276.1 million, $31.3 million, and $73.9 million for the years ended December&#160;31, 2024 and 2023 and the three months ended March&#160;31, 2025 and 2024, respectively. Our free cash flow was $(253.6)&#160;million and $(298.4)&#160;million for the years ended December 31, 2024 and 2023, respectively, and $(34.0) million and $(75.7) million for the three months ended March&#160;31, 2025 and 2024, respectively. For additional information regarding free cash flow, a non-GAAP financial measure, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Financial Measures.&#8221; Additionally, as of March&#160;31, 2025, we had cash, cash equivalents, and short-term marketable securities of $33.4 million, and the aggregate principal amount of debt outstanding under our existing term loan was $400.0 million. For additional information regarding our liquidity and capital resources, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Industry</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cancer is a Large and Growing Disease State with a Significant Human Cost and Economic Burden on Society</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Addressing the complexity of cancer remains a major challenge in healthcare and a critical area of unmet medical need, despite enormous investments in research and development (&#8220;R&amp;D&#8221;), and the introduction of new oncology therapeutics and treatments. According to the Centers for Disease Control and Prevention, cancer is the second leading cause of death in the United States, exceeded only by heart disease. The American Cancer Society (the &#8220;ACS&#8221;) reports that in January&#160;2022, there were more than 18&#160;million Americans with a history of cancer and that approximately two million new cancer cases will be diagnosed in 2024 in the United States. Furthermore, approximately 611,720 Americans are expected to die of cancer in 2024. The International Agency for Research on Cancer predicts that the annual global burden of cancer will reach 35&#160;million new cases and 18.5&#160;million cancer deaths by 2050. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The annual burden of cancer care in the United States was more than $200&#160;billion in 2020 and is expected to increase over the coming decades. According to an article published in JAMA Oncology, a peer-reviewed medical journal published by the American Medical Association (the &#8220;AMA&#8221;), it is estimated that the total cumulative global economic cost of cancer from 2020 to 2050 will be approximately $25&#160;trillion. Better information and solutions are needed to detect and treat cancer earlier and more effectively to improve lives and manage healthcare costs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">137</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Central Dogma of Biology Drives the Fundamental Need for Comprehensive Molecular Information</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At its core, cancer represents the uncontrolled division and growth of the body&#8217;s cells. There are numerous biological processes in place for preventing the proliferation of cancerous cells. However, the failure of one or multiple genetic processes can lead to cancer. A cell is considered cancerous when it no longer responds to the body&#8217;s attempts to control its growth, function, and location due to abnormalities in its DNA. The central dogma of biology states that genetic information flows in one direction, from DNA, to RNA, to proteins. Thus, when present, DNA abnormalities in the exome, also referred to as genomic mutations, are transcribed into defective RNA in the transcriptome. This defective RNA, in turn, is translated into defective proteins, ultimately causing a cell to replicate uncontrollably or become cancerous. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The behavior of a specific cancer cell depends on which processes are not functioning properly. Oncogenes are genes that, when aberrantly active, cause a normal cell to become cancerous. Tumor suppressor genes must remain activated to prevent cancer; if deactivated, the cell proliferates uncontrollably. Many cancers begin with a few discreet genomic mutations, but additional mutations accumulate as the cells divide. In addition, chemical modifications to proteins post-production, known as post-translational modifications, can impact structure and function and may also result in uncontrollable cell growth. This dynamic range of potential mutations results in varying cancer types. For example, some cancer cells may simply divide and produce more cancer cells locally, while other cancer cells may invade normal tissue, enter the bloodstream, and metastasize to a remote site in the body. Given the complexity of a cancer&#8217;s origin and drivers, we believe comprehensive molecular information incorporating DNA, RNA, and protein profiles provides the most robust picture of a patient&#8217;s disease and potential treatment pathways. The below graphic depicts the central dogma of molecular biology and the profiling technology that can be used to capture the relevant molecular information at each step. </font>
        </div>
        <div style="position:relative;margin-top:7.71pt; text-align:center; width:456pt;">
          <img src="fc_centraldogma-4c.jpg" alt="[MISSING IMAGE: fc_centraldogma-4c.jpg]" height="198" width="580" >
        </div>
        <div style="margin-top:16.4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Technological Advancements have Ushered in a Molecular Revolution in Precision Oncology</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The molecular revolution is upending the traditional paradigm of complex workflows of diagnosis, treatment, and monitoring of diseases, which largely uses a symptomatic, reactive approach to medicine. For example, early detection of cancer has traditionally been performed using a myriad of different non-molecular tests, including mammograms for breast cancer, colonoscopy and fecal immunochemical test for colorectal cancer, pap test for cervical cancer, and low-dose computed tomography (&#8220;CT&#8221;) scan for lung cancer. Despite these techniques, cancers can still go undetected as many of these tests can be subject to interpretative bias or risk of inaccurate results. Further, prior to the use of genetic biomarkers for the treatment of cancers, all cancer patients were treated with generic chemotherapies with a broad applicability, often resulting in lower efficacy. Comprehensive molecular profiling is augmenting these different testing modalities by introducing streamlined workflows and replacing the patchwork of tests currently in use, using a small sample of the patient&#8217;s tissue or blood. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Molecular profiling in oncology began with single-gene testing focused on individual genes in an attempt to match patients with effective targeted therapies. With the declining cost of sequencing and growing number of targeted therapies, profiling evolved to include targeted testing focused on a small number of identified gene alterations correlated with effective targeted therapies and further expanded to include profiling using 500 to 1,000 gene panels. These targeted profiling methods are now acknowledged as being inefficient in the use of limited tumor tissue, as they generate a sub-optimal and incomplete amount of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">138</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:145pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">molecular information. For example, a study titled &#8220;Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients&#8221; published by authors associated with Memorial Sloan Kettering Cancer Center in New York in June 2017 in the scientific journal, </font><font style="font-style:italic;letter-spacing:0.2pt;">Nature Medicine</font><font style="letter-spacing:0.2pt;">, found that &#8220;hotspot&#8221; panels can miss 81% of actionable mutations in refractory cancers. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Over the last several decades, significant advances in genomics, proteomics, molecular technology, and computing power have enabled a comprehensive, multi-omic approach to the molecular profiling of diseases, both efficiently and at scale. Innovations in genomic sequencing and computing power have revealed deep insights into the cellular pathways and molecular nature of all types of cancer, heralding a new era of precision oncology. For example, a 2004 study published in Nature Reviews Cancer identified approximately 300 genes as being linked to cancer; a 2022 Genome Biology study identified approximately 3,350 genes were well-known or predictive drivers of cancer; and a 2022 Trends in Genetics analysis showed that of the approximately 17,300 human genes with at least one paper in PubMed, approximately 15,200 have at least one paper mentioning cancer. Precision oncology is defined as the use of molecular profiling&#8212;including analysis of DNA, RNA, and proteins&#8212;to identify a cancer&#8217;s alterations that can be targeted with specific therapies. NGS, the most advanced high-throughput sequencing method, has far surpassed other techniques used to analyze tumors and has become a cornerstone of precision oncology. This is due in large part to the genomically-driven nature of cancer, as well as the continued ongoing steep declines in the cost of sequencing over the last 30&#160;years and technology advances in speed and accuracy, which have made NGS far more available in the clinical setting. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The treatment paradigm for oncology continues to evolve with molecular medicine practiced across the entire continuum of the disease course: from using blood-based testing to detect cancers at its earliest stages; to the determination of whether a patient is at a high-risk of relapse after completing therapy; to the advanced/metastatic setting where molecular profiling is used to guide therapy interventions. Large scale studies interrogating cancers using NGS have led to the identification of thousands of biomarkers. Oncology therapeutics are now increasingly biomarker-driven targeted therapies. Over 100 biomarker-assisted therapeutics have been approved in the United States, and numerous clinical trials are currently in progress. In addition to being predictive markers for patients likely to benefit from certain treatments, biomarkers may also be used as diagnostic indicators of the presence or type of cancer, as prognostic indicators for patient outcomes, or as tools to monitor therapy response, residual disease, or recurrence. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The information provided by comprehensive molecular profiling is driving a revolution in medicine, where molecular information is used to guide individualized patient diagnoses and treatment. Beyond oncology, this precision medicine approach has applications across a wide range of broad disease areas including cardiology, neurology, and metabolic conditions, among other chronic diseases. </font>
        </div>
        <div style="margin-top:3pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Importance of Comprehensive Molecular Profiling</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Comprehensive molecular profiling provides greater clinical and economic value than traditional targeted panel testing approaches. Comprehensive molecular profiling entails evaluating thousands of potential biomarkers, including DNA, RNA, proteins, and other molecular and clinical information for characteristics unique to a particular patient&#8217;s disease. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">139</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:13pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;min-height:322pt;margin-top:0pt;border-collapse: collapse;border:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="height:17.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:4.5pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">Case Study: Advancing Cancer Treatment with Caris Molecular Profiling </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:63pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Caris was presented with the case of a female patient in her early 50&#8217;s with a history of Stage I endometrial cancer. Her oncologist discovered a softball-sized tumor in her ovary. After undergoing a biopsy, it was determined to be late-stage ovarian cancer, which had metastasized into surrounding tissues and her bowels. She underwent immediate surgery to remove her ovaries and 18 inches of her sigmoid colon and began a standard chemotherapy regimen. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:75pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Despite the surgery and three rounds of chemotherapy, the cancer grew back within three&#160;months, now spreading into the patient&#8217;s lymph nodes. Her oncologist recognized the urgency of her situation and sent the patient&#8217;s tumor biopsy to Caris for molecular testing, noting additional rounds of chemotherapy would not be beneficial. The profiling using our MI Profile solution revealed the tumor was microsatellite instability-high, indicating responsiveness to immunotherapy and supporting her oncologists&#8217; prior suspicion of Lynch Syndrome, also known as hereditary nonpolyposis colorectal cancer (&#8220;HNPCC&#8221;). </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:63pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HNPCC is caused by mutations in genes responsible for DNA mismatch repair (&#8220;MMR&#8221;), leading to an accumulation of errors in DNA replication and an increased risk of cancer development. Individuals with HNPCC have a higher lifetime risk of developing various cancers, particularly colorectal and endometrial. Identifying it in patients can help guide screening and surveillance efforts to detect cancers at an early, more treatable stage, as well as inform preventive measures to reduce cancer risk for their families. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:75pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With the guidance of molecular profiling results, the patient commenced immunotherapy treatment, leading to remarkable results. Within three&#160;months, her tumor disappeared, and the cancer in her lymph nodes significantly regressed. The patient went from having no real treatment options to having multiple with the use of comprehensive profiling, and to our knowledge remains cancer-free. Additionally, the identification of Lynch Syndrome is invaluable in guiding screening and surveillance for her children and grandchildren. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:29.5pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;border-bottom:0.75pt solid #000000; ;padding:2pt 0pt 6pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This transformative outcome underscores the importance of comprehensive profiling in tailoring treatment strategies based on individual genetic profiles.</div>
            </td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.5pt; width:456pt; line-height:12pt;font-style:italic;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">The Importance of WES/WTS</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:12pt; width:420pt; line-height:12pt;font-style:italic;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">DNA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">Mutations and copy number alterations (variations) can be detected using the polymerase chain reaction (&#8220;PCR&#8221;) or NGS, while DNA methylation is analyzed using PCR or pyrosequencing, which is a method for sequencing short stretches of DNA on the basis of the detection of pyrophosphate. DNA sequencing can be performed for an entire genome, exome, or, as in the case of targeted panels, within specific regions containing common cancer-associated alterations. NGS-based targeted panels are currently FDA-approved for several tumor types. These targeted panels identify known alterations in key cancer genes but do not provide a comprehensive overview of a tumor&#8217;s molecular makeup. </font>
        </div>
        <div style="margin-left:36pt; margin-top:12pt; width:420pt; line-height:12pt;font-style:italic;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">RNA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">While mutations detected in DNA may be silent (not expressed) and therefore of little clinical relevance, those in RNA are one step closer to producing an abnormal protein. RNA is also needed to understand gene expression and splice variants through </font><font style="font-style:italic;letter-spacing:0.2pt;">in situ</font><font style="letter-spacing:0.2pt;"> hybridization and RNA sequencing. RNA sequencing provides information that DNA cannot and is superior for detecting expressed fusions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">As with DNA, RNA sequencing can be performed for one, multiple, or all transcribed genes, in either targeted areas or the full transcriptome. Transcriptome analysis using NGS generates information on splice variants and gene fusions, including fusions not previously described. This information can help define molecular signatures, stratify risk, and guide targeted therapy use. In combination with WES, WTS provides information on all expressed genes, thereby detecting alterations that can be targeted with FDA-approved therapies, standard-of-care treatments, and investigational therapies in clinical trials. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">140</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;min-height:247pt;margin-top:0pt;border-collapse: collapse;border:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="height:17.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:4.5pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">Case Study: The Importance of RNA Profiling </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:51pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Caris was presented with the case of a teenaged boy diagnosed with high-grade astrocytoma, a type of brain tumor. Two&#160;years prior, the patient&#8217;s oncologist had ordered DNA-only profiling from another provider who did not identify any actionable mutations in the patient&#8217;s DNA. As a result, the patient was placed on a standard chemotherapy regimen. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:63pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon recurrence of the tumor two&#160;years later, the oncologist ordered genomic testing from the same provider, who again did not identify any actionable mutations in the DNA. The patient began radiation therapy. Despite the initial profiling attempt and results, the tumor&#8217;s recurrence necessitated further investigation, leading the patient&#8217;s healthcare team to seek out more comprehensive testing with Caris. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:63pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Caris WES/WTS report revealed a significant finding: an FGFR fusion, which is a genetic alteration that can disrupt normal cell signaling and lead to cancerous cell growth, found in the patient&#8217;s RNA. Despite the challenges posed by the tumor&#8217;s recurrence, Caris&#8217; ability to detect this actionable variant offered hope for potential targeted therapies, including the National Cancer Institute-Children&#8217;s Oncology Group Pediatric MATCH trial* for pediatric patients with advanced, recurrent solid tumors. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:53.5pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;border-bottom:0.75pt solid #000000; ;padding:2pt 0pt 6pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This case demonstrated the critical role of comprehensive molecular profiling of both the DNA and RNA. By leveraging advanced testing methodologies such as WES and WTS, the provider was able to uncover potentially life-saving treatment options for this patient facing a challenging diagnosis,high-grade astrocytoma.</div>
            </td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:36pt; margin-top:11.2pt; width:420pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Signatures</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to individual gene alterations, profiling can provide information on specific patterns or combinations of molecular features that might otherwise be challenging to detect. These molecular signatures may be associated with particular cancer types, prognoses, or therapeutic responses. Examples of molecular signatures include: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">TMB</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;TMB is a measurement of the number of somatic mutations per megabase of DNA sequenced. A high TMB is used as a biomarker for the selection of certain checkpoint inhibitors to treat solid tumors. WES is the gold standard for measuring TMB as it covers the entire coding region of the genome. Measurements derived from targeted panels or comprehensive genomic profiling, on the other hand, vary significantly from panel to panel due to variable and incomplete coverage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Microsatellite instability (&#8220;MSI&#8221;)</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;MSI testing measures the ability of a cell to repair mistakes in DNA replication. Defective mismatch repair caused by alterations in mismatch repair genes is associated with elevated mutation rates in areas where short DNA sequences of base pairs are repeated. These areas are referred to as microsatellites. MSI analysis can identify candidates for immunotherapy or MSI-indicated clinical trials and diagnose Lynch Syndrome in colon and endometrial cancers. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Genomic loss of heterozygosity (&#8220;gLOH&#8221;)</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Loss of one copy of a genomic region, known as gLOH, may cause tumor suppressor gene inactivation, thereby promoting cancer development. gLOH is indicative of a form of defective DNA repair called homologous recombination deficiency. When a tumor exhibits DNA repair mechanism impairment, drugs targeting a secondary repair pathway can kill tumor cells without harming normal cells, a phenomenon called synthetic lethality. Thus, gLOH is a biomarker for therapeutic response to poly adenosine diphosphate-ribose polymerase (&#8220;PARP&#8221;) inhibitors which target the single-strand break DNA repair pathway. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Homologous recombination deficiency (&#8220;HRD&#8221;)</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Related to gLOH, inefficient repair of damaged DNA via homologous recombination can contribute to the development of cancer. HRD often results from aberrations in key DNA repair genes, including BRCA1 and BRCA2 genes, ataxia telangiectasia mutated (&#8220;ATM&#8221;), PALB2, and CHEK2, and is associated with increased sensitivity to PARP inhibitors, as above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">https://www.cancer.gov/about-cancer/treatment/nci-supported/pediatric-match</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:1.97000000000003pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">141</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">WES/WTS Offers a Complete Molecular Blueprint from the Beginning and Provides Value across the Patient Journey</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">WES/WTS streamlines the patient experience and clinical decision-making and offers increased value to patients, physicians, and payers. We believe WES/WTS provides the most efficient and cost-effective way to obtain the maximum information on a patient&#8217;s cancer at the start of the patient journey, potentially identifying additional mutations and expanding treatment options compared to sequential targeted panels. Through the use of WES/WTS, we believe we have significantly reduced the need for a trade-off between time and information, two valuable resources in oncology that have historically come at the expense of one another, particularly when relying on sequential targeted panels, due to cancer&#8217;s rapidly progressive nature. In a single test, we believe WES/WTS provides substantially all the relevant information needed for physicians to make the best-informed clinical decisions for their patients and does so in less time than running multiple DNA or RNA single or targeted panels sequentially. While using comparable tissue, WES/</font>&#8203;<font style="letter-spacing:0.2pt;">WTS enables accurate identification of a greater number of actionable genomic alterations that can be leveraged to match patients to the most effective treatments, yielding a higher probability of response and providing comprehensive predictive and prognostic information. Furthermore, the benefits conferred by WES/</font>&#8203;<font style="letter-spacing:0.2pt;">WTS have the potential to extend across the healthcare ecosystem, beyond patients and their clinicians. By supporting WES/WTS, payers can reduce waste and harm from suboptimal treatment selection and resulting over-treatment and/or misdiagnosis. </font></div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">WES/WTS can also inform on acquired resistance to treatments and suggest potential synergistic therapy combinations, as well as providing substantial clinical benefit to patients with cancer of unknown origin or rare cancers. Additionally, by taking a tumor-agnostic approach compared to using tumor-specific panels, WES/WTS can detect biomarkers that have targeted therapies in other cancer types, indicating the potential to apply those drugs more broadly. Armed with these molecular insights, clinicians can identify the most suitable therapies and trials available to their patients today. Having a full molecular blueprint </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> also facilitates future use of newly approved biomarkers and therapies. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We also operate a Look Back Program that leverages our comprehensive WES/WTS to provide long-term clinical insights that help oncologists optimize patient care and identify patients that may be eligible for newly approved biomarker-driven therapies without the need for additional testing. When a novel therapy receives approval, our team reviews all of our recent clinical sequencing results to identify previously tested patients who sequencing results match the new therapy&#8217;s criteria. Through our molecular science liaisons (&#8220;MSLs&#8221;), we then contact treating physicians to ensure they are aware of these newly approved treatment options for their patients. Many clinicians may not be aware of evolving biomarker-driven therapies, and our Look Back Program bridges this gap by providing updated insights. By conducting comprehensive molecular testing upfront, the need for repeat testing is significantly reduced when new drug approvals or indications arise. This ensures timely treatment decisions, increasing the likelihood of patients receiving effective, biomarker-driven therapies. Through the Look Back Program, Caris empowers oncologists with continuous, data-driven insights that enhance patient outcomes and drive precision oncology forward. Since 2023, we have used this program to identify 556 patients that may benefit from Trastuzumab and Teucatinib for HER2+/KRAS wildtype colorectal cancer, 134 patients that may benefit from Talazoparib + Enzalutamide HRR deficient prostate cancer, 233 patients that may benefit from Reptrectinib for cancers with NTRK gene fusions, 1,737 patients that may benefit from Capivasertib for PIK3CA, AKT1 or PTEN-mutated HR+/HER2- breast cancer and 78 patients that may benefit from Zenocutuzumab for cancers with NRG1 fusions and 1,847 patients that may benefit from Trastuzumab Deruxtecan for Her2 Score 0 HR+ breast cancer. We have not broadly marketed our Look Back Program, but we use it in payer-facing materials to highlight the advantages of our WES/WTS platform. </font>
        </div>
        <div style="text-indent:36pt; margin-top:5pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Aside from its clinical benefits, WES/WTS is also a powerful research tool for identifying new predictive biomarkers. For example, pancreatic ductal carcinoma currently has the worst prognosis among common cancers&#8212;a situation compounded by a scarcity of predictive biomarkers and therapeutic targets. In a recent study, a comprehensive profiling approach involving WES and WTS sequencing was used to identify novel potential markers and targets for this cancer. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">142</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:36pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below compares targeted panels with WES/WTS. </font>
        </div>
        <div style="position:relative;margin-top:10.3pt; text-align:center; width:456pt;">
          <img src="tb_panels-4c.jpg" alt="[MISSING IMAGE: tb_panels-4c.jpg]" height="451" width="603" >
        </div>
        <div style="margin-top:17.59pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Convergence of NGS, AI/ML Technologies, and High-Performance Cloud Computing</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NGS can generate vast amounts of genomic data. The availability of large libraries of molecular data for each individual patient is creating exciting opportunities for research in the diagnosis, treatment, and early detection of cancer, especially when paired with a patient&#8217;s clinical data. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">AI can be used to mine these large volumes of data to address complex biological questions and has the potential to deliver new insights and bring precision medicine into mainstream clinical care. ML is an AI approach that focuses on applications that learn from experience and large amounts of data to improve decision-making and predictive accuracy over time. While this is a promising field of research and clinical activity, there are significant challenges to achieving the promise of AI in cancer&#8212;specifically, generating accurate and broad molecular information to underpin algorithms. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accuracy of predictions made by AI/ML algorithms is highly dependent upon the accuracy and breadth of the underlying data used for training the AI/ML algorithms, analytically validating those algorithms, and applying the algorithms on real world data to make predictions. The accuracy of NGS-based genomic data is highly correlated to the depth of coverage of sequencing of the samples. Depth of coverage refers to the number of times a nucleotide is sequenced. A greater depth of coverage increases the confidence in the final results and allows for differentiation between sequencing errors and single nucleotide polymorphisms. A high depth of coverage is especially useful when a tumor is heterogeneous for specific mutations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ability to conduct research on genomic data using AI is also highly dependent on the number of genes being tested. Complex diseases are the result of multiple genomic alterations including point mutations, translocations, amplifications, and/or deletions. Cancers with more malignant properties and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">143</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">poorer prognosis are generally associated with larger numbers of genomic alterations. To accurately conduct research using AI, a large number of genes need to be tested and included in a given data set. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cloud-computing architecture has enabled massive scalability and distributed real-time collaboration across industries. In addition, it has created opportunities for greater cost efficiency for the storage, processing, and analysis of previously unmanageable amounts of data. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Caris platform was purpose-built to leverage the convergence of NGS, AI and ML technologies, and high-performance computing. </font>
        </div>
        <div style="position:relative;margin-top:10.1pt; text-align:center; width:456pt;">
          <img src="pc_unique-4c.jpg" alt="[MISSING IMAGE: pc_unique-4c.jpg]" height="434" width="578" >
        </div>
        <div style="margin-top:17.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limitations of Molecular Testing Today</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the molecular revolution has already changed the way cancer is being diagnosed and treated, we believe that molecular testing faces several major challenges in its current form, which have hindered broader adoption of precision oncology. These challenges include: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Targeted panels are subject to missing information and significant variability.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Targeted panels test for only a small portion of all cancer-associated genomic alterations. As a result, they can miss critical clinically actionable information. This information deficit can lead to suboptimal treatment decisions and/or the need for further testing, requiring increased patient sample, time, and expense. Further, the treatment landscape in oncology continues to rapidly evolve, with new agents and their cognate predictive biomarkers entering clinical trials and achieving regulatory approval. This renders targeted panels insufficient to account for newly implicated cancer genes absent re-development and validation of such panels. Using broad sequencing approaches with WES and WTS enables comprehensive identification of information to effectively treat a patient. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Lack of consistent RNA profiling.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;RNA, which is transcribed from DNA, can better represent which genes are actively involved in cancer. By including both DNA and RNA </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">144</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">coverage, we believe Caris captures more tumor-informed information than others in the market, leading to more accurate and comprehensive molecular profiling results for the physician and patient. This approach includes enhanced sensitivity for gene fusions with the incorporation of RNA, as well as the deployment of multi-gene signatures that use RNA to support predictive and prognostic endpoints. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Lack of clonal hematopoiesis derived variant subtraction technology in current blood assays.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Blood is comprised of two major components that are pertinent to patient testing: plasma and the buffy coat (a concentration of white blood cells). Most liquid biopsy providers analyze only the plasma. This is suboptimal as a plasma-only approach is unable to identify false positive mutations derived from clonal hematopoesis (&#8220;CH&#8221;) variants and that are not tumor-derived. CH mutations are common aging-related non-malignant mutations that occur in a substantial portion of the population and are not drivers of solid tumors but contribute to the formation of a genetically distinct subpopulation of blood cells. If CH mutations are not distinguished from tumor-derived mutations, it can lead to therapy selection targeted at a mutation that is present in the white blood cells instead of in the tumor, which is not beneficial for the cancer patient. Because of the prevalence of CH mutations, we believe that CH subtraction is of critical importance to optimal cancer care. Other liquid biopsy tests currently on the market cannot definitively distinguish CH mutations from tumor-derived mutations because they do not sequence the white blood cells. Caris Assure incorporates CH subtraction, resulting in fewer false positives and representing a differentiated ability to drive improved and more effectively targeted therapy selection. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Disparate data sets collected across testing modalities.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Currently, liquid biopsy providers do not offer a single blood-based testing solution across the continuum of cancer care. Instead, the use of different assay technologies across different applications and settings results in the accumulation of non-uniform data sets, which are difficult to leverage and interpret across a patient&#8217;s comprehensive care journey. We utilize a novel approach consisting of a single wet-lab test across the cancer treatment continuum, with consistently-generated uniform datasets. The elegant simplicity of a single test paired with a comprehensive assessment of the patient&#8217;s DNA and RNA allows Caris Assure to be this integrated diagnostic solution. This approach allows many more datapoints to be assessed, enabling us to select those markers that we believe provide the greatest potential for sensitivity, specificity, and overall accuracy of our test and capture the dynamic nature of biological processes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Logistical drawbacks and sensitivity limitations of current MRD assays.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;There are several limitations with current MRD approaches. Traditional tumor-informed approaches struggle with logistical drawbacks, which include needing to sequence primary tumor tissue first and experiencing long turn-around times due to the creation of a bespoke panel. Further, current tumor-informed MRD tests also limit their sensitivity by the small number of tracker mutations utilized. Because sensitivity is proportional to the numbers of tumor-derived alterations that are tracked over time, limiting to a small number of mutations artificially limits sensitivity. Currently deployed tumor-na&#239;ve approaches, while logistically superior, also limit their sensitivity by using a targeted panel of genes and do not encompass the myriad of tumor-derived signals present in the circulation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">False positives and a lack of early-stage sensitivity with current multi-cancer early detection assays.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Multi-cancer early detection (&#8220;MCED&#8221;) testing holds significant promise to make improvements in overall survival by detecting cancers at their earliest stages when they are most treatable. However, significant limitations exist with current assays. Their high rate of false positives when used in an average-risk population is notable. This leads to unneeded and costly diagnostics, such as imaging and biopsies. Also, a lack of early-stage sensitivity for many tumor types inhibits current MCED testing assays&#8217; clinical utility. As seen in our data, the use of Caris Assure and our Assure Blood-based Cancer Detection ai (&#8220;ABCDai&#8221;) algorithm leverages detection of a wide swath of cancer-derived analytes, resulting in significantly higher Stage I/II sensitivity while mitigating false positives by maintaining high specificity. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a result of these challenges, clinicians may make critical treatment decisions based on incomplete and/or inaccurate information and analytics, potentially resulting in suboptimal outcomes. We believe that </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">145</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">our comprehensive molecular profiling solutions and the data generated by our multi-omic technology platform is well-suited to address the limitations and challenges of today&#8217;s molecular testing alternatives. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Market Opportunity and Vision for Leveraging Molecular Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe we are well-positioned to pursue a very large market opportunity through the provision of precision medicine solutions across the entire cancer care continuum, as well as offerings to support biopharma drug discovery and development. Broad, deep, and consistent molecular information is expected to drive better clinical outcomes for patients and more efficient and effective drug discovery and development for biopharma companies. We believe our expansive multi-omic technology platform has application across multiple clinical and biopharma settings that collectively represent an estimated total addressable U.S. market of approximately $150&#160;billion in oncology, according to a market study by Nephron Research LLC (&#8220;Nephron Research&#8221;) that we commissioned. </font>
        </div>
        <div style="position:relative;margin-top:10.99pt; text-align:center; width:456pt;">
          <img src="pc_unlocking-4c.jpg" alt="[MISSING IMAGE: pc_unlocking-4c.jpg]" height="439" width="585" >
        </div>
        <div style="margin-top:18.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Early Detection of Cancer in the Asymptomatic Population</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The availability of an MCED blood-based profiling solution offers the potential to augment and disrupt the standard of care in preventative cancer screening. Preventative cancer screening today is limited to a small group of high prevalence cancers, including cervical, breast, colon, lung, and prostate cancers. Low adherence rates are common among patients with several of these cancers due to challenges related to socioeconomic status, age, personal attitudes and beliefs, awareness gaps, and lack of access to healthcare facilities and social support, among other factors. For example, the American Lung Association estimates that in 2021, there were approximately 14&#160;million high-risk individuals in the United States who were eligible for lung cancer screening using low-dose CT scans yet only approximately 0.6&#160;million screenings were completed, representing a dismal screening recommendation adherence rate of 4.5%. An MCED blood-based profiling solution that entails a minimally invasive blood draw could expand the reach of testing to more cancers and drive higher adoption in this market. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">146</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe screening offers the greatest benefit for individuals aged 45 to 75&#160;years given the prevalence of cancer and potential for improved outcomes and reduction in cancer mortality within the U.S. population. Based on U.S. Census Bureau data, the 45 to 75&#160;years-old cohort who would benefit from screening for cervical, breast, colon, lung, and prostate cancers based on the recommendations of the U.S. Preventive Services Task Force (&#8220;USPSTF&#8221;), an independent body of experts that makes evidence-based recommendations for cancer screening, represents approximately 112&#160;million people in the United States. Clinical unmet needs in this population include low patient adherence, poor performance, and lack of screening options for a majority of cancer types. Access to liquid biopsies that are reliable and can detect multiple cancer types should drive greater access and penetration of the early detection market, with early detection liquid biopsy solutions supplementing or in certain instances replacing existing screening modalities. Based on the estimated size of the cohort of individuals aged 45 to 75&#160;years who would benefit from cancer screening per the above-referenced guidelines, and assuming pricing of at least $900 for a high-quality MCED liquid biopsy solution (based on cash pay pricing for existing available liquid biopsies), the estimated total addressable U.S. market for early detection of cancer using liquid biopsy is approximately $100&#160;billion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Therapy Selection for Cancer Patients</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Patients with advanced and metastatic solid tumors are recommended to undergo molecular profiling to identify predictive markers for patients likely to benefit from certain approved biomarker-linked therapies. Molecular profiling of patients through either tissue biopsy or blood-based liquid biopsy allows physicians to identify a cancer&#8217;s targetable alterations. These molecular insights, particularly when generated through comprehensive molecular profiling, enable the tailoring of therapy to patients likely to benefit, while sparing exposure, toxicity, and cost for those who will not. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the ACS, approximately 780,000 of the two&#160;million patients in the United States who are newly diagnosed with cancer each year are found to have advanced-stage solid tumor cancers at initial diagnosis. The ACS also estimates that there are 16.5&#160;million cancer survivors in the United States, approximately 4.3%, or 710,000, of whom are expected to relapse annually. Based on National Comprehensive Cancer Network (&#8220;NCCN&#8221;) guidelines suggesting that breast and lung cancer patients would benefit from at least two tests during therapy, and assuming that these benefits would apply to other types of solid tumors, Nephron Research estimates that approximately 520,000 newly-diagnosed advanced stage and recurrent cancer patients in the United States would benefit from repeat testing. Additionally, turnaround time for a blood test is typically shorter, but tissue tests are often more comprehensive so physicians will often order both a tissue test and a blood test. Accordingly, based on the newly-diagnosed patient, recurrent patient, and repeat testing patient cohorts described above, Nephron Research estimates that the total addressable U.S. market for therapy selection is comprised of approximately two&#160;million unique patient profiles annually and, assuming an average reimbursement of approximately $4,000 based on blended Medicare, commercial payer, and Medicaid coverage rates for various genomic profiling tests, amounts to approximately $8&#160;billion. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Nephron Research analysis, the number of annual unique patient profiles is expected to increase with clinical and payer adoption of broad molecular testing in earlier stages for newly-diagnosed cancer patients. The study also suggests that a majority of the market is currently being tested by either single gene tests or targeted testing for a low number of biomarkers recommended under NCCN guidelines and is currently approximately 30% penetrated by broad molecular testing (both tissue and blood) using broad panels (50 or more genes). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Minimal Residual Disease Tracking and Treatment Monitoring for Cancer Patients and Survivors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the ACS, approximately 1.3&#160;million of the 2&#160;million patients in the United States who are newly diagnosed with cancer each year are found to have non-metastatic cancer. We believe MRD tracking and recurrence testing is most applicable to patients within this cohort. Patients in the non-metastatic cancer cohort are expected to be monitored during their treatment journey and beyond for up to five&#160;years for recurrence, including MRD testing for patients who underwent surgery for their cancer. In addition, patients with metastatic cancer are expected to receive treatment monitoring tests during their treatment journey. According to the Nephron Research analysis, these result in a cohort of approximately 5.6&#160;million patients being monitored at various points in their treatment journey. Assuming a range of two to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">147</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">three tests annually for each patient, consistent with MolDX coverage policy for MRD, pricing of $2,500 per reference test and $1,650 per follow-up blood test, in each case based on pricing for other tests available on the market, Nephron Research estimates that the total addressable U.S. market for MRD tracking tests represents approximately 16&#160;million tests annually and amounts to approximately $28&#160;billion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Core Biopharma: Profiling Services for Biopharma Drug Development and Commercial Testing</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Key services relevant for biopharma companies include prospective and retrospective profiling services, companion diagnostics development, and commercial services that include identification of patients for approved therapies. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the Nephron Research analysis, oncology testing associated with clinical trials includes approximately 250,000 cancer patients in targeted therapy clinical trials. Assuming five tests (one therapy selection test to establish cancer type and determine the therapeutic intervention(s) and four monitoring tests for follow-up consistent with typical trial designs) for each trial participant and pricing of $5,000 per therapy selection test and $1,950 per monitoring test, based on existing reimbursement rates for other tests available on the market, Nephron Research estimates that the addressable U.S. market for oncology testing in clinical trials is approximately $3.2&#160;billion. The development of companion diagnostics tests and the identification of patients for commercial targeted therapies are both attractive opportunities for molecular information-based services. Assuming approximately&#160;25 Phase 1b trials progress to Phase 2 each year based on recent historical data from ClinicalTrials.gov, with each trial having two partners per customary industry practice (a&#160;specialty lab and a distributable kit) and an average contract price of $10 million based on Nephron Research&#8217;s market analysis, the addressable U.S. market for the development of companion diagnostics tests is estimated to be approximately $500 million. For rare biomarkers, biopharma sponsors generally will reimburse laboratories that can help identify patients as candidates for their therapeutics. Assuming a rate of rare mutation of 4.0% within the population of newly-diagnosed cancer patients in the United States with advanced-stage solid tumor cancers, based on data from the National Institutes of Health, and an average reimbursement per patient of $10,000 based on Nephron Research&#8217;s market analysis, the addressable U.S. market for commercial services that include identification of patients for approved therapies is estimated to be approximately $300&#160;million. Accordingly, the estimated total addressable U.S. market for core biopharma services is approximately $4.0&#160;billion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Data Services for Biopharma Research and Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Matched genomic data has demonstrated use cases for biopharma applications across discovery, drug development, and clinical trial execution. Biopharma companies leverage multi-modal genomic data, including data they license, to identify key molecular characteristics of a particular disease or dysfunction that drives disease, enabling signature identification and drug target discovery. The valuable insights provided by multi-modal genomic datasets help biopharma companies identify optimal patient populations for therapeutic development and also help inform trial design, validate biomarker strategies, and assess execution feasibility of oncology clinical trials. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to Evaluate Pharma, global spending on pharmaceutical R&amp;D by biopharma companies grew from an estimated $145 billion in 2014 to an estimated $262&#160;billion in 2023. According to the Nephron Research analysis, it is estimated that approximately $70 billion of the $262 billion spent in 2023 represented R&amp;D investments in discovery, pre-trial costs, and real-world evidence, areas where matched genomic data has demonstrated use cases for biopharma applications. We expect biopharma companies to continue increasing the allocation of their total R&amp;D investment towards multi-modal genomic data and bioinformatics services to increase efficiency and development success rates. Based on Nephron Research&#8217;s market analysis, approximately 14% of the estimated $70 billion in R&amp;D investments in 2023 was allocated towards such data and services, resulting in an estimated total addressable U.S. market for this opportunity of approximately $10&#160;billion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Disease States Beyond Oncology</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe there is a large market opportunity for our platform in other chronic disease states beyond oncology, including cardiology, neurology, and metabolic conditions. This begins with a fundamental premise that approaching blood-based disease detection with a comprehensive WES/WTS approach </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">148</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:224.69pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">enables examination of biomarkers that go beyond oncology. It is already well known that other disease states have blood-based genomic markers that can be used for diagnostic assessment. The increasing role of CH in cardiovascular disease and neurology further buttress this approach. In cardiology, the first natural bridge exists in the field of cardio-oncology where, for example, biomarkers to predict cardiotoxicity to commonly used therapies could be implemented to help mitigate adverse events. In addition, the deployment of cardiovascular disease risk based on CH mutations could be used to augment early detection efforts. In neurology, disorders such as Alzheimer&#8217;s or Parkinson&#8217;s disease are difficult to diagnose, as the same symptoms manifest in different combinations across different disorders. Symptoms of one condition may often be similar to that of another, leading patients down the path of a &#8220;diagnostic odyssey.&#8221; The diagnosis involves tests such as CT scan, electroencephalogram, magnetic resonance imaging, electromyography, nerve conduction velocity, positron emission tomography, angiogram, spinal tap, myelogram, neurosonography, and ultrasound, among others. Personalized medicine and targeted therapies do not exist today for CNS disorders, however there is general consensus that detecting symptoms early and intervening can slow the development of disease. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Caris Platform</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We are leading a molecular revolution and developing the latest generation of advanced precision medicine information solutions that we believe have applicability across the care continuum for a broad range of conditions. The fundamental differentiation of the Caris platform and our business model is the depth, breadth, and scale of data, including how that data is integrated vertically and horizontally across our business, as well as the resulting innovation which it fuels. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our multi-omic technology platform is built on the following pillars: (1)&#160;Caris Assure; (2)&#160;MI Profile; (3)&#160;Caris Discovery; (4)&#160;Caris Strategic Data; and (5)&#160;Caris Infrastructure. These five pillars are designed to work together to create a virtuous cycle that can enable continued innovation and improved impact for patients and physicians. We believe our comprehensive approach to profiling will continue to drive demand for our genomic profiling capabilities, leading to further expansion of our clinico-genomic datasets, which provide additional valuable inputs to develop and enhance our solutions, with the ultimate goal of contributing to improved patient results. We believe this continuing cycle will deepen our competitive advantage and allow us to achieve meaningful innovation and business success in precision oncology, while illuminating a path to precision medicine for other chronic disease states, including cardiology, neurology, and metabolic conditions. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">149</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="pc_platform-4c.jpg" alt="[MISSING IMAGE: pc_platform-4c.jpg]" height="438" width="584" >
        </div>
        <div style="text-indent:36pt; margin-top:12.8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe our growth and competitive differentiation are driven by the five pillars of our platform, each of which are both a product of the upstream data and a foundation to further innovation and data generation across the platform: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Assure</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Our universal blood-based WES/WTS profiling solution is designed to deploy a single assay across the entire continuum of cancer care, including early detection, MRD tracking, therapy selection, and treatment monitoring, and generates over 42&#160;billion datapoints, spanning 168,000 molecular markers, per clinical case. We leveraged our experience and data from MI Profile to create Caris Assure, which enables us to understand how a patient&#8217;s disease started, what therapies the tumor may be sensitive to, how the tumor is transforming to resist therapies, and how best to control or cure the disease. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">MI Profile</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Our tissue-based profiling solution for therapy selection includes our comprehensive WES/WTS profiling assay and IHC protein expression testing. Our WES/WTS profiling solution generates over 28.8&#160;billion datapoints, spanning 84,000 molecular markers, per clinical case. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Discovery</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;The combination of our data and our AI enables us to discover previously unknown drug targets for antibody-directed therapies (such as antibody drug conjugates, degrader-antibody conjugates, and T-cell engagers), small molecules, targeted protein degradation, synthetic lethal interactions, and cell therapy. In addition, we believe Caris Discovery is well-positioned for neoantigen discovery for personalized therapy development given our ability to detect variants, insertions, and deletions by WES and to assess gene expression and detect fusions by WTS on every patient&#8217;s tumor. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Strategic Data</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;As of March 31, 2025, we have run more than 6.5&#160;million tests that have measured over 38&#160;billion molecular markers from over 13 quadrillion datapoints. To assist us with analyzing the data we generate, we utilize over 220 AI and AI/ML tools across our clinical testing, R&amp;D, and biopharma business. These tools include over 50 clinical sequencing </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">150</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">automation and variant calling AIs, over 100 RNA expression AI signatures, approximately 20 multi-omic AI/ML therapy response predictors, two ADAPT target discovery AI/ML algorithms, 37 digital image AI/ML classifiers, and 12 AI/ML support tools. We have used our datasets to create many of these algorithms and signatures. The breadth and depth of our data assets, together with our demonstrated ability to use them to create algorithms and discover signatures, represent a deep competitive moat for us. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Infrastructure</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;We have a well-developed laboratory, R&amp;D, and sales infrastructure that we believe is foundational to our business. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:72pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:92pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Operational Capacity</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We have substantial testing capacity, including over 275,000 square feet of space across four precision medicine laboratories with throughput capabilities of over one trillion reads per day generated by 50 NovaSeq sequencing systems. We believe this capacity provides us with ample capability to manage our current operations and future growth. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:72pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:92pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Research and Development</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We have a dedicated R&amp;D infrastructure, including a specialized laboratory and over 200 employees dedicated to R&amp;D efforts. In addition to our internal research, we regularly partner with outside academic centers and researchers. The Caris POA, which we established in 2015, is a growing network of leading cancer centers and research consortia across the globe that supports research partner engagement, collaboration opportunities, and the advancement of precision oncology research. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:72pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:92pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Commercial Channel</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;To support our sales activity and expansion, as of March&#160;31, 2025, we have assembled a targeted sales organization in the United States of over 270&#160;sales team members and nearly 50 highly trained Ph.D. or M.D. MSLs who focus on physician and provider education. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Caris Advantage</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe our approach is differentiated and we have a competitive advantage because: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">We purpose-built our Caris platform to put the patient first and make comprehensive precision medicine a reality</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our patient-centric ethos has guided us since inception. This guiding principle underpins our belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights would realize the potential of precision medicine, driving superior patient outcomes. Our approach, which includes deep sequencing all DNA encoding genes and RNA transcripts, maximizes the molecular information generated for each clinical case and enables us to analyze and provide patients and physicians with industry-leading breadth, depth, and accuracy of multi-omic information. By providing a high-quality, individualized molecular blueprint of a patient&#8217;s disease, our platform is designed to enable the discovery, development, and application of cutting-edge precision medicine that pushes the boundaries of current science. This differentiated approach has made Caris a destination for KOLs and clinicians seeking the most complete and accurate information available for treating their patients. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">We are a leading provider of tissue-based molecular profiling, including through our FDA-approved companion diagnostic tissue-based profiling solution, MI Cancer Seek</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;MI Profile is a leading tissue-based molecular profiling solution for therapy selection, with over one million tests performed on approximately 146,500 clinical cases in 2024, which represents a 31.2% compound annual growth rate in clinical tissue case volume since 2018. MI Profile consists of a WES and WTS NGS component, IHC analysis, and AI/ML analysis to identify the origin of a tumor for 90 unique cancer types with approximately 95% accuracy. This comprehensive solution assists clinicians in identifying patients who may benefit from treatment with specific targeted therapies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Our novel, universal blood-based profiling solution, Caris Assure, is unique in the market and poised for rapid adoption</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We believe our leadership in tissue molecular profiling uniquely positions us to capitalize on the increased use of blood-based profiling and adoption into </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">151</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">clinical practice with Caris Assure, our novel, universal blood-based solution that is purpose-built to extend across the entire cancer care continuum and to therapeutic development by generating over 42&#160;billion datapoints per clinical case. We built upon the data we have generated to date with MI Profile and believe our data is a significant competitive advantage in the development and clinical utility of Caris Assure. Caris Assure naturally enriches our AI/ML algorithms and transfers learning across the care continuum, yielding greater sensitivity and specificity, while continuously expanding our longitudinal patient datasets. Moreover, we believe that our single-test approach will enable us to scale our R&amp;D infrastructure to analyze increasingly large testing volumes, process expanding datasets, and reach economies of scale in liquid biopsy. To our knowledge, we have developed and launched the most informationally rich blood-based solution in the market. We have Medicare reimbursement and various levels of commercial payer adoption and/or reimbursement coverage for Caris Assure for therapy selection across the United States (other than New York State). </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">We have built what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our proprietary oncology clinico-genomics datasets provide insights into the fundamental building blocks of disease, potentially enabling breakthroughs from targeted therapies to truly personalized medicine. Our ever-expanding datasets include data generated from more than 6.5&#160;million tests that have generated measurements of over 38&#160;billion molecular markers from over 13 quadrillion datapoints as of March 31, 2025, as well as matched clinical outcomes for many of these patients. Our platform generates over 111&#160;million reads per clinical case, and each new case further expands our datasets allowing us and our biopharma partners to generate even more clinically relevant insights. We also expand and enrich our datasets through partnerships that add real-world evidence, longitudinal patient data, and clinical outcomes. The breadth and depth of our large and growing data assets represents a deep competitive moat for us, overcoming which requires significant capital investment, scaled sequencing capacity, acquisition of patient samples, and generation of corresponding clinical outcomes data. These significant data assets enable us to effectively deploy our proprietary AI/ML algorithms to analyze patient information and empower our customers to make better informed diagnoses and treatment decisions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:55pt; margin-top:8pt; width:401pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Caris platform is designed to create a virtuous cycle that can enable continued innovation and improved impact for patients and physicians. We believe our comprehensive approach to profiling will continue to drive demand for our genomic profiling capabilities, leading to further expansion of our clinico-genomic datasets, which provide additional valuable inputs to develop and enhance our solutions, with the ultimate goal of contributing to improved patient results. We believe this continuous feedback loop will allow us to achieve meaningful next-generation innovation in precision oncology as well as other chronic disease states. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Our first mover advantage, specialized commercial channel, robust infrastructure, and deep research collaborations enable our leadership and provide us with the ability to scale for future growth</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We believe we will be the first provider to achieve leadership in both solid tumor and liquid biopsy profiling solutions across the entire precision oncology care continuum. To support our sales activity and expansion, we have built a commercial organization specialized in precision oncology consisting of approximately 270 team members as of March 31, 2025, plus nearly 50 highly trained Ph.D. or M.D. MSLs, serving over 5,600 physicians in the United States across all major health systems, academic cancer institutions, and community settings. Due to the increased market acceptance of our solutions, we have achieved revenue growth and case volume growth without growing the aggregate sales headcount over the last three years.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:55pt; margin-top:8pt; width:401pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our robust infrastructure includes a team of over 60 Caris data scientists to decipher unique features from our datasets generated from millions of tests. We operate two precision medicine laboratories in Phoenix, Arizona, and one R&amp;D laboratory in Tempe, Arizona. Our Arizona laboratories all utilize state-of-the-art genomic sequencing technology, including 50 NovaSeq sequencing systems, with capacity to perform more than one trillion &#8220;reads&#8221; daily. Our newest laboratory facility in Irving, Texas, near our headquarters, is continuing to be built-out and will bring our total operational capacity to over 275,000 square feet. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">152</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:55pt; width:401pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since its establishment in 2015, the Caris POA, whose members work together to establish and optimize standards of care for molecular testing through innovative research to improve clinical outcomes for cancer patients, has grown to comprise 96 members as of March 31, 2025, including 45 NCI-designated comprehensive cancer centers. This academic-industry collaborative network has been exceptionally productive with over 145 peer-reviewed manuscripts published since the beginning of 2022. Close connectivity with this vast network of KOLs in oncology clinical care, research, and drug development has enabled us to remain at the forefront of precision oncology and closely attuned to the key needs of the most sophisticated researchers. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">We are led by a founder with significant experience building and scaling businesses in the healthcare industry and a management team with scientific expertise</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our management team has deep domain expertise in molecular biology, oncology, artificial intelligence, data science, medicine, and genomics and have a track record of delivering innovative, high clinical utility solutions to the market. Our management team is highly entrepreneurial and has significant experience leading and operating large multi-national organizations and building innovative healthcare companies. In particular, our Founder, Chairman, and Chief Executive Officer, David D. Halbert, has successfully built and scaled profitable enterprises for approximately 40&#160;years, including AdvancePCS Inc. (acquired by CareMark in 2004 for $7.5&#160;billion), and Caris Diagnostics (acquired by Miraca Life Sciences in 2011 for $725&#160;million), among others. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Strategies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As we execute on our vision, we will continue to put the patient first. Our solutions provide physicians and individual patients with actionable information throughout the disease journey, while contemporaneously generating data that can be aggregated and leveraged to unlock academic and biopharma scientific breakthroughs, which may lead to curative therapies for future generations. To achieve our goal of leading a molecular revolution and developing the next generation of precision medicine information solutions for a broad range of conditions across the care continuum, we plan to: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Drive the continued adoption and use of our tissue-based profiling and expand our blood-based profiling offering into early detection, MRD, and monitoring</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;MI Profile continues to be one of the most comprehensive tissue-based molecular profiling solutions available. We plan to leverage our leadership with MI Profile and our proprietary clinico-genomics datasets, to drive the adoption of blood-based profiling with Caris Assure, our highly differentiated, comprehensive multi-omic liquid biopsy solution. We believe Caris Assure will address the significant unmet need across the entire cancer care continuum, with solutions for early detection, MRD tracking, therapy selection, and treatment monitoring. Broadly launched in the first quarter of 2024 for therapy selection, we have seen over 3,400 physicians from over 480&#160;institutions order Caris Assure for therapy selection through March 31, 2025. We intend to leverage our existing commercial infrastructure, including our substantial testing capacity across two precision medicine labs and our specialized commercial channel, to support the continued launch and commercialization of Caris Assure. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Utilize the data generated by our existing solutions to develop new solutions with additional revenue using our existing sales channel</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We will leverage our clinico-genomic datasets to identify novel AI-based molecular signatures that are predictive of a patient&#8217;s clinical journey. This will allow us to reach new patient populations at earlier stages of cancer, who may not be eligible for our current solutions. We are currently using an AI/ML approach driven by H&amp;E slide images and clinical results data from more than 10,000 breast cancer patients to develop ESPai, a new algorithm to predict the risk of disease recurrence for early-stage breast cancer patients. We have obtained the samples and clinical data from the National Surgical Adjuvant Breast and Bowel Project and the ECOG-ACRIN Cancer Research Group. We are currently in the process of creating two AI/ML models for ESPai using these samples and are working to obtain additional samples for external validation studies. We are initially creating a model for late recurrence (five to 15 years following diagnosis), but we are also in the beginning stages of creating a model for early recurrence (zero to five years following diagnosis). The ability to deliver results to patients who would otherwise require multiple tests, or for whom testing would </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">153</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">not be a possibility, further differentiates us and provides significant value to patients and their physicians. This business model, possible only through our testing platform and the comprehensiveness of our underlying data, has created a new category of operational efficiency centered around patient care as shown below: </font>
        </div>
        <div style="position:relative;margin-top:9.7pt; text-align:center; width:456pt;">
          <img src="pc_strategic-4c.jpg" alt="[MISSING IMAGE: pc_strategic-4c.jpg]" height="447" width="596" >
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:8.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:8.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Leverage our platform to provide solutions to biopharma companies to drive advances in personalized medicine and accelerate the development of novel therapeutics</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We partner with biopharma companies to improve the efficiency and success of their therapeutic development and clinical programs by leveraging our platform. We provide prospective and retrospective profiling services, companion diagnostics development, data licensing, and commercial services that include identification of patients for approved therapies. Our biopharma business continues to gain significant momentum, with $63.1&#160;million of revenue generated in 2024, representing a 130.3% increase compared to the prior year. A key strategy for future growth is continued pursuit of opportunities to partner with biopharma institutions to accelerate scientific breakthroughs through access to our datasets. These arrangements, such as our partnerships with Moderna, AbbVie, Xencor, and Merck KGaA include research into molecular markers and tumor-associated antigens, characterization of resistance mechanisms, and the development of personalized therapies. We believe the future of therapeutics will become more and more personalized, requiring the information that we produce to create individually tailored therapies that will have the greatest likelihood of controlling and/or curing patients of disease. Recent advances of personalized therapies that are specifically created for patients demonstrate the value of this approach. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Continue to expand and enrich our clinico-genomic datasets to drive breakthrough science and develop new solutions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our continued comprehensive sequencing for patients, together with our leadership in tissue-based profiling and expansion into blood-based profiling, will enable continued rapid expansion of our datasets, both with new profiling data as well as with longitudinal insights as we follow patients over time. We plan to accelerate the enrichment of </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">154</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">our datasets through continuous R&amp;D at our own laboratories, third party partnerships, and collaborative research with Caris POA members to remain at the cutting-edge of precision oncology and stay attuned to the key needs of our researchers. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Maximize market reach through our regulatory approval and reimbursement strategy</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A key aspect of our commercial strategy is to obtain regulatory approval and reimbursement for our solutions. In November&#160;2024, we obtained a premarket approval (&#8220;PMA&#8221;) from the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) for a companion diagnostic and tumor profiling designation for MI Cancer Seek, a WES/WTS NGS assay that uses the whole exome for TMB calling and has been designed to meet the stricter requirements applicable to companion diagnostic devices. We currently market MI Cancer Seek as the WES/WTS NGS component of MI Profile. We have secured a PLA code of 0211U from the AMA and pricing from CMS for this PLA code. We have obtained Medicare coverage for MI Cancer Seek for CPT code&#160;0211U under the NGS NCD. For MI&#160;Tumor Seek Hybrid, we have Medicare and commercial reimbursement. For Caris Assure, we received Medicare coverage in late 2023, have secured various levels of payer adoption and/or reimbursement coverage, and will continue working to expand coverage. In July&#160;2024, the AMA issued a PLA code, CPT code 0485U, for Caris Assure, with an effective date of October&#160;1, 2024. In November 2024, CMS determined to price Caris Assure for therapy selection using the &#8220;Gapfill&#8221; method, a method used when there are no comparable existing codes available. There is no certainty regarding the pricing that we will obtain for Caris Assure during the Gapfill process. For additional information, see &#8220;&#8212;Government Regulation&#8212;Coverage and Reimbursement&#8212;Coverage and Reimbursement in the United States.&#8221; We plan to work closely with Medicare and private payers to continue to demonstrate the economic benefit of our platform and secure reimbursement coverage for our future offerings by leveraging our proprietary clinico-genomic datasets that contains a growing volume of corresponding clinical outcomes data. We believe this approach will lead to a differentiated reimbursement profile relative to our peers. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Capitalize on the ultimate potential of our novel, universal blood-based profiling solution, Caris Assure, and broader innovation platform in other chronic disease states beyond oncology, including in cardiology, neurology, and metabolic conditions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We believe there is a large market opportunity to diagnose and treat chronic conditions beyond oncology through molecular information-based approaches. Beyond oncology, researchers are actively exploring the genetic and biological connections between patients and other disease states, including cardiology, neurology, and metabolic conditions. These diseases are frequently multifactorial in nature and are characterized by significant individual variability. Accordingly, a comprehensive understanding of the underlying biological pathway dysfunction is critical if we want to understand the molecular origins of disease and generate insights to bring new therapeutics to patients. As we continue to scale, we believe our solutions will drive superior clinical outcomes, leading to additional demand for our profiling solutions and further expansion of our clinico-genomic datasets, allowing us to achieve meaningful innovation in other disease states beyond oncology. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Solutions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Caris Assure&#8212;Our Universal Blood-Based Profiling Solution</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Caris Assure is our novel, universal blood-based solution that is purpose-built to extend across the entire continuum of cancer treatment, including early detection, monitoring of MRD and recurrent cancers, and precision selection of molecularly targeted therapies. Caris Assure also has applications in therapeutic discovery and development. Customers for Caris Assure include treating physicians as well as researchers and biopharma companies. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our universal approach to blood-based profiling is unique. While Caris Assure is a single wet lab test, the backend bioinformatics pipeline and analyses are adapted to where the patient may be in their cancer journey. For example, the genes, molecular alterations, and features in late-stage metastatic cancer for therapy selection will be interpreted differently than in early detection. The elegant simplicity of a single test paired with a comprehensive assessment of the patient&#8217;s DNA and RNA allows Caris Assure to be </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">155</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">this universal diagnostic. This approach also allows many more datapoints to be assessed, enabling us to select those markers that provide the greatest potential for sensitivity, specificity, and overall accuracy of our test. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Liquid biopsies can be used across the care continuum, including for: therapy selection in the advanced/metastatic setting; MRD and monitoring in the curative/adjuvant setting; and early detection in the diagnosis setting. Because many of our competitors&#8217; liquid biopsy assays are designed to address only a single portion of this care continuum, in order to develop products for other portions of the care continuum, our competitors must invest in the development of new wet lab assays and generate disparate datasets across the patient journey for patients, oncologists, and researchers. In contrast, Caris Assure is designed as a single test applicable across the entire patient journey. To our knowledge, there is no other assay on the market that can be applied as broadly as Caris Assure. We believe that our single-test approach will enable us to scale our R&amp;D infrastructure to analyze increasingly larger testing volumes, process expanding datasets, and reach economies of scale in liquid biopsy across the entire cancer care continuum. The figure below shows the opportunities for blood and tissue sampling and treatment therapies within stages of the cancer care continuum. As a blood-based profiling solution designed for the entire cancer care continuum, Caris Assure has many more opportunities for testing relative to tissue-based profiling, as can be seen on the chart below. </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="lc_oursolutions-4c.jpg" alt="[MISSING IMAGE: lc_oursolutions-4c.jpg]" height="239" width="517" >
        </div>
        <div style="text-indent:36pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Caris Assure is currently being offered for therapy selection as a laboratory developed test (&#8216;&#8216;LDT&#8217;&#8217;), and we have Medicare reimbursement and various levels of commercial payer adoption and/or reimbursement coverage for Caris Assure for therapy selection across the United States (other than New York State), at current pricing under MolDX of $3,649. We are in the process of conducting studies and analysis to internally validate and refine the assay for application to early detection, MCED, MRD tracking, and treatment monitoring, with certain validation processes and results to date described below. The commercial application of Caris Assure as an LDT to the cancer care continuum beyond therapy selection is subject to further assay development, validation, and reimbursement coverage. Further, depending on the ultimate outcome of the litigation over FDA&#8217;s final rule to subject LDTs to its medical device authorities through a phase out of its historical enforcement discretion policy with respect to LDTs (the &#8220;LDT Final Rule&#8221;), the marketing of Caris Assure for these applications may require us to seek marketing authorization from the FDA. Because many of these factors are outside of our control, we are not certain regarding the timing of the availability of Caris Assure for the early detection, MCED, MRD tracking, and treatment monitoring markets.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Drawing blood is a routine medical procedure that is much less invasive than a tissue biopsy. Processing of a blood specimen, from collection to isolation, analysis, and reporting, enables faster time to results and potentially earlier start of treatment. Clinical guidelines for molecular profiling in cancer have focused on tissue as the gold standard, but with recent advances in blood-based profiling demonstrating its clinical utility, we believe that evidence and clinical guidelines support complementary usage of both tissue- and blood-based profiling across many major cancer types. We believe that one example of the benefits of blood-based profiling is that cancers frequently become resistant to new targeted therapies by developing genetic mutations that can make drugs less effective and lead to cancer recurrence. When resistance develops, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">156</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:102.52pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">clinicians need an updated molecular profile of the cancer to guide subsequent treatment strategies. At this stage in cancer progression, it is often not feasible to acquire additional tumor tissue to build the updated profile, or the amount or quality of accessible tissue is low. Small quantities or low quality of tissue from an inaccessible biopsy site can lead to a Quantity Not Sufficient (QNS) result when NGS fails for lack of input material. Without another way to generate an updated molecular profile of the patient&#8217;s tumor, the tools of precision oncology cannot be deployed. Conducting additional tissue biopsies also carries its own health risks, such as tumor seeding, which can occur when cancer cells are unintentionally deposited elsewhere in the body during the biopsy process, and infection. Liquid biopsy is a potential solution to the challenges and risks of tissue biopsies. A sample eligible for Caris Assure analysis consists of two 10 milliliter tubes of whole blood, gently inverted 10 times as is common practice in blood collection, shipped at room temperature.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Nonetheless, we believe that tissue-based profiling generally remains the gold standard for cancer therapy selection primarily because it is the most mature technology and is broadly supported by analytical validation studies. Microscopic examination of the tumor tissue is necessary for characterization of tumor type and stage and to confirm the presence of key proteins via IHCs. In blood, the variant allele frequencies of tumor biomarkers can be so low that negative results must be confirmed by tissue analysis. However, the tide is turning in clinical guidelines toward acceptance that tissue and liquid biopsy, used in combination, can improve clinical outcomes for patients. For example, the 2024 version of one of the prominent clinical guidelines for non-small cell lung cancer states that: (1) concurrent testing can improve time to test results and should be considered in the appropriate clinical situation, and (2) negative results (meaning absence of definitive driver mutation) by one method suggests the use of a complementary method.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We believe Caris Assure represents the most comprehensive blood-based solution on the market, featuring over 23,000 gene coverage at a raw average sequencing depth of coverage of 8,000 times for clinically relevant genes, as compared to other blood-based offerings in the market that only assess 500 to 1,000 genes from DNA. Caris Assure performs WES and WTS for every eligible patient blood sample. We couple this WES and WTS with advanced AI and ML technologies to offer diagnostic, prognostic, and predictive utility in a single test. Additionally, Caris Assure generates sequencing results from both the plasma and the white blood cells, or buffy coat, from each sample. This gives Caris Assure a differentiated ability to distinguish tumor variants, which are relevant for therapy selection, from both incidental germline variants and common age-related mutations that are not related to the tumor and which can confound analysis and therapy selection if not properly distinguished. For additional information regarding this capability, see &#8220;&#8212;Benefits of CH Subtraction with Caris Assure.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Molecular features we identify using Caris Assure&#8217;s WES and WTS data include single nucleotide variants (&#8220;SNVs&#8221;), insertions/deletions (&#8220;INDELs&#8221;), structural variants, gene expression, copy number alterations (&#8220;CNAs&#8221;), TMB, and MSI. In addition, we deploy our ABCDai algorithm on Caris Assure&#8217;s WES and WTS data to address important clinical needs in early detection and monitoring of MRD and recurrent cancers. We trained ABCDai using data for over 375,000 tissue profiles and over 7,000 paired blood and tissue profiles. In a first phase, separate AI models were trained on nine feature sets representative of cancer-related and cell-free nucleic acids. In a second phase, the 500 most important features determined by us from each feature set were used to train a final ABCDai model. We engineered three ABCDai models to work in concert with Caris Assure: (i) MCED; (ii) diagnostic pathway; and (iii) MRD and monitoring. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">157</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:173.45pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="fc_abcdaiassure-4c.jpg" alt="[MISSING IMAGE: fc_abcdaiassure-4c.jpg]" height="332" width="506" >
        </div>
        <div style="margin-top:18.69pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Caris Assure for Early Detection</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that one of the most promising uses for Caris Assure is for early detection, including both cancer-type-specific early detection and MCED. Our detection of cancer at very early stages would enable clinicians to treat disease sooner, which could significantly improve patient outcomes. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We trained ABCDai for MCED (&#8220;ABCDai-MCED&#8221;) using the aforementioned features on samples from 1,013 patients (507 patients with cancer and 506 individuals with no reported cancer). Performance was assessed on an independent set of 2,675 patients (526 patients with cancer and 2,149 samples from individuals with no reported cancer). ABCDai-MCED&#8217;s performance on the stratification of blood samples from the independent cohort of patients with cancer versus those with no reported cancer resulted in sensitivities for stages I-IV (n= 284, 129, 90, and 23, respectively) of 83.1% (stage I), 86.0% (stage II), 84.4% (stage III), and 95.7% (stage IV) at 99.6% specificity (n=2,149).</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The chart below illustrates ABCDai-MCED&#8217;s sensitivity in detecting a range of cancer types at stages I and II, at a specificity of 99.5% </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">158</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="bc_caris-4c.jpg" alt="[MISSING IMAGE: bc_caris-4c.jpg]" height="413" width="547" >
        </div>
        <div style="text-indent:36pt; margin-top:13.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ABCDai-MCED has been shown to be useful in detecting the presence of cancer in an asymptomatic individual. Additionally, the molecular information provided by Caris Assure can assist in predicting the diagnostic pathway that can confirm the presence and tissue of origin of cancer, which knowledge is needed for proper intervention. We focused diagnostic pathway prediction on those tumor types that are most common and thus provide the most clinical utility: colonoscopy, abdominal/chest CT, endoscopy, liver ultrasound, mammograph with MRI, neck ultrasound, pelvic ultrasound, and prostate-specific antigen (&#8220;PSA&#8221;). A model to predict diagnostic pathway, ABCDai-GPS, was trained by us using the feature sets described above obtained for treatment-na&#239;ve samples from 660 patients with stage I and II cancers and 506 individuals with no reported cancer. Using 5-fold cross validation, we observed that ABCDai-GPS predicted the diagnostic pathway for 100% of the ABCDai-MCED positive calls with a top-3 accuracy of 85% for stage I and II cancers. The relationship between the proposed diagnostic pathways and tissue of origin of the cancer is shown in the following table. </font>
        </div>
        <table style="width:456pt;height:128.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Diagnostic Pathway </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:300pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Cancer Types </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Colonoscopy </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:300pt;">
              <font style="letter-spacing:0.2pt;">Colorectal </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">CT Abdomen/Chest </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:300pt;">
              <font style="letter-spacing:0.2pt;">Pancreatic, Kidney, Bladder, Urinary tract, Lung </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Endoscopy </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:300pt;">
              <font style="letter-spacing:0.2pt;">Esophageal, GIST, Gastric, Small Intestine </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Liver ultrasound </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:300pt;">
              <font style="letter-spacing:0.2pt;">Cholangiocarcinoma, Liver </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Mammograph with MRI </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:300pt;">
              <font style="letter-spacing:0.2pt;">Breast </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Neck ultrasound </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:300pt;">
              <font style="letter-spacing:0.2pt;">Head and Neck, Thyroid </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Pelvic ultrasound </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:300pt;">
              <font style="letter-spacing:0.2pt;">Uterus, Cervical, Ovarian, Female Genital Tract Malignancy </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">PSA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:300pt;">
              <font style="letter-spacing:0.2pt;">Prostate</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are also in the early stages of developing a version of ABCDai to be used with Caris Assure for early detection of specific types of cancer. We are currently developing cancer-type-specific early detection for breast and colorectal cancers. We believe that cancer-specific early detection assays will benefit patients by providing them with clear treatment pathways. We currently intend to launch Caris Assure for early </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">159</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:145.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">detection of breast cancer and intend to do so in a capital efficient manner, with the expectation that we will leverage either a commercial partner or our existing sales channels, however, our plans and intentions may change. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Caris Assure for Minimal Residual Disease Tracking and Treatment Monitoring</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">A third model was trained by us using the feature sets described above for deployment in the settings of MRD and recurrence monitoring. This model, ABCDai-M&amp;M, was trained using samples from 3,439 patients (1,290 patients with cancer and 2,149 individuals with no reported cancer) and performance was assessed on two independent validation cohorts: 86 patients in the MRD study and 101 patients in the recurrence monitoring study. The disease-free survival of patients whose cancers were predicted by ABCDai-M&amp;M to have an event was significantly shorter than those predicted not to have an event using a tumor na&#239;ve approach (HR=33.4, p&lt;0.005, HR=4.39, p=.008, respectively). The ABCDai-M&amp;M model captured 89% of MRD recurrence events with 98% NPV and 76% specificity, and 45% of recurrence monitoring events with 92.6% NPV and 83% specificity. </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="lc_significant-4c.jpg" alt="[MISSING IMAGE: lc_significant-4c.jpg]" height="335" width="517" >
        </div>
        <div style="text-indent:36pt; margin-top:14.69pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following graphic illustrates the performance of Caris Assure for CRC in the MRD setting, in our clinical validation performed on 44 patient samples. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">160</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="lc_colorectal-4c.jpg" alt="[MISSING IMAGE: lc_colorectal-4c.jpg]" height="288" width="519" >
        </div>
        <div style="text-indent:36pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our MRD detection methodology based on ABCDai takes a tumor naive approach, and therefore does not require a bespoke panel to be created to track the recurrence of a patient&#8217;s tumor. This bespoke-free approach enables faster turn-around-time, enabling patients to be informed of additional therapy sooner to combat their disease. Additionally, because Caris Assure analyzes the entire exome, any tumor-derived alterations including those that may derive from subclones not included in the original tissue biopsy, are also detectable, thus accounting for tumor heterogeneity to help contribute to sensitivity of detection. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Benefits of CH Subtraction with Caris Assure</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For therapy selection, in addition to sequencing cell-free DNA and cell-free RNA isolated from the plasma to identify somatic tumor variants, we also sequence genomic nucleic acid (gDNA and gRNA) isolated from the white blood cells, or buffy coat, from each sample. Plasma contains a mixture of cell-free variants derived from tumor, blood and other cells. These variants cannot be separated based on plasma sequencing alone. Sequencing the buffy coat separately from the plasma allows Caris Assure to identify incidental germline (inherited) mutations as well as CH mutations. CH mutations are somatic mutations that accumulate in the blood with age, occur in a substantial portion of the population, and are not cancer-derived. Caris Assure &#8220;subtracts&#8221; CH mutations in the reporting of somatic tumor variants. If CH mutations are not distinguished from tumor-derived mutations, it can confound liquid biopsy results and lead to selection of a therapy targeted at a mutation that is present in the white blood cells instead of in the tumor, which is not beneficial for the patient with cancer. Because of this, the College of American Pathologists (&#8220;CAP&#8221;) and Association for Molecular Pathology recommend that cfDNA assays should incorporate whole blood controls to differentiate CH from tumor-derived variants. Caris Assure sequencing follows this approach, thus lessening the risk of incorrectly interpreting CH or germline mutations as tumor-derived and thus result in fewer false positive diagnoses and more accurate and effective treatment recommendations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2025, we published in </font><font style="font-style:italic;letter-spacing:0.2pt;">Clinical Cancer Research</font><font style="letter-spacing:0.2pt;">, a peer-reviewed medical journal on oncology, our validation study conducted in collaboration with leading cancer centers such as Rocky Mountain Cancer Centers, OU Health University of Oklahoma Medical Center, Hope Cancer Center of Nevada, and Texas Oncology. The study analyzed over 16,800 patients with advanced cancer across 49 cancer types and found that nearly more than four of 10 patients had at least one CH variant among reportable clinical genes. The study also found a median rate of CH variant classification of 20% for patients ranged from 65 to 69, 33% for patients aged 70 to 74, 33% for patients aged 75 to 79, and 50% for patients 80&#160;years of age and older. High CH rates were notably detected in BRCA2, BRCA1, CHEK2, ATM and NRAS. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">161</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:54.47pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following graphic illustrates the study&#8217;s findings on variant classification by gDNA and plasma variant frequency, and illustrates the types of diagnostic errors that can occur when variants are not properly characterized as tumor, germline or CH mutations. </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="lc_plasmabuffy-4c.jpg" alt="[MISSING IMAGE: lc_plasmabuffy-4c.jpg]" height="389" width="608" >
        </div>
        <div style="text-indent:36pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Because of the prevalence of CH mutations, we believe that CH subtraction is critical to optimal cancer care. As noted above, the identification of CH mutations by an assay can lead to improper therapy selection if such mutations are not shown to be from the white blood cells. By identifying and distinguishing variants that are not from the tumor itself and, therefore not relevant to therapeutic decision-making, the CH subtraction feature of Caris Assure further separates our solution from other liquid biopsy tests currently on the market that do not sequence the white blood cells and therefore cannot definitively distinguish CH mutations from tumor-derived mutations. To our knowledge, Caris Assure is the only commercially available tissue-naive blood-based profiling assay that directly accounts for CH mutations instead of using algorithmic approximations, which we believe gives Caris Assure a differentiated ability to drive improved therapy selection. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">By leveraging CH subtraction, somatic mutation detection from blood collected within 30&#160;days of matched tumor tissue showed high concordance to our tissue-based assays, with a positive percent agreement (&#8220;PPA&#8221;) of 93.8% and a positive predictive value (&#8220;PPV&#8221;) of 96.8% PPA and PPV are terms commonly used in the context of diagnostic tests and medical studies and are helpful for evaluating assay performance. PPA stands for positive percent agreement and is a measure of the agreement between a test&#8217;s positive result and the true positive status as determined by a reference standard. PPV stands for positive predictive value, which is a measure of the probability of a positive result correctly identifying a disease or condition. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">162</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;min-height:298pt;margin-top:0pt;border-collapse: collapse;border:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="height:17.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:4.5pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">Case Study: The Benefits of CH Subtraction in Therapy Selection </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:87pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A male patient in his 80&#8217;s with a history of renal cell carcinoma presented with a large osseous (bone) metastasis involving the thoracic and lumbar spine, ribs, and pelvis. Pathology was consistent with an origin in the prostate. Immunohistochemical studies performed by the outside pathology team was consistent with this diagnosis, and a liquid biopsy performed outside of Caris revealed a mutation in the ATM gene, which helps repair damaged DNA that was potentially actionable as supported by a specific FDA-approval for PARP inhibitors for patients with this mutation. This outside liquid biopsy did not specify whether the detected ATM mutation was derived from the tumor or potentially from clonal hematopoiesis. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:39pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A tissue biopsy was sent to Caris for molecular profiling. Tissue molecular profiling done at Caris confirmed the diagnosis of metastatic prostate cancer with mutations in FOXA1 and MEK1, genes that play roles in regulating cell growth and behavior. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:51pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The patient received palliative radiation therapy and began androgen deprivation therapy (&#8220;ADT&#8221;). The ATM mutation detected by the outside liquid biopsy also indicated potential benefit from the PARP inhibitor olaparib. After an increase in the patient&#8217;s prostate-specific antigen levels led the clinician to consider new therapy options, a blood sample was sent for Caris Assure molecular profiling. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:63pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Caris Assure confirmed the previously-identified FOXA1 and MEK1 mutations, MSS, and low blood TMB consistent with low tissue TMB, but showed that the ATM mutation was CH-derived rather than tumor-derived. Therefore, ADT could continue while the patient is responsive and tolerant, but the clinician could avoid prescribing the PARP inhibitor olaparib, knowing that the ATM mutation targeted by that therapy is a false positive from CH and not a tumor biomarker. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:41.5pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;border-bottom:0.75pt solid #000000; ;padding:2pt 0pt 6pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The CH subtraction capability of Caris Assure in this case provided the patient and his clinicians more accurate information about potential future treatment options, and helped the patient avoid the potential harmful side effects, time and financial cost of therapies that would likely have been ineffective.</div>
            </td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:9.11pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Caris Assure for Therapy Selection</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We initiated a broad commercial launch of Caris Assure for therapy selection in the first quarter of 2024 and currently offer the solution as an LDT, which the FDA has historically considered to be a category of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> diagnostic (&#8220;IVD&#8221;) test intended for clinical use and designed, manufactured, and used within a single laboratory. The FDA has historically exercised enforcement discretion and not required marketing authorization for LDTs. Accordingly, we have not yet obtained FDA marketing authorization for Caris Assure. However, the FDA recently issued the LDT Final rule, which if implemented, would have imposed medical device requirements on many types of LDTs that were previously subject to enforcement discretion. This rule was set to go into effect in May 2025. However, on March 31, 2025, a federal district court set aside and vacated the LDT Final Rule on the basis that LDTs are not medical devices. It remains unclear at this time what impact this court decision will have on the FDA&#8217;s oversight over LDTs moving forward, including which of our offerings may be eligible for or otherwise require FDA marketing authorization. We have anticipated seeking FDA marketing authorization for certain of our solutions in the future, including Caris Assure for therapy selection. Additionally, while we currently market Caris Assure for therapy selection as an LDT, it remains possible that marketing authorization would be required in order for us to market Caris Assure as a companion diagnostic device for therapy selection. We do not yet have specific plans regarding the timing of a PMA or other submission, if any, for Caris Assure for therapy selection or any other indication. For additional information, see &#8220;Business&#8212;Government Regulation&#8212;U.S. Food and Drug Administration.&#8221; We have Medicare reimbursement and various levels of commercial payer adoption and/or reimbursement coverage for Caris Assure for therapy selection across the United States. The current pricing of Caris Assure for therapy selection under MolDX is $3,649. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Caris Assure for therapy selection is available in all U.S. states (other than New York, where we intend to apply in 2025 for approval from New York State&#8217;s Clinical Laboratory Evaluation Program (&#8220;NY CLEP&#8221;)) and in Puerto Rico. We also offer Caris Assure for therapy selection internationally through distributors and direct contracts with hospital systems, where permitted by applicable regulations. </font>
        </div>
        <div style="margin-left:36pt; margin-top:11.51pt; width:420pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Caris Assure Profile Report</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Caris Assure for therapy selection generates a personalized report that provides oncologists with the information to tailor each patient&#8217;s treatment plan. This report is built to maximize clinical utility in an </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">163</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:75.68pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">easy-to interpret format. Our technology enables us to report our results for blood-based profiling even quicker than tissue-based profiling, as Caris Assure results are typically reported in approximately seven calendar days from &#8220;activation,&#8221; the time at which we receive the patient&#8217;s samples and required paperwork. A sample Caris Assure profile report is depicted below. </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="fc_miprofile02-4c.jpg" alt="[MISSING IMAGE: fc_miprofile02-4c.jpg]" height="541" width="579" >
        </div>
        <div style="margin-left:36pt; margin-top:18.69pt; width:420pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Technical Specifications and Analytical Validation</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Caris Assure analyzes all coding genes through WES (cell-free DNA) and WTS (cell-free RNA), and categorizes variants found in plasma as either tumor-derived or CH-derived and either somatic or germline. Caris Assure clinically reports SNVs, INDELs, and select fusions, as well as MSI, TMB, human leukocyte antigens, and select amplifications. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">164</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; width:456pt;">
          <img src="tb_technical-4c.jpg" alt="[MISSING IMAGE: tb_technical-4c.jpg]" height="534" width="606" >
        </div>
        <div style="position:relative;margin-top:14.69pt; width:456pt;">
          <img src="bc_novelcircul-4c.jpg" alt="[MISSING IMAGE: bc_novelcircul-4c.jpg]" height="287" width="608" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">165</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Caris Assure for Biopharma</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The same benefits that blood-based WES, WTS, and CH subtraction bring to patients in the clinical setting also offer significant and previously unavailable advantages to biopharma companies across the drug development continuum. Caris Assure allows biopharma companies to conduct exploration into biology and address elusive questions around response and resistance with repeat and/or longitudinal biopsies, without the restriction of earlier generation liquid biopsies. This enables biopharma companies to understand the molecular alterations responsible for resistance. In a drug development setting, the only way to get this understanding is through the WES/WTS sequencing technology underlying Caris Assure. With a typical results turn-around-time of approximately seven calendar days from activation, Caris Assure can be used in early-stage trials to identify and enroll eligible patients that meet inclusion and exclusion criteria, or more broadly to leverage this comprehensive molecular profile of patients for exploratory analyses. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Caris Assure is designed to be particularly valuable when used serially for time point studies, real-time monitoring of disease progression and treatment response, and post-treatment monitoring for recurrence. Caris Assure offers the biopharma industry the opportunity, for the first time, to incorporate complete WES and WTS interrogation at multiple timepoints throughout clinical trials in a non-invasive and easy-to-implement modality. This would enable biopharma companies to not only track changes in the mutation profile of a tumor in response to treatment, but also to assess changes in gene expression over time. Until now, different assays and analysis methods were required at different time points. Caris Assure offers biopharma companies the ability to use the same, consistent, and uniform assay across their full development program, allowing for more consistent, complete, and inter-comparable datasets across drug studies and time points. With Caris Assure, we believe biopharma companies would be able to generate more NGS data on individual clinical trial patients than has ever been possible using a blood-based assay in the history of cancer research and clinical trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MI Profile&#8212;Our Tissue-Based Profiling Solution</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">MI Profile is our tissue-based molecular profiling solution for cancer therapy selection, with over one million tests performed on approximately 146,500 clinical cases in 2024 and an additional approximately 40,000 clinical cases in the three months ended March 31, 2025. As of March&#160;31, 2025, we have performed over 6.5 million tissue-based tests on over 790,000 clinical cases since inception. MI Profile includes our comprehensive WES/WTS NGS assay and IHC protein expression testing. Our tissue microdissection process has, to date, resulted in a high success rate in identifying actionable biomarkers in 95% of patients profiled. Eligibility of tissue samples for our MI Profile tissue profiling requires a presence of at least 20% tumor nuclei and at least 50 ng of DNA for MI Cancer Seek, and at least 25 ng for MI Tumor Seek Hybrid, and the sample must meet other requirements detailed in our requisition form used by ordering physicians. MI Cancer Seek requires formalin-fixed paraffin embedded tissue samples, but we can accept samples in different forms for MI Tumor Seek Hybrid as detailed in our requisition form.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The information generated from profiling the patient&#8217;s tissue is used to create an interpretative report based on our bioinformatics pipeline and recommend individualized therapies for cancer patients. Our goal is to maximize the information generated and corresponding clinical utility for patients from the limited available tumor tissue. The information generated, which further expands our multi-modal datasets, also provides valuable insights to aid drug discovery and development efforts. Customers for MI Profile include treating physicians as well as researchers and biopharma companies. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have obtained Medicare and commercial reimbursement for MI Profile. MI Profile, including our MI Cancer Seek assay and our proprietary clinical molecular signatures GPSai and FOLFIRSTai are available in all U.S. states and in Puerto Rico. We also offer MI Profile internationally in over 40 countries through distributors and direct contracts with hospital systems, where permitted by applicable regulations.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have obtained a PMA approval from the FDA for a companion diagnostic and tumor profiling designation for MI Cancer Seek, a WES/WTS NGS assay that uses the whole exome for TMB calling and for which we have obtained a Proprietary Laboratory Analyses (&#8220;PLA&#8221;) code, Current Procedural Terminology (&#8220;CPT&#8221;) code 0211U, at a reimbursement rate of $8,455. Our MI Cancer Seek solution was commercially launched in January 2025, and we currently market it as the WES/WTS NGS component of MI Profile. We have obtained Medicare coverage for MI Cancer Seek for CPT code 0211U under the NGS </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">166</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">NCD. MI Tumor Seek Hybrid, which is a WES/WTS NGS LDT assay that we currently offer as an alternative assay in the event a specimen does not meet the requirements for MI Cancer Seek, is currently priced by MolDX at $3,500. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">MI Profile Report</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">MI Profile generates a personalized report that provides oncologists with the information to tailor each patient&#8217;s treatment plan. The MI Profile report was built by oncologists for oncologists and is designed to maximize clinical utility in an easy-to interpret format. We generally report our results for tissue-based profiling approximately 10 calendar days from activation. A sample MI Profile report is depicted below. </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="fc_miprofile-4c.jpg" alt="[MISSING IMAGE: fc_miprofile-4c.jpg]" height="678" width="510" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">167</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:140.25pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Technical Specifications and Validation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:12pt; width:420pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">MI Cancer Seek</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The current WES/WTS NGS component of MI Profile is MI Cancer Seek, for which we have received FDA approval for use as a companion diagnostic device to identify cancer patients who may benefit from treatment with targeted therapies. The assay includes one pan-cancer and five tumor-specific indications for numerous FDA-approved therapies. To our knowledge, MI Cancer Seek is the first and only simultaneous WES and WTS-based assay with FDA-approved companion diagnostic indications for molecular profiling of solid tumors. MI Cancer Seek is available for adults and pediatric patients between the ages of one and 22. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">MI Cancer Seek is a NGS-based in vitro diagnostic device using total nucleic acid isolated from formalin-fixed paraffin embedded tumor tissue specimens for the detection of SNVs, InDels, MSI, TMB in patients with previously diagnosed solid tumors, and CNA in one gene in patients with breast cancer. MI Cancer Seek is intended as a companion diagnostic to identify patients who may benefit from treatment with the targeted therapies listed in the Companion Diagnostic Indications table below, in accordance with the approved therapeutic product labeling. </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="fc_companion-4c.jpg" alt="[MISSING IMAGE: fc_companion-4c.jpg]" height="345" width="578" >
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">168</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:252.73pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tb_micancer-4c.jpg" alt="[MISSING IMAGE: tb_micancer-4c.jpg]" height="370" width="578" >
        </div>
        <div style="text-indent:36pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">As of March 31, 2025, MI Cancer Seek had 20 FDA-approved therapies and therapy combinations associated with its companion diagnostic indications. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Beyond the MI Cancer Seek FDA-approved indications, MI Cancer Seek reports additional sequencing-based features from DNA such as gLOH, HRD, HLA genotype, chromosomal alterations, viruses, and additional sequencing-based features from RNA such as gene expression, fusions, and variant transcripts. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">169</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tb_micancerseek-4c.jpg" alt="[MISSING IMAGE: tb_micancerseek-4c.jpg]" height="461" width="603" >
        </div>
        <div style="margin-top:4.9pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:36pt; margin-top:11.7pt; width:456pt; line-height:9.5pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">PPA and NPA are terms commonly used in the context of diagnostic tests and medical studies and are helpful for evaluating the performance of diagnostic tests: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:10pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:56pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.16pt;">PPA</font><font style="letter-spacing:0.16pt;"> stands for Positive Percent Agreement. Similar to NPA, it is a measure of the agreement between a test&#8217;s positive results and the true positive status as determined by a reference standard. It reflects the test&#8217;s ability to correctly identify positive results.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:10pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:56pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.16pt;">NPA</font><font style="letter-spacing:0.16pt;"> stands for Negative Percent Agreement. It is a measure of the agreement between a test&#8217;s negative results and the true negative status as determined by a reference standard. It reflects the test&#8217;s ability to correctly identify negative results. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:36pt; margin-top:12pt; width:420pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">MI Tumor Seek Hybrid</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our legacy MI Tumor Seek Hybrid profiling solution combines WES analysis of DNA for mutations, CNAs, INDELs, and genomic signatures (TMB, MSI, gLOH, and HRD) with WTS analysis for RNA fusions and variant transcripts. We have also analytically validated MI Tumor Seek Hybrid for viral detection and report HPV, MCV, and EBV presence from the WES data in the appropriate tumor context. MI Tumor Seek Hybrid achieves accurate results through high coverage depths for DNA and RNA sequencing. MI Tumor Seek Hybrid consistently reaches 1,500 times depth of coverage for clinically relevant DNA genes and 300 times depth of coverage for the whole exome. Our WTS technology allows for fusion detection, variant transcript analysis, and gene expression profiling. </font>
        </div>
        <div style="margin-left:36pt; margin-top:12pt; width:420pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">AI Signatures</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our WES/WTS profiling solutions generate over 28.8&#160;billion datapoints, spanning 84,000 molecular markers, per clinical case. To interpret this data, MI Profile utilizes an advanced, AI-powered bioinformatics pipeline. This bioinformatics pipeline includes a sophisticated rules engine, variant calling, fusion calling, copy number prediction, and expression analysis. We use over 220 AI algorithms in connection with the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">170</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">bioinformatic pipeline of our tissue-based sequencing. These AI algorithms assist in sample processing, quality control, biological processing, and biological interpretation. Collectively, these AI algorithms generate data on 84,000 molecular markers for each WES/WTS run.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">MI Profile can also include our proprietary clinical molecular signatures, GPSai and FOLFIRSTai, which were developed by training and clinically validating AI/ML algorithms with our extensive multi-modal clinico-genomic datasets. These molecular signatures, which we currently offer as LDTs, provide clinical utility for molecular diagnosis of cancer and prediction of patient response to treatment. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">GPSai</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our GPSai signature is a molecular disease classifier that utilizes multiple deep neural networks and hundreds of thousands of molecular features to predict a histologic diagnosis and tumor origin directly from the DNA and RNA sequencing data. The result is a probability of the most likely diagnosis, which is then reviewed by a Caris Board-Certified Pathologist in the context of all available clinicopathologic information before report release. The primary indication for GPSai is to determine if the initial diagnosis is correct and serves as a quality control for all patients. In addition, it can be used to help identify the tissue of origin for Cancers of Unknown Primary (&#8220;CUP&#8221;), cases where the starting point of the cancer is not yet clear, which is a major unmet need in clinical oncology. This tissue of origin prediction is provided along with the comprehensive biomarker data without the need for additional specimen utilization; this tool runs on the MI Profile exome and transcriptome sequencing results. GPSai is also utilized as a quality control metric where it is run on every clinical case and the results reviewed by a pathologist. If the GPSai results do not match the outside pathologic diagnosis of the specimen, our pathologists will do additional work-up, including IHC testing, to support a new diagnosis to provide the best overall service and patient care. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:55pt; margin-top:8pt; width:401pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">GPSai was trained and clinically validated by us through retrospective profiling data from over 250,000 clinical cases using the outside pathologist diagnosis as the baseline. In a prospectively run clinical validation study that we conducted, GPSai demonstrated overall accuracy of 94.8% and an overall call rate of 95.1%. This clinical validation of GPSai enabled us to offer the solution as an LDT in accordance with the Clinical Laboratory Improvement Amendments of 1988&#8217;s (&#8220;CLIA&#8221;) requirement of clinical validation of a variety of performance characteristics, including accuracy, precision, specificity, sensitivity, reportable range, and reference interval before an LDT is used in clinical testing. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FOLFIRSTai</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our FOLFIRSTai signature is our first clinically validated, AI-powered molecular predictor of efficacy of oxaliplatin-based chemotherapy combined with bevacizumab in patients with metastatic colorectal cancer (&#8220;mCRC&#8221;). According to estimates by the ACS, one in 23 men and one in 25 women in the United States will be diagnosed with colorectal cancer in their lifetime. FOLFOX, FOLFIRI, or FOLFOXIRI chemotherapy with bevacizumab is considered standard first-line treatment option for patients with mCRC. Some mCRC patients benefit from one combination chemotherapy regimen over the others, and identifying which patients would benefit from which regimen is a challenge for physicians. FOLFIRSTai is included for all clinical cases with completed WES results and a diagnosis of advanced stage colorectal adenocarcinoma. The FOLFIRSTai results appear in the MI Profile report as &#8220;Increased Benefit&#8221; or &#8220;Decreased Benefit&#8221; with additional detail provided about the results in the report. FOLFIRSTai is broadly accessible to patients and is covered by almost all insurance companies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:55pt; margin-top:8pt; width:401pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We clinically validated FOLFIRSTai using a real-world evidence dataset collected from the Caris POA registry, insurance claims data and samples from the TRIBE2 Phase&#160;3 clinical trial, which compared first-line use of FOLFOXIRI and FOLFOX. In a clinical validation study that we conducted, FOLFIRSTai demonstrated that the overall survival of patients treated in a manner consistent with the FOLFIRSTai prediction was 17.5&#160;months longer than the overall survival of patients treated counter to the prediction (representing a 71% difference). This clinical validation of FOLFIRSTai enabled us to offer the solution as an LDT in accordance with CLIA&#8217;s requirement of analytical validation of a variety of performance characteristics, including </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">171</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:55pt; width:401pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">accuracy, precision, specificity, sensitivity, reportable range, and reference interval before an LDT is used in clinical testing. </font>
        </div>
        <table style="width:456pt;min-height:416.7pt;margin-top:10pt;border-collapse: collapse;border:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="height:17.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:4.5pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">Case Study: The Power of Caris&#8217; AI Signatures to Inform Diagnosis and Treatment </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:87pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Caris was presented with the case of a female patient in her early 50&#8217;s with bilateral adnexal masses (growth occurring in or near the uterus, ovaries, fallopian tubes and connecting tissues), the largest of which measured 22 cm in greatest dimension. The patient&#8217;s pathological diagnosis was ovarian adenocarcinoma based on a morphological examination under a microscope. The patient underwent total abdominal hysterectomy (surgical removal of the uterus), bilateral salpingo-oophorectomy (removal of both ovaries and fallopian tubes) with pelvic debulking of tumor (removal of as much cancerous tissue in the abdomen as possible). </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:51pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A representative post-surgery tissue specimen of the patient&#8217;s right adnexal lesion was sent to Caris, to help her oncologist decide the best options for therapy. Based on the patient&#8217;s comprehensive sequencing results using WES and WTS, a GPSai&#8482; score was generated highly suggesting the colon as the malignant tissue of origin, as shown in the excerpt below: </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:106.7pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:3.5pt 0pt 4pt 0pt; width:444pt;">
              <div style="position:relative;text-align:center;">
                <img src="ph_cancercate-4c.jpg" alt="[MISSING IMAGE: ph_cancercate-4c.jpg]" height="132" width="505" >
              </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:39pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To help further validate the GPSai&#8482; finding, a panel of diagnostic IHCs (protein analysis) was performed that showed the tumor to be positive for colon-specific protein expression further pointing toward a diagnosis of colorectal cancer. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:75pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a result of these findings, the patient underwent colonoscopy that showed large nearly obstructive colonic lesion. This case was reviewed at the hospital tumor board and there was consensus that this patient would be best managed as metastatic colonic adenocarcinoma. As a result of the Caris GPSai&#8482; finding, the patient&#8217;s diagnosis and course of treatment was altered based on a detailed discussion of the results with the ordering physician. Caris also provided the FOLFIRSTai result for therapy sequencing and, through NGS, generated a targeted therapy recommendation for the treating physician. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:41.5pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;border-bottom:0.75pt solid #000000; ;padding:2pt 0pt 6pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This was an example of a use of Caris&#8217; collective sequencing and proprietary AI signatures to help a patient obtain a targeted therapy recommendation and avoid the potential cost, time and side effects of ineffective therapy.</div>
            </td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:36pt; margin-top:11.7pt; width:420pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">QuantumAI Report</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">We also use the in-depth sequencing data generated by MI Profile to produce the QuantumAI report, a research use only description of the patient&#8217;s molecular tumor biology and characterization of their phenotype using whole exome and whole transcriptome sequencing. The QuantumAI report, which we have analytically validated but not yet clinically validated, contains various biological signatures such as DNA variants counted towards TMB across the whole exome, the Catalogue of Somatic Mutations in Cancer (COSMIC) signatures resulting from a subset of TMB variants, genomic loss of heterozygosity, genomic scar score, and copy number alterations at the chromosome band level as well as exon-level copy number alterations on over 700 genes. An enhanced eKaryotype shows copy number alterations per chromosomal band along with associated confidence intervals to highlight areas of strong or likely amplifications and deletions. RNA gene expression signatures include consensus molecular subtypes (colorectal cancer), PAM50 (breast), and purIST (pancreatic). The report also includes measurements of tumor infiltrating lymphocytes and RNA heatmap expression for hundreds of genes relative to nearly 90 distinct cancer types. An additional RNA component is a circos diagram representing all RNA fusions observed across the whole transcriptome, to help oncologists and researchers understand relationships between genetic variations, mutations, and other molecular features and to help tailor precision medicine approaches. The report also </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;">
          <font style="letter-spacing:0.2pt;">172</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">features MGMTai, an AI signature that uses both DNA and RNA features to predict response to temozolomide in glioblastoma. Anticipated future additions to the report include pancreatic, lung, and breast cancer drug therapy response predictors using AI signatures, a brain metastasis predictor using AI signatures, an image of the H&amp;E stain used for sequencing, raw depth of coverage per genes/exons, gene expression interpretation and genetic predispositions. </font>
        </div>
        <div style="margin-left:36pt; margin-top:12pt; width:420pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">IHC Testing</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We leverage a broad menu of third-party IHC tests to create a customized set of tests for each patient to reveal a more complete molecular blueprint of the patient&#8217;s disease. We use IHC testing to complement our WES/WTS profiling both to inform decisions regarding therapy selection as well as to act as confirmatory testing in circumstances where our GPSai algorithm indicates a different diagnosis than that indicated in the patient record prior to our profiling or in CUP cases. We believe we have one of the broadest IHC testing menus available to patients and physicians to provide the most appropriate therapy results and diagnosis.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Testing patient specimens for protein-based biomarkers by IHC is the standard of care for both predictive and diagnostic purposes. For predictive IHCs, we run third-party companion diagnostic IHCs when available to provide therapy associations that cannot be identified through NGS testing. For example, checkpoint inhibitor therapies require IHC testing for PD-L1. We also utilize a number of third-party diagnostic IHCs to help with refining or changing a diagnosis. Most samples come to us for molecular profiling with a diagnosis in hand. However, WES and WTS provide a broad and deep data set that can help alter or refine a diagnosis. In some cases, we receive patient sample labeled as &#8216;Cancer of Unknown Primary,&#8217; where it is hoped that molecular profiling will allow a more specific diagnosis to be applied. Once we evaluate the molecular data, including the results of GPSai if applicable, our pathology team will often order diagnostic IHC testing to provide additional support for a specific diagnosis. </font>
        </div>
        <table style="width:456pt;min-height:223pt;margin-top:10pt;border-collapse: collapse;border:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="height:17.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:4.5pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">Case Study: Caris GPSai&#8482; Helps Diagnose Origin of Metastatic Malignancy </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:63pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A woman in her early 30&#8217;s presented to her primary care physician with symptoms of abdominal distension and gastrointestinal discomfort. Imaging revealed widespread metastatic disease, including pleural effusions (excess fluid in the space between the lungs and the chest wall), pulmonary nodules (small growths in the lung), and extensive lymphadenopathy (swelling of the lymph nodes). A biopsy of a soft tissue mass in the right abdominal wall was preliminarily thought to represent carcinoma. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:39pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IHC testing showed certain positive and negative markers that together led to a diagnosis by the patient&#8217;s physician of metastatic cancer of unknown primary (CUP). Seeking further clarity, the patient&#8217;s tissue sample was sent to Caris for molecular profiling and GPSai&#8482; analysis. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:39pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;padding:2pt 0pt 1pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The GPSai&#8482; result returned with a 99% probability of mesothelioma, suggesting the cancer originated from mesothelial cells, such as those lining the lungs and abdomen, rather than being a metastatic adenocarcinoma from another primary site. </div>
            </td>
            <td style="padding:0pt;background:#E1E9F2; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
          <tr style="height:65.5pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="background:#E1E9F2;border-bottom:0.75pt solid #000000; ;padding:2pt 0pt 6pt 0pt; width:444pt;">
              <div style="line-height:12pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The integration of Caris GPSai&#8482; into the patient&#8217;s care pathway facilitated a more precise understanding of her tumor&#8217;s origin and molecular characteristics, guiding personalized treatment decisions tailored specifically to mesothelioma. By pinpointing the precise nature of the cancer, Caris GPSai&#8482; enabled a more targeted and effective approach to treatment, with the goal of ultimately optimizing treatment and outcomes.</div>
            </td>
            <td style="padding:0pt;background:#E1E9F2;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;background-color:#E1E9F2;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.5pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">MI Profile for Biopharma</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Maximizing knowledge and extracting the most information out of every patient sample on a clinical trial reduces the risk of researchers missing potential efficacy or safety signals. Sequencing the whole exome and the whole transcriptome not only yields far more biomarker data from limited specimens, but also allows for the power of such comprehensive information to be aggregated and deployed to improve patient outcomes in the future via real-world data analyses. The breadth and depth of data make our methodology fundamentally different from the currently available DNA panels, which are limited by only looking at known biomarkers. We believe that a non-comprehensive, subset panel of genes or DNA-only assay that ignores RNA is an inadequate solution for efficient and successful drug development, and represents </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">173</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the central underpinning for why we believe we are uniquely positioned in the marketplace to be the industry leading innovator and strategic partner of choice for biopharma companies, to jointly bring forward the next generation of novel therapies for patients with cancer. Oncology therapeutics are inevitably shifting from single driver alterations with single biomarkers to more sophisticated and complex biomarkers that can stratify patients such as novel signatures for DNA damage response repair targeting molecules and RNA-based expression for immunotherapies. Our comprehensive WES/WTS NGS assay is optimally positioned to seamlessly validate these novel biomarkers that are already included in our assay. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Molecular profiling has broad applications for our biopharma partners, including prospective screening, retrospective testing and deep translational analyses, stratification of patients for existing or future trials, and treatment monitoring. When our tissue WES/WTS assay is deployed as an integrated component of early development programs and clinical trials, that same assay can be leveraged for companion diagnostics development and commercial services that we deliver for our partners. Commitment to Caris as registration partner allows early regulatory interactions while minimizing pharma sponsor costs, maintaining flexibility to changing timelines and evolving biomarker strategies. We have obtained a PMA approval from the FDA for MI Cancer Seek as a companion diagnostic device, and we believe approval by the FDA will serve as another important inflection point for our biopharma business. Furthermore, the comprehensiveness of our WES/WTS approach creates a deep competitive moat for us. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to testing of both DNA and RNA, we offer companion diagnostic partners opportunities to use samples sourced from our vast biobank of clinical specimens. This offers partners access to a large selection of fully characterized specimens of known positive and negative biomarker status. This can alleviate one of the most difficult hurdles of companion diagnostic development, namely access to enough biomarker-positive specimens across the minimum number of cancer types required to conduct FDA validation studies. For companion diagnostic projects involving a biomarker with low incidence, we offer partners a significant advantage. Beyond companion diagnostics, our biobank carries significant value for exploratory translational studies. When novel discoveries are made </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;">, or based on DNA or RNA, the path to validate these findings requires tissue for proteomic assessments or targets or biomarkers. Having any tissue is valuable however, our tissue biobank is unique because of the scale due to the number of cases and tests we have completed to date, the heterogeneity of tissue types which reflects cancer prevalence, and most importantly because of the amount of WES and WTS information we have generated. In aggregate, our biobank with accompanying data and digital images provides biopharma companies with a unique and highly valuable set of research tools to help validate and derisk the next wave of oncology therapeutics. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Caris ChromoSeq</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Through an exclusive license arrangement with Washington University in St. Louis (&#8220;WashU&#8221;) that we entered into in October 2024, we are developing Caris ChromoSeq, an assay that detects and analyzes hematological (blood) cancers using whole genome sequencing (&#8220;WGS&#8221;) and WTS for commercial launch. We are internally validating this assay, which is based upon the licensed assay and also includes our WTS technology, and developing it for commercial launch subject to successful validation and a successful application for reimbursement from MolDX. If successful, we believe this assay designed for genomic evaluation of patients with blood cancers would serve as a valuable complement to our existing tissue and liquid assay solutions, which are oriented towards identifying and profiling cancers of solid tumor origin, and enhance our position as a provider of choice for molecular profiling solutions. If we determine to commercialize this assay, we anticipate initially doing so as an LDT.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The licensed assay is a high coverage WGS assay currently designed and initially validated for the comprehensive genomic evaluation of patients diagnosed with acute myeloid leukemia (&#8220;AML&#8221;) or myelodysplastic syndromes (&#8220;MDS&#8221;). The licensed assay requires only 50 ng of tumor DNA (blood or bone marrow) for sequencing and is designed to identify over 600 clinically relevant chromosomal rearrangements known to be recurrent in myeloid malignancies. The licensed assay is an alternative to existing conventional diagnostic and risk assessment tools for AML and MDS, which are primarily cytogenic testing (karyotyping, or visual analysis of chromosomes), fluorescence </font><font style="font-style:italic;letter-spacing:0.2pt;">in situ</font><font style="letter-spacing:0.2pt;"> hybridization (&#8220;FISH&#8221;), or sequencing assays targeting specific genes or RNA transcripts, each of which conventional methods may provide incomplete information, have limited sensitivity, or present challenges in obtaining viable samples for testing. In a study published by WashU in 2021, the licensed assay was used to obtain genomic profiles for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">174</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">263 patients with myeloid cancers, including a 146 patient retrospective cohort and a 117 patient prospective cohort. Overall, the licensed assay identified 100% of the clinically significant abnormalities that had been identified by conventional cytogenic analysis and identified new clinically reportable genetic information not detected by conventional methods in 17% of the patients tested. Additionally, for 19 of the 117 patients in the prospective cohort (16%), analysis performed by the licensed assay changed their risk categorization on the basis of standard risk categories promulgated by the European Leukemia Network and the International Prognostic Scoring System&#8212;Revised. The licensed assay displayed similar performance as conventional cytogenetic analysis when predicting clinical outcomes using existing genetic risk groups (adjusted p=0.09 by log-rank test in groups identified by conventional testing; adjusted p=0.01 by log-rank test in groups identified by the licensed assay). The licensed assay was also found to stratify patients who had inconclusive results by cytogenetic analysis into risk groups in which clinical outcomes were measurably different&#160;(adjusted p=0.03 by log-rank test).</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WashU has obtained Medicare coverage for patients diagnosed with AML and MDS. We believe the methods used by the licensed assay, to be modified by us, can be applied to, and we are working to expand and validate the assay&#8217;s capabilities for, hematological cancers beyond AML and MDS. In order to obtain MolDX coverage for Caris ChromoSeq, we will need to submit, and MolDX will need to approve, a technical assessment for Caris ChromoSeq. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Caris Discovery</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Caris Discovery is our drug target and therapeutic discovery business. Caris Discovery leverages our profiling solutions, multi-modal clinico-genomic datasets, wet lab facilities, proprietary Adaptive Dynamic Artificial Polyligand Targeting (&#8220;ADAPT&#8221;) platform, and AI/ML-enabled </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> analyses to identify potential drug targets and develop therapeutics. We launched Caris Discovery in 2022 to partner with biopharma partners to address the lack of novel cancer-specific targets and the herding of biopharma pipelines around a discrete number of lower-risk targets. Caris Discovery is disease- and modality-agnostic and can be applied to any therapeutic modality, including antibody-directed therapies (such as antibody drug conjugates, degrader-antibody conjugates, and T-cell engagers), small molecules, targeted protein degradation, synthetic lethal interactions, cell therapy, and neoantigen discovery for personalized therapy development, among others. In addition to working with biopharma partners, Caris Discovery is developing a wholly-owned pipeline of biologics based on our platform.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An antibody-drug conjugate is a targeted cancer therapy that combines an antibody with a cytotoxic drug. The antibody specifically targets cancer cells, delivering the drug directly to them, which helps minimize the impact on healthy cells. This approach aims to increase the effectiveness of the drug while reducing side effects.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Degrader-antibody conjugates (&#8220;DACs&#8221;) are an emerging class of therapeutic agents that combine the targeting ability of antibodies with the protein degradation mechanism of degraders. DACs are designed to bind to specific proteins on the surface of cancer cells through the antibody component and then recruit the cell&#8217;s degradation machinery to eliminate the target protein inside the cell. This dual action allows for precise targeting and removal of disease-causing proteins, potentially leading to more effective treatments with fewer side effects.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">T-cell engagers are a class of artificial engagers that are designed to specifically direct the body&#8217;s immune system to target cancer cells. They function by simultaneously binding to CD3 on T cells and to a specific antigen on the tumor cell, thereby bringing the T cells into close proximity with the tumor cells, which can result in the T cells attacking and killing the tumor cells.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A small molecule refers to a low molecular weight organic compound that can regulate a biological process, with a size on the order of 1 nm. In the pharmaceutical industry, small molecules can include drugs that can be orally or intravenously administered and are often used to regulate biological processes. The term contrasts with larger molecules, such as biologics.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Targeted protein degradation is a therapeutic strategy that aims to eliminate disease-causing proteins from cells. It involves the use of small molecules, known as proteolysis-targeting chimeras, or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">175</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:252.49pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">molecular glues, that can bind to specific proteins and tag them for destruction by the cell. This approach is particularly useful for targeting proteins that are difficult to inhibit with traditional drugs or for which no inhibitors exist.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Synthetic lethal interactions in drug discovery refer to a relationship between two genes where the loss of function of either gene alone is survivable by the cell, but the simultaneous loss of both is lethal. This concept is utilized in drug discovery to target cancer cells with specific genetic mutations. By inhibiting the function of a gene that is synthetically lethal to a mutated gene already present in the cancer cell, the cell can be selectively killed without harming normal cells.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Cell therapy is a form of treatment where living cells are injected into a patient to help cure a disease. In the context of cancer treatment, cell therapy can involve the use of immune cells that are either taken from the patient or from a donor, modified in a lab to enhance their ability to fight cancer, and then injected back into the patient. This approach is part of a broader category known as immunotherapy, which aims to harness the body&#8217;s immune system to combat cancer.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we believe Caris Discovery can be leveraged to discover personalized therapies for cancer. A major paradigm-shift in cancer therapy in recent&#160;years has focused on harnessing the immune system&#8217;s ability to recognize and eliminate cancer cells. One promising approach involves using personalized therapies to stimulate the immune system against tumor-specific antigens also known as neoantigens. Those neoantigens are proteins that are produced by mutations in the DNA of cancer cells and are not present in normal cells. We believe Caris Discovery is well-positioned to be able to discover personalized neoantigens for cancer therapies given our ability to detect variants and INDELs by WES and to assess gene expression and detect fusions by WTS on every patient&#8217;s tumor. We also leverage our deep proteomics expertise utilizing mass spectrometry to validate neoantigens using our biorepository of contemporaneous molecular profiled remnant patient tissue that can be predicted by deep ML from our Caris Assure blood and MI Profile tissue sequencing. Furthermore, we can predict who may or may not respond to personalized therapies and who should be excluded from personalized therapy trials due to defects in antigen presentation machinery, such as loss of major histocompatibility complex genes due to mutations or downregulation. We are working with multiple partners that have a personalized therapy in clinical development or clinical trials. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">176</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our proprietary repositories of tissue and data, each of which we believe to be at an unmatched scale, are a resource that could not have been amassed without our underlying commercial profiling business, and as such are a significant differentiator and enabler of our discovery efforts. </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="fc_discovery-4c.jpg" alt="[MISSING IMAGE: fc_discovery-4c.jpg]" height="433" width="577" >
        </div>
        <div style="text-indent:36pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have achieved external validation of our Caris Discovery approach through strategic partnerships with established biopharma companies, such as Merck KGaA and Xencor, to develop therapeutics against novel targets that emanate from our molecular insights and proprietary technology. Our Caris Discovery partnerships are designed to emphasize both near term revenue and the potential upside of successful therapeutics developed against novel targets identified by us, thus aligning our partners&#8217; financial interests with our own. Our proprietary discovery proteomics and downstream target validation work is performed, by over 50 Caris scientists, in our R&amp;D laboratory in Tempe, Arizona, a 59,000 square foot facility that includes a cell culture laboratory and state-of the-art instrumentation dedicated to drug target discovery. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">In Silico Target Discovery Leveraging the Caris Clinico-genomic Dataset</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Caris Discovery leverages our multi-modal clinico-genomic datasets to define clinically relevant cohorts of unmet need for drug target discovery. Stratifying cases by molecular profile, histology, and/or clinical features </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> prior to performing our proprietary proteomic work on the profiled cases in our tissue repository is extremely powerful to identify drug targets in highly relevant therapeutic areas. Once potential targets are identified, the clinico-genomic data can be integrated with our proteomics data and can be utilized to filter the initial target pool down to the targets with the highest potential value for further downstream wet-lab validation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The proteomics work leveraging our </font><font style="font-style:italic;letter-spacing:0.2pt;">in silico</font><font style="letter-spacing:0.2pt;"> discovery work is driven by three complimentary components: (1)&#160;our ADAPT Biotargeting, (2)&#160;Proximity Labeling, and (3)&#160;the Caris Surfacesome. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">ADAPT Biotargeting&#8212;Aptamer-Based Proteomics Discovery System.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our ADAPT system uses a broad library of synthetically manufactured molecules called aptamers that bind to a wide range of biological targets and characterize complex biological systems, enabling the profiling </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">177</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of biological samples at a systems-wide scale coupled with affinity purification-mass spectrometry to identify the underlying target proteins. ADAPT is able to simultaneously measure millions of molecular interactions within complex biological systems in their natural states and directly from patient tissue. ADAPT is powered by real world contemporaneous patient samples, including our combined clinico-genomic datasets, thus overcoming the limitations of traditional target discovery approaches, such as comparative genetics, molecular pharmacology of variants, analysis of molecular signaling pathways, cell-based and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> disease models, limited panel based proteomics with a defined set of target proteins and traditional proteomics, which result in a high degree of off-target activity, false positives and bias, and lack enrichment of patient enriched cancer proteins. ADAPT allows us to make unbiased identification of unique features of disease state and allows for elucidation of novel biological mechanisms. Actionable drug targets (or molecular markers) include proteins that are present in diseased tissue but low to no detection in normal tissue. Traditional biomarker discovery tools suffer from a signal to noise challenge and require a hypothesis of where to look before being deployed. ADAPT can filter out features shared by both cancer and normal cells and enriches for features specific to cancer cells. </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Proximity Labeling&#8212;Antibody-based Proteomics Discovery System.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We also apply proximity labeling on molecularly profiled remnant patient tissue to examine protein-protein interactions as well as to identify components that localize to discrete subcellular compartments. This approach enables us to identify actionable drug targets in patient tissue and permits the systemic analysis of spatially restricted proteomes. Applying proximity labeling on our proprietary tissue profiling data has resulted in the discovery of numerous novel drug targets potentially actionable for bispecific antibodies, dual targeting antibody modalities, and cell therapies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Caris Surfacesome.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Cell-surface proteins are key to antibody-based therapeutics, and we have developed our own cell surfacesome comprising a database of cell surface proteins detected by mass spectrometry. This in-house database comprises genomic, transcriptomic, and proteomic data for multi-omic data analysis in addition to prepared cytosections and live cells instrumental for antibody quality control and wet-lab validation of drug targets discovered from our Aptamer and Antibody-based discovery systems. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Caris Strategic Data</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Data and molecular information are at the core of every aspect of our business. Our team of more than 60 data scientists deploy our proprietary advanced AI/ML algorithms to decipher unique features from our resulting clinico-genomic datasets, helping us decode and further unravel the molecular complexity of disease. Our 17-year history of utilizing AI and ML algorithms, together with the breadth and depth of our clinico-genomic datasets, provide us a significant advantage in sophisticated analysis of cancer, and a foundation that we believe will have applications in additional disease states. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of March 31, 2025, we have run more than 6.5&#160;million tests that have measured over 38&#160;billion molecular markers from over 13 quadrillion datapoints. To assist us with analyzing the data we generate, we utilize over 220 AI and AI/ML tools across our clinical testing, R&amp;D, and biopharma business. These tools include over 50 clinical sequencing automation and variant calling AIs, over 100 RNA expression AI signatures, approximately 20 multi-omic AI/ML therapy response predictors, two ADAPT target discovery AI/ML algorithms, 37 digital image AI/ML classifiers, and 12 AI/ML support tools. This tremendous amount of data, which we have deidentified for research use, provides us a differentiated capability to advance precision oncology research through many business models, including training new profiling solutions and signature development, therapy development, and research into new ways to treat and cure disease, including personalized treatments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our goal is to develop the next generation of precision medicine tools that will allow us to transition from intuitive medicine to empirical medicine. As a leader in the transition to WES/WTS sequencing through our launch of a WTS solution in 2019 and a WES solution the following year, we believe we have more molecular data and information than any other company and are well-positioned to make precision medicine widely accessible. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">178</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Power of Big Data</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With a dataset as large as ours, a key task is to reduce the dimensionality of data to those key features that are useful to understanding the systems biology while avoiding any preconceived bias in how we might expect the features to be related. We accomplish this through mathematical embedding, which we use to reduce the dimensionality of the datasets to provide powerful insights into the underlying relationships within the data. This massive amount of information, across the whole transcriptome and multiplied across hundreds of thousands of patients, then undergoes a process where features that tend to occur together more often (or clusters) are associated into a multidimensional vector space. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">One example of this methodology, and how additional data drives better predictions, can be seen in the pictures below, which show the clustering of a single gene set enrichment analysis (GSEA) across increasingly large datasets, from our research into a predictive algorithm for brain metastasis. This clustering, which reflects screening through AI to reduce dimensionality and identify underlying clusters, shows that meaningful clustering groups can only be seen with larger amounts of data. The clusters become increasingly visible as the datasets grow from 1,000 to 200,000 cases. </font>
        </div>
        <div style="position:relative;margin-top:9.6pt; text-align:center; width:456pt;">
          <img src="ph_powerofbigdata-4c.jpg" alt="[MISSING IMAGE: ph_powerofbigdata-4c.jpg]" height="170" width="578" >
        </div>
        <div style="text-indent:36pt; margin-top:12.2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In this study, once we identified the relevant clusters, we then used the coordinates of the clusters as inputs into a separate AI/ML model that would predict the likely outcome&#8212;in this case, whether a patient was more or less likely to develop a brain metastasis. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our in-depth profiling of patient samples has led to the creation of what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology based on the more than 6.5 million tests we have run on over 849,000 cases, which have generated measurements of over 38&#160;billion molecular markers. Leveraging high-powered computing and AI/ML algorithms, we, and our biopharma and research partners who use our data and bioinformatics services, analyze our datasets to determine the key molecular characteristics of a particular disease or dysfunction that drives disease, enabling signature identification and drug target discovery. We believe this wealth of data and processing power, together with whole-slide imaging, our tissue and slide repository, can help our researchers and external partners gain previously unattainable insights about specific patient populations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A study that we recently published in </font><font style="font-style:italic;letter-spacing:0.2pt;">Nature Communications</font><font style="letter-spacing:0.2pt;">, a peer-reviewed scientific journal, demonstrated the power of our real-world clinical and genomic dataset, augmented through agreements with external providers of clinical outcomes data, to drive clinical insights. This study evaluated real-world outcomes for patients eligible for available tissue-agnostic&#160;therapies, which are powerful &#8220;pan-cancer&#8221; therapies that target specific molecular alterations across multiple cancer types and of which several have FDA approval. The study, using the largest real-world clinical and genomic dataset of tissue-agnostic indications reported to date across more than 295,000 de-identified patients and over 50 tumor types, demonstrated that over 20% of cancer patients are candidates for a tissue-agnostic therapies based on current FDA-approved indications. Additionally, the study found that over 5% of patients lacking any tumor-specific indication were found to carry a tissue-agnostic indication and thus to be candidates for a tissue-agnostic therapy. The study also generated insights into the different outcomes produced by tissue-agnostic therapies in different tissues. We believe the datasets built by our profiling solutions help enable further development of clinical insights with therapeutic and economic implications. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This study was conducted in 2024 by our researchers using data from all patients who had undergone comprehensive tissue sequencing at our Phoenix tissue laboratory between 2015 and 2023, who had successful </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">179</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">sequencing results, and for whom claims data was available. The study primarily measured time-on-treatment (&#8220;TOT&#8221;), determined as the interval from the initiation to the conclusion of treatment with an indicated therapy, and overall survival (&#8220;OS&#8221;), defined as the period from treatment initiation to the date of the patient&#8217;s last known clinical activity. Kaplan-Meier survival estimates were generated for patient cohorts defined by molecular characteristics. Significant p-values (generally p &lt; .05) were seen for the following major analyses of highly clinically relevant indications: (a) poor clinical uptake of therapies targeting NTRK gene fusions, which are rare but potent drivers of tumor growth that promote cancer cell survival and proliferations; (b) differences in tissue specific outcomes in TMB-high and MSI-high settings, as well as in BRAF V600E-mutant cancers; and (c) differences in TOT and OS outcomes for non-trial patients receiving pembrolizumab and similar TOT benefit of pembrolizumab and nivolumab, two widely-used PD-1 inhibitor therapies, for patients with TMB-high tumors across various cancer types. Collectively, these analyses test the assumption that FDA-approved tissue-agnostic therapies are truly tissue-agnostic in the sense of having similar benefits across all tumor types, and demonstrate the power of large real-world datasets combining clinical data with NGS data, such as the comprehensive data generated by our solutions, to further the medical community&#8217;s understanding of cancer.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Data for Biopharma</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We launched our data licensing business in late 2022. We license deidentified multi-modal datasets, components of which were generated from our clinical profiling business to external researchers, including those with biopharma companies, with the aim of generating insights directly responsible for superior clinical outcomes for patients. As the adoption of our tissue and blood-based profiling solutions continue to grow, this will result in further expansion of our multi-modal datasets, which can provide additional valuable insights to aid biopharma companies&#8217; drug discovery and development efforts to bring innovative therapies to market. We utilize a third-party tokenization process to match deidentified data from various sources to create the multi-modal product. The linked data is then provided to the external researcher. Prior to the tokenization process, we run a series of software solutions through standardized data fields designed to remove and replace any PHI with a randomly-generated string of letters and numbers. We then use a third-party expert to certify that the data is deidentified pursuant to 45&#160;CFR &#167;164.514(b)(1) under HIPAA. We contractually require recipients of the data to maintain compliance with laws and regulations. The end customer takes on the contractual responsibility to properly maintain the data, not to attempt to reidentify any patient from the deidentified data set, and to obtain its own expert certification before combining the Caris data with any other data. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To further broaden the applicability and usefulness of our multi-modal datasets for biopharma companies, we have entered into agreements with clinical data partners, such as ConcertAI, Flatiron and COTA, to enable the creation of matched clinico-genomic datasets that can be licensed to biopharma companies for their use in drug discovery. These datasets generally consist of Caris molecular profiling data (and in some cases claims data), together with matched clinical data from our partners. We and our partners have entered into agreements with AbbVie, Moderna, and others to license our datasets for use in drug discovery. Together, our combined multi-modal data create a differentiated capability to advance precision oncology research through novel target identification and discovery, translational sciences, clinical trial design solutions and patient enrollment facilitated by our right-in-time trials network, post-market label expansion, and commercialization insights. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have a rich pipeline of data opportunities that we believe will deliver new partnerships, as we continue to introduce biopharma companies to this unique data offering. In addition, many of our biopharma-related data initiatives and data partnerships allow for the flow of multi-modal data to our internal research teams, providing further synergies and enabling AI/ML powered research across the broader Caris enterprise. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Data for Clinical Research: The Caris Precision Oncology Alliance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We established the Caris POA in 2015. The Caris POA is a growing network of leading cancer centers and research consortia across the globe that supports research partner engagement, collaboration opportunities, and the advancement of precision oncology research. It consists of members that demonstrate a commitment to precision medicine and work collaboratively toward a common goal: to advance tumor </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">180</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">profiling and establish and optimize standards of care for molecular testing through innovative research to improve clinical outcomes for cancer patients. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of March 31, 2025, the Caris POA was comprised of 96 members. This represents a five-fold growth in total membership since 2017. Additionally, since 2020, we have more than doubled the number of NCI-designated comprehensive cancer centers in the Caris POA, from 20 in 2020 to 45 as of March&#160;31, 2025. </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="bc_carispoanet-4c.jpg" alt="[MISSING IMAGE: bc_carispoanet-4c.jpg]" height="447" width="596" >
        </div>
        <div style="text-indent:36pt; margin-top:13.4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We estimate that the members of the Caris POA have over 3,000 oncologists in over 650 locations that treat more than 650,000 new cancer patients annually. Members participate in the various activities of the Caris POA through the following: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">profiling cancer patients using our comprehensive profiling solutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing guidelines to integrate molecular testing into cancer care and patient treatment management; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">participating in research studies and clinical trials, both prospective and retrospective; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborating in molecular tumor boards to advance the institution and industry&#8217;s understanding of cancer and the clinical utility of profiling in clinical care; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tracking longitudinal outcomes and contribute data to the Caris POA; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">publishing novel research and clinical data. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As part of the Caris POA collaboration, we contribute de-identified molecular data obtained from tumor profiling of cancer patient samples, and our partners have an opportunity to contribute outcome or clinical data for use in joint research projects. Physicians and researchers across the Caris POA network are provided with information from our datasets as part of our mission to give greater access to and disseminate </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">181</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">this data in furtherance of creating solutions for oncology. Caris POA members access our datasets through CODEai, a custom interface for our multi-modal clinico-genomic datasets that we launched in 2020. CODEai allows users to explore a cohort of over 295,000 matched datasets and clinical outcomes. CODEai users can define patient cohorts of interest and direct the underlying AI to mine the data, extract cogent information such as molecular markers that correlate with defined patient cohorts, and perform various analyses. Working with leading oncologists at Caris POA member sites, we have established a number of tumor-specific working groups comprised of key academic thought leaders and subject matter expertise to assist us in ensuring our profiling components remain clinically up-to-date with the latest important molecular markers and testing threshold criteria. </font>
        </div>
        <div style="position:relative;margin-top:10.6pt; text-align:center; width:456pt;">
          <img src="lg_datacliniclogo-4c.jpg" alt="[MISSING IMAGE: lg_datacliniclogo-4c.jpg]" height="640" width="578" >
        </div>
        <div style="text-indent:36pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We also contribute to academic research to advance the understanding of molecular science and further enable the delivery of precision medicines through our collaborations with member institutions within the Caris POA. We routinely collaborate with leading cancer centers to publish and present new learnings with immediate implications on the clinical use and utility of comprehensive molecular profiling. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">182</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:37.04pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Together with collaborators, our medical and scientific experts have authored over 380 manuscripts in peer-reviewed medical and scientific journals, and more than 660 abstracts, posters and presentations at leading industry conferences and symposiums that expound on our innovative platforms and technologies. </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="bc_publications-4c.jpg" alt="[MISSING IMAGE: bc_publications-4c.jpg]" height="447" width="597" >
        </div>
        <div style="margin-top:18.69pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Data Driving Development of New Clinical Solutions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">A significant benefit of generating WES and WTS results for every eligible patient is that the resulting dataset becomes a unique and proprietary resource to fuel the development of new molecular-driven signatures, products, and profiling solution enhancements that are only possible due to the availability of large datasets. Our datasets have also been augmented through agreements with external data providers. We have leveraged our vast datasets to drive the development of AI-based signatures and other enhancements, including our ABCDai algorithm and hundreds of other AI algorithms that are used in our bioinformatics pipelines for our profiling solutions. These solutions are designed to allow us to better leverage our data to improve patient outcomes and significantly differentiate us from our competitors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We plan to utilize our datasets and molecular profiling knowledge to continue to create proprietary molecular signatures that leverage NGS-based testing results and to utilize digital scans of tissue slides to predict the presence of certain molecular markers without the need for NGS profiling. In addition, we plan to establish patient-level prognosis and prediction of therapeutic benefit, with an initial focus on breast cancer, but that we believe will have therapeutic benefits across all cancer types. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">183</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tb_molecular-4c.jpg" alt="[MISSING IMAGE: tb_molecular-4c.jpg]" height="369" width="582" >
        </div>
        <div style="margin-top:17.99pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Caris Proprietary Molecular AI/ML Driven Signatures</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We plan to utilize our datasets to continue to create proprietary molecular signatures and potentially establish patient-level prognosis and prediction of therapeutic benefit, with an initial focus on breast cancer. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to our two clinically validated proprietary molecular signatures, GPSai and FOLFIRSTai, which can be ordered as part of MI Profile, we have a pipeline of proprietary molecular signatures that we are in the process of refining and validating. For example, we are developing MGMTai, a predictive signature that will help oncologists assess a patient&#8217;s risk of developing brain metastases, and other signatures in development include pancreatic cancer response predictors, a predictor of response to checkpoint inhibitor therapy for lung cancer patients, and a predictor of response to platinum-based therapies for ovarian cancer patients. Similar to our FOLFIRSTai signature, we believe these types of multi-omic, ML-driven signatures will add significant and differentiating clinical value to our solutions, positioning our profiling solutions as the most complete and comprehensive for late-stage cancer available. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that whole exome and whole transcriptome data is critical to develop robust AI signatures. For example, we are using whole exome and whole transcriptome data to train two AI signatures that predict therapeutic responses, which are in the early stages of development. The first AI signature that we are training predicts the response of lung cancer patients to immunotherapy and chemotherapy. This model demonstrated the capability to identify, at a p-value of less than 1%, patients that would benefit from immunotherapy along with chemotherapy, versus patients for whom chemotherapy would not be expected to have a benefit, with a sample size of 94 patients across both patient groups. Over 60% of several hundred genes and transcripts that this model identified as the most significant features are not included in a commercially available 700-gene panel. The second AI signature that we are training predicts response of pancreatic cancer patients to FOLFIRINOX and Gemcitabine + Abraxane&#174;. This model was shown to identify, at a p-value of less than 1%, Stage IV pancreatic patients who would have a survival benefit from FOLFIRINOX treatment but not Gemcitabine + Abraxane&#174;, and vice versa, with a sample size of 112&#160;patients across both patient groups. Of the dozens of molecular features that feed into this model, nearly half are not analyzed in a commercially available 700-gene panel. Thus, we do not believe these types of models could be replicated without whole exome and whole transcriptome data like that produced by our sequencing solutions. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">184</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our basic strategy for molecular signature development is to utilize our proprietary WES/WTS and claims data clinical databases for initial signature creation, with validation in external datasets (when advisable), including datasets that have been developed in other prospective clinical trials. These external datasets will, in many cases, be derived from active and ongoing collaborations with cooperative oncology groups or single academic institutions, many of which are active members of the Caris POA. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Digital Pathology Innovation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are also utilizing our datasets and AI/ML analysis to develop the ability to use digital scans of tissue slides to predict the presence of certain biomarkers without the need for NGS profiling. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have captured more than 4.4&#160;million images of patient tumor tissue as of March&#160;31, 2025, including approximately 3.1 million digitized IHC images and approximately 1.4&#160;million digitized hematoxylin and eosin (&#8220;H&amp;E&#8221;) images, and each image is associated with the patient&#8217;s full WES/WTS profile and clinical information. The workflow for WES and WTS sequencing of patient tumor tissue requires the sectioning of a Formalin Fixed Paraffin Embedded tissue specimen, leading to the creation of a set of unstained slides containing the patient&#8217;s tumor material. We stain two slides with traditional H&amp;E reagents, others with antibodies for downstream IHC testing, and others with Nuclear Fast Red stain to facilitate microdissection and DNA/RNA extraction for sequencing. We have implemented a fleet of seven Pramana SpectralHT next generation, robot-controlled digital slide systems (each with four scanners for 28 total scanners) to capture ultra high-definition images of all H&amp;E and IHC slides. The images are used to drive efficient and rapid analysis and processing during the testing workflow and also provide a unique and previously unavailable rich resource to fuel new assay development and innovation based on image-driven AI. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our data scientists are using this powerful combination of molecular and visual data together to fuel the development of new image-driven AI signatures. The goal is to use the molecular data to validate AI signatures that can predict molecular status based on the digital slide image alone. The applications of this new approach include rapid image-based diagnosis, biomarker status determination, and prognostic determinations rapidly and cost-effectively, using just the slide image. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are currently using an AI/ML approach driven by H&amp;E slide images and clinical results data from more than 10,000 breast cancer patients to develop ESPai, a new algorithm to predict the risk of disease recurrence for early-stage breast cancer patients. We have obtained the samples and clinical data from the National Surgical Adjuvant Breast and Bowel Project and the ECOG-ACRIN Cancer Research Group. We are currently in the process of creating two AI/ML models for ESPai using these samples and are working to obtain additional samples for external validation studies. We are initially creating a model for late recurrence (five to 15 years following diagnosis), but we are also in the beginning stages of creating a model for early recurrence (zero to five years following diagnosis).</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As an additional example, we have developed an AI tool that uses the digital image of a slide that has been stained with traditional H&amp;E reagents to predict whether a patient has an increased likelihood for being positive for a ROS1 fusion, which is a particular type of gene fusion that is associated with non-small cell lung cancer. Biopharma companies developing new ROS1-targeted therapies typically must use NGS or FISH testing to screen more than 100 patients to identify one or two positive patients, resulting in very high cost and long timelines for clinical trials. The Caris ROS1 AI signature can be used on the slide alone and identify patients who are 33 times more likely to be ROS1 positive, thereby reducing the number of patients who need to be screened by more expensive and precise methods by more than 97%. Imaged-based, low-cost AI signatures like this might also be useful in the future in countries with limited access to sequencing technology. We expect to develop more of such image-based AI signatures using the power of ML on the combined image and molecular datasets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Laboratory Infrastructure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have built substantial testing capacity with throughput capabilities of over one trillion &#8220;reads&#8221; per day. We operate two precision medicine laboratories in Phoenix, Arizona, and one R&amp;D laboratory in Tempe, Arizona. Our Arizona laboratories all utilize state-of-the-art genomic sequencing technology, including 50 NovaSeq sequencing systems. Our newest laboratory facility in Irving, Texas, near our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">185</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">headquarters, is continuing to be built-out and will bring our total operational capacity to over 275,000 square feet. We believe this operational capacity provides us with ample capability to manage future growth. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our solid tissue clinical laboratory in Phoenix, Arizona is an approximately 66,000 square foot, state-of-the-art laboratory. We provide high quality, reliable molecular testing services for all stages of the drug development cycle and routine clinical use. From pre-clinical research for compound development efforts to&#160;established, commercially available therapies, we provide robust genomic and proteomic testing capabilities across a variety of specimen types and high-throughput technologies. This laboratory has the following certifications: ISO 15189, ISO 13485, CLIA: CMI&#160;03D1019490, College of American Pathologists (&#8220;CAP&#8221;): 7195577, and New York State Department of Health. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our blood-based clinical laboratory in Phoenix, Arizona is approximately 35,500 square feet. This laboratory started testing operations in February&#160;2022 following the installation of liquid-handling robots and NovaSeq sequencing systems. This laboratory has the following certifications: ISO 15189, CLIA:&#160;CMI&#160;03D2210981 and CAP: 9536852. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We also have an approximately 59,000 square foot R&amp;D laboratory in Tempe, Arizona that is utilized for R&amp;D and therapeutic discovery work. This laboratory has ISO 13485 certification. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have leased an approximately 114,500 square foot facility in Irving, Texas, close to our corporate headquarters, which includes office space and will house a clinical laboratory. We expect to build out the clinical laboratory in phases in the future to coincide with product launches and provide us with additional profiling capacity as we continue to grow our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We test patient samples on the most powerful sequencing systems available, which are built for high throughput sequencing, scalability, and speed and allow for high throughput more economically than prior platforms. Our use of high performance NGS sequencing systems improves our throughput efficiencies and lowers our cost of sequencing. We have an installation of 50 NovaSeq sequencing systems as of March&#160;31, 2025. In addition to NGS, we employ other technologies in our operations, including 33&#160;liquid handling robotic systems, ultra HD digital image scanning, dynamic light scattering, flow cytometry, fragment analysis, IHC, </font><font style="font-style:italic;letter-spacing:0.2pt;">in situ</font><font style="letter-spacing:0.2pt;"> hybridization, laser capture microdissection, mass spectrometry, Sanger sequencing, pyro sequencing, quantitative polymerase chain reaction, RT-PCR, and surface plasma resonance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Commercialization Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The precision medicine industry is characterized by rapid changes, including technological and scientific breakthroughs, frequent new product introductions and enhancements, and evolving industry standards. Education of customers, both physicians and biopharma companies, remains one of the key barriers to higher adoption of molecular profiling. More than ever, oncologists need a trusted profiling partner to provide reliable, high-quality molecular profiling information to guide precise and individualized treatment decisions. Our relationships across key oncology stakeholders include more than 5,600 physicians and partnerships with more than 100 biopharma companies. Additionally, we have executed agreements with or recently engaged in commercial discussions with all of the top 30 pharmaceutical companies measured by market capitalization. We have optimized our systems to provide industry-leading reports, service, and turn-around-time, helping oncologists (1)&#160;navigate among therapies with potential benefit, (2)&#160;identify therapies that may not have been considered, (3)&#160;determine drugs with potential lack of benefit (avoiding unnecessary toxicities and costs), and (4)&#160;match patients to clinical trials. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, we market our solutions to clinical customers through our marketing and commercial sales organizations. Our commercial footprint consisted of nearly 300 sales team members at the end of 2021 compared to approximately 275 sales team members and approximately 25 marketing team members at the end of 2024. Since the end of 2021, the size of our sales organization has generally remained constant, though the team has grown slightly during certain periods and contracted slightly in others. Our sales team members cover the entire U.S. market, focusing on the community setting where the majority of cancer patients are treated. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, as of March 31, 2025, we had nearly 50 highly trained Ph.D. or M.D. MSLs who focus on physician and provider education and consultation, enabling us to provide a personalized consultation experience for oncologists. MSLs are responsible for communicating the value of Caris to external </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">186</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">stakeholders, such as physicians, nurses, scientists, and other interested parties. This communication primarily involves face-to-face discussions with customers. The MSLs use a variety of opportunities such as molecular tumor boards, educational seminars, and conference participation to act as a conduit of information and feedback between the medical community and us. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Decisions about which profiling services to use have become increasingly &#8220;institutionalized,&#8221; where cancer center directors and other medical leaders are adopting the approach of designating a &#8220;preferred partner&#8221; that is a technology and service leader for molecular profiling services. We believe that the Caris POA and our deep, high-quality institutional relationships provide us with an advantage in being selected as a preferred partner, and we expect this trend to continue to accelerate to further drive growth in ordering of our profiling solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We market our solutions to biopharma companies through a separate Biopharma Business Development team. This team is differentiated from traditional sales organizations by recruiting professionals with a diversity of direct biopharma experience and strong scientific backgrounds and business acumen. We believe the credibility that our partnering team brings to discussions with biopharma companies has been well-received, and when combined with our profiling solutions and molecular datasets, has created a strong competitive edge.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We estimate that approximately two-thirds of our top 200 customers based on case volume were either academic medical centers or corporate physician practices. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">International Distribution</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Globally, we market our solutions through distributors and direct contracts with hospital systems, where permitted by the applicable regulations. Our distributors are generally obligated to obtain required in-country regulatory approvals and comply with in-country regulations. We have performed our clinical solutions to patients in over 50 countries since 2022 and are considering filing for regulatory approvals in Japan and the European Union. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EHR Integration and Electronic Ordering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have established bi-directional electronic healthcare record (&#8220;EHR&#8221;) interfaces with individual institutions and/or specific provider locations. Test ordering can be done within the local EHR, and discrete test results can be returned to the ordering site automatically. We have integrated connections with every major EHR vendor. In addition to EHR integrations, we have a physician portal in which physicians can order testing and receive clinical reports electronically. Together, our EHR and portal ordering constituted approximately 47% of our clinical volume during 2024, and approximately 58% of our clinical volume during the three months ended March 31, 2025. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Competition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The precision oncology industry is highly competitive and subject to rapid change. An increasing awareness of the importance of genetic information to accurately understand cancer and deliver solutions for early detection, MRD tracking, therapy selection, and treatment monitoring is leading to more companies offering services in genomic profiling and sequencing. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our competitors in tissue-based molecular profiling include Foundation Medicine (Roche) and Tempus. In addition, some academic centers, such as Memorial Sloan Kettering Cancer Center and New York Presbyterian&#8201;&#8212;&#8201;Weil Cornell, offer profiling to patients in their networks. Our competitors in blood-based early detection include Grail, Freenome, Guardant Health, Exact Sciences, and Delfi Diagnostics, among numerous other companies pursuing the early detection market. Our competitors in blood-based molecular profiling for therapy selection include Guardant Health and Foundation Medicine (Roche). Our competitors in blood-based molecular profiling for MRD tracking and treatment monitoring include Natera, Guardant Health, and Adaptive Biotechnologies. Our competitors in core biopharma services include Foundation Medicine (Roche), Guardant Health, Tempus, Natera, and Personalis, among others. Our competitors in offering genomic data and AI services include Tempus and Foundation Medicine (Roche). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">187</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other companies offering testing in the precision oncology industry include Illumina, NeoGenomics, Myriad Genetics, Laboratory Corporation of America, Quest Diagnostics, and BostonGene. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some of these companies may have substantially greater financial and other resources than we have, such as larger R&amp;D staff and more established marketing and sales forces, or may operate in jurisdictions where lower standards of evidence are required to bring products to market. In addition, other established diagnostic, medical technology, biotechnology, or pharmaceutical companies may decide in the future to invest heavily to accelerate discovery and development of similar services that could make our solutions less competitive. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that we compete favorably based on the following competitive factors: our patient-first approach that includes deep sequencing all DNA encoding genes and RNA transcripts utilizing comprehensive WES and WTS, enabling us to provide patients and physicians with industry-leading breadth, depth, and accuracy of multi-omic information; our tissue-based molecular profiling solution; our novel, universal blood-based profiling solution; our large and comprehensive multi-modal clinco-genomic dataset; our specialized commercial channel, robust infrastructure, and deep research collaborations; and our highly experienced management team. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Protection of our intellectual property is fundamental to the long-term success of our business. We seek to ensure that investments made into the development of our solutions to transform healthcare through the use of comprehensive molecular information, AI/ML algorithms, and proprietary molecular technologies are protected by a combination of patents, trademarks, copyrights, trade secrets, license agreements, confidentiality agreements and procedures, employee agreements (such as proprietary information, intellectual property, restrictive covenant, and arbitration agreements), and other legal and contractual rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patents</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We seek patent coverage for our foundational multi-cancer, multi-purpose molecular profiling solutions for tissue and blood and for our R&amp;D activities, including biomarker discovery using our expansive molecular profiling datasets and tumor tissue archive. Our policy is to enter into invention or patent assignment agreements with our employees and consultants that obligate these employees and consultants to assign to us any inventions they develop while working for us. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our company-owned and in-licensed patents and applications generally fall into the following categories: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Patents and applications related to our molecular profiling services.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of March 31, 2025, we owned 79 patents (including three allowances) and 75 pending applications, and had an exclusive license to one patent application, which collectively relate to our molecular profiling solutions, including claims directed to early detection of cancer, monitoring disease recurrence, identifying treatments of likely benefit or lack of benefit for cancer patients, and the use of AI and ML for prediction of response to various cancer therapies, prediction of tumor origin, and to assess other characteristics of cancers based on NGS data and/or digital pathology. The Caris-owned patents and applications are assigned to our subsidiary Caris MPI, Inc. and include 17 issued U.S. patents, 16 pending U.S. applications, 62 foreign patents (including three allowances), and 59 pending foreign applications. The in-licensed patent application is a U.S. application and is exclusively licensed to Caris MPI, Inc.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Patents and applications related to our pharma research and development services</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As of March&#160;31, 2025, we owned 103 patents (including four allowances), and&#160;24 pending applications, and had exclusive licenses to 43 patents and applications, which collectively relate to aptamer library screening and uses thereof, including uses in biomarker discovery, as well as cell targeting constructs and therapeutic applications thereof. The Caris-owned patents and applications are assigned to our subsidiary Caris Science, Inc. and include 16 issued U.S. patents, six pending U.S. applications, 87 foreign patents (including four allowances), and 18 pending foreign applications. The in-licensed patents and applications are exclusively licensed to Caris Science, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">188</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Inc. and include two issued U.S. patents, one pending U.S. application, 36 foreign patents, and four pending foreign applications. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Patents and applications of particular importance within our portfolio that relate to our commercial molecular profiling services include:</font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">63 patents and ten pending applications directed to systems and methods for comprehensive molecular profiling for cancer patients independent of cancer type. These include 14 issued U.S. patents and one pending U.S. application, and 49 foreign patents (including two allowances) and nine pending foreign applications between Australia, Austria, Belgium, Canada, China, Denmark, Europe, Finland, France, Germany, Iceland, India, Ireland, Israel, Italy, Japan, Mexico, Luxembourg, the Netherlands, Norway, Portugal, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, and the United Kingdom. These patents and applications are Caris-owned and assigned to our subsidiary Caris MPI, Inc., and are expected to expire between 2027 and 2033;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">One issued patent in Japan and 17 additional pending applications directed to AI/ML systems and methods for predicting cancer type. These include two pending U.S. applications, one PCT application, and 14 pending foreign applications between Australia, Canada, Europe, Israel, Japan, South Korea, and Mexico. These patents and applications are Caris-owned and assigned to our subsidiary Caris MPI, Inc., and are expected to expire between 2040 and 2044; and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">14 patents (including one allowance) and 16 pending applications directed to AI/ML systems and methods for predicting response to platinum compounds, including FOLFOX regimens. These include three issued U.S. patents and two pending U.S. applications, and 11 foreign patents (including one allowance) and 14 pending foreign applications between Australia, Canada, Europe, France, Germany, Ireland, Israel, Japan, South Korea, Mexico, Netherlands, Switzerland, and the United Kingdom. These patents and applications are Caris-owned and assigned to our subsidiary Caris MPI, Inc., and are expected to expire between 2039 and 2040. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additional patents and applications with varying levels of importance within our portfolio that relate to our commercial molecular profiling services include:</font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">16 pending applications directed to AI/ML systems and methods for predicting response to various chemotherapies. These applications are Caris-owned and are expected to expire in 2041; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Six pending applications directed to AI/ML systems and methods for predicting likelihood of metastasis. These applications are Caris-owned and are expected to expire between 2041 and 2045; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">One pending application directed to profiling hematological malignancies using whole genome sequencing. This application is exclusively in-licensed and is expected to expire in 2042. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additional patents and applications with varying levels of importance within our portfolio that relate to our pharma research and development services include:</font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">38 patents directed to methods for use of microvesicles and microRNA as cancer biomarkers. These patents are exclusively in-licensed and are expected to expire in 2028;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">47 patents and six pending applications directed to methods of sequencing aptamer libraries to detect targets of interest. These patents and applications are Caris-owned and expected to expire between 2028 and 2033; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">47 patents (including two allowances) and nine pending applications directed to methods for aptamer library enrichment. These patents and applications are Caris-owned and are expected to expire between 2028 and 2038; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Nine patents (including two allowances) and 14 pending applications directed to compositions and methods related to cell-targeting technologies. These patents and applications are either Caris-owned or exclusively in-licensed and are expected to expire between 2036 and 2044. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">189</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The expiration dates described above are subject to, in the case of pending applications, our continued prosecution to allowance at the applicable patent offices, and in the case of allowed, issued and granted patents, our payment of applicable issue fees, maintenance fees and annuities. Patent expiration dates are estimates and may be subject to terminal disclaimers and patent term adjustments.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In some instances, we have acquired or in-licensed patent rights developed by third parties to enhance our patent portfolio and competitive advantage. For example, we have acquired patent families related to aptamer technologies and in-licensed patent applications related to cell targeting and hematological cancer assay technologies that are currently under development. Under such license agreements, we would be obligated to pay royalties for future sales in which the patents are used in the product or service sold. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Trade Secrets</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to patent protection, we have determined that certain technologies are better kept as trade secrets, such as aspects of our NGS methodology, bioinformatic analysis techniques, and identity of cancer biomarkers under development. We have a policy to restrict access to our trade secrets to a need-to-know basis. To further mitigate the chance of trade secret misappropriation, we enter into confidentiality agreements with parties who have access to trade secrets, such as our employees, collaborators, outside scientific collaborators, consultants, advisors, and other third parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Brand Protection</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our customers and partners recognize us as a leader in the molecular profiling field. Thus, just as patent and trade secret protection is essential to protecting our technology, we believe that it is equally as important for us to protect our brand and identity. We have obtained, and will continue to obtain, trademark protection for our name, logo, and solutions in countries where we operate, including our MI Profile and Caris Assure branding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Additional Information</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We will continue to pursue intellectual property protection, whether developed in-house or via third parties, that we believe will advance our business objectives. Despite our efforts and vigorous defense, our intellectual property rights in the United States and abroad may be invalidated, circumvented, or challenged in the future. In addition, the laws of various countries where our solutions are distributed may not protect our intellectual property rights to the same extent as the laws in other countries. For additional information, see the section titled &#8220;Risk Factors&#8212;Risks Related to Intellectual Property.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our regulatory strategy aligns with our overall business objectives. We believe that receiving FDA approval of our diagnostic solutions would positively impact our ability to sell our solutions and enhance our reimbursement efforts with payers, including Medicare. The current marketing status and relevant regulatory approvals obtained, planned, and/or potentially required for each of our solutions is summarized in the table below. We currently market all of our existing solutions, including Caris Assure for therapy selection, MI Tumor Seek Hybrid, GPSai, and FOLFIRSTai, as LDTs and, as required under CLIA, continue to analytically validate such solutions across a variety of performance characteristics, including accuracy, precision, specificity, sensitivity, reportable range, and reference interval. We have obtained an FDA marketing authorization for MI Cancer Seek, and it is possible that we may seek FDA marketing authorization for Caris Assure for therapy selection and additional solutions in the future. Additionally, while we currently market Caris Assure for therapy selection as an LDT, it is possible that marketing authorization from the FDA would be required in order for us to market Caris Assure as a companion diagnostic device for therapy selection. We do not yet have specific plans regarding the timing of a PMA or other submission, if any, for Caris Assure for therapy selection or any other indication. For additional information, see &#8220;&#8212;Government Regulation&#8212; U.S. Food and Drug Administration&#8212;Laboratory Developed Tests.&#8221;</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">190</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:179.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:72pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Solution Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:72pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Marketing Status</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:84pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">NY CLEP Approval</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:192pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Anticipated FDA Approval/Requirements</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:72pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MI Cancer Seek</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:72pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Marketed since January 2025</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:84pt;">
              <font style="letter-spacing:0.2pt;">Not applicable</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">PMA approval obtained in November 2024</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">MI Tumor Seek Hybrid</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">Marketed as an LDT since&#160;2022</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Approved in 2024</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">None planned*</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">Caris Assure for Therapy Selection</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">Marketed as an LDT</font>
              <br >
              <font style="letter-spacing:0.2pt;">since 2024</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;">
              <font style="letter-spacing:0.2pt;">Plan to submit for NY CLEP in 2025</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">Potential to submit PMA application, a </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> request or 510(k) notification </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">FOLFIRSTai</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Marketed as an LDT</font>
              <br >
              <font style="letter-spacing:0.2pt;">since 2020</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;">
              <font style="letter-spacing:0.2pt;">Approved in 2024</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">None planned*</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">GPSai</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Marketed as an LDT</font>
              <br >
              <font style="letter-spacing:0.2pt;">since 2019</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:84pt;">
              <font style="letter-spacing:0.2pt;">Approved in 2024</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">None planned*</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.6pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-style:italic;font-size:9pt;">
          <font style="font-style:normal;letter-spacing:0.18pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-style:italic;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Pending resolution of litigation over the LDT Final Rule. If the LDT Final Rule is implemented or the FDA otherwise accepts applications for LDTs, we plan to seek FDA marketing authorization for each applicable LDT solution.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA premarket review process can be long and requires significant resources to complete all of the regulatory requirements necessary for market launch of an FDA-approved prescription medical device or diagnostic product. As we work with the FDA to seek marketing authorization for our diagnostic solutions, we must accurately describe the solution in terms of its intended use, indications for use, target population of patients, functional and/or performance characteristics, labeling, and anticipated marketing claims for the device, among other things. These factors, when combined with the result of the device classification, applicable product code for the device, and whether a predicate device exists, will allow us to plan the most appropriate submission type and regulatory pathway. Determining the appropriate pathway early is crucial to setting milestones, planning necessary preclinical and clinical trials, estimating cost requirements, and creating a timeline for when the product may reach the market. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA encourages participation in the FDA&#8217;s Pre-Submission Program, which allows manufacturers to seek the FDA&#8217;s feedback prior to an intended premarket submission. We have had formal pre-submission meetings with the FDA Center for Devices and Radiological Health (&#8220;CDRH&#8221;) and anticipate several more in the future to seek additional feedback from the FDA on solutions that we intend to submit for premarket review. Feedback from these meetings are critical for our team to be able to put together the appropriate study designs to support a premarket submission. Though the FDA provides non-binding feedback within these discussions, obtaining this early input from CDRH can allow for necessary changes or modifications to the regulatory strategy and potentially provide long-term savings in cost and time. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have obtained a PMA approval from the FDA for a companion diagnostic and tumor profiling designation for MI Cancer Seek, a WES/WTS NGS assay that has been designed to meet the stricter requirements applicable to companion diagnostic devices. We currently market MI Cancer Seek as the WES/WTS NGS component of MI Profile. For additional information, see &#8220;Risk Factors&#8212;Risks Related to Regulation and Legal Compliance&#8212;The marketing authorization processes of the FDA and comparable foreign regulatory authorities are lengthy, time-consuming, and unpredictable. If we are ultimately unable to obtain any necessary or desirable marketing authorizations, or if such marketing authorizations are significantly delayed, our business will be substantially harmed.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Government Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are subject to complex and frequently changing national, state, and local laws and regulations that govern various aspects of our business. In many jurisdictions, including the United States, the clinical laboratory and medical device industries must operate in accordance with extensive and complex legal standards, including laws and regulations related to certification, licensing, development, research, testing, manufacturing, laboratory operations, distribution, ordering and billing practices, advertising, promotion, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">191</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">marketing, sales and pricing practices, anti-markup practices, health information privacy and security, and consumer protection and unfair trade practices. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, the laws and regulations governing the marketing of diagnostic products are evolving, extremely complex, and in some instances, there are no significant regulatory or judicial interpretations of these laws and regulations. Clinical LDTs are regulated by the CLIA, described below, as well as by applicable state laws. In addition, the Federal Food, Drug and Cosmetic Act (&#8220;FDC Act&#8221;) defines a medical device to include any instrument, apparatus, implement, machine, contrivance, implant, </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> reagent, or other similar or related article, including a component part, or accessory, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals. Among other things, pursuant to the FDC Act and its implementing regulations, the FDA regulates the research, testing, manufacturing, safety, labeling, storage, recordkeeping, premarket clearance or approval, marketing and promotion, and sales and distribution of medical devices in the United States to ensure that medical products distributed domestically are safe and effective for their intended uses. The FDA has statutory authority to assure that medical devices are safe and effective for their intended uses. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For information on the risks we face related to the regulatory environment and other legal matters, see the section titled &#8220;Risk Factors&#8212;Risks Related to Regulation and Legal Compliance.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Laboratory Improvement Amendments of 1988</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Congress passed CLIA to establish rigorous quality standards for laboratories in the United States. Under CLIA, a laboratory is any facility that performs laboratory testing on specimens derived from human beings for the purpose of providing information for the diagnosis, prevention, or treatment of disease or the impairment or assessment of health. Such testing may also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CLIA requires that such laboratories obtain certification from the federal government and maintain compliance with various operational, personnel qualification, facilities administration, quality control and assurance, and proficiency testing requirements intended to ensure the accuracy, reliability, and timeliness of patient test results. The CMS, part of the U.S. Department of Health and Human Services (&#8220;HHS&#8221;), administers the CLIA certification program. CLIA requires that we hold a certificate that specifies the categories of testing we perform and that we comply with certain standards applicable to such tests. For every LDT used in clinical testing, CLIA requires analytical validation of a variety of performance characteristics, including accuracy, precision, specificity, sensitivity, reportable range, and reference interval. In addition, CLIA specifies certain testing categories requiring periodic proficiency testing, and certified laboratories performing these tests must enroll in an approved proficiency testing program. To demonstrate proficiency, such laboratories must test specimens received from an outside proficiency testing organization, such as CAP, and then submit the results back to that organization for evaluation. Failing to achieve a passing score on a proficiency test may lead to loss of certification to perform testing in the corresponding category. Furthermore, failure to comply with other proficiency testing regulations can result in revocation of the laboratory&#8217;s CLIA certificate, among other penalties.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We currently have two clinical laboratory facilities in Phoenix, Arizona, and we are in the process of building a laboratory in Irving, Texas. Both of the Phoenix laboratory facilities hold CAP and CLIA Accreditations. A CLIA Certificate of Accreditation is issued to a laboratory facility that performs moderate and/or high complexity testing after an accreditation organization conducts a survey and determines that the laboratory is in compliance with the CLIA regulations. Our newest laboratory facility in Irving, Texas, near our headquarters, is continuing to be built-out and will seek a CLIA Certificate of Registration from CMS, and upon required inspection, a CLIA Certificate of Accreditation. The CLIA Certificate of Registration allows the laboratory facility to begin conducting moderate and/or high complexity testing, subject to a survey to determine compliance with the CLIA regulations. After a laboratory obtains a Certificate of Registration, CLIA begins scheduling regular, routine inspections. Once the inspection process for the laboratory facility is successfully completed, the facility qualifies for a CLIA Certificate of Accreditation and thereafter is inspected every two years. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">192</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to offering a new solution at our laboratories, we must also satisfy certain notification requirements to change our solution menu, such as notifications to regulatory and accrediting bodies. At their discretion, these entities may inspect our clinical laboratories at any time. CLIA accredited laboratories are subject to are required to be reviewed biannually by a CMS-approved accreditation organization (for example, CAP) and may be subject to additional random or &#8220;for cause&#8221; inspections. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If our laboratories are determined to be out of compliance with CLIA requirements at any inspection or otherwise, we may be subject to a wide range of enforcement actions and sanctions, including suspension, limitation, or revocation of the laboratory&#8217;s CLIA certificate, as well as directed plan of correction, on-site monitoring, civil monetary penalties, civil injunctive suit, or criminal penalties, as well as significant adverse publicity, all of which could have a materially adverse impact on our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">State Laboratory Licensure Laws</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to the federal certification requirements for laboratories, certain states, including Maryland, Pennsylvania, New York, California, and Rhode Island require state laboratory licenses. The state laboratory licensure requirements establish standards for the day-to-day operation of a clinical laboratory, including the training and qualifications required of personnel, quality control, and proficiency testing. CLIA provides that a state may adopt laboratory regulations that are more stringent than those under federal law. A number of states have implemented their own more stringent laboratory regulatory requirements, and those states may conduct their own inspections. These states may also include reporting requirements that we must comply with in order to maintain licensure. Moreover, certain states, including New York, require approval of certain tests, including certain tests that have not been cleared or approved by the FDA (such as LDTs), through a premarket submission containing, among other information, documentation relating to device analytical and clinical performance data. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Several states require licensure of out-of-state laboratories that accept specimens from those states and/or receive specimens from laboratories in those states. Our Arizona solid tissue laboratory and our Arizona blood-based testing laboratory have obtained out-of-state licenses in states where we believe they are required, and we will file applications in additional states as applicable when we offer solutions in those states. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a laboratory is deemed to be out of compliance with state licensing laws or regulations governing laboratories, penalties may include suspension, limitation, or revocation of the license issued by that state, disapproval of a licensure application, assessment of substantial financial penalties or fines, onsite monitoring requirements, or imposition of corrective action plans. Certain statutory or regulatory noncompliance may also result in misdemeanor charges under state law. Loss of a laboratory&#8217;s state license may also result in the inability to compliantly perform laboratory testing and receive payments from third-party payers, all of which may have a materially adverse impact on our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to laboratory licensing, certain states, including New York and California, impose registration and/or licensing requirements on companies that manufacture medical devices. These laws can apply to a manufacturer before its products are commercialized, including when a company is evaluating its product candidates in clinical trials. Violations of these laws may result in the denial, suspension, or revocation of the registration or license, as well as other fines and penalties, including imprisonment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other states may adopt licensure requirements in the future, which could require us to modify, delay, or discontinue our operations in such jurisdictions. If we identify any state with such requirements or if we are contacted by a state advising us of such requirements, we intend to follow such instructions from the state regulators as to how to comply with such requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. Food and Drug Administration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, laboratory tests are subject to regulation by the FDA under the FDC Act and its implementing regulations, and other federal and state statutes and regulations. The laws and regulations govern, among other things, medical device development, testing, manufacture, labeling, storage, premarket clearance or approval, advertising and promotion, export, import, and product sales and distribution. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">193</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Laboratory Developed Tests</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the FDA&#8217;s regulatory framework, IVDs are a type of medical device that can be used in the diagnosis or detection of diseases, such as cancer, or other conditions. The FDA considers LDTs to be a subset of IVDs that are intended for clinical use and are designed, manufactured, and used within a single laboratory. Until recently, the FDA has historically exercised its enforcement discretion and not enforced certain otherwise potentially applicable provisions of the FDC Act and regulations with respect to LDTs, with certain exceptions. Even under that enforcement discretion policy, the FDA has issued warning letters to, and published Medical Device Safety Communications about, manufacturers for commercializing laboratory tests that were purported to be LDTs but that the FDA alleged failed to meet the definition of an LDT or that otherwise were not subject to the FDA&#8217;s enforcement discretion policy. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA has for a number of&#160;years stated its intention to modify its enforcement discretion policy with respect to LDTs and impose applicable medical device requirements to LDTs more broadly. On May&#160;6, 2024, the FDA issued the LDT Final Rule in an effort to clarify the FDA&#8217;s historical view that LDTs are medical devices subject to the requirements applicable to IVDs, and to phase out the FDA&#8217;s enforcement discretion policy over a period of four&#160;years from issuance of the final rule, which would involve a phase-in of medical device requirements to these products over this time period.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the LDT Final Rule, the FDA established certain targeted enforcement discretion policies. Specifically, the FDA intended to exercise enforcement discretion and not enforce certain medical device requirements (including the requirements for marketing authorization and compliance with certain elements of the Quality System Regulation (&#8220;QSR&#8221;) with respect to LDTs that were marketed as of the date of the LDT Final Rule&#8217;s publication, although such products would still be required to comply with certain other FDA requirements, including registration and listing, portions of the QSR, medical device reporting, labeling, and corrections and removals reporting. However, where these tests are modified in certain ways from the version of the test marketed as of the final rule&#8217;s publication date, this enforcement discretion policy would no longer apply and the FDA would then enforce all applicable FDA requirements (including premarket review and marketing authorization requirements) consistent with the phase-in policy. In addition, for LDTs that receive approval from NY CLEP, FDA did not intend to enforce marketing authorization requirements when these requirements would become phased in more generally at either three and a half or four&#160;years following the date of publication of the LDT Final Rule. However, these tests would still be subject to the remaining medical device requirements, including registration and listing, medical device reporting, and quality system requirements, at the time that such requirements become phased in more generally. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, on March 31, 2025, the United States District Court for the Eastern District of Texas vacated the LDT Final Rule and remanded the matter to the FDA for further consideration. The U.S. government decided not to appeal the District Court&#8217;s decision by the formal May 30, 2025 deadline. The District Court&#8217;s decision currently remains subject to appeal procedures until June 30, 2025, and at this time it remains uncertain whether such appeal will be sought by then and if such appeal would be successful. Accordingly, it remains unclear whether or when the FDA may be able to implement the LDT Final Rule, or otherwise exercise its medical device requirements with respect to these diagnostic tests, including any LDTs for which we have obtained or plan to obtain PMAs. In addition, Congress has, for over the past decade, considered a number of proposals, which if enacted, could subject LDTs to additional regulatory requirements. As a result, the FDA&#8217;s oversight with respect to LDT products remains subject to significant uncertainty.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">FDA Classification and Premarket Review of Medical Devices</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">PMA Pathway.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The FDA categorizes medical devices into one of three classes&#8212;class I, II, or III&#8212;based on the risks presented by the device and the regulatory controls necessary to provide a reasonable assurance of the device&#8217;s safety and effectiveness. Class&#160;I includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be assured by adherence to the FDA&#8217;s General Controls for medical devices, which include compliance with the applicable portions of the QSR, facility registration and product listing, reporting of adverse medical events, and truthful and non-misleading labeling, advertising, and promotional materials. Class&#160;II devices are subject to the FDA&#8217;s General Controls, and special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. Special </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">194</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">controls are established by the FDA for a specific device type and often include specific labeling provisions, performance metrics, and other types of controls that mitigate risks of the device (usually incorrect results for an IVD). Devices deemed by the FDA to pose the greatest risks, such as life sustaining, life supporting or some implantable devices, or devices that have a new intended use, or use advanced technology that is not substantially equivalent to that of a legally marketed device, are placed in Class&#160;III, requiring approval of a PMA. Some pre-amendment devices are unclassified, but are subject to the FDA&#8217;s premarket notification and clearance process in order to be commercially distributed. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Class&#160;III devices require PMA approval before they can be marketed. Obtaining PMA approval requires the submission of &#8220;valid scientific evidence&#8221; to FDA to support a finding of a reasonable assurance of the safety and effectiveness of the device. A PMA must provide complete analytical and clinical performance data and also information about the device and its components regarding, among other things, device design, manufacturing, and labeling. Following receipt of a PMA, the FDA determines whether the application is sufficiently complete to permit a substantive review. If the FDA accepts the application for review, it has 180&#160;days from the day of filing under the FDC Act to complete its review of a PMA, although in practice, the FDA&#8217;s review often takes significantly longer. An advisory panel of experts from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. The FDA may or may not accept the panel&#8217;s recommendation. As part of the FDA&#8217;s review of a PMA, the FDA will typically inspect the manufacturer&#8217;s facilities for compliance with QSR requirements, which impose requirements related to design controls, manufacturing controls, documentation, and other quality assurance procedures. The user fee costs and the length of the FDA review time for obtaining PMA approval are significantly higher than for a 510(k) notification or a </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification. In addition, the FDA collects user fees for certain medical device submissions and annual fees and for medical device establishments under the Medical Device User Fee Amendments to the FDC Act, which is subject to reauthorization by Congress every five&#160;years following extensive agency and industry negotiations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">FDA will approve the new device for commercial distribution if it determines that the data and information in the PMA constitute valid scientific evidence and that there is reasonable assurance that the device is safe and effective for its intended use(s). FDA may approve a PMA with post-approval conditions intended to ensure the safety and effectiveness of the device, including, among other things, restrictions on labeling, promotion, sale and distribution, and collection of long-term follow-up data from patients in the clinical study that supported PMA approval or requirements to conduct additional clinical studies post-approval. FDA may condition PMA approval on some form of post-market surveillance when deemed necessary to protect the public health or to provide additional safety and efficacy data for the device in a larger population or for a longer period of use. In such cases, the manufacturer might be required to follow certain patient groups for a number of&#160;years and to make periodic reports to FDA on the clinical status of those patients. Failure to comply with the conditions of approval can result in material adverse enforcement action, including withdrawal of the approval. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain changes to an approved device, such as changes in manufacturing facilities, methods, or quality control procedures, or changes in the design performance specifications, which affect the safety or effectiveness of the device, require submission of a PMA supplement. PMA supplements often require submission of the same type of information as a PMA, except that the supplement is limited to information needed to support any changes from the device covered by the original PMA and may not require as extensive clinical data or the convening of an advisory panel. Certain other changes to an approved device require the submission of a new PMA, such as when the design change causes a different intended use, mode of operation, and technical basis of operation, or when the design change is so significant that a new generation of the device will be developed, and the data that were submitted with the original PMA are not applicable for the change in demonstrating a reasonable assurance of safety and effectiveness. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">510(k) Notification Pathway.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To obtain 510(k) clearance, a manufacturer must submit a premarket notification demonstrating to the FDA&#8217;s satisfaction that the proposed device is &#8220;substantially equivalent&#8221; to another legally marketed device that itself does not require PMA approval (a predicate device). A predicate device is a legally marketed device that is not subject to premarket approval, i.e., a device that was legally marketed prior to May&#160;28, 1976 (pre-amendments device) and for which a PMA is not required, a device that has been reclassified from Class&#160;III to Class&#160;II or I, or a device that was found substantially equivalent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">195</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">through the 510(k) process. The FDA&#8217;s 510(k) clearance process usually takes from three to 12&#160;months, but often takes longer. The FDA may require additional information, including clinical data, to make a determination regarding substantial equivalence. In addition, the FDA collects user fees for certain medical device submissions and annual fees for medical device establishments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the FDA agrees that the device is substantially equivalent to a lawfully marketed predicate device, it will grant 510(k) clearance to authorize the device for commercialization. If the FDA determines that the device is &#8220;not substantially equivalent&#8221; to a previously cleared device, the device is automatically designated as a Class&#160;III device. The device sponsor must then fulfill more rigorous PMA requirements, or can request a risk-based classification determination for the device in accordance with the </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> process, which is a route to market for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device. Once a </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification request is reviewed and granted, it results in the device having a Class&#160;I or II classification and future devices from the company or a competitor may use the company </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;">-classified device as a 510(k) predicate. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After a device receives 510(k) clearance or </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change or modification in its intended use, will require a new 510(k) clearance or, depending on the modification, PMA approval or new </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification. The FDA requires each manufacturer to determine whether the proposed change requires submission of a 510(k) or a PMA in the first instance, but the FDA can review any such decision and disagree with a manufacturer&#8217;s determination. Modifications that do not rise to the level of requiring a new 510(k) are accomplished through a &#8220;letter to file&#8221; in which the company documents the rationale for the change and why a new 510(k) is not required. However, if the FDA disagrees with a manufacturer&#8217;s determination, the FDA can require the manufacturer to cease marketing and/or request the recall of the modified device until new marketing authorization for the change is obtained. Also, in these circumstances, the manufacturer may be subject to significant regulatory fines or penalties. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">De Novo Classification Pathway.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If no legally marketed predicate can be identified for a new device to enable use of the 510(k) pathway, the device is automatically classified under the FDC Act into Class&#160;III, which generally requires PMA approval. However, the FDA can reclassify or use &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification&#8221; for a device that meets the FDC Act standards for a class I or class II device, which in turn permit the device to be marketed without PMA approval. To grant such a reclassification, the FDA must determine that the FDC Act&#8217;s general controls alone, or general controls and special controls together, are sufficient to provide a reasonable assurance of the device&#8217;s safety and effectiveness. If the manufacturer seeks reclassification into Class&#160;II, the classification request must include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety and effectiveness of the medical device. The FDA may reject the classification request if it identifies a legally marketed predicate device that would be appropriate for a 510(k) notification or determines that the device is not low to moderate risk or that general controls would be inadequate to control the risks and special controls cannot be developed. The </font><font style="font-style:italic;letter-spacing:0.2pt;">de novo</font><font style="letter-spacing:0.2pt;"> classification route is generally less burdensome than the PMA approval process. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Investigational Device Exemption Process</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Clinical trials are almost always required to support a PMA and are sometimes required to support a 510(k) submission. All clinical investigations of investigational devices to determine safety and effectiveness must be conducted in accordance with the FDA&#8217;s investigational device exemption (&#8220;IDE&#8221;) regulations which govern investigational device labeling, prohibit promotion of the investigational device, and specify an array of recordkeeping, reporting and monitoring responsibilities of study sponsors and study investigators. If the device presents a &#8220;significant risk&#8221; to human health, as defined by the FDA, the FDA requires the device sponsor to submit an IDE application to the FDA, which must become effective prior to commencing human clinical trials. A significant risk device is one that presents a potential for serious risk to the health, safety, or welfare of a patient and either is implanted, used in supporting or sustaining human life, substantially important in diagnosing, curing, mitigating or treating disease or otherwise preventing impairment of human health, or otherwise presents a potential for serious risk to a subject. An IDE application must be supported by appropriate data, such as animal and laboratory test results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE will automatically become effective 30&#160;days after receipt by the FDA unless the FDA notifies the company that the investigation may not begin. If the FDA determines that there are deficiencies or other concerns with an IDE for which it requires modification, the FDA may permit a clinical trial to proceed under a conditional approval. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">196</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the study must be approved by, and conducted under the oversight of, an Institutional Review Board (&#8220;IRB&#8221;) for each clinical site. The IRB is responsible for the initial and continuing review of the IDE and may pose additional requirements for the conduct of the study. If an IDE application is approved by the FDA and the study protocol is approved by one or more IRBs, human clinical trials may begin at a specific number of investigational sites with a specific number of patients, as approved by the FDA. IDE reporting to all reviewing IRBs regarding study progress is required at regular intervals and at least annually for ongoing IDE approved studies. For a significant risk device, the progress reports must also be submitted to FDA. If the device presents a non-significant risk to the patient, a sponsor may begin the clinical trial after obtaining approval for the trial by one or more IRBs without separate approval from the FDA, but must still follow abbreviated IDE requirements, such as monitoring the investigation, ensuring that the investigators obtain informed consent, and labeling and record-keeping requirements. Acceptance of an IDE application for review does not guarantee that the FDA will allow the IDE to become effective and, if it does become effective, the FDA may or may not determine that the data derived from the trials support the safety and effectiveness of the device or warrant the continuation of clinical trials. An IDE supplement must be submitted to, and approved by, the FDA before a sponsor or investigator may make a change to the investigational plan that may affect its scientific soundness, study plan or the rights, safety, or welfare of human subjects. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During a study, the sponsor is required to comply with the applicable FDA requirements, including, for example, trial monitoring, selecting clinical investigators and providing them with the investigational plan, ensuring IRB review, adverse event reporting, record keeping, and prohibitions on the promotion of investigational devices or on making safety or effectiveness claims for them. The clinical investigators in the clinical study are also subject to FDA regulations and must obtain patient informed consent, rigorously follow the investigational plan and study protocol, control the disposition of the investigational device, and comply with all reporting and recordkeeping requirements. Additionally, after a trial begins, we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons, including a belief that the risks to study subjects outweigh the anticipated benefits. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Expedited Development and Review Programs.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The FDA has established programs to support and expedite the development of devices that meet criteria for Breakthrough Device designation, which can be voluntarily requested by sponsors. The program offers manufacturers of certain devices an opportunity to interact with the FDA more frequently and efficiently as they develop their products with the goal of expediting commercialization of such products to help patients have more timely access, as well as use of postmarket data collection, when scientifically appropriate, to facilitate expedited and efficient development and review of the device, opportunities for efficient and flexible clinical study design, and priority review of premarket submissions. The program is available to medical devices that meet certain eligibility criteria, including that the device provides more effective treatment or diagnosis of life threatening or irreversibly debilitating diseases or conditions, and constitutes a device (i)&#160;that represents a breakthrough technology, (ii)&#160;for which no approved or cleared alternatives exist, (iii)&#160;that offer significant advantages over existing approved or cleared alternatives, or (iv)&#160;the availability of which is in the best interest of patients. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Postmarket Regulation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;After a device is cleared or approved by the FDA for marketing, numerous and pervasive regulatory requirements continue to apply. These include: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishment registration and device listing with the FDA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with the QSR, which requires manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation, and other quality assurance procedures during all aspects of the design and manufacturing process; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">labeling regulations and FDA prohibitions against the promotion of &#8220;off-label&#8221; uses of cleared or approved products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">requirements related to promotional activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">clearance or approval of product modifications to 510(k)-cleared devices that could significantly affect safety or effectiveness or that would constitute a major change in intended use of one of our cleared devices, or approval of certain modifications to PMA-approved devices; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Medical Device Reporting, which requires that a manufacturer report to the FDA if a device it markets may have caused or contributed to a death or serious injury, or has malfunctioned </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">197</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:56pt; width:400pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and the device or a similar device that it markets would be likely to cause or contribute to a death or serious injury, if the malfunction were to recur; </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">correction, removal, and recall reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDC Act that may present a risk to health; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA&#8217;s recall authority, whereby the agency can order device manufacturers to recall from the market a product that is in violation of governing laws and regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">post-market surveillance activities and regulations, which apply to certain Class&#160;II or III devices when deemed by the FDA to be necessary to protect the public health or to provide additional safety and effectiveness data for the device; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">complying with the laws and regulations requiring Unique Device Identifiers on devices and also requiring the submission of certain information about each device to the FDA&#8217;s Global Unique Device Identification Database. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Device manufacturing processes subject to the FDA oversight are required to comply with the applicable portions of the QSR, which currently cover the methods and the facilities and controls for the design, manufacture, testing, production, processes, controls, quality assurance, labeling, packaging, distribution, installation, and servicing of finished devices intended for human use. The QSR also requires, among other things, maintenance of a device master file, device history file, and complaint files. Manufacturers are subject to periodic scheduled or unscheduled inspections by the FDA. A failure to maintain compliance with the QSR requirements could result in the shut-down of, or restrictions on, manufacturing operations and the recall or seizure of products. The discovery of previously unknown problems with products, including unanticipated adverse events or adverse events of increasing severity or frequency, whether resulting from the use of the device within the scope of its clearance or off-label by a physician in the practice of medicine, could result in restrictions on the device, including the removal of the product from the market or voluntary or mandatory device recalls. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">FDA Enforcement Powers</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA has broad regulatory compliance and enforcement powers. If the FDA determines that a manufacturer has failed to comply with applicable regulatory requirements, it can take a variety of compliance or enforcement actions, including the following: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">issuance of warning letters, untitled letters, fines, injunctions, consent decrees and civil penalties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">requesting or requiring recalls, withdrawals, or administrative detention or seizure of products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">imposing operating restrictions or partial suspension or total shutdown of production; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusing or delaying requests for 510(k) marketing clearance, or PMA approvals of new products or modified products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withdrawing 510(k) clearances or PMA approvals that have already been granted; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal to grant export approvals for products; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">criminal prosecution. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Healthcare Fraud and Abuse Oversight</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A variety of federal and state laws prohibit fraud and abuse involving federal and state healthcare programs, as well as private insurers. These laws are interpreted broadly and actively enforced by various state and federal agencies, including CMS, the Department of Justice (&#8220;DOJ&#8221;), and the Office of Inspector General for HHS (&#8220;OIG&#8221;). While we seek to conduct our business in compliance with all federal and state fraud and abuse laws, we are unable to predict how these laws will be applied in the future or whether our arrangements will be subject to scrutiny under them by federal or state enforcement agencies. Violations </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">198</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of such laws may result in a range of penalties, including but not limited to significant administrative and civil fines and penalties, criminal fines and penalties, loss of licensure, disgorgement, imprisonment, exclusion from federal healthcare programs, additional reporting obligations, and oversight or other agreement to resolve allegations of non-compliance with these laws. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Federal and State Physician Self-Referral Prohibitions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are subject to a set of federal laws aimed at preventing physician self-referral, including the federal anti self-referral law commonly known as the Stark Law. The Stark Law generally prohibits entities from billing, presenting, or causing to be presented a claim for designated health services, including laboratory services, payable by the Medicare or Medicaid programs when the physician ordering the service, or any member of such physician&#8217;s immediate family, has an ownership interest in, or compensation arrangement with, that entity, unless the arrangement meets certain delineated exceptions to the prohibition. We rely on certain exceptions to the Stark Law, and if those exceptions were to change, we could face penalties for violations. Notably, the Stark Law is a strict liability statute, which means that no proof of scienter is required to demonstrate a violation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sanctions for a violation of the Stark Law, among other things, include denial of payment for the services provided in violation of the prohibition, refunds of amounts collected by the entity in violation of the Stark Law, monetary penalties, and exclusion from federal healthcare program participation. In addition, violations of the Stark Law may also serve as the basis for liability under the federal False Claims Act (the &#8220;FCA&#8221;), which prohibits knowingly presenting, or causing to be presented, a false or fraudulent claim for payment to the federal government. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many states also have their own self-referral bans, which may extend to all self-referrals regardless of payer, with which we may have to comply unless an exception applies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The Anti-Kickback Statute</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The federal Anti-Kickback Statute (&#8220;AKS&#8221;) prohibits any person or entity, including a laboratory, from knowingly and willfully offering, paying, soliciting, or receiving remuneration, directly or indirectly, in order to induce either the referral of an individual, or the furnishing, arranging for or recommending of an item or service that is reimbursable, in whole or in part, by any federal healthcare program, including the Medicare and Medicaid programs. &#8220;Remuneration&#8221; is broadly defined to include anything of value, which can include (but is not limited to) cash payments, gifts or gift cards, discounts, research opportunities, co-payment waivers or patient financial assistance, or the furnishing of services, supplies, or equipment. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. The AKS can be interpreted broadly to prohibit many arrangements and practices that are lawful in businesses outside of the healthcare industry or which are innocuous or beneficial. The AKS contains statutory exceptions and regulatory safe harbors that protect certain interactions if specific requirements are met. If an arrangement meets all of the requirements of a safe harbor, it is deemed not to violate the AKS. An arrangement must fully comply with each element of an applicable safe harbor in order to qualify for protection. The failure of a transaction or arrangement to fit within a specific safe harbor, however, does not necessarily mean that the transaction or arrangement violates the statute. A violation of the AKS may result in significant penalties, including imprisonment, fines, and possible exclusion from Medicare, Medicaid, and other federal healthcare programs. Actions that violate the AKS or any similar laws may also incur liability under the FCA. Some states also have their own AKS laws and they may apply to all payers, instead of just a state healthcare program. These statutes also typically have their own safe harbor provisions, or they may cross-reference the federal AKS safe harbors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Federal and state law enforcement authorities scrutinize arrangements between healthcare providers and potential referral sources to determine whether the arrangements were intended to induce referrals or the purchase, prescribing or ordering of products or services reimbursable by federal healthcare programs. Law enforcement authorities and the courts have also demonstrated a willingness to look behind the formalities of a transaction to determine the underlying purpose of any remuneration exchanged between healthcare providers and actual or potential referral sources. Generally, courts and federal agencies have taken the position that the AKS may be violated if even one purpose of an arrangement is to induce referrals. We rely on safe harbors to the AKS statutes in certain arrangements with potential referral sources, and those safe </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">199</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">harbors could be revised or eliminated. In addition, the OIG periodically issues Special Fraud Alerts setting forth the agency&#8217;s view of how certain arrangements between laboratories and referring physicians implicate and potentially violate the AKS. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The penalties for violating the federal or state AKS provisions can be severe. Consequences include, among others, criminal and civil penalties, imprisonment, and possible exclusion from federal healthcare programs, among others. Moreover, claims submitted to federal healthcare programs for items or services that were the result of a violation of the AKS are deemed to be &#8220;false&#8221; for purposes of the FCA. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Eliminating Kickbacks in Recovery Act</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2018, Congress enacted the Eliminating Kickbacks in Recovery Act of 2018 (&#8220;EKRA&#8221;), as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (&#8220;SUPPORT Act&#8221;). EKRA is an all-payer anti-kickback law that criminalizes paying or offering any remuneration directly or indirectly to induce referrals to, or in exchange for, patients using the services of a recovery home, a substance use clinical treatment facility, or laboratory. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although it appears that EKRA was intended to reach patient brokering and similar arrangements in the context of substance use recovery and treatment, the language in EKRA is broad. Moreover, although there is some overlap between EKRA&#8217;s exceptions and the AKS safe harbors, certain arrangements that are expressly protected under the AKS do not expressly receive protection under EKRA. As such, compliance with a federal AKS safe harbor does not guarantee protection under EKRA. EKRA thus potentially expands the universe of arrangements that could be subject to enforcement under federal fraud and abuse laws, as well as substantial penalties. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">EKRA permits DOJ to issue regulations clarifying or expanding the statute&#8217;s exceptions, but such regulations have not yet been issued and thus there is little guidance to indicate how and to what extent it will be applied and enforced by government agencies. The relationships between laboratories and physicians, sales representatives, hospitals, and customers may be subject to scrutiny under this statute. Sanctions under the EKRA could have a negative effect on our business, if imposed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">False Claims Act</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FCA prohibits, among other things, a person from knowingly submitting (or causing to be submitted) a false claim, making a false record or statement in order to secure payment, or knowingly retaining an overpayment by the federal government. The government may assert that a claim including items and services resulting from a violation of the AKS constitutes a false or fraudulent claim for purposes of the FCA. Moreover, overpayments from certain payers must be repaid within 60&#160;days of identification unless a favorable decision is obtained on appeal, or they may be subject to reverse false claims liability. Penalties for violating the FCA include payment, among other things, of up to three times the actual damages sustained by the government, plus substantial per-claim civil penalties, as well as possible exclusion from federal healthcare programs. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Another notable feature of the FCA is that its </font><font style="font-style:italic;letter-spacing:0.2pt;">qui tam</font><font style="letter-spacing:0.2pt;"> provisions allow a private individual to bring an action on behalf of the federal government and to share in any amounts paid by the defendant to the government in connection with the action. Because the </font><font style="font-style:italic;letter-spacing:0.2pt;">qui tam</font><font style="letter-spacing:0.2pt;"> whistleblowers initially file their complaints under seal, the action may be pending for some time before the defendant is even aware of it. If the government is ultimately successful in obtaining redress in the matter or if the plaintiff succeeds in obtaining redress without the government&#8217;s involvement, then the plaintiff will receive a&#160;percentage of the recovery. It is not uncommon for </font><font style="font-style:italic;letter-spacing:0.2pt;">qui tam</font><font style="letter-spacing:0.2pt;"> lawsuits to be filed by current and former employees, as well as competitors or consultants of healthcare providers, including clinical laboratories. Several states have enacted similar laws modeled after the FCA that apply to items and services reimbursed under Medicaid and other state healthcare programs, and, in several states, such laws apply to claims submitted to any payer, including private insurers. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For a discussion of such a proceeding in which we are currently involved, please see &#8220;&#8212;Legal Proceedings.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">200</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Healthcare Fraud and False Statements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The federal healthcare fraud statute criminalizes knowingly and willfully defrauding any healthcare benefit program. A violation of this statute may result in fines, imprisonment, or exclusion from government healthcare programs. Exclusion from governmental healthcare programs also impacts the ability of the company to contract with private insurers. The false statements statute prohibits knowingly and willfully falsifying, concealing, or covering up a material fact or making a materially false, fictitious, or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items, or services. A violation of this statute may result in fines or imprisonment. Conduct that could be considered a violation of the other healthcare related laws described herein could also form the basis of a claim under this statute. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Civil Monetary Penalties Law</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The federal Civil Monetary Penalties (&#8220;CMP&#8221;) law prohibits, among other things, (i)&#160;offering or transferring remuneration to a federal healthcare program beneficiary that a person knows or should know is likely to influence the beneficiary&#8217;s decision to order or receive items or services reimbursable by a federal healthcare program from a particular provider or supplier; (ii)&#160;employing or contracting with an individual or entity that the provider knows or should know is excluded from participation in a federal healthcare program; (iii)&#160;billing for services requested by an unlicensed physician or an excluded provider; and (iv)&#160;billing for medically unnecessary services. Conduct that could be considered a violation of the FCA or the AKS can also form the basis of a CMP complaint. Penalties for violating the CMP may include exclusion from federal healthcare programs and substantial fines. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Physician Payments Sunshine Act</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The federal Physician Payments Sunshine Act (&#8220;Sunshine Act&#8221;) was enacted by Congress in 2010 as part of the Affordable Care Act (&#8220;ACA&#8221;) and was amended in 2018 by the SUPPORT Act. The Sunshine Act requires certain manufacturers of drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program, with specific exceptions, to collect and report annually to CMS certain data on payments and other transfers of value by those manufacturers (and in some cases their distributors) to U.S. licensed physicians, teaching hospitals, and certain advanced non-physician healthcare practitioners, including physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, and certified nurse-midwives. The reporting program (known as the Open Payments program) is administered by CMS. Several states have enacted similar reporting requirements. The sale of covered medical devices triggers reporting obligations under the Sunshine Act as well as the similar state counterpart requirements. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While we intend fully to comply with applicable federal and state fraud and abuse laws, and similar laws of other states and countries as we commercialize solutions, it is possible that some of our arrangements or arrangements we may enter into in the future could become subject to regulatory scrutiny, and we cannot be certain that we will be found to be in compliance with these laws following any such regulatory review.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Potentially Applicable State Laws</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the laws described above, states may have other fraud and abuse laws that apply to our business practices. Such laws include fee-splitting restrictions, insurance fraud laws, anti-markup laws, certain direct billing requirements, prohibitions on waiving coinsurance, copayments, deductibles, and other amounts owed by patients, and prohibitions on the provision of solutions at no or discounted cost to induce physician adoption. Other potentially applicable state laws prohibit the corporate practice of medicine, and are designed to prevent interference in the medical decision-making process by anyone who is not a licensed professional. Violation of these laws may result in a range of penalties, including civil or criminal penalties, as well as sanctions imposed against the business corporation and the professional through licensure proceedings and criminal penalties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additional International Regulation and Product Approval</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may have to obtain or submit approvals, markings, notifications, or satisfy other premarket requirements from regulatory authorities in non-U.S. jurisdictions prior to marketing our solutions in those </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">201</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">countries and territories. The laws and regulations in other jurisdictions vary from those in the United States and may be more difficult to satisfy, and they are subject to change, in some cases frequently. Certain regulatory authorities regulate LDTs and IVDs differently than the United States, and our solutions may need to satisfy additional requirements to be offered commercially within the jurisdictions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">European Union</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In May&#160;2017, the European Union adopted a new </font><font style="font-style:italic;letter-spacing:0.2pt;">In Vitro</font><font style="letter-spacing:0.2pt;"> Diagnostic Medical Devices Regulation&#160;2017/746 (&#8220;IVDR&#8221;), which replaced the IVD Directive in May&#160;2022. Under the IVDR, many more IVDs will require the involvement of a notified body in their conformity assessment procedure. Under transitional provisions, IVDs with notified body certificates issued under the IVD Directive prior to May&#160;2022 may continue to be placed on the market for the remaining validity of the certificate, until May&#160;2024 at the latest. After the expiry of any applicable transitional period, only IVDs that have been CE marked under the IVDR may be placed on the market in the European Union. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other Jurisdictions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event we expand our business into other countries or jurisdictions around the world, we will be required to comply with such countries&#8217; and jurisdictions&#8217; healthcare and other laws and regulations covering comparable subject matter to that discussed in the foregoing paragraphs and that do not currently apply to us. Such laws and regulations are complex, change frequently, and vary among jurisdictions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Coverage and Reimbursement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Reimbursement and billing for clinical laboratory services is highly complex. Laboratories must bill various payers, which may include federal healthcare programs (such as Medicare, Medicaid, and TRICARE), as well as Medicare Advantage plans, private insurers, and managed care organizations. Submitting claims to various payers is complicated because each payer may have different billing requirements. Additionally, the audit requirements laboratories must meet the ensure compliance with applicable laws and regulations, as well as internal compliance policies and procedures, add further complexity to the billing process. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are currently pursuing and will continue to pursue payment for our solutions through a diverse and broad range of channels, including coverage and reimbursement by government healthcare programs and commercial third-party payers. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General Coverage and Reimbursement Considerations</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Across jurisdictions, a decision by a payer (regardless of whether it is a governmental or private payer) to cover a solution does not guarantee that those payers will provide adequate reimbursement for that solution. Moreover, third-party payers are increasingly examining the medical necessity and cost- effectiveness of medical products and services, including clinical laboratory tests, in addition to their safety and efficacy. Furthermore, coverage and reimbursement for products, and services that utilize such products, can differ significantly from payer to payer. As a result, the coverage determination process is often time-consuming and costly and requires us to provide scientific and clinical support for the use of our products to each payer separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained at all. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In certain foreign markets, the government controls the coverage and pricing of many healthcare products, including clinical laboratory tests. In order to obtain coverage and reimbursement for any product that might be cleared or approved by regulators for sale, or for any procedure that utilizes such product, it may be necessary to conduct health economic studies in order to demonstrate the medical necessity and cost-effectiveness of the products. The cost of such studies would be in addition to the costs required to obtain regulatory approvals. If third-party payers do not consider a product to be cost-effective compared to other available products, they may not cover the product after approval as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow a company to sell its products at a profit. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The marketability of our solutions may suffer if governmental and third-party payers fail to provide adequate coverage and reimbursement. In addition, emphasis on managed care in the United States </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">202</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">has increased, and we expect will continue to increase the pressure on medical products and services pricing. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for our solutions, less favorable coverage policies and reimbursement rates may be implemented in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Coverage and Reimbursement in the United States</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, there is no uniform coverage for clinical laboratory tests. The extent of coverage and rate of payment for covered services varies from payer to payer. Obtaining coverage for solutions like ours that involve genomic sequencing can be particularly challenging. Medicare is the single largest healthcare payer in the United States, and a particularly significant payer for many cancer-related laboratory services given the demographics of the Medicare population, a large portion of which includes elderly individuals. Many other U.S. payers look to the Medicare policies as a benchmark and model for their own coverage and reimbursement decisions. Medicare provides two main forms of insurance coverage: traditional Medicare fee-for-service, administered by the federal government and its contractors, and Medicare Advantage, administered by private insurers that must generally follow traditional Medicare rules and guidelines. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Medicare coverage is limited to items and services that are within the scope of a Medicare benefit category that are reasonable and necessary for the diagnosis or treatment of an illness or injury. National coverage determinations are made through an evidence-based process by the CMS, with opportunities for public participation. Medicare&#8217;s National Coverage Determination (&#8220;NCD&#8221;) for NGS, first established in 2018 and subsequently updated in 2020, provides national Medicare coverage for certain molecular diagnostic tests when: (1)&#160;performed in a CLIA-certified laboratory, (2)&#160;ordered by a treating physician, (3)&#160;the patient meets certain clinical and treatment criteria, including having recurrent, relapsed, refractory, metastatic, or advanced stages III or IV cancer, (4)&#160;the test is approved or cleared by the FDA as a companion IVD for an FDA approved or cleared indication for use in that patient&#8217;s cancer, and (5)&#160;results are provided to the treating physician for management of the patient using a report template to specify treatment options. The NGS NCD also states that each Medicare Administrative Contractor (&#8220;MAC&#8221;) may provide local coverage of other NGS tests for cancer patients only when the test is performed by a CLIA-certified laboratory, ordered by a treating physician and the patient meets the same clinical and treatment criteria required of nationally covered NGS tests under the NGS NCD. Palmetto GBA is the MAC responsible for administering Medicare&#8217;s MolDX, which issues local coverage determinations (&#8220;LCDs&#8221;) for molecular diagnostic tests that are not approved or cleared by the FDA. Our MAC for the Phoenix laboratory locations is Noridian, and Noridian relies on MolDX to make coverage and pricing determinations relating to molecular profiling. To achieve coverage under MolDX&#8217;s LCDs for molecular profiling, a test must demonstrate analytical and clinical validity, and clinical utility at a level that meets the Medicare reasonable and necessary requirement. Our MI Cancer Seek solution has Medicare coverage under the NGS NCD. Our MI Tumor Seek Hybrid solution and our Caris Assure solution for therapy selection are currently covered by Medicare under the MolDX Program. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January 19, 2021, CMS released an NCD that covers future tests for colorectal cancer (&#8220;CRC&#8221;) screening if and when such screening tests have FDA approval and meet pre-specified CMS criteria. In addition, MolDX LCDs provide coverage for MRD for CRC, breast cancer, lung cancer, and other indications when applicable coverage criteria are satisfied. Amongst other items, this coverage criteria includes published literature showing the clinical validity of an assay for the intended use of the assay in the intended population. While we have had preliminary discussions with MolDX regarding coverage for Caris Assure for MRD for CRC, it is possible that MolDX will require us to complete additional publications or validation studies and timing for MolDX coverage, if any, is uncertain. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">MolDX has also issued an LCD for coverage of NGS assays for myeloid malignancies where applicable coverage criteria are satisfied. Among other items, this coverage criteria includes that the assay has completed a technical assessment by MolDX for the assay&#8217;s stated indications. In order to obtain MolDX coverage for Caris ChromoSeq, we will need to submit, and MolDX will need to approve, a technical assessment for Caris ChromoSeq. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Coding plays a significant role in how our solutions are reimbursed both from commercial and governmental payers. The CPT codes, which are maintained by the AMA, are a set of codes for medical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">203</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">services, including profiling services. In addition to CPT codes, there are PLA codes, also maintained by the AMA, that are a set of billing codes for laboratory services that are more specific than CPT codes. New In addition to CPT and PLA codes, Z-Code Identifiers are used by certain payers, including under Medicare&#8217;s MolDX, to supplement CPT codes for molecular diagnostics tests. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A laboratory launching a new advanced diagnostic laboratory test (&#8220;ADLT&#8221;) or clinical diagnostic laboratory test (&#8220;CDLT&#8221;) can apply for a PLA code with the AMA. This process requires the laboratory to submit an application to the AMA. The AMA then makes coding methodology recommendations to CMS that could include &#8220;Crosswalk&#8221; or &#8220;Gapfill.&#8221; A Crosswalk is used if it is determined that there is an existing similar code, set of codes, or portion of a code that could be used to describe the new test. In this case, pricing would be the equivalent of the existing comparable code, the sum of multiple comparable codes, or a fraction of the comparable code. Gapfill is used when there are no comparable existing codes available. In this case, pricing is based on historical payments from other payers and/or resources required to complete the test. CMS will review the recommendation made by the AMA but will ultimately decide upon the coding methodology independently. This initial decision will be posted for public comment, and pricing will be published at the end of the public comment period. After pricing and coding is published, a request is then submitted to CMS for coverage under an existing NCD, or a request is made to create a new NCD. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In July&#160;2020, the AMA issued a PLA code, CPT code 0211U, for our MI Cancer Seek solution with effective date October&#160;1, 2020. CMS subsequently established national pricing for CPT code 0211U under the CLFS at $8,455. We have obtained Medicare coverage for MI Cancer Seek for CPT code 0211U under the NGS NCD. Our MI Tumor Seek Hybrid solution is reported to Medicare and to some commercial payers using unlisted molecular pathology CPT code 81479 and unique Z-Code Identifiers. In July&#160;2024, the AMA issued a PLA code, CPT code 0485U, for Caris Assure for therapy selection, with an effective date of October&#160;1, 2024. In November 2024, CMS determined to price Caris Assure for therapy selection using the &#8220;Gapfill&#8221; method. There is no certainty regarding the pricing that we will obtain for Caris Assure during the Gapfill process. Changes to these coverage polices or to the codes used to report to payers may result in significant changes in reimbursement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our early detection solution could be considered a screening test by Medicare and is not currently covered by Medicare. Medicare coverage for preventive services such as screening tests must be expressly authorized by statute or by CMS under an applicable NCD. Under CMS regulations, additional preventive services covered under an NCD must be (a)&#160;reasonable and necessary for the prevention or early detection of an illness or disability, (b)&#160;recommended with a grade of A or B by the USPSTF, which is an independent, volunteer panel of experts in the field of prevention, evidence-based medicine and primary care, and (c)&#160;appropriate for Medicare beneficiaries under Part&#160;A or Part&#160;B. None of our solutions have received such a grade or determination from USPSTF, which generally waits for FDA authorization before undertaking review of novel technology. In addition, the NCD process may take multiple&#160;years to complete, and currently, coverage decisions for preventive services are not made prior to FDA authorization. Even if we go through the lengthy NCD process, it is possible that the early detection solution will never become eligible for Medicare coverage and reimbursement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are evaluating opportunities for nearer-term coverage and reimbursement through Medicare Advantage plans as a supplemental benefit while generating evidence to meet the requirements of the traditional Medicare path. Medicare Advantage plans generally must cover all of the services that traditional Medicare covers (except hospice care), but they have the discretion to offer their enrollees additional, or supplemental, benefits not otherwise covered under traditional Medicare, including those benefits referred to as optional supplemental benefits, for which enrollees may elect to pay extra to receive coverage. Obtaining such coverage may, however, involve lengthy negotiations with individual Medicare Advantage plans, and there is no guarantee that we will receive such coverage. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We also intend to pursue coverage and reimbursement from private payers for our solutions. Many of these private payers must cover certain services required by federal and state laws, such as preventive health services that have received a rating of A or B by the USPSTF. Like Medicare Advantage plans, private payers have discretion to extend greater coverage than recognized under traditional Medicare but obtaining coverage from such payers may involve lengthy negotiations and there is no guarantee that we will receive such coverage. Even if we are successful in receiving coverage, the reimbursement amounts may not meet expected levels. State Medicaid programs make individual coverage decisions for diagnostic tests and have </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">204</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">taken steps to control the cost, utilization and delivery of healthcare services meaning that, even if we receive coverage through private payers, there is no guarantee that our solutions will be covered by individual state Medicaid programs. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">With respect to private health plans, the ACA mandates that such plans cover evidence-based items or services recommended by USPSTF with a grade of A or B, with certain prohibitions on cost-sharing requirements. Accordingly, if the USPSTF does not recommend use of Caris Assure or other solutions we are developing or requires a substantial amount of time to review such solutions, our business, financial condition, and results of our operations would be harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Protecting Access to Medicare Act of 2014</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2014, Congress passed the Protecting Access to Medicare Act of 2014 (&#8220;PAMA&#8221;), which included substantial changes to the way in which certain clinical laboratory services are paid under Medicare&#8217;s CLFS. Under PAMA (as amended by the Further Consolidated Appropriations Act in 2020 and Further Continuing Appropriations and Other Extensions Act of 2024), laboratories that receive the majority of their Medicare revenue from payments made under the CLFS and Physician Fee Schedule and receive at least $12,500 in Medicare revenues for CLFS services during a data collection period are subject to certain reporting requirements. CMS uses the data reported, including certain private payer payment rates, the volume of tests paid at each rate, and the HCPCS code associated with the test, to calculate a weighted median payment rate for each test, which is used to establish revised Medicare CLFS reimbursement rates for tests that are considered to be CDLTs. If the test falls into the category of new ADLT instead of CDLT, the test will be paid based on an actual list charge for an initial period of three quarters before being shifted to the weighted median private payer rate reported by the laboratory performing the ADLT. Laboratories offering ADLTs are subject to recoupment if the actual list charge exceeds the weighted median private payer rate by a certain amount. Accordingly, if newly developed tests receive Medicare coverage in the future, the reimbursement rate we receive for such tests may be affected by payment rates made by private payers for such tests. In addition, PAMA codified Medicare coverage rules for laboratory tests by requiring any local coverage determination to be made following the local coverage determination process. PAMA also authorizes CMS to consolidate coverage policies for clinical laboratory tests among one to four laboratory-specific MACs. These same contractors may also be designated to process claims if CMS determines that such a model is appropriate. It is unclear whether CMS will proceed with contractor consolidation under this authorization. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Congress passed legislation that delayed data reporting requirements for CDLTs that are not ADLTs, and delayed the phase-in of payment reductions under the CLFS from private payer rate implementation. The revised reimbursement methodology described above generally results in relatively lower reimbursement amounts under Medicare for clinical laboratory services than has been historically reimbursed. Any reductions to reimbursement rates resulting from the new methodology are limited to 0% in 2025 and 15% per test per year in each of 2026 through 2028. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subsequent data reporting period for CDLTs that are not ADLTs will occur in three-year cycles, with the next cycle beginning in 2026. The pricing for our solutions may be negatively impacted by the PAMA reporting process. Given the many uncertainties built into PAMA&#8217;s price-setting process, we cannot predict how payments we receive under the CLFS, and thus our revenue, may change from year to year. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Healthcare Reform</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States and certain foreign jurisdictions, there have been a number of legislative and regulatory changes to the healthcare system. Changes in healthcare policy could increase our costs and subject us to additional regulatory requirements that may interrupt commercialization of our solutions, decrease our revenue and adversely impact sales of, and pricing of and reimbursement for, our solutions. For example, in March&#160;2010, the ACA was signed into law, which substantially changed the way healthcare is financed by both governmental and private insurers in the United States. The ACA contains a number of provisions, including those governing enrollment in federal healthcare programs, reimbursement adjustments, and fraud and abuse changes. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">205</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The implementation of the ACA in the United States, for example, has changed healthcare financing and delivery by both governmental and private insurers substantially, and affected medical device manufacturers significantly. The ACA included, among other things, provisions governing enrollment in federal and state healthcare programs, reimbursement matters, and fraud and abuse. Since its enactment, there have been judicial, U.S. Congressional and executive branch challenges to certain aspects of the ACA. On June&#160;17, 2021, the U.S. Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress. In addition, on August&#160;16, 2022, President Biden signed the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in ACA marketplaces through plan year 2025. The IRA also eliminates the &#8220;donut hole&#8221; under the Medicare Part&#160;D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and creating a new manufacturer discount program. It is unclear how other healthcare reform measures, if any, will impact our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. For example, the Budget Control Act of 2011, among other things, resulted in reductions in payments to Medicare providers, which went into effect on April&#160;1, 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2032, unless additional Congressional action is taken. In addition, as a result of the American Rescue Plan&#160;Act of 2021 (&#8220;ARPA&#8221;), an additional Medicare payment reduction of up to 4% was required to take effect in January&#160;2022; however, Congress has delayed implementation of this reduction until 2025. Additionally, the American Taxpayer Relief Act of 2012, among other things, reduced CMS payments to several providers, including hospitals, and increased the statute of limitations period for the government to recover Medicare overpayments to providers from three to five&#160;years. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that there will continue to be proposals by legislators at both the federal and state levels, regulators, and third-party payers to reduce costs while expanding individual healthcare benefits. Certain of these proposals to further reform healthcare or reduce healthcare costs may limit coverage of or lower reimbursement for the procedures associated with the use of our solutions. Changes in healthcare policy could increase our costs, decrease our revenue, and impact sales of and reimbursement for our solutions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Privacy Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Data Privacy and Security Regulation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Numerous state, federal, and foreign laws, including consumer protection laws and regulations, govern the collection, dissemination, use, access to, confidentiality, and security of personal information, including health-related information. In the United States, numerous federal and state laws and regulations, including data breach notification laws, health information privacy and security laws, including HIPAA or HITECH, and federal and state consumer protection laws and regulations (for example, Section&#160;5 of the Federal Trade Commission Act) that govern the collection, use, disclosure, and protection of health-related and other personal information could apply to our operations or the operations of our partners. In particular, we are a &#8220;Covered Entity&#8221; as defined under HIPAA when performing our healthcare services for customers, and also act as a &#8220;Business Associate&#8221; when performing certain services for or on behalf of Covered Entities, which requires us to develop and maintain policies with respect to the protection of,&#160;use, and disclosure of PHI, including the adoption of administrative, physical and technical safeguards to protect such information, and to provide notifications in the event of a breach of unsecured PHI. In addition, many states have also implemented healthcare privacy and genetic testing and privacy laws imposing specific patient consent requirements and protecting test results by limiting the disclosure of those results. Failure to comply with these laws, where applicable, can result in the imposition of significant civil and/or criminal penalties and private litigation. Privacy and security laws, regulations, and other obligations are constantly evolving, may conflict with each other to make compliance efforts more challenging, and can result in investigations, proceedings, or actions that lead to significant penalties and restrictions on data processing. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a healthcare provider, we are also subject to Section&#160;4004 of the 21</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">st</font><font style="letter-spacing:0.2pt;"> Century Cures Act, and regulations promulgated by HHS related to patient access to electronic PHI (&#8220;EHI&#8221;), to promote interoperability and to ensure the access, exchange, or use of EHI. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">206</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other International Privacy and Security Regulations</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our business is subject to a complex and evolving global web of laws and regulations governing data privacy, data security, cross-border data transfers, and data localization. Local, state, federal, and foreign governments are increasingly implementing or expanding their data protection regimes, resulting in additional compliance costs and risks. Many of these laws and regulations are subject to change and uncertain interpretation and could result in regulatory or litigation claims or actions, changes to our business practices, monetary penalties, increased cost of operations, declines in clinical study participation or engagement, or otherwise harm our business. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We rely on information technology systems, including third-party hosted services, to support our business processes and activities and to store personal data (including employee and patient data). Consequently, we are at risk of a cybersecurity-related attack, intrusion, or disruption, including by criminal organizations, hackers, foreign governments, and terrorists. A cybersecurity incident could result in some or all of our systems being unavailable, the loss, misuse, or unauthorized disclosure of genetic information or other personal data, negative publicity and reputational damage, exposure to risk of loss, and litigation and regulatory investigations. In the event we are a victim of a cyberattack, data breach notification laws may require us to notify regulators, affected individuals, and potentially other third parties in multiple jurisdictions. Cyber threats are constantly evolving, increasing the difficulty of detecting and successfully defending against them. Despite our security measures, we cannot guarantee that these measures will prevent all possible security breaches or attacks. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employees and Human Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025, we had 1,769 full-time employees. Of these employees, nearly 50 have Ph.D. or M.D. degrees and over 200 are engaged in R&amp;D activities. None of our employees are represented by a labor union or party to a collective bargaining agreement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing, and integrating our existing and new employees, advisors, and consultants. We believe our success depends on our ability to attract, retain, develop, and motivate diverse highly skilled personnel. In particular, we depend upon the personal efforts and abilities of the principal members of our senior management to partner effectively as a team and to provide strategic direction, develop our business, manage our operations, and maintain a cohesive and stable work environment. We also rely on qualified managers and skilled employees, such as scientists, engineers, and laboratory technicians, with technical expertise in operations, scientific knowledge, engineering skills, and quality management experience in order to operate our business successfully. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our compensation program is designed to retain, motivate, and attract highly qualified personnel, including through the granting of stock-based and cash-based compensation awards, in order to increase shareholder value and the success of our Company by motivating such individuals to perform to the best of their abilities and achieve our business objectives. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Key Relationships</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Supply Agreement with Illumina</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2022, we entered into Illumina, Inc.&#8217;s (&#8220;Illumina&#8221;) &#8220;open offer&#8221; supply agreement wherein Illumina provides products and services that we use in our laboratory operations for certain research and clinical activities, including certain sequencers, equipment, and other materials (the &#8220;Illumina Agreement&#8221;). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Illumina Agreement, Illumina grants non-exclusive, non-transferable, personal, non-sublicensable rights to use certain Illumina know-how and technology with Illumina products purchased under the agreement, and we granted Illumina an irrevocable, perpetual, worldwide, fully paid-up, and royalty-free license covering improvements to certain Illumina know-how and technology. The Illumina Agreement does not contain any minimum purchase requirements but provides for volume discounts and other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">207</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">promotions. The Illumina Agreement also contains use limitations, representations and warranties, indemnification, limitations of liability, change notification, audit rights, and other provisions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Illumina Agreement is irrevocable by Illumina until its expiration in August&#160;2033. We have a unilateral right to terminate our supply relationship with Illumina at any time and for any reason without termination liability upon 90&#160;days&#8217; prior written notice to Illumina. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Master Supply Agreement with Roche</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In July 2024, we entered into a master supply agreement with Roche Diagnostics Corporation (&#8220;Roche&#8221;), for Roche to provide sequencing probes and other testing supplies and equipment for clinical and research uses in our laboratory operations (the &#8220;Roche Agreement&#8221;). Under the Roche Agreement, we receive certain pricing levels if we purchase a specified minimum annual quantity of supplies. Under the terms of the Roche Agreement, we also agreed to make rolling forecasts of our expected needs, which forecasts currently become three- and six-month binding purchase commitments for catalog and custom products, respectively. The pricing is fixed for the initial 12 months of the agreement term described below, and subject to increase thereafter. The Roche Agreement also contains negotiated use limitations, representations and warranties, indemnification, limitations of liability, and other provisions.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Roche Agreement has an initial term through April 2027 and will automatically renew with successive one-year terms unless either party provides 90-day advance notice of non-renewal. The agreement also provides for other customary termination rights, including in the case of material breach by, or insolvency of, either party.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Facilities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our corporate headquarters are located in Irving, Texas, where we lease approximately 30,500 square feet pursuant to a lease expiring in 2028. We also lease office space in Arizona, Massachusetts, and New York, and in Switzerland and Japan for our international offices. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We lease an approximately 66,000 square foot solid tissue clinical laboratory facility and an approximately 35,500 square foot blood-based clinical laboratory facility in Phoenix, Arizona, with leases expiring in 2030 and 2026, respectively. We also lease an approximately 59,000 square foot R&amp;D laboratory facility in Tempe, Arizona and an approximately 114,500 square foot laboratory facility in Irving Texas, with leases expiring in 2026 and 2035, respectively. The laboratory facility in Irving, Texas is continuing to be built-out and will bring our total operational capacity to over 275,000 square feet. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We lease an approximately 54,500 square foot customer service office and an approximately 22,550 square foot warehouse facility in Phoenix, Arizona, with leases expiring in 2030 and 2031, respectively. We also lease an approximately 23,400 square foot warehouse facility in Irving, Texas, with a lease expiring in 2032. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We do not own any real property. We believe that our facilities are adequate to meet our needs for the immediate future, and that, should it be needed, suitable additional space will be available to accommodate any such expansion of our operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2025, we received a Civil Investigative Demand (&#8220;CID&#8221;) from the DOJ in connection with an investigation under the FCA regarding our compliance with Medicare&#8217;s date of service rule (also referred to as the 14-day rule), particularly focused on patients of certain health care providers, and our policies, procedures, and training related to compliance with the 14-day rule. The related investigation continues to evolve and is in too early a stage to assess potential outcomes. We are cooperating with the investigation. We have implemented compliance policies, procedures, and training designed to foster compliance with the 14-day rule, but there can be no certainties regarding the outcome of the CID. In June 2022, we entered into a settlement agreement with the United States in connection with a previous&#160;investigation into our compliance with the 14-day day rule. Pursuant to this settlement agreement, under which we admitted no fault or liability, we paid approximately $2.9 million in restitution and penalties and we obtained a nationwide release from all 14-day rule claims prior to January 1, 2018.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">208</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:484pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to the matter described above, we are, from time to time, party to various claims and legal proceedings arising out of our ordinary course of business, including claims or proceedings relating to, among other things, regulatory matters, intellectual property, competition, tax, and employment matters, medical malpractice, product or professional liability or other tort claims. We cannot predict with certainty the results of any claims or proceedings. We may receive unfavorable preliminary or interim rulings in the course of litigation, and there can be no assurances that favorable final outcomes will be obtained. Moreover, the existence of any claim or legal proceeding, regardless of the outcome, may adversely impact us because of diversion of management time and attention as well as the financial costs related to resolving such disputes. For additional information, see &#8220;Risk Factors&#8212;Risks Related to Regulation and Legal Compliance&#8212;We have been, are currently, and in the future may be the subject of government investigations, claims, audits, whistleblower and payer audits, overpayment and recoupment efforts and other litigation in the course of our business that could adversely affect our business and financial statements.&#8221;</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">209</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMAN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Officers and Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Set forth below are the names, ages, and positions of our executive officers and directors as of the date of this prospectus. </font>
        </div>
        <table style="width:456pt;height:317.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 2.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt; width:17pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:2pt;padding-right:2pt;letter-spacing:-0.16pt;">Age </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt; width:207pt;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:172pt;letter-spacing:-0.16pt;">Position(s) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:216pt;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:17pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:207pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David D. Halbert, D.Sc. (h.c.) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">69 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <div style="white-space:nowrap; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Founder, Chairman, and Chief Executive Officer </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Brian J. Brille </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">64 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Vice Chairman and Executive Vice President </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Spetzler, M.S., Ph.D., M.B.A. </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">49 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">President </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Luke Power </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">44 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Senior Vice President, Chief Financial Officer, </font>
              <br >
              <font style="letter-spacing:0.2pt;">and Chief Accounting Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">J. Russel Denton </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">42 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:207pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Senior Vice President, General Counsel, and Secretary </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:17pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:207pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">George H. Poste, D.V.M., Ph.D., D.Sc., F.R.S. </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">81 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Vice Chairman </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jonathan Knowles, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">77 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Vice Chairman </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nathan Burns</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">43 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter M. Castleman</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">69 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Fredrickson </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">50 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Joseph E. Gilliam</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">49 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jon S. Halbert </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">65 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laura I. Johansen</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">60 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lloyd B. Minor, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">68 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vijay Mohan</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">45 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Danny Phillips</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">65 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jeffrey Vacirca, M.D., F.A.C.P.</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">56</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:207pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.09pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.6pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8.6pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Member of the audit committee of our board of directors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:4.6pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4.6pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Member of the compensation committee of our board of directors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:4.59pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4.59pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Messrs.&#160;Burns and Mohan resigned from our board of directors effective as of immediately prior to the effectiveness of the registration statement of which this prospectus forms a part.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">David D. Halbert, D.Sc. (h.c.)</font><font style="letter-spacing:0.2pt;"> founded our Company in 2008 and has served as our Chief Executive Officer and the Chairman of our board of directors since our inception. Mr.&#160;Halbert and his family also created and solely support the Caris Foundation, a non-profit, private foundation formed in 2002 that aids impoverished people by helping to provide for their basic needs. From 2005 to 2011, Mr.&#160;Halbert served as Chairman and Chief Executive Officer of Caris Diagnostics, a Texas-based pathology company specializing in gastrointestinal pathology, which was sold to Miraca Life Sciences in 2011. Prior to Caris Diagnostics, Mr.&#160;Halbert served as Chairman and Chief Executive Officer of AdvancePCS Inc. (&#8220;AdvancePCS&#8221;), a prescription benefit plan administrator that he founded in 1987. Mr.&#160;Halbert holds a Bachelor of Business Administration from Abilene Christian University and an honorary Doctor of Science from Abilene Christian University for his contributions to precision medicine and his global philanthropic work. We believe Mr.&#160;Halbert&#8217;s extensive knowledge of the healthcare industry, business experience, and 20&#160;years of leadership as Caris&#8217; Founder, Chairman, and Chief Executive Officer make him well-qualified to serve as a member of our board of directors. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">210</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Brian J. Brille</font><font style="letter-spacing:0.2pt;"> has served as our Vice Chairman and Executive Vice President and as a member of our board of directors since January&#160;2018. Mr.&#160;Brille currently serves as a member of the board of trustees at the Cancer Research Institute, a non-profit organization funding cancer research. Since 2022, Mr.&#160;Brille has also served as member of the board of directors at the International Biomedical Research Alliance, a non-profit organization with a mission to support the NIH Oxford-Cambridge Scholars Program. Prior to joining Caris, Mr.&#160;Brille served in various finance-related roles for Bank of America Merrill Lynch (now BofA Securities, Inc.), a multinational investment bank and financial services company, from 1999 to 2013, including most recently as Chairman &amp; President of Asia Pacific from 2009 to 2013, as Head of Corporate and Investment Banking from 2005 to 2008, and as Head of Healthcare Investment Banking from 1999 to 2004. Mr.&#160;Brille began his career in 1987 at Morgan Stanley &amp; Co. LLC (&#8220;Morgan Stanley&#8221;), a multinational investment bank and financial services company, and founded Morgan Stanley&#8217;s Healthcare Services Investment Banking Group. Mr.&#160;Brille holds a Juris Doctor from Stanford Law School, a Master in Public Policy from the Harvard Kennedy School, and a Bachelor of Science in Accounting from the University of Illinois. We believe Mr.&#160;Brille&#8217;s extensive experience in the investment industry and knowledge of healthcare and technology companies make him well-qualified to serve as a member of our board of directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">David Spetzler, M.S., Ph.D.</font><font style="letter-spacing:0.2pt;"> has served as our President since November&#160;2016. Dr.&#160;Spetzler has also served as an adjunct faculty member of the molecular cellular biology program at Arizona State University since 2007. Dr.&#160;Spetzler joined Caris in August&#160;2009 as a Senior Scientist and has served in a variety of roles of increasing seniority during his tenure. Before Caris, Dr.&#160;Spetzler served in various research faculty roles at Arizona State University from January&#160;2003 to August&#160;2009. Dr.&#160;Spetzler holds a Master of Science, a Doctor of Philosophy in Molecular &amp; Cellular Biology, and a Master of Business Administration from Arizona State University. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Luke Power</font><font style="letter-spacing:0.2pt;"> has served as our Senior Vice President, Chief Financial Officer, and Chief Accounting Officer since February&#160;2023. Mr.&#160;Power joined Caris in December&#160;2011 as a Financial Reporting and Accounting Manager and has served in a variety of roles of increasing seniority during his tenure, including as Chief Accounting Officer from April&#160;2017 to February&#160;2023, Senior Director of Accounting from May&#160;2016 to September&#160;2016, and Director of Accounting from August&#160;2013 to May&#160;2016. Prior to joining Caris, Mr.&#160;Power worked as a Manager in the international assurance practice at PricewaterhouseCoopers LLP, a provider of business advisory services, from November&#160;2002 to October&#160;2011. Mr.&#160;Power is a certified public accountant and a fellow of Chartered Accountants Ireland. Mr.&#160;Power holds a degree in finance and accounting from Waterford Institute of Technology in Ireland. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">J. Russel Denton</font><font style="letter-spacing:0.2pt;"> has served as our Senior Vice President, General Counsel, and Secretary since September&#160;2022. Prior to joining Caris, Mr.&#160;Denton served as a partner at Shearman &amp; Sterling LLP, an international law firm, representing clients in mergers and acquisitions and equity financing transactions from March&#160;2018 to September&#160;2022. Prior to Shearman &amp; Sterling LLP, Mr.&#160;Denton served as a partner at Andrews Kurth Kenyon LLP from May&#160;2012 to February&#160;2018. Mr.&#160;Denton began his career in September&#160;2008 as an associate at Skadden, Arps, Slate, Meagher and Flom LLP. Mr.&#160;Denton holds a Juris Doctor from Stanford Law School and a Bachelor of Science from Duke University. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">George H. Poste, D.V.M., Ph.D., D.Sc., F.R.S.</font><font style="letter-spacing:0.2pt;"> has served as our Vice Chairman since our founding in 2008. Since February&#160;2009, Dr.&#160;Poste has served as the Chief Scientist of the Complex Adaptive Systems Initiative at Arizona State University, a program that links expertise across the university in research on synthetic biology, ubiquitous sensing, and healthcare informatics for personalized medicine, and as the Del&#160;E. Webb Professor of Health Innovation. From May&#160;2003 to February&#160;2009, Dr.&#160;Poste served as Director of The Biodesign Institute at Arizona State University. Since January&#160;2000, Dr.&#160;Poste has served as the Chief Executive Officer of Health Technology Networks, a consulting company that specializes in the application of genomic technologies and computing in healthcare. From July&#160;1992 to December&#160;1999, Dr.&#160;Poste was the Chief Science and Technology Officer and President, R&amp;D, of SmithKline Beecham Corporation, a pharmaceutical company. Dr.&#160;Poste served on the Defense Science Board of the U.S. Department of Defense from January&#160;2000 to December&#160;2009 and is a member of the Bipartisan Commission on Biodefense as well as other U.S. government organizations to advise on national security policy on advancing defenses against bioweapons and biowarfare. Dr.&#160;Poste has served as a member of the board of directors of Exelixis, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">211</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Inc., a genomics-based drug discovery company, since 2004. Previously, Dr.&#160;Poste served as a member of the board of directors of Monsanto Company, a provider of agricultural products and solutions, from 2003 to 2018, Orchid Cellmark, Inc., a DNA forensics company, from 2002 to 2009, AdvancePCS, from 2002 to 2005, Structural GenomiX, a biotechnology company, from 2000 to 2003, and Illumina, from 2000 to 2003. Dr.&#160;Poste also serves on several scientific advisory boards, including Synthetic Genomics Inc., VirBiotech, the University of Michigan Taubman Institute, and MIDAS Advanced Computing Initiative. Dr.&#160;Poste is a Fellow of the UK Royal Society, the UK Academy of Medical Sciences, American Institute for Medical and Biological Engineering. Dr.&#160;Poste is also a member of the Council for Foreign Relations and previously served as a member of the Hoover Institution, Stanford University, and has received several honorary doctorates from several universities. Dr.&#160;Poste holds a Doctor of Veterinary Medicine and a Doctor of Philosophy in Virology from the University of Bristol, England and Board Certification in Pathology from the Royal College of Pathologists. We believe Dr.&#160;Poste&#8217;s training as a scientist, knowledge of the life sciences, healthcare, and biopharma industries, and extensive service on multiple boards make him well-qualified to serve as a member of our board of directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Jonathan Knowles, Ph.D.</font><font style="letter-spacing:0.2pt;"> has served as our Vice Chairman since 2010. Dr.&#160;Knowles served as the President of Group Research at Roche Holding AG (&#8220;Roche&#8221;), a Swiss multinational healthcare company, from September&#160;1998 to January&#160;2010 and as a member of its Corporate Executive Committee from January&#160;1998 to January&#160;2010. From January&#160;1998 to January&#160;2010, Dr.&#160;Knowles served as a member of the board of directors and as Chairman of the Corporate Governance Committee of Genentech, Inc., a biotechnology corporation that later became a subsidiary of Roche. From January&#160;2007 to January&#160;2010, Dr.&#160;Knowles served as the Chairman of the Research Directors&#8217; Group of the European Federation of Pharmaceutical Industry Associations. He has also served on the boards of directors of various pharmaceutical companies. Dr.&#160;Knowles is a Professor Emeritus at the &#201;cole Polytechnique F&#233;d&#233;rale de Lausanne, a Distinguished Professor in Personalized Medicine at the University of Helsinki, Finland, and a visiting Professor at the University of Oxford. Dr.&#160;Knowles holds a Bachelor of Science in Molecular Genetics from the University of East Anglia and a Doctor of Philosophy in Genetics of Mitochondria from the University of Edinburgh. We believe Dr.&#160;Knowles&#8217; extensive experience in the pharmaceutical industry and&#160;years of experience in his leadership roles as a director and executive officer make him well-qualified to serve as a member of our board of directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nathan Burns</font><font style="letter-spacing:0.2pt;"> served as a member of our board of directors from August&#160;2022 to June 2025. Mr.&#160;Burns is currently a Managing Director &amp; Healthcare Portfolio Manager at Highland Capital Management, L.P., a global alternative investment manager based in Dallas, Texas. Mr.&#160;Burns joined Highland Capital Management, L.P. in July&#160;2014 as a Director of Healthcare Absolute Return Investments. Prior to joining Highland Capital Management, L.P., Mr.&#160;Burns was a Private Equity Associate at Ripplewood Holdings, a global private equity firm, from September&#160;2007 to December&#160;2013. Mr.&#160;Burns began his career as an Investment Banking Analyst in the Global Technology Mergers &amp; Acquisitions Group at Lehman Brothers, a global financial services firm, from June&#160;2004 to June&#160;2007. Mr.&#160;Burns holds a Bachelor of Science in Analytical Finance and Economics from Wake Forest University and Master of Business Administration from Columbia Business School. He also is a CFA charterholder. Mr.&#160;Burns was selected to serve as a member of our board of directors because of his extensive experience in the investment industry and knowledge of healthcare companies. Mr.&#160;Burns resigned from our board of directors immediately prior to the effectiveness of the registration statement of which this prospectus forms a part. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Peter M. Castleman</font><font style="letter-spacing:0.2pt;"> has served as a member of our board of directors since 2008. Mr.&#160;Castleman is a private company investor and entrepreneur. Mr.&#160;Castleman is actively involved with about a dozen private companies where he is a significant owner through his family office, which he established in December&#160;2006. Prior to establishing his family office, Mr.&#160;Castleman was the Chairman and Managing Partner of J.&#160;H.&#160;Whitney &amp; Co., LLC, a private equity firm, from December&#160;1992 to December&#160;2006, where he oversaw all the firm&#8217;s activities, including the private equity investing business. Prior to joining J. H. Whitney &amp; Co., LLC in May&#160;1987, Mr.&#160;Castleman was with Morgan Stanley &amp; Co. LLC in their leveraged buyout investment group. Mr.&#160;Castleman started his career at J.P. Morgan Securities LLC, where he was an international banking officer. Mr.&#160;Castleman holds a Master of Business Administration from Harvard Business School and a Bachelor of Arts from Duke University. We believe Mr.&#160;Castleman&#8217;s extensive experience in the investment industry and&#160;years of experience in his leadership roles as a director and executive officer make him well-qualified to serve as a member of our board of directors. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">212</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">David Fredrickson</font><font style="letter-spacing:0.2pt;"> has served as a member of our board of directors since August&#160;2024. Mr.&#160;Fredrickson currently serves as Executive Vice-President, Oncology Business Unit of AstraZeneca PLC, a position that he has held since October&#160;2017. Previously, Mr.&#160;Fredrickson served as President of AstraZeneca K.K. in Japan, and Vice-President, Specialty Care of AstraZeneca in the United States. While in Japan, Mr.&#160;Fredrickson also served as Vice Chairman of the European Federation of Pharmaceutical Industries and Associations Japan and was a Director of the Japan Pharmaceutical Manufacturers Association. Before joining AstraZeneca, Mr.&#160;Fredrickson worked at Genentech, Inc., a biotechnology corporation that later became a subsidiary of Roche, where he served in several functions and leadership positions, including as Oncology Business Unit Manager in Spain, and in strategy, marketing, and sales roles in the United States. Prior to this, Mr.&#160;Fredrickson worked at the Monitor Group, LLC (now Monitor Deloitte Group, LLC), a global strategy consultancy firm. Mr.&#160;Fredrickson holds a Bachelor of Arts in Government from Georgetown University. We believe Mr.&#160;Fredrickson&#8217;s extensive experience in the pharmaceutical and oncology industries and&#160;years of experience in his leadership roles as a director and executive officer make him well-qualified to serve as a member of our board of directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Joseph E. Gilliam</font><font style="letter-spacing:0.2pt;"> has served as a member of our board of directors since April&#160;2021. Mr.&#160;Gilliam is currently the President and Chief Operating Officer at Glaukos Corporation, an ophthalmic pharmaceutical and medical device company, a position he has held since April&#160;2022. From May&#160;2017 to April&#160;2022, Mr.&#160;Gilliam was Chief Financial Officer and Senior Vice President, Corporate Development at Glaukos Corporation. Prior to Glaukos Corporation, Mr.&#160;Gilliam served as a Managing Director in the Healthcare Investment Banking group at J.P. Morgan Securities LLC from 2013 to May&#160;2017, where he led the initial public offering for Glaukos Corporation. From 2000 to 2013, Mr.&#160;Gilliam held positions of increasing responsibility at J.P.&#160;Morgan Securities LLC and its predecessor organizations, The Beacon Group and Chase Manhattan, with experience spanning mergers and acquisitions, primary and secondary public equity offerings, bank lending, bond offerings and other transactions. Mr.&#160;Gilliam started his career at PricewaterhouseCoopers LLP as an Auditor. Mr.&#160;Gilliam holds a Bachelor of Science in accounting from the Kelly School of Business at Indiana University. We believe Mr.&#160;Gilliam&#8217;s extensive experience in the investment and healthcare industries and knowledge of healthcare companies make him well-qualified to serve as a member of our board of directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Jon S. Halbert</font><font style="letter-spacing:0.2pt;"> has served as a member of our board of directors since May&#160;2014. Mr.&#160;Halbert currently serves as a member of the board of directors at Allegiance Group, a leading provider of fundraising services to nonprofit organizations in the United States, a position he has held since January&#160;2023. Since August&#160;2007, Mr.&#160;Halbert has also served as a member of the board of directors of the Pursuant Group, a nonprofit-focused marketing and fundraising organization that merged with the Allegiance Group in April&#160;2023. Mr.&#160;Halbert also currently serves on the boards of directors of CitiSquare and Forest Forward, Dallas-based nonprofit organizations that focus on poverty and the revitalization of South Dallas, respectively. Mr.&#160;Halbert served as the Chairman of Phytel, Inc., a technology driven provider-led population health improvement company, until its merger with the International Business Machines Corporation in 2015. Prior to Phytel, Inc., Mr.&#160;Halbert co-founded and served as Vice Chairman of AdvancePCS from 1987 until its merger with CVS Caremark Corporation in 2004. Mr.&#160;Halbert holds a Bachelor of Accounting from Abilene Christian University. We believe Mr.&#160;Halbert&#8217;s extensive experience in the healthcare and technology industries and&#160;years of experience in his leadership roles as a director and executive officer make him well-qualified to serve as a member of our board of directors</font><font style="font-style:italic;letter-spacing:0.2pt;">.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Laura I. Johansen</font><font style="letter-spacing:0.2pt;"> has served as a member of our board of directors since our founding in 2008. Ms.&#160;Johansen served as our Vice Chairman until February&#160;2012. In 2015, Ms.&#160;Johansen founded and currently serves as the President of Pence Management, a family office focused on real estate and equity investments. Ms.&#160;Johansen previously served as the President of Halbert &amp; Associates, LLC (&#8220;Halbert &amp; Associates&#8221;), the family office of Mr.&#160;Halbert, from 2004 to 2010. Ms.&#160;Johansen began her career at AdvancePCS as General Counsel in 1996 and served as the Senior Vice President and Corporate Secretary from 2001 until its merger with CVS Caremark Corporation in 2004. Before joining AdvancePCS, Ms.&#160;Johansen served as an Associate in the Corporate and Securities Group of Akin, Gump, Strauss, Hauer and Feld, an international law firm. Ms.&#160;Johansen holds a Bachelor of Business Administration in Marketing and a Juris Doctor from the University of Texas. We believe Ms.&#160;Johansen&#8217;s extensive experience in the healthcare industry and&#160;years of leadership experience as our Vice Chairman make her well-qualified to serve as a member of our board of directors. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">213</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Lloyd B. Minor, M.D.</font><font style="letter-spacing:0.2pt;"> has served as a member of our board of directors since August&#160;2021. Dr.&#160;Minor is currently the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, a position he has held since 2012. In addition to being the Dean of the School of Medicine, he became the Vice President for Medical Affairs at Stanford University in August&#160;2023. Dr.&#160;Minor has also been a professor of Otolaryngology&#8212;Head and Neck Surgery and a professor of Neurobiology and Bioengineering, by courtesy, since 2012. Prior to 2012, Dr.&#160;Minor served as the Provost and Senior Vice President for Academic Affairs at Johns Hopkins University from 2009 to 2012. Dr.&#160;Minor began his career at Johns Hopkins School of Medicine in the Department of Otolaryngology&#8212;Head and Neck Surgery as a Professor from 1993 to 2003, before serving as department&#8217;s Andelot Professor and Director (Chair) from 2003 to 2009. Dr. Minor has served as a member of the board of directors of Biogen, a global pharmaceutical company, since 2024. Dr.&#160;Minor holds a Bachelor of Science in Biology and a Doctor of Medicine from Brown University. In 2012, Dr. Minor was elected to the National Academy of Medicine, formerly the Institute of Medicine. We believe Dr.&#160;Minor&#8217;s experience as a professor and knowledge of the medical and healthcare industries make him well-qualified to serve as a member of our board of directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Vijay Mohan</font><font style="letter-spacing:0.2pt;"> served as a member of our board of directors from August&#160;2020 to June 2025. Mr.&#160;Mohan is currently a Co-Founder and Partner at Sixth Street Partners, a San Francisco-based investment firm, a position he has held since its founding in May&#160;2009. Prior to Sixth Street Partners, Mr.&#160;Mohan was a Managing Principal at Bardin Hill Investment Partners L.P., a New York investment firm. Mr.&#160;Mohan began his career in the Technology, Media, and Telecom Group of the Investment Banking Division of Goldman Sachs &amp; Co. LLC, a global investment banking, securities, and investment management firm. Mr.&#160;Mohan currently serves as a member of the Board of Visitors for Columbia College. He holds a Bachelor of Arts in Economics from Columbia University. Mr.&#160;Mohan was selected to serve as a member of our board of directors because of his extensive experience in the investment industry and&#160;years of experience as the co-founder of Sixth Street Partners. Mr.&#160;Mohan resigned from our board of directors immediately prior to the effectiveness of the registration statement of which this prospectus forms a part. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Danny Phillips</font><font style="letter-spacing:0.2pt;"> has served as a member of our board of directors since August&#160;2015. Mr.&#160;Phillips is currently the owner of the Diamond P Longhorn Ranch in Lindale, Texas, and manages his own financial investments. Mr.&#160;Phillips currently serves as a member of the board of directors of Fortress Youth Development Center, a non-profit organization that aids the homeless community and low-income families in Fort Worth, Texas, and served as its Chairperson from 2007 to 2015. In addition, Mr.&#160;Phillips currently serves as a member of the board of directors of Mission Increase Fort Worth, a non-profit organization that offers teaching, coaching, consulting, and fundraising tools to help other non-profits grow and be successful. He also currently serves as a member of the board of directors of Texas Mutual Insurance Company, a workers&#8217; compensation provider in Texas, a position he has held since 2012. Mr.&#160;Phillips has also previously served as a member of the board of directors of various academic organizations, such as on the board of regents at Pepperdine University and the investment board of Abilene Christian University. Mr.&#160;Phillips served in various finance-related roles at AdvancePCS for over 11&#160;years, including as its Chief Financial Officer and Senior Executive Vice President until its sale to CVS Caremark Corporation in 2004. Prior to AdvancePCS, Mr.&#160;Phillips served various senior financial roles at Harken Energy Corporation (now HKN Inc.), a company engaged in hydrocarbon exploration in Texas, and Aloha Petroleum, Ltd., a gasoline marketer and convenience store operator in Hawaii. Mr.&#160;Phillips holds a Bachelor of Arts in Accounting from Abilene Christian University. We believe Mr.&#160;Phillips&#8217; extensive experience in the pharmaceutical and investment industries and&#160;years of experience as a director and executive officer make him well-qualified to serve as a member of our board of directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Jeffrey Vacirca, M.D., F.A.C.P.</font><font style="letter-spacing:0.2pt;"> has served as a member of our board of directors since November&#160;2024. Since 2008, Dr. Vacirca has served as Chief Executive Officer and Chairman of the Board of New York Cancer &amp; Blood Specialists, a cancer care center specializing in hematology/oncology and medical oncology. Since 2011, he has served as President and Co-Founder of National Translational Research Group, a group focusing on non-clinical research, and, from 2012 to 2023, he served as a Medical Director and Strategic Advisor for the International Oncology Network specialty group at Amerisource Bergen, a pharmaceutical products company. Since 2018, Dr. Vacirca has served as the Medical Director of the Oncology Network Development at Mount Sinai Health Network and as an associate clinical professor at Icahn School of Medicine at Mount Sinai, New York. He served as Medical Director for the Long Island Association for AIDS Care from 2008 to 2024. Dr. Vacirca also serves on the boards of directors of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">214</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">privately held companies Annexus Health, OneOncology (where he was a co-founder) and PatientPoint. Dr.&#160;Vacirca served as a director of Assertio Holdings, a publicly-traded pharmaceutical company, from July&#160;2023 to November 2024, Spectrum Pharmaceuticals, a publicly-traded pharmaceutical company, from November 2018 to its July 2023 acquisition by Assertio, and BeyondSpring Inc., a publicly-traded biopharmaceutical company, from December 2020 to April 2022. Dr. Vacirca is the past president of the Community Oncology Alliance and continues to be a member of its executive committee. Dr. Vacirca also served on our Scientific Advisory Board from 2014 to 2020 and was a consultant for us from February 2022 through his election as a director. He has also been part of early funding for various companies including Cedar, Thyme Care, and Sherpa Health. Dr. Vacirca co-founded Odonate Therapeutics, a publicly held pharmaceutical company, in 2016 and served as a director until September 2019. Dr. Vacirca is the founder and Chairman of the Board of Directors of the New York Cancer Foundation, which provides financial assistance to patients undergoing treatment for cancer. Dr. Vacirca holds a Bachelor of Arts in Human Biology from the University at Albany and a Doctor of Medicine from St. George&#8217;s University. We believe that Dr. Vacirca&#8217;s extensive clinical expertise in oncology, experience in the healthcare and pharmaceutical industries, and leadership roles in cancer-focused organizations make him well-qualified to serve as a member of our board of directors.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Family Relationships</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">David D. Halbert, our Founder, Chairman, and Chief Executive Officer, is the brother of Jon S. Halbert, a member of our board of directors. Aside from the foregoing relationship, there are no family relationships among any of our executive officers or directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Composition of Our Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our business and affairs are managed under the direction of our board of directors. Messrs.&#160;Burns and Mohan resigned from our board of directors effective as of immediately prior to the effectiveness of the registration statement of which this prospectus forms a part. There were no disagreements between us and the resigning directors on any matter relating to our operations, policies, or practices. Our board of directors upon the completion of this offering will consist of&#160;12 members, eight of whom qualify as &#8220;independent&#8221; under the listing standards of Nasdaq. Our amended and restated certificate of formation and amended and restated bylaws, each of which will become effective immediately prior to the completion of this offering, will provide that the number of directors on our board of directors will be fixed from time to time by resolution of the board of directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When considering whether directors have the experience, qualifications, attributes, or skills, taken as a whole, to enable our board of directors to satisfy its oversight responsibilities effectively in light of our business and structure, the board of directors focuses primarily on each person&#8217;s background and experience as reflected in the information discussed in each of the directors&#8217; individual biographies set forth above. We believe that our directors provide an appropriate mix of experience and skills relevant to the size and nature of our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Independence</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the completion of this offering, our board of directors undertook a review of the independence of each director who is not an employee of Caris. Based on information provided by each such director concerning his or her background, employment, and affiliations, our board of directors has affirmatively determined that each of our directors, other than David D. Halbert, Brian J. Brille, George&#160;H.&#160;Poste, and Jon S. Halbert, do not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is &#8220;independent&#8221; as that term is defined under the listing standards of Nasdaq. In making these determinations, our board of directors considered the current and prior relationships that each non-employee director has with our Company and all other facts and circumstances our board of directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director, and the transactions involving them, if any, described in the section titled &#8220;Certain Relationships and Related Party Transactions.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">215</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lead Independent Director</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">David D. Halbert serves as both our Chief Executive Officer and as Chairman of our board of directors. Our board of directors has appointed Peter M. Castleman to serve as our lead independent director. As lead independent director, Mr. Castleman will preside over all meetings of the board of directors at which the Chairman of the board or directors is not present, including any executive sessions of the independent directors; call meetings or separate sessions of the independent directors; approve meeting schedules and agendas for the board of directors; approving information sent to the board of directors; acting as the liaison between the independent directors and the Chief Executive Officer and Chairman of the board of directors; and when appropriate, meeting or otherwise communicating with major shareholders or other constituencies.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Committees of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors has established an audit committee and a compensation committee, each of which will have the composition and responsibilities described below upon the completion of this offering. Members will serve on these committees until their resignation or until as otherwise determined by our board of directors. Each committee will operate under a written charter approved by our board of directors that satisfies the applicable rules of the SEC and the listing standards of Nasdaq. Upon the completion of this offering, copies of each committee&#8217;s charter will made available on our website. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We do not intend to have a standing nominating committee. In accordance with Rule&#160;5605 of the Nasdaq rules, a majority of the independent directors may recommend a director nominee for selection by the board of directors. The board of directors believes that the independent directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Audit Committee</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the completion of this offering, we expect our audit committee will consist of Danny&#160;Phillips, Peter M. Castleman, and Joseph E. Gilliam, with Mr. Phillips serving as Chair, and each of whom meet the requirements for independence under the listing standards of Nasdaq and SEC rules and regulations. Each member of our audit committee also meets the financial literacy and sophistication requirements of the listing standards of Nasdaq. In addition, our board of directors has determined that each member of our audit committee is an audit committee financial expert within the meaning of Item&#160;407(d) of Regulation&#160;S-K under the Securities Act. We intend to comply with the listing requirements of Nasdaq regarding the composition of our audit committee within the transitions period for newly public companies. Following the completion of this offering, our audit committee will be responsible for, among other things: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the appointment, compensation, retention, and oversight of our independent registered public accounting firm; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and discussing with management and the independent registered public accounting firm our annual and quarterly financial statements and related disclosures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and discussing with management and the independent registered public accounting firm the adequacy of our internal control over financial reporting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing procedures for employees to submit concerns anonymously about questionable accounting or audit matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">discussing our policies on risk assessment and risk management; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and, if appropriate, approving related party transactions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">pre-approving, all audit and all permissible non-audit services to be performed by the independent registered public accounting firm. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">216</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Committee</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the completion of this offering, we expect our compensation committee will consist of Peter&#160;M. Castleman, Joseph E. Gilliam, and Laura I. Johansen, with Mr. Castleman serving as Chair. Following the completion of this offering, our compensation committee will be responsible for, among other things: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing, approving and determining, or making recommendations to our board of directors regarding, the compensation of our executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">recommending compensation for non-employee directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">administering our equity compensation plans; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and approving, or making recommendations to our board of directors, regarding incentive compensation and equity compensation plans; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing and reviewing general policies relating to compensation and benefits of our employees. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to the terms of our compensation plans, our compensation committee will have discretion to determine the amount, form, structure and implementation of compensation payable to our employees and executive officers, including, where appropriate, discretion to increase or decrease awards or to award compensation absent the attainment of performance goals and to award discretionary cash compensation outside of the parameters of our compensation plans. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Role of the Board in Risk Oversight</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors is responsible for overseeing our risk management process. Our board of directors focuses on our general risk management policies and strategy, the most significant risks facing us, and oversees the implementation of risk mitigation strategies by management. Our board of directors is also apprised of particular risk management matters in connection with its general oversight and approval of corporate matters and significant transactions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors does not have a standing risk management committee but intends to administer its oversight function through our audit committee, which will be responsible for overseeing enterprise risk management, including the management of financial risks and cybersecurity risks, reviewing and discussing our guidelines and policies with respect to risk assessment and risk management, and discussing with management the steps management has taken to monitor and control these exposures. In addition, the standing committees of our board of directors will address risks inherent in their respective areas of oversight. Our compensation committee will oversee risks related to our executive compensation, equity incentive plans, and other compensatory arrangements, and our will oversee risks associated with our corporate governance framework. Our board of directors intends to implement its risk oversight function both as a whole and through delegation to its committees, which will meet regularly and report back to the board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Committee Interlocks and Insider Participation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">None of our executive officers currently serves, or in the past year has served, as a member of the board of directors or compensation committee (or other board committee performing equivalent functions) of any entity that has one or more of its executive officers serving on our board of directors or compensation committee. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Code of Business Conduct and Ethics</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors has adopted a written code of business conduct and ethics that will apply to all of our employees, officers, and directors, including our principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions. Upon the completion of this offering, the full text of our code of business conduct and ethics will be posted on our website, </font><font style="font-style:italic;letter-spacing:0.2pt;">www.carislifesciences.com</font><font style="letter-spacing:0.2pt;">. In addition, we intend to post on our website all disclosures that are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">217</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">required by law or the Nasdaq rules concerning any amendments to, or waivers from, any provision of the code of business conduct and ethics. The information on our website is deemed not to be incorporated in this prospectus or to be part of this prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For 2024, we provided a $50,000 cash retainer, paid in quarterly installments, to certain non-employee directors for their service on our board of directors. We also provided additional cash retainers to committee chairs and members as follows: audit committee chair ($24,000); audit committee members ($10,000); compensation committee chair ($17,750); compensation committee members ($8,000); governance and nominating committee chair ($10,000) and governance and nominating committee members ($5,000). Dr.&#160;Minor did not receive an annual retainer but instead received a fee of $40,000 for every meeting he attended. We also reimbursed all of our directors for their out-of-pocket expenses in connection with attending board of directors and committee meetings, and our directors are eligible to obtain our solutions on the same terms and conditions available to our employees. We did not provide compensation for 2024 to our investor designee directors, Messrs. Burns and Mohan, for their services on our board of directors. David D.&#160;Halbert and Brian J. Brille, who are employees of the Company, did not receive any additional compensation for their services on our board of directors. See the section titled &#8220;Executive Compensation&#8212;</font>&#8203;<font style="letter-spacing:0.2pt;">Summary Compensation Table&#8221; for the compensation received by Mr.&#160;Halbert and Mr. Brille for 2024. </font></div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding compensation paid to our non-employee directors for the fiscal year ended December&#160;31, 2024. </font>
        </div>
        <table style="width:456pt;height:173.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 1.167pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1.16666666666667pt;padding-right:1pt;letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fees Earned or </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid in Cash ($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock Awards ($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards ($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">All Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation ($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total ($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">George H. Poste </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">55,000</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font></font></td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">107,500<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font></font></td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">162,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jonathan Knowles </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nathan Burns</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter M. Castleman </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">77,750</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">77,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Fredrickson </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,000</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">963,000</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">988,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Joseph E. Gilliam </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jon S. Halbert </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laura I. Johansen </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">63,000</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">63,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lloyd B. Minor </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">160,000</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">160,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vijay Mohan</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Danny Phillips </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">74,000</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">74,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:111.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jeffrey Vacirca </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">12,500</td>
            <td style="padding:0pt;padding-left:10.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">972,000</td>
            <td style="padding:0pt;padding-left:21.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">984,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">As of December&#160;31, 2024, certain of our non-employee directors held outstanding options to purchase a number of shares of our common stock, as follows: Dr.&#160;Poste&#8212;175,000 shares; Dr.&#160;Knowles&#8212;2,500 shares; Mr.&#160;Fredrickson&#8212;75,000 shares; Mr.&#160;Gilliam&#8212;75,000 shares; Mr.&#160;Phillips&#8212;100,000 shares; and </font>
          <br >
          <font style="letter-spacing:0.18pt;">Dr. Vacirca&#8212;100,000 shares. Additionally, as of December&#160;31, 2024, Dr. Poste held a total of 218,625 restricted stock units (&#8220;RSUs&#8221;), which RSUs fully vest only upon the occurrence of an initial public offering or a change in control of the Company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">The amounts in this column reflect the aggregate grant date fair value of stock options granted under our 2020 Plan in 2024, as calculated in accordance with FASB ASC Topic 718 (without any reduction for risk of forfeiture) as determined based on applying the assumptions used in Note&#160;7 to our consolidated financial statements for 2024 included elsewhere in this prospectus. Options were granted to each of Mr. Fredrickson and Dr. Vacirca in connection with their election to our board of directors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Reflects the aggregate grant date fair value of RSUs granted under the 2020 Plan in 2024, as calculated in accordance with FASB ASC 718 (without any reduction for risk of forfeiture) as determined based on applying the assumptions used in Note&#160;7 to our consolidated financial statements for 2024 included elsewhere in this prospectus. The RSUs will fully vest only upon the occurrence of a specific performance milestone (either an initial public offering or a change in control of the Company). Assuming the maximum performance levels are achieved, the maximum value of the RSUs would be $4,250,070. This amount may not reflect the actual value realized upon vesting or settlement, if any. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">218</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:300pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:11pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(4)</font>
          <br >
        </div>
        <div style=" line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">The amounts reported reflect fees received for consulting services provided to the Company and for service on the Company&#8217;s Scientific Advisory Board. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Messrs.&#160;Burns and Mohan resigned from our board of directors effective as of immediately prior to the effectiveness of the registration statement of which this prospectus forms a part.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Paid to Employee Directors for 2024</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">David D. Halbert is the Chairman of our board of directors, our Founder and also serves as our Chief Executive Officer. Brian J. Brille is the Vice Chairman of our board of directors and also serves as Executive Vice President. Mr. Halbert and Mr. Brille do not receive any additional compensation for their services on our board of directors. For the compensation received by Mr.&#160;Halbert and Mr. Brille for the fiscal year ended December 31, 2024 and a description of the elements of their compensation, see the section titled &#8220;Executive Compensation.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Non-Employee Director Compensation Policy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Effective January 1, 2025, our compensation committee adopted a Non-Employee Director Compensation Policy, pursuant to which our non-employee directors are compensated effective January 2025. Under the policy, each non-employee director will receive an annual cash retainer equal to $50,000 and an annual equity retainer consisting of time-vested RSUs with a grant date fair value equal to $300,000. The non-employee director, if any, who serves as a lead independent director will additionally receive an annual cash retainer equal to $30,000. The committee chairs of the audit committee and compensation committee, will receive annual cash retainers equal to $25,000 and $18,000, respectively. The committee members will receive the following annual cash retainers: $12,500 for service on the audit committee and $9,000 for service on the compensation committee. A non-employee director may elect to receive any cash retainer or specified portion thereof in shares of our common stock. Upon election to our board of directors, a non-employee director will receive an initial grant of RSUs with an aggregate grant date fair value of $500,000, which will vest ratably in three equal installments on the first three anniversaries of the grant date. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">219</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEXCO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXECUTIVE COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This section sets forth the compensation of our named executive officers (&#8220;NEOs&#8221;) for the fiscal year ended December&#160;31, 2024. Our NEOs are our Chief Executive Officer and our two other most highly compensated executive officers (as determined in accordance with SEC rules) for the fiscal year ended December&#160;31, 2024: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">David D. Halbert, Founder, Chairman, and Chief Executive Officer </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Brian J. Brille, Vice Chairman and Executive Vice President</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">David Spetzler, President </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As an emerging growth company, we have elected to take advantage of exemptions from various reporting requirements that are applicable to public companies that are not emerging growth companies, including reduced disclosure obligations regarding executive compensation in this prospectus and, while an emerging growth company, our future periodic reports and proxy statements, as well as exemptions from the requirements of holding nonbinding advisory votes on executive compensation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table shows the total compensation paid to or earned by each of our NEOs for the fiscal year ended December&#160;31, 2024. </font>
        </div>
        <table style="width:456pt;height:119.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 2.167pt 0pt; width:142.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:2.16666666666667pt;padding-right:1pt;letter-spacing:-0.16pt;">Name and Principal Position </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Salary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">All Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation </font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:142.46pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">David D. Halbert</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Executive Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">750,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,500,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,250,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:142.46pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Brian J. Brille</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Vice Chairman and Executive </font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Vice President</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,200,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:142.46pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">David Spetzler</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">President</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</font></font></td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,800</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,213,800</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.01pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">The&#160;amounts shown in this column are the annual bonus amounts payable in respect of fiscal year 2024 to each of our NEOs. See &#8220;&#8212;Narrative to Summary Compensation Table&#8212;Annual Bonus&#8221; for a description of the terms of these bonuses. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Reflects&#160;the aggregate grant date fair value of RSUs granted under the 2020 Plan in 2024, as calculated in accordance with FASB ASC 718 (without any reduction for risk of forfeiture) as determined based on applying the assumptions used in Note&#160;7 to our consolidated financial statements for 2024 included elsewhere in this prospectus. These RSUs will fully vest only upon the occurrence of a specific performance milestone (either an initial public offering or a change in control of the Company). Assuming the maximum performance levels are achieved, the value for the RSUs granted in 2024 would be $2,123,820. This amount may not reflect the actual value realized upon vesting or settlement, if any. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">The&#160;amounts in this column represent matching contributions to the Company&#8217;s 401(k) plan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.91pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Narrative Disclosure to Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Base Salary</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our NEOs each receive a base salary to compensate them for services rendered to our Company. The base salary payable to each NEO is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role, and responsibilities. For 2024, the NEOs&#8217; annual base salaries were as follows: Mr.&#160;Halbert&#8212;$750,000, Mr. Brille&#8212;$600,000, and Dr.&#160;Spetzler&#8212;$600,000. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Annual Bonus</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We maintain an annual cash bonus program in which each of our NEOs participated for 2024. Each NEO&#8217;s target bonus is expressed as a percentage of his annual base salary. Bonuses for our NEOs are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">220</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">determined by the compensation committee based on a rigorous assessment of Company performance. The 2024 annual bonus targets were 200% of base salary for Mr.&#160;Halbert and 100% of base salary for each of Mr.&#160;Brille and Dr.&#160;Spetzler. In February 2025, the compensation committee determined to award two separate bonuses to Mr.&#160;Halbert: one bonus of $750,000, with respect to the first half of 2024, and another bonus of $750,000, with respect to the second half of 2024. In certain instances, we may also provide other cash bonus opportunities to our employees, including our NEOs, to incentivize or reward work with respect to specific business goals. In 2025, the compensation committee approved a special cash bonus of $750,000 to Mr.&#160;Halbert to be paid upon the completion of this offering. This bonus does not appear in the Summary Compensation Table for 2024 included in this prospectus but will appear in the Summary Compensation Table for 2025. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity and Long-Term Incentives</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that equity awards provide our executive officers with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executive officers and our shareholders. To date, we have used stock option and RSU grants for this purpose because we believe they are effective means by which to align the long-term interests of our executive officers with those of our shareholders. The use of stock options also can provide tax and other advantages to our executive officers relative to other forms of equity compensation. We believe that our equity awards are an important retention tool for our executive officers, as well as for our other employees. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We award stock options broadly to our employees. Grants to our executive officers and other employees are made at the discretion of our compensation committee and are not made at any specific time period during a year. In 2024, all of our equity incentive awards grants were made under the terms of the Caris Life Sciences, Inc. 2020 Incentive Plan, as amended and restated (the &#8220;2020 Plan&#8221;). See &#8220;&#8212;Equity Incentive Plans&#8221; for additional information on our equity plans. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In August 2024, the compensation committee approved a grant of 360,750 RSUs to Mr. Halbert, subject to shareholder approval that was obtained in March 2025. Such RSUs were granted in March 2025 following such approval and will fully vest upon the completion of this offering. In March 2025, the compensation committee approved a stock option grant to Dr.&#160;Spetzler with respect to 750,000 shares at a strike price of $18.60 in order to further align his interests with those of our shareholders.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Approximately 27% of the share reserve of the 2025 Plan will be utilized shortly following the effectiveness of the registration statement of which this prospectus forms a part for compensatory grants to our employees, including 413,839 RSUs to Mr.&#160;Halbert and 132,429 RSUs to each of Dr.&#160;Spetzler and Mr.&#160;Brille, our NEOs, based on the initial public offering price of $21.00 per share. These awards will consist of RSUs that will vest over four years, subject to the grantee&#8217;s continued employment through each vesting date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Benefits</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain of our NEOs (and their guests) may use aircraft or private travel service arrangements or programs (such as car services) that we have access to for reasonable personal use and for which they bear the cost. In addition, Mr. Brille and Dr.&#160;Spetzler have certain severance rights. For further information, on Mr.&#160;Brille and Dr. Spetzler&#8217;s severance rights, see &#8220;Narrative Disclosure to Summary Compensation Table&#8212;</font>&#8203;<font style="letter-spacing:0.2pt;">Employment Agreements&#8221;. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employment Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Employment Agreement with Brian Brille</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We entered into an employment agreement with Mr. Brille, dated as of May 31, 2018 (the &#8220;Brille Agreement&#8221;) in connection with Mr. Brille&#8217;s &#8220;at-will&#8221; employment with us. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Brille Agreement, Mr. Brille is entitled to an annual base salary of $500,000 and eligible to receive an annual target bonus equal to 100% of his salary. For the fiscal year ended December&#160;31, 2024, Mr. Brille&#8217;s base salary was $600,000 and his annual bonus target was equal to 100% of his salary. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">221</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:56pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Brille Agreement provides that Mr. Brille is eligible to participate in the Company&#8217;s employee benefit plans and includes certain vesting rights applicable to his equity awards. Upon the termination of Mr.&#160;Brille&#8217;s employment by the Company without cause or by Mr. Brille for good reason, Mr. Brille would be entitled to the following payments and benefits, in addition to any accrued obligations: (1) a lump sum payment equal to six months of his then-current annual base salary; (2) six months of company-paid COBRA benefits; and (3) continued eligibility for consideration for any annual bonus that would otherwise be due to him with respect to the fiscal year of termination, prorated based on the number of days during the fiscal year that he was employed and payable at the same time as the bonus would have otherwise been paid had his employment not been terminated (a &#8220;Prorata Bonus&#8221;). Upon Mr. Brille&#8217;s termination of employment due to death or disability, Mr. Brille or his estate, as applicable, will be eligible to receive a Prorata Bonus, as well as any accrued obligations, and in the case of his disability, any disability benefits he is entitled to under any applicable Company plans. The Brille Agreement also includes an indefinite confidentiality covenant, as well as non-competition, customer non-solicitation and employee non-solicitation covenants that each apply for one year following Mr. Brille&#8217;s termination date and a non-interference with vendors and suppliers covenant that applies for two years following his termination date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Employment Agreement with Dr. David Spetzler</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We entered into an employment agreement with Dr. Spetzler, dated as of February 1, 2010, and an amendment to this employment agreement on July 27, 2015 (as amended, the &#8220;Spetzler Agreement&#8221;) in connection with Dr. Spetzler&#8217;s &#8220;at-will&#8221; employment with us. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Spetzler Agreement, Dr. Spetzler is entitled to an annual base salary of $320,000 and eligible to receive an annual target bonus equal to 50% of his salary. For the fiscal year ended December&#160;31, 2024, Dr. Spetzler&#8217;s base salary was $600,000 and his annual bonus target was equal to 100% of his salary. The Spetzler Agreement provides that Dr. Spetzler is eligible to participate in the Company&#8217;s employee benefit plans and, upon Dr. Spetzler&#8217;s termination of employment by the Company without cause or by Dr. Spetzler for good reason, Dr. Spetzler would be entitled to the following payments and benefits, in addition to any accrued obligations: (1) a lump sum payment equal to six months of his then-current annual base salary; (2) six months of company-paid COBRA benefits; and (3) continued eligibility for consideration for a Prorata Bonus. Upon Dr. Spetzler&#8217;s termination of employment due to death or disability, Dr. Spetzler or his estate, as applicable, will be eligible to receive a Prorata Bonus, as well as any accrued obligations, and in the case of his disability, any disability benefits he is entitled to under any applicable Company plans. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Proprietary Information, Intellectual Property, Restrictive Covenant and Arbitration Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dr.&#160;Spetzler is also party to the Company&#8217;s Proprietary Information, Intellectual Property, Restrictive Covenant and Arbitration Agreement (the &#8220;PIIA&#8221;). Under the PIIA, Dr. Spetzler is subject to an indefinite confidentiality covenant, as well as non-competition, customer non-solicitation, employee non-solicitation, non-interference with vendors and suppliers, and non-disparagement covenants that each apply for one year following Dr. Spetzler&#8217;s termination date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Invention Assignment Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Messrs.&#160;Halbert and Brille are also each party to an Inventions Assignment Agreement with us, under which they agreed to assign their right, title, and interest to any inventions and related intellectual property that they may develop in the course of their employment, and are subject to confidentiality restrictions related thereto. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">222</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:10.96pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Outstanding Equity Awards at Fiscal Year 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding outstanding equity awards held by our NEOs as of December&#160;31, 2024. The awards shown in this table were granted pursuant to the 2020 Plan. </font>
        </div>
        <table style="width:456pt;height:263.39pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
          <tr style="line-height:7.8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.156pt;">Option Awards</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.156pt;">Stock Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.76pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0.61pt 0pt 0.68pt 0pt; width:54.58pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-right:1pt;letter-spacing:-0.156pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.156pt;">Grant Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.156pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Securities </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Underlying </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Unexercised </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Options </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Exercisable </font>
                <br >
                <font style="letter-spacing:-0.156pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.156pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Securities </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Underlying </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Unexercised </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Options </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Unexercisable </font>
                <br >
                <font style="letter-spacing:-0.156pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.156pt;">Option </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Exercise </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Price ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.156pt;">Option </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Expiration </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.156pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Shares or </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Units of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Stock That </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Have Not </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Vested (#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.156pt;">Market </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Value of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Shares of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Units of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Stock That </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Have Not </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Vested </font>
                <br >
                <font style="letter-spacing:-0.156pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.156pt;">Equity </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Incentive </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Plan </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Awards: </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Unearned </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Shares, </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Units or </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Rights </font>
                <br >
                <font style="letter-spacing:-0.156pt;">That Have </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Not Vested </font>
                <br >
                <font style="letter-spacing:-0.156pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.61pt 0pt 0.68pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.156pt;">Equity </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Incentive </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Plan </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Awards: </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Market or </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Payout </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Value of </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Unearned </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Shares, </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Units or </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Rights </font>
                <br >
                <font style="letter-spacing:-0.156pt;">That Have </font>
                <br >
                <font style="letter-spacing:-0.156pt;">Not Vested </font>
                <br >
                <font style="letter-spacing:-0.156pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.35pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0.217pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">
              <div style="margin-left:7.8pt; text-indent:-7.8pt; line-height:9.34pt;">
                <font style="letter-spacing:0.156pt;">David D. </font>
                <br >
                <font style="letter-spacing:0.156pt;">Halbert </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11/15/2018</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,000,000</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.44</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.217pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11/14/2028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.35pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0.467pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">
              <div style="margin-left:7.8pt; text-indent:-7.8pt; line-height:9.34pt;">
                <font style="letter-spacing:0.156pt;">Brian J. </font>
                <br >
                <font style="letter-spacing:0.156pt;">Brille</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#65279;(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1/15/2018</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,000,000</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.44</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1/14/2028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.78999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2/27/2020</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">800,000</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.00</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2/26/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.78999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8/11/2022</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">437,500<font style="position:absolute;"><font style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">16.20</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8/11/2032</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.35pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0.467pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">
              <div style="margin-left:7.8pt; text-indent:-7.8pt; line-height:9.34pt;">
                <font style="letter-spacing:0.156pt;">David </font>
                <br >
                <font style="letter-spacing:0.156pt;">Spetzler</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#65279;(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">6/24/2015</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">75,000</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.44</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.467pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">6/23/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.78999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9/12/2016</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,250,000</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.44</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9/12/2026</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.78999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4/1/2020</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">800,000</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.00</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4/1/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.78999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8/11/2022</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">300,000<font style="position:absolute;"><font style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,580,000</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.78999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5/17/2023</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">42,500<font style="position:absolute;"><font style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;">(6)</font></font></td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">790,500</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.78999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:54.58pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8/14/2024</td>
            <td style="padding:0pt;padding-left:0.774999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.825pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.530000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">109,250<font style="position:absolute;"><font style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;">(6)</font></font></td>
            <td style="padding:0pt;padding-left:5.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.507pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,032,050</td>
            <td style="padding:0pt;padding-left:0.129999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.16pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Except&#160;where otherwise described in these footnotes, stock option awards vest over five&#160;years, with one-fifth of the shares subject to the stock option vesting annually on each of the first five anniversaries of the grant date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The&#160;market value of the restricted stock and RSUs as of December&#160;31, 2024 is calculated by multiplying the number of unvested shares or&#160;units outstanding under the award by $18.60 per share, which our board of directors determined equaled the fair market value of a share of our common stock as of December&#160;31, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The shares of common stock subject to this option are immediately issuable pursuant to Mr.&#160;Brille&#8217;s right to early exercise this option. As of December 31, 2024, Mr. Brille had not early exercised this option. The shares underlying this option vested 20% on the date of the option grant with the remainder vesting in equal 20% installments over four&#160;years on the anniversaries of the grant date, subject to Mr.&#160;Brille&#8217;s continued services to us on each vesting date. As of December&#160;31, 2024, 262,500 shares of common stock underlying this option had vested, with an unvested balance of 175,000 shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents shares of restricted stock acquired pursuant to Dr. Spetzler&#8217;s early exercise of an option to purchase 750,000 shares of common stock. The shares vested 20% on the date of the option grant with the remainder vesting in equal 20% installments over four&#160;years on the anniversaries of the grant date, subject to Dr.&#160;Spetzler&#8217;s continued services to us on each vesting date. As of December&#160;31, 2024, 450,000&#160;shares of common stock underlying this option had vested, and the remaining 300,000 shares were unvested. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents RSUs that will vest in full in connection with this offering, subject to the RSU holders&#8217; continuous service through the completion of the initial public offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">223</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Policies and Practices for Granting Option Awards</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has not granted any option awards as a reporting company. The Company does not plan to time the disclosure of material non-public information for purposes of affecting the exercise price of the options or the value of executive compensation or grant options during the four business days prior to or the one business day following the filing of a periodic report on Form 10-Q or Form 10-K, or the filing or furnishing of a Form 8-K that discloses material non-public information. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Long-Term Incentive Plans</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The purpose of our equity compensation plans is to attract, retain, and motivate our employees, officers, and directors, by providing them with the opportunity to acquire a proprietary interest in the Company and to align their interests and efforts with the long-term interests of our shareholders. In connection with this offering, our board of directors has adopted, and our shareholders have approved, the 2025 Plan. Under the 2025 Plan, we will have 15,125,002 shares of our common stock reserved for issuance (plus any shares underlying outstanding stock awards granted under our 2020 Plan that expire or are repurchased, forfeited, canceled, or withheld), as further increased as described below. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Caris Life Science, Inc. 2012 Incentive Plan was initially adopted by our board of directors in May 2012 and, in August 2020, was amended and restated to become the 2020 Plan. The 2020 Plan was further amended and restated in connection with this offering in order to reflect certain changes applicable in light of the Company becoming a publicly traded company. Following completion of this offering, we will not make any additional grants under the 2020 Plan. Grants, including to our NEOs, have been and may continue to be made under the 2020 Plan prior to this offering. The material terms of the 2020 Plan are substantially similar to the 2025 Plan, except with respect to the number of authorized shares, as described below. For additional information on the equity awards held by our NEOs and outstanding as of December&#160;31, 2024 see &#8220;&#8212;Outstanding Equity Awards at Fiscal Year End&#160;2024.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2025 Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Types of Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our 2025 Plan provides for the grant of incentive stock options (&#8220;ISOs&#8221;), nonstatutory stock options (&#8220;NSOs&#8221;), stock appreciation rights, restricted stock awards, RSU awards, performance-based awards, and other awards. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Plan Administration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors, or a duly authorized committee of our board of directors, may administer our 2025 Plan. Our board of directors has delegated concurrent authority to administer our 2025 Plan to the compensation committee under the terms of the compensation committee&#8217;s charter. We sometimes refer to the board of directors, or the applicable committee with the power to administer our equity incentive plans, as the administrator. The administrator may also delegate to one or more of our officers the authority to (1) designate employees (other than officers) to receive specified awards and (2) determine the number of shares subject to such awards. The administrator has the authority to determine the terms of awards, including recipients, the exercise, purchase or strike price of awards, if any, the number of shares subject to each award, the fair market value of a share of common stock, the vesting schedule applicable to the awards, together with any vesting acceleration, and the form of consideration, if any, payable upon exercise or settlement of the award and the terms of the award agreements for use under our 2025 Plan. In addition, subject to the terms of the 2025 Plan, the administrator also has the power to modify outstanding awards under our 2025 Plan, including the authority to reprice any outstanding option or stock appreciation right, cancel and re-grant any outstanding option or stock appreciation right in exchange for new stock awards, cash or other consideration, or take any other action that is treated as a repricing under generally accepted accounting principles, with the consent of any materially adversely affected participant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Authorized Shares</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The maximum number of shares of common stock that may be issued under our 2025 Plan is equal to (a) 5% of our common stock on a fully diluted basis after giving effect to this offering (including, but not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">224</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">limited to, all shares in respect of the Warrant Net Exercises, the Preferred Stock Conversion, and the Notes Conversion, shares subject to outstanding awards under the 2020 Plan, and the issuance of the common stock to be sold in this offering), plus (b) the number of shares that would have returned to the share reserve of the 2020 Plan following the effectiveness of the registration statement of which this prospectus forms a part, all of which may be issued as ISOs. The 2025 Plan&#8217;s share reserve will increase on January 1 of each calendar year during the term of the 2025 Plan, beginning in 2026, by a number of shares as determined by the administrator of the 2025 Plan and in consultation with the Company, provided, that such increase (if any) will be no greater than the amount by which (y) 4% of the aggregate number of outstanding shares of our common stock as of the last day of the immediately preceding fiscal year exceeds (z) the aggregate number of shares remaining available for grant under the 2025 Plan on the last day of the immediately preceding fiscal year. Shares issued under our 2025 Plan will be authorized but unissued or reacquired shares of common stock. Shares issued pursuant to awards under our 2025 Plan that we repurchase or that are forfeited, as well as shares used to pay the exercise price of an award or to satisfy the tax withholding obligations to an award, will become available for future grant under our 2025 Plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Eligibility</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Awards under our 2025 Plan may be granted to our employees, including our officers, our non-employee directors and consultants, and the employees and consultants of our affiliates. ISOs may be granted only to our employees, including our officers, and the employees of our affiliates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stock Options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ISOs and NSOs are granted pursuant to stock option agreements adopted by the administrator. The administrator determines the exercise price for a stock option, within the terms and conditions of the 2025 Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Options granted under the 2025 Plan vest at the rate specified in the stock option agreement as specified in the stock option agreement by the administrator. The administrator determines the term of stock options granted under the 2025 Plan, up to a maximum of 10&#160;years. Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the administrator and may include (1)&#160;cash, check, bank draft, or money order, (2)&#160;a broker-assisted cashless exercise, (3)&#160;the tender of shares of common stock previously owned by the optionholder, (4)&#160;a net exercise of the option, and (5)&#160;other legal consideration approved by the administrator. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless the terms of an optionholder&#8217;s stock option agreement provide otherwise, if an optionholder&#8217;s service relationship with us, or any of our affiliates, ceases for any reason other than disability or death, the optionholder may generally exercise any vested options until the earlier of (i)&#160;the date 90&#160;days following the termination of the optionholder&#8217;s service and (ii)&#160;the expiration of the term of the option. If an optionholder&#8217;s service relationship with us or any of our affiliates ceases due to disability or death, or an optionholder dies within a certain period following cessation of service, the optionholder or a beneficiary may generally exercise any vested options until the earlier of (x)&#160;12&#160;months following the termination and (y)&#160;the expiration of the term of the options. In the event of a termination for cause, options generally terminate immediately upon the termination of the individual for cause. In no event may an option be exercised beyond the expiration of its term. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Tax Limitations on ISOs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The aggregate fair market value, determined at the time of grant, of common stock with respect to ISOs that are exercisable for the first time by an option holder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will be treated as NSOs. No ISOs may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our parent or subsidiary corporations, unless (1)&#160;the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant and (2)&#160;the term of the ISO does not exceed five&#160;years from the date of grant. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">225</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restricted Shares</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Restricted shares may be granted to any eligible individual and made subject to such restrictions as may be determined by the administrator. Restricted shares may generally not be sold, or otherwise transferred or hypothecated, until vesting conditions are removed or expire. Except as otherwise provided in the applicable award agreement, restricted shares that remain subject to vesting conditions that have not been satisfied will not vest. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restricted Stock Units</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">RSUs may be awarded to any eligible individual, typically without payment of consideration, but subject to vesting conditions based on continued employment or service or on performance criteria established by the administrator. RSUs may not typically be sold, or otherwise transferred or hypothecated, until vesting conditions are removed or expire. Stock underlying RSUs will not be issued until the RSUs have vested, and recipients of RSUs generally will have no voting or dividend rights prior to the time when vesting conditions are satisfied. Except as otherwise provided in the applicable award agreement, RSUs that remain subject to vesting conditions that have not been satisfied will not vest and will be canceled without payment to the participant therefor. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock appreciation rights are granted pursuant to stock appreciation right grant agreements adopted by the administrator. The administrator determines the strike price for a stock appreciation right, which generally cannot be less than 100% of the fair market value of common stock on the date of grant. Upon the exercise of a stock appreciation right, we will pay the participant an amount equal to the product of (1)&#160;the excess of the per share fair market value of common stock on the date of exercise over the strike price, multiplied by (2)&#160;the number of shares of common stock with respect to which the stock appreciation right is exercised. A stock appreciation right granted under the 2025 Plan vests at the rate specified in the stock appreciation right agreement as determined by the administrator. The administrator determines the term of stock appreciation rights granted under the 2025 Plan, up to a maximum of 10&#160;years. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless the terms of a participant&#8217;s stock appreciation right agreement provide otherwise, if a participant&#8217;s service relationship with us or any of our affiliates ceases for any reason other than disability or death, the participant may generally exercise any vested stock appreciation right until the earlier of (i)&#160;the date 90&#160;days following the termination of service and (ii)&#160;the expiration of the term of the stock appreciation right. If a participant&#8217;s service relationship with us, or any of our affiliates, ceases due to disability or death, or a participant dies within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation right until the earlier of (x)&#160;12&#160;months following the termination and (y)&#160;the expiration of the term of the stock appreciation right. In no event may a stock appreciation right be exercised beyond the expiration of its term. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Performance Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our 2025 Plan permits the grant of performance-based stock and cash awards. The compensation committee can structure such awards so that the stock or cash will be issued or paid pursuant to such award only following the achievement of certain pre-established performance goals during a designated performance period. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Changes to Capital Structure</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event there is a specified type of change in our capital structure, such as a stock split, reverse stock split or recapitalization, appropriate adjustments will be made to (1)&#160;the class and maximum number of shares reserved for issuance under the 2025 Plan, (2)&#160;the class and maximum number of shares by which the share reserve may increase automatically each year, (3)&#160;the class and maximum number of shares that may be issued upon the exercise of ISOs, and (4)&#160;the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding awards. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">226</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Corporate Transactions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Under the 2025 Plan, a corporate transaction is generally the consummation of (1)&#160;a sale or other disposition of all or substantially all of our assets, (2)&#160;a sale or other disposition of at least 50% of our outstanding securities, (3)&#160;a merger, consolidation, or similar transaction following which we are not the surviving corporation, or (4)&#160;a merger, consolidation, or similar transaction following which we are the surviving corporation but the shares of common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction. In the event of a corporate transaction, unless otherwise provided in a participant&#8217;s award agreement or other written agreement with us or one of our affiliates or otherwise expressly provided by the administrator at the time of grant, any stock awards outstanding under the 2025 Plan may be assumed, continued, or substituted for by any surviving or acquiring corporation (or its parent company), accelerated in full or in part or canceled for or without consideration, as determined by the administrator. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Transferability</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">A participant may not transfer awards under our 2025 Plan other than by will, the laws of descent and distribution, or as otherwise provided under our 2025 Plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Plan&#160;Amendment or Termination</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors has the authority to amend, suspend, or terminate our 2025 Plan, provided that such action does not materially impair the existing rights of any participant without such participant&#8217;s written consent. The 2025 Plan will continue in effect for a term of 10 years commencing on the effective date of the 2025 Plan. Certain material amendments also require the approval of our shareholders. No ISOs may be granted after the tenth anniversary of the date our board of directors adopted our 2025 Plan. No awards may be granted under our 2025 Plan while it is suspended or after it is terminated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2025 Employee Stock Purchase Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with this offering, our board of directors has adopted, and our shareholders have approved, the ESPP, which will be effective following the offering. The ESPP is designed to allow our eligible employees to purchase shares of our common stock, at periodic intervals, with their accumulated payroll deductions. The ESPP is intended to qualify under Section&#160;423 of the Code. The material terms of the ESPP, as it is currently contemplated, are summarized below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Plan Administration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to the terms and conditions of the ESPP, our board of directors, or a duly authorized committee of our board of directors, may administer the ESPP. The administrator will have the authority to administer and interpret the ESPP. All decisions made by the administrator pursuant to the ESPP will be final, binding, and conclusive on us and all participants. We will bear all expenses of administering the ESPP. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Authorized Shares</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The maximum number of our shares of our common stock which will be authorized for sale under the ESPP is equal to 0.85% of the fully diluted shares of our common stock after giving effect to the offering (including, but not limited to, all shares in respect of the Warrant Net Exercises, the Preferred Stock Conversion, and the Notes Conversion, shares subject to outstanding awards under the 2020 Plan, and the issuance of the common stock to be sold in this offering). The ESPP&#8217;s share reserve will automatically increase on January&#160;1 of each calendar year during the term of the ESPP, beginning in 2026, by a number of shares equal to 1% of our common stock outstanding on the last day of the immediately preceding fiscal year, unless the administrator should decide to increase the number of shares available under the ESPP by a lesser amount. The shares reserved for issuance under the ESPP may be authorized but unissued shares or reacquired shares. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">227</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Eligibility</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Employees eligible to participate in the ESPP for a given offering period generally include employees who are employed by us or one of our subsidiaries on the enrollment date of an offering period. Our employees (and, if applicable, any employees of our subsidiaries) who customarily work less than five&#160;months in a calendar year or are customarily scheduled to work less than 20 hours per week will not be eligible to participate in the ESPP. Finally, an employee who owns (directly or through attribution) 5% or more of the combined voting power or value of all our classes of stock or of one of our subsidiaries will not be allowed to participate in the ESPP. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Participation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Employees will enroll under the ESPP by completing a subscription agreement designating the&#160;percentage of their compensation to be withheld as payroll deductions during the offering period (of at least 1% of their compensation but not more than 15% of their base compensation). Such payroll deductions may be expressed as either a whole number&#160;percentage or a fixed dollar amount, and the accumulated deductions will be applied to the purchase of shares on each purchase date. However, a participant may not accrue the right to purchase shares of common stock at a rate that exceeds $25,000 in fair market value of shares of our common stock (determined at the time the option is granted) for each calendar year the option is outstanding (as determined in accordance with Section&#160;423 of the Code). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Offering</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the ESPP, participants are offered the option to purchase shares of our common stock at a discount during a series of successive offering periods, the duration and timing of which will be determined by the ESPP administrator. However, in no event may an offering period be longer than 27&#160;months in length. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The option purchase price designated by the ESPP administrator will be no less than the lower of 85% of the closing trading price per share of our common stock on the first trading date of an offering period in which a participant is enrolled or 85% of the closing trading price per share on the purchase date, which will occur on the last trading day of each purchase period within an offering period. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A participant may withdraw all (but not less than all) of the payroll deductions credited to the participant&#8217;s account and not yet used to exercise the participant&#8217;s rights under the ESPP at any time by giving us written notice no later than 30&#160;days prior to the end of the offering period. All of the participant&#8217;s payroll deductions credited to the participant&#8217;s account during an offering period will be paid to the participant as soon as reasonably practicable after receipt of notice of withdrawal. As a result, the participant&#8217;s rights for the offering period will be automatically terminated, and no further payroll deductions for the purchase of shares will be made for such offering period. If a participant withdraws from an offering period, payroll deductions will not resume at the beginning of the next offering period unless the participant timely delivers to us a new subscription agreement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A right granted under the ESPP to a participant will not be transferable other than by will or the applicable laws of descent and distribution and is exercisable during the participant&#8217;s lifetime only by the participant. Except in the case of a participant&#8217;s death, a right under the ESPP may not be exercised to any extent except by the participant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Changes to Capital Structure</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon any reclassification, recapitalization, share split, or reverse share split; any merger, combination, consolidation, or other reorganization; any split-up, spin-off, or similar extraordinary dividend distribution in respect of the common stock; or any exchange of our common stock or other securities, or any similar, unusual or extraordinary corporate transaction in respect of the common stock; then, subject to any required action by the shareholders under applicable law, the ESPP administrator will equitably and proportionately adjust (i)&#160;the ESPP share reserve, (ii)&#160;the classes and number of shares and price per share subject to outstanding rights; and (iii)&#160;the purchase price with respect to any outstanding rights. In the event of any of the above described transactions or any unusual or nonrecurring transactions or events </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">228</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:44pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">affecting us or our subsidiaries or our financial statements, the ESPP administrator, in its discretion, will be authorized to provide either: (i)&#160;the termination of any outstanding right in exchange for an amount of cash equal to the amount that would have been obtained upon the exercise of such right had such right been currently exercisable or the replacement of such outstanding right with other rights or property selected by the ESPP administrator in its sole discretion; (ii)&#160;to provide that outstanding rights under the ESPP will be assumed by the successor or survivor corporation or a parent or subsidiary thereof, with appropriate adjustments to the number and kind of stock and prices; (iii)&#160;to make adjustments in the number and type of shares (or other securities or property) subject to outstanding rights under the ESPP; (iv)&#160;to provide that participants&#8217; accumulated payroll deductions may be used to purchase shares prior to the next occurring purchase date, following which the participants&#8217; rights under the ongoing offering period will be terminated; or (v)&#160;to provide that all outstanding rights will terminate without being exercised. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Plan Amendment and Termination</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ESPP administrator may amend, suspend, or terminate the ESPP at any time. However, no amendment will be effective unless approved by the shareholders to the extent required by applicable laws. The ESPP will continue in effect for a term of ten years commencing on the effective date of the ESPP. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additional Narrative Disclosure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Retirement and Employee Benefits Plans</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All of our current NEOs are eligible to participate in our employee benefit plans, including our medical, dental, vision, life, and disability insurance plans, and may obtain our solutions, in each case on the same basis as all of our other employees. We maintain a 401(k) plan for employees. The 401(k) plan is intended to qualify under Section&#160;401(k) of the Code so that contributions to the 401(k) plan by employees or by us, and the investment earnings thereon, are not taxable to the employees until withdrawn from the 401(k) plan, and so that contributions by us, if any, will be deductible by us when made. Under the 401(k) plan, we make a matching contribution of 100% of the first 3% of salary contributed and 50% on the next 2% of salary. The maximum match is 4% up to the IRS limit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Change-in-Control Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain of our senior executives (including Mr. Brille and Dr.&#160;Spetzler but excluding Mr.&#160;Halbert) and non-employee directors participate in the Caris Life Sciences, Inc. Executive and Director Change in Control Plan (the &#8220;Change in Control Plan&#8221;), which is administered by our compensation committee. Under the Change in Control Plan, upon a &#8220;Change in Control&#8221; &#8203;(as defined in the 2020 Plan) and subject to the execution of a general release of claims in our favor, all outstanding and unvested equity awards granted to a participant will automatically vest in full immediately prior to the consummation of the Change in Control. The Change in Control Plan does not contain excise tax gross-up provisions and, instead, employs a &#8220;best-net&#8221; approach under which payments and benefits are either reduced to avoid the excise tax on excess parachute payments within the meaning of Section&#160;280G of the Code or not reduced, depending on which approach would result in the greatest after-tax amount being retained. At any time prior to a Change in Control, the Change in Control Plan may be modified, amended, or terminated by the compensation committee without notice to participants. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clawback Policy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have adopted a compensation recovery policy that is compliant with the listing rules of Nasdaq, as required by the Dodd-Frank Act, to be effective upon the completion of this offering.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">229</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCRAR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following is a description of transactions since January&#160;1, 2022 and each currently proposed transaction in which we have been or are to be a participant and: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the amounts involved exceeded or will exceed $120,000; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any of our directors, executive officers, or holders of more than 5% of our outstanding capital stock, or any immediate family member of or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transactions with Our Founder</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Guarantee of Office Lease</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We lease approximately 30,500 square feet of office space in Irving, Texas for our principal executive offices pursuant to a lease expiring in April&#160;2028. Our complete and timely performance of each obligation under the lease agreement is unconditionally and irrevocably guaranteed by David D. Halbert, the Chairman of our board of directors and our Chief Executive Officer, and his spouse, in their personal capacities. During each of the&#160;years ended December&#160;31, 2024, 2023, and 2022, we recorded rental expense of $0.9&#160;million in connection with this guaranteed lease. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Aircraft Charter Arrangements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2017, we entered into an intercompany consulting agreement (the &#8220;Caris Air Consulting Agreement&#8221;) with Halbert &amp; Associates and Caris Air Services, LLC (&#8220;Caris Air&#8221;), each of which is affiliated with Mr.&#160;Halbert. Pursuant to the Caris Air Consulting Agreement, we have the right to use, from time to time, an aircraft owned by Halbert &amp; Associates and operated by Caris Air. The Caris Air Consulting Agreement has an initial term of one year and automatically renews for subsequent one-year terms on an annual basis. We only use the aircraft for business purposes and reimburse Caris Air for our usage of the aircraft based on hours of use, operating costs, and related expenses. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2021, we also entered into an aircraft charter lease and services agreement (the &#8220;Aircraft Agreement&#8221;) with Caris Air, pursuant to which Caris Air dry leases from us an aircraft we own and provides chartered aircraft services, as operator of the aircraft. The Aircraft Agreement has an initial term of one year and automatically renews for subsequent one-year terms on an annual basis. Under the Aircraft Agreement, we are entitled to receive payment from Caris Air for rental of our aircraft, and we reimburse Caris Air for the chartered aircraft services it provides to us. Mr.&#160;Halbert and his family members also use our aircraft from time to time for personal use and reimburse us based on hours of use, operating costs, and related expenses. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the foregoing aircraft charter arrangements, we generally credit amounts owed to us by Caris Air and Mr.&#160;Halbert and his family members for rental and use of our aircraft against any amounts owed by us to Caris Air for the chartered aircraft services it provides under either the Caris Air Consulting Agreement or the Aircraft Agreement. During the&#160;years ended December&#160;31, 2024, 2023, and 2022, we paid Caris Air aggregate net amounts of $1.6&#160;million, $1.8&#160;million, and $1.6&#160;million, respectively, pursuant to these arrangements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Convertible Loan Agreement with Sixth Street</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2023, pursuant to a convertible loan agreement, dated as of September&#160;21, 2018, between us, as borrower, certain of our subsidiaries, as guarantors, and entities affiliated with Sixth Street, as lenders (as amended, the &#8220;Convertible Loan Agreement&#8221;), we issued an aggregate of 31,055,901 shares of our Series&#160;C preferred stock to the Sixth Street-affiliated lenders, TOP III Barnett Investments, LLC, TAO Barnett Investments, LLC, and Sixth Street Specialty Lending, Inc., at a conversion price of $1.61 per share, in connection with the conversion of the original aggregate principal amount of $50.0&#160;million outstanding under the Convertible Loan Agreement. Entities affiliated with Sixth Street collectively hold more than 5% of our outstanding capital stock, and Vijay Mohan, a former member of our board of directors, is a Co-Founding Partner of Sixth Street. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">230</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The loans under the Convertible Loan Agreement had an interest rate of 8.0% per annum, payable in kind (&#8220;PIK&#8221;) and accretive as additional principal. Upon the issuance of shares of our Series&#160;C preferred stock and following our September&#160;2023 cash payment of $3.0&#160;million in respect of accrued and unpaid PIK interest under the Convertible Loan Agreement, all of our obligations under the Convertible Loan Agreement were deemed satisfied in full, and the Convertible Loan Agreement was irrevocably terminated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Term Loan Refinancing with Sixth Street</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September 2018, we entered into a secured term loan agreement (the &#8220;Original Term Loan Agreement&#8221;) with Sixth Street Specialty Lending, Inc. and Barnett Debt Holdings, LLC, which provided us with an initial term loan of $50.0 million (the &#8220;2018 Term Loan&#8221;) and a delayed term loan draw option of $50.0 million, which we drew down in full on October 4, 2019 (the &#8220;2019 Term Loan&#8221;). In April 2020, we amended the Original Term Loan Agreement (the &#8220;Amended Term Loan Agreement&#8221;) to obtain additional term loan proceeds of $75.0 million (the &#8220;2020 Term Loan&#8221; and collectively with the 2018 Term Loan and the 2019 Term Loan, the &#8220;Original Term Loans&#8221;).</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January 2023, we entered into the 2023 Term Loan Agreement. The net cash proceeds from the 2023 Term Loan were used to repay in full the Original Term Loans (with an aggregate principal amount of $175.0 million), including a prepayment premium of $5.0 million and accrued and unpaid interest of $1.0&#160;million. As of December 31, 2023, we have no continuing obligations associated with the Original Term Loans. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Officer Promissory Notes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;30, 2022, David Spetzler, our President, and J. Russel Denton, our Senior Vice President, General Counsel, and Secretary, exercised their options to purchase 750,000 shares and 255,000 shares, respectively, of our common stock at an exercise price of $16.20 per share through the tender of promissory notes, each with an interest rate of 2.93% per annum. As of December&#160;31, 2024, no principal or interest payments had been made with respect to these promissory notes. In March 2025, the full outstanding principal amount of, and accrued and unpaid interest on, each of the promissory notes was repaid by each of the executive officers in the form of stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investors&#8217; Rights Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are party to an amended and restated investors&#8217; rights agreement (the &#8220;Investors&#8217; Rights Agreement&#8221;), dated as of April 1, 2025, with certain holders of our capital stock, including David D. Halbert, the Chairman of our board of directors and our Chief Executive Officer, entities affiliated with Mr.&#160;Halbert, and entities affiliated with Sixth Street, J.H. Whitney VI, L.P., and Highland Capital Management, L.P., each of which are holders of more than 5% of our outstanding capital stock and/or entities with which certain of our directors are affiliated. Under the Investors&#8217; Rights Agreement, certain holders of our capital stock have registration rights, including the right to demand that we file a registration statement or request that their shares be covered by a registration statement that we are otherwise filing. The Investors&#8217; Rights Agreement also provides certain of these shareholders with information and observer rights, which will terminate immediately prior to the completion of this offering, and a right of first offer with regard to certain issuances of our capital stock, which right will terminate immediately following the completion of this offering. For a description of the registration rights that will continue to apply following this offering, see the section titled &#8220;Description of Capital Stock&#8212;Registration Rights.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are party to an amended and restated voting agreement (the &#8220;Voting Agreement&#8221;), dated as of April 1, 2025, under which certain holders of our capital stock, including David D. Halbert, the Chairman of our board of directors and our Chief Executive Officer, entities affiliated with Mr.&#160;Halbert, and entities affiliated with Sixth Street, J.H. Whitney VI, L.P., and Highland Capital Management, L.P., each of which are holders of more than 5% of our outstanding capital stock and/or entities with which certain of our&#160;directors are affiliated, have agreed as to the manner in which they will vote their shares of our capital stock on certain matters, including with respect to the election of directors. The Voting Agreement will terminate in its entirety upon the completion of this offering. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">231</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Right of First Refusal and Co</font><font style="font-weight:normal;letter-spacing:0.2pt;">-</font><font style="letter-spacing:-0.2pt;">Sale Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We are party to an amended and restated right of first refusal and co-sale agreement (the &#8220;ROFR and Co-Sale Agreement&#8221;), dated as of April 1, 2025, with certain holders of our capital stock, including David D. Halbert, the Chairman of our board of directors and our Chief Executive Officer, entities affiliated with Mr.&#160;Halbert, and entities affiliated with Sixth Street, J.H. Whitney VI, L.P., and Highland Capital Management, L.P., each of which are holders of more than 5% of our outstanding capital stock and/or entities with which certain of our directors are affiliated. Under the ROFR and Co-Sale Agreement, we and certain holders of our capital stock have a right to purchase shares of our capital stock that shareholders propose to sell in certain circumstances to other parties. The ROFR and Co-Sale Agreement will terminate in its entirety immediately prior to the completion of this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consulting and Expert Advisory Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We previously entered into consulting and expert advisory agreements with George H. Poste and Jonathan Knowles, members of our board of directors, pursuant to which Dr.&#160;Poste and Dr.&#160;Knowles have provided certain consulting services to us as independent contractors and have served on our Scientific Advisory Board, a team comprised of leading scientists and clinical experts who advise us on research, development, and strategy matters pertaining to precision medicine. All such agreements were terminated in December 2024. We also entered into a consulting agreement with Jeffrey Vacirca in February 2022 pursuant to which he provided consulting services to us, which agreement was terminated upon Dr. Vacirca&#8217;s election to our board of directors in November 2024. During the years ended December&#160;31, 2024, 2023, and 2022, we paid Dr. Poste $107,500, $137,917, and $147,083, respectively, for consulting services provided to us and for his service on our Scientific Advisory Board. During each of the years ended December 31, 2024, 2023, and 2022, we paid Dr. Knowles amounts not exceeding $120,000 for consulting services provided to us and for his service on our Scientific Advisory Board. In February 2022, we granted Dr.&#160;Vacirca an option to purchase 25,000 shares of common stock at an exercise price of $17.16 per share pursuant to his consulting agreement, and we have not paid any additional amounts under such consulting agreement. For additional information, see the section titled &#8220;Management&#8212;Director Compensation.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employment Agreements and Family Relationships</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are party to employment agreements with certain of our executive officers. For additional information regarding agreements with our named executive officers, see the section titled &#8220;Executive Compensation.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Michael Halbert, our Senior Vice President, Human Resources, is the son of David D. Halbert, our Founder, Chairman, and Chief Executive Officer, and has been employed by us in various capacities since June&#160;2011. Michael Halbert does not reside with David D. Halbert and is not one of our executive officers. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Awards to Directors and Executive Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have granted stock options and other equity awards to our directors and executive officers as more fully described in the sections titled &#8220;Management&#8212;Director Compensation&#8221; and &#8220;Executive Compensation.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director and Officer Indemnification Agreements and Insurance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation and amended and restated bylaws will provide indemnification and advancement of expenses for our directors and executive officers to the fullest extent permitted by the Texas law, subject to limited exceptions. We also have entered into separate indemnification agreements with each of our directors and executive officers, which require us to indemnify them in certain circumstances, and have purchased directors&#8217; and officers&#8217; liability insurance for each of our directors and executive officers. For further information, see the section titled &#8220;Description of Capital Stock&#8212;Limitations on Liability and Indemnification of Officers and Directors.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">232</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:348pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reserved Share Program</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At our request, the underwriters have reserved up to 5% of the shares of common stock offered by this prospectus, excluding the additional shares that the underwriters have a 30-day option to purchase, for sale, at the initial public offering price, to certain individuals identified by management, including certain of our directors, officers, employees, and certain other parties related to us. See the section titled &#8220;Underwriting&#8212;Reserved Share Program.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Policies and Procedures for Related Person Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors recognizes the fact that transactions with related persons present a heightened risk of conflicts of interests or the perception thereof. Our board of directors has adopted a written related person transaction policy setting forth the policies and procedures for the review and approval or ratification of related person transactions. This policy will cover, with certain exceptions set forth in Item&#160;404 of Regulation&#160;S-K under the Securities Act, any transaction, arrangement, or relationship, or any series of similar transactions, arrangements, or relationships, in which we were or are to be a participant, where the amount involved exceeds $120,000 in any fiscal year, and a related person had, has, or will have a direct or indirect material interest, including without limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness, and employment by us of a related person. In reviewing and approving any such transactions, our audit committee will be tasked to consider all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction and the extent of the related person&#8217;s interest in the transaction. All of the transactions described in this section occurred prior to the adoption of this policy. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">233</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:88.34pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRINCIPAL SHAREHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table contains information about the beneficial ownership of our common stock as of May 31, 2025 (i)&#160;immediately prior to the completion of this offering and (ii)&#160;as adjusted to reflect the sale of shares of our common stock offered by this prospectus by: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each individual or entity known by us to beneficially own more than 5% of our outstanding shares of common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of our named executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of our directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all of our directors and executive officers as a group. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our calculation of the&#160;percentage of beneficial ownership prior to and after this offering is based on 254,575,191 shares of our common stock outstanding as of May 31, 2025, after giving effect to (i) the Warrant Net Exercises, (ii) the Preferred Stock Conversion, (iii) the Notes Conversion, and (iv)&#160;the RSU Net Settlement. The number of shares of our common stock to be issued upon (i) the Preferred Stock Conversion, (ii) the 2025 Warrant Net Exercise, and (iii) the Notes Conversion, in each case, will vary based on the actual initial public offering price per share, and the exact number of shares of our common stock that will be withheld from any shareholder in connection with the RSU Net Settlement may differ based on such shareholder&#8217;s personal tax rates. For further information, see the section titled &#8220;Prospectus Summary&#8201;&#8212;&#8201;The Offering.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Beneficial ownership and&#160;percentage ownership are determined in accordance with the rules and regulations of the SEC. Under SEC rules, a person is deemed to be a &#8220;beneficial owner&#8221; of a security if that person has or shares voting power or investment power, which includes the power to dispose of or to&#160;direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60&#160;days. Securities that can be so acquired are deemed to be outstanding for purposes of computing such person&#8217;s ownership&#160;percentage, but not for purposes of computing any other person&#8217;s&#160;percentage. Under these rules, more than one person may be deemed to be a beneficial owner of the same securities and a person may be deemed to be a beneficial owner of securities as to which such person has no economic interest. Except as indicated in the footnotes to the following table or pursuant to applicable community property laws, we believe, based on information furnished to us, that each shareholder named in the table has sole voting and investment power with respect to the shares set forth opposite such shareholder&#8217;s name. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The table below does not reflect any shares of our common stock that our directors, executive officers, or other shareholders may purchase in this offering, including through the reserved share program described under &#8220;Underwriting&#8201;&#8212;&#8201;Reserved Share Program.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For further information regarding material transactions between us and certain of our shareholders, see the section titled &#8220;Certain Relationships and Related Party Transactions.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise indicated in the footnotes, the address of each of the individuals named below is: c/o&#160;750 W. John Carpenter Freeway, Suite 800, Irving, Texas 75039. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">234</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:336pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:17.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 1.667pt 0pt; width:228.13pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:9pt; padding-bottom:0pt;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares Beneficially </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage of Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:12.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Before this Offering</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">After this Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Greater than 5% Shareholders:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with David D. Halbert</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">124,906,296</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">56.7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">44.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with Sixth Street</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">24,385,399</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">11.2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">J.H. Whitney VI L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">20,256,615</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Named Executive Officers and Directors:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David D. Halbert</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">124,906,296</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">56.7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">44.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Spetzler</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">2,987,732</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.4<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Brian J. Brille</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">3,762,500</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">George H. Poste</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">701,219</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jonathan Knowles</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">291,750</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nathan Burns </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Fredrickson</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">2,500</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter M. Castleman</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">10,373,406</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">4.7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Joseph E. Gilliam</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">77,500</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jon S. Halbert</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(11)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">1,350,000</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laura I. Johansen</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(12)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">314,576</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lloyd B. Minor </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vijay Mohan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Danny Phillips</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(13)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">102,500</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jeffrey Vacirca</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(14)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">15,000</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.667pt 0pt 1pt 0pt; width:228.13pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">All executive officers and directors as a group </font>
                <br >
                <font style="letter-spacing:0.2pt;">(17 individuals)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(15)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 1pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">145,312,767</td>
            <td style="padding:0pt;padding-left:6.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">64.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:24.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">50.7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.9pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.41pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Represents beneficial ownership of less than 1%. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:3.4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.4pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 1,881,294 shares of common stock held by David D. Halbert, of which 1,662,500 shares of common stock are pledged as collateral to secure certain personal indebtedness of Mr.&#160;Halbert, (ii) 2,000,000 shares of common stock underlying options to purchase common stock held by Mr.&#160;Halbert that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025, (iii) 101,261,532 shares of common stock held by Caris Halbert, L.P., (iv) 8,528,805 shares of common stock held by ADAPT I Ltd., (v)&#160;8,414,427 shares of common stock held by Carisome I, L.P., (vi) 645,149 shares of common stock held by Caris Investment II Ltd., and (vii) 2,175,089 shares of common stock held by Caris Investment III Ltd. (collectively with Caris Halbert, L.P., ADAPT I Ltd., Carisome I, L.P., and Caris Investment III Ltd., the &#8220;DDH Entities&#8221;). Caris Investment Management, LLC is the general partner of each of Caris Halbert, L.P., Caris Investment II Ltd., and Caris Investment III Ltd. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. David D. Halbert, our Founder, Chairman, and Chief Executive Officer, is the managing member of Caris Investment Management, LLC and the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held by each of the DDH Entities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:11pt; margin-top:3.51pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.51pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:36pt;font-size:9pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 5,687,176 shares of common stock held by Barnett Equity Holdings, LLC (&#8220;Barnett Equity Holdings&#8221;), (ii) 10,103,175 shares of common stock held by Barnett Equity Holdings II, LLC (&#8220;Barnett Equity Holdings II&#8221;), (iii)&#160;3,881,988 shares of common stock held by TOP III Barnett Investments, LLC (&#8220;TOP III Barnett&#8221;), (iv) 3,493,789 shares of common stock held by TAO Barnett Investments, LLC (&#8220;TAO Barnett&#8221; and, together with Barnett Equity Holdings, Barnett Equity Holdings II, and TOP III Barnett, the &#8220;Barnett Holders&#8221;), and (v)&#160;1,219,271 shares of common stock held by Sixth Street Specialty Lending, Inc. (&#8220;SLX&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:36pt; margin-top:2.49pt; width:420pt; line-height:10.5pt;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">TSSP Sub-Fund&#160;Holdco, LLC, a Delaware limited liability company (&#8220;Sub-Fund&#160;HoldCo&#8221;), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (&#8220;TAO SPV&#8221;), and Empire SPV GP, LLC, a Delaware limited liability company (&#8220;Empire SPV&#8221;). TAO SPV is the managing member of each of (i)&#160;Barnett Equity Holdings; (ii)&#160;Barnett Equity Holdings II; and (iii)&#160;TAO Barnett. Empire SPV is the managing member of TOP III Barnett. </font>
        </div>
        <div style="margin-left:36pt; margin-top:2.5pt; width:420pt; line-height:10.5pt;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">TSSP Holdco Management, LLC, a Delaware limited liability company (&#8220;Holdco Management&#8221;), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (&#8220;Adviser </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">235</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:36pt; width:420pt; line-height:10.5pt;">
          <font style="letter-spacing:0.18pt;">Holdings&#8221;). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (&#8220;Adviser&#8221;), are managed by Adviser Holdings, the sole member of Adviser. SLX is managed by Adviser. </font>
        </div>
        <div style="margin-left:36pt; margin-top:2.1pt; width:420pt; line-height:10.5pt;">
          <font style="letter-spacing:0.18pt;">Sub-Fund&#160;HoldCo is managed by its sole member, whose managing member is Alan Waxman (&#8220;Mr.&#160;Waxman&#8221;). Holdco Management is managed by a board of directors, which is currently comprised of Mr.&#160;Waxman. Mr.&#160;Waxman is the CEO and Managing Partner of Holdco Management. </font>
        </div>
        <div style="margin-left:36pt; margin-top:2.3pt; width:420pt; line-height:10.5pt;">
          <font style="letter-spacing:0.18pt;">Because (i)&#160;of Sub-Fund&#160;HoldCo&#8217;s relationship with the Barnett Holders, Sub-Fund&#160;HoldCo may be deemed to beneficially own the shares of common stock owned by the Barnett Holders; (ii)&#160;of the relationship between Mr.&#160;Waxman and the Barnett Holders, Mr.&#160;Waxman may be deemed to beneficially own the shares of common stock owned by the Barnett Holders; and (iii)&#160;Mr.&#160;Waxman is a member of the board of directors of Holdco Management, he may be deemed to beneficially own the shares of common stock owned by SLX. Each of Sub-Fund&#160;HoldCo and Mr.&#160;Waxman disclaims beneficial ownership of the shares of common stock except to the extent of their pecuniary interest therein. </font>
        </div>
        <div style="margin-left:36pt; margin-top:2.3pt; width:420pt; line-height:10.5pt;">
          <font style="letter-spacing:0.18pt;">The address for each of the foregoing entities is 2100 McKinney Avenue, Suite 1500, Dallas, Texas 72501. The principal business address for Mr.&#160;Waxman is c/o&#160;Sixth Street Partners, LLC, 1 Letterman Drive, Building&#160;B, Suite B6-100, San Francisco, California 94129. </font>
        </div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of 20,256,615 shares of common stock held by J.H. Whitney VI L.P. J.H. Whitney Equity Partners VI, L.P. is the sole general partner of J.H. Whitney VI L.P. Paul R. Vigano and Robert M. Williams, Jr., as the managing members of J.H. Whitney Equity Partners VI, L.P., share voting and investment power with respect to the shares held by J.H. Whitney VI L.P. The address for each of the foregoing entities is 212 Elm Street, Suite 1, New Canaan, Connecticut 06840. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 199,490 shares of common stock held by David Spetzler, of which 150,000 shares of common stock are pledged as collateral to secure certain personal indebtedness of Dr. Spetzler, and (ii) 2,700,000 shares of common stock underlying options to purchase common stock held by Dr.&#160;Spetzler that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 3,262,500 shares of common stock underlying options to purchase common stock held by Brian J. Brille that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025, and (ii)&#160;an aggregate of 500,000 shares of common stock held by five family trusts, each of which Mr.&#160;Brille serves as trustee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 218,625 shares of common stock held by George H. Poste, (ii) 175,000 shares of common stock underlying options to purchase common stock held by Dr.&#160;Poste that are currently exercisable or would be exercisable within 60 days of May 31, 2025, and (iii) 307,594 shares of common stock held by a family trust, of which Dr.&#160;Poste serves as trustee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 291,250 shares of common stock held by Jonathan Knowles and (ii) 500 shares of common stock underlying options to purchase common stock held by Dr. Knowles that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of 2,500 shares of common stock underlying options to purchase common stock held by David Fredrickson that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 2,500 shares of common stock underlying options to purchase common stock held by Peter M. Castleman that are currently exercisable or would be exercisable within 60 days of May 31, 2025, (ii)&#160;100,000 shares of common stock held by a family trust of which Mr. Castleman serves as a trustee, and (iii) 10,270,906 shares of common stock held by CLS-PF-SPE, LLC (&#8220;CLS-PF-SPE&#8221;). CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE. Mr.&#160;Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of 77,500 shares of common stock underlying options to purchase common stock held by Joseph E. Gilliam that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 100,000 shares of common stock held by Jon S. Halbert and (ii) 1,250,000 shares of common stock held by Ke&#8217;Ohana Ventures, LLC, of which Mr.&#160;Halbert serves as the manager. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(12)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of 314,576 shares of common stock held by Laura I. Johansen. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.89pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(13)</font>
          <br >
        </div>
        <div style=" margin-top:3.89pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of 102,500 shares of common stock underlying options to purchase common stock held by Danny Phillips that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(14)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of 15,000 shares of common stock underlying options to purchase common stock held by Jeffrey Vacirca that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10.8pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.18pt;">(15)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10.8pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.18pt;">Consists of (i) 136,568,999 shares of common stock held by our executive officers and directors and (ii)&#160;8,743,768 shares of common stock underlying options to purchase common stock held by our executive officers and directors that are currently exercisable or would be exercisable within 60&#160;days of May 31, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">236</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOCS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF CAPITAL STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following summary describes the material provisions of our capital stock and certain provisions of our amended and restated certificate of formation and our amended and restated bylaws, each of which will become effective immediately prior to the completion of this offering, and the Texas Business Organizations Code (the &#8220;TBOC&#8221;), and is qualified by reference to the amended and restated certificate of formation, the amended and restated bylaws, and the TBOC. We urge you to read our amended and restated certificate of formation and our amended and restated bylaws, which are included as exhibits to the registration statement of which this prospectus forms a part.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the completion of this offering, our authorized capital stock will consist of 2,800,000,000 shares of common stock, par value $0.001 per share, and 100,000,000 shares of undesignated preferred stock, par value $0.001 per share. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025, after giving effect to (i)&#160;the Warrant Net Exercises, (ii)&#160;the Series E and F&#160;Issuance, (iii) the Preferred Stock Conversion, (iv) the issuance of the 2025 Convertible Notes and the related Notes Conversion, and (v)&#160;the RSU Net Settlement, there were 254,403,367 shares of our common stock outstanding, held of record by 524 shareholders. No shares of preferred stock will be issued and outstanding immediately after completion of this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Holders of our common stock will be entitled to one vote for each share held of record on all matters on which shareholders are entitled to vote generally, including the election or removal of directors, unless otherwise provided in our amended and restated certificate of formation or required by a non-waivable provision of the TBOC. Subject to preferences that may be applicable to any then outstanding preferred stock, the holders of our common stock will be entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. The holders of our common stock will not have cumulative voting rights in the election of directors. Upon our liquidation, dissolution, or winding up and after payment in full of all amounts required to be paid to creditors and to the holders of preferred stock having liquidation preferences, if any, the holders of our common stock will be entitled to receive pro rata our remaining assets available for distribution on a pro rata basis. Holders of our common stock will not be entitled to preemptive rights, and will not be subject to conversion, redemption, or sinking fund provisions. The common stock will not be subject to further calls or assessment by us. All shares of our common stock that will be outstanding at the time of the completion of the offering will be fully paid and non-assessable. The rights, powers, preferences, and privileges of holders of our common stock will be subject to those of the holders of any shares of our preferred stock we may authorize and issue in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation will authorize our board of directors to establish one or more series of preferred stock (including convertible preferred stock). Unless required by law or by the TBOC, the authorized shares of preferred stock will be available for issuance without further action by our shareholders. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors will be able to determine, with respect to any series of preferred stock, the voting powers (full or limited, or no voting powers), designations, preferences and relative, participating, optional or other special rights, and the qualifications, limitations, or restrictions thereof, of that series, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the designation of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares of the series, which our board of directors may, except where otherwise provided in the preferred stock designation, increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares then outstanding); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">237</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:36pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether dividends, if any, will be cumulative or non-cumulative and the dividend rate of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the dates at which dividends, if any, will be payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the redemption rights and price or prices, if any, for shares of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution, or winding-up of the affairs of the Company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether the shares of the series will be convertible into shares of any other class or series, or any other security, of the Company or any other corporation and, if so, the specification of the other class or series or other security, the conversion price or prices or rate or rates, any rate adjustments, the date or dates as of which the shares will be convertible, and all other terms and conditions upon which the conversion may be made; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on the issuance of shares of the same series or of any other class or series; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the voting rights, if any, of the holders of the series. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will be able to issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority, of the holders of our common stock might believe to be in their best interests or in which the holders of our common stock might receive a premium for their common stock over the market price of the common stock. In addition, the issuance of preferred stock may adversely affect the rights of holders of our common stock by restricting dividends on the common stock, diluting the voting power of the common stock, or subordinating the liquidation rights of the common stock. As a result of these or other factors, the issuance of preferred stock may have an adverse impact on the market price of our common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a Texas corporation, we are subject to certain restrictions on dividends under the TBOC. Generally, a Texas corporation may pay dividends to its shareholders out of its surplus (the excess of its assets over its liabilities and stated capital) unless the dividend would render the corporation insolvent. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The declaration, amount, and payment of any future dividends will be at the sole discretion of our board of directors, subject to restrictions under the 2023 Term Loan Agreement, and the holders of our preferred stock we may at the time have outstanding. Our board of directors may take into account general and economic conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax, and regulatory restrictions and implications on the payment of dividends by us to our shareholders or by our subsidiaries to us, including restrictions under the 2023 Term Loan Agreement and other indebtedness we may incur, and such other factors as our board of directors may deem relevant. See the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently expect to retain all future earnings for use in the operation and expansion of our business and have no current plans to pay dividends. See the sections titled &#8220;Dividend Policy&#8221; and &#8220;Risk Factors&#8212;Risks Related to This Offering and Ownership of Our Common Stock&#8212;We do not intend to pay dividends for the foreseeable future. Investors in this offering may never obtain a return on their investment.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Options and RSUs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025, we had outstanding under our 2020 Plan options to purchase an aggregate of 24,113,482 shares of our common stock, with a weighted-average exercise price of approximately $10.18 per share. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025, we had outstanding under our 2020 Plan&#160;RSUs that may be settled once vested for an aggregate of 1,284,540 shares of our common stock. 1,048,250 of these RSUs will vest in full </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">238</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">in connection with this offering, subject to the RSU holders&#8217; continuous service through the date of this prospectus, and will be settled in the RSU Net Settlement, where we will issue 751,464 shares of our common stock, after withholding an aggregate of 296,786 shares of common stock to satisfy associated estimated tax withholding and remittance obligations (based on an assumed tax withholding rate of 28.3%).</font>
        </div>
        <div style="margin-top:11.91pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of March 31, 2025, we had outstanding warrants to purchase an aggregate of up to 25,094,437 shares of our Series C Preferred Stock at a weighted-average exercise price of $1.76 per share, or, at the holder&#8217;s election, a split-adjusted equivalent number of shares of common stock. In connection with this offering, these warrants, which, in each case, would have expired upon the completion of this offering unless earlier exercised, will be exercised in full, on a cashless basis, for 16,699,621 shares of our Series&#160;C preferred stock, based on the initial public offering price of $21.00 per share. The 16,699,621 shares of our Series&#160;C preferred stock issued upon the exercise of the warrants will convert into 4,174,907 shares of our common stock in the Preferred Stock Conversion, based on the initial public offering price of $21.00 per share. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In April 2025, we issued warrants to purchase shares of our common stock, at an exercise price of $0.04 per share, if exercised on or before June 30, 2025. In connection with this offering, these warrants will be exercised in full, on a cashless basis, for 784,231 shares of our common stock, based on the initial public offering price of $21.00 per share. </font>
        </div>
        <div style="margin-top:11.81pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Convertible Notes</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In April 2025, we issued the 2025 Convertible Notes to certain investors in aggregate principal amount of $30.0 million. The 2025 Convertible Notes mature on January 1, 2026 and accrue interest at a rate of 8% per annum, payable quarterly in cash. Immediately prior to and in connection with the completion of this offering, the 2025 Convertible Notes plus accrued interest will convert at a conversion price equal to 70% of the initial public offering price per share, or into 2,076,596 shares of our common stock, based on the initial public offering price of $21.00 per share. </font>
        </div>
        <div style="margin-top:11.82pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Registration Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Investors&#8217; Rights Agreement, following the completion of this offering, certain holders of our common stock, including, but not limited to, certain holders of more than 5% of our outstanding capital stock and entities affiliated with certain of our officers and directors, will have certain registration rights, as set forth below. Such registration rights will terminate upon the earliest of (i)&#160;the fourth anniversary of the completion of this offering and (ii)&#160;the completion of certain liquidation events. Under the Investors&#8217; Rights Agreement, we will generally be required to pay all expenses (other than underwriting discounts and commissions and certain other expenses) related to any registration effected pursuant to the exercise of such registration rights. The Form S-1 and Form S-3 demand registration rights described below are subject to specified conditions and limitations, including the right of the underwriters to limit the number of shares of common stock included in any such registration under specified circumstances. </font>
        </div>
        <div style="margin-top:11.82pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Form S-1 Demand Registration Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the completion of this offering, the holders of up to approximately 212.9 million shares of our common stock will be entitled to certain Form S-1 demand registration rights. At any time beginning 180&#160;days after the effective date of this registration statement, the holders of at least 20% of the shares having these rights then outstanding may request that we file a registration statement on Form S-1 to register the offer and sale of their shares. We will generally only be obligated to effect up to two such registrations. Each such request for registration must cover securities the anticipated aggregate offering price of which, net of underwriting discounts and commissions, is at least $10.0&#160;million. If our board of directors determines that it would be materially detrimental to us and our shareholders to effect such a demand registration, we will have the right to defer such registration, not more than once in any 12-month period, for a period of up to 30&#160;days. </font>
        </div>
        <div style="margin-top:11.71pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Form S-3 Demand Registration Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the completion of this offering, holders of up to approximately 212.9 million shares of our common stock will be entitled to certain Form S-3 demand registration rights. At any time when we are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">239</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">eligible to file a registration statement on Form S-3, the holders of at least 20% of the shares having these rights then outstanding will be able to request that we register the offer and sale of their shares on a registration statement on Form S-3 so long as the request covers securities the anticipated aggregate public offering price of which, net of any underwriting discounts or commissions, is at least $3.0&#160;million. These holders may make an unlimited number of requests for registration on a registration statement on Form S-3. However, we will not be required to effect a registration on Form S-3 if we have effected three such registrations within the 12-month period preceding the date of the request. If our board of directors determines that it would be materially detrimental to us and our shareholders to effect such a demand registration, we will have the right to defer such registration, not more than once in any 12-month period, for a period of up to 30&#160;days. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Piggyback Registration Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the completion of this offering, the holders of up to approximately 245.9 million shares of our common stock will be entitled to certain &#8220;piggyback&#8221; registration rights. If we propose to register shares of our common stock or other securities under the Securities Act, either for our own account or for the account of our shareholders, in connection with such offering, all holders of these shares then outstanding will be able to request that we include their shares in such registration, subject to certain marketing and other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to (i)&#160;a registration relating solely to our stock plans, (ii)&#160;a registration relating to a corporate reorganization or other transaction covered by Rule&#160;145 promulgated under the Securities Act, (iii)&#160;a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the shares having registration rights, or (iv)&#160;a registration relating to the offer and sale of debt securities, the holders of these shares will be entitled to notice of the registration and have the right, subject to certain limitations, to include their shares in the registration. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anti-Takeover Effects of Certain Provisions of Our Amended and Restated Certificate of Formation, Amended and Restated Bylaws, and Texas Law</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation and amended and restated bylaws will contain and the TBOC contains provisions, which are summarized in the following paragraphs, that are intended to enhance the likelihood of continuity and stability in the composition of our board of directors. These provisions are intended to avoid costly takeover battles, reduce our vulnerability to a hostile change of control, and enhance the ability of our board of directors to maximize shareholder value in connection with any unsolicited offer to acquire us. However, these provisions may have an anti-takeover effect and may delay, deter, or prevent a merger or acquisition of us by means of a tender offer, a proxy contest, or other takeover attempt that a shareholder might consider in its best interest, including those attempts that might result in a premium over the prevailing market price for the shares of common stock held by shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Authorized but Unissued Capital Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Texas law does not require shareholder approval for any issuance of authorized shares. Accordingly, the authorized but unissued shares of our common stock and our preferred stock are available for future issuance without shareholder approval, subject to any limitations imposed by the listing standards of Nasdaq and restrictions under the 2023 Term Loan Agreement and other indebtedness we may incur. The listing standards of Nasdaq, which would apply if and so long as our common stock remains listed on Nasdaq, require shareholder approval of certain issuances equal to or exceeding 20% of the then outstanding voting power or then outstanding number of shares of common stock. These additional shares may be issued in the future for a variety of corporate finance transactions, acquisitions, and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could make more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger, or otherwise. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Business Combinations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are subject to the affiliated business combinations provisions of Title 2, Chapter 21, Subchapter M of the TBOC (Sections&#160;21.601 through 21.610), which provides that a Texas corporation may not engage in specified types of business combinations, including mergers, consolidations, and asset sales, with a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">240</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">person, or an affiliate or associate of that person, who is an &#8220;affiliated shareholder.&#8221; For purposes of this law, an &#8220;affiliated shareholder&#8221; is generally defined as the holder of 20% or more of the corporation&#8217;s voting shares, for a period of three&#160;years from the date that person became an affiliated shareholder. The law&#8217;s prohibitions do not apply if: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the business combination or the acquisition of shares by the affiliated shareholder was approved by the board of directors of the corporation before the affiliated shareholder became an affiliated shareholder; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the business combination was approved by the affirmative vote of the holders of at least two-thirds of the outstanding voting shares of the corporation not beneficially owned by the affiliated shareholder, at a meeting of shareholders called for that purpose, not less than six&#160;months after the affiliated shareholder became an affiliated shareholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have more than 100 shareholders and are considered to be an &#8220;issuing public corporation&#8221; for purposes of this law. The affiliated business combinations provisions of the TBOC do not apply to the following: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the business combination of an issuing public corporation where: (a)&#160;the corporation&#8217;s original certificate of formation or bylaws contain a provision expressly electing not to be governed by the affiliated business combinations provisions of the TBOC; or (b)&#160;the corporation adopts an amendment to its certificate of formation or bylaws, by the affirmative vote of the holders, other than affiliated shareholders, of at least two-thirds of the outstanding voting shares of the corporation, expressly electing not to be governed by the affiliated business combinations provisions of the TBOC, so long as the amendment does not take effect for 18&#160;months following the date of the vote and does not apply to a business combination with an affiliated shareholder who became affiliated on or before the effective date of the amendment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a business combination of an issuing public corporation with an affiliated shareholder that became an affiliated shareholder inadvertently, if the affiliated shareholder: (a)&#160;divests itself, as soon as possible, of enough shares to no longer be an affiliated shareholder; and (b)&#160;would not at any time within the three-year period preceding the announcement of the business combination have been an affiliated shareholder but for the inadvertent acquisition; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a business combination with an affiliated shareholder who became an affiliated shareholder through a transfer of shares by will or intestacy and continuously was an affiliated shareholder until the announcement date of the business combination; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a business combination of a corporation with its wholly owned Texas subsidiary if the subsidiary is not an affiliate or associate of the affiliated shareholder other than by reason of the affiliated shareholder&#8217;s beneficial ownership of voting shares of the corporation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neither our amended and restated certificate of formation nor our amended and restated bylaws contain any provision expressly providing that we will not be subject to the affiliated business combinations provisions of the TBOC. The affiliated business combinations provisions of the TBOC may have the effect of inhibiting a non-negotiated merger or other business combination involving us, even if that event would be beneficial to our shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vacancies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation will provide that, subject to the rights granted to one or more series of preferred stock then outstanding, and except as otherwise provided in the TBOC, any vacancies on our board of directors may only be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director, or by the affirmative vote of a majority of the voting power of our then-outstanding capital stock entitled to vote generally in the election of directors. </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">No Cumulative Voting</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under Texas law, the right to vote cumulatively does not exist unless the certificate of formation specifically authorizes cumulative voting. Our amended and restated certificate of formation will not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">241</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">authorize cumulative voting. Therefore, shareholders holding a majority in voting power of the shares of our capital stock entitled to vote generally in the election of directors will be able to elect all of our directors. </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Special Shareholder Meetings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation will provide that special meetings of our shareholders may be called at any time only by or at the direction of the board of directors, the Chairman of the board of directors, our President, our Chief Executive Officer, or by our Secretary at the written request of holders of&#160;at least 50% of the voting power of our outstanding capital stock entitled to be voted at the special meeting. Our amended and restated bylaws will prohibit the conduct of any business at a special meeting other than procedural matters or as specified in the notice for such meeting. These provisions may have the effect of deferring, delaying, or discouraging hostile takeovers, or changes in control or management of the Company. </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Requirements for Advance Notification of Director Nominations and Shareholder Proposals</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated bylaws will establish advance notice procedures with respect to shareholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. In order for any matter to be &#8220;properly brought&#8221; before a meeting, a shareholder will have to comply with advance notice requirements and provide us with certain information. Generally, to be timely, a shareholder&#8217;s notice must be received at our principal executive offices not less than 90&#160;days nor more than 120&#160;days prior to the first anniversary date of the immediately preceding annual meeting of shareholders. Our amended and restated bylaws will also specify requirements as to the form and content of a shareholder&#8217;s notice. Our amended and restated bylaws will allow the chair of the meeting at a meeting of the shareholders to adopt rules and regulations for the conduct of meetings which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions may also defer, delay, or discourage a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#8217;s own slate of directors or otherwise attempting to influence or obtain control of us. </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholder Action by Written Consent</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation will provide that any action required or permitted to be taken at an annual or special meeting of shareholders may be taken by written consent in lieu of a meeting of shareholders only with the unanimous written consent of all holders of shares entitled to vote on such action. </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendment of Bylaws and Certificate of Formation Provisions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation and amended and restated bylaws will provide that our board of directors is expressly authorized to adopt, amend, alter, or repeal, in whole or in part, our amended and restated bylaws without a shareholder vote in any manner not inconsistent with the laws of the State of Texas and our amended and restated certificate of formation. The shareholders may not adopt, amend, alter, or repeal our amended and restated bylaws unless such action is approved, in addition to any other vote required by our amended and restated certificate of formation, by the affirmative vote of the holders of at least a majority of the voting power of all the then-outstanding shares of our capital stock entitled to vote thereon, voting together as a single class. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of formation will provide that the affirmative vote of the holders of at least a majority of the voting power of all the then-outstanding shares of our capital stock entitled to vote thereon, voting together as a single class will be required to amend or repeal any provision of our amended and restated certificate of formation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The lack of cumulative voting will make it more difficult for shareholders to replace our board of directors as well as for another party to obtain control of us by replacing our board of directors. Because our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing shareholders or another party to effect a change in management. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These provisions may have the effect of deterring hostile takeovers or delaying or preventing changes in control of our management or of us, such as a merger, reorganization, or tender offer. These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">242</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of our Company. These provisions are designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions are also intended to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they also may inhibit fluctuations in the market price of our shares that could result from actual or rumored takeover attempts. Such provisions may also have the effect of preventing changes in management. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exclusive Forum</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated organizational documents will provide that the Business Court in the First Business Court Division of the State of Texas shall be the sole and exclusive forum for certain shareholder litigation matters, unless we consent in writing to the selection of an alternative forum or if the Business Court in the First Business Court Division of the State of Texas is not accepting filings or determines that it lacks jurisdiction, the exclusive forum will be the federal district courts in the Northern District of Texas or, if such federal district courts do not have jurisdiction, the State District Court in Dallas County, Texas; provided, however, that the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act and provided, further, that the foregoing choice of forum provision shall not apply to claims seeking to enforce any liability or duty created by the Securities Act, the Exchange Act, or any other claim for which the U.S. federal courts have exclusive jurisdiction. Although we believe this provision benefits us by providing increased consistency in the application of Texas law in the types of lawsuits to which it applies and in limiting our litigation costs, the provision may have the effect of discouraging lawsuits against our directors and officers, may result in increased costs for our shareholders to bring claims, and may limit our shareholders&#8217; ability to obtain a favorable judicial forum for disputes with us. However, it is possible that a court could rule that this provision is unenforceable or inapplicable to a particular dispute. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conflicts of Interest</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-size:9.9pt;">
          <font style="font-size:10pt;letter-spacing:0.198pt;">Texas law permits corporations to adopt provisions renouncing any interest or expectancy in certain opportunities that are presented to the corporation or its officers, directors, or shareholders. Our amended and restated certificate of formation will, to the maximum extent permitted from time to time by Texas law, renounce any interest or expectancy that we have in, or right to be offered an opportunity to participate in, specified business opportunities that are from time to time presented to our officers, directors, or shareholders or their respective affiliates, other than those officers, directors, shareholders, or affiliates who are our or our subsidiaries&#8217; employees. Our amended and restated certificate of formation will provide that, to the fullest extent permitted by law, no director (or his or her affiliates) who is not employed by us will have any duty to refrain from (i)&#160;engaging in a corporate opportunity in the same or similar lines of business in which we or our subsidiaries from time to time are engaged or propose to engage or (ii)&#160;otherwise competing, directly or indirectly, with us or any of our subsidiaries. In addition, to the fullest extent permitted by law, in the event that any non-employee director acquires knowledge of a potential transaction or other business opportunity that may be a corporate opportunity for himself or herself or his or her affiliates or for us or our affiliates, such person will have no duty to communicate or offer such transaction or business opportunity to us or any of our subsidiaries, and they may take any such opportunity for themselves or offer it to another person or entity. Our amended and restated certificate of formation will not renounce our interest in any business opportunity that is expressly offered to a non-employee director solely in his or her capacity as a director or officer of our Company. To the fullest extent permitted by law, no business opportunity will be deemed to be a potential corporate opportunity for us unless we would be permitted to undertake the opportunity under our amended and restated certificate of formation, we have sufficient financial resources to undertake the opportunity, and the opportunity would be in line with our business.</font><font style="font-size:10pt;">&#8203;<font style="letter-spacing:0.2pt;"> </font></font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limitations on Liability and Indemnification of Officers and Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The TBOC authorizes corporations to limit or eliminate the personal liability of directors and officers to corporations and their shareholders for monetary damages for breaches of directors&#8217; and officers&#8217; fiduciary duties (other than breaches of such person&#8217;s duty of loyalty to corporations or their shareholders), subject to certain exceptions. Our amended and restated certificate of formation will include </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">243</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">a provision that eliminates the personal liability of directors and officers for monetary damages for any breach of fiduciary duty as a director or officer, except to the extent such exemption from liability or limitation thereof is not permitted under the TBOC. The effect of these provisions will be to eliminate, other than limited exceptions, the rights of us and our shareholders, through shareholders&#8217; derivative suits on our behalf, to recover monetary damages from a director for breach of fiduciary duty as a director or officer, including breaches resulting from grossly negligent behavior. However, exculpation will not apply to any director or officer if such person has acted in bad faith, engaged in intentional misconduct, knowingly violated the law, authorized illegal dividends or redemptions, derived an improper benefit from his or her actions as a director or officer, or engaged in an act or omission for which the liability of the director or officer is expressly provided by an applicable statute. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated bylaws will provide generally that we must indemnify and advance expenses to our directors and officers to the fullest extent authorized by the TBOC. We also have entered into separate indemnification agreements with each of our directors and executive officers and will be expressly authorized to carry directors&#8217; and officers&#8217; liability insurance providing indemnification for our directors, officers, and certain employees for some liabilities. We believe that these indemnification and advancement provisions and insurance will be useful to attract and retain qualified directors and officers. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These limitation of liability, indemnification, and advancement provisions may discourage shareholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit us and our shareholders. In addition, your investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There is currently no pending material litigation or proceeding involving any of our directors, officers, or employees for which indemnification is sought. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dissenters&#8217; Rights of Appraisal and Payment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the TBOC, with certain exceptions, our shareholders will have appraisal rights in connection with a merger, a sale of all or substantially all of our assets, an interest exchange, or a conversion. Pursuant to the TBOC, shareholders who properly request and perfect appraisal rights in connection with such merger, sale of all or substantially all of our assets, interest exchange, or conversion will have the right to receive payment of the fair value of their shares as agreed to between the shareholder and us or, if unable to reach agreement, as determined by the State District Court in Dallas County, Texas. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholders&#8217; Derivative Actions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the TBOC, any of our shareholders may bring an action in our name to procure a judgment in our favor, also known as a derivative action, provided that the shareholder bringing the action (i)&#160;is a holder of our shares at the time of the transaction to which the action relates or such shareholder became a shareholder by operation of law from a person that was a shareholder at the time of the transaction to which the action relates and (ii)&#160;fairly and adequately represents the interests of the Company in enforcing the right of the Company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our common stock has been approved for listing on the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;CAI.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transfer Agent and Registrar</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transfer agent and registrar for our common stock will be Equiniti Trust Company, LLC. The transfer agent and registrar&#8217;s address is 48 Wall Street, 22nd Floor, New York, New York 10005.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">244</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSEFF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SHARES ELIGIBLE FOR FUTURE SALE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before this offering, there has not been a public market for shares of our common stock. As described below, only a limited number of shares will be available for sale shortly after this offering due to contractual and legal restrictions on resale. Nevertheless, future sales of substantial amounts of shares of our common stock, including shares issued upon the exercise of outstanding options, in the public market following this offering or the possibility of these sales occurring, could cause the prevailing market price for our common stock to fall or impair our ability to raise equity capital in the future. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following this offering, we will have outstanding 277,932,779 shares of our common stock, based on the number of shares of common stock outstanding as of March&#160;31, 2025, after giving effect to (i)&#160;the Warrant Net Exercises, (ii)&#160;the Series E and F Issuance, (iii)&#160;the Preferred Stock Conversion, (iv)&#160;the issuance of the 2025 Convertible Notes and the related Notes Conversion, and (v)&#160;the RSU Net Settlement. This includes 23,529,412 shares of common stock that we are selling in this offering, which shares may be resold in the public market immediately unless purchased by our affiliates and assumes no additional exercise of outstanding options other than as described elsewhere in this prospectus. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The remaining 254,403,367 shares of common stock that are not sold in this offering will be &#8220;restricted securities,&#8221; as that term is defined in Rule&#160;144 under the Securities Act (&#8220;Rule&#160;144&#8221;). These restricted securities are eligible for public sale only if they are registered under the Securities Act or if they qualify for an exemption from registration under Rule&#160;144 or Rule&#160;701 under the Securities Act (&#8220;Rule&#160;701&#8221;), which are summarized below. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of the lock-up agreements and market stand-off provisions described below, and subject to the provisions of Rule&#160;144 or Rule&#160;701, the earliest these restricted securities may generally be available for sale in the public market is as follows: </font>
        </div>
        <table style="width:456pt;height:59.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Earliest Date Available for Sale in the Public Market </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">December&#160;1, 2025, which is 10 trading days prior to the commencement of the quarterly blackout period under our insider trading policy that begins on December&#160;15, 2025. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">All remaining shares held by our shareholders not previously eligible for sale, subject to volume limitations applicable to &#8220;affiliates&#8221; under Rule&#160;144 as described below.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, pursuant to certain exceptions to the lock-up agreements, shares of our common stock will be eligible for sale in the open market during the Lock-Up Period (as defined below) in sell-to-cover transactions in order to satisfy tax withholding obligations. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We expect each sell-to-cover transaction to extend over a multi-day period based on trading volumes. Because the purpose of sell-to-cover transactions is to generate proceeds sufficient to satisfy tax withholding obligations or remittance payments due as a result of the vesting or settlement of RSUs or the exercise of options that are expiring during the Lock-Up Period, the exact number of shares sold will depend on the sale prices of the common stock in such transactions and our shareholders&#8217; personal tax rates. In addition, if net settlement transactions occur on or prior to the dates set forth above, the number of shares of common stock to be sold in each sell-to-cover transaction will be reduced proportionally. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rule&#160;144</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, under Rule&#160;144 as currently in effect, a person who has beneficially owned shares of our restricted common stock for at least six&#160;months would be entitled to sell their securities provided that such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90&#160;days preceding, a sale, and we are subject to the periodic reporting requirements of the Exchange Act, for at least 90&#160;days before the sale. In addition, under Rule&#160;144, any person who is not an affiliate of ours and has held their shares of common stock for at least one year, including the holding period of any prior owner other than one of our affiliates, would be entitled to sell an unlimited number of shares of common stock immediately upon the completion of this offering without regard to whether current public information about us is available. Persons who have beneficially owned shares of our restricted common stock for at least six&#160;months but who are our affiliates at the time of, or any time during the 90&#160;days preceding, a sale, would </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">245</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of either of the following: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">1% of the number of shares of our capital stock then outstanding, which will equal 2,779,328 shares immediately after the completion of this offering, assuming no exercise by the underwriters of their option to purchase additional shares of common stock; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the average weekly trading volume of our common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, in each case, that we have been subject to the Exchange Act periodic reporting requirements for at least 90&#160;days before the sale. Such sales both by affiliates and by non-affiliates must also comply with the manner of sale, current public information and notice provisions of Rule&#160;144. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rule&#160;701</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any of our service providers who purchased shares under a written compensatory plan or contract prior to this offering may be entitled to rely on the resale provisions of Rule&#160;701. Rule&#160;701, as currently in effect, permits resales of shares, including by affiliates, in reliance upon Rule&#160;144 but without compliance with certain restrictions, including the holding period requirement, of Rule&#160;144. Rule&#160;701 further provides that non-affiliates may sell such shares in reliance on Rule&#160;144 without having to comply with the public information, volume limitation or notice provisions of Rule&#160;144. All holders of Rule&#160;701 shares are required to wait until 90&#160;days after the date of this prospectus before selling such shares if such resale is pursuant to Rule&#160;701. All Rule&#160;701 shares are, however, subject to lock-up agreements and will only become eligible for sale upon the expiration of these lock-up agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-Up Agreements and Market Stand-off Provisions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with this offering, our executive officers, directors, and other existing security holders have agreed not to sell or transfer any common stock or securities convertible into, exchangeable for, exercisable for, or repayable with common stock, for 180&#160;days after the date of this prospectus (the &#8220;Lock-Up Period&#8221;) without first (a)&#160;providing prior written notice to BofA Securities, Inc., J.P. Morgan Securities LLC, and Goldman Sachs &amp; Co. LLC and (b)&#160;obtaining the written consent of BofA Securities, Inc. and either J.P. Morgan Securities LLC or Goldman Sachs &amp; Co. LLC, who may release the securities subject to any of the lock-up agreements in whole or in part at any time. Specifically, we and these other persons have agreed, with certain limited exceptions, not to directly or indirectly </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">offer, pledge, sell, or contract to sell any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sell any option or contract to purchase any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">purchase any option or contract to sell any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">grant any option, right, or warrant for the sale of any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">lend or otherwise dispose of or transfer any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">request or demand that we file or make a confidential submission of a registration statement related to the common stock, or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into any hedging, swap, loan, or any other agreement or transaction that transfers, in whole or in part, the economic consequence of ownership of any common stock whether any such hedging, swap, loan, or transaction is to be settled by delivery of shares or other securities, in cash or otherwise. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any director, officer or shareholder is granted an early release from its obligations under any lock-up restrictions with respect to our securities in an aggregate amount in excess of one&#160;percent of our outstanding common stock, then every other lock-up party automatically will be granted an equivalent early release from its obligations under their respective lock-up agreement on a pro&#160;rata basis, provided that such release shall not apply (i)&#160;if it is effected solely to permit a transfer not for consideration and the transferee has agreed in writing to be bound by the same terms described in the lock-up agreement to the extent and for the duration that such terms remain in effect at the time of the transfer and (ii)&#160;in the event of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">246</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">an underwritten public offering, except with respect to the lock-up party&#8217;s participation in such underwritten public offering, provided that the lock-up party shall be offered the opportunity to participate in such underwritten public offering in accordance with, and subject to, the terms of any rights agreement (including the Investors&#8217; Rights Agreement). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The agreements of our executive officers, directors, and other existing security holders do not apply to transfers, sales or dispositions: (i)&#160;as a bona fide gift or gifts, including, without limitation, to a charitable organization or educational institution, or for bona fide estate planning purposes; (ii)&#160;by will, testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the lock-up party; (iii)&#160;(A)&#160;if the lock-up party is an individual, by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement or (B)&#160;if the lock-up party is a corporation, partnership, limited liability company or other business entity, pursuant to a merger or reorganization with or into another entity; (iv)&#160;pursuant to an order of a court or regulatory agency having jurisdiction over the lock-up party; (v)&#160;to any corporation, partnership, limited liability company or other entity controlled or managed, or under common control or management by, the lock-up party or the immediate family of the lock-up party; (vi)&#160;to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i)&#160;through (v)&#160;above; (vii)&#160;to any immediate family member or any trust, partnership, limited liability company or other entity for the direct or indirect benefit of the lock-up party or one or more immediate family members of the lock-up party, or if the lock-up party is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust; (viii)&#160;if the lock-up party is a corporation, partnership, limited liability company, trust or other business entity, (A)&#160;to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule&#160;405 promulgated under the Securities Act) of the lock-up party, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control or common investment management with the lock-up party or affiliates of the lock-up party (including, for the avoidance of doubt, pursuant to a merger, acquisition or reorganization of the lock-up party and, further, where the lock-up party is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B)&#160;as part of a distribution to partners (general or limited partners), limited liability company members, shareholders or other equityholders of the lock-up party or holders of similar equity interests in the lock-up party; (ix)&#160;to us upon the lock-up party&#8217;s death, disability or termination of employment or other service relationship with us; provided that such common stock were issued to the lock-up party pursuant to an agreement or equity award granted pursuant to an employee benefit plan, option, warrant or other right disclosed in this prospectus; (x)&#160;pursuant to a bona fide third-party tender offer, or in connection with a merger, consolidation or other similar transaction, that is approved by the our board of directors, made to all holders of our capital stock involving a change of control of us (including, without limitation, entering into any lock-up, voting or similar agreement pursuant to which the lock-up party may agree to transfer, sell, tender or otherwise dispose of lock-up securities in connection with such transaction, or vote any common stock or other securities in favor of any such transaction); provided that, in the event that such tender offer, merger, consolidation or other transaction is not completed, the lock-up party&#8217;s lock-up securities shall remain subject to the restrictions set forth in this lock-up agreement; provided further that any shares of common stock not transferred, sold or otherwise disposed of in such third-party tender offer, merger, consolidation, or other similar transaction shall remain subject to the restrictions set forth in this lock-up agreement (for purposes hereof, &#8220;change of control&#8221; shall mean the transfer, sale or other disposition (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of shares of our capital stock if, after such transaction or transactions, such person or group of affiliated persons would hold more than 50% of our outstanding voting securities (or the surviving entity)); to us in connection with the conversion or exercise of any of our outstanding equity securities into shares of common stock or in connection with the reclassification or exchange of shares of common stock, in each case as described and as contemplated in this prospectus; provided that any shares of common stock received by the lock-up party upon such conversion, exercise, reclassification, reclassification or exchange shall be subject to the restrictions set forth in this lock-up agreement; (xii)&#160;in connection with the vesting or settlement of restricted stock&#160;units or the exercise of options or other rights to purchase the shares of common stock (including, in each case, by way of &#8220;net&#8221; or &#8220;cashless&#8221; exercise), including (A)&#160;any transfer, sale or other disposition to us for the payment of exercise price, tax withholdings or remittance payments due as a result of the vesting, settlement or exercise of such restricted stock&#160;units, options or rights, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">247</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and (B)&#160;any transfer, sale or other disposition of shares of common stock necessary to generate such amount of cash needed to satisfy tax withholdings or remittance payments due as a result of the vesting or settlement of restricted stock&#160;units or the exercise of options, which are expiring during the lock-up period, to purchase the shares of common stock; provided that, in each case, any such restricted stock&#160;units and options to purchase shares of common stock were granted under an equity incentive plan or other equity award plan that is described in this prospectus and provided, further, that, in each case, any such shares of common stock received by the lock-up party upon such vesting, settlement or exercise that are not so transferred, sold or otherwise disposed shall be subject to the restrictions set forth in this lock-up agreement; (xiii)&#160;up to 15% of the lock-up party&#8217;s lock-up securities, to any third-party pledgee in a bona fide transaction as collateral to secure obligations pursuant to lending or other arrangements between such third parties (or their affiliates or designees) and the lock-up party and/or its affiliates or any similar arrangement relating to a financing arrangement for the benefit of the lock-up party and/or its affiliates; and upon foreclosure of any such lending or other arrangements; (xiv)&#160;if the lock-up party is not our officer or director, in connection with a sale of the lock-up party&#8217;s shares of common stock acquired (A)&#160;from the underwriters in this offering or (B)&#160;on the open market or in other transactions following this offering; or (xv)&#160;to the underwriters pursuant to the underwriting agreement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, notwithstanding the restrictions in the lock-up agreement, the lock-up party may make any demand or requests for, exercise any right with respect to, or take any action in preparation of, the registration by us under the Securities Act of the lock-up party&#8217;s lock-up securities or other securities; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that (i)&#160;no public filing with the Securities and Exchange Commission or any other public announcement may be made during the lock-up period in relation to such registration, (ii)&#160;the representatives must have received prior written notice from us and/or the lock-up party of a confidential submission of a registration statement with the Securities and Exchange Commission during the lock-up period at least five (5)&#160;business days prior to such submission and (iii)&#160;no lock-up securities or other securities of us may be sold, distributed or exchanged during the lock-up period. Notwithstanding the foregoing, the lock-up party also may establish trading plans pursuant to Rule&#160;10b5-1 under the Exchange Act for the transfer, sale or other disposition of lock-up securities, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that (1)&#160;none of the securities subject to such plan may be transferred, sold or otherwise disposed of until after the expiration of the lock-up period and (2)&#160;no public announcement, report or filing under the Exchange Act, or any other public filing, report or announcement, shall be voluntarily made regarding the establishment of such plan during the lock-up period, and if any such filing, report or announcement shall be legally required during the lock-up period, such filing, report or announcement shall clearly indicate therein that none of the securities subject to such plan may be transferred, sold, or otherwise disposed pursuant to such plan until after the expiration of the lock-up period.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event that (i)&#160;at least 150&#160;days have elapsed since the date of this prospectus and (ii)&#160;the end of the restricted period would fall during one of our quarterly blackout periods during which trading by certain of our employees in our securities would not be permitted under our insider trading policy then in effect (a &#8220;Blackout Period&#8221;), or within 10 trading days prior to such Blackout Period the restricted period shall end on the date that is the later of (a)&#160;10 trading days prior to the commencement of a Blackout Period and (b)&#160;the 150th day after the date of this prospectus. For a further description of these lock-up agreements, please see &#8220;Underwriting.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the restrictions contained in the lock-up agreements described above, the holders of outstanding equity awards and holders of outstanding common stock issued pursuant to the vesting, settlement, or exercise of equity awards, are subject to market stand-off provisions in agreements with us that impose similar restrictions on the ability of such security holders to offer, sell, or transfer our equity securities during the Lock-Up Period.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Registration Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the completion of this offering, the holders of up to approximately 245.9 million shares of our common stock will, subject to the lock-up agreements referred to above, be entitled to certain rights with respect to the registration of such shares under the Securities Act. The registration of these shares of our common stock under the Securities Act would result in these shares becoming eligible for sale in the public market without restriction under the Securities Act immediately upon the effectiveness of such registration, subject to the Rule&#160;144 limitations applicable to affiliates. See the section titled &#8220;Description of Capital Stock&#8212;Registration Rights&#8221; for a description of these registration rights. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">248</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Equity Plans</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">We intend to file a registration statement on Form S-8 under the Securities Act covering all of the shares of our common stock subject to options outstanding or reserved for issuance under our equity plans. We expect to file this registration statement as soon as practicable after the completion of this offering. This registration statement will become effective immediately upon filing, and shares covered by this registration statement will thereupon be eligible for sale in the public markets, subject to vesting restrictions, the lock-up agreements described above and Rule&#160;144 limitations applicable to affiliates. For a more&#160;complete discussion of our stock plans, see the section titled &#8220;Executive Compensation&#8212;Long-Term Incentive Plans.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">249</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMUFI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS OF OUR COMMON STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences to Non-U.S. Holders (as defined below) of the purchase, ownership, and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local, or non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely&#160;affect a Non-U.S. Holder. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the purchase, ownership, and disposition of our common stock. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Non-U.S. Holders that hold our common stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a Non-U.S. Holder&#8217;s particular circumstances, including the impact of the Medicare contribution tax on net investment income, the special tax accounting rules under Section&#160;451(b) of the Code, and the alternative minimum tax. In addition, it does not address consequences relevant to Non-U.S. Holders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons holding our common stock as part of a hedge, straddle, or other risk reduction&#160;strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">banks, insurance companies, and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">brokers, dealers, or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons deemed to sell our common stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;qualified foreign pension funds&#8221; as defined in Section&#160;897(l)(2) of the Code and entities all of the interests of which are held by qualified foreign pension funds. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership, and certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP, AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">250</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL, OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Definition of a Non-U.S. Holder</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Non-U.S. Holder&#8221; is any beneficial owner of our common stock that is neither a &#8220;U.S. person&#8221; nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S. person is any person that, for U.S. federal income tax purposes, is or is treated as any of the following: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an individual who is a citizen or resident of the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a corporation created or organized under the laws of the United States, any state thereof, or the District of Columbia; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a trust that (1)&#160;is subject to the primary supervision of a U.S. court and the control of one or more &#8220;United States persons&#8221; &#8203;(within the meaning of Section&#160;7701(a)(30) of the Code), or (2)&#160;has a valid election in effect to be treated as a United States person for U.S. federal&#160;income tax purposes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Distributions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As described in the section titled &#8220;Dividend Policy,&#8221; we do not anticipate declaring or paying dividends to holders of our common stock in the foreseeable future. However, if we do make distributions of cash or property on our common stock, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital and first be applied against and reduce a Non-U.S. Holder&#8217;s adjusted tax&#160;basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated as described below under &#8220;&#8212;Sale or Other Taxable Disposition.&#8221; </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the discussions below on effectively connected income, backup withholding, and&#160;FATCA (as defined below) dividends paid to a Non-U.S. Holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income tax treaty, provided the Non-U.S. Holder furnishes a valid IRS Form W-8BEN or W-8BEN-E (or other&#160;applicable documentation) certifying qualification for the lower treaty rate). A Non-U.S. Holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">If dividends paid to a Non-U.S. Holder are effectively connected with the Non-U.S. Holder&#8217;s&#160;conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such dividends are attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described above. To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI, certifying that the dividends are effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the regular rates in the same manner as if the Non-U.S. Holder were a resident of the United States. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted for certain items. Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide for different rules. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">251</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sale or Other Taxable Disposition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the discussions below on backup withholding and FATCA (as defined below), a Non-U.S. Holder will not be subject to U.S. federal income tax on any gain realized upon the sale or other taxable disposition of our common stock unless: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the gain is effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such gain is attributable); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Non-U.S. Holder is a nonresident alien individual present in the United States for 183&#160;days or more during the taxable year of the disposition and certain other requirements are met; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our common stock constitutes a U.S. real property interest (&#8220;USRPI&#8221;) by reason of our status as a U.S. real property holding corporation (&#8220;USRPHC&#8221;) for U.S. federal income tax purposes at any time within the shorter of the five-year period preceding the disposition or the Non-U.S. Holder&#8217;s holding period for our common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular rates in the same manner as if the Non-U.S. Holder were a resident of the United States. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Non-U.S. Holder described in the second bullet point above will be subject to U.S. federal&#160;income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the sale or other taxable disposition of our common stock, which may be offset by U.S. source capital losses of the Non-U.S. Holder (even though the individual is not considered a resident of the United States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to such losses. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With respect to the third bullet point above, we believe we currently are not, and do not anticipate becoming, a USRPHC. Because the determination of whether we are a USRPHC depends, however, on the fair market value of our USRPIs relative to the fair market value of our non-U.S. real property interests and our other business assets, there can be no assurance we currently are not a USRPHC or will not become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our common stock by a Non-U.S. Holder will not be subject to U.S. federal income tax if our common stock is &#8220;regularly traded,&#8221; as defined by applicable Treasury Regulations, on an established securities market and such Non-U.S. Holder owned, actually and constructively, 5% or less of our common stock throughout the shorter of the five-year period ending on the date of the sale or other taxable disposition or the Non-U.S. Holder&#8217;s holding period. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Non-U.S. Holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Information Reporting and Backup Withholding</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Payments of dividends on our common stock will not be subject to backup withholding, provided the applicable withholding agent does not have actual knowledge or reason to know the holder is a United States person and the holder either certifies its non-U.S. status, such as by furnishing a valid IRS Form&#160;W-8BEN, W-8BEN-E, or W-8ECI, or otherwise establishes an exemption. However, information returns are required to be filed with the IRS in connection with any distributions on our common stock paid to the Non-U.S. Holder, regardless of whether such distributions constitute dividends or whether any tax was actually withheld. In addition, proceeds of the sale or other taxable disposition of our common stock within the United States or conducted through certain U.S.-related brokers generally will not be subject to&#160;backup withholding or information reporting if the applicable withholding agent receives the certification&#160;described above and does not have actual knowledge or reason to know that such holder is a United States person or the holder otherwise establishes an exemption. Proceeds of a disposition of our common stock conducted through a non-U.S. office of a non-U.S. broker generally will not be subject to backup&#160;withholding or information reporting. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">252</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:200pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Copies of information returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement to the tax authorities of the country in which the Non-U.S. Holder resides or is established. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a Non-U.S. Holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additional Withholding Tax on Payments Made to Foreign Accounts</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Withholding taxes may be imposed under Sections&#160;1471 to 1474 of the Code (such Sections&#160;commonly referred to as the Foreign Account Tax Compliance Act, or &#8220;FATCA&#8221;) on certain types of payments made to non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below) gross proceeds from the sale or other disposition of, our common stock paid to a &#8220;foreign financial institution&#8221; or a &#8220;non-financial foreign entity&#8221; &#8203;(each as defined in the Code), unless (1)&#160;the foreign financial institution undertakes certain diligence and reporting obligations, (2)&#160;the non-financial foreign entity either certifies it does not have any &#8220;substantial United States owners&#8221; &#8203;(as defined in the Code) or furnishes identifying information regarding each substantial United States owner, or (3)&#160;the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the diligence and reporting requirements in clause (1)&#160;above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain &#8220;specified United States persons&#8221; or &#8220;United States owned foreign entities&#8221; &#8203;(each as defined in the Code), annually report certain information about such accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account&#160;holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the applicable Treasury Regulations and administrative guidance, withholding under&#160;FATCA generally applies to payments of dividends on our common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of stock on or after January&#160;1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prospective investors should consult their tax advisors regarding the potential application of withholding under FATCA to their investment in our common stock. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">253</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUND">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">UNDERWRITING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">BofA Securities, Inc., J.P. Morgan Securities LLC, Goldman Sachs &amp; Co. LLC, and Citigroup Global Markets Inc. are acting as representatives of each of the underwriters named below. Subject to the terms and conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally and not jointly, to purchase from us, the number of shares of common stock set forth opposite its name below. </font>
        </div>
        <table style="width:456pt;height:183pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:398.59pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Underwriter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
                <br >
                <font style="letter-spacing:-0.16pt;">of Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">BofA Securities, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,349,412</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">J.P. Morgan Securities LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">4,752,941</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Goldman Sachs &amp; Co. LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">4,158,824</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Citigroup Global Markets Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,614,118</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">TD Securities (USA) LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,020,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Evercore Group L.L.C. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,020,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Guggenheim Securities, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,188,235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">BTIG, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">712,941</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nomura Securities International, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">677,294</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">WR Securities, LLC </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">35,647</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.25pt 0pt; width:398.59pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">23,529,412</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:12.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the terms and conditions set forth in the underwriting agreement, the underwriters have agreed, severally and not jointly, to purchase all of the shares of common stock sold under the underwriting agreement if any of these shares are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the nondefaulting underwriters may be increased or the underwriting agreement may be terminated. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make in respect of those liabilities. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters are offering the shares, subject to prior sale, when, as and if issued to and&#160;accepted by them, subject to approval of legal matters by their counsel, including the validity of the shares, and other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officer&#8217;s certificates and legal opinions. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. Sales of shares made outside of the United States may be made by affiliates of the underwriters. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Commissions and Discounts</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The representatives have advised us that the underwriters propose initially to offer the shares to the public at the public offering price set forth on the cover page of this prospectus and to dealers at that price less a concession not in excess of $0.882 per share. After the initial offering, the public offering price, concession, or any other term of the offering may be changed. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table shows the public offering price, underwriting discount, and proceeds before expenses to us. The information assumes either no exercise or full exercise by the underwriters of their option to purchase additional shares of common stock. </font>
        </div>
        <table style="width:381pt;height:56.5pt;margin-left:37.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:175.94pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Without </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">With </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:175.94pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Public offering price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">21.00 </td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">494,117,652.00 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">568,235,283.00 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:175.94pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Underwriting discount </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.47 </td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">34,588,235.64 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">39,776,469.81 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:175.94pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Proceeds, before expenses, to us </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">19.53 </td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">459,529,416.36 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:51pt; text-align:right; white-space:nowrap;">528,458,813.19</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">254</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The expenses of the offering, not including the underwriting discount, are estimated at $7,400,000 and are payable by us. We have also agreed to reimburse the underwriters for their expenses relating to clearance of this offering with the Financial Industry Regulatory Authority in an amount up to $40,000. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have engaged NCMG LLC to provide certain financial advisory services in connection with this offering. The underwriters have agreed to reimburse us for such financial advisory services provided by NCMG LLC in connection with this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Option to Purchase Additional Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have granted an option to the underwriters, exercisable for 30&#160;days after the date of this&#160;prospectus, to purchase up to 3,529,411 additional shares of common stock at the public offering price, less the underwriting discount. If the underwriters exercise this option, each will be obligated, subject to conditions contained in the underwriting agreement, to purchase a number of additional shares of common stock proportionate to that underwriter&#8217;s initial amount reflected in the above table. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">No Sales of Similar Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We, our executive officers and directors and our other existing security holders have agreed not to sell or transfer any common stock or securities convertible into, exchangeable for, exercisable for, or repayable with common stock, for 180 days (the &#8220;Lock-Up Period&#8221;) after the date of this prospectus without (a) providing prior written notice to BofA Securities, Inc., J.P. Morgan Securities LLC, and Goldman Sachs &amp; Co. LLC and (b) first obtaining the written consent of BofA Securities, Inc. and either J.P. Morgan Securities LLC or Goldman Sachs &amp; Co. LLC, who may release the securities subject to any of the lock-up agreements in whole or in part at any time. Specifically, we and these other persons have agreed, with certain limited exceptions, not to directly or indirectly </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">offer, pledge, sell, or contract to sell any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sell any option or contract to purchase any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">purchase any option or contract to sell any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">grant any option, right, or warrant for the sale of any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">lend or otherwise dispose of or transfer any common stock, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">request or demand that we file or make a confidential submission of a registration statement related to the common stock, or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into any hedging, swap, loan, or any other agreement or transaction that transfers, in whole or in part, the economic consequence of ownership of any common stock whether any such hedging, swap, loan or transaction is to be settled by delivery of shares or other securities, in cash or otherwise. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This lock-up provision applies to common stock and to securities convertible into or exchangeable or exercisable for or repayable with common stock (collectively, the &#8220;lock-up securities&#8221;). It also applies to common stock owned now or acquired later by the person executing the agreement or for which the person executing the agreement later acquires the power of disposition. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The agreements of our executive officers, directors, and other existing security holders do not apply to transfers, sales or dispositions: (i)&#160;as a bona fide gift or gifts, including, without limitation, to a charitable organization or educational institution, or for bona fide estate planning purposes; (ii)&#160;by will, testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the lock-up party; (iii)&#160;(A)&#160;if the lock-up party is an individual, by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement or (B)&#160;if the lock-up party is a corporation, partnership, limited liability company or other business entity, pursuant to a merger or reorganization with or into another entity; (iv)&#160;pursuant to an order of a court or regulatory agency having jurisdiction over the lock-up party; (v)&#160;to any corporation, partnership, limited liability company or other entity controlled or managed, or under common control or management by, the lock-up party or the immediate family of the lock-up party; (vi)&#160;to a nominee or custodian of a person or entity to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">255</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">whom a disposition or transfer would be permissible under clauses (i)&#160;through (v)&#160;above; (vii)&#160;to any immediate family member or any trust, partnership, limited liability company or other entity for the direct or indirect benefit of the lock-up party or one or more immediate family members of the lock-up party, or if the lock-up party is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust; (viii)&#160;if the lock-up party is a corporation, partnership, limited liability company, trust or other business entity, (A)&#160;to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule&#160;405 promulgated under the Securities Act) of the lock-up party, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control or common investment management with the lock-up party or affiliates of the lock-up party (including, for the avoidance of doubt, pursuant to a merger, acquisition or reorganization of the lock-up party and, further, where the lock-up party is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B)&#160;as part of a distribution to partners (general or limited partners), limited liability company members, shareholders or other equityholders of the lock-up party or holders of similar equity interests in the lock-up party; (ix)&#160;to us upon the lock-up party&#8217;s death, disability or termination of employment or other service relationship with us; provided that such common stock were issued to the lock-up party pursuant to an agreement or equity award granted pursuant to an employee benefit plan, option, warrant or other right disclosed in this prospectus; (x)&#160;pursuant to a bona fide third-party tender offer, or in connection with a merger, consolidation or other similar transaction, that is approved by the our board of directors, made to all holders of our capital stock involving a change of control of us (including, without limitation, entering into any lock-up, voting or similar agreement pursuant to which the lock-up party may agree to transfer, sell, tender or otherwise dispose of lock-up securities in connection with such transaction, or vote any common stock or other securities in favor of any such transaction); provided that, in the event that such tender offer, merger, consolidation or other transaction is not completed, the lock-up party&#8217;s lock-up securities shall remain subject to the restrictions set forth in this lock-up agreement; provided further that any shares of common stock not transferred, sold or otherwise disposed of in such third-party tender offer, merger, consolidation, or other similar transaction shall remain subject to the restrictions set forth in this lock-up agreement (for purposes hereof, &#8220;change of control&#8221; shall mean the transfer, sale or other disposition (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of shares of our capital stock if, after such transaction or transactions, such person or group of affiliated persons would hold more than 50% of our outstanding voting securities (or the surviving entity)); to us in connection with the conversion or exercise of any of our outstanding equity securities into shares of common stock or in connection with the reclassification or exchange of shares of common stock, in each case as described and as contemplated in this prospectus; provided that any shares of common stock received by the lock-up party upon such conversion, exercise, reclassification, reclassification or exchange shall be subject to the restrictions set forth in this lock-up agreement; (xii)&#160;in connection with the vesting or settlement of restricted stock&#160;units or the exercise of options or other rights to purchase the shares of common stock (including, in each case, by way of &#8220;net&#8221; or &#8220;cashless&#8221; exercise), including (A)&#160;any transfer, sale or other disposition to us for the payment of exercise price, tax withholdings or remittance payments due as a result of the vesting, settlement or exercise of such restricted stock&#160;units, options or rights, and (B)&#160;any transfer, sale or other disposition of shares of common stock necessary to generate such amount of cash needed to satisfy tax withholdings or remittance payments due as a result of the vesting or settlement of restricted stock&#160;units or the exercise of options, which are expiring during the lock-up period, to purchase the shares of common stock; provided that, in each case, any such restricted stock&#160;units and options to purchase shares of common stock were granted under an equity incentive plan or other equity award plan that is described in this prospectus and provided, further, that, in each case, any such shares of common stock received by the lock-up party upon such vesting, settlement or exercise that are not so transferred, sold or otherwise disposed shall be subject to the restrictions set forth in this lock-up agreement; (xiii)&#160;up to 15% of the lock-up party&#8217;s lock-up securities, to any third-party pledgee in a bona fide transaction as collateral to secure obligations pursuant to lending or other arrangements between such third parties (or their affiliates or designees) and the lock-up party and/or its affiliates or any similar arrangement relating to a financing arrangement for the benefit of the lock-up party and/or its affiliates; and upon foreclosure of any such lending or other arrangements; (xiv)&#160;if the lock-up party is not our officer or director, in connection with a sale of the lock-up party&#8217;s shares of common stock acquired (A)&#160;from the underwriters in this offering or (B)&#160;on the open market or in other transactions following this offering; or (xv)&#160;to the underwriters pursuant to the underwriting agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">256</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, notwithstanding the restrictions in the lock-up agreement, the lock-up party may make any demand or requests for, exercise any right with respect to, or take any action in preparation of, the registration by us under the Securities Act of the lock-up party&#8217;s lock-up securities or other securities; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that (i)&#160;no public filing with the Securities and Exchange Commission or any other public announcement may be made during the lock-up period in relation to such registration, (ii)&#160;the representatives must have received prior written notice from us and/or the lock-up party of a confidential submission of a registration statement with the Securities and Exchange Commission during the lock-up period at least five (5)&#160;business days prior to such submission and (iii)&#160;no lock-up securities or other securities of us may be sold, distributed or exchanged during the lock-up period. Notwithstanding the foregoing, the lock-up party also may establish trading plans pursuant to Rule&#160;10b5-1 under the Exchange Act for the transfer, sale or other disposition of lock-up securities, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that (1)&#160;none of the securities subject to such plan may be transferred, sold or otherwise disposed of until after the expiration of the lock-up period and (2)&#160;no public announcement, report or filing under the Exchange Act, or any other public filing, report or announcement, shall be voluntarily made regarding the establishment of such plan during the lock-up period, and if any such filing, report or announcement shall be legally required during the lock-up period, such filing, report or announcement shall clearly indicate therein that none of the securities subject to such plan may be transferred, sold, or otherwise disposed pursuant to such plan until after the expiration of the lock-up period.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any director, officer, or shareholder of the Company is granted an early release from its obligations under any lock-up restrictions with respect to our securities in an aggregate amount in excess of one&#160;percent of our outstanding common stock, then every other lock-up party automatically will be granted an equivalent early release from its obligations under their respective lock-up agreement on a pro&#160;rata basis, provided that such release shall not apply (i)&#160;if it is effected solely to permit a transfer not for consideration and the transferee has agreed in writing to be bound by the same terms described in the lock-up agreement to the extent and for the duration that such terms remain in effect at the time of the transfer and (ii)&#160;in the event of an underwritten public offering, except with respect to the lock-up party&#8217;s participation in such underwritten public offering, provided that the lock-up party shall be offered the opportunity to participate in such underwritten public offering in accordance with, and subject to, the terms of any rights agreement (including the Investors&#8217; Rights Agreement). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event that (i)&#160;at least 150&#160;days have elapsed since the date of this prospectus and (ii)&#160;the end of the restricted period would fall during one of our quarterly blackout periods during which trading by certain of our employees in our securities would not be permitted under our insider trading policy then in effect (a &#8220;Blackout Period&#8221;), or within 10 trading days prior to such Blackout Period the restricted period shall end on the date that is the later of (a)&#160;10 trading days prior to the commencement of a Blackout Period and (b)&#160;the 150th day after the date of this prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our common stock has been approved for listing on the Nasdaq under the symbol &#8220;CAI.&#8221; In order to meet the requirements for listing on that exchange, the underwriters have undertaken to sell a minimum number of shares to a minimum number of beneficial owners as required by that exchange. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before this offering, there has been no public market for our common stock. The initial public offering price will be determined through negotiations between us and the representatives. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the valuation multiples of publicly traded companies that the representatives believe to be comparable to us, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our financial information, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the history of, and the prospects for, our company and the industry in which we compete, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an assessment of our management, its past and present operations, and the prospects for, and timing of, our future revenues, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the present state of our development, and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">257</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:36pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An active trading market for the shares may not develop. It is also possible that after the offering the shares will not trade in the public market at or above the initial public offering price. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters do not expect to sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Price Stabilization, Short Positions and Penalty Bids</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until the distribution of the shares is completed, SEC rules may limit underwriters and selling&#160;group members from bidding for and purchasing our common stock. However, the representatives may engage in transactions that stabilize the price of the common stock, such as bids or purchases to peg, fix, or maintain that price. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the offering, the underwriters may purchase and sell our common stock in the open market. These transactions may include short sales, purchases on the open market to cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering. &#8220;Covered&#8221; short sales are sales made in an amount not greater than the underwriters&#8217; option to purchase additional shares of common stock described above. The underwriters may close out any covered short position by either exercising their option to purchase additional shares of common stock or purchasing shares of common stock in the open market. In determining the source of shares to close out the&#160;covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the option granted to them. &#8220;Naked&#8221; short sales are sales in excess of such option. The underwriters must close out any&#160;naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of our common stock in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of shares of common stock made by the underwriters in the open market prior to the completion of the offering. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Similar to other purchase transactions, the underwriters&#8217; purchases to cover the syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. The underwriters may conduct&#160;these transactions on Nasdaq, in the over-the-counter market or otherwise. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Neither we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our common stock. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Electronic Distribution</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such as e-mail. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Relationships</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some of the underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in the ordinary course of their business activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">258</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Wolfe | Nomura Alliance&#8221; is the marketing name used by Wolfe Research Securities and Nomura Securities International, Inc. in connection with certain equity capital markets activities conducted jointly by the firms. Both Nomura Securities International, Inc. and WR Securities, LLC are serving as underwriters in the offering described herein. In addition, WR Securities, LLC and certain of its affiliates may provide sales support services, investor feedback, investor education, and/or other independent equity research services in connection with this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reserved Share Program</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At our request, the underwriters have reserved up to 5% of the shares of common stock offered by this prospectus, excluding the additional shares that the underwriters have a 30-day option to purchase, for sale, at the initial public offering price, to certain individuals identified by management. If these persons purchase reserved shares it will reduce the number of shares of common stock available for sale to the general public. Any reserved shares of common stock that are not so purchased will be offered by the underwriters to the general public on the same terms as the other shares of common stock offered by this prospectus. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Management will provide the list of potential participants to Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, which is an affiliate of BofA Securities, Inc., a participating underwriter, and which will administer the reserved shares program. At this time, no indications of interest will be taken. Once the preliminary prospectus has been filed, an invitation package will be made available or sent to each person identified by management, which will include the preliminary prospectus and other reserved share program documentation. An invitation to participate in the reserved share program does not guarantee that the participant will receive an allocation of common stock. Accordingly, we cannot provide any assurance that any director, officer, employee, or participant will receive an invitation or an allocation in the reserved share program. If a potential participant is interested in participating, that participant will be required to complete the required documentation and will be required to return such documentation to the program administrator. The program administrator will not accept funds from any participant until after the registration statement for this offering is declared effective, this offering is priced, and the participants are notified of their final allocation and given an opportunity to confirm that they wish to purchase the shares of common stock allocated to them. After the registration statement has been declared effective and this offering is priced, we and the program administrator will prepare a final approved list of allocations. The program administrator will notify each participant who has been allocated reserved shares of the number of shares of common stock that have been allocated to them and the total purchase price due upon confirmation of their participation. Thereafter, participants will be required to wire or transfer their funds to the program administrator. The shares of common stock under the reserved shares program will be allocated following pricing and settle in the same manner as the shares sold to the general public. If purchased by directors, officers or employees, these shares will be subject to a 180-day lock-up restriction described in this prospectus. If any potential participants purchase reserved shares, it will reduce the number of shares available for sale to the general public. Any reserved shares that are not so purchased will be offered by the underwriters to the general public on the same terms as the other shares of common stock offered hereby. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Participation in Our Initial Public Offering</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neuberger Berman has indicated an interest in purchasing up to $75.0 million of shares of our common stock being offered in this offering at the initial public offering price and on the same terms as the other purchasers in this offering. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters could determine to sell more, fewer, or no shares to Neuberger Berman, and Neuberger Berman could determine to purchase more, fewer, or no shares in this offering. The </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">259</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">underwriters will receive the same underwriting discounts and commissions on any of our shares of common stock purchased by Neuberger Berman as they will from any other shares of common stock sold to the public in this offering.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">European Economic Area</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In relation to each Member State of the European Economic Area (each a &#8220;Relevant State&#8221;), no shares have been offered or will be offered pursuant to the public in that Relevant State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that offers of shares may be made to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">a.</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to any legal entity which is a qualified investor as defined under the Prospectus Regulation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">b.</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent for any such offer; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">c.</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in any other circumstances falling within Article&#160;1(4) of the Prospectus Regulation, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided that no such offer of shares shall require the Company or any underwriter to publish a prospectus pursuant to Article&#160;3 of the Prospectus Regulation or supplement a prospectus pursuant to Article&#160;23 of the Prospectus Regulation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each person in a Relevant State who initially acquires any shares or to whom any offer is made will be deemed to have represented, acknowledged, and agreed to and with the Company and the underwriters that it is a qualified investor within the meaning of the Prospectus Regulation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the case of any shares being offered to a financial intermediary as that term is used in Article&#160;5(1) of the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in a Relevant State to qualified investors, in circumstances in which the prior consent of the underwriters has been obtained to each such proposed offer or resale. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company, the underwriters and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements, and agreements. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to any shares in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017/1129. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The above selling restriction is in addition to any other selling restrictions set out below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in the United Kingdom</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In relation to the United Kingdom (&#8220;UK&#8221;), no shares have been offered or will be offered pursuant to the public in the UK prior to the publication of a prospectus in relation to the shares which has been approved by the Financial Conduct Authority in the UK in accordance with the UK Prospectus Regulation and the FSMA, except that offers of shares may be made to the public in the UK at any time under the following exemptions under the UK Prospectus Regulation and the FSMA: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">a.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to any legal entity which is a qualified investor as defined under the UK Prospectus Regulation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">b.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to fewer than 150 natural or legal persons (other than qualified investors as defined under the UK Prospectus Regulation), subject to obtaining the prior consent for any such offer; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">c.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">at any time in other circumstances falling within section 86 of the FSMA, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">260</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided that no such offer of shares shall require the Company or any underwriter to publish a prospectus pursuant to Section&#160;85 of the FSMA or Article&#160;3 of the UK Prospectus Regulation or supplement a prospectus pursuant to Article&#160;23 of the UK Prospectus Regulation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each person in the UK who initially acquires any shares or to whom any offer is made will be deemed to have represented, acknowledged, and agreed to and with the Company and the underwriters that it is a qualified investor within the meaning of the UK Prospectus Regulation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the case of any shares being offered to a financial intermediary as that term is used in Article&#160;5(1) of the UK Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in the UK to qualified investors, in circumstances in which the prior consent of the underwriters has been obtained to each such proposed offer or resale. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company, the underwriters and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements, and agreements. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to any shares in the UK means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares, the expression &#8220;UK Prospectus Regulation&#8221; means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, and the expression &#8220;FSMA&#8221; means the Financial Services and Markets Act 2000. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This document is for distribution only to persons who (i)&#160;have professional experience in matters relating to investments and who qualify as investment professionals within the meaning of Article&#160;19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the &#8220;Financial Promotion Order&#8221;), (ii)&#160;are persons falling within Article&#160;49(2)(a) to (d)&#160;(&#8220;high net worth companies, unincorporated associations etc.&#8221;) of the Financial Promotion Order, (iii)&#160;are outside the United Kingdom, or (iv)&#160;are persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section&#160;21 of the FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as &#8220;relevant persons&#8221;). This document is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in Switzerland</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#8220;SIX&#8221;) or on any other stock exchange or regulated trading facility in Switzerland. This&#160;document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or&#160;art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art.&#160;27&#160;ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Neither this document nor any other offering or marketing material relating to the offering, the Company, the shares have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#8220;CISA&#8221;). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in the Dubai International Financial Centre</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority (&#8220;DFSA&#8221;). This prospectus is intended for distribution only to persons </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">261</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus. The shares to which this prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their own due diligence on the shares. If you do not understand the contents of this prospectus you should consult an authorized financial advisor. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in Australia</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and Investments Commission (&#8220;ASIC&#8221;), in relation to the offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (the &#8220;Corporations Act&#8221;), and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any offer in Australia of the shares may only be made to persons (the &#8220;Exempt Investors&#8221;) who are &#8220;sophisticated investors&#8221; &#8203;(within the meaning of section 708(8) of the Corporations Act), &#8220;professional investors&#8221; &#8203;(within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section 708 of the Corporations Act so that it is lawful to offer the shares without disclosure to investors under Chapter 6D of the Corporations Act. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The shares applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12&#160;months after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring shares must observe such Australian on-sale restrictions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains general information only and does not take account of the investment objectives, financial situation, or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their needs, objectives, and circumstances, and, if necessary, seek expert advice on those matters. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in Hong Kong</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a)&#160;to &#8220;professional investors&#8221; as defined in the Securities and Futures&#160;Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b)&#160;in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies Ordinance (Cap. 32) of Hong&#160;Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document relating to the shares has been or may be issued or has been or&#160;may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to the shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance and any rules made under that Ordinance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in Japan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The shares have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948, as amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for re-offering or resale, directly or indirectly, in Japan or to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">262</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">effect at the relevant time. For the purposes of this paragraph, &#8220;Japanese Person&#8221; shall mean any person resident in Japan, including any corporation or other entity organized under the laws of Japan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in Singapore</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the shares were not offered or sold or caused to be made the subject of an invitation for subscription or purchase and will not be offered or sold or caused to be made the subject of an invitation for subscription or purchase, and this prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares, has not been circulated or distributed, nor will it be circulated or distributed, whether directly or indirectly, to any person in Singapore other than (i)&#160;to an institutional investor (as defined in Section&#160;4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time (the &#8220;SFA&#8221;)) pursuant to Section&#160;274 of the SFA, (ii)&#160;to a relevant person (as defined in Section&#160;275(2) of the SFA) pursuant to Section&#160;275(1) of the SFA, or any person pursuant to Section&#160;275(1A) of the SFA, and in accordance with the conditions specified in Section&#160;275 of the SFA, or (iii)&#160;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Where the shares are subscribed or purchased under Section&#160;275 of the SFA by a relevant person which is: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a corporation (which is not an accredited investor (as defined in Section&#160;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">securities or securities-based derivatives contracts (each term as defined in Section&#160;2(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred within six&#160;months after that corporation or that trust has acquired the shares pursuant to an offer made under Section&#160;275 of the SFA except: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section&#160;275(1A) or Section&#160;276(4)(i)(B) of the SFA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">where no consideration is or will be given for the transfer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">where the transfer is by operation of law; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">as specified in Section&#160;276(7) of the SFA. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in Canada</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 </font><font style="font-style:italic;letter-spacing:0.2pt;">Prospectus Exemptions</font><font style="letter-spacing:0.2pt;"> or subsection&#160;73.3(1) of the </font><font style="font-style:italic;letter-spacing:0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;"> (Ontario), and are permitted clients, as defined in National Instrument 31-103 </font><font style="font-style:italic;letter-spacing:0.2pt;">Registration Requirements, Exemptions and Ongoing Registrant Obligations</font><font style="letter-spacing:0.2pt;">. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section 3A.4) of National Instrument 33-105 </font><font style="font-style:italic;letter-spacing:0.2pt;">Underwriting Conflicts</font><font style="letter-spacing:0.2pt;"> (NI&#160;33-105), </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">263</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:488pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notice to Prospective Investors in Brazil</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The offer and sale of the securities have not been and will not be registered with the Brazilian&#160;securities commission (Comiss&#227;o de Valores Mobili&#225;rios, or &#8220;CVM&#8221;) and, therefore, will not be carried out by any means that would constitute a public offering in Brazil under CVM resolution no 160, dated 13&#160;July&#160;2022, as amended (&#8220;CVM Resolution 160&#8221;) or unauthorized distribution under Brazilian laws and regulations. The securities may only be offered to Brazilian professional investors (as defined by applicable CVM regulation), who may only acquire the securities through a non-Brazilian account, with settlement outside Brazil in non-Brazilian currency. The trading of these securities on regulated securities markets in Brazil is prohibited. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">264</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a><a name="tEXP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:436pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The validity of the issuance of our common stock offered in this prospectus will be passed upon for us by Latham &amp; Watkins LLP, New York, New York. Cooley LLP, New York, New York is representing the underwriters in this offering. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements as of and for the year ended December 31, 2024, included in this prospectus and elsewhere in the registration statement, have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are included in reliance upon the report of such firm given their authority as experts in accounting and auditing. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Ernst &amp; Young LLP, an independent registered public accounting firm, has audited our consolidated financial statements at December&#160;31, 2023 and for the&#160;year then ended as set forth in their&#160;report. We have included our financial statements in the prospectus and elsewhere in the registration statement in reliance on Ernst &amp; Young LLP&#8217;s report, given on their authority as experts in accounting and auditing. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">265</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCIRPAF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:120pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CHANGE IN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July 17, 2024, we notified Ernst &amp; Young LLP (&#8220;EY&#8221;), which had served as our prior independent registered public accounting firm, of our intention to obtain proposals from other accounting firms to perform the audit of our consolidated financial statements as of and for the year ending December 31, 2024 (our &#8220;2024 Audit&#8221;). On July 24, 2024, EY notified the Company of its decision to decline to stand for re-election as our independent registered public accounting firm for our 2024 Audit. On September&#160;9, 2024, the audit committee of our board of directors approved the engagement of Deloitte &amp; Touche LLP (&#8220;Deloitte&#8221;) as our independent registered public accounting firm for our 2024 Audit, effective immediately.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The reports of EY on our consolidated financial statements as of December 31, 2023 and 2022, and for the years then ended, did not contain adverse opinions or disclaimers of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the years ended December 31, 2023 and 2022 and the subsequent interim period through July&#160;24, 2024, there were:</font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">no &#8220;disagreements&#8221; &#8203;(as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions thereto) with EY on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of EY, would have caused EY to make reference to the subject matter of the disagreements in its report on our financial statements as of December 31, 2023 and 2022, and for the years then ended, and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">no &#8220;reportable events&#8221; &#8203;(as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions thereto), other than the material weakness identified in our internal control over financial reporting, which pertained to the aggregation of several deficiencies reflecting ineffective control activities related to the incorrect application of generally accepted accounting principles. The audit committee of our board of directors discussed the above material weakness with EY. We have also authorized EY to respond fully to the inquiries of Deloitte concerning the subject matter of the material weakness.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We provided EY with a copy of the disclosure set forth in this section and requested that EY furnish us with a letter addressed to the SEC stating whether EY agrees with the statements made herein, each as required by applicable SEC rules. A copy of the letter, dated September&#160;12, 2024, furnished by EY in response to that request, is filed as Exhibit 16.1 to the registration statement of which this prospectus is a part.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the years ended December 31, 2023 and 2022 and the subsequent interim period through September&#160;9, 2024, when we engaged Deloitte, we did not consult with Deloitte with respect to (i) the application of accounting principles to a specified transaction, either completed or proposed, the type of audit opinion that might be rendered on our financial statements, and neither a written report nor oral advice was provided to us that Deloitte concluded was an important factor considered by us in reaching a decision as to any accounting, auditing, or financial reporting issue, or (ii) any matter that was the subject of a &#8220;disagreement&#8221; or a &#8220;reportable event&#8221; &#8203;(each as defined above). </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">266</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:336pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have filed with the SEC a registration statement on Form S-1 under the Securities Act, with respect to the shares of common stock offered by this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits and schedules to the registration statement. Please refer to the registration statement and exhibits for further information with respect to the common stock offered by this prospectus. Statements contained in this prospectus regarding the contents of any contract or other document are only summaries. With respect to any contract or document that is filed as an exhibit to the registration statement, you&#160;should refer to the exhibit for a copy of the contract or document, and each statement in this prospectus regarding that contract or document is qualified by reference to the exhibit. The SEC maintains an internet website that contains the registration statement of which this prospectus forms a part, as well as the exhibits thereto. These documents, along with future reports, proxy statements and other information about us, are available at the SEC&#8217;s website, </font><font style="font-style:italic;letter-spacing:0.2pt;">www.sec.gov</font><font style="letter-spacing:0.2pt;">. The information on the SEC&#8217;s web site is not part of this prospectus, and any references to this web site or any other web site are inactive textual references only. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the completion of this offering, we will become subject to the information and reporting requirements of the Exchange Act, and, in accordance with this law, will be required to file periodic reports, proxy statements and other information with the SEC. These periodic reports, proxy statements and other information will be available on the website of the SEC referred to above. We also maintain a website at </font><font style="font-style:italic;letter-spacing:0.2pt;">carislifesciences.com</font><font style="letter-spacing:0.2pt;">, at which you may access these materials free of charge as soon as reasonably&#160;practicable after they are electronically filed with, or furnished to, the SEC. The information contained on, or that can be accessed through, our website is not a part of this prospectus. Investors should not rely on any such information in deciding whether to purchase our common stock. We have included our website address in this prospectus solely as an inactive textual reference.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">267</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a><a name="tITFS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:321.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INDEX TO FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Caris Life Sciences, Inc. and Subsidiaries</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:245.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:424pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Audited Consolidated Financial Statements </font>
                <br >
                <font style="letter-spacing:-0.2pt;">As of and for the Years Ended December&#160;31, 2024 and 2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fROIR"><font style="letter-spacing:0.2pt;">Report of Independent Registered Public Accounting Firm </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fROIR">F-2</a></font> <a href="#fROIR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fCBS"><font style="letter-spacing:0.2pt;">Consolidated Balance Sheets </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCBS">F-4</a></font> <a href="#fCBS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fCSOO"><font style="letter-spacing:0.2pt;">Consolidated Statements of Operations and Comprehensive Loss </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCSOO">F-5</a></font> <a href="#fCSOO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fCSOR"><font style="letter-spacing:0.2pt;">Consolidated Statements of Redeemable Convertible Preferred Stock and Shareholders&#8217; Deficit </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCSOR">F-6</a></font> <a href="#fCSOR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fCSOC"><font style="letter-spacing:0.2pt;">Consolidated Statements of Cash Flows </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCSOC">F-7</a></font> <a href="#fCSOC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fNTCF2"><font style="letter-spacing:0.2pt;">Notes to the Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fNTCF2">F-8</a></font> <a href="#fNTCF2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Financial Statements </font>
                <br >
                <font style="letter-spacing:-0.2pt;">As of and for the Three Months Ended March 31, 2025 and 2024</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fCBS1"><font style="letter-spacing:0.2pt;">Condensed Consolidated Balance Sheets </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCBS1">F-43</a></font> <a href="#fCBS1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fCSOO1"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Operations and Comprehensive Loss </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCSOO1">F-44</a></font> <a href="#fCSOO1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#fCSOR1"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Shareholders&#8217; Deficit </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCSOR1">F-45</a></font> <a href="#fCSOR1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fCSOC1"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Cash Flows </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCSOC1">F-46</a></font> <a href="#fCSOC1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#fNTCF12"><font style="letter-spacing:0.2pt;">Notes to the Condensed Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fNTCF12">F-47</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fROIR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the shareholders and the Board of Directors of Caris Life Sciences, Inc. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion on the Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have audited the accompanying consolidated balance sheet of Caris Life Sciences, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December&#160;31, 2024, the related consolidated statements of operations and comprehensive loss, redeemable convertible preferred stock and shareholders&#8217; deficit, and cash flows, for the year ended December&#160;31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2024, and the results of its operations and its cash flows for the year ended December&#160;31, 2024, in conformity with accounting principles generally accepted in the United States of America. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Going Concern</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note&#160;1 to the financial statements, the Company has redemptions in connection with the Series&#160;C preferred stock and debt payments in connection with the 2023 term loan and the 2025 convertible notes which raises substantial doubt about its ability to continue as a going concern. Management&#8217;s evaluation of the events and conditions and management&#8217;s plans in regard to these matters are also described in Note&#160;1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to this matter.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis for Opinion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ Deloitte &amp; Touche LLP </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">San Jose, California </font> <br ><font style="letter-spacing:0.2pt;">April 4, 2025 (June 9, 2025 as to the effects of the reverse stock split described in Note 2) </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have served as the Company&#8217;s auditor since 2024. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:138pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the Shareholders and Board of Directors of Caris Life Sciences, Inc. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion on the Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have audited the accompanying consolidated balance sheet of Caris Life Sciences, Inc. (the&#160;Company) as of December&#160;31, 2023, the related consolidated statements of operations and comprehensive loss, changes in redeemable convertible preferred stock and shareholders&#8217; deficit and cash flows for the&#160;year then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2023, and the results of its operations and its cash flows for the&#160;year then ended in conformity with U.S. generally accepted accounting principles. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis for Opinion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ Ernst &amp; Young LLP </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We served as the Company&#8217;s auditor from 2020 to 2024. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dallas, Texas</font>
        </div>
        <div style="margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">March&#160;18, 2024, except for the third paragraph of Note 2, as to which the date is June 9, 2025</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fCBS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">C</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">onsolidated Balance Sheets</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:7.30999999999995pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:7.05pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 1pt 0pt; width:344.26pt;" rowspan="2">
              <div style="white-space:nowrap; line-height:9pt; padding-bottom:0pt;">
                <font style="border-bottom:1px solid #000000;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands, except share data) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:9.1pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.05pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.05pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.07pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <font style="letter-spacing:-0.18pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.33pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.33pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.33pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.33pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">65,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.33pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.33pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">60,007</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.33pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Short-term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.33pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.33pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">2,201</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.33pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.33pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">65,184</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.34pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accounts receivable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.34pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.34pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">88,244</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.34pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.34pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">55,299</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.34pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Supplies </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.34pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.34pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">39,572</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.34pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.34pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">48,998</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:1.32pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.32pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.32pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">20,270</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.32pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.32pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">13,124</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.1pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.1pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">215,729</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.1pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">242,612</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.35pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.35pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.35pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">67,817</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.35pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.35pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">107,088</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.35pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Goodwill </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.35pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.35pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">19,344</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.35pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.35pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">19,344</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:1.34pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.34pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.34pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">40,844</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.34pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.34pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">43,856</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.09pt 0pt 1.205pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:-0.18pt;">Total assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.09pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.09pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">343,734</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.09pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.09pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">412,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.62pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <font style="letter-spacing:-0.18pt;">Liabilities, Redeemable Convertible Preferred Stock, and Shareholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.37pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.37pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.37pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.37pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">27,791</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.37pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.37pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">26,680</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.38pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.38pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.38pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">77,542</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.38pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.38pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">68,291</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:1.36pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Current portion of indebtedness </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.36pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.36pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">60,090</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.36pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.36pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">167</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.13pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.13pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.13pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">165,423</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.13pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.13pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">95,138</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.39pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Long-term indebtedness, net of debt discounts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.39pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.39pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">319,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.39pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.39pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">166,421</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.39pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Warrant and derivative liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.39pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.39pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">91,642</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.39pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.39pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">116,184</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:1.37pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Other long-term liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.37pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.37pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">44,418</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.37pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.37pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">54,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.15pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.15pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.15pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">620,921</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.15pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.15pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">432,566</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.4pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Commitments and contingencies (see note 10) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.4pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Redeemable convertible preferred stock: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.21pt 0pt 0.5pt 0pt; width:344.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Series&#160;A preferred stock. par value $0.001: 490,000,000 shares authorized as of December&#160;31, 2024 and December&#160;31, 2023; 485,795,293 shares issued and outstanding as of December&#160;31, 2024 and December&#160;31, 2023; and $296,335 aggregate liquidation preference as of December&#160;31, 2024 and December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">709,261</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">709,261</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.21pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Series&#160;B preferred stock, par value $0.001: 30,000,000 shares authorized as of </font>
                <br >
                <font style="letter-spacing:0.18pt;">December&#160;31, 2024 and December&#160;31, 2023; 29,629,630 shares issued and </font>
                <br >
                <font style="letter-spacing:0.18pt;">outstanding as of December&#160;31, 2024 and December&#160;31, 2023; and $16,000 aggregate </font>
                <br >
                <font style="letter-spacing:0.18pt;">liquidation preference as of December&#160;31, 2024 and December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">42,963</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">42,963</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.21pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Series&#160;C preferred stock, par value $0.001: 142,000,000 shares authorized as of </font>
                <br >
                <font style="letter-spacing:0.18pt;">December&#160;31, 2024 and December&#160;31, 2023; 116,200,835 shares issued and </font>
                <br >
                <font style="letter-spacing:0.18pt;">outstanding as of December&#160;31, 2024 and December&#160;31, 2023; and $408,715 and </font>
                <br >
                <font style="letter-spacing:0.18pt;">$381,908 aggregate liquidation preference as of December&#160;31, 2024 and December&#160;31, </font>
                <br >
                <font style="letter-spacing:0.18pt;">2023, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">408,715</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">381,908</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0.2pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt; margin-bottom:-0.503333333333343pt;">
                <font style="letter-spacing:0.18pt;">Series&#160;D preferred stock, par value $0.001: 102,600,000 shares authorized as of </font>
                <br >
                <font style="letter-spacing:0.18pt;">December&#160;31, 2024 and December&#160;31, 2023; 102,516,283 shares issued and </font>
                <br >
                <font style="letter-spacing:0.18pt;">outstanding as of December&#160;31, 2024 and December&#160;31, 2023; and $1,060,712 and </font>
                <br >
                <font style="letter-spacing:0.18pt;">$996,458 aggregate liquidation preference as of December&#160;31, 2024 and December&#160;31, </font>
                <br >
                <font style="letter-spacing:0.18pt;">2023, respectively </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0.2pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.2pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">1,060,712</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0.2pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.2pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">991,152</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.15pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total redeemable convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.15pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.15pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">2,221,651</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.15pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.15pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">2,125,284</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.4pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Shareholders&#8217; deficit: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Common stock $0.001 par value; 1,150,000,000 shares authorized as of December&#160;31, </font>
                <br >
                <font style="letter-spacing:0.18pt;">2024 and December&#160;31, 2023; 36,686,819 and 36,447,778 shares issued as of </font>
                <br >
                <font style="letter-spacing:0.18pt;">December&#160;31, 2024 and December&#160;31, 2023, respectively; 36,504,319 and 36,265,278 </font>
                <br >
                <font style="letter-spacing:0.18pt;">shares outstanding as of December&#160;31, 2024 and December&#160;31, 2023, respectively; </font>
                <br >
                <font style="letter-spacing:0.18pt;">shares issued and outstanding include 662,000 and 968,000 unvested shares subject to </font>
                <br >
                <font style="letter-spacing:0.18pt;">repurchase as of December&#160;31, 2024 and December&#160;31, 2023, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.21pt 0pt 0.5pt 0pt; width:344.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.77pt;">
                <font style="letter-spacing:0.18pt;">Treasury stock at cost, 182,500 shares of common stock as of December&#160;31, 2024 and December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.21pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.41pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.41pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Related party promissory note receivable (see note 7) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(26,456<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(25,701<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.41pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(2,472,300<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.41pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(2,119,175<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:1.4pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accumulated other comprehensive income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.4pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.4pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">210</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.4pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.4pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">218</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:1.15pt 0pt 0.5pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total shareholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.15pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.15pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">(2,498,838<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.15pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.15pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">(2,144,950<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.15pt 0pt 1.205pt 0pt; width:344.26pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:-0.18pt;">Total liabilities, redeemable convertible preferred stock, and shareholders&#8217; deficit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.15pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.15pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">343,734</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.15pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.15pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">412,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:9pt; margin-top:5.21pt; text-align:center; width:447pt; line-height:10.5pt;">
          <font style="letter-spacing:0.18pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fCSOO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:54pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">C</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">onsolidated Statements of Operations and Comprehensive Loss</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:535pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:9.25pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 2.5pt 0pt; width:331.17pt;" rowspan="2">
              <div style="white-space:nowrap; line-height:9pt; padding-bottom:0pt;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands, except share and per share data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">349,115</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">278,748</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">63,145</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">27,380</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total revenue</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">412,260</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">306,128</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Costs and operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">223,075</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">207,509</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">10,403</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">9,309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">152,602</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">142,925</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:331.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative expense (includes related party amounts of $1,869 and $2,061, for the&#160;years ended December&#160;31, 2024 and 2023, respectively) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">169,386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">149,053</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">113,916</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">116,883</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total costs and operating expenses</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">669,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">625,679</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Loss from operations</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(257,122<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(319,551<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other income (expense), net: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">7,122</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">11,258</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(50,025<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(31,610<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">18,484</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">11,094</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(12,606<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total other expense, net</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(24,768<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(21,864<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Loss before income taxes and provision for income taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Provision for income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other comprehensive (loss) income, net of tax: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Unrealized (loss) gain on available-for-sale securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(1,660<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign currency translation adjustments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(15<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">180</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Comprehensive loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(281,898<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(342,895<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Net loss attributable to common shareholders: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adjustments of redeemable convertible preferred stock to redemption value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(96,367<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(121,112<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss attributable to common shareholders</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(378,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(462,527<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share attributable to common shareholders, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(10.66<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(13.24<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.583pt 0pt; width:331.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted-average shares used in computing net loss per share attributable to common shareholders, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">35,496,832</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">34,942,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fCSOR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">C</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">onsolidated Statements of Redeemable Convertible Preferred Stock and Shareholders&#8217; Deficit</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:12pt;margin-bottom:213.85pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:382.05pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
          <tr style="line-height:7.87pt;height:27.2pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:0pt 0pt 2.66pt 0pt; width:133.2pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:7.88pt; padding-bottom:0pt;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.14pt;">(amounts in thousands, except share data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.66pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center; line-height:7.86pt;">
                <font style="letter-spacing:-0.14pt;">Redeemable Convertible </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.66pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.14pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.66pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.14pt;">Treasury Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.66pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.87pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.14pt;">Additional </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Paid-In </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.66pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.87pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.14pt;">Related </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Party </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Promissory </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Note </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Receivable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.66pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.87pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.14pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.66pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.87pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.14pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Comprehensive </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.66pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.87pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.14pt;">Total </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Shareholders&#8217; </font>
                <br >
                <font style="letter-spacing:-0.14pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:7pt;height:13.39pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.26pt 0pt 2.95pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.14pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.26pt 0pt 2.95pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.14pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.26pt 0pt 2.95pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.14pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.26pt 0pt 2.95pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.14pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.26pt 0pt 2.95pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.14pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.26pt 0pt 2.95pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.14pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:3.26pt 0pt 3.7pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.14pt;">Balances at December&#160;31, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:30pt; text-align:right; white-space:nowrap;">703,086,140</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,954,172</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:3pt solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">34,376,983</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; white-space:nowrap;">37</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">182,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:18pt; text-align:right; white-space:nowrap;">(24,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(1,678,549<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">1,698</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.26pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(1,702,113<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.98999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.767pt 0pt 2.383pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">15,241</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.767pt 0pt 2.383pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">15,241</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.583pt 0pt 0.5pt 0pt; width:133.2pt;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt;">
                <font style="letter-spacing:0.14pt;">Issuance of common stock upon exercise of </font>
                <br >
                <font style="letter-spacing:0.14pt;">stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">614,295</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">1,864</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">1,865</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.583pt 0pt 0.5pt 0pt; width:133.2pt;white-space:normal;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt;">
                <font style="letter-spacing:0.14pt;">Interest income from related party promissory notes </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">(732<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(732<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.583pt 0pt 0.5pt 0pt; width:133.2pt;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt;">
                <font style="letter-spacing:0.14pt;">Vesting of shares from early exercised stock </font>
                <br >
                <font style="letter-spacing:0.14pt;">options </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">306,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">4,958</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">4,958</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.583pt 0pt 0.5pt 0pt; width:133.2pt;white-space:normal;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt;">
                <font style="letter-spacing:0.14pt;">Adjustment of redeemable convertible preferred Series&#160;C and Series&#160;D to redemption value </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">121,112</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">(21,901<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(99,211<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(121,112<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.583pt 0pt 0.5pt 0pt; width:133.2pt;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt;">
                <font style="letter-spacing:0.14pt;">Conversion of convertible note into Series&#160;C </font>
                <br >
                <font style="letter-spacing:0.14pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">31,055,901</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.583pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.98999999999998pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:3.517pt 0pt 2.383pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">(1,480<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(1,480<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.98999999999998pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:3.517pt 0pt 2.383pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 2.383pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.52pt 0pt 2.95pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Foreign exchange gain </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:18pt; text-align:right; white-space:nowrap;">(162<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(162<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:3.27pt 0pt 3.7pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.14pt;">Balances at December&#160;31, 2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:30pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,125,284</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:3pt solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">35,297,278</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">182,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:18pt; text-align:right; white-space:nowrap;">(25,701<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(2,119,175<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">218</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.27pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(2,144,950<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.98999999999998pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.777pt 0pt 2.373pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">18,643</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.777pt 0pt 2.373pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">18,643</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.593pt 0pt 0.5pt 0pt; width:133.2pt;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt;">
                <font style="letter-spacing:0.14pt;">Issuance of common stock upon exercise of </font>
                <br >
                <font style="letter-spacing:0.14pt;">stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">239,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.593pt 0pt 0.5pt 0pt; width:133.2pt;white-space:normal;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt;">
                <font style="letter-spacing:0.14pt;">Interest income from related party promissory notes </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">(755<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(755<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.593pt 0pt 0.5pt 0pt; width:133.2pt;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt; line-height:8.38pt;">
                <font style="letter-spacing:0.14pt;">Vesting of shares from early exercised stock </font>
                <br >
                <font style="letter-spacing:0.14pt;">options </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">306,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">4,960</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">4,960</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.39pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:2.593pt 0pt 0.5pt 0pt; width:133.2pt;white-space:normal;text-align:left;">
              <div style="margin-left:7pt; text-indent:-7pt;">
                <font style="letter-spacing:0.14pt;">Adjustment of redeemable convertible preferred Series&#160;C and Series&#160;D to redemption value </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">96,367</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">(25,133<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(71,234<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.593pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(96,367<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.99000000000001pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:3.527pt 0pt 2.373pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.527pt 0pt 2.373pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.52pt 0pt 2.95pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.52pt 0pt 2.95pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:3.28pt 0pt 3.7pt 0pt; width:133.2pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.14pt;">Balances at December&#160;31, 2024</font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:30pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,221,651</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:3pt solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">35,842,319</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:6.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">182,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:18pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:18pt; text-align:right; white-space:nowrap;">(26,456<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(2,472,299<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">210</td>
            <td style="padding:0pt;padding-left:10.905pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.28pt 0pt 2.95pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(2,498,837<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fCSOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.2pt;">Consolidated Statements of Cash Flows</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:624.99pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:7.95pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 1.2pt 0pt; width:349.93pt;" rowspan="2">
              <div style="white-space:nowrap; line-height:9pt; padding-bottom:0pt;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.2pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:10.9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.95pt 0pt 1.2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.95pt 0pt 1.2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.95pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from operating activities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.19pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.19pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Adjustments to reconcile net loss to net cash used in operating activities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.19pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Depreciation and amortization </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">48,913</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">49,001</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.19pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">18,643</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.19pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,241</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.18pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Non-cash operating lease expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,601</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,332</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.18pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Amortization of debt discounts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,378</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.18pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(18,484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(11,094<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.18pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Loss on debt extinguishment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10,915</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.18pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Others </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(1,329<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.17pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.17pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(33,816<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(15,081<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.17pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Supplies </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,459</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(4,435<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.17pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(1,408<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.17pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.16pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.16pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.16pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">121</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.16pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.16pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(588<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.16pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.16pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.16pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(226<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.16pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.16pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,171</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.16pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.16pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.16pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">803</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.16pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.16pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1,260</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.91pt 0pt 0.75pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.91pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.91pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(245,199<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.91pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.91pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(276,100<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from investing activities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.15pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Maturities of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.15pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.15pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">61,376</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.15pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.15pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">300,488</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.15pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Purchases of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.15pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.15pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.15pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.15pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(63,395<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.15pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Purchases of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.15pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.15pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(8,444<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.15pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.15pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(22,319<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.9pt 0pt 0.75pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash provided by investing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.9pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.9pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">52,932</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.9pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.9pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">214,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from financing activities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.14pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Payments made on finance lease obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(157<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(743<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.14pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,865</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.14pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Payment of deferred offering costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(1,059<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.14pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.13pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from the 2023 term loan, net of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.13pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.13pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">199,978</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.13pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.13pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">191,310</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.13pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Payment of third-party debt issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.13pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.13pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.13pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.13pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,300<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.13pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Repayment of the Original Term Loans </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.13pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.13pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.13pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.13pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(180,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.88pt 0pt 0.75pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.88pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.88pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">200,292</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.88pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.88pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">10,132</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effect of exchange rate changes on cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">62</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.87pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net decrease in cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.87pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.87pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.87pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.87pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(51,132<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.12pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash at beginning of year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.12pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.12pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">60,007</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.12pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.12pt 0pt 1.2pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">111,139</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.87pt 0pt 0.75pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash at end of year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.87pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.87pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">68,028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.87pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.87pt 0pt 1.2pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">60,007</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Supplemental disclosure of cash flow information</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.11pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">49,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">15,776</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.11pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Supplemental disclosure of non-cash activity</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.11pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash paid for amounts included in the measurement of lease liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.11pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating cash flow used for operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11,297</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">12,062</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.1pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating cash flow used for finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">78</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.1pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Financing cash flow used for finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">157</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">743</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.1pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property and equipment included in accounts payable and accrued liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.1pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deferred offering costs, accrued but not yet paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">3,266</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">254</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.1pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Conversion of convertible debt to Series&#160;C Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.1pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.09pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Lease liabilities arising from obtained right-of-use-assets </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.09pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.09pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.09pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">725</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.09pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.09pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,782</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.09pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.09pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.09pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.09pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.09pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fNTCF2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 1. Nature of the Business</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Caris Life Sciences, Inc. (the &#8220;Company&#8221; or &#8220;Caris&#8221;) is a patient-centric, next-generation artificial intelligence (&#8220;AI&#8221;) TechBio company and precision medicine pioneer. The Company commercializes and develops innovative solutions to transform healthcare through the use of comprehensive molecular information, and machine learning (&#8220;ML&#8221;) algorithms. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s current molecular profiling services portfolio is focused on oncology and consists of MI Profile, a tissue-based molecular profiling solution, and Caris Assure, a novel, universal blood-based molecular profiling solution, with the aim to address the entire continuum of cancer treatment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company also collaborates with biopharmaceutical companies to provide commercial services and prospective and retrospective testing, along with data and bioinformatics collaborations and novel target identification and discovery solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company was incorporated under the laws of the Cayman Islands in November&#160;2011 (Caris Life Sciences, Ltd.) and re-domiciled to be incorporated in Texas in July&#160;2020 (Caris Life Sciences, Inc.) and is headquartered in Irving, Texas. The Company also has locations in Phoenix, Arizona; New York, New&#160;York; Cambridge, Massachusetts; Basel, Switzerland; and Tokyo, Japan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Going Concern</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of December 31, 2024, the Company&#8217;s cash balance was approximately $64.0 million, and the short-term investments balance was $2.2 million, and the Company has a 2023 Term Loan (see Note 8) outstanding with a balance of $400.0 million. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2025, the Company issued the 2025 Convertible Notes (see Note 15), in the amount of $30.0 million. In connection with the Company&#8217;s Series&#160;C redeemable convertible preferred stock, the 2023 Term Loan and the 2025 Convertible Notes, the following payments may become due within 12 months of the date of the issuance of the consolidated financial statements if, the Company has not completed an initial public offering raising at least $100.0 million in gross proceeds prior to such date: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Series&#160;C redemption rights will become exercisable on March&#160;31, 2026; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Company will be required to make a one-time acceleration payment on December 31, 2025 (see Note 15) in an amount equal to 15% of the outstanding principal amount under the 2023 Term Loan (or $60.0 million based on the principal amount currently outstanding) together with any applicable repayment premium and exit fee as described in the Term Loan agreement on such date; and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The 2025 Convertible Notes of $30.0 million will come due on January 1, 2026.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If these payments become due, the Company&#8217;s existing cash resources and projected operating cash flows may not be sufficient to repay these amounts and continue to fund operating activities for at least the next 12 months from the issuance of the consolidated financial statements. These conditions raise substantial doubt as to the Company&#8217;s ability to continue as a going concern. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Management intends to raise additional funding through an initial public offering raising at least $100.0 million in gross proceeds which would eliminate the requirement to make the one-time acceleration payment related to the 2023 Term Loan. Further, the initial public offering would cause the Series&#160;C redeemable convertible preferred stock and the 2025 Convertible Note to convert to common stock and thereby not be subject to redemption and repayment upon maturity on March&#160;31, 2026 and January&#160;1, 2026, respectively. Management may seek alternative private financing through additional debt or equity offerings that will fulfill its operating, capital and debt requirements for at least 12 months from the date of the issuance of the consolidated financial statements. However, the Company may not be able to complete such an initial public offering or otherwise secure such financing in a timely manner or on favorable terms, if at all.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 2. Summary of Significant Accounting Policies and Estimates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis of Financial Statement Presentation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements include the accounts of Caris and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASUs&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Effective June 1, 2025, the Company&#8217;s Board approved a one-for-four reverse stock split of the Company&#8217;s common stock. This also resulted in an adjustment to the conversion price for each series of the Company&#8217;s convertible preferred stock, to the underlying number of shares outstanding with respect to the restricted stock units, and to the exercise prices and number of shares of common stock underlying the outstanding stock options. Accordingly, all share and per share information relating to common stock for all periods presented in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted. The shares of common stock retain a par value of $0.001 per share. Accordingly, an amount equal to the excess was reclassified from common stock to additional paid-in capital or, in the absence of additional paid-in-capital, accumulated deficit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preparation of the consolidated financial statements in conformity with GAAP in the United States requires the use of estimates and assumptions about future events that affect the amounts reported in the Company&#8217;s consolidated financial statements and related notes, including the amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the periods reported. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Significant estimates and assumptions are used for, but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">revenue recognition </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fair value of stock-based awards and common stock </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fair value of financial assets and liabilities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Future events and their effects cannot be predicted with certainty. Accordingly, the accounting estimates require the exercise of judgment. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. The accounting estimates used in the preparation of the Company&#8217;s consolidated financial statements may change as new events occur, additional information is obtained, and the operating environment changes. The Company will evaluate and update the assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could materially differ from those estimates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reclassifications</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the preparation of the financial statements for the year ended December&#160;31, 2024, a reclassification was made to the prior period&#8217;s financial statements to conform to the current period&#8217;s presentation. This reclassification has no impact on previously reported net income attributable to common shareholders, total assets, or total liabilities. The details of the reclassifications is as follows: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of services was previously included under the caption &#8220;Cost of services&#8221; in the Consolidated Statement of Operations and Comprehensive Loss. Cost of services is now presented separately as Cost of services&#8212;Molecular profiling services and Cost of services&#8212;Pharma research and development services. The reason for the reclassification is to provide a clearer presentation of the Company&#8217;s operating expenses and enhance comparability with industry peers. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash, Cash Equivalents, and Restricted Cash</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company considers all highly liquid investments with original maturities of three&#160;months or less from date of acquisition to be cash equivalents. Refer to Note 4 for information on the Company&#8217;s restricted cash. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Marketable Securities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company classifies its marketable securities, which mainly consist of high-grade U.S. treasury bills, as available-for-sale. High-grade U.S. Treasury Bills with original maturities from date of acquisition between three and twelve&#160;months from the balance sheet dates are classified as short-term marketable securities, while those with maturities over twelve&#160;months from the balance sheet dates are classified as long-term marketable securities. The Company records all marketable securities at fair value, with changes reflected within unrealized gain or loss on available-for-sale securities on the consolidated statements of operations and comprehensive loss. The cost of short-term investments is adjusted for amortization of premiums or accretion of discounts to maturity, and such amortization or accretion is included in interest income. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign Currency Transactions and Translation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s operating international subsidiaries, Caris Life Sciences Switzerland Holdings GmbH and Caris K.K., use their respective local currencies as their functional currencies. Assets and liabilities for operations in local currency environments are translated to U.S. dollars at exchange rates on the last day of the reporting period. Income and expense items are translated at average rates of exchange prevailing during the reporting period. Transactions denominated in currencies other than the functional currency are remeasured based on the exchange rates at the time of the transaction. Cumulative translation adjustments are recorded as a component of accumulated other comprehensive loss. Transaction and translation gains and losses arising from intercompany balances are reported as a component of net loss and presented within the consolidated statements of operations and comprehensive loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue Recognition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes revenue under ASC Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). Revenue is recognized when control of goods and services are transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ASC 606 provides for a five-step model that includes: </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Step 1: Identify the contract(s) with a customer. </font> <br ><font style="letter-spacing:0.2pt;">Step 2: Identify performance obligations in the contract. </font> <br ><font style="letter-spacing:0.2pt;">Step 3: Determine the transaction price. </font> <br ><font style="letter-spacing:0.2pt;">Step 4: Allocate the transaction price to the performance obligations in the contract. </font><br ><font style="letter-spacing:0.2pt;">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. </font></div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company derives revenue from two distinct channels: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Molecular profiling services involving the provision of precision oncology solutions utilizing MI Profile and Caris Assure. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Pharma research and development services involving delivery of laboratory, strategic data, and research services to biopharmaceutical customers. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Profiling Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the majority of its molecular profiling services, the Company recognizes revenue from the sale of its precision oncology solutions, provided to customers, including certain hospitals, institutions and patients, at the point in time when the results of the profiling services are delivered to ordering physicians. Most cases requested on behalf of customers are provided without a written agreement; however, the Company determines that an implied contract exists with its customers for whom a physician orders the case. Results from molecular profiling services are delivered via fax, electronically, or in hard copy. Shipping and handling activities are considered fulfillment activities and as such, amounts incurred are recorded within Cost of services&#8212;Molecular profiling services on the consolidated statements of operations and comprehensive loss. The Company identifies each sale of the Company&#8217;s profiling service as a distinct performance obligation (&#8220;contract basis&#8221;). Payment terms are a function of a patient&#8217;s existing insurance benefits and applicable reimbursement contracts established between the Company and payers. Collection of consideration the Company expects to receive typically occurs within 90 to 120 days of billing. Occasionally, payers may recoup or we may refund consideration, mainly as a result of claim processing.</font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The total consideration to which the Company expects to be entitled in exchange for the Company&#8217;s services may be fixed or variable. Consideration includes reimbursement from patients, hospitals, and third-party commercial and governmental payers, such as insurance companies, adjusted for variable consideration related to implicit price concessions that the Company may grant. The Company estimates the variable consideration under a portfolio approach for third-party payers, hospitals and patients with similar reimbursement characteristics. This includes analysis of an average reimbursement per case per portfolio and a percentage of cases reimbursed by considering the historical reimbursement data (including any refunds and recoupments) from such third-party payers, hospitals and patients. Specifically, the Company calculates the historical average reimbursement rates for each portfolio and applies an estimated reimbursement rate, based on historical trends, to the number of cases delivered each period. The period for which historical data is drawn upon is determined on a by- portfolio basis for each payer group, taking into consideration the average collection period. Additionally, the estimate also considers current contractual and statutory requirements, patient insurance eligibility and payer reimbursement contracts, and any known current or anticipated reimbursement trends not reflected in the historical data and only recognizes revenue for variable consideration that the Company determines is probable will not result in a significant reversal in the future. The Company monitors the estimated amount to be collected at each reporting period based on actual cash collections in order to assess whether a revision to the estimate is required. Subsequent changes to the estimate of the transaction price are recorded as adjustments to molecular profiling services revenue in the period where such changes occur. Both the estimate and any subsequent revision are uncertain and require the use of management&#8217;s judgment in the estimation of the variable consideration and application of the constraint for such variable consideration. </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the remaining portion of its molecular profiling services, the Company has determined that collectability of the consideration to which it expects to be entitled is not probable, and thus does not recognize revenue for such services until it has provided the services to the customer and received nonrefundable consideration from the customer in exchange for the services (&#8220;non-contract basis&#8221;). The Company continually reassesses the likelihood of collection for these types of services. If collectability is deemed probable prior to receipt of consideration, then the Company recognizes revenue at the point in time that collection is deemed probable. For the&#160;year ended December&#160;31, 2023, the Company recorded $4.4&#160;million of revenue related to the transition of payers from non-contract basis to contract basis. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2024, all payers were on the contract basis. Molecular profiling services revenue recognized by contract type for the&#160;years ended December&#160;31, 2024 and 2023 was as follows: </font>
        </div>
        <table style="width:384pt;height:71pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:284.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:284.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:284.59pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:284.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services&#8212;contract basis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">349,115</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">240,119</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 0.5pt 0pt; width:284.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services&#8212;non-contract basis </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">38,629</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:284.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total molecular profiling services revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">349,115</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">278,748</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pharma Research and Development Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company collaborates with biopharmaceutical companies to provide commercial services and prospective and retrospective testing, along with data and bioinformatics collaborations and novel target identification and discovery solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Contracts with biopharmaceutical customers may include multiple distinct performance obligations, such as molecular profiling services, pharma research and development services, and strategic data services. The Company evaluates the terms and conditions included within its contracts with biopharmaceutical customers for proper revenue recognition, including whether services are capable of being distinct and considered distinct within the context of the contract. The performance obligations for biopharmaceutical customers vary by contract. Such contracts may include a performance obligation to provide molecular profiling services, to facilitate the development and regulatory approval of drugs, or to provide target discovery services. Under those contracts, the Company receives payments upon the achievement of milestones, as well as provision of on-going support. The transaction price of the development services contracts may include variable consideration, due to the uncertainty associated with the achievement of the milestones. In making the assessment of whether variable consideration should be included in the transaction price, the Company considers its historical experience with similar milestones, the degree of complexity and uncertainty associated with each milestone, and whether achievement of the milestone is dependent on parties other than the Company. The Company recognizes pharma research and development services revenue over the period in which biopharmaceutical research and development services are provided. Depending on the nature of the service, the Company recognizes revenue using either the output or input method to measure progress, whichever provides a more faithful depiction of the transfer of goods or services. Use of an output method or input method to depict the transfer of services generally does not result in a material difference with respect to the timing of revenue recognition because most services commence and end within the same reporting period. A constraint for variable consideration is applied such that it is probable a significant reversal of revenue will not occur when the uncertainty associated with the contingency is resolved. Application of the constraint for variable consideration is updated at each reporting period as a revision to the estimated transaction price. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Standalone Selling Price</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company determines standalone selling prices by considering the historical selling prices of its performance obligations in similar transactions, where applicable, as well as other factors, including, but not limited to, the price that customers in the market would be willing to pay, competitive pricing from other vendors, industry publications, current pricing practices and management estimates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Contract Balances</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period the Company delivers goods or provides services, or when the right to consideration is unconditional. In situations where revenue recognition occurs before invoicing, an unbilled receivable is created, which represents a contract asset. As of December&#160;31, 2024 and 2023, the unbilled receivable balance was $4.6 million and $6.6&#160;million, respectively, which is included in accounts receivable on the consolidated balance sheets. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes contract liabilities primarily related to payments received in advance of satisfaction of performance obligations from contracts with customers. Contract liabilities are relieved as the Company fulfills its obligations under the contract and revenue is recognized. As of December&#160;31, 2024 and 2023, the contract liability balance was $7.5 million and $6.2&#160;million, respectively, which is included in accrued expenses and other current liabilities on the consolidated balance sheets. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-left:36pt; margin-top:12pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table shows the changes in the contract liabilities during the period: </font>
        </div>
        <table style="width:416pt;height:108pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:327.78pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:327.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,190</td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:327.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Increase in contract liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,816</td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:327.78pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Revenue recognized during the period that was included in deferred revenues </font>
                <br >
                <font style="letter-spacing:0.2pt;">at the beginning of the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(5,406<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 1.833pt 0pt; width:327.78pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Revenue recognized from performance obligations satisfied within the same period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(6,130<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:327.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,470</td>
            <td style="padding:0pt;padding-left:21.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:13.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The amount of revenue recognized during the year ended December&#160;31, 2023 pertaining to amounts deferred as of December&#160;31, 2022 was $0.7&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Transaction Price Allocated to Remaining Performance Obligations</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transaction price allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes contract liabilities and non-cancelable amounts that will be invoiced and recognized as revenue in future periods and excludes performance obligations that are subject to cancellation terms. The Company has elected not to disclose information regarding the transaction price allocated to the remaining performance obligations for which the original expected duration of the contract is one year or less. The amount of transaction price allocated to the remaining performance obligations for contracts with original expected duration over one year as of December&#160;31, 2024 and 2023 was $5.8 million and $5.6&#160;million, respectively. The Company expects to recognize the amounts within twelve&#160;months from the respective balance sheet dates. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, for the&#160;years ended December&#160;31, 2024 and 2023, the Company recorded $3.9 million and $(1.9) million of adjustments to revenue related to services delivered in prior periods, which is based on variability that was subsequently resolved. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Practical Expedients and Contract Costs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Payment terms and conditions vary by contract and customer. In instances where the timing of the Company&#8217;s revenue recognition differs from the timing of its invoicing, the Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised services to the customer will be one year or less. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a practical expedient, the Company recognizes the incremental costs of obtaining contracts, such as sales commissions, as expenses when incurred, if the amortization period of the asset that the Company otherwise would have recognized for the capitalized costs is one year or less. Sales commissions are recorded within selling and marketing expense on the consolidated statements of operations and comprehensive loss. The Company did not capitalize any sales commissions or contract fulfillment costs for the&#160;years ended December&#160;31, 2024 and 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Collaboration agreements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company is party to various collaboration and licensing agreements under which the Company out-licenses certain know-how and molecular data. The collaboration arrangements are intended to solidify the Company&#8217;s third-party partnerships to align oncology capabilities and create industry-leading molecular oncology research platforms to accelerate drug development and novel research. Under these collaboration arrangements, the Company generally receives a split of fees from its collaborative partners that are earned pursuant to statements of work (&#8220;SOWs&#8221;) executed with end users of the Company&#8217;s licensed molecular data. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s collaboration and licensing agreements are within the scope of ASC Topic 808, Collaborative Arrangements (&#8220;ASC 808&#8221;) and ASC 606 because the counterparty to these agreements meets the definition of a customer. As such, the Company recognizes revenue earned from the licenses of molecular data granted to the Company&#8217;s collaborative partners in accordance with ASC 606. Each license of molecular data granted by the Company to a collaborative partner represents a distinct performance obligation in the contract. The transaction price for a given arrangement is entirely variable and depends on the SOWs executed by the counterparty with end users. The amount of revenue allocated to each license is equal to the amount of revenue to which the Company expects to be entitled. The Company recognizes revenue at the point in time that it delivers the molecular data to the third-party collaborative partner. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized collaboration revenue of $16.2&#160;million and $5.8&#160;million, respectively, which is included in revenue from pharma research and development services on the consolidated statements of operations and comprehensive loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cost of services&#8212;Molecular profiling services</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of services for molecular profiling services generally consists of cost of materials, direct labor including bonus and stock-based compensation, and equipment maintenance and depreciation&#160;expenses associated with processing cases (including accessioning, sequencing, quality control analyses and shipping charges to transport tissue samples), freight and profile results for ordering physicians. Costs associated with completing the molecular profiling services are recorded as the service is performed, regardless of when revenue is recognized with respect to the service. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cost of services&#8212;Pharma research and development services</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cost of services for pharma research and development services generally consists of cost incurred for the performance of the services requested by the Company&#8217;s biopharmaceutical customers related to the delivery of laboratory, strategic data and research services, and will vary depending on the nature, timing, and scope of customer projects. Costs associated with delivery pharma research and development services are recorded as incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Concentration of Credit Risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments that potentially expose the Company to concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company maintains its cash primarily with domestic financial institutions of high credit quality, with balances that exceed amounts insured by the Federal Deposit Insurance Corporation as of December&#160;31, 2024 and 2023, respectively. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company invests in treasury bills issued by the U.S. Government. U.S. treasury bills with original maturities of three&#160;months or less are classified within cash equivalents. Short-term marketable securities are comprised of U.S. treasury bills with original maturities between three and twelve&#160;months. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions. The goal of the Company&#8217;s investment policy is to ensure safety and preservation of the principal balance, and diversification of risk over cash balances held on deposit. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to credit risk from its accounts receivable. The majority of the Company&#8217;s accounts receivable arise from the provision of molecular profiling services and pharma research and development services and other, primarily with biopharmaceutical companies, all of which have high credit ratings. The Company has not experienced any material losses related to receivables from individual customers, or groups of customers. The Company does not require collateral. Accounts receivable are recorded net of allowance for credit losses, if any. Concentrations of credit risk are limited due to the number of payers and their dispersion across multiple geographic regions.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the years ended December 31, 2024 and 2023, the Company&#39;s revenues were primarily derived from the sale of the Caris molecular profiling services. As discussed above, payment terms of the services </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">are a function of a patient&#8217;s existing insurance benefits and applicable reimbursement contracts established between the Company and payers. Revenue associated with each payer, including its affiliated entities, as a percentage of the Company&#8217;s total revenue for the respective period, and accounts receivable balance attributable to each payer, including its affiliated entities, as a percentage of the Company&#8217;s total accounts receivable balance at the respective consolidated balance sheet date, are as follows: </font>
        </div>
        <table style="width:456pt;height:76pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:278.72pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% Revenue for the&#160;years </font>
                <br >
                <font style="letter-spacing:-0.16pt;">ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% Accounts receivable </font>
                <br >
                <font style="letter-spacing:-0.16pt;">as of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:278.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Major Payer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:278.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payer 1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">33.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">35.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">16.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">18.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:278.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payer 2 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">11.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">20.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:278.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payer 3 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">14.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">14.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">19.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.64pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:6.61pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:6.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents major payers below 10.0%. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, as of December&#160;31, 2024, one biopharmaceutical customer represented 22.3% of total accounts receivable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accounts Receivable</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accounts receivable includes billed and unbilled receivables, net of an allowance for expected credit losses. Accounts receivable primarily represent receivables from biopharmaceutical customers and third-party payers. Accounts receivable for pharmaceutical services are established based on the amounts outstanding per the contractual arrangements with biopharmaceutical customers. The Company applies the current expected credit loss standard in ASC Subtopic 326-20, </font><font style="font-style:italic;letter-spacing:0.2pt;">Financial Instruments&#8212;Credit Losses</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 326-20&#8221;) and reserves a portion of the accounts receivable based on assessment of the collectability of customer accounts at the time of revenue recognition. The Company regularly reviews the reserve by considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer&#8217;s ability to pay. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Receivables deemed to be uncollectible are written-off against the allowance for credit losses at the time such receivables are deemed to be uncollectible under a specific identification or estimated method. Recoveries of accounts receivable previously written off are recorded when received. As of December&#160;31, 2024 and 2023, the Company had an immaterial allowance for credit losses related to its accounts receivable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Supplies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Supplies consist primarily of laboratory items and reagents used by the Company in providing services. All supplies are raw materials and are stated at the lower of cost or net realizable value on a first-in, first-out basis. The Company periodically reviews its supplies for excess or obsolescence and writes down obsolete or otherwise unmarketable supplies to their estimated net realizable value. For the&#160;years ended December&#160;31, 2024 and 2023, the amount of write downs associated with the Company&#8217;s supplies was immaterial. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deferred Offering Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred offering costs consist primarily of accounting, legal, and other fees related to the Company&#8217;s proposed initial public offering (&#8220;IPO&#8221;). These costs are recorded as prepaid expenses and other current assets on the consolidated balance sheets. The deferred offering costs will be recorded against IPO proceeds upon the consummation of the IPO. In the event the planned IPO is terminated, the deferred offering costs will be expensed. The Company had $4.5&#160;million of deferred offering costs as of December&#160;31, 2024. Deferred offering costs were not material as of December&#160;31, 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment, Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company reports property and equipment at cost, net of accumulated depreciation, amortization, and any asset impairments. The cost of properties held under finance leases is equal to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">present value of lease payments not yet paid, adjusted for initial direct costs, prepaid lease payments and lease incentives received. Major improvements which add to productive capacity or extend the life of an asset are capitalized. Normal repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation and amortization are removed from the accounts, and any resulting gain or loss is reflected in the accompanying consolidated statements of operations and comprehensive loss for the period. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation and amortization expenses are calculated on a straight-line basis and applied to asset classes based upon the Company&#8217;s estimate of the asset class&#8217;s useful life, as summarized below: </font>
        </div>
        <table style="width:384pt;height:98.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:186.87pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Estimated Useful Life </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laboratory equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer equipment and software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Furniture and fixtures </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Aircraft </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements/leased buildings </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Lesser of remaining lease term or useful life </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leased equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Lesser of initial lease term or 5&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Computer equipment and software includes the purchases of hardware, software and capitalized labor costs associated with internally developed software. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company capitalizes purchased software which is ready-for-service and capitalizes qualifying internal software development costs incurred on significant projects. Capitalization of costs begins when two criteria are met: (1)&#160;the preliminary project stage is completed, management with relevant authority authorizes and commits to funding the software project, and (2)&#160;it is probable that the software will be completed and used for its intended function. Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. Costs related to preliminary project activities and post-implementation operating activities are expensed as incurred. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development costs and other computer software maintenance costs related to software development are expensed as incurred. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Capitalized software costs are included in property and equipment, net. These costs are amortized using the straight-line method over the estimated useful life of the underlying software, which is three&#160;years. The Company capitalized $1.1 million and $3.3&#160;million in development costs for internal use software for the&#160;years ended December&#160;31, 2024 and 2023, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is a lessee for various types of property and equipment. The Company determines if an arrangement is or contains a lease at inception by evaluating whether the contract contains an identified asset that the Company has the right to control the use of throughout the contract term. Lease classification as either an operating or finance lease is determined at the lease commencement date when the leased assets are made available for use. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon lease commencement, the Company recognizes a lease liability and right-of-use (&#8220;ROU&#8221;) asset. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make payments arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term, regardless of whether the lease is an operating or finance lease. Lease payments consist primarily of fixed payments under the arrangement, less tenant incentives, if any. For each lease, the Company first assesses&#160;whether the rate implicit in the lease is readily determinable. When the rate implicit in the lease is not readily determinable, the Company uses an estimate of its incremental borrowing rate (&#8220;IBR&#8221;) based on the information available at the lease commencement date in determining the present value of lease payments. In determining the appropriate IBR, the Company considers information including, but not limited to, its </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">credit rating, the lease term, collateral and the currency in which the arrangement is denominated. ROU assets are measured based on the corresponding lease liability adjusted for (i)&#160;prepayments made to the lessor at or before the commencement date, (ii)&#160;initial direct costs the Company incurs, and (iii)&#160;tenant incentives under the lease. Certain of the Company&#8217;s leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with recognizing and measuring the ROU asset and lease liability when it is reasonably certain the Company will exercise that option. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. Amortization expense for finance leases is recognized on a straight-line basis over the lease term, and interest expense for finance leases is recognized using the effective interest method. The Company presents operating lease payments within cash flows from operating activities on the consolidated statements of cash flows. The Company presents finance lease payments related to principal amounts within cash flows from financing activities and finance lease payments related to the interest on the lease liability within cash flows from operating activities on the consolidated statements of cash flows. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The presentation of the Company&#8217;s leases on the consolidated balance sheets depends on whether the lease is classified as an operating or finance lease. Operating lease ROU assets are included within other assets, the current portion of operating lease liabilities are included within accrued expenses and other current liabilities, and the long-term operating lease liabilities are included within other long-term liabilities. Finance lease ROU assets are included in property and equipment, net, the current portion of finance lease liabilities are included within current portion of notes payable, and long-term finance lease liabilities are included within long-term indebtedness, net of discounts. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company elected the practical expedient to not separate lease and non-lease components for its leases. The Company does not record leases on the consolidated balance sheet that have a lease term of twelve&#160;months or less at the lease commencement date. Refer to Note 9 for additional disclosures related to the Company&#8217;s lease arrangements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrant Liability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2020, the Company issued warrants and amended its outstanding warrants to include a provision to allow the purchase of either common stock or its Series&#160;C redeemable convertible preferred stock upon exercise. Because the warrants may be exercised for shares of the Company&#8217;s Series&#160;C redeemable convertible preferred stock, the warrants are classified as a liability pursuant to the guidance in ASC Topic 480, </font><font style="font-style:italic;letter-spacing:0.2pt;">Distinguishing Liabilities from Equity</font><font style="letter-spacing:0.2pt;">. The Company recognizes the liability associated with outstanding warrants within warrant and derivative liabilities on the consolidated balance sheets. The warrant liability is adjusted to fair value until such time as the warrants are no longer outstanding or the underlying securities are no longer redeemable outside the control of the Company. Changes in fair value of the warrant liability are reported within changes in fair value of financial instruments on the consolidated statements of operations and comprehensive loss. Refer to Note 8 for additional information about the warrant liability. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value Measurements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Fair value is defined as the exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions market participants would use in pricing an asset or liability. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The basis for these assumptions establishes a three-level fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Level&#160;1&#8212;</font><font style="letter-spacing:0.2pt;">Observable inputs such as quoted prices in active markets for identical assets and liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Level&#160;2</font><font style="letter-spacing:0.2pt;">&#8212;Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Level&#160;3</font><font style="letter-spacing:0.2pt;">&#8212;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Assets and liabilities measured at fair value are based on one or more of three valuation techniques. The three valuation techniques are as follows: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Market approach</font><font style="letter-spacing:0.2pt;">&#8212;Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Cost approach</font><font style="letter-spacing:0.2pt;">&#8212;Amount that would be required to replace the service capacity of an asset (i.e., replacement cost); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Income approach</font><font style="letter-spacing:0.2pt;">&#8212;Techniques to convert future amounts to a single present amount based on market expectations (including present value techniques, option-pricing models, and lattice models). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments consist of cash, cash equivalents, restricted cash, short-term marketable securities, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued expenses and other current liabilities, debt (see Note 8), warrants, and derivative instruments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2024 and 2023, the carrying amounts of the Company&#8217;s cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued expenses and other current liabilities approximate their fair value based on the short-term nature of these items. There were no transfers between Levels 1, 2 or 3 for the years ended December 31, 2024 and 2023.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used in such measurements were as follows: </font>
        </div>
        <table style="width:456pt;height:110.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:9.25pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 1pt 0pt; width:289.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;1 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;2 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;3 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:289.5pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Short-term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2,201</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,201</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Warrant liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">91,642</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">91,642</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,058</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,058</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:110.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:9.25pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:284.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;1 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;2 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;3 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:284.5pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:284.5pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Short-term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">65,184</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">65,184</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.5pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Warrant liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">98,733</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">98,733</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,451</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,451</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.19pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Short-term marketable securities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s short-term marketable securities, which have maturities of less than one year, are mainly comprised of U.S. treasury bills which have observable quoted prices. There were no outstanding U.S. Treasury Bills as of December 31, 2024. The following is a summary of the Company&#8217;s available-for-sale securities as of December 31, 2023: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <table style="width:456pt;height:68.5pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:9.25pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:266.97pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;height:31.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amortized</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Cost </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Gross</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unrealized</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Gain </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Gross</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unrealized</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Loss) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Estimated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:266.97pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:266.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">U.S. treasury bills </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">63,099</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:12.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">(12<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:8.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">63,092</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Warrant liability</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company utilized a probability-weighted scenario approach factoring in various exit strategies and the related timing of such to estimate the fair value of its warrant liability. For each scenario, the Company utilized a Black-Scholes option pricing model with the following assumptions: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Fair value per share of the underlying stock&#8212;</font><font style="letter-spacing:0.2pt;">The fair value of the underlying stock represents the fair value of the Company&#8217;s Series&#160;C preferred stock that the warrants are convertible into. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Volatility&#8212;</font><font style="letter-spacing:0.2pt;">The volatility is derived from historical volatilities of several unrelated publicly-listed peer companies, since the Company has no trading history. When making the selections of industry peer companies to be used in the volatility calculation, the Company considers the size, operational and economic similarities to the Company&#8217;s principal business operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Risk-free interest rate&#8212;</font><font style="letter-spacing:0.2pt;">The risk-free interest rate is based on U.S. treasury yield as of the measurement dates interpolated to match the maturity equal to the respective term to exit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividend yield&#8212;</font><font style="letter-spacing:0.2pt;">The expected dividend assumption is based on the Company&#8217;s current expectations about the Company&#8217;s anticipated dividend policy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected term (years)&#8212;</font><font style="letter-spacing:0.2pt;">Based on expected term under various exit strategies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The below table summarizes the significant unobservable inputs used in the fair value measurement of the warrant liability as of December&#160;31, 2024 and 2023: </font>
        </div>
        <table style="width:456pt;height:119.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:203.69pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:203.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:203.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">2018 </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:57.7pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">2018 </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:203.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value per share of the underlying stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$3.66&#8211;$5.65 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$3.66&#8211;$5.65 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:57.7pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$2.97&#8211;$8.14 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$2.97&#8211;$8.14 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:203.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">47.6%&#8211;63.0% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">61.2%&#8211;63.0% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:57.7pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">43.0% -55.0% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">50.0%&#8211;55.0% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:203.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4.2%&#8211;4.3% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4.3% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:57.7pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4.4%&#8211;5.3% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4.0%&#8211;5.3% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:203.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:57.7pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:203.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.29&#8211;0.75 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.29&#8211;2.25 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:57.7pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.5&#8211;1.72 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.5&#8211;3.25</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Derivative liability</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;18, 2023, the Company entered into a credit agreement (the &#8220;New Term Loan Agreement&#8221;) under which the Company issued senior, secured promissory notes (the &#8220;2023 Term Loan&#8221;) by which the New Term Loan lenders agreed to lend the Company up to an aggregate principal amount of $400.0&#160;million, $200.0&#160;million of which was received by the Company upon issuance. The Company identified certain embedded features in the 2023 Term Loan, including various contingent prepayment, compensatory payment, and default interest rate features, that are required to be bifurcated from the 2023 Term Loan and separately accounted for in the consolidated financial statements as a compound derivative liability. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Fair value of the derivative liability was estimated using the discounted cash flow method under the income approach. This approach involves significant Level&#160;3 inputs and assumptions including an estimated probability and timing of certain contingent events, such as events of default, change of control, sale of assets, etc. The analysis also required the selection of a discount rate representative of the Company&#8217;s credit risk. The discount rate used for the initial fair value was calibrated to the transaction. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The initial fair value of the derivative liability was $28.3&#160;million at the inception date of January&#160;18, 2023. As of December&#160;31, 2023, the fair value of the embedded derivative liability was $17.5&#160;million, resulting in a remeasurement gain of $10.8&#160;million reported within changes in fair value of financial instruments in the consolidated statements of operations and comprehensive loss. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Refer to Note 8 for additional information about the compound embedded derivative liability. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Debt</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of December 31, 2024, the estimated fair value of the 2023 Term Loan, excluding the bifurcated embedded derivative, was $380.9 million, compared to a carrying value of $373.1 million. As of December&#160;31, 2023, the estimated fair value of the 2023 Term Loan, excluding the bifurcated embedded derivative, was $176.1&#160;million, compared to a carrying value of $166.1&#160;million. The Company estimated the fair value of the 2023 Term Loan as of December&#160;31, 2024 based on a discounted cash flow analysis, and an income approach, which represented the use of Level&#160;3 inputs in the fair value hierarchy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities acquired through a business combination. The Company evaluates goodwill for impairment in accordance with ASC Topic 350, </font><font style="font-style:italic;letter-spacing:0.2pt;">Intangibles&#8212;Goodwill and Other</font><font style="letter-spacing:0.2pt;"> on an annual basis on October&#160;1, or more frequently if events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, or the Company may determine to proceed directly to the quantitative impairment test. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the Company assesses qualitative factors and concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount or if the Company determines not to use the qualitative assessment, then a quantitative impairment test is performed. The factors utilized in the qualitative assessment include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, and Company-specific events. The quantitative impairment test requires comparing the fair value of the reporting unit to its carrying value, including goodwill. The fair value of the reporting unit is determined based on the present value of estimated cash flows using available information regarding expected cash flows of each reporting unit, discount rates, and the expected long-term cash flow growth rates. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has identified that its business operates as a single operating segment which is also a single reporting unit for purposes of testing goodwill for impairment. An impairment exists if the fair value of the reporting unit is lower than its carrying value. If the fair value of the reporting unit is lower than its carrying value, the Company would record an impairment loss equal to the excess of the reporting unit&#8217;s carrying value over its fair value. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There were no impairment losses for the&#160;years ended December&#160;31, 2024 and 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities. The costs include direct costs for salaries and benefits, materials, contract services and other outside costs, and costs to acquire in-process research and development projects and technologies that have no alternative future use. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Advertising</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company expenses advertising costs as incurred. The Company incurred advertising costs of $1.2 million and $0.6&#160;million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Self-Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company offers medical insurance coverage to eligible employees under a self-insured program managed by a third-party administrator, leveraging stop-loss insurance policies to mitigate risk. The Company records an estimate of its liability for medical claims, which includes the incurred claims amount plus an estimate of incurred, but not reported claims. Self-insurance liability of $1.9 million and $1.8&#160;million for the&#160;years ended December&#160;31, 2024 and 2023, respectively, is included within accrued expenses and other current liabilities on the consolidated balance sheets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comprehensive Loss</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Comprehensive loss consists of net loss, unrealized gains on available-for-sale securities, foreign currency translation adjustments and gains affecting shareholders&#8217; deficit that under GAAP are excluded from net income or loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company accounts for stock-based compensation awards in accordance with ASC Topic 718, </font><font style="font-style:italic;letter-spacing:0.2pt;">Compensation&#8212;Stock Compensation</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 718&#8221;). Stock-based compensation expense is measured based on the fair value of the stock-based awards at the grant date for all stock-based awards to employees and non-employees and is recognized as expense over the requisite service period on a straight-line basis, which is generally the vesting period. Forfeitures are estimated using historical trends. Refer to Note 7 for additional information on the Company&#8217;s stock-based compensation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensated Absences</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When the Company&#8217;s obligation relating to employees&#8217; rights to receive compensation for future absences is attributable to employees&#8217; services rendered, the obligation relates to rights that vest or accumulate, payment is probable and amount can be reasonably estimated, a liability is recorded. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Loss Contingencies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company accounts for liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. Refer to Note 10 for additional information on the Company&#8217;s loss contingencies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Redeemable Convertible Preferred Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s redeemable convertible preferred stock is recorded outside of permanent equity because, while it is not mandatorily redeemable, it is redeemable at the option of the holders for cash upon the passage of time or the occurrence of certain events considered not solely within the Company&#8217;s control, such as a merger, acquisition, and sale of all or substantially all of the Company&#8217;s assets (each, a &#8220;deemed liquidation event&#8221;). The redeemable convertible preferred stock classified in mezzanine equity is subject to subsequent measurement under the guidance provided in the SEC Staff Announcement: Classification and Measurement of Redeemable Securities. In accordance with that guidance, the Company has elected to recognize changes in redemption value immediately as they occur through adjustments to the carrying amounts of the instruments at the end of the reporting period with the corresponding amount recorded to additional paid-in capital or, in the absence of additional paid-in-capital, accumulated deficit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treasury Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company records treasury stock purchases under the cost method by recording the entire cost of the acquired shares of common stock as treasury stock. In the case of re-issuance of treasury stock, amounts that exceed the acquisition cost will be recorded in additional paid-in capital. If the re-issuance </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">price is below the treasury stock&#8217;s acquisition cost and additional paid-in capital is insufficient to cover the difference between the acquisition cost and the re-issuance price, the shortfall will be recorded in accumulated deficit. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the Company decides to retire treasury stock, the Company will deduct the par value from common stock and reduce additional paid-in capital for any excess of cost over par value. If additional paid-in capital is insufficient, the Company reflects the shortfall in accumulated deficit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Net Loss per Share Attributable to Common Shareholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company calculates its basic and diluted net loss per share attributable to common shareholders in conformity with the two-class method required for companies with participating securities. Each series of the Company&#8217;s redeemable convertible preferred stock is considered to be a participating security because the preferred shareholders have a right to receive dividends on a pari&#160;passu basis with the Company&#8217;s common shareholders. The two-class method determines net income (loss) per share for each class of common stock and participating security according to dividends declared or accumulated and participating rights in undistributed earnings. The two-class method requires income (loss) available to common shareholders for the period to be allocated between common and participating securities based upon the respective rights of each to share in earnings as if all income (loss) for the period had been distributed. The participating securities are not required to participate in the losses of the Company, and therefore during periods of loss there is no allocation required under the two-class method between common and participating securities. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because the Company has reported a net loss for the&#160;years ended December&#160;31, 2024 and 2023, basic net loss per share attributable to common shareholders is calculated by dividing net loss attributable to common shareholders by the weighted-average common stock outstanding during the period, without consideration for potential common stock equivalents. Net loss attributable to common shareholders is equal to net loss, less accretion on preferred securities to their redemption value to the extent such securities are outstanding. Diluted net loss per share attributable to common shareholders is calculated by adjusting the weighted-average stock outstanding for the dilutive effect of potential common stock equivalents outstanding. For purposes of calculating the diluted net loss per share attributable to common shareholders, convertible preferred stock, convertible promissory notes, warrants, and stock options are considered to be potential common stock equivalents but are excluded from the calculation of diluted net loss per share attributable to common shareholders because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share attributable to common shareholders was the same for all periods presented. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income Taxes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company accounts for income taxes under the asset and liability method as set forth in ASC&#160;740 &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Income Taxes</font><font style="letter-spacing:0.2pt;">&#8221; &#8203;(&#8220;ASC 740&#8221;). Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. The calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across its global operations. The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related taxing authority. For tax positions not meeting the more likely than not test, no tax benefit is recorded. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At December&#160;31, 2024 and 2023, the Company has accumulated net operating loss carryforwards in both the U.S. and foreign jurisdictions, and no provision for income taxes is required. The Company&#8217;s deferred tax assets are subject to a full valuation allowance. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:22.49pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recently Adopted Accounting Pronouncements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2023, the FASB issued ASU No. 2023-07, </font><font style="font-style:italic;letter-spacing:0.2pt;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</font><font style="letter-spacing:0.2pt;">. This ASU requires disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analyses. The amendments require disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount and description of the composition for other segment items to reconcile to segment profit or loss, and the title and position of the Company&#8217;s CODM. The ASU also extends certain annual disclosures to interim periods. The Company elected to early adopt this ASU for its annual reporting period ending December&#160;31, 2023. There was no impact on the Company&#8217;s reportable segments identified and additional required disclosures have been included in Note 13. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recently Issued Accounting Pronouncements Not Yet Adopted</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2023, the FASB issued ASU No. 2023-09, </font><font style="font-style:italic;letter-spacing:0.2pt;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</font><font style="letter-spacing:0.2pt;"> which requires presentation of specific categories of reconciling items, as well as reconciling items that meet a quantitative threshold, in the reconciliation between the income tax provision and the income tax provision using statutory tax rates. The standard also requires disclosure of income taxes paid disaggregated by jurisdiction with separate disclosure of income taxes paid to individual jurisdictions that meet a quantitative threshold. For public business entities, the ASU is effective for annual periods beginning after December&#160;15, 2024, with early adoption permitted. For entities other than public business entities, the ASU is effective for annual periods beginning after December&#160;15, 2025. The amendments of the ASU should be applied on a prospective basis; however, entities have the option to apply retrospectively for each period presented. The Company does not expect the adoption of this new standard in 2026 to have an impact on its consolidated financial position, results of operations, or cash flow. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In November 2024, the FASB issued ASU No. 2024-03, </font><font style="font-style:italic;letter-spacing:0.2pt;">Income Statement- Reporting Comprehensive Income-Expense disaggregation disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses</font><font style="letter-spacing:0.2pt;">. This ASU requires disclosure of specified information about certain costs and expenses in the notes to financial statements. This ASU is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. We are currently evaluating the impact that this guidance will have on the disclosures within our financial statements, and expect to adopt this ASU for the year ending December 31, 2027.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 3. Consolidated Balance Sheet and Statement of Operations and Comprehensive Loss Components</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Prepaid Expenses and Other Current Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets consist of the following: </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December 31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,562</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,766</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,708</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">1,358</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.25pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total prepaid expenses and other current assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">20,270</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">13,124</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment, Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment, net consist of the following: </font>
        </div>
        <table style="width:456pt;height:156.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer equipment and software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">99,233</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">95,573</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laboratory equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">103,795</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">98,985</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Furniture and fixtures </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9,110</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,883</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements/Leased buildings </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">63,039</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">66,579</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Aircraft and leased equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">21,249</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">21,204</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">296,426</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">291,224</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation and amortization </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(228,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(184,136<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">67,817</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">107,088</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Total depreciation and amortization expense was $48.9 million and $49.0&#160;million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Out of the total depreciation expense, amortization associated with finance leases was $0.1 million and $0.5&#160;million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accrued Expenses and Other Current Liabilities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accrued expenses and other current liabilities consist of the following: </font>
        </div>
        <table style="width:456pt;height:171pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trade accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,680</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued payroll and employee medical </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,882</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,049</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued bonus </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,736</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,824</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current portion of early exercise stock option liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,957</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,957</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contract liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,470</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,676</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current portion of operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,080</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,420</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued interest on current portion of notes payable and convertible loan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,332</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">8,286</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">3,839</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">77,542</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">67,777</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Long-Term Liabilities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other long-term liabilities consist of the following: </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Long-term operating lease liabilities, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">38,651</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">44,099</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Long-term portion of early exercise stock option liability </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">5,767</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,724</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total other long-term liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">44,418</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">54,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Expense, Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other expense, net consists of the following: </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:367.78pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:367.78pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:367.78pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:367.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss on debt extinguishment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,915<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:367.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.21pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.21pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:367.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,606<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 4. Guaranty Agreement and Restricted Cash</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company entered into a Master Continuing Guaranty Agreement with Bank of America in 2011 to provide a guarantee for credit exposure related to the Company&#8217;s commercial bank accounts with Bank of America. The agreement was guaranteed through collateral accounts of $0.3&#160;million as of December&#160;31, 2024 and 2023. The agreement contains various customary affirmative and financial reporting obligations and is considered to be restricted cash, as the account is under a security deposit agreement. All obligations are in compliance with the terms of the agreement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company entered into a lease agreement with KCP NNN II Leasehold 4, LLC on July&#160;25, 2019 to lease 114,500 square feet of space in Irving, Texas. As part of the lease agreement, the Company delivered an unconditional, irrevocable letter of credit for $3.4&#160;million from a nationally recognized bank. The Company obtained this letter of credit and placed $3.4&#160;million in a security deposit account. As of December&#160;31, 2024 and 2023, amounts outstanding are $2.7 million and $3.1&#160;million, respectively, and are included within cash, cash equivalents, and restricted cash and other assets on the consolidated balance sheets. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The remaining restricted cash amounts are not material individually. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheet that sum to the total of the amounts shown in the consolidated statements of cash flows. Restricted cash is presented within cash, cash equivalents, and restricted cash and other assets on the consolidated balance sheets.</font>
        </div>
        <table style="width:456pt;height:96pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:175.5pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:179.09pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:175.5pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:179.09pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Consolidated balance sheet line item </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:175.5pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:179.09pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:175.5pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:179.09pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">63,950</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">56,402</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:175.5pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restricted cash&#8201;&#8211;&#8201;short term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:179.09pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,492</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,605</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:175.5pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restricted cash&#8201;&#8211;&#8201;long term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:179.09pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2,586</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:175.5pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:179.09pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">68,028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">60,007</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 5. Income Taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For financial reporting purposes, income before income taxes includes the following components: </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(283,720<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(339,724<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Foreign </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1,830</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company had no income tax expense or benefit for the&#160;years ended December&#160;31, 2024 or 2023. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The difference between income taxes expected at the U.S. federal statutory income tax rate of 21% and the reported income tax benefit are summarized as follows: </font>
        </div>
        <table style="width:456pt;height:188pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:354.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:354.89pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computed statutory benefit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(59,197<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(71,697<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">67,333</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">85,643</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">State taxes, net of federal benefit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,173<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(15,342<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Permanent differences </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,946</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,231</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Permanent difference&#8212;warrant fair value adjustment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,489<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(55<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Foreign rate differential </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(267<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adjustments to foreign NOL&#8217;s </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">117</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adjustments to state NOL&#8217;s </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(114<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(522<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adjustments to stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">137</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">671</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Rate change </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(68<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">775</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(58<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income tax benefit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows: </font>
        </div>
        <table style="width:456pt;height:307pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:349.93pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Deferred tax assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net operating loss carryforward </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">290,514</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">249,229</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,449</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,854</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,993</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,346</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest limitation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">35,614</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">26,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development credits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,842</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,842</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Intangibles </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">3,557</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">3,286</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lease obligation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11,601</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">13,038</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contractual allowances </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">16,867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">17,543</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,140</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">40,911</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property and equipment basis difference </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,796</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,249</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Others </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1,956</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1,621</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total deferred tax assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">434,329</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">366,646</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Deferred tax liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Right of use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(9,033<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(10,401<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Excess tax goodwill amortization </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(262<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(240<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Derivative liability fair value adjustment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(3,456<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(1,736<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Others </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(24<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total deferred tax liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(12,751<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(12,401<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(421,578<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(354,245<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net deferred tax asset (liability) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit the use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss over the three-year period ended December&#160;31, 2024. Such objective evidence limits the ability to consider other subjective evidence, such as the Company&#8217;s projections for future growth. On the basis of this evaluation, as of December&#160;31, 2024, a valuation allowance of $421.6&#160;million has been recorded to recognize only the portion of the deferred tax assets that is more likely than not to be realized. The amount of the deferred tax assets considered realizable, however, could be adjusted if additional objectively verifiable positive evidence materializes in future reporting periods, such as a demonstrated operating profitability. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The valuation allowances increased $67.3&#160;million and $85.6&#160;million during the fiscal&#160;years ended December&#160;31, 2024 and 2023, respectively, primarily due to increased U.S. federal and state net operating loss carryforwards. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has gross federal, state, and foreign net operating loss carryforwards of approximately $2,152 million which expire as follows: </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 2.167pt 0pt; width:246.76pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">(amounts in thousands)</font>
              <br >
              <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">Expiration Year </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:10pt;padding-right:10pt;letter-spacing:-0.16pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:10pt;padding-right:10pt;letter-spacing:-0.16pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:4pt;padding-right:4pt;letter-spacing:-0.16pt;">Foreign </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:14pt;padding-right:14pt;letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:246.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2024&#8211;2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">6,338</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,630</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,736</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">31,704</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:246.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2031&#8211;2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">209,538</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">289,839</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,913</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">501,290</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:246.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2041&#8211;2045 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">516,068</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">516,068</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:246.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Indefinite </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">934,839</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">168,226</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,103,065</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:246.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,150,715</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">985,763</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">15,649</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,152,127</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2018 through 2024 net operating losses do not expire under the Tax Cuts and Jobs Act of 2017, and are subject to the 80% of taxable income limitation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Federal tax laws impose substantial restrictions on the utilization of net operating loss and credit carryforwards in the event of an ownership change, as defined in Section&#160;382 of the Internal Revenue Code of 1986. Accordingly, the Company&#8217;s ability to utilize these carryforwards may be limited in the event of any such ownership change. We have completed a Section&#160;382 analysis for changes in ownership through December&#160;31, 2023 and continue to monitor for changes that could trigger a limitation. Based on this analysis, we do not expect to have any permanent limitations on the utilization of its federal net operating losses. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has U.S. federal and state tax research and development credit carryforwards of $2.8&#160;million as of December&#160;31, 2024 and 2023, with expiration dates through 2031 and 2026, respectively. The Company has recorded a full valuation allowance related to the credit carryforwards as of December 31, 2024.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to taxation in the United States and various states and foreign jurisdictions. As of December&#160;31, 2024, all loss&#160;years remain open to examination by the taxing authorities. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The recognition and measurement of certain tax benefits includes estimates and judgment by management that inherently involve subjectivity. Changes in estimates may create volatility in the Company&#8217;s effective tax rate in future periods and may be due to the expiration of various statutes of limitations, settlements with tax authorities, or acquisition of new information about particular tax positions that may require management to change its estimates. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;22, 2017, the Tax Cuts and Jobs Act (TCJA) created new taxes on certain foreign earnings. Namely, U.S. shareholders are now subject to current tax on global intangible low-taxed income (&#8220;GILTI&#8221;) earned by specified foreign subsidiaries. Available guidance related to GILTI provides for an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future&#160;years or provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. The Company has elected to recognize the current tax on GILTI as an expense in the period the tax is incurred. As of December&#160;31, 2024, the Company has a GILTI tax inclusion of $2.3&#160;million. As </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of December&#160;31, 2023, there is no GILTI tax inclusion. As of December&#160;31, 2024 and 2023, the Company had no undistributed earnings from its foreign subsidiaries due to losses generated since inception. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, TCJA includes a requirement to capitalize and amortize research and experimental expenditures beginning in 2022. Prior to 2022, the Company expensed these costs as incurred for tax purposes. The capitalization of the research and experimental expenditures resulted in a deferred tax asset of $52.1&#160;million and $41.9&#160;million as of December&#160;31, 2024 and 2023, respectively, which was offset by a valuation allowance, resulting in no significant impact to income tax expense for the&#160;years ended December&#160;31, 2024 and 2023. This deferred tax asset will be amortized over five&#160;years for the domestic costs and fifteen&#160;years for the foreign incurred costs. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company accounts for uncertainty in income taxes in accordance with ASC Topic 740, </font><font style="font-style:italic;letter-spacing:0.2pt;">Income Taxes</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 740&#8221;). Through December&#160;31, 2024, the Company has evaluated all tax positions for which the statute of limitations remained open, and the Company has not recognized any reserve for uncertain tax positions or any penalties or interest through the income statement or balance sheet as of December&#160;31, 2024. The Company has not recorded and does not expect any material changes to the liability for uncertain tax positions during the next 12&#160;months. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 6. Redeemable Convertible Preferred Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Redeemable convertible preferred stock as of December&#160;31, 2024 and 2023, consisted of the following: </font>
        </div>
        <table style="width:456pt;height:127.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:157.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:157.43pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">(amounts in thousands, except share and per </font>
              <br >
              <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">share amounts)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:50.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:7pt;padding-right:7pt;letter-spacing:-0.16pt;">Authorized </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:50.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Issued </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and </font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:5pt;padding-right:5pt;letter-spacing:-0.16pt;">Outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:46.91pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Original Issue </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price Per </font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:14pt;padding-right:14pt;letter-spacing:-0.16pt;">Share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:45.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Liquidation </font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:5pt;padding-right:5pt;letter-spacing:-0.16pt;">Preference </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:45.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Net Carrying </font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:13pt;padding-right:13pt;letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:157.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">490,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">485,795,293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.61</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">296,335</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">709,261</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:157.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">30,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">29,629,630</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.54</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">16,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">42,963</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:157.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;C Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">142,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">116,200,835</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.76</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">408,715</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">408,715</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:157.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;D Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">102,600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">102,516,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">8.10</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,060,712</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,060,712</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:157.43pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total redeemable convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">764,600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,781,762</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,221,651</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:127.5pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:157.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:157.43pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">(amounts in thousands, except share and per </font>
              <br >
              <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">share amounts) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:50.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:7pt;padding-right:7pt;letter-spacing:-0.16pt;">Authorized </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:50.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Issued</font>
                <br >
                <font style="letter-spacing:-0.16pt;">and</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:5pt;padding-right:5pt;letter-spacing:-0.16pt;">Outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:46.91pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Original Issue</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price Per</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:14pt;padding-right:14pt;letter-spacing:-0.16pt;">Share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:45.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Liquidation</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:5pt;padding-right:5pt;letter-spacing:-0.16pt;">Preference </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:45.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Net Carrying</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:13pt;padding-right:13pt;letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:157.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">490,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">485,795,293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.61</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">296,335</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">709,261</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:157.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">30,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">29,629,630</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.54</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">16,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">42,963</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:157.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;C Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">142,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">116,200,835</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.76</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">381,908</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">381,908</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:157.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;D Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">102,600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">102,516,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">8.10</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">996,458</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">991,152</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:157.43pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total redeemable convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">764,600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,690,701</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,125,284</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:12.7pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The rights, preferences, and privileges of the redeemable convertible preferred stock are as follows: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Voting Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On any matter presented to the shareholders of the Company for their action or consideration at any meeting of shareholders of the Company (or by written consent of shareholders in lieu of meeting), each holder of outstanding shares of preferred stock will be entitled to cast the number of votes equal to the number of whole shares of common stock into which the shares of preferred stock held by such holder are convertible as of the record date for determining shareholders entitled to vote on such matter. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Dividends</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All classes of preferred stock are entitled to receive dividends out of any assets legally available only when, as, and if declared by the Company&#8217;s board of directors, prior to and in preference to any declaration or payment of any dividend on the common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Liquidation Preference</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of shares of Series&#160;C and Series&#160;D preferred stock then outstanding will be entitled to be paid out of the assets of the Company available for distribution to its shareholders at an amount per share equal to the greater of (i)&#160;the Series&#160;C and Series&#160;D original issue price, plus (A)&#160;any dividends declared but&#160;unpaid thereon and (B)&#160;a 7.0% cumulative accruing dividend, compounding annually from the date of issuance of such share of Series&#160;C and Series&#160;D preferred stock, (ii)&#160;the amount that the holder of a share of Series&#160;C and Series&#160;D preferred stock would have received upon conversion to common stock, or (iii)&#160;solely with respect to the Series&#160;D preferred stock, 1.2 times the Series&#160;D original issue price. The Series&#160;A and Series&#160;B preferred stock are then paid on a pro&#160;rata, pari&#160;passu basis an amount equal to the greater of (i)&#160;the respective original issue price plus any dividends declared but unpaid thereon, and (ii)&#160;the amount that the holder of a share of Series&#160;A or Series&#160;B preferred stock, respectively, would receive upon conversion to common stock. The remaining proceeds will be distributed to the holders of common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Conversion Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The holders of the Company&#8217;s Series&#160;A, Series&#160;B, Series&#160;C and Series&#160;D preferred stock have the right to convert their shares into a number of fully paid and nonassessable shares of common stock as determined by dividing the respective Series&#160;A, Series&#160;B, Series&#160;C and Series&#160;D preferred stock original issue price by the conversion price in effect at the time. The initial conversion price of the Series&#160;A, Series&#160;B, Series&#160;C and Series&#160;D preferred stock was $0.61, $0.54, $2.76 and $8.10, respectively, and is subject to adjustment in accordance with anti-dilution provisions provided for in the Company&#8217;s Certificate of Formation. As of December&#160;31, 2024, each share of Series&#160;A, Series&#160;B, Series&#160;C and Series&#160;D preferred stock was convertible into 0.25 share of common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Redemption Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At any time on or after the fifth anniversary of the Series&#160;C and Series&#160;D original issue date, which will begin for Series&#160;C in August&#160;2025 and for Series&#160;D in May&#160;2026, upon written notice from the applicable shareholders, the Series&#160;C and Series&#160;D shares shall be redeemed by the Company at a price per share equal to the greater of (i)&#160;the original issue price plus (a)&#160;all declared by unpaid dividends thereon and (b)&#160;a 7.0% cumulative accruing dividend, compounding annually, or (ii)&#160;the fair market value as determined by an independent appraiser. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Anti-dilution</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to certain exceptions, the conversion price of the Series&#160;A and Series&#160;B preferred stock is subject to broad-based weighted average adjustment to prevent dilution in the event that the Company issues additional shares at a purchase price less than the then-applicable conversion price of the Series&#160;A and Series&#160;B preferred stock, respectively. Subject to certain exceptions, in the event the Company sells additional shares of stock at a price per share less that the Series&#160;C and Series&#160;D original issue price, the conversion price of the Series&#160;C preferred stock is adjusted to the lower price that the Company sells shares in such offering, and the conversion price of the Series&#160;D preferred stock is adjusted based on a broad-based weighted average anti-dilution formula. In the event the Company sells shares in an initial public offering, for less than 110.0% of the applicable Series&#160;C and Series&#160;D conversion price, then the Series&#160;C and Series&#160;D conversion price will be reduced (but never increased), concurrently with such issuance or deemed issuance, to 90.0% of the purchase price in such initial public offering. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 7. Shareholders&#8217; Equity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2024 and 2023, 1,150,000,000 shares of common stock with a $0.001 par value were authorized. There were 35,842,319 and 35,297,278 shares outstanding at December&#160;31, 2024 and 2023, respectively. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s shareholders. Common shareholders are entitled to receive dividends if and when declared by the Company&#8217;s board of directors, subject to the preferential dividend rights of any preferred stock then outstanding. No dividends have been declared or paid by the Company since its inception. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treasury Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the&#160;years ended December&#160;31, 2024 and 2023, the Company did not repurchase any shares of common stock. Previously repurchased common stock is shown on the consolidated balance sheets and consolidated statements of redeemable convertible preferred stock and shareholders&#8217; deficit as treasury stock. The Company had 182,500 shares of treasury stock as of December&#160;31, 2024 and 2023. These shares have not been retired. The Company has not reissued any shares of treasury stock as of December&#160;31, 2024 and 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2020 Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the 2020 Incentive Plan (the &#8220;Plan&#8221;), the Company may grant awards of options, restricted awards, performance awards or share appreciation rights to employees, consultants, and directors of the Company. A total of 24,824,360 shares of common stock are reserved for issuance upon the exercise of all awards granted or available to be granted under the Plan as of December&#160;31, 2024. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent permitted by applicable laws or any exchange rule, any shares of common stock issued under this Plan that are issued (a)&#160;in connection with the Company&#8217;s acquisition of an unaffiliated business entity, (b)&#160;to the employees of such entity, and (c)&#160;in substitution of equity incentive awards previously issued to such employees by such entity shall not reduce the number of shares of common stock available for issuance under the Plan. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Plan provides for a repurchase feature for vested stock-based awards at the option of the Company if the employee&#8217;s continuous service terminates for any reason, with or without cause, including death or disability. The repurchase shall be exercisable at a price equal to the fair market value of vested shares or, in the case of exercisable options, the fair market value of the common stock underlying such unexercised options less the aggregate exercise price of such options. The Company&#8217;s repurchase lapses when the Company&#8217;s common stock becomes publicly traded.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Option Activity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Plan, the Company has granted incentive stock options and non-qualified stock options to its employees and other service providers (non-employees). Most of the Company&#8217;s stock options vest incrementally over five&#160;years, subject to the grantee&#8217;s continuous employment with the Company (&#8220;time-vesting options&#8221;). The Company recognizes compensation cost on a straight-line basis over the requisite service period for its time-vesting options. In addition to its time-vesting options, the Company has also granted stock options to certain non-employees for which vesting is tied to the grantee&#8217;s performance (&#8220;performance-vesting options&#8221;). The Company evaluates whether it is probable that the performance metric will be achieved for its performance-vesting options and recognizes compensation cost on a straight-line basis over the implied service period if achievement of the performance metric is deemed probable. No option shall be exercisable after the expiration of 10&#160;years from the date it was granted. The exercise price of each option shall be not less than 100.0% of the fair market value of the common stock subject to the option on the date the option is granted. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the Company&#8217;s stock option activity during the year ended December&#160;31, 2024: </font>
        </div>
        <table style="width:456pt;height:171.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:256.04pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Options Outstanding </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:256.04pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Per Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Contract</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Term</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:256.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total outstanding as of December&#160;31, 2023: </font>
              </div>
            </td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">21,762,226</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.98</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.78</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">167,491</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:256.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,981,946</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">19.01</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:256.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(239,041<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.42</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,808</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:256.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cancelled/forfeited </font>
              </div>
            </td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(720,730<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.88</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,030</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:256.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expired </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(1,014,200<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2.44</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">16,316</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:256.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total outstanding as of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">21,770,201</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9.06</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">5.40</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">226,117</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:256.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total exercisable as of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">15,809,404</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.55</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">4.37</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">203,971</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:256.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total vested or expected to vest as of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">21,338,341</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.88</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.31</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt; width:5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">225,511</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:150.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:263.47pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Unvested/Vested Activity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:263.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Grant Date</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Life</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:263.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested outstanding, as of December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">7,553,377</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.75</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.48</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.54</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:263.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">1,981,946</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">19.01</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">12.37</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:263.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cancelled/forfeited </font>
              </div>
            </td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(574,050<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">14.71</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.59</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:263.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vested, outstanding shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:33pt; text-align:right; white-space:nowrap;">(2,302,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">12.14</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">5.90</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:263.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested outstanding, as of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:33pt; text-align:right; white-space:nowrap;">6,658,321</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">15.79</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.39</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.30</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.5pt 0pt; width:263.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Early exercised unvested, end of period </font>
              </div>
            </td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">662,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16.20</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.37</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Aggregate intrinsic value represents the difference between the estimated fair value of the underlying common stock and the exercise price of outstanding, in-the-money options. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The weighted average grant date fair value of options granted during the&#160;years ended December&#160;31, 2024 and 2023 was $12.37 and $9.52 per option, respectively. The total grant date fair value of options vested during the&#160;years ended December&#160;31, 2024 and 2023 was $13.5 million and $10.4&#160;million, respectively. The total intrinsic value of options exercised during the&#160;years ended December&#160;31, 2024 and 2023 was $2.8 million and $6.8&#160;million, respectively. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cash received for exercises of stock options during the&#160;years ended December&#160;31, 2024 and 2023 was $1.5 million and $1.9&#160;million, respectively. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2024, total unrecognized compensation cost related to unvested stock options was $49.0&#160;million. This amount is expected to be recognized as stock-based compensation expense in the consolidated statements of operations and comprehensive loss over a weighted average period of 3.3&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Modification to stock options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;9, 2021 and February&#160;23, 2022, the Company granted stock options to certain executives that are exercisable upon vesting for 331,250 shares and 2,000,000 shares of the Company&#8217;s common stock, respectively (the &#8220;Prior Stock Options&#8221;). The Prior Stock Options vested over five&#160;years. On August&#160;11, 2022, the Company&#8217;s Compensation Committee approved a modification to the Prior Stock Options, which was communicated to holders of the Prior Stock Options on September&#160;1, 2022. The </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">modification reduced the exercise price to $16.20 and modified the vesting conditions such that 20.0% vest upon grant, while the remainder vest over the following four&#160;years. The total number of grantees affected by this modification was twelve. The modification was not mandatory, but rather could be elected by holders of the Prior Stock Options on an individual holder basis. If the holder elected to participate, the holder&#8217;s Prior Stock Options were immediately canceled, and the Company issued the holder an equivalent number of new stock options in exchange (the &#8220;New Stock Options&#8221;) which could be early exercised prior to vesting. All of the holders elected to participate in the modification and exchanged their Prior Stock Options for New Stock Options. In addition, as an alternative to paying cash, holders of the New Stock Options that&#160;elected to exercise their options were able to pay for the exercise price by executing a full recourse promissory&#160;note with the Company that is secured by the holder&#8217;s restricted shares that are issued upon early exercise. Five grantees elected to early exercise utilizing the promissory note. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The principal of each note is equal to the exercise price of the New Stock Options. Interest on the unpaid balance will compound annually and accrue at a fixed rate per annum equal to the mid-term applicable federal rate in effect on the issuance of the note. The maturity date of the notes is the earlier of (1)&#160;December&#160;31, 2030 or (2)&#160;the occurrence of a change in control event, unless an acceleration event occurs sooner. An acceleration event would generally occur if required to ensure compliance with Section&#160;402 of the Sarbanes-Oxley Act of 2022, the termination of the holder&#8217;s employment, the insolvency of the holder or the breach of any warranty of the holder. The holder may elect to prepay the outstanding principal and accrued interest balance of the promissory note at any time without penalty. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the outstanding balance of the note becoming due and payable immediately, upon the occurrence of an acceleration event, if the holder defaults on payment of the note, then interest will accrue at the maximum rate permitted by applicable law. The Company will have full recourse against the holder for failure to pay the note as and when due. Such promissory notes will be secured by the restricted shares issued to the holder that are underlying the note. If the note is not repaid upon an event of default or acceleration event, the Company has the right to repurchase the restricted shares issued upon the exercise of the note for fair market value, which proceeds will apply to repayment of the note (with any remaining balance remaining due). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company accounted for the modification as a Type I (Probable to Probable) modification under ASC 718 that does not change the classification of the award (i.e., the New Stock Options continue to be classified within equity). The Company calculated the fair value of the Prior Stock Options and New Stock Options immediately prior to and after the modification using the Black-Scholes option pricing model. The incremental fair value was added to the original unrecognized compensation cost to arrive at the new unrecognized compensation cost, to be recognized over the remaining requisite service period. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unvested stock received from early exercises of the New Stock Options are subject to a right of repurchase at the lesser of (i)&#160;original issuance price or (ii)&#160;then-current fair market value in the event of the employee&#8217;s termination, either voluntary, or involuntary. The Company&#8217;s repurchase right with respect to these shares typically lapse over four&#160;years as the shares become vested. Early exercises of stock options are not deemed to be substantive exercises for accounting purposes and accordingly, consideration received for exercises of unvested stock options is initially recorded as a liability and subsequently reclassified into shareholders&#8217; deficit as the related shares vest. As of December&#160;31, 2024 and 2023, 662,000 and 968,000 shares from options exercised to date were subject to repurchase at a price of $16.20 per share. Of the amount subject to repurchase for the year ended December&#160;31, 2024 and 2023, $5.0&#160;million was recorded within other accrued expenses and current liabilities, respectively, and $5.8 million and $10.7&#160;million was recorded within other long-term liabilities on the consolidated balance sheets, respectively. In addition, as the early exercise was performed via issuance of a promissory note, a corresponding debt amount, plus related interest income was recorded as contra-equity. The total amount presented as contra-equity as of December&#160;31, 2024 and 2023 was $26.5 million and $25.7&#160;million, respectively, which includes interest income and the impact from exercises of both the vested portion of the New Stock Options and early exercises. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Restricted Awards Activity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2024, the Company granted to certain of its employees restricted stock&#160;units that will be settled in shares of the Company&#8217;s common stock upon vesting. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Vesting of the restricted stock&#160;units is contingent upon the Company completing either an initial public offering of its common stock or a change of control. The Company has determined that these performance conditions are not probable of being achieved, and thus has not recognized any compensation expense associated with its restricted stock&#160;units. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the Company&#8217;s restricted stock unit activity during the year ended December&#160;31, 2024: </font>
        </div>
        <table style="width:384pt;height:101.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:252.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Restricted Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Units </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average Grant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:252.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested as of December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">180,125</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">14.04</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:252.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">590,500</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">19.44</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:252.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vested </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:252.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cancelled/forfeited </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,125<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">19.11</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:252.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested as of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">762,500</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">18.19</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The total unrecognized compensation expense related to unvested restricted stock&#160;units as of December&#160;31, 2024 was $13.9&#160;million, which will be recognized upon the occurrence of an initial public offering or a change of control. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock-Based Compensation Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company recorded stock-based compensation expense in the consolidated statements of operations and comprehensive loss as follows: </font>
        </div>
        <table style="width:456pt;height:126pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:354.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:354.89pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,669</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,504</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,301</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,400</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,448</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,983</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">4,214</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">3,344</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">18,643</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">15,240</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:36pt; margin-top:13.2pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There was no tax benefit associated with the above stock-based compensation expense. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Valuation of Stock-Based Awards to Employees</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company records stock-based compensation expense for stock-based awards based on the estimated fair value of the awards on the date of the grant. The fair value of the Company&#8217;s restricted stock&#160;units is based on the fair value of the Company&#8217;s common stock at the date of grant. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company estimates the fair value of stock options using a Black-Scholes option pricing model. The absence of a public market for the Company&#8217;s common stock requires the Company&#8217;s board of directors to estimate the fair value of its common stock for purposes of granting options and for determining stock-based compensation expense by considering several objective and subjective factors, including contemporaneous third-party valuations, actual and forecasted operating and financial results, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, the rights and preferences of common and convertible preferred stock, transactions involving the Company&#8217;s common stock, and assumptions for a discount for lack of marketability. The fair value of the Company&#8217;s common stock was determined in accordance with the applicable elements of the American </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Institute of Certified Public Accountants Accounting and Valuations Guide, </font><font style="font-style:italic;letter-spacing:0.2pt;">Valuation of Privately Held Company Equity Securities Issued as Compensation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The key assumptions used in determining the fair value of options granted and a summary of the methodology applied to develop each assumption are as follows: </font>
        </div>
        <table style="width:384pt;height:97pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:246.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:246.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:56.87pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:56.87pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:246.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">62.5%&#8211;68.4% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">64.3%&#8211;77.2% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:246.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3.7%&#8211;4.6% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3.5%&#8211;4.4% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:246.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5.97&#8211;6.60 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5.90&#8211;7.50 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:246.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:246.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected forfeiture rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8.3%&#8211;8.5% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8.4%&#8211;8.6%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:6.31pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected volatility.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This is a measure of the amount by which the share price has fluctuated or is expected to fluctuate. An increase in the expected price volatility will increase the fair value of the option granted and the related compensation expense. As the Company is not publicly traded, the expected price volatility for the Company&#8217;s options was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the business corresponding to the expected term of the awards. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Risk-free interest rate.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for U.S. Treasury notes with maturities corresponding to the expected term of the awards. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected term.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This is the period of time over which the options granted are expected to remain outstanding and is based on the Company&#8217;s estimate, taking into consideration vesting term, contractual term and historical actual lives. Options granted have a maximum term of ten&#160;years. An increase in the expected life will increase the fair value of the option granted and the related compensation expense. Due to the lack of historical share option exercise data, the Company utilizes the simplified method for determining the expected term. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividend rate.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Company has not made any dividend payments, nor does it have plans to pay dividends in the foreseeable future. Therefore, an expected dividend yield of zero is utilized. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Forfeitures.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Forfeitures are estimated at the time of grant and reduce compensation expense ratably over the vesting period. This estimate is adjusted periodically based on the extent to which actual forfeitures differ, or are expected to differ, from the previous estimate. </font>
        </div>
        <div style="margin-top:11.52pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 8. Long-Term Debt</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The carrying value of debt presented within current portion of notes payable and long-term indebtedness, net of debt discounts on the consolidated balance sheets as of December&#160;31, 2024 and 2023 includes the following components:</font>
        </div>
        <table style="width:456pt;height:143pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:356.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:356.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:356.59pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:356.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Term loan Initial Draw&#8211;January&#160;18, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:356.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exit fee on term loan&#8211;January&#160;18, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:356.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Term loan Subsequent Draw&#8211;March&#160;5, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:356.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exit fee on term loan&#8211;March&#160;5, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:356.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: Amortized debt discounts and financing costs</font><font style=" position:relative; bottom:4.25pt;line-height:6.5pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(30,863<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(35,893<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:356.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net debt </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">373,137</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">166,107</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.5pt 0pt; width:356.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Compound bifurcated derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">6,058</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">17,451</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:20.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes debt discounts of $28.3&#160;million associated with the initial carrying value of compound bifurcated derivative liability. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Maturities of the Company&#8217;s debt are expected to be as follows as of December&#160;31, 2024: </font>
        </div>
        <table style="width:384pt;height:98.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:334.29pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Years Ending December&#160;31, </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">2025</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2026 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">340,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents 15% of the outstanding principal amount under the 2023 Term Loan Agreement, which is due on the earlier of (x)&#160;for dates prior to January&#160;1, 2026, any date that the redemption rights in respect of our Series&#160;C preferred stock or Series&#160;D preferred stock are or may become exercisable within 90&#160;days following such date, or (y)&#160;January&#160;1, 2026 or the first date thereafter if, as of such date, the redemption rights in respect of our Series&#160;C preferred stock or Series&#160;D preferred stock are or may become exercisable on or prior to the date that is six&#160;months after the maturity date. The Series&#160;C preferred stock redemption rights may be exercised on or after August&#160;14, 2025. All outstanding shares of our Series&#160;C preferred stock and Series&#160;D preferred stock will convert into shares of common stock as part of the Preferred Stock Conversion and any redemption rights thereunder will terminate in connection with the completion of this offering and consequently, the payments disclosed herein would not be applicable. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Term Loan Refinancing</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;21, 2018, the Company entered into a secured term loan agreement (the &#8220;Original Term Loan Agreement&#8221;) with Sixth Street Specialty Lending, Inc. and Barnett Debt Holdings, LLC (collectively, the &#8220;Original Term Loan Lenders&#8221;), which provided the Company with an initial term loan of $50.0&#160;million (the &#8220;2018 Term Loan&#8221;) and a delayed term loan draw option of $50.0&#160;million, which the Company drew down in full on October&#160;4, 2019 (the &#8220;2019 Term Loan&#8221;). On April&#160;2, 2020, the Company amended the Original Term Loan Agreement (the &#8220;Amended Term Loan Agreement&#8221;) to obtain additional term loan proceeds of $75.0&#160;million (the &#8220;2020 Term Loan&#8221; and collectively with the 2018 Term Loan and the 2019 Term Loan, the &#8220;Original Term Loans&#8221;). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;18, 2023, the Company entered into the New Term Loan Agreement with OrbiMed Royalty &amp; Credit Opportunities III, LP, OrbiMed Royalty &amp; Credit Opportunities IV, LP (collectively, &#8220;OrbiMed&#8221;), and Braidwell Transaction Holdings LLC (&#8220;Braidwell&#8221;, and collectively with OrbiMed, the &#8220;New Term Loan Lenders&#8221;). Pursuant to the New Term Loan Agreement, the Company issued senior, secured promissory notes by which the New Term Loan Lenders agree to lend the Company up to an aggregate principal amount of $400.0&#160;million, $200.0&#160;million of which was received by the Company upon issuance (the &#8220;Initial Draw&#8221;), and the remaining $200.0&#160;million was received by the Company in March 2024 (the &#8220;Delayed Draw&#8221;). Net cash proceeds from the 2023 Term Loan were $200.0 million and $187.0&#160;million after deducting customary debt discounts and debt issuance costs for the years ended December 31, 2024 and 2023, respectively. The net cash proceeds in 2023 from the 2023 Term Loan were used to repay in full the Original Term Loans (with an aggregate principal amount of $175.0&#160;million), including a prepayment premium of $5.0&#160;million and accrued and unpaid interest of $1.0&#160;million. A loss on debt extinguishment of $10.9&#160;million, reflecting the difference between the cash paid to settle the Original Term Loans and the net carrying amounts of the Original Term Loans, was recognized in other expense, net on the consolidated statements of operations and comprehensive loss for the year ended December&#160;31, 2023. As of December&#160;31, 2023 and onwards, the Company has no continuing obligations associated with the Original Term Loans. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:1.63999999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Until the earlier of December&#160;31, 2024 or the date on which the 2024 Term Loan amount was fully drawn, which occurred on March 5, 2024, the undrawn balance of the New Term Loan Commitment was subject to a fee of 0.5% per annum. The outstanding principal amount of the 2023 Term Loan is due and payable on January&#160;18, 2028. If an event of default occurs and is continuing, the New Term Loan Lenders may declare all amounts outstanding under the New Term Loan Agreement to be immediately due and payable. A final payment exit fee equal to 1.0% of the amount funded under the New Term Loan Agreement is due upon prepayment or maturity. Amounts borrowed pursuant to the New Term Loan Agreement may be prepaid at any time. Upon prepayment, the Company is subject to a prepayment penalty based on the timing of repayment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The 2023 Term Loan bears interest at a rate per annum equal to a fixed margin of 6.5% plus the greater of (a)&#160;forward-looking three-month secured overnight financing rate (&#8220;SOFR&#8221;) and (b)&#160;2.5%. In the event of default, the fixed margin shall increase by 3.0% per annum. As of December&#160;31, 2024, the interest rate was 11.1%. Regular quarterly payments are interest-only for the 60-month term of the New Term Loan Agreement, with the principal due at maturity. The effective interest rate for the Initial Draw of the 2023 Term Loan is 17.0%, and the effective interest rate for the Delayed Draw of the 2023 Term Loan is 12.0%. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s obligations under the New Term Loan Agreement are secured by a first lien security interest in substantially all of the assets of the Company and its subsidiaries. The New Term Loan Agreement contains certain customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default applicable to the Company and its subsidiaries. Additional covenants include those restricting dispositions, fundamental changes to its business, mergers or acquisitions, indebtedness, encumbrances, distributions, investments, transactions with affiliates and subordinated debt. At December&#160;31, 2024, the Company is in compliance with all covenants. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company identified multiple embedded derivatives that require bifurcation from the 2023 Term Loan. They are separately accounted for in the consolidated financial statements as one compound derivative liability. Those embedded features include various contingent prepayment and compensatory payment features as well as interest rate increases upon an event of default. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Convertible Loan Conversion</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the Original Term Loan Agreement dated September&#160;21, 2018, the Company issued $50.0&#160;million of convertible notes to the Original Term Loan Lenders pursuant to a convertible loan agreement (the &#8220;Convertible Loan Agreement&#8221;) with interest accruing at a rate of 8.0% per annum (the &#8220;2018 Convertible Loan&#8221;). The Original Term Loan Lenders had the option on each interest payment date to receive interest in cash or in kind in the form of additional term loan principal issued pursuant to the terms of the Convertible Loan Agreement. As of December&#160;31, 2022, the effective interest rate on the 2018 Convertible Loan was 9.4%. Following the amendment to the Convertible Loan Agreement in 2020, the Original Term Loan Lenders obtained the right to convert all or a portion of the principal amount of the 2018 Convertible Loan and any accrued but unpaid interest thereon (the &#8220;Convertible Amount&#8221;) into either Series&#160;C preferred stock or common stock at a conversion price of $1.61 or $6.44 per share (subject to certain anti-dilution adjustments), respectively. However, the maximum aggregate Convertible Amount that the Original Term Loan Lenders may convert without the Company&#8217;s consent is $50.0&#160;million. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2023, the Original Term Loan Lenders exercised the conversion right and converted the maximum $50.0&#160;million Convertible Amount into 31,055,901 shares of Series&#160;C preferred stock. In connection with the conversion of the 2018 Convertible Loan, the Company also paid cash of $3.0&#160;million to the Original Term Loan Lenders in settlement of accrued but unpaid interest on the Convertible Loan. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interest Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The components of interest expense associated with the Company&#8217;s long-term indebtedness, excluding finance leases, are as follows: </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:354.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:354.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:354.89pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Debt discount amortization </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,052</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,378</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:354.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">42,938</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">26,157</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:354.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense on long-term indebtedness, excluding finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">49,990</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">31,535</td>
            <td style="padding:0pt;padding-left:2.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.49pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrant Liability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As part of the Original Term Loan Agreement, the Company issued 13,694,623 warrants (the &#8220;2018 Warrants&#8221;). In connection with the amendment to the Original Term Loan Agreement in 2020, the Company issued an additional 11,399,814 warrants (the &#8220;2020 Warrants&#8221;) and amended the 2018 Warrants. Furthermore, these amendments also permit the exercise of both the 2018 Warrants and 2020 Warrants into Series&#160;C preferred stock or common stock at the option of the holder. The 2018 Warrants are exercisable into Series C preferred stock at a price of $1.61 and into common stock at a price of $6.44. The 2020 Warrants are exercisable into Series C preferred&#160;stock at a price of $1.93 and into common stock at a price of $7.73. As a result of the amendment to permit exercise of the warrants into redeemable preferred stock, the warrants are classified as a liability pursuant to the guidance in ASC 480. Therefore, the warrants are reported at fair value within warrant and derivative liabilities on the consolidated balance sheets, with changes in fair value reported within changes in fair value of financial instruments on the consolidated statements of operations and comprehensive loss. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table reflects the changes in fair values associated with these warrants. </font>
        </div>
        <table style="width:456pt;height:80.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:259.18pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:86.41pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2018 Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:86.41pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Warrants granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">13,694,623</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">11,399,814</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercise price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$1.61</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$1.93</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:259.18pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercise period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Earlier of 7&#160;years from the date of issuance, </font>
                <br >
                <font style="letter-spacing:0.2pt;">or immediately after closing IPO </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:259.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value at date of issuance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 0.833pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$0.8&#160;million</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 0.833pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$7.9&#160;million</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:84.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value at December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">54,498</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">44,498</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Increase / (decrease) in fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(305<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value at December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">54,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">44,193</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Decrease in fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(2,911<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(4,180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value at December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">51,629</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">40,013</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.5pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 9. Leases</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company enters into various building leases for office, lab and other uses. Additionally, certain of the Company&#8217;s arrangements to utilize data centers represent a lease. These leases are generally considered operating leases. The Company is obligated to make total fixed payments over the lease terms. Some of these arrangements include options to extend the leases. The Company determined that given the length of time between lease commencement and the renewal period, and the uncertainty of business and market conditions in the future, it is not reasonably certain that the renewal options will be exercised. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:85.12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has also entered into various information technology equipment leases. Certain of these leases are classified as operating leases and others are classified as finance leases, based on the terms of each lease arrangement. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lease assets and liabilities are reflected in the Company&#8217;s consolidated balance sheets as follows: </font>
        </div>
        <table style="width:456pt;height:236pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:157.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:196.86pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.75pt 0pt 2pt 0pt; width:157.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">Leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt; width:196.86pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:39pt;padding-right:39pt;letter-spacing:-0.16pt;">Consolidated balance sheet line item </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:8pt;padding-right:8pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:8pt;padding-right:8pt;letter-spacing:-0.16pt;">2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:157.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:196.86pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:157.73pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Assets </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:196.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:157.73pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:196.86pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other assets </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">34,950</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">40,426</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:157.73pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:196.86pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:157.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total lease assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:196.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">34,990</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">40,549</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 1pt 0pt; width:157.73pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Liabilities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:196.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:157.73pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:196.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:157.73pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:196.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,080</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,420</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:157.73pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:196.86pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current portion of notes payable </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">90</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">167</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:157.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total current lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:196.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,587</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 1pt 0pt; width:157.73pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:196.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:157.73pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:196.86pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other long-term liabilities </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">38,651</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">44,099</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2pt 0pt; width:157.73pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2pt 0pt; width:196.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Long-term indebtedness, net of debt discounts </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">243</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">315</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:157.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total non-current lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:196.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">38,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">44,414</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:157.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:196.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">45,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">51,001</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Total lease cost reflected in the consolidated statements of operations and other comprehensive loss were as follows: </font>
        </div>
        <table style="width:456pt;height:168pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:9.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:192pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Consolidated statement of operations </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and comprehensive loss line item</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:152.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">Lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:16pt;padding-right:16pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:6pt;padding-right:6pt;letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:152.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:192pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1px 0pt; width:152.59pt;text-align:left;">
              <div style="white-space:nowrap; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Operating lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:192pt;text-align:left;">
              <div style="white-space:nowrap; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1px 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1px 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">1,607</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1px 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1px 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,935</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:152.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Pharma research and </font>
                <br >
                <font style="letter-spacing:0.2pt;">development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:192pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">General and administrative expense </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">6,738</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8,037</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:192pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Research and development expense </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">2,416</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,116</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Finance lease cost: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:192pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Amortization of ROU assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:192pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">General and administrative expense </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">128</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:152.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest on lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:192pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Interest expense </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:32.25pt; text-align:right; white-space:nowrap;">37</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">78</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:152.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total finance lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:192pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:32.25pt; text-align:right; white-space:nowrap;">165.22463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">578</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-left:36pt; margin-top:12pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below presents additional information related to the Company&#8217;s leases. </font>
        </div>
        <table style="width:384pt;height:121pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.57pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.57pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:275.57pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Weighted average remaining lease terms</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:275.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8.04&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8.43&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:275.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3.28&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3.49&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:275.57pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Weighted average discount rate</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:275.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">11.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">11.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:275.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">10.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">10.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.255pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company was not party to any short-term leases, and variable lease costs were immaterial for the&#160;years ended December&#160;31, 2024 and 2023. As of December&#160;31, 2024 and 2023, the Company does not have any additional operating and finance leases that have not yet commenced. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth by year, maturities of operating and finance lease liabilities as of December&#160;31, 2024: </font>
        </div>
        <table style="width:384pt;height:168.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 2.167pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Operating</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:7pt;padding-right:7pt;letter-spacing:-0.16pt;">Leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Finance</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:2pt;padding-right:2pt;letter-spacing:-0.16pt;">Leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:9pt;padding-right:9pt;letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:249.92pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Years Ending December&#160;31, </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10,718</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">117</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10,835</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2026 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10,071</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">118</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10,189</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">7,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">117</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">7,199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,461</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">35</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,496</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thereafter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,671</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,671</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total lease payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">69,312</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">388</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">69,699</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less imputed interest </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(24,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(55<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(24,635<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:249.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Present value of lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">44,731</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">333</td>
            <td style="padding:0pt;padding-left:3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">45,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 10. Commitments and Contingencies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Purchase Obligations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company enters into various supply agreements that contains purchase commitments. Most of the commitments are based on a binding forecast for an agreed-upon period, which is 12-month or less. Future minimum purchase commitments under such agreements amount to $7.7&#160;million, of which all are due in 2025. The total amount of supplies purchased during 2024 under such agreements was $32.3&#160;million. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, in 2022, the Company entered into an arrangement for cloud computing services with non-cancellable purchase commitments for three&#160;years. The agreement was subsequently amended in 2024. For the&#160;years ended December&#160;31, 2024 and 2023, the Company purchased cloud computing services of $9.9&#160;million and $3.0&#160;million, respectively, related to non-cancelable arrangements. Under the agreement, the Company has purchase obligations of $11.3&#160;million, $12.4&#160;million and $13.7&#160;million for&#160;years ending December&#160;31, 2025, 2026 and 2027. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Corporate Liability and Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains professional liability, general liability, and other customary insurance on a claims-made basis in amounts deemed appropriate by the Company&#8217;s management based upon historical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">claims and the nature and risks of the Company. The Company&#8217;s business may subject the Company to litigation and liability for damages. The Company believes that current insurance protection is adequate for present business operations, but there can be no assurance that the Company will be able to maintain professional and general liability insurance coverage in the future or that such insurance coverage will be available on acceptable terms or adequate to cover any or all potential product or professional liability claims. A successful liability claim in excess of insurance coverage could have a material adverse effect on the Company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Litigation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">During the ordinary course of business, the Company has become and may in the future become subject to pending and threatened legal and regulatory actions and proceedings. While it is not feasible to predict or determine the ultimate outcome of these matters, the Company believes that none of its current legal proceedings will have a material adverse effect on its financial position, results of operations, or cash flows for&#160;years ended December&#160;31, 2024 and 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 11. Related Parties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s officers and directors have ownership interests in certain vendors providing services to the Company. During the&#160;years ended December&#160;31, 2024 and 2023, the Company made payments to these entities for services and expenses for $1.8 million and $2.1&#160;million, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 12. Net Loss Per Share Attributable to Common shareholders</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the computation of the basic and diluted net loss per share attributable to common shareholders: </font>
        </div>
        <table style="width:456pt;height:111.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:331.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands, except share and per share data)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adjustments of redeemable convertible preferred stock to redemption value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(96,367<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(121,112<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss attributable to common shareholders </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(378,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(462,527<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share attributable to common shareholders, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(10.66<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(13.24<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:331.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted-average shares used in computing net loss per share attributable to common shareholders, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">35,496,832</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">34,942,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:9.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common shareholders for the periods presented as they had an anti-dilutive effect: </font>
        </div>
        <table style="width:416pt;height:142.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">121,448,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">121,448,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7,407,408</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7,407,408</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;C preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">29,050,209</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">29,050,209</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;D preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">25,629,071</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">25,629,071</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">6,273,609</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">6,273,609</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">21,770,201</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">21,762,226</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested shares subject to repurchase </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">662,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">968,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">212,421,321</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">212,539,346</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 13. Segment and Geographic Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company operates as a single operating segment. An operating segment is defined as a component of an entity for which discrete financial information is available and regularly reviewed by the entity&#8217;s chief operating decision maker (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s CODM, its Chairman and Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis for the purposes of allocating resources, making operating decisions and evaluating financial performance. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Net loss as reported on the consolidated statements of operations and comprehensive loss is used by the CODM to assess segment performance against management budgets and prior period operating results for the purpose of making results-driven decisions about organizational resource allocation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Segment revenues are derived from molecular profiling, strategic data, and research services that are delivered to the Company&#8217;s biopharmaceutical and clinical customers, who are predominantly located in the United States. The Company provides these services primarily by leveraging the Company&#8217;s proprietary technologies and clinico-genomic database, which are core to the Company&#8217;s operations and are deployed similarly across the service offerings. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below is a summary of the segment profit or loss, including significant segment expenses: </font>
        </div>
        <table style="width:456pt;height:216pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:349.93pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">412,260</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">306,128</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Less: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8722;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">223,075</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">207,509</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8722;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10,403</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9,309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">152,602</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">142,925</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">169,386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">149,053</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">113,916</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">116,883</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,122</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11,258</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(50,025<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(31,610<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">18,484</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11,094</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(12,606<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:349.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Segment and consolidated net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(281,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(341,415<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the Company&#8217;s revenue by geographic areas based on the customer&#8217;s location: </font>
        </div>
        <table style="width:416pt;height:81pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:314.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years Ended December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:314.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:314.89pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:314.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">401,836</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">293,408</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:314.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">International </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">10,424</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">12,720</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:314.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">412,260</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">306,128</td>
            <td style="padding:0pt;padding-left:0.419999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:10.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">No single country outside of the United States accounted for more than 10.0% of total revenue during each of the&#160;years ended December&#160;31, 2024 and 2023. As of December&#160;31, 2024 and 2023, approximately 99.0% of the Company&#8217;s total assets are located in the United States. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:98pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">N</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">otes to Consolidated Financial Statements</font><font style="letter-spacing:-0.2pt;">&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 14. Employee Benefit Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company sponsors a 401(k) plan, and pursuant to its terms, eligible employees can elect to contribute to the 401(k) plan, subject to certain limitations, up to the lesser of the statutory maximum or 100.0% of eligible compensation on a pre-tax basis. For the&#160;years ended December&#160;31, 2024 and 2023, the Company contributed $8.0 million and $6.8&#160;million, respectively, to match employee contributions as permitted by the plan. The Company pays the administrative costs for the plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 15. Subsequent Events</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On March 3, 2025, five grantees of the New Stock Options (see Note 7), who had previously elected to early exercise utilizing the promissory note, signed agreements to repay their notes, plus accrued interest in the form of shares of our common stock. The number of shares of common stock used in the payoff was determined using the fair value of the Company&#39;s common stock at the time of the repayment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On March 25, 2025, in connection with the financing described above, the Company amended the terms of its certificate of formation to provide that the Series C redemption rights would not be exercisable until March 31, 2026 (from August 2025) and increased the original issue price and conversion price of its Series C convertible preferred stock used to calculate the conversion ratio of Series C preferred stock into common stock in connection with the initial public offering from $11.04 to $18.32 per share. </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On April 1, 2025, the Company closed a private financing in which it issued a combination of senior convertible notes (the &#8220;2025 Convertible Notes&#8221;), Series E convertible preferred stock and Series&#160;F convertible preferred stock, for an aggregate of $167.7&#160;million. The 2025 Convertible Notes have an aggregate principal amount of $30.0&#160;million. The 2025 Convertible Notes accrue interest at a rate of 8% per annum, payable quarterly in cash, and mature on January&#160;1, 2026. The Company issued 12,345,674 shares of Series&#160;E convertible preferred stock with a purchase price of $8.10 per share, for aggregate proceeds of $100.0&#160;million. The Company also issued 4,657,401 shares of Series&#160;F convertible preferred stock with a purchase price of $8.10 per share, for aggregate proceeds of $37.7&#160;million. In connection with this financing, the Company also issued warrants to acquire shares of common stock to the holders of the 2025 Convertible Notes. These warrants are not initially exercisable for any shares of common stock, but such warrants become exercisable for a specified dollar value of shares on a monthly basis commencing on June&#160;1, 2025 if we have not completed an initial public offering by such date. Any exercisable portion of the warrants will be automatically exercised prior to the closing of the initial public offering and such warrants will terminate upon the closing of the offering. </font>
        </div>
        <div style="text-indent:36pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Immediately prior to and in connection with the completion of the initial public offering, the 2025 Convertible Notes, Series E convertible preferred stock and Series&#160;F convertible preferred stock (plus an 8% accretion in connection with the preferred stocks) will convert into common stock at a price equal to 70% of the initial public offering price per share.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As further disclosed in Note 2, the Company effected a one-for-four reverse stock split of its common stock. The reverse stock split was effective June 1, 2025.</font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There were no other significant subsequent events identified through the date that the consolidated financial statements were issued, that could impact the financial statements.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fCBS1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:7.30999999999995pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 1pt 0pt; width:323.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands, except share data)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-left:19pt;padding-right:19pt;letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-left:25pt;padding-right:25pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <font style="letter-spacing:-0.18pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">32,704</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">65,442</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Short-term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">2,225</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">2,201</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accounts receivable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">80,174</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">88,244</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Supplies </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">36,552</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">39,572</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">19,578</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">20,270</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">171,233</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">215,729</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">61,651</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">67,817</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Goodwill </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">19,344</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">19,344</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">39,355</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">40,844</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:-0.18pt;">Total assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">291,583</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">343,734</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <font style="letter-spacing:-0.18pt;">Liabilities, Redeemable Convertible Preferred Stock, and Shareholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">24,226</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">27,791</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">78,235</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">77,542</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Current portion of indebtedness </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">60,093</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">60,090</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">162,554</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">165,423</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Long-term indebtedness, net of debt discounts </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">316,643</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">319,438</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Warrant liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">128,691</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">91,642</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Other long-term liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">37,447</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">44,418</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">645,335</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">620,921</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Commitments and contingencies (see note 9) </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Redeemable convertible preferred stock: </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;white-space:normal;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Series&#160;A preferred stock, par value $0.001: 490,000,000 shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; 485,795,293 shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024; and $296,335 aggregate liquidation preference as of March&#160;31, 2025 and December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">709,261</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">709,261</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;white-space:normal;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Series&#160;B preferred stock, par value $0.001: 30,000,000 shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; 29,629,630 shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024; and $16,000 aggregate liquidation preference as of March&#160;31, 2025 and December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">42,963</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">42,963</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;white-space:normal;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Series&#160;C preferred stock, par value $0.001: 142,000,000 shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; 116,200,835 shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024; and $415,616 and $408,715 aggregate liquidation preference as of March&#160;31, 2025 and December&#160;31, 2024, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">415,616</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">408,715</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:323.79pt;white-space:normal;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt; margin-bottom:-0.503333333333343pt;">
                <font style="letter-spacing:0.18pt;">Series&#160;D preferred stock, par value $0.001: 102,600,000 shares authorized as of March&#160;31, 2025 and December&#160;31, 2024; 102,516,283 shares issued and outstanding as of March&#160;31, 2025 and December&#160;31, 2024; and $1,078,273 and $1,060,712 aggregate liquidation preference as of March&#160;31, 2025 and December&#160;31, 2024, respectively </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">1,078,273</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">1,060,712</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total redeemable convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">2,246,113</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">2,221,651</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Shareholders&#8217; deficit: </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Common stock $0.001 par value; 1,173,000,000 and 1,150,000,000 shares </font>
                <br >
                <font style="letter-spacing:0.18pt;">authorized as of March&#160;31, 2025 and December&#160;31, 2024, respectively; </font>
                <br >
                <font style="letter-spacing:0.18pt;">36,858,169 and 36,686,819 shares issued as of March&#160;31, 2025 and </font>
                <br >
                <font style="letter-spacing:0.18pt;">December&#160;31, 2024, respectively; 35,237,531 and 36,504,319 shares outstanding </font>
                <br >
                <font style="letter-spacing:0.18pt;">as of March&#160;31, 2025 and December&#160;31, 2024, respectively; shares issued and </font>
                <br >
                <font style="letter-spacing:0.18pt;">outstanding include 43,603 and 662,000 unvested shares subject to repurchase as </font>
                <br >
                <font style="letter-spacing:0.18pt;">of March&#160;31, 2025 and December&#160;31, 2024, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;white-space:normal;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Treasury stock at cost, 1,620,638 and 182,500 shares of common stock as of March&#160;31, 2025 and December&#160;31, 2024, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(16,917<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Related party promissory note receivable (see note 7) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(26,456<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(2,583,231<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">(2,472,300<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accumulated other comprehensive income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">210</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:0.18pt;">Total shareholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">(2,599,865<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">(2,498,838<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:323.79pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:-0.18pt;">Total liabilities, redeemable convertible preferred stock, and shareholders&#8217; deficit</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">291,583</td>
            <td style="padding:0pt;padding-left:5.345pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:31.5pt; text-align:right; white-space:nowrap;">343,734</td>
            <td style="padding:0pt;padding-left:10.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fCSOO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:42pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND </font>
          <br >
          <font style="letter-spacing:-0.2pt;">COMPREHENSIVE LOSS (UNAUDITED)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:535pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:331.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands, except share and per share data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">114,081</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">73,233</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">6,834</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">7,444</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total revenue</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">120,915</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">80,677</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Costs and operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of Services&#8201;&#8211;&#8201;Molecular Profiling Services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">60,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">52,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cost of Services&#8201;&#8211;&#8201;Pharma Research and Development Services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,669</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">39,829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">39,609</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:331.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative expense (includes related party amounts of $515 and $480, for the three&#160;months ended March&#160;31, 2025 and 2024, respectively) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">52,119</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">44,354</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">23,066</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">34,376</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total costs and operating expenses</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">178,867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">172,902</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Loss from operations</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(57,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(92,225<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other income (expense), net: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">503</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(12,782<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(9,290<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(32,333<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(11,064<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(17<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(219<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total other expense, net</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(44,629<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(18,804<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Loss before income taxes and provision for income taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Provision for income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other comprehensive (loss) income, net of tax: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Unrealized gain on available-for-sale securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign currency translation adjustments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">35</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Comprehensive loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(102,546<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(111,013<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Net loss attributable to common shareholders: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adjustments of redeemable convertible preferred stock to redemption value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(24,462<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(23,113<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss attributable to common shareholders</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(127,043<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(134,141<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share attributable to common shareholders, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(3.57<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(3.80<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.583pt 0pt; width:331.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted-average shares used in computing net loss per share attributable to common shareholders, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">35,623,042</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">35,313,037</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fCSOR1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS&#8217; DEFICIT (UNAUDITED)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:12pt;margin-bottom:214.06pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:381.69pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
          <tr style="line-height:7.28pt;height:24.91pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:112pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.77pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center; line-height:7.29pt;">
                <font style="letter-spacing:-0.13pt;">Redeemable Convertible </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.99pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.77pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.13pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.77pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.13pt;">Treasury Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.77pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.29pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.13pt;">Additional </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Paid-In </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.77pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.29pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.13pt;">Related </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Party </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Promissory </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Note </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Receivable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.77pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.29pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.13pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.77pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.29pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.13pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Comprehensive </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.24pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.77pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:7.29pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.13pt;">Total </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Shareholders&#8217; </font>
                <br >
                <font style="letter-spacing:-0.13pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;height:13.03pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.25pt 0pt 3.03pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.13pt;">(amounts in thousands, except share data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.03pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:10pt;padding-right:10pt;letter-spacing:-0.13pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.03pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:6pt;padding-right:6pt;letter-spacing:-0.13pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.03pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:8pt;padding-right:8pt;letter-spacing:-0.13pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.03pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;letter-spacing:-0.13pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.03pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:6pt;padding-right:6pt;letter-spacing:-0.13pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.03pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:3pt;padding-right:3pt;letter-spacing:-0.13pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:3.25pt 0pt 3.625pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.15pt;">Balances at December&#160;31, 2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:30pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,125,284</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:3pt solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">35,297,278</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">182,500</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">(25,701<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,119,175<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">218</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,144,950<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.75pt 0pt 2.25pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">4,458</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">4,458</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:112pt;white-space:normal;text-align:left;">
              <div style="margin-left:7.5pt; text-indent:-7.5pt;">
                <font style="letter-spacing:0.15pt;">Issuance of common stock upon exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">39,304</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">210</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">210</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:112pt;text-align:left;">
              <div style="margin-left:7.5pt; text-indent:-7.5pt;">
                <font style="letter-spacing:0.15pt;">Interest income from related party </font>
                <br >
                <font style="letter-spacing:0.15pt;">promissory notes </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">(186<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(186<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:112pt;white-space:normal;text-align:left;">
              <div style="margin-left:7.5pt; text-indent:-7.5pt;">
                <font style="letter-spacing:0.15pt;">Adjustment of redeemable convertible preferred Series&#160;C and Series&#160;D to redemption value </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">23,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">(4,668<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(18,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(23,113<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:3.5pt 0pt 2.25pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">15</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">15</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.875pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:3.25pt 0pt 3.625pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.15pt;">Balances at March&#160;31, 2024</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:30pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,148,397</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:3pt solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">35,336,582</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">182,500</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">(25,887<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,248,648<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">233</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,274,594<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.75pt 0pt 3.625pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.15pt;">Balances at December&#160;31, 2024</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:30pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,221,651</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:3pt solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">35,842,319</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">182,500</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">(26,456<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,472,299<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">210</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,498,837<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.75pt 0pt 2.25pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">14,691</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">14,691</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:112pt;white-space:normal;text-align:left;">
              <div style="margin-left:7.5pt; text-indent:-7.5pt;">
                <font style="letter-spacing:0.15pt;">Issuance of common stock upon exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">833,350</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">1,433</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">1,433</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:112pt;text-align:left;">
              <div style="margin-left:7.5pt; text-indent:-7.5pt;">
                <font style="letter-spacing:0.15pt;">Interest income from related party </font>
                <br >
                <font style="letter-spacing:0.15pt;">promissory notes </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">(128<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(128<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:112pt;text-align:left;">
              <div style="margin-left:7.5pt; text-indent:-7.5pt;">
                <font style="letter-spacing:0.15pt;">Payoff of related party promissory </font>
                <br >
                <font style="letter-spacing:0.15pt;">notes </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">26,584</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">26,584</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:3.5pt 0pt 2.25pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Repurchases of common stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(1,438,138<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,438,138</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">(16,587<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(16,587<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:112pt;white-space:normal;text-align:left;">
              <div style="margin-left:7.5pt; text-indent:-7.5pt;">
                <font style="letter-spacing:0.15pt;">Adjustment of redeemable convertible preferred Series&#160;C and Series&#160;D to redemption value </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">24,462</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">(16,110<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(8,352<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(24,462<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:3.5pt 0pt 2.25pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">(14<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">35</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.25pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">21</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.875pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:30pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.875pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:3.25pt 0pt 3.625pt 0pt; width:112pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.15pt;">Balances at March&#160;31, 2025</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:30pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,246,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:3pt solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.99pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">35,237,531</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,620,638</td>
            <td style="padding:0pt;padding-left:0.00500000000000078pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">(16,917<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:18.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,583,231<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:12.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt; width:3.24pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.875pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,599,865<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0949999999999989pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fCSOC1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:622pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:343.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.25pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from operating activities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Adjustments to reconcile net loss to net cash used in operating activities:</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Depreciation and amortization </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,045</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">17,705</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">14,691</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,458</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Non-cash operating lease expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,452</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,551</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Amortization of debt discounts </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,945</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,590</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">32,333</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11,064</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">456</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,919</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities:</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,913</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,378<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Supplies </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,061</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,024</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,470</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(81<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">326</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(1,739<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,778<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">2,580</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(297<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(31,338<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(73,925<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from investing activities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Maturities of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">61,376</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Purchases of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(2,689<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(1,738<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash provided by (used in) investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(2,689<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">59,638</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from financing activities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Payments made on finance lease obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(22<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(80<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,434</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">210</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Payment of deferred offering costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(105<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from the 2023 term loan, net of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">199,978</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Purchase of treasury stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(22<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1,285</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">200,108</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effect of exchange rate changes on cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net increase (decrease) in cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(32,738<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">185,822</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.25pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash at beginning of year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">68,028</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">60,007</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 3pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash at end of period </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">35,290</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">245,829</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Supplemental disclosure of cash flow information</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10,829</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">6,080</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Supplemental disclosure of non-cash activity</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash paid for amounts included in the measurement of lease liabilities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating cash flow used for operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,847</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,853</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating cash flow used for finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financing cash flow used for finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">22</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">80</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property and equipment included in accounts payable and accrued liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">242</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,413</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:343.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deferred offering costs, accrued but not paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,420</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,989</td>
            <td style="padding:0pt;padding-left:4.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fNTCF12">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 1. Nature of the Business</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Caris Life Sciences, Inc. (the &#8220;Company&#8221; or &#8220;Caris&#8221;) is a patient-centric, next-generation artificial intelligence (&#8220;AI&#8221;) TechBio company and precision medicine pioneer. The Company commercializes and develops innovative solutions to transform healthcare through the use of comprehensive molecular information, AI, and machine learning (&#8220;ML&#8221;) algorithms. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s current molecular profiling services portfolio is focused on oncology and consists of MI Profile, a tissue-based molecular profiling solution, and Caris Assure, a novel, universal blood-based molecular profiling solution, with the aim to address the entire continuum of cancer treatment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company also collaborates with biopharmaceutical companies to provide commercial services and prospective and retrospective testing, along with data and bioinformatics collaborations and novel target identification and discovery solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company was incorporated under the laws of the Cayman Islands in November&#160;2011 (Caris Life Sciences, Ltd.) and re-domiciled to be incorporated in Texas in July&#160;2020 (Caris Life Sciences, Inc.) and is headquartered in Irving, Texas. The Company also has locations in Phoenix, Arizona; New York, New York; Cambridge, Massachusetts; Basel, Switzerland; and Tokyo, Japan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Going Concern</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025, the Company&#8217;s cash and cash equivalents balance was approximately $31.2&#160;million, and the short-term investments balance was $2.2&#160;million, and the Company had a 2023 Term Loan (see Note 8) outstanding with a balance of $400.0&#160;million. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2025, the Company issued the 2025 Convertible Notes in the amount of $30.0&#160;million. In connection with the Company&#8217;s Series&#160;C redeemable convertible preferred stock, the 2023 Term Loan and the 2025 Convertible Notes, the following payments may become due within 12&#160;months of the date of the issuance of the condensed consolidated financial statements if the Company has not completed an initial public offering raising at least $100.0&#160;million in gross proceeds prior to such due dates: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Series&#160;C redemption rights will become exercisable on March&#160;31, 2026; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Company will be required to make a one-time acceleration payment on December&#160;31, 2025 in an amount equal to 15% of the outstanding principal amount under the 2023 Term Loan (or $60.0&#160;million based on the principal amount currently outstanding) together with any applicable repayment premium and exit fee as described in the Term Loan agreement on such date; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The 2025 Convertible Notes of $30.0&#160;million will come due on January&#160;1, 2026. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If these payments become due, the Company&#8217;s existing cash resources and projected operating cash flows may not be sufficient to repay these amounts and continue to fund operating activities for at least the next 12&#160;months from the issuance of the condensed consolidated financial statements. These conditions raise substantial doubt as to the Company&#8217;s ability to continue as a going concern. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Management intends to raise additional funding through an initial public offering raising at least $100.0&#160;million in gross proceeds which would eliminate the requirement to make the one-time acceleration payment related to the 2023 Term Loan. Further, the initial public offering would cause the Series&#160;C redeemable convertible preferred stock and the 2025 Convertible Note to convert to common stock and thereby not be subject to redemption and repayment upon maturity on March&#160;31, 2026 and January&#160;1, 2026, respectively. Management may seek alternative private financing through additional debt or equity offerings that will fulfill its operating, capital and debt requirements for at least 12&#160;months from the date of the issuance of the condensed consolidated financial statements. However, the Company may not be able to complete such an initial public offering or otherwise secure such financing in a timely manner or on favorable terms, if at all. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 2. Summary of Significant Accounting Policies and Estimates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis of Financial Statement Presentation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The condensed consolidated financial statements include the accounts of Caris and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASUs&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Unaudited Interim Consolidated Financial Information</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for the fair statement of the Company&#8217;s financial position as of March&#160;31, 2025 and its results of operations and cash flows for the three&#160;months ended March&#160;31, 2025 and 2024. The results of operations for the three&#160;months ended March&#160;31, 2025 are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2025, or for any other future annual or interim period. The condensed consolidated balance sheet as of December&#160;31, 2024 included herein was derived from the audited financial statements as of that date. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted from these unaudited condensed consolidated financial statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Effective June 1, 2025, the Company&#8217;s Board approved a one-for-four reverse stock split of the Company&#8217;s common stock. This also resulted in an adjustment to the conversion price for each series of the Company&#8217;s convertible preferred stock, to the underlying number of shares outstanding with respect to the restricted stock units, and to the exercise prices and number of shares of common stock underlying the outstanding stock options. Accordingly, all share and per share information relating to common stock for all periods presented in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted. The shares of common stock retain a par value of $0.001 per share. Accordingly, an amount equal to the excess was reclassified from common stock to additional paid-in capital or, in the absence of additional paid-in-capital, accumulated deficit.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP in the United States requires the use of estimates and assumptions about future events that affect the amounts reported in the Company&#8217;s condensed consolidated financial statements and related notes, including the amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the periods reported. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Significant estimates and assumptions are used for, but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">revenue recognition </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fair value of stock-based awards and common stock </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fair value of financial assets and liabilities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Future events and their effects cannot be predicted with certainty. Accordingly, the accounting estimates require the exercise of judgment. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. The accounting estimates used in the preparation of the Company&#8217;s condensed consolidated financial statements may change as new events occur, additional information is obtained, and the operating environment changes. The Company will evaluate and update the assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could materially differ from those estimates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash, Cash Equivalents, and Restricted Cash</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company considers all highly liquid investments with original maturities of three&#160;months or less from date of acquisition to be cash equivalents. Refer to Note 4 for information on the Company&#8217;s restricted cash. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue Recognition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes revenue under ASC Topic 606, </font><font style="font-style:italic;letter-spacing:0.2pt;">Revenue from Contracts with Customers</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 606&#8221;). Revenue is recognized when control of goods and services are transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ASC 606 provides for a five-step model that includes: </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Step 1: Identify the contract(s) with a customer. </font>
        </div>
        <div style="margin-left:36pt; margin-top:2pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Step 2: Identify performance obligations in the contract. </font>
        </div>
        <div style="margin-left:36pt; margin-top:2pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Step 3: Determine the transaction price. </font>
        </div>
        <div style="margin-left:36pt; margin-top:2pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Step 4: Allocate the transaction price to the performance obligations in the contract. </font>
        </div>
        <div style="margin-left:36pt; margin-top:2pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company derives revenue from two distinct channels: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Molecular profiling services involving the provision of precision oncology solutions utilizing MI Profile and Caris Assure. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Pharma research and development services involving delivery of laboratory, strategic data, and research services to biopharmaceutical customers. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Molecular Profiling Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the majority of its molecular profiling services, the Company recognizes revenue from the sale of its precision oncology solutions, provided to customers, including certain hospitals, institutions and patients, at the point in time when the results of the profiling services are delivered to ordering physicians. Most cases requested on behalf of customers are provided without a written agreement; however, the Company determines that an implied contract exists with its customers for whom a physician orders the case. Results from molecular profiling services are delivered via fax, electronically, or in hard copy. Shipping and handling activities are considered fulfillment activities and as such, amounts incurred are recorded within Cost of Services&#8212;Molecular Profiling Services on the condensed consolidated statements of operations and comprehensive loss. The Company identifies each sale of the Company&#8217;s profiling service as a distinct performance obligation. Payment terms are a function of a patient&#8217;s existing insurance benefits and applicable reimbursement contracts established between the Company and payers. Collection of consideration the Company expects to receive typically occurs within 90 to 120&#160;days of billing. Occasionally, payers may recoup or we may refund consideration, mainly as a result of claim processing. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The total consideration to which the Company expects to be entitled in exchange for the Company&#8217;s services may be fixed or variable. Consideration includes reimbursement from patients, hospitals, and third-party commercial and governmental payers, such as insurance companies, adjusted for variable consideration related to implicit price concessions that the Company may grant. The Company estimates the variable consideration under a portfolio approach for third-party payers, hospitals and patients with similar reimbursement characteristics. This includes analysis of an average reimbursement per case per </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">portfolio and a&#160;percentage of cases reimbursed by considering the historical reimbursement data (including any refunds and recoupments) from such third-party payers, hospitals and patients. Specifically, the Company calculates the historical average reimbursement rates for each portfolio and applies an estimated reimbursement rate, based on historical trends, to the number of cases delivered each period. The period for which historical data is drawn upon is determined on a by- portfolio basis for each payer group, taking into consideration the average collection period. Additionally, the estimate also considers current contractual and statutory requirements, patient insurance eligibility and payer reimbursement contracts, and any known current or anticipated reimbursement trends not reflected in the historical data and only recognizes revenue for variable consideration that the Company determines is probable will not result in a significant reversal in the future. The Company monitors the estimated amount to be collected at each reporting period based on actual cash collections in order to assess whether a revision to the estimate is required. Subsequent changes to the estimate of the transaction price are recorded as adjustments to molecular profiling services revenue in the period where such changes occur. Both the estimate and any subsequent revision are uncertain and require the use of management&#8217;s judgment in the estimation of the variable consideration and application of the constraint for such variable consideration. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pharma Research and Development Services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The Company collaborates with biopharmaceutical companies to provide commercial services and prospective and retrospective testing, along with data and bioinformatics collaborations and novel target identification and discovery solutions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Contracts with biopharmaceutical customers may include multiple distinct performance obligations, such as molecular profiling services, pharma research and development services, and strategic data services. The Company evaluates the terms and conditions included within its contracts with biopharmaceutical customers for proper revenue recognition, including whether services are capable of being distinct and considered distinct within the context of the contract. The performance obligations for biopharmaceutical customers vary by contract. Such contracts may include a performance obligation to provide molecular profiling services, to facilitate the development and regulatory approval of drugs, or to provide target discovery services. Under those contracts, the Company receives payments upon the achievement of milestones, as well as provision of on-going support. The transaction price of the development services contracts may include variable consideration, due to the uncertainty associated with the achievement of the milestones. In making the assessment of whether variable consideration should be included in the transaction price, the Company considers its historical experience with similar milestones, the degree of complexity and uncertainty associated with each milestone, and whether achievement of the milestone is dependent on parties other than the Company. The Company recognizes pharma research and development services revenue over the period in which biopharmaceutical research and development services are provided. Depending on the nature of the service, the Company recognizes revenue using either the output or input method to measure progress, whichever provides a more faithful depiction of the transfer of goods or services. Use of an output method or input method to depict the transfer of services generally does not result in a material difference with respect to the timing of revenue recognition because most services commence and end within the same reporting period. A constraint for variable consideration is applied such that it is probable a significant reversal of revenue will not occur when the uncertainty associated with the contingency is resolved. Application of the constraint for variable consideration is updated at each reporting period as a revision to the estimated transaction price. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Standalone Selling Price</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company determines standalone selling prices by considering the historical selling prices of its performance obligations in similar transactions, where applicable, as well as other factors, including, but not limited to, the price that customers in the market would be willing to pay, competitive pricing from other vendors, industry publications, current pricing practices and management estimates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Contract Balances</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">in the period the Company delivers goods or provides services, or when the right to consideration is unconditional. In situations where revenue recognition occurs before invoicing, an unbilled receivable is created, which represents a contract asset. As of March&#160;31, 2025 and December&#160;31, 2024, the unbilled receivable balance was $1.6&#160;million and $4.6&#160;million, respectively, which is included in accounts receivable on the condensed consolidated balance sheets. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes contract liabilities primarily related to payments received in advance of satisfaction of performance obligations from contracts with customers. Contract liabilities are relieved as the Company fulfills its obligations under the contract and revenue is recognized. As of March&#160;31, 2025 and December&#160;31, 2024, the contract liability balance was $7.7&#160;million and $7.5&#160;million, respectively, which is included in accrued expenses and other current liabilities on the condensed consolidated balance sheets. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table shows the changes in the contract liabilities during the period: </font>
        </div>
        <table style="width:416pt;height:105pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:365.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:365.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">7,470</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:365.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Increase in contract liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,774</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:365.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Revenue recognized during the period that was included in deferred revenues at the beginning of the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,797<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:365.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revenue recognized from performance obligations satisfied within the same period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,783<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:365.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">7,664</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:12.01pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The amount of revenue recognized during the three&#160;months ended March&#160;31, 2024 pertaining to amounts deferred as of December&#160;31, 2023 was $2.0&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Transaction Price Allocated to Remaining Performance Obligations</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The transaction price allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes contract liabilities and non-cancelable amounts that will be invoiced and recognized as revenue in future periods and excludes performance obligations that are subject to cancellation terms. The Company has elected not to disclose information regarding the transaction price allocated to the remaining performance obligations for which the original expected duration of the contract is one year or less. The amount of transaction price allocated to the remaining performance obligations for contracts with original expected duration over one year as of March&#160;31, 2025 was $7.1&#160;million. The Company expects to recognize the amounts within twelve&#160;months from the respective balance sheet dates. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, for the three&#160;months ended March&#160;31, 2025 and 2024, the Company recorded $3.9&#160;million and $(3.9) million of adjustments to revenue related to services delivered in prior periods, respectively, which is based on variability that was subsequently resolved. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Practical Expedients and Contract Costs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Payment terms and conditions vary by contract and customer. In instances where the timing of the Company&#8217;s revenue recognition differs from the timing of its invoicing, the Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised services to the customer will be one year or less. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a practical expedient, the Company recognizes the incremental costs of obtaining contracts, such as sales commissions, as expenses when incurred, if the amortization period of the asset that the Company otherwise would have recognized for the capitalized costs is one year or less. Sales commissions are recorded within selling and marketing expense on the condensed consolidated statements of operations and comprehensive loss. The Company did not capitalize any sales commissions or contract fulfillment costs for the periods ended March&#160;31, 2025 and December&#160;31, 2024. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Collaboration agreements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company is party to various collaboration and licensing agreements under which the Company out-licenses certain know-how and molecular data. The collaboration arrangements are intended to solidify the Company&#8217;s third-party partnerships to align oncology capabilities and create industry-leading molecular oncology research platforms to accelerate drug development and novel research. Under these collaboration arrangements, the Company generally receives a split of fees from its collaborative partners that are earned pursuant to statements of work (&#8220;SOWs&#8221;) executed with end users of the Company&#8217;s licensed molecular data. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s collaboration and licensing agreements are within the scope of ASC Topic 808, Collaborative Arrangements (&#8220;ASC 808&#8221;) and ASC 606 because the counterparty to these agreements meets the definition of a customer. As such, the Company recognizes revenue earned from the licenses of molecular data granted to the Company&#8217;s collaborative partners in accordance with ASC 606. Each license of molecular data granted by the Company to a collaborative partner represents a distinct performance obligation in the contract. The transaction price for a given arrangement is entirely variable and depends on the SOWs executed by the counterparty with end users. The amount of revenue allocated to each license is equal to the amount of revenue to which the Company expects to be entitled. The Company recognizes revenue at the point in time that it delivers the molecular data to the third-party collaborative partner. For the three&#160;months ended March&#160;31, 2025 and 2024, the Company recognized collaboration revenue of $1.3&#160;million and $1.4&#160;million, respectively, which is included in revenue from pharma research and development services on the condensed consolidated statements of operations and comprehensive loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cost of Services&#8212;Molecular Profiling Services</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cost of services for molecular profiling services generally consists of cost of materials, direct labor including bonus and stock-based compensation, and equipment maintenance and depreciation expenses associated with processing cases (including accessioning, sequencing, quality control analyses and shipping charges to transport tissue samples), freight and profile results for ordering physicians. Costs associated with completing the molecular profiling services are recorded as the service is performed, regardless of when revenue is recognized with respect to the service. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cost of Services&#8212;Pharma Research and Development Services</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cost of services for pharma research and development services generally consists of cost incurred for the performance of the services requested by the Company&#8217;s biopharmaceutical customers related to the delivery of laboratory, strategic data and research services, and will vary depending on the nature, timing, and scope of customer projects. Costs associated with delivering pharma research and development services are recorded as incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Concentration of Credit Risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments that potentially expose the Company to concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company maintains its cash primarily with domestic financial institutions of high credit quality, with balances that exceed amounts insured by the Federal Deposit Insurance Corporation as of March&#160;31, 2025 and December&#160;31, 2024, respectively. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company invests in treasury bills issued by the U.S. Government. U.S. treasury bills with original maturities of three&#160;months or less are classified within cash equivalents. Short-term marketable securities are comprised of U.S. treasury bills with original maturities between three and twelve&#160;months. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions. The goal of the Company&#8217;s investment policy is to ensure safety and preservation of the principal balance, and diversification of risk over cash balances held on deposit. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to credit risk from its accounts receivable. The majority of the Company&#8217;s accounts receivable arise from the provision of molecular profiling services and pharma research and development services and other, primarily with biopharmaceutical companies, all of which have high credit ratings. The Company has not experienced any material losses related to receivables from individual customers, or groups of customers. The Company does not require collateral. Accounts receivable are recorded net of allowance for credit losses, if any. Concentrations of credit risk are limited due to the number of payers and their dispersion across multiple geographic regions. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the three&#160;months ended March&#160;31, 2025 and 2024, the Company&#8217;s revenues were primarily derived from the sale of the Caris molecular profiling services. As discussed above, payment terms of the services are a function of a patient&#8217;s existing insurance benefits and applicable reimbursement contracts established between the Company and payers. Revenue associated with each payer, including its affiliated entities, as a&#160;percentage of the Company&#8217;s total revenue for the respective period, and accounts receivable balance attributable to each payer, including its affiliated entities, as a&#160;percentage of the Company&#8217;s total accounts receivable balance at the respective condensed consolidated balance sheet date, are as follows: </font>
        </div>
        <table style="width:456pt;height:85pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:239.91pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% Revenue for the </font>
                <br >
                <font style="letter-spacing:-0.16pt;">three&#160;months ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% Accounts </font>
                <br >
                <font style="letter-spacing:-0.16pt;">receivable as of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:239.91pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">Major Payer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:14pt;padding-right:14pt;letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:14pt;padding-right:14pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">March&#160;31, </font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:9pt;padding-right:9pt;letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:15pt;padding-right:15pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:239.91pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payer 1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">51.2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">36.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">64.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">16.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:239.91pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payer 2 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">13.5<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">13.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">10.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">19.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:239.91pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payer 3 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:13.145pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">11.5<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:13.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.11pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.6pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents major payers below 10.0%. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accounts Receivable</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accounts receivable includes billed and unbilled receivables, net of an allowance for expected credit losses. Accounts receivable primarily represent receivables from biopharmaceutical customers and third-party payers. Accounts receivable for pharmaceutical services are established based on the amounts outstanding per the contractual arrangements with biopharmaceutical customers. The Company applies the current expected credit loss standard in ASC Subtopic 326-20, </font><font style="font-style:italic;letter-spacing:0.2pt;">Financial Instruments&#8212;Credit Losses</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 326&#8209;20&#8221;) and reserves a portion of the accounts receivable based on assessment of the collectability of customer accounts at the time of revenue recognition. The Company regularly reviews the reserve by considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer&#8217;s ability to pay. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Receivables deemed to be uncollectible are written-off against the allowance for credit losses at the time such receivables are deemed to be uncollectible under a specific identification or estimated method. Recoveries of accounts receivable previously written off are recorded when received. As of March&#160;31, 2025 and December&#160;31, 2024, the Company had an immaterial allowance for credit losses related to its accounts receivable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Supplies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Supplies consist primarily of laboratory items and reagents used by the Company in providing services. All supplies are raw materials and are stated at the lower of cost or net realizable value on a first-in, first-out basis. The Company periodically reviews its supplies for excess or obsolescence and writes down obsolete or otherwise unmarketable supplies to their estimated net realizable value. As of March&#160;31, 2025 and December&#160;31, 2024, the amount of write downs associated with the Company&#8217;s supplies was immaterial. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deferred Offering Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred offering costs consist primarily of accounting, legal, and other fees related to the Company&#8217;s proposed initial public offering (&#8220;IPO&#8221;). These costs are recorded as prepaid expenses and other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">current assets on the condensed consolidated balance sheets. The deferred offering costs will be recorded against IPO proceeds upon the consummation of the IPO. In the event the planned IPO is terminated, the deferred offering costs will be expensed. The Company had $5.8&#160;million and $4.5&#160;million of deferred offering costs as of March&#160;31, 2025 and December&#160;31, 2024, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment, Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company reports property and equipment at cost, net of accumulated depreciation, amortization, and any asset impairments. The cost of properties held under finance leases is equal to the present value of lease payments not yet paid, adjusted for initial direct costs, prepaid lease payments and lease incentives received. Major improvements which add to productive capacity or extend the life of an asset are capitalized. Normal repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation and amortization are removed from the accounts, and any resulting gain or loss is reflected in the accompanying condensed consolidated statements of operations and comprehensive loss for the period. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation and amortization expenses are calculated on a straight-line basis and applied to asset classes based upon the Company&#8217;s estimate of the asset class&#8217;s useful life, as summarized below: </font>
        </div>
        <table style="width:384pt;height:98.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:186.87pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Estimated Useful Life </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laboratory equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer equipment and software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Furniture and fixtures </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Aircraft </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">15&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements/leased buildings </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Lesser of remaining lease term or useful life </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.87pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leased equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.13pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Lesser of initial lease term or 5&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Computer equipment and software includes the purchases of hardware, software and capitalized labor costs associated with internally developed software. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company capitalizes purchased software which is ready-for-service and capitalizes qualifying internal software development costs incurred on significant projects. Capitalization of costs begins when two criteria are met: (1)&#160;the preliminary project stage is completed, management with relevant authority authorizes and commits to funding the software project, and (2)&#160;it is probable that the software will be completed and used for its intended function. Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. Costs related to preliminary project activities and post-implementation operating activities are expensed as incurred. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development costs and other computer software maintenance costs related to software development are expensed as incurred. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Capitalized software costs are included in property and equipment, net. These costs are amortized using the straight-line method over the estimated useful life of the underlying software, which is three&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value Measurements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Fair value is defined as the exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions market participants would use in pricing an asset or liability. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The basis for these assumptions establishes a three-level fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Level&#160;1</font><font style="letter-spacing:0.2pt;">&#8212;Observable inputs such as quoted prices in active markets for identical assets and liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Level&#160;2</font><font style="letter-spacing:0.2pt;">&#8212;Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Level&#160;3</font><font style="letter-spacing:0.2pt;">&#8212;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Assets and liabilities measured at fair value are based on one or more of three valuation techniques. The three valuation techniques are as follows: </font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Market approach</font><font style="letter-spacing:0.2pt;">&#8212;Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Cost approach</font><font style="letter-spacing:0.2pt;">&#8212;Amount that would be required to replace the service capacity of an asset (i.e., replacement cost); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Income approach</font><font style="letter-spacing:0.2pt;">&#8212;Techniques to convert future amounts to a single present amount based on market expectations (including present value techniques, option-pricing models, and lattice models). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments consist of cash, cash equivalents, restricted cash, short-term marketable securities, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued expenses and other current liabilities, debt, warrants, and derivative instruments. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025 and December&#160;31, 2024, the carrying amounts of the Company&#8217;s cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued expenses and other current liabilities approximate their fair value based on the short-term nature of these items. There were no transfers between Levels 1, 2 or 3 for the periods ended March&#160;31, 2025 and December&#160;31, 2024. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used in such measurements were as follows: </font>
        </div>
        <table style="width:456pt;height:110.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:281.15pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:281.15pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;1 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;2 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;3 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:281.15pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:281.15pt;">
              <font style="letter-spacing:-0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:281.15pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Short-term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,225</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,225</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:281.15pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:281.15pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Warrant liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">128,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">128,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:281.15pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,342</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,342</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:110.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:289.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:289.5pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;1 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;2 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Level&#160;3 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:289.5pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.5pt;">
              <font style="letter-spacing:-0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Short-term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2,201</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,201</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Warrant liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">91,642</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">91,642</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.5pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,058</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,058</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.9pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Warrant liability</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company utilized a probability-weighted scenario approach factoring in various exit strategies and the related timing of such to estimate the fair value of its warrant liability. For each scenario, the Company utilized a Black-Scholes option pricing model with the following assumptions: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Fair value per share of the underlying stock&#8212;</font><font style="letter-spacing:0.2pt;">The fair value of the underlying stock represents the fair value of the Company&#8217;s Series&#160;C preferred stock that the warrants are convertible into. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Volatility&#8212;</font><font style="letter-spacing:0.2pt;">The volatility is derived from historical volatilities of several unrelated publicly-listed peer companies, since the Company has no trading history. When making the selections of industry peer companies to be used in the volatility calculation, the Company considers the size, operational and economic similarities to the Company&#8217;s principal business operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Risk-free interest rate&#8212;</font><font style="letter-spacing:0.2pt;">The risk-free interest rate is based on U.S. treasury yield as of the measurement dates interpolated to match the maturity equal to the respective term to exit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividend yield&#8212;</font><font style="letter-spacing:0.2pt;">The expected dividend assumption is based on the Company&#8217;s current expectations about the Company&#8217;s anticipated dividend policy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:36pt; line-height:12pt; margin-top:7.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:56pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected term (years)&#8212;</font><font style="letter-spacing:0.2pt;">Based on expected term under various exit strategies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The below table summarizes the significant unobservable inputs used in the fair value measurement of the warrant liability as of March&#160;31, 2025 and December&#160;31, 2024: </font>
        </div>
        <table style="width:456pt;height:97pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:204.52pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:204.52pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:56.87pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2018 Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:56.87pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:56.87pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2018 Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:56.87pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:204.52pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value per share of the underlying stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$4.76&#8211;$7.43 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$4.76&#8211;$7.43 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$3.66&#8211;$5.65 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$3.66&#8211;$5.65 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204.52pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">46.0%&#8211;62.0% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">59.4%&#8211;62.0% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">47.6%&#8211;63.0% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">61.2%&#8211;63.0% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204.52pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4.2%&#8211;4.3% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3.9%&#8211;4.3% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4.2%&#8211;4.3% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4.3% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204.52pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204.52pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.19&#8211;0.50 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.19&#8211;2.75 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.29&#8211;0.75 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:56.87pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.29&#8211;2.25</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Derivative liability</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;18, 2023, the Company entered into a credit agreement (the &#8220;New Term Loan Agreement&#8221;) under which the Company issued senior, secured promissory notes (the &#8220;2023 Term Loan&#8221;) by which the New Term Loan lenders agreed to lend the Company up to an aggregate principal amount of $400.0&#160;million, $200.0&#160;million of which was received by the Company upon issuance, and $200.0 was drawn down in March&#160;2024. The Company identified certain embedded features in the 2023 Term Loan, including various contingent prepayment, compensatory payment, and default interest rate features, that are required to be bifurcated from the 2023 Term Loan and separately accounted for in the condensed consolidated financial statements as a compound derivative liability. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Fair value of the derivative liability was estimated using the discounted cash flow method under the income approach. This approach involves significant Level&#160;3 inputs and assumptions including an estimated probability and timing of certain contingent events, such as events of default, change of control, sale of assets, etc. The analysis also required the selection of a discount rate representative of the Company&#8217;s credit risk. The discount rate used for the initial fair value was calibrated to the transaction. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Refer to Note 8 for additional information about the compound embedded derivative liability. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Debt</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025, the estimated fair value of the 2023 Term Loan, excluding the bifurcated embedded derivative, was $377.8&#160;million, compared to a carrying value of $375.1&#160;million. As of December&#160;31, 2024, the estimated fair value of the 2023 Term Loan, excluding the bifurcated embedded derivative, was $380.9&#160;million, compared to a carrying value of $373.1&#160;million. The Company estimated the fair value of the 2023 Term Loan as of based on a discounted cash flow analysis, and an income approach, which represented the use of Level&#160;3 inputs in the fair value hierarchy. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities acquired through a business combination. The Company evaluates goodwill for impairment in accordance with ASC Topic 350, </font><font style="font-style:italic;letter-spacing:0.2pt;">Intangibles&#8212;Goodwill and Other</font><font style="letter-spacing:0.2pt;"> on an annual basis on October&#160;1, or more frequently if events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, or the Company may determine to proceed directly to the quantitative impairment test. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Company assesses qualitative factors and concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount or if the Company determines not to use the qualitative assessment, then a quantitative impairment test is performed. The factors utilized in the qualitative assessment include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, and Company-specific events. The quantitative impairment test requires comparing the fair value of the reporting unit to its carrying value, including goodwill. The fair value of the reporting unit is determined based on the present value of estimated cash flows using available information regarding expected cash flows of each reporting unit, discount rates, and the expected long-term cash flow growth rates. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has identified that its business operates as a single operating segment which is also a single reporting unit for purposes of testing goodwill for impairment. An impairment exists if the fair value of the reporting unit is lower than its carrying value. If the fair value of the reporting unit is lower than its carrying value, the Company would record an impairment loss equal to the excess of the reporting unit&#8217;s carrying value over its fair value. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There were no impairment losses for the periods ended March&#160;31, 2025 and 2024. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities. The costs include direct costs for salaries and benefits, materials, contract services and other outside costs, and costs to acquire in-process research and development projects and technologies that have no alternative future use. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Advertising</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company expenses advertising costs as incurred. The Company incurred advertising costs of $0.1&#160;million and $0.2&#160;million for the three&#160;months ended March&#160;31, 2025 and 2024, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Self-Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company offers medical insurance coverage to eligible employees under a self-insured program managed by a third-party administrator, leveraging stop-loss insurance policies to mitigate risk. The Company records an estimate of its liability for medical claims, which includes the incurred claims amount plus an estimate of incurred, but not reported claims. Self-insurance liability of $2.0&#160;million and $1.9&#160;million for the periods ended March&#160;31, 2025 and December&#160;31, 2024, respectively, is included within accrued expenses and other current liabilities on the condensed consolidated balance sheets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Net Loss per Share Attributable to Common Shareholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company calculates its basic and diluted net loss per share attributable to common shareholders in conformity with the two-class method required for companies with participating securities. Each series of the Company&#8217;s redeemable convertible preferred stock is considered to be a participating security because the preferred shareholders have a right to receive dividends on a pari&#160;passu basis with the Company&#8217;s common shareholders. The two-class method determines net income (loss) per share for each class of common stock and participating security according to dividends declared or accumulated and participating rights in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">undistributed earnings. The two-class method requires income (loss) available to common shareholders for the period to be allocated between common and participating securities based upon the respective rights of each to share in earnings as if all income (loss) for the period had been distributed. The participating securities are not required to participate in the losses of the Company, and therefore during periods of loss there is no allocation required under the two-class method between common and participating securities. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because the Company has reported a net loss for the three&#160;months ended March&#160;31, 2025 and 2024, basic net loss per share attributable to common shareholders is calculated by dividing net loss attributable to common shareholders by the weighted-average common stock outstanding during the period, without consideration for potential common stock equivalents. Net loss attributable to common shareholders is equal to net loss, less accretion on preferred securities to their redemption value to the extent such securities are outstanding. Diluted net loss per share attributable to common shareholders is calculated by adjusting the weighted-average stock outstanding for the dilutive effect of potential common stock equivalents outstanding. For purposes of calculating the diluted net loss per share attributable to common shareholders, convertible preferred stock, convertible promissory notes, warrants, and stock options are considered to be potential common stock equivalents but are excluded from the calculation of diluted net loss per share attributable to common shareholders because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share attributable to common shareholders was the same for all periods presented. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income Taxes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company accounts for income taxes under the asset and liability method as set forth in ASC&#160;740 &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Income Taxes</font><font style="letter-spacing:0.2pt;">&#8221; &#8203;(&#8220;ASC 740&#8221;). Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across its global operations. The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1)&#160;we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2)&#160;for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related taxing authority. For tax positions not meeting the more likely than not test, no tax benefit is recorded. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At March&#160;31, 2025 and December&#160;31, 2024, the Company has accumulated net operating loss carryforwards in both the U.S. and foreign jurisdictions, and no provision for income taxes is required. The Company&#8217;s deferred tax assets are subject to a full valuation allowance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recently Issued Accounting Pronouncements Not Yet Adopted</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2023, the FASB issued ASU No. 2023-09, </font><font style="font-style:italic;letter-spacing:0.2pt;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</font><font style="letter-spacing:0.2pt;"> which requires presentation of specific categories of reconciling items, as well as reconciling items that meet a quantitative threshold, in the reconciliation between the income tax provision and the income tax provision using statutory tax rates. The standard also requires disclosure of income taxes paid disaggregated by jurisdiction with separate disclosure of income taxes paid to individual jurisdictions that meet a quantitative threshold. For public business entities, the ASU is effective for annual periods beginning after December&#160;15, 2024, with early adoption permitted. For entities other than public business entities, the ASU is effective for annual periods beginning after December&#160;15, 2025. The amendments of the ASU should be applied on a prospective basis; however, entities have the option to apply retrospectively for each period presented. The Company does not expect the adoption of this new standard in 2026 to have an impact on its condensed consolidated financial position, results of operations, or cash flow. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2024, the FASB issued ASU No. 2024-03, </font><font style="font-style:italic;letter-spacing:0.2pt;">Income Statement- Reporting Comprehensive Income-Expense disaggregation disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses</font><font style="letter-spacing:0.2pt;">. This ASU requires disclosure of specified information about certain costs and expenses in the notes to financial statements. This ASU is effective for annual periods beginning after December&#160;15, 2026, and interim periods within fiscal&#160;years beginning after December&#160;15, 2027. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. We are currently evaluating the impact that this guidance will have on the disclosures within our financial statements, and expect to adopt this ASU for the year ending December&#160;31, 2027. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 3. Condensed Consolidated Balance Sheet and Statement of Operations and Comprehensive Loss Components</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Prepaid Expenses and Other Current Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets consist of the following: </font>
        </div>
        <table style="width:456pt;height:76.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.79pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:311.79pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,924</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,562</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,654</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,708</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">19,578</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">20,270</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.01pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment, Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment, net consist of the following: </font>
        </div>
        <table style="width:456pt;height:167pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.79pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:311.79pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer equipment and software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">77,118</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">73,312</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Capitalized software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">22,622</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">25,921</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laboratory equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">103,900</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">103,795</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Furniture and fixtures </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9,110</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9,110</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements/Leased buildings </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">63,290</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">63,039</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Aircraft and leased equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">21,249</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">21,249</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">297,289</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">296,426</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation and amortization </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(235,638<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(228,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">61,651</td>
            <td style="padding:0pt;padding-left:6.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">67,817</td>
            <td style="padding:0pt;padding-left:12.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:12.3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Total depreciation and amortization expense was $7.0&#160;million and $17.7&#160;million for the three&#160;months ended March&#160;31, 2025 and 2024, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accrued Expenses and Other Current Liabilities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accrued expenses and other current liabilities consist of the following: </font>
        </div>
        <table style="width:456pt;height:61pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.79pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:311.79pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trade accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,470</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,131</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued payroll and employee medical </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">14,264</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,882</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <table style="width:456pt;height:121.5pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.79pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:311.79pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued bonus </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,150</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,736</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current portion of early exercise stock option liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,957</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contract liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,664</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,470</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current portion of operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,023</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,080</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">11,337</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">8,286</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">78,235</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">77,542</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="height:4pt;line-height:4pt;">
            <td style="padding:0pt;font-size:0pt;line-height:0pt;" colspan="14">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Long-Term Liabilities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other long-term liabilities consist of the following: </font>
        </div>
        <table style="width:456pt;height:76.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.79pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:311.79pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Long-term operating lease liabilities, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">37,067</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">38,651</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Long-term portion of early exercise stock option liability </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">380</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">5,767</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total other long-term liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">37,447</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">44,418</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:15.61pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 4. Guaranty Agreement and Restricted Cash</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company entered into a lease agreement with KCP NNN II Leasehold 4, LLC on July&#160;25, 2019 to lease 114,500 square feet of space in Irving, Texas. As part of the lease agreement, the Company delivered an unconditional, irrevocable letter of credit for $3.4&#160;million from a nationally recognized bank. The Company obtained this letter of credit and placed $3.4&#160;million in a security deposit account. As of March&#160;31, 2025 and December&#160;31, 2024, amounts outstanding are $2.7&#160;million and are included within cash, cash equivalents, and restricted cash and other assets on the condensed consolidated balance sheets. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The remaining restricted cash amounts are not material individually. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheet that sum to the total of the amounts shown in the condensed consolidated statements of cash flows. Restricted cash is presented within cash, cash equivalents, and restricted cash and other assets on the condensed consolidated balance sheets. </font>
        </div>
        <table style="width:456pt;height:91.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:138.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:179.09pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Condensed consolidated balance sheet line item </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:138.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:179.09pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:138.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:179.09pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,201</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">63,950</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restricted cash&#8722;short-term </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:179.09pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents, and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,503</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,492</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:138.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restricted cash&#8722;long-term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:179.09pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2,586</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2,586</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:138.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:179.09pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">35,290</td>
            <td style="padding:0pt;padding-left:10.925pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">68,028</td>
            <td style="padding:0pt;padding-left:16.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:15.61pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 5. Income Taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to tax liabilities imposed by multiple jurisdictions. The Company determines our best estimate of the annual effective tax rate at each interim period using expected annual pre-tax earnings, statutory tax rates, and available tax planning opportunities. Certain significant or unusual items are separately recognized in the quarter in which they occur, which can cause variability in the effective tax rate from quarter to quarter. The Company recognizes interest and penalties related to uncertain tax positions, if any, as an income tax expense. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The effective tax rate on income for the three&#160;months ended March&#160;31, 2025 and 2024 is 0%. For the three&#160;months ended March&#160;31, 2025 and 2024, the tax rates differed from the U.S. federal statutory rate of 21.0% primarily due to the impact of net operating losses and valuation allowances. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to taxation in the United States and various states and foreign jurisdictions. As of March&#160;31, 2025, all loss&#160;years remain open to examination by the taxing authorities. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for temporary differences between the financial reporting bases and tax bases of assets and liabilities based on enacted tax rates expected to be in effect when such amounts are realized or settled. However, deferred tax assets are recognized only to the extent that it is more likely than not that they will be realized based upon consideration of available evidence, including future reversals of existing taxable temporary differences, future projected taxable income, the length of the tax asset carryforward periods and tax planning strategies. The effects of remeasurement of deferred tax assets and liabilities resulting from changes in tax rates are recognized in income in the period of enactment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 6. Redeemable Convertible Preferred Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Redeemable convertible preferred stock as of March&#160;31, 2025 and December&#160;31, 2024, consisted of the following: </font>
        </div>
        <table style="width:456pt;height:127.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:168.01pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:168.01pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">(amounts in thousands, except share and per </font>
              <br >
              <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">share amounts) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:50.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:7pt;padding-right:7pt;letter-spacing:-0.16pt;">Authorized </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:50.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Issued</font>
                <br >
                <font style="letter-spacing:-0.16pt;">and</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:5pt;padding-right:5pt;letter-spacing:-0.16pt;">Outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:36.33pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Original</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Issue Price</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:2pt;padding-right:2pt;letter-spacing:-0.16pt;">Per Share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:45.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Liquidation</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:5pt;padding-right:5pt;letter-spacing:-0.16pt;">Preference </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:45.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Net</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:13pt;padding-right:13pt;letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:168.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">490,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">485,795,293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.61</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">296,335</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">709,261</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">30,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">29,629,630</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.54</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">16,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">42,963</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;C Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">142,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">116,200,835</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.76</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">415,616</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">415,616</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:168.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;D Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">102,600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">102,516,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">8.10</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,078,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,078,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:168.01pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total redeemable convertible preferred </font>
                <br >
                <font style="letter-spacing:0.2pt;">stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">764,600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,806,224</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,246,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:127.5pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:168.01pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:168.01pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">(amounts in thousands, except share and per </font>
              <br >
              <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">share amounts) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:50.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:7pt;padding-right:7pt;letter-spacing:-0.16pt;">Authorized </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:50.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Issued</font>
                <br >
                <font style="letter-spacing:-0.16pt;">and</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:5pt;padding-right:5pt;letter-spacing:-0.16pt;">Outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:36.33pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Original</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Issue Price</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:2pt;padding-right:2pt;letter-spacing:-0.16pt;">Per Share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:45.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Liquidation</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:5pt;padding-right:5pt;letter-spacing:-0.16pt;">Preference </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:45.41pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Net</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:13pt;padding-right:13pt;letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:168.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">490,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">485,795,293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.61</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">296,335</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">709,261</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">30,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">29,629,630</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.54</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">16,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">42,963</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;C Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">142,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">116,200,835</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.76</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">408,715</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">408,715</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:168.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;D Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">102,600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">102,516,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">8.10</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,060,712</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,060,712</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:168.01pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total redeemable convertible preferred </font>
                <br >
                <font style="letter-spacing:0.2pt;">stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">764,600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">734,142,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,781,762</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,221,651</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:14.19pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The rights, preferences, and privileges of the redeemable convertible preferred stock are as follows: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Voting Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">On any matter presented to the shareholders of the Company for their action or consideration at any meeting of shareholders of the Company (or by written consent of shareholders in lieu of meeting), each holder of outstanding shares of preferred stock will be entitled to cast the number of votes equal to the number of whole shares of common stock into which the shares of preferred stock held by such holder are convertible as of the record date for determining shareholders entitled to vote on such matter. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Dividends</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All classes of preferred stock are entitled to receive dividends out of any assets legally available only when, as, and if declared by the Company&#8217;s board of directors, prior to and in preference to any declaration or payment of any dividend on the common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Liquidation Preference</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of shares of Series&#160;C and Series&#160;D preferred stock then outstanding will be entitled to be paid out of the assets of the Company available for distribution to its shareholders at an amount per share equal to the greater of (i)&#160;the Series&#160;C and Series&#160;D original issue price, plus (A)&#160;any dividends declared but unpaid thereon and (B)&#160;a 7.0% cumulative accruing dividend, compounding annually from the date of issuance of such share of Series&#160;C and Series&#160;D preferred stock, (ii)&#160;the amount that the holder of a share of Series&#160;C and Series&#160;D preferred stock would have received upon conversion to common stock, or (iii)&#160;solely with respect to the Series&#160;D preferred stock, 1.2 times the Series&#160;D original issue price. The Series&#160;A and Series&#160;B preferred stock are then paid on a pro&#160;rata, pari&#160;passu basis an amount equal to the greater of (i)&#160;the respective original issue price plus any dividends declared but unpaid thereon, and (ii)&#160;the amount that the holder of a share of Series&#160;A or Series&#160;B preferred stock, respectively, would receive upon conversion to common stock. The remaining proceeds will be distributed to the holders of common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Conversion Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The holders of the Company&#8217;s Series&#160;A, Series&#160;B, Series&#160;C and Series&#160;D preferred stock have the right to convert their shares into a number of fully paid and nonassessable shares of common stock as determined by dividing the respective Series&#160;A, Series&#160;B, Series&#160;C and Series&#160;D preferred stock original issue price by the conversion price in effect at the time. The initial conversion price of the Series&#160;A, Series&#160;B, Series&#160;C and Series&#160;D preferred stock was $0.61, $0.54, $2.76 and $8.10, respectively, and is subject to adjustment in accordance with anti-dilution provisions provided for in the Company&#8217;s Certificate of Formation. The Company&#8217;s Certificate of Formation also specifies that, solely with respect to the calculation of the conversion of the Series&#160;C preferred stock in connection with an initial public offering, the original issue price and the initial conversion price of the Series&#160;C preferred stock are both equal to $4.58. As of March&#160;31, 2025, each share of Series&#160;A, Series&#160;B, Series&#160;C and Series&#160;D preferred stock was convertible into 0.25 share of common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Redemption Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At any time on or after the fifth anniversary of the Series&#160;C and Series&#160;D original issue date, which will begin for Series&#160;C in March&#160;2026 and for Series&#160;D in May&#160;2026, upon written notice from the applicable shareholders, the Series&#160;C and Series&#160;D shares shall be redeemed by the Company at a price per share equal to the greater of (i)&#160;the original issue price plus (a)&#160;all declared by unpaid dividends thereon and (b)&#160;a 7.0% cumulative accruing dividend, compounding annually, or (ii)&#160;the fair market value as determined by an independent appraiser. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Anti-dilution</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to certain exceptions, the conversion price of the Series&#160;A and Series&#160;B preferred stock is subject to broad-based weighted average adjustment to prevent dilution in the event that the Company issues additional shares at a purchase price less than the then-applicable conversion price of the Series&#160;A and Series&#160;B preferred stock, respectively. Subject to certain exceptions, in the event the Company sells additional shares of stock at a price per share less than the Series&#160;C and Series&#160;D original issue price, the conversion price of the Series&#160;C preferred stock is adjusted to the lower price that the Company sells shares in such offering, and the conversion price of the Series&#160;D preferred stock is adjusted based on a broad-based weighted average anti-dilution formula. In the event the Company sells shares in an initial public offering for less than 1.11111 times the applicable Series&#160;C conversion price, then the Series&#160;C conversion price will be reduced (but never increased), concurrently with such issuance to 90.0% of the purchase price in such initial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">public offering. In the event the Company sells shares in an initial public offering for less than 110.0% of the applicable Series&#160;D conversion price, then the series D conversion price will be reduced (but never increased), concurrently with such issuance to 90.0% of the purchase price in such initial public offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 7. Shareholders&#8217; Equity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2025 and December&#160;31, 2024, 1,173,000,000 and 1,150,000,000 shares of common stock with a $0.001 par value were authorized, respectively. There were 35,237,531 and 35,842,319 shares outstanding at March&#160;31, 2025 and December&#160;31, 2024, respectively. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s shareholders. Common shareholders are entitled to receive dividends if and when declared by the Company&#8217;s board of directors, subject to the preferential dividend rights of any preferred stock then outstanding. No dividends have been declared or paid by the Company since its inception. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treasury Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the three&#160;months ended March&#160;31, 2025, the Company repurchased 1,438,138 shares of common stock for an amount of $16.6&#160;million, mainly associated with previously early-exercised options. Refer to below for further details. No common shares were repurchased during the year ended December&#160;31, 2024. Repurchased common stock is shown on the condensed consolidated balance sheets and condensed consolidated statements of redeemable convertible preferred stock and shareholders&#8217; deficit as treasury stock. The Company had 1,620,638 and 182,500 shares of treasury stock as of March&#160;31, 2025 and December&#160;31, 2024, respectively. These shares have not been retired. The Company has not reissued any shares of treasury stock as of March&#160;31, 2025 and December&#160;31, 2024. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2020 Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the 2020 Incentive Plan (the &#8220;Plan&#8221;), the Company may grant awards of options, restricted awards, performance awards or share appreciation rights to employees, consultants, and directors of the Company. A total of 26,091,009 shares of common stock are reserved for issuance upon the exercise of all awards granted or available to be granted under the Plan as of March&#160;31, 2025. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent permitted by applicable laws or any exchange rule, any shares of common stock issued under this Plan that are issued (a)&#160;in connection with the Company&#8217;s acquisition of an unaffiliated business entity, (b)&#160;to the employees of such entity, and (c)&#160;in substitution of equity incentive awards previously issued to such employees by such entity shall not reduce the number of shares of common stock available for issuance under the Plan. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Plan provides for a repurchase feature for vested stock-based awards at the option of the Company if the employee&#8217;s continuous service terminates for any reason, with or without cause, including death or disability. The repurchase shall be exercisable at a price equal to the fair market value of vested shares or, in the case of exercisable options, the fair market value of the common stock underlying such unexercised options less the aggregate exercise price of such options. The Company&#8217;s repurchase lapses when the Company&#8217;s common stock becomes publicly traded. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Option Activity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Plan, the Company has granted incentive stock options and non-qualified stock options to its employees and other service providers (non-employees). Most of the Company&#8217;s stock options vest incrementally over five&#160;years, subject to the grantee&#8217;s continuous employment with the Company (&#8220;time-vesting options&#8221;). The Company recognizes compensation cost on a straight-line basis over the requisite service period for its time-vesting options. In addition to its time-vesting options, the Company has also granted stock options to certain non-employees for which vesting is tied to the grantee&#8217;s performance </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(&#8220;performance-vesting options&#8221;). The Company evaluates whether it is probable that the performance metric will be achieved for its performance-vesting options and recognizes compensation cost on a straight-line basis over the implied service period if achievement of the performance metric is deemed probable. No option shall be exercisable after the expiration of 10&#160;years from the date it was granted. The exercise price of each option shall be not less than 100.0% of the fair market value of the common stock subject to the option on the date the option is granted. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following tables summarize the Company&#8217;s stock option activity during the three&#160;months ended March&#160;31, 2025: </font>
        </div>
        <table style="width:456pt;height:174.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:248.04pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Options Outstanding </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:248.04pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Per Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Contract</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Term</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:248.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total outstanding as of December&#160;31, 2024: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">21,770,225</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.06</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.40</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">226,117</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:248.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,835,296</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">18.60</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:248.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(171,484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.34</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,766</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:248.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cancelled/forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(320,555<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9.78</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">2,839</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:248.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total outstanding as of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">24,113,482</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">10.18</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">5.71</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">361,193</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:248.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total exercisable as of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">16,850,241</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.20</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">4.44</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">302,635</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:248.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total vested or expected to vest as of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">22,975,156</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.82</td>
            <td style="padding:0pt;padding-left:2.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.56</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">352,524</td>
            <td style="padding:0pt;padding-left:4.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:150.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:259.47pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Unvested/Vested Activity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:259.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Grant Date</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Life</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested outstanding, as of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">6,658,321</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">15.79</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.39</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.30</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">2,835,296</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">18.60</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">15.56</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cancelled/forfeited </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(35,716<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16.75</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.50</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:259.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vested, outstanding shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:33pt; text-align:right; white-space:nowrap;">(1,497,160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">14.54</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">9.60</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:259.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested outstanding, as of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:33pt; text-align:right; white-space:nowrap;">7,960,741</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">17.02</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.54</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.41</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.5pt 0pt; width:259.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Early exercised unvested, end of period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">43,605</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16.20</td>
            <td style="padding:0pt;padding-left:1.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.37</td>
            <td style="padding:0pt;padding-left:5.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Aggregate intrinsic value represents the difference between the estimated fair value of the underlying common stock and the exercise price of outstanding, in-the-money options. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The weighted average grant date fair value of options granted during the three&#160;months ended March&#160;31, 2025 was $15.56 per option. The total grant date fair value of options vested during the three&#160;months ended March&#160;31, 2025 and 2024 was $14.4&#160;million and $5.9&#160;million, respectively. The total intrinsic value of options exercised during the three&#160;months ended March&#160;31, 2025 and 2024 was $1.8&#160;million and $0.4&#160;million, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Modification to stock options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;9, 2021 and February&#160;23, 2022, the Company granted stock options to certain executives that are exercisable upon vesting for 331,250 shares and 2,000,000 shares of the Company&#8217;s common stock, respectively (the &#8220;Prior Stock Options&#8221;). The Prior Stock Options vested over five&#160;years. On August&#160;11, 2022, the Company&#8217;s Compensation Committee approved a modification to the Prior Stock Options, which was communicated to holders of the Prior Stock Options on September&#160;1, 2022. The </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">modification reduced the exercise price to $16.20 and modified the vesting conditions such that 20.0% vest upon grant, while the remainder vest over the following four&#160;years. The total number of grantees affected by this modification was twelve. The modification was not mandatory, but rather could be elected by holders of the Prior Stock Options on an individual holder basis. If the holder elected to participate, the holder&#8217;s Prior Stock Options were immediately canceled, and the Company issued the holder an equivalent number of new stock options in exchange (the &#8220;New Stock Options&#8221;) which could be early exercised prior to vesting. All of the holders elected to participate in the modification and exchanged their Prior Stock Options for New Stock Options. In addition, as an alternative to paying cash, holders of the New Stock Options that elected to exercise their options were able to pay for the exercise price by executing a full recourse promissory note with the Company that is secured by the holder&#8217;s restricted shares that are issued upon early exercise. Five grantees elected to early exercise 1,530,000 options utilizing the promissory note. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The principal of each note is equal to the exercise price of the New Stock Options. Interest on the unpaid balance will compound annually and accrue at a fixed rate per annum equal to the mid-term applicable federal rate in effect on the issuance of the note. The maturity date of the notes is the earlier of (1)&#160;December&#160;31, 2030 or (2)&#160;the occurrence of a change in control event, unless an acceleration event occurs sooner. An acceleration event would generally occur if required to ensure compliance with Section&#160;402 of the Sarbanes-Oxley Act of 2022, the termination of the holder&#8217;s employment, the insolvency of the holder or the breach of any warranty of the holder. The holder may elect to prepay the outstanding principal and accrued interest balance of the promissory note at any time without penalty. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the outstanding balance of the note becoming due and payable immediately, upon the occurrence of an acceleration event, if the holder defaults on payment of the note, then interest will accrue at the maximum rate permitted by applicable law. The Company will have full recourse against the holder for failure to pay the note as and when due. Such promissory notes will be secured by the restricted shares issued to the holder that are underlying the note. If the note is not repaid upon an event of default or acceleration event, the Company has the right to repurchase the restricted shares issued upon the exercise of the note for fair market value, which proceeds will apply to repayment of the note (with any remaining balance remaining due). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company accounted for the modification as a Type I (Probable to Probable) modification under ASC 718 that does not change the classification of the award (i.e., the New Stock Options continue to be classified within equity). The Company calculated the fair value of the Prior Stock Options and New Stock Options immediately prior to and after the modification using the Black-Scholes option pricing model. The incremental fair value was added to the original unrecognized compensation cost to arrive at the new unrecognized compensation cost, to be recognized over the remaining requisite service period. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unvested stock received from early exercises of the New Stock Options are subject to a right of repurchase at the lesser of (i)&#160;original issuance price or (ii)&#160;then-current fair market value in the event of the employee&#8217;s termination, either voluntary, or involuntary. The Company&#8217;s repurchase right with respect to these shares typically lapse over four&#160;years as the shares become vested. Early exercises of stock options are not deemed to be substantive exercises for accounting purposes and accordingly, consideration received for exercises of unvested stock options is initially recorded as a liability and subsequently reclassified into shareholders&#8217; deficit as the related shares vest. As of March&#160;31, 2025 and December&#160;31, 2024, 43,605 and 662,000 shares from options exercised to date were subject to repurchase at a price of $16.20 per share. Of the amount subject to repurchase as of March&#160;31, 2025 and December&#160;31, 2024, $0.3&#160;million and $5.0&#160;million was recorded within other accrued expenses and current liabilities, respectively, and $0.4&#160;million and $5.8&#160;million was recorded within other long-term liabilities on the condensed consolidated balance sheets, respectively. In addition, as the early exercise was performed via issuance of a promissory note, a corresponding debt amount, plus related interest income was recorded as contra-equity. The total amount presented as contra-equity as of December&#160;31, 2024 $26.5&#160;million, which includes interest income and the impact from exercises of both the vested portion of the New Stock Options and early exercises. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;3, 2025, the Company repurchased 1,429,213 common stock shares issued upon early exercise of stock options at $18.60 per share and proceeds were used to pay off the promissory notes and accrued interests. Repurchased common stock shares included 810,816 and 618,397 common stock shares, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">respectively, that were for options vested and unvested at the time of the repurchase, respectively. On the same day, the Company granted 1,530,000 new stock options to the same employees. New options were issued at an exercise price of $18.60 per share, have the same vesting status as cancelled options and are not early exercisable. The other terms of the new options are substantially the same as the original options. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company accounted for the repurchase of the shares and grant of the new options as a Type I (Probable to Probable) modification under ASC 718. The Company calculated the fair value of the original options and new options immediately prior to and after the modification using the Black-Scholes option pricing model based on the following assumptions: risk-free interest rate of 3.93%&#8201;&#8211;&#8201;3.99%; dividend yield of 0.00%; stock price volatility of 68.96%&#8201;&#8211;&#8201;69.48%; and an expected life of 5.0&#8201;&#8211;&#8201;5.3&#160;years. The total incremental fair value was $15.1&#160;million, of which $8.6&#160;million corresponding to the vested options was immediately recognized as compensation expense, with the remaining $6.5&#160;million and the original unrecognized compensation cost of $5.7&#160;million being recognized over the remaining requisite service period. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Restricted Awards Activity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company grants restricted stock&#160;units that will be settled in shares of the Company&#8217;s common stock upon vesting to its employees and non-employee directors. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Vesting of the restricted stock&#160;units is contingent upon the Company completing either an initial public offering of its common stock or a change of control. The Company has determined that these performance conditions are not probable of being achieved, and thus has not recognized any compensation expense associated with its restricted stock&#160;units. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the Company&#8217;s restricted stock unit activity for the three&#160;months ended March&#160;31, 2025: </font>
        </div>
        <table style="width:384pt;height:72pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:252.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Restricted Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Units </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average Grant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:252.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested as of December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.28pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">762,500</td>
            <td style="padding:0pt;padding-left:7.28pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">18.19</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:252.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.28pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">522,040</td>
            <td style="padding:0pt;padding-left:7.28pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">18.60</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:252.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested as of March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.28pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,284,540</td>
            <td style="padding:0pt;padding-left:7.28pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">18.36</td>
            <td style="padding:0pt;padding-left:12.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.2pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock-Based Compensation Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company recorded stock-based compensation expense in the condensed consolidated statements of operations and comprehensive loss as follows: </font>
        </div>
        <table style="width:456pt;height:126pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:337.75pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">466</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">427</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8211;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,243</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,118</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,636</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,945</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2,346</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">966</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">14,691</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">4,458</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:36pt; margin-top:14.2pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There was no tax benefit associated with the above stock-based compensation expense. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Valuation of Stock-Based Awards to Employees</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company records stock-based compensation expense for stock-based awards based on the estimated fair value of the awards on the date of the grant. The fair value of the Company&#8217;s restricted stock&#160;units is based on the fair value of the Company&#8217;s common stock at the date of grant. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company estimates the fair value of stock options using a Black-Scholes option pricing model. The absence of a public market for the Company&#8217;s common stock requires the Company&#8217;s board of directors to estimate the fair value of its common stock for purposes of granting options and for determining stock-based compensation expense by considering several objective and subjective factors, including contemporaneous third-party valuations, actual and forecasted operating and financial results, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, the rights and preferences of common and convertible preferred stock, transactions involving the Company&#8217;s common stock, and assumptions for a discount for lack of marketability. The fair value of the Company&#8217;s common stock was determined in accordance with the applicable elements of the American Institute of Certified Public Accountants Accounting and Valuations Guide, </font><font style="font-style:italic;letter-spacing:0.2pt;">Valuation of Privately Held Company Equity Securities Issued as Compensation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The key assumptions used in determining the fair value of options granted and a summary of the methodology applied to develop each assumption are as follows: </font>
        </div>
        <table style="width:384pt;height:101.5pt;margin-left:36pt;margin-top:9.99999999999997pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:302.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:69.75pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:302.25pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:69.75pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">69.0%&#8211;69.5% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.25pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.75pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3.9%&#8211;4.1% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.25pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.75pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5.00&#8211;6.55 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.25pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.75pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.25pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected forfeiture rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.75pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.0%&#8211;8.3%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:36pt; margin-top:8.89pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No awards were granted during the three&#160;months ended March&#160;31, 2024. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected volatility.&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">This is a measure of the amount by which the share price has fluctuated or is expected to fluctuate. An increase in the expected price volatility will increase the fair value of the option granted and the related compensation expense. As the Company is not publicly traded, the expected price volatility for the Company&#8217;s options was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the business corresponding to the expected term of the awards. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Risk-free interest rate.&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for U.S. Treasury notes with maturities corresponding to the expected term of the awards. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected term.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This is the period of time over which the options granted are expected to remain outstanding and is based on the Company&#8217;s estimate, taking into consideration vesting term, contractual term and historical actual lives. Options granted have a maximum term of ten&#160;years. An increase in the expected life will increase the fair value of the option granted and the related compensation expense. Due to the lack of historical share option exercise data, the Company utilizes the simplified method for determining the expected term. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividend rate.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Company has not made any dividend payments, nor does it have plans to pay dividends in the foreseeable future. Therefore, an expected dividend yield of zero is utilized. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Forfeitures.&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">Forfeitures are estimated at the time of grant and reduce compensation expense ratably over the vesting period. This estimate is adjusted periodically based on the extent to which actual forfeitures differ, or are expected to differ, from the previous estimate. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 8. Long-Term Debt</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The carrying value of debt presented within current portion of notes payable and long-term indebtedness, net of debt discounts on the condensed consolidated balance sheets as of March&#160;31, 2025 and December&#160;31, 2024 includes the following components: </font>
        </div>
        <table style="width:456pt;height:138.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.79pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:311.79pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Term loan Initial Draw&#8211;January&#160;18, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exit fee on term loan&#8211;January&#160;18, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,000</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,000</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Term loan Subsequent Draw&#8211;March&#160;5, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">200,000</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exit fee on term loan&#8211;March&#160;5, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,000</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,000</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: Amortized debt discounts and financing costs</font><font style=" position:relative; bottom:4.25pt;line-height:6.5pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(28,918<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(30,863<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net debt </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">375,082</div>
            </td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">373,137</div>
            </td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.5pt 0pt; width:311.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Compound bifurcated derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,342</td>
            <td style="padding:0pt;padding-left:8.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">6,058</td>
            <td style="padding:0pt;padding-left:13.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.01pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes debt discounts of $28.3&#160;million associated with the initial carrying value of compound bifurcated derivative liability. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Maturities of the Company&#8217;s debt are expected to be as follows as of March&#160;31, 2025: </font>
        </div>
        <table style="width:384pt;height:98.5pt;margin-left:36pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:334.29pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Years Ending December&#160;31, </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Remainder of 2025</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2026 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">340,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:334.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 144pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.01pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:36pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents 15% of the outstanding principal amount under the 2023 Term Loan Agreement, which is due on the earlier of (x)&#160;for dates prior to January&#160;1, 2026, any date that the redemption rights in respect of our Series&#160;C preferred stock or Series&#160;D preferred stock are or may become exercisable within 90&#160;days following such date, or (y)&#160;January&#160;1, 2026 or the first date thereafter if, as of such date, the redemption rights in respect of our Series&#160;C preferred stock or Series&#160;D preferred stock are or may become exercisable on or prior to the date that is six&#160;months after the maturity date. The Series&#160;C preferred stock redemption rights may be exercised on or after March&#160;31, 2026. All outstanding shares of our Series&#160;C preferred stock and Series&#160;D preferred stock will convert into shares of common stock as part of the Preferred Stock Conversion and any redemption rights thereunder will terminate in connection with the completion of this offering and consequently, the payments disclosed herein would not be applicable. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.02pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Term Loan Refinancing</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;21, 2018, the Company entered into a secured term loan agreement (the &#8220;Original Term Loan Agreement&#8221;) with Sixth Street Specialty Lending, Inc. and Barnett Debt Holdings, LLC (collectively, the &#8220;Original Term Loan Lenders&#8221;), which provided the Company with an initial term loan of $50.0&#160;million (the &#8220;2018 Term Loan&#8221;) and a delayed term loan draw option of $50.0&#160;million, which the Company drew down in full on October&#160;4, 2019 (the &#8220;2019 Term Loan&#8221;). On April&#160;2, 2020, the Company amended the Original Term Loan Agreement (the &#8220;Amended Term Loan Agreement&#8221;) to obtain additional term loan proceeds of $75.0&#160;million (the &#8220;2020 Term Loan&#8221; and collectively with the 2018 Term Loan and the 2019 Term Loan, the &#8220;Original Term Loans&#8221;). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;18, 2023, the Company entered into the New Term Loan Agreement with OrbiMed Royalty &amp; Credit Opportunities III, LP, OrbiMed Royalty &amp; Credit Opportunities IV, LP (collectively, &#8220;OrbiMed&#8221;), and Braidwell Transaction Holdings LLC (&#8220;Braidwell&#8221;, and collectively with OrbiMed, the &#8220;New Term Loan Lenders&#8221;). Pursuant to the New Term Loan Agreement, the Company issued senior, secured promissory notes by which the New Term Loan Lenders agree to lend the Company up to an aggregate principal amount of $400.0&#160;million, $200.0&#160;million of which was received by the Company upon issuance (the &#8220;Initial Draw&#8221;), and the remaining $200.0&#160;million was received by the Company in March&#160;2024 (the &#8220;Delayed Draw&#8221;). </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until the earlier of December&#160;31, 2024 or the date on which the 2024 Term Loan amount was fully drawn, which occurred on March&#160;5, 2024, the undrawn balance of the New Term Loan Commitment was subject to a fee of 0.5% per annum. The outstanding principal amount of the 2023 Term Loan is due and payable on January&#160;18, 2028. If an event of default occurs and is continuing, the New Term Loan Lenders may declare all amounts outstanding under the New Term Loan Agreement to be immediately due and payable. A final payment exit fee equal to 1.0% of the amount funded under the New Term Loan Agreement is due upon prepayment or maturity. Amounts borrowed pursuant to the New Term Loan Agreement may be prepaid at any time. Upon prepayment, the Company is subject to a prepayment penalty based on the timing of repayment. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2023 Term Loan bears interest at a rate per annum equal to a fixed margin of 6.5% plus the greater of (a)&#160;forward-looking three-month secured overnight financing rate (&#8220;SOFR&#8221;) and (b)&#160;2.5%. In the event of default, the fixed margin shall increase by 3.0% per annum. As of March&#160;31, 2025, the interest rate was 10.8%. Regular quarterly payments are interest-only for the 60-month term of the New Term Loan Agreement, with the principal due at maturity. The effective interest rate for the Initial Draw of the 2023 Term Loan is 17.0%, and the effective interest rate for the Delayed Draw of the 2023 Term Loan is 12.0%. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s obligations under the New Term Loan Agreement are secured by a first lien security interest in substantially all of the assets of the Company and its subsidiaries. The New Term Loan Agreement contains certain customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default applicable to the Company and its subsidiaries. Additional covenants include those restricting dispositions, fundamental changes to its business, mergers or acquisitions, indebtedness, encumbrances, distributions, investments, transactions with affiliates and subordinated debt. At March&#160;31, 2025, the Company is in compliance with all covenants. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company identified multiple embedded derivatives that require bifurcation from the 2023 Term Loan. They are separately accounted for in the condensed consolidated financial statements as one compound derivative liability. Those embedded features include various contingent prepayment and compensatory payment features as well as interest rate increases upon an event of default. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interest Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The components of interest expense associated with the Company&#8217;s long-term indebtedness, excluding finance leases, are as follows: </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:337.75pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Debt discount amortization </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,945</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,589</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,829</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">7,690</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:337.75pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense on long-term indebtedness, excluding finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">12,774</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9,279</td>
            <td style="padding:0pt;padding-left:8.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrant Liability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As part of the Original Term Loan Agreement, the Company issued 13,694,623 warrants (the &#8220;2018 Warrants&#8221;). In connection with the amendment to the Original Term Loan Agreement in 2020, the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Company issued an additional 11,399,814 warrants (the &#8220;2020 Warrants&#8221;) and amended the 2018 Warrants. Furthermore, these amendments also permit the exercise of both the 2018 Warrants and 2020 Warrants into Series&#160;C preferred stock or common stock at the option of the holder. The 2018 Warrants are exercisable into Series C preferred stock at a price of $1.61 and into common stock at a price of $6.44. The 2020 Warrants are exercisable into Series C preferred stock at a price of $1.93 and into common stock at a price of $7.73. As a result of the amendment to permit exercise of the warrants into redeemable preferred stock, the warrants are classified as a liability pursuant to the guidance in ASC 480. Therefore, the warrants are reported at fair value within warrant liabilities on the condensed consolidated balance sheets, with changes in fair value reported within changes in fair value of financial instruments on the condensed consolidated statements of operations and comprehensive loss. </font>
        </div>
        <div style="margin-left:36pt; margin-top:8pt; width:420pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table reflects the changes in fair values associated with these warrants. </font>
        </div>
        <table style="width:456pt;height:80.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:259.18pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:86.41pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2018 Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:86.41pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 Warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Warrants granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">13,694,623</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">11,399,814</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercise price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$1.61</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$1.93</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:259.18pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercise period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Earlier of 7&#160;years from the date of issuance, </font>
                <br >
                <font style="letter-spacing:0.2pt;">or immediately after closing IPO </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:259.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value at date of issuance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 0.833pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$0.8&#160;million</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 0.833pt 0pt; width:86.41pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$7.9&#160;million</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:84.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value at December&#160;31, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">54,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">44,193</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Decrease in fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(2,911<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(4,180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value at December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">51,629</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">40,013</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Increase in fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">20,405</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">16,644</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value at March&#160;31, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">72,034</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">56,657</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 9. Commitments and Contingencies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Purchase Obligations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company enters into various supply agreements that contains purchase commitments. Most of the commitments are based on a binding forecast for an agreed-upon period, which is 12-month or less. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Corporate Liability and Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains professional liability, general liability, and other customary insurance on a claims-made basis in amounts deemed appropriate by the Company&#8217;s management based upon historical claims and the nature and risks of the Company. The Company&#8217;s business may subject the Company to litigation and liability for damages. The Company believes that current insurance protection is adequate for present business operations, but there can be no assurance that the Company will be able to maintain professional and general liability insurance coverage in the future or that such insurance coverage will be available on acceptable terms or adequate to cover any or all potential product or professional liability claims. A successful liability claim in excess of insurance coverage could have a material adverse effect on the Company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Litigation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the ordinary course of business, the Company has become and may in the future become subject to pending and threatened legal and regulatory actions and proceedings. While it is not feasible to predict or determine the ultimate outcome of these matters, the Company believes that none of its current legal proceedings will have a material adverse effect on its financial position, results of operations, or cash flows for the periods ended March&#160;31, 2025 and December&#160;31, 2024. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 10. Related Parties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s officers and directors have ownership interests in certain vendors providing services to the Company. During the three&#160;months ended March&#160;31, 2025 and 2024, the Company made payments to these entities for services and expenses for $0.7&#160;million and $0.5&#160;million, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 11. Net Loss Per Share Attributable to Common shareholders</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the computation of the basic and diluted net loss per share attributable to common shareholders: </font>
        </div>
        <table style="width:456pt;height:111.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:331.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.16pt;">(amounts in thousands, except share and per share data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adjustments of redeemable convertible preferred stock to redemption value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(24,462<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(23,113<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss attributable to common shareholders </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(127,043<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(134,141<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:331.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share attributable to common shareholders, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(3.57<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(3.80<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:331.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted-average shares used in computing net loss per share attributable to common shareholders, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">35,623,042</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">35,313,037</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:8.1pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common shareholders for the periods presented as they had an anti-dilutive effect: </font>
        </div>
        <table style="width:416pt;height:142.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">121,448,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">121,448,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7,407,408</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7,407,408</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;C preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">29,050,209</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">29,050,209</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;D preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">25,629,071</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">25,629,071</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">6,273,609</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">6,273,609</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">24,113,482</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">21,501,676</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested shares subject to repurchase </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">43,603</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">968,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:291.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">213,966,205</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">212,278,796</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.1pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 12. Segment and Geographic Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company operates as a single operating segment. An operating segment is defined as a component of an entity for which discrete financial information is available and regularly reviewed by the entity&#8217;s chief operating decision maker (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s CODM, its Chairman and Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis for the purposes of allocating resources, making operating decisions and evaluating financial performance. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Net loss as reported on the condensed consolidated statements of operations and comprehensive loss is used by the CODM to assess segment performance against management budgets and prior period operating results for the purpose of making results-driven decisions about organizational resource allocation. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Segment revenues are derived from molecular profiling, strategic data, and research services that are delivered to the Company&#8217;s biopharmaceutical and clinical customers, who are predominantly located in the United States. The Company provides these services primarily by leveraging the Company&#8217;s proprietary technologies and clinico-genomic database, which are core to the Company&#8217;s operations and are deployed similarly across the service offerings. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="text-indent:36pt; margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below is a summary of the segment profit or loss, including significant segment expenses: </font>
        </div>
        <table style="width:456pt;height:216pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:337.75pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">120,915</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">80,677</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Less: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8722;Molecular profiling services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">60,894</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,894</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost of services&#8722;Pharma research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,958</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,669</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Selling and marketing expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">39,829</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">39,609</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,119</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">44,354</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">23,066</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">34,376</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">503</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,768</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(12,782<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(9,290<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Changes in fair value of financial instruments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(32,333<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(11,064<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expense, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(17<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(219<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:337.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Segment and consolidated net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(102,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(111,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:12.7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the Company&#8217;s revenue by geographic areas based on the customer&#8217;s location: </font>
        </div>
        <table style="width:416pt;height:81pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:297.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:297.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:297.75pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:297.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">118,432</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">78,430</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:297.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">International </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">2,483</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2,247</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:297.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">120,915</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">80,677</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:36pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No single country outside of the United States accounted for more than 10.0% of total revenue during each of the three&#160;months ended March&#160;31, 2025 and 2024. As of March&#160;31, 2025 and December&#160;31, 2024, approximately 99.0% of the Company&#8217;s total assets are located in the United States. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 13. Employee Benefit Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company sponsors a 401(k) plan, and pursuant to its terms, eligible employees can elect to contribute to the 401(k) plan, subject to certain limitations, up to the lesser of the statutory maximum or 100.0% of eligible compensation on a pre-tax basis. For the three&#160;months ended March&#160;31, 2025 and 2024, the Company contributed $1.9&#160;million and $2.2&#160;million, respectively, to match employee contributions as permitted by the plan. The Company pays the administrative costs for the plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Note 14. Subsequent Events</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;1, 2025, the Company closed a private financing in which it issued a combination of senior convertible notes (the &#8220;2025 Convertible Notes&#8221;), Series&#160;E convertible preferred stock and Series&#160;F convertible preferred stock, for an aggregate of $167.7&#160;million. The 2025 Convertible Notes have an aggregate principal amount of $30.0&#160;million. The 2025 Convertible Notes accrue interest at a rate of 8% per annum, payable quarterly in cash, and mature on January&#160;1, 2026. The Company issued 12,345,674 shares of Series&#160;E convertible preferred stock with a purchase price of $8.10 per share, for aggregate proceeds of $100.0&#160;million. The Company also issued 4,657,401 shares of Series&#160;F convertible preferred stock with a purchase price of $8.10 per share, for aggregate proceeds of $37.7&#160;million. In connection with this financing, the Company also issued warrants to acquire shares of common stock to the holders of the 2025 Convertible Notes. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14.5pt;font-weight:bold;font-size:12.5pt;">
          <font style="letter-spacing:-0.25pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:426pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These warrants are not initially exercisable for any shares of common stock, but such warrants become exercisable for a specified dollar value of shares on a monthly basis commencing on June&#160;1, 2025 if we have not completed an initial public offering by such date. Any exercisable portion of the warrants will be automatically exercised prior to the closing of the initial public offering and such warrants will terminate upon the closing of the offering. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Immediately prior to and in connection with the completion of the initial public offering, the 2025 Convertible Notes, Series&#160;E convertible preferred stock and Series&#160;F convertible preferred stock (plus an 8% accretion in connection with the preferred stocks) will convert into common stock at a price equal to 70% of the initial public offering price per share. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As further disclosed in Note 2, the Company effected a one-for-four reverse stock split of its common stock. The reverse stock split was effective June 1, 2025. </font>
        </div>
        <div style="text-indent:36pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There were no other significant subsequent events identified through the date that the condensed consolidated financial statements were issued, that could impact the financial statements.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 3pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:36pt; margin-top:14pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Through and including July&#160;12, 2025 (the 25th day after the date of this prospectus), all dealers effecting transactions in the common stock, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to the dealer&#8217;s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.</font>
        </div>
        <div style="margin-top:36pt; text-align:center; width:456pt; line-height:18pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">23,529,412 Shares</font>
        </div>
        <div style="position:relative;margin-top:14pt; text-align:center; width:456pt;">
          <img src="lg_carislifesciences-pn.jpg" alt="[MISSING IMAGE: lg_carislifesciences-pn.jpg]" height="96" width="116" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Common Stock</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:59.167pt; text-align:center; width:456pt;">
          <div style="margin-left: 27.522%; margin-right: 27.522%; margin-top: 59.1666666666667pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:19pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">P R O S P E C T U S</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:18.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 27.522%; margin-right: 27.522%; margin-top: 18.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:52pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">BofA Securities</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">J.P. Morgan</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Goldman Sachs &amp; Co. LLC</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Citigroup</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">TD Cowen</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">Evercore ISI</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">Guggenheim Securities</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">BTIG</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">Wolfe | Nomura Alliance</font>
        </div>
        <div style="margin-top:48pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">June&#160;17, 2025</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:14.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 14.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 3pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_carislifesciences-pn.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_carislifesciences-pn.jpg
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M @   @ " #A"24T$)0      $/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4
M9,     !_]L A  $ P,# P,$ P,$!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)
M" H*# P,# P*# P-#0P,$1$1$1$4%!04%!04%!04 00%!0@'" \*"@\4#@X.
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!3_P  1" %U <0# 1$  A$! Q$!_\0 P0 !  (" P$!
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M]'<V=5RMW=7&//L^J0HI8YHVRPO;)$\=3'L(<UP/(@C@5UDQAO=G$X[G-11
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M2<S8VS3C'&-OY;/EM6RU_9%6$\)V?A*"ZAVX@(" @(" @(" @(" @(" @("
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M@\"M%N6JK=4TU1A,-ZMW:;E,54SC$N^N-R" @(" @(" @(" @(" @(" @("
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MAFM?OW-EOR1VRV[*Z!8M[;GGGLA.^,Q6,PMG'C\/906%A%PCMK6-D,3?8U@
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M]M;V<$=K:0L@M86AD,,30R-C&\ UK6@  >@+4YJF9QG>VR*8B,(W/JHH@("
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MN[7MRU'KJFKHV=[I+ON.[/HIBGIV]R.\MYC=Y,NXF34TMI&>4=E%!; >QT;
M[\+EVEO1\I1_#'IQEU=S6,W7_/#HPAJ-[N)K_).+K_5.6N">8DOKAP_!UT7V
MTY.Q3NHICJA\56<OU;ZZIZY8J3.YN8UFR5U(>=7SR.-3[7+FBU1')'8X9NUS
MRSVOR/.9N(]462NF'TMGD:>'+DY)M43R1V$7:XY9[65LMPM>XYP=8:HRUL6\
MO"OKAH_ 'T7#5E+%6^BF>J'-3F[].ZNJ.N6VXKS$[R8AS3%JB>Y8.<=['#=
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M44T4Q33&$0[*P9B @(" @("#3==[J:&VYMO&U1E(X+IS>J#'0_;7DH_)B;Q
M/TG4;ZU]V5R-[,SY*=G'D[7PYK/6<M'GJV\.7L57UYYOM6Y@RV6A[./ 8\U:
MV]G#;F^<#VBH,<?L#7'T.6XY7V]:HVW9\<\-T=[3LU[ANU[+4>"..^>Y7[,Y
M[-ZBO7Y'/9&XR5\^O5<7<KYG\>- 7DT'J'!;+;M46XPHB*8YFM7+M=R<:YFJ
M>=CUR.(0$! 0$! 0$!!WL3F<O@;QF1PE_<8Z_C]RYM)7PR#M]YA!7'<MTW(P
MJB)CG<ENY5;G&F9B>9/N@O-UK/!.CL]:6S-18T4:;EO3;7[1Z>IHZ'T]#F@G
MZ2US-^W[5S;;GP3VPV3*>X+UO9<CQQV2M3H+=K0FY$ =IG*,??!O5-B[C[&]
MC]-8G'O =KF%S?6M.S>GWLM/GIV<>1N.4U"SF8\E6WARMW77NP$! 0$! 0$'
MQN[.TR%K-97T$=S9W##'/;S-$D<C'"A:YK@001V%94U33.,3A,,:J8JC"8QB
M5-=\O+'<Z?%UJ[;N%]U@FUFOL(VKY[5O-SX:U,D0[6^\W\H>[O6EZW%S"W>V
M5<E7'IYVBZIHDV\;EG;3RT\.CF5D6V-29C2VJ,UHS/66I-/W!MLI8OZXG\VN
M!X.8\<.ICA5KF]H7!?L47J)HKC&)<]B_79KBNB<)AZ/;6[DX?=#2MOJ'&$17
M;:0Y3'EU7VUT!WF'TM/O,=VM]!J!Y;GLE7E;LT5;N2>,/4\CG:,U:BNG?RQP
MENJ^!]X@(" @(" @(" @(" @Z]_?V>+L;G)9&=EM86<3[BZN)#TLCBB:7.<X
M]@ %5E11-4Q3$8S+&NN**9JF<(AYS[V[KWNZNK)+YA?%IO'E\&#LG<.F$D=4
MKQR\26@<[T"C>/35>HZ9D(RMK#^4^J?MT0\NU//SF[N/\8],??IE&G/@%VKJ
M5NO+_P"6L0BUUON/9UF[LV)T_.VH;VMFNFGM[6Q'E\[CW1I6K:UCC:LSTU?:
M._L;MI.BX87;T=%/WGN[5L5IC<Q 0$! 0$!!TLOF,7@<=/ELU>16&-M6]<]U
M</$<;1ZR>T]@YE<ENW5<JBFF,9EQW+E-NF:JIPB%1]U?-M?7SI\+MBPV=EQ9
M)G[AG]8D!X'P(G"D8]#G@N]32MUR&@4TX57]L_UY.OBTK/\ N"JK&FQLC^W+
MU<%8+V]O<E=S7^1N);N^N'%\]S.]TLKWGF7.<22?:MMIIBF,(C"&HU535.,S
MC+X+)B(" @(" @(" @(" @(/M:W5U8W$5Y93R6UW"X/AGA>Z.1CAR+7-(((]
M(4JIBJ,)C&&5-4TSC$X2LMM3YL\MB#!A=R6ORF,J&,S<0'QL0Y#Q6"@E:/2*
M/^L5JF?T"FO&JSY9_KR=7#Z=#:\AK]5&%-[S1_;EZ^/UZ5OL'GL-J;&09G 7
MT60Q=R.J&Y@<'L/I![0X=K3Q':M(NVJ[54TUQA,-WM7:+M,543C$LBN)RB @
M(" @(""KN_OEJCRXNM:[=6HCR_&;)X*$49<GFZ6W:. E[71C@_L[W!VWZ3K7
M@PM7IV<E7#IYN?DZ-VH:MHOCQNV8V\M/'HY^;EZ=].'L?&]T<C2Q["6N:X4(
M(X$$%;RT9OVS^Z&2VKU;#FK?KGP]S2WS-@T\)K8GFT'AXD?O1GY.3BNMU#(T
MYJUX9WQNGG[N+L=.SU65N^*-T[XXQW\'H_B<MCL[C+3,XFX;=8R^B9<6MQ'[
MKXY!4'TCU@\0O+;ENJW5--483#U.W<IN4Q53.,2[BXW((" @(" @(" @(" @
MJ'YL]W#--_E=@)_L8BR;4<\9X.?P?%:U'8WA))Z^D=C@MVT#3\(_?7'_ %[^
MYI.OZAC/Z*)_[=W>J@MR:8N)Y=/+NW&MM-P->6M<FX-GPF&F;_9QS;<3M/\
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M9MS15_Q/%]F3S=>6N173_P QP>DVD=58?6VG;#4^"F\;&Y",2,K0/8X<'QO
MK1[' M</2%Y7F+%=BY-%>^'JN7OT7[<5T;I9M?.^@0$! 0$!!T<SA\;J#%7F
M$S%NR[Q=_$Z"ZMY/=?&\4/K!',$<0>(XKDMW*K=454SA,..Y;IN4S35&,2\W
M]W=LLCM9J^XP-R738N:MQA[]PX3VKC05( '6P]UX]/'D0O4]/SM.:M17&_EC
MA+RS4,E5E;LT3NY)XQ\;UQ/+'N&=;[>18R^F\3.Z:++"[+C5[[:A^&E/M8TQ
MDGB2PGM6CZWD_P!%_P 4>FO;U\OQSMXT3.?OL>&?51LZN3XYDU+H'?B @("
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M?LY'.];Z"3V.6LZEEO\ /F*J(W;XZ)^,&S:;F?\ 1EZ:YW[IZ8^,6_+K79"
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M7LD>RC7#\L=J[_/7?U9>WEXX>*KIG;$?',Z#(VOVYBYF)X^&GHC9,_'.FQ=
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M;.Q\%[+S-ZB[3OIV3STSW3M[6YKX'WB @(" @(" @(" @(" @(" @(" @("
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MPYXG;BE)=.[@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MCF,?86(B ?!>6KIGNEJ:NZP[E2G#I00WKC<3?+;F6#[^9C+BQN'%MO?V\!?
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M[;>'<2W.7=<NLH[.?!20X5]\T])M6W9:'U#A3J\3CV!5&Q?YMS?<WPOW5_\
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M((M\PMHRYVNR4CFAS[6>UFC)^:[QFQDC\UY"L)*F"R1Z':< ;I[$AH :+*W
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M#%,WE\VOAPV,AUQFH0[,Y!G5C(WC^SVKQPD%>3Y1QKV,]KE)6$[**(" @("
M@KWK_3%OC-^=&YNV9X<6;N(I)PT4!N;1P:YWYS3'7UU*J+"**(" @(""!/,]
MJCX+ 8W2D#Z39.7XJ[:.?P]L>Z"/0Z0@CZBL)*OFH-&973F&T_F[ZGPNH;=]
MU:AH-6!CJ!KB>%2US'CU.51('EPU5]R:W=@YW]-EGHO  )H!=0U?$?E'6P>M
MP22%OEBR$! 0$! 01UOM'XFU>?XTZ6V[OP742L)*D:R1Z'Z=_P /XG_H[?\
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MBWD'S9(G![3\A"R1Z":;SEMJ7 8W/6G\QD+>.X#0:])>WO,/K:ZK3[%@R91
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MGD\$]K/);7,;H;F%SHYH9&ECV/8:.:YIH0010@K)&RZ&U_J'0&4&0PD_V$A
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MQEYEKUW19V,$ES.[T,B:7N_$$%#((\CN#K=C'DG(Z@R%9".(8;F2KC]5@/X
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M001R(51:K9_?6TSL,&F]97#;;/, BM,C(0V*[[ UYY-E]O!WMX'&87%.JBB
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M)D+R0GJNI*]1B8X\7%Q]]WS1ZR%91<V*..&-D,+&QQ1M#(XV -:UK10  <
M%BR<D! 0$! 08?4&E=.:JMA::AQD&0A%>@S,[[*_0>*.:?JD((?U!Y7]-7CG
MRZ=RMSC'GBV"=HNX0?0#5CP/:YRN*8- R/EDUY:N)L+O'W\?9262%_RA[*?Q
ME<3!@)]@MU;<U;A6R@<>J*ZM3^(R@IBF#Y-V.W8>>G[@D%>UUS:@?CF3$P=Z
MV\O&Z,]/$QT%L#VRW4)I_P -STQ,&S8GRMZEG<TYK-6=E&3WA;-DNG@?G"(5
M^5,5P3AMWM;IW;BWG&*=+<Y"[#6W=]<$%[FL)(:UK0 UM36@XGM)H%%;NH,'
MJBQU/?6,<>E<K#B;YLG5)-<6PNFOCZ2.D N'2:T->*"+]2[1;E:PA^#U!K\3
M6!(+K6&R$$)IRZF12,#J'Z55<4:TSRI'I^UU5WZ?-L.%?EN$Q,&RZ4V<U]H5
MLT.E]<1Q64[B^6UGL!)"7T ZNETK^EQ %2VB8B7<);Y:UQ=M!G+R/(95C3\3
M>0Q"W8]Q<2*1@NI04'/CS45WT! 0$&H[B:/R6N,"[ V.:=AK:=W]>+;=MQX\
M0H1&:O86BHKW3QY<D$+.\J=X >C5,9/8#9.'_CE7%,'TL?+'GL9=Q7^.U<VT
MO8'=<-Q!;R1R,=Z6N;*"$Q,$F872N[&.FMF7^N8+^PBD89V2XV,ROB::N:'A
MP-2.'4:H)'45A-46.IK^P9%I7*PXB_;('23W%L+IKHJ$%H:7"AJ0:\>2"'M2
M["ZSUG>,O=4:X;>S0M+(/ZETLC:XU(;&R1C6U[2!Q[5<4P8IWE2/3W=5]_UV
M'#]83$P9O36R&O=&&1NF->_!0S$/EA^#ZXG/I3J,<DCV5IPK2J8F"2=*XC7V
M/O))-5:DMLQ8^&6Q00V++63Q200\O:ZE  1T]/&OJ45MJ @(""*=8>7_ $/J
MBX??V;9,)D)"72/LNGP'N/,NA<.D'ZA:KBF"/Y_*I=!Y^&U1&Z/L\2S<UWXI
MBF)@V? ;4;L:9B9;XC<$,M6<&6\UNZYB:/0ULQ>&CZJ"1M*8O7-A-,_5N?ML
MO"Y@;!#;V;;4M?6I<7AW'APITJ*R^>MLU=XJ>#3]]'C<L[I\"[FA%RQM' N!
M82VM14>I!#VJMEM?ZW,+-3ZZ9=6\#B^&W98B.)CR*5#(Y& FG#J=Q5Q1@F^5
M+N][5??X<K#AZ_\ S"8F#O8+R]:LTI>_>&FM;_ W;@6/?':.:',K6CFF9S7"
MO8X)B8)%P.GMTK+(6TF;UC:Y+%QNZKF 8V**61H^:'L+>FOTD5OJ@("",MQ]
ME-/;@W1R[KB7&9[PVQ&\B DCD:P$-\2)Q%:<JM<TJXI@A'+>6C7UD]WW;-99
M.'YI9*8)/E;*T-'\,JXI@^=CM]YA,&!!BVY*VA;P$=ODHA%0<!W1<4_$@R;]
MJ]_M3#X?.Y.:*V?P>R^R9DBH>=60NE'\5%;GI'RR8/'2QW>K;]V6E:0[X&W!
M@MJCL<ZO6\>SI4Q,$Y65E9XZUAL;"".ULK=HC@MX6AD;&#D&M;0 **^Z @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#HY7&1Y:T-I+
M<7-LVO4);*>2VE!H1[\9![>1X(*[[=7.JM0;I9G1V9U1EY\/@C>EK67;XI)?
MA;AL#!(]E'$$.J:4XJHLG%&(8F1-+G-C:&ASW%[B&BE2YU23Z25%<T'PN[5E
M[;26LCY(V2CI+X)'0R#ZKV$.!]A05PQ]QJFXWMEV\EU3ESIV":62@NWB<Q,M
MC<-891WJ5(:>VGK519*WA;;01V[7/>V)H8'RO=(\AHI5SG$DGTDJ*Y/8)&.8
M20' M):2UPKPX$<04%;MX;[4NC-887&:?U-EK?'YAC#-#)=OG\-WC>$3&9"2
M 0>1/-6$28[;'.T^SW!U #^5+$X?R @^VW.#U3@<OJ:SU+EKS-1-EM1C+^\+
MNA\!C<]P8TDM!:YW2_IYT""05%5XW[N]0Z#?B,CIG465MFY-UQ'<VTEW)-$#
M"&.:Y@D+BVO6:\?0K"2WV#;;-3VT,[-?ZA:Z6-C^,T+AU.:">'ACAZD'<VYP
M>IL#?ZEL]1Y:\S36W, QU_>%W2^W,(?W&N) +7/+7]/ D(K?E 0$'XYS6M+G
M$!K14D\  $$,Z9N<SO/>97,7&7O,1H6QNGV6,QV,D-K-=%C0YTEQ,WO4(<T]
M X<:=E75'YK;;&]T[AYM0:(U!F[2_L2R26R^-FN(YX>MH> '$GJ#22.8-*4[
M4$T**((FO]?ZDUMJ&[TEM>88;;''IS&JKEGC00N-1TV[.3W5! )J'4/S>\JC
M),VBCNAXNH-69_*W;O?/QSK: '\B*( -'JJ4Q'3O]EPUAETUJ_/8B^ ^S<;V
M2XA)[.IA+7'^&F(Z^TT^O[74VJ-,ZXRC\D[$QVCK20AI8]ESXI$C7]+7$.#.
M3N1J.Q)$MJ*@KS W6=TA98_46G,[D;&>\NG6US;-NI'6Y#HW2!S8W$AA'33N
M\%824D[=8Z>VTMB[^\R-[DK_ "5G;75U-?7#Y_M)HQ(0QKCTL +J -'+FHK;
M$&-S6&CS=K\+)=WED17IGL+B2UE!(I7J816GY0(05VVLFUCKG46>P65UEF;:
M/$-/@R6\S0]SFS&/O];75X!5&\:NV[UM8X:6\P>N,[>W$3XO$L7R OFC=(UK
MPQT(8YI#27=O)!,0 : T<AP':HK]05R=O#=Z(W>U%B<Y*^?2=U=M8]I+GNLW
M^&QHEC'$]/TV#VCCP-P18BWN(+NWBNK65LUM.QLD,T;@YCV/%6N:1P((/ J*
M^J"$M](LWI/!V^I=-9_*65U->MM;BV^+EDMRR=LCZACR[H+7- '304/L5A)2
MQI_#C"XZ.U-[=W\I:TRW-_</N97OZ0":O-!7T- "BLJ@BK,[AZ@U-J:XT/M@
MR%]U9<,UJ.Y'B6MGWNDMC;R>^H(%:@D'A0%PJ.ZS:0W@\74FK\]E;MWO]%X;
M.VKZ60PBC?X10=>]V7MPSQ,!JS/XB]'N2MOI)XZ_E,<6D_PPF)@Z&V#MQ,7K
M;.Z5UOEWY.WLK.&YL)'!I;+'-*6ME:[I#_F.:X$\#7VH)?4577?J[U'H*;$9
M#3.HLI;Q9,W$=S:R7<DT;70>&6N9XA<6UZS7C3DK"2D&+;;-36\4T>O]0M,D
M;7]Z:%P#G"O^S'#U(.YMQ@]2X&\U)9ZCRMYF>F[A&/O[POZ7VQ@:\=#7$@$.
M>YK^GA4(-]45&NY^L\QC,C@M$:5D9;ZDU++X;;^1H>VTM@0'2!IX.<>/3]4]
MM%4?1VSN)N(/Z_G\]=9)P^TR#LE*V0O/:UH[C0#R'3P3$?;;+&9_ RZCP.=R
MMWF187L8Q]Y>.>]SK26W9(P!SR>(+BUU#2H14@* @(""M^T?^OFN/_NG_J$2
MJ+(**(""M^)__::^_P![_P"GA7D19!11!6[S%@?MOHL@=X\*]O\ :645A)61
M45Q;)&\O#'!QC/2\ @EKJ T/H-""@Y(*\>:O_P"GZ8_37?\ )B5A)3]CP186
MH/ B&.H_-"BONV2-[GL8]KGQD"1H():2 0".S@:H.2 @(/G/$V>&2!]0R5KF
M.(YT<*%!5W:[7$NT&ILIM]K)I@Q3[LEMX0:0S$!K92.V*5@8:]G ^E9(M'#-
M%<1,G@D;+!*T/CE80YCFN%06D<"".16*N:".][M4SZ4V]R%Q9O,=_?N;CK:0
M&A:;@'K<".((C:^A[#16$E^;&X&WP6VV',3 +C),.0NI.U[YS5M?9&&-^1)(
M2*HH@Z46*M(<M<YE@<+VZ@AM9C7NF.W=(YG#TUD<@[J""?-+_A'#?WE_X$BL
M)*6]'?X1P']VV?\ R&**S: @K?Y>_P#4/6Q[/M/UIRLI"QLLL4+#),]L<8H"
M]Y#6BIH.)])*BN: @K[:Z(Q.X.L-T\!DF".=MU93X_(!H,EO/X<@JWE5KN3V
MUXCT&A%1@MN=?9K:34$NW.X ='AFR4M;IQ+F6QD/=D8X\[>3F?HGCP/4$%G6
M/9*QLD;@^-X#F/::M+3Q!!',%141^9!I=M]"?HY.U)_@R#]]6$E+D7\VSZH_
M<45I6[FJ9M(Z!RV4M'F/(2,;:63QP+9K@]'6#Z6-+GCV*P,)Y?L#!A]N+&\:
MP?&9A\M[<R4[Q[YCC%?0&,!]I*2D)24408\8:R&<=J$!WWB^T;8$]7<\!DCI
M1W?3U./%!D$%=O-9_8=+_I;S^3"K"2L#8@BRM@10B)E1^:%%?9LD;W/8Q[7/
MC(;(T$$M<0' $=AH04')! 'F$M<U@,[IC<G$,ZQB7"WF)!<QCVR>)'U@?,DZ
MGL)^2M2%824IZ"W#P&X.*;?XF7P[R,-%]CI"/'MWGL(^<TGW7C@?4:@16V("
M @(""M^T?^OFN/\ [I_ZA$JBR"BB @K?B?\ ]IK[_>_^GA7D19!11!6OS)1-
MGUAH^!Y<ULK7,<YAZ7@.G8*M/8?05824FR;-X9[7!NH=1,<>3VY24D>SJ!'X
M4Q&3VPTQ=:2T_=8>]=)+.W(WDGQ<U#+<QNEI',XU-2Y@;S*BMT05X\U?_P!/
MTQ^FN_Y,2L)+>;;9W"SV,#AG]0Q%\3#W,I)PJT< "TC\28C+[8Z3N=&XK*XJ
MY?).7Y2XG@O+AP?-/ YL;8WR.'-U&])]G)16[H" @((_W.VIPNXUB'R$6>H+
M9A;8Y)HKPY^'*![S*_*WF.T&HA+;_6^J-GM5-T+K</;@)) PMD/6RW$KJ-N(
M']L)/O >LT#@0:+6\^(Y+%4(^:"VEET/CKA@K'!DX_%]0?#* ?PJPDM\VGOH
M<AMOIF> @M98Q6[J=C[8>"\?PF%16Y(" @(()\TO^$<-_>7_ ($BL)*6]&_X
M0P']VV?_ "&**S: @JCM'I2SU7KK5]M>7M]9-@?+(U^.N7VKW$W+A1Q9S'J6
M4HE++[-107N%R.,R^7O_ (/)V4]U89&\-U;OMF3M=(>EX%"T#JYGER4Q$N**
M((>VW?3=[<MG'C):.]7 /'[ZJ-FW0VSQFXV&-O)TVV<M0YV,R%.+''CX;Z<3
M&[M]',>LJ)=I=RLIH7,.VQW#ZK6&WD^'L+J<_P!E>3W8WN/ POJ#&^M&_4/=
M2C?/,6T';HD\VW]H1[>IP_?2"4KQ?S;/JC]Q140^92"6;;?Q(Z]$&0MI):<N
MDMD9Q_.<%826P[)WT%_MAI]\!KX$+[>0=K7PRO80?P525AOZ@(" @KMYK/[#
MI?\ 2WG\F%6$EOD&SN%GLX7#4&H8R^-A[F4DX5:. !:1^),1E]L-*76CL/DL
M3=NDE<[*74T5W.X/FN('=#8I)".;BUH!]B*W90=;(8^QRUC/C<E RZL+IABN
M+>4=3'L=S!""K.O-L=3;0Y9NM]"W4KL+#)U>(WO36H<1]G,.4D3N7413L=V$
MY(GS;'<"TW$TTS+QQBWR,#OA\E:-)(CG: :MKQZ' ]3?P<P5BK<T! 0$%:=I
M+A@W]UD&D%LQRK6GV7S'</P*HLLHKJVV1L[RZO;.WDZ[C'O9%=L (Z))(VRM
M;4BA/0]KN'I0=I!6W$O;_P#E->\?>,S1[1CA7]Q7D3E624405K\Q;C^W>CFD
M]UK6GV5N6U_<5A)64440$%=_-7_8-,#M\:\X?FPJPDI^QI!QUH0:@PQD'\P*
M*Y/OK1E]%C72@7T\4D\4/'J,4+F->[T4!>T?*@[" @(,9J+-0Z<P=_G;F,RP
M6$3IY&-(!+6\^)09($. <TU:>((Y$((,\SV+L+C2N)R)8#F(K]MM:%HK(^*>
M-[GL '$BK&G_ /E6$E,V$@N+7#8ZVNS6[AM88YSS^T9&T._&%%8K7FE(-:Z3
MR6G)G"-]W'6VF=RCN(R'Q.-.- X#JIV500-LGKR70&7O=MM;@XZ,W!^%EG/2
MRWNG4#F/<> CDX.8^O37CR=464A9L$$ @U!X@A17Z@PT.H(KC5-WIF&/K?8V
M4-[=7 <"&/N9'LCB+:<RV-S^?*GI09E!!/FE(_9'##M^\N7^XD5A)2SHIW7H
MW3S_ *6,LC0>NW8HK.H""MOEX<)-P-9R 4#@\@>VZ<592%DE%=;'Y"SRME!D
M<?*)K*Y:)()0" YIY$!P!0=E!"^W3Z;U;C1U]X0.Z?3TD"OXU430HJ.-V=JK
M#<3%^/;AEMJBS8187AX->WGX,M!Q83R/-IXCM!J*^97<#.-T-?[7:S@G9G,;
M<VPL)915XCAD!=%*2>/2WC&\5ZF^JA-1<B+^;9]4?N+%DP^KM.6VK=-9/3EV
M>B*_A=&V2E>B04=&^G;TO#7?(@KKM!K.ZVKU+D-O-< V%C//U,GDX1P75 T/
MZC_12M#>_P AP/(DK*46C:YKVM>QP<QP!:X&H(/(@K%7Z@PW[00NU5^RT<1?
M,S'G)3S@\(VNF$,;"*<WT>>?S?6@S*"NOFL<WX32[*]XR7IIZ@V%6$E8*P_L
M-M^BC_DA11U_:,OH\8Z4"^FB?<1P\:F*)S&/=RI0%[1\J#L(,3CL];Y',9G#
M1MZ9\*^WCG/4#U?$PB9IIS H:(,E<6\%W;RVEU&V:VG8Z*:%X#F/C>.ES7 \
MP0:%! OENQILLCK=UFXOPC+R*TLY:U:\P/GX@]M&.97VJRD)^440$'3RGWK\
M&_[E-N,A4>&;P/,-*\:B.CN7)!3W3-ME_P#,B8Z8R>0_;CXNZ^)#,?:^#U];
MOB.HRWO3T<_>'LXT63%.TT&^_P .[HOK'Q.DTZ+.#Q:^KKNNBOMX**R&RS96
M:<R@OY;F;/\ WO=_?K[V-D,WQW3'U#ICDD;T]'1TD.I3EPHDB0+[X[X2;[M\
M+X_I/P_Q'5X/7V=?1WJ>Q155L?!E/\]7NM[\_MS\?<%\3[)OW;3P7]8Z_B_$
M\/PJT/1U<NU9(M-C/O3X-GWQ\/\ 'U/B?"=?@TKPIXG>Y<UBKMH*I[[0WS]:
M8]VJ+UT-[\*S[ICQ5F)H>CQWTZWSW43O$ZO>[M.2RA)65P U,+=PU,ZR?. S
MPWV+96 FG>+VR.=0U[&N*Q5ET!!6CS'0W<F1PYU/>?#XK^M_=#<=:_$./&+K
M\=TUQ#1U.CW13FK"2VC2L&]PT_8?!W[38_#L^$.2LK477@](Z.KHNSQZ:>_Q
M^EQ09/;V/4K-Q,N==7$\VHSC(_N]KH((;46'C]\PF":0'[3IZJ@.]/8@EQ11
M 0:MN2VQ=H+4+<D^6*Q-C,)Y+9C99FLIS:Q[F-<1Z"X>U!'&W@WOCT]:"P?C
M;C">$W[M=J-DUO>F"GV?=M'3=VE*>(>JBJ.+XW-W&P;MW[B:7)N<[]F(H((X
MM/LN:M]Q_C22NEZNGI\5C37IK\U!.2BB"&]\QM.;2(:V,C<_T?U(XP-=DA'Q
MYAQ#3'7EXIISZ>*L)+2=!0[NQVL?^7]YD+C3'3_5!J.UM[> 1]@CK<RO+?T7
M=0;K?CS'&V>&/P[#0]ZP:'S_ )HNG-97VE-@^NQ,<<9U2,A<9"XU>;R$YYV5
MA9;S-=T.\(-#99B6TZJ.)'#D*))"8%%5Y\R$5[)#BOO^[%MIX7$WP(Q]M\3<
M&7PV_P _XL\+1PKT]%>VO8K"2DC:INIF:3P;<A+:S83X"'X%XC?#?>%TCP?%
M:))(Z]'/I=^^@WY16.S8SAL'C3SK9F2)[CKUKWQ!M#4],9:2>5!4!!4C;"WS
MXU;<'0.2OCGO#D^\A/86HM_#\0=7B%]Z13KI2G>KR63%+.J8-]/N.\\6^'P_
M@N^(^[+.V^*\*AZ^CJNJ]5/H=[Z/%14JZ.%D-)8$8USG8X8ZT^%<\!KS%X+.
M@N )H:<Q4\5%9#(_>/P<OW3X'WA0>#\5U^#6O'JZ.]R]""O.AH=3MW?U0[&7
MT4FI*3_?<5W9F/&]'BLZ?"?'=/EY]/15E>GFJBQD'C^!'\3T?$]#?&\.O1UT
M[W37C2O*JBOH@K_YC6[?O%B,C+)#K?NFT?9QMF?\/U'A<M<^,>&37H/5U \@
M1U*PDI^93H;3E04KZ%%<D$3;X?Y6_=D/[>%XRG2?NTV :<ETU->@&C>BM?YW
MN5]:L)*-MOX=T60@[9WN3GTP>,#=06EM!:AOHC+KF4D>N$ *B0+L>8XV[PQV
M$:ZAH;1O5-R^:+AS8Z_6*@^6Q\;X\SJW[]N,C<:W+[0YC[T@CMW-CI)X0BZ)
MI>IOK[K:=/2*)(F=159/,9#=R97#G55Y\/CNFZ^Z&XVU%P2.J/K\9TUQ#1U/
M#]T45A);=IF#? 8&R^&OV&T\!GPQR5E:BZ\*@Z.KHNSQZ?I\?3Q09+;N/4K-
MP,V=<W$\VI#CH?@0^""&V%AXSNOP3!-*#W^GJJ ?2@EM14!9^/6'^<^7DVYN
M+C[W-O:??5O>01_=(B\!OA%\HFZS4<@(@\'JZ:MJJC/:L9O++@[D9>:QM<4(
MS]X.TK%+=9-T-/M/#%[+ &U;] E_H0;;M;^Q_P"Q6/\ V'K]R4=7Q:?$>/7[
33QZ?TE>?92G3W:**W) 0$'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>pg_carislifesciences-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg_carislifesciences-4c.jpg
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M%!04%!04%!04%/_  !$(!G($^P,!$0 "$0$#$0'_Q #C   !! ,! 0
M         P0%!@$"!P@) 0$  P$! 0$!             0(#! 4&!P@0  $#
M P,!!00%! H*#0@$#P$" P0 $04A$@8Q05$B$P=A<3(4@9%"(PBAL5(5P=%B
M<I*R,R06%X+20U-SD[/3-%3AHF-$=+34)355=3<8\,*#HV2413;QA&65)G8X
M">+#I+565QG$I2=&$0 " @$# @0#!0<# P(& 04  1$" R$2!#%!46$3!7$B
M,H&1H=$4\+'!0E(5!N$C,_%B<H)#DJ*R4R0T%L+28T0E_]H # ,!  (1 Q$
M/P#W]0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0'+/4GU)S_#\['QF*C0WHSL1$E:Y*75+"U..((!
M0X@6L@=E>WP>#CSXW:S<S&GV'E<OEWQ72JET*BGUQYB>L'&_XM__ #U=W]IP
M^-OP_(X_[EE\%^(JGUMY>>L+&_XM_P#SU1_:L7C;\/R+?W')X+\3<>M7+C_O
M+'?XM_\ SU1_:L7C;\/R+?W#)X(W'K/RXC6%CO\ %O\ ^>J/[7B\;?A^1']P
MR>"_$4'K'RT]86/_ ,6__GJC^UXO%_A^1/Z_)X(W'K!ROMAX_P#Q;W^=J/[9
MB\7^'Y#]?D\%^(I_6]RK_4X'\![_ #M/[9B\7^'Y$_K\G@C(]7.4D:Q('^+>
M_P [4?VS%XO\/R'Z_)X(4'JSRG_5('\![_.U']MQ>+_#\BWZ[)X(TD^K/+4L
MJ,>+CO. \.]MXIOW'[X=:I;V[&NC?X$KG7\$4#,?B6Y]B-_G8G%)2TX@E:FY
M WH"@EUH R!M= NMO=HL IT4-?,R8:U<:G93/:W@)8#\2WJ-.E+9R^)Q$5 E
MLP@$M2$E"G6C+<*RJ419E@ N'])0JF'#NM;=HE'XZ_@+<AKH7[&^LG)\A',[
MY."U">4/DBIMX+6UT#BOO=-YU2+?#7ITX&.VLN#F?,NNR'O]:W)O]5@_P'O\
M[6O]NQ>+_#\C/]=?P0?UK<F_U6#_  'O\[3^W8O%_A^0_77\$']:W)O]5@_P
M'O\ .T_MV+Q?X?D/UU_!!_6KR?\ U6#_  'O\[3^W8O%_A^0_79/!!_6KR?_
M %6#_ >_SM/[=B\7^ _79/!&O]:_)_\ 5(/\![_.U']NQ>+_  _(?KLG@C!]
M6.3C_>L#^ ]_G:M_;<7B_P /R(_7W\$8_K:Y..L6!_ >_P [3^VXO%_A^0_7
MY/!"9]7.4C_>D#^ ]_G:M_;,7B_P_(K^OR>"-/ZW^4_ZIC_X#W^=J?[7B\7^
M'Y$?W#)X(U_KAY5_JF/_ ,6__G:?VO%XO\/R']PR>"-3ZQ\K'^\\?_BW_P#.
MT_M>+Q?X?D/[AD\$:?US<L_U/'?XM_\ SU6_M6+QM^'Y%?[CD\%^(F?6GEP_
MWECO\6__ )ZG]JP^-OP_(K_<LO@OQ-3ZV<N'^\L=_BW_ //5/]JP^-OP_(G^
MY9/!?B:'UOY</]Y8W_%O_P">J?[3A\;?A^17^YY?!?B)_P!>/,?]1QO^+?\
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MH?6+F8T^2QM^W[M__/5(-5>LG,TZF%C?\6__ )ZH3D0:_P!<_,^R#CO\6_\
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M4(,@4!Z Q?\ T;#_ , U_$%8,V0[J % % % % % % % % % % % % % % %
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M56DB$(ENK%!-3?45,B!!2/JJ2HDM&E2#K_X<4@<NR=O^KE_Y=FO!][_X:_\
ME_!GL^T+_=?P_BCTQ7QQ]2% % 0',/\ H?\ ]*C]FH8*"!:LR J4 %;(@*,!
M1 *,&JNM0#6@-3T-02:4 7H61B@-2;4(9J57H),7N#5;:$HU-53)-#4D,T)O
M5R!,T!K0&JJD&M2B&8J2#(J& JJ)-=U:$&>FE50-Q4 42G3KTI -QK5F@9M[
M:$A:I8 BJI$,354- UM0E :F 8J&H("@,BB)"P.M3(8$WJ)("]ZE  +4)18>
M$_\ S)%_>N_Y-5.Q)UFJ@* * K?/U!/#LNHW(#(Z"Y^--37J#SE\PC]%?\ U
ML4@V#Z!T0O\ @&I(%&I1;<2MKS$+!T7M*2/IJ">I-(R#<QORI0"7SH%@62H^
M[L-3)$$+E<=N4;BVNI- >5_4OC/,).95R' -287(,.'DNXYE83*=@.. F2R$
M_P JBX <3^B1<5BRZ.5,QN5>H69BX:#!^:SCR]J7XL)$7:HD7=E+;2A'@M?<
M1I;MH#U1Z?\ +&\URKDL.-)3+P>)^5Q_ZP3JT[*C1T)?6%#10+EP%=HJR(9U
M=A3)%@XG^$*L5':%-#3>DCWBA,"@6W>^]/\ "%3)6!86(%B-=>M209O;KTH2
M)J)40M! =3T)Z$=J3[#^2H NRZAQ.X:'HI).H5W5)!.8=D+B2G+?"#^1!-:5
MZ%+$3%1M80GV?LUF6%@*D!M/=0 4D=AJ"1%YM7A=0/O6[E([P>H^F@%DV4D+
M1JE0N+BA ;3W&@#;0!MJ08(J"0H!"3X$MO= TL%7[U6A_/0#CV=U" J0% 8-
MA2 8) ZT!J5 GI0DBLY#^?C-,;BE/FA2MIL2$B]KCL/;4$">/A"(A2$_ H@I
M3UM8>W6CT")   Z#6A(C-B)F1G(REJ:\U*DAUNP6@D:*3?M% 0N,XLG'S3.<
ME./.J)4XFR4I=7L" X[874H :=FM1!,D_M% %A0&J$[Y+:?LM@N*]_04('=6
M 4!W[%_]&P_\ U_$%<[-D.Z@!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0''
M?5=&[D<4]T)O_*NU]![=_P ;^/\ !'C\WZU\"DAH?17I2<$&[EFFU.:>%).M
M[:=.@)K.2\'/N49!<G'R$N1Y4)II8D,S&[OLQI39NA]M[:A38)^-"T[5))M8
MUY>>[<SH==*E5QW.5.N)R4F8AB8]#8ESTA"RGYW#2$I#B4];/PUJ0I%KW37)
M7DRIG6/Q3_(U](1@<PD1FY<B"HD8MQY7D.E1/ZKRTI3:D[[6^Z<4TX@#4:WJ
MN'DMJ?#\RSH=9XYRYK*_+M$**W8I?2ZI.WS E12VI0/PJ78BW>*]2N=-I>*D
MY[XX+A'=:DLI?:5N;(O<>SK6VC*:CA"=X!&H(N#W@TD&_E]]0# 0DWL??4R1
M VGQ?.B.MG8+I58N7+=[=%VUV'HKV52^J)1Y?]0,9/:R"82%%"D3D[8;JT..
MQUR4>%I3H%B''$MJ2[\+J;+^+=7SW(3EJ?S1Z&-RBG1IC;$W'8UI(::A*5'R
M,P.!3TI_=9;AT.UIM)2AH'0>TDFO/58HUHOVZDKJ=FX/D'4HE9[';%1,:CRF
MV$765-)22YX22'4(;L7+75XE*U%ZZ.#\MG:%II\/S\3&RTU*3F,TG(F69;S;
M<%+RF69'F%7EQ20XE"U64IP-G: +*4I-K:BK9;;I7;L:54(ATQ&$\A$&>5N/
M,;2'%LAIE]F4BRFU-J(#2"=KB%$?:K.BUU@M5Z%@7GF&\E"AC)QWV& EIR.A
MQR$I3J%>7M<DOI*G$?X)(OU-:+;O3>L?MU91ZG1N/<L:7R)B"PZQ'Q"4.*=+
M:B6]Z'$H3JHW65G<E-^I'=7H8>7NR1V,+TT+S.EAR'(OH67TMH%_TMBTW^A5
M>EER:/Q1BJ%%Y7S5K$N/O,K^8=9RD2-%8:LIQX!Q^2L#=H-B4)W*.B:\CD<K
MP?2R4_?_ *'12AS1O)3\V](5D5M-,//K0?,4I#326RL$E1\6U2CJH]?R5P8T
M[]=/S.AI+H7;CO$MTR.51RVM*$J4W*02TXE!VI4TY$4DH1;X%H6H'[8O7IXL
M&[HH?F87RJ#K;3'EMH;W+5M%MSBBM7TJ.IKZ"JA(\Y]3!35Y9034CZ:M)$&A
M;%)8VH2+=^M6EE8$5('?VU8@24@:]AJTLK"$BCO%NZI(@2*;=VM6*B"FZDH)
M*;JP@04V ?95RL"*FP>E7DI BIH U,B!,HUM4E1)38)]M3(@T*/IJ9$"2FQ5
MI*0A)38UO4R(&ZFK5,E($E-ZVJ9$'6_P[)V\MR?_ &<O_+M5X7O7_%7_ ,OX
M,]CVC_E?P_BCTG7R!]0% % 0',/^B/\ TJ/V:K;H"@U%2 J\$!20%60"C!@]
M#4 TJ08-0#4FVE02:5*!KNN;6-ZT6*UNA#LEU%W84IICYEYLM,6OO60@>_7L
MK?'QYZLQMF2Z$>F4RZ@N-J#J ;%:3N'U]*[J\:B['/;+9]35F/*GN>:V3'@M
M?RCJS\7UUT;:U70YG>S8?.1G)!897OV_:'0VTTKSN7BVI,[<%Y<"A/Y*\P[S
M2]S4=P:*ZU**LU]E6(->^I0$ZL@%2 %58 5#(9@GLJ$0:BM ;)K,D42*LB!9
M*?;4@42+59L@VVU6 9 J6H)1JH7J Q,@=E0P)*%C;NJ :U*!FU2#?;[:B &T
M5+0,$6I ,6JK1*-2+U+)  BHDAEAX0?_ ,)(@[TN_P"350(ZU4$A0!0%<YY_
M\H9;_ C^.FK5ZD,\\6O6Q04&AH0;6/?>@ )OT^FH+)CR/-"4_+SD>=%Z _;1
M[N\>RI3(:(SD7"<3FVHTV."F?#47<=/86I#S*R+**%#47&BD]#VBC4D2<IY=
MPGEN01*#V?DCCZ(TE>4@H+###B6V5*'F%"&W7 HCIOZ]=*S:9=$3Z!8CD&)&
M7P.3XHK#LL.@2,BUM^1D.A*0I*4[E$+2>NU1'Z5C4(,[6EM>,( 1OA]J=H4I
MOW=XJP)9CRG6TK0E*D*%P0!K4D&_E-_H)_@BA!3N3<=E,MNY#%*?^47XIL)A
M:@Z@=KL?7J.U'U55HF2@9;A4^?B@_AN7<@EM3%)7: 6_."$_$W=3B2F_;VBH
M!0T<2YE'R?RR.5<WB;2D(4_\G)ON_<"4"JW;X:@DMV,YSFO3C,(C<WGJSG#Y
MSR(AY XTIE['SE#1B>PHJ+)/4+!V*&HZ&K*T$'J3C'RZN/S'X^TMN;U)4G4$
M>7H01V6-=%7H8VZD"([%KE OVDUF7-DQV#\*1^6@-Q%9'V/ST( Q63T1^4_M
MT!CY-G]"WN*OVZ 2$9#;FT@[%_!92A90ZCK]-"17Y=!_2_A*_;H#4L)'0G^$
M?VZ /)3WK_A&@,%A)^TO^&K]N@ ,I'12_P"&: PMA*TE!6L@@BVXT!K'0I;*
M2IQS=T5KVC3NH@*ADCHZY]8_:I! %M?8\OZQ^U4@J'*\]G\1)C0<2&79$PH;
MC?-72WYBR1XE)Z"JMLM!S7E/J+ZK8"26ERN(Q4MB[OSLB7YG?HAA"K >VJRR
M4D:\7]3?5/D$AMIE[B$YMX#R3#ERTKU[=CS:;U$L.#IW%,[F,[*>@YAIAB;
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M"^X$((M]%'T(6@KZ:K1D^'8_(*(<GRO,?RJ[;=V0?5YSQ &@!WI*1V)L*A=
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MJ'ZKF-_&P^A1/[Q:3^:J6+(0_5[LU+T-YYZ,R9$G<_&6&GMI4%-^/:;"Q-5
MWF8EW%8R6Q$?D3D>2EQ+\Q:7GDO)>18)6$I(NDT@227!8RV^7YU*A8/35.)O
MW*0#5Z=2'T.@36=DE21H+)_-5[=2JZ$+AY.6F_._K3'?J[R)3C$7[P.^>PBV
MQ[3H%WZ55%B6V&A!@H)H#12"* 0=5L0I7<"1[^E"3"&PTTA Z@6- !L: Q0'
MH#%_]&0O\ U_$%8,V0[J % % % % % % % % % % % % % % % % % <J]3$
MDYZ.1_J:/\J[7N^WO_;?Q_(\GF+YU\"HI;5H!7?)R0QPEH:Z7K,N*>4-#VC4
M>PCMJ'#)DB<QQ>!E5*E.,H<R!26VY#_WGEH(L0V%!24'M"DH*@=1KK7/?%6W
M4TK9HI&4X.OYJ'%8Q[DE49?SC3:5+,9AU LVX^$%2G+GQ)92HJ6H76XE(L>"
M^"=(.A7?62EY/TSS+<J) @P'S)E.O1<5)=++$F3)=0IR3*D)4I7EL-WLJR+;
M38?$+<ML5JZ)3/WFU;I]2NX'-2L#EXWS$L%MSSL%/E;R_CWPZ=C5W4@? I(<
M23K<!8^*JTZSXJ"S4G7N+YU"<Z82TE*<D8Z9 < 0$?.H*6UDWL0AQ92;=EB*
M[:7:LZOR,+5T.E8Z>WE6&6K+;>?BI?20=B[@EIP!7>E:2#77NDR=8/.?J+P7
M)Q\S+S.'6A$KX0FQ#$DW.P)-O L)2I25'P'6U>5R,$N3HHY)'T?Y\&</B</)
M4I,@YA$/Y8JLH-R$DI!!%[ A5[]M.)EV)4\X(O6=2_>HS R,=3+K;"F]CJ=\
MA:D%+;J5(+B%(U 0JVXWL% *(*2H5MRVVM",21Y/>BMAI1==#3R 42%N7*1L
M!U00-5&QO7D5-;%XXAF40V(D92"WBIJ"XA3AW)1(;3HBR0H@%!\257N%&X[M
MW95CP95HBY\V;*6]E;HB...+3)5H[(?$K<M"=M[N#385@;1]JYK*GS6=NP9;
M\9#QT-+&.G2(R6PVVH-F0E\NG<#L3Y;:G3XC>Q4CVFK9GM3C4AZC7%XN/C&9
MDZ,M41>02ZACR$I4\VVMP[BD$_:!LGM[JPIBLJP^K74BSTA%F3*B<<XI-6$W
MR?R;TEF0^H;"_"6&T)"@+BY>03KU%J]&M*XJ1.K\?(JE+*@R'.19C).&;9O(
M1A'45K;;V.J=:W[$K4G>5)CI"?T>WLO?'%VVBUM#IO&.'8F[3.1^6,I&Y,>$
M\"S)LDW)25N!I:?M7:4:W2K;Y>G[S*UF=)B<;@,(:V!6QL[FTA3@*=;V"BXN
MP]@-J[L7'I3HC"UVR7V   =G?7890A,HO[*F2L":D?35I*P)J2#[*-B!(MVZ
MZ5:65@3*1W58B!(M=U3+*P)EO6IEDPA(MU:64$%)UJQ FIL=VM6*;1)2#KIK
M4R1 @4WT^NIDB!)3=_?5S.!%:/K[:F28$5-B^E7DI FIH5,B!)2!5I*P)%L4
M$"11W5:"LB2D>RXJ1 DI!.M6*G4_0)-N59'_ +/5_EFJ\/WG_BK_ .7\&>O[
M5_R/X?Q1Z'KY,^E"@"@*MS]SRL 5_P"[-C\]5L2CE@FZ]=*IN+FXFCOI)*1N
M)J3VU @/G!WT$&1+'6]60@R9H[ZF2K1K\V/TJ;A!CYP=]3)$",C.PH"+S;AM
MSPA8UU[J]+AIVM".3DK0K.3]3N/8DJ;:C.OK^R  E/TDU]!3A9+=3R;9ZU15
MI7KCEU'R\9CV8B!H'%DN+]_=777VRJZLY'SIZ(<PN<<@Y$ SDYRE,*U\N^UN
MW=855\7'C<U6IHN19K4Q/D0&5[0K>H=0BMJ5;.2[1"2)L^9,,6*V0VI.T)3U
MO[ZZ*UK75G)=W>B)OC/IZI4E$_+INVV=R&^RX[S7'R.7IMJ>AQN)JK6.D!89
M'E=$CX/=7Q>>L6\SZK&YJ'G#OKF1J'FI/;4HJPWBI(-2H&I  @]M %" J"
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M!%Z=&CV\]1:OT\P;:@'HC$J"\7!4DW2J.T0?84"L6;#RH 4 4 4 4 4 4 4
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M#<2J 4#Z;4!D/)/;009#B3VT$&=XH59LE0OUH0.&^S6M40.T=]&2A5/90"M
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M"N*XWE=3O:)/4[CUJNTM*/5N$06\-CFU?$B*RDVZ7#:161H/J * * * * *
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M]PZ2I_ \_-8Z:6P  D:#H*]J3B@3+8%7DI BI'[?T4D0);4GIJ#VU,E8$BV
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M&O9KB32JNW[:BW0NF!]'L/B@T])7YTMLW2E;#1CHN2;(9NI-M;77N)]]=F/
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MI;6[>AP"Y2M!LI) ]E2B"ZL@G6Z_K-6*CA*+]5*_A&I *8!L0I25C5*KWL:
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M;>1_)N#J#;\HHT"+:>6%F/)NW(3TL!M6!VI/[%02T+;.Y9^H5)!C:?[Y^04
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MU-BE2%- @@]Q%<%^IUU1A+Q'4:?152P.23L("=562.G;0(<XMY/ZSA#9_=D
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M6VB3MV(4E>)@*0;H5'9*3TT*!:N1]3H0\J"0H H H H H H H H H H H H
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M_P#!@J_XA>,#_<<E_P#N]^A*/J?0D* * B>3_P#0,[_!C^,*M7J0^AR8C[Q
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M/_5D_L5 '86;"@1G>:$P=9@_Z%&_P2/XHK!FHO4 * * * * * * * * * *
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M@>;+:20DLF0YL2KON DF_;7YYM4/R/T&CT7F=74W8]E<QU&-AH#'D)5\212
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MKB=M#H1-P<7+DD)9:4M1[$@FN*^1+N:U+;CO3GDLY(4U"<2DZW7X1^6N9Y?
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M#MJ($AYH[Z0)#=4$!O/OJ29,^8>ZH$F?,_)402;>91H&?,Z7J(!N%F^OUU$
MV"]>O;4$B@6;]=.T4!L'--* 40\;>SH:JUW(%$O=;Z@U%JMDHW*DD:&HK6"1
M): 1<?DK22!!;?6U"#M/X1T%/KWQSV,Y#\L%^KTZE+=#Z6UT&84 4!#\I_\
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MU6DAO4]T\,EN3>.X*8^HJ?D1&77"3KO7J;V]M3)#/-^967U27DD63,DI4HD
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ME\K;[$69\;D>/+A/G.H=V-)*5(=2$$>)"K;MHUZ_174Z*QSJ[J0RN(3UR5B
MXF2HJ*TID.A!MUL'+6_)>L+8VC>M]QUOTLX!$Y%-BQ\XXVPEM?WD%92MQ7E@
M*65)0-6D"UO"-QZ]M5QTW6U+9;170];1X^+2RW%2ECY=E(;::4I-D@"P-KC7
MOKU4XZ/]O \IIMZ_B,LAP7B66%\EB(\A/>IM'7ON$W_+713/EI]-FO@SGOAQ
MV^M)_$JV1]#_ $ZF$E&/7$6>GRSJV_R74/R5W8_=>57^8X[^V<:_6I69OX;L
M"[<XW,2F";[4NA#J0.SJ$FNO'[WE4[JIR<E_9<+Z-HKDW\,_(&[G'YF)(_12
MZVMH_21N%>AC]_H_JJT<%_\ 'W_+?[RLSO0GU%@W(QS4L G2.^@J-NX+VUVX
M_>N-;JW7XG!?V3D5\+%9G<(Y?BQ_SC@)T=(^UY"W!]:;UTXN7@LOK6OV&63B
M\BG6C^S4@7F%,K*'D%A5_A<2I)^H@5WII]')Y]JPX:V_$U6VV!\0UT\*KU2T
MP6>U=?P<@46U2J_<+6J=K\"7=+HY-?)3VWJ-1MKW!.U)Z6(]]42;-%:M1(D@
MG3\EZO!S[M3;Q::GITZBL_YC=3!NTM;:][9+:Q]I!*3]8JKJGU1LLED]'!/8
MWF_,<. C&YR6R@:[/,*T_4N]<5^!Q[VUHNAV8^?GHM+%KA>NOJ!$04R7V)J$
MW\+[5B;"^I1;\U<&3V3"TW5M0CLK[UD3BR76#H_IMSF=ZAX./R;(L-Q7#*\L
M1F22D%E0!4;]?9W5\LJ;6SZ:M]U46[FWJ:SQ#D,/!_J-[)KELKDJ<8=2VI(2
MLIL H$6%KDDBNSB>W_J*6MN5=OB<_(Y?HWK7:WN\!3 >J/&<Y\\AP2<*]C61
M(F-9()0D(4L(&Q0)WG<= D:]E9\K@7P5W-JR?=&F#EURMJ&GX,MF/RF/RD1B
M?BYK,R%)3YD>0RL*0M(.TE)!Z!7A/<=.M>?!U2AV38_>-@6[>W37WU D1#2%
MMA)1?8=4+&Y"MBKC<#<$7M4-)Z/H6EK5=4>?O4;C#O%LQF)V+D?_ (.Y%3K\
MZ'(VB+&NA*B%N$$AQ257;L-W:-0:^?M=5LZ]^A]'C6ZJMVZG&,+RM[!Y2,,5
M*+V4;5\HPX"ORDJDM+84RK>/&4[MP<-CK<ZBNQ-T9QW^='LOAV9C9SC6*R42
M.Y&A.QT-LLO'[P?+#R5=221N0;$ZGK7ITLG5,\JRVV:9+3\C&QK279)5M6=J
M-J;W5W:5=F<@N9&\UE9*4_:05+ )" 2;:Z6O5-.Y>2EP?4K&8Z6F-DFY$4[U
MA$Y2=Z7%INI)(2=VJC8 =E>?R5:T1V9%+P*L<X::;*4CS9CR ]*;D$M%FRE7
M(4192;IW =@M7-?%IM1=6@G(\Z//CQ'H[ZEJ?2'FF22=Y=-CKTL".O9TKC=_
M2:?7]QHOF%'<F]%9<,-[S7&]9"+C<-_:V3:Y!%C>LL?)LXE=28A:B3&2A.8U
M;C/WL5*DK5O^!7BL.NI%SM]E>E-;)%$.!+99)92M2G6KJ24*_E$GH4[=+6N.
M_2M*NVZ&RS@OGI<^ZYFI@ <2P8Q4I"B2D.%:._M(-7P.VJ;DHDI.K5TEPH H
M#@OXO4!STCVGI^M8?YG*X.<_]K[3HX_UGE+BD-L)0=N@M7S&X]NB.I8UM*4(
M"186JK9UI$NG2U9LNC#A%[CNJ421D^Q;)-:U,KG.N0EM*EI]YK6#DLSDV8<2
M)"K=IK7&CDLR.0N]:-%$Q9S(O1V[(60;518TV2[013F;FDJ\9]AKI6&IGO9'
M2)3\@[GEE1[ :WK15Z%);(R2G>#?\M=--"C(5Y.U1KLJS!B"B$E*3\2C9"1J
MHGN &I-:25<'0>'>B_J7S0)>Q>#<B8XV)R63/R4?:>U/F>)7N2FO0P\;)?6#
MAR\O%31O4]0>D'X><7P1*\MR;Y;/<F>\*5%DKB1&P;V80X+J6H_$XH7[!7M8
M.*L>KAL\'E\VV7Y:S6O?Q?\ H=,Y!Z:<$YA,3D>3\?BY/);4-B7(02^IML;4
MI*@1<)&B;]E;6I5]D<].3EIHK-+]O$X=ZN_A6B/15YOTM83%G) +V!4X2P\
M=?)4OX%]MB;&N/+QE9?+H_P/5P>XV3C-T_J7\?+S/-<[B/,\5YS64P&0C_**
M\N45,**$.)&FJ;WT[JX'BR+JF>YCM6T;6K3X,CW\)FF([3\C&RVXDO2.^IA8
M2KW&U9VQ6C5:,U6KA=B1XZS,<>$;Y*0X@I7$D)2RX;)(\)^'LK*M',0;4K;P
M+5@H.=XV(K?(L9)C1?-4UOD((0\V!X/$?TAWU]![7B=95U"MXGA^ZU66L4:M
M:O9/4]U<18Q64X5C,QC4_=SVF5MJW>8I.P65=1U)W#6]=%[M7A]#YVN'[&7J
M XJ9$1YP"WVAL=1TWI&E_?7!?Y+:'8J;U#.3^JWH9PSG;+TM^,(F7<!^5Y!#
M2$2VW0-$OI%DO(]BO%[:BV&F;KHR*9<F#IK4\/\ .N"\F].LN,1R5@)#UU8_
M(LW7#F-)/QLK[_TD*\2>VO'R87C<,^@P<BN52BL!PB]8-'1)D/7ZU$$IF?,M
M[ZJ3)D.4)DR'*JT)-TNV/LJ&B9DV#NNE1!)N'">M(!L%@]*JU % NU_RU -T
MK-"9-DK-O;4-$R*@D]*K!,BB4*-K Z5 '34=2M: >L1;=0:AN"1\VT .ZB!V
MO\+*;>M> _P4_P#XD]6E.I2W0^AM=!D% % <W]?>19+B7H]RWD>'<::R6/B)
M=C.2$!UH*+S:?$@D7%C4KJ&?.5'XK/4]M"6Q+PJMHM?Y%-_\I6DE3=O\6'JB
MTZA3LC$*9!^\"(("K>SQU&X%LB?B<Y1.;26YN,)/5)BH20>[552K$M(DO_$%
MREQ%G9..3<:_S9-_XU2K%6B%S'K9R9B(]*:5 DLK +MF2DHL;CHNC8*ZKUJY
M*PM/ZTA1D-/7$<M)2"5 ;C?<LZ6JDD]1*9ZX(@Q6I<J*A*I+BVFF466ZG8D>
M,I!^$DZ5,HK#+#Q+/Y?U;R"N.QL6XWBXFR9DI.Y#: EM5DM[B22IQ6@2!^:K
MP.AV-?$LLI(;3@E+2$@-I);<19.@'Q6]VE:3XHK'F,9&'Y!C$+BIP3Z67Q]Z
MS'0TM*OWR4]1[Q4I^!5HYW.]%L%(S$7DD#"Y+CV9A26YC3D. Z[#6\TK>DN1
MUC98D:["FJ.B>O0LK03G//4SUVX;A7N3%_!R,+&6VW)6[BY41\*?5M2=KZ@E
M1)TVH/MJMI1:L,Y?_P"++U440DKPN]71'R9W'W#S+U7<RT(U5^*CU7ZJ1B@E
M7PG]7N $^SQZTW,B$(_^*'U8U6&\7M4;E1Q[FWNZERU-S)A"9_%7ZGI)27<*
ME0Z@Q+$?6[3<-J,C\5OJ=U\_"6_X+K_E:;B-ID_BS]46&UN(>P:EI%PGY2]_
M_6U#L3!(O_B)]878+.0G<>Q3C#Z$K,Q.YI!2O5)(#UDW[*B63"%_ZU_656,_
M7']%<68Y2%AKYA/S.T]OD>?YG^UZ5&I"1&)_$9EV7"N3QLA]AQ++H\IQ-GG!
M=*/Y3J;7 [14R&I(?U8@\GY%EV^69C%&*]);CPS%QLB-- #:;H*VVGU+3>_B
MWZ Z4$%57QJ7&RT?"3531E)+:GVFV',<MCRTZ$EPO% Z=%*O00.<C#QW'G8Q
MR$7,(5)4&F66G($AIYTZ;;M*64$G[.Z_=1LB&>Q<SZ@Y;C'IL[G<:RVC.,XI
MI\,N-^>A+B4)NDH2=0#UL:V;A&:ZG #^*_U8+B&A^J"ZX 6VQ 5O7?M0G?=0
M/L%9[C2!&3^*GU93<OC$- =2Y 6W;^$L4W,B",?_ !.^HLI*D.2,)90(($6V
MA%O[[423 P3^)+U C+LE>'[.D<D:"VEG:22.A^*3U)2+(<PH'=\L?\[3<R(!
M7XI_4T_W7"G_ .JG_.TW,F!]$_$IZA\B;7@GX$+)N*!=#<*,$^  #4EWJ":L
MIMH5<+4H.7QV>RV1SG(<_C%XW)9I0<1';*4H*4J2I1;2LE=TK0GV5#HUJR5:
M>A49KG(UAQA]4AR.HV=2$A 5[%;0+BM;\G+=0[.!M0ZB&4N&B+*\QN*RLN,H
MNM"VEJZJ0 +IO[*P)+WQ3FL/B:<6W"=>R;>*?5+B,.ML( <\14E>Y%UMJN0M
M*KA7L%63@HZGH'C/XK\W!PL)P\&,F&EI*HKT64&D*WE2R%@^9L))/L%)&TYQ
MR/U0Y''^92]Q!^(XR_)E2V98<4IE!\:O&G8A0 M8HOI4+H6-&OQ:<]AQ8B,=
MC,5%Q:FB([DMIW[Q3:MJMJB]K;H?;3<3M0I_XOO4@V^ZP5CT/DN'_P#6TD0C
M/_B]]2-2&L%;O\APC_*TED09'XN/4QY35XV$>V+2ZA"8[I\20;='#WTEDPA=
M'XO?4U=_)A81=B 0W'>60>X[73:FXF$9<_%UZJ-)WO0L.RU>WF.1'T(OW;E.
M 7^FDD0?33A\]W*\2P.3?V^?-QT.2[Y>B-[S"%G;UTN=*S+$U0!0!0!0!0!0
M!0!0!0!0!0!0!0!0!0!0!0!0'BK\83DC^L/'1&(S+GS.#BDNNVW?<S9:K:_9
M%];=:RR9531B).08?D:8[SEYZC#0&&I,Q:MZE(C*\Q2$@ "RB?A'A%O94+EI
M=F5@E..925R/D4"1#<;A-B2EYP..%Q8;;.T$ BZG#?I;I]-;4S.[1+4%:]39
M.6Y/(Y''$QJ+AF9*6&WF-ZTNNG:WYB$I-RLH !VUS/--SKKA:H4*;&2SQE7'
M\9YC&5D)=0\'4D;PAT*=7X;J!4G:E/T]M'1;I997>R((S#XM_#N-&0XE,0J0
MR\4?W..2%+%NTKM8VZ"J9=2<3V]2T<HY"KE_F8_$QTH;8"4!DW6I+:M;J"1J
M7"-O<!7-2NPZ\E]RT.9R7%0)"D9)F286XI)9<4RZW?J.S5/8#HH5VU9Q67D7
M3CT!"O*E\>DM9.>EQMK'15J2EYQUWHDH<NL!-[JTT%ZM.U:LHE+A%H.3Q' ^
M5(A2X9RR)\!8R+J%K;=<EE06@M*20IH*62EI/4I O5\5[8VKUZH9%2R=;=']
MY--<HRT9@##2<ACPI1=<$N077VK]&38J1X1^CJ?97Z%Q.&^0M^?&JKM6-7YL
M^ YG-7'_ -O!=V[VNW*7_:O,D8GJESV$0490/6Z&0VA9^FP!KLO['QGT37P/
M-I[]R*]T_C_H6)CUYYM%0@OLQ91W)&BEHW7/PVNJUZX,OL-(^6[7Q/0Q_P"0
M7_FHG\+%GA_B+.B9N%<61J0RMI8M]2#7';V')/RW7XG;7_(,3ZTM]D,L,+\0
M7#G+":Q)CK.A3Y2B![R"JN2WLW*71)G57WGB/K:/BF62%ZN\ F6"<PVRLC1#
MAVG_ &P37#DX6>G6C1VX^;Q[?3=/[2Q0^58"6 8>5C+*]1M<22?X)-<KI:O5
M-'8K)]&AQ(QV)R2/YU'C2D*[7&VW+_2H5%<FWH_Q)=9ZE=R'I5Z?Y3<M[C\4
M.*O=UE/EG_:$5V+G<A=+O]YR6X>&W6B*ID?P^<%E'^9F3#)'5+IL#WA*@JNV
MGO7)KU:M]AQ9/9N-?^7:5:?^&LJ)_5&>58#02V@K7WH*3^2NZGO]E]5%]C."
M_L-7]-W]T_D5G(?AWYQ&O\D_"GI'4I6ID_[=-=F/WW#TM6R.+)[%E_ELG^!5
M\AZ2^H4!5GL"Z\D?:CE+P/\ !5>NRONO%MTN<UO:N35_3/VE8EX/.0'%)FX^
M5&( N7F'$#Z[6KJIFQ7;BR?VG-?!FKUJ_M0Q2/$1=(/0W-JZ74YZV;?8RE/W
MA NH[>P>VJ1\VOA_$ON7;45"#<CM*K?DJS6C^#*OZE_Y(ZM^'![?P);&N]C(
M/GZ/":_.F]3[_'])=O6KBW*<KE,5FN.8YZ=\O'<9>5&(*T%2PXFZ"05"NWVW
MG8>/NKEF+/LI,>;P\F9)XXW+Q9SG"X+DV6RSR<U#R.)E0T-38<\0U*^7EQ7D
M+9):6 '$$WW(OJ*ZO<>5Q\W'C%:6FM##A8.13-.6L*.LR36=Q^;RR_UFN?#@
M/R(TC"?JD1Y&-CN,R6U2'0EM06 H.EIY!)ULJ]?-JWD>WL\QKCI7J5C<6G'8
MJ:M]V%CF8C;F+F(E)DN(G^>@(3O+K'FMK6TI>T[0C2Z=*;B=IWGD?G3^-RE"
M*XW-\@2 VU*,9R.X62I12ZW\:D$%("?B/2N?E+_;<?$VXEHRK3N>9<VA65?$
M3D61C1Y61C*AHQN]TMI>0 D.I2YN*MJ@E3CKAU-[=:^>Q.%*7G)]#E^:T3Y0
M4_T^XFC(Y/,Q76GTOXV(M4E*M4K9U;=*$(Z=-R%5WWNE6?$\^E)M#.N>@?)I
MDYR5Z?R),E+++#BHSSJ_OF P4E24@Z;'$KWFW2NWBW5EM./ETA[CM#,;S7%R
MF7@B&E?E-H6"4I1MMT-@1H+DUU0><F07)LPE68B<>8+;#2]X?9!(/FR4;D +
M2"HHTNK;V&J6ZP6W%)RHB8_,R=F.;QKN*VI3N*WTNK6X;.#<JP![;>RN>T)O
M2(*E<Y=GMTQ2HCCGWXW3/F;%M:U?>%I:TA(VA0W-A/9UK*]YU1(E@\IF)D.3
M/C9&0W#CMM.)C+4E&T.V;4I"=+JOJH ]!>LX5Y3[%DSH$+-Y%#TWCF60U-DP
MW0IBX\OS6'1O4YO2;*"+%20GK7#DX+;BO8T5X1)PW\3"P.0R*5JDOQ_OIVPD
M(NA8*;)(LF]PH@==:Z\*^7Z8=2U7J/V9C;^&"D(6I3>TQY1(WN-INA,BU[ZD
M*NGL%4SXW>TP-QT'T*R>0_I'/PF02#Y./#T9P*WD-AY"2%*[22J_NJ>-B=+M
M3V+)R=\KT2P4 4!P?\71MZ2C_M2'^9RO/Y__ !?:=/'^L\K<6=26T:]E?*O0
M]NC.F8Y0+:==;5!UHDR;"][^RI)$7'P![:B-29T(#,3PVT;FQUKHK4Y[V.3\
MBSR6E.%:KC47KI53@R7@Y=D<W&<>4L+[=:ZL>"QQ6R#5K-1SX4J!55W@L560
MT?G%T=?HI7'!;=(W*[BM((DT)TJP&KNM:5(;+;Z8>D67]5,J^EI\XWC>.*?U
MIE]H6H*7JEEA)T6ZKKKHD:FO6X7%MGM'8\KF<RN!>-NR/6_"/2'@G!@W^H,0
MU^L+6>RLS^=S5V[?,<!"/_1I%?5XN)BQ+1?>?+9>5ES.+/[%T.F1824A.\E1
M.H!UUK2UY%<>TE$1$ILK;8'NZU@[&NTW0U>X0-J?TA5=Q;:;Q&4N!^.X1M7T
MO2[(59&C^+2TRII;H4P3J@BX-]-0;BKK,R%QZ@]@\>MEEM49IU"0 VA2$%"?
M<DBPJOK/Q-/TZF8U%H7%L1&^\1 CH6K512R@$GVZ56V9EO13ZS]XOFN.XC-0
ME8_(P6I410_DW4 BXZ6[JI7+9:R66)5<TT?BBNX'C\;AL!&#QX(PK1<5'8%_
MN?,45%()[+FMG964F;W3J]2>Q4IL+4@$;@:RO4Z*.27=C)?21;[MSXAV7KG5
MH9ILDYYS7A>$Y%BI?'^30DS\!+%W6K6<9=MX9+"NJ'$=XZ]MZZVJY5#.*+8K
M;JG@OU.]+.2>E^5=9R#:Y?&77",3R%";QGVU:H#BDZ-NVZI5]%>'FX]L;\CW
M./RJY5IU*(5$BPM>N>#L,%:AUJI*8>8>E0T3)N'1VU$ V#E^E02;AP4+2;A=
MJJR4*(756B1=%U"J@<-M+5H+U ';452C=7YJ@E(=LP]OOJI,#UJ(!;0WJK)0
M[3'M;LJ26+I38:4(,E5NM5T0.Q_A9<"O6WCZ1_>I_P#Q)ZK8[38K;H?0^NLR
M"@"@*QZB1XTOA69C3&!*C.,6<8*0X%C>DVVGK4KJ#S:CA'$;;E8"*V1JXE49
MJX/;<6K6$5EFAX9Q'Q \?C$7L%",VD*U[-*;4)8FO@_$" K^CT=25:H*8B#K
M[]NAT[:C:A+$WN)<50DI3A64KL=VV,D$%/\ 8U.U"2 F<7XY]XE6.4M-_@4R
M%IOUZ;+ 421#9%+X[QAL.-_JPI6@:A+#6G=X@BU-J$C1_C'&7$H4,<XK:;I)
M0R2E1ZW.WK4P5D&^/<<=6 EIYE25)*5AQR)<C0$%E2-WN538F3N@GMS\=E+:
M)KRFQH-TAY8O[RNK+&1N(]UB*MPRI16LI-PY\P\;#LTW]:ET@22F!E"=.CPF
M9#R_,6$E+;[B3;W;NZJP"W9+A>%EMH+V+=R"VR/+$AQ3P'ML\5#\E1M+;B*5
MP3CRW XKBS1=;U2LHCE:2>H0=OTT@B37^AN'605\=0D7\.]+"Q<=+63H:0),
M.<*P>P?_ (/,N:@% ;95;VVV]!2"9-#P'BSEU.\9CD_%M\AA0/T[*B!)N?3O
MB8%T<8BDD7*/*CCW6\';3:-PHQZ;<3<)*^+1Q87!#3 U[K;*;2-QJ[P+C:"0
MGC<)M5[W(9 MW:HJ4B&QH>%\=0?,1QV(5]ETM=ITUV]:0)-QPW#O$$\>CN-@
MI-R6@C<.T I[.^D"2I\BX[AH^5>9;P,5GRPD&RV];BY/\F;7'MHT2AH,)BTE
M"%8>%YJDE>P!NX(Z)(\KK;NH"1B8&-\Q'8.!@H=6I-FTD*40K[1LU8$>_2H@
M'7$<=QK\#Y5<-M;"6PD(3<)MVI%@+5=HS3U(IWT]P!<:>3A(OFM?R3RD_>H&
MM@E5KI^BU1M+[AC)]/\ %..*#N"@K1<64M6Y1O[T'\]($D1-]/<$T%6XY V"
M^H2.H[=&]*B!)&J]-\ 20]QR&EL@'?<6 /\ 8BFT2;->G7%TH'_,45#0-DA6
MT]?>C6IVB34>GG%CM_\ P>CEI1T44I(-NX;:AH2.CPG 162_$PK,:R@G>V0/
M%["E-Z0)*;RKC. RSVS-8E,H-*WQOF'E$) T.W;8@GNN*LJE9*\WPK@1)#O'
M$K"=2A+KBE@ 7/1=M*OZ8W$@CB/ %.(B1.,.*6JR25+=UW: Z*OK6>TM):.+
M^G'"$F.^WQYEB8LKLIY:U:H[!YETD'OJ4D0V=SP/',5#QS,>/CV6&-HV,);0
MIH#ML".A]E0R)*3GL+CG5J;=AI7'\U:?*<V[3;V$&P[J$R)0_3SB<QE*G<'#
M7?5 +39'T$I[JJT63'7]5_#T"Z,!#4GJ"F.S^32D$R:GTQX<E(*L!%L?%?Y=
MH:_P340)!'IKQ$*LG 16UJ("?N6TGVV.SI2!(LWZ;\1960S@(K6X^)2&FT@^
MTD"Y)I! JKT[XR\WY#^'9=9N/NE(0I.G;8IZBI@F3T_A66X^'Q\=E ;::C,M
MMH L$I2VD  #N K$N/J * * * * * * * * * * * * * * * * * \2_C'$
M-7J/AT/(0Y(5A&4MI4/$E*I4JZCV6%OSUQYWK]@//!BLR70S#:42VL!3B#L:
M"B1<W-[Z]@JE6R&/QEHG$Y4AMIQ!RQ23YC3A<2D.@I4H*'Q* Z^VM:N5)KC6
MLB?&<@);3^:DLCY"."C&MMW(7+>)2A>Y778G<NXTO:N;)\OTGI8W,MD1/9.9
MF..PRME&.94E/DI"B7%$$*N>G05T8*3HSGSVC5#1<*)"B-CSPJ3(9+I<==4V
M3O5M"=?!XB?BTJN2C7<MCNIU1:O3_'X1O'RI^1G?JM49]#DEIP>6X_8A#:5*
M5;1;BMJ+=ESTK%)SJ=-FGT.>Y09OD7)<J_#BJ?G.2E*E1V=RO+2I6U*=UMH2
M;6%;44'+D<EWX4C"<3AJY#EWBB5Y+PG0%-);EMI&FUHD7/FE.Q:A\(-7:G["
MJ:JOB/9<C]<R&<[)CM,9QQM3K@806VXYD6/EI!-U. 627%:]@M:ON?9?9_IS
MYM>]:^'FSX;WGWB-V#!HU]5O_P"E>8RD*1%:+CJ;(3MN238;B$C0>TU]?R.2
ML*5GT;A^7G\#XG!@>1VHOJ2G\_M-E-%ME;R4W4G=M2= 0$DZU7FY_2PWOX5D
MCC8?4NEXVC[").5!5C64-7==#8"UIV7<<(3N(.M@"2*^>P>]*^W<NZ_ZGOY/
M:MB<>&@LZ\Q 8EY5_P ;:U%#8-[EMHE+:1;M422:UXW*KQ\'K7>MVX7E)CFQ
M//F6*JT75BF.D*G,)D.HV((*K+4+ #J2:]7C<MWP^K?Y$>;FP;<_IKYX-]RW
MPRHIL-7 " /"@:7'M)%=<RUYF<V=9<:>2!* A6YL>6KO3=)^NNATJ^JDY5GO
M76KV_"21A9O.8]87 R4J.L:7;><_,217-?@X+_51'53W'D4Z7988OJAZA15#
MRLZZ]9*0/F$H< *B;=@/97E9/9^-9M*L0CV,?O7)K6K=IE^!8(7KMSR*RAV5
M\I.3L)<44*1JDV.J5=XKR,'M6'+5_,ZVJVG]AZ&3WK-B:W55D^D>9,8O\2<N
M4\MJ5A&W%ME*%_+N[;K*-ZDCS!>Z17FX.!ZJLZWB/$]+)[LL=JUM36W@RQX_
M\17&GP3D,=+B(!VA24!T&VFX%*M1W4Q^UY\M5>B33-[>[8*N+S7["Q0O6?T]
MGVW94Q3?X925(Z]UQ:L;^W<FG_MO[#>ON/&OTR+[2PQ^7\.RR VQEH;Z#T2M
M: #[!K7)?%>O6K7V'96];=&F$KC/"\XV1)QL&8T>Y#9U_?6O^6IIGOCZ6:^T
M7QUM]54RLS_1'TZGW+>*5$4K[41Q:;:]@W$5V8_<^11Z7DXK^V\>_6B*GD/P
M\8(K+F/RTN*4^((="7A<=]P*[Z>]YEUJF<=_9L+>C:$O3OTVG>G$+(8A^<W.
MBO+7*CR6QL6-Y *2BYL1;K7C;]S/5KCVU.T(V+9:*5W!0@BRK_9%8P;2:J2X
M+$+-DZ@'I^0U7:B9&[S0=%I#;;R3U2L!0M>_10(K0I!!3N(<6R!6N9A6"XXG
MRUO,H2TXI%]UBIO:2+ZCNJ-B$^8^D1H,B$<2^"(*F#&VJ25*0@)V)(OU(%+X
MU:NWQ%,EJ6E=CS#SB0UQ]UOC68@._,-O-(3FT+"V2&=R"?AON#92E*5:6L>H
MO7SM<=J.R;Z/H?16R*]:M+KW(G*2)7IIF_UKCI#JL;-0MF/.2V5^>AM%U1U:
MV&X*T[*U366D/0SVO%:5J:>F>2<8STSE,!:X7ZO4TY(0O:O?$E*V/(*%&QO<
M"]].M3CNL;1GFH\E7Y'8LOS*9+9<<;<$./#6'VE+;4I<EX'XE)OJA( "K:GL
MKT?4;9X*U(K-+Y&U.GYY^2N,_&"64..AFY4]J-XM\)/ANGOZUE:MM6^Q#90)
M7)\[GVI*G%.(G!*/F'G!NNRT"A01?\@ Z5SNT]>II'B,2Q)GAY<8K(#/FH*D
ME0W!-E'ML *P@A&^'RZVH+2&]BWV&E-O(4"04@]>M@#>Q]E)<DOK(Z_I*ZM^
M6]&E&+D"AMI$4>(+*4;$I"^FGB]A%:S+T-"5PO(LA(8>C')I49#;B'$BY0 M
MLI!VG2_2W<>EJJKLI+3+QQ[,EO"0XV"+LX+9::=$YQ"!'>-U*%T^(IU4J_=V
MUUTMHHU-&B__ (9)&9_K4Y#!R:TK8;Q+JV%-$E"B9C(*R3U4K36LJ?6RV-R>
MMJZ#8* * X%^,->ST?*N[*0_S.5Q<Q3C.C _F/%7'\^8I0E:K)O7R]Z.3UJV
M@ZCA>2-+2D%P6(K,ZJW+2WEH[B!=P=.RKP:;T,YV9@QVU*<>2D 7U(%2X12V
M6IR/F/J/CHNY#<A"E"XL%;OS5V8L=K]$>=EY"70XEG>8R,DZKR_"R20!7LXN
M,EUZGFWS.Q6URUKO<ZDW)KL548R:"0M)NDV/?4M)DDC'R859#IL1VCMK"V..
MA=6'Z)04+WK%T+[C?ST^^J;2^XPI0.IJ5H2>P/PYQVHWI1"+=MTN;,DNV'VR
MH)%_<!7VOM%8P)^+9\5[JYSM'9(3"E%.W4:#Z*]*S..M=$32$ANU[;Q7.V="
M0^:N6]V[PCMK(T2D.HMT2/RU$EMHD0M*@H::TDLJCDV?\*AJ.RJLU51_&C@@
M7'UUBV:;1^&;  5EN--IJMKL ^FI3#J,7X:7+I(]YK17@R=)(I[$-I45QE%M
MT]O96ZR>)BZM.4*Q9TJ-9F8@D=-Z3H:H\:>J+UR^(L^N+*T2H%U(^$]H/9K1
M)U)LU8K67P#11\L_&9F\=GH4S,@2FTO1R";[5H5I:^J3U2:W5JWJU8XLF-TL
MK5/!/K3Z7*X'E%9[!15(X'DGE)AG<7/D'[F\5U2M;:;FE*ZC3J*X.5Q?3<KH
MSTN!S?5KMM]2.7%5R#>X->:ZGKF"==/HK%EC&[OH#=.X]!:@%6VG">AU[*JR
M4/&H;BNHUJLED/V,8X=2#[ZJ[(N23&, L;?766X02#4%%KVT-5;@F!XB($G4
M5$EA9+"1KV4!GPCIUZBH!A3J10-B*I*1>]$GW(D;N3/;4*A$G8_PH2-_KKQU
M/>UD/R07JVHE)6S/I!6Y0* * A.8$CC61(%SY6@Z_:%6KU(9Q8/MDW\)7H!9
M)%B.MK]?IK<S,I?4O<0DV.FH-A[Z 3==58A)U)M8?F]E 1<Z4@)-MQ%[)4+]
M1U'^S0DK4N87'%-H"BE!N5%)TN-!?MH".FRKI*DM@J59-C;<I0^U[?HJ45:&
M:YKK25;V4J04[=6RD7^C7I[ZF2((',9!;@80A)WDDI*0-MAWW(.O2M$RK1!O
M9&4RL*+2W(Q"DBQW!+BM#H#H:NF0"<A)L-F.<7,W;0%I3L4 -+#< "!WU6[T
M)1:>!RY3_)F&IV&6Q$4@CYYSP%"DINFUE6 )[.VN?<:=CM.U:=V^^U0LG15Q
M^Q:I($U*\RZ5(/A\("1T'T]M0V3 V4YMN&A<HT)M?0=A!ZGVT3(:$RZ4)-]J
MG.I61M5KV:FI -R%@)*O"I&H*]4@'H+=M0!;S%A"5I*/,3<@)!M?M/6DDI#E
MIPN#<25:$D] .ZPZU$B!C*D%>]2R-R;ZJ\5S;2P'::2((?\ 6:3?S&G$M@!"
MK- *-M#H;WI)$&S623N\H-*"6[G>I.TZ&P6+"XTZBIDB"F\EY$IG*R6G8X6F
M,4;"M#A"T;?LD)(!U[Z-EDB)8Y3'V LX<//+45>!I1?VV^PJY.M^[2HDF"=A
M\R:2_%2Q@W$ON/) C)2ZA9%@D*02D)N/M BFXB#K3$X+;+BFMMA8(4"!<]FO
M6U7;*)&%2&P=RPDA1.FTV^L562T#:1(2D !&Y:SM ZV([K=PI(@B)^0<2A;;
M;2 YJ57"R"![J2((9V>L$;F5+ZJU;.T7^S?NO4IDP:"9'6DN+<V/6-CMTNKL
MMI1L0.$3(C822M(/PN)0A9&[LU'2])$&<A(8CP"HJ\Y2M+7&Y*B;I%A[:21!
MS#,R93LV9 81()9<4XLI9W,V38CRR2?':_70"M*/4K9##'R'7PI#=W2IP)<C
M-LD*2 ="==";WM:QKJ9F2\UN6@-I3'0W,2;N.-H5M"$? E(O?S+=O0=U<5GJ
M;)%DXT]+\J('8[WG)WI*O)\2=P-E:  W^T-;4(.T07DHB,;T(W! "PD>&X'B
M /3Z*@@H/(5.*<+;,=:4K*DJ<()"03I=-[]/T:ALM!-8M]26F_,V7V@E124W
MTM?7H:B28'VY5CMZC["4D)V>T]AH#?>0D@6"5:DGP]>ER>T4;)2-"^H'<$@F
MX2A*#K8Z'KTM59)@6#Q"=SJ=20+)Z=+6N=+U,B#/FMMI)\)0J^TG2QI)$'<,
M:;XZ(?\ <6_X@K%F@ZH H H H H H H H H H H H H H H H H H#PO^,R*
MN5ZJXDI.\-<?C.?+H3N<)3.F:Z$$"WT5AEJWT*MP<!<F^<X(##>].SS$0@D[
M$(0#O<4$G<5B_307[ZSK1):B-VB(7,MO%S&+:CI82N,\]Y VI>#"7M2I0NE)
MTW*'4UM1U=?@=%JVIH.HN1R 0U%;?3\H@J4(:DD-I4L=46OJ0.E8WNEV-Z5?
MB=>X;@ACL<W&?4AK+9AM:7U6!6SYYLH@=Z&QI^Z-<"S-Y9J=SQ1C^;J<VYDI
M3W+):8L9/ZN;\J%BHS=UM!B,DI3N*>AW762>O;74ZM]#G3541:</DY2]BT)<
MEMA"GFU@I2E"R1YAO=.U/4E/04<U<,A?-JCJ>$A<6X?Q>;+\]N:\ZTII*BO:
MY)DN)T*1J4( &BC\*?::FEK*TDWJML>)SJ&6L]/CY3+J0N/CW@J[MFV5O-$!
M+(%_A"MI5?L]]>CPZUR957(]M>[\CR?<,ML.&UZ5=FNB7B65]#P)7(5_**45
M. AQ)6HW*@4]NNE?KN&V.]?DU27X'Y!EO>L^I-9GKXO6=.XPD142XKL8V4EV
M[9.NH4#4<JM;8K;_ *=KG\_L,^-DM2U735JZ^WR?D1>'R#SJ'8<H602J.XET
MZ)6U9=TJ!U\((]M? _KK6P[&Y4.K^$:,^SR\-+*[=Y5E_$1S\R.[DHI96'72
M4IBN[=H4 JS>Y)Z#:+W[:^?I*K!Z[7W"?(W8C\MN&VK_ )NA-[E FP);)WO*
M4- DGPVU.G?7J>MZ]JNWTT227P.'#B]*MH^JS8[Q\5UR+&7.:+:&4WBQE#;X
M@39UQ/8?T$&^T==>GVO"X^3*E?+T7TU_BT?+\WDX\$UQ_4^K)%"!YSYU*4)2
MS<]Y\:OSBO7KK:? XK-5I!@(:!!_+72<2=38-+(44ME.X':2"1?L)/=>LK6<
M:-26K:JM\Z:J-H"BXJ2U+;+4QI82MH]+;;!0/:DVZUP<3E^M:U;+;==5^1W<
MGCK#16G=5_2U_$5A-K+.3BK\#;:"]YA.FT$'\UP*^5S9/T^?-/FU_P"I'N8Z
M>KAQ1_VI_P#I9%X-3;&(7\N G(9)YY;JBF^R*R0GKWJ-@#7%P<3S9%C_ )4O
MF^W]H._F9-J=M)[?$DBP HH0D!(.U*=;5^CJBJDET1\5N=[/3OYFB@W8A*;'
MVZ_GJ8?<>I1?2M?/4;-LLJ+BE)"O&1K[ *S2F?B7FJ0Y:G3HI"HDM]@CIY;J
MT_F-5MQL=OJJG]AI7F9*?39K[28B^H'-X"PB+GI:$I;W!"E[TW"K=% UYM_;
M.-:\.BZ'IT]UY"INWZ_83T3UH]1&BE"\@U(2;"SK0O\ 6DBN>WL6!]-R^TZ:
M_P"09UVJ_O+7Z8>I&<]1F,JYG&V6/U:\8>R/>SG504HG4="-MZ^.O3;?[S['
M'EW5D[M$*5PXRBD:M(MIW"U8M&TF5(0!TL?82*0$Q!5QT6;^T@_GJT$2(++H
MN0L$>T6_,:N48U4\Z"D%(T)%P2/B'MIJ5[0<P]1N'YOD<B0KRFOZ.SH[K,AQ
M"@5-9)MHN1W7$D ]4&R@;6)%?-<ZGI<C>Y^>(_B?2<+)ZG'V+K3K_ X+\Y*S
M>:5@)(<^0DSFTS/,'E@J:2$[VT7.S=;PA*M$]:OHM2NK<$QC&\-Q;)\BXO.>
M >F%R.R^%(V.-%.T!5_AOU!&FE9-;ZIHV3V-IBG&^5.\KP$&)) 8R&'6]$2@
M+W+?;2H-I<VFQ%@FPKMW:1X'@\C'MMN71G1X\IO,1TKSB;L2(GEN)=-RE45(
M4-A&MEA-K>^U;*VYR^C.1:%8Q*X6+:FXZ8IMB<\?/QTK:I3ZGKW2V@)ZA:3M
M(Z:UG6J4HTD2<4F7 ==QROEE1$+5(:79M;JGP+_"?LJ\)L/;5&I70EE3:9,;
M*>=,;790)D,M )4"E)OL/0ZC7O%<Z\"S6AODTL/QVY)0AR<PM!6T"4)7&<0+
MWVC4=Y[*SK:-&0@#<=+K66Q<E3$SR%H9CM;4K,@J 2E:3?<D@@$>VXK90UJ:
MHGWS.9BPX27W F$R=00A*'XU]R&E)M9/VAVD:4K=KY9(F#M7X/Y:IOJ!GG'=
M7DXIRZQ<@I<DQR/JM5\+EEZ+4]FUU&P4 4!YZ_&=?^IE6WK^M87YG*Y>5]!M
MA^H^?T53XM8]E>':J/11*-/Y! !;>4CW$BLO31?4R]E\X@';.= &FBC18Z^!
M#;@JV7GY)\D/277+]0I9-=^*E5V..Y4Y#"UK*CU[Z]*MDCF:&QC$GI6NY%=H
M"&H]EJ;T-IGY)0ZBF]"#0Q5 ]*G<AM%VDNHJC:)2'+:G!UZ5BS1(=@[NM9LT
M2/7?X=):%^ES24@)^4GRFG#^[)"KGW@U]G[.]V"/!L^*]V6WD-^*1V_$2BJ*
MVK<%;B=I_<UZ=ZZG)2Q+M.M+)2YI[JYW4W5AT"ML M^-KH4_LUF7%PD+0%H-
MTV_+5&C1,3) T.E27'$5HJ6%5E9FR)IANW97-8V0Z VC6J&HD5#6]$(-!Y9!
M(%JE,AH2,="S?I>M%8Q=1I(8()2DZ>W6M:W*6QC1R PHA83]YVJ3IK5]YBZ"
M:VW6VW6U+*FUI*2D]E]+U:=9*7JX@IJL-%CH=@SX+4_#RDAF;&DMI>:6D&X4
M4+!!M7=9JZAGG.KH]RZG'/43\)7$>1(<RGIO+3QW,*\1QCQ4[BWB>MNJV2>\
M;D^P5Y>3CSJD>I@YKK\MM4>5^3^G7+.%9-6(Y9BW<;-U\DK\3#Z1]MEU-T+3
M[0:\O+1UZGMX\BNM&1C6'4===:YFX-TI'[&&!MX:S=D7VDBQAT 7MK[JR>0E
M(?-8U"#T^BJ[I+JH[1$2FU[50F!9+20;=U)0-KI3>U@*A.1)HI](/6]6(D0<
MF)%S<4@AL:KG#L/2I@B1JN;<GQ?E[ZG;H0V-UR>\_15H*L05(*R C77IVU9:
M"8.[_A%B3#ZY\>DN(*64LY#4^V"\/V:+J1,GTHK4!0!0$%S(@<8R1-R T+[1
M<_$*M7J0SC20IS:$ K)U(TL/?[:W,S6RE-N*M9 5M-DDBX[ 1K0"&Q*TI4-J
M2BZBIQ6O3NH&R/>EP%;E/;PX04D= >R]K&] 03S:#?RWG51Q=2@SY>[73Q)L
M-#021LZ9#6&V;J1;0H9LXOV%03V^R]6((I]V$PI3;\E:%VVM-!.P7]I\2KVZ
MU ("=-GR-T9A1BI:/W;HCI5<#M\P[B3_ &-;UT,V12HSC+3Z7_.D.K 5Y@*4
MWN>JDH  U]E73D#J&TY(2@LMM?-(1XDD(9;'M*'B%*/N36-RU2_<+F3Y4LI2
M26FD;;DAE15W)3:P^BL4:,O=E((0IQ);!^):ED@]P J2H+*FTD+)0TKH3NN?
M<*B"9$P^2 FY\.B2X0";]R>I^FH)-5[5H5O3<D$^<39(/9I:DD,1::6XE0!.
MMKD@*!MW6.M .&X[BDA3:'%/ _ D#=;L[3:@D<-*4H%'10)%B"%&W82#0#20
MDJW%.U:TCJD%*0#UONZBH)&KD0I86]Y#A)T%[>6?J%Q^:@9B+#?6XE4E"DC3
M;L4E*K#L]U25*GR6*J3D283S2D*5N>* 7-P2+6(!-BC]+2DDC"*)+H^2"79C
M+ *K-D!()^'<L; E*CUVW54H,><?D39DD$E#"4/%5VF%RE+*=%?>ND&B1#.F
M,2$?+E;-_%:Q6-0!VCN]U2R$.6T)6BY4E=AN7L(-O>1T/=402F(ONQTM@,K2
MEQP^%*?CVCM.FOT&A,$9("WD?=NI4;Z!!T-^I.[Q:>VHD$=*"(R/-<)"6]5
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M>RHZAZ'HK&@#'0PD[DAANQ[QL%8LT0ZJ"0H H H H H H H H H H H H H
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M.1]2JUS^DG]L5:2L$:^(2[G[LGLU"3^Q5BL$;)3#4-B[%M?W;NQPI5L<!0L
MWTNDFL\E%DHZSV:_(TQV>.ZM'=/\SA_KNS&P/-?DUY%Y,)F&VB&T07EJ9C)#
M38#MDVW-)2L%6[=V5\EQ'=5::U3U/J>16KA^.IP%3;<@/3D1 'G'-["5^8"J
MY^UN _;%>A&L'&G*.W>B^*COYQ6+>4II*D!YD$DA*KH)': 0$J"?97G<R\54
M>)W\2NK;\"LYC!,MY+(S8DD(+4AQYEM(NG>EY22A/NMTKT:4W4^!\[R%&1KQ
M(KY#YIE]$95@LJ>CH(T 5JI!/M-[4IIKW,7J-A@98;C34R&W62A10E*2E81N
MVC=8]018UI:ORDLRF*A2U2E !UQ"FW&R;#0:V]_6LGT@E]![BY#<B*(CR=SL
M98*#T(0L;% >X6-9O0IYC3)K4I]41Q96E*K@C0WO87'9N&OOI5%ZZBL*6IM:
M(JS8/)#8N;64+VO]=4:D-:'I_P#!2G;ZEYX*N%#!K 'V2$RXXN*VP=2V/J>Z
M*[#8* * \]?C/0M?HRH(Z_K6$?R.5ICZDJ#Y_1&96FAMV7[ZWLE!=/P)-MMV
MP!!]]5A$RQ;Y=XC2X'MJ'!*8W>AN$:GKV&HE!MD>YCUJ)%].VJ.]40DS",8+
MW4M([JR>:I*HQVWC&M"5W/=67KU-%1BXQC !U)]EJK^H1.QFJ\='_04?HJOZ
MDG8(*@LGHV3[S57G8],T.,0K4-_EJ/7L/31@8M(ZHJ?78=$87CVPD^#W5HLS
M,W4:*QS9).T5T5S,S=1YQ_B!Y-G8&!:;!,UT)>41HAA'B=4?<D&NSCVMENJ+
MN<G(R+#C=WV/6F/],.(9!:$-X2*CRPEME24$*2V@62 4D$6 K[*^2M%"['Q&
M.V:\S9_,YB2YCT<P$F (DADN,$6+#BUK01W>(FN3^X-,Z%PG]2ZD>.!2N'1@
MUQUA+,%"BKY4"R-=3;NO6U>12^C*VQ9*N;:C['9T2QY2[-26_"MI6A'N[ZK?
M%X%Z9_$G6<@0 +^PZUR/&SM661\WDC>R3IVUF\9O7*.FIZ JZC8=W6]8VQFR
MR#EN:@>).GL-4],OO'3<M-KWO?NJKH-XIYJ";7UJ-I&X4.TIN*E(AV$TDO'8
MLV2.ZI@HV96T2-J4$COHG!1FA<^7%DH%SWUHE)@[0-/$XLJ<NXH_9&@%6T1&
MK%@ET"Y;"159+PS!0ZO0"DI$[6S9,4WNL^X=E'8E5@T5$1OO;6IW$P1>7P>.
MRT=47)1&YD90(+3R L:^^IE-0]41MVN:MU?D<2Y;^%[@^;4Y)PGF8.:JZMK/
MCCJ)[T'I]%<N3BX[?3H_P.['R\B^OYE]S.9R_P /6;XZO>]%3/B).DN-=8'[
MY)U%>3EX]ZR=U,E;]&2F+]/V@$[6;* M_P#37#7[S?8^Y=,;P5M-ON;?15TI
M1*4%K@</918^7?\ )5T3!88?'$- ?=V^BKD23,?#)1;PU,$2236-0FD$263B
MC"6\S'4!T"_XAJ8A"3H=02% % 0G+S;C61-@?NNA-A\0JU>I#Z'"-ZE++;*$
M)&N]2R/]KNN:W,Y%$MOE/EN!5CH&P;DCO[JJ68R>Q\IBRDM2&XZUVV72A=N\
M!(-_IJ\,S;1K-7&CM(#8>*?[HMPK60>T#:FUZHRR1&34",DN;7$LVW.*?VMB
MW6Y4>E:5=BK2& RTEU'EJR86PK^0BI0@,V'85D#=4-$F)3V4F05".AM38ZMM
MI!*K^W4"HZ$]2K9+ 99X)5)9C8Y)\33DE80H6[$H;LK3VJK65!1Z#&*J4RVI
M$^2Q+>;40%1UA2%H2?"DC<57/72I:U$B\>1E9RE.1\4GRR=F]:$@#;V);6+^
M\@U+CN54R7G#0LHXRE$^#$AADA0L@7L!<> N!)O[165H-46*+\]Y"ICWF2(W
M1"7%(2;_ +S8=.X7JI A,7&1Y;DJ"M4A=DM.6VIL>@ V_EJ%).@NE,UU.Q1#
M3:=&TIUT[;GI521-,#(.M.*4ID)O]VM<E*U7]J4$$'V"D"1U$Q^1D ?<!3B+
M$O-K<VJ[]%"D"12:RE#*HKK1CK7XG&U-K\Y9[!ON38]EC4HAC8KG.L)CPV$1
M4- )W.DJ<MVV"M*LVBJ3-HHAL/(>ENER0+BY)"U^RUB!]%JI#+RA=Q;DQ]QS
M&M/MJ9U45;0E1&I \!4+_I U9)=RCE]"-DY)28CICXAU*]VZ26BLI)/:;BYU
M[JE4UZC=H1 :1DD+2J#\K(4+@RW9*7]>OEA"C8&I:CX$IR.X&)*7FV3C&OF5
MZ("//4A  ZK)))/TU56GH6VQU+' 889/DR9EGD D-(W"POKIKH/:;U$"1TJ3
MBU(<3YP="AL0E"74+/M)VV%3!7<8BX6"E?FI;>;DJ%DA*U.*MWW4K]BD>1,C
M&9&C!05D66GH+!/B6E>_>.T@+!)]QHGX$,8.N81"//CR48['I-P2D-W6>S:X
MKJ??>HU[$RAHUD,9F"J*(Y#[1*G?FV%A!(/A*5K(2![A5X:164V-)4F,TI*7
MGF"@KL0MQ!5N'< I)^DBJJMB79#']:G'R0ZJ([DD2/Y,0XRGFU ] 7+IL1VV
MZT5)\B[9*Y6$2W&FNQ0TT;H6/,##[6[N3=5R.[6JZHB45_(I9<\Z*P4+S#(;
M#R$I^;=""?!YF[:4!0ZUK22EH'*G8<Z-&3!AQH3: 2?)7+3N619P;]H(3?L&
ME2PD6*+,:^48$6:T7MH2O>YO4M%M ALW4%=FXF]5:<]"4TR9Q45'DNB8'_.W
M_<,*6ARZ;7N+6L/8K6HGR):%WT1XJ_/<4G:A%U H4;D=H(OT]AJR<F;20Q<3
M!G+:=E(4[8'RG&U$$^T@G3ZJI#[%VT;.NO)"5Q664G=9P&Z'K#06-NGNJ8?<
M:=AH]D68ZGGXQ2I]/B?;:"77+=#X-VA)[]:C;J2V-F!^O77Y"V)>-;0@;Y*T
MAC<5=+)N2JW6]+?+U(6O0=IAPOEV[SD/-DA(^Y4YO"#?<JVHU%ZKN+;11"%)
MM-F2$K4E5F$#<TVG6]B@IL;^^DR(@0C3,@93JGFRNY5Y;!;2[MN.RXN![+T[
M#4]%XK_HN%<6/R[6A%B/ .RL30=T 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
M 4!X=_&BWB<+ZH\1Y6\%N99>-1";0?&RB.P_)=6LH.@42[;=7+RE\FG<[>)]
M6IP#-\[7,F;8#8;D/)$2(R5[U;W[)0L Z #N5VFO+2>DGJ;D5AI_-R&97%DX
MF1(E,[H^1+@*D-./.>+8!]D*.ZNQ+5,Y;0JM'4_3]6!9B-J?6@S&F;JB6^-:
M&RDKD.)^R-0V@=-3UKNNDU!PT>UR5WD^4R47E0C89*V(N03'3'AQP&]BE'8
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MTAKS5)&S7<KR[IM;KN%7MJBBT9.)$UB."U(7,B)62A2M0V!_8C<#[:S5C2$
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M_P!7X#]:,Z2-V((!/5,EI5AW]!6BY'_:RKPK^H;NBNLYH&"P?-'<I)!^@WJ
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M/KH2[::$=(R..CQ0_DF68[D@I2N(4!Q]:_LBZ;G6K1KH5G34GX.1CNQTXU&
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MFVTV%X]]USU^(WMI4J"&9E8[&ML!B3'CQW;!8L2[NMK=*NQ5ZM+92$M0_7;
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M&ECY124+ZJ?!3M UN!<55JK+)M"[,!!"74S%-)T3Y2D*6+#3L&E1%2SW#O\
M4L^2L.IF%J$GHIE "CMZJLKLK)FD$O!>CQFR)3C2 @$-%0"5J3WJ[ :A%K"<
MI[CFU+\A]*]XT2W=2S_!J6D4394QF&E91R+ ALF"$W=5+W!TJ)TL0;6JNA?5
ME/YGQ^9R^4AK%<BAXE#"5^9&:6IDE1ZWM:]JWQ7K7J89:OL<D8_I?QAZ0VS)
M\R*I6P.%*W6'-AMHI1Z&N].K.-[D7GC?.F_.9AY&,I#SR@VM38);'[JW8.^N
M?/C74VPY&=#C-QY$G;%DM@VNLI4 GW:=:\U'?HA:-DX$24EG*+6PA:BADVW!
MPC]$CM/MJZ0<B*T1WI2K%2E*U0E:E:#LOV7%"KT-9&&?Q@;EN!I<4.#<&5:A
M*M25;M3716R2AF#K+';W/>.J?;:Q:5*E7L](T;2$IT N.MJT5'$E'9)P67$<
M7P'(0WF5N%P.D'Y<K%DCM\ Z$];5ENMT-974E9/&, V5,N.%MG7RF%J"4@GN
M2*S:T)5M2I15YIY4M.5B-(CMNEJ)(;4H>8TG0*5<5-H[!-F?G<E\REI.],=I
M.U:R0!<] FW:.VJZHN,,Q'"HRG6V$.RAJRI7A\9Z7/;5U=HI:B95<C"FS<4$
MA _6K;J%%#) ;<V*\2"3T%=-;.YSVJJZD^Q\UDXI8F-K8==&TMLV%K= %:Z5
MSVQM,VKDE#['R\ICVDA^2XA]D>7Y#B=% =";7O[ZR4)ZFCE]#T9BUJ<QD)Q?
MQK8:4JW>4 FJLD=U "@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@/$OXP3EI/
MJ7!Q.,Q<1\R>/Q9!RDAM3KL<Q9LT[0!T2H+U4+$=^M3LW%JV@\JPIH@1)JG,
M5$D9!_>)&:<2LMJ4GJH#IJ3X23T%JA)C0Z!Q.,YB>,IG9&.IO(2T_,2$MIW:
M'^22/9;7Z:N@B@^I&5*,*<:VI0GY9P,@$;2EHK 6H@_9N0GZ:K:QG9QJ5J%B
MWL9.9:=BL(Q\.19Z2WHYN:2I6]U23=82 2!8#I>N%VW*9ZG':VY'/7EH>D/Y
M%\G8^XI;+:K%:@22 !J!8?0/;7:E".M*%!?N(7QO'<CG)+6KOAC-:H2I /4K
M-R25^\Z:5AFU:7@<>?5I$AD(LC$.X[)R ]*S0;2X6&$A#(4!X-57\0"A8'MU
MKGK%E'8SI;=/9$9%^?08*6Y*(S:WUHDM%0=0EY2E;0 1<W.I63I8GH*T>W73
MH:N%/P('*IGY;E3./0E'SRRU 4VFR6E%)*%!1TN.OB[>M;5:ICGMU-\?RT.J
MX'+2&U0L=BGG'(#TA<'%H)0S9,=/E/25]P*KVL+]I.E>==-/?TMU;_@<=Z_)
M\W=DJ,LV,DA29"Y$!IM\#QW>+FZRG"LV595MJ1VBMZ9FHM92<SQ+TX\2?P?,
MN0>>[#QSK2/FR8,:($)0@ )\I(2/8I15WDWO7=7W7-5POYNWQT.?)P<=HE="
MT^O),"1Q#BC3JVX&*CK=E%@@+.QM+*1;K9002>VQTKGYNB55V/6N^QR1S+HD
M);;BJ0AEPJDN*;\6UO:-H63J3<&R37F5I'4Y6HF3K_H.B/A^(R,\#M8\V7D!
M<E0;;QL8E *CJ?O%DZ]M>UQU%&_M^X[L>E6SSY.R[!Q\M2=[60?>1))!"60%
M;E%P#7M[K#Q&O/V-VUZ&"U>I?>#P)V4YCZ;0Y* 6H#2YGF)*CN<2PY(-[Z':
M"A([KZ5V8:K>=2R3HNR%N:>FO)N1\SS4YF(G8O(J<C*<>1N4TRA+2$MW59&\
M)UN+UI?&W:0Z>93G>&\@XA+,N?C(ZV9[*VVXK6Y]+=G%[@CR_B5N;4@'O2;5
MS9L36VKF>OV=#E66MVTGT(W-8>?D, [EL>R^_A6C&91-6AM.^8YXD#:FR@1M
M6I?8"$@DU>N)]5T-G=5LD5G(Q)9Q$Z<XI2TM/-,2K!2E%Q=]ZEJ)O=2D;5[O
MM"M:5U+IJ815$RE1YR'[!7D.H=VV!N4$*M8]>E7:[&W8]#9H9)KT]XRS&?;<
MGY_*/I?:2A:&UI7#9WH&B=0E=KW[.NE5IQ%LAOO)Y=6MS\$=0@8K$9-WF6":
M#<1J5'#,*0W9#R?E(33H"5@W"BM%E_I7N:ZOTZ<J#&UX=6>-L@7''LBMT$.E
MY\K!!!"KG0@Z_754HT/471'>L:I 1C5%TV BGXK= CNJ#HD[/E RL3TI.Y*F
M'1>Y)-TK%26DX9BW#&R^)D#0MRHJK^YU-%U,V]#UVL_?.#H-Q_/728&U[5,$
M2*!0[:01(*/<:0)&[SJD.MMA)(7NNL"X!2+B_OJK?S)=B9$)2_NPX;7;4E7U
M'6KP),'4WI!!R[US,@8'"OB$96-8G+.0<2E*BTEQO8@FX) )N+C3H#V5GD1I
MC9P%J&Y(49$&;Y*1NWL6""D=!X5&YN.RN9IG1*)6;F,A%@MPY2G?,>1Y39=*
M&V%M.Z[ E%K)N+CQ7JL>))TJ5B\CR+TJR.6;E,(ESL2AQEJ*MWS$R,4L%LJ7
MN("BAI04.OB(KZ"N1Y.-51K4\F^/;E?@SS?\^\]%2)'B;96F4PI=U6*="4E-
MR-"?IKGR+?3IJBF).M].C'LF/BY>'7D'9S+.2R"B)#28KH2MUHE-TN)2$-N*
M.W=;PF^NM975;U5U\K-JZ6AZI%Q]&,T49I7'<[+;5B.3PW(#BVE)66W%((VN
MH(!#C>B[6L=O6LLEK7JF_J70T6.M97:W4K&49@8'+2,;EXCC.3AN.QY$K'/%
M:T/INDN%A:4IW$ 'P]1VFNIWJXM,3X&&U]/#L_S/5/X#C$7ZBYYR-DTSDIP2
MVT)^6,<D"7&WN"Y-KJT4@&U]1:L.3&Q1;=KX07XZ?J/Y=NGC)[^KS#T0H H"
M'Y+_ -&_^D3^S5Z=2K*?6Q0V"AT% 9H H#(%Z S:U0P%029%20PH09 O4@SM
MH VT!FPH2%A0&: U=05LNH'52% ?P33NB.J@I<-P!A*;:C3VU]"T?/5L.TKZ
MV%R-:JT6DW2HD7L?HJCT)6HJC5(WFUNFOYZ@AH43&+@O8;>_MJ=T%=@SF8NZ
M;I3<?EK2F2#')BDC/U*\[N*$:)ZUT^LD<?H.=!%N$^RKX#<'33]JJVNF:UK9
M#]H3[;4'3LN#6%MIUULQXAC+JM90K)NIT+4<-Q,A>ZW% 7UM56UV+(>-Q7#\
M3BK#L-9-EU:!9,9"3:YL:@LG(LDMM>$&U0T60JEP*Z&J0:CELIT[:S99"UA4
M$"3A ]EJE,#1U76W;5DRJ&3SFEC8UJD3 R=4@I\77V58#-T#;H=:SL6JX-6P
M;DCLJ$&S8KOHKZ*M(0EM-R>H[*JRZ-2-;C2_45!#-DD)1J-!U/;4R5:DF.&(
M'])8BQ\)2[;_ !:JQS_06Q*+'5J\T[PH H"'Y4VR]QZ>V^K:RIOQJ[@% U*!
MP6=GL)CBN+C8[T^0/"4,CK]-="HWU*-P<YSN:D2\J(#T5&(4-2AN[D@@_I*%
M[5.Q54E-UGH.<+CL"W,NRP<CDAJ4K5O4/:J^@K1*_7L5:HG'<N6:R$X8;:^T
MQCV4#[INP0%$=.GB5>LK0]8+U;6A"8-^4MA,OD#JUN?W&"PD,LI1V%7:3[ZM
M:U5HD0JV;U9(2N6NMM&/AVOE5('B=* H7/Z/2]9;DNAIM?<@_P"D4]06\ZMU
MUR]E.O6U/L Z55V+JHSF9V8PE<M848Z4W+:$ZGVDU5*27H4^9SK+3"Y'B1T,
MQU:*4O5937=7 EJSCMG<PB?X;G);\H(:C*4RD>-:E*VCW"]1D2@8VV^A<\_S
MC*X;%./8UI#9;%U*6;$CV5S4ULD=-E"DYQ%S_J+S)WS=[ORBU;4-H24I)[!W
MD"NYUI4Y$[6.M83CF0Q.-:3,;\Z64_>OK%R5'KI[*X;V3>B.JM874?-/8PO;
M9V3*7DC5JQ5M [/94;9Z$NT"4R9B)(5'Q\=Z6\/@V)T*CIJ386HZ$*Y$HA\L
MQB@^S$=2VK1>]Q*46/4J"=;5*A"SDE&.2*@^7&F2F6A\6QD72/I-0]>A"<=3
M1XNRG/FHJ2OS25!PINFWLO4J[1+JA>.RPTA+[Z2X_8GRTDJ5O[^P 5I)2!XN
M=/2Q9*U)'7:3<^ZL9U-(T*MFN7S6Y0;C8]$[*&S;:4-W+:>T[K=:Z51/N8R_
M O?'&YDC'-2).WS%_&R0D;3VCW^VL+)&M6*Y3)+84XAZ(%(19)4DA>X=-"*I
MT+P:1,DW("@XCY6+8)0V/&2.WITI$B8(7,<\P^"D*BNQ75-C3S$D"X'<36M,
M:9G:\%0S7/N/R [Y&/D)\S3:ZY95[=;=U;+"8/*2N#_YZB(DS0N C;=E).T*
M2.W0#K7/=0X.BMM#=S'R)#Q7&(;:!/@5H56[?IJ4ZI$.9DVD<.BY/RERUI<%
MO@L$)2K]T1K^6LTB[?B4/*<(GX>>['>R3AQCOB5&B(4YM2HZ)2E6@M71ZT?$
MP]*>^AT&/P_BS.&3+GR&V\0RV/.D*LA5M-'%CH;]:R;M9Q)HMM5T'60C<'3A
M!(8^4>QL1)<0XVX/" .S80HJ-6V-.&BNY/63F7$WLCD,B)N9R2XN!:5YD+%*
M2%*58Z)6XL7M;I5[.BT2(JK/5EW3E([LC<I3#<5Q9(6D^%M(Z^TUDL;[(TWK
MQ)F?AL!G6&&(F:#(;7YKY;4 I>G;N[*T3=>QFTGW%$\5XGBF]T%"'I"A92R0
MLKOK<]@K*]FS2E8%TLX]"8R6(S<-YDJ*I+2E!2U*/Q*M[*I)I Y=:\'F)<\]
M:=4F]]UNR_6I(-&<CE$-/1G&'6V/B\Q\H<; 7]E/:+=E7F"D%<7DH'%D?,Y5
M\.02;/*=*BZH]+@Z_52M79PA9PC5O-83EJR]Q51GB,"LE14TEIPZ *O:X/LJ
MU\3J]2M,BLM!P[!E+9*&8H9R!%UAH[V_,ZFRCK8U3<Z]"^U/J6C$0HZHGE.Q
M%,+4+O-*(W;B-=14.S9"JD-,KB&D,*=B!Q+C8O8#=T]]4@T.X8@DXF 2+$QV
M21[=@J"H\H H H H H H H H H H H H H H H H H H#S]Z\_AZS7J_R*/F
MX&=:QK$;&#'-Q'0Z 7O.><4XHM]19:18]QJR>@.-+_ SSA;[25<KQB\<U>\9
M;<E27%G[:P !H=0GI^>C9*+Q._"ERJ1%9B,Y^ &V@D%2T/ JV)VI-DIM4[D)
M*+DOP+<SRF7DY61R7%*4E#2,:DHD_=>4H+NH;+&ZM3;K6&16MT,+UM9C?+?@
M5]09V/EL1N4XAJ9D;_.NJ1)*3K;P#RR1]WX/=65,$->"Z%*X8<^!3O\ ^F_Z
MB*6%+YEAB!;3RY70=!_)]E=)T07UC\#/+F,;B('](\2[^KE>8\%M/A#BTI(0
M0-IL!W=M87QNTZG,\+=ID=*_ YGI\V?E<OG,<[DRT48E;)E):9>64A;BT;?%
MX=UAWD?HU-<4)K[B;8K=$X0S_P# ;GO+;0CD.-1Y2E+""B0M*ECX"= =.G;I
M4>F_$IZ%O$@N._\ YO[GV)Y"CD&1Y7AYSS96Z&]DM(4\YH22$"PL5#3I5\E-
MU=IO>DUA%H3^!_E:UF1)Y+C?.89\F$B,V]'"24D$J7L6=I)U&VY'VJHL*,GA
M;?D.L;^![,PBF4]RF*_*\A+3K!9<\A3@T+@)!(5;III5_3JU#(>%LD^,_@VS
MF#S^%R\OD<.4UC7TR9#(:=27%MG<D#LU5JHFHKBJK266)R2W./PK<FY?F,GD
MT\@AM,RS%\B*XA:D@1&RTG<H-[AHM9LE6IM6MDK.0\3;DJ:?P/\ (3C&<>[R
MJ$H-K?<46XZVM7G4KV@I3>UAUZBUAI>LK4F"GH.9.A8+\-N=PW$'^+G)0'M\
M!Z EPA[:X9:RMY;ET^T 6K96BFTZ'C6V%U[_ .A3V/P:Y6)C9,1B9AG)4J*M
MI4B0VZYL?VA+2FON@4(;^*UR2>T5HEB2>CDY/T]VU+T)7AGX4N3\=Y'"S61S
M6.D(@QI33?E)?+I=E>2@$E20 E+;1[+[E'LJE8J=%<;3)-_\/7J$F1+D0\GA
M Z]N4TZ\)A4E:P=RB$@ C<=!W4W3U-;+LNA <B_"=S?+I88QV=P\#'1HS<&-
M +4MU+32'%.J6EU2MY6I2U=>@-K];\]\6^RLW]/0YGQJPHZ]R*_\&7+V(,6/
M#Y#CDO,.65O^8\OR 0NP ;^-2Q=:K:BPMI75C:JM1DPVLW$:D/R'\$GJ=G,6
M] /-\6U\PE+3K#$9V+$+"' X&E-MH)5XO&I:E%2E=:FUY[$8\#JYDI"?_P W
M#Z@?-(?7R_#%L+"E(\N5JD$7'\GW5G)UQH7Z5^"7U!R&%QF,R7,8,E['2I<I
M+_\ .$J DH9;0ALJ;7LVI:L5!-^ZW6NVF>J4-'$^/:90HG\"^>\U]3G*8ZFG
MG&BI&Y\;T)3XDDE!V@*U %RK[2NRNBG+Q5;^5_>86XN5KK6?@RD2O_S=WJ!(
M=E.'F.(/S"W%!2T2E+LLFVXE&IMUKSMZ/05'".BQ?P9<PCLQ6SR/&%3"64DA
M#^I: !^QVVIO1J7^1^'/D;SSCB<Q" <;+=MKO;?]R>^F\DYN?P5<R\UIQ'),
M8/*6A8\$C["@K]#V4WHI!VP^BV:*BK]91=?W+G[5:^LO SV,S_4OFO\ K*+_
M  7/VJGUEX$>FS8>C.8'_P 2C?P7/VJ>NO >FS/]3.8_ZRC?P7/VJ>LAZ;-5
M>C&9/3)1OX+G[5/70]-B#OHCFG$*1^LXME CX7.WZ*>LO GTV8_J0SFT#]9Q
M;@:^%SK]5/61'ILB^3?AYS/(..Y+!KR4(B>P63Y@>V:J"@3M%]+=E0\R:)5&
MCCCWX&.;R'6EO<KQ3B63H2P\DK]JK)/B[]=:YVS<=*_!1SD LHY%B'(R@ IM
MQ,FQL>HLWI4:"=(+AP?\*G*.+L3X\[-P)+$T-@QV?/2T"-R5JLM!U4DA&@Z#
M6NKCYUCF9,,N/?$')5__ )O;G'FE#7+,4F&%NJ:3MDA82LG8+ANV@.HJ'F13
MTFAE(_\ S=_J0];;S/#H&T%0#<H NIMXK;.AL"1WUCO<0;*J'4?_ /-]^I$3
M+QLI'YCB$):>;><;")5U;#=0!\O2]U#Z:.[F0JZ#_F_X!>><HSAS4/EV+C.N
MM(1(2I$D%2VO E?A1U* G=[:AV<EDE!T[\+OX5N8>@_-,MR3/\B@Y>#D<6K'
M(C0TOAQ+ID,NI62ZD )"6U#3OJLLF$>K:@!0!0#'+07,A$^7;4$*W!5U7M8>
MZI3@AJ2"_HI+_P!8;_VW[5:*Y3:']%98_P!\-_4K]JF\;3/]%Y?^L-_4K]JF
M\;38<7E#J^W]2J;R=ID<8E#^[M_4JHWC:9_HS)_O[?U&FX;0_HS)_O[?U&FY
M" _HS)_OZ/J--XVFW]&G_P"_(^HTWC:']&Y']^1]1IO&T/Z-R/[\CZC3>-H?
MT;D?WY'U&F\;0_HW(_OR/J--XVA_1N1_?D?4:G>(-OZ./_WU'U&F\;0''9 -
M_.1^6F]$;2M*].<BF2\MB:REAQ96V@A=P%&]NE>G3GU54FG)YF3@V=FTTD;I
M]/,D#K,9(]R_VJG]=7P9'Z&WBA5/ <BG03&;>Y?[54?-KX%EPK+N*C@LVUC)
M9UZZ*_:J/UE? O\ I+>(Y:X=+:T3(; ]ROVJH^77P8_26\14\4EJ38O-7[[*
M_:I^KK/1A\.T=4;-<4D--J2'V]ZNIL?VJ/EIOH0N&_%&G]$'NUYJ_N/[56_6
M+P*O@OQ1C^A\@?"\V/H/[5/UB\"5PK+NC(XG,'^^&_J557RZ^!9<2WB9_HI,
M_P!8;^I51^JKX%OTMO$#Q6:-$/M#WA7[5/U5?!C]*_$T/$\@3_I+0'L"OVJ?
MJJ^#)_2OQ,#A\K=N5(;/T*J/U5? M^G?B*IXI)3T?;^HU#Y*\"_H/Q%D<<E)
M_NZ/J-5]>O@/0?B+_J*38?>H_+5?77@3Z+$G..25W^^1]1IZZ\!Z+$%<6F$6
M^8;^I57_ %-? KZ#\1NOALM7^^&_J5^U5_U5? GT7XB2^#S%"PDM#Z%?M5'Z
MI> ]%B2N!SB+"4U]2OVJA\E> ]%FG] 9XZ2V1]"OVJC]0O GT6!X!/-OYVS]
M2OVJ?J%X$^DS;^@,VUA+:'T*_:I^H7@1Z+\30^G\^Y/S;/U*_:I^H7@3Z+\3
M4^GN0/\ OQGZE?M5'ZA>!/I,?8#ADW$95C(.R6G&V@L*0D*W'<@ITO[ZIDS*
MU8)KCAR72N4W"@"@(7EV'E\@XWD<-!D")*F-^6W(4"0CQ DZ:] 15JN')#.8
MX_T6R\%E+*<E'"4ZJ4@.!2U=I4;:UTVS^",E3Q%)7HWE767&H\R$RIVX7(\M
M9=L>X[:YW:39:$3C?P^3<.I2\;DV67G#=UX^8I:CV]1I6KSV:@S].O4F5>CN
M2<4EYZ9%=E)%@\YYJU#W7&E9.TFBT&[OHQFW%:Y&+M]H<O?ZJAL)LT5Z)Y8I
MLF?%)]H< _BU!:1B]Z!9V:ZE<K/,-,I-PQ'95;Z2KK]565H*O4,K^'B5,@.L
M1<V4R"FS07N2T#WJ"4W-65]9*QH0^$_##-QJ%?/96+.>4;E2D. #W"QJU\SL
M5K1(G7/13E,=LM8G(XZ*D_:*';CW (K--=R[;[00X_#KRJ8Z3F.0QGV"0HM(
M0[8D>\5L\RB$C%8W,MEH:]&\Y#:0C&9:/%6VG:AQ*%FWT6K+>Y-MJ@PSZ5^H
M!0I,WE##Q5VI;6C3NZ5?U"FPVC>C.39*EOSXSSB]2I0<T)[>FIJ/5#I)9,;Z
M;C&M!+;S2W#JM9!Z^S32J.TEE6.@[?X7-=0M(D-7(LD$*L#]5'9$I%;8]'G$
M(<+[T9V0ZHJ6[M7?7L%P:AM$CT^F^8#081/82T !MLNWAZ:6I(-4^F>7"%)_
M6+ 4KN0JP^L5.X#69Z;<L+8;Q^0@-=[KJ7%*/T!-JE.O<A[NPWC^E?*"X/G,
MC \NVODMN)43[["IM:O8JE;N23'IEDV4J!FLK)^$7<2/IL*S3+MLCGO2[EK[
MP=_6D)E"5>%E"75)V=Q) N:ELF25:],IJ!=4]LKM:P"@G\U5>HDKG*?0B1R=
MI##V1;82VK>A;96E>[W[:O6[KT*VJK=1GQ[\/!Q#$A,Z9'R<E]0*7I <5Y:1
MT";UI;-9E%CJBQ#THR@0VU\_'\IK^3&U=DCI8"UJQF31)(>(]-)K320A^.ZX
M.UPN $?0FB:#$9OIQG78ZH\5S'M@V4/,\Y0\P:@D!(JRLD5:9 'T<YG*7YF0
MSD$E:[N^2TZ+I/4 GIITK3U$NB*[7W9I*_#?B7<7*Q$7(R(L&9XI,=$AU32U
M];E*P;ZU>N=KH5>-,H)_!S.9?;^3Y7MA;@7F5MK!*0;V!2;?DK=\QOJM3)<>
M.CT.E_U(.&*B(N3'6TA ;&X+N0D6!.G6N#=K)U]H*5D/POYYY_\ F&>C,QA\
M*5A[?J=0;"NJO(A0<[PRRR8_T+ST)II#F3AO+0D(4X0ZDD)Z?9-5>9/J2L;7
M0LD;TJR##0;,Y@J'102H?L5S-G0F*CTRR>\J5-CJ!&T A?3ZJ@F1PGTYR*4;
M4S& OM("[?FJ1(T?]+\I(4"Y.8('9]Y:_?TI(D9R_27+R&7&OG(;H6/@>0M2
M+^WPFI3@AN2MGT+YLRY?'9O'060;I98;=0CZ0$ZUNLE>\F#HRS8OTRYE";2F
M5G(KZTD*W):6B_>#H:QM:>AJEXD^C@4L'SB\PF2>JDE=C^2JR2B->].,_)<4
MM[(L)3T2E!<&GM\(H3)T>&RJ-#CQUD*6RVAM2AT)0D D?54$"] % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % % % % % % % 53D_+9& G-Q&HJ'TK9#I4I12;E2DVT'[FM*
MUDH[00?]9<SLQ[?^,5^U3:-PUG^JTV%#<DC&M*6DH2E!<58[C8]G8*.I*9$C
MUMR1_P#A#-O\*O\ M:C83*%!ZT9,_P#PAG_&J_M:;2)9M_7-DSTQ+'TNK_M:
M;1N1HKUHS";?\QM*%]2E\]/<4BFT2+)]9Y7]TQ2&_P!\M?[":;1N%T>L#[GP
MX]DC_"G]JFP;A4^K,M*"HXYK07 \Q6OY*ML(W"R/5*6H#_FYNYZ@.*_:J-@W
M"@]3I1_^'M_PU?M4V#>;'U+E@%1Q[82!?^45^U383N-T>H\TI!5CVP3K;S#^
MU381N,CU&EG_ 'BV/[-7[5-A,A_6).%S^KVBD:W#BA^0BFPF26PW-$9!2OGT
M-PT@>"ZE$J/OM85&TB2S,R6)"=S#J'1WH4%?FJFI8C<EG!C9D=AU \AQ)6ZX
M2;I -NG;5DI162OO\_6EQ7D0TJ9!LE2U$$_0!5_3(WB7]8,L?[Q;_AG]JHV$
MR:)]0IUU;H+6V_@LM5[>W2HVB3"?466HZ0&]OZ7F'7W:4VB3;^L.5_J+?\-7
M[5-HDP?4.:/A@-*_](H?G%-HD;O^ITIKR0G'(/FN!LDK4 +_ $:U*K(=H1+3
M^:R(:FPF(A>^][K(Z?14NA"L-/ZP)1-ODF[]V]7[51L)DQ_6%*5HB"VH]JMY
MVCZ;4V"13^GTKMA-^_>K]JFP28_I_*_U)O\ AG]JFP2:GU!E=$P4*/[\V^NU
M-@DR.?R[:PF_H6?VJC:)&LWU S7EG]70HOGB]DR7' @^S<A)(^JFTC<5UCU3
M]1W9YAO\6@1V$]9JIRE,D>S:@J)]EJ;29+6US^:4#S831<MXBA2MM_9<7IM$
MFW]/I?\ J*/X:OVJ;1)J?4*0-!"0I0[$K)_8M4[1)LGGTSJN"V/8'"?V*;!)
ML.>R?]21;]^K]JFP28//Y'00T%7<%D_L4V"3!Y_*2"IR$VA/M</[53L*N\#-
M[U06T2$PD.=VU:K?7:GIE?50^B<]D2L6K)"*RDH>\E4?S%;R#T4G344V%E>2
M3XWRB1G)CL9V*AA#;9<"DK*B2% 6M;VU6U8+)R6:J%@H H H H H H H H H
M H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H
M H H H H H H H H H H H"%Y;FW>.<<R&;99$AV$V'$LDD!5U!/4 GMJMG"
MDE*6<;_\0^34+HPD=0[?OUZ>_P .E9>J:;#7_P 1&5_ZB8_QR_[6GJ$;!)[\
M1N6:3I@8ZEG1*?/7J?X-3Z@V!_XC<L.N!C_X]?\ :T]0C:*Q/Q'R?,*<C@T-
M,]DAEU;@'[Y&T*'O%ZMO(:+-$]9')C9?8A,NPW$_=2XZU/\ E+MH'&@$J4DG
MKL.X?HFH5PE)3>4^OWJ'QR(N:GBF.E8XJV,Y>/+>D0=_8EY2&PME1M\+J$J]
MAJSLT3M*=C?QK2DS(\/DW$VL4\ZK:!\V5LND=?EY)0&UG]PO8KV5*L5AG:N,
M^M>$Y8T%8D(,D)"G(3JBW)1<=J#J1[4U?X%9+)_3)ZUS%1[]QM^:H)-OZ8O?
MZLC^$?VJF 9'+WNV,C^$?VJF ;#EKW^K)_A']JH@@S_2M[_5D_PC^U4P)-OZ
M4O?ZNG^$?VJ0)-OZ4/?ZNG^$?VJ0) <H=[8Z?X1_:I DW')73_O=/\(_M4@2
M;)Y&ZK^X)_A']JD V_I Y_>4_P (_M42!M^OG#_<4_6:G:)-AFUDV\I/UFFT
M2;_KE9_N0^LTVD29_7"O[V/K-2JD;C8995M6P#[ZG8-QN,F3;P"Q]M-@W&59
M(@VV#ZZ;!N-%950'\F/KIL&XT.76/[D/K-1L&XP<RL?W(?6:;!N,?KI?8T/K
M-0ZDR8.;<']Q'UFFT2)JS[@_N*?X1_:J-HDU_I [_>$_PC^U2!)I_21W^\)_
MA']JFTF0/)71_O=/\(_M4@28_I*[_JZ?X1_:I D/Z3._ZNG^$?VJ0)#^DSO^
MKI_A']JIVD28/)G1_O=/\(_M4VDR8_I.]_JZ?X1_:IM$F#RAX?[W3_"/[5-H
M,?TJ>_U9/\(_M4VDF/Z5N_ZNG^$?VJ;2)+*RLNM-N$6*TA5O>+U0DWH H H
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M:6J2&-WI,=K1;F]7Z".GY*E(J[0,G,H[T:2EI/9I<_M5,)=2F]OH0^4S,*"
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M0:G2D$, ;WO4!!1$A5B#2A)H2:@DU42+6H0S6A".B1?]%8_P:/XHK(N+4 4
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M#!-Z$&* Z)$_T5C_  :/XHK$T%J * * * * * * * * * * * * * * * *
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MU ,4!BQH#% =%B?Z*Q_@T?Q16)H+4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
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M4^*H?.1L7.1VAR.XVKZ"TZD?DKGO[!QWT=E]O^AM7W7,NL,N.(_&6NX1GN*
MI[7H,JQ_Q;K?_GUPY/\ '?Z+_>CII[Q_57[F=(P'XHO2C-%#<N9)PKZOLY".
MK9?NWL%U(]ZB*\O+[)R:=$K?!_G!W8_<\-NKCXG5,+R+ <CC_-X#*1<G'L"7
M(CR'P+]^PFWTUX^3#?&XNG7XGH4R5NIJTR3K(T"@"@"@"@"@"@"@"@"@"@"@
M"@"@"@"@"@"@"@"@(7EMSQS(6.T^7U[O$*I?H6KU.$Q3.>F27I.U4%(2F$D(
MVKLH74HZFX/07%].XURHZ24;F/I;\G<EV.-?EWD[T#^Q.J?[&U6DB!I/&(4A
M/GI7$+MP$)0J2SH+FZ1XQ]2K5#:$,A5X<EDR<:^AV(-%.,*#S (ZA2;W;/[[
M;4 C'DN-I)D-V3_?&KK1;O(ZBH)&+T5MQLN)6E2?TATUH"+<C*W[C<(ZI01U
M/>?VJ!CK$YO,\?D*?PTYV"5:N(;L6E^Q;2KH5](J59HJU)+JSO%LVVIGDN)_
M5LMPW5F<,D $][L11"2._P LIJ\HC:1DS@TMUA<_C4QC/0$:K,(GYA">MW(J
MK.I]M@1[:@JT592%MJ*5W2M)LH$$$']BDB(,M.*0\A]E:F92-4/M$H<'TCK[
MC5I,TBTX;GLZ(M3.029D=:"W(EL!*75)_0=;-VWAW@BB<$C?,^FG O4"(ZK$
MEF%(<%WF&VRY#4OK=V&KQLG]VS]":;D3M3.:S>#>IOIG*&1PSCZXK5C'<+JW
MHQ0CL9G-A2T?X.0E0';:M-S*M1T.@\%_$HX[E(W&.8X]Y&7?VI:6AL)>U(3O
M4$GRG6[G5QI7T5HK%3O Y)!C3!C\MOQ[KA"8TE^WRCY(Z(>'A2H'3:YMJ\D0
M3-]2GH>MCW'H?<:D@V![Z$F;VH0* ]U2@;7%6(-P: V!/?4$HW![J W![JDD
M4N:E%68434,A"2E=U5),7)J2#%Z22:J-$#0GNHP8N31!FBE=U6*FMR:$F#0&
MI-J U*NZ@,7)J 8H#-C0&!=6ZP)"=5$= !U)/90$#D>9<9QCGR[V0;?F=D.$
M#,?/LVLA0']D142B6GV.O8]T/0(KR4J2EQEM82L;5@*2#90UL>^LF7'- % %
M % % % % % % % % % % % % % % % 4#G OE62/]73_ !UUM3H96ZE74 .M
M:%1M)1]V=>I% A-+8J2!1"=.^H$BB4=:DB1?RZ@L*(184 NA'0]14$CEM(TO
MI4E1PA%K&I('+:+FUM*@0.4HU%AKV5(%VDVZC6H N@D: VH)!0)U[:$&I3WB
MDDB1;)Z:5: 1CB+9E2>MV&[C^S54$CE35 )EH5 !+5 .F8Z3;<*$#LM,[; "
M_NJ21H['!.HTI!!7N3-;6\:/_:K_ )!4,GL3#C(<))[-!4@:KB ^ZH)D;KAH
M/Q)![-14$R-U8IG=N2BQ[TW!_)2!)J84A.B'EI'6QLH?EUI DYYZIHY2O&1H
M_'53&Y+LQEN=+Q[94ZU$"%J<UL=NX[1>NSB5J\JW]#EY#>WY>IR!CT;SN27\
MW-;$>6M6]W(9)]4E]6IT#8W$#OUKZVG+PXM*)?8OXGS.3CWOK9O[=?P+1B_1
M;CD/:YE'W\@Z;;T)/R[)/=9-UD?V58W]QR6^GY2:\2BZN2\XK 8?"I#>'Q[$
M(=-S* %_2LW5^6N"^6]NKDZU2J6B)=#9ZG4GM.M9%ATVT!J.^DDP/&VQ63+#
MIML#I5)+0.F-R"%(T4.AJCU+K0LD#(I<2&Y%@NW7L/[5<]\;1U8\DZ,6>GQT
M&R3] JBQMEK710LYG77LI,CLH 2E26MQZ]!^W5+J&7HY0YRD1E,ILO,)+R6D
M>6ZI-U)&VP*>MO>*P:.RO0F_3EI3.0D)6XI:_(5<K-S\::SMT+HZ1698* *
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M ]X-1 3)N#B\7BVPSCH;,5H?9:0$#\E2#JD3_1&/\&C^**Q9H+4 4 4 4 4
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MZ$H*MI"02=+"N=G8NA8N$-J1FI@_N89-CVZK15+EJE^K(N% % % % % % %
M% % % % % % % % 4CU"]5^&^FD/SN03-V0<251<5'LY+=[K(N-J?W:R$_37
M?Q.!EY+BBT\>QR<CE8\*^9Z^'<\>^I/XC.<<\4[ Q[IX_P =7=(@PUD/.H_W
M9\;5*OVI3M3W@U]OP_9\.#5_/;Q?\$?-<CW#)ET7RHX]7MGF!0  2;#4GH*
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M$QL#O*HY< 'OKT\7N/&R?3=?;I^\XK\/-3K5_O*,XVXRXIIU"FW4$I6A0*5
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M[ZD&US4@V![J$"@5W4)-PJ_2K%0*KU5DB.X]]028J40S52NZK%37<>^A)B]
M!- 8H  N0D:J/0#J: 8Y/,XC$ ?K.>S$6?[FM8\TW[FTW6?H34 C#R61+5LP
MF'F3$GI*DV@1_>DNW6H>Y%"-/$T,?EDY5YV39Q<<]8V-9WNV[_/D;E _O4BF
MH,Q^)81MXRI;"LE-/63D7%2UD]_WA*1]"12$3+)E*-J0A("4#HD: >X4 $$=
M: Q0AA84".DQ/]$8_P &C^**Q9J+4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
M4 4!1N9C_G-D_P"X)_CKK?'T,K]2M*3KITK0H-Y \/TU!)JA(M0@4">\4$"@
M'=4@WJ) JV+C7IVT X%06%4)T'?4D#?*2Y4"$Y)BI0MYM*E);<)"%$#H2D$C
MZ*,A:FN(E<OGL1W5X-B\EM3[243 @EM*@F]G&] ;Z53U([%U61I,YRSB)SF/
MR^,E1Y+6B_(6Q+2#UL2VL:CW4WD;19OU%XO="7E2V%+3N >BN#PG[5T;]*M*
M(@?Q^<<2DJ\MK+->8 5%"D/(( ZD[T"P%)1$,E&<Y@Y !CY6$Z#TVR6K_5NJ
M91$,?-*0_JPXET=;MD+'UIO0F#;:KN-"I%.@?KWI_<&OXZJE%B2(!-C42(-0
MG4W&G921!G:.ZDB#8"U"11*>\:4(% +5(*SS #=B?;(/[%"I-0T ^;^^'YJ$
M]QPI/<*22:%'>*2("H), 74">^IDJ49W@.1R?)',XN8TVVB.ZPS&*5*/F//!
MPK*AH!M2$UMCR^F]=3#)BWJ!C.Q\W&.EB:WL(.U*P04JMW$5Z%+*^J//NK4T
M8V%CTUK4Q&'(LPUQO 9'/.@*^19*VFST4\KPMCV^(B_LK7%1Y+JOB5NU52>8
ML8G,OO2N2R9>/!E*=$N3E'D >8M0*UJ:(*U];)L*^FNJJ*)/3P/*=I3<]2(E
M1G7<F%X9\YF25ID>=CV7U(2\%[@E)6"HVL-:MN2K\VAO1ST['N*.%NL,O.#:
M\ZTVXZ#U"UH"E#Z"37QCT;/470<I:&EZC4N+I;Z:Z=:B2(%PD]E4+F0G4$]+
MZT!SW&??99L]-\I2O]N37%;J=U47E48+<4OM)*C61T$YQ%O;+><M:[:A_MTU
M2_0O7J6^L30* * * * * * * * * * * * * PI24)*E$)2D74HZ  =IH#S-
MZQ?B@C8E4CC?INXW+R2;MR<^0'([*NA$<&X<4/TSX.[=V?5^W^R.\7S:+^GO
M]OA^\\'E^YJORX^OC^1Y(R.2R&7G/Y/*279F0E++DB4^LN.K6>U2E7)K[.E*
MT2K50D?.6L[.7JQM5RI=^%>D?J!SY2%\>P[JL>HV.2D_S>(.\AQ=MUNY&X^R
MN#D^X8./]=M?#JSKP\3+E^E:>/8]#\0_!]AHH;D\WS+N0>&JH..'D,7[BZL%
M:A[DHKYGD?Y#=Z8JQYO]OS/:Q>TU7UN?@=QXSZ9\"X>E/]'>/PX;R+6E>6'9
M.G>\[N<_VU?/YN;FS?79O]WW'K8^-CQ_35(M=<9T!0!0!0!0!0!0!0!0$!R+
MA'$.6-EODF$AY*^@<?9274_O7  M/]BJNG#R<N+Z+-&.3#3)]23.)<N_")Q#
M)!R1Q'(R,)*-RF,__/(GN&XAQ/O*U>ZO>X_O^6NF1*R^Y_D>5E]IH_H>W\3S
MUS?T(]2."^;(GXLS\2W<G)XV\E@)':L !:![5H ]M?3<;W3CY]%:'X/0\7-P
M<N+JI7BCFU>H<)LTZXRXAYE:FWFU!;;B"4J2I)N""-00:-22G!Z;](/Q1S("
MH_'?4MQ4N"2&V.0V*GVKZ 2$@7<2/TQX^_=U'R?N'LBM-\.C_I_(][B>YM?+
MDZ>/YGK:',B9&*S.@/MRH4A <8D,J#C;B%"X4E2200?97QEJNKAJ&CZ---2A
M>JDA0!0!0!0!0!0!0!0!0!0!0!0!0$+RW_Y<R'^#'\85*!QU)O<'WU8 IAI=
M[HU/:/VJLVR-HB[C&'!92;BVEAI]1O\ D-4V59.ZR(F5QA+BKQW"VM)W)0-1
MN'311OI[#65L'@:+,14N%FX"T++*GPD$A;5]Z>FMNH^JN6U&C=63-$\J4XGY
M?(H1+2#J)23YJ>_:Z"%I^DFJRR83-GE8')I\IN1\H5"RH\Y/GQ[^QU"20/WZ
M/IJ!!2\WP[$A]:6=L1\#?OCK2]'4#T( )%O<:F2&B'C<;C1WR]D[/MI/W/EI
M/EJMVK[1[J20D3B09"D-1$^9N\+3;(W$^Q(%06)R-PY3+(FY!2&W@0H0DZ@C
MM#A!U]P^DU#(T)#)<RAP&1'<0&O+&U##5DH ]R= /8*S=FR(2.<\@YK*G%3;
M:MC(^%*>SZJO6A%F4YQY;JRI1)5U))O6A22P8![RI#1[JJP=*:?\[DG RJW^
MCYS3K_JM:T?RAG:8Q_F[7[VNU&(NE7?5D0;5("P/6H8&N0Q4#*)2F:R%K0=S
M3Z24.MJ_20M-E ^ZJP$QIYV>Q%O,!S>/2.HVHR" ._HEZWMVJ]M-43HR1QV6
MQ^5;4Y >\U38^^9(*'VO8XTJRD_5;VU)#4#ZY[ZD@W![J V![J 4"NZI1!JI
M5M+ZT8$RJW6H),;K]*(AF#5D0:F]2#.@2I9^!(NI1T2!WDG04!$2>48)E99:
MD&=*&GRV/0J6Y?\ ]'=/UJ%1),,;JR/)9H QV*:@MG^[Y-ZZQ[F8]_J4NA#-
M%83(3A;,YF4^V?BC1+08ZO8I+7B5]*Z$#R#A</C#N@0FF71_=PG<Z?>M5U'Z
MZ%A]8:^WK0B L.Z@"I1#"@1A790,TH09H0=(B?Z*Q_@T?Q16+-T+5 "@"@"@
M"@"@"@"@"@"@"@"@"@"@"@"@"@"@*3S$7R37^ 3_ !UUM3H97ZE<()K22@VD
MI&TU($D]*@DVWGNH #A42 DJMJ; Z =I[J TAS8LNZHK[4E-U#[AQ#NJ?B'@
M*NG;1*>@Z=20:((!';4"!P/_ **$B[9)M4D&LM^+%")<QGYB(UN4\S^DG:;B
MH82U*#E\]YTA^3A6G,7'!;2RRVZL*"=;DF^E^X:5FBUHDKJUNK*E+)45$J4I
M1NI1.I))J"21=;"\.Y* LIIQAJ]NFY*CU^BK]BL:C_AKH7.G%"E%*<?+)U)!
M\%M>^H1%AMQ[B_\ 2%X,1VHX*$@NO/[$I0#H#XA<^X5#<%HDF\AP&-@9L)4V
M1#>WOM)$5EPMN+2I0N0@;21WU"<EHA$MF,_C\+D9>+C85L^01Y;@D2$]4@]
MJK-1W*)RN@WP$_(SH>;FJ?6F6AO^:JW%SR; D!.^^@[C>KUZ%;=41T#DW-'6
MPI&1\T: %V*R0;_ND[*JF2VD.9?J,[@%ACD>1QS4EVR(T="5"0I:B FZ I1U
M]UJO#91W78GI_*\CCYB(9QR)*5,M.;P_Y*][@U!!21U]M5;AEDI4DP,T$1S(
M?:92$C<XAJ6R\I/9V6J-Q:!HUS?#*)2XS.:'Z3D912/I055;<BK3)!OE/'W&
MB]\Z&VDD)4MQMU "CT!)1UJ=R$,BN2SH.0&*<@R$2&TR"%*;.X!6FA[C1,AH
MG8*TB4XDD)!'B)-AH38"^EZE@D2@]=IL?902:*2.WI4$FNU/=0&JO"A:A]E)
M5]0O4D=CFS'J)DW<YE\1&CMM,XY,4!]1*E+7);+A%N@VBU=>'%6REG'FR6JQ
M"7+E9!XOS'"XLZVZ)!/<*[:U55"."UG;5F&T7Z"Q[: JGJO*Q<'AA5F(+F1@
MN2V$*B,OF*5+&Y22IP)4=H(U ZUV\*MGD^5PX?F<_(==D-:'(\7EVY#+LSCW
M%N,8AMA7EJF9-:I4@>'=N"92U;O[%'6O6MBAQ>]G\-$<CNU]-4AMB.<>I?)<
MSB^/P,V[!$^4U'^7QC;4%K8I8W:,(38!()ZU;)QL&.KLU,+N37)DLZJ=9U^!
MZ\\M"24L_P DD[4?O1H*^33<'KPA4)%AI4R3 JEL=W9599:!4)%NE1),";IV
M(6O]!*E?P0354Q!S[C:/,R$4VT)6OZP37(SM1T@,C7W?L54V)+BP 6L]I0K^
M,*ROT+UZEGK$U"@"@"@"@"@"@"@"@"@"@"@"@&\Z=#QD-_(Y&0W%@Q4*>D27
ME!#;;:!=2E*.@ %6K5V:24MD6LJJ7T/%/KA^(>=SA<CB_$''(7$ 2W(DB[;\
M\#0[NA0R>Q'57VOT1]Y[9[0L$7R:W_\ I_U/E>;[@\ORTTK^_P#T.!U]&>.7
MCT^])N:>I4KR^/P2G'(5MD9:3=J&UW^.QW*'Z* I7LK@Y?/P\9?.]?#N=?'X
MN3,_E6GCV/6OI[^&7@G#PS.SB/Z29Q%E>;+0!$;6+'[N/J#8]KA5]%?%\OWK
M-FTK\E?+K]_Y'T?']MQX];?,_P /N.UH0AI"6VTA#: $H0D62$C0  = *\)N
M3U3:H 4 4 4 4 4 4 4 4 4 4 4 4 4!RKU!_#[Z?<]#LLQ/U-G5W(R>.2EL
MJ6>UUKX'/:;!7[JO8XGNV?!I.ZO@_P"!Y_(X&++K$/Q1Y']2?0KG'IL5S)<<
M9/CP/AS$)*E-I'9YR/B:/[[P]RC7V?#]TP\G1/;;P?\ #Q/F^3P<F'5ZKQ.9
M5ZQP'6/1SURSGI?,3 D[\EP]]=Y6-)\;)4=78Y4;)5VE/PJ[;'Q#QO<?;*<I
M2M+^/YGH\3FVP.'K7P_(]V\<Y)A>6X:+G^/RT3<7+3N:>;[#VI4DZI4DZ*2K
M4&OSW-AOBNZ74-'UV/)7)7=5RB5K$T"@"@"@"@"@"@"@"@"@"@"@"@(7EVG&
M\A;^]C^,*E XV@VZ]:L!5)UUZ5* L/::-"6;A M;J/;4HJPVW 2=4CL(!3]1
MJ8GJ0M!E-P>,R0M+CI4OIO N?H)L1_"JCPUL662R*QD?3I?B7AY91;7R7;J'
M["OR&N:W':Z,V68I^1PW(<4?,GP5.-IU\QB[B$^TVUO[Q7.Z-=37>F1\1X37
M0@.>2V%!+KS@-D7-M;51EI+U"5@./-*>B*2N4M/WLU5MZQVA-M /8/K-4W$0
M4WE7.%26S$A>% -RH=33J#GTJ;(D$J6LJOV5I!0CG"2J_7WU=%3+0)4+4()K
M&+VO(([.M0R3H$!\_P!(^#$'01\UH?:8U6IT)L=\C?Z.U^]_9KN1@+BK(@V!
MJ09H#8'OH#) /6H9 PGX:#D'$2'$*9GM?R,Z.KRI"/<L=GL.E1!,B"9V:Q(_
MYT9.4@)&D^(BTE(']]8%@O\ ?-V/:15=43HR5A3H>18$K'OHDL=%+;-]I[E@
MV*3[% 59$#L*[JD@V!TTH#"[FI F3WGI1D,3D28T-'F2W6XS9%PMY26P?=N(
MO]%01U(H\G@O$HQ4>3E%= N,T4,$]WG.[4CZC4ID[30KY5,.IBX=@]P,V3])
M5M;'T)-3J(0G_1J%((7EWY&7<&H$UPEH'V-(VH ^BH@22K$=B(T&8C2([(Z-
MM)"$CZ$@"I(%"">M"3-"#7MH J40PH08J0% 8)O4 Q0@P3:@.DQ/]$8_P:/X
MHK%FR%J@D* * * * * * * * * * * * * * * * * I?+Q?)-?X!/\ '76]
M.AC?J5TBU7*C:2+)-2!M4$@05$)!U)L/IH#PC^(#UQS/(.793B\5Z3 XGA'W
M,<F A9C_ #4IE12XZ^4$%5U#P).B4^VN2[=GY'31*J.=\4B<O>\C-X/YF 4K
M\R!DTN&.&BR-5I>)2-X/>/?6#:3@Z:U=E)[R]#.6<RY'Q94;U"^75RN L(,F
M,MI1EQUH2XEQ2&E* 6@*"7+=I%]:Z\5]R.3-C=&=62H&W?6QB+H-@#0#3.)2
M[C'6E+"$K"DJ6;V2%"Q)MKIUJ651S[+8:-C?!%R;62"PDJ<CA:4IM>P5NZFL
MR_<C?EGE#0J'T_MT@F2<_5SSW&IC-R5&5%*3:]@$+TJT:%9U'/$H;\5_([B+
M#'R0GP@:E-*HBS&$&--=6TVRSYKBR$H2D6NI707Z7-06DD7<1*B9;'G,8WRI
M'GMK:4X$E8*5#4:DBH)?07Y<B_),A9LJ\:=18?9%'U(KT$X.0<Q&%GR&&RIY
MYYEE#=[7WA5[D7-M*TQZF=^IR/FW).<RYST?'988J"V4LLQXK:05+5I;=8J_
M+772M:]486;8UX=P^$QF<8]/><RF7?EMJ=EOFY*@K=TUTT[:G):5T*56LG>>
M6(<&=:+;K:;-,A:%@DD>\$5YUF=M>@0$H5#S*MZ2OY=)W Z"[R>VH3+-=!K$
M2PMQ ?7M1?QK191 [P+BYJ4RK1:S^H&,(\$.R'HOFH\U1(;4';>&W7P]]3K
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MJY(SY>>=:+4*$3K%:<'B6NW1Q8TM]D>TUXG/YBR?)1_+^\]#C86OFMU.RI2
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MLIO>VI _)0ED-R<A.+0R1HY+*B/WJ3^W1 8\2:'SDM=K!#&W^$H5+9"194M
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M7RL9/1F8T!YB0-?"JX6C]RH=M?G?.XCXV5T?3M\#Z_BYUFQJW?O\2ZUP'4%
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M^*\>9MY>.9.W4%P>8?\ ;7J8$DJS$BL#:Q';: [$I %2!:UK6%K=U 9L3[:
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M7Q/,Q^GFO7M^>I[6"S>-/N9_HGC<%(E9KC.)QS.=<2L#;&9B!TN:J2M]EOS
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M[21JGJ+$UT<KCUQT3G5LYN%RK9KM-:)'I2O,/7"@"@"@"@"@"@"@"@$(<./
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M:YMVFM9T*P."I3>XH44J;L7$CL!T\0[O?6"LZEK55AHN)!=85'<9'E+!2L)
M6A25=0I"M#7/>CNY/.R<)+Z614+TSXQ)E./+08S6T!+,>0IAD_NO+!L#[K5%
M$YZE*4R*5;H3D3TSX;"'@BLA*CN4I4AQ5R>_QT]/Q9?TF^I*L<2XE%39,>*
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M3LNA.]/J9+$S&+3+87=E1LF0R;H/L(/3W&LFT]&:U7=#UI47,)6V0&LBV+E
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M9 MT'=5?JT703MZ]1C,GN2-\N8Z&HZ2+K5TUZ #M)[A6RBJT,G-G(K%DIO\
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MI1ZGJ&L#4* * * * * * * * :9/*8W#0G<CEI;4* R-SLB0M+;:1[2HCZ*
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M',8N/F\9)Q4I2T1Y2=BU-*V. 7!\)[.E2G#DAJ5!0U>D4)@@P<_EHO=9_?\
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MV^*K(@]0>F?#F."\+Q> ;0$RT-A_(K'5<QX!3I)[;'P)_<@5#)+;4 * * *
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ML<G6LA0)\Z*RK3VVKS=R\#OAE(Q7"<SG43)K>2906YDAE?F-J!6M*[J5X38
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M<E_X+&_RBZEA'JJJDA0!0";[#,IER-);2]'>2IMYEQ(6A:%BRDJ2;@@@V(-
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M6"0$I'<D: "JD@10!0DOT7_1F?WB?S"N-]3I705J"0H H H H H H H H H
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MB!8BK[BNT40HWU&E%8C:.4DV'2K;B'44&O9:IW%=IN*B28%!;MJ9(%$@?74
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M==4$-C52ED) 'O-($EC]+I<:=G,G)B+#C)82D+'0E*D@VJC+(ZI52P4 4 4
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M <*DMRHSB76E%"BE6U:"0;$$:&@%94J+!CNS)K[<:(RDK>?>6EMM"!U4I2B
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MLDJT'Z.O=22' U_6W(7]JY[V0<N=B76G-H;7NN+W*4JN/AW#MJ8$F(^"2\"
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M7_$:0,/Q$DV Y%$))[O+=J4#M%0 H#C6(_\ REN0?_B\U_E(U3V!V6H!PSU
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M6)Z'MTTZTDF!%Z.\HDJ=ELS&@/*<=6ELCML6+>)6O1)N2:22.%9&> 8KSJ7
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M_P#<4"I)/5GX,U7XKRG_ +59_P"+"I15GJ)!N!0@734B3=))J23<:4 E,/\
M-'K?H&H; ON%0 N* +B@"XH N* +B@,T 4 4 5,@34!K21 @JP!OUH2(+5;4
M?300(E?::@%N]+%;L]D_\"?XS=0R4=9JI(4 4 4 4 4 4 4 4 4 4 4 4 4
M4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
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M4A<L(4E3$>-YFWYN005)2/B"=ME D@75V=A- -Y,-J&RIR0KS5(*27W=S@<
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M+$D :7/;4DGJC\&[EN*\GMVY5H__ +.*DAGJ=A6Y([Z%1T-*DDV!M4@W'2A
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M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
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M5RC",3&GF6"7%02?)='5QE)U(_>GQ)[TU)3HSD>5!$],< J=2@)2E(N3J;6
MJ"TGKC\'\*1%XMR,24;%.9-I823J 6 -:L@STVV+6H5'*"0?90"Z5=HJ23>I
M A-TAO?O?V156(%R=:D!N%02&X4!F@"@"@,T 7- %S0&* 25VT*C5Q7MJP&3
MBNV]02(A0-JJ6+OZ1D'.Y.W]Z7_';J&#L%02% % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
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M%\#8M6P !MYYL@%1M=*4CW@B]1 D6=\A#L<S([OFHL#+9"0"5?"E-AH3IN4
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MERZ^CIOG<L/W#G^4;H0=EJ"0H H H H H H H H H H H H H H H H H H
MH H H H H H H H H H H H H H H H H H H H H H H H H H H H H H
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M#I46F?$ GRR5+618I\PV3X05'2]6:DJ+S5Q)<+YN7YLE]*DL?-H<5YL5QEP
MI L0ON3TTK.67T(UQU$X2'L:M7E%;JVI"6D2"PJVPIN;)W?$5KM8=]ZGH0-8
MSJ88B?+O!3SK"G&7DE1(7>PW*%P /T>MJ=2!9F1&D,(A;FWW]H4RG<6&S95U
M+1H-RM3UL>^](8-_F6U':E0+!=0&4$%1*T75LW @&W<:"1PAQY_85H<<C((6
MW*"D^0' 2HI#9OMV]%;C4,LC8K<BM(AL@RGFG M#"TJ6O>K<M)\P7W)(-[+T
M2:3(%5-"*CRXJENQ8R2E]2EVDGS"I2D'S+*!-P-#^2@$A:*J,\RTI;LINS*4
MJ*CX?$IM6U0L01?3X;>VB(;-8\AF1'==;>#,],@6>&TA\(^%2DVZE5Q96MJD
M@66OYB)=#"TJ2"(B72?-=\M-]K0"BH $W%]?=406"?-?82J.VL J05J0ZBS2
MUI N"E6J#8V*C<WZ"H0&+[L-_P#G3*2I:6T---QVW"M03<VZW<-C[DV[#4E=
M#$M(<9M%2"E]0>?+"OO&_+"4A1\%KJ/9>Y'MUJ$&8'SZ(A+Z''&_%Y3C! 4T
MFX-QN)*KJ\ !&[MJ0-7(V5;D^<XIH.>:$MP)"VGD;D:@+!&XD)[>FM3H5DC\
MBVA\K0Q&O&<)+ZP&DAQ: =@<(W;RD^&YJ.A8KTMIM]C=$6XMY((\MDEM)6=2
MV3=)4O7;I?IW4!4GXB/)?@R7VR77B&QN"EM.@70I1&FNJ5#J*DHT=Z_#"@M\
M>Y$TMO8^WD6TNWZW#/3Z*LB#O2.GMJ"10&K0#8'OI %4KN-?KH!.<?YD]^]'
MYQ0E#A74U4&-* UOK[*%3-Z$A0!0&:M D*J29OI:I!J3W=:$B:R/VZ25&;A%
M0!DX14DB2#>W?52Q=?1LWSV7_>._Y1NH!V>H)"@"@"@"@"@"@"@"@"@"@"@"
M@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"@"
M@"@"@"@"@"@"@"@"@.8?B*5M]%.8J[H2?\LW73Q?^6IAR%.-GS"7.["JP&E@
M.VOI-R/#V1T$?F[HVVL+W\?;4;B=OB:"657UNH>W]FJR60D9 L0L[E6T2:JV
M6@2^87U!T/0VH# =OJ-1VW[J$FI4+7[2;>(U!!IN 5[.VU2(0I<=";=P'2I0
MA&=VRZA>^@ ';[S4E6@T^T;Z:CJ*%3:^T7M9-^O6@,%0-DCLO?Z?90&";>RP
MM>A)IN4H:BW<>E5+(U(M[O\ RUJ"PHT1V=_2J,M5'?\ TID1X_"V5J\L/2)+
M[3B'0@M/ %)0A>ZYZZIV@>^OF?<?^;[#W^!_Q(O3T5C,E36,;??;C1T.MQ7'
M$>?&*3?[EU8"I;9O_)V.W\M>>=Y&N3\EC5L-95I,8A83 Y*VLQ]X-]S2_-N5
M)O\ $V^H)[.E"".F3 ZF2XN4#(CR4N%,4%J&XZX@DN(6A0*'+I!\I-]W1.E(
M$B+TS-3HJ8L9YF%CBYYK>0>3Y?S2G3N4M6RY8<"K>6NW4=14I(:FV-Q<:&%Q
M9(=8EJ45>1,2AU3B2+>8E-MB^S[Q)OK<W-5EEH188V7;D(:@ON.,+4%I3" \
MZ9Y:0$MJCO !*^MRV^.G3I2"2$_5$C&^;(8!&,9#GF3(FY:VG'O"H.BY5%5;
M]#<@]B14S)$&B\;#\M1:2D(642&4ME:XLCS--RDBWB%O$X%)U[#42(,17G8D
ME&]+024%M"F'!Y7S#9NDH5M2GX=+&QO;I1Z@RZX9<US)9",CYAD;5/J0XTE'
MG $6005%7:G?=)/151 %($J- D*>Q[KSX;*@[.2V6VT%1T;6"HG<4G<$MA2;
M4:+)DA+E1<<QY\)QR!EE"TEE11\L=INE3A-FW0/T6]CG>":(,@SBG,G)<+H$
M:>D!29K""Q&7N4-1'4E*KJ%B%/ >^K21 X5DIF&C%J8PI34I)O-"$OAQ*E>6
MI*VU^#0ZC;8?NC41),P+N38K#81#E+6SM+*8@3N) N@GQ^)H ?W/Q@U!)A1A
MQVD(R!9CQ+I<^7CIN$NE-VB0+@J4D$>5H>I J"!BE#V96ZQ!5_,6B72RXI7S
M"4BY6XDC1BP[574.\"K3!$" AXU(2PS=W>%>6^MKSVR@Z%Q \/F;>U9N+] =
M*E-D-(1?A36&'6; M71=*#O6AL^!)4L$;!;Q!("2OH>TU;<BNUC*1'0^E2PM
M7WUELG8AY3FU2;%:=-K8^R4WV] :LK%70<.8Z+)<>=@OIF*0A*%A+A>0$@6"
MQ<@GPDV0DD^RIW$.A$SVFVTN(AMN#RS9B1' #@4D;E+&[;8[3J2$A([=+5,D
M0)8B2T"DR5_-/#PN>:573MOJ'!8+-OM&X]MJBQ*),LHE)7)92MR*NQ^]"3(<
MT !\Q&TAD] +^(]1;K4L1<K*L+R!0S.,5#A"%AT!2[H)W(2X@!01KKH/HJR1
M5L0G2YS2/.;CK<2R5((3JIQ=@I*U!9!V'XMIO<VO4I$'TNX:I:^(<?6Y?>K&
MPRJ_6Y81>]=:Z'$^I-U) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4!Q;U9]
M,^5\NY?"SF";B+@-8X0Y1><#4G<VZZZE+:BA6U*BM(6>Z]63T(.:O?ASY])<
M0\Z8* ^X7YK/GEY!W)&YD!:1N2LC4Z;>B15MWB(\!VO\/7.5_ ]';3M+;C8>
M2D.)N+?"@!)2!X2E-_:!54P)Q/0+U)@[!'7"0IEWS&W0Z%N=H!W+3]*E*!5?
MI1LE"3_X?_4D7\AC%N)21L:=?4IL@$DZE.Y)4JRU=YZU*:(,(_#MZB*DH?<>
MB(45)?D[9"K*6";H:LD%L6-A;I42@!_#UZAMR _'$1/EAQMD"0EL;7- I24M
MV.T:V[>V]Z-HE&COX<^?H<M'$!R,I>YUI3H:0H)3I]VA&U(4HDD)Z=E0G# F
MO\-W/]A0P(+8) 0DNH4E(2 !;<A121=6J>RIDAC7_P -?J:SY_D/0@DI"64>
M<+)65A2E ;  +=+@D&YI* [QWX=_46"^%F/CU!U2%3MLHAIY*4_"6RCM5V[N
ME1;4E"A_#[ZE1W?-QR(#"G5#SE_,*+FU*38FX4.M@+= !0#<_AO]1BO<XG'/
M>9\97)6D@K(WJ.U%U* T3XO?0D6D_ASY^L/^2W! 6E9CVD>6XVMP65XDMVLJ
MWCT.ZA4PO\-W.WFOODP?/4$K06I"@AIVP*K @;M1H3]5"39?X>?4L.G:<>]$
MV(+<1V2I+:'%&ZR"AL*400%))/;KTH#5K\.GJ&&5M+$)1*=[:G'PYL=W;B4W
M1U/Z1OWZ5!(LO\/GJ#(;\AYN(AOQ(=6W*L7$DW"D;4)\LD^)0'Q'KI5I*P-I
M_P"'/U'DAM;7R27@^AYPIDD(6$HV$+!1:YZW OV7M4)@;#\-GJ6T%%E<(*2;
MM@2/ 5* W$I*-+:VH]0*'\-_J)(COMO1L;&<DG>\N/)7<J 'A3<>!)(!.W7V
MTG40,V_PR^IL9Y<F.N$7'$E)2Y(2OJG;95T 'I\5K]O6DR(&4_\ "KZCR]B2
MWCSY2+M*1+4@(7IN_N=R2+IU_)4!D#-_"-ZONN/!@8KY9XE6PR/$#H 2=@&X
MC0D=E6T(@ZEZ/^@G/>%8S*1\ZB&)<V2TZE3$@NA2&V]EU'8/%V43$'21Z=\B
M'8Q_C/\ 8J90@V_J\Y%W,?XS_8J=P@!Z>\B[0Q_C/]BFXB#8>G_(AV,6_P )
M_L4W(0$GT^Y"['<:2&-R@ /O.X@]U1),"IX%GR2;,_XS_8J)$&/Z \@[F?\
M&?[%)(AA_0#/]S/^,_V*23!C^@'(.YG_ !G^Q22-IG^@.?[F?\9_L4DF _H#
MR'_<?\9_L5,HB _H#R'N9_QG^Q3<(8?T!Y!_N/\ C/\ 8J)1:#/] N0?[C_C
M/]BID0:G@'(.YG_&?[%)$&BO3[D)Z!C_ !G^Q421 W7Z<<D5T#'^,_V*F4(&
MR_3'DZN@C_XW_P#1J)$&B?2_E (.V/\ XW_]&H+%D].^%9SC.6R$O)AD,24K
M#7E+WFZEH(N+#L2:$'1Z@D* * * * * * * * * * * * * * * * * * *
M* * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
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M+,?S%BWW274%6IMT%^E%B;*7OMZC1'J-'7TQ[G^,3^U5_0\S/UO(73SQI?2
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M[WC)R<GC8>22@MIF,-2$MD@E(=0%V)'6UZZ4Y1QM0X'520% % % % % % %
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MOP(J/RV8Y*=B_(H2AOHXI9UTO4P4W,TG<MG-((1":5W@K4*KT)5I(MC.9/)
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M1ZZ(]>C^5-GU+X@%#B>!"M%#'1+CV^0BO6KT1XUNK)FK%0H H H H H H H
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M0;ZFI*LR1W5)4 GO%2D0S;RR*M"*FWDT@&?*O0&/*M4- PI/<*J0:%-Z QM
MJ :V-0P!3[:(!L';5H)%&F''G$,LI*W7"$H0.I)[!1^ 74:YG%Y:3DF.(H8=
MCRYJ/.G/$6#<2]MJ5:C<X=*Y\U+9+^BN_5FF*ZHGD>L=B(RD=/.LXUZ?X6S?
M!N.+0KD#Z#9J3,:U3&"AU0WU7WJK2R66RPUTI3K]A1-XUO>M[O0D?4'CV4YB
M]QWC\60(_$&TB3*#! 4^M!"4)'99('@[ ?$>@K&]'EO6J^EEL=_2W3UDA.6Y
M:3!<8],.!I2WF74)3,DLZ(@10-+*[%$?#W#Q]2*VY6358,9;%55^>W4M_&.
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M,?\ *(KGY'TFV'J=/KA.L* * * * * * * * * * * * * * * Y3^(_C/\
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M+&WX05FRT_0K\]8Y#LQVE%5">\5D;"J10JS?;[*E%&QS"=^7DQWR+AIUM?\
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M!CLM#ES&D)9<CLO)4X'$^(IMVD#72]$TQW@E960<B/1&VXCLE$EPM..M %#
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M&->R^)R^8YOR/,NX:4W-AM9*2B2A*VG$N$#S$$I"B@!6V@.\T 4 4 4 4 4
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M,I9T!1N\13[>E5MT-:J6>_.,DGC>')%B8,:X[ON4UU+H>5;J2M20% % % %
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M!*DJ%Q=-?"YZ9%DNLB:M)]EBS4KBKL:VQ]QS/DZ'<IE',KPZ:8B')"I##&2
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M0% *LV!HV+"US^DJE^2DH1S>X>^UQT]/!\SZ.WA\".DICXI"GYSA:9?65-,
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MR#F"5$1+9GPYTH-(EQU)01'6I0;&O46O7!R[875;.LG5@KD5OFZ'LJO+.T*
M* * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
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MO*G$@!2./*3IV[YL<_\ FT[!'TIJI(4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
M4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
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M%<G1A<M"RBU@-0GPJ0U:^]!\*@+]X)K[3EW63%:K>D,\OCK9=6KU/3?])L=
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M/_G595^1OS7\2D_-'D?2"LC0* * * * * * * * * * * X'Z\^NG)/2CDV
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M+/DXV:,E$1\S#>7'=V*#ET[VRDV-NEZ [1")5#CJ425%I!).I)*10"] % %
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M.8Z(M((L;*801IV5[%>B/"O]3)FK%0H H H H H H H H H H H H H H H
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MLUG;3N77P/I%P[7B. (Z?JV'_D$5[5>B/!O]3)NK% H H H H H H H H H
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MHI5*#YV^6UWJ^IWOT&A.9/C6380\'1'R#8$9Q)(076K[@1?112;W[17POO\
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M:EMZ%LF['8@,QT.%J6AQLO/AGYQ8<\T!*&V1J%BXLI6@)%8\B\+:B*)SJ5Z
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M)<M^]6&G#[$&@.EX_P!0<1+]-F?4IU03B3BOUL^A)U3L:\QQH?NDJ!;_ 'U
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MIC(P)$^)%<<5Y+B@IY(NE>\!1ND@A1%^ZLWH74'9,!-$_$P) LM3K#2"4^$
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M=M3GJ9!"0D)V@=^NE8FI[!__ #=3F_U9Y+_^+KO_ !Z)1A'THJI(4 4 4 4
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M*QHH'8&4$=2I9%TIO0'3OQ+?]R'+?\%%_P".L4!8?32*Q.]).)09*=\:3QZ
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MW.>4R8;L%K.8L3<<S(04.*@!^.W'<(_=-I0=-#V:5(+A^,'_ +GU_P#:</\
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MY.30+QIS0VAU"=-;:'3J*_3L=?5KLM]2Z6\3Y+)?T_G[>!9)#KT2)MBI!+8
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M*3M&[Q$6!OX:\S!P./ABUF[W6DL\I4R6UZ:E-F<Y4W'V8]GY..WM'FJ"8^@
MO]Y(%K7.T*"!7I6S6[(Z+TWV=KVFS.=<FY[@5(PO(,CG\<F/Y\I"73*^8"[
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M\!!O(Y):WH\MA<924$G>I*[^SI>FA$"S64RT-#+4*&[.047(;+=T^S:L&]-
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M7'KQ_=?^-?'^#/1X'UOX'N>OF3VPH H H H H H H H H H H H H H H H
MH H H H H H H H H H H H H H H H H H H H H H H H H H H H H H
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M#Y?R=KDJF5LQC':8:<L5+"U*4NW7;H.E>GQ>*\*<N6?4^T\"W%5G9J;1^!C
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M=9&];25 ^8PZDA+B+=%)(5WZU.U7J[4:LN_C\&CBP<G'EF'KT?Q.A+YM^O\
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M KZWWG.ZXUB[O5_!'!Q:)V=SK?X?^21'.$Y2!)QR9<O%/%*7%)+P2)*0I3Q
M!6D;4&Z1<%0^BOSSEY[8[*'$J#[+V^M;8[)KZ7)W5&<DAAEW&X9!B;([:(C0
M5(,L(0EM*] D((2!XK=!XJ\UTLJL];<I3@X%^*K)-RH&#B/J0<A)E/S%L(5N
M*&T-^7>X[B;>VMO;TW:UO@CS_=K+;2OQ95>-3_G.,XM845.)82A2ATW(!!2;
M>ZO<^)\P^I2.<N.*S@25E+*F&MP%MR@ 0!K[:]'&WZ27:2L_,+P%Y"-B,:^_
M(4_"6'418:K;&4;KKM;M43>]=O <9+_80T=W] ^?(Q$N5QA84IR0Y\_CU7^$
MMI'GIMWD +T[C7+[Q@3C(NG1GH\#+IM'/JKZ3JA1<ES3AX&1Q3[BYDW"$);7
M$#GC<6PJX"F@;J*#JGLN.EO;_==E/3RKIT97E\%SOHSS+%5+Y9FH<!#ED+4H
M-MDG:AI("B0#J217%SN9;*Y?1=#GX^*;1XGJ#$\/PZN.PL;^JV-D- (:<; 4
M5+^T>T_37R^3+;LSZ7'@K$01G.?2G!1\8I[C*&X>5E-66%I!399&]"#V7(ZU
MU8^1XG'EX:UVZ,XUP/(2^*\ZCX>=X$3)#<.6TI5@%[P6W!<:D=/=7JX[GB9*
M-:,]VIDA(ZV4K0?5769ICN%*#3B4J-[Z$50E,LD9:5)!!J(-$QRE9O;LJ"3*
MEF]2092;BH8,$V-N^H)-'&P1?\E2B&+Q<@&&5P9S*9F+>26WHSJ$NI+:OB3M
M6"E23VI4+5*9:)//OJU^&U(9?Y9Z5H,K'D*?E\:1=;C21XE*ADDJ<2.UE7C3
M]G<*]3C<QPJW^\\O/Q%;6N@I^!I.WU/Y"""E2<$ZD@@@@B9&N"#J#5O<8]--
M>)'$3K=I^![WKP#U H H H H H!";!A9**Y"R,9J7">&UZ-(0EUI:>Y2%@@C
MWB@. >H7X=F,4IWG?HH\[Q?FV/0M]N!"61%EA(NII+9N$*4!8)_DU?"I.NX
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M<K#=<"VVW&]H!>%KAS\E2#U3#$@0XXE_Z4&T>?T/WFT;NGMJ +T!YXPP,_\
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M%H5=*AV$4!,T 4!YVP?_ .6)R7_\7&_XL*I!Z)J <@_%#_W'<H_^H_\ 'X]
M36*X\GEOH7C>,J4$'+<6BPT.'HA;T!"4*_L5$&@*#^%/F:)'$I/IGF;Q.7<0
MD2([T!ZR7C&4\I6X#M\MQ2FUV^'P_I"@/0= % >:/0:<WZ=^J'//2#-*^6>F
M3U9?CI<\*9#*P20DGJHL^6JP_17^C0'I>@"@"@"@/.OI@3._$YZJ9'K\O%C1
M+]U@PBW_ *F@.]9W#PN0X7(X'(HWP,G&>AR4]OEOH*%6]MCI0'C;&<YS'#_0
MSF/I(^HKYCCLTKBV.80?&MC)N+*]B>I!V2-I'Z::D'K+T[XC'X)PC!\3C[?^
M;(J&WUIZ+DJ\;ZQ^_<4I7TU .._BW_FN$X1E^GR7(XYW=UVUK_\ U= 6K\37
M$I?+O2++-8]LO3L2MK+,LI%U*3%N';>T-+<(';:U 6?TBYU ]0^ 8;D,-Y+D
MKR$1LHT#XF9S* EY"AU%SXDWZI(/;0%XH H#S1P.:WZ8?B/YGP_,*$7&\\4C
M+8-]?A:=DK6XZ&TDZ E3C[8[U("1U% >EZ * U<!*% =2"!]5 >=?P9D)].,
MXPHV>;STCS&^U-XL8:_4: ]&4 4!YD]7,%CN'>O/I?RGBC:(.<Y%D50\U'C
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MS'Y3JI$DDMALW<)6;)VI2B]R.U*-!]HFO-P8%6J55_H?%4QXN-CA16J77_\
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M[UZ+A6EIF4]BR<[;3^O$2@#:9':=-Q;Q)%CKV]FM<N._RDP/>!R'&_UBUJ$
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MM 5X@-P*3JE0N;@41CCWXLL A./A<DX_GX;?A9FY!M:).T=-^UI-S[2I1]M
M6#BG#/7=_DN.SW/^<PTXR M3B\!AHUF) 4DHV.N*0R2-;^(+L>ENM =CH H#
MEWIUZ7Y3A_/^>\SR4^/+:Y9*2]"882L+990XZL)<*M"=JT#P]U =1H#BV8]
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M+X;A?XA\KFL9D>:<ZQ^-Q,&2U*>Q.#C%0D):4%%IQ:T-*VK VJ\2A;LH#MU
M>=WO2#U5]/.7YOD/HOE\;^HN0NF3-P&9#@;:?4HJNWL2;A)4K:0I)VG:=U@:
M Z+#X]ZG9OT[R>"Y=R"+C.:9 NHCYC!-K\N*RLI*0D+\I14 %)*@0;'0W%Z
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M^!VK%9U97.2^M/+,\ZW'Q!_5\914DJC?'M4-0N2Z-+6^PE->OQ?\?X^)3?\
MW'Y]/L7YEJX4EKU*"^ZF5E?,ES/G9S@)<;96O<M1[%/*W.+)[D]:^DI5545T
M7D;)#5UV4'W(:V%XQ*5%+T6*4)>6  2"5$C=;]-6E6AHED/(S,/&LN2&7ABX
M\EP,F0Z\V\M2?\.M(()^TAL 'W5:LVT2EF=OE4O0CX*<KR[*2N/\?ANQ),@%
MV-GU-A<#R6E;5N((OOO\*-36F1X\--]WT_E/(Y?N5,%'/[,MZ?3_  /'8,C*
M<DDIR_/Y,5QAU3=RROS"$(/D'0%* -;7O<UPKEYL]]M%MQ_MW/$XN?D\O,K5
M48DT_C Y)2RPX5NM1VF E#B ;)2OJ LHN=0GX4ZU[.?DY,JU>BTA'Z;[C[WR
M>6E2UMF/M1>';X_:5K.<XF*:9PD!DO+6?+A0(Z4-K<?)&X.N6NV%?9"C8U3&
MFZ-=$?..T6\?X)%DQ/&,?Q5\Y:?).6Y78E+KJ$%F A2=4-I%TET E)<[NM>?
MNOR(248_QM_H?.4K?FOU,JVX?#O;_J5:?(SG)YG]',8EZ)&>"WI.17N2E#:G
MB5$%0.]P]GZ)U/97JX:PIZ578^KP<7U$_P"7'7ZK?PKXV\$2TR0O*-8STWX?
M941#2/UF\V2CY:,"2XM2E7)*E"]_M+]@I2BJV^]CDFFY5KI7\8(M^9CPN#+:
MC)<]/.-3%LL0&RI3N1EI39RZ;'S+$)W=1<U>6F1;+_N.R6BT7\/B6[@>"=S'
M(A(R:=R\:K]8YM05YB%9F2B[325&XVQ&? D?96HUTU7<XK6.Q-MH?>+GD@N*
M/;^Q6JEG/H7O!L)2A V"PK95,F6%YD! 5LOIV:5JZRC*=2&GH;0E2E-)4;=O
M^Q634&LE/Y;AF>2<=G88,A+RVBN.4V"DOH%VR-.Q5E7]E9NJ:+5LTSS0X)C4
MS]98T&/F\>P_D46T1Y@NUE8P&TIN% /-))[37G643XG?1PT^Q-83,0N+Y%H0
M0A_@W*XY=CJ*[L(=>94B3$ &TB]]X%_"#I6>3%OKM?Q^X8TD]CZ?RD9BG<KP
M+*,X.4MYZ#M9FXK*&ZB6D*2L(WIN4N-'07-U  B]5LEEK#Z-1:OC]A.#(Y]-
MZ-%DYE@\?.9R7J9B"ZWF&0F3G<+!;;2U.;T"YPWD!M;7QOA(\7Q=*\K!NP6K
M@>N)SLMWK_V/^!/T.>@TXYRB'D6HTAIY2DK"7(SS0*5+0E0<VA%]RDDBZVC[
MTUV7QKID1KFQ8\M(LE9?MJ3F:XWA?4;F/',;D'TXN;*B3!#S# 25M2]NYMQE
M2OB\0";'7LT->5GODX&"UZ+?#7R^*G7\#EXW"]"EJS*F:^2*9RCCG+O2=^1"
MYI]UPR/O;@YY*W77YCZ02VIT)!VJ5J %6VVTKIX7/P<^LXG%X^:O@=N+,ZJ+
M=!['RK<R QD-SBU2&V)<6;]Y\YM(MNL=H5<?"E=E=MZZ;UVN'U.ZMZVAKH2#
MT]KYK?D%JE$$;,A&;4S(! U+B%C6P^(*!]]4MU@O68)W"9W)8OSI,!:9^/!\
MQ3C*=]M+7<CWN!WJ:(KFR<>F3JH?B>?R/;,/(ZUAKNOXKN6"=RS$Y?C61*E)
M9DN0W6T.(1O0I100$72+IN>@6GZ:\W])>ETTY4H^<I[+EP\BMJI6JK+7R(C+
M>D7&>285F(\VF%YN/;;6F(/*4DE .Y(U0JQU.E%S[XKM]=>_@>9?W'DXLMJ*
MR=)?RM:K7LSFL+T/RW#<W'R&%>>R4T1EI>6Z5-E[>--%7! TT"KUZC]V66KW
MJ%)Z?!][XROMNK4M$S#VQY,IL_U#Y>9?ERN*MPVHCPB95 :4EHNI7M5M*C\5
MNM>QDK@O#3UC[SV^-R,C6GS*2_K5&$4F,-K!V*0#V"_2O+JFWJ>VU"DPYC\A
M$4[,7$0N/-<):^8OY;J !?:018BMK5O1)M:,YZVK9M+JA"06'''Y3<(PLD4!
M(;0$EA0 VD@IM8V[QK579,T2:)+&2LS(8:C084.9!19#L>4@%:+]5[D$. ?7
M5MJ9+LT,<G^IG7G&!B50,DTH^8ZEU+T4A/:@J 7[JJDZD36Q]+^'DGB6 )U)
MQT.Y]OD(KWZ?2CYV_P!3^)-58H% % % % % % % % % % % % % % % % %
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M;J /T'.MN\&N)W:TLCNK5/5/0^F?#=.(<?\ ^S8?^017N4^E'SU_J?Q)NK%
MH H H H H H H H H H H H H H H H H#E/J:;9Z/\ \#1_E7:VIT!4$'2_
M;5WU!DD$Z_74"#0D#2U3 @2]]3!4;.JZ^RI#.?\ .I99;2A)LHZ >^KHQNV<
M6G3%97CW+\0JRG6&E+:!ZDBR@1](J"J. 8_%9/*S?G5-?+PMV]QUP6W ==B>
MIZ=:[.-P,N;YHBOB1DSUHH[DAGX\M,C&96*B[L98=9U^)4=06@7'3PBOFE%;
M6J^S/76JK9'J/T^]15Y_%C(8AL+\Y ,F#,05I;<&A4BWMO7+$-H]_%FE2CG_
M .(@Y/*M8EV<!_-0MP("=@"5)-RE Z7O:]:8[J3DYOS(Y+P7&2)QGLMW4TRM
M,A2R+^64- D^SNKH6=8\U+^#/*KB=\=J^)= EV.TIF0@H4 &W6U]+J&OUU^Q
MTO6^-/JK*3\_R*WJV<0ZE85!3CB[%9!#2UN/M$D^%"E7V@]NM?G7NG&>#.ZO
MH]4?4\7+ZF-/N83%D2$ICLC?)><2VR@'JKNN>P&O+.L[4GCYXKQER,L_S9+:
M%!M8LIV5M(4Z$Z$$[[)]G6M:HHV<;RO+XD/E#63QP^<$-IN-E7E.;S(=.CKB
M5'3<@ "_0[;5G.I=+0[/DN$+R^*GK@A*V<E%^8CV;"0RZVD+94">NXV3:W;T
MJSB"L.3CF%D-N2([<OP-K=2F0E6A3KM6%#KI:H=K4^:NC70THD[)/H61_B<F
M2^&,:XP"ZZIEAN40+$#< '+;3N!N.VO9Q_Y!14_W:ZKNOVT(7 ;O\KZG+LTT
M8F.GL;D+4B<4W:.Y/W5@NRAV7%;Y\JR\7=7I:Q@ZNN2&^@<(;4O)RG$@;DMI
M2">PDW)_+5_8J-Y+/R.?E.*:E^6 RRLW*W "I2CK<]@^NOM;+91ON>+5^I?3
M2#FW+CY60CL*N/*8O8]5+<5<GWDU\#[NFLE:^7XL]_CM;9)J!AYC^.QF/ALN
M?,*2J5)0VDJ<"4@;M$ZVN1<5Z:=,&''6[V3XBE;7LX4DH]$>2AQ*TO,I'^D!
MULI)MVJ4K46OH*<ODXEBLE;6RZ%:TM.JZ#.#&2[+4M8"FXVU5R.JST^JO,]H
MXV_*[OI7]Y?/>%"+ \R9+#K5U!"PM.Y/4;A;3W5]Q>CO1KXGD*RHU)16.!Y%
MZ1LG/(1%2H;7$>(NI';:_AN.M?*8_9,CO-WI^\]"W*HJZ'>O1^%BVI.0Q+T=
MMU2VT/QUN '8&O"L#N%B"?=7E?Y5P/36/+7I]+_@>W['R5D=ZM>9%<QR6*R,
MY<;$Q64Q&'5E<M  4^LGJ   $"WA ]]>O_C_ +&L%5ERJ<ENB_I_U/.]W]S5
MFZTTJGU\2GS(3<AM;+S:5I=&U04._3\E?39^,FFGK)Y&/D2Y*=(X1FL:1(QK
MA4XT? A2K*_L3T(]AKY?)[-FQO?B>J.]<JCT;'_#,A)Q\S*9!"FXKK\=R)-@
M(2$K\SJE>I\-R;G;>O,M@M96OHFOJK_$VM95TZR=3XFY?&((U\=OIKF97N>@
M/3^;\S!0S?Q)5M/T5#+TZG1VU@:=;U4U'"#<Z5!*' /=1DF0;FH!O?;I2"#4
MF](),:]: N7IL/\ GB5_P8_Y1%9V!TZLP% % % % % % % % % % % % % %
M % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M % % % % % % 4SU:@-Y/TZY! =0AQM^.E)0YJ@V<0?$.T:5P\Z^W!9^1Q\R
M^2F&SQO;:-'X'DR+B\1C7XZTK'F,)-PV W'3;J;#PBO@;YKVJU&GXGY_Z=;9
ME:]K9,GVQ^1R_P!1YV.R&9*\<\F0&H^QUUNY1N*[V"NAM[*]C@4M7'JH/TOV
M#CY,6*^Y0K6E?<:XGG/*XF(;XIB9DAJ"E:UB/"2&GEEW4[W4@KL>X6ID]NX^
M3+ZMZ[K>?Y'T;I5N61>1:ELB\Z6W"2OQ/1XZ@M\WZEU0/7]^NO2KHH[%FDA[
M!4Z"U&PT )DNINV^$_-3%@C0I'1 />$CWU*4*$%H17ELMSGG,NY.?6-&L?#2
MA;CKJ3906\HD) []?=2$!NU)0](=^6QZ(4;>$LQHSRE%2+:J+JOMD]5"HC4E
M+1D!%S_%$S7(@GM?,H66D1&VW%[GEJL&TJ NHE751KJ]"^UMZ0<?KT3B9+EP
M?T6]6^59%G^D;J(7",@A2YB%(;#OD!1#;0;6 0%&UE'L%>#SO?\ B<>EEC<Y
M/P^\Y[7ONUZ$YDL1Q[TO]1LO#XM#::B,M-1R"K>2]Y;9)64@DJW7NA-C<VTK
M/AY,O/XE;Y7JV_+N_P"!ERN'7DXMC^75-OX##*3\A*DR'<NI^9)<!4W#;_E;
M$7.X)N&4 "Y2GQ6^(UZV'%2B^10CLP<;%@K&-1Y]W\2"GYCY !];["S$9NT-
MFV'&+HL%-EPA*U)_3(*=WZ76NE2^AO=Q6>R(G%0,]RS(26,:F1 PZXRY">3Q
MBA:'$1DFX2.W<K0F]]#;2F3+3"I;ES$?$\;E\^M;>FM;6LJZ==?RZEKQ43Y.
M+$:DOJ?<0TA*I3I-R$:+6LZ #J5'ZJ]#+R)KMJH7[S[CG^\)X:\3!_QUT=NC
MR-?U>7@BM9S.2YLYG$XMI#\N2%(85(2OY9"C:RGE-C[M MX$W]IUKGIBTE]#
MYNM+W;VK5)SX)+77P\O,M#K^#X'!3&Q\(%$A:7Y2EK< ?DK WN[E@J+0(NA'
MPJ-88Z6N]U^O\ODOAXGC\;#9SGR?59:+^A=E\?%_85O .XS'PD<[RR'42G&G
MVX2'U)46DJ4M1?"0D%.[: 4G7W5W2J*%JWH>]7+3'@5J/_<OJ_"M/!?'61WC
MT.8N"U,A27QS+EOELPUKV_S-AVY*5I2H@A8.]2KCP]>E4H]6NU=#S:I/3Q_<
M/N-<<<GY["JQ"1+P^ G#'M+2DI*UV)F2UE0  -_L^ZM8G0I:R<OL=^<"%.E(
M(V !MM N+)2+ 5UKJ<:)7&A*2D Z=HOK]%:(AE[PY20@7^BNBJ.:Q8]=FO9W
M5HB" R3=]W3V6O>LV:E8DPVUEQ0N'%V"E)*K[:P:+(H/JEQY<C LYJ($#)8-
M],U#[H) :900XE>T$V4V5)T%87KW.C%?6#CXQ4+(ASCC,M:%XY:N1\4?BL[W
M%0WF5$PT*6I"2"04&_0@5QWKW-JN%YH:YHX^3@(_J3C2ZO(HCQ&,O&;*4%;#
M;P2)*A9:E+;^$!/7MO4M-Q72(_Z%HLK*U5-7UCK\?S)GD*\;GN+#D<7',3^1
MX5 5%D/NO-G]7WWOM(2R;N.'PJ:!3?J!7G5HZYE9.*6^I1_-V?DO$O9*OSKM
MU\&'%^4LS6D.J0/(4@A2)"0VA32CM4TM"P#XKV6"-#XNA-7S8E>L/QT^/D_
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M;35M:=OL-J7=#T7Q1D1^+8-@&X:Q\1 /2^UE Z5^[XK;J)^*1YUNK)>M2H4
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M1H /::\31'N2V0["9#;^0:>>+J4J0$Z@H! UVV[*LX)K/<>N+B*W,3&GWF[
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M#,/R^"CRFLFQO<8ON\I]"BV\W?2^QQ*D@VUZT!QQ[_\ +$8__%P_Q54!Z)H
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MCT/2] +_ (15*5Z-1 HDA,^:$@]@W@V'TF@(Q[_\L1C_ /%P_P 55 >B: *
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M2CT"NGQ$=!7BY<SS7FQ\)[G[CEYV=Y<OP2\*KHO,J>=Y1B(J<BX^](8Q<R0
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M 4 4 4 4 4!RGU,%\]'_ .!H_P J[6U.@*8=*V(;@358 6.O[=00)N&POWU
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ME*)]P% <<_")_P!S<7_M";_'% 1KW_Y8C'_XN'^*J@/1- % % % % % % %
M% % % % % % <T_$$S(D>C7+F(C:G9+D1*6FT"ZE*+S8L*PY#2QMLO3)7&]U
MG"1\^^*>D$*?,)Y.VF2D_>O1&_Y%)'0+6+75[!7S7(YSQTFC^!\MS_\ (_6N
M\7&6G>_Y>'Q&G,<9$Q'(9L3'QT1826HX:8:&U"0 16O%R.^--N6?2?XZ[6XF
MZVKW6\^XECU29BD0XK!F24#PMJ 2PTD?:<)T-NOBLFNQY+;%2=#[2W.SWPK
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M=*3[%:6 L?X<^&<DX%P*3QWE$ 8^:WE)3L=L.MOA<9Q+90L*;6L"Y"A8F^E
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M+:$Z74M0U/8-:[%=:*W3L>CGR['6.MG"\^Y*9*9Y.-#:&WIF25;YB#$; *6
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MGK\.V.UZTR?\=FDY_EU^K[$4?!\FBQ7WL3'PDO'+QSVQ:TH(0IJ,YL(1N&I
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M$@WW#O\ HH27;TQ-\S*_X*K_ "B*I?H#JE9 * * * * * * * * * * * *
M* * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
M* * * * * * * * YK^(%,E7HWRY$1"G)*X:4--HON4I3S8MI[ZQS?0S?!]:
M/G 6H6 )3,",KR4#<(8-XD.XT+I'Q*_<CIVUXR3/;Z$%$,M3,IR:I*I2EH\P
MH ";WN;6J^A3IJR0E12_YC3:2M;J=G:  H=]35.ST1V<3BY.1?9C4V_!+S9&
M0_3/ QS"GR"I"HJ@Z^A1\#EB+!5SH!7OTPM5W6Z'W''_ ,3XN"E,^5N*-.T]
M'KW+HHNR%(CL,E]YVQC0^A< UW.=-K8ZV/4=;"N#D\UW;K7H<GOG^06SMX,#
MC'T;_J^'A7]_<(OS<AZ1"QCZ'<BZA1RN96H)8982/$E*NB&4CJK[70::'SDC
MX68T('(J:CS6FL('E,L[")<E("I"NOG>6H62A75"5=EKU:2>KU\"HHE<XRN7
M984WY.+DRE+5+4D**FVC=Q3B[ZWKTL>&L:G9PO;.5R,F.*_[=K3NCM7K/D=#
M?E,-+2U=;49FV[R_B (\*4?[HOHG]$:];5CR,RM\M>A]%_D'NZSM\?#IBHX<
M?S/\D0&4<F,3UMJ9;"V%%+D5%G$-;$A7E*[-POXAW]:XTCY#JY[L7XE.Y%"D
M9&?R/#HBPW821!;=2%><[(7N!-R>J1XA5<RI;;M<ZZGR_(I_<'7'6WRUM-HT
MZ>8US><C05N/9-]3+4A@*6^+EU2'_#N"1XDA8\*?W'L-;8J2H1] G6E8Z)=#
M./Q/'H,!KE..>D&=D(*G7BZHK"6BZ" $GIJ@:=+5#M=MT:A59YW&63+FO>RB
MM;?)]W7]XS:?QG(,BX^,T^R8!;DSH[5T1]B5? M>VZB3W=YKKJMM?W'KX?3R
M5M?<ZWK#JEW9)2&Y66RC276,?(P^BIK3IWR4,I!V@(-PC<1[ZI7Y:SW"=MKR
M36R;VZOYCN7",8F%A$2W2$R,A]ZK=X3Y"!9L?LUMCTJ>=:9:\&6W=$0W<D%1
M.A&EO=]-7T*0)MN"X0V0"K12NS7N'LJ T;->!7Q;SUW'MJR*CU"06[;_ &VT
M_P#+6I@ACZ,RXA8*5W2 +]4@&U7JRC198#BV@+W.G4]*Z),FB8;<%@5$ CKK
MH*LF5:-9+E[;=4TLPB,EA*D^-6E^EM*S;+H8ON!22D-DG[+ENI^FH+0)M-J\
MH*=VC]#6Q -0 \ME5V9"B%_$+BP5[B.V@.?>J&'D.11(QJX[>4>:6W#=EMA]
M#;R!HLI4%7NC<G2N7.E'Q_@:5K*:.+2%8+(<78EY7/+EM\>94\E7&U%H.)?*
M4J;4FY-D'XDJ-[>RN2+RH24^/9&V1WR8JWKI#U^'\Q$R&HO+<BWYGGR^-B&F
M$\X\A;+J2\L["L$72#MMN/VO?5=<=I^'W'H8;4NTK:U;^_7I/8VXWG>.8B6>
M.P(4B"W%FI9G^<E?E>6A1;W)<5NT&_=;KM-:9J2Y[/H6RO%ZMEC36.7MW>'^
MA->HD/E>'D-' 1FI,QF5Y4]MTC8MM2#L=O< I5H2H=M;52O\MNM3W[9>1[CQ
M:8Z+?EQ-SXND*/C!"8>3E&\ICW)#;4=Z2D)5&5XF272=S1(T 4K2YK@=4Y/
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M)^4<3QD>4UD>)OIC9%R0AM+*UK6X@%HI<42+MGXDIH"Z$@=3;LH H H H H
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M4OV.1\W61EI(_>_Q14F+ZGGWU #;62\^VT%.Y9]U8WZEZ%3XK+VY%]"B0Y(
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M#CQGGU27F6D-N27+!;BD) *U6[5$7- +T 4 4 4 4 4 4 4 4 4 4 4 4 4
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M1U+MV7M0#_TO]8>09#E4GTN]4\8WA?4&*@NPW&/]$R#"4E14U<J\6T%?A)!
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M!F]""]^E/_3DS_@A_P HBJ7Z$G7*R 4 4 4 4 4 4 4 4!R#\4/_ ''<H_\
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ME;V[J%;057/LKTDZ8*;H^!^S8/T_L_"KDNOFA:/JV^PW:6_D)32(;6_)2B1
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M-&P1\@@I*B;CX;]AJK+(9.*WBQZJ )2/$"!VW/2JD@IH-E!W!3:SV]!;W]M
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M#C3B2E25 ]00;&@/-4# >J7X=,K.9XCB'N<>E$YY4EK&QU%62@+7U"4@*4;
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MOA'"<_EV),AIJ;D78XC1H\=:PEQW<"Y?8FYLK9?I>@.X4 4 4 4 4 4 4 4
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MT K0R2&*"[*7NV;020%=Z+T)'@:8CM^:M-T"]TC73OJ2&S,:0A2%%T#:D^%
M%BI/8*%9':BM:"XSM2A-MMNH^D]E2B!1B0MLV2L@$7W=IUUOWU8$FQ-V(25D
M!)U.X'J3I5D18EH<AMU-M_WE^WKK[*T3,VB99?+6PK6D;+E5A>Y/95DRK'@F
M!5@=$#0D6L">X5)4U"[JW^*]K$DBWLJ&R4,Y+R M)2? >MSVBHDGH-E/-!O<
M3H1M![#VVTJK+P-G'E.()"K[!<)/?[?942(,JDH8: )LX-0#8#WTD0*M/E20
M\KXE)%P19))&E[=E2A!EU*"ZH@ : W'NUM4D-%!]3($<0XN=2PV)T5P(<>0
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M1I8T!Z/H H#  %R!:_6@,T 4 4 4 4 4!@@&Q(U'2@,T 4!@@'0B_OH#- %
M% % % % % % % % <H_$ND+]"N;(.@,%()/3^7:K/)]+-<7UH^2*^6KC2G(T
M5#?DH)27"#N)3H2!V"L*\964MG3;DM.$M"1XY->DQISZR5,J=3L6?M$D7-99
MZJK21K@N[)MEWB2Y,A"8+:PRTSN6[)M_(MGJKN*CT36&][=O8]F_+R6P+!N^
M1-N/-^/\#7(6<@KF-)3%Q4,AF*A>I6XKK^^</Q*[JHD<;14,[RA6-:C-Q&$^
M,EQ2'+^)?0N*([>Q([!75BQ*R>IQY<KIT1/\#R<N1"R65G>%IQP_+.$62&T)
M 44WU(W6'M-=DK%70^R]AYOZ3B9,]U&Y[:>?YH>NRPP$8]]!=ERG$.9!LKV*
M\A)W)C!?V;_$X>_W5Y3;LY/FLF2U[.UW-GU(F5G,?*RSBY<UOYB;(2T4MW(:
M0!L;;0G[+:$@)3]?;73CQ.UM2.*L>3-6EW"LX99%.(+[<2$V+ME++#B]00D;
MPI7[E.KJ_<*9LBLX1[GOO+K?*L6/Z,7R_$?\!P6+SG)9DF<H-X#$ Y&67#=Q
MYIDIVA5^U:O$1]%>+[CR+X<<4^J_RK[3Y>^J@9\Q6,U%F\B<4(<K-SE?J[')
M'Q,,V+CCEM;(W(0!]M:NY->CQN/Z6.E7_*H_-D+2J1$IP7)N)9"9 S>4,E$B
M-$<5#05);;<=3YJ4K0=-S8/6K8<V/D55ZKHVI[^'7S,*S+9U?@&*;Q_'?GG"
M$3<DK?O4=1';N$BWM.M=U2&Y+*)&PMH?3]VHFW4%1[_=5B!47?7M: 1;2_9>
MA#9K.E?+L*;"KK5\:]+6JR161C'<<<<*EW2WHI-NMKU,$$L7-R=XU* 5 6N/
MI]]( E'>6%%]:#9P6ZBP'=KVT8)+:7DME)20+6-M03U/T5=!DI!\"PB_AOXB
M>^U61DR=C*0OMLI-K)Z?3:M$0/&%*;.W36YM;H34MD0:*=/F*.ZU^I.B?HJL
MDP,I3NY1)3ML#MVFX-^VH)B1NDEQK:H';<;2--3W^^H984;"W+H \3@(5I8
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MD=L)Q]U.Q7SKX2?A]A%>HK31-]R;^Q\E4]5+Y(W)^);&42W<6PXZYO=2@>8
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MHDII2TH"DE-P5*M<J\?9K0@>(CM%L%RQ+EMBBGZ"?;]- /CC(P9W(6$A&XV
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MKH*$F2?;0%_](U$YZ8/_ &-7^5;JE^@.Q5D H H H H H H H H H H H H
MH H H H H H H H H H H H#AF1_##QIG*/9G@O(LUPR=(67'DXR4HL%2B2?
M"HA?4G3S+>R@-'/PY9'-)$7FWJ7R3/XD_P KCO/^69='<L%3H([]+^V@.M<3
MX?QO@^&:P'%L>WCL8T2KRF[E2UD %;BU$J6LV%U*)- 3E % % % % % % %
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MAHW)]6N%A0X=QX+MO&,A!5NE_ET7KUJ]$>%?JR<JQ4* * * * * * * * *
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MF";E/PC60;4@#MK\-7K:@KMQ)Q-U [A)A7TMT^_]_6K 4_\ #3ZT.[@OB;B
M"0G^<PK%(Z"P?.OM-1! ]:_#?ZOM.-N#B;JT!)W-JDPTJW6*>H?M[:$,6_\
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M3!8^<V6IL3'Q&)+1(44.M,(2M-P2#8@C2O070\RSELF:DJ% % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
M% % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
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MBB_\LJ=K$FP__. >B1)'ZNY%<?\ L47_ )93:Q)L/Q^>B9Z8[D7_ +E%[?\
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M"YL@+R[)[HZ?XZZ]'C?3]IYO*^K["&:;L+BNJ#FZ#EM&FM4DT1R+U(:4ODR
M.QA/YS7E<E3<]GC.*05A+"K6L![>^N:$=,BB8P'Q4VC<*!EL :@]U3"(D4'D
M#J1]=21J9$J*C30_30 ,G';U%OKH08.<9%]1?LUJ))$'.2- ?&-.\BID"!Y0
MA1VH7<^RD@0<Y*XE).H [0*B4"/=YPRV3=8"AU!-C42"D<VFF?"7-/10(OUK
MMQ=#AR]3SGF"527";:$W]U9L(C1V*M8CO[Z@L;*.A()W=] (.G3Q*T[J :+
MW$"^G4BD@$N/(.A %^O4?34 RE:P02D6ZV%2#5<EVQ0I VGKW:=E$Q P<?)/
MC1H+VMW?15I EYQ N$$WT(OWU,@R'7/T;6[* V2\O;K:R>A]]2#=+SFJ2LE1
M!U^&DD026.N7!J5!1T!-S4D'2\4BT9-O9?\ :KFOU-ZD3RC)_+NLM:!0'0FW
M6E!9E<7F=3=79UK0IN&Z\L=;=#U I!$C=>57T!(/0#WU(EB"\FX=+D6&IJ (
M*G+T-SKTJ2!-4MPV.ZQZZT)$U25JZK-AV=*@&I>65@$WH"6QBQ<7TU^FH8+]
MAHR'-M^A(O5#1%NCQ4H2D]^NE4+CO9I:UNZJM0#T+^#T6]0,W_V.OV_[ZCU:
MG4K8]H5J4"@"@/-/XZM?0EP?_:\'\SM"4?+,)VR%'LOTJI,ELQ<=+C(*A;2A
M G.QEMR@G3KI5H*$%(A*2KPIL;]G;0"20MLZC2H Z;>TM>@'#;F[3KI4,#UH
M'3VZ5 &&679)!^CZ*E KA(*B:N2&HH09%_?[10D43;JJ@,7 OM_+0&P4"1IK
MVT!E)(MW]M "C?X=/IH#9!L-10&R$AUQ"!IO(2?[(VJ4I9#.J<.=^3=;8WWV
M;?J->A?'L<&-M3J4DI6E"NQ0ZUS6)1 3% !:>I!ZU5%R'0@*DM ]KB?SU)6Q
MZC@ME./QR?T8K0_)4!L>'L-5MT)QN+"@(TMV]M?)<^I]S[?:4:O=*\%H^@KT
M(F0C?<T1:2&E04.I.E-PZE>F81*R1M]VE:+(4VC!&$\I=P-15UD&PFX,=Q "
M0*I9E^A=..!J-))<(\T(NF^EE>SZ*RH]3GS7>W0G9V=^319*OBZ7[:[*J3SI
M\#SWZA<F^9ES!'7=E*U(3;V=?RUIBQ:G=?-%#B<K<Z^7"#UO7MUA(^;NVV.(
MR=!4,A#AQ M:H#,QH^]732I;(528;Q^Y &VL=QKM&DC&;?LZ597*VH13\#:3
M<:5K6Y@\9&2L=>Y K=7.>V,[3^#B$6?Q#<8<MH&<E^7'OUU8KRSCRTBLGU(K
MK.(* * :9.?'Q<!^?*W?+L *<V#<JUP-!]- ,L9G\-F0%8V:VZKJ6KV<%^]*
MK&C(2)+2^G94D#',9:'A8#T^:K8RT/[)2CT2GO)-$&SA&8R\O.Y!S*3205^%
MEG[+38^%*1^>M$@1JE"X-]:J!,]:S[EPMWU$$P9O;4Z =30D0*/F%#8-K0ZK
M&A/NJ"19MIYD600XC]'H14J2!1#J5$)5X5'[*M* 6Z5) HD'0T8+=Q1 +*B.
MMS:NK'T.6_4@,LTG];2E*\2M^E^@'LKGNOF9O5_*A )MI52TFP1;VWJ2)-P!
MTZT),E24ZJT!_+4 U2A2]4C8@]O;4 42DIZ"WMJ8$FX!%06$&_FOGG4J%X8;
M06E#KYA/B'N J2H\2DWUT%06 N#X4C>KV=/KH "%J_E%63^BG]NH NE*4"R0
M /94D&X%C:K@52#[J00.$J"1<FP[;U)$#J%/?AOI?@DA8ZVT21W'OJ>I4D).
M:R,_1^04)/\ <6_ GZ;:FA,#1("19( [ZN5-P+5$B W 5:8 W?R$=@?>+"2.
MSMK.46@8JR4B2K;"84I/Z:A9-5FS+0A1O#Y*:093I"3U0C05=4GJ5WI$M#XV
MPS;[L7_2M<_6:T5$9N[)B/BVT6 2-/96J,VQV(2$]!59(D7$4) (%ZG<1!MY
M(_1M4$F-MNRK2"P-?R2/WH_-7&^ITHWJ"0H H H H H H H H H H H H H
MH H H H"E<N1NRK)_P!P3_'77H\;Z?M/.Y/U+X$.EL: ]*Z99S0*[0*J71S#
MG&(F3N0%Z.!8-(3KWUX/,Y%:9(9[?&JWCD@OZ+Y?;<D!/>:X'S,:[G0JMC9?
M'<ET+FOL%4MSZ%O38HCAN3>^%X_0*J_<*D;&8=X1.;%UO*/T5C;W2B+K%(S_
M *&2'%V+JK=X-8_W:A/H,7_J\?(*U.J^NJ6]XJB%@8S>X*L$)"5J4/;7,_>T
M^AI^G9LCTU<>%U(-^RY-;X_<;6Z!XB2A>G9C[;-@ =2K6NK]79]2JH22^#Q7
M18J!61H.E%R2WID>GTJ@RW07D!5SKI1\FQ5T15N>\-A*BRL0QM9D-HT3TTM8
M:5[OMV1WQZGF<FL64'CSD^'FXR>^U(0K:%6"@+@V/6MGU*(@4@VZC\]"38@Z
M$_1VT8$7;6U O^36H S4"38:"^M  %M3[B3KUH#(N +WN0+T @_>Q%_9I4H#
M!VX4+=I^BI GKN5K<G4"I0,V-@;Z7O\ 5T%2!1(O:Q%NW6X/UU(%4I2-5"Y(
MT/?>@)3';2ML;>VQ'[5JJ5.GX@;HA.W<D"Q('32L+(Z4SGG,I6[*[0=$IU/9
M4T6AE9RRM^:FY -_?K6A$&%N*/2I(@TNK0[K%.HO4$F#<].M!)FQ N3>VGLH
M),%"[:C6_9K0&;*TVB^FMQ>@,I;W64 ;]M]: D\>0A8OU^J@+WA):4VN;]W^
MS6;-$7.%(W].A_+6;1<E$6-R:02>A?PA6_I[F2/^IU_\:8J:=2ECV76I0* *
M \R?CQ44>@[BAU_7$'\SM0R4?+Z,WYKUSU)J T7S$QP&1W #6I2*LDG2RMG9
MY:1M%MPZGVUNFH*PR&>@H4DV%R>RLPR)D8HZ@BJM!$0]$6RLZ5 D5CZ'44))
M5KX;@50$1F5W!%ZL@0&TDZ58DWL=/94D&;FA( FU_HH H Z4!M8D#7VT!L-#
M>^O<: R"HF_8*@&P)W@CPD=H[^^I1!<>&S7C(6EU>Y0(L?9716S?4K9';8J_
M/AM+)T %6LC-$1/2?,6D'MJJ+,C&4$S(Z3_?4#_;5!'8]1));BPP/LQVA]2:
MK)+1LE[<0#K5NQ5=14KM>OE^>C[?VQFA43U-?/V1]&G V6+FU8]"TB)8"@:H
M)&;T8DZ#WU5L2-5Q;7N*)ES#;&P[@-1TJ^XABKDH#[Q*@AP=O:#4+1F%E*(G
M)9R9+;5&"MJ4@CS$CQ*OIH:]#&X.)U@Y]FL&'T&R+=;V_9KK5T8M-J"BY# %
MLJVIK=9#GMA(Q,!;:K6T%:;S#TX-_EUGLO4[BNTEL;CBLBZ:I:YI6A9F<99
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M, 9[?^!3_&57H\;Z?M/.Y/U?80UK5U'*;)%[56QHBG9Q]3>96$C[*=:_(?\
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M4!0T%ORU$DP2\*,G=<"W:*J62+3 :M8CL%5;+P3[-PD6ZVM1E6>A_P (9_\
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M)' ;[15DBLF0@G5(O[31HO(*;"=7% #LOH*HT%)LE (N#<'M%02!187H!-0
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MZ_'O\E__ 'G\$?9>WK_91OBY+SP^'P]!W5Y.##DN_E1KDA#Y<,/N#2]C7O\
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M^1C[RCHM@QV)K$\L?>4$38KD95[$.I-OH-?9<7WS'=?-HSQLW$CHRXQ7&9*
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M8OV:G6K21 &UO;VU4D05VVJR0%X[MQ:JM :YIRS1-49*92'B"XI0UO58+"=
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M2" *LBK&#J$WN!6R9FT-2@WMTJ0;);/9J*B21TANP'?56R5J+)0+:U$EH-@
M*@E(VJ"34JL;5)!E*KZU#Z 4!O5"P7%3 ,;A2!(;A4P#&ZD U*A4D2:[QWU,
M%=QC=4D&%=: Q0&A/=TJ03;7\FC]Z/S5ROJ="Z&]02% % % % % % % % %
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M6%;<7(=:KHCU+<ZEG-J)MF\3UK]&)BRVUP20MP"ZD1VU*('?9)I?V7W&O_\
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MKHCI42.&6Q;K7V55!X38X-AV58J!'=0#G#I/ZT:/L5_%-8Y?I-*=2UUQ'2%
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M)# &] 9J"0J2K,$T81HHGH*J6+"S_)-_O1^:N9G0C>H 4 4 4 4 4 4 4 4
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M^4?^(^VM_0>@O<<_B93^)SUF (^98([?N"/V:H_\0]M_H++W+/XF3^)_UB(
M6[&*0?B\DFP[[47^(>VKI0G^Y9_$QZT\M8YAB>/SOUN]E\IM"Y<4#:PTHC4V
M[^ZO:]M]KP<%-8JPF<V?D7S0[.3CK@<""3&((!MH:]G<<B/47$F/F. X1T)M
M9I22GNL;UT=49%NG-^=";4C7PI/Y*JP(P9;C#5KV %K59%6,,J\Y*8=0HW*P
M0!666VVC?D3139%S]+<<8L%YZUO%M%_RU^'^^9=UH/N^+6*'1P; 5\HSK,%7
MNJ4@)EPCK5]H-2KVU: :;JM $R:M $'E=@K6J($KWJX ]*E ;K)K9%2^<*QE
MD)?4G5>OY:^]_P :X3;>1H\3W'-"@ZG$ 0VE([J_3TH/E&Y%[5)!KM-$#%3(
M-;$U('V'2?GVSW!7\4UEE^DO3ZBSUPG4% % -,F\W'@/O.FS:$W4>O:*M7J5
MMT*RC-XRW\N ?:#73*,$A65-B.PW_+>2HEM2=#UN.RBZD,;Q+?T:TZ>20??K
MI4#N4#+\@@X(-?-H><6]<-,L-EQ9L+G0=![:I:VU27JI*DOUNXECIZ&,HI,>
M(L[7 M:O- [[!-M*S69OL6="RX[U/],9*TNQ\V@HZA2@I/UW'2MED3*.K)5G
M-\/R;P./S,5QMPW)2\@JUUZ7J=]?$G:R>6U!D!!BSD*L+;D+!%0TF^I96=5!
M)M)\IA#>[>0/BN"35T9,P$ZW-20*..AIA:MX0L))03KKV:=M0Y@+J1&&>G/1
MGTY^879?F*2TF&/*1Y)&BC>YO[*YUZG<W>WLBD>J49H0HA3D_DL1\W##JY6X
MG>AY*M]P.RW3V56[=5U[FN*N^T1V.5\E4VO.RLI'=#Z)+I+3R;I"HXT"@#KX
MATKY?F9-UV?5</&ZXUH,<<L/>:Z;;0;(^KMK'"CNLQZV++*_I-=J1SNQ'Y6?
M LB/+E--/7W^2I8"K=AL>H-;PX*5NI*MD&<9.E$)6DN'1!&HW$WN"14;6;+4
MO/%VYS<%SRG;1I)1N   =0C0@K[0%#I>IHM(1EEMKJ=X]/L2N%%D9!\%I<H[
M6T*[4H \7N->SQ,;JI9\U[CE5FJKHBQX^P0%AO8M3Q"CT)V]M=CU/*@E$RV]
MR4%7B6=!KVTVD;M1P5:U4OW-:DAA0@PHV%ZD!?2A!N@U#)0HE5JJT61N%"UZ
M@LF!6*@DU44VTZU)5FM208)%$#0@=G6I),5)!HHT(;, T(-@;Z4 $F]"9 'O
MH U/7I4%@%0$85TJMBZ+ U_)(_>C\U<YJ;T 4 4 4 4 4 4 4 4 4 4 4 4
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M(=%*-=.FK/(3<U7>/E7CXMCEMEQYP16]5#52NP)'4U1W24FU:.UMJU?<D $
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M^FM,K^8RPI;3O/X<GV,]#R<A3ZI<EY#;KSKA)<4O8 22JY-SVU>CEZ&=EH=
MP_,$SN0X_'_(?*K<><9<"U$J06;@D]G94NQ5+4OG(,%C>3P7,;D4K\EU)2A]
MAQ3+S9/13;B2"DBH23ZFK;1Y3]=>%9/@N!PF(<COYC$/3VD(Y0ZOS'B5. I9
ME@Z[OT5=%5XV+BY\?*MDM><=NE? Z=O'=)JFK]YZ?8>?^69F; YAG8[ "6FI
MCB$A!4@$ #L20.VO4MU92$0$J4]D)"%I:2TI>UM+38 223UJ!!<N%<+Y(_RU
M&/?X9.YG&C(49F+QB5*3=U!\M1?0-J=JB"031IHA-'=WOPOMR^!XY!XP,;Z@
M*<:=G153F4O+B[KN@[U;-Y3H$WO78J8X6IB[.2Q\B]*5.Y;B4O/X0Q3C&50<
M7!5%0MB3X;A$A3=P387ZUUY,6&-U-=JZ'.K76C)'C_X;LBCD$S/0\+%C-Y5)
MVF='0(<,J&TEM"E;AI^YJV/+Q75-T>[P(LLC770ZMP#TTXCZ5,R&>/,-2\_-
M!;R&:#"&5%N]_):2F^U .I-[J[:X\MU>TJJJD=-*NJAN2?RL=$S&S8SZ?,:?
M8=;=':4*00H#Z.VN>ZFK1OC<631YBSS<_BV3>X],45^4A#D%]6OG17!=I8/?
M;PJ]HKX[/@=+1]I]QQLU<E91-P&]S+04-OA%_8>VMZ*$99-7)+Q/,9)^TVKH
M.VM9*&\^#D-J'W(SH8?'W3Q0=B@.MCTTJT26K9+1DOPG!QY<\F4#Y+(WN::7
M[ :OCHIUT,N3F5:Z,ZUCXOS?FI9GNP@TK:TCRT+3MMTL>VO4X^3?,.#YC,]?
MF4BK/%<BPMQX3HD@&ZT;H:&U!0U!)0-?IKT5:\?5H<EG1O2L$?!Y?EY$R7@E
M+97*APWI+S^TAOS [L;'\$ZU.UPGXLIIJD7.([DU(3YJHZF%(24V"PNQ2.O9
MUJFL^1&A*)<( W$7 UM5B#<.)ZT" N#H.M0/(T+HL;58@:S)*V8KSZ$>:XV@
MJ0V"$E1'07/2]3&I)YJ=_$5ZAP.0?\X\4;;PH<6E$9H++BT@_9=)U7IW6-;W
MX=MW^W>MU';L:T^E[ZVIK&O?ST/2$*>)D2/+2E2!(;0\EM0LM(<2% *'81?6
MN62D#Y+ES?\ +4D"@5K>D$FX7J!V5$ V4M"!N40/?6=FDI?0NIG0;+R<-!\;
M@TZBU>!F]_X.%Q:YU5XF2W8T.6A*!V.7 ZZ6KGQ_Y)PLCBEI9H^'D74@<OR-
MZ&%?*)2\M.H0.[WUS<CW6[UK?:CNX_"J^I2IWJ'GV2E7DI::42/,(!T'6U?*
M<GW;DIQ7-^"/>Q>V8FM4/V.2Y5^,T^J2=S@N;"PUKXW-_D?N-;NOJN/L*OA8
M4_I \CRMR!)5]0K%_P"0^Y?_ 'K?@3^DQ?TH0>Y/EFR%E]:Q8W0FP)]G2O2]
MN]YYN7*EES6=0^'C[50[3F)3K:2MUQ)6D$I4HW!->3S?=<ULMJUR6CXD5P57
M9#K&Y64) 27%%)[";UZ/L7N7(7(5;6;^UF')P5VZ(N;#JEI"CU(K]VPY-U99
M\S:L,W4YV5IN*P6IC^1;_>I_-5RHI0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
M!0!0%+Y>DJR35A?[A/\ '75E:$874LA4,6U4-*.[93:+  : 6JD%P(MK2  %
M($@14P0%M*G:),6J-H,%/;2 :D6J4@:GI5H!H2 +GI4!B:E)UUJ2!)3@L: 1
M6\FQ%3 &KDD 42(D9N2P- :M! S>G[1>_2I@B1.'.:?EICNV*739LG]/N^FO
M6X.9T^5]SQ/<^.LBWI="83B7&G#+:LIP@@)/P*!T(-^RO6>:5#/GZ\5JV]:_
MN.=YWC,.',5(E-JBQIQ*TH4F[8)-CK[Z]GCYW>L+5H^:Y>%8+[K+:K?<,\;Q
M1&)FKR$=U#\-](!#*[V4#U(K2V?<H:AHQ7'7U)II^#D5?X1-5R;+<A3&4ZLH
MC-Q04[@%!FU_?<Z5ABY%*J)U9U<GB9;I0G%?XCC'>FRRI&3Y4ZJ#";45N(*R
MY(>W#X&FQKN5TO5<WN%4MF+YG^"^+)X_M%I]3-_MKOK-K+_M7\K^!/2L'S3-
M048GCF)=P'%&=(T3: Z\"=5OJ/51KEKFX^*V[+=7R/J_#_Q.RW&YN;&L?'Q/
M%AK]*<?-XN\]_P!F-V/23,)=CF8EI+&[^<+4XE1VV[$C6]7M[KBCY6R<?L/)
M7UI*>KGI]A?$<8AM1_E4L%+#:4AK8M3:20=04I[*\A\JSM,GT->!2M-NW3XF
M?U)#94Z4LM(;4FQ2$W/O!-2\]VEJQ7B8TWHH^!5>59GC_%XQGYO(L8N*FZ6G
M9:@DJ(T^[0+J6?8E)KIID?<X[<9WM%%)P;D'XBV$/KB<3B-?+#PC(9 ;G%6[
M4L@@)'[\DUWXZ5:^>WV(J^%==$I\RCS_ %'R/(I")><EJG202E)=(V(3^BA
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MU#8@5;1KKV]E5; Y2 !I0DU6NPHB)%\2;Y%JW2ROXIJF3Z67Q]2S5Q'4% %
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MUXF5_3]D_N5:U^3>X>SY^':+KY?ZNQ]=Q^7CS+1Z^!#D^VO&@[36]"#&X5,
MU)J2#0JJR VE(\QO::VQVAD-%>BXD*S495C\>E?0\'D[,E7YG-GINHT>HN*I
MVX]I(_1'YJ_7,-IJF?$Y5#+$!<7UK?J8BZ&NA(TJL@52D :4D@2<(&G;4H,0
M4J_2I($B;=:E: =X0@Y)GW+_ (IK++])KCZEMKB.D* * I_JGB\EFN!9C%XA
ML.Y"0EE+*%+#:3:0VI5U*L -H-ZM5PY(?0\>9[\*;_*N5S.3<BY4SC?/:3'1
M#Q<=4Y\)2225..%I"3W6O75D:LY,:)Q!;\/^&CTDBI=&1<S&63)9;8ELNOHB
ML.!KX;ML)N/;XJS=59RR^IT3BOIIZ5<1:;9X]Q&#'#2@M"WD&2YO_2)?*]?H
MJRK5$0V=$9G(<2$"R1T"$>$ #I8#2KIE(-Y#;K@):<%NQ*KC7WBC(&8;"W%,
MRQ:_4$!2%'VBK5<$-20'(,!#4R9,5L)2G5SR]+'I<#LJ]7!#15\1/<CY96(E
M*W"0V5QG#]H)ZW]HZUK9:21*+3CU7)(-G$**%I/8>E9M%DRLYU"W<#*C'4%8
M4F_8I))3;Z:M4J]-1'C4\SL4DK/W[!+3OO'0_2*NT4[DZT_L\MP)*TA5EH'4
MH/7ZC6-DS9,G4L(4A*TI4$'H3IU[ZH)-E^6TA25N(0D==ZTBWUFI((3/<5XS
MRZ)\CF"E[R0IS'O(=+:T+4+J2E:3;:NWUZUQ\CCURU2?5=SNXW*O@LW7N4"3
MZ-\-AM_-3(4N6S'(>+,QY3L<%O4%: D;@#KKI7E/@TJYAGJ_W+)?243_ !J&
MTZ[&=;3I+NXE8%DI3?P^X5W8,:C1'+FRN'+$O63@K?,,#\C*:2IWR%H9"AXD
MR4ZHZ] K;MM[:TY%):L<W%O"=3QYP^!D>$YI,A#9<P3SA3/CJ!*6E$6*U)_0
MM_* >_J*\;E\?<MRZGM<7,JO:^C/5_I9ZC+Y7C7 VOR,KB-L'*0]UW4!L[6E
MJ_220!XAUT/;73PN7:RV7^I='Y'-S.*JMVJM'U7F=-B921-W-7NH%*FG" H-
MN6L5:]--":]FC39XV2B2%B_B<A&D8/)I:GPWDD.QI2$2&E$_I)<"DG6MG5=S
M!SV.7X;T+XWQCU1PW-^!0V,5"3'FQL_C/.6&O-?2/)=CI<*K7-PXC=IH16+K
M#DTF5#.NNLOLK#3C:@X>@ O<=XMUJQF:*2ZD[5-K"NT;3>I RR+9=B.-.H5Y
M>A(*3;0W%%U$%&?S4;"Y8,I0VXSM\M_S'T(42?%?8KI7955:U<,I96[(9->I
M42;ED8Q,%^%YRBD/>:TI*0 2GPI.[6U:6PK;I9-^!3=:NK6GB6.&K-QY@==:
M5)2ZI*@^U98*5=JR#:PKQZMIG<X:+Q!D(=0%)5=75?L/=6]7)A;0D@J^O4&D
ME3-^V@(7D2C^JI1_<?LU\?\ Y5;_ / R_!?O/9]L4Y:G-7'MC6^Q4>@2.I/8
M*_!^-@]3)M/L&])%<;CLL]N=>:LZYJ&TJ!VCVF_6O8R>R\N[2Q8K/S@YOU.-
M+6R)4<?S+G1BP]JDC]FNG%_B7N>3_P!J/BU^9A;W'CU_F%1Q3+*3J6DG]$KU
M_(*]"O\ @_N+4Q7_ .(Q_NW'\7]P@OBV73_<VU>YQ(_/6%O\/]QIUJOO-:^Y
MX+=&_N&CO',TDD"/N_>K0?V:Y[?XWSZ?R3\&C>O-PON-4\?ROSC*I$%Q4?7S
M;65H1;4 U[OL/M?(P<JM\N.RK7]YS\OD4OB=:V4B^&XGA.-,N,X3$F"RMQ3[
MH0V;J6HW)43<U^E^XKC\JU<N9;K8^FG0^;P5R8_EJ]&1[^-@2''5RF X5J)(
M4+7]XK\ Y?,N\U[5?=GV^&:T2\AJG 81!44PFKD@].WV5S_K<_>S+NS8_ V@
M) T&@]U<EM62>B<5_P!%PO\ @[7\05_2_!__ %\?_A7]R/@,WUV^+'==ID%
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MVBJ@-@[J@&-HH(#8.^] 3?#V$HRC[H "BP0;?OTU2#6K+M0N% % >>_QF?\
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MT _1K%="T#,*).HZUJD5.\XW_HZ'_@&_X@KB?4W0ZJ"0H H H H H H H H
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M3 DAJ0EU%T*2+C4]E54@O'%4H=C<K<<&XLX<;">Q3DAM-Z^:]\O;_:7C?_\
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MYY;S1&Y(*;'O!N*UXV1X[VM7P.;G85DQJK)21ZA\W,'$;\L],3!?<?CMNA(
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MI&RD7M<5!(FIH=M63(9HI(2*DB"/ENA*34-EDBOR7-RK"LS0U:%]: PZL 4
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MF-7%04.O-J*TI) 60>U"NJ5I.H[ZE(J[$EC>:Y27B5L^5(D3HR$>:A+:]JG
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M$70UEX;<I@^PO,$*]Q"*NN19=H*6QKXG(^7_ (>>0\<;<FSN+-9''-@J<R>
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M(0V,;#"$IT 3Y"+ 5ZU>B/,MU)NK%0H H H H H H H H H H H H H H H
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M'NF-+ )LE?0UCG^:IT<;Y;%G;LJUCIWUYK9ZIN;@V[.TU4DR* P3V54DP*@
M:@L8H2:$]W2@,&J@L'$A::]_@C_&34(M4M]6+A0!0'FG\='RY]#MLIWR659F
M""X!>QVNVK7%9*VI6W0^7#Y?#A7'5N2+V"AV=YKI;LM49Z=Q>)*C/1WD/H<^
M=20&BGX+=MZFN9O1HEUUE#%[YAJZFG#:]MI%Q6+;KT)F>H\?>;G--I+7D )
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M@)60AY)O*8M:F<F2N- =;T6A*A9YP'O(\(-4HW5RNI9]"QQ\:X);:@@NNI4
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MN&F?1W@HMPCC0[L5!'_[,BOH:]$>';JR?JQ4* * * * * * * * * * * *
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M4L)'A3L)^(ZWKFS7SNVZTUK5]M9^)C? K-;+:D/P_AL7DLV9A9TLPI:$*6-
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M"*5"T.&E?06(.OTUIL17>_(^TO %%?!.+K-@58B 3;IK&;J""Q4 4 4 4 4
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M&YD7(RN7F$F5D93U_P!-]RWU @59)(K+&1:2L[G!YBN]9*C^6]2#*6TBX0@
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MJ:1Y)[=4:5:2K+9E\?Q^'"3+Y+(1$"_@*/Y55^RPZU9*02O%IW$\O&&+X_*
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M0G>2FYN0-.ZL,MH1U8JRSL?"<,(L)!(LM0%]*\2]MS/8I6$="CM;1ITJI8=
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M2390!%P>T4 USF<Q/&\8]F<W)3#QD<H#TA84H)+JTMHT2"=5* Z4!(4 4 4
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M :\=Y$F9SG!2\4ZB/C^1-9)Q^"J>]-E.HCA*FW7V5%3;"D*\.U)W)W;#T(2
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M?HH!AF9D3%,HD<-SS\QR9@\I*RKPEKF70Q#*V9JMRB&G ]M2DI"0K<1;PC:
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ME-]QLH)4KQ ;<AY<B1#Q*L)G-[RN,9F<XJ,]O\;,2.6WEV-MR5*)3NUO?VT
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M,S(Q.'9:8Q^!1'G-B',RTIIA[(Q926W U-9"E/I0@[VA<:*OMNBR )7&$.Y
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MCML(:1Y;:6D)0$HO?:D) L+]E :Q\=CXBPY%B,L+'F64TVA!'G*"W-4@?$H
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MI[#:@-H^/Q\1Y^1$BLL2)*MTEUIM"%N*N3=:D@%1N2=: S,@0<BR(^0BM2V
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MK::6N?KH!!>)QZ\FUF%L).08;<::=_12]LWFWZ1#:!NZV%NE /: * * * *
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M!7^<9CF.,P>7PV0D0?FLEAI\K'Y&(T\UY+L-"5/LJ;+BB;MN$M.A:;$:IZ7
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M2L=C,GG/OL?CT19617Y/E[TH"&'$K6J^KBTI"4 VZ^(@.<+R[D'+T158%N)
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M0D;?L^'2@(#^K['%T3CDL@<Z)"97ZZ\QKYNZ&51PBWE>5L\M2D[?*[=WQ:T
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M;@ '2@%'^#8R>N<O,2YF4$R,]!0F4ZD"/&DK2XXEGRD-E)*FVSO5=0V)L=*
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M2DZB[06DW6/L@D7H#9[FD=EMD?JG*/3EL&4_CV8OF28[ 4I 6ZD+(!64*\M
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MB5&XN!3L3SG,S<2O.OS),&7DVLNN'BYL-!;3^KFW%->0MM7A" D>:7M_F*T
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MFXH!]A.:1\@UBHS:9&5G38S,N1*B13'9:9D.+:;==;==4IM*U-KLD*6JR2:
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M0$9%Y?ALB9:,2X<D_!FC'3&(I0IQIS>A"UJ"E)\"-]U*'<;7.E 2WST+YO\
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M@3$K7#E,R$-+\MQ33B5A*Q]E1238Z]* V9E19#:G8[[;K2%*0M;:DJ2E2-%
MD&P([: 8Y3D6%PR\>C)S6HWZT>^7A*<6E*5K#:G>I-K;4'7W#M% /3.A"4B"
M9+0FN(\U$8K3YJFQ]H(O<CVVH!CE^08[$19SBWFW9L**],./2Z@2%H8;+ALD
MF^H'6U *XG,PLO";E,.(#A9:>D1PXE3C!>0' EP Z&Q[: W=RD0-35Q5";(@
M(4I^)%4A;^X)*@C:5 !2K>$*(H#*\I!8;BKFOMPG)@3Y#,EQ#;BEJ .P#=8J
M%[$))H!-&9AI:#L\_JW<^Y&:1-6VTIQ3:R@%%ED$+MN1K>Q%P#I0#F1.A1-G
MS<EICS%I:;\U:4;G%_"D;B+D]@H#1Z3CFI<=F0\RB>Z%"*VXI >6 /%L!.XZ
M=;4!A4[;D1 5'=""SY_SIV"/?>$!N^[=O-[_  VMVWTH!6-,B3 XJ(^W(2TL
MM.EI:5A+B>J5;2;*%]0: U<G0F9+4)Z2TW,?!+$=:TI=6!U*4DW-K=E *EYH
M)6HN)"6S9:KBR3W'NH#'S$<O",'4?,%*EAK<-Y2DA*CMZV!(!- 5%'/C\V^I
M_#26\ SD58=67#C*TIDA\1@I;(5O2V7#MWV-M"0$Z@"8X_R2'GHK;HVQ9JU2
M/Y@XXA3X1&D+CE>T&^TE%[V[: DA.A&6<>)+1GI3YBHH6GS@C](HONMKUM0&
M4SH2Y3D%,EI4UI(<=C!:2ZE!Z*4B]P->I% :IGPW'7H[+[;TMA(6[&;6E3J4
MJ%TW3>XW=EZ UASVY<)N8M"HI4VAUZ/(* ZQO0%[70E2DA0!U\1'MH!V""+C
M4&@(/"\JQN=R6;Q<1+J'\'(3&D+>2$-N[DW+C1N=R L.-$Z>-"AV4 ]=R\5J
M2EBQ6PE+JI4U*F_EXQ92A6UY16"DJ2L%/A.G6VEP-VLMBGV79#$Z.['8&Y]U
M#J%(0G752@; :'K0"K<V&]&3,:D-.1%I*TR$K2ILI ))"@;6 !H!-65QB80R
M2IK"<<H73++J P03;1=]O7VT GE\HUB\).S81\RS"BNS VVH7<2RV7+)5T\0
M&AH!LOD<$8:9E65(>=@1#,E0FW$*=;(:+H;78^%1 L+T K"SD"3C\9-D.MPU
MY5IIV+'><0E:E/(2L(3<C<H;@/#0#Q^="BN,LRI+3#TE6R.VXM*%.*TT0"05
M'4:"@&N:S4+"0GI4EQ'G(9>>8BEQ*'7RP@K*&PHZFP[* 9/\G:8P>)S9C+4C
M+.X]E# 4G<V<DXVV"3T.SS+FW6U /)F;@18F2D,O-RG\6RX_)BM.(+J?+0I8
M2H G:3MTW4!C"YR%FX<:0PXA$IZ,Q*>A>8E;S D-AQ*7$I-QU[J ?R)$>(RN
M3*=0Q';&YQYU00A([RI5@* 1<R6.:1'==EL(;EE*8JU.("75+^$()/B)[+4!
MN]-AQWF8S\AIJ1()$=I:TI6X4ZG8DFZK=MJ 4#S)"B'$D( 4LW&@(N">[2@$
MG9T)AQAEZ2TV]*)$9M:TI4Z1J0@$W5U[* RN=";?:BN26D27RH,,J6D..% N
MH)23<V[;=* U>R$"-(9B2)3+4J1HPPXXE+CA_<I)!/T4 W8S,16/:R,^^+0Z
M!=F>IIIQ"E$I"5V6I-R1I91H!U)FPX00J9(:CI=6&FB\M+84XKHE.XBY/8*
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M+20W=!3<7-^@ZT VR'(\=!2$LK$V5\W'@*BQEH6ZAZ2X$#>+^$)!*U;OLI-
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ML,OBE23"3.CF8%;#'#J"Z%_H[;WO[* 49GP9#C[4>4TZ[%.V4AMQ*E-*UT6
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ME*5%!VJ4.G6@*VIM$>*,>K'"!Q7*S\A*Q#DO%KR)9;5Y*$1F8RDGR?FEE]Y
M<2!L\.VYT ;XO&/,C%.9;&.C,3>%B#'>?BDR3D&$+*VE+"24.A!^%2O8+T U
M7@W%[H?)I3N+8GXC%Q,4M[%?K#8VF&E#C;+EE*9>;?WK4@A)N4J%^P"QY3BC
M;N)]0I+^.7,S-T'&SG&U+E..1,7%#3K"@+A0=257:MX[]M 3G&HT&'SSE =@
MICY*;\I-C2/EMA=8^5:;=4EX(L?O00I.Z]];4!7\SC6$.\T@Q<9MS4K*8N>Q
MY,0A;T(KQX6XEU* %I\QMS>-UP4DD=M )RX6-.4Y-@T+<?P.0;G/YG*-07&L
MAC'UNH<\LOAK^=-.+*BAO:HA";>)OH 8O).PI7'N09."EG!8U[*0!E<?!=CL
M/-RFXZF92HH25M)<4A;:C8IWBX.U2: CGH<Q;L7)Y%F1B\"K)Y]YQ<S&F:EM
M^5+0J*\\PNY0EQH+#;FW3=8V*J N2,#B$>F3^(E9.2O"O-.NB>S&4RXTTZ^7
MD);C);)#;=P@-%!'EBQ\- 59[(2)N'@XS)8R+%Q3IG(B9=G"*E-S%)4A+268
M2P?)7(2I:CYEPK8=MP;@!UAN-G(LM/Y[$N29C?"L;$!FM*6I,K^<EYNRK@/7
M"-]O$--: 93<"O$<>XX]C\<N&^OBV3CYF0AM2'2HX]I:1*</B*_-25;G#NW7
MUN30&L"-@YV%XZQQ;#28^3QV(>&84(KL=QN,]BEH^6D+4!YKCCRF5)3=9)05
MW[2 Q<P;CA5$Y-+=Q;.0Q&+B8I;V*_6&UM,-*'&V7+*4R\V_O6I!"3<I4+]@
M'3\]!DA[AK2?.F&%E$&1)4G<O:C'RVRZX4BPNHBYZ7- 4[CO&QB^/>GTN)BE
MQLRU/2,@^&5"4EF0Q)#P?61OV*)3<+-K[>Y- /.2O<=B^J+<ODL-4F&CCVQI
MY<=<R.TM<ZQ2IM"5V6O0(44:@*%^P@1F$XS.<R$1;>+>C/1,%E3QX3D$B"J3
MD2Y";)5O"'6V?+ 'Q(2+=] 0\+"Q_P"CLQY61>:SF*X]D&LABQC/U<^I;L,H
M<3)D 6<(<'F!6\[E>,$C6@)>$K%"-@IG"N/R#EL'BY#F4C&*Y&4MDP"$09"E
MI'FNNOEI0%UFZ%*OVD"'?Q;V5C<A:A,N3\1DX>&"S!QCN*BN.M90AYMM%@M1
M;;-EE7B"+ GN E>=HD.SI.*Q>/3!EXE[&G"1H6+4[)D1VWF'%/HE)3L9::*G
M$$(LI(2HGX@* =Q\7'BN<AQS6,\K*?TIQ^0<2S%*5.8]V=$<2Z%H0 M'@6I5
MB=I!O0#-,-E>);P(QCW]9[>53)7D#%7YB7/GO,5-,K9M,<LZ?'JC[K;?P4!*
M#C3#6$.3CXE2,X.5KF-R0TKYL-.9LI*PH^(-F.HBWP^6>Z@)OEV&D9'D^*DP
M(C:L@WB<PW$R#C*5B/+48ACGS"D["% J3[C[: K.&CXM]7$(F Q#\+DF(=0>
M0/.1'&7&&!&6F4W*>4D!XOK(V^)>]5G!HG=0$[@,,G">D"8D+'KCSU8-;C\8
M(5\RY+5$.[>#XU.*5IKKV4!&XW 9=K-0N,/Q7?Z/23$Y#-D!!$=+T5A#+D19
M-P5.24-2-O<%T Z]/XV23E,<]-B/L!OC,&(XMYM2 'F)+Z5()4/B  -NXT!O
MQWB2\G*SZ\T_,3C#R"3,9Q"@AJ*]Y9;4VXH[ XX@J2%[=^PD="-* A_U"Q Q
M\?+9'$NO8U?)<E.Y*VEA;K[S)D2Q%>=0+K<8:6IMS8 0$V4!9- )'#0LMGF<
MCBL*I7$W\YCW8R'8I2PIU$*2F5*;8<0"VVJ[+97M2%+25:WN0"=A^0.1IK.)
MBR&<BXSS%,-U*%)*5R<@RIK:H[0%.("O*)(!ZWM0$QP7$89_*2)D28'DI@F#
M+Q Q/ZJ;2A:TJ2E])0 I;>U2 D_"%*[Z OPQ&)3(,M,&.)9()?#2/,)2M3@.
MZU]%+4KWDGMH#E?J([D,AEIL2-$+&4Q\C'.8I,;&KD3);27F'%R!,V[6FVBI
MQ!VG<D)43\0% ;3N-J_H]S'(MXMS^D"N0KEX^6&5*E@-OQO+<85;<$A*3;9I
M:_>: RZY-R'.L;,:B_+3H.=?9F18V,6VMN$69+*)$F<1XDOI#:P$G;XDI.J;
MT!'P\7FX.&X[CXS3L=[F..3Q[)H+82[%7&\QY,A:564-L8R&[_I>4* >Y2"Q
MCLMR'$\<C#(M3X,]$YA4%Q,K'*3 *&@Q)* %LN%"&DLZD$C8=H( "L%+&#S^
M*?9;$N5*APTY^%+AJ0[CV&H'EJE,S5) ;;2E*4N,E1!45;=JRH* L&0981QG
MB>:XKCG96%PSL:>QC$)69!Q[D5QB[;;EU*<;0\'$H4=QVV^*U ;<@YIC<A@Y
M(PK)R(2MA$_YB#(=:BQG'0EQ]QA;:"YY0\9;'BTN; $T!5,)Q].2,.-,A.3L
M(.5KF-%V#\C&<CG"JLZ(Z0$ADODV*A9:]3J: 2R<$P&IV4=9/ZZ8S>9<P^*F
M0')L7(HD*:/E[4H)0M90@,O C;XM%)W"@+]R9,Z0KBDMN$X9#&1^9?BHLLMD
M8V9X%+'A WE+>XZ7(H#F8CSLRQFY,2"X7Y_%<O'G0(.+7C6V,@YY!1"\T[5N
MOI)<"=W350V[K4!*96!&RJ&F?3K&/X_(PL3/B9)2([D!P(<80EN(XMP(W/E8
MN@[E>6057%_$ GG(V*R\9P\$P\B&F)@LO%RH9ANP5!#L/8S#6E2$%Q\/;5)2
M-Q1M5J-WB VYS!1'Q2^*8_%H@L,X12\.(^*.0E2Y:T.E;#"P-K2VU(0M15XU
M*6%7%B: UR.*D+D\O99QS@Y!EL=C)49;+/ER9<9IM"9Z&I 2G[Q:0IL@K"KD
M>PT!KRB)B<]&R;O"L0^UC_U%-@Y8QH3L)+SCJV1&CI;*&U*>:(<5=*;MIN+C
M=0$SR? JQF<:X_@(XBXKF["<;.;BH2A,8PKN//VN GS(I<9N!\8;[Z FN>0<
M6RGB\N;CVWL5B\HCY@_*_,ICQG(DA@'8E"R$;U-)T%AH3TO0%2A87S>1OQ,U
MD%P<\K-KG1@<4''766Y/FQRQ-LO[HLI2RK4;4[D$"@'6-&*1Q3)X25C7&O4/
MY')?.ER*XN4]+6V[O=;DA!"T.WNT4N?"0C0C: $<IQM6,Q?'D8+%+BN+XUDX
M,_Y5E27%?S!HM-/%(W%7F)\&_P 6Z]NIH#&4XVK&XOC[>$Q*XZW>-9.%D1&8
M(6N\!HM-/D"ZE%Q/AW^+=?O- /N/#!XJ>ZURW&.#(2T8U.&DRH;DELQ40V$)
M8:4$.!M;3X=+B#M-U;^AT C,HE]N*]A<C!\B%-FY^0W->Q9RCKCSN0=#<9AI
M0VI4\V?,"E:+%@GM( D>-\7;R:7W>38E4F2KBN$B*,]HK5YP:E^>@;K@. E.
M^WBZ7/2@&F);<QV4XI-0VO(<DG0,0QF<9D(;SCS+:60A<IF4M-F5M;E*=0I5
ME:C1PZ@+^J&)GY#(Y81H4B2T_P <,7<PA:MREY%DJ;"D:[BBYL-;:T!9H6(;
MQ?J*I>,@B'BY&%M)5':\J,N0U*'E[MH"2X$*5;MVGNH"H9F+ #'+\1F<1)F\
MSR<N0[@GD1UNO/(6A(@KC2DIVM)CV3N\:?+4E2CUNH#'('9$# \VXO(ARI?(
MLJ^F7#9B175HEH>C16UNMK"=@2E:%[P5 IMTU3<"Y\-P[47,<LRCT+RI\O+N
M;)3B"''(PC1@D(4H7\NZ3HGP[KGK>@(WC'%')KN4D9B3-^2;Y!.G1L2O:S&4
MIN25M.&R XXC<$NH"EE.[6QH"&QW&Q&XYQ_(-8I;6>3R4R9$D-*3+#3^3?#J
MUJMN\M32S<'P[#W6H!G$B1U8J!@DXM\>IT;*-R9$]<9PN(=$WS'IJY>T)5'6
MUN%O,\2%!JU_" ,\2PF[*8YK)Y%V/RK'2I,R9"5C W)></G!P+G!*@XRZ%7"
MM_B3M&BA8 2G'>,,8O%>G,B+BC%R+:"UDW@TI+X;>QCY<3(4?$0IT(OYGVPG
MMM0$$G#9 XWC[B,3*5C,=B<6WS6$&UI7D&&TA3,=""+K7%)\UY(U4W=G7=M
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MN[9<D WMK0%G@8E&+]1'U8R"(>*DX9'S!CM>5&<DM2E!&[: DN)0I5NW;[*
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M .B<9E/N8QK'SUN.9C&-1XF4><;<2E<L1VUN*0M:4AP$J^-%Q>XZ@T!,T 4
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C 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>pg_bynumbers-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg_bynumbers-4c.jpg
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M%!04%!04%!04%/_  !$(!=P$90,!$0 "$0$#$0'_Q #U  $  04! 0$
M         @0%!@<( 0,) 0$  04! 0               0($!08' P@0   %
M!  " @D+#0\! PD##0 ! @,$$1(%!B$',1-!46$BTA2450C1,G.T%746-E87
M&'&!D;%"DK(CD[-4=">A4F)R,U/3)#34)96E9C>"P:)#X<)DQ#5%928HXF.#
MHX0XPT2UQ49V\:2&A1$  @$" @0("P4&!0,# P +  $"$0,2!"$Q405!87&1
M4A,&%H&AL<'1(C*24Q050G*"LC3PX:+"(S-BXG,D-?'2)4,'%X.3LV/#1:-$
M=(3C5#8F_]H # ,!  (1 Q$ /P#L+2M*TU_3==>>UW&./.8R$MQQ<*.I2E*C
MH,S,S14S,^R +[\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!
M=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%T
MCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/
MDUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^3
M6*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8
MKR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO
M(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\A
MC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/
MX  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@
M !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^
M'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ?
M 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!
M=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%T
MCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/
MDUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^3
M6*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8
MKR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO
M(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\A
MC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/
MX  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@
M !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^
M'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ?
M 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!
M=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%T
MCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/
MDUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^3
M6*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8
MKR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO
M(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\A
MC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/
MX  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@
M !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^
M'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ?
M 72/DUBO(8_@ !\!=(^36*\AC^  'P%TCY-8KR&/X  ? 72/DUBO(8_@ !\!
M=(^36*\AC^  +%+TK32W+$,EKN,)E>,R:UME"CVFI$C'DDS*RAF1*.A]TP!?
M=%^)&M>]4'VN@ 7\
M
M
M
M       6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P
M
M
M
M                             !8)GQWPWO5E?;&. #1?B1K7O5!]KH %
M_
M
M
M                                                    %@F?'?#>
M]65]L8X -%^)&M>]4'VN@ 7\
M
M
M
M               6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P
M
M
M
M                                     !8)GQWPWO5E?;&. #1?B1K7
MO5!]KH %_
M
M
M
M%@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\
M
M
M
M                       6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P
M
M
M
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M?3UPF@+-B?2WBY7*P<6G4W&E39#,8G#GI5;URR1=3Q<JTKT5"A!TH()
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M7@VW2E@@DV6
M
M                         "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
M          P#G<1'RGVNI5_J*C^PM( _/(5$   !=,!LF?U:>C)Z]D7\;.13
M\;'6:+B+L*+H47\%1&0 [DY&\V/G/UY[W10AG9<2:&LDVWP0ZEPCZM]!=@E6
MJ)2>PHNT9""3:@@          '-FW>EG$Q.0FXK!:XY(D0WW(RI$U]+2+F5F
M@S)MM*S,C,N'?D)H06OE=S^WW?\ F?A<#D3AP\)+.2;\.(Q2XFHKKB2-QU3B
M^"DD?>F04!U.()/S_P#2#_YAV?V2-[49%1!AFH?&S ^^,3\^@ ?IF*20
M          #\UN8'Q]VGWWR'MEP5$&. #K/T3^87C>/E\N\B[^/@W3<-<?KH
MZU5>:+^(M5Y%TG<KL)$,'2[G\FKZA_:$$GY;KX+41=%3%1!T?Z'WQDV3]19_
M/"&#KL02                    :WY^?\0[3^KM>V&@!^?8J(.L?0[_ /9>
MV?K$/\!X0P=-B"0
M
M                            L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@
M            ,!YV_P#%&U_J*OPD@#\\140=/^B!"A2U;<J5&:?6W[G]6IUM
M*S3=XS6TU$=*TXB&#;W.?1M+RV@Y[(96!%C3,="?E0LDAM#3S;[2#4VDED1&
M9+424&C[JO;H!)P$)(.BO1$9F_"K8YC*#7$9QB6W$UHDWW'TJ:(SZ",R0Y00
MP9M*]+?!PI+T*7JT]F7'<4R^TIYDE(<;,TJ2?=(RH% 56#]*_6<SFL=B%X*9
M$3/DLQ?&G'6E(:Z]9(O414.U-:GW H#H(02:#V?TIM<UK8LIKRL'+EKQ<EV&
MY);=:2A:V5&A1D1U.E2,30@H8/I:87)SHV.@ZM/>FS'41XS*7F:K==42$)*O
M;,R(* Z*+N](@DUSS7YNX[E0WBG,AC'\BG*F^EOQ=:$6'')LSNOZ:]9PIV@!
MP1FY[>5S61RC2#;:FRGY*&U&1J2EYQ2R(S+@9D1BH@R#E?N$70MXQ>US(SDR
M/ Z^^.RHD+5UT=QDJ&KAP-=0!UMRZ](C#<Q=H8U>%A94)]]MUTI#SC:T))E!
MK.I)X\:4$4).9O2#_P"8=G]DC>U&1)!ANGD:MNP"4E4SR,,B+N]>@ =?[_Z3
MVHZE/?P^#B+V')QE&W(6TX3$-#B3H:>M-*S69'TVIIW1%"3$</Z84=<I+>>U
M=3,-1E<_"E$ZXDNR?5N-H)7WY!0@Z)U?:<%N6&CY_79:9F-D5(EIX*0M/KD+
M2?%*D]DC^T()+P -=<PN=>C\N%G#RTE<S-&FXL5!)+KZ2,JD;AF:4MD?\)5:
M<2(Q(--3/3%?ZXRQ^I(\7+UIOS3O/NF26:%]DPH09+JGI::GE9+<39\6_@C<
M,D^-MK*9&29]E=J$+27U$*"@-_0IL/)1&9^/?;E09*"=CR&5$XVXA15)25)J
M1D8@D^X  #\UN8'Q]VGWWR'MEP5$%@0P\ZVZ\VVI33!$;RR(S)!*,DD:C[%3
M.@ NNI[+D-.V3&[-BU4F8UY+R4UH2T>M6VK^"M!J0KN& /T?P.<Q^T8&#GL2
MYUN/R4=,B.HZ5(G"]:HBK123[U1=@RH*23\RGTFAYQ"O7)4HCIVR,5$'1WH?
M?&39/U%G\\(8-T\U.=N+Y5Y''X_(8J1D%Y!E4A#C#B$)22%V&1W<:@28!],'
M6_DU._+,A0@WYK.<:V;7<5L3#*F&<I%9F-LK,C4A+Z"623,N!F51!)K#F/Z0
MN'Y<;.YK,["RIK[;+3_C#+C:$&3Q5(B)7'@)H#$OI@ZW\FIWY9D*$&\=LVIG
M4]2G[8]%<E,0&$R5QFU)2XI)FDC(C5PX75$$FCOI@ZW\FIWY9D30@V"GGOI<
M?0,;OV8-V QE>O3!Q7>NS'5QGE,K)"4F1&54U-1F22J53J!)JB;Z8JBDF6.U
M,E0R/@J1-M=47U$,F2?LF%"#9O++T@-2YC3$84VG,/L3A&IF#(43C;UI543+
MI$1*,BJ=JDI.G17B%"1S'](/3.7TQS#DES,Y]K@]!B&E+;)_O77E5)*OX*24
MHNR1!0&L(_IBN^,EXWJ22AF?'JIQFZ1=OOF"(_W H0;XY>\S-6YEXQ>0UY]1
M/Q[4S<>^1(DL*67"Y)&9&DZ':I)F1_5(R$$EHY^?\0[3^KM>V&@!^?8J(.C_
M $;]XUSE_J6VYS9I7B\0Y4-MAM!7O/N]6\=C2"XJ.G3V"Z3,B$,%YR?IB(3(
M-.&U4UQ2/O79DNQQ1=U#;:B3]^84!E.D^E1I^PRVL=LL-S7)+IDE$IQPI$*X
M^PMPDH4BO;4BTNR9!0DWTE25I):#)2%$1I41U(R/H,C$ \<<;9;6\\M+;3:3
M6XXLR2E*4E4S,SX$1$ -&;CZ4VBZ](<@X".]L<ILS)3T=26(=Q=@GE$HU?52
M@T]HQ- 8.WZ8LWKB-W46CCUXI3.42Z?5-@R_<"A!M;EWZ0.C\P)3>)2IS#YY
MT[68,VTDO*[33J3M4?\ !.U1]@C"A)M<0#G?(^EIK^-R$O'.ZW.-V(\Y'6?7
M,E532S0?[I":$&9\MN>NO\PT9I[Q-S"Q<&PB5+DS76S;)E=]RC,J4)-G&H$F
MO]G]+O$0YJXVJX)S)Q&SIX]+>.*E=.RALD+50^P:C(^X%"#>VD[$O;=2P^RN
M1RBN92,B2J.E76$@U]@E&15^P()-;[SZ2^AZC*=QF.)W8,HR9H=3"-*8R%ET
MI4^JI&?\1*A- :W5Z8L_K#-&HLDS7@DYRC53ZO4$7[@4(,RT[TJ=:V3*PL+D
ML'-QLZ>\W&C*94B8T;SRB0DC,B;653/L(,* WZ()
M
M                            "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
M             P'G;_Q1M?ZBK\)( _/$5$&8:-S.V_ET4XM5EMQ2R75>-]8R
MV_=U%]E.L2=*=8KH #;N:>_;RR479LT]+@DHEE#0E#$>Y/09MLI0E1EV#41@
M"U:IKJ=IS3.(7E8.'2[Q.=E'O%XZ2(R*EU#JHZ\"[/; '?G+#EU@^6VM-X?#
MN>-NR#*1.R2B(ER75$1$K@9D2"+@A)'P+MF9F=))REZ3FF_!KF&O,QF[,;LC
M?CJ#(J)*4BB)"?JF=KA_QQ4B#2R%J;6EQ"C2M)DI*BX&1EQ(R 'Z2ZQM<?,:
M'C=Q>41,OXU$^494[U2&KGB_Z5$HA22?G%D9KV3R$O)2.+\QYR0Z?\-U1K/]
MTQ40;;]&;5/A%S+CY%]%T' -+R#AF7>F_P#R;)?5)2KR_B P=T"DDY]]*'2]
MJW&/K#>L8E_**B+FJE>+DD^K)PF"1=4R]=:JGU!*(..I4:1"DO0Y;9M2H[BF
M7VE<%(<;,TJ2?=(RH)!5X3!Y;8\FSAL'$<G921?U$5DJK7U:#6JE:="4F8 W
M]Z/_ "SW[5^94++9_ 2H&-1'E-KDO$DD)4MHR21T5V3X"&#7OI!_\P[/[)&]
MJ,B0:T(S29*2=#+B1ET@"^EI&XGA#V4L#// $GK#R7B[GB_5_O[[:6_PN@ 6
M$ ;Z]%3;I.)WIW57'3]S<\PX:63/O2EQ4&ZA9=JK9.)/M\.T0A@Z'YX<R5<M
MM,<FP33\(,BLX>)2HB58X:3-;QI/I)M/'M7&DCX&!)P'*E29LEV9,>7(EOK4
MZ^^ZHUN+6LZJ4I2JF9F?29B2#<>K>C)S!V? ,Y[K86,3+;)Z%#FK<2^XVHJI
M4HFVUD@E%Q*IU[9$%0:HSV#RFM9B9@<U'5%RD!PV9+"J'11<2,C+@:3(R4DR
MX&1U( ;_ /14YB2H6;=Y>9%XUXS(I<DXE*SKU,IHC6XA->A+B"4HR_?)X<5&
M(8.O!!( 'YK<P/C[M/OOD/;+@J(,TY!Z]&V_8-BU.62>KS& EL-N+XDT^EZ.
MXR[3MH6DC!@UAD($O%SY6,GM&Q.A.N1Y+*O7(=:4:%I/ZAE0 =1^B7OAN,Y'
ME[/=J;-V1Q%Q_<*,BD-%7M*-+A$7;68A@Y>R;9LY*8R?2V^ZCCT]ZLR$@Z']
M#[XR;)^HL_GA# ],'XR:W^HO?G@0.;A(/T<Y4?\ &6H>]$+\PD4DG)?I2?\
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MTYB\@?+;"/FU"80AS/.-G0W77"):&#,ON$I,E*+LF9%]SQ('.NOX#+;1F8>
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MLXJ IV;X\VI+\92V6U=476-F9)/K#29$JA\.@0#L802
M
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M$=^9J;6H^"2,U$KHK6A'%"3?8@
M
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MARI!GPJX\PA:C^R8I)+X
M
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M&D,,(_>MM))"2^L1"DD^X
M
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MZZB0X70<I^0^GAVT+<-)_>A4&QL?CL?BHJ(.+B,PH37!N-&;2RTDNXE!$1"
M5(
M                                                   +!,^.^&]Z
MLK[8QP :+\2-:]ZH/M=  OX                      #1GI5X#W4Y;MY=M
M%7L)-9?4HN-&)%6%%]=2VS^L)0.*XT63-D-Q(;+DB4\HD-,,I-QQ:CZ"2E)&
M9G]020=:\A/1_E:[+8W;>&4IR[17XG$JHKQ=1EP>>I4NL+[A'W'2??4MAL'2
M0@D
M
M
M                        "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
M                   M^<P>+V3$R\'FHY2L7-1U4F.:E(N34C]<@TJ+B5:D
M8 MNMZ%INH$9ZUA(F.=,K5/M-D;YEVC=559E]50 R(
M
M
M
M      %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\
M
M
M
M                             6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?
MP
M
M
M                                                   !8)GQWPWO
M5E?;&. #1?B1K7O5!]KH %_
M
M
M
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M](>FV[/+CG+CP>K=.Y@B69JZPDV%_)JX&JO  7X
M
M
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M1EVA- 90US0TZ5IK^]XZ8O(8&,:$R#B-+=D(<6M"+%,T)9*(UI,R,NCCT<1
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M3H?9( 7H
M
M                           %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\
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M
M
M                   6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P
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MHGYSAWFV?W5K9=\?9N2HA+(.GQ!(
M
M                                               !8)GQWPWO5E?;
M&. #1?B1K7O5!]KH %_                                 :IG:ASKB
MY*<[K^]Q',7+?<?9CY* E;D9+JC5U:%))=4IK1->'<$@K>7_ "H5J^9R&X;/
MF7=DW;*-]1(R;J"9;:9X5;9;29V^M(J\.!4222K4#-\#K^%U?&-8; 0FX&,8
M-1M1VB.TC6HU*,S,S,S,SZ3,0"Y
M            PS>M=WG,/8^=I.TE@),(G">BO1D28THG;?Y2[H--O>]Z?2?0
M ,(E\H-XW>7#+FIMS>2U^$ZE\L%BX_BK+[B*T-QSO54H=.@SH9VFGI$@R_F5
MJ&U[=B86!U;/)UW&.+4UFE-MU=<A*1:2&C21&5.BTE)J1]-.!P"^Z=J&%T;7
MHFMX)HVX,4CJM=#===5Q6ZXHJ54H^G[!4(B( 7X
M
M
M6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P
M
M
M
M                      !8)GQWPWO5E?;&. #1?B1K7O5!]KH %_
M       6N5LNNP9"XDW+PHTINA.,/26FW$U*I52I1&7 ZCVC8N255%M<C/"6
M8M1='))\J/C\+]2\_8[RMCPQ5\M=Z,N9E'S=GIQ]Y#X7ZEY^QWE;'AA\M=Z,
MN9CYNSTX^\A\+]2\_8[RMCPP^6N]&7,Q\W9Z<?>0^%^I>?L=Y6QX8?+7>C+F
M8^;L]./O(?"_4O/V.\K8\,/EKO1ES,?-V>G'WD/A?J7G['>5L>&'RUWHRYF/
MF[/3C[R'POU+S]CO*V/##Y:[T9<S'S=GIQ]Y#X7ZEY^QWE;'AA\M=Z,N9CYN
MSTX^\A\+]2\_8[RMCPP^6N]&7,Q\W9Z<?>0^%^I>?L=Y6QX8?+7>C+F8^;L]
M./O(?"_4O/V.\K8\,/EKO1ES,?-V>G'WD/A?J7G['>5L>&'RUWHRYF/F[/3C
M[R'POU+S]CO*V/##Y:[T9<S'S=GIQ]Y#X7ZEY^QWE;'AA\M=Z,N9CYNSTX^\
MA\+]2\_8[RMCPP^6N]&7,Q\W9Z<?>0^%^I>?L=Y6QX8?+7>C+F8^;L]./O(?
M"_4O/V.\K8\,/EKO1ES,?-V>G'WD/A?J7G['>5L>&'RUWHRYF/F[/3C[R'PO
MU+S]CO*V/##Y:[T9<S'S=GIQ]Y#X7ZEY^QWE;'AA\M=Z,N9CYNSTX^\A\+]2
M\_8[RMCPP^6N]&7,Q\W9Z<?>0^%^I>?L=Y6QX8?+7>C+F8^;L]./O(?"_4O/
MV.\K8\,/EKO1ES,?-V>G'WD/A?J7G['>5L>&'RUWHRYF/F[/3C[R'POU+S]C
MO*V/##Y:[T9<S'S=GIQ]Y#X7ZEY^QWE;'AA\M=Z,N9CYNSTX^\A\+]2\_8[R
MMCPP^6N]&7,Q\W9Z<?>0^%^I>?L=Y6QX8?+7>C+F8^;L]./O(?"_4O/V.\K8
M\,/EKO1ES,?-V>G'WD/A?J7G['>5L>&'RUWHRYF/F[/3C[R'POU+S]CO*V/#
M#Y:[T9<S'S=GIQ]Y#X7ZEY^QWE;'AA\M=Z,N9CYNSTX^\A\+]2\_8[RMCPP^
M6N]&7,Q\W9Z<?>0^%^I>?L=Y6QX8?+7>C+F8^;L]./O(?"_4O/V.\K8\,/EK
MO1ES,?-V>G'WD/A?J7G['>5L>&'RUWHRYF/F[/3C[R'POU+S]CO*V/##Y:[T
M9<S'S=GIQ]Y%; S.(RIN%B\A&G&U0W2C/-O6W5I=89TK0Z5'G.U.'M)KE1ZP
MO0G[,D^1U*T>9Z@  !0/YW"1G5,2<E%9?0=%M./MH6D^T9&HC(7$<O=DJJ,F
MN1EI/.V(/#*Y%-<#DCY_"37?.\+REKPA/RE[H2YF4?4,M\2'O1](^$FN^=X7
ME+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'O1](^$FN^
M=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'O1](^$
MFN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'O1]
M(^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'
MO1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M
M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?
M4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+W0E
MS,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+
MW0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I:\(
M/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO"\I
M:\(/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDUWSO
M"\I:\(/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'PDU
MWSO"\I:\(/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z/I'
MPDUWSO"\I:\(/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB0]Z
M/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZAEOB
M0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9CZA
MEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z$N9
MCZAEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'O1](^$FN^=X7E+7A!\I>Z
M$N9CZAEOB0]Z/I'PDUWSO"\I:\(/E+W0ES,?4,M\2'O1])50\CC\@2S@2V91
M-TZPV'$.VUZ*VF=*T'G.U.'M)KE5#WM9BW=K@DI4V-/R%2/(]P   MA['KR3
M-*LM#(RX&1R&JD9?]0N?E;W0ES,L?G\M\2'O+TCX2:[YWA>4M>$'RE[H2YF/
MJ&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2
MYF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE
M[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$
M'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4
MM>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:[YW
MA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:
M[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ(>]'TC
MX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ(>]
M'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0RWQ
M(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,Q]0
MRWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O="7,
MQ]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^4O=
M"7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REKP@^
M4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+REK
MP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?.\+
MREKP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"37?
M.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^D?"
M37?.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#WH^
MD?"37?.\+REKP@^4O="7,Q]0RWQ(>]'TCX2:[YWA>4M>$'RE[H2YF/J&6^)#
MWH^DK8LR).:Z^$^W)9J:>L96EQ-2Z2JDS(>,X2@Z233XRYMW87%6#4EQ.I]A
M0>H           %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\            !^
M?_I!I_;%L_LL;VHR.H[F_1P\/E9Q[?S_ -]<\'Y4:RM&8,%46@*BT!46@*BT
M!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@
M*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!4Z@]#@J
M3-P]BQ_X4@:;VFU6_P 7F-\[)>U=_#_,=6C2#H0   <9\VE4YC; 1?I!?FT#
ML6Y?T5OD\Y\W=IE_Y.]][S(PN\9DUN@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O
M 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X
M"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"AT+Z,U#C[*?9OAE7ZSXY_P!K
M'IM?B_E.O?\ M\O5O\L/YC?8T0ZN   '!$]5)\HBX$3SA$7_ %&.[VWZBY#Y
M0OK^I+E937CT/&@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4
M%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@O 4%X"@
MO 4%X"@O 4%X"@O 4%X"AU9Z/M/F_(^W-D5^P@<L[3?K/PKSG>NQ"_\ '?CE
MYC:@U<WL           "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
M    X"]()-><&S^R1O:C(ZEN;]'#P^5G&]_O_?7/!^5&M+1F#!5%H"HM 5%H
M"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM
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M *"X!07 *"X!0ZQ]'HZ\O4_KLC[2!R[M+^L_"CN_8G_COQR\QM4:N;T
M      !8)GQWPWO5E?;&. #1?B1K7O5!]KH %_             <"^D 7[7]
MF]DC>U&1U+<WZ.'A\K.,[_?^_N>#\J-:VC,F!J+0%1: J+0%1: J+0%2OQ.!
MS>>>5'P>,E9-]/%3<)AR0HJ]LFTJH/*Y>A;59R4>5T/>U8N772$7+D3?D+AE
M-#W;",*E9C7,G!BHXJD/PWD-%V>*S3:7V1XV\Y8N.D9Q;XFCVN9',6TW.W))
M<+BZ<]#'Z5%V653VT!4JH>+R61O]SX3\OJJ=9XNTMZVZM+K".E:'2H\YW(P]
MII'K;LW+GL1<J;%4^LG YN&RJ3,QDN/'12]YZ.ZVA-3H55*21%4SH(C>A)T4
MDWRE<\M=@JRC)+C3*"T>I;U+GB-9V+8#6G XB;E#;]?XE&=D6_5ZM)T'A<OV
M[?MR4>5I%Q:RUZ[[$)2Y$WY#W,:OLNO$@\_AIV+2YP0J;&=CDH^X;B2(PM9B
MU<]B2ER-,F[EKUI5G"4?O)KREKM'N6U1: J+0%2Y8?6]AV%Q36 Q,S*.(]>4
M*.Y(M_C=6DZ?7'A=OV[7MR4>5T+BSEKM[^W"4N1-^0GF=6V77326?P\W%WG:
M@YD=UA*C_@FM)$?U@M9BU=]B2ER-,F]E;UG^Y"4>5->4M5H]RVJ>H:6ZM+32
M#6ZLR2A""-2E*/H(B+B9B&Z:R4FW1&2*Y<<P$Q?'5:KERB4N-XX,BVVE:^LZ
M*=D6?SV7K3K(U^\B_P#IV:I7JIT^[+T&-J;4A2D+2:5I,TJ2HJ&1ETD9'T&+
MQ:2P=4Z,\M$D5+OAM2VC8DJ7@,+.RB$G:MR'&=?0D^T:D),B^R+>[F;5KVY*
M/*TBZLY2]>TPA*7(F_(?#+Z_G< \F/G<7+Q;ZRJAN:PY'4HB[1.)*OUA5;O6
M[BK"2ER.I1=L7+6BY%QKM37E+?:/8\*BT!46@*BT!46@*BT!46@*BT!46@*B
MT!4Z;]#TJ2]N]C@?A2!IG:;5;_%YC?\ LA[5W\/\QU2-'.B@  !Q5S>/]I.Q
M?K)?FT#L&YOT=OD\Y\Z=I5_Y*]][S(PFX9@UV@N 4%P"AZ5RC)*2JH^!$7$S
M,*BA?H^D[I+;)Z+KN3>:5Q2XB&^I)EW#)%!92S^6BZ.Y%?B1DH[JSDE56;C7
M%"3\Q83,R,R,J&72+VIC#RX":'UCL2);R(T5E;\AP[6V6DFM:C[1)21F8IE-
M156Z(KA;E.2C%-M\"+E\%]G\R3_)7O %O\Y8Z<?>1>?3<U\*?NR] ^"^S^9)
M_DKW@!\Y8Z<?>0^FYKX4_=EZ"UNMNL.K8?;4T^THT.-K(TK2I)T,C(^)&1]@
M7*DFJK46,H.+::HT0N$D4%P"@N 4%P"A)!+<6EMM-RUF24I+I,S.A$(;HJA1
MJZ(S_P"9+FCYA/RJ)_3#!_7LE\3Q2]!M/=/>GPOXH?\ <8GL.N9O5,A[E9^(
M<.?8ETFE*0NK:ZT42FU*29<#[(RF6S5K,0QVWB7[;3!YW(7\G<ZN]'#*E::'
MH\%46QM+CKB&FDFMUQ1)0A)5,U*.A$1=LS%PVDJLLU%MT6EF?_,ES1\PGY5$
M_IA@_KV2^)XI>@VCNGO3X7\4/^XQ+/Z_F=7R2\1G8IQ,@VE+BF36ASO5E5)W
M-J4GC]493+YFWF(8[;K']MI@LYD;V4N=7>CAELT/R5-@:]R%W'8< SGFGX<1
M,MI+\*+(6X3KC2RJE2C0A24W%0T\?JT&#S/:'+V;KMM2='1M?]3:<EV/SF9R
MZO)QCB2<4VZM/D3I5:5XZ&'ZUJ,S/;BQIDISW-G.//1GUN(ZSJG8Z5J4DTD9
M5.J+>D97-9V-G+N^EB5$^6M/28'(;KGF<XLK)X)5DGPT<4Z^2FLSS=>1$K3=
M8G[(YG&YB(/5&<9,8VS5UKR&O7&XJE+Z] PF1[0K-7XVL&'%7378F]G$;-O;
ML@\CE97W=Q8::,--<E'7B>TM'+;E,_S%Q\V<UE48_P 2>2P;:F#>NN1=6I+1
M07>]-\K)3C%PQ8E773S%EN+LV]YVY35S!A=/9KP<J+/S(T-WEWF8V'=G)R"I
M$5,OKDM&R224XXW;0U+KZRM:BZW9O%9VVYJ.&CIKKP)^<QN_-T/=M]67+'6*
ME6E-;DJ:WT3)\=Z/^[9' -9IMR(U)D-%(8QCJUI?4A2;DI49IL2LR^Y,^'9,
MACKO:/+0NNW1T3HY<'II^R,S9[&9V[EU=3BFU50=5+R43XGX6C53B'&7%LO(
M-MUM1H<0HC)25).AD9'T&1C9E)-51I,HN+H]#1"X2107 *"X!07 *"X!07 *
M"X!07 *"X!0Z+]& ZQMF]DA?:?&@]J_:M?B_E.M=@?9O\L/YCH :*=3   #\
M_<BK_$)?LSGX1CNEKV%R'RO?7]27*RFN'H>5!< H7>#J^T9.,F9C<)/F1%U)
M#\>*\ZV9EP.BD),CH+6YG+%MX93C%[')(OK.[LS>CBMVIRCM49-<Z1:#,RX&
M5#+I%U4L*%\QNG;=F&DOXK!3I<=?K7VHSJFCX5]?;;^Z+.[GLO:=)SBGRJID
MK&Z\W>2=NU.2?"HNG/2A297 YW!+2WFL9*QRUUZLI3*V;J=-IK(B/ZP];.9M
M7O8DI<CJ>&8R5_+NEV$H5Z46O*6ZX>Y:T%P"@N 4%P"@N 4,HUSEYNNV,^,X
M'#O2(G&DI9H8850Z':X\I"5&1]-IF,=F=YY;+NER:3V:WS*IF,EN7.YR.*S;
M<EMT)>!R:3\!<\MR=YD8:.N5)P;CT='%2HCC4I1%V[&E*70NR=HMK.^\G==%
M.CXZKQO07F8[,;QL1<I6FTNBU+Q1;?B,$J9'0RXETD,U4UJ@N F@N 4%P"@N
M 4%P"@N 4%P"ALC0.3^6Y@89[-0<C'B,LR5Q#:?2M2C4A"%F?>E2E'!K^\=]
M0R=Q0E%NJKH\*\QMVYNS-S>5EW8S45&6'378GYS!\YC'<%FLAA7G$O/8Z2[$
M<=14DJ4RLT&95XT,R&9R]Y7;<9K1B2?.:SFLN[%Z=INKA*4?=="WW#W+>AE>
MC<OMAY@RY,;!DRVW#2E<J5*6I#2.LK8GO$K49JM.E$]@8S/[RM9.*=ROK:DM
M9F]T[ES&\I2C9HL.MR=%IU:DWIT\' 2^;[.L[PQH>0ZJ'E7W4MI>49K8-*TF
MM+B32532HBX<.G@=#K2/J5IY9YB-7%+P\A*W)?6=63G2,VZ5X*:ZJFM-:N9T
M=:7;F#RFRG+S&Q<E/R,>8W+?\70VPEQ*B.PUU.XJ4X"UW;OF&=FXQBU15TF0
MWUV;N;MMQN2FI*3IHKLJ74N16;/42V_W5BE$/&^ZWB]CG6=7U'7V5I2M. MN
M\%OYCJ<+KBPUT;:%WW2N_)?-=9'#U?64HZTPXJ&-Z+RQV;F U*D8;Q=B)$43
M;DF6M2$*=,KK$V(69G3B?"A#(9_>UG)M*=6WP+]D8G=/9_,[R4I6L*C'163:
M5=BHF8UF<3D-?RLO#91KJ<A"<-I]NM2J7$C(RZ2,CJ1]H9&Q?A>@IP=5(P^:
MRMS+796KBI*+HR@N'L6U!< H+@%!< H+@%!< H+@%#K3T>#KR\3^O2/M('+N
MTOZO\*.Z=BO^/_'+S&UQK!O(           %@F?'?#>]65]L8X -%^)&M>]4
M'VN@ 7\            !P1S_ "_:]LWLD;VHR.I[E_1P\/E9Q?M!^ON>#\J-
M;4,9DP%10P%10P%10P%10P%3-.5.D(Y@;SC=<DK4UCEFN1D'$<%^+,)N4E)]
M@UG1!'V*U&-WEF_EK$IK7J7*S,;HR/SF9C;?LZWR+TZO"=G[=L^H\D],:DLX
MXF,<VXF)CL7!0ELW7UI-5*GP+@DU+<54_JF?'G.6R][/WJ-U>MM[/VU(ZMF\
MU8W9ET\-(UHHQVZ_2VWY2T\J>=V%YI29N+;Q[N*R\1KQ@XKKB7T.1[B0:D+2
ME/%*E$2B-)=)4KQI<;QW3/)I2KBB]%=6DMMT[\MY]N*BXR2K37H_;BX327I/
M<N<-K&2QNU8".B''S*W6<A#:22&BDMD2TN(27 KTFJXB(BJFO29C9.S^>G>C
M*W-U<=3XOW&I=J-W6[,HWK:HIZ&N/;X>']YH./&D2Y#,2(TI^5(6EIAELC4M
M;CADE*4D7$S,SH0VJ4E%-O4C281<FHI5;.\^6>H8CE#IF.Q60=;1F<I(93/?
MZ3>R,JB4M(/LI016I[A&KLF.6Y_,SSMZ4H^S%.G%%</[<AVC=F3M[OR\82?K
M2:KQR? OVX]I2^D97YGMA(CZ3A$?EK ]-Q_K(?B_*SQ[1_H+GX?SQ.9.17*]
MCF3M#ONL2O@UAT(?R24&:3>6X9DTQ<1D:27:HU&7&U)D1D9D9;IOC>#RMKU?
M;EJ\[\!S[<.ZUG;SQ^Q#2^/8O#IT[%P.C.KMYY@:;R;P,%IZ+U;;M6<5A\>V
MA!J2V1&HR*J4I0FI7*[O9&B93)7L]<='RR9TO/;PR^[K2JM&J,8_MJ1]-$Y@
MZCS@P,WQ2->VW2/E<//;0LTDX1FFY-5)6A=#M/N'T&(SF2O9&XJODDB<CO"Q
MO&T\*JM4HR\_$SD_GQRQC\N=K;/$(4G6LRA<C'-J,U=2MLR)YBX^)DDU)4DS
M^Y41<3*HWO<^?>:M>M[<=#X]C.:[_P!V+)WU@]B>E<6U>#SFJZ&,Z:U4SGE'
MR^7S'W.+@W5*;Q+*3F99Y'!28K1D1I2?84M1I01]BM>-!B]YYWY6RYK6]"Y3
M-;GW?\[F%!^RM,N3]^KQG:.R[+I?)O4F7WHZ8.)8-,;'XV"V76.NF1G:A-2(
MSH1J4M:NZ9UZ><Y?+WL]>HG66MMG6,SF<ONZPFUABM"2X?VXQJ&Y:=S@UB2]
M#8\:QRS.)D\7/;3>A1D2K7$54DR,CJE23,OKD=&9RM[(W4FZ/6FAD\[8WA9;
MBJQU-27[?MQG&_.CEVGEON;V,AW'@IK93<2I9FI265F:5-*4?2;:B,NFMMIG
MTCH>ZL]\U84G[2T/]N,Y5OO=WR>8<8^Q+3'DV>!^*C>LZ:Y"\I<;I>N0]BR<
M9+NWY1E,AU]Q-5167DU0PW4N].T_QAEQ-52Z"(:7OC>4K]QPB_4BZ<O'Z#H6
MX=TPRME7)+^I)5Y%LXN/C*^!Z0?+[([H6EQWI'7+?.&QE%(3XB[)NM)"%DLU
M44KO4J-%IGV:4,_*>Y<Q&SUK2U5IPT/:WV@RL\QU";K6F+[+?%IKXO,8]Z1?
M*C&[!K<S=<1%0QLN(;.3,6TDD^-PVRJZ3E*56A/?I6?&A&GLE2[W'O&5NZK4
MG6,M"XGP<_[RQ[1[JA>LN]%)3AI?'%:Z\FNO%3DT/R(Y9,\QML7[K(4K6L.A
M$G))2=.N6LS)EBI'4B6:5*49?<I,N!F1C:-\9]Y6SZOMRT+SOP><TS<&[5G+
M_K^Q#2_,O#I\">K0=9;US$T[E!AH*)S!MM.F;&,Q&.:0E1H:(KC2BJ$)0BI5
MX]D:)D\E>STW1\LF=+SV\,ONZW'$J+5&,:<&Q:%1%5B\EI7.32_&"83DM>R!
M*:?B2D$EUEY'!25$1F:'$5J2DJ[1I/H,47+=_(WJ5PR7"N'TH]+5W+[RR]:8
MH2UIZT_,UQ<J9P[S*TA_E]N61UE:U/1F5)>@2%^N=BO%<VHZ$17%ZQ5/NB,=
M+R&;69LJYP\/*<@WID7D\Q*WK7 ]J_;1RF)T,9 Q=3//F<WGX&_#SQ>/\'/%
MO'NN\81UG4=NSIKW!B?JECKNIJ\5::C._1,S\OU]%@IBU\!@=#&6,%44,!44
M,!44,!44,!44,!44,!4Z9]$ J2]N]C@?A2!I?:?5;_%YCH/8_P!J[^'^8ZG&
MCG1@   XGYOJ_:5L7ZR7YM Z_N;]';Y/.?._:1?^1O?>\R,(N&8-=H+@%#(=
M*U')[SGV,#BZ)6LC=DR5$9H8809$IQ5.U4B(NR9D0L<]G892T[D_ MKV&4W7
MNRYG[ZLPY6]BX7^W#0ZUP.F:%RMQ)SS3'BJ83_6LW.-/7J4? ^_5ZV[H)#=*
M]HS'+\QGLUG[F'2ZZHQU<WG9W+)[KR&Z;6/1&FN<M?.]5>BN:ICF0](WE[#>
M4U&3/R"2Z'H\=*6S^IU[C2O^Z+^WV:S<E5X8\K]"9B;W;7(0=(J<^-1T?Q.+
M\1R<M9*6I1=!F9E]<QT]'#4J(C<!50V3R'B'+YG8E=*HBMR7U_4)A:"_[RR&
MO]H)X<E/CHO&C;>R5ISWE;?14F_=:\K1T_MO,'5=(7$;V.8J,N:2U1TH:<>,
MR:M)1GU:54]<72.<Y/=U_-5=I5PZ]*7E.R[PWQE<BXJ_+#BK30WJY%QF-_/Y
MRP\ZN>2R/Z,7_=_.]%>]'TF)[V[L^(_=EZ#E3;\E%RVV9W*05FY"FY"5)C.&
M1I-33KREI.BJ&52/H,=,R=N5NQ"$M<8Q3\".([QNQNYJ[<CIC*<Y+D<FT6:X
M798T,TR'*W;\7JJ=REL,IP2F&)1.)>2ISJI1H)L["XU/K$U(8BWO;+W+_4)O
M'5K5LK7R&P7MP9JUE%FI)=6U&6O325*:/"C"[AES7Z"X!0N>MM>,[%B(U*]=
M-C-T_CNI+_M%MFI8;,WLB_(7N0ABS-N.V<?*CO=^0S&)!O*M)Q:6D=U:SHDO
MKF.)QBY:CZ:E-1UG/_I.X+\7@]G;07>FYC9*^SWU7F2_<=&\]ELQIG:?WEY'
MYCEW;O)Z+5]+;!_FC_,:VY*Z_P#"+F'BT+1=%QIGDI/<*-0V_LNFV1C8-^9G
MJ<I+;+U5X=?BJ:CV7R7S.\(5U0]=_AU?Q83LA$IA<EV(A9'(92AQU!=*4N&H
MDU^K:8Y,XM)/@9W]33DX\*\YRAZ1;75<Q+Z?RT".O["EH_\ -'3>S4JY3DD_
M,<1[:PIO"NV$?*UYC)M3Y^S</JL+$S=;D3)T".B-$D,&:&76VDDALU50HR.A
M%6VM>GAT#'9SL_&[?E.-Q)2=6GK5=9F-V]K96,I&U*RY2A%1BUJ:2HJZ^#7K
MV\1A/*_)R\QSFQN5GI),V=-ER9"$D:4I<=:>6HB(S,R(C.A$,QO6W&WNZ4(Z
MHQBEX&C7>S]Z5[?$+D_:G*<GRM2;.@^>7#E9G_J1?;C(T;</ZZW^+\K.G]K?
M^+N_@_\ R1,+]&(ZZ_G?UQO\T,MVI_NP^[YS!]A/T]S[_F,.])DZ;MC/>IOV
MP^,OV7_32^^_RQ-;[<K_ '\?]*/YYF08GTA\C%UZ/%DZS(DYMEE#3<A!FF,\
M9)(B<41(N*O2:4UKV#+L6%[LY"5YM7$H-ZN%<6LS.6[97(Y=1E9<KB22=?5E
MH]K5HY%SK@Y]ERWYLM^;*5?*D.+>?70BJXXHU*.A='$QO,(J$5%:EH.5W)RN
M2<Y.KDZOE9Y&CR9CI,0V7)#ZO6M,H4XL_K)(S$RG&*K)T0MVI7'ABFWL6DJY
MN$S>-;)W(XR7$:.E')##C2>/1Q6DB'E#,6IND9)\C3/>[DK]I5G"45QQ:\I;
M[A[EK0^[<.:\@G&HSKC:O6K0VI1'3AP,B%#N16AM'I&S.2JDWX"+#$B2\F-&
M96](4=$LMI-:S,NP22J8F4E%5;HBF%N4VHQ56]A]IN,RF-M]T8,B'?ZSQAI;
M5U.U>15%%N]"Y[,D^1U/6]EKMK^Y&4:[4UY2DN'J>%!< H+@%#HWT73K&V?V
M2%]I\:#VK]JU^+S'6.P7LW^6'\QT$-&.I   !^?.15_B$OV9S\,QW.U["Y#Y
M:O+^I+E937#T/*ALSDY/Y>X^?E)N^-,+**RV]CER4J=02TK-*TI9(E$M9W),
MJI.E#/MC7M]0S<X1CEV]+:E31X^!:S<.S-S=]JY.6;2T).-:M:]/J\+TK@X&
M]IU+IVT8_<<"QG<4RXQCWEN-,-O$E*[6%FW6U)J(JV\"J.;9W*SRUUVYNLE3
M5QZ3M&[<_;SMA7K::BZTKQ.G <+QYCD'(-3F22;T9]+S9+(E)-3:[BJ1\#*I
M<2'9I04XN+U-4/FFQ-VY1FM<:/F-^Y/TG[9%N%U^Z&DR_&3'[7%%V>\;29)^
M^4-(M=E='KW-/$O2=4O]N_6_I6?5_P 4M/,EHYV;:P\S"\UM$8F9" :<;F&G
M$NQ'C):FUMK4THT+H7%*DF:%D1'T'PZ!K%Z%S=^:<8R]:#U[>'_JC=LK=L[W
MR*E.'JW$ZQ? TVM#XFM#T/AT,XB=)*'5H0LG$)4:4K+@2B(Z$?'MCL*=4?.C
M2KH,LY<:.?,'/N8),\L<:(SDKKS:Z^O5J0FVV]'3?TU&,WGG_D[768<6FFNF
MWE,YN3='U*^[6/!2+E6E=32VK:6+8<7[@Y[*8,WO&#QLIZ)U]ME_4.&BZVIT
MK2M*F+S+WNNM1N4IB2?.C%YO+]1?G:K7!*4:[<+:KXBVW"X+:ALSDGH<?=]G
M6[DV^LP6(2F1,:/UKKBS,FFCX]!FE2E=LDT[(U[?F\'E;-(>W/0N+:_VVFW]
MEMT1SV9K<5;=O3);7]E>?D5.$W1S;YMER[*)@<!%9>S3S).VND?B\:/4T([Q
M!IJH[3M34J$53[%=0W/N?YVMRXVHI^%LZ'VB[1?3<-FS%.XU73[,8ZN"FS0N
M#AX\:Y8<^\GG,_&UW;FF"]T%$S"GQTFT9/J]:AQ)J,C)9]ZDTTH=*UK4LCO7
ML_"U:=RRWZNEI[.+D,1N+M==S&85G,J/KZ(R6CUMCT\.I4X=M='P](K0H;$9
MK>L6R33ZG4Q\PA!42OK/Y-XZ="KBL4?W52[1UK[-[PDV\O-U5*Q\Z\_.>7;3
M<\%%9NVJ.M)\==4O,]M5L-70>4?,#(X=K/0\4ES%/L>--O\ C,9-6;;KK5.$
MHN'8I4;)<WSE(7';E/UDZ:I:^8TFUV=WA<M*[&U6#54\4-7O5,8P>&R>R96-
MA<,R4C)2S43#)K0V2C0DUGWRS2DN"3Z3&1OWX6(.<W2*,1E<I=S-U6K2Q3EJ
M6A<?#1%WVKE]MNE,1Y.R0"ALRUJ;843S+URD%<94:6JG#MBURF\;&:;5J6)K
MB:\J+[/;FS>2BI7X8%+0M,7^5LNFO\G^86R1&<A!Q74X^0DG&),MQ#!+0HB-
M*DI4=YI,CJ2K:&0MLSOK*6).,I5:X%I_<7N2[-9_-04X0I&6E.32\6O3P.E&
M>['R>Y@:Q"=R4[&$_CV$FM^1$<2^3:2XFI22.\B(N)JMH79#+;ZRM^2C&5)/
M@>C]Q.>[,Y[*0<YPK%:W%IT\&OE=*(P.ZO1QKT#-&LT-CXOD9S(RD),Y.,1%
M0XDEMM2WD,O*(^V@S,T_470Q@+N_\G;EAQ5Y%5?MR&W9?LEO&]#'@4>*32?-
MP>&AO3D+@LOK>JY/$9R&Y"R+.5>-3+A%Q2J.P1*2HJI4DZ'123,AIG:#,6[]
M^,[;Q1<%Y9'1^R&3O97*W+=Z+C+K'H?W8>!KC1H'.ZOG=PYG;5BM>C%+GHR$
M]]31N-L_BT2329U=4DNE1<*C>+&;M9;)6IW'188KA?V>(Y;F=WW\YO&_;LQQ
M2ZRXZ52T8WTFMI3,\JM\?V!S6$8H_=5AI$B276M*99:=K:I;J5F@JT.B:W'V
M"%<M[Y56NMQ>JW1:'5ODUE$.SV?E?ZCJ_723>F-$GPMIT\%:\1EW+G&\V-.V
M/8,5J<")D)4'Q=G-1'G6^HN<):V5$I3K2C,BO]:?U2Z!B]Y7<CFK-N=Z3BI5
MPM)UX^!\1G=SV-ZY#,7;>6A&<HX5--QP\+B],H/;J?*>8Y[;'^>^(=W9I$?/
M+DM&Y':4A3331LGU:46*61$2?X1GV^(7586ZYJPZPH].W3IKJ)RTLW+?EN6:
M6&Y5:-%$L.BE&U3P\NDSWTG#IK&&_7S_ #*QA>RW]^?W?.;1VZ_2V_O_ ,K,
MR3_PB1_[5+_]W#%?_M/_ .M_.9=_\#__ $W_ .J-'\FY_-6#CLBYHF-BY3$K
M>),EF:XVA+<@D$=R2-YE533;7I(;AOJWD9SC\Q)PE312NKF9SWLY>WK:MS^3
MMQN0;TXFM$J<'KP>JG$:\W1S8%[3E%[41)V WC.<E)I4E*Z%1*309IH2:$5#
MZ!G<CU2L1ZGV*:#5]Z/,2S4WF%2Y7UM7FJM7&9%@>3/,388J)T;%>*Q'2N:<
MFN)CFHCZ#)"N_H?8.VABPS&^\I9EA<JOBT^/497)]E]X9F*DH88OAD\/BU^(
MMVU<M-UTUGQO.8Q2,?4D^.L*2^P1GP*Y2#,T5,Z%>15%QE-Z9;,NEN6G8]#_
M '^ M-X;ASF26*[#U>DJ->+5X:%!JVF['NDF1$UN(4R1%;)UY!NM,T0I5I'5
MU22/CVA[YO/6<JD[KHGQ-^0M<CNS,YV3C8CC<=+TQ7YFBZPN5&_3\Y,UYC$J
M]T,?U?CRE.-]0SUR$N(N=)1H,S2HCM29GW!:SWOE86E<<]$M6AU=-&K67UGL
M]G[MZ5E6_6A3%I5%5)K36FIUHFV1VWE=NNEQ2GYJ 7N:9D@YD=:7FDJ4=")=
MO%-3X$:B(CZ!.3WMELU+#"7K;'H9&\>S^<R,<=V/J]).J\/"O"C#;AEC 4%P
M"AUMZ.IUY=I_7I'VD#E_:3]7^%'<NQ?_ !_XY>8VR-8-X            L$S
MX[X;WJROMC' !HOQ(UKWJ@^UT "_@            .#.?I?M=V7V2-[49'5-
MR_HX>'\S.*=H7_O[G*ORHUM09@P%10!44 5% %10!4SGE#NL?0-[Q^?GI4K%
MF3D3(6$9K2P^5#61%6MBB2LR[)%08S>>4>9R[A'7K7*C-;ESZR>:C.7LZGR/
M]JG96Z:CK'./36H93B<@/*3,Q>5AJ2X3;R24DEEQHHJ*4E2#_<,JESG*9F[D
M;U::=33.L9[)V=Y9=1KHUQDMOGXUYS%^3G(YOEA/R&:GY).3R\ILXC"FFS::
M:BFLEGP4:C-:S2FO:I0A?;TWN\W%04<,5I\)C]S;BCD)2FY8I-4V:/V1H[TB
M.:$#>\S#P>"O5AL&IV^2XA39ORW*)49(711)02;2J1&9FKL4&S[CW=++P<Y^
MU/Q+]YIO:3>T<U<5NW[,*Z=K_=Z>(R+T8.6GNA/7S$R[-8<!2F,(VM/!R32U
MQ\J])-D=B3_?U[*!9]H<_ACU$7I?M<FSP^3E+_LKNS'+YF:T1T1Y>%^#5R\<
M3*=UY@M;'SUT_2L<X3F*P&1ZR>HCJAS)=6M-.R7X@JI[BE*+L"QRN1=K(7+L
MM<XZ/N_O\E#*9O>2O;SM6(NL;<M/WJ/\NKEJ9KZ17'E!G_XT/VXR,;N/]9#\
M7Y693M)_Q]S\/YXFO_1%DQCQ6T0B,BFHDQGEI[)M+;6E)_6-*AENTT7C@^"C
M,)V/G%VKD>%-/P/_ *,MWI8ZUF9$[![/&CN2,.Q&<AR7&TFLF'>LZQ*ETZ"6
M1T(_X/U!Z]F[\%&5MNDFZ\IX]KLM<DX74JQ2:?%_U\Q\?1.P6?8S.;SSL5UG
M7WH:8R'W$FA+TDG4K3U=:76I)=QET5(5]I+UMPC"OK5KR*AY]D;%Y3G<:I;:
MIRNNBG)I,G]+6*RO3L',53QAG)]4WV['8[AJI]="18]FI/KIK_#YT9'M?%?+
M0?#C_E?H.1:#H!RRIU+Z(F.:3"VG+&1&^X]%BI5V20VA;AD7U367V!HW::;Q
M6X\K\ATKL?:6"Y/:TN:OI+-Z7$]YS/ZWBC/^KL1'Y1)[%[[I(,_L-BY[,P75
MSEM:7-_U+3MA<?66X[$WSO\ <?'T2)[K6U;#BR51B3CVY2T5X&N,\2$G3N$\
M8J[2P3M0ELE3G7[CS['W:7KD-L:^Z_\ ,9[Z1VOQ\WD.7B'4D9R,VC&K[K4Q
M3=Q'W.\&*W%>=N-ZG!#%S5,]VCR\;LK%>&XH^"5/0;8WS(.XG2-CR;"^KD1,
M9,>87T4<0PLT']]08+)04[\(O4Y+RFQ[PNNUEKDXZXPDURT=#\Y6EN,*0\TH
MT.M&E:%I.BB4DZD9'VR,AU]JJHS@JDTZK0S]*XQM9O!LG+01LY&(DWV^P:9#
M97%]A0XS*MNXZ?9?D/H.-+D%7[2\IIST6L,WC-(RT@R+QF1EY#*W"[+<5#;:
M2^L=_P!D;%VANX[\5P**\=?W&J=EK#MY:3>MS?B2\]347I2Y!V9S+:AJ/\5C
M\=':0FO C=4XZHZ=L[B^P0V#L[!++5VR?H-6[67&\VEP**\[,Z]$.<ZJ#M>,
M4H^H9>AR6T]@EOH=0L_KDTD8OM-!*5N7"ZKFIZ3,=CKK<+L.!.+YZ^A%F]+K
M'MMYS6<J1$3DB))BK5V;8[B%I_/&+GLS.MN<=C3Y_P#H6O;&VE<M2X6FN9K_
M +CG'AVR&X&@'8U2^BO6O#W"Z?\ K'.__P!J_C.N?_L;_P"F<<\.V0Z(<C/:
M *B@"HH J* *B@"HH J=,>B$5)>V^QP/PI TOM/JM_B\QT+L;[5WDC_,=2#1
MSI    <1\X3_ &E['^LE^;0.O;F_1V^3SGSUVC_Y&]][S(P>HS!KM!4!0ZJ]
M&O7FH.HR]A6@O',O)4A#G3_5HO>)(NUWYN5[?#M#FW:;,N=]6^""\;_=0[/V
M*R2MY65YK3<E_#'1Y<7B,HW'EBGF!F4/[+DWT:]!2DL=BH1DW<Z?%QUY:TJJ
MH_6D22X)+IJ9C'9+>GR=NEJ*QRUR?B2_;69G>6X_J-U.]-JW'V81T:>%R;3U
MZM&I:GI9C&:]&O3Y<11829+QT\B_%+<64ADS_AH41*^]60R-CM-F(R]=*2YG
M^W@,/FNQ.4G'^E*4)>\O"M?,SFK9M=RFI9N5@,RT3<Z(JBC2=S:T**J5H.A5
M2HN)?NT/@-_RN9AF+:N0>AG)<]D;N3O2M7524>9\:XG_ -=)::BZ+&ANST9(
M9O;CE)QE5$;'*;(^TMYYNG[B%#4>U$Z9>,=LO(F="[#VF\W.?!&%/"Y+T,W7
MOO*? <PYT6=F9DUAR&R;#+<1;2444JXU&3C:SJ?1TC4=W[WNY.+C!1=7737T
MHZ!O;L_8WE.,KLI+"J+"UYXLU%MWHUY#'Q'9VI9$\D;1&H\=*03;ZDEV&W$]
MZI7\$TI^KV!M&3[30G)1O1P\:U>%?]31]X]B9VXN67GCI]F6A^!ZF^*BY30[
MB5M+6TZDVW6S-*T*(TJ2I)T,C(^@R,;FFFJHYO*+BZ/0T0N(210ZPW<R^CBP
M?8]R,-^'%'-,C_R[^_<_F.R[S7__ #L?].SY;9RA<0Z6<9H*D H9+R[;Z_?=
M8;(JURD,S+N)?2H_W"&/WC*F5N/_  2\AE=T1<L[92^)#\R.L><>6<P>C/Y9
MG^7AS,?(:XTJIF8TY3ZY)H.9[FM*[F5!ZI1DN>+.W=H[[L9)W%KC*#7@G%DN
M;F):V3EIF4L4=-J,61BN%Q_LU'JI_C()2?KAN>\[&<A7A>%^'1Y1VBRZS.[K
MB7!'&OP^MXU5>$U]Z,.")K$YK97$%?*?1!CJ,N)(83UBZ'VE*<3]Z,WVHS%9
MPM+@5>?1YO&:QV&RF&U<O/[345X-+YZKF,PY=YPL]S!YC2&UFJ-%D8^"R5:D
M11$/M+M[AK2I7UQB]XV.JRF73UM2?/A?D,UN;-=?O'.-/1%VXK\.-/QILU%Z
M3;9HW?&.T[U>*;*O;-,A^OVR&T=EW_MI+_&_)$TCMQ%_.P?!U:_-,Z&Y>F9Z
M%K!GYJ@^UT#1MX_JKOWY>5G4MS_H;'^G#\J.;=157TB7:])YK*?^L#?<Y_Q*
M^Y#^4Y1NW_GW_JW?YS>7/3ARKV#ZD7VXP-/W#^MM_B_*SH7:S_C+OX/_ ,D3
M"_1?.NOY[]=;_-#+=J?[L/N^<P?87]/<^]YC#?2<.F[XSWJ;]LOC+=E_TTOO
MO\L37.V_Z^/^G'\TSI;6SKKN(,^DX4;\TD<^S/\ =G]Y^4Z_D_[$/NQ\AQQJ
MNF2-^YAR,$VM348Y,F1D)*:&IJ,VZ=RBKV3,TH3W5%V!U7-9U93**YPT22VN
MG[,X/D=V2WAO!VM2Q2<GLBG_ -%RLZL=+2>4NKN2T,-XW$122E9M(ND/NGP2
M1GZYQQ1]E1_827#FR^9WA>2KBD^9>A?MK.SR^3W1EG))0A'8M,GY6^7R(MVC
M\V]1YB2I&(@(?CSTMJ7XE.;077,E0E&DT*6DZ5*Y)G7N&51[Y[=%_)I3E1K:
MN!^(M=U]H<KO&3MP34J5I):UX&UX-9JCGSRIQN#B%N>LQDQ876):RL%HB2RV
M;IVH>;27!)&JB%)+A4RH72-EW!O:=V74W75_9?#R/RFE=K.S]NQ#YFQ'#&M)
M16I5U-+@TZ&EM7&;.Y"N&YRMPQ?S:Y:?_P#*=/\ [1KV_P!?[V?X?RHV_LF_
M_&6_Q?GD>Y'.\LN4DZ2J<Z4?-YY]W(3%I;5(EN=>Z:C4HT).QHE&9(3P+@="
M,[C$6[&<WA%856%M**X%H7C>W_H3=S6[=T3EB>&Y=;G+0Y2=7PTU1V+EI5U,
MQIKN[8!"U)8RVOY-HEHO3<VXA70=%$1I41_44E7:,AB_ZN5N\,)Q?[?MJ9G*
M9?/6$VE<MS5=/#SZFN=/C.)-[UOX'[=EM<2LW&83W]76NAJ-AU).M&HR(BNL
M45>'2.NY#-?,V(W.DO'J?C/GO>N1^3S4[-:J+T<C557CHU4QVHOS%T%0%#I#
MT6CK%VCV2%^"^-"[5>U;_%YCJ_8/V;W+#^8Z$&C'4    _/3(G_B$OV9S\,Q
MW*W["Y#Y>O+^I+E935'H>-!4!0[(Y \>5^*]EE^V7!RGM!^MER1_*CO79+_C
M;?++\S..G3_&N?QE?;'54<#BM"-O\J)?)IC!++F F.>>\=6;'C#4IPO%C0W9
M4VDFW2Z_UWUQJV]X[P=S_;UP8=-''75[=.JAO?9ZYNF-I_.4ZS'HJIOU:1IJ
M6'776;PW2%L&PZ04?E;.@-8]^.I#:6")/6QZ6]5&=0?5M\"-'%/#MII4:?DI
MVK.9KFE*J?#P/;):WM\S.C[SM7[^2PY"4%%QHJ<*V0?LQV:O#$Y;TSESL6\S
MI^-Q/4QY>-21RFYJELFDS4:+:$A1W$9'4C'1L[O.SE8QE.K4M5-/G..;LW)F
M,_.<+=(N&O%5>9F\>4'*#:]%VMS-9IR&N&N&[&(HSJW%WN+;47!3:2I1)]D:
M?OC?%C-V%""E7$GI7+QG1.SG9S,[OS+NW7%IQ:T-[5Q+88SMG('><WM.:S,-
M['E$R$Z1*8)QYQ*R;>=4M-Q$T=#H?'B,CE.T.6M680DI5C%+4N!<IAL]V/SM
M[,7+D7"DYRDM+U2DWT33VTZYD-0STO7<JII4^'U?6J84:VSZUM+J:&9)/UJR
M[ VG*9F&9M*Y"M'MXG0T;/Y&YD[\K-RF*-*TU:4GQ;3H/T7DL^X.?6G^T',:
M)SMV$UWO[IJ&C=J6^MALH_*=0["J/R]U\.)<U-'G-5\]U._.EFR=K0DQ":KT
M6>*M='UZC9=P4^2A3_%^9FE=JZ_4[M?\/Y(F#813Y9K&G%KXUXTQU%O3UG6)
MMI]<9>_3JY5U4?D-?RF+KH8=>)4Y:G8O/ VD\K=@Z[UIHCDFG[_QIJW]V@Y9
MN*OSMNG'^5G=.U5/IEVO^'\\:$]*_P"'L9[RG^94*<]^OE]_SGONS_B[?^E_
M*<S<E#_:?KWLCWM9T=!WW^BN<B\J.0]F/^2M<LORR-M^E$=,-KWZT_\ FTC6
M>RW]RYR(W?MU_9M?>?D+'I4?GSLVM8R)@YK>$UR*REF%+D$EI;S:/6F1V.NF
M1%0DF24I,NV+S/2W98O2=Q.<V]*6FGC2\YC=V0WYF<M"-J2M6XJD7+1B7!P2
MER:$J;3>>DX[;L9ASA;GDV,OD4N'U4MA!H,V325$KJE-QD=>-.CI&G9ZY8G<
MQ68N$=CVG1MV6<U:LX<S-7)5UI<''J-'\MM(Q:N=VQ-FR@\=KCS\F"Q3O$.K
M>(F"H=?Y-*C-/:4DC&X;SS\_IUO3ZUQ)/FT\_G.=[EW5;^L7:I8;+DXK@3<O
M5T?X5XTF9%SPYN9[3\K$US6'&XTM3!2YDU;:7ED2U*2AM"7"-)<$F:C-)])4
MIQ%AN+=%K,P=R[I5:):O#H,GVI[09C)W(V;#PMK$Y43>O0E6JX'6J>M4H9MR
M@WB?ONHEELHTAO(Q9+D*2MHK4.*;0A9+)-3I5+A5+MUI0N Q&^,C'*7\$'ZK
M55Q:_0;#V=WI/>&5ZRXDI1DXNFIZ$Z\SYS5/+4__ *A-I+_[[*^V2&R[S_XJ
MUR0_*:3N#_G+_P!Z]_\ D,_YL\S&.69L>Y6-9E;#F2-:W7:I;2U'(D)4Y;12
M_742DC+L\>WA-T;L>>KCDU"'GV;#:>T.^UNQ+JX*5RYPO52.WA>O0N73MQWD
M!L,O:]BW?89S;3,N<>/<=:8)1-D:4OH[TE*4?W/9,7W:#+QR]JS;C5J.+7X#
M%=D<Y/-W\S>FDI2ZNM-7VEPM^4LFR'_]3&-+_P"\B>U1=Y;_ (>7XOS%CF__
M /8X?A_(7WTGSIJ^%_7S_,K%GV6_O3^[YS(]N?TMO[_\K,T3_P 'I_\ Z4+_
M /=PQ7_[3_\ K?SF7?\ P7_]-_\ JC"_1@.NKYK]?+\R@97M1_>A]WSF([#?
MI;GW_P"5%GUW5X6R>D'L;^1:)Z'AUJFDTHB-"W_Q:&B41]@C4:_JI%UF,U*S
MNJVHNCGH\&FOH\)8Y3(1S._KLIJL;?K<5?52KSU\!>.?/-+8=1R&.UW6GRA2
M7F/'9DRQ#BS0I:FT-IZPE$7%"C4=*]%#Z:VNX-U6LQ"5RZL23HEXV_'Y2\[5
M[]S&3N0LV'A;6*3HGPM)*M=C;T;-.LRKE%N+W,G2G_A&TU)FL.N8_(D:$DW(
M;4A*B4ILBM*Y*[5$14J1\"Z!C=\9-9+,+JVTFL2XO"9KL]O&6\LF^N2DTW"6
MC1)4UM:M*=&M1@O)G!-ZSS:W+ LU\7A,+1'N.JNI4^VINI]D[#*HS.^LP[^1
MLW'KD]/+1U\9KG9O*+*[TS%I:HITY,2:\1=>=7-K/:)FH6"UMJ.T\^P4^7*>
M;ZPU7K4VE!%4B+^3.XSX]%*4XVVY-T6LW;=RZWH>%)<_G+WM-VAOY"]&U92T
MK$VU7A:2\6GP:C8&%GL\Q^7+,O(1TMHSD!QN4R530E:B4VLTUJ9$2B,T]DN'
M9&$OVWDLVU%^Q+1Y?^ILV6NQWED%*:_NP::\3IX=1PU4=B/G05 4.NO1SX\N
M4_KTG[2!S#M)^K_"CN/8S_C_ ,<O,;:&L&[            6"9\=\-[U97VQ
MC@ T7XD:U[U0?:Z !?P            '!_/LJ\W-E]DC^U&1U3<OZ.'A_,SB
M7:)_^0N<J_*C6]HS)K]1: J+0%1: J+0%3:_('EUCM^VYY6<1UN$PS*94B-V
M'W5KM:;52G><%*5VZ4[(P&^\]++65@]J3IR;6;5V<W;#-WV[FF$%6FU\"Y-?
M,=(\WN8C/*/58:<%CV#R$U9Q<7%LZN*REM-RUFANW@FI$22I4S&F[LR+SUUX
MVZ+2WPLZ!OG>2W;86"*J]$5P+_IL,9Y)\]YN^9-6K;/%:9S75+?AS(I&AI]+
M5#6A2#-5JR+OJD=#(CZ*<;W>^YHY:'66V\-=*? 8[<7:"6<GU5U)2I5-:GQ4
MV_OU<,/2-Y=8C-8[';6RV47+-3HD&?*:25SL26XE@C67W2VU*389]BI=JC<6
M>G;E*V],:-I<:T^,GM)NRW>A&[JDI13>U2=/%P&Y(&!AX?7F=<P9GCHD6+XI
M"<:))K:(D6I65Q&2ED??&:BXJXF-=G>=RYUD_6;=6;7;L1MVE;AZJ2HN+]_*
M:OUGT<=8UC98.TQ\QDI60@OG)(I*F5)<<,CJ:S)LE'6ZI\1G,QOV[>M.VXQ2
M:IHKZ37<KV;L6+ZO*<W).NFGH-B;QJ$'>]9FZODGW8T.:;1N/1[2=+J74NE2
M\E%Q-!5X##Y/-2RUU7(I-K;QJAG,]DXYNR[4VTI4U:]#KYCCS(S9G(7FUD(^
MJ/N2HN/)EEYJ;3^LQY##3ZVW+"21=\KO5$7"A'VQT6$([RR:=Q4<JZN!IM'*
M+EV6Y\_)6G51HM/"FDVC>N+]*3EY+B)<R;$_'3*?C(YLD^F[^ MM7?%W32GZ
M@U:YV=S,7ZK4ERT-TL]K,G.-98HO92OD_<9KR^YCIYCO3Y^%QC\75H=K#.1F
M4;=E2C.JTMMI-1$AM-*J-53-1%0J&,9G<A\JDIR3F^!<"Y=K,QN[>7SKE*$6
MK:T*3^T^);%MX]1IWTMLZRKX.:PVNKZ3>R4E'[U!D3+1_7/K/L#8^S-E^O<X
M-$?._,:GVQS*I;M+7ID_(OYCF+AT5XC=CFYU/Z(\QH\9M&.J1/-R(LBWLFAU
MM:*_6- T7M/!X[<N)KR'3>QUU.W<APII\]?06#TM8+J-EUW(FG\2_!>CI73I
M6P]>95[A.D+OLS-.U..QUYU^XL>V,*7;<ML6N9_O/CZ)D%Q>WY[(DG\5'QJ8
MZE]@E2'T+(OKDT8J[33I9A';*O,OWGGV/MUOSGLC3G:_[38GI#YN-A\ERZ6^
MHDFSG6\@HS.E&H:F[S,^Q_*$,/N.R[D;U.A3GJ;#VCS$+4\OB?\ ZBEX(TKY
M39_,*$YDM#V:"TDUO/XN8AI!=)KZA=I?9H,)D9J&8MM\$H^4V'>4'/*W8K6X
M2IS,_.M+:G+4((U+71*4EQ,S5P(AV X&M9^E,%"<1A(S<M1)1 BH2^OL$3#9
M$H_W!Q>;QS=.%^4^AX+!!5X%Y#4/HOY1O(Z+DVZD3S.8E+4V1UHB0AMU)_4,
MS47UAL/:&U@OQXXKQ5-5[*WW=RLJZU-^-)^DTWZ4$%R-S.\965$3<=&=;/L&
M2#<:/]U V/L[-/*TV2?I-2[61<<XGMBO.O,9UZ(L-U$;;)ZB,F77(3"%=@U-
M)>4HOK$M(Q?:>2K;CP^MYC,=C8/#=EP/"N;%7RHKN?F=P6/YE\OD[ E#N(QO
M7S<BTMHGR-A]:4%<W0[B,VCX4'EN6S<GE;W5^U*B7!I7'X2Y[09BS#.9?K:.
M,:N2I70Z<'X2L^=?T;_-$+_)4?T0\_IN\^D_?_>>GU7<W1C_ /;_ ,IL[X0Z
M3\WGPC\6:^ OB?7>*^*EU7BM:6^+VTI_!M&#ZB_\S@K_ %*ZZ\/*;)U^6^4Z
MRBZK#JIHP_=\QK'YU_1O\T0O\E1_1#.?3=Y])^_^\UOZKN;HQ_\ M_Y3F7>Y
MV&RNXYK):ZA+>#E2EN06VVNH231D5*-D16_4H-UR4)PLQC<]I+3IJ<ZWE=M7
M,S.5KV&]&BGB,>M%X8ZHM 5%H"HM 5%H"ITMZ(I4E[;[' _"D#2^T^JW^+S'
M1.QGM7>2/\QU$-&.D@  !P_SB/\ :9L?ZR7YI Z[N;]';Y/.?/G:-?\ D;WW
MO,C![AF#7J"X!0[/Y"O-N\J\&ELZJ:.6APNTKQMU5/L*(<HW\FL[/\/Y4=Y[
M*-?3+:^_^>1HCG]LV=G;[D,%*DN(Q.,)E$2&E1I:_&,H=-Q22.BE&:^D^Q0A
MN79_+6X9:-Q+UI5J_"U0YUVMSMZYG9V9/U(4I'@]E.KX])M#T:]IR^<P>6P^
M4?7*:P[K'B;[JC6LFY*7*MW'Q,DFW5-?WU.B@UWM+E;=JY&<%3'6O@II\9M_
M8S/W;]JY:N-RZO#1O725='@PZ.6FI(Q;TI(D=O+Z[D$T\:?C2&'3[/5L+0I%
M?KNK&2[+3;MW(\":?/\ ]$8?MU:BKMJ?"U)>!-4_,S0%PW4YI0K\;GLUA>N]
MQ\E*Q_C!$3_BCSC'6$FM"5U9E6E3Z1X7;%N[3'%2IM52YL9F]8KU<Y0KKPR:
MKRT+UC>9>_8E]$B%L>0N0=20](7(:/L\6WC6@_KD+6YNW*W%25N/-3QK27]G
M?.>M2Q1O3\,G)<TJKQ'8/++;).[:7CM@FLI9G/$XU)2@C)LW&'%-FI%>PJVM
M.QT=@<NWGE%E<Q*W%U2U>$[EN7/RSN4A>DJ2=:^!T\?[C0NX*U75O2!=G[ P
MRYKKA>-SHZF"DM];)AJ(S4T9*)1J=,G.CI.HW/)]??W6HVV\>I.M-4MO)H.;
M;QCE<MOQRO).T_6DL-5IAPK36LO6\-3-?G+]'GS3"_R9']$,3].WKTY?_<_>
M9[ZIV?\ AP_^RO\ M-EY?/:A$T9.?RC+;FG+BQGB85')QLX[YMDR74&D^%5(
M[VWA]88"S8ORS/5P?]2KX>%5KIYS;<QFLI')=;<2=AQCHPU6&5,/JTXUHIH-
M:_.5Z//FF%_DR/Z(9_Z=O7IR_P#N?O-2^J=G_AV__LK_ +3FW99>/F;'F)F)
M0EO%2)LEV"A".J2F.MU2FR)!$5I$DR[WL#?,M&<;4%/VE%5X=--.DY9G96YW
M[DK:I!REAT4]6KIHX-' 9)R>:\8YFZVWVI)N?DFUK_[!8;YE3)W.3SF6[-PQ
M;QM+C\B;.A_2+>ZKEJ\BO\M,C(^K11K_ /-&C]G%7-KB3.H=L)4W>UME'T^8
MO7*++M[3RRPYRJ.*:CJQDM'37Q:K)$KNJ025']46F][+L9R=-N)>'3Y2^[/9
MA9G=UO%P+ _P^KXU1^$IL+%5RDY1.>.FWX[B(LE]9D96.2G7%J:29_PE+0@>
MEZ?U#/>KJFTO EI\[/'+0>Z-UO&UBMQD^)R;=%X6TC7GHM2%NN[;UJC6ZX<%
MQ:E'51F9R:F=>Z8SG:E45JG^+^4U?L*VY7V];P?SEM]*1JW.Z^_3U\1Y%?XC
MA'_YP]^RTOZ5Q<:\A;]N8?U;3_POQ/\ >;XY=_$'5_>J%[70-.WC^JN??EY3
MHFY_T-G_ $X?E1S7IY__ %%.E_\ &LK_ .L#?<Y_Q/X(?RG*MVK_ ,\_]6[_
M #F].>W#E3L'U(GMQ@:?N'];;_%^5G0>U?\ QEW\'YXF%>BX==>SWZZW^:&5
M[4_W8?=\YA.P_P"GN?>\QAGI/G3>,9[TM^V7QENS'Z:7WW^6)KG;;]?'_3C^
M:9TSK/Q<P_ZC&_,I'/\ ,_WI_>?E.NY/^Q#[L?(:)]'1#*MOW5U5/&$*2AOM
MV*D.FK]U*1N/:)OJ+*X/W(YYV0BOFLR^&O\ -*OF*[TI'9*<'K[2:^*+EO*=
M+[GK$-$2*]VBET'CV62ZR;X:+R_]#W[<N746E]G$^>FCSFF^3KLEOF;KAQ*]
M:<DTJI_-*:6ES_N&8VK?*3R=RNSSZ/&:)V;Q+>-K#KKYG7Q'5?-U+"N6NRE(
MIU90U&5?WZ5)-'_>(ASC=#:S=NFT[+O]1>[[V+H^/@\99O1_X\KL3[++]LN"
MZ[0?K9<D?(BP[)_\;;Y9?F9S]S[<4?-7.)4HS)"8:4$9U(B\49.A=KB9F-WW
M O\ 90_%^9G,.U3;WG=XL/Y(F^_1X=6YRRAI6HS2W)E(;(^PGK#50OKF9C2^
MT*7SCY%Y#I?9%OZ='EEY317I T+FADZ%0S8B&?=/J$C<>S_Z./++RG.NUJ_\
MC/DC^5&L+AL)J%!< H=)>BP=8NT>R0OP7QH7:KVK?XO,=5[">S>Y8?S'0PT<
MZ>   'YX9)7^(R_9G/PS'<;?L+D/F&\OZDN5E-</0\:"X!0[+]'_ (\KL3[+
M+]LN#E7:#];+DCY$=X[)_P#&V^67YF<D83$R-AV&#@HIVOY&6B*A=#42.M<M
M-9D7821W'W"'3;]Y6;4KCU153B&2RTLQ=A:CKFTN?A\&LV=D?1NY@19)MP'(
M,^*9]X^EXV3MKP-2'$\#[B34->M]I<K)5DI1?)4W&]V+SL94BXR6VM.=->DW
MURRU)?+32CQ^;R#:UMN/3YSYJMC,$I)7)2I=M$))%QF=.)F8TS>>;^=S&*$=
MD5M?[SH^Y-W_ $S*8+LZZ7*3KZL='!7@5*\M6<F9[<9ZMOV#.ZS/DXV/E)LA
MY"XCKD9;C*W5*0:[%$=3([C(^R.E9?)QZB%N[%2<8I:4GIH<6S6\+GS5V[8G
M*"G*3]5N-55M5T_LS9WH^;1LN9WMZ)ELS.GQ2Q[[A,2I+K[=Y.-$2K5J,JE4
M^(U_M#E;-O+)PA&+Q+4DN!FW]D,[F+V=<;ER<U@>B4FUKCM9A6^[MN,3>-DB
MQ=AR3$9C)S&F66ICZ&T(0\HDI2E*R(B(BH1$,OD,EEY9:VW;BVXQ^RMAKF\]
MYYN.;O*-V:2N322G+0E)TX3!9V0G9.4Y.R4EV9-=IULF0XIUU5I$DKE+,S.A
M$1#+PA&$<,4DMBT& NW)W9.4VY2?"W5\[-H<A-^@Z?LS^/S#R8^'S:&V7)*^
M"&I+1GU2EJ/UJ#O4E1]!5(SH1&->W_D)9FRI0590X-J>OPZC;NRF]89+,.-Q
MX87$DWL:]FKX%I=>6KHDS;_.3D\_OCL?8->>::SK#1,/,O&:6I#*3-2*+(CH
MM-3(JE0R[)4&K[FWPLHG;N)X&Z\C]!O/:/LZ]X-7;32N)4TZI+@\*\?@,7Y7
M\@LQAM@C;'N+C"&L:LGX<!A?6J6^CBA;BB(DDE)]\1$9F9EQH73D=Z;_ (7;
M3MV:^MH;>SB,1N/LG=L7U>S#7J:5%:=/ WR:^7QTGI$<R<;D6&=(P4E$I+;J
M9&7DLJ);9*;J2&"4DS(S(SN7VC))=-Q%Z=G=VS@W?N*FBD5Y_1X>(\.U^^K=
MR*RMIXJ.LVM6C[/G>S0M=4MH\HID+8>5>(CH75"(J\=+2DRN0MHU-J(Z5H9I
MHHNX9#7M[PE9SLWQXEY3<.S]V&8W;;2X(X'X-'DT\C-=\N>1VP:?N[.PYV=$
M3B,4MSQ9QM9WR%/(4RWWJB(D%W]3J9G7O2K6HSF\=^VLSEG;A%XI:^*FE\O[
M,U?<_9:_D\ZKUR4<$*TVRJJ+DU[>+36I=/2/*$IK3TY(Z8Y6244L^)49,D7]
M'\&HMNS;DG=P^UAT<NDO>V*@XV%<]G'IY-%?$;!YD0-JG:5)AZ"Z3&65U1,D
MRM+"SCD97)9<,TI0=.@ZEPZ!A=VW+,<PI9A5CIUZ=/&N$V7?-K,SRDHY5TGH
MI31HXGP%FY+:EM.JX&:>WO+7E,A(ZXH[CYR5--I222N7<HKE'4S))GV.->BZ
MWUF[-^ZNI7JQ5-5*EAV;R&9RMB7S+]>4JTKBHN7;R5,!TO98F%](#:L;.<2T
MUFGG(K"U'0O&D+0MM-3X=\5R2[:C(AFL[EI7=UVI15<"3\'#^VPUS=V=C8WY
M>A-T5QT7WM%.?2N-T+WSKY/YG=LI$V+6ELJG(83$EQ'U]5>E"E*0XA1D95*X
MR41TX$5!:;DWQ;RL';N5I6J:+_M+V=NYZY&]9:Q)86GHY&N?29ERDTMS0=7/
M S);4G+./JG3T,JN0TM]*4)2FI$=+6RXF7$ZC%;WSJS=[K$J1I1<=/\ J9SL
M_NM[ORW52DI3;Q2IP-I+1X(\]34O+0__ *AMI+_[[+>V2&S;S_XJUR0_*:3N
M#_F[_P!Z[_\ D/AZ49TSNO\ ZH]^<(5=EO[=SE7D([=?W;7W9>4K_17.KFU_
M4@?^L#Q[5:K7XOY3W[":[_X/YSY;(?\ ]3>,+_[R)[5%66_X>7XOS#-__P"Q
M0_#^0OOI1'35L+^OJ_,K%GV7_O3^[YS(]N/TMO[_ /*S-4?\&I__ *3+_P#=
MHQ7_ .TO_K?SF6?_  7_ /3?_JC"O1=.NK9K]?3^90,KVH_O0^[YS$]A_P!+
M<^__ "HL^N[7"UKTA-DC9)TF8>86J$EY1DE"'_Q:VC49]!&:31]51"ZS&5E>
MW5;<55PT^#37T^ L<IGHY;?MU3=(W/5XJZ&J\U/"7SGORJV'<9^/V'6&DRYC
M#'B4N$IQ#2S;2M3C:T&X:4G0UK)55%V*5XBTW#O6UEHRMW71-U3\OD1>]JMP
MW\[<C>L+$TL+54N&J:KHX773LH9/RHU)7+#1Y"ME?:C2G7',ADUFLC:CH)"4
MD@U]!VI34S+LF9%48[>V<^>S*ZI-KV8\9F-P;O>[,F^N:3;<Y;(Z-5>)+3Q[
M3 >26?3M'-?<<^A)I9GL..L)5P43/C"$MDKB?&PBJ,UONQU&1M6^B_'1U-;[
M,YOYK>=^]P23IR8E3Q&+^DT=-_@^]3/MB0,CV9_2O[[\D3#=ME_OH_Z<?S3-
MY<F_^*]?_5G?SS@T_?/ZV?*O(CHG9S_C;7(_*SB:[B8ZV?/]!< H=>^CB=>7
M"?UZ3]I YAVD_5_A1V[L;_Q_XY>8VV-9-V            L$SX[X;WJROMC'
M !HOQ(UKWJ@^UT "_@            .$N?1?M:V3V2/[49'5=R_HX>'\S.(=
MHO\ D+O*ORHUQ09HUZHH J* *B@"HH J;=]'K?L;I&W2(V<=*-A\VTF,Y+7P
M0S(;5<TIP^P@[E),^Q4C.A$8UW?N1EF+*<%64'6FU</A-L[-;SAE+[C<=(7%
M2NQ\%>+77GT*IT_S+Y<8?FEK[6.E23BR&%E)QN29(G>K4I-#JFI$M"DGQ*XN
MP=1HV[\_/)W,255J:_;A.F;TW9;S]G!)T:TQ>STHQ/E3R#A<NLRO8I^4/*Y9
M+:V(A(:ZAEE+G!:J&I9J69=[TD1$9\#Z2O\ >6^I9N'5J.&/#IK4Q6Z.SL<C
M<ZV4\<J46BB7ETF*^DMS*QR,>SHN$E$[ERDM2LFZPK^S%&.]MLU)Z'#7:JE:
MI)/'I(9#L_N^3D[TUZM*+CKYJ&+[5;UA&"R]M^O5.5."FKPUT\5.,T+\Y_,D
M^/PMRWECWA#;/IV6^''W4:)]6SGQ9^]+TF8\I]_WO*<Q]<Q^2V7)2X+\LD/Q
MGI3KC2TV*X*2I1D9#&[SR.7AEIRC"*:6Q&9W)O',W,[;C*Y-IO4Y-K4^,Z3Y
MYY3)X7E?F\EAY;T#(,G%)J5&6IIU!+E-(512:&52,R&E[FMPN9N$9I-:=#^Z
MSH?:"].UD9R@W&2PZ5H?M)'&^O0IW,3><;C\]DI#LO,R6X\G)/&<A^A)M2=5
MGQHE))*I\"'1\Q..5R\I0BJ16K4CD>4MRSV:C&Y)UF],GI?CXM!TIAO15TF%
M)2_F,E.RK:#(_%JHC-++M+ZLC69?Q5I&DW>TE^2I&*CQZ_W>(Z-9[(Y6$JSE
M*7%J7IYFC/MKWC1^4F :C/&S&*.U9B\%$M)YRG024%ZU)GZY:N'U3Z<5ELG?
MSURJJZZY/]O$9S.;PRV[K23HJ+U8K6_!YSB#<-HRN[;%.V3+&1S9RZI:3ZQI
MM)6MM([B4D1=WI/B8Z?E<M#+VE;CJ7[5.+Y[.SS5Z5V>M^);/ =Q8S":WHFB
M1963QT1OW#Q;:Y[Q,-$XM<5@NL,SMJ:U&D_JF8Y=<O7<SF&HR?KRT:7PL[79
MLVLGE4Y)?TX:738M/A.4^5_--S6>9DG:\XHRQV?<>1FC0DS)M,ESK2<2A/8;
M73@15LJ1$-^WCNWKLJK<-<*8?!HIX5XSENZ=\_+YUWKGLW&\7A=:TXGXJI'5
M>_Z#KO-G6X\61*HVE29>+RT,T.VFM-+DGQ2M"TGQ*O'@?8&A9+.W<E=;2XG%
M_MK.H;PW?9WC92;T:XR7[:4R/+SEYKW*;7Y4>/*O-U1R<IEI9H:N)LCI=QM0
MA":T(SX5,Z\1.>SUW.W$VN)17[:V1N[=MG=UII/CE)Z-7D2])R=SOY@,<PMS
M<E8U1JP.,;\2QJS(T]:1*-3CU#Z+U'WO9M)-2(QO^Y\B\K8I+VI:7Z/!Y3EN
M_P#>:SN9K#V(:(\>U^'R4.G^2O,B#OVJ18[[Z?A-C&41\K&69=8OJRL2^1=E
M+A$1F?854NU71M[Y"66O-I>I)U7H\'D.E;BWI'.9=5?]2*I+_N\/ET%DQWHV
M:;CMT1M+4E]6.8D>.Q<&I*.H0\2KTD:^E3:5<4H,NT1F9=-S<W_?G8ZMI5:H
MY</_ %XRSM=F,M#,]<FZ)U4>"OH6SGJ3](+F5!U;59>L09"5[-FV51B809&I
MB(Z5KKJR+HN35".@S,ZEZTPW'N^5Z\KC7J0=>5\"]([2;UAELN[2?]2XJ4V1
M>MOR+]QHWT?.8T/1-G?QV:>)C7\XE#3TA7!#$EHSZIQ1]A!DI2%'V*D9\"&T
M;\W?+,VE*"K*'C7"C2^S6]8Y2^XW'2%SAV/@?)KKSZD=*<SN5&"YJ0H)RI2X
M4^$:E0LC')+E6GJ&I"DF9$M)T(RX\#Z.DZZ5N_>5S)2=%5/6F=%WKNBUO",<
M3<7'4UQ^7]N,N.J:SJ_*/35042B8Q4.^7D<E+4E)N.KH2G%TH1="4)278(BX
MGT^.9S%W/7ZTK)Z$D>^3REC=V7PITC'2Y/ROR+P'%O-'=5<P-UR&PH)2,>HT
MQL:TOUR(C/!%2[!K.KBB[!JH.F;MR?RMB,.'6^5_M0X[O?>'SN9E<^SJCR+T
MZ^5F'4&1,/4[!I_]+E/_ ('_ .<.<_\ [5_&=@__ &+_ /3./J#HQQ^HH)%1
M0!44 5% %10!44 5.E/1'*DO;/8X'X4@:3VHU6_Q>8Z+V+]J]R1_F.H!HQTL
M   .'.<A_M.V3]9+\T@==W/^CM\GG/G_ +1?\A=^]YD8-49<UZ@J H;W]'CF
M5 P#TC3<](3&@SW2D8V4X9);1)41(6VM1\")9)2::\+B/]\-.[0[ME=2O6U5
MQ5&N+;X/VU'1>R&^(6&\O==%)UB_\7"O#HIQ\IMGF9R8PW,64SE?'%XK--()
ME<IMLGFW6DF9D3C9J152:G11*+AP.O"FM[LWS<R<7"F*.NFJGA-PWUV<M;QD
MIXL$TJ5I5-<:JN>JXZZ"]:3I>O\ *S6GHK<HB9)2I63RDLTM7*(B*Y1F=$(2
M14(J\/JF8M,[G;N>O)M:=2BOVUF0W;NZQNO+N*>CVI2EH_Z)'.6Y;?B.:7-O
M#,.K,M1;E1L8RI5S?7,*>_&.'Q(T=::J$? R32M#&]9/*7,CD9M?W*.7(Z:%
MQT\IR_>.?M;UWG;3_M8HP6M56+2]JQ>!I4J=/YK5=5G:Y(PF1@1F<$AA:303
M:&T,(2D^_10B)!H+B2BZ!SZSFKT;JG&3<Z\_IJ=;S&1RT[#M3C%6Z;$DEM6R
MGB.>>37)_7=[U&?E=@Z]MY<TV($F,YU;B6V4)-1T42D&2E+IWR:]Z-VWQOB[
ME;\8VZ4I5I\?C.9=G>SUC/964[U4\5$T^!)<JUNFK@,QC^B]JS<HG).9GO0R
M.IQTDTVHR[1K))_N)&,EVHON-%"*?A,[#L1E5*KG-K9H\M#9N0RFG\K]7:*0
MMK%X. WU<.(@ZN.&7&QM)G<XM1G4^S6JE'TF-?MVK^>O.E92EK?IV+_HC:KM
M[*[KRRK2$(Z$MO$N%MZWX6^%G$VW[-*W#9<ELDQ)-NSW;TLD=Q-M)(D-HK0J
MVH2E-:<1UG)Y99>S&W'[*_Z^,X)O#.2SF8G>DJ.;U;.!+P*B+&9\!=EA0ZUW
MD_\ Z;6#_P#@^%_#BCFV1_Y9_?N?S'8MY?\ ^O1_T[/E@<EU'23CM!4!0V5R
M":-[FKA5$54M(EN*[A>*NI(_LJ(8'?TJ9*?X?S(VGLK!O>5MK@Q?DEYS=7I.
M.FCE_"21TZS*L),NV1,2%?;(:GV97^Z?W'Y8F^=MFUDH4^(ORS,<]%K/DIG/
M:PXOOD*;R49'9,EEU+Q_6M:^R+[M18TPNK[K\J\YC>P^:5+EA\4UY)?REY])
MS8O$-5Q^NM+H]EY/6O$1],>&1*,C^JXILR^H+7LSE\=Z5Q_87C?[JE_VTS?5
MY:-E:[CT\D?WM<QBWHKNTRNR,_OH\9=*?O5N%T_]0R/:E>I;?&_,8CL,_7O+
MBCYRK]*MLB5JKY=)E/09_4\7,OMF/+LJ_P"ZON_S'IVZ6FQ^/^0W5RZ^(&K>
M],'VN@:IO']5<^_+RF^[G_0V?].'Y4<U:?7Z1KI?_&\K_P"L#?<Y_P 4ON0_
ME.5[N7_GG_J7?YS>O/?ARHV'ZD3VXP-0W%^MA^+\K.@=JO\ C+OX/SQ,)]%H
MZZ]G_P!=;_-#*]J/[L/N^<PG8C]/<^]YC"_2A.F\8SWI;]LR!ENS'Z:7WW^6
M)KO;7]?'_3C^:9TWK/Q;P_ZC&_,I'/\ ,_W9_>?E.N9/^Q#[L?(<A<O=[;T'
MF3,R4TS]QI;\F'D[2-2DM+>-1.$1=)H4DC/@9VU(N)CIN\,B\WE%%>TDG'EI
MJ\)Q7=6\UD-XRG+V).49<E=?@=-NBJ6LZFVS6->YHZH4!R23N/E62L?D8BDK
ML=36UQ!\4F5#-*B[)&9<#XESS*9J[D;^)+2M#3\AUO/Y&QO/+8&ZQ='&4::]
MJ\CXFS$^6G(W%\O\LO.R<BK+Y5*%-PUFR4=MA+A6K42;W#-9EWM;N@S*@R6\
MM^3S<.K4<$>'36OD,-N7LQ;R%SK92ZR?!HHEXWIX*UU,P_TB.9F-<QJM"PLA
M$F4\XA>9=;42D-(942TLU+@:S625*X][;0^GAD^SV[9J?7S5$EZO'7AY*&%[
M7[XMNW\K;:DV_7XJ.M.6O-3C,Y]'[_BS$^RR_;+@Q&__ -;+DCY$;#V4_P"-
MM\LOS,YZY]G^U?/?4A^TV1N^X?T4/Q?F9S#M3_R=W\/Y(F_/1SX\LXWZW*_#
M&E]HOUCY$=*[(_\ 'QY9>4T9Z0A_M1R7L$3\PD;AV?\ T<>5^4Y[VM7_ )&?
M)'\J-75&PFH4%0%#I/T53K%VGV2%^"^-#[5>U;_%YCJG87V;W+#^8Z)&CG30
M   _.S)'_B,SV=S\,QW"W["Y#YDO+^I+E935'H>-!4!0S37N;6_ZKBF<)@LL
M47&,&M33!QHSM#<4:U=\XVI7$S,^D8G,;IRM^;G<C63XY>9F=RN_<]E;:M6K
MF&*U+#!Z]/#%LQ*)/FP);<^#(<BSF5=8U)86;;B%]M*DF1D?U!DYPC..&2JG
MP,PMJ<K<E*#<6M33HUX38D+G[S0A,DR>6;DI25$JD1F5K(B_A$E)G_U5&#GN
M')R=<-.1LVFUVKWC!4<\7+&/H\ICVS\RMVW%KQ?/Y=V1#K7Q-LD,1S,CJ5S;
M1))5.P:JF+W*[MR^6=;<$GMUOG9B\[OC.9Q4NW&ULU+F5$Z<%:F*U&2,/0O.
ML;9G].R*LMKDLH<];2F%.FVV]5M9I496NI472DNP+3,Y6UF88+BJJUX5Y"^R
M6>OY.>.S+#*E*T3T>%/86_)9*9E\A+RN0<ZZ?->7(DNVI1<ZZHU*5:DB(JF?
M01#WMVXVXJ$="BJ+P%M=N2NSE.3K*3;?*W5^,IJCT/*AY4 9OK/-W?\ 4XR(
M.*RZUX]LJ-Q):4R6T$14(D=81J01?O4J(AB,SNG*YAXIQT[5H\FOPFP9+?\
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MRRK8+[<N+'9;;:82^RHEH6I"4T6:5%4K[AX6-TY:RFHQ]I4;X:/R> NLUO\
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MHUDW4           "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
M X5Y\%7FSLGLD?VHR.K;D_1V_#^9G#NT;_\ (7>5?E1KFT9HUVHM 5%H"HM
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MH*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J
MH*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J
MH=A^C:=>6R?U^3]I YCVC_5_A1VKL?\ H/Q2\QMX:T;H           !8)GQ
MWPWO5E?;&. #1?B1K7O5!]KH %_             <,<]B_:QL?LD?VJR.K;D
M_1V_#^9G"^TC_P#(W>5?E1KNT9HUVHM 5%H"HM 5%H"HM 5%H"HM 5%H"HM
M5%H"HM 5%H"HM 5%H"IY;7I 5%H"I[: J+0%1: J+0%1: J+0%1: J+0%1:
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MP_F.C1I!TH   /SDR:O\2F>SN_AF.W6_87(?-5Y>O+E92W#T/&@N 4%P"@N
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MDM?+REGO/)RR]U5EUBG&,HRTJL6M&AZ5JI3@,8J+\Q0J %0 J %0 J %0 J
M%0 J %0 J .R/1H_XT3^OR?M(',^T7ZO\*.S=D?T/XI>8W"-:-R
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M"X!07 *"X!0[+]&8Z\LT_K\G[2!S3M%^K_"CLG9+]#^*7F-Q#6C<0
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M=!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!<
MH+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%
M!< H+@%#J3T1#K$VWV2!^#(&C=I]=O\ %YCI/8WV;O+'^8Z6&EG0P   _-#*
M'_B<WV=W\,QVFW[*Y#YXNKUY<K*2X>AY4%P"@N 4%P"@N 4%P"@N 4%P"@N
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MC<PULVX           "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
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M3K(   ?G]SQ/]K&T_K1?FD#JVZ/TEOD\YQ3?GZZ[R^9&OJD,L805( *D %2
M"I !4@ J0 5( *D %2 "I !4@ J0 5( *D %2 "I !4@ J0 5( *D %2 "I
M!4@ J0 5( *D %2 "I !4@ J0 5( *D %2 "I !4@ J0 ZH]#\ZQ-N]D@?@R
M!H_:?7;_ !>8Z-V/]F[^'^8Z:&EG0    _,C*&7NG-]G=_#,=HM^RN0^?;OM
MOE925(>AYBI !4@ J0 5( *D %2 "I !4@ J0 5( *D %2 "I !4@ J0 5(
M*D %2 "I !4@ J0 5( *D %2 "I !4@ J0 5( *D %2 "I !4@ J0 5( *D
M%2 ';/HN?\7)]\)7VD#FW:']5^%'6NRWZ+\3\QND:X;8           !8)GQ
MWPWO5E?;&. #1?B1K7O5!]KH %_             <9\Z4UYG9_V1CVLT.N[B
M_16_#^9GSQVI?_D[W+'\L3 K>X,X:O46]P!46]P!46]P!46]P!46]P!46]P!
M46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!
M46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!46]P!
M46]P!46]P!46]P!46]P!46]P!46]P!4W_P"C"5).S>QPOMOC1>U?LVOQ?RG5
M.P'M7^2'\QT4- .M@  !^??/(_VL[3^ME^:0.J[I_26^3SG%M^?K;G+YD:]J
M,L86@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@
M*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@
M*"H"AU5Z'IUB;?[) _!D#1^TVNW^+S'1.R'LW?P_S'3@TPW\   /S$RI_P"*
M3?9W?PS'9[?LKD. 7?;?*RDJ/0\Z"H"@J H*@*"H"@J H*@*"H"@J H*@*"H
M"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H
M"@J H*@*"H"@J H*@*"H"@J H*@*';GHM?\ %J??&5]I YOV@_5?A1UCLO\
MH_Q/S&ZAKAM8           %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\
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MN 4%P"@N 4%P"@N 4.WO18.O*Q/OC*^T@<W[0?JOPHZMV8_1_B?F-V#73:@
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MZNY2M6S9@PYG            +!,^.^&]ZLK[8QP :+\2-:]ZH/M=  OX
M
M                       "+BTMH4XLZ(253/N "U,XI#Y$^LS;2LS431=A
M)]!5 %V2E*$DA)42DJ$7<( >@       *"3BFGW3=)9H4KBHB*I&?; 'TQYI
M2R;%MKC)FEQ/=[?UP!5@
M
M                         "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
M
M                         HW_ .M2$Q2_DFZ+?[O[U/\ V@"L
M     4<DCCNIF)];ZQ\B_>GT']8 5A&1E4N)'T&
M
M                                             +!,^.^&]ZLK[8QP
M :+\2-:]ZH/M=  OX
M                                           ^4E\H[*G#XJZ$)[:C
MZ" $8K)LM=_Q>6=[JNVHP!]P            'BDI6DTJ*J5%0R[A@"EB*-I2
MX3AU4UQ;,_NFSZ/L=  JP
M
M                         6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P
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M\9Y]*W:/,,#[][PA'=BSTY>(GOI?^''QD?I7;1YA@??O>$'=BSTY>(GOG?\
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M3 J1$021,"HZ_P#0_P#BGL/OBC\PD:%VD_NP^[YSI/93^S/[WF.CAJ9NH
M?F!E2_Q2;^L._AF.S6_97(<$NOUWRLH[>X/0\JBWN *BWN *BWN *BWN *BW
MN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BW
MN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *BW
MN *BWN *BWN *BWN *BWN *BWN *BWN *BWN *G;_HKE3E6GWQE?:0.;]H/U
M7X4=6[,?H_Q/S&[!KIM0           %@F?'?#>]65]L8X -%^)&M>]4'VN@
M 7\            !^?WI"?\ ,6T>RQO:;(ZCN;])#P^5G'M_?KKG@_*C6A#,
M&!/1)!,@*21 02(202("D](203("DD0D@D0%)(A)!(@*3T""9"2"1"2DD0$$
MB I)$)()$!!(24DB ADB I)"2"1= %)(A)!(@*29"2"1"2DD0$$B$E),@*62
M(2022!2R21)2R9"2"9 4LDGI$E+-\^C>\AA>S.K,J);A][4JGQ>Z"&B=K/9M
M?B_E.K?^WJ]:_P D/YC>3&8);I(<;M0HZ$HCK2O;'/SKY=0  '$_,/X];'[Y
M2OSJAVK=?Z2U]R/D/F+?G_(7_P#4G^9F+'V1D3#D#$%2(F(*B!](%1$^D05(
MB8@DB8%1 Q!4B)@21,05$3 DB8@J(&!)X8@J1$P)(F()(&!41,05$3 D\,02
M0,"HB!)$P*B)B"2)B"HB8$D3 J(F()(B"2)@5$0)(F(*B)@21$$D3 J1$021
M,"HZ_P#0_P#BGL/OBC\PD:%VD_NP^[YSI/93^S/[WF.CAJ9NH   ?F)E2_Q2
M;[.[^&8[/;]E<AP&[[;Y64E!Z'D* !0 * !0 * !0 * !0 * !0 * !0 * !
M0 * !0 * !0 * !0 * !0 * !0 * !0 * !0 * !0 * !0 * !0 * !0 =M^
MBS_Q:GWQE?:0.;]H/U7X4=8[+_H_Q/S&ZQKAM8           %@F?'?#>]65
M]L8X -%^)&M>]4'VN@ 7\            !^?WI"?\Q;1[+&]ILCJ.YOTD/#Y
M6<>W]^NN>#\J-:$,P8$]$D$R I/:TX]H"#IS2?13B97%0<SL>QJ4S.9;DM1\
M4VFWJGD$M)D^\1UJ1ET-_9&FYOM%*$W"$-3IZWH7I-_R796%R"G<N54DGZO'
MQO7S&82?1+Y?+8-$3*9=F12B75NQW4U[9IZA-?K&0L(]I,Q73&-/#Z3(OLEE
M::)3YX_]IH+FKR:S_*Y]B1)>3DM?F+-J)E&D&W1VAJZMY!F=BS(C--%&1D1T
M/@9%M6[MZ6\XFDL,EK7H-+WMN6YD6FWB@]3\S1BVGZAGMYSK&O:['Z^<\1K6
MM1VM,LII<ZZKC:A-?JF="(C,R(7^9S5O+VW.;HO+Q(Q.3R=W-75;MJK?,EM>
MQ?\ 1:6D=,X/T2]88CH/8\W.F3*$:R@DU%9(^R17H=49=VI?6&EWNTMUOU()
M+CJ_0=#L]D+"7]2<F^*B7C4BGV3T3,0N(MS4<W)8G)(S;8R9(>9<5V$FXTAM
M2/JVJ^H/3+]I9XOZL53_  _OK7Q'EF>Q]MQ_HS>+_%1I\R5.6C.9,OA\EK^4
MEX7,1U1,G!<-F3'70S2M/:,JD9&7%*B.AEQ+@-WM78W8*<'5,YO?LSLS<)K#
M*.M?M^SX"D(>I;GH$$R$D$B$E)?])Q4/.[A@<+D"4J#D)\:+))M5BC;><)*J
M*XT.ABTSEV5NQ.<=<8M\R+W(6HW<S;A+5*44_"TCL!OT?N4<1HU/X4W$I*JW
M7IDHJ$79,TO)(ASA[]SLGHG_  Q]!U[NQNY+3;_BG_W'S1R-Y+Y%"VX.+;4M
M/!2XT^2XI'_Y=1?9(5/?6?A[4N>*]!0NS>[)^S#FG-_S&J.:?H\%K.*E;+J$
MIZ7C8:3>FXZ31;[;*>*W&W$D5R4EQ-*DU))5J8V'=F_^NFK=U)-ZFM1J6^NR
MOR]N5ZQ)N,=+B]:7"T]BV;.%EB]'7!ZQG=VD,[&RS+=8AJ>QD.21*:<>2M)*
M58K@M24&9DDR/LJIWM2O.T%^]:RZ=MM5>EK9YOV7"8_LIELO?S35Y*34:Q3U
M-^>BX/#P:,T])G7=0Q6/P\_&Q8T#8GY"FU,Q4(9-Z(2%&I:TH(JV+)!$K^%0
M8SLWF+\Y2C)N4$N'31_M4S7;'*9:W;A."4;C?!15C36^1T5>,V3R+BQ7>5.N
MK=8;6LT2:J4A)F=);Q=H8/?DFL[.CZ/Y4;'V6BGNVW5=/\\C1FP(;+TCF6R0
MDF_=W'ILH5M#-GL= V_+M_2G_IR\YS_/K_SJ_P!6UY8'1/-*)%;Y=;,MMAM*
MBQ[U#)"2,N]^H-'W7)O-6]/VD=/WU"*R-[1]B7D-*>C3K^J9B3FI.7C1YV:B
M=3XG'E)2X3;"KKW$-KJ1G<22-5.]X=%W';>TF8OVU!0;C%UJUMV5_:O@- [&
MY3*WI7)7$I3C2B>FBVI<M-/!Q5TT'I'8+5L+L.+5@66(F2E,.KR<.,E+:$DE
M2>J<-""(B4NJZ]NVH]^SE^]=M2ZQMQ36%OQKP:"U[997+6;T.J2C*2>)+1R.
MG'IYC3!#;#0"1"2DD0$$B$E),@*62(2022!2R21)2R9"2"9 4LDGI$E+-\>C
MBPB2K9F5%Q-$.U79(R-X:'VM6BU^+^4ZO_[>NDKZXH?SFZO<Y<9QMR09=1>1
M*4D^CM5KV!H!U\OP$  <3\P_CUL?OE*_.J':MU_I+7W(^0^8M^?\A?\ ]2?Y
MF8L?9&1,.0,05(B8@J('T@5$3Z1!4B)B"2)@5$#$%2(F!)$Q!41,"3,.7G+?
M-<Q\@_$Q;S$:-#)"YLI]7K$N&9)M;+OEF=I]'#MF52&*WCO*WDXIR3;>I+TF
M?W/N:]O&XXP:BHTQ-\%>+6WKXMK6@WK ]%W46F2+*9?(RI'W2XYLQD']1"FW
M3+[X:=<[3WV_5A%+CJ_.CH=OL1EE'U[DV^+"O$U+REEVKT7F$Q5R--RSJY3:
M3-,')6&3AEV$O-I1:?:N09=LRZ1=97M.W*EZ*IMCZ'Z2RSO8E*-<O-U7!.FG
M\22IS:=J.=),&7#G.XR6T;$]AU49]EVB#0ZA5BDJ-1D14/IJ-WC.,HJ2TIJI
MS2=J4)N$M#3H^)K0= ZOZ+;[S+<G<,P<9Q155 QR4K4FO8-YRJ:EV;4&7=&E
M9GM.DZ68UXY>C]YTK)=BFTGF)T_PQ_[GZ/"9-*]%O1G&#3$R>49D4HEUQQAU
M->V:2937ZRB%A'M-F*Z8QIX?29278O*4T3N5Y8_]J-"\S.56>Y:S&BF+3.PL
MM1IA91I)H2I22J;;B#,[%TXTJ9&709T.FW;NWI;SD73U9+7']M:-!WON2]NZ
M2Q>M!ZI+R/8_+P/73%-?U_+;3F(N"PD<Y.2EJM:;+@1$154I1GP)*2*JC&0S
M&8A8MN<W1(QF4RMS,W5:MJLI'2>!]%77VXB#V;,RY,\R(UIQ_5L,)5V2(W6W
M%*+N][]0:-?[37'+^G!)?XJM^)HZ7E^Q=E0_JW).7^&B7C3\Q9-W]%U4* ]D
M-'R+TU]E)K/%SK#==(N)DVZA*"N[25(X]L7.3[28I*-Z*2?"O.BTS_8[##%E
MY.37V94J^1JGD\)S@M"VUJ;<2:'$&:5H41DI*B.AD9'T&1C=4ZJJ.=--.CUG
MS,2")B"2)B"HB8$D3 J(F()(B"2)@5$0)(F(*B)@21$$D3 J1$021,"HZ_\
M0_\ BGL/OBC\PD:%VD_NP^[YSI/93^S/[WF.CAJ9NH   ?F1E"_Q.;[.[^&8
M[1;]E<A\_77Z[Y64E!6>510!44 5% %10!44 5% %10!44 5% %10!44 5%
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M:X;8           !8)GQWPWO5E?;&. #1?B1K7O5!]KH %_
M?G]Z0G_,6T>RQO:;(ZCN;])#P^5G'M_?KKG@_*C6A#,&!/1)!,@*20$&PD\[
M.9$?7L;K..S*\;B\8PF,R<1)-OK0BMM[QU7P([2M-)4+H&*>ZLL[DKDHXG)U
MT^@SGUS-JU&U&6&,531KY]?-0V?Z.6]\SL[NR,9-R$W-:NIEY63>G*5(3'-*
M%&TI+SE5$I2Z)MNXD9\.%2PV_,GE;=G$DHST4IHKMT<AG>SF>SEV^H2<IV].
M*NFFC1I>G7HIQZMFU?29EX^/RHGL3#3XU+DQ&L>E7KC?2\EQ1I^HVA8P>X(R
M>;36I)UYO30V/M-.*R,D];<:<M:^1,P'T0FX!HVMVB3RA*AIJ?KRCF3I\.X:
MBX_4+N#*]IG+^GLT\^@PG8]0I=Z7J\VG]N8\]*]6X-R,.Y'7(1I74*2^;"ED
MSX^;BJ]?;P]9;U=_\*G9$]F^II*M.LKXN+QU\!3VM^8K&E>JIII6F*OVN#53
M#7CH9OZ,LS9IO+YQS/N//0DS'$89Z2:E+5&)*;B2I7$VR7<23^J700QF_P"%
MJ.8]2E:>M3;Z:&9[,3O3RE;C;6+U:[/16IH_TEY&/?YIR4PC2;[,**U/-/Z0
M1*453[9-J00VCL_&2RBKM=.3_K4TKM5*#SKPZU%5Y?\ I0U"-C-0.G?F\TGZ
M/OPL]Q(_PA]R/&/'^_ZSKJTO]=2HT?YZ_P#4>KQ/#BI0Z=],RWTGK<"Q]76O
M&<S$-Y.7DB$E)EG++_D;4_?:%^?2,?O']+<^Y+R&2W5^LL_ZD/S([1YM_P#&
MFT^][_X(YENO]5;^\CM6^?T5W[DO(<7\O8&V3-KQGP-0^68;?;4E]DE$AM-Q
M7*>47 FZ5ONX&7 =.S\[,;,NNIAI^U.,XINNWF9YB/R]<:>O@7WN+;MU'<N[
M96!A-1S>4R:DE"8AO=8E1D1+-:#0ELJ]E:C)!%V3,<IR=J5R_",=;:_Z^ [G
MO"_"QEISGJ47X>+PZD<:\H= ;YB;%)Q2\D[BEPHASFI+""6NY#K;9$7?)IZ^
MM2,=.WKGGE+2EAQ5=*>!^@XKN+=JS^8=MR<,,7*JXG%><R7G%RE+0<=!S3F>
MDYF5-D>*K\:;HHDDVI9'>;BSX4I066Z-Z_-3<%!025='_0R?:'<?R5N-UW'<
M<G32N+;4W[R'_P")]=_BRO;CPT_?OZV?X?RHWWLK_P ;;_'_ /DD:'V#_P#2
M19]_L?\ A,C<,M_Q+_TY^<Y]O#_G5_JVO+ Z.YK?\<;/[WO?@C1MU?J[?WD=
M1WW^AO?<EY#F7DWRR3S!5E92<R_AY.)5')IR,BY2O&2=KWUZ#*EG8[8W_?&\
M_E%%8%-3KKXJ>DY+V=W-]0E-JX[;MX:-?XL7&MA\.;W+A'+W(8Y'NL]EG<FV
MZZZZ^W8LE-*273>HU5N[(]=S[Q^<C+U5##34>7:+<WT^</7=S'5Z5L\+VGQY
M=<HMCYA$<R.I..P3:C0YDGTFHE*+I2T@J&LR[/$D]VO 5[QWQ9R?JOUI[%Y]
MAY;G[.YC>'K+U+?2?F7#XEQFX&?1>UU+%K^=FKDT_E$-M(;K_$,E'_WAJ[[4
MWJZ(1IX?V\1N\>PV7P^M<DWQ42YM/E-=<P>1.P:9#=S..D%F<&P5TAQ"#;DL
MH[*EMU41H+LJ2KNF1$,_N[?UK,R4)+!-\S\.WB-3WQV4OY*#NP?66UKT4DN5
M:="VI\J2,8Y:Z8SOFS)P#\Q4%"F'7R?0V3IU:(N%#4GIJ,CO/.O*6>L2Q:4C
M#;DW6MX9GJ7+!H;K2NKPHV+L/HYY2%.Q,+7IR\@F<MU,V4^R3+$5#:4F2EFE
M2S.ZID14XF,'ENTL)1G*Y'#AI1)U<C9\[V*NPN6X698\5<3:HHTIQO69.SZ,
M>$*,29&>E+F4XN-M-H:N_B&:CI_UC'2[57,6BVJ<K_;Q&9AV#L8?6NRQ;4E3
MFT^4T[S"Y=9;EYDVHDYQ,J!+)2X,]LK$N$@R)1*09F:5)J52J?3TC;=V[SMY
MV#<51K6MASS?>Y+N[+JC-J49>S+;37HX&JKGUF()&7-=9,A)!,@*623TB2EF
M_?1H_M.R?Q(?VWAHG:SV;7XOY3JO_M[[=_DA_,= N-I=0IM952HJ&.?G8"GA
MN*(E1G3JZSPK^^3V# %4 .)^8?QZV/WRE?G5#M6Z_P!):^Y'R'S%OS_D+_\
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M1)$7"HR%C+V[,<,%1&*S6<NYF>.[+%(M5![EI44 5% %10!44 5% %10!44
M5% %10!44 5% %10!4[1]&+ARQ3[X2OM('->T/ZK\*.P=E/T/XI>8W*-;-O
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M1$Q!)$Q!41,"2)@5$3$$D1!)$P*B($D3$%1$P)(B"2)@5(B()(F!4=?^A_\
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M@4LDD24LF0D@F0%+))Z1)2S?OHT?VG9/XD/[;PT3M9[-K\7\IU7_ -O?;O\
M)#^8Z#'/SL    <3\P_CUL?OE*_.J':MU_I+7W(^0^8M^?\ (7_]2?YF8L?9
M&1,.0,05(B8@J('T@5$3Z1!4B)B"2)@5$#$%2(F!)$Q!41,"2)B"HO<+3=AR
M.M9#;H<7K,%C'"9EOWI)1+.RMJ*W*)/6(N,BX5^J+.YG+4+T;+?KRU?MX#)6
MMW7[F7EF(QK"#HWS<&O155Y>4HL3@,GG&\D[CFTN(Q,1>0FW+2@TQVE)2I17
M&53(U%P+B/2]?A:<5+[3PKE/++Y6Y?Q8%7!%R?W52OE+48]RV,Y5RCV\E-1K
ML:>6D-H=8P_NE$3/6AU-Z32RIPC.J>-!A_JUC2_6PK[6&6'GH;$]P9E4C6&-
MZH8XX]/%4P>5'D0Y#L26TMB4PM33[#J30XAQ!VJ2I)T,C(RH9&,K&2DDTZIF
M"E%Q;C)4:UIGP,2")@2>&()(&!41 DB8%1$Q!)>(VL3I6K9#;6W62QV.E,07
MF5&KKU.24FI)I(DFFTK>-5"TEF8QO*UIK)-\6@R$,E.5B5]-88M)[=/@\Y8S
M%T61$P*B)B"2(@DB8%1$"2)B"HB8$D1!)$P*D1$$D3 J.O\ T/\ XI[#[XH_
M,)&A=I/[L/N^<Z3V4_LS^]YCHX:F;J   'YP9,O\2F>SN_AF.VV_87(?-M[V
MY<K*6@]#QJ* *B@"HH J* *B@"HH J* *B@"HH J* *F2:YHN9V:!+RL-V%$
MQ<%Q#$F;D9;,)E+KI&:$W.J*IG06&8SMNS)1:;D]2BFWXC*Y3=MW,P=Q.,81
M='*4E%5?*4VQ:CG=65%/+QTE%G)4Y G1W6Y,20A!T4;3S*E(52I5*M2J52'I
ME\U;OUP/3'6G5-<J>D\,UDKN6:QK1+3%IIQDMJ:JGY=*KK+)0798U/L[!F,1
MX\M^.XW$EW^*OK0I+;O5G:NQ1E15I\#IT"A3BVTGI6OB/25N48J332EJ? Z:
MZ;:'QH*SSJ7SX*3_ (&_#?K6?<OW3]QNHJKQCQCJ/&+J6VV6\*W5KV!:?,QZ
M_J=.+#BXJ5ISE]\G/Y;YBJPX\''7#BV4I3C\!8Z"[+&HH J?=R#,9BL37H[K
M<*4:TQI"T*2TZIHR)9(4945;4KJ=%10IQ;<4U5:STE;G&*DTZ2U/@=-=.0^%
M!6>=10!44 5% %2]ZKJF2V[)KQN.4RPEAAV9-FREFW&C16"JX\ZLB,R2FI=!
M'TBTS69AEX8I5=71):VWP(O\EDKF:FX0HJ)R;DZ)):VWL*/,X^)C<@[#@Y%C
M+14$DT3HJ74-+N21F1$\E"B,JT/@/6S.4XIRBXO8Z>8\<Q;C;FXQDIK:J^=(
MH*#V+:HH J* *B@"HH J* *B@"HH J* *B@"HH J=D>C1_QHG]?D_:0.9]HO
MU?X4=G[(_H?Q2\QN$:T;B   %''_ *R^J6K^335#!=SLJ^N *P      6"9\
M=\-[U97VQC@!3Z7)4UIVNME'=42,9"22B(J'2.@J]( OOCB_T5[[!>J *6?/
M>2T1-MN,FHZ&M1$7#M$ *?&2WSDI94LUH76I*.M*%6H$E\ @      #\_O2$
M_P"8MH]EC>TV1U'<WZ2'A\K./;^_77/!^5&M"&8,">B2"9 4DB @D0D@D0%)
MZ0D@F0%)T%C([F7TS!\ME+4?NYJ$G)XN.E-RE96'D7YK-M>B]"7$&9=@QJ<Y
M*%Z5_H75%O\ PN*B^9T9O=N#GEX96OMV7**X<:G*:YU5'UY+]3@$:9B%F29N
M\SI\^<1&I*RQT&'(B14+3VEO+=<+MVBG>M;O6RX+2BE]YRC*7BHBK<=+'4PX
M;\I2?W8QE&*?$Y8FN0UY@</KV!TD]ZV/'^[4N;/7B\)AW77&(O\ 5T$MZ0^I
MDTK61&9(2@E)X]-2Z,S>NW+E_J;;PI+%*6MZ=25=''4UW+6+-K*_,W8XW*6&
M$:T6JKDZ:>*F@OD7"Z]DX^H\PM;@>XR?A%%PN8PY/+D,)E$:'VWF%.FI9(6D
MCN2M1T5T"VE>N0=RQ<>/^FY1E2FC51TT%Y;L6+BLYFU'!_5C"4:U5=$JJNFE
M-=>$OB]%/8MVYD[&O"O['[D99Z/!P4=PV4R)4I]SOWG$&2R:90FY24&1J,TE
M<15%M\[U5BQ;Q*&**;D]-$DM2U5?'JTZ"Y6[?F,SF;K@[F"<DH)TQ-R>MZZ1
M6G12KII6DILSREE92+K,PL$>G9C+Y<L%D,6:UOL&3B.N1-80ZXM:4DDG"6@W
M#*J>%!Z6=Z*#N+'UL8QQIZGLPNBILHZ<)YYC<DKD;4L'4SG/!*.M:=.-5=:4
MK58N#08EL>9T2&O(X'7]6:=BQR<BQ<[+ERE3UO-F:"DFE"TLD1\3)OJJ=%1D
M<O:S$E&<[FEZ<*4</)JKX:F'S=[)PE*W;M52T*;E+$WTM#4?!A(<QL#BM?G8
M!C$L&PW-P6-GRB-:EWR9+9J<7WYG2I]@N!=@5Y"_.ZIN3K2<DN1/0>&],M;L
M]5@5,5J$G]YK2_VT&S7M>Q&J[]S7P."8\5Q434I'B[!K6Y;UK$-U7?.&I1U4
MHSXF,&K\[^6RTYNLG=7EDC9'E;>6SN;MVU2,;$J+2]<;;X>-F*\O\ C,X^!=
MR_1E,:ITV<GL$J<]"ZR]P^$92WF&$K;3PM(EF9EQZ:#(9Z_U<G_6PNFB*BGP
M<.ART^ QFZ\HKT8URV.-?6FYRC73]GUHQJO#QZRKQFC:CB\KS'A;&T_-@:F2
M'8+C+IMR%)3)HE!F1$FKJ32VM1H.VIF1#SN9Z].%AVVD[NO1HU>;6M.D];.[
M,M:GF8WDY*S3#1Z?:T+9ZRHGHT::&M,M*A9')O2<9CT8J"\I/48]IQQY#14)
M-"6Z9J54RJ=>V,_:C*,$I2Q/;JKS&I9BY"4W*$<$>"-6Z>%Z3=W-]*-@A;;'
M29JEZ/EHSC!J7T8W)QVHZVT)Z3M?:0KN7#5=TMVI6GP7H/WHMNONM\QO?:!*
M_&\N'+SC3[ER,8M+\<4_#H(9-I6-U+9.7S3BB^#NMP'I[)T-/NG)GM391\.F
MTEH:J?1;056I8[]O,/\ ]2Y*GW5%QCYWX2C,6W#*W<HG_:M0<E_C=Q3GY5'P
M%DY>ZTSGX^*:D:&B5A)+A1LAL4B<[$>6I;AI-R,:W6FC-HC_ )-*%FJVAF+O
M>&9=IR:O4DM*@HIKDEH;T[:JACMTY%9B,*Y;%!NDKCFXMZ=<?6C'U>BHRK2C
M8PFFZGC(W,23LL=_)L:9.BL1>H=..X^1RGX_5J,C,DI=-*+U4-24UMXBJ]G+
M\W85MJ+O1;=56GJIU\&FFWA//+9#*VXYJ5Z+FLO**5'1OUY1IR2HJO6E[.DN
M^LZU*Y@<MY6-P$-./C/;:4EUI"EO-PH28!W*JLS6NPC(B*M5'P%MF<RLIFU*
MX\3ZFFS%+%S+S%YDLC+>&0<+4<"^8KPO#'J^-U=*\K98]=UG6MUVR:SKF)E*
MUS X]<DH2'5>/91QA1(1>M5R6E/K65Q(21)01T*[B+S,9F]EK"=R2QSE2M/5
MA7BX<*VZWK,;D\CE\[FI*Q"3MVH5I7UKCCH57JBYMZ:+1%:%725NR:&_\"\K
ML4_4SU#(X5V.;:4.O.QYL:2X3)IL?<=4EUHS2J\ET41G5-:#SRV?7S$;<;O6
MJ:? JQ:5>!+0].BFC:>V=W0UE)WIV?EY6W'A;4XR>&E).34HZ-*='5U1[NN'
MY>879XNHQ("X12W<<[D\R](=44!F0AI3B&6U&9**P^L4MR[BJA$5HG(WLW=L
MN\Y5HIX8T7K-5I5\NBBIJ*=Z9?=]G-++1AAJ[>*;E+U%+#5):GH>*LL6MK10
MM?,G$,8!]>,:U)&'C>,78K-MR)$A,N&E)T.];BV5FNY+AF@DFGHH+G=EYWEB
M=W&Z>M&B6&7,FJ:M.LL=]Y6.6DX*QU:Q>I/%*6*/A;BZZ):*4U4,!(9TU8F0
M%+)$)()) I9)(DI9,A)!,@*623TB2EF_?1H_M.R?Q(?VWAHG:SV;7XOY3JO_
M +>^W?Y(?S'08Y^=@  BM:4)-:CHDN)@#B7?5K<W787'$V*7D92K>X;JC+[)
M#M6[/TEK[D?(?,.^Z_4+]?B3_,S&C[(R)B"!B"I$3$%1 ^D"HB?2(*D1,021
M,"H@8@J1$P)(F(*B)@20/H$%1T;@=>V'%R=.TT\-.<U>9AY3&QS68Z^K\8SZ
M34N]9=[^(L9*XSX4,:+?S%J:NWL<<:FG!5X+?%K];UCJ>5RM^U++Y9VY]5*W
M)7&HO7=K6KU>I2.FIKC1<?)Q+G,?%34V3(.OY"-(27&CC,EE"B^R0SF>N*XK
M$XZI7(OGBS5MU6I6KF:MRUQLW4^52@F8S+Y?[7#P!;+(B,HPQLMR2?*9$4OJ
MGK;#ZI+QN5.XN]LJ79(7T<_9E<ZM-XJM>S+@XZ4,?/=69A9Z^45@HG7%'4]6
MC%7AV5-D\P-19F[K#SV1V/%X7%MP\6Y(6N87NDVAF.U<IN*V2G3<X5;H7'AQ
M& R&;<;#A&W*<JS^SZNMZY/13:;7O?(*>:5V5V%N.&%?6]=)16E12<L71\!:
MMAD:MD2S_-K*8P\DQE\NO':_A77'([1DRRE2Y4@V32L^%O>)67?&=:D+BQ&]
M#!E8RPN,,4I:];]E5T>&FHMLU++W5=SUR&)3G@A&K2T+VY4H_ GKKKUE)%Q&
MBY:!K^]'BRQV&]VFL'M&$*0^N.27F[TR67#4;J$VU-237ZXJ%PZ:Y7<S;E.Q
MBQ2P8X2HJZ-&%K5XCQA8R=R%K,X,$.L5NY'%*FE5QJ5<25-KUZ.7ZZQRWP1;
M%M6&V<UDS'FGK. >,G$D>6FJ=.*\9H-)&E*&;C(ZD=Y<!3F=X7.JMSM\*ZR6
MKV%3$O'XBO)[HLJ_=MWJT4NJ@VG_ ')5P2T4X(UIJ]9%CPFE1)NJ0$2FNKVK
M9=@:P>(6\;B2CL1R24EZQ)D2OQCJ$*N(Z4X4%S>SDHWG1^I;MN4N-O4N9-EI
MEMW0EEXXE2Y=NJ$:U]5+VI4X=+2==7$9^URF:G9R1J7P#E8_ VO1H6Y./O*E
MI?:2JR4\@W.I4TXI)5:2VFB5<#J,,]Z.-M7>N4I:&[=%2G16BM5MJS8UN)3N
MNRK#C"C2NN3Q5Z35<+3HO5HJ)Z&83'QNCX'EOA=KS.%7E<_,EY""F*<EUB*Y
MU)IHZZ;9U_%%P2E%MQJJH^ RDKF8N9J=J$L,4HNM$WR+EX]5##0L92UD;=^<
M'.<G)4Q-)\;ILV*E:Z3(8_+*3A,?A&F^7TC;E3XK$[-Y1;[S'5^-$2_%X:67
M$)2II-+G'+[E5X$D64MXJY*?]96\+:BJ)ZN&55P[%2BXS)6]SRM0M_[=WL24
MIRQ-4KIPQPM)8='K/%5UU(M61Y>:WHL_=,GL#;F;Q.N2HL#"X[K393+D9%OK
MV_&'F:*(F6CJLD4N5V2'O#/W<S&U&'J2FFY.E:*.C0GM>JNHMKFZK.3G>E=K
M<C:<8Q5:8G)5TM=&.NE*O80D9# 9/DKL,S#XKW&E*S6/3/A,O./0S43:['&.
MN-3B+B,R4A2U<2J1T.A0H7(9Z"G+$L$J.E'P:Z:/$BMW;5S=ER4(8'CC55;7
M*JZ5R5?F-/F-C-/(F!41,021$$D3 J(@21,05$3 DB()(F!4B(@DB8%1U_Z'
M_P 4]A]\4?F$C0NTG]V'W?.=)[*?V9_>\QT<-3-U   #\X\FG_$IGL[OX9CM
MUOV%R'S5>?KRY64MH]#RJ+0%1: J+0%1: J+0%1: J+0%1: J+0%1: J;4TS
M".Y[E/LT!F7"A+]U\>YUV1D-PV.];<X=8X9)N.O AKN<O*UG;<FF_5E[*J^#
M@1N&[K#O[MNQ4HQ]>.F4L*U/A9<\7@<5F86L<G8^79RLQS*2LQF,ACC4\Q%9
M;C'6-&=4DDN*6A!JN25A+/LCPNWIVY7,VXN*PJ,5+0VZZY+@H_#0][&7MWHV
MMWJXIMSE.4HU:BE'V8NE'5)NNI2T:3[2N7"\GB=@\:T-[4F\9"?R&(RYR'GE
M+\4*\V)2775(4IU-U%H)%JJ<#(4PWA@G"EY7<4E&4:):^&-%71L=:GI=W1CM
M77++NPH1<HRQ-^SIPR3DT\6G2J4T:&BAW?-8!SEII*&]9CM+EQ,D4!PI4M7B
M2D3#2M2"-RB[U%?^,NIT%P'MDK-U9N[_ %'H<:Z(^MZO)HIJT'AO',V'N^Q2
MTEB5S#ZTO5]?3PZ:O3IK0K](T.-MZ86-FZ,G#X;(Q33&V1R<ZF?XPEHU%)0T
M^\A+S:U$7>-LT(E5J/'.YYY=N4;V.47IAA6&E?9JEZKXW(N-V[KCFU&,LO@A
M..BYC>*M/:HVE)/8HTTU+=@I&&@\BWI&>@+R;#6U*\4@)=4PTY*/'I(NO6BB
M^K2F]5&S)2E4*I%4>U^-R6\4H/"^JTNE=&/@X*\I:96Y9ANARNQ<UU^A5HJ]
M7]IZZ4KJTUIP'QB8W0<KBL-O;F&+'XR-EV\/M6%;??7&-F2V:D2V5FOK46\:
MHO.ID705:USN9FW.=C%BDX8H2HJZ/LO@?+0IMV<G=MV\U@PP4\%R&*5-*KC3
MKB5.C5\&K36EB<OX&"VG=6=E97(P6H19#R4K4ILI#LBC>/2I39D9=;UB5\#[
M KEGY7;-IVW25UKP4]O7LI0\K>ZX6,Q?5Y-PL1;UTQ-Z+:;6K%5/07;;,S@S
MY1Z*A>M1UN2F\PQ!5XU+(H;R'FTK=;+K._-Q9]9:Y<DCX%P%OE;-SYV]_4>C
M!71'UM#T:N!:-!=Y[,V/IN7K:6E74O6EZK356M.FKTT=4M1>OFI5A,G!UIW0
M9&?QYI9;S.RID/-O=<^E)N+B$AQ#:4,&HZ$XVJ\T\3%I]4ZR#N*\H/3AA1:E
MTM%:RXGH,A]#ZJY&T\N[D=&.YB:=7K<-*5(UX4ZTTEAP_+_'0&=M8BXE&Y;3
M@LH<%K#+=<8,L:BZLU+<=Q"W5*,B18A1V5K07EW/SD[3<NJA.-<5$_6Z-6J+
M;5ZS&V-UVX1O)0Z^Y;GAPU:]15]>D6G*NJB;:-69'JW\G*.+!]SVUO+)G'$I
M:S8(U4)JYRJSMZ.^XC8;=5!5>+1KV\>@U*\T[DJ1PJK]73HXM.G1J-B[#'T3
ME_FTZ?D-<3L#\%#2<]EW)<AEY3[S:7%IB):6A"$MW43>A1J/IX#"9=YG-V^N
MC/ I>S&B>C_%73IXC9LW')Y&\K$[76.-,<L4DVVD_52:2IQIUU&5:]B<)HN5
MYBZ^>-;S41G N9"+/?>>9<D8V1XNXF,LFE)(B._OEI)*JEVAC\Q=N9J%BYBP
M-S46J)TDL6G3R:C+92S9R-[,V7#K$K4I*3;3<'@]71RZ6J.J-&SWH\J;(D0X
MB(,5U9J9AMK6XAI!]""4X:E'3MJ.HVRW%QBDWB>W;S&@W9QE-N*PIO0M.CGJ
MRFM'H>=1: J+0%1: J+0%1: J+0%1: J+0%1: J+0%3L;T:BIRU3^OR?M(',
MNT?ZO\*.T=D/T'XI>8W -:-R  I)BU+-,-LZ+>]>?[ULND_K]  J4(2A*4(*
MB4E0B[A "0      L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@#YO,MOH-MU-R
M3^V *+Q=O'/(?;+\2KO'35Q-->@Z@"X@       /S^](3_F+:/98WM-D=1W-
M^DAX?*SCV_OUUSP?E1K0AF# GHD@F0%)(@()$)()$!2>D)()@4FQ9W,.(SG]
M!SF!:?;7J.,Q\*4AXDHZU^,ZXY()%JE5;63AI(SH?<&(AD6[=V$Z?U)2:XDT
MJ>%4,]/><5>L7()KJH0B]6EQ;K37H=2N7S,Q"N;>)W2/#>B:GA5,1L;C&THZ
MYF!';-%B4WDFJE*6LROZ5=(\UN^?R<K3:<YU;>V3_:FH]GO:W\_&^HM6X448
MZ*J*5*:Z;7KX2@Q&TZO.UN;I&TMRX^)]T7,I@LO";0_(ANNEU:T.LK6@EM+2
M1&9)61DKM]CVNY:[&ZKUNCEAPRB]"?(Z:_ 6MG.6)699>ZFH8L4)+2XO5I55
M6-.!/7M*J1NVNXN-KFL:RU+<UG#Y9K.92=+2A$N=,0:4&I+25*2VA#:32A-_
M&O'B*(Y.[-SN7*8Y1PI+5%<O#IUZ#TEO"Q:5NU:4L$)J<F]<I+1H5:)4U*O+
MI*A>_P"M93*[K SD::K4=LGGDX[\8FRR$*2TXM;+A-K5U:JI6:'$&KHZ%"GY
M&["%J4&L=N.'37"U15X^->0?4[,YWHW%+JKTL2I3%%U;6AZ--:/3R,LC>3UW
M3\YA<[IF2F9;(XV24I]4^(B%'4ELTFE"4H?=6=Q7I76G#H%V[=S,6Y0NQ45)
M4T.K\B\!8*]9REV%RQ)SE%U=8J*X-"]:3VI^(J]C=Y8Y9S(9S$R,MCYLTG'F
ML"J*PZPU*<[\R*43R?Q!*.A?BKZ"C+K-P48249)?:J]7W:>UX:'IFY9&ZY78
M.<7*OJ88Z):_:Q>SP>SB+ID=HY?[1C\#D=E:R;>?P6/8Q<C'0TM>*Y!N&1DR
MKQA:[V347!U5BN'K2'A;RV9LRG&VXX9R<JNM8UUZ-3XM*XRXNYS)YB%N5U3Q
MVX*&%4PSPUIZU:Q_Q.CXD7')\T,'D=QWK9#CRDQ]IP*L3#:L;O;E+8C-U<[^
MA-DIE7$JG2G >=O=MR%BS;JJVYXGKU5EQ:])Z7M\6IYJ_>PRI>M."U53<8+3
MIU>J]KXBCF[7HN?QFK2,ZG(-3=8@M8Y>!B-M>)S/%U&M+I/J674FX?\ +'U2
ME'V.V/6&5S%J=Q0PTN2Q8G6L:\%*::?9TH\KN>RE^W:=S%6U'#@26&5.'%7U
M<7V_5;V:JD\IS"P<R=S'DLLRNKV]#2<9>ALC0:'DNGUQ$X=O N%MPBUN^Y&-
MA-K^E6NO931H)O;WLSEF6E+^O3#JT4==.GR5->0'6&9T5Z21JC-O-K>2DB-1
MMI41J(B,RXT&;FFXM+70UBU*,9IRU5T\ALG&\R,(QS-SNTY. [.U//'):F8Y
M:$*>7'6:7&2-)K)-Q.-MF??=%>D82YNZX\I"U&6&Y"E'QZGQZFS9+6^+2S]R
M]<@Y6KN).+2;PZUHK36E73M+-A=T:1+W2?GB==E[3CIC"3CI2:2FR7VWTJ42
ME)H@C2?14R[0N[V2;C:C;I2W*+T]%)KG,?EMY*-R_.[5N]":T=*4DZZ7JT/:
MS(G]RT;)R=6V/*>Z?NEKD6##5@&4->*.*@&1I6W(4NK;:J7*1U1J,^%2]<+.
M.3S$%<MQPX;CD\3K58N*FE\=?09*6\<G<E9O3QXK,81P)*CP<*E70GPK#7C^
MT4<K?,,_C^9<5#,GK-RG1IF+,T((FVV)KDE1/=_WIVK(BMNXCVAD+BEEW5?T
M8M2\,5'1H]!93WI:<,W&DJYB<91U:$KCEZVG8^"NDM^-W1&*T)&OP%R(^P,Y
M]G-L2D$GJ4ML1^K25;JFLG**H::#WN9)W,SUDJ.#MN%.'2_)3C+:UO+JLDK,
M*JXKRN5T4T1HO#BH]5"^.<P-87GG\T6-?1%V;'N0-RQC)(:0E]TTJ7)@K-2^
M^-:2<)+J>FI5[ZI6JW?>ZI0Q*MN6*V^)?9GX-&CS:;V6][#ONY@=+T,-Z*HE
M5ZY6]+TU]9*2UU5?6JL5S472V(AJP&4R,Z:M:3;:EPVHS3;1W7)6M,APU++O
M?6I)/2,E8EF'+^I&,5Q2;T^ZM!A,S;RD8UM3G)MZG!1HM.AO&ZO5J5-?@N&Y
M;#A-KW<\T:93.#?*$U((D-^-DW'8:9=-"36:#5WBC357:K0>62R]S+Y;!H<U
MBIKII;:X^'2>^\LY:S>==VDE;DX5U8J*,8RX:5T.FG94KLKL.OP=+?T[!39V
M8;ES6IW79!A$9F&EE*BM8;)UT^L6:J.+J16E0BXU'E9RUV>85ZY&,*1:]5U<
MJ[71:%P(]\QG+%O)O+6I2N*4E+UHJ*A1/V5BEZSKZSU4T)<)@Y#-&MDR I9(
MA)!)(%+))$E+)D)()D!2R2>D24LW[Z-']IV3^)#^V\-$[6>S:_%_*=5_]O?;
MO\D/YCH,<_.P  4CQ^,R4QBXM-46\?=^Y3_V@2M!QES$,SWO8Z^<97[CJAVK
M=?Z2U]R/D/F'?O\ R%__ %)^4Q8^R,B8<@8@J1$Q!40/I J(GTB"I$3$$D3
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MDB8%1 Q!4B)@21,05$3 D@9D(*B)@2>&(*D1,"2)B"2!@5$3$%1$P)/#$$D
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M$D$R I9)/2)*6;]]&C^T[)_$A_;>&B=K/9M?B_E.J_\ M[[=_DA_,=!CGYV
MHT_UJ4;G2Q'.U':4YV3^L *P <3\P_CUL?OE*_.J':MU_I+7W(^0^8M^?\A?
M_P!2?YF8L?9&1,.0,05(B8@J('T@5$3Z1!4B)B"2)@5$#$%2(F!)$Q!45.-R
M#N*GL9%EIEYV.J]+4II$AE1T,J+;<(TJ+CV1Y7;:N1<6VJ['1\Y[V+KM34TD
MZ<$DI+PIZ#;7PK/YJ?A;[@X'W9^$'N7?[DQ.K\6\2Z^EEE*W=D:S\K_O>IZR
MYAZO%[<M>*FTW3YN'TWYCJ;./KL']J'LX,6S:8@K3<IL*6MES61PNLHS2[\?
M'FJ\12^CUG6-,L-+)MJI>O7:D^GNC)?.PLUMPC.Y@UT]:G$VWI?$JF*^F7<P
ME>N2M65<]E2]2JVJ,8ND>-TV\99RT+:%;0YIYPK,TS5;R5K23+;"4WF\IVMA
M-6G=?7]W@+AY^SU/75]5\]=E-O$6JW3F?F7E\/KK7L2UXF]5*</G/OEN7\Z#
MB)6<QN5QN?QL!:6\DYB7UNJC7G:A3B'6VE6*/@E:2-(\[6\(SFH2C*#EJQ+7
MR4;T\1[7]T7+=J5V$X78Q?K8)5P[*U2T/:JHR+<,%D-EE<NL)B6TKG2]9BVW
MJ2VA*4.2%K6M1T(DI2DU*/M$+'*7XV8WYSU*[+^4R6?RT\S=RUJ'M2L0XN&;
M?,E4P;8M>9P/BYL9O&YI$CK"-6+=<=ZLVC(C)PG6VC*M>].E#XC*Y?,.[6L)
M0ITDO,V87-Y-9>G]2%RM?8;=*;:I> R%,*$?)-[(^+->Z);0W'*9U:>OZDX"
ME=7UE+K+N-M:5%DYR^?PU=.JK3@KCUT,CU4/I>.BQ==2M--.K;I772NFA\](
MAPY&G<P9$B,T\_%QT5<9UQ"5K:4J6E)FA1E5)F7301G9R5^RDVDY.O'ZIZ;L
MM0EE<RY13<8QIHU>MP;"X[7RXPV(T37L]$SF*/(OQI<B=;*>6J<:'[4)BH-J
MAFVGO%D=O?5Z1X9;>$[F8G!PE1-):%ZNC[6GAX->@NLWNBW:RENY&Y#$U)OU
MGZWK:,.C@6AZM)D. B3XF^Y%G*0,9 D*T^2ZAC#MFW&-MR%>A:B5_P"*9'WY
M]L65^<99>+C*4EUJ]K7[7DV&4RMN<,W-3C"+ZB3I!46F->?:8$>'R$[3-40^
MUAL=C,AD)<>/FG"4S+O2:;_'7B)7XI%W>4(Z#*J]&-^Y1SDXQ3P\'X5M,$\O
M.>6M55N$9RDE/5+\<NBJZ#[2N5$UK"Y7/1-FP&2@89HGY_B4QQQ2"69DVGBR
MDKW#*U":\3%,=Z1<XP=N<7)Z*QY^'@X3TGN2:M3N1NVI*"J\,F^3[.MZEQGQ
MB<JLW*3$C.Y/%P]BR#29$#7)<DVLB\AQ-S14L-I"W"XH0XXE1]H3+>=N-6HR
M<8NCDEZJV\-='"TF4PW+>DDG*$9R55!RI-[."B;X$Y(M.OZ+ELZQD)[[\;"X
M?%K)B?E,LM4=AN0=:,$24+6MTZ>L0@S+LTX#WOYV%II).<I:E'2Z;=E/"6^5
MW;=O*4FU",-#E/0J]'4W7BIRF8;C@9&O\G->BOOQ9;3V=FOQ)\%U+\>0PIA*
M26A9$1D5Q*2:5DE23(R,B,8S*WE=SLVDUZBJGH:=?VXC-YW+NSNV$6U+^I*C
MBZIJGIT:=.TU(8V$U,B8@DB()(F!41 DB8@J(F!)$021,"I$1!)$P*CK_P!#
M_P"*>P^^*/S"1H7:3^[#[OG.D]E/[,_O>8Z.&IFZ@  !^>&23_B,OV9S\,QW
M&W["Y#YAO/\ J2Y64MH]#QJ+0%1: J+0%1: J+0%1: J+0%1: J+0%38D"+A
M](U#%[1/QD?,[+L*WSQ4:>GK8<2'&5U2G7&:EUCBU'WA*JFG'N'@KDKF:ORM
M1DX0MTQ./M2;TT3X$N'A-IM1M9'*0OS@KER]BPJ6F,8Q=&W'A;X."FGEQ[-;
MEDL] .!D(6,31Q+C<F+ C1)#:4$9$VE;"$'9QZ#J+ZSDH6I8HN7(Y-KETMZ3
M%9C>,[\,,HPUZU",6ET4XI>J7*'RQR\IN&T[DL9"S>2;2]CL%+DFU.?2X56B
M(K#;0IW_ ,-+CB3,6\]YVXMM1E*,7IDEZJV\;IPT3+R&Y+TE&LX1G-5C"4J3
M=?9X,*<OLJ4D4N&Y>9[-8V9EDN18,'&RR@Y-W(.^+>*J-)F:W;D\$D?>4*JS
M49)))F/2]O"U:FH:9.2K'"JUY/+LIIJ>66W1>O6Y7*QA&$L,L;PX>-UYNE70
MD4^RZ3D]:1CI*Y$7)XS+)4K&Y'&N&_'>4V9)6@JI2HEI,R(TJ27$>F6SL+^)
M4<90UJ2HT>6=W;<RN!MQG&Y[,H.J=-:X'5<.@O*>4V<-XL8K)XI&T*;ZU.MK
ME&60,S*XF_6=43AEWUANUH+1[VMTQ89X.G3U>776G'0OUV?OXL&.WUM*]7B]
M?DU8:\-,1;,)H&;SF.F95MR-"@8V4B'DWI[OBY136E1WNW)X)(RLH55FHR22
M3,7%_/V[4U"CDY*L<*K7D\NRG"6F6W3>OVY7*QC&$L,L3PX>-\7!MJZ),N;_
M "HS$;J9DC+XEK7)+:7(VQJE*]SG5K4:>I0KJ^L-TC2JY'5U30S.A$+>.];<
MJI0GC3TPIZRX]=*<==)=RW#=C23N6^K:T7,7J-]%.E<6AU6'11U/MKFG['@N
M9$37?$<7DLKU;KT9K)$<G$R6%1ENDZ1I(KTF@C4@_P!\7&E#%.8SEJ[E'<Q2
MC'17#HFGB2IQ:=?$,INZ_9WA&QAA.>EK'ZUN2P-UXU32O\7(6#7]+R6?A2<N
M<B+BL%$63+^6R3ALQNO45Q,HM2M:W#+C:A)T+II4A>YC.0LR4*.4W]F.ETV[
M$N5F/R>[KF8A*=8PA'0YS=(UZ*T-N7$D^/6BV9K%(P\TX;60B9-NQ+B9<!:W
M&#)95I5Q"%$HN@R-(N+-UW(U<7'BEK\Y:YFPK,\.*,^.+JO&EY#9N[9^1J$3
M3H."@XQF).UO&SYZ'<;"D'(D/$LEJ<6ZTI1W$DJ]\-?R6768E=E<E)N-R<5Z
M\E1+91FT[RS3R<;$+48)3LVY2_IP>)NM<3<6]--I9=CQ^&V;3&-\Q&/8P^48
MGEB\[CXGXN&M;J.L:DM(49DT1^L4DCI7M=F[RURY8S#R\Y.<7'%%OVMCB]NV
MI9YVU:S.46;MP5N2E@G&/LZJJ45]E<#6W9PV^3RXFI@9";B\UB<T]BFCDY&#
MC9"WI#4=/KW2N:0AQ"/NU-K41#VCO*.*,90G#$Z)R5%79KJF^"J1;3W--0G*
M%RW<ZM5DH2;:7"]232X6FR[.\O,/\W&/V-&;Q;66??D./+=DO=\VAA#B8B$$
MT9=>DS[Y/;,N^%LMX7/FY6\$L*2X%M:Q:_9_:A?2W19^GQO=9#&VV_6>K"G@
M2I[:V<>LLV'Y>2LXS$*#G<.>7GM]9#PJY9E+</C:V9DV;2'%4X(6Z1BZO;P5
MIO%">&.N6'1RZZM<:1C\ONB=^,<%RWCDJJ&+UGQ:L*D]CDC$G67&'5LO(4V\
MVHT.-K(TJ2I)T,C(^@R,91--51A))Q=&J-$+1)346@*BT!46@*BT!46@*BT!
M46@*BT!46@*G7OHX\.7"?UZ3]I YAVC_ %?X4=O[&_\ '_CEYC8>9==)Q#1&
M9-6W<.R=1K)NQ+"K69NHZ4<%5[O0 +N!         6"9\=\-[U97VQC@ T7X
MD:U[U0?:Z !?P    .G@8 HXU8SRH:OY,ZK8/N=E/U@!6     _/[TA/^8MH
M]EC>TV1U'<WZ2'A\K./;^_77/!^5&M"&8,">B2"9 4DB @D0D@D0%)Z0D@F0
M%)(A)!(@*21"2"1 4E?A8WCN9QT.EWC$IAFG;ZQQ*?\ M'E>EAA)[$SWR]OK
M+L8/[32YS>B$,[KS'YE<N94IN*WGIGC$*4]51-2L,^1JM*O U,$Z1GW!JVG+
MY:Q?2K@6E<4U_P!U#=JK.9S,Y5R4>LEH;X';EIHN..+F++'SZ-Q?YMS8R23!
MDXE+N/:2FPDP\;)9;CE;T$:6DIKW1=2L/+K+)ZU+3RR3KXRSMYI9J6;:U2A5
M<'JPE'#XJ%WS;LW.X'5,OK.CP-PQK>&AXQ^1U,V5+BRX2#0['=;BR$&@B/OD
M*-LKB56ICPLJ-NY<A<NRM/'*6N*33U-5CY^ ]LQ.Y=LV9V;,;\5;C!O#.4HR
MCKBU&2IM55IK6I11X<_;)FX;?FM6;RN]XA>/B-:BVB03+39()@WUQT.&\]:E
MM*;2<H5:GPI3UE.-B-JU"YAM2Q/'HKMI6E%KV<A;PMSS,K^8NVL=^#@NKI*B
M^SBPUQ2U:J\;T4+AMY[>UA^5JL1CF<=N4:1EW(^)Q;2$)8>0ZRZ39LDI1$LT
M<76U'7B9**M2'EE.H<\QCDY6VH>M+AT-:_(^8N-X?,X,IU<5"ZG<:C#11IQ>
MKD]I/D:UHH<O#QT%&L;_ )_ ? W9"V%A$_%I2XPU+B-&E]R8W%>[]HD&1(,D
M]Z=>V/:U.<NLL6Y];#JW1ZZ-Z%%R6A[=I;WX6X=3FKMOJ+G6K%'2L451N:@]
M*IJT:-/&7O$Z/LD7GVK8)47J->>R[V0CY=Q24PWFIIK6PEEPSHXXN]*20BJJ
M]/ C,6UW.VI;NZM.L\"CAX5AI6JX$MK+O+;MOV]\=;)4MNY*2E]EJ=7&CX6Z
MI4577B,.DFZCE%GDI,TI7MR$.D1T)22C.JH?;*I$8R<$GG8?Z7\R,'?<ENV=
M.',:?<EYZ&0)7(S&AZG)UO3X.UMXV*YC\FTIN5(F1)1/K<.YJ*\V9(=)76)5
M:?9J9"SHK>9N*Y=E:Q.JTQ2:HN&2>E:C(-RNY*S*Q8A>4$XR5)2E&56]4)+1
M+VJT?&?3%Y/-;-E-DU3+8V/KNV2M;8P^$QR$KBU;C*0^B+^/6I1+=:,B*]70
M7$+MJW9A;NPD[EM7'*3UZZK%H6I/8,O?NYFY=L7(*U>=E0A%+#H5)8/6;=91
MVO@TEOU/5,_KVF;Z]GHJ\8Y)Q241H,O\3*=2S(0;CJ6545U:*I3>94JJA5XC
MWS6:M7LQ95MXJ2TM:4JIT5=KV<1;;OR5[+Y3,NZG!RAHC+1)TDJO#KHM&FE-
M.@U,0V8TADB I)D)()$)*21 02(24DR I9(A)!)(%+))$E+)D)()D!2R2>D2
M4LW[Z-/]HV3^)#^V\-$[6>S:_%_*=5_]O?;O\D/YC>\B8A2>IBK)<AP[$VG6
ME>D_K#GYV J&6DL-):1ZU)4^KVS 'T '$_,/X];'[Y2OSJAVK=?Z2U]R/D/F
M+?G_ "%__4G^9F+'V1D3#D#$%2(F(*B!](%1$^D05(B8@DB8%1 Q!4B)@21,
M05$3 DV(?_ 7_P#MW_\ #1@?_P!I_P#T?YS:O_V+_P#U'_ZHKMXUK/[N>M[#
MJ,![,8>1B86.2B$DWBA28B.K=CND7%LDJ.ZY9$DR54C'ADLS:RW66[TE"2G*
M6G1B3TJ2V^#27>\LG>SO4W<O!S@[<(^KIP2CH<7LIM=%I,F?EPIV<EZ+"G,'
ML1:5'UEN4EQ)-/92,LG7(J':DD[T_BKE&7$J=(QZA*-M7Y)X.N=RFR+T*5.+
M69=SA*\\K&2ZQ996:IZ'..EP3U:?9JZ:50Q/4L%F-&PVXYO;X3N(AS,-+PD*
M/-0;+TJ;,-!()IM9$:THMO4M/ OLC(YN_;S5RU"TU-J<9NFE**KK?'JH8C(9
M2[DK5^[?B[:E;E;CBT.4I4IA3UI4JW^\JLR]L\/+\MYFHQER\[&U9AUF,VUU
M_6-$J3UJ3;^Z2ILU$9%QX\.(\K*LRMWXW72+NO36G1IIY3VS,LQ#,96=B.*<
M;$&E2OQ*Z.2J\FDL/,?!0(>&P>?7A%:KL647)1/UX[TMFVP:;9+3+M7&4+4:
MDV+X<.]X%4[O=]^4KD[>/K81I27+]EM:)<J\)9;VRT(VK=UVW9N3Q8H:::/M
M)/3%-Z,+_#H57]=5AR=NY8YK3,,DGMA@Y5C/1X!&1/2HY1U1W2929E<IO@HT
MEQIT5,49J:R^;C>GHA*+A7@3K55Y=1ZY&U+-Y">7MZ;D)JY3ADL+BZ<FM^+2
M3@8?(Z-RZVQ_:(Z\7D=D1$QN&QDI)MRGB:?)U]TVE46E"$IH2C*E3^I6FY=C
MF<U;5MXE;K*36I55$JZJGI:LSR61O.\L$KV&,(RT2=)5DZ:TDN';X*_#:<5D
MLERFT7*X^*Y+QV+9RK.3D,)-Q$5Q4TUI)XTULJ2B,KND3E[L(9R]&3HY8*<?
MJ\&TIS5BY/=V7G%.2AUF)K3AK.NG9X3/%I/YSII4_P#Y%/\ _=R2&(7Z5?ZW
M\YLTE_OI?_R_\AA'N%D]FY9<OL!AVNNR60S&5:CMF="_\,U*4?82DB-2C[!$
M,GU\;.:O3FZ*,(><PCRT\QD<O:@JRE.="MWW6MGPV.CZE@]:R1Z/K:SF9?)+
MBN-)R4UHOZQ+6JE":2DC2SQ.B.-3KP\LEF+5R3NSN1ZRYHBJKU5P1Y=O&5[Q
MRU^U;5BW:EU-K3*6%K')>U)O@CP1V1TU9DNXO['(W0MKU/E]CMG@9!UC)879
M([$^4IRTD&A3JF9));<;4FU25H12WHH+'*QM*QU=V]*VXU4HMQ7-6.E/BJ93
M/W,Q+,]=8L1NQDU*$\,Y;-=)Z*/1I2U&*2F\WS(Y>9 L-&.1L\39IN:SV!AI
M4;QIR"")+[3)F:UI;75JA7*+L]L7\7;RF9CC=(.W&,9/_#P-ZM.O@1C9*YGL
ME+!&MQ793G%:_66M1UZ/9II92;?@<EKO)G7L=EDI:R"<[+<D0[R6[%-V,A26
MGDD9V.&FCAH/B1**M#%65O1NYV<HZL"T[=+TK:N"I&=R\[.[+<)^TKCJN&-8
MZGL=--.,U(8V$U,B8@DB()(F!41 DB8@J(F!)$021,"I$1!)$P*CK_T/_BGL
M/OBC\PD:%VD_NP^[YSI/93^S/[WF.CAJ9NH   ?GID4_XA+]F<_#,=RM^PN0
M^7KS_J2Y64UH]#QJ+0%1: J+0%1: J+0%1: J+0%1: J+0%3:",8YS(T;!0,
M I#VVZLF1%DXA2TMO283J^M;=8)9D2NKXI4DN^_[M=<=Q9+,SE<T6[M&I<"E
MJ:?+P?\ 4W)6GO/)6H6G6]8Q)PU.46ZJ4=N'4UK\5;OU6YQ^4^UQ-VANQ8L)
M&*C8)N;';C.$3<M).):.Q*U=XE-3X\!;5R[SUIV&FY8W.CK]G17@UEZ_G%NJ
M_',Q<5%6XV\4<.J2K30F]%-)=MND9K(;6G:-6T:#LF.R"H\S%9YEB;)6HT(0
M1$\;$DDMK;4FQ25I32WH%KDX6H6.JNWI6Y1JI1K%;=58Z4]=4WK+S>%Z_<S7
M7Y?+0O0GAE"XHSEJ2]K#.D7%Z&FHTIJ,2G3YN5Y:[;E)[11YT[:&9$MALE(0
MEUQMU:TDE1F="4?09F,G"W&WG+4(NJC::7@:,-<O3N[MOW)JDI7ZM:M+3;5.
M7@948&?%Q.BZ1EL@9^(P-M5(?50U&EII+*U&1=PB,Z"C,6W<S-Z$=<K-/"ZG
MKE;T;61RUR;]6&8J^186R;V@[2KF@K-)0KW!5DSS2=H)2?<\H1O^,=?XS7JZ
MDGC;=6HI6?L?)8/MX<&#[6*E*8=95+=69^I=;_Z6/K.M^Q@Q8L6+V=7&?/8L
ME$S.G[WEL=7Q"?M+#["BJF]M:7U)49'0^^X*H8JRUJ5O,6(2UQM-?E*<Y?C>
MR>9N0]F5]-<:>)^/70L.PW?-=I23,[?',P9%7AZ]C_RB]RR_WM[DM_S&*STG
M]/RJX[WE@;)PJ5'S)Y7UXJ/3VB__ ,2;3]P8"_\ H\S_ *S_ #0-MRW_ "61
M_P#Y=?DNF$HQ4[;^5N%@ZPRJ9D==FS59C%QJKDK3-4A3,DFD]\M*2+JZD1F7
MU*C+N['+9V<KKPJY&.&3U>K6L:\&TU_J+F<W9;C83E*S*>."]IXJ898>&GLZ
MO%4U_E,/E,+*\1R\-Z!,L2X<>2VIIPDK*J3-*B(RJ,Y:O0NQQ0:DMJTFL7[%
MVQ+#<BX2V-4?C-I<P]1VC86]&>P>&F9".6JXIE3\9A;C27")PS2I9%:1D2B/
MB?9&M[NS=FR[ZN3C%];/6]/!P&X;WR&9S"RSM6Y37R]I546U73PZD4Z\=C,%
M@L/RRRN091E\YFX\O8W8SK;C<"*5&$,K=(U-FX5QN*H=$TX\.)UJY.[=GFH1
M>&%MJ%5[3UU2UTX.,IE:MY>Q;R-R:QW;L97*->I'V<+>E57M/933HUY9C\1D
M</.W#$M:C%P&!BXC+QH,]UMPYTPR979U<AY:C>-1$:U$T5I%]88V=V%R-F;N
MNY-S@VJK#'2M<5JV:=)F8V+EGYFU'+QM6XVKJC)IXY^JZ4E)^M77ZNA+P& ^
MY>0R_)Z"YBXKDQ.*S$UW(DPDW%,-+C-K)QPDU,D42=5]!#-=9&WGVIM+%"-*
M\/K/0N/B-;=J=W=,7"+E@NRQ45<*PIU?%QZC-]?UUS7=BU1K7=8BY#!/%C9T
M[<IR%/$HW5I6ZIIU:TLL&@SL;;MZRXB]<9\<1F,PKUJZ[EQQFL:5M:-6JJIB
ME76W[--E#8,GE)97,6%9LQN6WU<G>DJZW5M2;484U1C3'5+VFT:AW9!IW/8T
MF1D992:1D? R_K"^D;1D?T]O[D?(C1]Z_K+W^I/\S+%:+TQE1: J+0%1: J+
M0%1: J+0%1: J+0%1: J==>CGPY<I_7I/VD#F':3]7^%'<>QG_'_ (Y>8VL\
MPR^FUY!*(NBO8&L&[%,VE,*23:2I&?\ 6?P7"['UP!6@         L$SX[X;
MWJROMC' !HOQ(UKWJ@^UT "_@     "GELJ=;)3?!]H[VS[I=CZX ^C#R7VD
MNIX5Z2[1]D@!]   'Y_>D)_S%M'LL;VFR.H[F_20\/E9Q[?WZZYX/RHUH0S!
M@3T203("DD0$$B$D$B I/2$D$R I)$)()$!22(202("DD1F1U+@9=!@03-2E
M*-:E&:S,S-1GQ,SZ:F)(>DDE2DD9)49$HJ*(CI4NT8%)]XLR9"4I4.0[&4LK
M5FRXILU%VCM,JD*90C+6JE<+LX.L6UR'K$F1%>*1&><9?36CK:U(652H??),
MCXB914E1JJ*(3<'6+HUL/$N.%:9+41I.Y-#/@H^R7:/@*J(\ZT/K(E2ICG72
MWW)#QE3K'EJ<50N@JJ,S$1@HJB5"JY<E-UDVWQDCE25(::4^X;3!F;"#6HTM
MF9U,T%6B:]P,*TNFLI<Y42KH6KB(DI5MMQVF=337@9EV:"L\S[QI4J&YUT1]
MR.[2G6,K4VJA]BJ3(Q3*$9*C52J%R4'6+:?$14M:U&XM1J<,[C69F:C/MU,5
M4H>3==9]G94F0XIZ0^XZ\LB2MQQ:EJ414H1F9F9D5!$8J*HD3.<IMN3JV?,A
M6>;)$!23(202(24DB @D0DI)D!2R1"2"20*622)*63(203("EDD](DI9O3T>
M$NK1M*63*O5P[DTJHRJ_6G#M#0^UNJU^+^4ZQ_[>4Q7^2'\YN2,AU4ALFJWD
MHCX=B@T Z\90!  '$_,/X];'[Y2OSJAVK=?Z2U]R/D/F+?G_ "%__4G^9F+'
MV1D3#D#$%2(F(*B!](%1$^D05(B8@DB8%1 Q!4B)@21,05$3 DB9G;;4[>FG
M8J()H3:E2HY.)CON,I>38ZEM:D$M)]A5#*I?5%,H)TJM1ZQN2BFDVJZ^,IS$
MD(^DB5*EJ2N4^X^I"20A3JU+-*2Z"(U&="[@IC!1U*AZ3N2FZR;?*?-+SS:T
M.(<4EQJAM+2HR4DR.I6F71Q[0-)B+:::X",A]^4ZI^2ZMY]?KG75&M9TX<34
M9F(C%15%H17*<INLG5GS2M;2TN-J-#B#)2%I,TJ(RZ#(RXD):KH8BVG5"1(D
M2G5/RG5OOJI<ZZHUK.G JFHS,4QBHJB5$5RG*;K)U9XF1(;:<CMO+0P]3KFD
MJ,D+M.I7)(Z'0^BH.*;3II1*G))I/0]?'0^9NNUOZQ5]MEUQUMI2E>U3A0*(
M5($XXFTDK41(,S01&94,^DR[70%$34DJ7+4DT*D.F@RH:36HR,NU2HIP+8>F
M.5*5/&ILV.RY'CR7F8[O\JTVXI"%]CODD9$?UQ#A%NK6DKC=G%.*;2>M;3Y,
MR)$5U+\5U;#Z:VNM*-"RKP.BDF1B914E1JJ(A.4'6+HSYK<<54E+4HC4:S(S
M,ZJ/I/CV3[84%6]9\S$DD3$$D1!)$P*B($D3$%1$P)(B"2)@5(B()(F!4=?^
MA_\ %/8??%'YA(T+M)_=A]WSG2>RG]F?WO,='#4S=0   _/G(I_Q"7[,Y^&8
M[G:]A<A\MWG_ %)<K*6T>AXU%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"I[;0Z
MEP,N@P%2;SK\A1+D.K=614)3BC4="['$S%,8I:D52G*3JW5DF9,N.VXU'?<:
M:>*CK;:U)2LNTHB,B/I[(B4(R:;6HJC=E%-)M*6OCY3Y=]:::G:9U-->%2[-
M!50\ZCOK214[2.I)KPJ?<"@J?3KI'B_BG6K\5NZSJ+CZN^E+K:TK3LB,"K6F
MDKZR6'#716M./;RGS[XDF@C.PSJ::\#,N@Z":%%10S(DF9VEQ(NP1F)H*GO?
M5(ZG4N!'7H(10C029<>C.I>CN*9>3ZUQM1H47U#(R,1**DJ-517"Y*+K%T:(
MN*<=6IUU1N.+,U+6LS4HS/I,S/I$I)*B(<FW5ZSZ%(E)9..E]PHZN)M$M1(/
M_IK01@5:TTD]9+#AKHV<!\;!44U/LY(E/=7US[CG5)ZMJ]:E6(Z+4U/@7<(4
M*$5J17*Y*5*MNBHN38>-//L$XEAU;274V.DA1I)23["J'Q+N&)<4]:U"-R4:
MT=*ZQUTCJ"C=:OQ8E=83-Q]7?2EUM:5[H856M-)'62PX:Z*UIP5VGS,C,S,^
M)GTF8J*:GEH"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5.M?1S6D^7IH+UR)T
M@E%]4D&.7]I/U?X5YSN78MUW?^.7F-MC6#>#Y2&2D-*;/@9\4J[2BZ# $8CQ
MO-=_P>;.QTOX1>J /N        L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@
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M!4DDD^;)&5Y(K;6IGT5,6F8SM[,4ZR3E354R&3W9ELFV[,%#%KIPT+R+,R0
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MH1K6B+@+<O"C1_591M=#$@S4WVB7V2^N *P >*,DI-1]!$9G]8 8XB?(:/\
M%*M;(S-+?2DB,ZT DNZ,DPI"5&E9&9$9D23,J_5 @E[HQ^TO[PP ]T8_:7]X
M8 L<N8P>XXAWOJ)QF332TZ]](QY]'U@!4:+\2-:]ZH/M=  OX    *.362\F
M&GUA46^?\$NA/UP!6=' N@ ?"6\;+7><7EG8TGMJ/U !*.R4=I+9'4RXJ5VU
M'TF /J              "C7_ %643G0Q(.U?:)SL']< 5@
M                 IY;RFFR2WQ?=.QLNZ?9^L /HPREAI+2>-.D^V9])@#Z
M                       *:8TI2$O-?R[)W([I=DOKD /LRZE]I+J/6J*O
M_D $P
M     !1E_6Y=>EB,?#M&[_Y !6               ^;[*7VE-*Z%%P/M'V#
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MUP!6
M    IY;RFVR0UQ?=.QLNZ?9^L /HPREAI+2>A)<3[9]DP!]
M   !1R2..\F8GUAT0^7\$^A7U@!6$=>)=                         *>
M1"CR3)3J>^+A<1T.@ ^<,BC.+A'P(N_:/]\@_P#M( 5@
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M.W.&B2:Y2XM7[=U5A)2Y&GY"H,Z<3Z!YGL4<8CD/*F*]854,%_!+I5]< 5@
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M,_L-CG':#]5^%'5>S/Z/\3\QN)7]:E$CI8CG57:-SL%]8:Z;25@
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MLNVI1-T]4<X[0?JOPHZKV9_1_B9N^.R4=I+9'4^E2NVH^DQKIM)]0
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M8@J(F!*(F(*B)@2=P>BK_P 5I]\97VD#G':#]5^%'5>S/Z/\3\QNT:Z;2
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M>E27C+LK)Y3)&?\ TM)&6[0W'+.23^RHKQ5\YKW9"U&&[8-?:<F^7$X^2*-
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M$Q!41,"3N#T5?^*T^^,K[2!SCM!^J_"CJO9G]'^)^8W:-=-I
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MB"HB8$HB8@J(F!)W!Z*O_%:??&5]I YQV@_5?A1U7LS^C_$_,;M&NFT@
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M+9B7/A]!N7E7PY;:I[UQ/S21K>\OU5S[S\IM^Z?T=K[D?(<S:F7_ -3T@_\
MX]EO_6!NV:_XI?<A_*<WW?\ \V_]2[_.;\](+_B'9/XL3VZP-3W'^MA^+\K-
MX[3?\=<_!^>)A/HFE34\][XI_,(&3[3?WH?=\YBNQWZ:?W_,C!?2O*N\X?WI
M1[9?&5[-?IY?>\R,#VP_5P^XOS2.K\-_[(Q_ZLS^;(:#=]M\K.J6O87(CB?D
MUS#C\N]Z>E90U%@,G?#R2TD:C:+K+FWK2XG8KUQ%QM,Z$9T(=-WMD'FK%(^U
M'2O1X?*<8W%O59',5G[$M$N+8_!Y*ZV=8[UI.N\V-5;Q[THE1EJ3,Q>5B*2[
M8X1&1+09':M*DJ,E%6AEW:&7/\GF[N2O8DM.II_MH.J9_(V=XV%%O1[49+R\
M:_;71F,<JN1.*Y:Y)_./Y%68S+C9L1WC9*.VPTNEUJ+W#-2J4-5W1PITB^WE
MOF>;BH*.&/+6OD,;N?L_#(3<W+')Z$Z4HN2KT\9KSTE>:&,R,-O0-?E)E&3R
M7\Y(942VDFR=6XY**I*5=WZZ>M-)%TU(LSV?W;.,NOFJ:/5]/H_Z&O\ :G>\
M)Q^6M.NGUVM6C[//I>RB6TV1Z.14Y38CV69[9<&$W]^LER1\B-C[,_\ 'PY9
M?F9S?Z0I?M>V#^+"]I,#==Q_HH?B_,SG':3_ )&[^'\D3H;T9RIRMC?KLO\
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MF?T?XGYC=HUTVD           "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
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M1U7LS^C_ !/S&[1KIM(           %@F?'?#>]65]L8X -%^)&M>]4'VN@
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MB@"HH J* *FU]FE:[I>-U.+%U+$Y%66P,/*9"5/*6X^M^0:TKM4W(022[RO
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M-YFU;<.JC*W&3I--R5/;5=6+1ZNFA8X>HY+!.[!C\UKK.7EM8=Z<VXUD63*
MT3G5E+K'<6EQ2%%_)&=>Y3INYYJ%U0E"XXK&E[+];_#I6BNTL;>1N67<A=M*
M<NK<O;7J*M,?JMIT?V?,?''<I-\RL6),@8^.\S.;;=BE[H0$N+2ZDE)_%J?)
M9&9'ZTTU[@JN;TRT&U*33CK]67H*;6X\Y=C&4()J237KPX>+%4M\/0-IG3LI
M ;B-LKPCIQ\M)DR&(\2,ZE9H-"Y#CB6[KB.A)49GV![3SUF,8RK7'IBDFV_
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M;D>K47+!^<]-;-=KKT=ULY>/*IEQ_K1&VE/:&,SJE;O3M1__ (A1IL3]F?\
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MDX\O[4,5=R&8M7.KE"2ELIY-O*M!G48E)Y6Z@2B,E%MCQ&1\#(R0UP&(D_\
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M3$%1$P).X/15_P"*T^^,K[2!SCM!^J_"CJO9G]'^)^8W:-=-I
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M-ZZ[<+<[#A1P6&JF\-)+AIK3U^.MHY6MOP=C/:U/IBXK6FE3\H\I'6&N.O\
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M)1$Q!41,"3L_T5NM^;IJRM/=2;=VK;&1S?M!^K_"O.=8[-?HE]Y^8W\->-F
M           L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@            .,.=9
M?M/V#V1CVLT.N;C_ $5OP_F9\]]J?^3N\L?RQ,!H,V:O44 5% %10!44 5%
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M[]^7E,0J0R!C!4@ J0 5( *D %2 "I !4@ J0 5( *D %2 "I !4@ J0 5(
M*D %2 "I !4@ J0 5( *D %2 "I !4@ J0 5( *D %2 "I !4@ J0 5( *D
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M6[OTUO[J\AQ'>B_W=W[\O*8?<,@8V@N 4%P"@N 4%P"@N 4%P"@N 4%P"@N
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M1KIM(           %@F?'?#>]65]L8X 4^H,J=T36C;X/-XN"MH^Z4='#ZX
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M0QU#I/$:":)!U,B*G$AJV^<[;S5R,K=:)&X[AW?=R=N4;E*MUT<AN(8 V4
M9TXGT #E1_D7OTR0_)99BFTXZM2%'(3Q(U'QZ!U*WVDR:BE66KHG!KO8K>3F
MW2.E](^/S <Q/YB)Y2GU!7WDR>V7,4=RMY;(^\1/T?\ F(?_ ($3RE/J".\F
M3VRYB>Y6\MD?>//H_<Q?YB)Y2GU [R9/;+F)[E[QV1]XC]'WF-_,1/*4^H([
MR9/;+F*NY>\=D?>(GZ/?,:O\A$\I3Z@=X\GM?,3W,WCLC[QY]'KF/_,1/*4^
MH([QY/:^8GN9O'9'WB)^CSS'_F(GE*?4#O'D]KYB>YN\=D?>(GZ/',C^8B>4
MI]01WCR>U\Q/<W>.R/O'A^COS)_F(GE*?4#O'D]KYB>YV\-D?>//H[<R?YB'
MY2GU [QY/:^8GN=O#9'WB)^CKS*_F(?E*?4$=XLIM?,3W/WALC[QY]'3F5_,
M0_*4^H'>+)[7S$]S]X;(^\1^CGS+_F(?E*?4#O%E-KYB>Z&\-D?>/#]'+F7^
MCP_*D^H([Q93:^8J[H;PV1]X\/T<>9GZ/#\J3Z@=XLIM?,.Z&\-D?>(_1PYF
M_H\/RI/J!WBRFU\Q5W1S^R/O$3]&_F;^CP_*D^H([Q93:^8GNCG]D?>/#]&[
MF=^CP_*D^H'>'*;7S$]TL_LC[QY]&WF=^CP_*D^H'>'*;7S#NEG]D?>/#]&S
MF?\ H\/RI/J".\.4VOF)[I9_9'WB)^C7S/\ T>'Y4GU [PY3:^8GNGG]D?>/
M/HU<T/T>%Y4GU [PY3:^8GNGG]D?>(GZ-/-#]'A>5)]0.\.4VOF*NZF>V1]X
M\/T:.:/Z/"\J3Z@CO#E-KYB>ZF>V1]X\^C/S1_1X7E2?4#O#E-KYAW5SVR/O
M'S+T:>:"E*1U$&Y-*EXVBM#[/0*>\.4VOF*^ZF>V1]X]^C+S2_1X7E2?4$]X
M,IM?,1W6SVR/O$3]&3FG^CPO*D^H'>#*;7S$]UL]LC[QY]&/FG^CPO*D^H([
MP93:^8GNMGMD?>(GZ,7-3]'A>5I]0.\&4VOF)[KYW9'WCSZ,/-7]'A>5I]0.
M\&4VOF)[KYW9'WCP_1@YJ_H\+RM/J!W@RFU\Q/=C.[(^\1/T7^:WZ/!\K3Z@
MCO!E-KYB>[&=V1]X\^B]S6_1H/E:?4#Z_E=KYB>[&=V1]X^;GHP<UDVEXO!-
M2CHE/CB",^R9E4NP([P93:^8J79C.;(\Y[]%SFO^C0?*T^H'U_*[7S#NSG=D
M><\^BWS8_1H/E:?4#Z_E=KYB>[6<V1YSIGD5I.>T'12P&Q(:;R!3'WR)APG4
M]6Z2+>)$7'@? :?O;-0S%_'#51&][ER=S*Y?J[E*U;-F##F<
ML$SX[X;WJROMC' !HOQ(UKWJ@^UT "YG_59=>AB2=#[27?\ R@"L
M     4F1C+DQ[&_7I,E$7;Z2I^Z +5'C/,/M.R$&VT2R(U'V^Q]8"3( (
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M*1P2TK@:2Z:=JH$E\8-"F6U-E1LTD:2[14 @^@
M                   I)B5-FF8V55L^O(ONFSZ2^MT@"J0I*TDM)U2HJD?<
M, >@         \,R(C,SH1<3, 4D4C?=5-47!7>,$?8079^N *P
M        !8)GQWPWO5E?;&. #1?B1K7O5!]KH %[?92^TII70HN!]H^P8 HV
M,FR1):D*H\D[5J+BFI<*U+M@"X=/$N@            !!UI+S:FEE5*BH8 ^
M,-U1I4P[_+LG:H^V78/ZY "I
M$'74LMJ=6=$I*I@#XPVE$E3[O\N\=RB[1=@OK$ *D
M             !1R2..\F8GUGK'R+]Z?0?U@!6$9&52XD           /F\Z
MEAI3J^A)5IVS[! #YPVE(0;KO\N\=[G<[1?6 %0
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MUAJ,UUK<?'B0$F4H-1H2:BHHR(S+N@02
M
M4A8Z&ESK2;XUJ2:][7Z@ JP         4KF.B.N=:I'?'Q,B,R(S[H J2(DD
M22*A%P(B[0 ]                  6"9\=\-[U97VQC@ T7XD:U[U0?:Z !
M=ICJDI2PU_+O':GN%V5?6( ?9II++:6D>M25" !U2D-+6DJJ2DS(NZ1 #&_&
MY/6=;UJK^FM?^P"2^)E2321G%74R(^E($'OC,C]$7]\GU0 \9D?HB_OD^J '
MC,C]$7]\GU0 \9D?HB_OD^J 'C,C]$7]\GU0!9'Y4AQY2U+4E1&=$D9E;3L
M27V&XI^(VMTJJ41DJO9XT_= @^<4S8=7"4?!/?L&?90?8^L *P
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M#BDYUI-)OZ:]WZG0 /N
M
M                      L$SX[X;WJROMC' #S1C).CZVI1T26*@F9]PHR
M!=8A&\M<U94O[UDC[#9>J *L ?&2_P!0T:R*JS[UM/;4?00 ^#&,CH)"W4WO
M%Q49]%W3T=  K0         4K^/BOJ4M2*.*^Z(S+CVZ #V$X:FS9<X/,=XL
MNYV#^N0 3&E+0EUK^79.]ON]LOK@#ZLNI?:2ZCUJBK]3N #Z
M                   "C:_K4DWSXLLU0UW5?=*_[ !6
M     "@DMIG22CF7XMDKG%ETU5T)(_W0!41HC,4C)HCJKI4?$S 'W
M ?-YEN0V;;I52?V2/MD *'Q9K'/-OHJ;1]XX:N)INZ#( 7(
M
M
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MZ0!]@          !%QM+J%-K*J5%0R %/#<41*BNG5UGA7]\CL& *H
M
M
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MZ=>P9$? 30&5\L^9N!YA8J8]B">8FXQPV9N+F$3<N.NE20X53+ZBB.A_6,A
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MJ5%4C[A@#T
M
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M#5_)G5;!]P^E/U@!6
M
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M*2-2CXJ,S,S,SZ"* 4')O0<CRNUY[6<I-:GKES7YS4AA*D(+K4H389+XU[P
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MWM'W2['UP!]&'DOM)=3PKTEVC+I( ?0
M
M                                           !8)GQWPWO5E?;&. %
MJU>>\QIVM,,]Z98F :E4J=3CHZ*@29%B7NNZXUE5XS)2E]LN@B^L!!<@
M               4.5<2W&(S*JS475G^]47&H I(.2D+?2T\9+2LZ$="(R/Z
MP$E=,2ILTS&RJMKUY%]TV?27UND""J0I*TDM)U2HJD?<, >@
M        "C5_6I1(Z6(YU5VC<[!?6 %8      /"4DS-)&1J+I*O$ >@
M     \N36VI7=JO$ 1=<2TVMU7K4$9G]8 6-W)O/U;<(B8497)3ZZTCXE4"2
M_(MM39ZVA6_4 @]                   !9'YRXLIY,8B)!JJHE%4KRZ3+Z
MH$ESAR2EL$[2U1':HNZ0$%0
M
M                                  +!,^.^&]ZLK[8QP H]1Q[<O2M9
M6:C0X6*@E<7&I>+HZ2 DOD!I,5UV*9?C#HM*_P!\CH_< @KP
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MHFD'7LFH^R9@0?8
M
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MY*3_ $0?2,WT'XO2/KF2^(N9^@?/[R@^5,?\E)_H@^D9OH/Q>D?7,E\1<S]
M^?WE!\J8_P"2D_T0?2,WT'XO2/KF2^(N9^@?/[R@^5,?\E)_H@^D9OH/Q>D?
M7,E\1<S] ^?WE!\J8_Y*3_1!](S?0?B](^N9+XBYGZ!\_O*#Y4Q_R4G^B#Z1
MF^@_%Z1]<R7Q%S/T#Y_>4'RIC_DI/]$'TC-]!^+TCZYDOB+F?H'S^\H/E3'_
M "4G^B#Z1F^@_%Z1]<R7Q%S/T&4ZKNVK;M&D3-6R*,E&BN$R^XVEQ!)697$7
MXQ*3Z!99C*W;#2N+"V7^6SEG,INU+$D7\6I>   !A2^;G+E"U(5GF24DS2HN
MK>Z2X'_X8S2W)G7_ .F_%Z36'VHW8G1WES2]!Y\[W+CS^S^3>_HQ/T/._#?.
MO21WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_
MHP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W
M+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_
MC+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#
M?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;
MW]&'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G
M>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW
M7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYW
MX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^
M3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!
M\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.]
M.Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/
M._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V
M?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO
M0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1
MWIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^
MAYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+FEZ!\[W+CS
M^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O2.].Z_C+F
MEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&'T/._#?.O
M2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO0/G>Y<>?V?R;W]&
M'T/._#?.O2.].Z_C+FEZ!\[W+CS^S^3>_HP^AYWX;YUZ1WIW7\9<TO09)@\_
MA]D@^Z6#E)F0KU-=<@E)*]%*E11$?"HQN8RUS+SP7%A9F\GGK&;M]99EBC6E
M>/PER%L7H           %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\ 4;?]5E&
MST,/U4WVB7V2^N *P         ''/.95.9>>+^&Q[6:'7]Q?H;?A_,SYT[5K
M_P I>Y8_DB8)<,Y4U6@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"
MHH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X
M*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*BAOOT9C
MK)V7^)#^V\-$[6>S:_%_*=7_ /;Y>M?Y(?S'0PY^=>   #\X^:Y?M-V_WWF_
MGU#K6[OTUO[J\AQ+>C_W=W[\O*8?07YC:B@"HH J* *B@"HH J* *B@"HH J
M* *B@"HH J* *B@"HH J* *B@"HH J* *B@"HH J* *B@"HH J* *B@"HH J
M* *B@"HH J* *B@"HH J* *B@"HH J* *G7_ *(!4U/8??%'YA(T/M)_=A]W
MSG2>R?\ 9G][S'1HU(W8   .!\@K^ORO9G/PC'=[3]1<B/E&^OZDN5^4IKAZ
M5/"@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH
M+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*B
M@N"HH+@J*"X*B@N"HH+@J*"X*B@N"HH+@J*"X*BAU;Z/IUY?)_79'VD#EG:7
M]9^%'>NQ'_'?CEYC:@U<WL           "P3/COAO>K*^V,< &B_$C6O>J#[
M70 +^ /C)8Z]HT$=%EWS:NTHN@P BO\ 7M$I14<2=KB>THND ?8       !Q
MKSH53F;G_9&/:S0Z]N+]%;\/YF?._:I?^3O<L?RQ,"N&<-7H+@%!< H+@%!<
M H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@
M%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H;[]&=[
MJY>Q$HOQ;B8B27V"42G:%]>HT/M8]%K\7F.K?^WZTW^2'\QT8-!.M   !^<_
M-8OVF;=[[S?SZAUO=WZ:W]U>0XAO1_[N[]^7E,/H+\QE10!44 5% %10!44
M5% %10!44 5% %10!44 5% %10!44 5% %10!44 5% %10!44 5% %10!44
M5% %10!44 5% %10!44 5% %10!44 5% %10!44 5% %3KWT0BIJ>P>^*/S"
M1H7:7^[#[OG.E]DO[,_O>8Z+&I&[@  !P#D5?XA+]F<_",=UM>PN1'RK?7]2
M7*_*4UP]3QH+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H
M+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!
M< H+@%!< H+@%!< H=8^CT=>7J?UV1]I Y;VE_6?A1W;L3_QWXY>8VL-7-Z
M           L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@  *-W^JR2D%P9>HA[
MN*^Y5_V "L        <8\ZCIS.V#V1CVLT.N;C_16_#^9GSUVI7_ ).[RQ_+
M$P*X9PU>@N 4%P"@N 4%P"@N 4%P"@N 4%P"A?=;T_9MO5)1KF/5/5#)!R;%
M-H)!.5)-3<4GIM/H%EFL]9RU.MEAKJU^8R>1W5F<[BZB&/#2NE+7JUM;"_\
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M *"X!0ZT]'<Z\NT_KTC[2!R[M+^K_"CNO8K_ (_\<O,;7&L&\
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MWJVT[#JN68R&O2G699.((V$&HVW^/\FXV7!9*Z*?8XBSS65M7X.-Q)KR<:?
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M7F-N#63=0           +!,^.^&]ZLK[8QP :+\2-:]ZH/M=  OX
M    #B/GB=.:FQ>R1_:K0ZSN3]%;\/YF<$[3+_R5WEC^6)KZX9LUJ@N 4%P"
M@N 4%P"@N 4%P"@N 4%P@4.P-5Y5\L=DTO"%(@P\C,9A,HE9" \:5G(-%7+U
MQU)N,E&9=_4QS+-;USEG,3I*44VZ*2X.#7YCMF1W%N[,Y2W6,)M1590?VJ:=
M,:5T[3(->Y/\N]3FHS&/Q9>/1SO9E2W7'^J,N-R2<4:2,NDE4J7;%EF-[YK,
M1P2EH? E2ID\IV?R.5GUD(>LN%MNG.Z>'687SBYVX7%XF9K6J2T3\[-;5'?F
M1EW,Q&UE:LR<2=%.T.B22?>GQ,^%#RNY]RW)S5RZL,8Z:/7+P;/*8'M#VDM6
MK4K-B6*<DTVGHBN'2OM;*:M;U4>">C!B%2]NRF94FK.-A=22NT]+<*W_ +K:
MQE^T][#8C#I2\2_ZHU[L3EW+,SN<$(T\,GH\29>O2@VPC7BM,C.>MKDL@DNV
M=6V$G3_\11D?\$Q:]F,K[5Y_=7E?F\9?]ML][&73_P 4O)'^;1R&<Z]RHY7[
M'J.&2]!AY"3'A,-2,CCWC0I;Y-D;BE+CK3<=QGZ^IC$9C>N<LWYTE**;=%)<
M'!K\QL&4W#N[,96W6,9M1590=*NFEUB].G:7[7N47+S4)B<QC\8DIT?OVY<M
MU;W54^Z23BC2DR_?4J7;%GF-[YK,1P2EH? E2ID,IN#(Y2?60AZRX6VZ<[IX
M=9@G.3G;AH&(F:OJ<M$_,S4*C2IL=5S$9I96KM<+@IPR.TK3[WI,ZE09?<^Y
M;DKBNW5AC'2D];?)L\IK_:'M):MVI6+$L4Y*C:U17#IV\FK7K5#7GH\Z_JN=
MS&:1LY0I)>*MQH>.FFV:W%/KN4XTE??7()LBN1Q*[NC.=H,Q>M6X=5B6FK:X
MN!\M>'8:QV2R>6OWKG7X9>JDHRIIJ]+5>%4UK5BXS=:_1_Y6K?)XL2ZA!'4V
M$RY'5GW.+AJ_[PU1;_SM*8OX5Z#?.Z>[:_VW[TO34O\ E-AT+E;A$19#T;$P
M8Z#.+C6*&^YV>\:352C4?2H^SQ4?9%E:R^9SURJ3FWK;U<_[<1DK^;R6[+2B
MW&W%:HK6^1:WQOPMG'?,3>)>_P"SR<_)1U,<TICP(M:]3&;K:DS[)F9FM7\(
MSIP'3]W9*.4LJVM+UM[6<1WOO*6?S+NO0M45LBOV;Y6=&\D>;6*V#!P]7S<M
M$;9<>A,9GKE$DIC+96MJ0I72X2:)6FM3I=V3IHV^]U3M7'=@JPEI^Z^'P?\
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M&^@  !^=F25_B,SV=S\,QW"W["Y#YDO+^I+E92W#T/*@N 4%P"@N 4%P"@N
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M!07 *"X!07 *"X!0[ ]&XZ\MT_K\G[2!S'M'^K_"CMG8[]!^*7F-NC63=
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M%#U-RC)*2-2CZ"(JF?V!%10\N$B@N 4%P"@N 4%P"@N 4%P"@O+M@*"X!07
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ML0JVI=(N\]F?E[$KG17CU+QEANS)?-YF%FM%)Z>1:7X:+09'/YM9&#/?@ZC
MQV.TYI?51L,Y!CR$/QVU4(Y*WD+=<4X1=^?65X\.V+&&ZXRBI792E<Z6)JC_
M ,--"IP:#)W=]SA)PL1C&SJP.$7B7^+$G)MK7I])6[#R_8V;8]<=T=AN#&W+
M&N9.-CW%*ZF/+BMN+DQT*(C.VK?><*5.G!(\\OGW9M7%>=7:EAKM3IA?CTGO
MG-U+,7[3RZ45F(XE&NB,DFY16C5HT<O BQR.6<]&(R61Q^8QF4G81LG\WB8+
MRW),5OH6JIH)MTFSX.*:6I*3[)BZCO*..,91E%3]F36A^.JKP52+"6YIJW*<
M9PE*VJSBGZT?%1T^UA;2VLH\1HS\S"M;)F\K#U[ 27%LP94\W5N2EM'1SQ=A
MAMQQ:4'0EKH22/LU'K=SJC<ZN$7.2UI4T<K;25>#A/"QNURMJ[<G&U!ZG*M9
M4UX8Q3;HZ5>I;1C=%DY*1E7&\M ;U["V>/[&M;I0:N^L2V75]:XM7$DH2W6H
M7,\H*/JRQSU1T8O#IHEQU)M;KE<<WCCU=OVIZ</@T8F]BPGTGZ;,P*\-G(TV
M-F-<GRT,Q<M -9M$\VLC-EU#J$+:=M[ZQ:>)=%:&*89R-U2@TX3BM,7LVJE4
MUQHJGN^5B5NXI*=N4M$HUI78ZI.,J::/P5HS)-^U?)[7S=VV+ 4RPQ$>5*GS
MY:^IBQ8S;:"-QU=#,BXT(B(S/L$+'(YJ%C)6W*K;T)+6WL1E=Z9&YFMY7E"B
M4=+D]$8JBTMF+9C1WH.$7LV&RL/8, PZF/,EP.N2Y%=<+O.O9?;;6A*SJ2%T
MM,^S4Z#(6<ZI7.KG%PE2J3IIY&FT^-:S#W]VN%KKK<HW85HW&M8_>C))JO ]
M3Y70K6^6LMN-!3E<WC<3F\LRF1B\),<=3)=;<XM]8M+:FF#<X=7UJTU[-H\G
MO*+;PPE*,724E2G@TU=.&B/=;FFE%3G"$YJL8.M7RNF&-?LXFJ\1<L?J&S:O
MFMTULT8J1.QF >DY54M"WT(C.-LNJ.*JPC*0DG4DDS[VM>/08\;F;M7K=JYZ
MR4II1IHTZ5ZW^'0>]K(9C+7;]FD'*-J3E73ZM(OU73VU54X-?$6-C1K<+#RV
M8SV.PSV38<EXK'S#D'(?CM&:>L/JFEI;2LTF3=YE>9<!=//?U'&$)347235*
M)^%JM.&FHLX[LI;C.Y<C;<U6,98JM+A=(NE:>K7VN R!G1-=>Y5Q=D5F\9&S
M+V3<0Y*><E]ZRB*ESQ.Q#2BZXE'>?>TXEWXLWGKJSCMX)..'5ZNO%[6O5^U#
M(1W79>[U>QP4\>MN>K#7!11?K5TZO"6!W1%P<-&R>;S>/Q4[(0CR>,Q$DWSE
M/Q:*-"JMM+;0;MOXHEK*[N"\6>4KCC"$I*+PN2I1/PNKIPT6@Q\]V.W:4[DX
MQ<HXXQ=:M:=B:5?LU>GB,0J,D8>AT?Z)IUE;7['!_"?&D]J-5O\ %YCI'8GV
MKW)'^8Z;&B'3P   X#YG%^T7:O?69^>4.P[M_2V_NQ\A\^;X?^]O??EY3%+1
MD#$U%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"IO".O>,=RST9S0<2N4
MY.1D_==R-BF<@;BFYBDM$ZI;#IEPN(JF71W!JDEEYYN\K\J8<&&LW'[.FFE&
M]6YYNWN_+O*Q;Q=9BI;4]4]%?5D4TN PKFKCXFGP<.WGEX@U9_&RFB>Q#&53
M$=7,:;0W>DK"30B09D2ZD?9'I";^3D[KGAQ^JTZ3<<2PO@U\? >5R"^H0A8C
M;QN'KQ:K;4\$G.-%74EP5];0^$U_@M*?RN)=V+)Y*+@M=;>\53D)W6JZZ12I
MMLM,(<<<-)'55$T(NR,Q?SBA/JXQ<YTK14T+C;:2,!EMW.Y:=Z<E;MITQ2KI
M>R*BFWQE2]RVS;6P83!(D1)#&QFCW&S##BG,>^E2K3,EDBXC0KO5H-%R3Z2Z
M!0MXVW;G.C75^U%^TO!Q\&FC*Y;IO*]"TG%];[,DW@?AIP/0U2JV:BMC\J,E
M)E.8-&9Q9;DA*U_!HWEG),VR,S:ZXD&QUU"KU76U+LT,C(>,MZ0BL>&75].F
MCEI7%3CH>\-RW)2ZK'#KM?5UTZ.#%3!B_P .+EH9#A<$]F.1K\%<J/C6XFV+
MD3I>06;++#:,>EOOB)*EJ4:U$DD(0I1GV*5,6=Z^K>\%*CE6U1)::^OS>%NA
MD<OEI7MTN-5##?JW)T2_ITXWKHJ)-\1A.Q:+.UZ1B35/A3<-G2NQ>;CN*\2<
M2E9-KN4M*5(-LS+K"-/>C*9?.QNJ6AJ4/:B]?[Z\&TPF:W;.Q*'K1E"Y[,T_
M5UT==E/M;"IF\OTHP^0R^#V#&Y\L.259:+!\82\RVM?5]:@GVF^M:)1D2EHZ
M*EV!1#/_ -2,)PE#'[+=-/%H;H^)GK<W9_2E<MW(W.K]I1Q56FE56*Q1VM>0
M*Y<9./K<?:\AD($'#38;DN"M]U1.OO-J<3XJVV2;E.GU=?WA$HJJKP#ZA!W7
M:C&3DG1Z-2T>LWLT\O$/I%U65>G*,82CB57I;T^JE2N+1R:=? 71/)[*-3HF
M+R6=Q&/R64:9>PL5]YR^7XPVE:*6M'U9&:C;(W;;EI,DU+B/![V@XN483DHM
MXFDM%/#IVZ*Z-9=+<-U3C"=RW"4TL"<GZU:4^SHV>M2LE15UE.URFS3A28*\
MCCV]LBL+EN:LIU2LAU3236HBM0;766E>31.76\3IT"I[TMJDL,NK;ICIZOII
MP5I2I0MQWM,7*"NI5ZNOK457P*F*FG#6M-.@L>!UG&Y:(<S([+C<(DW3CLL3
M/&''UK)*5$HT,-.6-]]2]1D5:B[OYB=N5(VY3T5T4IXVM/$8_*Y2%V.*=V%O
M31)XFZ\D8ND?\3*+8]=R.K9F3@\JE!3(QI,ULK)QIQMQ)+;<;672E:5$HOW:
M&/7+WXW[:G'4SPS>5N9:Z[4]<=FE;4UQ-:2UVBX+2HM 5%H"HM 5%H"HM 5%
MH"HM 5%H"HM 5%H"HM 5.JO15*FL9W]?1^92.?=I_P"]#[OG.L=BOT]S[WF-
M^C3SH(   ?F_DS_Q*9[.[^&8[;;]A<A\VWEZ\N5E+7NCT/*@KW0%!7N@*"O=
M 4%>Z H*]T!05[H"@KW0%!7N@*"O= 4%>Z H9WH&'PY8O8=YV",60QNM-L%&
MQ:S-+<J?-6;;"7#*AFVBAK<21\>'8J1XC/WIXX6;;PNY6KV16NG&]2,_NO+V
ML%S,W5BC94:1X)2DZ1KQ+6UYM#^$_FKM^1@R<4\N WAY"%M>Y[.-A-LM(61I
MHU1F]!I(^]42KBH7$5V]V6(24UBQ+AQ2J^72>=W?.9N0=MN.!U6%0@DEQ>K5
M4X-->,E#Y=.^(8Z;L&>QFN+S+9/8F)DEO=<\RLZ(>63+3A,M+XVN.&5:=H1/
M>"Q25N$KF#VG&E$]FEJK6Q"WNEX(RNW(6NL58J3=6N!NB>&+Z3/G#Y9;5,S^
M:UCJV(^9P48YLMI]Y+;:F"6TF]#I]Y::74N7*4E-E3KV!5/>5F-J%S2XS=%1
M<.G@U\%.4HAN?,2OSL42G;6)U=-'J\.K[2>FF@KCY537X"<UBM@Q&1UYI:VL
MKEVWG6H\!QLB/\<3K:'#)=:-&VA1K/@1<2KX_5(J6"4)1G]F-%67)1TT<-6J
M%R]QS<.LA<A*&E2E5I1:VU5=/V:)UYJV[,:!/Q<W M1\A#R.*V59-XC,1E+\
M66OK4M+2LE():%-J45Y&GA]7@/>UGXSC-N+C*W[47KU5Y-/ 6^8W5.W.VHRC
M*-[V9+5KHZZ*JE=.@O!\G<WX[-P3>7Q;VWPTNNEKC3ZU2W6F:G5"K.KO4DNL
M2V:[[3JHD] MOJ]O"IX9=6_MTT+QUIP5I2NTN^[]W$[>.'6JOJ5]9I5U:*5>
MM*M<.ETU%NR'+>;$PF1R\/,XW*2,)U?N[C8+JW)$0G5$BM302'$H4=JU-*4E
M)]DRXCVM[QC*Y&#C**G[+:T/QU7%6A;W=SSA:E<C.,W;]N,6VXU\%'3A:;2/
MAB]$.3C(65S>=Q^O1\J:BQ",@IXW)!(58;AI8;<ZMJZJ>L<H7#M<17<SU)N,
M(2FX^U2FCBTM5?$BBSNMNW&=R<;2G[.*M7Q^JGAC_B=.8^L#E=MF0S6<UY#3
M+.7P#:'IK#[I-I-I;B$]8APRLL)*R=N4HBLX]P4SWG9C;A<TX9ZM'BV\%.4J
MM[DS,[MRTDL5O75TT56E<%*/%P:.8C$Y?29TS*>+YK&GKV&)KQ_9E..)QQ+>
M02B;;/J^L<76J22EOB9=J@F6\%&,:QECGJAHQ>'31<XANB<Y3I.&"W3%<J\&
MG@6BK?!J+CK6$?A9C+LZQD<+L+98&=+>E26'U--QT$9.DAM]I"D22)-4<+:'
MQ.AF/',7U*$7<C.'KQ5$UKX-3TQVGME<LX7+G4RMW4K4Y5DGH6IT4HZ)[."C
MUT99M?U#'9J-%<D[5B<3,GK-F'"F*D&Y>2K"ZY33*T,I4?0I:NCB+B_G)6VZ
M6Y24=;5/%5U?@+7+;OA=BL5V$'+4GB_BI%J*V59D^F8N?@8G,_"Y-OJ<A PK
MT>2U6I$M$ELCH9<#(^DC+I(6&<NQNRR\XZ4YI^)F6W;8G8CF[<U24;;3YT:N
MJ-@-2H*]T!05[H"@KW0%!7N@*"O= 4%>Z H*]T!05[H"@KW0%!7N@*"O= 4.
MR?1HX\M$_K\G[2!S/M%^K_"CLW9']#^*7F-PC6C<0           +!,^.^&]
MZLK[8QP :+\2-:]ZH/M=  OX            #A?GN?[6=D]DC^U61U;<OZ.W
MX?S,X;VC_P"0N\J_*C7L<_ZPS[(C\(AF):C74CH'8M\S$;GE.UC+Y%R9I&1F
M,XN?B)+AJAE%FM-MF9%7O+5+ON29'P&GY?)0>[U<C&ER*<E):ZIOGV'1,UO&
MY#>LK,Y.5J;47%OU:227@I6NBA1:[&D8[5]DY>XC#X[8]HP.Q/2U8?*-FX<B
M"EGQ<GXZ$NM&M:#1Q(ON55[(]<Q)3NV[\Y2MPG;2Q1X'6M'H=%IYT>64A*W8
MNY:W"-VY;NMX9K7&F'%%557HYGQGRQ&V9K7]STU&\8&+I6#C*R"H28<9<4VU
M9)@XRWUH==<4DDKL,S.G"I]@57<M;NV+O4S=V3PUJZ^RZTT(\K.<NVLUEWF+
M<;$(XZ4CA]N.&K3;:TTV$N5'+C9-6YC09^<.*Q":9G>(/IE,NED#7$=27BI(
M4:EE:HW#4:2))%15%4(1O/>%J]E91A5NL:Z'ZOK+VMFSR:"=R[HOY;/0G<PI
M+%3UD\?JM>KIJ]#KJU+31Z#'\1A,GNG)]C$ZRP>1S6$SCTF;C&32<GQ66PE*
M'DH,R,TW%:=/M$+N[>AE\ZYW'AC.%$^"J>HL;&7GF]VJW96*<+E7'AHXZ^2N
M@RCW.>PC_([%2W6')4/)2FY9QW4/-MO'D6G%M&M!FF]NZU=#I=4JF++K%<6;
MDDZ.*I54^P]/AX#(2L.Q\A;DU6,Y5HZZ>MBZ5VK4^,MV/P"9#&W[%K^#C[3N
MC&QR(?N7)1XVB) 4I:BDE%)1$X:W#LJNY)4Z.D>MR_1VK<YNW;=M.JT5ET<7
M!HTE%O*I]?=MVU>NJZXX7ZRC'3ZV'AJ]&FJT<IDS!R/G,Y2'.*"B4G'/(DHQ
MA,IAMO(7));:"8_%D:#[U1(X75%C*GRN9I6F)>U6OV=.G3I\ADXU>>RE<-<+
MKAIA36*JT:-&ITX36W*I9JS>WJ<7<I6N9LU+4?%1FWTU/I,QG-Y^Q:I\2'E-
M4W-IE?;?_HW/(7SE>K%[5K4?%Y]]MMK0<@6RD;Q&LUX:TUS&$)+MNH;/NFL6
M>\<=FZY07]Z.#\?V6_ WS&2W0[>8LJ%UI?+2ZW;_ $]<XI?>2KRFJL[F9>PY
MK(9V:?\ 7,C(=E.EQ,DJ=4:K2KV$UH7<&P6+2M6XP6J*H:IF;\K]V5R6N3;Y
MS9^\8#*\TY,7F#I;)YA[(1(S6P8V.I*ID/(1VDLJN9,R4;2R01H614Z:TX#!
M9/,0R2=B\\.%O"WJE%NNO;M1L^\,G<WE)9G+K'CC'&D],9I4U:Z.FA\M:<-O
MS+">7_+J7I^1>;/<=EG1Y.4QS+B'3@P8-5-(?-!F275K5=94Z)Z:&/:U+YK,
MJ['^W;347TG+73B2X=I;WX+(Y*5B5.MNR6))IX8QTQ4J<+;K39KH9ALN?Q>N
M^E$>8RRTIQC+T5MUY1E8WU^,;92X9]@D*62C/L#&Y>S.[NG!'71^*;9E\SF+
M=C?W63T13CX[:5?!4I>5W+G:=2YIXO);"VW"Q,5]Y#&3=>1U,Y<AAQ#113)5
M73<)5]"Z$UNI2@]-Y;PLW\I*-O3)I:*>S1JN+93RE&Y]T9C*Y^$[M(Q3:4J^
MU6+2P[:Z^2M2DT^9(RG+9C%ZYK^*V;/8;)2W\AALBTMZ4<>4E%DF.VAUHUD1
MIZM9)N5T<"(>F;@H9IRN3E;C.*I*+HJJOJO0^5:N$\=W7)7,A&%FW"[.$FY1
MDJNC2I**Q*O1>MZB]Z-EMH=YM:'A=HP$766,='R3V,QL5A48DLS(T@UJ4EQQ
MQ15<09D2C+C7MBUSEJRLG>G;F[CDXU;==*<>)<#+W(7\Q+>.7MWK<;2BIN,4
MJ:)1EP-OA1@W)U9$K?[CH9Z?F.GLF9M#+;V_]'_6AYS ;B__ (C_ /E[G\I\
M=U5^RSEB5:T9S7"O0?CQ=@3D_P!7F/\ Z?Y2G/?\?E?_ *O_ .0SH\KC8&QZ
M-&RDQN UE]!;Q+63=51N(_,2^AIQ2B]:1'1)G]S7C0ABNKG*U=<5BPWW*FU+
M#5&==ZW;OV8SE@4\K&&+HN6*C_;46SEUH&Q:EELW*V,F(!*P64;@LG(9=<F5
MCF9K92TM1FVE)7&X?>]!=(]\_GK5^$%;K+UX5T/1IX:\/$>6ZMUWLK<N2NTC
M6W.FE-RT<%'JXS7G+/:F=,WC";)*2:H<1XTRZ%4R8D-J9<41%TFE*S41=F@S
M.\,L\QEYVUK:T<JTHUK=.;65S<+LM47IY&G%OP)E\R?)K<#RJRUF*6:UJ2M3
MN,ST=UI4-<4S,TK=<N(FS27\H2Z4,CZ2%I;WO9P?U'@FM<6G6O$N'B+^[V>S
M/6?TECMOV9IJCCM;X./C,^U?+8KYUM(U/!S43\=JF*G07,BTK\0_.=AR')"V
M55XMW&24GW.R5#&(S-J?R=Z[-4=R473A4<44J\9GLI?MO>.7L6Y*4;,91Q+4
MY.$W)KBV>BA@/)]5']UXT(]2S!<3I7O$<.Z,QO75:_U8><U_<O\ _$?Z%SR(
MN.:P&5W[2]/R>G,*RAX/'GB<OAXADN3%D-O+63QLD=QI>)5UR2,N'$>%F_#*
MW[D;KPXY8HR>IJFJO^$O,SE;F>RUF=A8^KC@E!:XM-^M37ZWF)XW 9?*\NLO
MRWC1[-XPV=3F9&$6I"9$B*J'U*B:*O?K:/OE((^@^WP$7,Q"&9CF&_Z<X8<7
M GBKIV)BUD[MS)3RB7]:%S&X\+C@P^KM:X5LX]!%R#(TSE_%UG8B*/L>;ST/
M(Q\,X9&_%B1D6&^ZDC/JU.&JPDJH9I^N"FLQF7<MZ80@XXN!M\"VTUE75/*9
M.-F[_<G<C)1X8Q2IB>QO5IIH\)E6<LS>T<W-&A.MHV'/O0'L.VZM+:9*L>X3
MJXZ5J.EZR5WB:\3(6%G^G:RUYKU(*6+BQ*E>1<)D\U'KLQG,O%K'<P.*>BN!
MU:Y7P<AA\+"Y+0] VU6W,JQLW8FHN/Q&&DT3(D+9DD\X^;5;DH:)/>K45#,Z
M$,E.]'-9FWU7K*W5RDM2JJ4KQ[##PRT\ED[W7K"[N&,8O6Z2JY4_P\#V^ N/
M,/5,EO\ M#N_:Z]$<U'+MQ'7<D_*89:QQML-M.-2R4HE-J;-!]Z23N+UM3X#
MQR&:AE;2L7$^LC711^MI;K';7_K0]]ZY"YGK[S-K#U4U%XG))1]5)J>RE./1
MJJ]!EVRN$KFKS?56A'J+MM3I7^JPOMC'9?\ 1Y;_ %5^:9E,U_R.<_T)?EMF
M-Z5A\]GL-C<'S!P"7= 3#>DP-N<HR]C(QI4XDT2DJM4B_P#\!PC.I]%"H+W.
M7K=J<IV)_P!6J3AP2?W>3[2++=^7O7K4;6:MUL86U<X8+7HEJI7[,O(J%@QN
M*R&P<E'8N$9.?*Q.PO3\C'9,E/-0UP$)2\I%:V&:%%7N"\N78VL^G-T4K:BG
MM>+5XS&V+$[^ZY1MK$X7<4DM:CU:TTV:'S%_U_$YW/Z^QCN9. (M3@XA<G$[
MLY^*?@QNI-V*@GTJM?;-1DA,=55%=V*"SOW;=JXY9>?KN=)6^"3K26C[+X<6
MK09#*V+M^THYNW_3C"L;NIQC1N.G[2X%#6JFDB5P&TFD4.D?1+.LO:_8X/X4
M@:3VHU6_Q>8Z/V*]J]R1_F.G1HITT   .!^9A?M$VGWTF?GE#L6[?TMO[L?(
M?/.^?UU[[\O*8I09 Q-10!44 5% %10!44 5% %10!44 5% %10!44 5-V+P
M^_97EGRZ/1V\@M32<J4E>.=6T2%JG&;9N&E22+LT-0U7KLM;S=_K\/V*8E_A
M-[C8SMW=^6^6Q?\ JUPNG_J:*Z>4N\%Z$YS8U=*Y$:5L[."EM[1,B*0II>0\
M2DU):T=ZMU*:$XHC/C]06TXR62N:&H.:P)]'%'F6PNX3A+>=C2I75"2N-4IC
MZN?"M<E]I^@PU>)G[URQU>%JS)Y#*:L[D&LMBF:*E$B>^EYJ0AHN^6BG>*,N
M@^Y49-78Y7-W'=>&-U1PRX/55&J\#X3#/+SSN[[,;"QRLN:E%>UZ\DTTN%<'
M*9'A6?@_DN5NDY!Q#FR0<P[D,A&2HG%042W$=7'4I)F1*42;UIK5/9%C>?6P
MS%Z/L2@DGTJ)U?F3,IETK%S*9:='<C-RDM>#$U2/AUM<&@MN+T#9(7,Y.SSD
M(;U7'98\Q)V-3B3@*BL23=,R>(S(UJ--EGKB5P,ND>]S/VI93JH^W*.%0^U5
MQIJV<-=5"UM;JOQWAUTO[4;F-W*^KA4JZ]NBE-:>L^.RY*/F>4F8RT5'51\A
MOTF8PR="-+;\)2TE0NT1BO+6G;SL8/7&PES2/+.7XWMVSN1T*6:E+GA4GCL9
MB<UJW*G$9Z24;$2LGEVY3MQ)HA3S1DF[[F\^]KV*U$7+D[=[,SMJLE&%.9^0
MJM6;5ZSDK=UTA*5VOO1T<5=7C,CAP=AQ^(WJ)E-6QFK8UK"3F,=&89;1.?ZI
M;9F:7UJ4_(;2DJN.76&HT_4%A.=J<[+C<E=>.+;KZJU\'LQ>Q:]9E;5N];M9
MB,[,+,5:FHI+UW2GVGZTXK[4M3=#7^_*,]&Y<HNJE.-F&2:U(C.6JO#NT(9G
M(+_<7_O1_*:]O5_[/*_=E^8N&]\>:>!,CJ1,8$JUX%1EC[ \<C^CGRW/*RYW
MF_\ R5K_ .EY(EYU(Z>DQ(5<1%[LY?OJ\*&W)[/U!;YO_B5]R'\I[;M?_G7_
M *MW^<M^M:Z\UHN+SNGZ_#V?8LA)EL9IZ<RB8WBTM*(F$=2ZHFDDXBKBG7$F
M1=LN ],SF$\S*%Z;MPBDXT=,>W2M.AZ*(HR.5:R<+F7M1O7)N2FY+%@I[*PO
M0JK3B>KF+5SKO5N$5:UQW%*Q&-,W85OBJS\7(C-FSO>K,_64X4%SN;^P]?MR
MUZ]?#Q[2R[2-O,1;:?\ 3AIC[+T?9XMG$:YH,X:Q44 5% %10!44 5% %10!
M44 5% %10!44 5% %3JCT6"IK&=_7T?F4CGO:?\ O0^[YSK78G]/<^]YC?8T
M\Z$   'YMY,_\2F>SN_AF.V6_97(?.%Y>O+E92U'H>5!4!05 4%0%!4!05 4
M%0%!4!05 4%0%!4!0V+RYGXO)8'9^7N4F-8YW841I&'GRE61T9""LUI;<5T)
M)TCMN/@7U:#"[PA.%RW?BL6"JDEKPRX? ;)NFY"Y9NY6<E'K5%Q;U8HNM'LQ
M:J^<MF0Y4<Q<8Q,E3L ^S#@LKD299J:..33:34:DNDLTJX%PM,S/L#WAO3+3
M:49IN3HEIKS%K<W'G;:<I6VE%5;T4HN.M'X#+=[U+8.8>5QFUZ5$5E\+E8$*
M.28RD&G'R(S"67(\BY1=2233=<NB#KP,8[)9JWE(2M7GAE&4M?VDW5-;?!I,
MOO+(WL]=C?RZ<X3C'53U&HT<7I]6E*U=%IUE_E93'R\UN$#'2VYQ8/E_[C2<
MDPJK4J3$5')U:%?=%4[*]F@M(VY1MVY25,=_%38GBHB^E=A*]=A&6+J\JX.7
M!)QPU?F\!K_75%\TV\<>/C^%X5[2W^P,OF/UEGDG_*8#)_H,QRVO+(O>)41Z
M;RS(S*I;3)X&9<"-V-]@A:7?[]__ $UY)&2L?ILI_K/RQ+GIZR^DY)42B)/N
MWF#NK0J62>R/+-_\4ON0_E*]W?\ ./\ U+O\YBG*]1>*;^1F15U:=2O;Z^.+
M_>6NS_JQ\DC%;E_]?_0GY8&>S9N3V#6=5R>HZ9B=PAQ,1#Q.0-^,[+GPYD0E
M-K:<0R^A26U?RB%6\:F=1B(0A:NW(W;LK3<Y25&E%I\.E:^!FQ3N7+N7LSL6
M87U&$82K%RE&2T4:35%PITXRUP<OGLE+YH2-CB,XO-M:XF'(A14]4ALF%,MI
M12]?W!$1]\?:'O.U;A'+JVW*/65J^.K\I;VKMZ<LV[L5"?54:6C51;7P<99=
M;@2-RY4RM0U\R?V?&YL\RO$$I*'94-R*3%[)*,KUMF1U27W/=,A=YBXLOG%=
MGHA*&'%L>*NG94QV3LRS>[Y6+6FY&YCP\+CAPU6UKR<>O[\O=?SNLYG8HNP0
M'<;+D:EEI+,>475.*:4V:"4:3XE525%QXBG/9BW>A;<&I)78+1RD[MRMW+RO
M*Y%Q;R]QT>C13Q:BXXG79F/U76LEI>NXS-(RL=3^?V;+--RV(4AMP^L8<3(5
MU,9MI%#4XI-5]@Q;W,PIWIQO3E#"_5A'0Y+:J:9-[. O;63=NQ;E8M0N*<:S
MN3]91:;JG7U8**UO[7@+WL2DGNG.@R,K5X5*D'4J*)7BQD9=NI<2%KE_[&5^
M_P#]Q?YK]5G?]/S1.?*C<CG-!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05
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M;Y&G'0P   _-?)J_Q*9[.[^&8[9;]E<A\YWEZ\N5E+<*SRH+@%!< H+@%!<
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M5->CMBSSN8^7LRN4KA1D=VY3YO,PLUPXWKUF2L:3J6Q.SL9I^9FJV"$T\\W
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M)C"9&6[AD1'%08<['HO0Y'E+ZLDJ:45MK39(41C$RBH2M7+=KJTYQ6*NEJ7
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M7!44%P5%!<%10[3]& Z\L$^^$K[2!S;M#^J_"CKW93]%^*7F-SC6S;@
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M"X@%!<0"@N(!0[6]%XZ\KT^^$K[2!S;M#^J_"CKG97]%^)^8W0-<-M
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MZDO*8Q09(PU10!44 5% %10!44 5% %10!44 5% %10!44 5% %10!44 5%
M%10!44 5% %10!44 5% %10!44 5% %10!44 5% %10!44 5% %10!44 5%
M%10!44 5% %3IOT9"IK>;_7D_F4CG7:G^]#[OG.Q]A/TUW[_ )C>0TPZ2
M'YD90_\ $YOL[OX9CM%OV5R'S]=7KOE925'H>5!4!05 4%0%!4!05 4%0%!4
M!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4
M!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%#MGT7./*Y/OA*^T@<V[0_J
MOPHZUV6_1?B?F-TC7#;            +!,^.^&]ZLK[8QP :+\2-:]ZH/M=
M OX            #@3T@3_;!L_LD;VHR.I;F_1P\/E9QK?\ ^NN>#\J-:5&9
M,#05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!
M4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!
M4!0Z<]#PZR]O]C@?A2!I?:;5;_%YC?\ LA[5W\/\QU4-(.B   !P[S%3_P#/
MNR^^4O\ .J':-V?I+7W(^0^:=^/_ ']__4EY68S:,B8:HM 5%H"HM 5%H"HM
M 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H
M"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"ITQZ,Y4US-
M?KJ?S21SGM5_>A]WSG9>P7Z:[]_S&\!IATH   /S$RI_XI-]G=_#,=GM^RN0
MX!=7KOE925'H>=!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05
M4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05 4%0%!4!05
M4%0%!4!05 4%0%#MOT6N/*U/OC*^T@<W[0?JOPHZQV7_ $?XGYC=8UPVL
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M\QNP:Z;4           !8)GQWPWO5E?;&. #1?B1K7O5!]KH %_
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M4U9XN;AG6Y1UKU@P>]=YQSBC2.'#7QT-AW-NB61<VY*6*G!LKZ3;XP)L@
M:(V3T?\ )9W8,IFD9IAE&0E/24-*969I2ZLU$DS)7$RJ-ZRO:6%FS"W@;PI+
M7L.4Y_L1=S.9N7E=BE.3E3"^%UVEK^C5E//T?\@OPA==Z[?PWSHL?_C^]\:/
MNOTCZ-64\_1_R"_"#O7;^&^=#_X_O?&C[K](^C5E//T?\@OP@[UV_AOG0_\
MC^]\:/NOTCZ-64\_1_R"_"#O7;^&^=#_ ./[WQH^Z_2/HU93S]'_ ""_"#O7
M;^&^=#_X_O?&C[K](^C5E//T?\@OP@[UV_AOG0_^/[WQH^Z_2/HU93S]'_(+
M\(.]=OX;YT/_ (_O?&C[K](^C5E//T?\@OP@[UV_AOG0_P#C^]\:/NOTCZ-6
M4\_1_P @OP@[UV_AOG0_^/[WQH^Z_2/HU93S]'_(+\(.]=OX;YT/_C^]\:/N
MOTCZ-64\_1_R"_"#O7;^&^=#_P"/[WQH^Z_2/HU93S]'_(+\(.]=OX;YT/\
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M&^=#_P"/[WQH^Z_2/HU93S]'_(+\(.]=OX;YT/\ X_O?&C[K](^C5E//T?\
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MGQWPWO5E?;&. #1?B1K7O5!]KH %_
M
M
M
M                    %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\
M
M
M
M                                           6"9\=\-[U97VQC@ T
M7XD:U[U0?:Z !?P
M
M
M
M     !8)GQWPWO5E?;&. #1?B1K7O5!]KH %_             <Z<R.;6[ZY
MNN5PN*FMM8^*IHF6U,-+,B6RA9]\I)F?%1CHFZMRY6_E87)Q;DZ\+VLXUO\
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MRKO=O+IKW8^@\/T@N9_G)GR1CP [OY/HOWF3WNWCTU[L?01^D'S0\Y,^2,>
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M)PC)4C)I:%M,=^DUS?\ .T?R.-X N_H64Z+YV67>/.])>ZA])KF_YVC^1QO
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MC^1QO #Z%E.B^=CO'G>DO=0^DUS?\[1_(XW@!]"RG1?.QWCSO27NH?2:YO\
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M+*=%\['>/.])>ZA])KF_YVC^1QO #Z%E.B^=CO'G>DO=0^DUS?\ .T?R.-X
M?0LIT7SL=X\[TE[J'TFN;_G:/Y'&\ /H64Z+YV.\>=Z2]U#Z37-_SM'\CC>
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M[S'10U(W@   /S$RI?XI-]G=_#,=GM^RN0X!=]M\K*2@]#SJ* *B@"HH J*
M*B@"HH J* *B@"HH J* *B@"HH J* *B@"HH J* *B@"HH J* *B@"HH J*
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M]S)77;GIV/:OVUKRZS$Z"_,944( * *B@"HH J* *B@"HH J* *B@"HH J*
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M/,9B*E*?LI_P\/#[3_P\ASQ2O$^GN= VTT04 5% %10!44 5% %10!44 5%
M%10!44 5% %3MGT7.'*Y/OA*^T@<W[0_JOPHZUV6_1?B?F-TC7#;
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M#36:<>CO1U]7(:6RY^\<2:%?841&-B33U&IRBXNCT,^=!)344 5% %10!44
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M.J)-:T(UF9TJ8NHPC%4BJ&.N79W'63<GQZ2GH*SSJ* *B@"HH J* *B@"HH
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M"HH J* *G:/HQ?\ &*??"5]I YKVB_5?A1V#LG^A_%+S&Y1K9MX
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MX4=B[)_H?Q2\QN0:V;@           !8)GQWPWO5E?;&. #1?B1K7O5!]KH
M%_             <><Y?^2L]_'8]K-#K^XOT-OP_F9\Y=J_^4O<L?R1,"/I&
M<-7(&(*D0,05$3Z0*D0/I$%2(F!)$Q!*(&!6B)B"2)B"2)@5$3$$D3 J(J$$
MHB8%1$Q!) P*B)@5$3$$GA@20,05$3 DB8%1$Q!)$021,"HB8$D3$%1$Q!)$
MP)(@5$3$$D3 J(B"2)] %1$021,"HZ?]#C^V;A[%C_PI TSM-JM_B\QOO9+V
MKOX?YCJX:2=!   #\_N9Y?M&VOWUF?GE#L&[?TMO[L?(< WN_P#>WOOR\IB=
MHR!B:BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@
M*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!46@*BT!
M46@*BT!46@*G5OHI%35\]^OH_,I'/NT_]Z'W?.=6[&?V+GWO,= #4#?P   _
M-S)I_P 2F>SN_AF.V6_87(?-]Y^O+E92VCT/*HM 5%H"HM 5%H"HM 5%H"HM
M 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H
M"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"HM 5%H"IV7Z,Q4Y9I_7Y/VD#
MFG:+]7^%'9.R7Z'\4O,;B&M&X@           6"9\=\-[U97VQC@ T7XD:U[
MU0?:Z !?P            ''G.7_DK/?QV/:S0Z_N+]#;\/YF?.7:O_E+W+'\
MD3 CZ1G#5R!B"I$#$%1$^D"I'WQ^-G9>?'QF,85)GREDU'8;*JE*/]PNV9GP
M(N)CRNW8VH.<W1+67&7L7+\U;MK%*3HD9<]HNN8]:X.9W;'Q<TV=KD5B/+EL
MH<[*%R&F[",CX*MK0QB5O"]-8H69..UN,7[K=389;HRUIN%W,PC<7 HSDD]C
MDE3EUT,#50C,JU[HS)K2(&!6BY1<0S*PF0RZLE%8>@+90C&NK4F5()Y1I-3*
M:&2B12JN/ OK5MIWG&Y&&%M2KZW J;>4O+>74[,[F.*<''U7[4J]';3AXO!6
MTF/<MB^ZAJSFW95S&HF-0&X\9^;(E/I6M"&8R;EG:V1F9T[ LLYFEEX*5'*K
M226UF4W;D'G+KAB4%&+DVZZ%'7J+AD=$CGB)N=U;/1=BQ^,L5DD,M/Q)3#;A
MVDX;,A"34W7@:D&=.SPJ+>WGWUBMW8.VY>SI33XJKAY2\O;JCU4KN7N*]&'M
M44HRC7APR6E<:KS5,,,90P9!0@J1X?0!)<L=B&)^,RV2<R<2&O&(:6U"D+44
MB6;J[+6$D1W&GI5QX<.Q4RMKEYPG&*BWBKI6I4VE[9RZG;G-SC' EH>N573U
M5Q<.SDJU:#,7!:ESRV'9QL+%RVLG$GKR3!ONQHJS6[$42K>K?(R*U1EQI_V4
M,[:U><Y23BXX72KX>-%]?RRM0A)3C+&JT3TQXI<?[<;M!BX+0\,"2'8$%1D.
MJZ=/VHYTE$F/C<)BFTO9;,3E&B-'0LS)!':2E*6LRM;0DJJ,66:S<;%%1RE+
MV8K6_P!RX7P&3R60EF<3JH0AIE*6I5U>%\"X67>9RZB2L5/R^E;)$V=K$M>,
MY2&TR_"FM1T^N>2S(21N-(^Z4D^%2J0M89^49J-ZV[>)T3JFJ[*K4]A?7-UP
ME;E/+W8W<"K)4<9)<+I+6EPO@,!,R&6,$1$%1$S+HKQ DB9ET=D"HR3 :HC-
MZUM6P*EFPK6V(KZ(Y-DLGSE/DS0U7%;;T]!U%C?S/5W;<*5QM^"BJ9++9/K;
M%V[6G5J.BFO$Z&+F9%TF+PQY$P*B%2[8%1X?$0")@5$1!)$^@"HB()(F!4=/
M^AQ_;-P]BQ_X4@:9VFU6_P 7F-][)>U=_#_,=7#23H(   < \SB_:+M7OK,_
M/*'8=V_I;?W8^0^?=\?K;WWY>4Q2@R!B10 * !0 * !0 ;)E\JL9!FQL%+W/
M'1]GEML.,XY^/+0S64A*VTJD]6;:3.XND8*.\YRBYJU)P5=-8UT?X:U-IGN2
MW"2M2OQ5V27JM2II55ZU*&!9;%3\'DY>'RK)Q\C!=4Q)949':X@Z'0RJ1EVC
M+@9<2&8M78W8*<75/2C7+UF=F;MS5)1=&BCH/4\10 *%T=D * "_Z5J<O=]F
M@ZQ!?;C2IW6V/O$HVTDRTMY5;2,^)(,B[HL\YFHY:R[C55'SNAD-W9*6<S$;
M,71RKI?$F_,7I[EY!G8_(3M/V:'L3F*CJFY""AB3"DIC-^O<;3)0DG$HZ56J
MJ1=CC06L<_*,HQNVW;Q.B=5)5V.CT%_/=<)PE/+W8W<"Q25)1=.%K$M*7#I\
MI@W 98P!=<1A6<I%RDAW)Q,>K'1CDM,2UJ0Y*42B+JF"(CJL^U_V5,K>[><'
M%*+EB=-'!QOB+S+Y=78S;G&.!5I)^UQ+C_;C5JH+@LQ0 9-A-13F-0VK:3EF
MRK6O$+8I-W$_[H/FSQ7<5ME*^M.O<%A>S75W[=JG]S%IV854R>7R76Y:[>Q4
MZK!HIKQRIKKHIR,QFA"_,8* !0 .'3V  H %  H71V0 H %" "@ < !7Y7"9
M+".1FLFSU#DR*S/CIO0NZ-)3>VOO#.EQ<:'Q+LCQM7H7*X76C:?*M9<7K%RU
MAQJF**DONO4_VTE!0>Q;B@ 4 "@ 4 "@ ZK]%3XKYW]?1^92.?=I_P"]#[OG
M.L=B_P!/<^]YC?PT\Z    'YP9,O\2F>SN_AF.VV_87(?-E[VY<K*6@]#R%
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M7=C)Y:[GLOBZN<IJ?61A1PK&+PNFI-JCT46)521CVH)@;G.S.P+Q6%QV/U:
MVWA,9+-$7')<D/DTRN:\NIOF@KE*-T_QBZ5I47F;Q9>,+>*<G<EZS6F6A5>%
M?9\&I&/W?@S<IWG"W"-F*48RT0K*5$YR?M4T^U[4J:JGTS^#C9W7VF<[E=;=
MW#W2AQ\;+P+L4W9$66KJ74/M1$MH,FC-"T*--:5(18O2M7:PC<ZO#)M34J)K
M2J.57ITZ#TS.5A?LI7+EEWL<5%VW&LE+U6I*.%>KH:>S0>9#9\?@>836EXW
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MT<%8)RYZJO*T9E[PR$Y*4LKIX5&XXQ;XHX6XK8E+0?$MTPTO!XG&Y_ >Z,[
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MD3Z *B(@DB8%1T_Z'']LW#V+'_A2!IG:;5;_ !>8WWLE[5W\/\QU<-).@@
M!P9S++]H6T>^DO\ /*'8]V_I;?W8^0^==\O_ 'U[[\O*8M09$Q%10!44 5%
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M&Y'%%J2?"M*%VU.U)QG%QDN!JCYF4U!Z'E44 5% %10!44 5% %10!44 5%
M%10!44 5% %3K_T;^'+=/Z])^T@<Q[1_J_PH[9V._0?BEYC;HUDW4
M    "P3/COAO>K*^V,< &B_$C6O>J#[70 +^             X\YR_\ )6>_
MCL>UFAU_<7Z&WX?S,^<NU?\ RE[EC^2)@1](SAJY Q!4B!B"HB?2!4B!](@J
M1$P)(F()1 P*T97RVQ$;+[CC_="B<1CK\IE'%%<A,2 DWUW_ ,%5I(_ZAB]Y
MWG;R\L/M2]6/++1^\SNX\O&]FX8_8AZ\MF&'K.O$Z4\)>.8LV1N&OZ]S$?-"
MY\HY.(S1LH)#:),5Q3K%2+[I;#A?62+/=T%EKMS++4J2C78U1\TEXS(;XN3S
MEBUG)4<I8H3HJ)2BZQ\+B_$9_K?_ "ARF_\ Z4:]JS1A,S^BS7^J_P T#9LG
M_P GD?\ ^7C^2Z:J.'F/FD]T/=/_  #X1>+^XW4(_M?B5_C'7^O]9WG5]'9&
MQX[?SV'#Z_5UQ5X,7LTU:]-33NJN_3,>/U.NI@HO:ZOVL6O5HIJX2;&E:OF6
MLA&U?97<CF\?%=G%&?@*BL2FHZ+W4L+ZU:[TI(S(EMIN[@HEG;UMQ=VWAC)I
M54JM5U5T)4Y&Z'M'=F7NJ:L7G.<(N5'!Q4DM+PO$W5:=<54^<'1,0K4L=N><
MV%.-QDU^1$5&1%5)E]<R96$T@EI)9&5REJ4I!(H7KC41!<S\^OE9A;Q2BDZU
MHJ/;HT<6NO%0JM;IM_*PS%R[@C)R5,+DZK5155>-MQIQMD<ERTR*=BPF#UR6
MWFHNR,IE86>E"F$K9.Z\W4*N-LV[5&LJG0N[P"WO*'53G<6!VW22UZ>+;7@%
MW<MQ7[=JU)7%>582U57#5<%*.JTZ.8H,Y@]*QK$IC%[,_E<U&L2AMK']7"?<
M-:4K2T^;YJHDKC)1M47PITCUL7\Q-IRMJ,7_ (O67*J>?0>&:RN5M*2A><Y1
M_P %(O3II+%P:77#1Z*%W1RXPB,LQI\[9DQ][D$AOQ!,8W<>S-=*J(CLM+E>
MM,S2E1H:4E*N]J8M7O&Y@=V-NMI<-?6:Z2C35RM-K27\=SV^L5B5W#>?V<-8
MJ7!!SK[3T:HM)U568$4&2G(EC'FS;ED^49QI7 TN$NPTG]0^ R_6+#B6JE3
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MO,;:&L&[@           6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P
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M8@DB8%1%0@E$3 J(F()(&!41,"HB8@D\,"2!B"HB8$D3 J(F()(B"2)@5$3
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M_F-XC3#I(   ?G[D4_XA+]F<_",=TM>PN1'RO??]27*RFM'H>-1: J+0%1:
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MM 5%H"IUCZ/14Y>I_79'VD#EO:7]9^%'=^Q/_'?CEYC:HU<WH
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M,!46& J+# 5%A@*BPP%188"HL,!46& J+# 5%A@*BPP%188"HL,!46& J+#
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M./E;/0CS(^[$6-%2:8S+;*5'51-I)!&?;.A$*)3E+6ZGK"W"'LI+D/J*#T
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M]ZH/M=  OX
M
M
M
M L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@
M
M
M
M                       "P3/COAO>K*^V,< &B_$C6O>J#[70 +^
M
M
M
M                                              +!,^.^&]ZLK[8Q
MP :+\2-:]ZH/M=  OX
M
M
M
M         L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@
M
M
M
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MM9$9IKPN34NZ(!EP  #XL2XDE3J(S[;RV%=6^EM:5FVNE;5$1G0Z=@P!]@
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M%?*5&9DDFTGFTN$D^)E>1'3]T ?4
M
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M*C.)=C/H2ZRZ@ZI6A97)41ETD9'40#Z
M
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M(^-"(B(0"_
M
M                         L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@
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M56IJHS]<9F9\3/A2 4VB\K?@7%VN-[J^._":4]+NZCJNHZY*RMIUB[Z7=/
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MUQ&95I=4SD%RU/4N9<+-M9;<=Y]UXC*%H3B(L%F(PLW$T)2UHH9FD^)</KB
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MHD&WF4+;:;;<6;CB4DE3AD1&HR*AF9%VQ )@
M
M                                                  L$SX[X;WJR
MOMC' !HOQ(UKWJ@^UT "_@
M       #PB(C,R(B,^D^V /0
M &,9#0L#DMVQ>_2>O]W\1'7$B6N48ZMPG2.Y%.)_CE<:]KM #)P
M
M
M             %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\
M
M
M
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M6U0G;K:7D5?6F,=G=VW\I3K53%JTUU&9W9OO*[P<E8DW@I70UKY>0R48TS8
M  8+F>;VC8'*2</DYKK4^(KJWT)8=61*H1\#2DR/@8SEC<>;O6U<A%89:M*-
M5S?:G=^6NRM7)-2CH?JR]!0_/KRW\XO>3/>"/?N[G>BO>1:]\]V=-^[+T#Y]
M>6_G%[R9[P0[NYWHKWD.^>[.F_=EZ!\^O+?SB]Y,]X(=W<[T5[R'?/=G3?NR
M] ^?7EOYQ>\F>\$.[N=Z*]Y#OGNSIOW9>@?/KRW\XO>3/>"'=W.]%>\AWSW9
MTW[LO0/GUY;^<7O)GO!#N[G>BO>0[Y[LZ;]V7H'SZ\M_.+WDSW@AW=SO17O(
M=\]V=-^[+T#Y]>6_G%[R9[P0[NYWHKWD.^>[.F_=EZ!\^O+?SB]Y,]X(=W<[
MT5[R'?/=G3?NR] ^?7EOYQ>\F>\$.[N=Z*]Y#OGNSIOW9>@?/KRW\XO>3/>"
M'=W.]%>\AWSW9TW[LO0/GUY;^<7O)GO!#N[G>BO>0[Y[LZ;]V7H'SZ\M_.+W
MDSW@AW=SO17O(=\]V=-^[+T#Y]>6_G%[R9[P0[NYWHKWD.^>[.F_=EZ!\^O+
M?SB]Y,]X(=W<[T5[R'?/=G3?NR] ^?7EOYQ>\F>\$.[N=Z*]Y#OGNSIOW9>@
M?/KRW\XO>3/>"'=W.]%>\AWSW9TW[LO0/GUY;^<7O)GO!#N[G>BO>0[Y[LZ;
M]V7H'SZ\M_.+WDSW@AW=SO17O(=\]V=-^[+T#Y]>6_G%[R9[P0[NYWHKWD.^
M>[.F_=EZ!\^O+?SB]Y,]X(=W<[T5[R'?/=G3?NR] ^?7EOYQ>\F>\$.[N=Z*
M]Y#OGNSIOW9>@?/KRW\XO>3/>"'=W.]%>\AWSW9TW[LO0/GUY;^<7O)GO!#N
M[G>BO>0[Y[LZ;]V7H'SZ\M_.+WDSW@AW=SO17O(=\]V=-^[+T#Y]>6_G%[R9
M[P0[NYWHKWD.^>[.F_=EZ!\^O+?SB]Y,]X(=W<[T5[R'?/=G3?NR] ^?7EOY
MQ>\F>\$.[N=Z*]Y#OGNSIOW9>@?/KRW\XO>3/>"'=W.]%>\AWSW9TW[LO0/G
MUY;^<7O)GO!#N[G>BO>0[Y[LZ;]V7H'SZ\M_.+WDSW@AW=SO17O(=\]V=-^[
M+T#Y]>6_G%[R9[P0[NYWHKWD.^>[.F_=EZ!\^O+?SB]Y,]X(=W<[T5[R'?/=
MG3?NR] ^?7EOYQ>\F>\$.[N=Z*]Y#OGNSIOW9>@?/KRW\XO>3/>"'=W.]%>\
MAWSW9TW[LO0/GUY;^<7O)GO!#N[G>BO>0[Y[LZ;]V7H'SZ\M_.+WDSW@AW=S
MO17O(=\]V=-^[+T&2ZIO.N;JF6K7Y"WRA&V4B]I;5#=NMI>15]:8QN=W=>RE
M.M5,6K3749O=F^<MO!2=AMX*5T-:ZTU\AD8QQF0   URYSQY=-.+:7D'26A1
MI47BSW21T/[D;$NSV=:KA7O(TR7;+=B;3F]'^&7H(_/KRW\XO>3/>")[NYWH
MKWD1WSW9TW[LO0/GUY;^<7O)GO!#N[G>BO>0[Y[LZ;]V7H'SZ\M_.+WDSW@A
MW=SO17O(=\]V=-^[+T#Y]>6_G%[R9[P0[NYWHKWD.^>[.F_=EZ!\^O+?SB]Y
M,]X(=W<[T5[R'?/=G3?NR] ^?7EOYQ>\F>\$.[N=Z*]Y#OGNSIOW9>@?/KRW
M\XO>3/>"'=W.]%>\AWSW9TW[LO0/GUY;^<7O)GO!#N[G>BO>0[Y[LZ;]V7H'
MSZ\M_.+WDSW@AW=SO17O(=\]V=-^[+T#Y]>6_G%[R9[P0[NYWHKWD.^>[.F_
M=EZ!\^O+?SB]Y,]X(=W<[T5[R'?/=G3?NR] ^?7EOYQ>\F>\$.[N=Z*]Y#OG
MNSIOW9>@?/KRW\XO>3/>"'=W.]%>\AWSW9TW[LO0/GUY;^<7O)GO!#N[G>BO
M>0[Y[LZ;]V7H'SZ\M_.+WDSW@AW=SO17O(=\]V=-^[+T#Y]>6_G%[R9[P0[N
MYWHKWD.^>[.F_=EZ!\^O+?SB]Y,]X(=W<[T5[R'?/=G3?NR] ^?7EOYQ>\F>
M\$.[N=Z*]Y#OGNSIOW9>@?/KRW\XO>3/>"'=W.]%>\AWSW9TW[LO0/GUY;^<
M7O)GO!#N[G>BO>0[Y[LZ;]V7H'SZ\M_.+WDSW@AW=SO17O(=\]V=-^[+T#Y]
M>6_G%[R9[P0[NYWHKWD.^>[.F_=EZ!\^O+?SB]Y,]X(=W<[T5[R'?/=G3?NR
M] ^?7EOYQ>\F>\$.[N=Z*]Y#OGNSIOW9>@?/KRW\XO>3/>"'=W.]%>\AWSW9
MTW[LO0/GUY;^<7O)GO!#N[G>BO>0[Y[LZ;]V7H'SZ\M_.+WDSW@AW=SO17O(
M=\]V=-^[+T#Y]>6_G%[R9[P0[NYWHKWD.^>[.F_=EZ!\^O+?SB]Y,]X(=W<[
MT5[R'?/=G3?NR] ^?7EOYQ>\F>\$.[N=Z*]Y#OGNSIOW9>@?/KRW\XO>3/>"
M'=W.]%>\AWSW9TW[LO0/GUY;^<7O)GO!#N[G>BO>0[Y[LZ;]V7H'SZ\M_.+W
MDSW@AW=SO17O(=\]V=-^[+T#Y]>6_G%[R9[P0[NYWHKWD.^>[.F_=EZ!\^O+
M?SB]Y,]X(=W<[T5[R'?/=G3?NR] ^?7EOYQ>\F>\$.[N=Z*]Y#OGNSIOW9>@
M?/KRW\XO>3/>"'=W.]%>\AWSW9TW[LO09AK6SX?;<;[K81U3T+K%,WK0IL[T
M4KP41'V1B,WE+F6G@N*CI4V/=^\;.>M=;9=8UIJIJY2\"S,B           !
M8)GQWPWO5E?;&. #1?B1K7O5!]KH %_             <<\YE4YEYXOX;'M9
MH=?W%^AM^'\S/G3M6O\ RE[EC^2)@EXSE35:"\*B@O"HH+PJ*"\*B@O"HH+P
MJ*"\*B@O"HH+PJ*"\*B@O"HH+PJ*"\*B@O"HH+PJ*"\*B@O"HH+PJ*"\*B@O
M"HH+PJ*"\*B@O"HH+PJ*"\*B@O"HH+PJ*"\*B@O"HH+PJ*"\*B@O"HH+PJ*"
M\*B@O"HH+PJ*&^_1F.LG9?XD/[;PT3M9[-K\7\IU?_V^7K7^2'\QT,.?G7@
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M@%!< H+@%!< H;^]&(ZR=F]CA_;?&B]J_9M?B_E.J=@%ZU_DA_,=$C0#K@
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M_'+S&UAJYO0           %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\
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M H+@%!< H+@%#H'T7SK)V;V.%]M\:+VK]FU^+^4ZGV!]J_R0_F.BQH)UH
M.*>;Q_M)V+]9+\V@=@W-^CM\GG/G7M(O_)7OO>9&$W#,&N4%P"@N 4%P"@N
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M!< H+@%#K7T=SKR[3^O2/M('+NTGZO\ "CNO8K_C_P <O,;7&L&\
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M-RE,2K0Q&\,G\IF)V:XL#I6E*^#3Y2SW"[,?07 *"X!07 *"X!07 *"X!07
M*"X!07 *'07HNG63L_L<+[;XT;M5[-K\7F.I=@EZU[DA_,='#03K    <3<X
M%4YE;%^LE^;0.O[F_1V^3SGSQVD7_D;WWO,C"+AF#7*"X!07 *"X!07 *"X!
M07 *"X!07 *"X!07 *&P^3.\0M)V[QO+.$UAIL=R-,>L4M3="ZQM1$A*E'5:
M230NWW!@=]Y&6:R](:91::\C\1M?9G>D,AF\5S1"2:DZ5IPK4F]:IX:\!L7+
M>E A,LT8/ &Y"2?!V8]8ZM/\1M*B3]\H8&SV6]7^I<T\2]/H1ME_MVL7]*UZ
MO^*5'S*M.=FV^7F^X[F%@O=B"RJ*^RX;$R&M1+4TZ1$K@HB*Y)D9&2J$-7WC
MN^>3NX).J>E/:C>-S[VM[QL=;%86G22V/EX5QG-O/O6H6M[TIW'-DS$R\=,X
MV4%1"'E+4VX22[IIO^JH= [/YJ5[+4DZN#P^#@]'@.1]KLA#+9ZL%17%BXJU
M:?DKX3HCE;I471M2BQ3;)&6EH1*R[ZBHLWU)K89_O6R.Q)='2?29C1-[9Z6;
MOMU]5:(\G[]?_0ZKN#=4,AE8QIZ\DG-\>SDCJ7A>MLUNUZ2C#FWI@GCVTZ@M
M[Q=,XU+*2235:3YD?>V_=66UIV:\!GWV9:R^+%_4I6G!R<O&:G'MM%YO#A74
M5IBTXOO<G%2O'P&Q>;6F1MRTZ:P3)*R\!M<O%ND7XPGFTW&V1\.#A%89=%:'
MV"&!W/GI97,)U]66B7)M\&O_ *FT]HMUQSV4DJ5G!.4-M5P?BU;-3X$:']'[
M2HVS;(_F\FT3V-P:4.(9654.2W3/J[B,N)()*E_QK>P-T[19Z5BRK<725SR+
M7SZN<YKV/W5',YEW9JL;5-&V3U<VE\N$W1S<YJ%RYB0V(,9N9F\A>IEMXS)E
MIINA&M9),E'4SHDB,NSQX4/4MS[I^=DW)X81V:WR'0>T6_WNV$5"*E<G6E=2
M2X7POB6CATZ--SY8\P(_,;75Y%<8HL^,X<;(1".]%]I*)2*\;%D?W79J7&E3
MM]Z;O>2NX:U354_VX47NXM[K>67<W'#*+PR7G7$^/AJM.M\T<YM/CZ9NK\;'
MHZK$Y!M,Z$V1=ZV3BC2MLJ$142M)VEV$F0Z%N3.O,Y9.7M1]5^GF\9R#M-NR
M.2SC4%2$UBCQ5UKP->!4->W#.FJT-L0>3"9O+=7,#W;-!IA/SO<_Q6I?B#65
MG6]:73;TV#6;F_,.<^7P?:2KBV\5/.;M:[+]9N_YSK?LREAP=&NBN+BV&I[A
MLQI-!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%!< H+@%#HWT73K&V?V2%]
MI\:#VJ]JU^+S'6>P7LWN6'\QT&-&.H@  !^?&15_B$OV9S\,QW.W["Y#Y;O+
M^I+E937#T/&@N 4%P"@N 4%P"@N 4%P"@N 4%P"ATAR4V/0M:T)>=S)P\=E6
M)3\1^8LB5,D%1+J2017.&5JR31!4[WZXT#?F6S5_-=7#%*+2=/LK@Y.#A.M]
ME\YD<KD7=NX83C*47+[4M4M&MZG2BV&Y]6V6!M^"B[#C$.H@3#=)@GTDEPR9
M=4T9F23415-!TX] U+-Y666NNW.E535QJIO^[\];SMA7K=<,JTKKT-QX]AQY
MS;5^TG8_UL_P$CJNY_T=OD.$=I%_Y&]][S(PNX9<URAD6B[4G3-JQ^RKBG.3
M!ZT_%2<ZDU]:RMKU]JZ4OKZT6&?ROS5B5JN'%33KU-,RNZL]\CFH7\./!716
MFN+6NCV[#='TI6?DLKR\O[N-1[J?_I?X?\QO_?U__P"/_P#O/_[9G'+/FW)Y
MD9*9$8P"H$*"T3DB:<HGB)QQ5&V[>J1Q41*.M?N1A]Z;GCDH)NYB<GH6&G*]
M;XN<V3<7:*>\[DH]3@C!5<L>+2]2IACKT\Q:O2,V>+B].1KE"7.SCJ+4_O&(
MJT.J7P[-Q(25>FI]H7/9O*RGF.MX(+QO1Z2T[:9Z-K)]1]JZ^91:;?/1>%["
ME]';28V.UX]REM$O*94UHAJ47%F(VHT=[4JD;BB,S/LI)/=KZ=I,]*=WJ4_5
MAKXW^[RU/#L9NJ-JQ\S)>O<U<44Z?Q/Q4(<P^?KNI[4O7\/C69S&/4E.3>>6
MI)K6I)*4VT:."321T-2B/OJE;PJ=6[NSZS%CK)R<7+V:>5_MX2G?/:Z63S74
MVH*2A[3;UZ-4::J;77354X7LUQG \Q].1US?78;-Q4NH)1)ZQOK$U29=))<;
M5]A1#75*[DLQH=)0?[>!FXRA8WGE-*K"[&O&J\_K+RG)VF\OI&9YE%I61KU.
M/DO%E5HJ1&Q#4=]#J1D3AD2$GV+B,=-SN\E:R?7QUR2P\LO1K\!Q#=NY97]X
M_*SU0D\?W8O3L]K4GQIG4V];;C>6NI*R:8J3;8ZN'C,>U1I"G#(R0V5"HE*4
MI,^!=!<!S?(92>>OX:Z],GKY6=HWIO"UNO*X\.A4C&*T:>!<227,C%^4?-]7
M,)^9B<K$:AYJ*WXRWXO?U+L>XD*,B6:C2I)J37ON->'9&1WQN;Y-*<&W%Z-.
MM,PW9WM&]XN5NY%1N15=%:-5XZT:JN'2:[](_3(N+R$+<,<T32,HM4?))25$
M'*2FY#E/WRTDJ[^+7I,QGNS6>E.#LR?LZ8\FSP><U3MKNJ%JY',P5.L=)?>X
M'X56O)76V:)N&Z'-:&T^6')Y/,;#R\L>:/&^*R3B]24;QBZC:%W7=:W3UU*4
M&M[TWU\E<4,&*JKKIYF;GN/LS]2LRN=9@PRPTPXN!/I+::QDH\7DO1[KNJ6I
MNZE*V&95I]8;#&6))FH3AADUL9\KA6>=!< H+@%!< H+@%!< H+@%!< H+@%
M!< H=;^CJ=>72?UZ1]I Y?VD_5_A1W/L7_Q_XY>8VR-8-W            L$
MSX[X;WJROMC' !HOQ(UKWJ@^UT "_@            .*N=I_M1V'V1CVJT.M
M[C_16_#^9GS_ -J/^2N\L?RQ-?U&;-9H*@*"H"@J H*@*"H"@J H*@*"H"@J
M H=$>BR=7-J^I _]8&B]JM5K\7\IU'L'KO\ X/YRA]*$Z9W7_P!4>_.$/7LM
M_;N<J\AX]NO[MK[LO*C0M1NIS2AFW*&,W-YEZVRX1&E,KKB(_P!\PVIU/V#2
M0Q&^)N.3N-;*<^@V'LY:5S>-E/I5]U-KQHZ@YVR'(W*[87&CHHVF&C/^"[):
M;5^XHQSO<<5+.VT^/Q1;.O=J+DH;MNM?X5SSBGXF<;X62Y%S..DM'1UF4PX@
MRX44AQ)E]H=5OQ4K<D^%,X3E9.%Z$EK4D_&=Y;1';EZUF8KO%I^#*:67\%;*
MDG^X8XQE9.-Z#7!)>4^D,];5S+W(/5*$ESIG-OHVR<5C<QG<QE9T:"TS$:C)
M<E/-L$?7N&LZ7J*O\EQ&_=I8SG;A"$7*K;T*NI?O.4=BY6;5V[=N2C##%*LF
MEK=>'[IO>9B>6F^3$29*<7GIJ&NI0XAYN0X32%&JTNK69T(U&8TV%W.92-%C
MMJM=31T>=C=V\)8WU=YTI5-2T> PK</1VU/+1'7M6NPN6(C4R@UK=AN+Z:+2
MLUJ21]%4'P_>GT#+9/M'?MR2N^O'Q^#]_.:]O+L;E;L&\O\ TY\&EN+?'6K7
M@U;'J-4<CL/)A\W&(&39-F?BD32>94950\AM3*BX5(Z7'T?5&R[]OJ60<HNJ
MGAYJU--[+964-Z*,U25O'5<=''SFY/2*DKC\MW6TF9)DS8S2R+LI(U.<?KH(
M:IV<C7-I[(OT><WSMC-QW>UTI17G\QS5RX?<9Y@:NMI1I4>4AMF9?O7'DH47
MUR,R'0-Y)/*W*]"7D.1[GDXYZRTZ?U(>.23\1U]S3CMR>76RMNE5*8#SI?QF
MBZQ/[J2'+MU2<<W;:Z2\>@[KOV"GD+R?0;YM)QA&U?:)C#<J)A)\B*\5S3[4
M5Y;:T]M*DI,C+Z@ZQ+-V8NCG%-?XD<"AN[,SBI1M3:?"HRIY#>WHV87-8G)[
M K*XV5!0ZQ')M4IAQDE&2UU))K25:5&F=I;]NY"W@DI:7J:>PZ3V*REZS.[U
MD)0JH^TFMNTUSS-U?:)G,#8I,3"3WXSLQQ33S45Y;:DG3BE24F1D,]NO-V8Y
M6VG.*>'I(U7?N[\S<SUV4;<VG+6HR?F,'R&%S6(2VK+8Z5 2\9DT<IAQDEFF
ME23>DJTJ5:#,6[]NY[$E*FQIFMWLI>LTZR$H5U8DUY2@J/<MJ"H"@J H*@*"
MH"@J H*@*"H"@J H="^BT=96T>QPOPGQHW:KV;?XO,=/[!^U>Y(?S'2 T(ZN
M   '$7.$_P!IFQ_K)?FT#KVYOT=OD\Y\]=H_^1O?>\R,'J,P:]05 4%0%!4!
M05 4%0%!4!05 4%0%!4!05 4%0%!4!0[*Y'Z5,TW3B]U$&UELJ[X[)841DIE
M!I)+;:B/H422N478,Z=@<IW[GHYG,>I[,%1<>UG>>R^[)9+)^OHG<>)K9HT+
MEV[&Z&FN:^=A;?SBQN+CJ2[ @2(F)<67%"W#D5>^PI9MG_%&U;IL2RV[Y3>A
MR4I>+1Y*^$T3?^8AG=[PMK3&+A;>Q^MZWEIX#I3=7W(NF[#*9.UYG&37&U=I
M2(ZS(_LD-!R,5+,6T]3E'RHZKO6;AD[THZU;FUX(LX&NX#M1\V4/T!UN0N7K
MN(E.G5Q^%&=69\3-2VDJ/[8XCF8J-V:7!)^4^F\G-SL6Y/6XQ?B-;>CY 8@Z
M[L"&DT-&=EQ[OX##;24E]:IC8.T-QSNVV_AI\[9J/8^U&W8O17V;TH^!1B:H
M]).0MWF"PTKUK&-80CZBG'5G^ZH;+V:265?')^1&F=M77/KBA'RR])D?HM2%
M%,V:+]PMN&[]="GD_P#G"P[51]6V^.7F,KV#=)7EM4/%B])4^D_"7(DZEXJR
MIZ;(.9'0VVDUN+.L>Q*4E4S.JCH1#S[+3PQNU=$L+_,5]NH.4\NHJKEC7+[%
M%XS1WP.W#Y/9/R-_P!N'SN7^)'WEZ3GWTO-_"G[DO0=.X7&Y)OT?7,8Y#?1D
MSQ,ULH2FED_>I3MJ>KI=4Z\"H.>7[L'O53JL...FNC@X3K^5L7%N)VW%XNKF
ML--/VN#6<Q? [</D_DO(W_ '0_G<O\2/O+TG(/I>;^%/W)>@M,J-*@R'(DUA
MR-+:.CK#R#;<2=*T4E1$9"YA.,U6+JN(L;EJ5N3C-.+7 ]#/C45E%!4!05 4
M%0%!4!05 4%0%!4!05 4%0%!4!0Z0]%HZQ=H]DA?@OC0>U7M6_Q>8ZMV#]F]
MRP_F.A1HYU    /STR)_XA+]F<_#,=RM^PN0^7KR_J2Y64M1Z'E05 4%0%!4
M!05 4%0%!4!05 4%0%!4!0[1Y%\>5>O_ %)?MQ\<FW]^MN?A_*CO?9/_ (RU
M^/\ _)(YCYNG^TK9/UL_P$CH6Y_T=OD.2]H_^1O?>\R,*J,N:]05 4/:F? N
M)]@@(.V^5&FHT72XD*4DF\I)+QW*J5P,GW$D=AG4RHVDB1P.E2,^R.0[VSOS
M>8<E[*T1Y/WZSZ$[/[M^0R<82T3EZT^5\'#[*HM&C17A.5.:&Y*W?<I^8;4:
ML<V?BF,+M163,DJH9$97F:G#(^BZ@Z3NO)_*Y>,/M:Y<K]&KP'&=^;Q^?S<K
MJ]GV8_=6K@3TZ9:=5:'8/+YEMC1-9;:*U/N7"53NK80HS^N9CEN\6WFKE>G+
MRG<MRK_86/\ 3A^5'$^WRE2]LSTI9U6]D9;AGT<5/K,=<R<<-B"V1CY#@&\G
MBS=U[9S?\3.L>0DA3_*[$)4=>I7*:(S[127%%^$.:;_C3.SX\/Y4=J[)NN[;
M:V.7YF6S4<>PUSVWR2VFBFX<-)?_ )TTPXOAW314>^<N-[LL+CEXG)%GNZS'
MZUFI\*C!>]&+?C1CGI1RU(QFMPB,['I$IXR[%64-I+\X8O\ LK#U[DMB2YZ^
M@Q7;N[2W9AM<G[M%_,:WY 27&>:&+:0?>R&9;3G\4HZW/MH(9_M!%/)2>QQ\
MJ7G-3[)7'#>5M+[2DG[K?F-Y>D0PV[RUD.K*JH\N,ZV?:4:C;^TLQIW9R36<
M2VI^DZ-VPMJ6[I-_9E%KGIY&SEM.H;<I)+3@,DI*B(TJ*&^9&1\2,N\'1OG;
M'3C[R])QU;KS;_\ 2G[DO0=+>CCB\GBM4RC.4A/P7EY%2T-R6ELJ4GJ&BJ1+
M(C,JETCG_:2["Y?BX-26'@=>%G6NQN7N6<K-7(N+Q\*:^S':<Y3]0VY<^4I.
MOY(TJ><,C*&^9&1K/^ -\MYVPHK^I'5TD<JO;LS;G)]5/6_L2]!9LAC<GB74
MQ\I"?@OK3UB&I+2V5F@S,KB)9$9E4C*HN[=V%Q5@U)<3J8^]E[EF6&Y%Q>NC
M37E*2H]3QH*@*"H"@J H*@*"H"@J H*@*"H"AUWZ.?'ERG]>D_:0.7]I/U?X
M4=P[&?\ '_CEYC;0UDW8           "P3/COAO>K*^V,< &B_$C6O>J#[70
M +^             XFYWG^U/8?9(_M5H=:W'^BM^'\S. ]IU_P"2N\L?RQ-?
MW#-FM4%P"@N 4%P"@N 4%P"@N 4%P"@N 4%P"AT5Z*QU<VOZD#_U@:+VJU6O
MQ?RG4.PFN_\ @_G*'TI#IG=?_5'OSA#V[+?V[G*O(>/;G^[:^[+RHTKB-?S^
M?-TL%BY>3-BWK_$V''^KOK;=8DZ5M.E>T-LNYBU:ICDHUVM+RG/K&4O7Z]5"
M4Z:\,7*G,F9AI^)V#0]]U3);-C7\7'D3D-MKE(ZNJ%&EIQ5#XT23I&8Q><O6
MLWEKL;4E)J/!SKR&>W=E[^0SMB=Z#@I2IIT<3YL1U)S:Q3^:Y<;% C)-;_BI
MR$(3Q4HXJTOT(BZ3/J^!#G>Z;JM9NW)[:<^CSG7M_P"7=_(78+7AK[K4O,<9
MZ?CG<UM6$Q3*36N7-CMF1$9T0;B34HZ=A*:F?<'5<Y=5NQ.;X(OR'"MW6'>S
M5N"5<4HKQZ>;A.W-^RC6&TG8,DZHD$S D$V9]!NK;-#9?76I)#D>[[3N9BW%
M<,E^_P 1W_>M]6<G=GLA*G+2B\9P17H(QV8^<*$VWG&7$O,K-MULR4AQ!FE2
M5%Q(R,N)&0-)JC*HMQ::UH[CY2Y3,YGEY@LCGE+7DG65$MYTC)QUM#JT-.*K
MQ,UMDE5WW7KNR.0;VM6[>:G&W[-?-I7/S:CZ#W!?NWLA:G=KB:X=;2;2>G:J
M.O#KX34;F4B8KTHEJ-:4,2U-0W#*E.ND8]"4E]4W+2,;.K4KFYN-5?--^8TA
MWU9[1NK24FH\]M4YY4-A\_,6]D^6>26PDUN0'&)II253L;<)*S_Z4J-1]PA@
M]P75#.1K]JJ-J[56'=W=.BJXM2YGIYEI.9^4F->R_,C7([)&?4S&YCAET$B)
M^/,S^\H-_P![W5;REQOAC3GT><Y+N#+.]G[27!)2]WUO,=4<Y\FWBN6>P.K5
M1<A@HC9=E2I*TM4+ZRC/ZA#G.YK3N9R"V.O-I.Q]H[ZM;ONO:L/O.GG-+ZEZ
M1B=7UK&:\>MG+/',)8\9\=ZN^WLV]0JGU+C&UYOLYU]Z5SK*8G6F'_,:#D.V
M+RN7A9ZG%@5*XZ5\&!FV>5O-U/,N5DHI8<\9[GMM.7G)\8OZU2BI3JFZ4M[H
MUK>FZ/DHQ>/%BKP4\[-TW%O_ .IRFNKP8*?:Q5K7_"C&-K](U&K[)D]>/6SE
M>YSZH_C'CI-7VTXV]0JGWPR.4[.=?9C<ZRF)5IA_S&(WAVP>5S$[/4XL#I7'
M3Q8'Y34O-3FX7,N-C(Y8@\7[G..N7')\8OZU*2I3JFZ4M[HV7=6Z/DG)X\6*
MG!3SLTO?O:#ZG&$>KP8&_M8JU_"C6=PV U.@N 4%P"@N 4%P"@N 4%P"@N 4
M%P"AT/Z*YUE;1['"_"?&C]JO9M_B\QT[L+[5[DA_,=)#0CJH   </<XS_:;L
M?ZR7YI Z[N;]';Y/.?/O:)?^1N_>\R,'N&8->H+@%!< H+@%!< H+@%!< H+
M@%!< H+@%!< H>H);BTMMI-;BS)*4)*IF9\"(B+I,Q#=-+)46W1:SIWDSR1/
M#J8VW<V"/+%1S&XIPB,HQ]).O%T&[V4I^XZ3[_UO/M\[\ZRMFR_5^U+;Q+BV
MOAY-?6>S?9CJ6LQF5Z_V8='_ !2_Q;%]G6_6]FIYR\[(V!8D:MJ,E+V?<(VI
ML]E1&B&70I*%%TO=CAZS^-T>>YMRNZU=O*D.!=+]WEY"X[1=I8V(NQEW6X]#
MDOL[?Q?EY3F/%3SQN4@Y(N)PY#4BA=)]4LE_]@Z#=ACA*.U-'),O<ZJ[&?1:
M?,ZG?&=B)V#6,E B+):,K ?88<(^],I+*DI,C[1W#C%B?4WHR?V))\S/H_-V
MEF<M.VG_ '(25?O*AP"W&E.RDP&VEG,6X3"6"([S=-5A)MZ:UX4':7-*.*N@
M^;5:DYX4GBK2G#78?H%&3'U_ ,HDK),7%0TD\YT$3<9HKE?4HD<4E6]==-<G
MY6?2L%'+V55TC"/BBC4'HT9Q.2P>Q0G#+QM&2.>X7\&:V1%^ZRH;1VEL8+EN
M2U8</NO]YH_8K,]99NQ?M8\;_$J?RLP7TG,8]&W'&Y6PRBSX!-)<[!O1G%WE
M]9+B/LC,=F+J>7E#AC+Q-?N9KW;>Q*.;A<X)0IX8MU\31DOHLXUY,38\RM%&
M'G(T1A?8-;*5N.%]8G$"P[4W4Y6X<*J^>E/(S*]A;$E&]<X&XQ7*JM^5$?2!
MVMK"[SI3B6O&7<$H\LY')5EY+?;M1=15*^+GV#^H)[/Y5W,M>5:=9ZM? _\
MN*.U^=5K.9=TJ[3QTV^M'17CP> ^?TJD?),_\P+^[">ZO_Z7^'_,1W[?P/\
M]Y_D-LP-_*;RV5S#]SS0283\[W.ZXC/\0:RLZVSLV=-GUAK4\AAS?R^+[25:
M;>+]YNMK>N/=_P W@^S*6&NRNBM.+9X#4WTJD?),_P#,"_NPV7NK_P#I?X?\
MQI7?M_ __>?Y#2&Z;+\+MHR6R%&\3+(.)<\6-SK;+4)12^U-?6_O2&W9++?+
MV8VZUP\.HT#>6=^<S,[V'#CX*UX*:Z+R%AN%Z8V@N 4%P"@N 4%P"@N 4%P"
M@N 4%P"@N 4%P"ATEZ*YUB[1[)"_!?&A=JO:M_B\QU7L+[-[EA_,=#C1SIP
M  ?G?DE?XC+]F<_#,=QM^PN0^8;R_J2Y64UP]#RH+@%!< H+@%!< H+@%!<
MH+@%!< H+@%#M3D3_P 4Z_\ 4E^W'QR??OZVY^'\J.\]E/\ C+7X_P \CF#F
M\?[2]E_6S_ 2.@[G_1V^0Y/VB7_D;OWO,BQ8C5=HS[)R<'AIN1C)7U2GXL=Q
MYM+A$1FDUI29$9$HCH9B]O9NS:=)SC%\;2,58R&8OJMJW.:K2L8MJO*D?'-X
M#-ZW);A9Z"[CY;K9/MLR$V+-I2E))5.U5)E]856,Q;O+%;DI*M-!&:R=[+24
M;L7!M5H]G[(V+R#TE6T[BC+2T78? &B6[7H7*J?4(Z2Z%%UA])=[0^D8/?\
MGNHR^!>U<T>#A]'AXC9^RFZ_FLVKDO8M4D^.7V5KVZ>%:*/6;LY_;F6L:6YB
MXSEN4S]\-HBZ4QJ?UA?WIDC_ *Z]@:EN#)]?F,;]FWI\/!Z? ;_VLWC\MDW;
M7M7?5_#]KQ:/"<>5'43AU#NGE7E&LORZUN6R=21!:BJ_CQ"\77_WFS''MZVG
M;S=Q/I-\^GSGT-N&]&[N^RXZE!1]WU7XT<><Q<:]AM[V* ^DT&B>^XV2NDVG
MUFZVKZZ%),=0W==5S+6Y+HKQ:'XSB&^;$K6=NQ?3D_ W5>)HZTY*8U_%\L<
MS)0:'GVG)9D?[R4\MUL_KH4DQS7?=U7,Y-K@=.9)/QG9^S-F5K=UI2UM.7@E
M)M>)HP?1=GC3>?\ N3!+*R:R<5@_WSN,ZIHR+ZR%G]89?/95QW7:?1=?!*K\
MZ,!NO.QGOO,):I*GAAACYF3])_&/2-7P^6;2:FX,Q33QD5;4R6^"C[17-D7U
M3(1V8NJ-Z<.E'R?]2>V]ARRUNXE[,J>\OW&M?1RQ;L_F,W.2DS9Q<20^XOC0
MC=3U"2KVSZPZ%W#&?[1W5#*8>DTO/YC5.QV6ZS/J=/[<9/G]7^9FVO25R:(>
M@L8^XNNR,]E!(KQ-ME*W5*^L:4E]<:SV:M8LTY=&+\>CTFZ]L[^#)*'3FEX%
M5^5+G,2B^E(B-&9CGJIK-EM+=_N@15L(BK3Q8^F@R<NRV)M];K_P_P"8P<.W
M+C%+J-7_ .D_R&V>6',0N9.'EY8L:>,\5DG%ZDWO&+J-H7==U;=/74I0:UO3
M=WR5Q0Q8JJNJGG9NNX][_4K,KF#!AEAI7%P)[%M-82?2E1'DO1_@JI75.+;N
M.>15M495IXN=.CMC88]EJI/K?X?\QJ%SMRXR:ZC4^G_D-1\T.89<Q\Y%S)8[
MW,*-$3#Z@WO&+K7''+KK&Z>OI2G8&S;KW?\ )6G#%BJZZJ<"6U[#2-][U^I7
MU=P8*14:5Q:G)UK1=(PFX9<P5!< H+@%!< H+@%!< H+@%!< H+@%#KWT<#K
MRX3^O2?M(',.TGZO\*.W=C?T'XI>8VX-9-U            L$SX[X;WJROMC
M' !HOQ(UKWJ@^UT "_@            .(^>)_M4V+V2/[5:'6=R?HK?A_,S@
MG:;_ )*[RQ_+$U]49LUJ@J H*@*"H"@J H*@*"H"@J H*@*"H"AT)Z+L^#"7
MM)S93,8EE )'7.);NIXQ6EQE6@TGM/"4NKPIOVOY3I?8BY&#O8FE[&O\90^D
M[.A3<W@%PY+4A"8KQ*-EQ+E#ZPNFTSH/7LS"4;<ZIK2O(>/;:<9W;6%IZ'JY
M3-O1APYQ-0R>96DTKR4WJT&?W3,5!)(R/^.MPABNTU[%?C#HQ\;_ ')&<[%9
M;!E9W&M,Y<ZBO2Y&H.?&V)V?F!+9C.&K'X5)8V.9&=#<:49O*(NC^4,TU+I)
M)#9MQ97J,JF]<_6]'B-)[4YY9K.R2]FWZBY5[7CJN-)&].4W.?"[7B8V*V":
MW"VJ,A++I2%$VF785"=;4JA&I72I'36M"H-0WMN>Y8FYVU6V]GV>+]YT/</:
M&UFK4879*-U:'71BXUQOA7F,KQNA<N].R3^TPL=$QDQ9*-<UQPTM-$YZ[JR<
M78T1D=.\(N'#H&.N9_-9B"M2DY+9MY::7X3+6=TY')W'?A",'MKH7)5TCX*:
M-&HT5SWYOX[9F$Z?JTCQC$H<)W)ST5)#ZVC[QILSI<A*N^-5**,BMX%QV_<6
MZ)67UUU4E]E;.-\?[ZG/^U&_X9F/R]AUA7UGMIJ2XN&O#HHZ:[QR$QO+W)Z=
M+QNQKQDW+S)JW509G5^,-M)0EM%A.45^^.Y'[X6N_KN:A?4K>*,5'6JT_;E+
M[LM8R-S*N%[!.<I-X94Q)426O3MTK:;1C<F^5L"061;UZ->COZON.O,%V:FV
MZXING_2-?EOG.S6'K'X*)\Z53:X=G-VPEC5I>%MKF;<?$6_?.=6GZ7!<CX^4
MSE<Z2;(N/B+)QM"B*A&\M%4H27[VMW:+LE[9'<U_,RK).,>%OS;?(>.].T>5
MR<&HM3GP1CYWP>7B./I6<RDS-.["_)4>9=DG-5*3WJBD7WDI-.!4/H(N@=.C
M9A&WU:7JTI3B.(SS-V=YWF_7KBKQZSL3EWS9UCF#B&X61?CQ=@4T3.1Q4@R2
MAU2BM4;1+X+0OCWO$RZ#[9\PWCNJ]E+F**;A71)<'+L:VG;MT;]R^\+2C-I7
M*4E%\/W:ZT]FEKAX[QB--Y=\N5R\Y BQ<,J0DTR)K[ZB2ENMQH2I]9DA-2K:
MFE:%VB%K>SF:SB4)-SIJ27H6DO<ON[([O<KL(QMUUR;X/Q/0N2G!L1SKSSYK
M1-XEQ\#KZU+UW'.&\N09&DI,FAI):2/B2$)-1)Z*W'W!O&X]URRL7<N>W+Q+
M]YS+M1ON.=DK5IUMP=:]*6WD2K3;5\1IZHV@TBAOOT89T*%E-B7-DM1DJ8C$
MDWG$MU.]SHN,JC3.T\)2A;HF]+\QT?L3.,)W<32T1U^$UGS4?:?YB[*ZPXEU
ME<UPT.-J)23*A=!D9D8S^ZDUE;:?1-4W\U+/W6G58C$*C*&#H*@*"H"@J H*
M@*"H"@J H*@*"H"@J H=$^BJ=96T^QPOPGQH_:GV;?XO,=-[#>U>Y(?S'2@T
M,ZF   '#?.0_VG;)^LE^:0.N;G_1V^3SGS_VB7_D+OWO,C!JC,&OT%0%!4!0
M5 4%0%!4!05 4%0%!4!05 4%0%#>?HUX[67<IF,WG#CED,9XL6,7*<2DD&]U
MO6+0E9D1J*Q-%=CZXU#M)<O*$(0K25<5.*E#H/8RS8=VY<N4Q0PX:\%<5?#H
M7(=,+SN 6E2%Y.(:5$9*+QAOB1_]0T%6+J^R^9G5WF+3^U'G1C1:QRC(J>Y>
MO_79AF?[I"_^:SW2N<\C$_3]V?#M>[ T7Z1>-U+&JUOX+1,?%)TIOC7N:AE%
MUO46=9U7:JJVO=&W]G;M^?6=:Y/V:8J_XMIS[M?E\M:=KJ(PC7'7"DNC2M#+
M>1_.3#NX6)I^TS$0LC 23&.F2%$AE^.G@VV:SH25H+O"K2XB+LU&,WWN>XKC
MO6EB4M+2UI\+Y'K,UV9[06G9CE[\E&4-$6]":X%7:M7&J<)L\N7W+]G/'O'N
M9&3EC4<DYYK5U/6'Q-ZPU=5?]U?;6O?=/$8#ZAFG:ZC$\.JG#R;?!X#:_I&2
M5_YG!''KKP5Z5*X:\-::].LU1SRYRXAW$2-,U*8B;)F?BLK/8.YEMC[IIM9'
M12E]"C35))J72?#8]Q[GFKBO751+V4]==KY/*:=VF[16W:>7R\L3EHE):J;$
M]3KPZU2JUZM.<KN8#W+S:&LNI"G\7(1XMDXR*7J849'<@C,BO09$I->GBFI5
MJ-HWID%G+.#5):8OC]#_ 'FD;DWK+=^8ZRE8O1)<7%QK@YJJM3KAY'+WFU@V
MVW%QLYC*I>0A#BD/,N4X5L4EQM5#XD=.[P'-4\UN^Y55A+Q/S,[/)9'>UFCP
MW8:]>E/P4E%\6@^.3V+E_P I=?3"-UC'Q(B%'%Q,=1.2G5'QHE!J-:E*/I6L
MZ?OE"JWE\UO"[BTR;UR>I>;P+P%%[-Y+=-C#5145H@O:?(M;Y7X6<;;GMD[=
M=DG;'D"ZMV6LNJ82=R6F4$26VR/A6U)<3IQ.I]D=1R>5CEK,;<>#QOA9P[>6
M>GG<Q*]/0Y<&Q<"_;7K+%47ICJ'56#R>-+T<W(9S8Y2_<:<GJ#>;)RZYWA:9
MUKW!SF_;G]54J.F./!R'8LK>M_0G'$J]7/A7^(Y4N'1CCM#VH"@J H*@*"H"
M@J H*@*"H"@J H*@*"H"@J H*@*'2GHJG6+M/LD+\%\:%VI]JW^+S'4^PWLW
MN6'\QT2-(.F@  !^=>2/_$9GL[GX9CN%OV%R'S)>7]27*RFJ/0\J"H"@J H*
M@*"H"@J H*@*"H"@J H*@*'97([,8F-RMP#$F?'9?04J]MQY"%E68\95(S(^
M@QRS?EJ<LY-J+:]7@_PH[CV7O6X[MMIR2?K\/^.1S1S;?:?YD;&ZPXEUE<HS
M0XVHEI,K$]!D9D-]W2FLI;3V'+>T#4MX76G55\R.GN0^)3A.6&,>?+JG)YO9
M%\U425KJS)"C/M&VA!C0-^WNMSDDM.&D?V\-3J_9?+=1N^#:HYUD_#J?NI'*
M_,7:CW/=,MGFU&J*^]U4$CJ7]69(FVN!]%R2N,NV9CHF[LK\MEXV^%+3RO2S
MD&^,]\YFYW?LMZ/NK0N31IY:G6'*W$8#0]/AX=W)0RRCO]:RBBD-'64Z17)J
M2C(R01$V5.FVO9'-]Z7KN:ON:B\.J.AZOWZSLNY,K9R&5C;<HXGIEI7M/T:O
M <Q<X-V+=MVFS8SE^(@_U'&4/O39:,[G"]D6:ED?3;0NP.@;GR7RN747[4M,
MN79X-1R;M#O'YW-RE%^I'U8\BX?"]/)0P.HS)KE#=O(CFW!U%3NJ[*Z;.#F.
M]=#G'4T1GU$1*2YTF3:Z%Q+UJNG@HS+4M^[IEF*7;?M):5M7I7C\&G?NR^_H
MY1]1>T0DZJ71?'_A?B>O0VUT!EM'Y>;Y)B[%D8,7+NM)3U$UIY1MK;2=R24;
M*R2XDNTNI?6&F6L]FLJG;C)PXJ>E:#H]_=F1S\HWIQC<IJDGH:\#I)<M3&^9
MW./7])Q+T#"RF9NSK0;4.)'4EQN,JE"<>MJ221TD@^*N'"E3*]W9N>[F9J4T
MXPX6^'B7I,9OKM#9R5MQMM2NZDE]GCELILUODTKDO7]CR6M[!"V6"Y=D83Y2
M"-PS,G*UO2LZU,EI-25=PQTG,9>%ZT[<M35/VY#C64S=S+7XWHOUHNO+MKRZ
MF=G:[NFB\U< N%>Q(3,;ZO(8.6:2?0?29&@Z&9$952XCZI&1EPY9F,GF<A=Q
M:535):OVXF=TRF\,GO2RXZ)8EZT'KYO(UY2H@8OEWRFQ<EV/XM@H+Q];)=>=
M4IUTT$=I5=4MQ=*G:A->G@7$47+N:S\TG6;6K1JYM"Y2NUE\CNJW)QPVHO6V
M]+YZM\2YEI.5N;_,@^8FQ(?ADMK XY*F,:TO@I5QD;CRB[!KH7#L)279J.B;
MHW=\G:H_;EI?F7@.0]H=[_4+]8_VX:(^=^'R)&O:C.&LT.H?1FR6.A:?E4S)
MC$=:LDHTH>=0A1EU#7&BC(Z#GO:6W.5^-$WZNSC9UWL7=A#*34FEZ^W_  Q.
M9\BM*LA+4DR4DWW3(R.I&1K/B1D-^M^RN0Y/>H[DFMK*:H]#RH*@*"H"@J H
M*@*"H"@J H*@*"H"@J H=@>C=QY;I_7Y/VD#F/:/]7^%';.QWZ#\4O,;=&LF
MZ            6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P            '$'
M/,_VJ[%[)']JLCK&Y/T5OP_F9P;M*O\ R-WE7Y8FO+AFS6Z"X!07 *"X!07
M*"X!07 *"X!07 *"X!05 4%>T H='PN=FG:9RRC:SJKSTO8XL(F67#84VPF8
M^=SKAJ<(JDE:UK(K>-*=T:+/<U_,YMW+J2@Y;=-%J7,=0M]HLKD]WJS8;E<4
M::FEB?M/3L;;X]1SB:U*,U*.Y1G52CXF9GTF8WDY>])Y42*'IK,RH9F9=HS$
M$4/+A)-!4!0]O52EQT[51!%$>5$DT%P"@N 4/369])U^J=1!%#RX2307 *"H
M"@N 4%P"@N 4%P"@N 4%P"@N 4%P"@N 4%P"@N 4.B_12.LK:?8X/X3XTCM3
M[-O\7F.E]A_:O<D/YCI<:&=2   #ACG,=.9^R?K)?FD#KFY_T=OD\YP'M"O_
M "%W[WF1@EPRY@*"X!07 *"X!07 *"X!07 *"X!07 *"X!07 *"H"@J0 5(
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M=YZ'3FML?LD?VJR.K[D_1V_#^9G".TJ_\C=Y5^5&N[AFC7*"X!07 *"X!07
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MQN :T;D           !8)GQWPWO5E?;&. #1?B1K7O5!]KH %_
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M07 *"X!07 *"X!0[)]&@Z\M$_K\G[2!S/M%^K_"CLW9']#^*7F-PC6C<0
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M<]NFDP>\(68YB:LNL$]'[;-CX46.X7984%P"@N 4%P"@N 4%P"@N 4%P"@N
M4%P"@N 4.D?1+.LO:_8X/X4@:3VHU6_Q>8Z/V*]J]R1_F.G1HITT   .#N=1
M_M2V;]:+\T@=9W/^DM\GG.$[_7^_N\OF1@5PRY@:"X!07 *"X!07 *"X!07
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MT/XI>8W&-;-P            L$SX[X;WJROMC' !HOQ(UKWJ@^UT "_@
M        .$^?*J<VMD]DC^U&1U;<OZ.'A_,SA_:)?^0N\J_*C7-PS)KU!< H
M+@%!< H+@%!< H+@%!< H+@%!< H+@%#RXC 4/;@%#RI=/9 "I  1D70 %2
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MX!07 *"X!07 *'9WHR'7EDGWPD_:0.:=HOU?X4=B[)_H?Q2\QN0:V;>
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MV;O+'^8Z5&E'1    _-/**_Q.;[.[^&8[5;]E<A\[75Z\N5E+</0\J"X!07
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MP_S'3(TLZ$   'YEY17^)S?9W?PS':+?LKD/GNZO7?*RDN'H>5!< H+@%!<
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MCAX?*SCN_OUUSP?E1K.HS!@:"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J
MH*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J H*@*"H"@J
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ML&NFU            6"9\=\-[U97VQC@ T7XD:U[U0?:Z !?P
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M?X?\P^AQ#^6#G^7I_O =YG\/^+]P[I1^+_#_ )A]#B'\L'/\O3_> [S/X?\
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M&. #1?B1K7O5!]KH %_
M
M
M
M          %@F?'?#>]65]L8X -%^)&M>]4'VN@ 7\
M
M
M
M                                 6"9\=\-[U97VQC@ T7XD:U[U0?:
MZ !?P
M
M
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M( 7T
M
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M&9]/  6W-Z/D<E%V-R),9C9O(3X^4P4Y39N%$D0HS#+*EI/UW?-+N(N!I50
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MGSRDV3D=D78XV9+>9)+2(A$9E1!H;2HW>*DD:N!G0 94
M
M
M                                L$SX[X;WJROMC' !HOQ(UKWJ@^UT
M "_@
M
M
M                                                      "P3/CO
MAO>K*^V,< &B_$C6O>J#[70 +^
M
M
M
M                 +!,^.^&]ZLK[8QP :+\2-:]ZH/M=  OX
M
M
M
M                                        L$SX[X;WJROMC' !HOQ(
MUKWJ@^UT "_@
M
M
M
M  "P3/COAO>K*^V,< ,%T_YY/@C@/$O@SXG[FP_%^N\?ZWJ^H1;?;PNITTX
M27K]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO
M^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1
M#]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U
M?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV
M_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$
M /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[
M5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /
MVV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_
MU$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_
M +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40
M_;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7
M_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;
M;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_4
M0 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\
MM7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]
MMO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]
M1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1 #]MO
M^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U?]1
M#]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV_P"U
M?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$ /VV
M_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[5_U$
M /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /VV_[
M5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_U$ /
MVV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40 _;;_M7_40 _;;_ +5_
MU$ /VV_[5_U$ /VV_P"U?]1 #]MO^U?]1 #]MO\ M7_40!997SR?"[%7?!GQ
9SW-R754\?ZKJ^O@7W=FZMEM.'37L #__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>pg_casevaluegrowth-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg_casevaluegrowth-4c.jpg
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M%!04%!04%!04%/_  !$(!+ #A ,!$0 "$0$#$0'_Q #A  $  04! 0$
M        !@,$!0<( @D! 0$  @,! 0$              0<$!08#" (0   %
M @,# @L/#PH%! $$ P ! @,$$042!@<A,1-!"%%A(C+3%+1U5A<W<8%"DK(C
M<[-T%97%-H9(D:&QP=%28M(SPR14E,06X7*"DS0E-28G&.)#4V15HF.$A43Q
MPH-&HV4X$0$  0("!08)"@4$ @,! 0$  0(#$00A,1(%!D%1<;%R-&&!D<$B
M,K(3,Z'14H*2PE,4%37PX4)S%F(C0R32!_&B)6/B%__:  P# 0 "$0,1 #\
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MM?MCWQP<7A8<&/#U.*E: GD;4TI\F&3.\EN[E;!$I>
M
M
M         #4/TGOF3\: GD2_2GR89,[R6[N5L$2EX
M
M
M        -0_2>^9/QH">1+]*?)ADSO);NY6P1*7@
M
M
M       U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
M
M
M     #4/TGOF3\: GD2_2GR89,[R6[N5L$2EX
M
M
M    -0_2>^9/QH">1+]*?)ADSO);NY6P1*7@
M
M
M   U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
M
M
M #4/TGOF3\: GD2_2GR89,[R6[N5L$2EX
M
M
M-0_2>^9/QH">1+]*?)ADSO);NY6P1*7@         "F\^S';-Z0XEII/7..*
M)*2\TSV +)N_V%Y9-M72(XXK82$R&E&?G$H!D=^T@
M      !#\W:I9$R)-8MV:KL5OF26NV&6C8D/8FL1HQ59;61;4GO,!;98UBTY
MSC=F[%ER]%-NKJ5N-Q^UY+54MEB4>)UI"=A=,!.0
M !1>E18].V'VVJ[N(M*:_5,![;=:>3C96EQ'WR#)1?5(![
M     !$,WZH9%R'+CP<UW4K?*E-F^PV;#[V)LE&FM66UD6TN4!:9:UDTXSA=
MV;#EV]%,NKZ5K:C]KR6L1-)-:NJ=:2G81&>\!.@
M                                   &H?I/?,GXT!/(E^E/DPR9WDMW
M<K8(E+P        '.6M7.-7EB?)RCD7AO7J.9M7"[.$3C49TM[;2#JE;B?1&
MKJ4GLH9UI."'*M\S/F+,TE4S,%TE7*0HZXI+JG"+I)29T27225!(QAH6226:
M3)"NM49;#IT# =@<T>'<CRO>[O,E/NPGI;<.%&=<6IIOM=O&XIM!G0L1NI(S
M+[T1(Z*$)            6MR@1[K;I=KED:HDUER,^23H9MO(-"J&6[88#YJ
MWZ-=\OWNXV*;(=*5;9+T1[JU$1J86:#,MNXZ5(?I#JWFDYF<N.5;SEV2Z;DB
MURTR6L9F:N!,1N*O(2VEG_2$2-Z9CO+&7<OW2_2:<"V17I:R/E)ELUT\^E!"
M7S2DW:YRY#TI^6ZI]]:G758U;5K,U*/?RF8_2';O-GRV[9=-8]TF8CG7YY<Y
M9N&9J)A/K3);>0TIQE_.$2EN,0   X[YWWRTL7>O]X=$PA&N;!Y6X'N29[48
MF1W2/RD                  $0U&U&L&FEA5>;VHW'G3-NWV]HRXTEXBKA3
M7<DMZUGL271,R(PXQSMKYJ-G-]U)7-RS6I1F3=NMJE,))'06XFCBS,M]54Z1
M#]8(:T>??DN&](=6\ZHZJ<<4:U&?3,ZF K0KE<;8Z3]MF/PWT[4NQW%M++S#
M09& ^B^F3-W9T_R[[_2WIUX=A-2)<F2HW'C7(+BX5*/:9H)1(V] ?E*5@
M            Y;S1SN9427)@9>RTVE<=Q;7;%P?-9&I!FFO":)/*7_4$X(;>
MT1SK>\_Y'1F._FSV^[+D-88Z#:;2VVHB21$9J/9T3,$M"\[_ .5F7N]R_;U!
M"$1YLOE>M7N>9W.L3([N'Y2
M                   U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>       "%Z
MLYL=R3I[?,PQE89[+'!@JWTDR5$RVJG+A->.G2 ?.E:UN+4XXHUN+,U+6HZF
M9GM,S,]YF/TAVAH/HAEZR9:M^:LR0&KCF6YM(EM)E()UN(RZ6)M*$*J6,TF2
ME*,JD>PJ4VQ*6\W8<1]DXST=MR.98396A*D4Z&$RH(&,<AP\J6&X+RW:64=K
MM2)K-MBI3&;>D837AZA-$FM14KA <<7WG2ZGW1U9VMV)98Q]8W&CI>62>FN1
MQ*GTR20_6"&#B\X?5^*\3W\1J>(M[;T:*M!ET#+A%]8,!T+HIS@TY_G)RMF>
M.U"S*I"EPY$>J8\OAEB4G"HS-#A)(U4J9&1'NW'& V%J?J5:-,,NG>KB@Y,M
M]? MUO0HDK?>H9[3H>%"2VK539TS,B.$N2+[SE]5KO)4Y#N35HC8C-$:%':,
MB+D(UO)<6?IO.'ZP0O<F<X36!Z_6VT^^3-V5/E,Q6X\V,U12GW$H(L;*6UEO
M^^# =F9BS#:<JV69F"^2"C6N"WQ'W3VGO(DI27*I2C)*2Y3,?E+D/.7.JSO=
MICK>44-6*U$9DRM3:),Q2>BM3A*01GT$IV??'O$X(1JU<Y#5RV24O.WI%Q:(
MR-4:9&84VKI5;0VLOZ*B$X#J[2+5RU:J6AUYIKM&_0,*;E;C5C(L?6NM*V8F
MU&1]-)[#Y#/\I;' <1<Z7*_O)J,5Z91AB9@C(DU+8GMA@B9=(NG1*%G_ #A^
MH0I<UW,7O-J<U;7%X8U\BO0S(^MXK9<=L_-];-)?S@D;ZYT&8O>73!^W-KPR
M;Y)9A)(NNX2#X[A^91LDG_.$0EQ98;/*S#>[=8H15EW*2U$9V5(E/+)!&?2*
MM3$H?0?-F;LKZ19.CR;@9H@06FH-L@M4-YY339);;01T+8E.U1["(?E+E3,W
M.CU*O,ASWE<CV""9^MM1VD2'B3^$Z^E53Z:4I'ZP0Q%LYQVKMND$\N^)G-U(
MU1Y<9A;:J<E4(0HOZ*B# =.:.ZY6G4]MRV2V$VS-4='$<A$HU-/M%L-QA1[=
MGHD'M+HF53*$M*\[[Y:6+O7^\.A"$:YL'E;@>Y)GM1B9&QM;M<-0,BZ@2\O6
M"5';MC3$=UM#L=#JB4ZV2E54K:>T0,US>]7L[:BYFNELS-(8>AQ(/;+266$,
MJ)WC-HK5/)11[ D77.(U8SEIS=+'%RQ(899GQWG9!/,)>,U-K2DJ&K=L,($0
MT=UXU$SGJ+9LMWR5&<M<WMGMA#<9#:SX49UU-%%M+JDD& RFN^M.?<@9Y*Q9
M=E1V[<J$Q))#L=#JB6XI:5=4K;Z$!&+7SK,S1,JSBN33-PS>[))%O4;),Q68
MO#ZI:R09&M6+8E.SHF?(; 08^<7J^<WMS^(*%BKVMVK%X-/O</"W>?7IB<!M
M5/.U4G(Z7#MC:L_\0XYM464' 22,I)[:[:X>$2JUVU(A& U4[SB]7W9G;A9@
MX>VI1T18I,D70PFT=2\TZB<!TQH5K2K4Z)*M=Z9;BYIMJ$NNDS4FI,<S)/%0
MDS,TFE1D2T[MI&6^A1*4OU*U*L.F-B*\7C$_)?4;5NMS1D3TATBJ9$9]:E);
M5K/=TS,B.!R5F'G-ZI7B0M=NFLV2&9^MQH;#:S)/)B<?2XHSZ-*>8/U@A5RQ
MSG]2[+*;5>9#-_MY'Z['DM-LNFGEP.LI29'TU$HND& ["R3G*S9]RY$S+8W#
M5$DD:7&5T)UEY&Q;3A$9T4D_JE0RV&0_*4A <!:_9RD9OU)NJ>*:K99G%6NW
MM5ZA*8ZC2ZHN2JW"4=>A0N0A^H0N=!])FM3LP2'+LI;>6;0E#D_A'A6\XZ9\
M-E*O0D>%1J46TB*FPS(R2.TK;E/)&5XK<.W6FW6Z.184$332%*IOJI18E'T3
M,S,?E*TO.4]-LPLJ8O-KM,M"O1J0REPCZ*7$T6D_,4 S4^8AFR3I%J=:-R+&
M=-A23):$+;;,T5(CW%0M@#BK_=!JU^NP_P!C:'ZP0EFIW.:S&<INRY%E,QH[
M##13;PVVEU;\E3:5.$T3B32A"5&:>M,S,JD=!& W#HUGR7.TD+.>>KJ3G:SD
MM4RX/DE%&F7#))4;253Y$D15,]A5,$M+9XYUV:)\QV-D:,U:;6@S2U,DMID3
M'"Y%&E6)M%?O<*O-#!""L<X76!A]+_\ $JW*'4VW(\52#Z1EPOL"<!O32+G+
MMYIN4;+&=V&8-UE*)J#<X]41GG5;$MN(49X%*/8DR/"9[*)$8#QS@-5-1M-L
MSP6+!*CHL5RB$\P3L9#BDOM+-#J<2MI[#0K^D$"RT(UQSIGG/)Y=S3(CO0WH
M3[L<FF$,J)]HT*(ZIWE@Q[ D9+G":SYIT^S#:K'E1]AI;L,Y<[C,I>,^(XI#
M9=5NIPU?5"!ZYO6LV:=0K_=K)FI]AUQF(F9"X+*63(FW";<KAW_E$!(P^N>N
MF=<DY\<RYE>1'9A18K"GTNL(>4;[Q&X9U5NZA2-@8"$L\X361VP2LR'-B)@1
M9;$"IPFZ+?D-NND1'TDM&9^:& T9)D.RY+TMXR-Y]:G7#(J%B69J.A%NVF)&
MP,G:WY^R)9$9?R])CM6YMQQY*78Z'5XW3JKJE )_SL'5R+]E5]TR-QVTDM9D
M5"Q*=,SV! U;I?G=G3S-C6:G(JIJXL>2AB,E1();SS2FT8E'N21G4Z$9@)+<
M^<?JY<)JI;-[3 :Q5;B18S!,H*M:>N(6I7])1A@-YZ$:_3<\W'^$,WI:3?E-
MJ=MT]E)-IE<,C4MM:"V$X22-9&GJ3(CV$9=5& Z"$)
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M-!TV50Z\EM9>>E1D)'T@'Y2
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M "]RMWWM_=+8D?2D?E(
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M?H^D WESE=-]0,\W*T3\M0$W&T6R*M"F6WD)D$^\Y5P^&X::D:4-TPF9](1
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M+G[)FC.J%NSCEZX3<LRV8<6YPWY#RN'A0TT^A2E'1>XB*HE#N\?E(
M                                              U#])[YD_&@)Y$O
MTI\F&3.\EN[E;!$I>
M
M                                            #4/TGOF3\: GD2_2
MGR89,[R6[N5L$2EX
M
M                                           -0_2>^9/QH">1+]*?
M)ADSO);NY6P1*7@
M
M                                          U#])[YD_&@)Y$OTI\F
M&3.\EN[E;!$I>         @DG4N.K4=C3>S6YRYSVV.V[U-0XEMF T9$98R-
M)FI1DI'4E3KD[=] B%SYT.F]JN4RUR6+H<F"^[&>-$=HT&ME9H4:3-XJE4MF
MP3@+7_=AIA^KW;]F9[.& S.4^<5D+.688.6;2S<4W&X*4AA3[#:&B-"%.'B-
M+JC+8D^0,!5T6U:N.J7O_P"^%L8MWO.Y';;X#JW>(;_%Q5Q)*E.&5/- ;6$
M                   "&ZIYTDZ?9)GYKB1437X:V$ICNJ-"%<=Y#1U-)&>S
M%4!>:>YG?SGDRT9HE1T1'[DR;RX[:C6A%%J30C,B,]B0$F 1O,V<8.5)=K3=
M65MVB>XZS*O!J0F-"<0T;K9/U/$7%PFA!D5,5"/>50P-]U+GV33Z-J K+,M;
M"B0_/M3CK;<R+$=,R2\I)$LCV85&C8:25U5,*J!,K'>K;F.SPK[:'B?MMP93
M(C.ELJA95H9<BB/8HN0]@#(
M
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M$1%4SIL$#7?-RFRK)*SCI=/=4XK+%Q6J I>\XSJUH5AZ"<2"<\UP3(WR(
M
M                                      !J'Z3WS)^- 3R)?I3Y,,F=
MY+=W*V")2\       &O=<WUQM)<U.-U)2HA-G3[UUU#:OK* -#&4,:2Y50V5
M$G$-P_YSCJUG]<P&P@',62__ /J_-'L,GVI@2ATZ(2Y&YK>3K)?<P9CS!=XZ
M)C]F<:;M[#R26TV[)4Z:G<*JEC(FR))\E3Y:"90VASF<J6BZZ:3[\[&;*[V5
M3#T2622)PD./(96V:BVFDTKKAW5(@A+#(SW=;+S6X>8FGU)O*H*;9$D$?5I/
MME4-*R5OQ);3B(^B0(9WFWY&M67L@6_,/:Z%W^^H5*DS5)(W$LJ49--(4>TD
MX2)1ERJ,^D$I8OG09(MMRR4YG2.PEF_V-UE1S&R)+KD9UQ+1H494KA4M*TF?
M6T.F\P@8#4/,LK-W-=MM^GKXL^0J(U*=/>MZ-)-A:SZ:C;Q'YH(;>T9\E>4^
M]S/V!"6G.<3Y6=-_9F.[FQ,(9#G2V2\K7E;-S4$[KENQ/.*NL*AFA)+<:75P
MB(Z(<)!MJ5N+9T0@;%R1JUIMJ2PQ;;?(:;N%$+38[@VEMU*FJ*3PTJJA>$RJ
M7#,Z4KL!*6YIN&5;3;"NV;W(C-L@NI>;?G)0I+;Y$9(4V2B,^)0S). L70$#
M36<-?-,,U6*ZY=:M5TS!"DLN,FY'@D;*5FD\"R-U:5)-)T4E6&I;Q."'GFCW
M&5)R+=K>\LUL0KDKM8C.N!+S*%*270+$1J\TS"1!M"LH6;,^K.;YU[83,9LL
MJ1(B0WBQLG)=E+2EU23V&:"2>&I;SKR -S\X#*MGOFF-ZERXK?;]I8[<@2R2
M1.M*941FE*M^%2:I,MWGD00E#<AYVN=EYL+^8$NF=QM,>5"@OF=5(4<@V6#V
M_P#3XB2(N@D$+SFP9&MD#)K>>);"9&8;XZ^I,UTL;K<=IU31)29U,L2D*6HR
MVJJ5=P2EZYTF4++/R"]FPXS;=]M+T?!,0DDNN,ON)94TM1=<GJR45=QELWG5
M \6NQ7C,O-:C66P$:KK)MI&RTDZ*=)J4;BVBZ:T)4@O- 8;0O63(67<L0\B9
MD3_#=[@+=:D.26S;CONJ<49K<<I5"]N%7%H14W\A$.C(34)F(TBW(:;@FG&P
MF.24M85]55.#90ZUV"$K@!S[DXSA<Z?.\1K\C)M:'7"_#-$)=?JJ/ZHD=!"
M
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MA)PW"+SRY D;N$#G[2.F8=<]2\W,]7#BF5J:>]"HR<2WU)\NR+7SQ*'0(A(
M
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M=PO"C/$HI#Q%1LSVUX:22D]M,53+> V*
M                  *+\EB,G$\LD] MYGYA ,<Y?$D=&6C,NBHZ?6(2A3*^
M/5VM),ND9D N6+S'</"Z1M'T3VI^J0)9%*DJ(E),C2>XRVD('Z
M                                       U#])[YD_&@)Y$OTI\F&3.
M\EN[E;!$I>
M                                        +.X3DPVZ)VO+ZQ/0Z9@(
MZXXMU9N.*-2SWF8E#R   "[A3W(BR+KF3ZY'VRZ8"1MK0ZA+B#JA15(Q"7H
M                                              &H?I/?,GXT!/(E
M^E/DPR9WDMW<K8(E+P
M                                               S(B,SV$6TP$5E
M/G)?6Z>XSZDN@DMPE"B      ,Q9)!]7&4>SKT?;(!F!"0
M                                :A^D]\R?C0$\B7Z4^3#)G>2W=RM@
MB4O
M                                6\Y1HB/*+?@,OJ[ $7$H      !=
M6U1IFM&7*9D?GD8"3"$@
M      U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
M
M      H3$&Y%>06\T'3S2*H"+"4       N[6@US6N@FJC\X@$E$)
M                                       !J'Z3WS)^- 3R)?I3Y,,F
M=Y+=W*V")2\
M                                       !^*4E"36LR))%4S/=0!$W
MN&;JS:KPJG@KT!*'@      9NS1C0VJ2LJ&YL1_-+E\\!E1"0
M                                   :A^D]\R?C0$\B7Z4^3#)G>2W=
MRM@B4O
M                                  ,R(JGL(MY@(_<KAVRK@M'ZPD]I
M_?']P2ACP     !D8%L6^9.OD:62VDD]AJ_D 9XB(B(B*A%L(B$)?H
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MW1Q;=SN:HL3:BF*L=.UCJIF>;P-VCCUC
M                                             #"72X8S.,P?4%L<
M47+TBZ0E#%  "[@0E3'-NQE/7J^T73 95RSQ%[4XFS_!.I?7J(2IE8V*[7%F
M7G$)%TQ;HC!XDMXE%Z)6TQ N@
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MYT6Z0(MS@K-R%-9;DQG#2I!J:>22T'A61**I&6Q1$8(7
M                                    ,3=+A@(XS!]6>QQ1<G2+IB4,
M*  *\.(N6Z3:=B2VK5T" 29EEMAM+3940D0E[
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M&>NT%%22S+<:2IU!$9F9449]29G3=4P?EG0
M                        !CKE<.UD\%H_7U%M/[TON@, 9F9U/:9[S$H
M%6/'<DNDTV6T]Y\A%T3 26-&;BM$TWYJE<IGT1"58
M                                    &H?I/?,GXT!/(E^E/DPR9WDM
MW<K8(E+P       <V<YC3G.V=[[8I65;0Y<H\6(ZU(<;6T@DK4[B(CXBTGN'
M7;BSMFQ15%RK9F9\+B.(MWW\S<HFU3M1$>#G:-\0.L'@L_\ UT;LHZ3]8RGT
MX\D_,Y3]"SOX<^6/G/$#K!X+/_UT;LH?K&4^G'DGYC]"SOX<^6/G;!T1TAU(
MROJ=8[Y?K ["M,7MKMB2MUA24<2(\VFI(<4>U2B+80U>]=Y9>[EJJ**\9G#G
MYX;C<VZLU8S=%==$Q3&.G1]&?"[$' K*
M                                         %G<)R8C=$[7U=8GH=,P
M$<4I2U&M9U4HZF9]$2A^ /332WG$MMEB6K81 )+"AHAM82VN*VK7T3^X(2N0
M                                                        &H?I
M/?,GXT!/(E^E/DPR9WDMW<K8(E+P
M                                                 !;3)B(;6-6U
M9[$(Z)_< 1MUU;SBG7#JM6TS$H> 'ZE*EJ)"2JI1T(BWF8"16^"F(C$K:^HN
MJ/H%T"$)7H
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MY9(
M         *,F0W%:-UP]FXBY3/H$ C4B0Y)=-UP]I[BY"+H$)0I &_86\!G[
M9;^UT\9XO7U%L+[TC^V(2R(
M                      -0_2>^9/QH">1+]*?)ADSO);NY6P1*7@
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M$(Z!"4+<  9JUV_!24^75;VTGR=,P&6$)
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M.5,<H6QE/6)^V8E"T  &5M=OXAE)?+ULMK:3Y3Z)](!FQ"0
M     8^3&N#EXM\IB43=M8:DIF1.5UQSA\)1;/085^F 9
M                          !J'Z3WS)^- 3R)?I3Y,,F=Y+=W*V")2\
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M%%ZY+)M"73+IKI4_J@/R+'M92'ID-AA,MW8^^VA*7%ER8E$1&?G@+P
M    #,B*I["+>8"/W*><E7":/UA)^F/H^8)0QX  R%M@')5Q72]82?ICZ'F
M) 1$14+81;B$)                    8>;&@N9CM$IZ7PI[#$U$6'4O7D.
M<'B*IOZC"GTP#,                                         -0_2>
M^9/QH">1+]*?)ADSO);NY6P1*7@
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M6Y*%'>%L3#MZRK@)I/!XY'0Z;:MTJ0#+@
M             -0_2>^9/QH">1+]*?)ADSO);NY6P1*7@
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MK9!.%Q5269:RG4KP.#PJIKA.G$Q]$NMY0&4
M                :A^D]\R?C0$\B7Z4^3#)G>2W=RM@B4O
M                                         'E:TMI4M9T2DJF?2(!0
MBH4K%)<*CCVTB/T*"ZTON@+D        !:I_1I)M_P#)?,U(Z!.<I>?O 70
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M>W&;2JT+:DG/<.F)+J>%P"+:1[:N5H1^< R(
M                #4/TGOF3\: GD2_2GR89,[R6[N5L$2EX
M                                          M7OTA\HQ;6D46_T_O4
M^?O 70          I2&2?:-%:*WH5RDHMQ@/R,\;S=5%1Q)FEQ/046\!6
M!97"<F(C"G:^HNI+H%T3 1U2E+4:E'52CJ9GO,Q*'X ]M-+><2TV55JW$ DD
M.&B&U@3M6>U:^B?W!"5R                         QTF+<'+Q;Y;$HF[
M<PU)1+B;:NN.\+A*_H85^F 9$
M     !J'Z3WS)^- 3R)?I3Y,,F=Y+=W*V")2\
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MAB8B+#J7KR'.#Q%4W]1A3Z8!F
M      &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P
M                  &-NS*GS90WU3M541TJ5,_.H 0K<ZVV?%=6VI1UPMJH
M7G[P%SVF?ZP]Z?\ D .TS_6'O3_R ':9_K#WI_Y #M,_UA[T_P#( QLVVR.*
MIQNKJ#*IJ,ZJV%R]$$LK$(DQFB2K&6$J*!"L P4VWR">=>(L31F:S57:1'M/
M9T@2S31$32"2K$1)*BNB5-X(>P           8^ZM&\VTA!U<-=$HZ.S;]0
MMD-V,2U/;#70B36N[H@+B3,8BH,W%%C+<V1]4?G (Y(D.273=</:>XN0BZ!"
M4*0 15V%O 9^VV_M9/&=+U]1;"^]+H>:(2R(#PAYIPS2VM*E%O(C(S(![
M      <U<Y#Y46GW!^><%D\*_ K[7FA2?'_>[?8^]+2]1V:M"H!4 J 5 *@)
M!D7Y:Y<[YP_;T#7[Q[K=[%75+;[F[_8_N4>U#MT4F^H    &(FN6E.8K2W)2
MH[PMB8=O65<!-)X/'K0Z;:MTJ0#+@
M         -0_2>^9/QH">1+]*?)ADSO);NY6P1*7@
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M/TGOF3\: GD2_2GR89,[R6[N5L$2EX
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ME'M0[A%)OIX   !CI3EU3>;>U&;2JT+:DG/=.F)+J>%P"+JB/;5RNP_. 9$
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MS"NG\%8>%A]<_P 4WTZ'3!*7Z4^3#)G>2W=RM@B4O
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M    8B;%A.9BM,IV7PIS#$Q$:'4O7D.<'B*IOZC"GTP#+@
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M@I5]-@   ,7+FH:OUL@G"XJY+,M:9U*\ F>%5-<)TXF/HEUO* R@
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MJF\V]J,VE5H6U).>Z=,274\+@$75$>VKE=A[N0!D0
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MKZ;    8Z3%N#EXM\MB23=M8:DHF1=M77'.'PE;O085_5 9$
M          ?AJ2DR(S(C/<1GO ?H      _"4DS-)&1J+>5=H#P^X;3+CA%4
MT)-1%YA ,-$F/OS&B>/B%4\*=Q$9EOV= $LZ"     !J'Z3WS)^- 3R)?I3Y
M,,F=Y+=W*V")2\   %JS^CO*BG^375;'_P"Y/G;P%T
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MMIGN(!(+; *,GBNEZ^HO2ET/-$)9   6KGZ-()XOR+U$.] E>A5]HP%T
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M@]Y +Q*DK22TG5*BJ1](P'Z     U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
M  "C)9-UOJ#HZ@\;:OPB^Z _&)33Y)(E$3IEU39GU1&6\J *X
M                       LKC"5+2@VU$2T5H1[C(__ - %.+:T-MGQS-3A
MG7J5*(B+SJ +CM"-T%>G5]T!KK4S4>T9%8.!!3VYF5Y%6HYK4:&$J+8X[M\]
M*=Y](AT6Z-S5YR=JKT;<<O/X(^=QG$7$UO=M.Q1A5>F-$<E/AJ\T<O0Y>NMV
MN5[G.W*[27)<UXZK==4:CIR$7027(DMA<@M.Q8MV:(HMQ%-,*#S6:NYFY-R[
M5-557+/\:(YHC1'(LQ[L4           !L+(.ILW+;C=LNRU2K"=$IKU3D;I
MHY33T4>EZ!\MO?<=&9B;EOT;GR5=/A\/E\'>\.\57<C5%J],UV?EHZ.>.>G[
M/-/0427&GQFID-U+T5Y)+:=0=4J2>XR,5C<MU6ZIIJC"87M9O47:(KHF*J:H
MQB82*UV_AD4E\O7#VMI/D+HGTQYO9E1   #RXVEUM3:RJE14,!:LS&V_T:2X
M1/H/!4]RBY#KTR 7@     9D15/81;S 6+LEN6918ZZFLZ.*+D06^GF[@%ZE
M))224E1)%0B+H$ _0       <Q<Y?Y56CO?^?<%C\+? K[7FA3''G>K?8^]+
M28[)6X      )#D+Y<9;[Z0O;T# WCW6YV*NJ6VW/WZS_<H]J'= I5],@
M,1-7:2S%:424J.\*8F' 46+ 31<'CXJ'2IU;I4@&7
M  4WW4L-*<5MIN(MYF>XO/ >8S2FFZN;7G#QN'^$?)YA;@%8      4I#)/M
M&BM%;T*Y246XP'Y&>-YNJBHXD\+B>@HMX"L M6/T=Y44]C:JK8\ST2?. 70
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M?= >F'2?:2X6RN])[R,MY *@   -0_2>^9/QH">1+]*?)ADSO);NY6P1*7@
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M9))X2/>6)9GBZ-$] :/BG,U57J;6/HTQCXY_EYW4\!9&BG+UYB8].JK9B?\
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MBFSM6*:_HU=<?RA97 .8V,W<M<E=&/CIGYIETN*U7>
M   .8.<U\J[/WO\ S[@L;A;X%?:\T*:X[[U;['WI:1'8JX      !(<@_+G+
M7?2%W0@8&\.[7.Q5U-MN?OUG^Y1[4.[!2[Z6    8B:NTEF*THDI4=X4Q,.
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MVS(15]9XS3R%7<5.D O@               6J?TF2:_^3'/"GH&YRGYVX!=
M   UEKTDU:>2#+<B5&,_,QT^V.FX;G_N1T2X;C:,=VU=JGK<HBUGS^
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MT=;-S4FPDGD<>4=.@F.X?VAH]^SADKG1'M0ZKA2G'>EGIGV:G80I]]'@
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M!VBQT5^G5]T!BY-K<:4MPCK'(\1GO42:[=G+0$LXC#A3A.J:%0^B0(?H
M"U?_ $=Y,HOR:Z(?_P#VJ\[< N@        %JG])DFO>S'.B>@;G*?G +H
M     &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P   >'6DO-J:7UJBI_* IQ75
M+0;;OY=H\+G3Z!^>0"N          +5?Z3()K_DLT4YT#7Z%/G;P%T
M         "A*=4A!-M?EW3PM]+HGYQ *C3266TM(ZU)4_E >P   0?6"%V_I
MS?&R*JFFVY">EP'4.']8C&\W'<V,[;GGF8\L3#EN*K/O=V7HYHB?LU1+CP7
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MO2T@.Q5R      "19!^7.6N^D+NA P-X=VN=BKJEMMT=]L_W*/:AW<*7?2@
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M::)>%Q:4I/$9)+K@2[ E-J4E+S15>9/$@NB7*GSR!^55IQ+K:7$'5*BJ0#V
M  #E[G.?*NS][_S[@L;A;X%?:\T*;XZ[U;['WI:/J.Q5T5 *@%0"H!4!(L@'
M_GK+/?2%W0@8&\.[7.Q5U2VNZ.^V?[E'M0[O%+OI0   !B)L6&YF*TRW9G"F
ML,3$1H52]>0[P>(JF_UO"GTP#+@+5C](>5*/\FFJ&/,]$KSP%T M?[3)_P#9
MCGYQN_\ " N@        %"4TI:"<:_+M'C;Z?1+SR 5&74O-I=1UJBKYG2 >
MP    &$GPI3DI2T(-:5TPF7)LW&"5^U%D(:0DY*B-)$1D1),BZ6T@0]]KO\
MZTOTJ/N ':[_ .M+]*C[@!VN_P#K2_2H^X '&D&1EVTO:7WJ?N ,5&M\M,I!
MJ2:"0HC-?)0CY/-!+/ @       !J'Z3WS)^- 3R)?I3Y,,F=Y+=W*V")2\
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MT                       #4/TGOF3\: GD2_2GR89,[R6[N5L$2EX
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MFE(,\)[TJ^]46TC 6T:YLO&AI9T>/89^A-72/I@+X
M   :A^D]\R?C0$\B7Z4^3#)G>2W=RM@B4O      'AUEMY.!U)*3OH8 VTVR
MC TDDIZ! /8    "B[%CO*);K9*47*8"E/D+BQ\;1%B,R26S80"T@W)]9J0\
MA3M-I&VFIEYNX$KSMW_MW_2?R@@[=_[=_P!)_* =N_\ ;O\ I/Y0#MW_ +=_
MTG\H!V[_ -N_Z3^4 [=_[=_TG\H!V[_V[_I/Y0#MW_MW_2?R@';O_;/^D_E
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MEHH=2W&1@+X           &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P
M         6LT\:$Q4D1N/'3;MHDMZO. 568[,=.%E))KO/E.G1,!5
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MR\H#(  "VE)-LTRVRJIK8LB]$V>\O.W@+A*DK22DG5*BJ1](P'Z
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M3RFH]A$ \QF3:;ZLZNK/&XKHJ/[@"L M6?TA]4D_R2*H8Z?WRO/W +H
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M(3\)\CH;<AM32JETE$0Z2U>MW8QHJBJ/!.+B;^6NV*MFY3-$^&)CK68]F,
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MRV7^%;IHZ*8AEY+W!:JDJN*,DMIZ*CW#&9S]CLDPT2*U5O6KHJ/:9@*H
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M1UJ2W]'I^> ]*4E"36HZ)253/I$ MXJ5+Q2G"HMWK2/T+9;B^V N0
M  !Y<;2ZVIM952HJ& HQ7%&E3#IU>9/"H^B7(KSR 7         #4/TGOF3\
M: GD2_2GR89,[R6[N5L$2EX            "U/\ 29--[,<ZGT#=_P"$!=
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MF37>S'.A= W?^$!C[NM]+R2J9,TZFFPC/E\\$LA;L?:;6,J'3J?YO("%T
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M,@               "Q?@-$9R&$4?2>,D^A,RVTITP%VTZEYM+J.M452 >P
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MH]J'>PIE]'    ,1-BQ',Q6F6[,X4QAB8B/"J7KR'>#C53?ZWA3Z8!EP
M            %JG]&DFW_P E\S4CH$YREY^\!=          "C)=4TV1-[7G
M#P-E^$?+YA;P'IEI+#26T[:;S/>9GO/SP%0        !J'Z3WS)^- 3R)1I>
MZI.GV3GE]9+LMN-9\A/=JM[>EB 38$         "VE*4O#%;.BW>N,O0MEO/
M[1 +A*4H22$E1*2H1=(@'Z                     _%*))&I1T215,SW$1
M ([<9W;;A)3L90?4]$SZ(E"R  &2MEOXYD^\7K)=:D_1&7V@&>$)
M  !X6TVZ1$X@ED6[$50'LB(BH14(MQ$  *,EI3K=6]CR#QMG^$7)Y^X!Z8=2
M^TEQ.RN\CWD9;R 5         'AYU++:G5[DE6G1/D+SP%.*TI"#6[^7=/&Y
MTCY"\X@%<!QCK4?^I^8/9&.YFA;NXNY6_'[4OGKBG]SN]-/LTH#4;MRY4 J
M5 *@%0&T.;^?^I,/W-)]K,<WQ'W.>F.MVG!O[E3V:NIUX*K7R  "U8_1W513
MZPZK8/I<J?. <Q<Z+Y6V;O=^?<%B\+_ K[7FA3_&_>K?8^]+1=1V"O2H!4 J
M 5 *@)'I]\O,L=]8/="!@;P[M<[%75+:;I[[9_N4>U#O@4R^C@   &(FJM)9
MBM*9)+]^#8F' ,L6 FBX/'Q4.E?R=*@,N                 I2&2?:-%:*
MWH5T%%N,!^1GC>;JHJ.I/"XGH*+> K         +5C](>5*/\FFJ&/,Y5>>
MN@         !J'Z3WS)^- 3R)7I>TE_2O)S2MRK';MO*1]JMT/S@$LBNJ<0:
M7-CS9X'"Z9<OG[P0K@       Q]V<>;83PC-*3.BU%OZ0"E9E+7QE+/$982)
M1G4Z;=GF ,J                      ,#<[AQS-AD_62/JE%Z(R^T)0QH
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M[!?;$H8@  74&$N8Y3<TGKU?:+I@)(VVAI"6VRPH25"(A"7H
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MV[_V[_I/Y0%O,N+C;1<)I;:S.F)Q-"\[I@/RU/KD+>6[U3O4]7TNA3D 9,
M         &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E(;JWQ6$(2?KAK(D)^^,]@
M#Q;(3L8UK>H1J*A)(Z^> O5OLH42%N)2L]R3,B,!4      %-+S#IJ:2M*U;
ME)(R/8 HQC-E:HBCZSJFC/E;/D\[< N@                 !B[I<.$1QV3
M]=/KU%Z$NAYHD8,$ "M%BN2W2;1NWJ5R$0"3,,-QVDM-E1)?5,^B8A*H
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MRCVH=\BFGT:    Q\F-<7+Q E,22;MC#4E,R-MJZXYP^$HMGH,*^7E 9
M               #*NP]P"@U$C,K-QILDK/E^YT %<    !X=:;>0:'4DI!\
MA@/QEAJ.G RDDIWGTP%0           &H?I/?,GXT!/(E^E/DPR9WDMW<K8(
ME)6/TAY4H_R::H8\ST2O/ 70# 2HDAZ8[PDFX6+:HMQ5*M#/I EE$1I*4)2<
MI52(BV)2>[S2!#UVO(_6E>E1]P [7D?K2O2H^X =KR/UI7I4?< >5QI*D*24
MI53(RZU);_,(!BXL20S,:XJ3;+%L4>XZ%N(^F"67E-J4E+S15>9/$@NB7*GS
MR!"JTXEYM+J#JE15(![               !87&>45'#;.KZBV?@ET0$>,S,S
M,SJ9[3,Q* ![996^ZEELJK5]CH@)-%BMQ&B;1M/>I7*9B$JX           +
M:>2CANX3PGAK7=L(]OU@&+MT:63QK35E-*&I2=A]*ATJ"64X,S]9+^K+[H(.
M#,_62_JR^Z <&9^LE_5E]T X,S]9+^K+[H"RN4:8M"#-?&21G4DIPT/HT(SJ
M"6O,F:YZ>YCSLO3FQ3W;A>R2^Z;S+"^TDG%(N*DGE4)1D>SJ*E796H"_U"UP
MR?IU=X^79L6YWO,;\=4]=HL,-5PE,0D'0Y#R24DD-D9'M,Z](#!5EZV9(:R%
M;=1K:<Z]V&[NHBV]FT0W9DQR2O'ZT;*2(T*2;:DJQT(C*E=I5&#UIMK/D_4^
M7<[59FY]LS#9L"KE8[S%5"GLH<ZU9MF:B-)])6S96E2J,&P'76F&EOOK2TPT
MDUN.+,DH2A)5-2C/81$6\P0@.F6L^2=7';VWDUV2^BPN,M2WI#!L-N%)XG#6
MT9F9J2HFE'M(CI39M!.#8((     '%VM9_ZH9@]D8[F:%M[C[E;\?M2^?.*/
MW.[TT^S2@-1O',%0"H!4 J 5 ;1YOI_ZE0_<TKVLQS?$7<YZ8ZW9\'?N-/9J
MZG7PJQ>X   #E;G2?*VS=[OS[@L3ACX%?:\T*AXW[S;['WI:)J.O5\5 *@%0
M"H!4!)-/3_S[E?OM![H0,'>'=KG8JZFTW3WVS_<H]J'?8II]%@   ,1-BQ',
MPVF6[,X4QAB8B/"J7KR7>#C52M?6\*?3 ,N
M                U#])[YD_&@)Y$FTS4I6F&2HK9T<>LENQ']ZWVJW4_M$
MFZ4I0DD)*B4E0BZ1 A2DO&RW5)5=4>%M/14>X!^QV28:)%:JWK5RFH]Y@*H
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M:).KVI]JM=@N=KAW>1!<M\=ZWG%:@1[='=;)F41'1A9D9$V@^NH8)EUF#\@
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MYE1Y222I=FMQ(0G:E#:8K>%)5KR A+P%JS^DOG(/\DW5#/3/T2OM +H
M   !:O?HSY2"V-.40]TC]"K[0"K(9X[1HK11=4A7046XP",]QFB4HJ.)/"XG
MH*+>0"J           "A+E-Q&C<7M4>Q">4S 1EYYQ]Q3KAU4KZW2(2AX "(
MU&24E4SV$1=$!F(T'AFEA6UYPL3ZB]"W]Z73,Q"68(B(J%L(MQ
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MF"H!4 J 5 *@-I<WP_\ 4N'[FE>UF.<XB[G/3'6[+@_]QI[-74[!%6+V
M<J\Z3Y76;O=^?<%B<,? K[7FA4/&W>;?8^]+1(Z]7X      ))I[\O<K]]H/
M="!@[P[M<[%74V>Z>^V?[E'M0[\%-/HL   !BI<UIJ_6N"J'Q7I+,M;<ZA'P
M"9X.)-:&9<3&7*76@,J
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M$7FWL1V25:7&I*ISQD6)#B.%P2(\1==5?(>[D 9$
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M/:AW\*;?1(   #'28MQ<O-OEL22;MC#4E$R-4ZNN.\+A*I2G485\O* R(
M                                     #4/TGOF3\: GD9O3^(_(TYR
M8^RG$@[%;$X=QD:8C9<O( G-N3AAM%BQ;#\ZI[O.!"Z           !:W%.*
M&Z6+#L*G3,CW>> LK;!D,O\ &=+ DB,J5VG7S %]*(VU)EH*IM['"+E;/?\
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M3,BPW,P6J6[+X4UAB8B/"J1<9#O!XBJ;SX>%/I@&6
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MFZK*CJ#PN)Z"BW@*P       . KC_B$OV9SU1B];7J1T/E2_\2KIGK6P]7B
M     #?W-B_M.9OYD/[+XX3BSU;7UONK5X ]:_T4?>=$#@%N    .*=;C_U2
MS#[)'[E:%M;C[E;\?M2H#B?]RN]-/LTM?U&[<R5 *@%0"H!4!M/F]'_J9"]S
M2O:S'.<1=SGICK=CPA^XT]FKJ=ABK5Z    .4^=-\KK+WM_/N"P^&/@5]KS0
MJ/C7O-OL?>EH>HZ]7Y4 J 5 *@%0$ET\/_/V5^^T'NA P=X=VN=BKJ;3=7?+
M/]RCVH=_BFWT0    P\U5J+,=H3))9W=3$TX"DUP$T7!X^*ATK^3I4!F
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M,:J/]RGP:_)\RT=T\993-X47?]JOP^K/15\^#9Y&1D1D=2/:1ENH.7=V_0
M           !J'Z3WS)^- 3R)?I3Y,,F=Y+=W*V")2\!:O\ Z.\F46QM5$/^
M9Z%7G;@%T         M6/TAY4H_R::H8\ST2O/ 70       ,7=+APR.,P?K
MA]>HO0ET/-$C!@@ 5XD5R6Z3:-A;UJY"(!)666X[:6FBHE/U3/HF(2J
M "U=_27RCEM:;HM[IGZ%/VP%T          +5K]&?..?Y)VJV>D?HD_; 7"T
M)<0I"RJE14,ND8"A%6HB5&<.KC.PC/T2#ZTP%R      /G_<3_O"7[,YZHQ>
MEKU(Z(?*]_XE73*UJ/5XE0"H!4 J 5 = <V'^TYF]CA?9?'"\5^K:^MYEI\
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M3Y,,F=Y+=W*V")2\!^*2E:30HJI45#+I& LFI;4:L62Y1;9X4J/E3R&8"^
M    %B[+:DTBQG*K</"I1<B>4R 7J4I0DD)*B4E0BZ1 /T      8^Y3RC(X
M31U?47I2Z("/F9F9F9U,]IF8E  J,,.2'4M-E51_4(NB8"318S<5HFV]^]2N
M4S$)5@     !2D/$PT:Z55N0GE-1[B ?D9DV6Z*.KBCQ.*Z*CW@*P
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M:WGG#JHS/ZQ$6XB+81;A;-FS1:HBBB,*8?/68S%S,7)N7*IJJJUS*T'LQP
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MIP#M(OUA[TX#\7!Q(4GCO;2,MJZEMZ) +&);)+<E"W*)0@ZU(ZUIT 2S((
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MT>U#Z!"G'T,    Q,R+$<S!:I;LSA3&&)B(\*I%QDN\'&JF\^'A3Z8!E@
M    8;-.9(&4K%+OMQ/UF,GJ&B.BG75;$-IZ:C^IOW$,S)Y2O,W8MT:Y^2.=
MK=Y;PMY'+U7KFJGDYYY(CI_FXQS%?[EF>\2KW=7.)+DJQ&1=:A!=:A!<B4EL
M(7-E<M1E[<6Z(T1_&+YGS^>NYR_5>NSC55\G-$>"&+&4P
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MB)2V%FI)8B+<HC2I)]&E>469NO/QG+$7,,)U3'A4;O[=,[MS4V<=J,-JF?\
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MAHY/LZNC!M\<@L8         :A^D]\R?C0$\B7Z4^3#)G>2W=RM@B4O
M          !2D2&XS1NN'L+<7*9] @$9DR7)3INN'TDIY"+H"4*0  SULM_
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M5 *@%0"H!4!)=.S_ ,_Y6[[0>Z$#!WAW:YV*NIL]U=\L]NCVH?004X^A0
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M:)\FOQ.T!3#Z9         &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P
M       !X==0RVIQP\*$[3,!&YLQ<QW$>QLMB$= ONB4+8  9FUV^F&4^6W>
MV@_LG]H!EQ"0           %O*;4:4O-%5YD\22Z)<J?/(!6;<2ZVEQ!U2HJ
MD ]     -<:A6?6&==&9>G^;;5E^PM12*7'N5O[;<.0E:U*=XF(B)& T%3DH
M9\H):XT<S3KAJ?D3-EX;S);$NJN:8&3+^JVX([T>"\:94@V*D:D/%1#>+:E1
M*J!*TMV:]=[9K98--KKFVTWZ*41R]YJ*%;$Q^T[:V>!"5+-1GC>69(22=J<2
M5&6$P&T]8LWW'3W2G-.=K>M#5YA127#6ZDEH0\\XAADC2>PZ*<+8?* CFD4[
M4_,$Z/>[SJ+ES-F6"8/MR#8XS?%1(=01H(WFG%8<)UWEMZ'0#=((      !\
M][B?]X2_9G/5F+SM^I'0^7+T?[E73*UJ/1XX%0,"H&!4# J!@5 P="<UPZRL
MS^QPOLOCAN*O5M?6\RT> _6O=%'WG1PX%;    #B+7$_]5,Q>R1^Y61;.Y.Y
M6_'[4J$XF_<KO33[-+7U1NG-E0"H!4 J 5 ;5YNQ_P"IT+W-*]J,<[Q#W.>F
M.MU_"/[A3V:NIV2*N7@    Y/YU7ROLO>W\^X+#X8^!7VO-"I>-.\V^QYY:&
M'7.!      !)=._E_E;OM![H0,'>'=KG8JZFSW5WRSVZ/:A]!!3CZ%    8Z
M2]=$7FWL1V25:76I*ISQEM0XCA<$B/$7757R'NY &1      &FN<7>%1<LVZ
MS-JHJXRC<<+HM14U,O3+0?G#LN%K&U?JN3_3'RS_ "B5:\>YK8RM%J/^2K'Q
M4_SF'-(LI2   );D_4;,F1F)4:R&QPI:T..D^UQ#Q((RV&1ER&-1GMU6,Y,3
M<Q]'FET6Z=_YK=M-5-G9PKF)G&,=3HK2C4&7J#:IQW6$AF; 6AMYQHC[7>2Z
M2C3A)1J,E%AZHJGR'RT*O-];LIR-RG8JQBKGUQA_&A<G#&_:]Z6J_>T1%5$Q
MC,>K5CCAACCIC#3'1/+A$9S9ERS90U4R=F*VLHB,W>4Y&EQVR)+1/J(FB6E)
M;L7&ZJA4V5WF8V>2S5W-;OO6JYVIHB)B>7#7AXL&CWID;&0WQE;]N-F+M4TU
M1&K:T4XX>':T\FC'7*>:HQ')VGV8&&BJI,13U"Z#!DZ?UD#0[GKBC.6YGZ6'
MET.LXDM3<W;>B/HX_9]+S-%<WJ(X_GEZ2DCX46"\I:N2JUMH(J]$ZG]0=SQ/
M7$92(YZH\ZJ^!+<U;PFKDIHJZZ8;+YPDU$?(K44S+B3)S+:4\N%"5N&?G82+
MSQS7#%O:S<S]&F?-#MN.KVQN^*?IUTQY(F?,U%E#6G-F4X+5JHS<K8P6%AJ4
M2N(V@MR$.)41X2Y"42J%L*A#KL]N#+YFN:]-%4Z\.7IC_P"%=[JXNSF1MQ:T
M7**=458XQ'-$Q.KIQPU0S<;-V<-:K[$RD^I%OL"E]L7)F$2D_HS*B49N+6:S
M,ZT2DNMQFDS+9LPJ\EEMTVIOQZ5>JG:YYYO/RX8Z6RHWGG>(LQ3E:IBBUCM5
M11]&.>9QQ\'].UA,QHC":7*X6W-VJ5FR'&;0>6,K)4^_%33@N2HS=$(H1F1I
M9,THPF7WY'L&EM6J\KD*\S,_[E[1$\L4S.F?K:_)+I[]^UG][6LE3$>XRVF:
M>2:J8T1T4:*<.U$Z#6O4;,64;E:;9E]],53C9RY3BFT.<1./ E'5D=$]2K%3
M;NVAP_NJSFJ*Z[L8Z<(^=/%^_P#,Y"[;MV)V<8VIT1..G"(T\FB<>5G-1H\3
M-^D[MWD,I0]VDQ=XIGM-IPT)<,B/II4I'GC!W555E=X1;B=&U-$^'DZ]+:;]
MHHWAN:;TQA.Q3=I\$X15U8PY.%L/GT  ':^G]X._9+LET6K&\[%0AY6^KK/K
M3A^>I)BE=YV/<YJY1R1/R3IA]/[CS7YG(VKDZYIC'IC1/RPD@UK=
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ME73*V'H\0      ="<UO^U9G]CA>J?'#<5>K;^MYEH\!^M>Z*/O.CQP2UP
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M      '0G-:_M6:/8X7JGQP_%7JVOK>9:' ?K7NBC[SI <"M<   !Q#KD?\
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MYLJ 5 *@%0"H#:_-U/\ U/A>YI7M1CG>(>YSTQUNOX2_<*>S5U.RQ5Z[@
M')W.K^5]E[V_GW!87#/P*^UYH5-QGWFWV//+0E1US@BH!4 J 5 *@)-IT?\
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MFE-R;SF&4F3=K@WM;3;F,3D9%,1[T$<I9%0]J$[1KZ<W%R)SER)BBU&%-/\
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M       !C[S_ &/^F7VP$?$H      !D;*9]MGTT'7ZI ,^(2
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MD_&@)Y$OTI\F&3.\EN[E;!$I>       "TN31NPW"+>DL1?T=OV $:$H
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M$-C#G79@          U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
M               .+\]WZ_:LZMYQLSV3[OGS)F0UM0F,IV^>FTVY;Z",WY,Q
MW$2GGL:5$PPA)FI)<FW$?INK)<?(&N&C5HM^5U7++>3T.)CR+1;I"H4EDX:C
M)V"ZXG$HVU&?58554DR.I&"&!YF#:&M%D-M)PMHN]R2E.TZ$3I$15/I 2N>=
M!E>^9NMV3+=!RK+S=885[3=<P6J"ZAA;L:*PM!-FM2T&6,W3+J3KO A6YMTG
M2%R/F6+IQE>3DW,4.0Q&S9E^XF^<QEUKBDP:N,Z[U.UTDX:;:U+<!+>H(
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MHJZG: K!=8   #DOG7'_ )PLG>W\^X+"X9^!7VO-"J>,N\T=CSRT%4=<X,J
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MS+N            &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P
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M-AFH-L @     1/4[R>9F[W2/4&-GNOO=OM0TF_>X7NQ5U.&!<;YR
M =<\W/R<I]W2/L(%8<2=[^K"\>#/V_Z]7F;:',.W    ?.FY?XC,]G<]68N^
MWZD=#YFO?$JZ96H]'B      #HKFI_VK-/L<'U3XXCBG5;^MYEF\#>M>Z*/O
M.EAP:T@   '#6NWE7S'[)'[E9%K[D[G;\?M2HKB3]QN],>S#78W3G
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MH72%>9W>%[-U;5R>B.2%R[KW/EMWT;-FG3RU3ZT],^;4D0US<@
M  #4/TGOF3\: GD2_2GR89,[R6[N5L$2EX
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MBXGSH5 *@%0"H!4 J Z[YN7DY3[ND_80*PXD[W]6%W\&_M_UZO,VV.9=L
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MCDSA2X[$Q#$*I%QTN\'&JE:GP\*?3 ,L
M             U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
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M*/O.F!PBT0   '#&N_E8S'[)'[E9%K;D[G;\?M2HSB3]PN],>S#70W3G
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M,M;4ZA'P":X.)%:5+B8BY?0@,J
M       U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
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M3R_0   &.E/W1%YM\>.P2[4ZU)5.?,MK;B.%P2(\1==5?(>[D 9$
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MR<O-OE1Y!(M;+4E,V-7:XXYPN"HBIZ'"OEY0&1
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ME+P         !'LU9[R=D=$-S-U[B6=-P<-B#VVX39O.)I4D%O.E2J?)4NB
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M_3T5=3M85BN8   !R-SLOEC9.]G[PX+!X9^!7VO-"K.,.\4=CSRY_'6N%
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MKMZP$XME@@          &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P
M'XI*5I4A:24A1&2DF52,CV&1D8#6VJ.B^7-2LN,Y?3P;&;4V-/[<B1&%N*[6
M,SX9D9)V*KM!*EG?37/5]NC<O)>H\W)=J*,B([9XEOBRXV%!J,UM<0T&TL\5
M#4GH%T &*+F^V^U:52=-<GYENE@F3I:;E<<T-.&NXRIAK2IUQY25-F>,D$FB
M5)V$5:[<0Q2K4K35G4K3:;IU/NK\9N<W$;=NN!#T@SAO-/XU)/"DU+-KJMV\
M!,+9"3;;;#MR5FXF(PU')Q14-1-()%3(NC0$+H      :;YR_D]C=]&/:7QU
M/#7>I[,]<.%XT[C';IZJG)(LM2P       #O?3[Y!Y8[U0>YT"FMX=YN=NKK
ME]'[I[E9_MT>S"1C ;0  $1U3\G.:.]LCU!C9;K[U;[4--OON-[L5=3@L7 ^
M>P       '8_-P\F;'NR5ZHA6/$7>YZ(79PCW".U4VV.;=B    ^;US/^\IG
ML[OJS%V6_4CH?-U[UZNF5I4>CR*@%0"H!4 J Z0YIA_I6:_8X/JGQQ/%&JW]
M;S+(X)]:]T4_>=.#A5G    .$]>O*UF3V2/W(R+6W+W.CQ^U*D.(OW"[TQ[,
M-<5&Y<Z5 *@%0"H!4!MSFV>52#[EE^U&.>X@[I/3'6ZOA7O]/15U.UQ6*Y@
M  '(W.S^6-D[V?O#@L'AGX-?:\T*LXP[Q1V//+G\=:X4      $GTW\H65.^
M\#NE P<_W:YV:NILMV=[M=NGVH?1(4^OL   !BIDQAJ_VN$N%Q7Y#,M;4ZA'
MP":X.)%:5+B8BY?0@,J
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M<T7FWQX[!+M3K4E4Y\RVMN(X7!(CQ%UV)?(>[D 9$
M !IO7?.&9,J'8?X?N"X/;?;?;&!*%8^'P<-<:5;L1[AV/#F1L9GWGO:=K#9P
M^56_&F],UDO<^XKFC:V\=6G#9PUQX6G/'!J/_P"?=_JV.QCL/T/)?AQY9^=7
M'^4[T_&GR4_,>.#4?_S[O]6QV,/T/)?AQY9^<_RG>GXT^2GYCQP:C_\ GW?Z
MMCL8?H>2_#CRS\Y_E.]/QI\E/S'C@U'_ //N_P!6QV,/T/)?AQY9^<_RG>GX
MT^2GYCQP:C_^?=_JV.QA^AY+\./+/SG^4[T_&GR4_,>.#4?_ ,^[_5L=C#]#
MR7X<>6?G/\IWI^-/DI^9DLO:KZ@S+_:HDF^.N1Y$R.T\V;;)$I"W4I46Q%=I
M&,;-;FR=%FNJ+<8Q3//S=+-R/$N\KF8MTU79F*JZ8G13JF8\#K45.^@@
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M=KMT>U#NL4@^HP       &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P
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M:HG'">:=6'\8X8PA@V;2.S.;9Y,8_NR5ZHA6/$/>YZ(73PEW".U4VZ.<=>
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ME+P       <R<Z4_[XR[[FD>V(%@<+?#N=,*FXY^+:[-77#0%1VJM2H!4 J
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M[SI\<*LP   !P=KYY7,R^R1^Y&1:NY>YT>/VI4EQ#^X7.F/9AKBHW+GRH!4
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M*@%0"H!4 J S&4C_ ,U6+OA$]O0,7.? K[-74V&[N]6NW3[4.]123Z<
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MI]J'T7%0KW    8Z3&N3EYM\J/()%K9:DIFQZ[7''.%P3+9Z'"OEY0&1
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M@,"I&!@5( J0!4!]!=._D!E;O3![G0*<WAWFYVZNM]";J[G9[%'LPDHP6S
M!#]5_)KFKO;)]08V6[.]6^U#4;Y[E=[$]3Y_U%O*#*@%0"H!4 J 5 =H\VGR
M7Q_=LKU1"LN(>]ST0N7A3N,=JIM\<XZX   !\T[I_B<WV=WU9BZK?JQT/G6[
MZ]73*U'H\P      =*\T;^UYL]C@>JD#BN)]5OZWF6)P9ZUWHI^\ZA'#+*
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M\?\ :M=NGVH?0$4J^E        &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P
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M5     <P<YHZ9JL_>_\ /N"Q^%O@5]KS0IGCOO5OL?>EI&H[!7.!4# J!@5
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M6.(*@%0"H!4 J E&FI_ZB93[\0.Z6QA9_N]SLU=38[M[W:[=/M0^C0J%>H
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MXDJ 5 *@%0"H"4::G_J)E/OQ;^Z6QA9_N]SLU=38;M[W:[=/7#Z-BH5Z@
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MQKHJHF::HPF.1ELG'_FZP=\H?MZ!CYOX%?9JZF7N^/\ LV^W3[4/H2*7?1P
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MFJ:9PU8QS/WO?=]&4O131,U4UTQ73CKPG'7X=#)6'*65X>0TZ@9K3<+C%D7
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MKO9E\_!;:B@       ':_-E\EL?W;*]40K/B#O<]$+AX5[C':J;B'.NL
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MIC:U1CCAY(A <G'_ )OL'?*'[>@;C-_ K[-74T&0[S;[=/M0^A@IA]%@
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MONEKL4^S"3C!;(  $(UA\F&:N][WV!L]U]ZM]J&GWUW*[V9?/P6THL
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MYXO9AK0;AH       ;AYLOE8@>Y9?M1CG]_]TGICK=1PSWZGHJZG<0K1;P
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MRKSM3_OK+7N63[8@=YPQZESIA6'&7Q;71/7#G2H[)7Y4 J 5 *@%0&7RF?\
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M7?J_>=3CAUC    .!N<!Y7\S>R1NY&1:6YNYT>/VI4SO_O\ <\7LPUH-RT
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MKJ9N0[S;[=/7#Z*"FGT,        U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
M      #E3G;G_?66?<LGVQ [SACU+G3"LN,OB6NB>N'.51V2ORH!4 J 5 *@
M,QE,_P#--C[X1/;D#&S/PJ^S/4R\G\>CM4];Z0"FGT$    T?SJO)K%[[1_:
M) Z?ASO,]F>N''<6=SCMQU5.,ZBQE3%0"H!4 J 5 *@/HIIMY/,I]YX'<R!4
M&?[S<[576OG=G=+78I]F$H&"V(  (1K%Y+LU][WOL#9[K[U;[4-/OGN5WLR^
M>]1;*CRH!4 J 5 *@%0';?-B\E<?W;+]40K7B#O<]$+=X7[E':J;D'.NK
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M&IJ;]ZN]7-=<[554XS*6:.G_ *G98]V)]2H:[>W=+G0VVX8_[]KM.\A4B^P
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MYZ(6[POW*.U4W(.==4    ^8UU_Q.;[.[ZLQ<]OU8Z'S_=]>>F5H/1Y
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M\6^W3UP^C0IM]!        -0_2>^9/QH">1+]*?)ADSO);NY6P1*7@
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MX3 Q 8&(# Q 8&(# Q 8)UHT?^J.5_=J?4J&JWMW2YT-WN*/^]:[3OD5*O8
M  !S'SO#I_"'_P!A^[#M^&/^3ZOWE<\9_P##]?[KF*H[=7&!4# J!@5 P*@8
M%0,&<R6?^<<O=\X7="!BYOX-?9JZF;D8_P"Q;[=/7#Z.BFWT         U#]
M)[YD_&@)Y$OTI\F&3.\EN[E;!$I>       #E#G=G2]Y8]RR?;$#N^&?4KZ8
M5IQA\2WT3UN;ZCL7!8%0,"H&!4# J!@5 P9C*1_YKL7?")[>@8^9^%7V9ZF5
MDX_WZ.U3UOI.*;7\    T;SK?)I$[[Q_:) Z;ASO,]F>N''\5]SCMQU5.+ZB
MQ54E0"H!4 J 5 *@/HUIKY.\I]YX'<S8J'/]XN=JKK7KNWNEKL4^S"4#";$
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M]V]TM=BGJA*1A-B  "#:R>2W-G>Y[[ V6Z^]6^U#4;X[G=[,OGE46PI,J 5
M*@%0"H!4!W!S7O)3']W2_5$*VW_WJ>B%M<,=RCM5-S#GG4@   /F'=3_ +TF
M^SN^K,7/;]6.A0-WUYZ96E1^WF5 *@%0"H!4!T[S//[9F_V.!ZJ0.,XFU6_K
M>9WW"'K7?J_>=5#B%B    . ><$?^L.9_9(W<C(M+<W<Z/'URIS?_?KGB]F&
MM*C<-"5 *@%0"H!4!N+FQ'_JU ]R3/:C'/[^[I/3'6Z?AKOM/15U.YQ6JV@
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M(# Q 8&(# Q 8,[DE7^<LN]\X7="!BYOX-?9JZF9D8_[%OM4]</I$*=7X
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MW:9PF:HGQHYFB/'CHBFPTAK$I>+ DDUH1;Z#QO1$8-KNZNJJ:L9F=2URB?\
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MM>$<D>&6I1UBO !OCFT_VG,G\R']EX<'Q9ZMKZWW5L_^O?6O]%'WG08K]<
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M3,X\^,3#4HZU7S/Y%^6N7.^</V] U^\>ZW>Q5U2W&YN_V/[E'M0[<%)OJ$
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MS%?9(;F]KAJMV>K5TL[HH?\ JME7W<GU*AI-Z]TN=#K]RQ_W;7:?0D50NL
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M_P NB-4>!CQD,-G\B_+7+G?.'[>@:_>/=;O8JZI;C<W?[']RCVH=N"DWU"
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MF-FKI9S1-+GC6RI5"B+MY.TTF1=:KI#1[U[K<Z'8;EF/SMO3_4^A8JE=(
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MU(V-_D8VZM=71"RR.HOXTRYWT@]T(&LS?P:^S5U.JR4?]BWVJ>M]+A3Z\P
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MH'T:        U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
M
M
M          #4/TGOF3\: GD2_2GR89,[R6[N5L$2EX
M
M
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MD'NH?0'MF-WS;M^\HJBNF)PG#DECY;><7+ONJZ*K=<QC$5<L-A#5MP
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MOWDQA3S8<L^&6VQHW1       U#])[YD_&@)Y$OTI\F&3.\EN[E;!$I>
M     PF:,H9;SI :MF:+>BXP&7BDM,N*6DDO)2I!*JA23W+47GC(L9FY8JVK
M<[,ZF+F<I:S%.S<IVHB<6%R]I)IUE6ZLWS+]A9@W6.2TLR4./*4DG$FA5"6X
MHMJ3,MPR+V\<Q>HV*ZL8GH8MC=>5L5Q7;HB*HY=/SBM(]-U9E_BY67HQWXW>
MV#?JYPS?Q8^+P<7"QXNJQX*UV[Q/ZCF/=^[VYV?-S8ZS]*ROO?>[$;6OQ\^&
MK'Q)+?+':LR6J39+Y&3,M4Q))DQEFI*5DE1++:DR,J&DCV&,.U=JM5171.$P
MSKUFB]1-%<8TSR+>ZY5L%[R\K*ESA)?R\MIIA4'$M">%'-*FTXD*2HL)H3Z+
MD'[MYBY;N>\IGTN?I?B[EK=RU[JJ,:-6'09<RIEO*,([?EJV1[9$6>)Q$=!)
M-:BV$:U;5*/IJ,POYBY>G&NJ:I,OE;5BG9MTQ3'@9@8[)      !8WFSVW,%
MLDV:\1RE6R8CAR8ZC4DEHJ1T,TF1\G(8]+5VJW5%5,X3#RNVJ+M$T5QC3.M"
MXFANE$&6Q/B9:8:EQ7$/L.$[(/"XVHE).AN&6PR&QJWKFJHF)KG">CYFKIW-
MDZ:HJBW&,=/SLEFC2S(&<[BS=LRV-F=<6"2E,C$ZTI24'5*7.$M'$(N0EU'C
ME\_?L4[-%4Q'\<^I[YG=F6S%457*(F8Z?-K\:MF+3;(V;&K>Q?[*Q+8M3:F+
M<S5;3;#2B21I0EI2"(J(21%R4'YLYZ_9F9HJF-K7X7ZS&[\O?BF+E$3%.KP>
M1^97TTR-DN5(F98LS5ODRFN!(<0MU>-JI*PF3BU%2I!?SU^_$1<JQB#+;NR^
M7F9MTQ3,Z.5;6/233G+=\5F2RY?CQ+P9FI#Z3<4EHU$9&;3:UFVW4CIZVDA^
M[N\<Q=HV*JYFG^-?+/C>=G=>5LW/>441%7\:HU1XDT&O;0       !K=6@>D
M*C,SRM'J>TZ.R"W^8Z-M^KYOZ<_)\S2?H>2_#CY?G9V_Z:9&S/9[?8;W9FI-
MKM+:&;:V2G&EQVVTI0E+;K:DN$6%*2,L6VA5&/9SU^U7-=%6$U:_#YF7?W=E
M[U%-%=,333J\'CUO3VG&1Y&66LG.65C^&65DZW;D8T(XB3-1*,TJ)1JJ=3,U
M;>41&=O1<][M3M\Z9W?EYM>YV(V(Y&/LNCFFF7;K&O=ER^S$ND-1KC2$./J-
M"C2:3,B4X9;C/>0];N\LS=IFBJN9B>AXV=TY6U7%=%$15&K7\Z1W3+-BO5QM
M=VND)$FXV1Q;UKD*-1*8<=))*-)),B.N%/75W#$MWZ[=-5-,X15K\+-N9:W<
MJIJJC&:/5\#+#P9        ""WG1O3/,%SDWF\Y>9EW.8OB29"G'TJ6NA%4R
M2X1;BY"&RM;SS-NF*::YB(Z&IO;IREVN:ZZ(FJ=>OYV29TYR0QEAS)B+*P>6
M'%*<7;EXUHQJ5B-1*4HU$JNTC)52Y!XSG;TW?>[4[?.]XW?EXM>YV(V.93L6
MF>1<M66X9?LMF:C6N[-K9N3>)QQR0VXE2#2XZXM3AE12B(L6RNP?J[GK]VN*
MZJL9IU>#Q:D6=W9>S;JMT41%-6O7I\>MA$:"Z1(6EQ.5XY+09*2?%D;R.I;.
M*,C]7S?TY^3YF+&Y,E'_ !Q\OSK^]Z.Z:YCNDF]7O+[,RZ3%$N3)6X^E2U)2
M2",R2X1;B(MA#SM;RS-JF*:*YB(Z'K>W3E;U<UUT1-4\NGYTARUE>P90MA6?
M+<)%OMI+4Z4=M2U%C<ZXZK4H]M.B,2_F+EZK:KG&69E\M;R]&Q;C9AEQX,D
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MGL0D               !J'Z3WS)^- 3R)?I3Y,,F=Y+=W*V")2\
M
M
M                  &H?I/?,GXT!/(E^E/DPR9WDMW<K8(E+P
M
M
M                 :A^D]\R?C0$\B7Z4^3#)G>2W=RM@B4O
M     >5K0VG$XHDI*E5*.A;3H6\!Z              'X2TFHT$HC6FAJ37:
M5=U2 ?H
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M"2ZVA)*;50CV&1J(856;<Z2)3:HZ;:S"FWZ9EV,A:7G'6FXO'-,I1DI)+4?
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M\!Y2IS;RX[*9#<K&:7,*W_7623Q$%3HU,+>;?,W3)5O)4)7OI GO*LSDB.Y
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M\G%=>LKD5+,N(2F^,W*8)VKC2E+P*(ZE0E&5*'RT(A*
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M7(,2S+?GSTMJN4B:BXDF*M\FFG&8QPVZK<6;CRN&:L2GC.IGUI84T"9@
M                                             #4/TGOF3\: GD2_
M2GR89,[R6[N5L$2EX
M
M                                            -0_2>^9/QH">1+]*
M?)ADSO);NY6P1*7@
M
M                                           U#])[YD_&@)Y$OTI\
MF&3.\EN[E;!$I>
M
M                                         #4/TGOF3\: GD5=,]3=
M.86G.4H<S-MGCRX]G@-/L.SX[;C;B(R$J0M*ED9*294,C(!*O&MIAX9V3X1B
M]D!&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.
MR?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM
M,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&
M!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",
M7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.
MR?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM
M,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&
M!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",
M7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.
MR?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM
M,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&
M!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",
M7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.
MR?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM
M,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&
M!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",
M7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.
MR?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM
M,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&
M!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",
M7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.
MR?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM
M,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&
M!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",
M7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.
MR?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM
M,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&
M!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",
M7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.R?",7L@&!XUM,/#.
MR?",7L@&!XUM,/#.R?",7L@&#5?C#R#_ +C/?C^*+5[T_P ']J]O]N,]K]L>
0^./A<7%@QX>JPUK0$\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>pg_revenuegrowth-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg_revenuegrowth-4c.jpg
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M%!04%!04%!04%/_  !$(!48#]0,!$0 "$0$#$0'_Q #H  $  04! 0$
M        !@,$!0<( @D! 0$  @(# 0               0<$!@(#!0@0   %
M P(!! </$ <%!0<"!P ! @,$$04&$@<A,4$3"%%A(C(4M#=Q@;%"(S.STW24
M%746-A>1T5)RDK)3<R1459755G97H<%BDS0U)X+2PR88X:)#I#C"XH/$U"5E
M\*.$\6-$1;4H$0$  0("!08)"0<% 0 "  <  0(#$00A,1(%!D%1<;%R-&&!
MD<'1(C(3,_"A4H*RPE,4%N%"DJ(C%35BTD,D!_%S8^*S5!=T)3;_V@ , P$
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ML7ZMC>U@8GT,;1_N-8OU;&]K Q/H8VC_ '&L7ZMC>U@8GT,;1_N-8OU;&]K
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M$<FEO,S;4AM:D:-)J0EQPDJI4B4KL@E,=F/)'@WQ%;?%FP1*<
M
M
M                                   "#W#RQ8Y_#-^\?LX!LQY(\&^(
MK;XLV!*<
M
M                                                      "#W#RQ
M8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M
M
M             "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M
M
M                                "#W#RQ8Y_#-^\?LX!LQY(\&^(K;X
MLV!*<
M
M                                                   "#W#RQ8Y_
M#-^\?LX!LQY(\&^(K;XLV!*<
M
M
M          "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M
M
M                             "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!
M*<
M
M                                                "#W#RQ8Y_#-^
M\?LX!LQY(\&^(K;XLV!*<
M
M
M       "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M
M<G$P%#PV'^<-?=I^N J-NM.D9M+2LBX&:3)7'S@'L
M
M   0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@        !'\YO$S'\,R"^V_1
MX?;;?)EQND+4CI66E+3J*I5*I .+I766W?DF?1WEJ,1^E9AQO1<;6?\ 2.6"
M%A_U![P_O.[[VB>TA@,Q:NL]NQ;G$*ESHMT:2?=-2XK22,NQ6.31_P!(8#HW
M:/?BQ[FK.SR8_P $Y2V@W/ E+UM/H1WRF%F1&9ERJ095(N):B(S*,$MMB
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M=&B$@
M                         "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
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M:VZDI"R*IH<0HB4A15Y%$0@9H
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M1\Z=24I_M*KS4$0EQ':+3><MOL:TVUM<^]W1_0V2E56XZX9J4I:U'YJE*4?
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M:3A_!>0'\'S&*GI-Q1&;"Z<FI+E"K]BI79"1W>.*0
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M!MH9EN)BAD=#^%X/$O="!(^D8XI
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M"1$B&=;_ .=F/?%R_9U! TYMIY1,4^-X/C"!(^D8XI
M
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MU*B6Z?&ER$MR'E+-MAU*U$DC8(C.A<.(8H=>"$@
M                                                         @]P
M\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
M
M
M                @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
M
M
M                                   @]P\L6.?PS?O'[. ;,>2/!OB*
MV^+-@2G
M
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MD,!:1LNQF7?Y&+1[HPO(HB=<BV:J/I3I2JNDZ5*BDGPY@&:
M
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MG2?<GVQ R8
M
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M4Q%<5J.US94-%>4D&:9!%_\ NB9&Z!
M
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M\KO';N[H_P!F.P1_TB9&_A
M
M                     "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M   ,+E]C3DV+7G'U4([G"D14*/D2MULTH5YRC(P&GNJI>U/8;=,3ED;5SQ^>
MXEQA7!2&I/=$1EV2<0Z1B9$CW5W'SK ;U;GK)BCM^Q14<U7*0TE9J2^I="2E
M;9+-&E*:F:V])ZN!\ $$G=:Q<UA=MQC#YSV3.I-+$9\^D2A9\AFVTDW%T^QH
MFO9#!#,]7C:[(L9?N^=9HA3&1WPE(;BN4Z9MIQSIG5NTX$IQ9)/3Z4BX\3H2
M4M]"!RQUL5E+R;![77@?3J-/X]YE%?\ N"80ZC>89D,.1GD$XPZ@VW&U%5*D
M**AD9=@R$)<(6W"KRYN9]";KBSL*+[X7(9/E4Q';4?35YC5&,Z>:.2'>*$(;
M0EMM));01)2E)4(B+@1$1#BERMU:%)B;JYS;",BHW(,D]IB:2/Z-8F4+;>O_
M -1^&?;V7Q]80)IUN3_T]M/QPUXM("$ICBQD6P$$S.A%BYU/S(:@&N>IZ9?
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MQQY"31+GH7<GTGP/\K5K;J79Z/143(V8(
M
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M+;:22A)$E*4E0B(N!$1$('Z
M                  #\4I*$FI9DE)<3,^0@&(E7GB:(I?\ Q%?U$)0QCDJ2
MZ=7'5'VJT+ZA *>I1<24=?- 5V9\MD^X=,R^Q5W1?T@,O#NS3YDV\71NGR'Z
M4S_J$)9$
M   $'N'EBQS^&;]X_9P#9CR1X-\16WQ9L"4X
M
M                  $>N4\Y+AMMGZ@D^']HRYQ*%@      ,U:9YN?DKQU6
M1>IJ/G(N8!EA"0
M      !![AY8L<_AF_>/V< V8\D>#?$5M\6; E.
M
M                    %C=7S9BF23HMP]!>8?+_ $ (Z)0      #]0M3:T
MN(.BDF1D?;(!+&7">:0ZGD61']40E[
M                       0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@
M
M                                    !A;XH];*.8B,_JT^L)0Q(
M     "16E1JA((_2FHOZ:B$KX
M                 !![AY8L<_AF_>/V< V8\D>#?$5M\6; E.
M
M                               &&OB#U,KYJ*3Z!B4,0         D=
MI0:82*^F,U?TB$KT
M        !![AY8L<_AF_>/V< V8\D>#?$5M\6; E.
M
M                      &-O*F?!B0L_5:D;9%R]OS@&!$H      !Z:;4\
MXEI'%2SH0"6-MI:;2VGO4$22\X0EZ
M                      0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@
M
M                                  %K-FMPVZGW3JN\1V>V?: 1QUUQ
M]PW73U+5RF)0\       15X%R@,]:X!QRZ=XO5E%W*?L2^N(2R0
M                                             @]P\L6.?PS?O'[.
M ;,>2/!OB*V^+-@2G
M                                                        MILU
MN&W4^+A]XCL_]@"-O/./N&ZZ=5F)0\  "XB0GIAGT="2GE6KDKV 'IRW3&SX
MM&HNRGNO0 4BBR3.A,KK]J?U@%PU:ICI\4=&GLK.G]'* RT2VL1:+/U1W[,^
M;S"$)7H
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M2532HT&=#*O(8"Z            J7U.4
M              6TV8W#;U*XN'WB.S_V (V\\X^X;KIU68E#P  +F%"<F.4+
MN6D]^O\ J+M@)(TTVRV3;9:4)Y"$)>P
M                               $'N'EBQS^&;]X_9P#9CR1X-\16WQ9
ML"4X         <==:9\V]QH::_\ ^)CG_P#OOBQ^&Y_ZL]J>J%1<7T8YR.Q'
M74TCX4?9&T;33/=GA1]D-H]V>%'V0VCW;Z+82=<,QT^S;(1_^70*;SGQZ^U5
MUOH+(=VM]BGJAG1B,YR+URXV0Y%D^WV(XU+D1KA(B9!/2B*ZMHW%0XK4A)&2
M#*O!E1%V*G0'*&7SC=*X9UU=\'C6&2MO+MSY%OQPGV5&3C3_ $O1W!TC29&2
M4J96@SYB74$*'5ZW*L.W/5]NV39I<WWK;9+]/@(>6:GY3Z]3?1--)4=36K56
ME2(N)F9$1F0E,[/UF8?PW8K9G.%WK"K?E*TM8[=[HEM49]QS3H2[H.K)JUI[
MZM*U.A<0,$/V[N%NLW6GWNO%T?;B6ZWVR+)F2W3TH:8:8CN.+4?,1$FI@<B4
M)ZTMO;C1,IN6$WVW[6SY"8L;-7VVN@[M9MH>7'2HW$,*5R.'R\Q5X 8))N#O
MW9L/R:+@N/62X9IG4I@IGP+94I7T$9152X^Z9Z4$94,N!\#(SH1IJ,%*1OPB
MV3-O;5D.)W.SWK/YDJ S;I2FB=@JB/-LZWBKQ2OI"6C3RIX]@#!GI^[-LM^\
M%JV>7;I"[K=;:N[-W)*F_!D-HZ;N%),]5?43Y"YR :'ZK61/XCM3G]Z@V*?D
M,AC+Y33-HL[2793BG6HC::)4I)$A.K4M7I4U/F!,MMX3ONC(,X1MQEV)W+"L
MNEQ5S[5%N2FGFI;#>HU=&ZT=-1$A1TI3N5<:E0$8,+C'6?L^890SB&/8I>)U
MW1=W+5=U,-D[&MT9MTF2F2'4:DI0I6K2D^-$JKZ74,$9ZX:/"W=KK0_*?C6N
MZY(W"N1,2%1M<9XVD+)2TF1%W)G11][R@0CS$"!M%UB,$P_:7(YMRL^1ID(R
MK%WIRKC'CLMI,TOGJ-6A1%K<*O=%HY=*J&2V-BG6BLN:9)&Q;'\5O$NXE<G8
M%Z=:;)R+;(S3AMIE27D52E"S)6E/82=3Y*D8+69UJ[<\F\7G$L(ON48)C[JV
M;ME<!#28A=$1*<6RE:B-Q*$GJ4=4T3W1T30P,&L^M%NRSF^/;?6K&(-TN6 9
M;,B3I<VWGT2;B@GELKM:3*IE(2I)ZFU%0EZ>6@)A*]H,KVUQW=:WX39=I+GM
M_EE_M[R42IY$V:X,9*WZJ2IQ1F2E,&6HBJ:BX\@(EJC!W\3A]6[=)>9,W%W'
M3S-3;[=D>;C3*F<0D:5.DI&DE4U)4DRIVP3RNA[OU@<:V_NN-[>MV"]76X7+
M'H=QL+,0BG2Y)N$;34955:C<TMJ4XZH]-",S,$8,WMAOW8MPY>166Z6J9B.3
MXJDWKS:+OI0IJ,7*\2RIW*?35(J5(^)'4#!#2ZW%G=MURRR%@^0RMN("G649
M<VP@HSK[?<I+HU&2D(6O2V2S/N346HB.I$,&Z,&RYK/,*M&96^*N*U>8B9D>
M)(41K1KKI2I2*ES<P(<7[96W;_=.^7V#O]E5WM>])7-]AN!)G+MC<9' FVX1
M*(VB42M1$BOV.E-.)G)U+FNZ%JVP=Q_!+1:KCEF97".2+188*DN2EQ8B=!R)
M+[ID2$=R=7%5U&1]@S(AAH76,LKN+YE=KK8+C9\IP-I#^08I-Z-$M+;W%M;3
ME=#C:RXDHOJ44DU#!&)/6\M!6&;F-NPB^S<(MZ(I2<@T-LQ3D25I:6TTIPR)
MSHG%=&HTJ[[^S11C!L3.]Z+'ACV$Q(L)^^SL]E-1;%'AJ;2:FW2;/IU&X9$2
M"Z5%3[=0,$!VORW;+&+_ +WY,TY=;:S9;RI>53+Q)3*BJ>;=DH(X3;=5)2I2
M3)*556JJ$ER$D@D>![\W'/KI!5 V]OT'";ETJHN6STM,Q.A:;6X3SB-1FEM6
MBB5$HRJ9 8,-+ZTEO3%E93:L)OMTVN@2%196:L(:3&/0X3:WF6%J)QQE*CH;
MG#L<O #!(<RW\M=CO5DQC#;%.SC);];DWR'"M1MMME:W",T/K==,B(ED7<E3
MS:5*HP;'Q>\RLAQ^!>IMJE6.7,:Z1VTSR2F5'54RT.$DS*O"H(9<
M                          6TR8W#;U*XN'WB.S_V (V\\X^X;KIU4?\
M^J$)0\  "YA0G)CE"[EI/?K_ *B[8"2---L-DTT6E">0A"7L
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MNNU6.3]R6ELY>\RLY:7V^AD*:)U9,+>;H6EQ31(4HJ$=>4B.I B6Q 0
M                           MIDQN&WJ5Q</O$<YG]8!&WGG'W#==.JC_
M *.T0E#P  +F%"<F.4+@V7?K['_: DC33;#9--E1">00E[
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MIY@3BWY9+-;L=LUOL%H9*/:K7&:A0F",ST,1T$VA-3XG0B+B8(7X
M                                    "VF3&X;>I7%P^\1SF?U@$;>>
M<D.&ZZ=5']0B[!"4/   N84)R8Y0N#9=^OL?]H"2,LML-DTT5$$(2]@
M                                                           (
M/</+%CG\,W[Q^S@&S'DCP;XBMOBS8$IP
M
M   "WF3&XC>M?%9]XCG,P$;??<D.&ZZ=5']0B[!"4*8  N8<-R8YI3P;+OU]
MC_M 2-EEMALFFBH@O_U4Q"50
M                              0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP
M)3@        !C+MD5AL)M%>KE&MYOZC9*2ZAK7HIJTZC*M*E49-G*WKV/NZ9
MJPYHQ8.:S^7RV'OKE-&UJVIB,?*QWTA8+^\EM]]-?[PR?[9F_P *O^&6%_?=
MW_CV_P".GTGTA8+^\EM]]-?[P?VS-_A5_P ,G]]W?^/;_CI])](6"_O);??3
M7^\']LS?X5?\,G]]W?\ CV_XZ?2SD*=#N45J=;WVY4-XM33[*B6VLJTJ2BX'
MQ(8-RW5;JFFJ,)CDEZMF]1>HBNB8JIG5,:87 ZW<
M                                                     +>9+;B-
MZU\5GWB.<S 1M]]R0X;KIU4?U"+L$)0I@ "YAPW)CFE/!LN_7V/^T!(V66V&
MR::*B2__ %4Q"50
M                      $'N'EBQS^&;]X_9P#9CR1X-\16WQ9L"4X
M    <^]9;U_&_M)GHLBP.$]5WZOWE0?^A>U8Z*_NM##?%2@  ['VE\G-@_$*
M]E6*=WWWVYT^:'TGPO\ XRSV?/*:#Q6S(-N%O#MSM6<).=WM-J<N).*A-]!)
MDK<2R:269%':<,J:BY0'C#MZ-L]P84^;AN0,W;X-85*F14)<9EH907%70/I;
M<IS:M-*\X)P7NVFY&/;K8LUE^,)DHM3SSL="9C:67M;"M*JI2I94KR<00EX
M      /Q2DH2:U'1*2,S/L$0#3#?6SZOKDQ,%.9M$ZI6DG%0YZ6:]MU4<D$7
M;-5 3@W#"G0[G#CW&W2&Y<"4VEZ-*86EQIUIPM25H6DS)23(ZD9 A7
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MP0E"F  +B'#<F.:4\&R[]?,1?7 21EEN.V331427U3/LF(2J
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MPF+;VXDVW.F>ELDKJ3JD$??+61I/D(SK4"72 (    6\N6W$:UKXJ/O$<YF
MC;[[DEPW73JH^0N8B[!"4*8  N(<-R8YH3P07?KYB+ZX"2,LMQVR::*B2^J9
M]DQ"50
M                0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@        !S[
MUEO7\;^TF>BR+ X3U7?J_>5!_P"A>U8Z*_NM##?%2@  ['VE\G5@_$*]E6*=
MWWWVYT^:'TGPO_C+/9\\IH/%;,TQNCM?E&7[M[89M9U1BLV(R)+MV)YU2'C0
M^;1ET2209*X(/E,@2VW=XKLVTSX3%.FDQWF6]1T3J<0:2J?8J8(:$P'97,\;
MZM5^VGN*H?RIN4>Z,QE-/*5%U3B,F]3AH(RY>/<@G'2B2M@=TL?:VGR:QL6>
M]Y!@=N>MEPQRYO+\ -;RWE%(9<T4UD3I&9F1&2D(,JT!.*]MNQ.[+\[>"[Y.
M_9WKON)8_ X:K>XZW&:F+:T]$:7&]1-M]X3AU-5-1E4P,4O=VBRY?5=+:$CB
M?*XK8B%4W5>"=*F43Q^J:*TTE]CR@CE8O<G9+-<JV&V_VXM*H7RBQIVSKN2G
MGEHCFFW0G([O1K)LS5W:RI5)5(#%)=TMK\GS#=G:_-;0<7X&Q"3)>NQ/NJ0]
MH>4T:>B22%$H^X/E,@&I+=L#OECV(YQM=9/DX_8<F?E2UY?-6\=UDM/(3I86
MA*#HM1H(C4NJ4:EJ3J.@)Q=&;68M=<0VNQS$+QT7PO:K:W"E="LW&NE;2:3T
MJ,DF9><#BU?M1L3D./[ Y+M1F*H?PG>UW+H7(SBGV$>%LH2RLU*0DZH<3K[W
MF($XHFWU>-SVL*V]ND=VS*W1V\3+M[<2X5FVFXVI]:S;:<-3=4J0VLT)[GGJ
M2DF23(G%L?#[9O2RU>YL_#\+QVZHMSB,>.#TJU+N1F6GPA;22I',N^))ZJ@A
M#;!LGG>5[KPMQ,_L./8I!A0)T&YPL>6XX]>%W&.[&6I\Z)2222[6JJKX4X\J
M1BL,8VGWPVP@+PO'\>PS,L<BNNG9+[>FS8FM,/+4X29*4IJO2:C.B35V"52A
M$&:R;:C=:U;MVK=?"H&/WB2NQLV659[FMUB);)""3J<A:4&:6B41FG3W=%+*
MG=5 1=KJX[H_1MNWB]PE6N7D><7:'=8,MEQ;$9PT2RDR#4DVS-KGT)[KL G%
MM'<;9&7N)LQ8,$<G-VS*\>8MS]MN"=2V&[C CDRHC,B)1MJ(UIU$52X*H=*&
M1BQS%MZQ^5XID>&Y_;\;:CSK!<;:S=($A_IY-Q?CFU'<-%#0VV9F9N]P7]DB
MY %H_LQF3G54+9M)P_E@45MBIO*\$U)N12S]4T5];+[#OOJ@8Z6QOH\7>-F(
M^U]]?*/(>QYBQS9,8^D)M]N(AE2T5TZB2M-2K340#0,O93?[(<!MVR^11\6=
MQNS.-(M>:*7)7/C1XRO4U,,H)!D\2/4ZF22-/ S],"<6W^KQ@.5[88=*PO*(
M=O)<6:_)CWNW/+<5<BDK,S>DH=22DND1)36ID:=)>EXD2U\[MUO_ (=O#G6>
M[>0<=G6[+EL)0=YD2"4TVPA)$9H9T&1UK7B8"5[?;'Y*><2-U]Y;W'R'.G(B
M[=;85O0IJV6V*ZA2%I9UDE:C-+BT]ZGOUF>I2JD,4&QW9W>+:=,S%L/L.(YK
MB"I#LBRS[\CH;A%;>6:NB?,D>J$DSKP,^T9<$D3BG^[NT^49_MACL2S)MMGW
M-QF5 O%M7"-3%N8N+)EX0EE1H-26JJ4M%4<32FO9!# KZL[L_J^P]LI5P9C9
MHU+^4+MW(C>85?5+6M1K[DC4C0LV-6FNDB50Z4,8LA@UAWM9OMH8R["<'B6R
M&ZD[I?("5>%NI:(]+D9M*")#AK)*NZ(BY:$7"@1.#U7K[><2W3Q?*9<:&[EN
M0*O^.38RU2.A6AQU;9O)-**:B7H615X*.G&@&+W?MJ>L#NQ9+#MSN9)LEJPR
MTOL.WJ\6MUY^==4Q"T()"%I)+9J*IJ-6DM7=4X: $>DQ\^@];K-7-K4VU=SM
M^/0"=M%V-QN+*@DQ"0;2'&ZFVXE6A2%'PX4/@">1*K=L5N3>XFZ&;9S+MWTE
M9[97K%;;;!6LH$&*IM*$MJ=4DS.O1M<A'329F:C4=",5QE6Q><7GJPV3:*(J
M"666_P %\(4M]28M&'UN*TN=&9GP47I0,=*1[K;4Y=F%SVCFV)40DX1=HMPO
M'A#JD'T;"HQGT1$A6L_4E<#IS (B]LYN?MWF.2W+;RS8SE^(91/>NWP;D+9-
M3($N0>IQ+;NDZM5X$6H^!%P(ZFH,IG.T6XF;VO:Y]^!8;3>L9OZ;SD4.U+<8
M@):2^A2?!R4V:E+Z-!:M7IN0Z )+N%M?DV3[W;<;@6PXQ6#%4RDW0G75(?,W
MTJ)/1H)!DKE^R(!@L'VUW6VYWHRR\6=-JN.V^<7+X5N<E]QQ%PBGZLYH;05"
M-1+=-/IB--#[DZD V!N:O>B.[:IFTS5CF,,],5YMU\4\VM[5HZ(V5M4).FBZ
MU47*7* UE8-B<WS;)\JSO>J7;XUUR&POXQ"M%@)2FHD.2FANJ<=*JG4<J>*B
MJ?+0B20Q8C%MN-_<&M<;#(V+8)DMOMU(]NR6XMK9>5%3P1X0VA&I2TIX5(C/
MLFKE,)[9MJ\DMW60NVZ2DQ&\1F6!JT166G#\(2\WX-PZ+022071*I178X ,;
MUDMF,MW(/'\AVZEQ[?F5G\,@.R)+BF$N6VY1U,O)UI0Y4RJ9$5.1:@(E;[M;
M"WB^;&8SM3@AQ2DV"3 <4Y,<4PTXF*TZEYRJ4+/4XXYK,J<Y@8OW,MJMT,<W
M7D;Q[/R;;+N%ZA,P,FQZ\J6TS(Z!*$)<:<;+@=&D<Z3(R/BHE&D!8YOM/NWF
MJL5W.<9QV)NSC:I4=ZQND[+LDRV/J5H9<4ZE2B<2E2N)%0S54E),B 2;$;;O
M4Q%ODV9A^%X[>40%(QWP+IE&N>:B_P 2MI)48,N9!ZJ_T!%L+V?W#N6]%KW:
MS"SV'#4V>,^S(A8XXMQVZR)+:VS<D'I).DB76JNZ[DBX\I#%TH"   4)<MN(
MWK7Q4?>(YS,!&I$AR2X;KIU,^0N8B[!"4*8  N(<-R6YH1P07?KYB(!)&&&X
M[9--%1)?5,^R8A*H
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M8T?>&9C,7ZKD1A%4K4W1DJLGE+=BJ8F:(PQCIEGA@/6
M                        $=B8)B4',)^?Q+6VUF%SCIA3KJ2G#<=CMDV2
M4&DU&@B(FD<B:]R0"1    MY<MN(@E+J9JX)27*8#S$G-2R422-*T\J3['9
M70    #\,R(JF? !CRO$<W=&E71UITG]= &1          %"5*;B-&XYRGP2
MGG,P$:D2')+ANNG4SY"YB+L$)0I@ "O$B.2W-"."2[]?,1 )*PPW';)IHJ)+
MZIGV3$)5                         &-NDZ;$E6IF)'Z=F9*-B6Y11]$R
M3#KFON>!=TA*>/#B R0
M     @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
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M/2QWY1MW!>G5T<?H'5$JM2IW:4%7CR@,D
M                   (/</+%CG\,W[Q^S@&S'DCP;XBMOBS8$IP
M                                                      /Q2DH2
M:U'1*2J9]H@%M$2IPU2W"HIW@V1^E;+D+S^4!=        &1&1D95(^!D M(
MIFPXJ&H^">Z9,^=!\WG +L      4)4IN(V;CA\?2IYS,!&Y$AR2Z;KA\3Y"
MYB+L$)0I  "O$B.2W-"."2[]?,1 )(PPW&:)IHJ)+E/G,^R8A*J
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M16U)'&5*,KF9DDZ1N@=,C+4=?7.CY.(#)
M                   "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
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M6DJ5VS)-3!#+@    ,;=&[LN7:E6Y9)C(E&JYD9D6J-T#I$15(Z^J&@^ #)
M                                             "#W#RQ8Y_#-^\?L
MX!LQY(\&^(K;XLV!*<
M                   *;[R6&E.JXDGD+LGS$ \165-MFISB^X>MP^V?-YP"
MN           "T1^2RC;Y&)!FI'8)SG+SP%V  *,F2W%;-QP_M4\YF C4F2Y
M*=-QP^TE/,1=@A*%(  5HL5R6YT;?)Z97,1 )+'CMQFB::+@7*?.9]DQ"54
M                             8VZ1;E(E6IR"_T,>/*-V>C4:>E8Z!U&
MBA$=>[4A5.T R0
M@]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
M                                 "T_Q4JG*Q&/SC=_]T!=@
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MU>23\[E_Q*?XH/AVQ_I.)_?M_P"\'Y:[]&KR2?G<O^)3_%!\.V/])Q/[]O\
MW@_+7?HU>23\[E_Q*?XH/AVQ_I.)_?M_[P?EKOT:O))^=R_XE/\ %"YC38<U
M*EPY#4A*3HI32TN$1]@])F.JNW51[43'2[[=ZBYIHJBKHG%7'!V@   ,;=($
MR9+M3\:1T#4*4<B4W51=*T;#K>CN3H?=+2KCPX ,D
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MD%(Z K?+.2;?X:K#K6CE+[/5S\@#)@
M               "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M                                  "TD%X4^F+RM(HM_P#]E/G@*[3#
M+!&32"01\M %0      6K\%A[4HDDEX^).%S*YC 5(SQO-545'4GI<3V%%R@
M*P"D]'8?ITR"53D,^4!1C>H.*AJ[TN[8/LH,^)><8"[             49,E
MN*T;KA_:IYS/L$ C,E]<EY3SG*? B+D(BYA*%,  >FTDXXE!J)!'RJ/D(@&?
MC2+=%:)MMTJ<YT.IGV3X"$JOPC"_#%]0_K 'PC"_#%]0_K 'PC"_#%]0_K +
M67=B09)BT7PJI9UIYG, NH$LY;1J46E:3HHBY/- 70        #ROO%>88F$
M3J<#R#+IW?MU>B+YIU0^3:X]:>E2J0Y.&!4@,"I 8%2 P*D!@5(# J0&#I'J
MUG6Q7OW6W[$*YXK^+;[,]:Y^ .[W>U'4W<-)6>    Q=VMS$Z99WWI!,+@2S
MDLMG3U99L.M:"J9<RS5P[ #*
M          "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M                            *4AXF&E.'Q,N"4\YJ/D(!^1639;[LZO+
M/6ZK^T?U@%8        !:/?DT@I)<&G:(>[1^E5_4 NP !;RVE+03C7K[1ZV
M^WV2\\@%5EU+[274<BBK3L'SD ]@         "C)DM16S<</AS%SF?8(!&Y4
MIR4X;CA\/2IYB(2A1  %:-&<E.$VV7VRN8B 22-&:BMDVV7VRCY3/LF(2K
M   +27 :EF2E&:%EPU%SD \P$)CFY$,J.)/62OLDGR'YW( O0        'E?
M>*\PQ,(G4X$D>ON_;J]$7Q3JA\G5^U/2ICDX        .DNK5_D-[]UM^Q"N
M>*_BV^S/6N?@#N]WM1U-WC2EG    ,5=X4"5,L[LR03+T28;T)%4ETKQQW4:
M.ZXGW"E*X<> #*@
M"#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M                  +0ORJ5JY6(YT3V#<YS\X!=@         #RXA+J%-K*
MJ5%0R\T!0B+41*C.G5UGA7[)/I3 7(  M$_DLHT?^!(.J>P3G.7G@+L
M   !2D2&XK1NNGPYBYS/L$ C4J4Y*=-QP^'I4\Q$)0H@ "M&C.2G";;+[97,
M1=DP$DC1FXK9-ME]LKG,^R8A*L       "VEH41)DM%5UGC3[)'IB 5T+2XA
M+B#JE15(_- >@       >5]XKS#$PB=3@.1Z^[]NKT1?%.J'R?7[4]*F.3@
M       Z2ZM7^0WOW6W[$*YXK^+;[,]:YN .[W>U'4W@-*6<    Q5V9M;LR
MSKN#QM26IAKMJ253I)/@[J3294.OJ9K.G: 94
M                       0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@
M                                       %O+=4V@D->ONGH;+M\Y^<
M J,M)8:2TCD27+V3YS 5            6LM*FS3+;*JFN#A%Z9L^4O.Y0%RE
M25I):3JE15(^T8#] 4I#)/M*;,Z'RI5SDHN0P'Y%>-YONRHZ@]#J>PHOK@*P
M      I2)#<5LW73X<Q<YGV" 1J5*<EN=(YR>E3S$0E"B  /U"%NK2VV55J.
MA%YH"418S<5HFT<OIU<YGV1"5<          6C/Y-(.,?!IRJV.T?ID_U@+L
M       'E?>*\PQ,(G4X!D>ON_;J]$7O3JA\H5^U/2ICDX@       .D^K1_
MD-\]V-^Q"NN*OBT=F>M<O /=[O:CJ;Q&E+-    8N[%:CF6?X1,RDE+/X,IJ
MH<GP=VM=/#UO7WW#SP&4
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MGL.=$GLID0W4O,J*J5H,E),CYR,JD8\.8F)PF,);335%4153,3$\L:87 AR
M !2D2&XS9NNG0BY"YS/L$ C<J4Y+=-Q? N1">8B$H4  !5CQW93A-M%QYS/D
M(NR8#-6^,VE1NH*K:*H:5SJ/TR_/Y"$)9$           %&4R;S5$'1U!ZVU
M=A1<@#]CO$^T3E**Y%I["BY2 50     !Y7WBO,,3")U. )'K[OVZO1%[4ZH
M?*-?M3TJ8Y.        #I3JT?Y#?/=C?L0KOBKXM'9GK7+P#W>[VHZF\1I2S
M0   &*NSMJ;F6=-Q:-R2Y,-%M41&>B3X.Z9J.AE3U,EEQ[(#*@
M                              +)"$375/.$2HZ*H92?$C^R5_4 O$I2
MA))01)27(1<" ?H  @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
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MG4C/S> )7MH6ZN.KI#,T$JB#/^D$,@
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M 9J1$\&MZVHQ&:CH;BB[Y1<XA*PM1.>&)T<A$>O[7_\ F"4@!
M   QUX)SP=)I];)7=_U +:S$[TJU%7H=/==C5S EF@0    \K[Q7F&)C6B=3
MY^R#/PAW[=7HB]J=4/E.N/6GI4ZF.3C@5,# J8&!4P,"I@8%3 P*F!@Z6ZLQ
MUL%\]V-^Q"N^*OBT=F>M<? 7=[O:CJ;R&E+,    8N[7"-"F6=A^,3[DZ6<>
M.X>GU%PF'7=?'CWJ#3PX\0&4
M  'XI24)-:CHE)5,^T0"VB)4LU2W"HMWO"/TK9<A>?R@+H    !![AY8L<_A
MF_>/V< V8\D>#?$5M\6; E. 'E:$.%I6DE%V%%4OZ0%LW^2R39Y&'ZJ;["5\
MZ?/Y2 78                                       /*T)<0I"RJE14
M,NT8"A$6I.J*Z=76>!']D@^],!<@   T7O%NXN M_$L6?TS"JW=+BV?%KF-E
MI1>G^S47>\A=U6F\[BW)%<1?O1H_=IY_#/@YHY>C757%?%,VIG*Y:?6U5U1R
M?Z:?#SSR:M>KG@S,SJ?*+#4X @              %S;[A-M4UFX6YY4>9'5K
M:=1RD?)YAD9<#(^!EP,=-ZS1>HFBN,:99&6S-S+W*;MJJ::Z9QB8^7EC5,:)
MT.DL!SJ)F, R626+S&(O#(I<AD? G&Z\J#/STGP/F,ZFWMNJO)7.>BK5/FGP
M]?EB/H7AWB"WO2UI]6[1[5/WJ?!/EIG1/),S6/'<DNDTT7$^4^8B[)CPVUI)
M%BMQ&^C;Y?3*YS,0E7 6TMM1$F0R7JK)ZJ%Z9)]\0"NVXEU"7$'5*BJ1@/0
M           "T/\ *I5.5B.?'L*=_P#= 79$1<"      'E?>*\PQ,:T3J?/
MR1_B'?MU>B+VIU0^5*_:GI4QR<        '2W5E_R"^>[&_8A77%7Q:.S/6N
M/@+N]WM1U-YC2UF    ,9=;D<&7:8Y1^G*X2SC&Y^!HPZ[KY#^PT\W* R8
M                                    M)'Y0\F(7K::+?/M<R?/ 78
M     @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G   I2&2?:-%:++ND*["BY#
M?D9[IVB4HJ.)/2XGL*+E 5@
M  6LM*D&F6V55M=^1>F;/E+SN4!<I4E:26DZI452/M& _0&K]Y-QCP^U%:+2
M[IR*XH/HUI/C'CG5)N_;&9&E';J?-QV?<.ZOS5S;KC^G3\\\WI_:T3BS?_Y"
MS[JU/]6Y'\-/TNGDI\<\CE52C49J49FHSJ9GQ,S,6HH*9Q?@E
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M   ,;=)\R'+M3$:/T[4V4<>4Y11]$T3#KFON2H7=(2GCPX@,D
M                          LY%RCQUFV=5N%RDGD(^P9@*D)&EDG#,E./
M>J+47.9\WG +@      0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@   %H[^3
M2"D%ZR[1#W:5Z57]0"[
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M    QMSEW&-*M34*/TS$F4;4Y>E2NB8Z!U>NI&5.[2A-3[(#)
M              +:;,3#;)6G4M1T2GD 4(ET;?U)>TM*+B1F="/ZH"Z\+B_A
MV_NB^N >%Q?P[?W1?7 /"XOX=O[HOK@'A<7\.W]T7UP#PN+^';^Z+ZX#'G>B
MZ6A-U9KRU[JG9 94C)1$HN)'Q(P&%F6R0;SCK1:T*,U\O$J\3*@)9."E"8C1
M(5J3IK7MGQ/^D$+@      0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@   'E
MQM+J%-K*J5%0R 4(CBJ*CNG5YGN3/[)/I3^H N0
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M<"H!4 J 5 *@%0'3/5C_ ,@OONQOV(5WQ5\6CLSUKAX#^!=[4=3>@TM98
M#&71VZMR[2FW-DN,[*-%R49$>F-T#ID?$RIZH2"X5 9,
M        !87%I,DVHR?7C/41_8I+E,P'[$MK4:JG#)U9\.)<"+S.("ZZ!C\$
MC[D@#H&/P2/N2 .@8_!(^Y( Z!C\$C[D@#H&/P2/N2 8M^TDWJ=;4:FT]UT7
M/0N4B/S 2RK2D+;0IOO#(C3Y@(>P%HC\EDFUR,OF:F^P2^<O/Y0%V      (
M/</+%CG\,W[Q^S@&S'DCP;XBMOBS8$IP     LIRDQE-S".BTGH4G[)!\WG<
MH#W$GLRS-**I67'2KL=D!=
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MJ0)9P$                     "T?\ RE],4O6D46_V_L4^?R@+L
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M2UZ'&R)J-0F6?52)2N):U'V2+CRC4]S;JO47ZLQF(]?DU:YUSH\GE6%Q)O\
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ME.U3,<\.ZS7L5TU<TQ/D=Y(42T)6GD41&7F&*(F,)?643C&+T(2
M             #ROO%>88F$3J?/61_B'?MU>B+TIU0^6:_:GI4QR<
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M5V_VKZ/UTK3PR/J\SNOZQM'#7?/JRT3CC_&SVZ?.Y5%J*!
M           '><'_  4;\4C[TA0]SVIZ7UG9^'3T0N!UNX
M        'E?>*\PQ,(G4^>D@_P H=^W5Z(O2G5#Y:K]J5*HEQP*@8%0,"H&!
M4# J!@5 P=-]6 ZX_??=C?L0KSBGXM'9GK6_P)\"[VHZF]QIBR0   &,NEM?
MGR[3(9D="BWRSDO([KU5!L.M:.!ESK)7&O( R9D1D9&52/@9 +2*9L.*AJ/@
MGNF3/G0?-YP"[                   !:)_*I6KE8CG1/84YSGYP"[
M        >'FDO-J:7WJBH?UP%*(ZI25-.^OLGI7V^PKSR 7 ##W60XS)1T7<
M+)'%9<ID9\G] )585Q<6T9.MN.*2=-;::\.W3G!"Y\-+\W?_ +L \-+\W?\
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MUQ3SS$.\VT$VA+:>1!$DO,(J"AYG&<7UG3&$8/0A(
M   /*^\5YAB81.I\\I'^(=^W5Z(O.G5#Y;K]J5,<G        !TYU8/F_??=
MC?L0KSBGXM'9GK6_P+\"[VHZF]QIBR0   &+NMM:G2[1(<D] J!+.2VWP]64
M;#K6CB9<RS5S\@#* +>6TI:$NM>OLGJ;[?93YY *K+J7FTNH[U15+ZP#V
M              PEX6[TZ4&9DUI(TES&?."5W:#<.*9+[PE'H\SG_I!#(
M           ".W)3GAB]?"E-'VO,"69MZG51&S>KJXT,^4RKP!#W(B,22(G4
MU-/(9<# >F66V$$VTG2DN;M@*@  @]P,_IBQPN;Y-7[A_P#Q]F -F/)'@WQ%
M;?%FP)3@  6COY3(*.7K+5%O=L_2I_K 78"TD?E#R8A>ME1;Y]KF3YX"[
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M*_H0/+WK>]UE+E7^F8\NCSO>X?R_O]X6:/\ 5$^*GUIZG:8I=]-@
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MI?:4TKA7D/G(^8P%JQ<6>Y:?5I?(]*C]*9EPK7M@+X
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M2D,D^T;=:*Y4*["BY# 6\>Y,.:6W%:7C[E1>EU<G ^3B O0
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MIE/O*6TZHUDDM1*/E+M ,H      +1S\FDD]R,OT2YV"7Z4_/Y %V
M   *4AXF&C<I57(A/94?(0#\BLFRU11U=4>IQ794?* K        @]P\L6.?
MPS?O'[. ;,>2/!OB*V^+-@2G     "T8_)GU13];75;'F>F3YP"[
M     6TM:E:8K9T<>X&9>E07?'_4 KH0EM"4(*B4E0B[1 /0
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MC_I,!0L%RL5VA*F8]-8N$(G7&'),9Q+R.F84:'$&I)F6I"B-)ES& RH
M9$94/B1\I ,<[;FF?RB.DS<;,EDV9U(R+E(@%^VXEU"7$'5*BJ0#T     \K
M[Q7F&)A$ZGSND?XAW[=7HB\J=4/EZOVI4QR<        '3W5=^;]^]V-^Q"O
M>*?BT=GSK>X&^!=[4=3?(TQ8X   #%795I3,LY7%!JDJEF5L,M5$R>@=,S/3
MP];U]]P\\!E0 !:RU&ZI,-LZ*<XN&7,V7+]7D 7*4DE))25$D5"+M$ \NN)9
M;4ZLZ)253 6C,%ITO")2*O.'K-/&A$?(5 %]R<"      'AUEI]&AU)*3V#
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M&S'DCP;XBMOBS8$IP      +0_R657D8D'0^P3O_ +P"[          %H_\
ME+Z8I>MIHM_S/2I\\!=@                 "T?_*7TQ2XM(HM__P!E/G\H
M"[       !Y<<0T@W'#TH3Q,S 1R=.7,73O64]ZC^L^V)0T-NCMLY'<>R;'V
M=<5=7+A";+NFU'Q-U!%RI/TY>EY>2NFPMQ;ZBJ(L7IT_NU<_@GP\W/JUZZ;X
MMX8JHJG-Y:,:9TUTQR?ZH_T_2C]W7[..SJ(;RJL               !<0($V
MZ3&+?;F%R9LE9-L,-E52E'S$.NY<IMTS55.$1KEWV+%=ZN+=N)JJJG"(AUCM
M;MG%P2WG*F:7\CF((I<@N*6D<O0MGV"/OC],?:(A5&^-[59RO"G1;IU1S^&?
MEH?0/#?#M&[+>U7ZUZJ/6GFCZ,>?G\C80UYN(       "T;_ "F2;W_@LU0U
MV#7Z97G<@"+[EYC/PJQ,W*'B5RS%E^04:?;K.TF1(;BK;6:W>B/UPBH2='/J
MY2 <W;/6B/G6_43=G:S$9>$;:Q(,J)?%R4-PV[E-5TC:FVXS2UH+2X:#5H[D
MC;J=%\IRE?[O[L[?YO8,BQ29M=?IVX<AM^VVMF39=,I,E)J1'D-R4ZG$H29D
MXG3Q,N%*& M,PVTW0@;&;59!-B/WK/=MI[-WGVI)F]*5 Z;I"8(TZC6XRA#*
M%$FO E4K3B&55=Y76'WNV_ON.62Z6_!L!)^YW2YW:*J%JG/:3;CMI54EJ2II
MNM#Y-1\Q5(83;^_HZM<C/\$S?#[I="N]SD7''[E;8!S6+O#?1H;C+<(C(C(B
MXI54DFM9'_:)ULIM;<\OZN&QUG>ON&W.\7;([^ZZ5@@$?3V^/,2DD)<+2LR4
M9-:DMF1=TO2HTJJ!K;8ZS$69<-B,RBP(STF6]$9)J,PVIUU1^%,F9$A!&9T+
MB= 1"3;:0WRVLPN,\VN/,8L=K(VW4FVXVZB(V1I4E1$:3(^!D9 )?'>Z=HET
MHLNY6GL*+E($*H   /*^\5YAB81.I\[)!_E#OVZO1%Y4ZH?,%?M2I5$N!4 J
M 5 *@%0"H#J#JN?-Z_>[6O8A7O%'Q:.SYUN<#? N]J.IOH::L<   !BKO/A0
MYEG9EQR?>FS#8AN&23Z%XH[KFLM7$NY0I/<\>/8 94!:._E,@HY>LM46]VU>
ME3_6 NP%&2]T#1J(JN'W+:>RH^0@'[&9Z!HD&>I9]TXKLJ/E,!5
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M'F'4FA:%%S&1\2%@T7*:Z8JIG&)Y5/7;5=JN:*XFFJ-<3KA1'8Z@
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M#+M$=R-TZI\LXS;G#U%1,.NZ^)'S(-/-R@+^2]T#1KI59]RA/94?(0#\C,]
MT25'5Q1ZG%=E1\H"L M&_P IDF^?K+-4-=@U>F5_4 NP           ?BDI6
MDT**J5%0R[1@+:(I39JB.'5;7%!GZ9L^0_.Y %T
M     (/</+%CG\,W[Q^S@&S'DCP;XBMOBS8$IP       ##W&4N/+JQW*]!$
MM7*1\Y<.T N(MS2XU5Y)](1T,T),R/Z@"MX>QV%_<*^L >'L=A?W"OK 'A['
M87]PKZP!X>QV%_<*^L \/7)I#2EH2HUD7<DI*B*O;,R 8^/.=D2V2D=V@E=R
MDBH1*/@1^<"6=!                  M7[?&D.=(LC)?.:3I6G9 ?D4^@6J
M&KD1W3)]E!G_ %& NP    'EQQ#2#<</2A/$S,!')\]<Q="[EE/>I_K,2A:
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M ]@            +68DTI3*1ZXQQ/FJCTQ /3$V-(5I:757+I,C(_P"D!<
M                       (/</+%CG\,W[Q^S@&S'DCP;XBMOBS8$IP
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M2 >P !Y6M#:#<<,DH253,P$=GSU3%T3W+">]3V>V8E"S  'IMM;JR;;+4M7
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M(BJE\QJ.M*]@!7?;-UEQLCH:TFDC\T@&!;A2&WVR=2;:361:SY*^:0)2($
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MR;O^?^HC_N2-]Z8M3AON<=J5"<:_Y*>S2U=4;.T<J 5 *@%0"H!4!LG8D_\
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MP%<            !:+_*I)-<K+!DISL&OF+SN4!=@*;_ $?0N=*=&])ZC[5
M&(CVEQ9H<=,DM'11IXZJ=@$LEX!#_ I_I!!X!#_ I_I / (?X%/](!X!#_ I
M_I / (?X%/\ 2 M)=I)Q1*C:6^923K3S><!6MC:66G&C]>2L^D+T*=HR 7P
M           "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
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M.                6C?Y3)-X^++%4-=@U^F5YW( NP
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M%5EI++:6D=ZDJ?\ : ]@            +1K\FDFP?K+U5M=I7ID_U@+L
M      0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@              6\MQ1)2
MPT?JSQZ4GV"YU><0"JTVEEM+2"HE)4(![                  'XM:4)-:S
M)*4E4S,!';A<%2U:$52PD^!=GMF)0L@ !^H0MQ9(01J6HZ$1 )% MZ(B-2Z*
M?47='S$78(0EZC?D[JH:N\[]@_[)\J?.,!=@                +1C\I?5*
M/UM%4,>9Z97G@/4E_N29841ONGH30ZZ>R9^8 K--)9;2TCO4E0@'L
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ME+[/5S\@#)@     "Q=M<9UTW3U)J=5)(^!F O4I)*22DJ)(J$7:(!^@
M*,F*U*02'*\.*5%RD \Q8;,0CZ.IJ5WRCY0'BXO.,Q5+:X*,R+5V"/G 8RV/
M.JF))1FNI&1FHS,R+EY^V"6>!              QMX<6AELD\"-5=7.1ER4
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ME%R<8K9_T )P             M))F^XF&GD5W;QES(+F\\!=D1$5"X$7(0
M                _%*2A)K69)2DJF9\E $>N%P5*5T;=4L)/@7.H^R8E"Q
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MO@%HC\EDFWR,2#-2.P3G.7G\H"[  %LF!$2[TI-EKK4N6A'YG( N0
M     'AUEM]!MNIU)/F >6(S,8C)E.FO*?*9^>8"J  (;;\ QBR9[-SJ%$Z&
M]7:$W;75HTI9)#+AN\$)25%*,^*J\>0!E[KAV(WZ44Z^6"VW.:2";*3-AL2'
M="3,R3K<0HZ$9GPJ _+?AF'VCP@[5CUL@G*;-B5X+#CL]*R?$T+T(+4D_L3X
M *5GP/!\=G.72P8S:K5<G:DY,@P8\9]1&5#JMI"5'7S0%[?<:QW*(A6_);1"
MO,$CU%&N$=J4T2NR274J*H#U:L>L%BMOP-9+5#MMGHHO@^'':CQJ++2KU-M*
M4\2X'P 6+V"81(L[&.R,:M3M@BZO!K4Y!CJB-:SU*T,F@T)J?$Z$ OK+C]AQ
MJ&5NQVUQ+1 (ZE%@,-Q6JTI70TE)5\X!D@ !2DO= T:R*JS[EM/94?(0#\C,
M] T23.KBCU.*[*CY3 5@'(G6&/\ U'?]R1OO3%I<.=SCIE17&7^1GLTM5U&R
MM**@%0"H!4 J 5 ;+V#/_4ZV?BI7BZQKW$/<JNFGKAM_"'^2HZ*OLR[$%4K[
M  !:22-AQ,Q/(7</$7.@^?S@%RLR-M1EQ(TG0_.$QK1.I\WY)_E#WVZO1,7=
M3JA\TU^U*E4<G$J 5 *@%0"H!4!U/U5/F[?_ ':U[$*_XG^+1V?.M?@KX%SM
M1U.@!IRP@   &*NS5J<F6=5Q=-N2W,-=M21F6N3X.Z1I.A'7U,UGQ[ #*@
M                 MY;:E)2\T7J[)ZD%V2YT^>0"JTXEYM+J#JE15(![
M       %HW^523=Y66#-+?8-?.?G<@"[           !![AY8L<_AF_>/V<!
M2V@9)_9[!VS.A_ 5M-*N<E%&;H8)3>*\;S7=E1U!Z'$]A1 A6         6T
MZ5X(STA%J69Z4D?)7M@+"++<G2&VI%-*#-9$DJ547)7S 2S (
M     ?BE)0DU*,B215,SY"(!'KA<%2E=&W4HY'P+G4?9,2A8@ #]0A2U$A!&
MI2CH1$ D-OMZ8B=:Z*?47$^QVB$)7P  M+BI"8BU*(ZD9&@RY257@8"TA71U
MY]++Q$9+X)-)4H8)98$                    *4ADGVE-F=#/BE7.2BY#
M?D5XWFN[*CJ#T.I["B^N K          "T;_ "F2;W_@L52UV#7Z97G<@"[
M '(?6&/_ %(?]R1OO3%I<.=SCIE1?&7^1GLTM55&RM**@%0"H!4 J 5 ;,V"
M/_4ZU_BI7BZQKW$/<JNFGKAM_"/^2HZ*OLR[%%4KZ  !^&1*(TJ*J3*AD?8,
M!:,*-GI(:S[PC-I1\[9_6Y!,(G4^=$G_ !#WVZO1,7=3JA\U5^U*D.3@
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M:JTVEEM+2"HE)4(![  '(76'\I#_ +DC?>F+1X<[G'3*C.,?\C/9I:I&RM*
M       ;-V!\I]K_ !4OQ=8U[B#N5733UPV_A'_)4=%7V9=C"JE\@   ,)>.
MEZ<ZUT=$KH_-TG7SQ"8?/)7?*\TQ>4/F6-3\$I        =4=5/YN9![M:]B
M%?<3_%H[/G6MP5\"YVHZG0(TY80   #%W9ZU-3+.FXM&Y)=EFBVJ))JT2>@=
M4:JER>IDLJ]L!E                     %&2R3S)IKI47=(5]BHN)& MX]
MS8=T-K/2Z? ^'<ZNT8"^      %O(F,1:$ZKNE<2215.G9 4X9E(6N89UU=P
MV7V*$_UGR@+P            !![AY8L<_AF_>/V< V8\D>#?$5M\6; E,I:B
M1&=4I.HM)U3V:@,/#N$E+K;:E:VS,D:3Y:'PY02SP(        ?BDI6DTJ*J
M5%0R[1@+:(HVU*AN'537%LS],V?)]3D 70            #\4HDD:E'1)<3,
M^2@"/W&XJE*Z)KA'+ZJC[)B4+   ?J4J6HD)*JC.A$7*9@)#;[>F*GI'**?4
M7$^9)=@A"5\    9D15/@1 +2,1ONJF*[T^X8(^9!<I^>8"[
M         :4ZR_S2M/QB7L#HW'A;O%?9\\*YX\[I;[?W:G,(LA2P
M [V3.;APHJ#+6[T2.Y(RX427*?$43<GUIZ7U7:C"B.B%2 ZF6X[)5ZX5$)1]
MBCE_I,<'8OP   <@]8@_]27_ ')&^],6CPYW..F5&<8_Y">S2U34;*TLJ 5
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M"F6=A^,3[DZ6<>.X>GU%PF'7=?'CWJ#3PX\0&4
M                        $'N'EBQS^&;]X_9P'YLSY(\&^(K;XJV!*71_
MRAY4L_6TU0P7:YU>> NP%C<6DR.BCI]>4JJ3^Q27*9@/,2UML&:GJ.J/@1&7
M OJ@+OP6-^!;^Y+ZP!X+&_ M_<E]8 \%C?@6_N2^L >"QOP+?W)?6 /!8WX%
MO[DOK ,7(M!MZW6U:FT]UT?IJ<Y$8)99I2%M(4WZV9%I\P$+=K\FD''/UEVJ
MV>T?ID_U@+L        !^&9)(U*.A%Q,SY* ,!<;B<E1M-'1@N?[(^SY@E#'
M@ #]2E2E$E)54? B+E,P$@MUO3%3TCA5D*+C_9+L$(2OP    'EQQ+3:G%G1
M*2J8"A$;5I4^Z5'GCU&7V*?2I\X@%R              +*YMI=90U_XJED31
M%V>>O:H H1+23:C7)-+G,E)5IYO&@"\\!A_@4_4 / 8?X%/U #P&'^!3]0 \
M!A_@4_4 :7ZRC#+.(VHFFTI,[D53+E]8=&X<+1_V*^SYX5WQW/\ T[<?_L^[
M4YC%D*6         'T$@?X&+^);^](47<]J>E]46?8IZ(7 ZW:    X_ZQ)_
MZDO^XXWWIBT>'.YQTRH[C'_(3V:6J*C9&EE0"H!4 J 5 *@-G=7\_P#5"U_B
MI?BZQKW$'<JNFGKAMW"7^2HZ*OLR[)%5KW    >7.\5YA^@)A$ZGS:D_XA[[
M=7HF+MIU0^;:_:E2')P        =5=5'YN9![M:]B%?\3_%HZ/.M7@OX%SM1
MU.@AIZP0   &,NMR.#+M,<H_3E<)9QC<_ T8==U\A_8:>;E 9,
M                                    0>X>6+'/X9OWC]G 6NTBE+VD
MP.(C@MZPV[4?V+?@K=3\_D($M@I2E"20DJ)25"+M$"!2DH2:U'1*2J9]H@%M
M$2IPU2W"HMWO"/TK9<A>?R@+H        !:,_DT@XQ^LNU6SVC],G^L!5DL]
M.T:4G1Q)ZFU=A1<@#]CO=.T2Z47WJT]A1<I *H      _#,DD:E'0BXF9\E
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M#R[V0S%GVZ*H\7G>]EM[9/,?"NT53S;48^36S@P7J
M (/</+%CG\,W[Q^S@&SJ5+VNPR4XE*''K%:]*$=ZALHC>E)5[! )P M)'Y0\
MF(7K946^?:YD^> NP         !1DLF\U1)T=2>IM7847( _8[Q/M$NE%<BT
M]A1<I **_P EDD[R,OF27.P2^8_/Y %V     _#,B(S,Z$7$S,!@;E<3D&;+
M)T8+E/[(_K"4,<  !$:C)*2JH^!$7+4!(+=;RC)Z5TJR#_[I=@NV(2R
M  I27N@:-9%59]RVGLJ/D(!^1F>@:))G5Q1ZG%=E1\I@*P
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M:<L    !C;I*N4>5:FX+'31Y$HVIZ])JZ)CH'5ZZD94[M*$U[8#)
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M%0"H!4 J 5 *@-G]7X_]4;7^)E^+K&O\0=RJZ:>N&V\)?Y&CHJ^S+LP56O4
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MO68]3ECZ/ACP=71JNOA?BK\SAELS/]3]VKZ7@G_5]KIU[H&F+,
M   $'N'EBQS^&;]X_9P&(VV6I.U>!-MJ,F/D]:U%0^!K.(WJ^H8)3^SJ<.,9
M*+N"4>@_1_I!#(              "/7-;OAB]54TH2*<.YY@2R\!3CL-!O<3
M,C+CSIY.((?D97@ZUQ'#[E!:VE'SM_\ 8 QERN1OF;#!T9+OE?9?]@E#&@
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M=T_E:_>6X_IU?RSS='-Y%^<)\0_G[7N;L_U:(_BIY^F/WO+T;2&K-\
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M?4%GV*>B%R.MV@   ..>L=Y3)'N.+]Z8L_AWND=,J2XO_P A/9I:E&R--
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MY(\&^(K;XLV!*926>G:-)'1Q)ZFU=A1<A@/V,]T[1+,J++N7$]A1<I *H
M     "F\^S'3K>622YJ\I^80#&NWQ!'1EHU?VE'3^@JB4+-^ZOOI)"D()&HC
M4GCQ(N8^(&*Z:OG&CS7#LH/^HP%"X7,Y!="Q5+/ICY#5_P!@#'   1&9D1%4
MSX$1 ,_;K<4<B>>*KY\A?8_]HA+(@         "R.UQ#=Z32?+717N:@+T
M %*0\3#2G#*I\B4\YJ/D(!^1639;[LZNK/6ZKLJ/ZP"L       "C)9Z=HTD
M='$GJ;5V%%R& _8SW3M$LRHLNY<3V%%RD 26>G:-%:++ND*["BY# ?D9[IVB
M4HJ.)/2XGL*+E 5@       :.ZS_ ,T+1\9%[ Z-OX7^/7V?/"O>..ZV^W]V
M7+%18RG2H!4 J 5 *@%0"H#Z'V__  $7\2W]Z0HZY[4]+Z?L^Q3T0N1UNT
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M_4)0\       1&9D1%4SY" 9ZVVTF")]\JO'WJ?L?^T$LD(
M   %HG\JE&OE8CG1/8-SG/S@%V     QEZR&R8ZB&Y>YS4%%PELVV";RM/33
M)1FEIE'94LRX$ R8   +1S\FDD\7K+]$N=I?I5>?R +L!:._DT@I!>LNT0]V
ME>E5_4 NP       :-ZT'S/M'QD7L#HV_A?X]?9\\*]XW[K;[?W9<KBQ5/
M       #Z(V__ 1?Q+?WI"C[GM3TOIZS[%/1"Y'6[0   '''6//_ %,D>XXO
MWIBS^'>Z1TRI/B[O\]FEJ2HV-IQ4 J 5 *@%0"H#:/5Z/_5.U?B9?BZQK^_^
MYU=-/7#;.%/\C1T5?9EVB*M7B    \N=XKS#] 3")U/FC)_Q+WVZO1,773JA
M\YU^U*D.3@        ZOZIGS;R'W<U["-!XF^+1T>=:7!OP;G:CJ=##3V_
M  ,7=;:U.EVB0Y)Z!4"6<EMOAZLHV'6M'$RYEFKGY &4       !K?>_(3L>
M"2H[*],J[+3 ;IR]&LC4Z?F&A)I_VAL?#V5]]FXF=5'K>CY]/B:5QCG_ ,MN
M^JF)]:[.QXI]KYM'C<F"V7SV  #JS8IEB!MY$=<6AM4Z1)D=THB,]+G0U_\
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M4\KG/@78+F(2A2       !F[3";2VF4HR6M7>=A/-]4$LJ(
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M*J7^T7_8"64$               !F1%4^!%RF M(Q&^XJ8KO3[A@CYD%S^>
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ML=,V:?\ ABN>*Z,+MNKGB8\D_M71_P"?W<;%VCFJB?+'_P#"W<-)6B
M   (/</+%CG\,W[Q^S@&S'DCP;XBMOBS8$IP  +.X1%2VDD@R):#J1'R'4!;
M0[4:3-<KCPHE*3,O/,RH N_@^)]@?W:OK@'P?$^P/[M7UP#X/B?8']VKZX"Q
MNL1EF,2VDF1ZR(ZJ4?"A]DS 8<2@       !F+$1^KGS=R7H@,P(2
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M[5ZY4AR<        '6/5*^;>0^[FO81H/$WQ:.CSK0X.^#<[4=3H@:>WT
M!BKLY:D3+.FXMFN2Y+--M41*,D2?!W3,SH="]3)9<> #*@       XUW59-C
M</($*Y3D])YSB$K+T1<FYJMK)VY\#YJXFHV=YWH_U8^6(E@L<NZ;#>X=U<C-
M36(Z_P HAOH2XV\RLC0X@R62B[I)F1'3@?$9V:L>^M541,TS.J8Y)Y)\KR<C
MF8RU^FY-,5Q3.FFJ,8JB=$QIQUQ,I^C$[/C%_N&62VTR\)@LMW*PH>(R1.<G
M$:H<>BCU'H,E=+P,Z-GJ30QX$YVYF+--FGU;U4S37A^[L^W5X_W>UHEML;KL
M9/,5YFN-K+41%=K'_DFO3;HTSCHT[?@HG:IPE&RQ.3<>@NM_O%OLDR^J5)@1
MYA.-*=2ZY0G33'94AAE1FK0I>E/#@6GB/2_.TT8T6J*KD6]$S3A.&$:O6G&J
MJ.6(QGQO$_MM=S9N7[E%FJ]ZU,5XQM8S[6%%$Q11,XX35LQHT1LZ6,:QEUJ[
M3K1?IL>QO6XS3+5-Z17=)62-+:6$.J69UU%I*AIXUH,FK-Q-NFNW3-R*M6SA
M\^,QAZ6%3D*J;U5J_5%F:/:VL>>(PB*8JFJ=.,8:,-.."YN6%S8$RSM,S(TV
MW7Y1(M=T84OP=9](32B42T)6E2#46M)IJ0Z[6?IKIKF:9IJM^U3.&.K'GPG'
MDTLB_NBY;KM1%5-=%_V*XQV9TX:<8B8F-&U&&A^95ADO$%>#76?#7="=4VNW
M1W%.OH;*NEU=$$E*5E1224HEZ5$>GL,GGZ<U&-%-6SA[4QA'1KY.7DQB=*-Y
M;IN9"=F[71MXS&S3,S5$<E4Z,(BK7&,Q5A,3LZ\*N 6"#?KVZJ[$I5DM,21=
M;HAL]+BXT1.HT),OLE&E)\2X5H=1PWGF:[-J-CVZZHHIZ:G9N3)6\S?GWOPK
M5-5RO#7--$:HZ9PCDT8X3BR"-SKB4LFG+5;%8SK[JP%"CDQT7)I)SH^E)?/K
MU5U<>T.B=T4;.,5U^\^GM58X]&.&'@PU,N.(KNWA-NW[G'X6Q1LX=.SM8\NU
MCCM:? K9)M\A-_NS.-OMG:F+8G(8+4A2B=<@+0E:DH.BB4I%3X*54R+LCAE-
MY_T:)NQ.U-?NYPU;6K3TNS>&Y(C,7(R]4>[BW[ZG&9QFWACHT:</#.F(Q1:!
MCTR?9+K?T.--0+0;"'NE4:5N.2EFA"&B(C)2BH:E<2H7$>I<S5-%VBU..U7C
MXL.=X5G(W+N7N7XPV;6SCCKG:G"(IY^>? S;.W<U3T>V2KI!AY/,;0[%L,A;
MJ9)FZDU-MN+Z,VFG7"TZ&W'"/NBK0S&%5O2G":XHJJMTSIKC##1KF(QVIB.6
M8CDG6]*G<=S:IMU5T47JXB:;56U%6G&8IF=G8IJJT;--543ZT8[,J-DV_N]Z
MMDJ\')BV^!;Y7@=R<GN*8..9(U:UD:3X:J-D154:S(M(Y9C>=NU<BWA5555&
M-.S&./1U\V'*X93<=_,6JKNU31315LU;<[.SHUSHY_5^EM3$8(R^A,>2XVTZ
ME]+2U)0^WJT+))T)2=9).A\I5(C'ITSM1$S&&/(\*NF(F8QQCGC'">C'"?+$
M2V9-QF'G<RPY/;4-V^VW-*VLI4R@FV(,BWMDN2Z="T(2XT72((^57*=3&M6\
MW5DZ;EFO&JJCX>.F:XJGU8YYPJT2WJ[NZC>5=G,VXBBBYC%[",*;=5$8UU<T
M153ZU/AUSC+%76$QF4R9DR7(>,X;%<1;K<IYM1=RVFJ&TMQT.+<=TGTCA\:5
M[ZE!E6;DY6FFSZUV[,;56'7C5,1$<D=3SLS:IWA75F8FC+Y>F8HIQCFU4Q31
M%4U58>M5S8Z\,&#G8E*MUXAVJ7.A-Q[@TB3$NQNJ\!7'62J.:].HBJE23(T:
MJE2@SK>=IN6ZJZ::L:9PFG#UL>;F^?!YE[===J_3:KKHB*XBJFO:]2:9QTXX
M8\DQIIQQC4]W3$BB6A5]M5UB7JV,NHC3%Q"?0Y'=<2:D=(V^VVHD*H9)72AF
M5.4<;.=VKGNZZ*K=4QC&.&F(YIB9TQRP7]V[%GWUJY3=HB8IJV=J)IF8QC&*
MJ:9V9U15JF=&M=7' )]HLC%^N=P@QXDV(S,MK1NJ4_)-])*-MMLD5U-D9:S.
MB2,R+4?-UVMYT7;LVZ*:IFFJ8JT:*<.69QY>3E\#)S&X[N7R\7[E=%--=--5
M$8SC5M<D1ACC3^]^[&,:>:)#UFO-_P#5ICGIR.4?(9Q&D^:73*/T2&@<65?"
MCM>9;W_GM&B_5V(^TWX-"6V         (/</+%CG\,W[Q^S@&S'DCP;XBMOB
MS8$IP          ([<X9QGC<07J+AU3VCYR$H6(      N(414MXD%P07%Q7
M8+_M 2=*22DDI*B2*A%VB$)?H                "T=_)I)/EZR]1#O:5Z5
M7]0"[     8O)GWHN-WB3&<4U(9@R7&74<%(6AE1I47;(RJ,G*TQ5>HB=,35
M'6PL_751EKE5,X3%%4QY)<;?2GN)^\D[^],6U_:<I^'3Y'S[^H-X?C5^4^E/
M<3]Y)W]Z']IRGX=/D/U!O#\:ORGTI[B?O)._O0_M.4_#I\A^H-X?C5^4^E/<
M3]Y)W]Z']IRGX=/D/U!O#\:ORGTI[B?O)._O0_M.4_#I\A^H-X?C5^5X5N=N
M"M:%JR*::D5TU=.G&G-R<P?VG*?AT^1']_WACC[ZORO?TI[B?O)._O0_M.4_
M#I\B?U!O#\:ORGTI[B?O)._O0_M.4_#I\A^H-X?C5^5TMLA>KM?\&1<+S,=G
M33E/H-]X]2]*330J]@A7F_K%NSFMFB(IC"-2X>%,U=S&1BN[5-=6U5IEL<:^
MVX   !HKK2_,ZS_&9>+NC;N&/CU]GSPT#C;NM';^[+E*HL14)4 J 5 *@%0"
MH!4!]&;=_E\3\2W]Z0I&Y[4]+Z8M>Q3T0N1UNT   !QGUDO*=(]QQ?O3%G</
M=TCIE2W%O?Y[-+451L;4"H!4 J 5 *@%0&T^KOY5;5^)E^+K'@;_ .YU=-/6
MVKA7_(4=%7V9=K"K5W    /+G>*\P_0$PB=3YF2?\2]]NKT3%UTZH?.]>N5(
M2X        .LNJ3\V\B]W->PC0>)OBT='G6?P=\&YVHZG1 U!OH   #%7:3;
M6)EG;GL=-(D3#:MZ])*Z*1X.ZK74S*G<)6FI=D!E0       <I[^6]4/<!V5
MIHBX16)!'S&:"-D_8Q:G#5W;R<1]&9CS^=0/&]CW>\IJ^G33/W?,U@-H:(G.
M0REJVRPR+TYJ0F3=#4P2ZD5'6])FFO#OE4KV3[(\/*T1&>OSAR6]/BG]C:,_
M=G^UY2C'1C>T8_ZJ<-'CG#IGG328]>LBA6BYXACUGR"$4")%DH=BM/RXDB.V
M3:V7"6M*B21IJA6G33^GQ:*;5BNNB_<N6IVJICUIBFJ)G'&-&'3RMJN5W\W;
MM7,K8LWZ=BBF<:(FJBJF,)IG&8G#1ZLX88?/B[2U<,GNV67FYVV'=]PX:HS4
M.SNFVJ,?1>H/.):2O2\;:6TE34:>->ZX#*OS1E[=FW15518JVL:M..G3$8X8
MTXS/3T/-RE-S.W\S>N6Z+N:HV8IHG#9T>I7.SM85[,4QRS3IQTZ%?(7)!1-N
MX]R5!;N4:ZRT3HUO*.VS&4<F,KHUICT;2HB/NOZ>-1PRL1M9F:-K9FBG":MJ
M9J]6K3&UIF.;YG9G:JHC(TW)HVZ;ES:BC8B*9V[<[,Q1ZL3$:_GTXH=E=V>M
MVXM_N+*(\M2;A,)"9;3<ME25.+254.$I)T+O>P/8R=F*\E;HG&GU*=4S3.J.
M9K6\<S5;WE>N84U_U+GM1%<8;541HG&-$:N9D,2S.*O)7CO[<:W6J\6V18YK
MUOC-14-,RJF3IMM)2DS)5*JI73YE!CYW(518CW4S5517%R-JJ9QF.3&?!\[.
MW7O6B<U/OHIMT7;=5JJ:*::=F*OWL(C#''#&>;HP4D[3Y24@ER#B,V E55D)
MRF%6_H-5.E2O61J(RXDFFKM$.4[ZR^&C:FOZ&S.UCS88?L<*.&,YM8U;--K\
M7;I]WL_2B<=,<T:_!"\G9W;V-RK=?;41JQRSICVR.3B*J<MS3?0.F:3^S2IP
MTU(N4JE4=-O=U<Y&JW7\2O&J>W,XQY)P9-W?-JG>EN]:^#9V:*<8_P".(V:M
M'AB:L-6N,8>\\3;\0B6W"K:^W/CM37KU<%-K2XVYTJ^CB(-1%4C*.FJBY.[Y
MQ&[9KS5568KB:9FF**>3##35/\6KH3OJ+61HHR=N8KB*ZKM6F)B<=%N.GW<8
MS&KU^5,+T]E5TOR\CPW'[->[7*<1+@7HHS!OMJ(DJH^M;B3;<;/EUTY/J>/E
MZ<O;M>ZOW+ENJ(PFC:G">S&&F)\#9\W7G+V8_,92S9O453%5-S9IVHU>U,U8
MTU4^'!")=SD7+;B^3I;J"GS\E1)EH;4224IQAU:J)(^*=1\![E%FFWG;=-,>
MK39PCQ51YFI7LS7>W7<KJF-JO,[56'+C15.KFQ^6A&H^53(]I.T)@VU;)MK9
M\(<@1ERJ.5J?3*1KU%7N55J0]*K)TU7-O:KQQQPVZMGR8X/$HWA539]UL6YC
M"8QFW1->G_5AM8QR3CH2'$9)L[<;@-D]T:G$VHD(UZ3564HE4*M3[G@KM#SL
M[1CG<O.'XGV7M;LN;.Z\[&.&/N?MSC\VMG,8F2KO@MMM..6NV7B^VB3+.9:[
MBRV](4Q)-+B7V$N*35):=#A)JKO>%!A9NW3:S=5=VNNBBN*<*J9F(QC1LU8>
M6.36]7=UZJ_D+=K+V[=V[:JKVJ*Z8FK9JPG;HQF-'[M6&,^SHP>&H\Z\99:<
M=SRVP;:B%#DNVBRL]'"8=?=U+:8<6TL^CZ1Q/(HR.O-W7&9JHM9>N[EJJJ]J
MJ-JN<:IB(US&,:<(^6AQBBY?SEO+YVBBWLT53;MQA13555C--,S3/J[57/IQ
MY,:M-]=&KW%V]R]C((%MLTMQRVKC6F"U&C/I:1(,C6XAJKBD&9D2#<4H^^/D
MXGT6:K56<LS:JKN1A7C55-4QCL\DSHQY\,.1E9BW?M[MS47Z+=JJ9M844113
M5$17KF*?6F/H[4S.OD17<QQM;>&DVM*]&,V]*B29*HJKM2.G(?9'J[IB8F_C
M^-7YFO\ $,Q/Y7#_ /IK7WD$'NM5=.]7>WG&PZ9/65%3IJ]!]EME"$%_WM0K
M'BB[M9FFGZ-/7C^Q>G =C8R-5<_OUSY(B(Z\6WAJ*Q0        !![AY8L<_
MAF_>/V< V8\D>#?$5M\6; E.          !X=:0\@VW"U(5RD P4NU/,&:V2
M-QKM=\7FD)0QX   +R+;9$DR49=&USK5V.T7. S\>.U&;)MHJ%SGSF?9,0E5
M                  'EQM+K:FUE5*BH8"A$<7I4PZ=7F3TF?V2>97GD N0
M  8?+?FK??B^7[ L9>3^/1VJ>M@;Q[K=[%7V9<%5%V/F(J 5 *@%0"H!4 J
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MM!GVB-"OJC>>%<QA77:GEC:CQ:^M57'^3VK5J_'[LS3/CTQU3Y7.XL-38
M                    #M;;ZR'CV%V6U+3H?:C)<D)YR>?JZX1^8I1D*5WG
MF/?YJNODF='1&B'T]N+)_E<C:M3KBG&>F=,_/*2CS7M@        "#W#RQ8Y
M_#-^\?LX!LQY(\&^(K;XLV!*<             *+L6.]Q=:2H^S3C]4!0^"H
M-:]%YVI7UP%9N%%:.K;22/LF53^J8"N          +"]WFWX]:9E[NKR(]O@
M-+??=<4E!$E!5I59I34^0JGR@,#M[N1BFYN/1,AQ>:VZW):)UV"IUE4R-J,R
MT2&VG'.C5PY#,!DKAF6)6J]0L<N5\@Q,@N)DF!:WI+2);QGR:&C5K.O-P 9E
MQQMEM;KJTMM-I-:UK,DI2E)5,S,^!$1 (YC^X6#97<YEFQC(;?>+G;T=)-CP
M)#<DVDFK151MFHN^X<H#&)WDVH7>TXXC-+,J]*7T*8B9K)F;M:='J)6G77AI
MK6O"@&"< (KE.YFWV$26(679-;K-,DD2F(TR2VTZI!G37H,ZDFOIC*G; 22)
M,B7"*S.@/MRH4A"78\EA:7&G&UE5*D+29DHC+D,C 4Y9&TI,Q!5-O@Z1<[9\
MOU.4!<I42DDI)U295(^T8#]  &&RWYJ7WXOE^P+&7D_CT=JGK8&\>ZW>Q5]F
M7!%1=CYD*@%0"H!4 J 5 *@.NNKQY.6O=DGT4BKN).^3V87IP9_CH[53:PUE
MNP   #1/6G^9MG^,R\7=&W<,?'K[/GAH/&O=:.W]V7*%18BHBH!4 J 5 *@%
M0"H#Z.6[_+XGXEO[TA2-SVIZ7TM:]BGHA<CK=H   #C'K)G_ *GR/<<7[TQ9
MO#W=(Z94QQ9W^>S2U%4;&U J 5 *@%0"H!4!M/J['_JM:OQ,OQ9P>!O_ +G5
MTT]<-JX6_P A1T5?9EVP*N78    \N>MJ\P_0$PB=3YE23_*7OMU>B8NJG5#
MYXJURI5')Q*@%0"H!4 J 5 =9]4CYM9%[N:]A&@\3?%HZ/.L[@_X-SM1U.B1
MJ#?    &+NMR:@R[1'<C=.J?+.,VYP]143#KNOB1\R#3S<H#*        C^<
M8ZG*\5N=CH73263.,9\"*0V9+:.O,6I)5[0]#=^:_+9BBYR1.GHY?F>/OG(1
MG<G<L\M4:.U&F/G<3.-N,N+:=2:'6S-*T**ADI)T,C+M"ZXF)C&'S!53-,S$
MZX>1+BV)<"M&W42VPRM46[Y;.B-S9[]S1X1&B(DIU-L-L&9(-PDT-2UD?:Y>
M&NVO>9ZJJK;JHM4U;-,4Z)JPUS-6O#FB&Y7XL;IHMT^[INWZZ8JJFY&U31%6
MJF*,<-J-<S./@UZ(O>L@=R0X;*K9;H#S*E))VW1D0S=Z4TT)W09)/33N3H7*
M8]3+Y:+&U.U75$_2JVL,.;E>#G,].:V8]W;HFG'V*8HQQP]K#1HY-6N5[?MO
M[]CA):N2HQ7)V64.-:FG>EG/$K427D,I(U=$I2=*350S,RX#HRV\[5_31CLQ
M3C-4QA3'@F>>.7K96=W'F,IHN;.W-6S%$3C75KPJBF-.S,QA&.$S/(O%[87P
MC<ALSK;)R!I"ENX^Q*)RX)T$:EI)!)T*6DB,S0APU=H=,;WM>U--<43^_-/J
M^#PX3SS&#)JX=S$8TQ7;JNQ_Q17C<T:XPU3,1IFF*IGP(\]8)[%ABY&?1KML
MJ0Y#(T*JMM]I)*-+A4X&:3U)[0]&G,T3>FU^]$1/3$\SQZ\E<IR].8T3155-
M.CDJC3A/3&F/ N;SB%\L;MI8FL>K7J,S+@H;JHU)?.B4'4BHLCI5/-4AUV,]
M:O17-,Z+<S$^+EZ'=F]UYC+3;IKC3=IIJIP_U:H[7/')C"56?;1EZ%E;=TNE
MO8NEE4B,T;DOHVFGB>;)Q;G<5T&2C;2?V=2H/*O[VF*K,T4533<T^SIF,)PB
M-.OEGP/>RW#T56\Q%RY;IKLS%,8UX4Q.U3M3.C5KHC_5C&"M9<?DS=OL@M45
MV*X<>]QDOW$WD(AH:;;<2;QO+T^IU,J&7$Z\"XCAF,S31G+=<Q,8VZO5PG:Q
MQC1ASN[*9&JYNV]:IFF=F_3C7C$41$1,;6U.'J\V&F<=$:41R3$KAC*(4E^1
M%GVVXI4N#<;>[T\9WHS(G$D9DE1*09D2B4DAZ^4SM&8VHB)IJIUTU1A,8ZO*
MUW>&[+F3V*JJJ:Z+D3LU45;5,X:^:<8Y=#-X*J-#QW+[TN#$FSK=&AJAG.CH
ME(;4]))I1DAPC*M#&#O&*J[UFWM54Q5-6.S,QCA3CR/2W151:RF9O311751%
MO9VZ8JB-JO9G1/@E7N9P\@P!_([A:8EJND.<S$@38#)1&YR74K4ZVII%$&IL
MB)6LB[79KPL[5C.1:IKJKIJIF:HJG:V<,,)QG3IYO&[LQ-&:W=5?KM46JZ*Z
M::*J*=F+F..U3LQHQIU[7B8R!M]/NL9M5LNMKEW1YCPEJRLRM<Y2=.LTDDD:
M#<)/$V^DU%V!DW=YT6ZIVZ*Z:8G#;FGU>O'#PX8,++[CN7Z(FW<M55S3M1;B
MOU]6.&&&&UAKIVL? R>)X);[]AM\O4FY08T]A<5N$J3*-E$;6ZI+AR"TG3I"
M*C79XC&SN\J[.9MVXIJFF=K'"G':T:-GHY6?NO<MK-9&]>JN44U1-$4[5>&S
MZTX[>C]Z/98"V8=,N+,F<[.A6^SQGU1#NDQXT1G7T\=#6A"UK,TGJ[E%"3Q.
M@S[N>IHF*8IJJJF,=F(TQ'/..$1S:];Q\ONJY=BJN:Z*+=,[.W55ZLU<U.$3
M5.C3HIU:9P6%^L-QQR?\'W%*-:D(?COLK)UA]ATJH=9<3P6A1<AEYG*1D._+
M9FB_1M4=$Q.B8F-<3'),,/.9*[E;FQ<CDQB8TTU4SJJIG5-,\D^*=,3#&#*8
M28;88R>5YI;K>M&N$POPN=PJ70,&2C(^TM6E'^T/'WOF_P ME:JN6=$=,^C7
MXFR<.;N_.YZBW,>K$[579I],X1XW98IM]*@          @]P\L6.?PS?O'[.
M ;,>2/!OB*V^+-@2G                            .=.M;@^:91%PZ^8
M]9E9;CV-7!<W(<-;<4VJ>V?1=&9)3Q7I)+B*))2N[X),M0)AE.KYE>R>3S;T
MYMYC+>'9FRTTUD-A<BI@RD-LJ,DGH1W"D$M1D9I(E5IK(JI EKK=';O$\(ZP
M>T5SQ^$IJZ9-D-QN5ZFO.N/NO/*7'4E)&XHR2AO6HD(21$1&"64ZV&37BYY3
M@NSELASKE;\C<<GWNT6IQ+$NX,L*HS%Z59DEMHU(6IU:N"2(E^E!$,WLUF5F
MQ;/E;/WK;&'MME<J$<VU+M[K$UJX1&M2J*E-H2M:R)"SJI2JZ%5TJ*AB6L.L
MC:L&M-H?V\L^UK>*0G+C$:3N9)@>#VN*3JD/+<3(C-N.N$HC4R:%<.6A=R0)
MAV/C,=J)C=GBL3_A1AB#&::N>HE^%(0RE)/ZB,R/I"+74CYP<7'.*7G;'&MT
M]VXW6+A-.99<[@M5I=NL)R<B19U&M++<+2VX950;9()-%&G21<4G0Y-B]2:Y
MRI>VU_MI=/\  5HR&9%L:91&3K45:&GNB,CY#2IPU*+[)1@B72QD1E0^0$+%
MMYN"I49]6ELNZ94?'N3YO.,!>I4E:24@R4D^)&7$@'Z PV7?-2^_%TOV!8R\
MG\>CM4]; WCW6[V*OLRX&J8NM\S%3 *F 5, J8!4P"I@%3 ==]7;R<->[)/H
MI%7\1][GLPO+@W_'QVJFUQK+=@   &B.M1\S;/\ &9>+NC;N&/CU=GSPT'C3
MNM';^[+D^HL-4A4 J 5 *@%0"H!4!]'K=_E\3\2W]Z0I*Y[4]+Z4M>Q'1"Y'
M6[0   '&'64\I\CW'%^],6;P]W2.F5,<6=_GLTM0U&QM1*@%0"H!4 J 5 ;4
MZNOE6M/XF9XLX/ W_P!SJZ8ZX;3PM_D*.BK[,NV15R[    'ESUM7F'Z F$3
MJ?,F5_B7OMU>B8NFG5#YYJURI#DX        .M.J/\VLB]W->PC0N)OBT='G
M6=P?\&YVHZG1(U!O@   #&72Y/P)=ICLQ^F1<)9QGE]UZD@F'7=? CYT$GC3
ME 9,        !RWOMABK#DOP_#;I:[T9N*-)=RB87%Q)_;^N%V3-78%H\.9_
MWUCW54^M;^SR>35Y%#<:;I_*YKW]$>I>T]%?+Y?:\O,U0-K5^V?D-EF;D,P,
MKQ0DSKFB&Q&OUJ0I*93,F,DF^E2VHZJ:61)TFFO;XU(M8RN8IR$U6;WJT[4S
M15^[,3IPQY)CEQ;SGLG7OBFG,Y;UZ]BFF[1JJBJF,-J(QTTU1AAACY<<+[+7
M,G<P2U*S5'19 N^U80^VRQ(.&4<B(]#9)/3K-7*7+YPZ,E%B,W7^7TT>[TX3
M,QM;7AY<,&5O:K-U;MH_.:+LWM&,4TU;&QS1AHVL?E@HWVZPK5ORY=+P9*A1
MKBSTKB^Z)M)-(0E9]IO@KSASRUFJYNF*+>N:)ZYT>-QSV9MV>(9N7M---RG'
M'DT1$3]71/B4;'A&46?/X]XNFIJRVZ85SEY&XJD)V(APG#<2\1FE1O).A)(S
M5W7$N4<\QO"Q=R<VZ--=5.S%O]Z*L,,,.39Y]6AT9'<^;R^\:;EW&+=NKWE5
MZ?8JIB<=K:U3MQR8XZ=,:U;$E6W.GLHQ^0KP6V/W)O)(C:U$VAF.U(-$KD]-
MX.[P+^R.&=V\G%J[&FJ*)MSX9FGU?YH^=W;K]UO.K,6*O5HJN1?IB9PBFF*L
M+FKE]W5T>KXV4QR]0,M<G9/<S698G=Y61-,NN]T4"0TIQMALCYT/QV4TY.Z&
M+FLO7EHILT?\U%-O5^]$X35/3355Y&;D,W;STUYFYC_UKM=^(FK3L54S,44]
M%=%$8:M*)X<FX9':\XAL$J;?[G$9E(830W7U-S6WGC27.9$>JA<3YAZV>V+%
MRQ5/JT453&/)&-$Q#7=V1=SEC-T4XUW;E--6'+5LW::JO'RX:YY((K$F'M9D
M,62A;$AF]Q6I#"R-"TK0VX2DK2=#(R,N)'SA7535G[=4:8FW5AY8<[=%5&Y[
MU-433,7J(F)T3HB=$QYE"2:CVB@:CJ2;_()-3K0CB-G0NQQ'.G_(U?\ XH^U
M+HF9G<T8_P#]15__ "Z5WM[=+A9<7S>Z6I\XT^/%@]"^G2:DZY9(5341EQ29
MD.K>=FB]F+%%<8TS-6CZK)W)FKN6R>;NVJMFNF+6$]-R(G7X)5;S<IN>;?KO
M]V<.5D.-S6HTB50D5MLTCZ,UI31)J)TM)*(BX<M1QL6J<EG/=41A;NTS,1_K
MIUX?5=F<S-S>>[9OW9VKN7KB)G5_3KU8\F.WHQYM:=X_858[G5KM]AQ^&>+H
M-AQ.6RR-Y<KI6B[IF0I?1DI:E:4-M)KYU1X69S/O\I75<N5>\T_TXT;.$\M.
M&.$1IF:FV9#)_E-X6[=BS1[GU9]_5ZVWC&NFO'9B9F<*::8QY=2!8C F73$,
M]LEN95(O#J[<^U :*KZVXTESI30@N)Z-15IV1[V>N4V\SE[E4X41MQM<FFF,
M-/A:?NBS7=R&;LT1C<GW4Q1'M3%-4[6%/+AC&KG9>WKD7';VRP[/CL3(;E87
MYS%VM\EM]R6PJ2\3B'$-,.M+4E1=RHS(Z&GS1AW8IMYRNJY<JM4W(IFFJ)C9
MG",)B9F)C'ECI>I8JJN[LM4VK--^NQ57%=%45373M58Q,4TU4S,3JF<)PP\$
MH9G,^^29-NA7VS,V-R!$2U$A,M.LF4=:U+3J)Y;B^^-7*8]G=UNU3355;KFY
MM5:9F8G3XHB&M;XO9BNNBF]:BS-%$133$3'JXS,8[4S.O'6BH]5X#J38G#%8
M_CBK].;TW.]DEQ!*+ND1$\6R[6NNL^UI[ J[B//^_O\ NZ9]6W]KE\FKRKYX
M+W3.5ROOZX]>]IZ*.3RZ_(VN-46           "#W#RQ8Y_#-^\?LX!LQY(\
M&^(K;XLV!*<                            UQNR_N_;H<2][6+LSK5M:
ME/WJU7IN0M4M"4)4V3"H_=$M.E="J6HS+L E -A,"RR[95/ZPNX3L5C)\NMC
M,6'9+>P[';APSZ(Z/$]W9NT9;*AUIQ[HZEI$I!NSMOE.7[I;5999&F%V?$9T
MJ3>5.O$VXEMXX^GHTT/6=&U 0\[U;7Y9D&1XEN?MN]%3GN&.NDS!N!FB+.A2
M2TN,J6GBE5#6DN3@M7$CH!# XIMUNKE>Z[6\VYD.VV.?8;6];,6QR'(.61//
M)<)3TAY%2T^JK+N:GQ+@6GN@P>;V7K5;G8O)VWON/XS:+;<S:8NV2,2UNMJ8
M;<2X9LL&I;B3,TERI\S3RD-#8=PQ?=?#(FV>);6R8+^)6,H]ORR1="+PEV%&
M2RV2D$=::DDZ=&^)*TEWM0&.W-B]8');],Q_!;/8K-82T-0,WGO]-<&6W6D]
M,N.T@E*:<2HU)2>GFK4N4@GFU6V]IVHPFWX;:752BC:WIL]TB2Y*EO'J=>41
M&=*GP253HDB*ITJ"$T 82YQ9"I)NI0I:%$5-)5I0J4X E=0X<I#"2-]35:GT
M9$1TKYH(5_!I/YVK[E/U@&'RR/(+%+Z9RE?Y=+]*G\ OB,K)_'M]JGK>?O+3
ME+O8K^S+@VHNQ\T%0"H!4 J 5 *@%0'7G5U\G#7NV3Z*15_$?>Y[,+RX-_Q\
M=JIM@:RW4   !HCK4?,VS?&9>+NC;N&/CU=GSPT+C3NM';^[+DZHL-4A4 J
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M%K:6EQM1H<2=4J2=#(RYR,A$Q$Z)3$S$XP\F9G6I\O$_-!&!4Z4YA(5/ZO*
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M[4=3HL:@WL   !C+H_=&9=I1;VNDC/2C;N*M-=$?H'5$JM2IZH2"KQY0&3
M        &N=UMLV<YMQ3;>26LEA(,HKAT23[9<>A6?F]X9\A]HS&Q;FWM.3K
MV:M-NK7X/#'G:9Q-P]3O*UMT:+U$:/\ 5'T9\T\D]+E"7$DP)+T*:RMB6PLV
MWF7"-*T+2=#(R/D,A:]%=-=,54SC$OGZ[:KM5S17$TU4SA,3R*(YNH
M         !(\+PR[YO>$6NV(TM)HN9,41FVPT9\5*[)GZ5/.?GF7G9_/V\G;
MVZ_%'+,_+6]K=&Z+V\;\6[<:/WJN2F.?T1RNP\;QVV8K9XUDM+71Q(Z>*CH:
MW%GWSBSYU*/E^H7 4_F\U<S-R;E<Z9^;P0^C]WY"UDK%-FU&%-/EF>69\,_+
M0RHQ'H            (/</+%CG\,W[Q^S@&S'DCP;XBMOBS8$IP
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M9_4+D+@*ISF=NYJY-=R=/S1X(?0&[=V6,A9BU9C".6>69YY^70S8PGJ
M        "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
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MSM1U.BQJ#>@   &,NC5U<EVE5N<)$9J4:[DDS(M4;H'2(N)'7U0T'PH R8
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M7;PJ]=    #RYZVKS#] 3")U/F)*_P 2]]NKT3%TTZH?/E6N5(2X@
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M<5'VS&K7\Q<O5;5RJ:I\+?<KD[&5HV+-$41X(^6+(#'9@
M  @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
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MHP:BWH   !C+I;I4Z7:7X\CH6X$HY$A'=>JMFPZUHX&1=\M*N/#@ R8
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MJIMP:TW(   !H3K7?,NS?&A>+NC;>&?CU=GSPT3C+NU';^[+D@6$J@
M   ?2FV_Y=$_$M_>$*3N>U/2^CK7L1T0N1P=@   #BKK,^5*1[BB_>F+,X?[
MI'3*G>*N_3V:6GAL34@       &U^KCY6;3^)F>+.#P-_=SJZ8ZVT<,=_HZ*
MOLR[?%8+G    >7/6U>8?H"81.I\P91_E+WVZO1,713JA\_5:Y4JCDXE0"H!
M4 J 5 *@.N.J'\V<C]W->PC0N)?BT='G67PC\&YVHZG1HU%O(   #%W6V>'R
M[1(\(Z'X/EG)T4]=JPZUHY2_":N?D 90
M                  0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@
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M1HU%O(   #%W:WQILRSOOR28<@RSD1VST^K.&PZUHX\>]6:N''@ R@
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MA\YE0"H!4 J 5 *@%0'9/5M\F;7NV3Z*16/$7>Y[,+IX1[A':J;=&MMQ
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M6A'S&9\ 3@W""         !![AY8L<_AF_>/V< V8\D>#?$5M\6; E.
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M'4Z.&HMX    8J[-6IR99U7%TVY+<PUVU)&9:Y/@[I&DZ$=?4S6?'L ,J
M                    #\4DE)-*N]41D?-P,!QZW:MWNJ%;[E*LT:%FFR93
M%39+!GX-=8*)"DMFI2J<>!(2:J.),^.E%3!RUNH[9<;'FN,V?*HK"),";%9O
M%I7):2;C1R&-;:R)5=#A)<,JEQ*ID#BTCU(O(<S\:S_10"9>^LUEI9!:D]7_
M  F,B\;@Y<;#;T-%#9MMO;<0^J3)41&3?!!:2/B2>[^Q)0A%\LQQK&M_^KUA
M,MPY5DQ^T/183KW(N7#BK03E#J1*-3+*O-H"6<OY)C]=O%%6[N7)>)O_  P2
M.&I"3F:#73EXH:Y>P0(Y$GZT&W.5;@X5:7,/8;N%YQJ[1[VFRO*2EN:AA"T*
M;+6:4FHM=2(S*I:BY3("&F]V,US3</</9B!-P>5A]R8R)F1%.XR679RS;>85
M)-MEKNTQVTH)2G5D1+YB[E0)=J X@        "#W#RQ8Y_#-^\?LX!LQY(\&
M^(K;XLV!*<         ,-EEUN]CQRXW>PVA=_N\1DW8EG9<2PY)61EW"5K(R
M2=./(?F .0,E*9OYN?CS>$[=3,+S7$;O$FYGDT\F8C\1A7JR$.);/4\I9)UM
M&HM1TX=RI1@Y.@^LG;;C=]C\QMMIAOS[C(BM)8B16U/O.&4EHS)*$$:CH1&?
M @1"I;<AN.WFP=AOAV"X7>[VC'[4W\GH;*SG.23888Z(VR2:DZ%*]4[DS0DE
M'0Z4 <U[>Y]=V<YE;L;K;=YM?]Q7C7%M#<.RK*U6B =4I;BI=6E6LR4K4LRY
M%'RJ4I1DMCY-\,[)=8*];I.X]<K[@.<6QF-.>LD<YDB%<8J6D)Z1HC(]*R:Y
M3,B/7P.J3($+?;)K-L0M.['6$NN(SG;WE,E,RQX>HC;N/P?&6LD&ZG2I23-+
MI&HM&K2V9DGB50V'/WZ?L%@Q>^9%M_DR$Y# \-EMVR"<\K>]4J,R.+9D:B[I
M-4D=*521UH,$*V-QO(,AWHS+>YS&).%XE>8*+;;+1/;*+,F.ZF%+E.L%WIGT
M-3.G$U\#5W1@2Z8!      X3WE/_ %/R7W5_PT"V]T=TM]"A.(/\A=[7FA!:
MCUW@%0"H!4 J 5 *@-W]5P_^?;C\5.^,,#5.)N[4]J.J6]<&=\J[$_:I=;BN
M%P    ,)F7S0O_Q;,]@6,K*?'H[5/6P<_P!VN=BKJE\\1<[YU         '9
M75K\F37NV5Z*167$7>Y[,+HX2[A':J;?&MMP    :!ZV/S*LOQH7B[PVSAKX
M]79\\-&XP[M1V_-+D6HL)58 5 *@%0"H!4 J ^EUM_RZ)^);^\(4I<]J>E]$
MVO8CHA=#@[    '$W6;\J<CW%%^],67P_P!TCIE4'%/?I[-+3@V)J8
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M(KA;X   #"9E\T,@^+9GL"QE93X]':IZV#G^[7.Q5U2^=U1<SYW*@%0"H!4
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M?Z.BK[,NYQ6*X@   'ESUM7F'Z F$3J?+J5_B7OQBO1,7-3JA0=6N5(<G$
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MT]</H2*6?2      X)WI/_5/)_=?_#0+9W1W2WT**W]W^[VO,@=1ZSPRH!4
MJ 5 *@%0&\^JM\_[E\4N^,,#5>)>[4]J.J6[<'][J[$]=+K\5TML   !@\S^
M9^0_%DSQ=8RLI\>CM4];"SW=[G8JZI?.>HN5\^%0"H!4 J 5 *@%0':75E\E
M[7NZ5Z*16?$/>Y[,+BX4[C':J;B&N-N    <_=;8Z839?C4O%WAM?#7QZNSY
MX:1Q=W:CM^:7(%18*KL"H&!4# J!@5 P*@8%0,"H&#Z;6W_+H?XAO[PA2USV
MIZ7T):]B.B%T.#L    <1=9_RJR/<43[TQ97#_=(Z95'Q1WV>S2TU4;"U4J
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M[=/7#Z&"EWT<     .!]ZO*GD_NO_AH%L[H[I;Z%&;^[_=[7F0(>J\(
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MWT_D>[V^Q3U0R@QF:        @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
M      #FWK9'1&)^;</_ )8;QPM_R_5^\K3C?59^O]US34;RK' J!@5 P*@8
M%0,"H&!4#!F<1/\ YKL7QC$]G0,;-_!K[,]3-R,?]BWVZ>N'T/%+OHP
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MO;[-/5#*#&9@       "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
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M_5>LU1C7$;451HT<NAD6-X9>O+4Y?,4U843,TU43&.G3,3CC&MA]PLX^6T^
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M*%JURI"7$       !U]U/?FQDGN]KV$:)Q)\6CH\ZQ^%/A7.U'4Z1&I-V
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MV^S3U0RHQF8        @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
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MF&F!L#5P       &W.K1Y7[/^)F^*N#PM^]TJZ8ZVR<.=^IZ*NJ7=XK-;@
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MU2[O%9K<    >7/6U>8?H"81.I\MY7^)>_&*]$Q<U.J%"U:Y4A+B
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M=4*%JURI"7$       !U]U/?FQDGN]KV$:)Q)\6CH\ZQ^%/A7.U'4Z1&I-V
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MJW[$="Z'!V    .&>M*?^K$GW#$^],61N#NL=,JIXE[Y/9AI>HV%K!4 J 5
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M;H&NMI    <\=;_YC6/XV+Q9X;5PW\>KL^>&F\5]WH[7FEQN-^5H
M /J+;/\ +8?XAK[PA35SVIZ5\V_9CH70X.P   !PQUI?*Q)]PQ/O3%D;@[K'
M3*J>)>^3V8:7&P-8        ;=ZLWE@L_P"(F^*N#PM^]TJZ8ZVQ\.]]IZ*N
MJ7>0K1;0   #RYZVKS#] 3")U/EO*_Q+WXQ7HF+FIU0H6K7*D)<0       '
M7W4]^;&2>[VO81HG$GQ:.CSK'X4^%<[4=3I$:DW8   !BKLFTJF6<[BLTR4R
MS.V$6JBI/0.D9'IX>MZ^^X>> RH      X*W!5_SWDWQI,]G6+FW?W:WV:>I
M\X;WC_NWNW7]J4<U#/>5@:@,#4!@:@,#4!@:@,#4!@Z8ZK1UM61^Z(WWBQ7_
M !3[=OHGS+9X%^%=Z:>J70 TI98   #676!\D]\^VA^.,CWMP]]H^M]F6K\4
M?XZY]7[4.3<&PR9F5U-E*DQK'!Z-^^71YQ##,6&:R):S6YW.JE=">?S",6)G
M<Y3EZ,==56BF-<S*H]V[OJS=S#513IKJQPBFGEG&?F]&+WF&'M6"^-0;+=(5
M\MUQ=7\$/0)+<EQ31N:&TO$DDZ'#J1&5*5K3D$93.3=M[5=,T33'K8QATX>!
MRS^[XLWHHMUTW*:Y]79JBJ<,=&US3\V.I=9=MAD6$V6%>KT_#-,Q]<142,_T
M[S#[1&:T.FA/1U32ADE:J&.O*;SM9FY-%$3HC'&8PB8\'+\SMSVY;^3M4W+D
MTX53AA$XS$\TZ,-'@F7MW:K)XV&2<XF+B1[;&:C2? U/ZYBV)JDI9<)MLE$D
ME:ZEK4DZ5X"(WI:F_%F,9F9F,<-&-.N,?05[ES%&5G,U;,4Q%,X8^MA5,13.
M$8Z\>681K'K#<<HO4.PVE!+GS5Z&]9Z4)21&I:UGQHE"2-2C[!#.S%^FQ;FN
MK5#S<IE:\S=IM4>U5/R\D:97N9XC<,'OKF/W-^/)E-M-/=-#4I;*D/)U)H:T
MH/D[0ZLGFZ<S;]Y3$Q'AUZ'?O#=]S)7?=7)B9PB?5TQIZ8AEL%VMR;< C>M*
MHL6"3JHR9DYXFD+D-MDZII"$DMQ2B0>H]**$7*8Q\[O.UE=%>,SACA$<FK'F
M^=E[MW+F,]&-O9B,<,:IPTX8X<LXX:=2&/-J8><869&MI:FU&7)5)T.GU!Z=
M-6,8O%JIFF9B>1]#L7^;5F]PQ?84BE\S\6OM3UOHS)_ M]FGJ988[+
M  0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@        !R]UPSHC#_-N/H1AN
MO#/_ "?5^\K[B_5:^M]UA-MI5QG;<VRV;0WFW6;<:-(D.9#!F(83.N*36:F>
MA<?2LE(2C3W%-/9,O39&>IIIS-569IJJM3$;,QCA3SXX?+S=&[:JZLI33E*Z
M:+T3.W$X;56G1AC&J(\'CY]4+R?(\5SBZ7F]VF$YE:5NMR(UQAH4S&E+I1YM
MA.ELEHI5LZ&GC7B/=BQ;O6*::*IV/!.N.;'7TM:JS-ZQF:J[E-,W/]5.J>>(
MT1C').GGTI9UEEJ5ND^I9U4=O@F9\E3-LSYA@;A[KXY>IQ/WOZL,WDF3RLJZ
MNRI\B%"MS3&3MQ8D"V,%&C,LMQ=1)2FJC,ZJ49J49F8Q[&7BSO#")FK&WC,U
M3C/M,G,9JK,;KFJ8IIPN81%,81$;/[5EM)!CX25AS*YMDK(\IN+%HQ**XDE=
M%%<?0U+N"D]C2HVFJTXF9T,N([-Y5SF-NU3[-NF:J^G#&FGSRZ]T6HRNQ>KC
MU[M44T1X)F(JK^['5,(3O ?^J67?&3_HD/1W9W6WV8>1OKOMSM-B;%91*DV3
M+L51"A1X,/&+I+=ELL$F;*>4HB2I]XS,U$A+AH2DJ%2G./*WOEXBNW<QF9FY
M1&&.B.B/$]K<6:JFW<LX4Q$6ZYQB/6F=&N?!BT_A9_\ -V/?&,+V= ]_-?!K
M[,]36,I'_8H[5/6^E8IU?      ^>F^9_P"K65>[/^&@6INGNEOH4SOKOMSI
M\S7M1ZKQRH!4 J 5 *@%0&_NJ.?^HES^)WO&8XU?B/N]/:\TMOX5[U5V)ZX=
MGBOEG@   ,#F_P R\C^*YOBZQE93XU':IZV)G>[W.S5U/FD+@44
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M%0"H!4 J 5 *@-_]4;RBW/XG>\9CC5^(^[T]KS2V_A;O578GKAV@*^6<
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MNT:2M    !BKM)MK$RSMSV.FD2)AM6]>DE=%(\'=5KJ9E3N$K34NR RH
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M5?E0"H!4 J 5 *@,YAA_\X8]\9P_&$#&S7P:^S/4R\G\>CM4];Z8"GUZ
M #YY;Y^5K*_=G_#0+4W3W2WT*;WUWVYT^9KT>H\8       !O[JC>46Y_$[W
MC,<:QQ'W>GM>:6W\+=ZJ[$]<.T17RS@   &!SCYE9'\5SO%UC)RGQJ.U'6Q,
M[\"YV:NI\SZBX%&E0"H!4 J 5 *@%0'<G58\E#/N^7Z*16^_^]3T0M7AKN<=
MJ6ZAKS:    '/'6_^8UC^-B\6>&U<-_'J[/GAIO%?=Z.UYI<;C?E:
M  #ZBVS_ "V'^(:^\(4U<]J>E?-OV8Z%T.#L    <,=:7RL2?<,3[TQ9&X.Z
MQTRJGB7OD]F&EQL#6        &W>K-Y8+/\ B)OBK@\+?O=*NF.ML?#O?:>B
MKJEWD*T6T    \K[Q7F&)A$ZG!3_ *^[]NKT1?-.J'R57[4]*F.3@
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M 5 *@%0"H!4 J ^CF+?-BR^X(OL*13&9^+7VIZWT-D_@4=FGJ988[+
M  0>X>6+'/X9OWC]G -F/)'@WQ%;?%FP)3@        !RSUR?6\-\VX^A%&Z
M<,_\GU?O-!XM_P"+ZWW7*PW1H        #.87\\<>^,X7C"!CYKX-?9GJ9>3
M^/1VJ>M],Q3Z\@    !\\M\_*UE?NS_AH%J;I[I;Z%-[Z[[<Z?,UZ/4>,
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M[5/6^F8I]>0     ^>6^?E:ROW9_PT"U-T]TM]"F]]=]N=/F:]'J/&
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MQ\.]]IZ*NJ7>0K1;0   #ROO%>88F$3J<%/^ON_;J]$7S3JA\E5^U/2ICDX
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M?,UZ/4>,        W]U1O*+<_B=[QF.-8XC[O3VO-+;^%N]5=B>N':(KY9P
M  # YQ\RLD^*YWBZQDY7XU':CK8F<^!<[-74^9PM]1H         [DZK'DH9
M]WR_12*XW_WJ>B%J\-=SCM2W6->;0    YXZW_S&L?QL7BSPVKAOX]79\\--
MXK[O1VO-+C<;\K0         ?46V?Y;#_$-?>$*:N>U/2OFW[,="Z'!V
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M@LI\"CLT]3+C'90       "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M    .6>N3ZWAOFW'T(HW3AG_ )/J_>:#Q;_Q?6^ZY6&Z-         9S"_GC
MCWQG"\80,?-?!K[,]3+R?QZ.U3UOIF*?7D     /GEOGY6LK]V?\- M3=/=+
M?0IO?7?;G3YFO1ZCQ@       &_NJ-Y1;G\3O>,QQK'$?=Z>UYI;?PMWJKL3
MUP[1%?+.    8'./F5DGQ7.\76,G*_&H[4=;$SGP+G9JZGS.%OJ-
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M]WM1U-VC25H    ,;<SNQ2K5\&D1Q3E'\)UT_P"&Z!VE-7'USH^]X^=4!D@
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M^M]URL-T:         SF%_/''OC.%XP@8^:^#7V9ZF7D_CT=JGK?3,4^O(
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M?V4^#1V:>IEQCLH       !![AY8L<_AF_>/V< V8\D>#?$5M\6; E.
M    '+/7)];PWS;CZ$4;IPS_ ,GU?O-!XM_XOK?=<K#=&@        ,YA?SQ
MQ[XSA>,(&/FO@U]F>IEY/X]':IZWTS%/KR     'SRWS\K65^[/^&@6INGNE
MOH4WOKOMSI\S7H]1XP       #?W5&\HMS^)WO&8XUCB/N]/:\TMOX6[U5V)
MZX=HBOEG    ,#G'S*R3XKG>+K&3E?C4=J.MB9SX%SLU=3YG"WU&@
M #N3JL>2AGW?+]%(KC?_ 'J>B%J\-=SCM2W6->;0    YXZW_P QK'\;%XL\
M-JX;^/5V?/#3>*^[T=KS2XW&_*T         'U%MG^6P_P 0U]X0IJY[4]*^
M;?LQT+H<'8    Y'ZPEKM\O<9]Z3'0ZZ<2,6I15.A),6GPY1$Y.,8Y941QGF
M+E&\9BFJ8C9I:L^ [1^9M?<C9?=T\S2?SE[Z4GP':/S-K[D/=T\Q^<O?2D^
M[1^9M?<A[NGF/SE[Z4GP':/S-K[D/=T\Q^<O?2D^ [1^9M?<A[NGF/SE[Z4G
MP':/S-K[D/=T\Q^<O?2D^ [1^9M?<A[NGF/SE[Z4ME;"VJW1=S;8]'C(;=2U
M*(EI*A\8ZR,:[Q#1$9*K".6GKAN'!^9NU[SHBJJ9C"K[,NP15*_0   'E?>*
M\PQ,(G4X*?\ 7W?MU>B+YIU0^2J_:GI4QR<        '1W5M_P BO?NMOV(5
MSQ7\6WV9ZUT_^?\ =[O:CJ;M&DK0    8VYQ+C)E6IV%(Z%B-*-V<C4I/2L=
M ZC10B.O=J0JA]@!D@     !\Z=RE%](>5_&T[QA8M[(=VM]FGJ41O./^W=[
M=77*+ZB&<\W U$!@:B P-1 8&H@,#40&!J(#!U;U1#K9\H]TQ?8W!HG$WMV^
MB?,LO@_X=WII\[I$:<WX   !JOK&^1^__;0O'61[FX^^4?6^S+7.(^X5_5^U
M#A&HM!3A4 J 5 *@%0"H!4!]*L3^:UC^+XGL*!3>9^+5VIZU^93X-'9IZF8&
M.R@       $'N'EBQS^&;]X_9P#9CR1X-\16WQ9L"4X         <L]<GUO#
M?-N/H11NG#/_ "?5^\T'BW_B^M]URL-T:         SF%_/''OC.%XP@8^:^
M#7V9ZF7D_CT=JGK?3,4^O(     ?/+?/RM97[L_X:!:FZ>Z6^A3>^N^W.GS-
M>CU'C        -_=4;RBW/XG>\9CC6.(^[T]KS2V_A;O578GKAVB*^6<
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M]"]'^J.IN\:2M$   !B[K;4SI=HD')Z X$LY*6_PQFPZUHY2^SU<_( R@
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MF?I1'[L]/.V?=?$6:R%NJW35,T335%,8^Q5/[U.B=6O#5,RPELRS([/=W+]
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M[GTI\LN\<<(DX]:4I*A%"C$1%R$71)%'9KXU?:GK?4V1G'+6^Q3U0R8QF:
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M E.
M
M !BKL]:VIEG1<&3=DNS#1;5$FO1R?!W5&HSJ5/4R65>V RH
M                                 @]P\L6.?PS?O'[. ;,>2/!OB*V^
M+-@2G
M
M    Q5WFP(LRSM3(Y//2YALPET2?1/%'=7K[KB7<)4GAQX@,J
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M:MDOI3N$N)'51U[6D]*327&G-0^"J=UF_P!NRMNY38KFKWE4:XPPB9U0\_\
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M)>@]!)Z2J>^IJ[0Q\S^2V)]UM[7APP965_N'O(]][O8_TXXMCCR7M
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MD3R&51U9'-8VIL5VYN4S.,8:XEV[PR<1>C,478M5Q&$XX83'R\R*[#P;A?\
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M4!AN+#CI)MB.RDFVT(3P)*4I(B(B[!# JJFJ<9G&9>E1131$4TQA$*PXN0
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M'2RHZ&0      #&W2=-B2K4S$C].S,E&Q+<HH^B9)AUS7W/ NZ0E/'AQ 9(
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M[<MDK.7C^G3%.*0C%9@       "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M
M                                                         #&W
M21<V)=J;@,]+'?E&W<%Z=71Q^@=42JU*G=I05>/* R0
M                             @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2
MG
M
MQMT5=DRK45M21QE2C*YF9).D;H'3(RU'7USH^3B R0
M                            @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
M
M
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MES;!<LCQHN58?/0@CADM#$JU3D=+"D$EQ2S):D<'$DHR(Z=F@#98(
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M#BYQVE_]5>]/N>U^PM EF\O[GK8;=*C>O.8[=D3C+E\&3K-NO:Z3D Y&^@0
M   T+UL#5\BL3;658#N861%QKR>#:W3.O:U$D$PDF]>SMMW88LBV;X]C>:X^
M^Y,QJ\Q3(W6G#T&X6C4A2DU0VJJ5$I)D7'E(Q"'[*;E;DHW+R'8_=)Z'>K[8
M8*;E$R.W$2"=CZF4DA]*221+,GD*+N$F5#(]52,"5EO_ .7;8,N;X4G^C$ A
MO/.<OM6 XC>,QO2J6ZSQER7$D9)4XLN#;23/AJ<6:6T]LR!#4O5;Q.ZLXO<]
MU<M3JS3<B4=YE+,CJU 4:CB-)(ZT2:5&XDB](I)>E!,H%N'M1FVQ6(9!N/M[
MN9<(W@DQR]W&R3VV%6^4],>2EPM%-.M54D54GJIIX<#(ET;@N8HRC",5R>Z$
MU;9^26^),3#6LD5?DL)=4AHEG51<3-//I!Q<L6NP9ONCNCNID>QE^+;Z+%>5
M9[STBU/G=[FT;J%2#:TGX+6BM+J2-:3/4GNE+H<DBV<O./W/JK9U8$69%F7C
M4&^6J_(2Z<AJ3,1"4X[*)U1F9FYKY*GI,J)[G2!.MN3J\JE*V0P,Y=>E^!XI
M)K^")-&_^YI!$ME@@  &@C-:^N2E,SO&L",[<1\E57+NS+M]\7F GD6FXNR6
M3,9G>-W-E<P3CF9O-I^'K5*T.6V8IAM)T=U:B;-24I,]:#+TQ&CB8&*5[%[F
MWK>C:?Y12$(LV2FJ5:WI3#?21TRV4%IDM-N&=4]VE6A2C+41E6@$M.^!9-MA
MUC\)?W7O#>XMQRAIRV8U?.C*WOVERIMK4F R:F22X;R4FOEIJ/E30R6X][-W
MG,'AM8EAL5R^[L9"VIG'K%$3TKC6LC3X9((N"&6^*JJH2C+F22U)(AJV^8OG
MFP?5SA8+@]MN%\S;()#B+[<K+&=F+A+FIU27FDMEJJEM*6&E'IX]W5)\ 2U?
M:LRM6);T[6L8[M[EMOM6,6:7;H]CG6WHKO,5)*3TDM#)*HLE*<-QY9&1%15.
M! .JNL*\<[9?<&WVM]#ESBVAUR5':62G6V:$XO6@CJDE-)695Y2!$-,YM<+,
M?4/MZDK;-IVS6B*P14[J:U+82XDO[1+0X9^88)Y66W'CW"%CO5K96FF0Q[[C
M["TKJ2R+P1"9!'S\W= AU("    '//5C@P;OM5E\"^-I6W<LBO[-^;6HTDHW
MS2AXEJX&54'0S!,M>Y%;=R>J):(^18CDS.5;.JFH;/&;MI3*81+-2R*,\GEK
MW2M3>DJGJ-M1:C!.MTMG%HS'+\8BM8%E*L,NKRVI*KBN S<%JCJ:55A33YD2
M#,U),UEQ+2#BTOU5YK=DR3<7;>\Q$2,]L]P*7D.5,ON2BNZWEN$3CAN<6UHK
MWA<*J5P)1*J3*ANM=)76/R9C9? ZNX/:)S4K/LN01G%0<8S,H4=RAI6Z9\>%
M>Z(O2I68&I5?8:M?76LK$I)-17\/./8DJ+N?43=U(09\Y)0Z?F <BIB!G*ZZ
M6?RX"R.%#QN*Q=%IXI\(44(T)49<-1)3_0?8 Y#K67*S9);L"PJSLMS,PRJ\
M(^1^0-2U1V+;(CK;0N3TK)*UT-U*>C+[;ODI(Q"-6*%E^VG63Q9K=VXMYY=<
MGMSEMQ;)4%X,[;>A2KI4^!H+06O5I4YRF2C5J[\@2V%B54];+<-,;_#KQRTK
MG4_.4F@FZ]OHZ@CD;[!   -,]:Y<I'5_S,XA56;,5+G$R,FE36"7R?V:@F%_
MG^U>+;M;86/%;E-7:TM(A2;!<HRDDZQ*:CT:-"5&1+(T&HC14JEQ(R,B,@U[
MMWG.Z^WV\-LV+W-NL;+XEX@NS+'D3"=$YM#"'5EX4GE.I,K2>O4JM#UJ*H#*
M]9;!]RKYC5^O=GS=$3!X-O\ ";KACL9$=$QB&2G9"3N+9],GI4%IT4TGR5X@
M0@.:[@WG*.K_ (!9]ML,O47%,K97"R!K'(KMRD6ZT6UTHLF,R=.*WS)1(6Z9
M:T$K54U'0E&]O<\A0>L];SM&!Y):K66-P\9@V&3 -N;!8)YA"94AHU&:8R2*
MJW349\:@<C:/7*^;6WY<WRPM_L3X(AT=*F0X2$.39#<=MQ:6FU/+2V2G%G1*
M2-1E51GR$"')>=YKD<C?1^_99MWEUWQ'!D/1\,C6BU+E0WKBJJ7;B\M>E"BI
MZSIU4(DJX&1U.2[ZE&1MSMJKEBLFT7!F+!=ERG;R^SIMLA,E5%--/&?=.((O
M5$TX 2G?4]4\K8/'B<-1L)D7%,0UUKT!3GJ<O;J");U!   -";BT7UG]G&Y9
M%X(B#D"X>H^'A)Q**IV]))!/(N-U=C;CE6:,[E;9Y8O$MSK?%1%><H3T64QQ
MZ-,AOB:2,BI4T+2HDEW%4U Q7/5WW;R'<?'<@8S=B+'R/$;B[:KI/A*+P&1T
M)'5U"B,TE32K5I/32BBH2J$)02_2I/6AW(L=JQQE?T+X)<DW*ZY*I)DS=;G&
MX)CQ#,N[0DC-*EI]*I2OP>H:F.S.WWS<3K-W&W[2W(L*S#$K2A&2Y2X?A!3F
MWTM*9CE!41H<)'2(JM?8_L(J2SW53EN6:\;B;=9##2YN%9KGX9DF2M/KE)NS
MDM3FAU2G"(T&DBX(X%W5=)*U B52S_\ K;R#^#V_98H'(W[?HELR"W7/$9<I
M*'+K ?8?8;6DI!1I*%,*<2FM:%JH2J4J"''N20=Z=CMB\BVYORL;/!F8\V!;
M<D=?<\,D1[DI9G&9AD6I<A9NKTFKN6RJ9F9(J#DRN?V*XXUU,<0MEP0MJ_QG
M;/(BM+JEUN3)F=.A%.4E)0X:3+F Y78:=6DM7?4XTY*@XOT          :&W
MS[K=;8UI_P#P!WZ:M=>3PA$=!L>?J,Z F&0WBV3<W R2TYKAN4.XENA8(RFH
M%P9HXAV(I2S)#S9&2M-5N)U%4C)2B4E1<"&*UZO6ZN9YI-S#!MPV8CN78-*:
MAS+O;?\ "2R=4ZBM"(DDLC956A)J1]ZDR,"4?NY__P#;EA[6&K]GE <B3=;K
M_P!/F7]LH%?UA' ALG;WY@XK\3V_Q5L$-*=7;RP[_?'T3[Z:"99_K5.JNO5]
MS4K)(1(5'\&3+Z!9.:4QYS"GT*TF=#2DCU$?(0$-<=86;:9'4_Q;P-2%M3(^
M/,VI*.-7"82K0@B],2$+*G:,$QK2[=EF5&SSJ](<_P \9NKK+IGW_1G$93*[
M=*%Q!#HD$    -![-'KWWWW<E?YD4VQHX]]X*F&Z35*\QI(@2A6;[9YKL:C)
M]V]D<M8:Q=3CUWOV'W0DO05FA1]+T#E::B.J4I+0YPT$M1T($NA]M<Q^D# L
M?S,XAP5WJ&W*<B&9J)MQ14625&1&:=1'I.G%-#!Q<U;",3I75MW@C6ROP@]<
M<F1&))54;BK:R22(BYS/D!RE6QZX6<NH9)63C91V[-/C.%4NYF+G.H2DRYE&
MZM)EYI=D#E;&P3/;)M-U;\+R'-GU,DW9H:8D-):I<IUUK6Q'8;,ZJ6I!IH7(
M1<5421F"%OU?L'RUV_Y7O=N)#.U9;G*FT0[&HC)V!:HY)2RV]J(C)Q24-D:3
M(C(D$9T4HTI$HCUQ)+U^M6V=NM=S89Q^[9,TS(NQDB5":?+U)IQPJFA:4:G5
M&A1T/2=0(?F1)SG8_=_;EB)G=ZR^S9]<%VR]6:_O(DZ%&ME"I$9*$H2TA)OD
MHDMI3ITTJI)T()=9-:>N!DZ8U/!G,+B+GT_.$S&R:KV^CKYP'(WX"
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MK#=CL&PG&;_C5N3,EGE3;K>1WB=(4]<YO3MK:4IR01),C(EK-.DBH:C/E,S
MQ84NK)M@>W=MVW?:FO6VT27)]LNJI.FYQY;R]:W&WD(2E-?L2;T\".FHJ@8K
MS!NK_A^%9(C,Y%RO.69<PRJ-"O.33CN,B,RLC2:6>X0E-24::T,R(S(C*I@8
MJVTV WZP7O-<[S(F$99FER)Y4:,X;Z(ELA)-F%'Z0R3J42*FLTE0^'8 ;1!
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M!>[@X)9-RL1N&%Y$I]%GN71>$*B.$T\70/(?3I4:5$7=(*O#D 9FT6R-9+3
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M8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M
M
M             "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
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M#Q,RK-VJ:Z*)G3<]GFGQL\,9E@
M                                      "#W#RQ8Y_#-^\?LX!LQY(\
M&^(K;XLV!*<
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M4[,S',V&BK:IB>=7'%S
M                               0>X>6+'/X9OWC]G -F/)'@WQ%;?%F
MP)3@
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M
M           "#W#RQ8Y_#-^\?LX!LQY(\&^(K;XLV!*<
M
M    IOL,2F'8LEM+T9Y"FWFED2D+0LJ*2HCX&1D=#(3$S$XQK<:J8JC"=4K.
MR6.U8Y;&+-9(Q1+7%U%'C(-2DH):C69%J,SI4SYQV7;M5VJ:JYQF779LT6:(
MHHC"F.1D!U.X      &+F8Y9)]Y@9!-A(?O%K2XBW2EZC4P3Y:7-!5TD:BX&
M=*CNIOUTT31$^K5K\+HKR]NJNFY,8U4ZIYL64'2[P
M                                                     !![AY8L
M<_AF_>/V< V8\D>#?$5M\6; E.
M
M
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MJEQ ''FFJ&ZXE!'R:C)-?J@/9&1E4N)'R&
M/+CC;*%.O+2VTDJJ6LR2DB[9F ]  #RVXVZG6TM*T&9EJ29**J3H95+L&5 '
MH        !^&9)(U*.A%Q,SY* /Q"T.(2XVHEMK(E(6DZD9'Q(R,N4C >@
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M$JV(:<-]Z(<YN"3_ $QKHEU*EZM&@TFDN4C/N0Q,7+,IQMG)Y<VX_#"Y&4_
MEHC>!NN'&4^E@]1(;=4M:&T&I71().I1<I5X!DX.9YC(<8QLV>BNMPG%%ME]
MN,!Z A<5,5<I]WP-:M2G&M!MI+62%&I*N91 ,AM\U=&<KSUN\NL2)Z9UO2<J
M,@VDO-E;6-"U-J4K2OE)1$HT\*ERT(,3E,/PW=)Q!XNQE"4X_&]1E.1T)8U3
MI%32F02B,UTXFG['CS +I=[N$3*+W8;!$APKG<;I!MS$YPG7$(0FT%+<=<;)
M>E2D-M&VTA&@C.FKD48#RG-\LME^>QVY^ RU1[U:;4B:TTXTIV+<8JWUN+;Z
M11(=)2:$1&::<>>A!4R/.LFAW*Z6BSLPBD,WNSV:$])2XI"&KJPVXZZXE*TZ
MU-FI1H2DTUH1'V0%BK<#*W+A**W1)$]BS7 K2_#CVF0X4\V%-M2GRE)7T3!D
MI3BFT<2[GNC[KN0DF+Y)=)^3W:SWZ0F%/94^J%8EQ5M*.$T]T;4IF4I9ID(6
MC2IS0GU-2M)DFG=$,'E.9YM;59C=+45N^#<0=CML0'T.FY/Z>*P^X3KQ*]1T
MF]1!H0JM.Z*@)7SV47ZQ7"\V/(KG$Z5J!%N,"[,PG=+:YDAR+X.<9#JU.JUI
M3T.E6I>K295*IA8V+<*_>$,,7MHO HMX^ [E+?B.P)%)D1J1"D&R;BR;(W%]
M NIT,U)46GB0#.MY9>3V\N^;*C,D^W$N%SL\19+0E41A#CD3ICU&=7$)2M9I
MI350N0$,-.S;*<4;?>O_ ('=/"+,[>(;<5"XI,RFGH['@RE*4YJ:-4E%'3(E
M%11F7(1$K;,KWG-@MUPM$^YQ%RKM9;I+M]SA1G&'(4RWL$ZM!(-Y6ILT*/HW
M-1*2HN.JI4"419>56[;I%PCDC(<H;MZ9$9O1X,4ATVR4E)D;BN-/[9:CYRJ"
M&)L&;S)D_&K:W/:NJ+F[<V+F^Y#=MTJ.] :2X3#D=:S-IQ)JHLEEQ*AERU,E
M:)S?++K>8=AMW@4-4R[WRV.37&G'5,QK2FK2T-](DE.*,R)6HR3S\U##Q;LP
MS9"(-UNR[>Y"^'E8O-@1FG4FO3+7#*8VZM9FE2EI2LV32HB14M9JH8"291=<
MF1DEAQK'EQ8K5VCW"1.N4IM3[C"8/@Y(Z%HE(2LUJ>H>M5"+CQY#(1R-FN93
M[Q:\3:\ CW3X0N<"\W/HG'&C:MC3#Z'8[/2%13J'T$I"UF2#U<5:2J2M+-N=
M?YI1,D?@2E8U,3(?D1"M<EHH<%EEYYN1X<M1-NF9-H):221&:^X[WN@O+]-R
M5S;J[9-D2X$R'+MA2F\?;9=0RTIS0M"524/)<<HDZ+,B3J/BG27 !7N.?72Q
M7K(U9!2'&M,29,M%F\&69W.+#82\;S$W4:#<J:DN,DC4@J&94[HPC639#E-S
MQ');=?8KKD%^SORW)*[9)MC462VMI/@Q+D&9/)62U&A1$2NX5JX&5 F?RRO1
MS7,=*/'^4:+ZFVT[KH_@M;?AQ2M.JM?!2-'+3IB[' !?W>ZW^;E*<5L$B/;O
M!H*+I.GR63E*4EYY;+3+;1.-%Q-IPUK-7 J$1<:D0BNTU[NK;-HQJ:S&;)Z+
M?+A,./K412V;VIDR;-9D?1GTJCHHM7)Q!*V9W-R&[H@6Z*VJ'<76)DV9,AVR
M3=DH0Q<7H3#9,M+(TZR94I:E*YJ)+C5(9?+KWDT[9R??F^EQG)%6\WGD+;4;
MK#B3HLDI-:%)U4[DS.J2,JE4!>_".9W*\SL;M5R@L2K#&CO3[C(AK64J7,Z1
M;;:64OET;24(+6HEFHS.B:4.H4IV?W0]JRSJVPF"O2VF4H@R%J5&*4N2F*M)
MK311MDLSHHBJ:>- !NX9]<Y]ULUJN-N:F8ZEAN1)D1'#;G3I#/A)(T)>JPPE
M"VTZB4M9G4_2T4'BQ[@W&]P+Y<FXC+#4*Q6^\P63U+43LZ,^\MMQ52)24J:(
MB-))J7'G(!C$9KF]W9NDFVKMT-JS6.V7PTNLNO'*D3(SS[D=7JB>C:]2(B66
MI15Y#IQ"Z<R;)\RC7=6-KB6V%;K='>6S.:7)5*DW""4LFE*;6WT;2$.H2:TD
MI1J,^%$T4$?L&0W"PXRW(LL"'\+-6#"V&ER%O:%_"+SD4TN&E5-+1&:D:$$9
MG6M>% D4O,<HL<V=C,M<.XWM4BU1[1<>A<CL'\,+?29R&4K5ZSX,XHM"RUEI
M3P550#.8]<\F:RFYXO?Y$2<S#@0Y\.X1F5QWG/"WI+:TNMFM:4Z.A+2:#[JO
M,"$O
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MEJH I77;C&;JLM2)$.(Y!3:9L&!(<B1I5O;2I#;#R&C*J4$M9(TT41*,JTX
M+Z)AM@A-3F(T=2&KE"CVN4GI%G6+$:6RTDN/ R0XHJEQ,!CIFVN-2NC2V<N&
MSX&U;)K$.4ZPB;"CH-MMJ3I.J]*5*22JDNAF6J@"[1@>,MQO!&HJD1B8MD5+
M:7%D1,V-TWH:2X\-"CX_9<X#QDV+6^?%N\UNVG<KI/8BMJC^%+B&L[>ZMV.I
MMY->A<;4XI:'$T/53B C^(X%,9EW2\7GPJ!,N/P:@C*XO2;BM%J>=>0<F2DT
MI-*S<T&RWW'1E0ZFI0);(!
M                    @]P\L6.?PS?O'[. ;,>2/!OB*V^+-@2G
M
M
M                                       @]P\L6.?PS?O'[. ;,>2/
M!OB*V^+-@2G
M
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MWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH
M?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6
MM]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J
M 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\
MEK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_
M:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_
M ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8
M/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+
M_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^
M6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RW
MR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK??
M?E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\
MM\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):W
MWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH
M?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6
MM]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J
M 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\
MEK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_
M:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_
M ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8
M/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+
M_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^
M6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RW
MR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK??
M?E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\
MM\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):W
MWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH
M?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6
MM]]^6#]J 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J
M 'RWR_\ EK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\
MEK???E@_:@!\M\O_ ):WWWY8/VH ?+?+_P"6M]]^6#]J 'RWR_\ EK???E@_
M:@!\M\O_ ):WWWY8/VH AT[,,I5NK891[?7E,AO'[TVF$<NR=*XAR;:C4XDR
4N)MDE!H)*M3A*JM.E)D2C22__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>pc_platform-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pc_platform-4c.jpg
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M%!04%!04%!04%/_  !$( L<#M ,!$0 "$0$#$0'_Q #<  $  04! 0$
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M',_]PG^C?\TH22;IS_+W:?[&QWZ*W0@DU * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4!S/_<)_HW_ #2A))NG/\O=I_L;'?HK=""34 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0',_P#<)_HW_-*$DFZ<_P O=I_L;'?HK=""34 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0',_\ <)_HW_-*$DFZ<_R]VG^QL=^BMT()-0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H#F?^X3_1O^:4))-TY_E[M/]C8[]%;H02:@% * 4 H!
M0'P-\XTD]8]QW_\ W/\ 0F*J1!]0?-K)/1W! GDY- __ -QZH9)R;YXG_P T
MVG_Y>9_XV:(@XWLF9U'F8O*;4V$S,=9FJ;EY08U"_'4AD*2E*W$<4H.H]VXU
M'R\JD&NV[O7>&Q\TG(8G(28<^,[_ 'B,ZI?AK4A5EMOM*(U D64%<?<- ?<>
MY>K&+P'2V/U(\'7[0BQW<= 4JQ7*EH"D-%7]DZBLCX*3:J23Y)QZNKO7G/RF
MH\Y^:MI)>?0IXQL?%;43I2$ Z4W/!( *E6N;V)JH@M8O>/4WHENYS%RY+Z'8
M+B!.PTAXO0WVE *%N*DC4DW2M'$?1% ?=V S4+<F$QV?QQ)@Y*.U*8U>D$NI
M"@%6Y$7L1Y:I)/F/YX.<D&9MO;2%E,1+3V1>;!X*<4KP6R1_9"5V^R-2B#6?
M-,V=C<OG<ONO(LI?=PB6&L<AP!01(D:RIT _"0E%DG^U?F!1@^P*@DBO4IK<
M3NQ,[\DY#T;<+<53T%R,D+>*V2'"A (-U+2DH%A>YX<: ^0G>C'77/QCE\V'
MP7.^#ELDA+RB?*'724GS*M51!&MJ]2=_]+MPJ9:G/*1!?+&1PTAXO17/"44K
M1P*T@\" XW[Q(H#Z*^<GN)Z5TKVYN3;\Z1$:R,Z*^RY'<4RM3$F&\ZD**"/-
MPJ$#YRQ75G>6*VOE=N0LG,,K,/LJ>GJD../(8:2M)::*B2@N%0U*20;"U2"6
M;9D9[%]$=^2G'ID+(>T<4I#RE.LNV6Y91"B0>/;0%_YN6X,_D>K&*C9#*S)4
M8L3"IE^0ZXV2(ZR+I4H@V-0P9G7_ *R[HR6[<GM'"3WL9M_$NJAO(BK+3DE]
MO@ZIQ:;*TA5TI1>UA<\31 C>/Z/]:?8T3=N$8D.L36FY;"X,Y!E>&Z I"M*'
M JY!O874.VI!]R8&'*Q^#QL"=(<ES8L5AF3*>45NNNMMI2M:U'B5*())JDDX
M9\[S_P"PL-^UT?HS]2B#C_S:=W;;V=O'*9#<V1;QL-_&+8:>>"BE3I?97I[H
M/&R2:E@]^<;U+VUU#SN*;VN52(>(9>;<R*FU->,M]23I2%@*T(".!4!Q4>':
M2!M>EV)F1N@?4S,O)4F'D$-L1BK@%&*+K4GRB[H3?RCS5 .?=$OYK[4_\\G_
M ,*JD'T5\X3!]6LWGL/C]A/Y%W#S8JTRHD)SU9A#[+G%3SH*  M+B0 M=NZ;
M5"!P+=G2WJAL:"O<.;6&FF5(\=UC(-N/MEQ02DE*7-9N2!=-ZD'6_FU=8=PY
M?.'8>Z9KF20^RMW$3)"BY(0XPG4II2SQ6DH"E J-QIMR/"&#Y\WMB-VX;->K
M;R9F,9-QOQF$9!:G'3&4M820I2E=W4%=O.]2"6]*=M]2\AD<-D]N1\DYM=K*
M,>MN175HC#PW6R[J2%@'N^EPH"+;^Q.Z\1N%UC>#,MG(.I+T=,]9<=,53BP@
M@E2N[<*MQ\M 3/HC@>H,[<F RN#8R#FTHN9C#).1G5(BI*'&EN^(D+2#9!!5
MPXB@)CUUZ^[@E9^=M'9DYS&8?&N+BS)\911(DR&R4N!+@XH;204C0>]:][$
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M_P#/)_\ "JI(.C?.$ZS;FE[KR&S-OSG<9@L4KU:4J*LM/29  +FM:;*"$DZ
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4!S/_<)_HW_ #2A))NG/\O=I_L;'?HK=""34 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0',_P#<)_HW_-*$DFZ<_P O=I_L;'?HK=""34 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0',_\ <)_HW_-*$DFZ<_R]VG^QL=^BMT()-0"@
M% * 4!!\SOF;C.INVMB-PVG(6<BRY3TQ2U!ULQ6UK 2D"QN4CG0&]WCG'ML[
M3S6XF&DOO8N$_,;962E*U,-E822.-C:@*-DY][=.T<+N.0RF._E(C4IQALE2
M$%U.JP)XV% ;Z@% * 4 H!0"@% 1C<F;W3C,YMV!@\![5Q.1D+:S60\9+7J+
M*=-EZ3Z5P5*_Y;<U"@)/0"@% * U&Z-QX_:. G[DRH<./QS?BOAA'B.%-PFR
M4W%S<^6@(_O?=\O'=+\AO; ?>90QS>0@B2@*TAX(6D+0#:]E<>/.@-]M'(RL
MOM3!9:<4JG3\?$E25(3H077V$+64IN;"Y-A0&YH!0"@.)[;ZD=7=YPYN9VSM
MO#.XJ',?@AB1,>;DN+CD7TG3H%P1Z52"==.NH#&_<;,<<@NXG.XF2N!FL0^H
M+7'DHY@+ &I)[%6'(U )E0"@% * 4 H!0"@% <MWONS>,S?>/Z9[#>C8[(NP
M%Y?*YJ6UZR&(H<+2$MM'@5%0XZO*//4@Z%@V,M%Q,2/G9;<_+MMA,N8RUX#;
MCE_22W<Z:@'..K?5V?T\GP,=AL0G,R%17<IET%908V/9<0T'!8?"4I0N>5JD
M'48<N//B,3HBP[%DMH>8<')3;B0I)'N@U (;THWS-ZA;4&X9\-J"_P"M/Q?
M86IQ%F%!-[J /&@+JMYS'^H<K:4!AI>)PV+&1SLY147&I$A1]7CIL0 I2$EP
MZ@>[0$;Z+]7I74YO)LY7'-XO)0@S(89:6I27HC^I(<3KX\%((/NBI!F]9.J+
MW3'#P)&/@HR68R#S@9AN*4A(C1FBZ^Z=()LCN#_FH!N_J;.VYM/9^XXL%F0[
MN:9CHCK+BU!#2<@RITJ20+DI(L+U .E4!8F2FH,.1.?OX$9M;SND%2M#:2HV
M YFPH#5;0W3CMZ[=A;GQ*'6\=/\ $,=,A(0[9IU;1)2E2@+E!(X\J WE * B
M>_=_X?8&-8ESVW9F1GNB+B<3$3KE2Y*K (;3Y!<:E=EQS) ($41N'K[);&09
MVAA8L90UIQ<G(+5-L>(!<0 T#[M2#J$)R4[#CNS61'F+:0J1'2KQ$MNE(*D!
M=AJ"3POVU +] * 4!@9S,1-OX:?G<AK]1QL=V7)\).M?A,H*U:4]IL* M[<S
MD7<V!QVX8+;C4+)L-RHZ'P$NAMT:DZ@DJ -CV$T!LZ 4!R3(]0NH>1Z@;AV3
MLO#8I].WT177Y63D/-%Q,ME#HTI;2>141[WGJ0;C9/4?(YC<D[8V[\-[!WC
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M0"@% * 4 H!0"@% * 4 H#F?^X3_ $;_ )I0DDW3G^7NT_V-COT5NA!)J 4
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M.[I"K6M>U =5J * 4 H!0"@% * 4 H!0"@% * 4!S/\ W"?Z-_S2A))NG/\
M+W:?[&QWZ*W0@DU * 4 H!0'--Q;9SLWK1LW<\6&7,#C(,]F=,UH ;<?:<2@
M%)4%&Y(Y"@)-U#QD[-;#W)B,8R9&1G8V5'BL I25NNM*2E-U$ 7)[30')\ML
M3><;:?2S)1<0,K.V4E"\MME;K:5.J4VVG4A2B6RMHH.GB>)X7J09N4QW4?>?
M4+8V[)NVO8^W,'*?'JKLEEV<E,EH:Y#P0=*4$I0E"$E2^!)YB@)'M7;&>Q_6
M/?>YID,M8/+1\<WCIA6@AU3#"$. )"BH6(([P% (>V,\WUXR&[EPR-N/;>3
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M1TCB[/W9#5$E.HG,3HA6A:@U+>=^$V5)XH7Y:D&@VL_U-Z8XE.R)FT7-V8:
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MX@4!H-J(ZF]),>[LIK:SF\,!%==5M[*PI3$=?@O++@:D(=XI(4HW5R%["X%
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MB=0-D$26($M22R\E9L]'6M!(&L!/>"K=EQ>XD&VB;SZAYG,P\=(Z:3L<ZZM
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M,NE("BI)3J^$D4!K-K3>K?3;!HV0]LX[J;QH4S@\U!F,QV7F-1+:7TNG4V4
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M2V.'90&UV)L#%[$B34Q9$C(Y;*O>M9?+S5!<F4_QL5$  )3<Z4]ESVF@)82
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M"@% * 4 H!0"@.9_[A/]&_YI0DDW3G^7NT_V-COT5NA!)J 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H"AX%3:@.=J U]"2]%22Y<<@.- 9M"!0"@% *
M4 H!0"@% * 4!2M:4"Y]X=IH"WX1=[SO;Z*1V?5H"CU1-_2-O)0&0E(2 E(L
M!0'M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"T^P'T
M6OI6DW;6.:5>6@*8[ZG+M.C3(;]-/81]</,: OT H!0"@% * 4 H!0"@% *
M4 H"AQU+0NKF>0H"TF4DFQ20#V\Z H0?6Y'B\X[!(;\BG.T^]V4!ET H!0"@
M% * 4 H!0%J0LH;NGF3:] 8-"3*BK)!0>-N(H09- * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@.9_[A/\ 1O\ FE"23=.?Y>[3_8V._16Z$$FH!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% 6U,-*-R./FX4!2I'A=]H<!Z2?** NI4%
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M)R&O_D3T=S)<LOD\V#7%8?T(R/G>8NXOM61;M_OB/R59W_U>?_Y%[/Q-=_\
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M * 4!S/_ '"?Z-_S2A))NG/\O=I_L;'?HK=""34 H!0"@% * 4 H!0"@% *
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M@CB""*-5)3:=4=KZ?]0DYE+>&S3@1EDC3'D'@) '8?(O^FN7UV@Z?GA]OP_
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M7;TMIW+CHE[^2YGPAU*ZEYWJ5G%9+)J+&.9*DXW&(42U':/T-2U6[Z[<?,
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M_<TJOZC3J^FW./FVXT3I7@\$19YN/$Z+[UB,*M&C[NCLLI4LJLA"5I2+D\>
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M3':!)N?9;/$\>U5<KK__ )-S_,=CV_\ ^+:_RHEU8)G"@% * 4 H!0"@% *
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MQQEQ#S*U-O-J"VW$$I4E23<%)'$$'MJ&DU1E49.+JL&?1O2OYPFLL[>ZB/\
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M<0IMQ(6VL%*T+ 4E23P((/ @]H-5%!CG'8U440%08RL>GBF&6&C'!O>X:*=
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MD\#7G-RW*W)PFJ26U'J5J["[!3@\T9;'Z>];C+JV710"@% * 4 H!0"@% *
MTN\/:XVKFG, ^J-FVH;SV/>2E*R'VD%:$Z5 @A13I/NU#V$K:0=OJ)/D;KQN
M62[X6Q',8&YK!2GAD9$%660X%VU=UAHHTWYJ]RJ:XE67#F:?&[BW)+R,.'N#
M-YMIUW"8[*+:PL)#^F1D7Y*UI=TQGBD(0&VTWMZ)-14J:6XD4'-9%O?<C';N
MRL_#2')RVMLP4MM(PV1@AK4A"7RTO7(-E*<0IU#@([J=/$U;RFF&!OY#V7RV
MZ<EB<;DE8Z/BL:P=:&D.DS<@M92XI*^"O";9[H/"Z^-[5.\IW&CQF2S[BMX8
MQS<$N5B\"_&;C9^/#9D3_$+?B2XB4,LJ;=6UW.\EG4DK*2"I-05/<6\%OC*,
M],<YO#(/#*/XE615 4\V(TEUF,HAA,UE 3X3W(.(TI(''2";43PJ''&AK<QN
M/?&T);6"E9AK+9+/0XAQTV1&;0F'D7YK,-XA#(0%, 2 XVA=U HL5$'A#;1*
M29>D9_=\#<JNG/MDR)LR;$]3W ZPSZVUCWXTB0^DI0A+*G0J*I#2BW:R[E)*
M>*N-!14J9T+?YP&#W&UNG(QI6;V[,EQ(BWUMQ',@TRRW(:)2FP\32\EM?AIM
MJ%["]JFM",M6J$DS.Y(CVS=P9S;>08E/8_'RWFI,9:'T-R68ZG$WM<7!L;&I
M;P*4L<2+,O[DVY!VGGQGI.7@YB1C869QV3#"[G*Z6TO1W&FVU(4VXM)*#J2I
M%^ -C4;"K!U1&<?U'W2ULJ=&RT[5N9QM&5P652TA/K&.7DTQWFBG3H+L74&W
M.'%"T*YDU35T*LJJ2+=&_9.*ZAQ(;658C[?Q3D&!FL6XIE#LA_.+*&W4E?WR
MT;[RJR.8<-^7"IO$IC&J))NG(YA[<&$V?A)GLUW)M2IV0RB4(<>:AP2TA2(Z
M7 4>(XMY(U*!TIN;7M4O@4K94TK6_-N;>@2T1<[+W)-1/:QZ8V16W&<9DO(6
MH)6ZXTP$-:6EK*U!7 =V_ 5%2K*V5P^JB<HN' PV$=GYN4[/BJB-2F/5FGL:
MEEQ9,D$I4VM#R"A: ?(0#>S,,M#QSJWCEPL:Y#QY]K3V)$E['3I<:!ZN(3ZH
MKR%/.JT*7XR5(0$<%6*KA/&F89#*Q?4:#NK,1,'@HCIC9#',9)4]U]J)(;CS
M6UE"V&5ZE.ELITN*1P0JPXT3J0XT-WLO(S<IMN*]DUAW)QW)$":ZD6#C\%]<
M93EAP!66]1MY:E$26))H?^*:^RJ)["J'W(WU8AFB@% * 4 H#F?^X3_1O^:4
M))-TY_E[M/\ 8V._16Z$$FH!0"@*%,MJ-U)%Z J"0D62+#R"@-%,_P 4[]E6
M7#884_N9&]X[8C[RVW.VW*DNPD34ITS8VGQV5MJ"TK;*P0% CM%2U4I3HZF,
M=CXE.Z\1NMEQUEW"X]S%Q8*"/5U-JL$+4+7*VTE:$>9:J4QJ*X4,+!;*S>WF
M%XZ!NJ2,/KF.,150XI6TN8XX\"'2FY\-;ETZAQM8U"1+E7<9V VJ_C<P_N/-
M95W-;@>C)QZ)2V6HK;4-#A=\-#3(M=2S=2E$GD!85*1#>%#02^G&1R.+8V^Y
MES!PF-R4B=#BL--2&9;#KGK##<MMY/$,.+59 .E6E*C>UJBA5FWFXRNUMQY?
M'-8M_=DAN,ZPY%RRFH<1+DE#I4%*0HI/A+T*T72".VUZFA2FN!@N;"G/@I:R
MSF+3AWXWR-]62A[U"-%B>JJ"PXG[YXP6X'$*)[NFQ!%ZBA.8]_AP8K$)_"YZ
M7CMQQES%RLWX;#SDLY1Q+TKQ6EI\.Q6A"F@!9O2 .%P5!F+4KI9!3&9Q^#R\
MW#XUS'-X3+L,^&ZN= :+A&I;B24/'QG;O)X]\^1)#*,Q)GMMXUR9AY3388;P
MOB"-&0A)0I#C!8"5$@FR4\JFA%3&W7ME_<36+5!R2L3/P\T9"');9;D)UAEU
M@I4VYP(TNGER-J-!.AK%=.X\J//7ELK*R&<R:X)EY9U+25)9QLA,EJ.PTA(0
MVUK!) XDJ)))M:*$YCW/]-\7G,Y.W"S-DXW(Y+%2,/+,71H6) 2A,BRAP>;0
M"VE?UIXWTBQH*5%0S5;%P+,[ 9'$L(Q<C;ZU> 8K;:?&CN1U1UL.]VY204JO
MS"D@U-",S+.0V;+&:F[@VQG'\#/R@:]K,I9:F1)#C"0VA[PGAW'= ""M"AJ2
M!<&PI05W,U,/I:,,S!&WLZ_#DQXC$"<](BQ9@EMQEN.-K4AQ "'$EU8"D<-)
ML0;"T92IRKM-IDM@0<CC=T8U4Y]IO=,AJ5)<0$:F%--,- -W%B#X />\M30C
M-LY'L/9+F,S[V4Q667'Q4N4[D)F)<C1WP9+_ !=+3ZT^(VE:N^4W/>O:P-J4
M(K@:A_IK+=&3<D93U_(;A=A,9F8IIN"D8V$ZIXA+4=.E;Z]1;+B^.DCD$@5%
M"K,=%)N2:J*#R@% * 4 H!0"@% * 4 H",;RW<C;<<1892YG)"=3*#WDL(/_
M %5CR_6)[>?*L_2:7K.K^U>_E]34=QUZT\<L?O>SES?R1QM:W'7%O/+4X\XH
MK=<6;J4M7$DGM)KI4DE1'#MMNKQ;*:$$DVCM%S=JI[3$YJ+)B-:V&%\5NK5R
M)'8V.2E#C>L+5:I6*-IM-^GK-IH- ]7F2DHN*P7'\#02HLF#*>A36E,3(ZBA
MYE?I)4/Z0>8/:*RXR4DFG5,UTX2A)QDJ-;46JJ*!0"@)'L;#X7.[@:QN;>6V
MRXDJCM(.@/N)XEM2^8X<>'.L+6W;EJWF@OPYFS[;I[5^^H76Z;N;X>FTFN>Q
M6Z=P2W]HXW&,8/:>-4#ZPM(\)P(2%H6% <;^1/+X1K66+MFU%792<YR]/3W&
M]U5C4ZB3T\(*W:AOW/>O1>MG*5MEIQQI5M;:U(44D*25)-B0H<".' UT"=54
MY!JC:X%-"!0"@% * O1XLF6YX41EQ]T\D-)*U?02#5,I**JW0KA"4W2*;?(D
M4'IWO"=8HQJV4'X4A26;>\HA7TJPYZ^Q'\U? V=OM.JG^2GC@3G:'2I<":G(
M[C4T_P"#94>&T2M!6.UPD"X'UHY]OD.JU7<\T<MNJY_0WV@[(X3SWJ.FQ?4Z
MC6A.L.:]1ND+'4R6RO-;@GQ\7% ,3%Q TEE#I%E.*U)45J/($^B. YF^ZT'=
M'HXO)"+D]K=:^!S_ '+LZUTEGN245LBJ4\>9!C\TG9MC;.9._9_A_P G6U_^
MSW_T1]_U-/\ _4-/^N7N^AB/_-%P*A_=MRS&SV>)':<_H4BKD?Y1<WVU[66I
M?P^UNN/V(T,[YHF71<XS<\9_ZT28KC'T2A;O]%9</Y1#\UMKP=?H85S^'W%]
MMQ/Q5/FR'Y7YLG5+'!:HL>'E$IXCU22E*B/,) :K8VOY#I)[6X^*^E35W?XO
MK8;%&7@_K0Y_F]@[UVWJ5G,!.A-)XE]QA99X?]Q(*/NJV]G6V+OV3B_7\C1W
M^WZFQ_J6Y1]6'MV$=K,, 4 H!0"@% 278^Q-Q=0<TC"[>CZUBRI4MRZ8\9HG
MTW5 &WF2.\KL%8.LUMK2PSS?@M[\#9=O[==UES);7B]R\3O4WI/TCC;"W-#C
MR'YF7VBTM[)[H9.G7D T5F*@$EM0%DI4V/0U :M=S7*0[GK'J+;:2C=V0_P_
MJX^O?PH=O/M&A6DN13<I6D\TU^JGVK=RINXYJL^7QRX\Z[D\W)!L?=,C96[,
M3NF,WXR\<^''&+Z?$96DMNH!XV*D*4 >PUB:S3+4696W^9?T]YG:#5O2WXW4
MJY7[MC]QU#K'MG;>YXLOK'LK-QG\3.6P,MBGU^',9F.:6[(0>)4;:E(/D*DE
M2>6B[5J+MEK27H-25:/<UZ?3:=)WO26M1%ZVS-.+IFCO3P7XM>+55LA6P.DF
M\>H;@>Q<81,(DD/YJ9=N*D)]+0;7<4/(CWR*V>M[I9TN$G67Z5M_ U';NS:C
M6.L5EA^I[/5Q]*T.OGH_TA7L;<@Q^5?ESMNH+D[>(N8HEM-E9C-(2KPU@ C6
MA&H@J2->KA7._P"ZZS]Q#-%)3V0WTXO>OZX'5_[+H/VUQ1DV[>VYNJE6B6Q\
MTJO%8U/F4<J[<\Y/:$'3.D75F9T\R)@SRN3M&<X#.B#O*8<-AZPR/K@/33\,
M><"M'W7MD=5'-'"XMCX\GZ8'2=F[O+1SR3QMRV\N:],3['AS(F0B,3X#Z),&
M4VEZ-(:.I#C:Q<*2?/7G$HN+<9*C1ZG&2DE*+JGL9>JDJ% * 4 H!0"@% *
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M42]F=[9J%L*'N[!2,7FK/,(R,P)?88*'92(ZTLL:E+2XDKTE+K@TE/$=E&\
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M[(1HDQ&18\!;L6?I;9D,G4KNA;C:N/--P0#2HIN)H18D>2JBD4 H!0"@% *
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M#WA\*_-=Y[7UX]2VO.O^I?5;O8==V'N_[>72NO\ MRV?X7]'O]O&OUH1;_\
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M<6-0X@I3S"B*B@JC(=Z>RGMDY7;J\@U[8SF1&8R$Q+2DQDR5S&I3B&FM14$
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MH#*T)U:M(U>6W&@/: 4!S/\ W"?Z-_S2A))NG/\ +W:?[&QWZ*W0@DU * 4
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MRU_IO:OT_A\#J>WZ_J_V[GW_ /=^/%'U!C<*QC&3&QS,;'1KW\"$PAI OQ[
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ML5(=CNR\C)F3ERXZ_6W/&"3I7X9464>C>UR+6I:="XI*OK)9N[#37F,UN7J
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MI]Z3% 0^I*'"TE*5VX%12I;BQWE$US7;K$=2Y7KOF==_M_H;74W':2A' XO
MSBMZ[@Q<;J9G<M,Q,9#K3+T=(F3@5=]++22"3XBQ:]C;W*W<K?1@W9C%-^I>
M)A0?5DE<DZ>HZ-G^BNVY6Q,KO#:+.X,--PS2Y#F,W,PELRF6DA:U-V ([MR"
M#:XL16NM=PN*\K<\LE+?'<7IZ:&1RC5-<2ESI/TQPVRML;[W9G\C QN5C-.3
M8;"4/OR),AL+2W&L@%"4V4I9-^%J?O=1*[.W"*;B_8N9*T]K*I2;29I>IG2W
M;6THVW=W;>RTB7T[SSK33\I82])BH< 7XB#9 6"@+(2H A2=)J_H]9.ZY6Y1
M2N1]C+5^Q&W22?E?N);@^B.P-ZQ)4;:XW5BYK;1<@9K.14M8^6J^E(2DI!L3
MV"QT\>-8=SN-ZTTYY&MZB\49*TEN54LR?%[S.Z9XR _\WS=6*W).]DXU.0F(
MRDY""\64,K8*]"!;4HE.A(\IJWK)O]Y"4%5T5%[2NQ#+:<9<ZD/W/TKV)D>F
M\OJ)TORLV9$Q1*<I R@27"E"DI<X!*2VM.M*]/%*D\JS+.MO1OJU>23EL:,>
MYIH.#E;=:<?3 G,W;+FV^J/2)*L[E,VB4V]X2,L^E],9M$<$(9"4(LGO?"N>
M XUA1N]33W_+&-.&_'>7IQ<;MO%OQ\"ZQMES<75CJLZSG<I@W(4:,%'$/I8]
M8;<BDEM[4A=TW0+6L1QXU$KJAI[/EC*K_-NQW$QBY7;F+6&XM;!A=/#\WC(F
M?)F-8&0?_J>8RRCUQJ5XC)6VP2DZFTJT:=5^9IJI7OWBHEF7VJN%,=O,FRH=
M%)['M(5)VM&'0?([@PF>S#N(5EW&X&"<=2F \GUT,,N.,A&KQ%)*5*&JVKC:
MLY7G^\491C7+C+?LKMX&-D_L53=*[-VWVFR3T:Z?[<E8;:^^<AFWMXYIMM2W
M\0Q?&P%OJT(0XLH5J[PL2?=( XU:_P!PO7%*=M1R1_5M="ZM)!*DFZ\MWU,?
M;?S?VGMU;NQ6Y<A(>Q6U$M+0WBVT^O3T2FE/LE"5:@@E";6%[K[HJJ[W2EN$
MH)5GQV*FWTX%$=&LS4G@N&\YGO>-LF)DV&-D>U6XR6C[2B9U"6Y4>3J-D
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MG*"M3:7BRT>S0Q][%O=TWKMM';R68KE\3S#N5[JZB<N=/9@1^LLUPH!0"@%
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MVY')&!BRG;MVG&+SN1O]T]0-BS>H72O*P]P1'L9@VWTY>4@N>'%*F$)3XET
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MJ4;DGF2:[T\F;J>4(% * 4 H!0"@ !)L.)/(4!]-[6Q(PFWX&-MI<::!>_\
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M+ERWQ2E[,/F?5U<">EE)XJ ]^@*J 4 H!0"@+"_2-0#U%]0M0%ZI H!0"@%
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M0#6\>38'NG^J@%GSS4E/N"_]- /"4?2<4?<X4![X#?,BY\Y)H"H-H3R2![U
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MO%SWPI1ROY3>@*J 4 H!0"@% * I+C8YJ'T: H\=OX-U>X#0#Q5GT6U>_84
MN^>Q*?=)- >:'5\"Y9/F% 4^J@^DM1'NT!<#+2>2![_'^F@*P .0M[E >T H
M!0"@% * 4 H!0"@% * 4 H#FES_^0=K\/D;R_P#YI0DDO3G^7NT_V-COT5NA
M!)J 4 H!0"@,:4DV2L<AP- :XM+:47(_;Q6SR2KSCR&A)L83B%M$I-E7[R#P
M4D^0BA!DT H!0"@/";6'EH#WE0%-RH7O9- >)N0+*X^0T!4#?S$<Q0 D#WZ
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MV[TZ5FJNFPWY'@'4G\$?2'D/EK!-H7N?$4!X4@\>1\HH#RZASXCRB@/00>5
M>T H!0'A('.@/ ">*O>% 54 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#F
M?^X3_1O^:4))-TY_E[M/]C8[]%;H02:@% * $@"YY"@+38*U%T\N2!YO+[]
M7: 4 ) %SR% 8T 'U9*SZ3A4L_\ ,2: R: 4 H!0'@)O8\NPT![0"P'*@% >
M >7F>= 6"0EU1:[Q4!=(Y7'GH#W2M7X<\.Q*?1]^@+BFTJ2 GNVXI([#0&GF
MPR[*THLEU:=;E_0YV!OYZ$EZ%C4,J\5]:5*'HI2> OVWH#.):TEMM.HGL']=
M" U="REWBXH<%=A'DH"_0'ATJ)2;$CB10'M * \)N;#WS0'SOU$-]V2DV *&
MVDFWD"3;Z5=?VS_07BSSOOG_ ,N7@B;=.NGO@>#N'.M?WC@Y!AK'H=H<6#\+
MZT=G/GRU^OUU:VX;-[^1M^T]JRTNW5CN7S?R)MN_=^ V+@)6Y-R2A%QD4<3S
M<<</HM-)^$M78/?-@":T]BQ.]-0@JMG2ZC40L0<YNB1^=?5WJWGNK.XE9+(%
M4;"Q2I&(Q*57;CM'F3R"G%VNM?O#N@"O1-#HH::%%BWM?$\VU^NGJIU>"6Q<
M/Q.>UL#6B@/KCYNOSD+>J[!ZAS.[W6,+G7U<NQ+$E9^@AP^XKRUR7=.U;;MI
M>*^:^AV/:>[[+5U^$OD_J?6.1QT++0W<?D64OQ'AI<;6.'F(\A',$<JY6W<E
M"2E%T:.MNVH78N$U5,X!O39<S:<L*!4_B'U6C2R.1^L<MP"O_%V=H'7:35QO
MKA);4>==Q[=+2RXP>Q_)\_B=MV9_]J8?_P HU_X17+ZO_6EXL[OM_P#\:W_E
M1O*Q3/% ?/7SPO$_AWB"G\%[9:U^[ZK(M72_Q[_7E_E^:-+W;_27C\F?%5=X
M<L* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@)ETD_
MFAL[]L0?_;HK!U__ ,>Y_E?P,K2_ZT/%'Z45Y8=R* I6D*%B H=J3Q!H#Y-Z
M_.&%U*3(@+]7D,Q(KB'&24+0XDJ*2"+$*%@1;S5ZA_'(J6BHU@Y2/#_YE-P[
MDI1=&HQQ6U/$Z=TCZO?*QAO 9V6AK=+8LPMU 0W,2!S!219P =Y/"_-/:!S/
M>>R2TS=RTJV_^W\/1G:_QO\ DT=9%6;[I>6Q[%/_ /EQ7K7*;;ZV7BM_X)W!
M;CA$HXKBSH]E/1WK6#C=Q?W1\(<*T>CUMS2W,\/6N)U>OT%K66G;N+P>]/BC
MX:W]L+-]/<\[A<NV5-$E4&>$%+,EF_!:+WL?KDWND_1KU30:^WJ[>>'K6],\
M;[EVV[HKN2>S<]S1%JV!JBIMMQYQ#+*%./.*"&VT J4I2C8)2!Q))Y"H;257
ML*HQ<FDL6S[%Z&=%!L^&UNC<,1M>[WTWCH>.M,!M0/!*1P\50/?5\'T0?2OY
MKWGO#U,G;MO^VO\ J_#@>L]B[%'2Q5VZJW7_ -/X\?8=+WEO6%L3#+S&:6AY
M![D6*R0AYYT\DI"C:PYJ/8*T^AT-S5W5"'K>Y(W'=.Z6>WV'=N>I;Y/E\^!\
M=[PW?F-[9I[-9AS4ZON,,)OX3#0/=;;!Y ?3/$\:]=T6BMZ6VK<%XO>WQ9\^
M]R[E>U]YW;KQW+<EP1]==*%*&P-NH&I;2H+:DK(Y*!(4GAY^5>4=VK^\NU_4
M>]_Q^G^W6:?I1-CQX'E6J-Z64W95H/X-7HGR'R4!>H!0'A2#Q' ^44!Y<CTA
M<>44 *T@7O0'@<!]WR4!Z!QNKG_10%5 * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4!S/_ '"?Z-_S2A))NG/\O=I_L;'?HK=""34 H"A;K;?!1X^2@*%+
M#Q#:#W>:SYO)0%[EP'*@% * L3%^'%>5VZ2![IX#^F@+C2/#:0W]8D)^@+4!
M70"@% * 4!X4W-[D'S4 (OPH"@N(0=*!J5]:/^- >:%N?A#9/UB?^)H"L)"4
MZ4=WR6H#QM2B"E8[R>!/8?/0'I2!Q!T^7R4!BPSXGB2EC\.KN^30G@G^N@,G
MPFCQTCZ% 5  < +#S4!XM 6G2?>/D- 4H6H'PW/3'(]A% >MHT DFZU<5&@*
MZ I)).E//M/DH#T  6% 0UG942;O"9N;(:7FVRVW#BD7 <;3Q6ORVOW1[]9Z
MUCC85N.&+JS42[=&>J=^>*HJ+FM[^1NMU;JP6RL%+W'N.6F'BX:=3CBN*E*/
MHH0GFI:CP2D<ZQK-F=Z:A!5;-A?OPLP<YNB1^=G6#K!GNK6>,R851-OQ%*3B
M,2%70T@\-:[<%.J'I*]X<*]$T.AAIH46,GM?IN/-M?KYZJ=7A%;%Z;SG%;$U
M@H!0"@/K#YNOSD/4O4]@=0I7]R[K&&SKZOP78AB0H_ [$.'T>2N[Q3RG=.U5
MK=M+'>OFOH=?VGN]*6KKPW2^3^I];Y6!#RD!^#/92_$>3I=:5R(_X$<P:Y*$
MY0DI1=&CL+EJ%V+A-53/,1CF<1C8V-CK6Y'C(#;2W""LH'*Y %S:JKMQW).3
MVLHL659MJ"V1,VK1?% <&^=O'\;I;'=M<Q\M&<OY II]O_TJZ+L#IJ7SB_D:
MCNJK9]9\/5WYR8H!0"@% * 4 H!0"@% * VNVL7C<UG8>*S&89V_C)!7ZSF)
M*%.M,)0@KXI21<JMI3QM>UZM7IRA!RC'.UNXERW&,IJ,I94]YT#='27;K&Q)
M743IWN\;JP6*?3%S3;L54-YDK4E 6E*K$BZTW!3R-P>=:RQK[CO*S>MY)2Q6
M-3.NZ2'3ZMJ>:*VFVP?1#9&[A(P>SNI<;,;[8C&6G')A.-07-(!*$O+()M<7
M()([4\ZLW>YWK-)7++C;K2M<?87(:&U<3C;N9IKV>GK-+M/I-B)NTHV]NH.Y
MODEA<G..*PS:(QF/OR$K4VM:@" EM*D+%_[))MPO?U&OE&Z[5J'4E%5>-*(H
MLZ)2@IW)9$\%XD4ZA;'RG3C=LS:67=1(?CAMR/+:!2V^P_\ @UA)XI/-*AV*
M!XUFZ34QU-I7(X5W<*&'J+$K$\DO;QJ:S<.WLSM/,RMO;AC>IYF%H]:C:T.Z
M/%0'$=YLE)NE0/ U=M7878*<'6++=RW*W)QE@T:RKI0* 4 H!0"@% * 4 H!
M0"@)YT48,GJQM%L"Y3DF7/>:)<_]&M=W)TTT_ S-&JWH^)^CU>7G;B@% ?('
MS@'0YU+G('_2CQ4'WV@O_P!*O5OXXJ:*/-R^)X-_,95[E)<(Q^!S-IUUAU#[
M"U-O-J"VW$$I4E23<$$<00>1KHVDU1[#CXR<6FG1H^I>CW61&Z$M[:W.ZAK<
M*$A,24;)3, '(CD'1Y/A=E>:=Z[(]/6[:7DWK]/X? ]H_C7\F6KI8ONES<_U
M_P#\OB=!WOL7;^_\&[@]P,>(T;KC24V#\=ZQ <:5V$>0\#R((KGM'K+FEN9X
M/Z/DSLM=H;6KM.W<6&[BGQ1\*[^Z<[AZ?;B.!R;2GTO*_P#ALQE"O#EMD@ H
M''O<0%(XD'R\"?5-#W"UJK>>+I3:N'IQ/&NX=LO:.[TY*M?M>Z7ASXK<?1W1
M;HB=FQXVZ=S,H=W3,TB'#<3J3 0H%5R>/WX@6)'H<AVUP_>N[O4/I6WY%M?Z
MOP^)Z'V#L:TRZMU?W'L7Z?Q^!TC?6\H.TL:N?F5AMMON1XC2KKD/6N$HY>^3
MP2*TFBT5S5W%;M^M[DN+],3?=R[E9T%EW;K\%OD^"^? ^1MU[KRV\,LYE<JY
M<\4QHR2?"8:OP0@=@\IYD\37KNAT-O26E""\7O;XL^?.Z=SO=PON[=?@MT5P
M7IB:.L\U1]M=,5>J].MKI*2?%BLCW/$NJ]>-=W==9<_S,^C?X^J=OL_Y$32M
M4;X\4D*24JX@T!;0HH5X2SQ^ KRB@+M * 4!9<%E5 /$WN+<Z OU(% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4!S/\ W"?Z-_S2A))NG/\ +W:?[&QW
MZ*W0@DU >$V!/DH#6DE1)/$GG0DK944N)MVFQ]^@-A0@4 H#%F]Y+37XQU((
M\P[Q_HH#*H!0"@% * 4!0IU*3;TE?6CB: ITN.>F="?K4\_?- 7$H2@62+"@
M/: 4 H##EK=T>KV&M\Z$*'D/I?0% 924I0E*$\$I "1YA0#3VIX&@/"L(_"6
M \M >J)*;MV)[+\J H\&Z3J42L\=7D/FH#UM9)T+X.#Z8\HH"HDWTIY]I\E
M>@ "PH#V@(]GMT8/9N,RV?W#+1#Q,$)=>=4>)*DV"$)YJ6H]U*1Q)J[9M2NS
M4(JK9:O7HVH.<W1(_/GK+UDS?5O/>L/!4/;4)2AB,5JN$)/#Q7;<%.J',\DC
MNCM)]#T&@CI84VR>U^FX\U[AW">JG79%;%Z;SF=;,U8H!0"@% * ^I?F[_./
M]C"-L+J%+*L.2EC#YIY5S%N=*67U'_H_6K/X/D>YZ'+=T[5GK<M+'>N/-<_C
MXG6=I[ODI:NO#<^')\OAX;/LIF^@))OIX7\H[/I5QIVY<H!0')/G+07<AT>S
MZ([1=D1 Q.2E(N4HC/(6XHCR!&JYK<=FFHZN%=]5[OJ:[N46]/*F['V'P!7I
M)QHH!0"@% * 4 H!0"@% * W^RMG9C?^YH.U,$&QD)I4HNOJTM-,M#4XXOM(
M2/@IXGLK'U.HAI[;N2V(OV+$KTU!'T#U;Z>;IV'TN7L?9V(ML>(MK([JW(_)
M83*R<M:D)2E+"5%24!S1P/D2.PJ5S7;]7;OZGJW)>=X1C1TBO$WFKTTH6';M
MKR[7S],#=[/Z+[YZ5;2DY7;&+9S/5;.QU0S+5(98B86.X+D-EQ0+KE[74D6U
M ?!'?Q]1W*SJKJC.66U%UI1UE]%Z>%ZQHY6(-Q59M;>!#5;0R_5?HKLW:VTB
MQ(W-LW*R(&X<:I]IMQD+=<29'>4-2!=*KCG<VO8UG+41TFKN3N5RW(IQ?R,>
M=B6HL1@J9HO'D8_6K??3I[JA*9RNW$;TBXJ# Q3$IK(O0$-2&7'''N]'"@X;
MN)2;\BDBKG;=+?6G3C/IN3<OM3PW;=ACZZ_9=_S1STHMM*.O]# ^<?FMGJW]
MNC#-;3\+=H7#*MT^T'E:AZNTO_"6\,=S[WS\_.KG9[=WH0EG\F/ERKB]^TM]
MQG;ZTHY/-AYJ_(X;6_-4* 4 H!0"@% * 4 H!0"@.N?-FQOM#K#A'"+H@MRY
M:_\ ECK0G[I::TO>IY=++G1>\V7;8UOKE4^_J\X.Q% * ^*>L4OUSJ7N%V]P
MA]+(_P#U#2&K?<U[!V2&716URK[6V?/'\EN9^Y7GSI[$E\B#UNCFRIMQ;2TN
MM**'$$*0M)(4E0-P01R(J&DU1DIM.JVGU#T>ZS-;A0QMC=3P;SZ0&X4Y9 3+
M[ E7D=_\?N\_-N]=C=FMVRO)O7Z?P^![-_&OY.M2E8U#I<V1E^OE_F^/B==F
M0\9*DQ?7HC4AYESUB(X\VESPGFQ8+05 Z5@'@1QKDHSE&M'2N#YH]!G;C*F9
M)T=5R?$U&^-U8?9^"<S.7>T!I0,1A)^^/OCBEM [2>T\@.)X5E:/17-5<5NV
ML>.Y+BS [CW&SH;+NW7AN6^3X+TPVGQSO7>F7WUFG,QE5!(MHBQ4$^&RU>X2
MF_;Y5=M>N:#06]';R0];WMGS]W7NM[N%[J7/^%;HKTVO>1RMB:<4!]U;'B-L
M;+VU%7Q6QCH:K7L0KP$W-O=)KQ/N$LVIN/\ Q2^)]+]IADT5F/"$/^U$DK!-
MH* I6@+38\#S!\AH"EM9-T+X.)Y^<>6@+E * \(!YT!YH'9P/8: ]!OP/,<Z
M ]H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@.9_[A/\ 1O\ FE"23=.?
MY>[3_8V._16Z$$FH!0&*Y%))+9%CV&A)4S'T'6LW(Y 4(,B@% * Q7._.81^
M+0MP^_9(H#*H!0"@% 4+=0C@>*NQ(XF@*;.N>D="?(.?T: K2A*!9(M0%5 *
M 4 H!0&*W]^F+<YH8'AH^S/%1][E0&0I"5BRA<4 0A*!9/+Z- /#;U:BD%1[
M30#2.8X&@/%+4D<1Q[#0%I9*QSLH>BKR&H!<:7<:5"RQS\_GJ07* P\F\MF*
M2V;*40FXY@&@/C3YXCN11D-I,^L.>R'HLIP1 HADRFW0DN%/(KT*2FYY"NO_
M (\HTFZ8U7LH<;_(W*L%7#'T]Y\QUUAQPH!0"@% * 4 H#[B^:#O/*9G8N5P
MF4D/3UX&8VU!UGQ'&XDEO4ANYXZ4J0O3?D.'( 5PO?+$875**IF7O1Z!V&_*
MY9<9.N5^[TJ?1K2W%(U.H\(WX)N%</>KGCHRVVY*UZ7&DZ#_ -1"[@>\0#0$
M:WEA?E5L[<^+])S)XZ5$BI'/O-*"#;SKXUDZ6[T[T)\&BS?AGMRCQ3/S2M;A
MY.%>L'!"@*FVW'5I:90IUU9"6VVTE:U*/()2D$D^Y1NA*3>",B?B\KBE-HRV
M/EX];M_"3,CNQRNW/3XB4W]ZJ8SC+[6GX.I,H2C]R:\4T8A(2"I1L!S)JHI/
M: R86.R63=+&+@R9[Z1J4U$9<D+"?*0VE1 JF4XQ59-+Q="J,92V)OP53&4E
M2%J;6DH<;44.(4"E25)-BE0-B"/(:J*10"@% 5(0XZM+32%..K(2VV@%2U*/
M()2+DD^04;H2E5T1Y=:";%;3@N#I*FU@CF#:Q'G%"/=[AXCQX*?=4.U*G7%
M^\5$4PX(8\7[67HS62FR$1(/KDN6Y?PX\=3[SJM(N2$())L.?"H;BE5T2]1*
M4FZ)R;\9%@*4VI3B%K:78H<4E2FUV^$%$$'W0:J*:TQK3W%]>-GQ83$YV!(8
MQD@Z8LQ;#C<=PGC9#BDA"K^8U3G3;557QQ*LC23HTO# KC8W+3V7I<.#,G1X
M]_69+++TA#=A<ZW$I4!8>4U$IQBZ-I5\$3&$I*J3?M9CLM/2'$M1FUOO+OH:
M:2IQ:K"YLE()-@+U+:6+(2;=$5MQ)3T5Z<RPXY!C*;1)E(25--+>OX:5J' %
M>E6D'G8T<DG1O%A)M56PH2VZM#CB&UK:9 +SB4E2&PHV!6H"R03P%^=344?L
M*W(DMF/'EO,.-Q)?B>J2%I(;>\%6ESPU'@K0HV5;D:A23;5<4*-)/<RU4D"@
M/74KCJ2B0E3*UI#B$NI*"I!&H* 4!=)'$$<*+'8'@Z/ NRX<R ^8L^.Y$E)2
MA:F'T%MP(=2%H44JXV4DA2?*#>HC)254ZHEQ<71JC+-20* 4 H#Z5^9SA3(W
M3N'/J1=$&"W#0H\@N8[KX>>S!^C7*_R&Y2W&'%U]G]3>]HA6<I<%\?Z'V+7$
M'3"@% ? NYLA[6W'E\IJU";,D2$GS.NJ4/I&O<=+;Z=F$/TQ2]Q\PZZ]UM1<
MN?JE)^UFKK),(4!Z"4D*2;*!N".8(H#Z&V%U\QR<&Y!WVIQ62QJ/$@S64%2Y
M8;'=;5IX!SLU&R5?"(/$\!W+^.2=U2T_VR>*_3S\.6W@>L=F_F4(V'#5US06
M#2KGY/\ Q<W1/?3?Q[?.^,QOS-+RV45H93=$*$@DM1VK^BF_,GFI7PCYK =;
MV_M]O1V\D-N][V_38C@.[=VO=QO=2Y@ORQW17UXO?X42C-;(TPH#U"2M:4)!
M*E$  <R34-T)2JZ'Z XV%ZE%9:5I\1MIMKN"R4I;2$A*;]E>$SEFDWQ9]36X
MY(1CP21F507!0"@*'$:K*3P6GT3_ ,* -KUCR*'!0\AH"N@% * \(OQ',<J
M W]WM% >T H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#F?^X3_1O^:4))-T
MY_E[M/\ 8V._16Z$$FH!0"@% * 4 H#%9[\R0OL0$-@^]J/]- 95 6WW"VW<
M<SP% 8)4HFY))\M"3(96XZ-&JP',]MJ R$-H1Z(X]I[:$%5 * 4 H!0"@+<A
MT,,K=/P1P'E/8/HT!3%:++"4*XK])9\JE<30%Z@% "0.= 4ZK^B+^?LH"E25
M*%^WR4!0$*)M:U0"B0ZTUI\182X/0MQ4?^4<ZD%"'Y4GNM(# 'I*<XJ]Y/\
M70%1Q[+B3XZE.N$6UJ/+W!R% ?,/SR]NJ1M#;6:!"Q!R3L0JM8A$U@K%_?8^
MG73?Q^=+LX\57V?U.7_D4$[49<'3V_T/C6NU.$% * 4 H!0"@% ?27S,L^(.
M_<UM]QS2WE\<'FD]BGH3@(^X=6:YKO\ ;K:C+]+^/HCJOX[=I=E#BOA_5GVX
MMQEL_?7$@]FH@?TUQ)W):E/!;0:86%+?/AI*3>P/,\/(* K,5L:%-]QQM.E"
MQ];:UCY10'YM]4]N':?43<N""/#8CSWG(J +!,:0?'8 ]QM:17JFAO=6Q"7+
MWK!^\X34V^G=E'G[MJ]Q$*S3')GT@_FOLK]KQOZ36#W#_P"-<_RLR]%_KP\?
MDS:;!D[@W)A]ZXK)/R\KMHXYSPVY+CDAMO..26V\9X"G"0B0XZK1W3=2"J]P
M*LZM0MSMR2495W?IIYJ\DO?0OZ5SNQFFW)4:QXU\OK)MMO9^U,?N3:V23C(:
M\GC-Y1=L9:##>G2,>7'V7%W<<EV\5]A;2KEK[TOM%K$X%[4W96YJKH[;FFZ5
MV\MB==^*,Q:>U;N0DECGR[738]M=ZIZ8&AV7L[;FZ<M#&<PD7%8G=N5EXO#%
MJ5D'9X7&2$NKB)1K;2EIQ25.+DFQU:0-(N,C4:FY:B\LG)PBF\(T]?JX%%O2
M0N2\T<N9NF+KXKU\31].EMIV3U%1+S#^$CZ<,EW)Q&W'G I$YP) ;:6@G41]
M=85DZQ?W;5(J7W8/_*C%T+I"[667[<?6S?Y-6S][Q$[H?B/NY#)YG&[,AYG)
M/*84E(Q[:%Y28VTHA;Y5]]TE93]<56XXT.K8>1-4497&EC^;[8\MQ?ET;R4V
MFVY*%=CV?<UOXXE,'86U-U9G/;9@XV1M8[<R\#%(S#[[DAR0W-R(QZD2T/$-
MB2H$OM>%H3W2FQ3W@EJ[MJ$9MJ>>+=*4I2.;"F[<ZDQTEJ;E%)QRM*M=M73&
MN_\ H:K#8;:&X,UN2(K!IP,/9\&9-7&E2IKDF6IB0W%0F<4!Q:0T5EU[U=I)
ML-/='>%ZY<NVX0>;,[C2P2HL*^7QV*K+-NW9G.4<N7(F]KQ\?3@9>+P73'+9
M08_"KB9/<>4C1&\9B'I.08PHRCCKK4F,S)*&WO$<2&5Q?&^]I4I25*) JB=W
M4PC655%-U=(YLN%&ULIMS4Q*X6=-*5%B\,*O+7>OIS+FU=KX&>=I2, PHS\?
MF,3%WG/$J3&S6.FRYY8LVA)#7JRNXAEUJ[B%\56)%1?OSCG4W@XR<%1.,DHU
M\:\4\&B+>GA2+2Q4HJ3KBFW[*8I*F.)D8W:.R9.5V5A,EB9,R?O>3EHTW*F:
MZAR,IK)R(C#S"!W5.)\-*G"YJ"^5@2553/47E&Y*,DE;472FWRIM/\-A<6GL
MN48R3;FY*M7N;+&V]F;2?R^SMJY##/91S<6(7G)NX&I+S12OPI#@;80W][#+
M):"'M0U%=^(L!55[4W5&Y-2RY)9<M%RV[ZO<4VM-:;A%QS9EFK5_TI\36=)A
MB\?A<WN3=$QZ%MS(KA[;<EP5*;EL3'UB>VZIUNZF8_\ =]#Q2"I25$)!(J[W
M#-*<8059*LL=C7VTYO'#WEOMZI%SEL=(\^/J1F9' I1UAVZOJ&N*B=N7,(R.
MY\6T$B#%9DSE(91XH40IM]"4N:K^@H7XDU1"[_[6?1K2$:1>]T6/LV>(N6J:
MF/4_/*K5,*;O;@>;;S.[\MO?=>,WF_*<QKD#-C>$"25*C16(T=TLJ#*NXT67
MDLB/H L=*4\Z7K=J%F$K=*UAD>]U:KCOJJU*K<[L[LHW/MI+,N"IA\C6]3,I
MG</N"-A<;,E8_:K&.@_)F+#=<8B.X]Z&VHOH#12EQ3RE+4\LW)7J!Y6J[HH0
MG!R:3E5YJ[:UV<J;BUJYRA/+%M1HLM-E*;N/,R^DWB[>A9_J"Q/AXB=B_5,3
M@9N1*T1_79KH>D)26VW#J]49<1Z/#Q*HU]+CC::<E*LI);:+!?\ 4U["K1)Q
M4KB:35$J[.+]QLMUX*'MS ]48&)4%X&3E]N9/#.MW\)>.R(ER8Q0>T!"](]R
MK5BZ[D[+E]RC-/Q65,N7+:A&ZH[&X27"CKL-KTSQ>.C;5Q6W,IE8..3U*=G-
MY*),4XF0]"\)4'$K:2EM0[DSQ'05*3R\E6=;.3NRG&+?1I2FROW3_P"FB+VC
MMI6U%M+J5KQILC]36PMLLR=C[=&XX3\M>U,7NC)/85M2FER9$7*,,*96I'?2
MALK+KVCO:$'ES%V5]J]/(TL\K:KPK%X_)<V41TZZ<%--Y%-T_P")8/TW&*-I
M;3?P,/>:<&^VRC;<S<4K;S<E\HD/M95..;LM=W4Q4)5XZPE6K3PU?"JO]Q=4
MW;S+[U'-18>7-X9MQ;5FTX*YD?VN66KQQI[-YZG;.QV]M/[]E8!TQ5X%G,M[
M:]<?0RW*&7]F$AP_??57T_?4I*M7 @*[:=>\[BM*2KFRYJ+9DS>&9;/D.C85
MMW90=*5RU?&GL>VAM\RWB,5L3=:I>+.8<<V[M"2F1D)+[KK!FHX(97JNAIM1
MNA"2!8!)NGA6/;<I7H4>7SW-B6-./-F9*,59;:;JH;W[C&WUCL%G,YNV'(QZ
MV]P83:^*S;6<#[A4XY&AP&RRIC\&&E-NVX#4%#5JXVJYI9SA"#3\LIRCEIQ<
ML:[:X&+J(VYW9QIYU!2S5X);BWN/;?3W#S>HD*'MIU?R"7%?AN/9"03,$B0U
M&<:EA) \(%S6@-:%"VDJ-[U-F]?FK3<U_=K^5843>'/QJ3=L:>#GY7Y*;WC7
MUEL[+V8-TY+;N.A-O9S*Q<3-VIA,K,D-1=&4A"2]&;DLA),E*UI3'+Z@@IO>
MZJ?N;W34V_+%R4I)*OE=$Z/=3;3$E:6SG<:5=$TFWOY\:[*G( "+I5<*22E0
M5P(4DV(-NT&MX:5'M02?<GS3]N'$=,U9AU&E_.S79*2>!\!BS"!]LA:A[M>?
M]^O9]1E_2OQ.L[7;RVJ_J9W:N>-N* T&^,L,%L_.96^E<:$\IH\OOJD%+8]]
M1%9V@L];40AQDO9O-7W74?M])=N?IB_;3#WGPA7MA\T"@% * 4 H!0"@-WLV
M <INW!XX"XDSXS:A_9+J=1]X7K#UMSIZ><N$7\#8]LL]75VH?JG'XGWG7B)]
M-"@% * 4!;<20?$;](<QY10%2%!:0I/(T!50"@% 4D'TAS_IH!K3Y: J!!XB
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@.9_P"X3_1O^:4)-IL'+)9V+M9I
M+14VC$0$ZB;$VC-B]K4!-&'VY#8=;/=/EY@^0T(+E * 4 H# >R7A.J;\.^D
MVOJM_P *NJW5%B5VCI0M^UO^U]U]2JND1UN1:9R'A>(2WJ+BRLF]K7[.794=
M+F.MR+OM;_M?=?4J>D.MR*'<EXJ=/A6XWOJ^I4=+F.MR+/K?]CZ=.ES'6Y%U
MG(!J_P!ZN3VZK?\ "G2YCK<BY[6_[7W7U*GI#K<A[6_[7W7U*=(=;D/:W_:^
MZ^I3I#K<A[6_[7W7U*=(=;D/:Q_%<.WO?4ITAUN19=G^*H*/B( %M*%Z1[OH
MWJ.ES'6Y%:\EJ;\,(4G@ %A?>X><BG2YCK<BSZZZK0'3XB$+"P#8$VY V'EI
MTN8ZW(R?:W_:^Z^I4](=;D/:W_:^Z^I3I#K<@<L3R:M[_P!2HZ7,=;D>#*#G
MX-SYU7_X4Z7,=;D>^UO^U]U]2IZ0ZW(>UO\ M?=?4ITAUN19=R+SJK EMKM"
M#91_YB#4=+F.MR/6IK+-RW'LH\U%5U'WR+TZ0ZW(J<R(60H-:5CDH*[/)RIT
MN8ZW(K&6(YM7_P";ZE.ES'6Y'(_G,QQG>C.?4&OOV,7%GM\;\&Y"&UGEV(6J
MMMVG^WJ8\ZKW&I[M_=TTL-E'[S\^Z[\\Z% * 4 H!0"@% 3CH[N?Y']3MLYU
M;GA1FYJ(\Q?8(TN[#M_<2N]8'<+/5T\X[Z>]8FR[;>Z6HA+G\<#])'9,.&HM
MH:\=X?A'%\3?W2#7F9ZD>1RB6\X]& 8?;2/#0+6/EU<.WE0&T8=#[270+7YI
M\A' CZ-"#Y ^>%M$Q-PX7>L=NS.2CG&S%)%AX\4J<;*CVE2%J \R*[?^/:BM
MN5I[G5>OT]YS/=[5)QGQ5/8?-%=4:(OP9TW&38^2QLA<3(1'$O193)TN-.HX
MI4D]A%4RBI)Q:JF51DXM-8-&QS.[=T[B0TUG,S+FL1W/&886YH:0\1;Q$MMA
M"=?]NU_/5NW8MV_MBD7+E^Y<^Z3^'P+F2WKO+,*:7E<_.EK8>:ELJ<>-T2F
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M09#GLIEY<IF#J^\ID.I2A;H3]<4I2DGR"KN59LU,=E>1;S.F6N' R7\]G),
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MSD<3J45*]<AC4A(O^,!+?_-6Q[;JOV^HC-[-C\&8>LL=:S*._=XGYX<N!KU
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M0"@% * 4 H!0'U=\S;>2 [G>G\U(>U#VQBFUD#O#2U)0G5VD>&NP\BJY'O\
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M$MBZC[@H"VF4VHV-T^<T!47;G2T-2NT]@H#22[^LNW-SJK*AL1A3^YD*ZC;
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M8T;4?*GP;)I6 ; 4 H!0"@% * 4 H!0"@% <VZ^;3.[^E.=B,M^)D,6E.9@
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MTZ[J_#XHUG\==T(P;74)[:3">F;T[U!+XE$Y71J*/&T?@[7!&FW/A?X57?\
M:K6?H]1]6E=GE\./IZBU_N]U6NOTO[6:FWS>/#\>6)<SO6O>$3);PBX#;$'(
MXS:#C;LK(NRG&PJ"Y8)5X=P2XJ^H:38 '@>%1:[9:<;;G-Q=S=3>57NZW8SN
M*%M25K%O-N\/>;+;?63.Y3=NVL5FMLM8G;N\F''=ORTRO6)7<!L7@FR;*(M8
M)20% W/&K5_ML(6IRC/-*W]RI1>HNZ?NER=VW&=O+&ZGE=:OU^F\B.P>J$7
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M6O/%KVNINV-YX+%2L$Z]FL>G)8>9N54=YG(O9E34:;AE-PU.RI.K679 '=0
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MU.:[.LUD>"QHZ<5[_%T\2"[!W3#V9!W+FH\I*LLQ)P[F&CN MO3&XV1,AXA
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MV4&DCBF.V?K$_"(])7'D$V\X[GW!ZJ>'V1V?4[#1:16(X_<]OT.K5IS8B@%
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MW=VAJ$HS\L_<_#Z'*:S02LO-'&/P.+UOC5"@% * 4 H!0"@% * 4 H!0"@%
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MYI>.Y?/V'JG\,[=EA+526,O+'P_,_;AZF=KKC3T<4 H!0"@% * 4 H!0"@%
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MST%['9)@D.QI""A8L2+CL4DVX*3<&NSMW87(YH.J.<E"4'22HS JX4"@% *
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M3?4#V=NW$MS&0#X+Y%GF21S;=1923[AL>VLO3ZJ[8E6#H6+UB%U4DJGS!O\
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MNE(!\PH#FO\ N$_T;_FE"23=.?Y>[3_8V._16Z$$FY<30%([QU'EV"@*J 4
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MWBA.8R\;L%O!3(TK 9F;CTB/"B9.. P\U-1CFDLM.+#K9\-PMI"%K;TW2!Y
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M4H)',D >_6Y.<;H=LZQ3#L7"8GI3@FTL8I<1N=EI.D%R6\ITBZB;D=]K6?\
ME2+)3:N-[+#]W=GK+F,JN,5^E4^CI[7M9Z-_);G^WV(=NLJD,JE-[Y/-]8U]
MB5$J'%V(LF47!%9<?+2%/.AM)7I;1Z2U:0;)'::Z^4XQVNE3SV%N4ZY4W15=
M-R6_P+55E H"8]-=E.[WW&U#<"DX>):1E7A?@R#P;!X66X>ZGWSV5J.ZZ]:2
MRY+[I81\>/@OPWG0=B[4]?J5%_9'&;Y</&6Q>M[CZV0AMI"&F4):9;2EMII
M"4H0@62E('( "PKRIMMU>T]Z244DE1+8BJH)% +'G;A0"@% +6H!0"@/;'R4
M(/*$GBDI6DH6 I"@0I)Y$'@10&O1@,&VUCV&\='2SB4J1C&PV-,="VRRI+8[
M 4**"/)2@J:MKI]LIB%*QK&$C-0)JFUR([84E!+*BIO2 H: DDZ0BP%11$YF
M7IVR-H9*+"A3,+$<BXY);@-I;#?@MFUT(*-)"56&I-['MI1#,RXYL_:KN4]M
M.X:(O*@LJ$I30*PN,06ECL"T:0$K]*PM>U*(59<E;5VY/Q/L*5BHSN(#JI"8
M9;'AH?6M3I<1;BE96I2M23>Y-*"K+D3;F!A-*8B8YAIMR*C'N)2FY7#:UE+*
MB;DI'B+X'RFE"*B/MS"0X$O%L0&T8W( IF12"IIQ!:2QH*57&@-H2V$C@$BU
M*"ID2L7C9N-<P\R(S(Q+S7J[L)U 6RIFVG04GA:U2*FMC[*VA&B*@M8.%ZHL
MM*=:4RE8<5'OX2G-5]:D:C92KFHHB:LK@;0VOC(C,.!B8S,9B2F>T@(!(F(%
MDO%1NHK X!1/ <*4%66IFQ]H3XD.#+PL1<7'E:H+8;T>#XJM2PA2;* 63=2;
MV5VTHAF9<3L[:B,JO.)PT09=;J9)F>$/$#Z$Z XD_!60;%0XGMO2B%65P=J;
M:QCH?Q^*C1G4OORVU-M@:'YB0E]:!R3X@'>T\Z4%68\/8VS<>S/CPL%"88R;
M:F)S2&@$N,JO=HCL;X^@FR?-2B&9F9D-N8'*^)[1Q[,@NQ_45J6GO&+K2YX6
MH6(2%I2KW12A";,G&XS'X:$UC<5%;AP& 0U'93I2+FY/G)/$D\2>=2&ZFRA_
MXIK[*J9["N'W(WU8AFB@% * 4 H#F?\ N$_T;_FE"23=.?Y>[3_8V._16Z$$
MD](_V1].@*J 4 H#'DO+3I99XR'>"?[([5'W* TS[8:>6VDDA)M<\2?/65#8
M84_N9KI.7QT/(X_$R7O#GY7QACVM*B'3&1XC@U 6!">]91X@&W*JRBA'IO4/
M;9VZ,WB<G'=$MF>O&.R$/^ M>,0XI]3H;07$MM^$K6=/+E>XO%2K*ZD=SW5K
MU7'[P;QL0M93:T:/(]<DM/\ J#P>0TXXK4I* E*0YW0576.\.%0Y$J&SF3C"
M;JP6XI<R#C'G/7('AJDQI#+L9T-/W\)U*7DH*FUZ5:5IX&QJ4REIHC6T^IF+
MRC+$;-OAC+2,E-Q;:VH[Z87CL2W6F(Y?*2T'EMH2=&OB>'.PJ$RJ4:&5$ZBX
M1O$8^7DY2).0R'K:VHV'CRYBE,PGU,N.):#7BA#=@EQ2D :N O<4J1E,B3U(
MV;'3'4WD%SE2X2,K%;Q\=^:MR M13XZ4L(6="2#J\E35#*S5.]4</#S\QN7*
M0[M=.'@9F#-AL/REJ8E./AV0LLI79A"4(.H@6X^]&8G*Z$BE[QP$*=$@R'G@
M)Q91'G)C/J@%R40&$&4$%H*<) 0-?$D#F14U*:,PW.I&RV5R4N9%0$.8G%R'
M!'?4VG(+=4RF,%!!"G2M!&A-SR\HNJB<K+<7J=LR8_'C-374O/R1CW [%D-)
MC3E$!$:4I;8##JR;)0X03<6YBZJ&5FTC[JPLC-';X6^SDR'3'3)C/QVI/JY
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M\/3(C* MPXBE"<VSP-?A>GVYHN\<5N7,2HDI>-D9)<C(>/)=ES&IJ%H8^]+
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MI7U?N6/ [W^,=A6I?[B\JVXORI[)M?&*W\7AN:/HTDJ)4HW)XDUY\>O-U/*
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M=$R)D7DRLDYA,4_GI* E*5Y,+D-%>E "1J0FW >BE-2MI2]A-ZJ*10"@% *
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MAU)YDAM*$J3\'@1VUK)Z%2U,;S>Q;#<6NX9-+*RE1M[?K[*>!*_FK;'EY[J
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M4+:S?3C9V<D1\AM0NN,1)K9;3)?U*"G' I(7;6I:;HMHU<4G@*L1U.HT5_\
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M<M*-O0<MYKUVND[A:U"\K\W#></K.VWM,ZR58\4<^K8FK% * 4 H!0"@% *
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M]VG^QL=^BMT()-0"@% * 4 H!0"@+3@[UZ@%*05&U 7=/G/T:D#2!Q*C;W:
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M7EN7J/4^W]KTVACELQ4>+WOQ?HB05@FT% * 4 H!0"@% * 4 H!0"@% * 4
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M>K]K[M;UD*;)K;'YKE\#P7OG8+W;KE?NM/[9?*7!_'=O2@5;PY@4 H!0"@%
M* E&V^G.]-UE*L-B'G(RO_>W1X,>WE\1S2#_ ,MS6MU7<]-I_OFJ\-K]B-UH
M>RZS6?Z5MM<7A'VOY'9=K?-ICME$G=^3+QX%4''W2B_D4\L7/_*@>[7(ZO\
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H#F?\ N$_T;_FE"23=.?Y>[3_8V._16Z$$FH!0"@% * \)MP'$GD*  6]T
M\S0'M 8<K),1E^&05N#F$]GNF@*$S#. 9C7;)XNK/-*?-YS0&8TTAE ;;%D)
MY"@*Z 4 H!0"@% * 4!X4@\Z 6%K=E -(M:W"@/$GL/,4!50"@% * Q4_?9J
MU_ 83H3]FOB?I4!E4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4!KLG@,%FDZ,SBXF11:VF6PV^+>2SB55<A=G#[6UX%N=J$_N2?BB$Y+H'T=R
MI496T(+97S,4+A\_)ZNINU9L.Y:F.R;^/Q,"?:]++;!>K#X$3F_-*Z.2B2Q#
MG0K\A'F.*M[GC!RLN/>]2MZ?J,278M*]B:]9HI7S+^G+BB8N9S+ ^M4Y&<'Z
M.DU?7?[V^,??]3'E_'K&Z4O=]#7K^91M,G[WN?(I':%,L*X^\!5S_P"P7/T+
MWEK_ .NV_P!;]Q3_ /A/M;MW3D/_ -@S4_\ V"Y^A#_Z[;_6_<=ZV#M*;LG
M-;>DYV5GH\4Z8,B>E'CM,!("6BM !6E)!TE7$#N\@*T.IOJ]/,HJ-=M#H-+8
M=F&1R<J;*_ WN3QD#,X^1B\I'1*Q\I!;?8<%TJ2?Z"#Q!'$'B*M6KL[4U.#I
M);"Y?L6[]MV[BS1E@T0F%T1Z90K%.$2^L?"D//N_2*]/TJW%SOVMG^>G@DOD
M<[:_BO;;?_I5\7)_,DN/V9M'%6]G8.!&4.2VXS07P_M:;_3K7W-=J+GW3D_6
MS;V>V:2S]EJ$?^%&[    %@.0%81LCP]TZNSM% 54 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@.9_[A/]&_YI0DDW3G^7NT_P!C8[]%;H02:@% * \)L":
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M H!0"@% * 4 H!0"@% * YG_ +A/]&_YI0DDW3G^7NT_V-COT5NA!)J 4 H
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MK%?2_KITV.LCU.4:4H)"%7) [.VG39*NHSJM%X4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * YG_N$_T;_FE"23=.
M?Y>[3_8V._16Z$$FH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * \4
M.T<QRH #<7% >T!K7<,TM94VLMI/$IM<>]RH#,C1FXK?AM]O%2CS)H"]0"@%
M * 4 H!0"@-?E?P3?V7_  J]:VEB]L-55\QA0"@% * 4 H!0"@% * 4  )(
M%R>  H"M33J!=:"D<KD=M0FF2TT45)!Z 3R__2_"@H>4!Z$**2H))2GTCV"H
MJ*'E2"AUYA@MA]YMDO*T,)=<2V7%_6H"B"H^9-2DWL1#PVE=02* 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H"MK\*C[(?TU#V$K:2*L,SQ0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#F?\
MN$_T;_FE"23=.?Y>[3_8V._16Z$$FH!0"@% * 4 H!0"@% * 4 H!0"@% *
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M-GE * 4 H!0"@% * 4 H!0%;7X5'V0_IJ'L)6TD589GB@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0',_]PG^C?\
M-*$DFZ<_R]VG^QL=^BMT()-0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H"E?HFU 6:@%UOT:D%= * 4 H!0"@% * 4!K\K^";^R_P"%7K6TL7MA
MJJOF,* B$S<FY,3N+&8_*8V%[(SLI['XUR-)<<EMO-,NOH6^@MI24+2TK5X9
M[EQSYU%2JBH:V1O3=6(RL_'YK'XUUG&8>3FY[N/DR%EE+5PPVKQ64B[Y0YIX
M\ @FHJR:(WNRLWE-Q8OVID%XI;+H0658>4N8A"]&IQ#JUH0 I!(X#W[5*92U
M0C<?JA);:A;ARV,1%V1F4S%8F:VZ5S4B$TZ^DR&E)2D>L-LK6V$+.GNI5Q/"
M,Q5EW;SQSJ7F,,P7MT8)##L_'#*X&+"D%UQU2W6F1">+B$!+R5R&M2TW18JM
MZ/%F&6NPDFVL_EYN6R>VMQQ(\3.XUN/+2J$ZMZ+(B3-80M!<2A8*5MK0L*'8
M".=A*92UO-WB<C&S..BY2%K]3F-AUDN)*%Z5"XND\0:DAX$.V5O7*;HBR=PS
M5XJ#MR.) E1 \X<E 7'61IF%5D(4$H4IQ) T]A4.-4IU*I*F!L(_4K9,AMYU
M.34TEB&[E5B1&D,*./CZ=<E"7&TE37?392;WOPJ<R&5FUE[FP<*0N'(E'UMN
M&,FIAMIUUPPROP@XE+:5%5U'2$CO>:E2*&M<ZB;.8@)R,G(*CLJE*Q_@O1I#
M<H34-^*8ZHZFPZ'2CO)0474+6O<4JB<K,MO>6VW<HC#HF*]<<>5$;4IEU,=4
MM""XJ.'RGPB\E()+>O4.(M<&E2*,C^7W;N).\9NVL2YA8<>#&@R"]EWWFWGU
MSEO)*6D-V'<#7E/%0J*XDT5*D@:WEMI_*>R&YO\ >_$=82XIIU$9;\9)4\TB
M0I :6XV$J*T)62+'R&TU(HS39?JGM?'8')YR(I[(''1/7VXB6'F52HZE!M+K
M"G&P%M%1"2ZBZ!S)L14.2)474D#FXL:UMQ_=2BXG%,179J_$;6P[X;*2I0\-
MT)4#W; $<:FI%,:&AVYOOQ=L2\QO=EK;^3Q,@P\U#"UNH9>7H6PENZ0M9<;>
M:T@)N5'2+U">&)+CC@;'Y>;72K'M/27V)F56MK'P7XDEJ6ZII:&UV96V%@)*
MTW44@ '5>W&IJ1E9Y"W_ +/R$TP8V43XA2^ME]QMQJ*^F'?QRQ(6D-.AJQ*_
M#4;#CRI5#*R@=0=JG'-91,B28TEWP(2!!EF1*46_&"H[/A>(Z@M@N:VTE.GC
M>E4,K-GF<]"PN(.7>"G6U^$B''0"'I#\A00RRVDV.MQ2@D \NVP!I4)5(P-^
M9$]*7NH"L<RUEFL>],5BR\IQA+[*E(+9=2D$I"D^D$U%<*DY?-0MM=0G,#EY
MV&W^[CX?JL:+-1E,>ITQM,YY4=IEUMP%:'%+1][XD+'*Q%*TVDY:[#?#?.V/
M6H\,S%H>D&.@%<=]+33LQ*5,-/N%&AEUP*&EMQ25<0+7(J:E.5F%ENH&$CQ,
MS[+E-NS,.U(6_)DLRDXMMV)P=;<E--+1J03924%2@>%K@TJ2HLR<GO3$14YB
M+%D)5E<1$?D25NLR?9[+K# ?+;\EMI:4D)4E:D"[FDWTTJ0D6Y/4+:F,4RQE
M<BAN3X$>1-6PT^]&BIEC[VI]Y*"EE"SZ!>*>'&E43E94_P!0]FQ\FO$/9,)F
MLRT8V3]Y>++$QT)+;3SP1X;:G-:?#UJ&JXM2J(RLQMY[T?VEF-L0_5$/XW,2
M7&<K*6LH5#83H;0\!R(\5UM*K\@;U#="8QK4M_+LCJ!.VLZPTS@,?CG)4G-.
M.E-IK'A..M6MI"&V7D+6LJX$VI7&@RX5-@WO_:*X<V>YD#&BX]IJ3),MA^,Y
MZO(44,NH;=0E;B'%#2V4).I7 <:FJ(RLT+'4@3\]D($)4=O'1'L)&;]?:E1)
M(>RSSR'6EMJ;UAS2A'@I4A*23WE6J,Q5EP-IENH&#8B9GV5+;=EX=J0M^5)9
ME)Q;;L3\(AR4TTM&I!-E)05*!X6N#4U(469$GJ#M"%DEXF7D@W.8DM0)EFGE
M,1Y<@(+3;SP1X;?B>(C05J&JXM2J(RLRCO#;@RHPIF?WPO\ J7B>$[ZKZX4>
M((QD:?"#VGCX>O5YKTJ*,I;STA6]I.UBP@16,5'R:9.H^(7'Y#K)04VMI ;!
MO>]*XBF%0[N_"(R:\&EYU&7(>3&0]&D-L//,-EU;;3ZT!IQ:4C4I*%DVOY#2
MHHS1[-ZFX+<.(PSF2F-1LUD('KCJ?">9A*<9;UR4L/NI\-?@BY6E+BBD"_8:
MA2J3*+1)\'N#%[CB&=B5NN1 0$N/1WHP6E20M*V_&0C6A22"E:;I-2G4AJAL
MZD@K:_"H^R']-0]A*VDBK#,\4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * YG_N$_T;_FE"23=.?Y>[3_ &-COT5N
MA!)J 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * IT)YVH"J@%
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M\TH22;IS_+W:?[&QWZ*W0@DU * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M7!1J'$<: WE * 4 H!0"@% * 4 H!0"@-?E?P3?V7_"KUK:6+VPU57S&% *
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MF@% * K:_"H^R']-0]A*VDBK#,\4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M 4!S/_<)_HW_ #2A))NG/\O=I_L;'?HK=""34 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0',_P#<)_HW_-*$DFZ<_P O=I_L;'?HK=""34 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0',_\ <)_HW_-*$E?3_>V'C[#VNPY%RY<:Q$!"BWA,
MLZBZ8S8.E;<525#AP4DD'LH"1_+O"?FF9^(<Q^IT('R[PGYIF?B',?J= /EW
MA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0
M#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q
M^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?
MB',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^
M:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+
MO"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.
M@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0Y
MC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,
M_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3
M\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^
M7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J
M= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXA
MS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF
M9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[P
MGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!
M\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_
M4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q
M#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-
M,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EW
MA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0
M#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q
M^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?
MB',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^
M:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+
MO"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.
M@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0Y
MC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,
M_$.8_4Z ?+O"?FF9^(<Q^IT ^7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3
M\TS/Q#F/U.@'R[PGYIF?B',?J= /EWA/S3,_$.8_4Z ?+O"?FF9^(<Q^IT ^
M7>$_-,S\0YC]3H!\N\)^:9GXAS'ZG0#Y=X3\TS/Q#F/U.@'R[PGYIF?B',?J
M= /EWA/S3,_$.8_4Z YU\L<3_'CU[U;*^!\DO T^Q\GXVOVEJOX/JWBZ;?#T
):;\+WX4)/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>fc_clinicalmole-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_clinicalmole-4c.jpg
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M%!04%!04%!04%/_  !$( LD#MP,!$0 "$0$#$0'_Q #B  $   <! 0
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H# ;Q_NB-]*X;_-(M -B_
MJ1MKZ*@_HZ* S] * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!@-X_W1&^E<-_
MFD6@&Q?U(VU]%0?T=% 9^@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MK:U=%2@;#ZOF^-R;_P!F3,SN>2B3/:R+L5M;;2&0&D,LK (0 #Q6KC1@ZQ4
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MX'KK$WI&[*Y:U#@W%)5CQ.M6G]VPR]R2LPM7]+&ZE.4I99)[4XT3CCCLK1/
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M=Y?C*<TU%+!);6Y.N&RB3\E>"ARZR^)B<]MZSI60C,P7VI?<2EOMI965RF%
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M"'IER\'!QOKE<F>@B@% * 4 H# ;Q_NB-]*X;_-(M -B_J1MKZ*@_HZ* S]
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MYGX3#9W<$B;BY E%^*X&]"^[BNK3>R >"@#TU)![&J"10"@% * 4 H!0"@%
M2K0AU"FG4A;:P4K0H I*2+$$'I!J4Z$-5P9AQL_:*0 ,!C@!P $-BW_HJ_\
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MTI*RO42I238='L*$'IWD?G,ON3EA@\SG9:YV5D>,]_)= "U=W*=0F^D <$I
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MX^RAXEJO>S]I^D?67S%]+<Q_B$GXRGP.G]W'V4/$M5[V?M/TCZR^8OI;F/\
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M:6JDM4K-%1QS<NTT<-#"6AE?J\T9Y>2E$_Q*NR]D8W>FV-RJ@.R5;ZPK*<A
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MM'*]',YJ>6BQPHGQ5X27?6PXVT,#LS( RD9+<,-R3DHLM(1W+K;B$A*$Z4J
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MLYLM/WZ5\Q@*RS!% >QO5'_4+,?2[GZ,Q7G_ ,Q_WX_E_%GI_P I?II_G_\
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MK1<18WYKK>IE;4)9\L:.5*5?'0Y;6[.;% >QO5'_ %"S'TNY^C,5Y_\ ,?\
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MESN^BRPM&H#A>]N'"H).)2,;ZT^9C',SLC.QK;G:;9>GQL2I1Z;!KO&=/M+
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MJB,AXPQ_*#[]6B^/&&/Y0??H!XPQ_*#[] 3EQ"4ZU* 2>@^W0$GC#'\H/OT
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M^_0#QAC^4'WZ JT!*M:&Q=9"1T7- 2>,,?R@^_0#QAC^4'WZ >,,?R@^_0&
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MVOHJ#^CHH#/T H!0"@/-7KA?W#MC_BY/\TBI1!J_)7_0CFA_L)7Z": TCU;
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M4VF(XU+?7';;0X5=IPK;5V;>U0DV#HX'@1TB@% 7$+_>$^T?VJ RE0#%S?\
M>%>T/VJD&F;JYA8?:64QV#E0,KE,QE&'YD6%AH+F0=\6B*0AUQ24$$!)<2/"
M;T!7PF^]M[C;@R\*\[)Q,^&_/;RRFBS#:1%=#+K3ZW2E33R5D@MK2+6-Z SW
MCL'Q=F89; AR"A,>27FPRX739 0O5I45=5CQH"/C<,*;3XVQK>4$,I[YO4M:
M@2E*1JNHD D =- 3)?CKDKA(?:5.;0EUR*EQ)?2VLV2I38.H))Z"10%@K.P#
MDL?C(VN:O(*E-B7#T/Q8ZX2 M:9#B5_DR;Z4BQX]-J$%['DQIC*9$-]J3'5<
M)>86EULE)L;*02#8]-"3*8_WJ_;%0"R<]^KVS^W4@T/(<W=FXK=4W:>0^4&9
M.-E1,?DLKXB\O%19F20E<5IZ4FZ4%P+2 2-() )% ;F[/Q["%./S8S3:5(;4
MM;[24A;OO$DE5@5?@CKZJ G>D18[J8\F0RQ(6E2T-.NH;6I*" I02H@D D F
M@")$9Q[Q9I]IR3I*^X0XA3N@*T$Z 2JP5V3PZ>% 2IF0EM2'T2XZV(:E(ENI
M>;4AE38NH.J"K((Z]5J L6MP8YV7D(ZBIB+C6(TIW*O]VWCG&I844%F05Z5:
M=/;Z +BUZ R@(4 I)"DD72I)!!!Z"".D4!D4?[@?X*OVS4 P&:R\#;V%R6X<
MJM36*Q$5Z?.<0DN*3'C(+CA"1Q40D= Z:D&O[1YE;7WFI]F"9>-GQH[$Y<'-
M1EXU]4&6DJ9DMAXV6TO2KM)5P((-C0&U-28K[ZHK$AEV4A"7EL-NH6X&G/>K
M*4DD)5U*M8T!JRN8VWCGYFVXC<G(SH*,<X\] 0W)8T99]R.TH*2Y[UM32N^/
MX(Z+T(,MFMU;8VXVX[G,Q$A(:?8B.!;J5+2_+6$,H4A)*DE9/#4 .L\*$D\+
M<&/F#(+7K@-8V2Y$<=G]W&;>[E*%%YE2EV6R>\2 OAQZJ$&0>D18RVVI,EEA
MQX*4RAUU#:EI; *B@*4-0 /$BA)4H#.#H%0"UG_Q(_A#]HT!C:D&N.[[VTQO
MMGEN_(6WNF1CCEV&EH(CJBI44FSM[:P$E13^+QH"QVOS/VKO-F)+VZ9<G'3)
M,Z'\H+C]S&9=QB4K<+ZUJ&A*PM/=*L=1\%"#8,CFX>.CMR$H=R"')K.-4C'!
M$E;;[RPB[@2L:4HO=SK2.J@+I4_'(#BE3HH0UW9=47V@$AXZ6RHZN&L\$WZ>
MJA)"1D(45;S+LAH2X[#DIR&'$>,=RT"5*#5]5N'3:U 6.UMQX_>&VL3NO$H=
M1C,S&1-B(D )>#3O0%A)4 ?:- 9N/_'M^V* KY#WZ/:_=H#GN]>:&#V'D(..
MS.*S<E>24TQ DXS&NS8STJ05]W&0X@@%\AM1[OIM0&T1\QCGL<WE'GT0F%,M
MR7FYJT1W8Z7N 3(0M7Y)85="DJZ% IZ10%T9,42T0#)9$YU)<:BEU >6VGI6
ME!.HI'XP%J QF'W7M?<&-5F<+F8DS$I<>95+2\A#87&<+3@/>%)&E0M<\#TC
M@10&4#S"E/H2^TI<4VE .()9.G7^4L>QV>UVK<.- 4OE'&^+(F^/1O$W$AQN
M3W[7=*05!(4E>K21<@7!Z>% 6L;<6!F9S([9B9%E[<.(0P[D\:E7Y9A$I)4T
M5 VOJ"2>S>W7:XH#.X_^.5_!_=% 6V1?:C>,RGSI8CH6\ZH"Y"&TE2C;KX"@
M-'V9S6VEOE]$7%"="DOP1F(3>6AN0!+QA4$F5'6NZ%M@J3J.JXN#:U ;:K(X
MU$)&27.C)QKFGNYJGVA'7K-DZ72K0;G@+&@*OC$:P/C#-BI2 >]18J1<J3T]
M*0#J'5UT! 2X1.E,N.I14$!*7FR2M5@E( 5<DW%A0$&YL%U"G6I<=;2'%L+<
M2\VI"7FQ=;94%6"D@7*>D4!!V? 8BMSWYD=J [H#4MQYM#"RY[S2X5!*M758
MT!40_'<??BMO-KE1M'C,="TJ=:[P71WB =2=0Z-0H#*8_P#BE?POW!4 NZ 4
M H!0& WC_=$;Z5PW^:1: ;%_4C;7T5!_1T4!GZ 4 H!0'+>=?*>=S5@8F%"R
M36-..>=>6IYM3NL.H2D :2+6M4@Q.Q>2&1VCR^W;LM_+LR7]QMNMLRT-+2AG
MO8Y9NI)42;$WX4!@.5_JX9;E_O;';KDYZ/-8A)?2N,VPM"U=^PMH645$"Q7>
ME2"]YN^K[E.9>[CN2+FV(#/BK,8,.LK<5=HJ)-TJ XZJ5!L&2Y03Y_)B+RM&
M491-CAH*R):46CW4GO\ @C5?HX=-"3&<E^1>2Y69^?F)F88R+4R&8@::96TI
M*BZAS42I1X61:@,US9Y&[?YH%O(E]6*W(PCNF\BV@.)<;%RE#S=TZ@">RH*!
M'LCA0'&(OJ?;C5+"9NY(3<&_:=99=<=T]=D*T"__ (Z5(/0.S^5NW]B;2F[9
MV\"'I[3B9F1?LIYYY;90%KM;LIOV4#@/;))@DY%L7U7\SM'=V&W,]N&-):QD
ME$AR.B.XE2PF]P"55-2#M7,S:$C?FR,KM.+*1"?R(9"9+J2XA/<OMO&Z4D$W
M"+5!)SWDQR*R7*S<$_,S,PQD6ID,PPRTRMI25%U#FHE2CPLBU2#5=Z^J[F=U
M[MS.Y&MQ1HS64EN2D,*CN*4A+AN$DA8!(I4@Z/SEY4S>:.%Q.*AY)K'*QSY?
M6XZVIP+!;T6 21:A)A=E<@(^%V#N#8>Y<@C(Q<V^F0B3%065L+;0D(4G65=I
M*D!7@/0>%*@YHCU/LY\I:%[FBC$:OX]+#GC);O\ R=]-[?\ Q*5(,F/5+G0-
MP-9+#[C93CXLEJ1%9E,*6]I:4E0"U(*4DW'4!2H.O<WN4V.YK8:-$>E''Y;'
M+6[CYP1W@3W@ 6VM-Q="M*2;&X(!\(,$G+^6?JU;BV3O?%[IR.:A2(N-<<7W
M$=#I<<"VEMCWZ4A/OK]=34@LX?JJ9J-N:/GU;DBJ0S/1.+(CN D(>#NF^OIL
M+4J#KG-3D]MWFG#9,]Q<#-PTE$+*LI"E)0HW+;B"1K1?B!<$'H(N;P2<(3ZG
MVYC*T+W) $*_\<&7B[;P]WP'_P!^IJ0>@.6'*C;O*[&.Q<45R\G+TF?DWP Z
M[H]ZE*1P0@7-DC[I-02<:Q7JJ9K';FA9]>Y(KB(D]J<ID1W 5!IX.E(.O@3:
MU34@Z+SMY.S^:YPGB649QHQ7C/>!YI3NOQCNK6TJ%K=W^S0DR_)KEM,Y7;9E
MX&9/;R+DB:N:EYEM324I6TVWI(43<W;O]VH!T6@)7?XM?\$_M4!A:D"@.7;O
MV+N3,[UW7GH#;#F/S'+]_:L$NOAM9RCDB0ZA*DV)2V4NINYU>"@-*B<HMW,2
M7F',(TO$S]KLX;<]\A%\8F2XV,CPVD8J1W7?0^VA:7N]465I2"$W50@M9'*K
MFDC&E36*QDN;D]J[AV6Y&3)C8XP8^4DAV')D>+,AAYW0") CH2"OB.LT)+O
M<F-T0-ZXO)9R.]*A1I.'R</+X^? 8,!6,Q[45<1U+L94I;25-N)"([X;=0LZ
MD@WN(/0Q-R3:U^H=%"2% 9&1_N:?:34 QU2"=I00XA2NA)!/W* \RPN0.\S
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M@MYK9C4.$UYM[8D[>E8^3(G0UY./%A.K5D(LR0E@.RE:%EMA+2T,=UV2DGI
MDP_('*LNX3$9+;&'^0,+,W:N4Z'F5-9)&9;/R8\J.$ W9N&=#M^["0H= L!;
M*Y [V9P0Q^):@P)4K:>&@Y_NY*4#*9O%9+QI]N0HMN!8>8NWW[B5C\!0*.%
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M?#H24== =+Q3K3['?L.)=8=2AQIU!U(6A:=25)(Z00;BH!:.>_5[9_;J02T
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M=#A>1C8L:$EX@)*Q&:2T%$#HU:;VJ 0<]^KVS^W4@EH!0"@% * 4 H#(H_W
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M_P"*5_"_<%0"[H!0"@% 8#>/]T1OI7#?YI%H!L7]2-M?14']'10&?H!0"@%
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M@JO[%2#VZPV66&F5.*=4VA*"ZLW6HI%M2B.L]=4DE2@% * 4 H!0$KO\6O\
M@G]J@,+4@4 H!0"@% * 4!D9'^YI]I-0#'5(% * 4 H!0"@*C'\<W_"'[= 7
M>0]ZCVS4 L*D"@% * 4 H!0%Q"_WA/M']J@,I4 Q<W_>%>T/VJD%O0"@% *
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M:- 8VI!J6[][/[:R^W-MX?#G.[HW.Y)^3X"Y"83"8N.;2[*><?4ARVE*TA"
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MP<:TJJ'$/LQ1O3K<'Y\>[70^./W4.@YGP!^^N=)'[,<;TZW!^?%/''[J'0/
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MW6_$M/*HTXC;Z#0_"IK/*=>UP&BSO5MCSITF:=[YYHR77'BVAX!">\45:0/
M+VK90WTXQ2[J&!JY[B<I-]]<QY2A]F.-Z=;@_/BJO''[J'04> /WUSI'V8XW
MIUN#\^*>./W4.@> /WUSI'V8XWIUN#\^*>./W4.@> /WUSI'V8XWIUN#\^*>
M./W4.@> /WUSI'V8XWIUN#\^*>./W4.@> /WUSI'V8XWIUN#\^*>./W4.@>
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M6X/SXIXX_=0Z!X _?7.D[NTCNFD-7*M"0G4>DV%KFN;;JSJ4J(U;F%L=&_\
M!M81>5EX=+<E$KQJ H(=5W:%HT$_BG7?[@K,T>J^'GFRJ6%,3!UVD^)MY,SA
MC6L3F/V8XWIUN#\^*W'CC]U#H-)X _?7.D?9CC>G6X/SXIXX_=0Z!X _?7.D
M?9CC>G6X/SXIXX_=0Z!X _?7.DE'JQQPHZM][@L;:!WPX>&_'C3QQ^ZAT$^
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M*"$#I4H@#[YHE4-I;2*5)4 I)!2>((X@U!(U)MJN+>'JH 2$@J4;)'$D]%J
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M! D 7- 2]Z/!0$] * 4 H!0"@,!O'^Z(WTKAO\TBT V+^I&VOHJ#^CHH#/T
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M;=R5N2E%T:*[MJ%V+C-*2? S [7Y;;(V89IVUAVX7RBD-S1K=>#B!>R2'EK
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MS/GXS.AH[,)J:CUHQRKDCQ"+L[;,)K-,Q<>AIG<3CKV:;"EZ9#DA)2XI0*K
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M0-1N>CJ% 1TIZ;4!&@% * 4 H!0& WC_ '1&^E<-_FD6@&Q?U(VU]%0?T=%
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M^V'_ -G_ /4?^6I],_Y/X?\ D/J__%_%_P 1]L/_ +/_ .H_\M3Z9_R?P_\
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M * 4 H!0"@% * 4 H!0"@% * 4!*>R=0Z.N@(]HGP#]N@! /2+T!&PM;JH"
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MVI8,8C9V5:DPH49@KBY'/M[?VT[DG1"E/1682(ZG%K>392TEQS6E:.]4@(!
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M% * 4 H!0"@% * 4 H!>@% >@O5&_7K-?1*_TEBN5^9/[$?S?@SM/E+]3/\
M)^*/8E< >GF*PG?]YE>^QR,>/'G.Z4BW]*1H;M(5;K5Q3Q_%H#*T H!0"@%
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M&6Z5#^21V4?=ZS0$[2&&'5--]E2QKT#WH [-Q0%>@% 0!!)'6* @OC8=9Z*
M *' $6H $\;DW- 34!!-^)/7T"@(T H"VGLK?BK;1Q7P('AL;VH#6RE0.D@A
M71;KO0DS<*-,8CI*%A*E7465CAQ]D<10@FD2UH1HD-*:N>*QVD??'10DII4E
M8U((4GP@WH"[B$V4GJ%C0@N: 4 H!0"@% * 4 H!0"@,!O'^Z(WTKAO\TBT
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MI7?^BK[MN\=-_P %/OO_ !4!F* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MFN,18X4IP(;3:PU+)4?NFLS0W)7+$)2=6T:S>EB%G4SA!4BGAP_>:O6::P4
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M2%*[+:R4 WX@7X=%=?"5:KA7V1P5VVU25,)?9]#P+*KA9% * 4 H!0"@% *
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ML2N /3S#;?,8N9CQ?(N9 C(N]\ER_P#1G.[;O'3?\%(LKA^-0&9H!0"@% *
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M_%'L2N /3S&8?QS7D_&X#4$>.N>+J9M>0SH19]=OPE&X-^/"@,G0"@% * 4
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M)W[CAD;>6M:<O&9E&XM\9?!JP;>1G2\#AVD2G(B5J4W'CL.)2A:[<=#:W$Z
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M=?\ +7KSYD<)\W?V[?._N/)==T>;EQ!?;C2VW74H4UQ0X7&DOA*'$E"E!M1
M4I(.I-R.U:J)JJ^R+EJ665?PKMY'YN4]%^K+OQO;><E\N,RXIF'EUIFX)R0
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M^%65=C:[Y.>:DDHRPXZ2I1\7 <Y?;2R\XTAU#R&UJ0EYO5H6$FVI.H)-CU7
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MU7;5R48IRC',Z\D=K\AIMAT]=;$TXH!0"@% * 4 (!Z10"@% * 4 H!0"@%
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MWO'0]>S<GNVM2&[@=@#21[9H#.T H!0"@% * 4!*L72: HU *R!9/'IJ034
MH!0"@% * E/OQ[ - 34 H!0"@% * 4 H!0"@% >%O67_ -7,K_L(?Z.BO2]Q
M?I(\[^\\A^9/UTN:/W'(JWQS0H"NU/G,1W8;$MYF*^;O1VW5H;6;%-U)! /
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M,3M>2,B# B/3Y;Y#;*,C*?=BF,V4)43=UI2$DCJ)40!>L>WO2.1RN*F+HO\
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M<'[H%""DMY9?:>6PZGNPH$!(5?5;P'V* G<FQE)*7"IO^$A0L?O4!.U.BK2
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MCS^V-Z2XORV/\.GAVJ]W/V7Z!XQH??6_;CZ1Y_;&])<7Y;'^'3P[5>[G[+]
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MI!Y@[#3T[GQ7W)L<_M+J?#M5[J?LOT#QG0^_M^W'TDWGWLF]SN+&IL.E4ME
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MZ+^SX*ZGY7I\6_R/[T<)\\U^ C3WBK[,OQ/+=>GGB0H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4!ZD]6;]3<I])K_1V:\U^:?U,?R?BSVCY%_1
MS_\ 8_\ ;$[57'GH8H!0"@,!O'^Z(WTKAO\ -(M -B_J1MKZ*@_HZ* S] *
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MP3CEJWGE3#%<Z[6%'PEUMSEOEMQ;A7C&6I3.$9FNP)&6=BE!:4UJ)ULJ6++
M *T:SHOQ-6]3O2W8LYFTYN*DHYMM>)\7$Z8E_0[CNZO4.W',H*3BYN&RE=L:
MK'CC7JUQ, WMC<#V/9RS./=<QLAQ++4E(!05N++:0;&Z=2AI!58$\*SGJ[2F
MX.2S)5IY_N-9#=^HG;5V,&X2=$^6M/)CACPF6SFP,SMQW)PLJR\<A 7%2V(C
M"I$5Q,LK2E2G@4Z+E.E *"5FXX6K%T^\;=]1E!K++-M='U:<'#RXX&;J]SWM
M+*<+B>:.7U8YHO-7;+#+LHL*R?,8^3LS=D.9%QTG"S$3YR%N0XW<J+CH:25+
M"4@$E2 .TGI3UBK\-=8E%R4XTCM==G%T\!BW-V:J$XPE;EFFJQ65U=,7AQKA
M6U<)99;"9? RDPLS">@REMI>;:?04%3:_>J3X0;6X=?"KUF_;O1S0DI+9@8V
MITMW3RR78N#I7'B?"9!>Q]W-S8V.<PTI,^8V7V(RD6<[I-M2E#I0$W%]=K==
M8ZU^G<7+.J1PK]MOD,Q[IU:G&#MRS254J8TY>+EK2A"+LK=TV=*QD7"S'9\)
M:6IC"6E:F5N)4I 7<=G4$DIOT]53/7Z>$5-SC26QUV\Q3;W7J[ER5N-N3E'U
ME396M*\5:8<9([L_=;*H2'<+-2YDBM,%LL+UO*:OJ2E-KZA:]K7MQZ*J6ML/
M-2<>KMQ6!3/=NJAEK:GU_5ZKJZ;<-O[,=AD8&P<RN1*8S3+^)+6*F9B,7FB>
M^3":+A0+J3:]M*NM/6*Q[F\;:2=MJ=9Q@Z/9F=*_;:9=K<U]N2NIVZ6Y7%6/
MK956G!Y>SPHLX&R=SY%[%--X]QI&9>;CPGWAI:*GAJ05'B4@I!6FX[202F]7
M;FOL04VY>HJM<WVIR/:6+.ZM3==M*#2NM*+>S'[L,5QK%5(R-C;K8G9''C&/
M//XI9;EEE)6D$)UC21[ZZ>V ..GC:D=X6'&,LR2GLK]N/#G*I[HU<;DX9&W;
MVTQY<./#'CIB76WMA9C-XZ9FGV7H>%CP9LYF>6M33RX395W8)4G@I0T:^(!X
M<3PJUJ=XV[4XVTTY.48TKLS/;^-"YH]T7M1:E>:<;<83EFI@\BV;5MV5QH^4
MU2MH:0Z[ZN*"KF \H'@C&R%*'A'>-#]VN4^9W32+\R^YG>?)"_\ OO\ )+[X
MGK&O,#V\\?<_;?6;D;?R,6_YA->K_+OZ*//+[SP3YO\ _P!*?-'_ &HU;9.S
M9^^<J]AL8^TS.1&<E-!_4$.%HI&BZ0;$ZNFU;/7ZZ.DMJ<TVJI8&GW5NNYO"
MZ[5MI247+'AI3#SF/SVW,YMB<O&YZ"[!EIZ$N#LJ _"0L72M/LI)%7]/JK6H
MCFMR4E]N@P]7HK^DGDO1<)<OX/8_(7^$VO'G8I[<.;R0Q& :?$)$@,JE/O2B
MCO"VTTDIOI3VE*4M(%QTDVJQJ-6X7%;MQSSI6E:)+95OGV43,O2;OC<M.]=G
MW=M/+6F9N5*T45Q+%MM+86SNV<FY&FY7%1WI^WXCCB1DDM% 4TVJW>*;N5)3
MQ&KJ238FKBU<%*,)M1FUZM>'BJ67H+KA*Y;BYVXM]:G OWJ;4N/@6RI63M#,
ML1'YF5@3H3(B.3(:O%%K2\&U- E1)1H:L\DEWB.@<;U2];;<E&$HR=:/K;-O
M/5X>J2MWW8P<KD)Q65RCU'C1QXZ4CUO6V<&-3'Y;!9C!+9;S$)V$Y(;#S2'A
MI44'AQ'2#X0>(J]9U%N\FX24J<18U.CO:=I78N+DJJOV\VTS>X=B3\!B\-D.
M_3+=RH2A^&RA?>Q9+C34AMASPK6V\A0 ]D=58>FWA"].<:4R</:56FUR)IFQ
MUNZ+FGM6YUS.YM23K&349*+Y7&2=.?B+/S'W;X\[C?DB1XZPR)+[.D7;:42D
M%9O9-R"FQ-[\.FKOQ^GRJ6=4;IY2QX1J\[AW<LR69KB7+Q<7/AM+!.!S2PE2
M(#Z@N(O(I(;5QA-%06__   4J[71PJ^]1;7[RVY?^[BYS$6DO/9"7JY]C]55
MZWY<'CL+U.R]V*<C-*P\IM<Q"W8W>MEH+:;""I=UZ0$#O$]H\./35IZZQ1O.
ML-M'7R8<.#P,F.Z]7)Q7=R6:M*IK!4J\:88K'9B5=O[1G9K+S\&\EZ)DX,29
M)\4+*E/J?AM%P,=V2E04HC3X1X#5&IUD;5N-Q4<92BJUPI)[:\A.CW=<OW)V
MG6,X1E++E=6XJN6F#J]GX%/S*W:<F<,G"RUY0-(D>+(:4M?<.*"$N#3<%!4H
M#5T55\?I\F?.LM:5KP\7/R$/=>K5WN>[EGI6E.#97FJ]NPMG-L[A:PZ=P.XR
M0C"J(2)I;(:[1T@W_%)[(5T$\+WJXM79=SNU)9N(LO0ZA6>_<)=WVJ8?]."N
MRN&TJ2]I;E@R(<63BI"9.1)3!:2@N*>6+70C1JNH7&I/OA?B*B&LLS3:DJ1V
M\G[.4KN[NU-J48RMRK/U52M>:G"N%;5PFTCE9)CXYN3E):X,]6+RN5=@K8!*
M#BUI0AO4'.(=U7U@</9K6>+QE.D%F6>$:U[?#LX.(W;^79QMYKDLDN[NS<<N
MSNW2E<W[W'P<3-/E[?SD$SQ,Q[[!Q:VVLCWB"GN%OW[L+OT:[=GPUMH:FU/+
MEDGGV<M-O0:"YHK]O/F@UW=%+#U:[*\_!QF9F[#S EQHF%:=RKCV-A9-T--A
M*D>/,AT- :CJ4+V3;M*ZA6'#>%O*W<:A24H[>RZ5Y/PXS.N;HO9HQM)W&[<+
MCHMF95R[75\7#+@1AF-NYZ5XGXMC9+OR@7TP0AI1+YBB[P; ':[O\*W167+4
MVHUK)++2N.RNRO.8$-'?GERPD\]<N#ZV7UJ<=.&A5=VKN5C%'./8F4WAPEIP
MSE,K#/=R/XM8418I4> 5T7X=-4K5V7<[M36;'"N.&TKEH-1&UWKMR4,.ME=.
MML=>)\>RM%PHR>(V#G9\J+'FQ7X(R,.9,QFIHJ<DJAQE2 A"+A7Y2P"3[-Q>
ML>]O&U"+<6I9914L=F:5-O(95G=-^<HQE%Q=R,Y0PQEDBY42VXX4?+55,>K:
M&YT94X1S%R&\HEL/JCK3H(95:SA4JR0DWMJ)M?ATU?\ C;'=]YF66M*\O%SE
MGPS5=]W+MO/2M.3CXJ<O'@7FV]B[@W#ET8U,&2PPU,:A9.265'Q13C@;7K2=
M/:0"5%%[V%6M5O"U9MYLR;RMQ5?6PKY^,O:'=.HU5W(HR24E&3ROJXT=5ABN
M%;<#!Y2&,=DYN/2YWR8C[K =MIUAI91JM<VO:_369:GGA&6RJ3-=J+7=790K
M7*VJ\='0M:NE@4![XPT=#T",Z^"XH-H"-9) &A/0#PKP:6U\[/JJ/JKF7W'-
M?60X; CC_P#R3'\T]75?+'ZM_D?WHX/YW_0+_P!D?ND>4:]//$3>-Y\J=U[,
M0)LACQ["+ 4WDX@*FP%<1WB2-39_A"W@)K2Z'>]C5=5/+/LO\.,Z3>GR]JM"
MLTEFM]J.SR\*\N'*S38<21/EQX$-LNRY3B&&&D]*G'%!*4CVR:V\YJ$7*6"2
MJSG[5N5R:A%5E)T2XV]ALNXMB9##Y]C!8ET9]<QA4F$]CT*67DM*<0Z$H&HW
M;6RXDC][>M=IMX0NVG<FN[RNCS<&RF/*FNDV^NW3.QJ%9MOOLRK')C6E4\,=
MCC)>0L#LW=*<HG"N8I]O)J9$E,=U(;)85T+NHA.DGA>_3PZ:O_'6,G>*2RUI
M7EXC'\+U7>]R[;4Z5H\,./BIP<^&TO$;(R3NWSDVT/*S",G(Q;N&[A0>0(<8
M275FYO=(N%(T\+5:>O@KN1TRY%+-7#K2RK_K4O1W5<EI^\5<_>2ADRX]6.:3
M\F-8TX"GC=A[GRN#F[BBPS\EPHYEEU9TEUI+G=J+0_"TD**CT62>OA4W=X6;
M=V-IOK2=.9TKCS_B4V-TZF]8E?C'J06:O&DZ.G'3&O,^' E.S<S+R,B#A(4R
M:(K#$B0MV,8JVTOM)<&M*E*"02JR"5=L<1TVJKXZW&"E<E&-6TL:UHZ8?CQ%
M*W9>N7'"U"4LJ3=8Y6JI/%5PY,>MM1)C]GYJ6YB7I,5V-B<M*8BMY#1K0CQA
MP(2H@$6N+E(5;5;A2YK;<5-)IR@FZ<WVQXB+.[+\W;<HN,+DE%2I58NG_2M,
MW 4<KMR; GYV/%0Y+@8&4N++G)1I0D!Y3+:U@$Z=:D\./3PJNSJHSA!O!W%5
M+R5?/0MZC0W+4[L4G*-F664J8>ME3>VE296SMTH1-6YB9*/D]*7)J%(*5M)4
MV'KE![7!M06JP[*>)M4+6V&XTFNMLY<:??ARO82]VZE*3=N2R).6&RJKLV[,
M7V5BZ&3R^R1C,<B:W(DRE+QF-REF8:E,H5DE%/=NNAPAO3^ HCMGA85CV=?W
MD\K277G'UL>KPI4QY>(S-3NKN;:GFE*MNW/"#HL_!*5<*<#_ 'GA1%25RXST
M';[&4FQWX^6E9)&-C8EUG2M:7&"]WFHJX$$:5)*>'7:J8;TM3NN$6G%1S.5>
M6E/VE=S<>HMZ>-R2:G*:@H...,<U:U\C5,.$MH/+K=T][*1D8]34G$Q4SI#3
MQTE;3A 1W9XA6H74D@Z2$GC5RYO/3P47FJIO*N?EXBW:W'J[DIQ4*.W',Z\3
MV4XZ[5P8/$MV]FYO(2VX>"@39[AB1YCH5&4P4B2V%"UU*!02=+:[CO.H5<>N
MM0CFN2C'K-;:[']_&N L0W9?NR4;,)SZL9/JT]95\JX(O#-P(HP=G;JR;4AZ
M!AIDAJ*IUN0I#*R$.1P"XV>'OT@BZ/?>Q5=S6V+;2E.*K2F/'L?-RENSNS57
ME)PMR>6J>#P:VKGQV;2TP^#R^X)1A86&[-DI075H:3?0VD@%2B;!*;D"ZCTF
MU7;^HMV8YIM118TNDNZF>2U%REMPXN-\2*XVKN16+=S:<7).)84M#LL-J+:2
MV=*R3^*D]E2N@'@3>K?QEG.K>99GP5+JW?J7:=WNY9%PTXMOD7"]B>&TNV=A
M;T?:COLX&:IF4M#<=P,JTJ+J0M!N1[U23<*/9]FK4MXZ9-IW(U6W'B+\-T:V
M<5)6ITDTEU7PXKR<NPHPME[MR"GDPL+,>5'><BOA+*^Q(9 4MI5QP< /O/?>
M 57/76(4S3BJI/;P/AYN786K.[=5=KDMR>5M/JO!QVQ_-_IV\A>/;*GG%;>F
MX\.S)^<$TJ@):TECQ![NE%2BKHMVE%02$]=6HZ^'>7(RI%6\N-=N95^VVIDR
MW3<[JS.%92O9^K3U<DJ8NOE;PR\)33L+=/R1E<TN"IJ+A7D1Y[;G8=0I:"X5
M!)Z4I3I)/[Y-KB]I\1L=Y"&;&:JN+B^W,RGP?5=U<NN%%:=)<:PK6G$L/:5*
MJM+*5M7<D-<-J3BI*'<@H-PF^Z4I3KAM^3 3<Z^([![7$<.-7H:RS)-J2ZNW
M'9R\W+L,:[N_4VW%2MR3GZN#Q?%^;_3MV88F0W+LN;M;#X:?DRMK(91<Q+V/
M<;"2R(:T(2H+"B%A>OP"UNNK&EUT=1<G&&,89<>/-7HH9>OW5<T=JW.YA*YG
MZM/5RM+;7&M>3RFL5LC2GJ/U9UH&SLFDGM')KX<+?[NS;KKS3YI_4Q_)^+/:
M?D7]'/\ ]C_VQ.UUR!Z$* 4 H# ;Q_NB-]*X;_-(M -B_J1MKZ*@_HZ* S]
M* 4 H#@WK/?W/M__ (E_^;37;_*G]RYS+[SS+Y\_LVOS2^Y'FJO0SR$4!?0T
M(90W*TA^4M8$)A/=NCO$+1</,J"B4J"K)'6:L3=<-BX=JX]C,BW&E'M=>KL>
M*:VQQP?GY<3T7RQY$1(C+&>WVUXYDE)2J/B'.TPPD#L]\#[]0'X'O4]''JX'
M>OS!*3=O3O+'AEPOFXN?;S'K.XOE&$$KVK6:7!![%^;C?)L7+P=S;;0TA+32
M0AM "4(2 $A(X  #H KBVVW5GI*22HCEE^;VXIN2G8#-XW'X9J?+A1(SS'>.
MI1#>4Q=1[I7%105>^KI?_P#/L1C&Y"<I98MM/#K*O'RG$)[WU4YSLW+<+:G.
M*3572$G'L\-*FY;$RN4S&V8TK-*;7EVG9,28XP+-+=B2'&"M(L."M%^@5J=X
M686KS5NN6B:KMI))_B=#NC47;^FC*[3.G*,J;*PDXU7/0L-\\LML;\C+&1CB
M/E0FS&5CI2F0@@=D*/\ [B?WJON6/&K^@WK?T<NJZQ[+V?L9C;VW%IMX1ZZR
MSX)KUOVKD?DH\3RENO:.5VAF%[;W$@%PW5C<@DI0V\%E#:%*=<%^Z2E/%)/8
M->FZ/6V]3;[VW_W+BVO9Q_>>([QW9=T5[N;R_)+!)UHJMO@26S]U\6TU%2=*
MBDD$@D7!N.'@(K:HT1"I H!0"@% * 4 H!0'4\1S1QN-V[M6!XO)^6L//C*R
MDI 1I?Q41]YY#"257)_+6L0!PZ:YF]NF<[UV55EG%Y5Q3DDJ^8[73[_MVM/8
MA27>6YQSRPZUN,I24-O^KDYR[A\T<"UN3<<]M>3Q.*R$"+C,(YCT,JE1&880
ME/9<<"1<(/0H]-6I[INNS;B\DY1E*4LU:2<J\A?M?,%B.HO27>6X3A"$,BCF
M@HTXY46S@;VEMM_?FW,'GYN?5G=Q2G)#Z%R6'68JT9!A+21W<D*>4 =16BX"
MK(MIL:N:G=]Z[:C;R6E188RZKKMCU>9\&.TL:+>^GT^HE>[R_)R>-5!YXT6$
MZR?#F2I6D=E&<SR,EJ9D)<R/'3$8D/..M16^*&D.**@VGV$@V%=':BXP46ZM
M+;Q\IR%^XKER4HK*FVZ+8J\'D.Q>K-^N&5^C%?I#-<G\T_IX?G_!G??(OZRY
M_P"O_P"43TV^\X%ICL6[Y8N5'H2GPG]RO-3V<U?"C#1IN<;;3("SD%JEJ=)[
M4DM-ZU(TFV@IT6]V@+G=3@C[0SLEMU3\(8Z87$D@K2 PN^DG]HUEZ)-ZBW3M
M1^]&NWI)1T=Z3X+<W_"SPQ7MY\RG0MG<V,KL;:LW!8&,A.3FRE23D7K.):06
MD-@(:(L5W23=1(_>FM#K=SV]7?C<N/JQ5,O'B^'B^U3JMV_,-W0:65FREGE)
MO,\:8)8+CPX<.1FD93*9'-3GLGEI3DS(2#J>D/**EJ(%AQ/4   .@#@*W-JU
M"U!0@LJ7 <Y?OW+]QW+C<I2VM_;_ *+ WB+S(B1VX^'^3$)VX,*O"2DH:9,Y
M9>;4XXXE]0) ,E7>A%]/#HO6EGNN4FYYNOWF=8O+@Z)4_+A7:=':WW""C;R)
M6^Z[N5%'.ZIMM2V_W'FILY*EE)WQ$DIE-NQ'7&7\'C,+W*G+)*L<[%<6HVZ$
MK[A8%N(U7J]#02C1IJJN3GL[2DO-F708EW><9IIQ=.ZM6Z5[$K;?,GDE3GKP
MFS)YJ[=AS,:J!C)"<= FSYK<8(C1PVU/AJC)8;2RD"S95?6NZE=)XFM<]T7I
M1EFDLTHQ5>LZY99JNO'Q+!&_7S%IK<X9(2RPG.5*0C13@XY4H\3>UXO:S'9?
M=CF-V3MW%..,2<Z\F,Y/4R_WRABH#JWH,=_1=*5%3JE% .I*4(U> 7[.C4]3
M<GBH*M*JG7DJ3DNC;L;<J&#J-Y.UH[-O!W'ES4E7^G!N5N,J8)UDW2N9*,<W
M$IAS.QL#,3,GB\<\ZB3N!G<7=2UH!%V'T/L@H!L0I\]TOJL"1>GA4YVU"<DJ
M6W;PYXY7T1Q0\>A;O2G;@VG>5WK/_3)2CALQEU7CP-JJ+/;NZ=D[7R+LO'1,
M@]I>BRHDN0W#7+08ZUJ<8NH+2A+@*?RS=E]GHL:NZG2:G402DXK"2:3E3'8^
M6G9>&):T6OT.DNN5N,WC&46U#-U:UCPT3JNM&DL.)F,WCNZ'N6% C18KL=<2
M9E):U.*2H%.2DA]"187!0!97AK(T6BE8E)MIUC!>S&GG,/>F\X:N$(QBUEE=
MEC_DEF71PF<F<R<1EI^+=R6*48;;;\G+I'=O![,R8R(RIJ67?R2M/=(6EM8T
MWU>&L.&Z[EN$E"6."CP4@I9LE5CPM57(;&[ORS>N0=RWU:-SV.MV45'O,KZK
MIE346J5KQEQ/YHXN6)*4P9*B[&PL5#BU-)43AY)>6M24)"1WB> ">"3[%6[>
MZ;D:=9;;CX?WXT\QD7OF&U/-2,L8V5P?^*>9MTPQ7%L*T;FEM]68@YO(8^<9
M6&R61F8QF.ZVAMQC*/K>4']0)[Q!7;L\%BP-K51/=-WNY6XRC2<8*54]L$EA
MR/S%5OY@T_>QNSA.MNY<E!)JCC<DY/-RJO!MV,PKN]-O(V9(V]C<<]#FSH$:
M',2@,&.N3&E(D*DJ<T]\M3@2>RI6EN]D@BULU:&\]2KDI*2C)M;:T<6LM/55
M./:^$U<MYZ=:)V;<'&4HQC+U:.49J69RIG;>-%6D:T2ILR4KFABAE\GG(&.D
M>-Y.=A\NN.^XCNFY.+6M3C84D74VL*&A5@1UBL:&Z;G=QMRDJ1C<A5+@FE1\
MZX3.N[_M.[.[&$JW)6;E&U12MMMJO#%\#I7D),=S%P& D8]G#0YSN,CR\AE)
M+LUULS#)GPU1$H;4@6"4 A2EGM+/&PL*JN[LNWHR<W%2:C%43RTC+-CS\7!R
MD6-]Z?33@K49N"E.;<FL^:<'"B:X%PO;)\5#6SNY++.SC&BZI6UBI:N^(4T^
MLS5RTBPXZ;*"36P^"J[U7A=XN#JJ)IO$LL=/ECC8J\=C?>.?099>Z]HG)9IU
M#&3\0W0RXG+E2V%2HSRY")0[AP_QJ-:-*PO25)\!K%6CU&2"K"MIK+MHUE<<
M5P.CPI6C,^6\-&[MQI7,M]//ZN:+<E/JO]Y55'7+5<I+D=_PY+$N'$AOM12[
MA40M3J>],7!M.-#OU(2 IQS6%<!9/W!4VMW2BTY-5I<KAPW&GAR+S^4MWM\0
M:E&$6HULJ...6RI+K-+%NJX*+R(V;:7,'%S=TI;DW@L3=SR=P^-2GD(9:8=B
MO-AM1/0NZP-5[5KM9NVY&Q5=9QM*W1+%O-%UYC>;LWS:EJ:2ZBEJ)W<TFDDG
M&2H^7'::VSO7;^+QR,-BHLYV"B%EVN^F.-%WQK,,(8X! L&FPV#TW4238=%;
M"6AO7)YYN-<UO96E(-OI=?(:>.]-/9AW=J,W')=76:KFNQ4>#]U95SMM\AD,
MES61*?AY6,TZS,,O'3,KBPQ$;BO'%D*3:2A'C"KE T!R^@$BY%6+6Z'%.#::
MRS495E59_P#37+STVF5?^8L[C<BFI9K<IPRP49=WLZZ6?:E3-7+5JK)XW,G#
M0S+:@)FPD-Y*1E\5,$:!*D)=F(0'$."0A024J3V'6U7*>!3T6IENNY*CEEEU
M5"2K-+JUI2CQY4^'A*[>_+$'+)GCUY7(/+;E*LDJIYDZ4:PE%UI@UL+./S P
M8QZ'I,&6<^C /[9 :=0F$&EM+0V_I(*M5U=M'O;]H<>%7I;NNYZ*4<G>*YLZ
MU:JJXN9^0QX;YL=TJQEWG<RLX-9:4:4N.O&MG#MP.<UT!R)U[U<!??LI9L C
M%R%$GJ'>LC]VN3^:'_\ 47YU]S.]^2%77R_]<OOB>HP^]) 3%NAD<%/D=/\
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M9.G]R3RQG-5XH]6JCAFVR_>V&3RO-,YX9=K(Q%14R<E%RN&DX\-1Y,1V*X4
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MR263+3&M4Z^@UVKT5NUIK-Z,G)W<U:JE''+LQ==NWD*T';V"RNV<A/Q\B?\
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M1%(#;SB0A:@XVESM)!(!&JU9NAU#U%F-QJC?IH:[>FC6DU,[*>91ICLVI/\
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M45)I23=:TRX/;TUE1+;A;Y'8V73+:;Q\)3:'Y,#'(BORH[LA,S(QD/M!6C0
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M"@,!O'^Z(WTKAO\ -(M -B_J1MKZ*@_HZ* S] * 4 H#@WK/?W/M_P#XE_\
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M*"B$I4> -KUZMN2+6AM\K_\ F_P/ _F:2\5O/"E%_P#S2Z:X+B=#F-=(<@*
M4 H!0"@% * 4!NT3FCN.%CMM8QI#!9VQ),J&M065O&Z[(>[?%(2XI TZ>R:T
MT]TV93N3=:W51\G-AR5X<3H;>_\ 56[5FVJ4L2S1P=7MPECLHVL*8=):1-_Y
MF+OE6_RTP]F%/.O]RX%F..];4UI "PK2E*K)[74.FKT]W6Y:7X;%1HERX.OG
MYBQ;WQ?AK?C.J[E6\4\N*I2E:T2V8])2VUN]K;00\C!8^?E(TD38.1E!_OF7
M4Z=/!MU"5)24ZDI4/?<>-5:K1._AGE&+5'%4HUY4_P#H4:#>*TJ35J$Y1EFC
M*6:J>'%))KA2>QXF!GSI63G2<E.<[V;,=<D272 -3KJBM2K  "Y/56;;MQMQ
M48X**HO(:V[=E=G*<W64FVWRO%G8_5F'_P"F.5-O_P V*X__ +=FN3^:?T\/
MS_@SO_D7]9<_]?\ \HGIMN2EU994"T\+W;5TD#P'H->:GLY:8?Y0U9$3Y;,M
M/CCGB:6 !W,?2C2TY8#M@W)OX: H;P6E&T\\I9"4C'2[D_[!=9>C_OV_S1^]
M&OWDZ:2Z_P#1/_:SP77MY\R"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MRHY<.@FS)N N]A<W(V+O])]WBGZO[B6:N;UNI*F/[W9,:6JL4OQ[W"259?\
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M"@,!O'^Z(WTKAO\ -(M -B_J1MKZ*@_HZ* S] * 4 H#@WK/?W/M_P#XE_\
MFTUV_P J?W+G,OO/,OGS^S:_-+[D>:J]#/(10%>-*<C*X#O(ZRDOQE*6EIY*
M%!02L(4DD7'A]JJ)P4N?CXN8N0N./-PK&CIC1TI]MAM>RMW;FV=,\=VE*+Z'
M"A,G$NI*TOJ[LK62PA1)2C2?RB2%6\%R*U>NT=C4QRWE3BEQ8X8\O%L-WNK>
M.JT4\VGE7C@\5+"KZJ?[M/6P=.*K1W?;?K&[0R32$;A9>PLS\-82J5&/LI4V
M-?'P%OAX37$ZKY9U$'_3:FNA^?#SGIFA^=M)=7]=.U+VH^95_A\K,MD\WR3W
M+)^5,EE8#L@H2V\KQIR,7FDFX0\A*V^]2#^"XE7WJQ;5C>5A9(PE3\J=.9XT
M\AL-1J=S:J7>3N0;IVW&JXI)-9ER23*V3YW\L\&P&H^1\=+20EN+CV5+[*18
M!*B$-@"W1KJFUN'6W75QRUX9/[/S%>H^:MVZ=44\U."";Z'A'SG'MY\Z]U;S
M8=@8)OS?V\X5,NRU.$.N'0I8;6^ $HUI3P0GB>C4175Z'<5C2M2N/O)\7%RJ
M/#3C\QP.\_FC5:Y.%I=S:V5KB]KHY;%5+U5S5:.3*E)8;+$$J2E:;//]IMQQ
M*TH*FE!*U)*$K2=/"YZ3U =2H5=9?;;CLVT.%SY52+VK%XJM:8;6J)K#CVO@
M2M*NED4!4CR)$1]N5%=6Q)94%LO-**%H6DW"DJ38@CPBJ914DTU5,JA.4)*4
M71K8UP&=F[[WEDC>?G)D@^+NPCK=)O'D:0ZV?"%Z4ZK]-A6%;W?I[?JPBL4]
MG"MC\AL[V]M9=]>[)]5QV_NRVKRT5>.AB',GD'8#&*=DN+QL9Q;T>*5$MH<<
ML%*2GJ)M64K4%-S269X-F!*_<E;5MR>6+;2K@F]ID\IO3=N:;C-9;-3);<-:
M78R77EG0ZCWJQQ]^.I1X^S6/:T.GM-N$(K-MP\W-R&9?WIJ[ZBKER4LF*JW@
MUP\_+M*LG?V]ICK;\G<$]QUEP/L*,A?Y-U+:F@M !LE6A:DW3X35$-W::*:5
MN..&Q;*UQ\I7<WOK;CK*[.J=5UG@Z-57%@WL+>;O#=61F0LA.S,N1.QMO$)#
MCRRXR1;BDWN";"ZND]=7(:*Q",HQA%*6U4VEN[O+579QG.Y)RAZKJZK]O&]K
MX2G+W1N.<\U(EY22Z^Q)5.8<+J@IN4X4E3J""-*KI3Q'@JJ&DLP32BJ-9=G!
MQ%N[K]1<:<IR;4G)8O"3IBN)X+9LX"YF;XWC/DQYDS.3794-Q3T1TO+"FG%I
M"5%%B--P+&W[IJW#0:>$7&,(I-4>&WG+]W>VLN24I79MQ=5UG@WAAQ?;C9!W
M>N['I&0ENYB2I_+,B+DE:S^792DH"%@<" DD#AUGPT6AL)12@J0=8\CY");T
MU4I3D[DJW%EGCZRI2C\GVQ(Q]\;PB3IF3C9R8UD,@A+<V2EY0<=2VG0C4;\2
ME/!)Z1U4EH-/**@X1RQV*FP0WKJX3E.-V2E-4DZNKI@NC@>U<!:,[DS['BO=
M9*0GQ*0N;%_**/=R7+%3HO\ A&W$U=>EM.M8KK*CPX.(LQUVHCEI.75EF6+P
MD]K^WXLQSKKK[JWWUJ<>=45N.+)4I2E&Y))Z2360DDJ+88DI.3;;JV=H]6;]
M<,K]&J_GV:X_YI_3P_-^#/0OD7]7<_)_\HGJ%;:5CCTCH(Z17FQ[.87!*@MO
M9?Q6&J)JGN>-.J24!^0&FDJ=L>H@!-QP.F_70$^[?U4SOT?+_F%UEZ/^_#\T
M?O,#>/Z6[^27^UG@JO;SYC% * 4 H!0%1N0^RAYIEU;;<A(;?0A12EQ 4%A*
M@.D!20JQZP#5+BFTVMA4I-)I/;MY<:_>D^=%.JBD4 H!0"@% * 4 H"K)E29
MKRI,QYR1(78+>=47%G2 D74HDFP  JB$(P5(JB+ERY*Y+-)N3XWBRE59;% *
M 4 H!0"@% =<]7+_ %!<^CI'_K:KE?F;])_W+\3NODG]>_R2^^)ZRKR\]Q/'
MW/W_ %-R7^QB_P PBO5_EW]%'GE]YX)\W_\ Z4^:/^U',JZ,X\4!7:A3'VEO
ML1W76&@I3CJ$*4A(0 5$D"PL#QJB5R,71M5+L;,Y)N,6TN0N&\/,#Z&)J%P.
M\87*:7):>2%MH0I8*0E"E$*TV"K:?"0+FK;O1I6/6QI@UZ?VE?<34DI++59L
M4]E&ZX)O&F#V<;2JU*WALPZAE;6/DK1(<2RPI++B@XZM(6E"2$\5%)"@!U<:
MEW[:K62PQ>*)CI;TDFH2=718/%M5HN6F/,96/LW+2]O+ST5M;[K>0.+7C6FG
M5RDK0P7U.%*4FR4@6/7>L66NMQO=V\.KFS55-M*&=#=5Z>G=Z*;:GDRI/-ZN
M9OF,(W!FO=UW49USQ@J#&E"E=X6_?!-AQT]=NBLQW(JM6L-IK8V9RI2+>;9A
MMIMH56<1EI!9$>!(=,A01'#;*U=XM2=02BP[1(XV'55,K]N-:R2IMQ+D=+>E
M3+"3S;,'CPX$HQF2*92Q#?*()TS5=TNS"KE-G#;L&XMVJGO888KK;,=O-QE/
M<7.MU7U/6P?5Y^+RDR,1EG$-.-P)*VWW$,,+2RX4K==2%(0D@<5*!!2!Q(J'
M>MIM9E@J[>#C)6GNM)J+HVDL'BWBDN5K8N$E;QF2=5)2U#?6J&%*F!+2U%D(
MN%%RP[-K<=52[L%2K76V8[>8A:>X\U(OJ>M@^KS\7E(?)N1\57.\3?\ $F])
M7)[M?=)#A(1==K#400./&G>PS9:JO%7$CN+F3/E>5<-'3'9B7.9V_FMO/,L9
MJ"["=?:0^R'DE.IMQ"5BQZ+@*&H=*3P-CPJBQJ;=Y-VY*5'3#[?]> NZG1WM
M.TKL'!M555QI/\<>)X.C)/D+-^,1X?R9+\;EH[R)'[ASO'4<3J;3INH<#Q%3
M\1:HY9E1;758<Y'PE_-&&26:6*65U:Y%PEN8,T*2@QG0M;ICH3H5<O)L%-@6
MXJ&H73T\:N=Y'C6RODXRUW4ZTHZMTV<*X.?%8<I,K'9!$=<M<1Y,1IPL.OEM
M8;2\.E"E6L%?O>FH5V#>6JJU7;P<9+L7%%R<7E3HW3!/BY^0K-8/-/K4VQC9
M3KB$*=6E##BB&T**%*(">"0I)23X1:J):BTE5R72BN&EO3=(PDVE7!/8G1OI
M37.BE&QF2F,N2(<-^0PTI*'766EN(0I?O0I200">J]52NPBZ2:3?*4V]/=N)
MRC%R2VT39(8,U,-.05&=$!:^Z1*+:@R7!QTA=M)/#HO4]Y'-EJJ\7"4NS-0S
MN+RMTK3"O%4H5<+0H!0"@% 3-*TN(5^*H'[QJ'L*HNC1] <<GNX_<C@&B$ >
MTD5X,W5OG/JA*B2Y$<K]9']0(_TDQ_-/5U?RQ^K?Y']Z.#^=_P! O_9'[I'E
M"O3SQ$4 H!0"@% 5')#[R&FWG5N-L)+;"%J*@V@J*RE(/0-2BJPZR:I44FVE
MM*G)M)-[,%R8M_>V^=LIU44B@% * 4 H!0"@*K$J5%[PQ7W&"\VIE[NU%&MI
M?!2%6(ND]8/"J)0C*E56F/E+D+DX5RMJJHZ<*?!S%*JRV* 4 H!0"@% * 4!
MZD]6;]3<I])K_1V:\U^:?U,?R?BSVCY%_1S_ /8_]L3M5<>>AB@% * P&\?[
MHC?2N&_S2+0#8OZD;:^BH/Z.B@,_0"@% * X-ZSW]S[?_P")?_FTUV_RI_<N
M<R^\\R^?/[-K\TON1YJKT,\A% * >U0%X,BZI2#*;;EI2I@E+R>*D1DZ$-ZT
ME*PC3P(2H7L.L"K7=+@PV[.7&O%4O=\V^M27J[?]*HE54=*88-<'"D2=_%+.
MCQ4=[W7=]Z%J_C>]U]X1T>\_)Z>CKZ:G+*NWA\U-G3B1FCEIEQI2M>'-6O1U
M:>7:3KFLAQ:HT-EE*EOE(5J>*6WTZ C\H2#W8N4*MJN;WZ+4JVZ8MO9R;.'#
MCX> J=Q5;C%+UN7!X4Q[/ ]M<:[*6[\A^2L./K+BPE#8*OQ6DA"1]Q( JY&*
MC@BU*3DZOB2Z%1>8IU44B@% * 4!?XS!YC,B2<3!>F"&T9$HL(*^[:3TJ5;H
M%6+NHMVJ9Y*.9T5>%F58TEZ_F[N+EE5715H@<)EQB$YXPGAA5.^+IGE![DN]
M.D*Z+\*?$6^\[O,LU*TX:!Z6\K7?97DK3-3"HPN%R>X<FQA\-',K)2=7<,)*
M4E7=H*U<5D 62DGB:7[\+,'.;I%<(TNENZFZK5I9I2V+F5>'D+#HX5?,44!?
MXO"Y3-&8,7',@P(KL^98I3W<9BW>.'41<"XX#C5B[?A:IG=,S45SO8C)L:6[
M?S=VJY(N<N2,=K+"KYC"@,O)VMN2'DXF&EXN2QEIP0J)#=;4AUQ+A*4E*3QX
MD$5B1U=F4'-23C':ZX(SIZ#40NQM2A)3G2D6L779@8MUIUAU;#Z%-O-**'&U
M@I4E238@@]!!K*3355L,.47%M-4:.T>K-^N&5^C5?S[-<A\T_IX?G_!GH7R+
M^KN?^O\ ^43U'7FI[.8O$"65Y,3)S4Y/CKGBZ6M/]'9T(LPNWX23<F_'C0%K
MNU*FMJ9XH!6CY.EGNQT_Q"^ ]NLO1?J+?YH_>:[>;II+SI7^G/\ VL\'U[>?
M,HH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!USU<O]07/HZ1_Z
MVJY7YF_2?]R_$[KY)_7O\DOOB>LJ\O/<3Q]S]_U-R7^QB_S"*]7^7?T4>>7W
MG@GS?_\ I3YH_P"U',JZ,X\4!O& WM%P>T8^&"7GI*<^QE9L(=B-*@L-)!9<
M5<WU+2+I*"GKZJTNIT$KVH<\$N[<4^&,F]J\G*=)I-ZQT^D5JC;[Y7&MD902
M]5OE:V4:X3/9[?\ A9>0+T20'L:^WFWPV(:V)+,G+0G(Z0XMQ]X*U*4G7W>E
M'9U6\&%I]W7(PI)4DN[7K534))X+*O)7'&AL=?O:S<G6#K%J^Z9&I*5VW**J
MW*5:MK-EI'"I9/\ ,<C$Y;'1<A.;[_#X;'XQ"%*0VS)QZ8XD$67V0=#ME =K
M5[-7H[L_J0DXQPG<E+E4LV7@YC'>^VK-RW&<U6W9C#@47!0S\.%:2QX:F;R?
M,7;&6>R3<;)Y/""5F(N83-BQT]XM$>"AE:%!#R2%J=2I23Q3?BKV,*UNR_;4
M6XPN4@X4;XY-I[-E/+Q&TU&_=-?E-1G<M9KD;F:,57"VHM82VN2JMJX7R28S
MF5M<Y:!GL@9L-_$Y;,SHL".RAX.,9D73^4+K806U#MC2=5^%57=UW^[E;CE:
MG"W%MNE'#DHZUX"C3[^TW>PO3SQ=NY>DHI)UC=Y<RRY7M5'7@X:8UCF#%7.V
MZPWDGH>(QV 3B)[,B.N0PIY86E\);:>;6D.)*1WK:TKX <!61+=LE&X\JE*5
MS.J.CIA3%IK#LM-&)'?,)7+,5-PA"SW<JQS*N.;",DU54ZT6I;-B+F/S"VY&
MQ+\;$(\0D09.5>QPR$5<Y4IC))TI#JDOI3WNC\DLO)<&FUC<<;<MVWI7$Y]9
M24%+*\N5QXL-E<5ERXEZWOG31LR5M9)1E=<<\7/.KFS,U)+-3JO,IJE,<"QF
M<R-6,FP(4^>RE6 Q6+@MI6I#;<R$I@O*3I7V04I< 5:YU'PU>ANOKJ4HQ?\
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MH^7_ #"ZR]'_ 'X?FC]Y@;Q_2W?R2_VL\%5[>?,8H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4!USU<O]07/HZ1_P"MJN5^9OTG_<OQ.Z^2?U[_
M "2^^)ZRKR\]Q/'W/W_4W)?[&+_,(KU?Y=_11YY?>>"?-_\ ^E/FC_M1S*NC
M./% 9C#;5W#N%MY[#8]R6TP0EQ:-(!6H$AM.HC6L@7"$W4?!6)?U=FRTIR2K
M]J\BY7@;#2[NU&I3=J#DH_:BXWR+'D,TKEYEI.V<1G\.R].=FMS7)T<)2GN?
M$GBWI0"K4XHI&M24IN*PUO*W&].W-J.5QH^/,N'BXC9/<EV>EMWK2<W)3<EA
MAEE3#&KPQHE4M)VPMPP&\(XXAA:<_%,Z$0^T@); 4HAQ3BD!)"1J-S;C:][@
M7;>\;4W.E?Z;RO!^:FW'[4,2[NF_;5IO+_6CFCUELVNM:4HL>+EK5*V.T\NV
MN3!D0I3>:9F18"(?=)*%.S4K4VDN:Q92PD%O2E06+G4.%[GQEMI24EE<92K7
M@C2N%.#AXN+BL/07E)VY1DIJ484IPRS4QKPTZM$U)5=5A5+V3NR#+@P9>)D-
M2\B%JAMJ2.WW7\8"0;)+?2X%$% XJM2&OL3C*2FFH[?PZ>#CX"NYNK56YPA*
MW)2N>KR\?-E_>3]7]Z@:V7NA^:[CVL:XJ0PRB4X=2 UW#MN[<#I5W92N]D$*
M[1X"YI+7V%%2<L&Z<M>%4VX</$3#=6JE-P4'5)2X*4>QYJY6GP8X\!-O?;S.
MU-SSL!'?7):A]R.^=2&UE3C*'% I!(&DJ*>GJJ-!J7J+$;C5,U?O:)WMHHZ/
M52LQ>91IB^6*?XFOUGFJ% * 4 H!0"@% * 4 H!0"@% * 4![GASY#09?*RL
MK;:+NKCJ[ _9KP:6U\[/JJ/JKF1HOK'J!Y?QC<"^28M[/Y%[HKJOEC]6_P C
M^]'!_._Z"/\ [(_=(\I5Z>>(B@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0'J/U:E!O96241V3E'+D<2/Z.QTB_[E>:?-/ZF/Y/QD>T_(OZ*?\
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MR?BSVCY%_1S_ /8_]L3I652M,Q95[U0!0?8M;]NN//1"A#;4[*:2GI"@21U
M=/[% ;%=QKWW;;\(Z1[=""*GFTI"M5P>BU :_NU]#F)8 -B,GB%=KA[W)QC^
MY0%78OZD;:^BH/Z.B@,_0"@% 2K6$)*U7LD7-A<T!P/UF7B[A]OGNEH3XR_Q
M6+?^VGJKMOE3^Y<YE]YYE\^?V;/YI?<CS?7HAY"* 4!%2E+45J)4I1NI1XDD
M]9-0E0ENI"I(% * 4!%2E+45*)4H\22;DT2H"% * 4 H!0"@+B%.G8Y],K'R
M78DI/!+\=Q33@!\"D$&K=RW&:I))KEQ+MJ].U+-"3B^-.C\Q2===?=6\^M3K
MSA*G'%DJ4I1XDDGB2:K225%L*)2<FV\6R2I*10"@% * 4!VOU9OUPROT:K^?
M9KC_ )I_3P_/^#/1/D7]7<_]?_RB>HZ\U/9S%83O^\RO?9%&0'CSG=)1;^BH
MT-VCJMUIXJX_C4!3W;^JF=^CY?\ ,+K+T?\ ?A^:/WF!O']+=_)+_:SP57MY
M\QB@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'7/5R_U!<^CI'_
M *VJY7YF_2?]R_$[KY)_7O\ )+[XGJ>;!3,2..EQ/O5>QX#7EY[B>/\ GA&7
M%YDY1"U!14W$5P]B,VG]RO6/EU__ $8<\O\ <SP'YNC3>EU\>3_9%?@<\KHC
MDA0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#Z$1/\ =6/]FC_T
MBO")^LSZGM^JN8Y+ZR) V!&N;7R; 'L_DGJZCY8_5O\ (_O1PWSO^@C_ .R/
MW2/*->GGB(H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!ZD]6;]
M3<I])K_1V:\U^:?U,?R?BSVCY%_1S_\ 8_\ ;$[,ZRT^G2Z@+ Z+UQYZ&09C
M,,7[E 3?I(Z?OF@*M 8][^-5PMQH28#=G]U,?2>(_P SC4(,AL7]2-M?14']
M'10&?H!0%)Y#KB0EI?=@GM* NJWL4!.VV&D!M)) ZR;G[] :GOOEYA>84:'%
MS+\EAN"M;C1B+0@DN  ZM:%^"MKN_>5S1-N"3S<?_5&BWON6SO*,8W7)9759
M:</.F:1]FG8W]?RGYV/\16Y^J=5V8=#_ )CG/H;0]NYTQ_E'V:=C?U_*?G8_
MQ%/JG5=F'0_YA]#:'MW.F/\ *2K]6S8J$E9G9902+Z4NQ[GVOR%1]4ZKLPZ'
M_,%\C:'MW.F/\I!OU;MAO(#C>1RBD*Z#WK'Q%3]4ZKLPZ'_,/H;0]NYTQ_E)
M_LT[&_K^4_.Q_B*?5.J[,.A_S#Z&T/;N=,?Y1]FG8W]?RGYV/\13ZIU79AT/
M^8?0VA[=SIC_ "C[-.QOZ_E/SL?XBGU3JNS#H?\ ,/H;0]NYTQ_E'V:=C?U_
M*?G8_P 13ZIU79AT/^8?0VA[=SIC_*/LT[&_K^4_.Q_B*?5.J[,.A_S#Z&T/
M;N=,?Y1]FG8W]?RGYV/\13ZIU79AT/\ F'T-H>W<Z8_RDJO5LV(@75D,H!_M
M6/B*?5.J[,.A_P P^AM#V[G3'^4D3ZN&P5&PR.4O[+K _P#D5'U3JNS#H?\
M,/H;0]NYTQ_E*OV:=C?U_*?G8_Q%3]4ZKLPZ'_,/H;0]NYTQ_E'V:=C?U_*?
MG8_Q%/JG5=F'0_YA]#:'MW.F/\H^S3L;^OY3\['^(I]4ZKLPZ'_,/H;0]NYT
MQ_E'V:=C?U_*?G8_Q%/JG5=F'0_YA]#:'MW.F/\ */LT[&_K^4_.Q_B*?5.J
M[,.A_P P^AM#V[G3'^4?9IV-_7\I^=C_ !%/JG5=F'0_YA]#:'MW.F/\H^S3
ML;^OY3\['^(I]4ZKLPZ'_,/H;0]NYTQ_E'V:=C?U_*?G8_Q%/JG5=F'0_P"8
M?0VA[=SIC_*2+]6K8_"V1R@/@[V.?_D4^J=5V8=#_F(^AM%V[G3'^4D^S5LD
M]&1ROYR/\13ZIU79AT2_F'T+HNW<Z8_R%1/JU[%/#Y0RE_9=CW_F*?5.J[,.
MA_S$_0VA[=SIC_*;5L;E+MS8&2D93#R9C\B2P8RTREMK0$%:5W 0V@WND==:
MW>&^;VL@H344DZX5]+-SNGY=T^[KCN6I2;DJ=9KC3X$N(WVM&=.6T3'PH"I*
MH;*653'E2I)3^&\L)2I9]DA(H!D8+63Q\O&OE26)C+D=U2" L(=04$I)!%['
MA5RU<=N:DML6GT%F_:5VW*#V2373@<C^S3L;^OY3\['^(KJOJG5=F'0_YCA?
MH;0]NYTQ_E)5>K;L-%M60RI)Z$AV/<__ +BH^J=5V8=#_F'T-H>W<Z8_RDI]
M6W9"5:USLHEL_@AUCL^W^0-/JC5=F'0_YB?H;0]NYTQ_E)E>K3L=2;MY'* ^
M'O8Y'\Q4_5.J[,.A_P Q'T-H>W<Z8_R%/[-&S?G+)_G&/B*?5.J[,.B7\Q'T
M+H>W<Z8_R%0^K9L1";KR.4_.Q[G_ /<4^J=5V8=#_F)^AM#V[G3'^4@GU:MD
M*)49^42D]">]C\![/Y"H^J=5V8=#_F'T-H>W<Z8_RDQ]6K8H!)R&4L.G\K'^
M(J?JG5=F'0_YA]#:'MW.F/\ *03ZMNQG0'!.RB 1P3WK'W^+!Z:A?-&J[,.A
M_P Q+^1M#V[G3'^4@OU:MCCHR642?9=CG_Y%3]4ZKLPZ'_,4_0VB[=SIC_(0
M'JX;&2C2J7DUJ_'#S /WNYM5/U1JJ^K#H?I*U\CZ&GK7.F/\I+]F_8@%E9'*
MH5X5.,?$6JKZIU79AT/^8I^AM%V[G3'^4J)]6S8B^*<AE/:#T<__ "*CZHU7
M9AT/^8?0VA[=SIC_ "DCGJY<OV39W)Y))\!>CW_F*GZIU79AT/\ F'T-HNW<
MZ8_RDK7JX;&?<5W60RG<HX%?>QSJ4? >XZ!4?5.J[,.A_P P^AM#V[G3'^4K
M_9IV-_7\I^=C_$5/U3JNS#H?\P^AM#V[G3'^4?9IV-_7\I^=C_$4^J=5V8=#
M_F'T-H>W<Z8_RC[-.QOZ_E/SL?XBGU3JNS#H?\P^AM#V[G3'^4?9IV-_7\I^
M=C_$4^J=5V8=#_F'T-H>W<Z8_P H^S3L;^OY3\['^(I]4ZKLPZ'_ ##Z&T/;
MN=,?Y1]FG8W]?RGYV/\ $4^J=5V8=#_F'T-H>W<Z8_RC[-.QOZ_E/SL?XBGU
M3JNS#H?\P^AM#V[G3'^4?9IV-_7\I^=C_$4^J=5V8=#_ )A]#:'MW.F/\H^S
M3L;^OY3\['^(I]4ZKLPZ'_,/H;0]NYTQ_E'V:=C?U_*?G8_Q%/JG5=F'0_YA
M]#:'MW.F/\IL6RN3FV=B9DYO$RIKTI3*XY1)<:4WH<*239#2#?L^&M?KM]WM
M7;[N:BE6N%?2;;=?RUIMWWN]MRFW2G6:ICS)'0ZT)U1S;=_)3:V],Z_N#*2Y
M[4R0EM"T1W&DM@-("!8+:6>@>&NAT6_;^EM*W!1:7'7A\IR.\OE;2ZZ^[UR4
MU)TV-4P5.&+,']FG8W]?RGYV/\16;]4ZKLPZ'_,:WZ&T/;N=,?Y217JW;"1P
M5D<I?P!U@G^8I]4ZKLPZ'_,/H;0]NYTQ_E(_9MV.I)2W,RB2>AQ;S%Q[0# _
M9JGZHU79AT/^8GZ&T-/6N=,?Y25'JU['U%"LAE2H?_%CCA['Y"JOJG5=F'0_
MYB/H;0]NYTQ_E*GV:=C?U_*?G8_Q%/JC5=F'0_YA]#:'MW.F/\I(?5MV,@67
M.RI'4L.L?L_D*CZHU79AT/\ F)^AM#V[G3'^4@/5QV"3PR&5/L!QB_Z/3ZIU
M79AT/^8CZ&T/;N=,?Y2/V;=D@ZS,RG=VMH[UC5[=^YZ:?5&J[,.A_P Q/T-H
M:^O<Z8_RD4^K9L18NG(90C_:Q_B*GZIU79AT/^8CZ&T/;N=,?Y0GU;-B+%TY
M#*$='\:Q\13ZIU79AT/^8?0VA[=SIC_*3?9IV-_7\I^=C_$4^J=5V8=#_F'T
M-H>W<Z8_RC[-.QOZ_E/SL?XBGU3JNS#H?\P^AM#V[G3'^4?9IV-_7\I^=C_$
M4^J=5V8=#_F'T-H>W<Z8_P H^S3L;^OY3\['^(I]4ZKLPZ'_ ##Z&T/;N=,?
MY1]FG8W]?RGYV/\ $4^J=5V8=#_F'T-H>W<Z8_RC[-.QOZ_E/SL?XBGU3JNS
M#H?\P^AM#V[G3'^4?9IV-_7\I^=C_$4^J=5V8=#_ )A]#:'MW.F/\H^S3L;^
MOY3\['^(I]4ZKLPZ'_,/H;0]NYTQ_E'V:=C?U_*?G8_Q%/JG5=F'0_YA]#:'
MMW.F/\H^S3L;^OY3\['^(I]4ZKLPZ'_,/H;0]NYTQ_E'V:=C?U_*?G8_Q%/J
MG5=F'0_YA]#:'MW.F/\ */LT[&_K^4_.Q_B*?5.J[,.A_P P^AM#V[G3'^4I
MN^K?L-ALNN3\J4IZ@['N3X!^0ZZ?5&J[,.A_S#Z&T/;N=,?Y2+?JU;)* 7)^
M4"SQ(#L?A?J_B#4?5.J[,.A_S#Z&T/;N=,?Y2?[-.QOZ_E/SL?XBI^J-5V8=
M#_F'T-H>W<Z8_P IV-M :;0VGBE "1?IL!:N2;JZG?Q5%0U/?^S,9OK&,8?+
MO2&(K+Z92%Q5(2LN(2M !UI6+66>JMAH-?<T=QS@DVU3'R<5.(U&]MTVMY6E
M:NN22EFZM*UHUPI\9SO[.6R?G'*?G(_Q-;SZIU79AT2_F.7^A=#V[G3'^0N6
M?5LV.M&I60RG3_*QQ_\ (J?JG5=F'0_YA]#:'MW.F/\ *3GU:=C$<,AE0?#W
ML?XBGU3JNS#H?\P^AM%V[G3'^4)]6C8XZ<CE"?\ :Q_B*?5.J[,.A_S$?0VB
M[=SIC_(1^S3L;^OY3\['^(I]4ZKLPZ'_ #$_0VA[=SIC_*/LT[&_K^4_.Q_B
M*?5.J[,.A_S#Z&T/;N=,?Y1]FG8W]?RGYV/\13ZIU79AT/\ F'T-H>W<Z8_R
MC[-.QOZ_E/SL?XBGU3JNS#H?\P^AM#V[G3'^4?9IV-_7\I^=C_$4^J=5V8=#
M_F'T-H>W<Z8_RC[-.QOZ_E/SL?XBGU3JNS#H?\P^AM#V[G3'^4?9IV-_7\I^
M=C_$4^J=5V8=#_F'T-H>W<Z8_P H^S3L;^OY3\['^(I]4ZKLPZ'_ ##Z&T/;
MN=,?Y1]FG8W]?RGYV/\ $4^J=5V8=#_F'T-H>W<Z8_RE%SU:MFI/8R&4*>K\
MI')_F*?5.J[,.B7\Q'T+H>W<Z8_R!KU:]E*4=61RG9Z4]Y'!_F*?5.J[,.B7
M\P^A=#V[G3'^4K?9IV-_7\I^=C_$4^J=5V8=#_F)^AM#V[G3'^4?9IV-_7\I
M^=C_ !%/JG5=F'0_YA]#:'MW.F/\H^S3L;^OY3\['^(I]4ZKLPZ'_,/H;0]N
MYTQ_E'V:=C?U_*?G8_Q%/JG5=F'0_P"8?0VA[=SIC_*/LT[&_K^4_.Q_B*?5
M.J[,.A_S#Z&T/;N=,?Y1]FG8W]?RGYV/\13ZIU79AT/^8?0VA[=SIC_*/LT[
M&_K^4_.Q_B*?5.J[,.A_S#Z&T/;N=,?Y1]FG8W]?RGYV/\13ZIU79AT/^8?0
MVA[=SIC_ "C[-.QOZ_E/SL?XBGU3JNS#H?\ ,/H;0]NYTQ_E'V:=C?U_*?G8
M_P 13ZIU79AT/^8?0VA[=SIC_*;[L;8F)V!C)&*P[TA^/(?,I:I2D+6%E"46
M!0A M9 ZJT>\-X7-9-3FDFE3#[,Z?=.Z;6[K;MVG)J3S=:G$EP)<1M%:TW(H
M!0%%Y@.]H&RO#0&O;MC:,2P5F]\GB  .'$Y.,!^W0%QL7]2-M?14']'10&?H
M"C(;<=;[MM6D*-G%=>CKM[- 54I2A(0D62D6 ]@4 4I*05*("1Q)/ 4!;>.*
M<OXLRIT#\/@A)]HJZ: >,R$\78J@GK*%!9^]P- 5FGFGTZFE:@.!'00?9% 5
M* I?D(P)X(#B^/LJ5PH"K0"@% * 4 H"RE$EVQZ .%"2C0%\RX%H O=0'&A!
M5!!Z#>@% * 4 H!0$"3T)^_U4 ";>R?#0$: @4@]/WZ AVA[(_9H"8&] * =
M'$]% 45*+H*&_>]:^K[E 191I!*AV[V*CQO0%6@*7<V-VU%'L#B/O4 T/?RG
M_P!V@(I:2#J)*E>$T!.DW%_9H"5>E:%)Z1T&U 3<$IX= % 4";FYJ * J(/9
M.K@!UGP5(+9Z1!0H]M)<MP".)O\ ^&] :^I2EJ*U*)43<D\:$F3P[KJ5.- %
M38&JP/0;T!EN_1T*ND_OA:A!.%)5Q201[% 1H!0"@% * 4 H!0"@)5+2@740
M* D[U2OXM!/[X\!0#NUJ_C%\/Q4\!0$Z6T(]Z /9ZZ FH"4H25!?X0Z#0$0I
M))2#Q'2* C0"@% 4G&M5U-G2HCC;H- 1:6FVBVE2>E)H"I0"@% * 4 H!0"@
M)5E002@:E#H3>US[= 2,B1Q4^I/'H0@<!]T]- 2JBI4YWA<<!O>P60/O4!.\
MEY21W"PA8-^T+@^Q0%JR7);@=> #3!(2$FZ5.#\+CU#JH"^H!0"@)'&TN)LK
M[AH"B(@OQ5<>"U"2<$L'2KBUU*\'MT(*U * 4 H!0"@% * 4 H!0"@*2NPZE
M?4OLGV^J@*M * 4 H!0"@'1Q- 6BY2K]@ )\)Z:$E1F1WATJ%E=5NNA!7H!0
M"@% * 4!@-X_W1&^E<-_FD6@&Q?U(VU]%0?T=% 9^@*$93CG>K7?25D-I/"R
M4\/V: KT!9Z?''E:^,5DZ0GJ6L=)/L"@.:<\-W9;;VTHTS;DQ<*9\K0(RY#0
M22IMU:M:1J!%CI\%;?=5J%V\XS55EDS2[YNW+5A2@W%YHK CE=UYJ+SOP.W1
M*<&!DX27*?@ITAM3[+CEEGA<D!%NFJ+5N#T,[C764TJ\F!-Z[..\(6TWE<&Z
M<%:F5YM3-V0MG.9/8C;QRG?,B:[$92_,;@$W>6PRO@MP6%A;HO[=4[MA9G>2
MNTI1TJZ*O!5\15O:=^%BMFM:JM%667ARKC^W*1Y19F#FMNR'X6Y9NXRB4I+Q
MRK2&)T-6E(,=U"4IX@@F_L\.BJMY6I0N)."AA^[BGRHIW3>C<M-JY*YCCF5)
M1_TLW'./"-ALA**BCQ>,Z\%IMJ26D%84+\+@BXK7VXYI)<;-K=GD@Y<29YFV
M[S+YC.[&E[;EY-Q_?>7?QKV!R"@@NI@9)A4A:T@) (:1&=N2.!5[5=E>T.G5
M]34?Z<5+,O\ 5%T\]4<!8WEJWIW;<GWLW#(_],E7S*+Z3?U\P\MC?5XC[R?F
M%W<DJ"F/'EKTA9FR'3'2YQ 3=%]?'AV:U:T4);P=I+JI[.1*IN7O"<-UJ\WU
MW&B?^INGFVE_RBW9E<IA-T8/,YEO-YS;4MYE.684AQ#\5YOO&' I' \0L?<J
MUO+30A.$XQR1FMG$^$O;HU<YV[D)SSRMM]9<*:P?WG,>6/,#=V8R>RVHFY\A
ME<_EY4CSCQ&1:;3CT8YAQ>IR.ZIM!+@;2%6;4KM<#:UCN=?H[,(W*PC&,4LL
MEZV9\:XJ\9S^[-??N3LI7)2G-O/&2ZN5<*=-M.*N)E-T<T=UP-_[OV-"RJHK
M^2R&*QV%R,A*?$\4T^U>0Z3I]\LJ2$!77<WX59T^[[4M/;NN-<L9.26V5-B,
MC5;TO0U5VQ&5'*4(Q;V036+\O ;+SCS&X-GL;%P^.S^4:1*?>BY*?$:1+R,D
M-MHLKN]-E+))-D@=-8>[+5N^[LI0C@JI/"*,_?%Z[IU9A&<L6TVE63P7!QF0
M=B;@SG*OY4QF[,YCLCC1-FF?.B-19SZ&$ND,O,E/!-P-*AQM5BMN&JRRMP:E
M143JE6F*9E+O;FBS1N33CF=912EA7!HN>24'<T_:D+=6Y-SRLVO-QFW4PI"4
M!N*M*U:N[4D DGH-ZM;U=N-UVX04,KVKA+^Y^]G85V=QSSKAX"CN')[EWAS-
MD<N,-F'-NX7#XQ&0R,N(VTN9(=?4D(0VIU*@A"0I))2+](/2+7;-NU8TRORC
MGE*5$GL5#'U%V]J-8]/"?=QA',VO6;?%78C7$[YW:WRYYCX_(9 N;HV4\Y!C
M[@CI#3C[:E]AQ2>TE+G!6K3P L.GB<KX.R]19E%=2ZJY>+]AA+>%]:741D^O
M9=,RX>7G*G*+=FX,ONR) QFX,ANK::\.F1FYF1CA*8>5)2>Z:D=TT5])&GM<
M.LVX1O+36X6FY15N>;JI/;'C:JRK=6LN7;RC&<KL,E9-KU9<2=%7F-+V5S"W
MQD9N 5B]SS\]NJ5FUQLWMMR.'(+6(#B@IY3H9 :(2 ;A7W.R0=CJM'9BIYH1
MA!0K&5<<W%MQ-7HM??G*WEN2G<<Z3A3JJ''LP.F2\AN[F#S'W-M3%9^1MC!;
M29BI4N"VTN3)FS4%Q*UJ<2JS:0"- Z?#X--&-K3::%R4%<E<;V[$E^)OISOZ
MO57+4;CMQM*/JTJW)5X>!<1JN2YG[ND<C=R9961#&[=N9;Y$>RL4(1XQW4AE
M)=2D I&I#ECIX<"16=;T-E:Z$:=2<<U'P8/#S&NN[QOO=UR6;^I;GDS+AHUC
MY4S.<K\_FMS[BW/@\/N;(Y;9D;'H;:RV4::9RD7*R> [M*FFU% 2%+'>-VU
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MCM^_ L[NU.IU5R,9UBK*:G_JG6G%Q*N'&=N"5.\7#V>I _=KFSJRL  +#@*
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M!>@(D@"Y-AX30%/O@>#8*S['1]^@&EY?OE! \">)^_0$R6FTF]KJ\)XF@)Z
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MJ9BYH],M/9C:3JHHP>[.6T?<.<C;KQ&7F;=W3'8,,Y*!H5WT51U=V\VXDI6
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M.$SR)[W*>":KB72/'M)QOH8^U=R<^<)GD3WN4\$U7$ND>/:3C?0RF[ZUO)P
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M)RLB5)! ) )Z!4BC!(3[X@>W0A*H*@!<D >$T%"/3Q'10"@% * 4 H!0"@!
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M5-CJ )46P>TXP+6"SQ2>R;]-=?NW72OIQDL8\/!_UY#C-Z:"&GI*#PEP</\
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MS#8[(LJW_!B1X*'6V4!F2VA:9"G=+RK)62E8*;\;\*JM[OO)65)K^FW7;Y.
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M3,JT=?*7;=V=NN5TJJ>0R?GUO/S;5L_Y>G':ZK XI3RE1PE*@H)"239&H:M
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MNDT=R%Z5ZXTY25*1V>?F,'6ZZU.S&S:348NO6VUQXL.%G)ZVYI!0"@% * 4
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M=$:.A@ICQVKW#;*+G2D??/2237=Z;4:+3PRPFO2>?:K3Z[4SSSA+HP7,:O\
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MV3_,GW:>):;MH>&:KW<N@?4?S<]#LE^9/NT\1TW;0\,U7NY= ^H_FYZ'9/\
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MN+D\,-H\ZMS_ #U/\J>^%4]Q;[*Z"UW]SM/I9!6Z-S*24JS4\I(L1XT]T?\
MGIW%OLKH)6HNK]Y]+ W3N9("1FIX %@/&GN@?^.G<V^RN@CO[G:?2R/G5N?Y
M[G^5/?"IW-OLKH'?W.T^ECSJW/\ /<_RI[X5.YM]E= [^YVGTL>=6Y_GN?Y4
M]\*G<V^RN@=_<[3Z6/.K<_SW/\J>^%3N;?970._N=I]+'G5N?Y[G^5/?"IW-
MOLKH'?W.T^ECSJW/\]S_ "I[X5.YM]E= [^YVGTL>=6Y_GN?Y4]\*G<V^RN@
M=_<[3Z6/.K<_SW/\J>^%3N;?970._N=I]+'G5N?Y[G^5/?"IW-OLKH'?W.T^
MEDJMS[E4I*E9J?J0;H/C;_ ^$=OV*=Q;[*Z"I:FZOWGTDQW7N@DDYN>2>))E
M/7)_\].XM]E="(^(N=I]+'G5N?Y[G^5/?"IW-OLKH([^YVGTL>=6Y_GN?Y4]
M\*G<V^RN@=_<[3Z6/.K<_P ]S_*GOA4[FWV5T#O[G:?2QYU;G^>Y_E3WPJ=S
M;[*Z!W]SM/I8\ZMS_/<_RI[X5.YM]E= [^YVGTL>=6Y_GN?Y4]\*G<V^RN@=
M_<[3Z6#NK=!0IOY;R&A?OTB6^ ?;[=1W%OLKH1*U-U?O/I9DML<Q=X[3S<#.
MXW+2G'\>\E],9^0ZXPZ.A;:TE5BE:;I5[?AJU>TEJ[!Q<5B7[.NO6YJ>9X<I
M]'=H[SQV]MK8W=.&(\3R30<"=06IIP<'&EVX:T*!2?:KS/46)6;CA+:CU+3W
MXW[:G'8S+A]T&^J_L&K!DEZVL.("AU](H034 H!0"@,!O'^Z(WTKAO\ -(M
M-B_J1MKZ*@_HZ* S] * 4 H!0'A?UK.5_FINM.]<2SHP.Y'%*DA [#.2L5.#
MV \ 71^^U]0%=YN36][;[N7K0^[]FSH//=_:'NKO>Q]6?^[]NWI//==&<R*
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#TCZKW,OQ26KEGF7K1)RU2-N
MNK/!N61J=C7/0'0-2!^.+?A5SF]]+5=['@];FX_)]W,=/N;6?^&7#ZO/Q>7[
M^<]3US)U(H!0'+.?G+KS^V4Y)Q[.O<VWPY-QND=MYBUY$?V=21K0/QDV_"K9
M[NU/<W<?5E@_P?X?]#5[RTO?VL/6CBOQ7X_]3PT#<7%=L<&* 4 H!0"@% *
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M H![- 0(!H#<U\RLPG 2,!C<9B,0F=%1C\IDL;!;CSYD1O3^3=>!-@LH27-
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MQ!@,IC0(C2(\2,V+(:9:2$H0GV !7"MMNKQ;._225$J)%2H)% 8S<FX<9M+
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MRE%5NT@B]8-R]=G%QE*F2Y#'J\--M,,/^IL;>GM6GFC#-GMSPZV-.*M7UO\
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M7(.-$J\*J7K/R_8MS4JN5.!T/0%<\=** 4 H!0"@% 8#>/\ =$;Z5PW^:1:
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M4$E1CE*&RE*NU<DD<* RT_<&8Q^.8;G2V83ZLD[CW<H[%<6DLMLN.H<2RE7
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MD-M%8=L.GP$$4(*T7/Y2-K<D/M!F*ZD/P[&2XJ&MX!4LNI6HA*05=FW9T\:
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M1I+,9E(0TT@!*4I'0 !0%6@% 48\6/$2M,9I+27'%O.! MJ<<45*4?"23Q-
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4!@-X_W1&^E<-_FD6@&Q?U(VU]%0?T=% 9^@% *
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M\((%)>R&VEPVL9*,2&W%=AY!6A#CTI#@80=14FP44M<5)MQZJ 0]A08B9/\
M3'W'7VW6 Z=&L-N-=PDDD$J6E ';4>T: J0MIJ+N:?R3Q*\J$,I[JW8;0A*5
MN)&D!*GECO%I%QT4!5>V7C%)85'6N--BK>>CS&TM]X'GW0]K5=-E6/"RN!!-
MZ J93;!S>/:@Y6<MXA+K4EQ#:&P\V\+%)1Q L0DCVN/ F@+1K92&5MO,3!%>
M;0-1B,-L(<?#R7N]=0+A?:3P"NBYX\: RN%PJ\,'T)EJ=C/.+=3&T);::6XH
MD]V$^]3;I3T:KJZZ NW<;$>67%)(4>)TFP)H"X::;90&VDZ4#JH">@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@+:9#1+;"5'2M/%*O!0%BSAB%@O. H'X*>
MN@,N  +#H% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * P&\?[HC?2N&_S2+0#8OZD;:^BH/Z,B@,_0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% 8#>/]T1OI7#?YK%H#PSC/[MA?\ #M?^@4*BZJ *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
G!0"@% * 4 H!0"@% * 4 H!0"@% * 4!:Y#_ '9/^WC?SZ*D'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>fc_keydevelop-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_keydevelop-4c.jpg
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M%!04%!04%!04%/_  !$( 3L#NP,!$0 "$0$#$0'_Q #7  $  04! 0$
M        !@(#! 4' 0@) 0$  @,! 0               04" P0&!Q   0,#
M @,$ @D,$ ,%!P0# @$#!  1!1(&(1,',4$B%%$(8:'A,F(C,Q4W<<%"<M*4
MM'6U%G88@9&Q4I*R@[/3)%1T-54V5C2$%X)#<Y,ET:+"4V-$./'#A29DU$41
M  (! @,"" H'" ,! 0$!   ! A$#,1($(5%!87'14A,T!8&1H;$B,G*2LG/P
MP4(S%!46X6*"PM(C) ;Q0[-$HF,E_]H # ,!  (1 Q$ /P#[=SV^]F[7F!C]
MQ9R'C)KC2/ML2GA:,FB(A0T0E[%423]B@-GA\UB=P8]O*X28U/QKRDC4J.:.
M-DH$HE8DX<%14H"/S>J?3C'3'X$[=&-8FQ7"9D,.26T,' 720DE^"HJ65* W
MV&SF(W% #*8.8U/QSA$#<I@M;9*VNDM))P6RI;A0&PH!0"@% * P<MF<1@81
MY+-SF,=CVU03DRG!9:12X(FHU1+KW)0$2<ZT]*FETENS'JOP7-:?MBBT!M,/
MU&V'N!X8V&W)CI<HN 1VY+?.*_H!50E_:H"3T H!0"@% * 4 H!0',M\]=MD
M=/LZ6W<\$Y9XM-OJL9@'&]#M[<2<%;\/14@E^S=W8K?6W8NY\(CHXV8KHM)(
M!&W+LN$T5Q0B3WPKWU -]0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0&IW/N+'[2P$_<>51Q<?CF^=(1@4-S3=!\(JJ7XKZ: @&S_ %@MA[WW
M%$VSA0GIDIO,Y*OQQ!KXILG2U$+A6X"O=4T!U6H H"(9GJGTYV^^47+;F@,2
M@6QL"\+K@KZ"%K4J+]5* N8+J9T_W-)"%@]QP9<US@W%%X0>-?0+9Z2+]A*
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ML=>^D4B7Y)O=$<7572AN-R&FK_\ BFV(?LZJF@);F]V[;VYB S^:R+47#.J
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M;IT I1-JO@%^*X""=N[PN$B_L5#!SCJ%O.3U/ZA.3<ID$A81R4D. X[J)B'
MYFA#4!NJ^'XP]/$E_8J09O4O:_2C#8R!+Z=[J<S,W6C&1AR!)"5%%5YP+R6D
M045-*BM^U/9H#H.T]WSMQ>K7O3!9-Q9#NWDCLQ7374217GFS:!57BN@@-!]
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MEQU'V"(IVU (GZHWT@9;\4.?A+%2P9_4_8_1C"[XS>3W;NF6DK(22E_F_@V
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M)T'E-AWFHJD)+9H6T;[--R7O[[ 9/JO?2S#_ +G+_FZ,$0ZQ?2ENW\9R/X]
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M-W54 E(2$Q15NB$*V[K76H!&=J>K5T\VP;\ESS65G.LNL-OS3;5&4>!6R)H
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M+5K;<O[U+6J ;'8'3G ].,+)P. <DNPI4@Y3A2W!<<1QP ;5$4 !$2P)W4!
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M^G5Y-)?[_NT<SF=VF];^KM9.LZB67'-G]+VLN[R&G//K<O6JO1R^CR5W^6G
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M)J+M6UNU;\5IE6X58&/'!;@RV*\.* *+X>*=B=U^%,JW"K"QXZVNRVNE1(?
M/ @]ZJ<.T>[T4RK<*L]%ED20Q; 31%%"04140ENJ7MV*O&F5"K*ZR((3U:_T
M.]^,L-^4X]6'=WWZ]F?PLK>\_N/XK?QQ)P[\H?VR_NU7+ LWB4U) H!0"@%
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M\IYC>L:.6.F3<2Z\S%RD9'#=!Z>T[=7)&MPR(]5JA(ELZ[4F(H!0"@% * 4
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M*7!R0+#DLR7@%QIH@=MXC A(--]2+PH0;!C-XYY=)NI'<60[#:;D_$FZZR9
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MS8J7U* W5 :S#;@PVX&/,X:6,MCEM/:P0D3ER YC9>)$]\/&@-G0"@% * 4
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M$HSK(QE7FGI+0+;2FK78-Q)502=#V#LW=^+W;(S6Y)DQQ[1*%Z0"QO)3FWW
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M&2W7'Y<)A]YV.<)UQUL#(XKJW-DE)%N!+VBO!: P(6S]JXYCRT'"PF&-+@*
M1VTN+P"TXA+:ZZP$0*_:*(B\$H#R=L_:N2CG%G8:&_'<Y*&!L!94BBH,]U_
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M33 9?#%+3*QO+FQCL+B5).*//XV(HO.@JHBJ&IS0)6XZ:D,Z!0@4 H!0"@%
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MNF@J36A H!0"@% 07;'TI]1/[KM[^8D58W^RV>6YYT55CME[V;7\Q.JKBU%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@,CN_DOKUKYS9S'DOY1/M?KK4PP$\2
MQ69K% 0KJ]]%^[/Q>?\ &&K#N[M-OVBM[T[)=]EDU3WH?:!_%2J\LV*$"@%
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M0"@% * 4 H""A]-TC]$(_P"5'JL?_B7S7\"*I=OE\J/QR)U5<6HH!0"@% *
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M^PBK5EW;%RO[%7T9_"RK[TDHZ>K=/2A\:?F)\[\H?U56JQ8%J\2FI(% * 4
MH!0"@% * 4 H!0"@% 0+JC-APUV/YM\&->[,9HYA(-](O7_82Z77V:LM!%RZ
MVB_ZY?457>$XQZJK_P"V/UD]5%1;+VIVU6EJ* 4 H!0"@% * 4 H!0"@% *
M4!!-Y3(D;?\ TT:D2&V779^31H#)!4M6-<;2R+VW,A'ZJHE66FBW8O-+@C\1
M5ZN26HL)O[4O@:\[2)W5:6@H!0"@% * 4 H!0"@% * 4 H!0$!S,J*'6;:$4
MWVQE.83+\MA21'"U.,DEA[>* :I]JOHJRM1?X2XZ;,\/K*R[.*UEM-[<D_Y>
M9^)D^JM+,4 H!0"@% * 4 H!0"@% * 4 H" -RHJ]=9,5'@62FT&$5E"1314
MR3AJBI]J2%]1;U9N+_!)_P#]7\**E-?F#7_\H_'(G]5A;"@% * 4 H!0"@%
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M\)64HSC'[OJ]J61I>FY;JNNW[552INF]S8=G=<GEY_#MS6GL ,W/N2(QN9?
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ML:>M_P#:-G_>^4_I:^>_X6Z[XX<Q]-IK]]KW9_U#3UO_ +1L_P"]\I_2U/\
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MT<@M>I&%$[Z>SC6_O;J_P[ZRN6J]6E<>,X^X^M_%+JLN:C]:M,.(^MM/6_\
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M'^Y/TN'!I)K-+P;7A!<GE([_ $<CXG(91J!(@<AO$8C'9%J6UD5.2Z\^<N&
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M7U;^CZI;YE?^_I/W=<WYUJ^DO=1U?D.BZ#]Z7.=188:BQV8K Z&&&P9:"][
MV*"*77T(E4[;;JR\2HJ(N5!(H")[TZ:[-Z@G"<W7!.8>/%P(A-ONL:1>5%)%
MY:I>ZBG;7;IM;>T]>K=*X[*G!J]!8U5.M5<N&UK'D(M^K?T?_P E?^_I/W==
MGYUJ^DO=1P_D.BZ#]Z7./U;^C_\ DK_W])^[I^=:OI+W4/R'1=!^]+G'ZM_1
M[_)'_OZ3]W3\ZU?27NH?D.BZ#]Z7./U<.C]T7YE?X<?^.D_=T_.M7TE[J'Y#
MHN@_>ESG5$1!$1%+"*((IZ$%+)5,7I[0"@(?O+I?LGJ!*B3=U0')<F$V3$<V
MY#K%FR+6J*C9(B\:[M-KKVG35MTKQ5.#5=WV-4T[L:TPVM>8C7ZM_1__ "1_
M[^D_=UU_G6KZ2]U'#^0Z+H/WI<Y\Z=:.D+VRMZ08&UXCK^#W$H!@V;JZ:2E4
M6SC*1<55"5"%5^Q).VRUZKNSO%7[+=Q^E#UN3?\ 3<>-[W[J>GOI6UZ,_5Y<
M,OC\Z.]X+U9NFL/#08N>@NY#--LC\X3 E/M Y(5+GI$"1$%%72/#L3CQKS5W
MOO42FW!I1X%18'K;/^OZ6,$IQ<I4VO,\39-^KITA:=!T,*_K;(3&\V2J7%;I
MPU^Q6E]\ZMKUE[J-R[BT2=<C]Z1U154E4E[5XK5.7AY0"@(9O'I3L7?V0CY7
M=./<ESXS"1&76Y#K"(RADX@JC9(B^(RXUWZ;7W]/%QMNB;KA4K=5W;I]3)2N
MQJTJ8M;/!RLCOZM_1_\ R5_[^D_=UU?G6KZ2]U')^0Z+H/WI<X_5OZ/_ .2O
M_?TG[NGYUJ^DO=0_(=%T'[TN<?JW]'O\D?\ OZ3]W3\ZU?27NH?D.BZ#]Z7.
M7HGJ]=)8,MB;&PSPR(S@/,DLV02(;9(0JJ*?'BE8R[XU4DTY*CXD9P[DT<)*
M2@ZK]YG4%52527M7BM5!='E * @^[>D/3_?.53-[EQKDG)HR$?G-R7F$5MN^
ME%$"1+I=>-6&G[QOV(Y8.BY$RMU7=FFU,\]R-72F+7F-%^KAT>O?YD?7_GI/
MW==/YUJ^DO=1R?D.BZ#]Z7.?-?4/H[E=O=36-E8!DGXF>=%S;SAW).0Z2H0N
M%Q^05"UJOV*:E[:];H^\HW-,[LW1P];Z<?!XCQ6O[IG:U:M6U53]7Z<7#Q;3
MZ-A^K3TFCQ(\>5C9$R4TV(/S%EOMJ\X*6)S0)Z1U+QLG!*\I+OO5-MII+=1;
M#V<>X-&HI.+;WYGM-CC>@'2G$Y&)E8.'>"=!>;DQC*9(-!=9)#!5%2LME3L6
MM4^]]5.+BY*C5,$;;?<FCA)2C!U3JO2? =,55)55>U>*U4ET>4 H"";JZ-].
M]Z9ES/[BQCDG*O VTZ\W)>90A9'2'A D3@B6JQL=Y:BQ#)"5%R(J]3W7IM1/
M/<C67*T:7]6_H_\ Y(_]_2?NZZ/SK5])>ZCF_(=%T'[TN<?JW]'O\D?^_I/W
M=/SK5])>ZA^0Z+H/WI<X_5OZ/?Y(_P#?TG[NGYUJ^DO=0_(=%T'[TN<SL-T'
MZ7;?RT+.8K$O-9+'O!)B.E+?<$76UN*J)$J+9>Y:UW>]=3<BX2DJ/8]B-MGN
M;26IJ<84<=J])G1ZJBX% * @&YNBO3?=^;D[BS^+=D9>9H\R\$I]H25H$;%=
M $B)X11.%6=CO/468*$)4BN)%3J.Z=+?F[DXUD\=KY#4_JW]'O\ )7_OV3]W
M6[\ZU?27NHT?D.BZ#]Z7.?,N1Z,9V/U9'IE&U$,EY'8>0(;C\UE<_,EV)X 1
M4)/WZ::]=#O.#TO7O@Q7[V[Z<&T\1<[GN+6?AUPX/]W?].'8?3(^K=T?$1'Y
MGD'I1$UE-D(I62UUL2)=?8KR/YUJ^DO=1[?\AT70?O2YS9X#H;TRVQF8>?PV
M)=9RD ^;%=.6^Z(G91NHD2HO!>^M5[O34W8.$I;'Q(WV.Z-+9FIPC22PVLZ'
M566PH!0'/-P=#NF>Z,S+W!FL2Z]E9YHY*="6^T)&@H-](DB)P3NJTL]Z:FU!
M0C+8N)%3?[HTM^;G.-9/':S6_JW]'_\ )7_OZ3]W6W\ZU?27NHT?D.BZ#]Z7
M./U;^CW^2/\ W])^[I^=:OI+W4/R'1=!^]+G'ZN'1_\ R5_[^D_=T_.M7TE[
MJ'Y#HN@_>ESFUVUT4Z;;1S<7<6!Q;L?+PM:QGCE/NB*N K9+H,E1?"2]M:;_
M 'GJ+T'"<JQ?$C?I^Z=+8FKD(TDL-KY#H%5A;"@% <YS70CI?N'+S<[E<0Z[
MD\@Z4B6Z$M]L2=/B1((E9+KZ*M;7>NIMP4(R5%Q(J+W<^DNS<YQK)X^DS6N>
MK9T@<;-L,3(9,Q41>&;((@4DLA(A$J*J=O%+5M7?6K7VEXD:'W#HFO5?O,^:
MMM=&LUDNJ[G3C)B3;6,>)W+302P_-S:H2/!VVYPD"-^R27[%KUM_O.$=+UT?
MM8+CW>#AY#Q6G[HG+6=1+"+VO]W?X=E.5'TQ^KAT>O=,(^G_ #TG[NO(_G6K
MZ2]U'MOR'1=!^]+G-SM;HUT[V7F6MP;=QCL;+, XVT\Y*>>01>'0?A,E3BBV
MKGO]Y:B_#).55R(Z=-W7IM///;C27*V3RJXM!0'J*J*BIVIQ2@.:93H#TJS.
M3F9>?AWCGSWW)4HQF2 $GGB4S5!0K)=55;)5M;[WU4(J*DJ)4P137.Y='<DY
M2@ZR=7Z3Q?A,3]6_H]_DC_W])^[K/\ZU?27NHU_D.BZ#]Z7.>?JW]'O\D?\
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M,CN_DOKUKYS9S'DOY1/M?KK4PP$\2Q69K% * 4 H!0"@% * 4!!.M'T89_\
MY+\.CU9=V=IAX?A95=[=DG_#\42>N_*']LO[M5BP+9XE-20* 4 H!0"@% *
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M#<_X@Q'\_)JPGV2'MS\R*^':[GL0\\B<57E@* 4 H!0"@% * 4 H!0"@% *
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M3SD='%(T--3?OK NE;(5KT%"[M;?LS<^[',:&-D8[#+AHV6B^?:%J0[YJ0Z
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M'\T2NUGWECYG\DB72@><C/-QSY4@P(6G%2Z":HJ"5O86N L3AD38^\)K>*W
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M$=2:>:JH/@H#<0\'N'.],-X0=P([GG),25\RX[(PI S&GU@J.B\X!)PB=55
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MF0VIAYF++$QFDQD8M*(L!MEHD$3YFE$)LATJ7%4T]O'MH"]B-K8+#8R-AL=
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M'1CPAOQ1'DC/$ETU>]]-0*&S?W9U1A2-P1RAXO)S,%CH4[YO@1Y7/>=G\\5
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M["1*._;@UGMK+1TE%XQ?-Y4RSMRE7++;LJI=+]OG6!-:X3>* 4 H!0"@% *
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M&6W%F)+@LOK'QS7*:A,L,-@'+?%5:=3@FA7%741)8*DIW1LMG=KS#.6R#Y8
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MJIJ[46J._8C&*G;>:#V<:>Z7U;SKMW&WEFJ3I6G ^-?7N);7&;Q0"@% * 4
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M;-G;XJ++YJ^4V;>T]L8G&S]M@80\%FI//A8G4+;<:62HZ7DT54T_&BCXMCP
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M1*F_IW:HZJ49826#_:N%'9;NJ=5@UBGBOV/@9(JYC:/J<* 4 H!0"@% * 4
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MO@95R[='Y4OCB3FJXM"RS,B22,([[;QM_*"V8DH_51%6U 5N/,M!S'7!!O\
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M-6$^R0]N?F17P[7<]B'GD3BJ\L#0R9>U\UD<?&=R,:1*@R?-182/-EKE-"2
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M\9,&U.$I*GHR3IA6J?@K2J\1'LWM?,S,'M+#Q,.!Y&3!W.ODYC9-("9 T>9
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M1>I(-GS'/WR\?96E$*LIJ2!0"@% * 4 H"CDLZR<Y8\PDTD=DNH^A5]% >Z
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M;0V(V2R61$X>B@#3++ (VPV+3:7L (@CQXKP2@/6VQ: 6PX"*62H2);J55)
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H#([OY+Z]:^<V<PE_*)]K]=:F& GB8]9FL4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
3% * 4 H!0&1W?R7UZU\YLYC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>bc_casevolume-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_casevolume-4c.jpg
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M%!04%!04%!04%/_  !$( LD#M@,!$0 "$0$#$0'_Q #A  $  04! 0$
M        !0,$!@<( @D! 0$  @,! 0$             !@<!! 4( P(0  $#
M P(# 0<*#A $ P<"!P$" P0 $042!B$3!S%!46$B%'4(<8$R(].T%396-Y&Q
MT4)2DK)SLR1T-947H<%B@M(S0U/#-%24Q+46&'*BDR9C)57AXH-DA&4G\,*C
M1*2%=CA%$0 " 0(!!P@$"P<$ P$! 0   0(1 P0A,1)R- 4&05%QL<$B,C-A
M@9$3H=%"4H*2LL)3%!;A8J+B)!47\",E-=)S!_%C0__:  P# 0 "$0,1 #\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * QG='Y\V5
MYY>_R;)4 Z<_-[M/S-CO>K= 9-0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M8SNC\^;*\\O?Y-DJ =.?F]VGYFQWO5N@,FH!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@,9W1^?-E>>7O\FR5 .G/S>[3\S8[WJW0&34 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M"CW5LR6T_16T!6: SC#YW"[AAIR&"R$?)0E< _%=0\B_>)038^ U@$A0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H#\4I*$J6M02A()4HFP ':2: P;+=9NEN%
M?5&G[IA!]!TK0PI4HI/>/(2Y8T!^8OK1TLS#R(\'=,+G.'2A+ZE1;D]P<]*.
M- 9W0"@% * 4 H!0"@% * 4!J;J-U]VYTUW"G;F5QDZ7*5';E!V+R>7I=*D@
M>.M)N-/>K- 9AT^WSC^HFVF=SXR,]%B/.NLI9DZ>8"RK22="E#CZM8!E- *
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M$E-E('[D"L UQZ.7SQ[<_P#K/>3]98(_KK\[>ZORM/X)%$#II_\ _P!6A_\
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M,MTT0-U^C]\Q#G_]S^FNL,'(FQ_CIMSSI"]\(K(/I=7Y,B@% * 4 H!0"@%
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M/%3D>= =-W8LR.HH>97P'%*AVV%Q8V%Z R&@% * 4 H!0"@% * 4 H!0"@%
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M2CL6'.>2#(6=2C:Y3?L /@'"@+B@% * _" 001<'M!H"VTB*^"D!+#Q"5 <
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M4J;!K(-H5@"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H"PA?U_)?COE'MK?XM_9O:4>)V_7?QG[Z@+^@% * 4 H#5'
M11D9;:^YLPZXH2MQ9W*OOO)-G$I*^0A*3W A*/%[U9!B^T]QYOH3B&-G;_P:
MU;0BON-P=X8Q/.C%$EY2P930NI!NJW?[@![2,&^HTF/,CLRXCJ7HKZ$NL/-D
M*0MM8"DJ21P((-P:P9.7-T-RV\UU!Z@XYO7D=F[HQ<]&D>.N,PQY/(:O]B4J
M!5X!63!LS?$Z/OK>&PMF0%<_$2"-VY8CL5 B"\4*'=0ZZJQ'@%#)@VW<]F-O
M>C-FLCAY:H67Q4V2TS);"=2%*R2-5@H$<0X1Z]#!/[B?>E=6.C$F0LN2'H,Y
MQUPVNI:X0*B;<.)-#)'8#(S</&Z]Y7&O&/D(4R7(BOIL5(=;9>4E0N".!%#!
M)'?^\<AMKIOM/ 34HWIO.$F1-SLAM+WDL9AH.//!LV2IQ0OI!X<".T@@9*^Z
MW]Z='/@S=3NZ)>Y]INRV8>X(&50R76D2#;RAAQM*"G2?K.SL[>X!^OY'J!N/
MJ]N[8V)W"K$;=BQ\?+7(0TV[*CI4PC4U%UBR2ZI94M:PK3;A0%WLS/;NVWU$
MSG33/Y1S<S36+&;P<Y]"&I12%AM3#A0+&ZE<%'O>&P A^EV7S>_GF,UDNH,F
M%NUB8M66V6VRPRRQ'8>(,?R=U',.I"1=VY*;_9"A@W9'PN)BS5Y&-#::GN<W
MF24I <5SRA3EU=IU%M%_4%8,FO>E]H&\NIFWV>$2-F6<DVGN!>5C)><MX-2;
MVK(-H5@"@% * 4 H!0"@% * 4 H!0"@% 6ROQB0$?R+!NKPN=P>MVT!<T H!
M0"@% >'6TNMJ;7[%0L: \1G%+26W/XYHZ7/#WCZXH"M0"@% * 4 H!0"@% *
M 4 H!0"@% 8SNC\^;*\\O?Y-DJ =.?F]VGYFQWO5N@,FH!0"@% * U;L8?Z<
MZG[[VK)\1.8<9W/B2?Y5J0D,RB/^!U('KWK('6O;N;W"QLY.%A.350-QPILP
M-6]KCM!>IQ5R. N* J]?<!F=S=,\CA\!#<GY-YZ*IN,S8K*6WTJ4>)'8!1 D
M>JN'RF9Z5YS#8J*N7E)$-MMF*W8N*6%H) N1V &L PR=M3>&V,GLWJ/MW%*R
MD['X*-@MR[?2M#4I4=*$JU-%1TJ6A?LDWXZ0!VDC(*\^'NKJYNC;CL_;TO;6
MR-MS$9=\Y;EMS9DUG^*;0RA2]*$\=2E'B">[:@*88WATUZE;JS,+;,O<FV-W
MF/*:=QA;4_'EL(*2AQ"U)LDE:O&)M:WA% >=CX[?^&WKU"WGG=N$3<M$A28&
M-BO(4AQ;2%!,8/JLDN(2$I<5;3JO;A:@+1S&93>_43;&Y,'LF?M"7B9:I.X<
MYD$-0U2(]K*CA+2U%_F<4ZSV#P4!;[(C;TV*C/[=<V/(RV\LG.E/L[JNSY!)
M;D&Z'9,I:M:$H]ER@"? %&A@B$["WDWT(VQM?X&D'/0,\F1*A )UH83*?7S/
M96TV4GCX: V?UYP.8W+TPR^'P,-R?DWW(A:C-6*U!N2VM5KD=B031&2 S>&W
M=LC?<3J/M_#.Y_&Y/%,8O<>)C%(FM.,!.AYI*B O@E*=(\/?! %E.C;^WEU/
MV+O"7ME_#[8Q3TMIMF2I"YR \QX[\E*"4M)4K2A"+E7BDGM% .J#N1WU R6U
M7.F>1D;B"UQ\)G'!&$1H!=FY F!84@6\<MV_<F@-Q;=A3\;M_%8[*R?+<I$A
MQV)LSB><^TTE+CG'CXR@3QK ,"Z2CX:R^^.H".,+<65$;&.CBEZ#AV_)&WDG
M[%:@NWJ5D&T*P!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4!'P1^/Y/\2\GNZU^,_VGVE'C_O?XO\ >T!(4 H!0"@%
M :IZ4^4;?E[XV(4I^$L3E7\EC&G"4(<@90<Z.;V-P%!25E(\4\.VL@Q_<VZN
MI6[FIG261LV)CMRYC'N.2)[N1:?@-X]2TL.24)2@KN%* 0@^,#QXVH#;^UL$
MWMC;6)VZT\J0C%1&(8?5P*^2@(U6XVO:]NY6 :_Z?[/GOM]2XNZ(#D:'N;-Y
M ,H=M=['O(Y:'$V)X%*C:L@L^AFR-U;?&3RF]T6S$=N/M_$WTG3B<8#RU)*2
M?%<4KN\?%% 8Q_HK=R.B._=K##R/A:3FY#N+A@)UOQ5RHSJ7$<;%-@L^M0P9
M/E=K[A?ZA=*,HUCG58_"09366?&G3'<<B!M*5\>TJX<*&2+B;0W.G&=;&%XM
MY+NX7I:L*DZ?QH.,NI26^/=*AV]^@/"MB;RQFW>FF\<!C^=NW9T(1<E@7EI9
M<D17VM#S:5FZ0XGQM-^_?M ! N]TIW?UF^#=K?Z7G;:VDW+9F;@R&8Y;3SB(
MYU>3L-(6LJU'Z_LX#UP)_;> S43K=O7<$F"ZUA,A Q[4*<JW*=6TTV%A/&]P
M00>'<H"@]@MP,==YF[6<8[(PR-LJBLR$E*4.RTOAP,A2CP40.[PH#%-U0LWU
M(S.!=P^P<AMC=L#(1Y,[=,U+$=#$=DGF)2\VLJD7[$IM^W0'0)(2"I1 2!<D
M\  *P#671U*LL=V[[(_%MT9EYS&+_G,=! BL.6/$:M"S;O5D&SJP!0"@% *
M4 H!0"@% * 4 H!0%*0Z6F[H%W5'2VGOJ/9]6@/UEH,MA -SVJ4>TJ/$GUZ
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M63Y.5^V$(]D0* RK"YG'[@Q<;,XI:W,?+3K86ZT['60"4G4T\E#B2".Q20:
MOZ 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@(^"4'(90)FJD*#K6N,>R,>0CQ!_Q#VS]]0$A0"@% * 4
M!\Y\EFWDY&6D.*L'W!VG[,U=UN?=70>:;V&[\NEEK\./?SBOHU]-,^7Y4^BF
M%.K#8Y7?C,G_ /AIJD[WF2Z6>D\.J6HZJZC1@]*?#G86ZMX?Z??.3V[E4XJ)
M@1(N[/0ZH\F0VYR?%0M#;[GL%6#2N)KXFS0V/&ZP=/ESL'A9V<BPMQ9Z/#D1
M,6M94M*L@V'&&EN)3H2MR_M:5J2I?UH-!0A=M]<=L2=M1<YO.3'V[)F3<I%8
MBJ4XZ.1B9SD-<A9"+H:!0GF.+ 0@JL54%#(,OU;Z<8'+9#!Y;<,:/D\3'\LR
MC5G%IBLV2H%YQ"%(0HA22$*4%$$$"A@CMY]5\;MW.X3;F(Y&4S$S<&*P.:B<
MTMN0&<Q'DR&GU )-R4QSI3W>_0R7J.L/314"?E'-QQH\#%KCHR#TH.1@SY8H
MH86H/(0>6XH$(<MH-C8T,$-NWJ\_C9>TXFR\,SN3_5L#(9>%)DSQB&$P\:TR
M\5%;S#G%Q+XTZPD#ZX@=@R5MN=>.FN>QF,F/YAK$S\CC!FG,7//+D1H?)+ZG
M'[72A 2"0X5:5<+'B*"A![Y](S9N#VC$W!M.9&S4K)91G!14OF1&8C27QK4[
M, 94\AMMOVRP:*EBV@&]Z"A8GT@'FF(;J&L+D6'MNR<XYE&LB]#Q:ID7+1\8
MJ.E^3'UH3=_V2VKZP$VXWH*&Q(/5;IUD]TG94#<41_=*7)+!QJ5*YG/@%0D-
M7(T\QO2HJ;U:M(U6T\:&!M;JKT[WMDW<-M7<,7*9-EMU]4=@JU%AAQ+2W4%2
M0%MZU!(<02DGL)L: Q?8W6=6\5YO-2<= P^P\*J:U+RDK*M_"45S'O%HB? +
M23&UA*UIUO$A(!(\84,T)U_K3TOBXQO+R]QQX\)V0N$WSD/-/&4VVETL\E;8
M=#A0M"TH*-2DJ!2#<4%"UW%UFV;CMH,;IP>5QV2^$HTF7@T299@QI3<%U#4D
MJD%IWEAI2]*BI'!7B]M!0EI?53I[!S.2P$O/QFLIAV%R\L@ZRU%::2%*YSP3
MRD* 4#H4O5Q'"A@M7.LG3-J!%R*]PLAF9+7CH[/+?,HRFDI6XVJ,&^<@H2I*
MUE;8"4J2HV!!H*&=4 H"E(=+3=TB[BB$MI[ZCV4!^L-!EL(O=7:M7=*CQ)H"
MI0"@% * MGO:'1)'\6JR'_4^M5ZU 7- 6S/M#QC'@VNZV?\ ]R?6[: N: 4
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M=GPDY/E;HQAR[F0C:FFF0Y%>D3%.*6IM"FW6GE%I:=((\7B%3H)(*4@*5J4
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M2.4IL@H*>YI(X6K6DFG1YS=A*,DG%U7H*E?D_8H!0"@% * 4 H!0"@% * 4
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M"=&^N,/?V/PV+W$CR'>V39GR$(9BR6<9)&.EN,.IAR'04/*:0&U.A"S:_P!
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M%".VIUKPN4Q>U69JG,ON7<41$];>W\?.=BL0W9"HZ9;W.1JCL:DVUO$=BB.
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M!0"@% 8SNC\^;*\\O?Y-DJ =.?F]VGYFQWO5N@,FH!0"@% * 4 H!0"@% *
MAG(DE^>MUI7B)7;FW]C;M '@H9)+DR/[2?M$_4H8')D?VD_:)^I0#DR/[2?M
M$_4H"C*BRG6%H2^5$_6D)2#X+B@/&*:<8#K3ILL$'E]X$=OKT!(4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% 0>5G\PF,R?:Q_&*'=/>]2LF".99<D.):;%U*^@
M!WS0$X,-$TI"M6H#QE VN:P9+AB!%CG4VBZQV*5Q- 7- * 4 H!0"@% * 4
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MO*6%WTLJ\G;TI1?N%-E&W=- 2= * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4!3>:#S:FR;$\4J':".(/K4!YCO%U%E\'DG2XG]T/VCVT!6
MH!0"@% 6RCY0^&QQ99LIP]PK^M'K=M 7- 8BZLN.K6KM4HD^N:R8/- * F\&
MLEEU![$J!'KC_P!E 2M8,B@% * 4 H"(GMS?+ N.%6( 24=G#O\ _MH9+\>7
M6XEJ_P"^H8'X[WVO^:@'X[WVO^:@/#OE_*7H+>JQMIU7]:] 6^*1*2MU;X4
M0!==]1(/AH"3H!0"@% * 4 H#&=T?GS97GE[_)LE0#IS\WNT_,V.]ZMT!DU
M* 4 H!0"@% * 4 H"VC^W.*E'V)\1D?N!VGUS^Q0%S0"@% * 4 H"V8]I<5%
M/L.*V3^Y[J?6/[% 7- * 4 H!0"@% * 4 H!0"@% * L<C.$1O0CB^L>*.\.
M^: QTDJ))-U$W)[I)K)@G\9 \G3SW1[<H<!]B#^W6#)(T H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% 6<3RKRR?SHZ&F.8CR9Y%M;R>4G4I?A"KI'
M@% 7E * 4 H!0"@% * 4 H!0%&4_Y,PIZVK3:P\)-J M8F2#Z5<QM04D_6)*
MAQ]2@+GRMO[!S_IJ^I0#RMO[!S_IJ^I0#RMO[!S_ *:OJ4!9OY;E/:$MDH%M
M15=*N/>!H"3!N+T H!0"@% * 4 H!0"@% 1#L"6N<7D*LDJ"@Y?L'J4!(<F1
M_:3]HGZE .3(_M)^T3]2@')D?VD_:)^I0%&5%E.L*0E\J)^M(2D'P7% ?F,C
M/1FE)>X:C<(O>U 7BUH;07'"$H2+DF@,4>4A3JU-@A!42D'ML363!XH!0&1X
MN,J/&\<6<<.HCO#N"L&2]H!0"@/#KJ66U.K]BD7-J M8^4CO:M9Y1'<61Q'@
MH"MY9$_GD?;"@'ED3^>1]L* >61/YY'VPH!Y9$_GD?;"@'ED3^>1]L* >61/
MYY'VPH!Y9$_GD?;"@*,?)LR'^2E)!-]"CW;4!>T H!0"@% * QG='Y\V5YY>
M_P FR5 .G/S>[3\S8[WJW0&34 H#R'&ROEA0UCM3<7^A0'J@% * _%*2@%2R
M$I':3P% $J2H!22"D]A'$4!^T!:ON)?(BM*!*_XTI-]*!V^N>R@+D ) 2!8#
M@ .]0'[0"@% * 4 H"C);4M 4W_'-G4V?".T>H1PH#TR^V^D%"AJM<HOXP\!
M% 5* 4 H!0"@% * 4 H!0"@% 6\R6B(UK5Q6>"$]\T!C+KJWG%..&ZU&Y-9,
M$KBL?>TIX<.UI)^Z^I0$S6#(H!0"@% * \K6AM)6XH(0GM4HV ]<T!ZH!0"@
M% * 4 H!0"@% * 4 H!0"@% * C,>8OPEE^0^X[(YS7E32[Z&E^3MZ4H\!39
M1\)H"3H!0"@% * 4 H!0"@% * MI'MRTQ!V*\9T]Y /9ZYH"LTRTRG2TD(3V
MV% >Z 4 H"@_%:?\8I = \1SN@CLH#U'=+K=U"SB24N)[RAVT!5H!0"@% *
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M 4 H!0"@% 1F.\C^$\QY.ZXN3SF?*VU^P;7Y.WI".'84:2?#0$G0"@% * 4
MH!0"@% * ME?C$@-_P BP0I?A7W!ZW;0%S0"@% * 4 H#\6E*TE"A=*A8CP&
M@*,9:@%1W#=QKA<_7)/L3]6@*] * 4 H!0"@% * 4 H!0"@!( N> % 0&2R)
M?)89/M ]D?LC]2LF"R88<D.!IH74?H =\T!DL2*W$:#:.*CQ6KNDU@R5Z 4
MH!0"@% 6T@EY:8J>Q7C/'O('<_?'A0%R!;@.R@% * 4 H!0"@% * 4!;206E
M)EI'L.#H[[9[?H=M 7(((!!N#Q!H!0"@% * QG='Y\V5YY>_R;)4 Z<_-[M/
MS-CO>K= 9(M:6T*<6;)2+D^ 4!2C(593S@LZZ;D?8I'L4^L* KT H!0"@% ?
MA (((N#P(- 6\8EI2HBCQ;XM$]UL]GT.R@+F@+9S\7?#W\D[9#O@5V)5^T:
MN: 4 H!0"@/#SH9;4XKC;L [23V >K0'B.T6V[KXNK.IP_NC^T.R@/,E2E:8
MS9LX[P)'UJ![(_M"@*Z4I0D(2+)2+ > 4!^T H!0"@*,EM2T!;?\<T=3?A[X
M]<<* ]M.)>;2XCV*A?\ ]E >Z 4 [.)H#'\G/\H5R6C[0D\3]D?J5DP6L:,Y
M*=#3?JJ5W ._0&3,,-QVDM-BR1W>Z3WS6#)4H!0"@(Z5@</-S&.W!+B(=S.)
M;D,XZ6J^MEN:$!\)L;>.&T7N.Y0$#-Z6[!R.T6MAS,(T[M)ETR$8O6\ELO%U
M3Y6I25A:B7%J6=2C=1O0%%WI+T^?AK@R,/SV'([$-2GI,IQT,Q)+DQG2ZMTN
M)6V\ZMQ+B5!8)]E:U 9'@,!AMKXB+@<!#;@8B$DHC16KZ4A2BI1)))4I2B5*
M4HE2E$DDDT!)4!%[B\F.%F>5Q%SHV@<R(U?6X-0X"W'PT!*4 H!0"@% * 4
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M?/U*P9+F@% * 4 H!0'AUQ+3:G%^Q2+F@*<9M24EQS^.=.I?@[R?6% 5Z 4
MH!0"@% * 4 H!0#MX'LH"VCW96J*KL3XS)[Z#W/WIH"YH!0"@% 8SNC\^;*\
M\O?Y-DJ _.G1 Z>;3)-@,-CB2?R5N@)SF(F.I;;4%,-V6X1V$W\5/[%Z NZ
M4 H!0"@% * H24**4O-_QK)U)'?'=3ZXH#TS)9D"[2PJW$CNB_@H#VXA+J%-
MK%TJ%B/5H"W8DI2?)GU@2$'3Q^N'</KB@+J@% * _%*2A)6LA*1Q)/90%JA:
M9;P6@ZH[/L3]DX1V^L* NE*2A)4HV2D7)\ H"A&2I6J2X++=MI!^M0/8C]LT
M!<4 H!0"@% * MA^+R"G^1?-T^!SNCU^V@+F@% 0V5R';%9/@=4/N?JUDP13
M3:WG$MMBZU&P% 9-#B(B-:$\5GBM7?-8,EQ0"@% 1VX)3\' Y2;%5HDQHDAY
ME=@K2XVTI238\#8BMC#04[T(O,Y)?":6.N2MX>Y..1QA)KI29RI^NWJ5_P"L
MC^[1O<ZM3]/X'YG\4OC*#_5^]/Q?X8?^(_7;U*_]8']VC>YT_3^!^9_%+XQ^
MK]Z?B_PP_P#$?KMZE?\ K _NT;W.GZ?P/S/XI?&/U?O3\7^&'_B;-Z*=0-V;
MOSV0A9^>)49B'SFD<IINSG-0F]VTI/834:X@W9A\+9C*U&C<J9WS/G)QPAOS
M&8[$3A?GI)0JLB66JYDC=]0@M$L,US_@N3Y-,1 ?TC1,=MH;-QQ-^'@H"_H!
M0"@% * 4 H!0"@% * 4 H!0"@% * C,=Y%\)YCR93BI7.9\L2OV"5^3MZ='@
MT:;^&] 2= * 4!'R8R)\C3?2ED66L=U1XZ?6% 7*(<5"0@-)-A:Y )/JF@/7
MDL;^91]J* >2QOYE'VHH#\\EC?S*/M10%FB$U ?0^"5-$E!)^L*N /[5 2"T
M(<%EI"AWE"] 4(Y+2U15=B!J:/?;/<_>]E 7- * 4 H!0"@% 6ND2GR5#4PR
M2E(/$*7W3ZW90%R    + =@% ?M * 4 H!0"@(V5$3/DG2K2&@$K7:]SVV'J
M T!<IQ\1*0GEWL+7)-S0'[Y#$_FQ]$_5H!Y#$_FQ]$_5H"&R+L8*+$5 %O9N
M GZ XUD%BA"EK2V@74HV2/":&#)(,)$-O[)Y7LU?M#P5@R7= * 4 H!0"@%
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ML*E*4+CO@F@$&'Y$VO6L**C<D<  * \>4LSG4QVS=L>,Y?AJ">P#U3VT!?T
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M7_.H^T/\*JX+H,?SS<M#$AR1+7#9("3.:N.4%$ $ &_ ]R@,GH!0"@% * 4
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M?#QGE>P3^V?!7))"8VXM;BU..'4M1N2:R8)7%8\+ E/"Z?Y-'J=TT!-5@R*
M4 H#PXXEIM3BS9*1<T!3C-J2DN.?QSIU+\'>3ZPH#V^Z&6RNUU=B$]TJ/ "@
M,0ZDM%GISN,*-W%0G5.*[ZCVUU=T[9;UD<#B'_KKVHSBR]7(>;:"]!07H*&_
MO1B-Y.YOO</Z;]07BOPVOI?=+5X \5_HA]XZ&<;2ZA3:Q=*A8BH 6X1TM<E4
M/DID-QWVWXZ'G7K:5LEY&M/'NN(NA/[HT!=QE*3JC.&ZVNPGZY!]B?VC0%Q0
M"@% * 4 H!0"@% * _%*2A)4HV2D7)\ H"A&2I6J2X++=]B#]:@=@_;- 7%
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M3BIKD_8SXX7&8G!7&[4I6Y9GR>IKL?*6F2R>0S$QS(924Y,FO&[C[RBM9MP
MN>X!P [E?:U9A:BHP2BER(U\1B+E^;N7).4GG;RLM:^IKG8G2!2U=-\"5^RY
M3@'J!]P#]BJ>WY3\[<Z5U(](\*MO==FO,_M,S>N(2@4 H!0"@% ?BE)0"I1
M2.TF@,?W*%+VKGY*^!<Q\O0D]QL,+M]'MK;P?GPUH]9H;QV6[J2^RSA&]78>
M9!>@%Z W?Z,GQKS'F_\ IVZAW%/D0UNQEB\"[5<U/O(Z@JN2Y2QS'E9QLCR&
M,W,EZ1RHS]N6LW'!5_!0%]V\#0%LP>0M451LD>,R3W4'N>L: N: 4 H!0"@%
M * 4 H"A)0JR7FQ=UHZ@/LD]U/KB@*J%I<0EQ!NE0N#ZM >J 4 H!0%G%\K\
MLG\]YMR/S$>2M(]FVCE)U!?A*KJ'@- 7E 6TCVYQ,5/L3XSQ_<#L'KF@+F@%
M * 4 H!0"@% * 4 H!0"@% 6S'M#BHI]AQ6R?W/=3ZQ_8H#G#TB,\N;N:'@&
MU?B^+8#CB?\ QY/C&_J("+>J:LOA?#*%B5UYYOX%^VI1_'F-=S%QL+-;C7Z4
MOV4-.=G$=M3$K8WKTGP\G:S<SJAO6<N# ?CJ1%3(4HORN:0KF$$ZE7T^UIXE
M?LNP F#;ZOQQ+C@\/'2DGEIFC3D^/FS=%J<+X26#4MYXN>A"46HZ7BG6CTN=
MUIW5GEXLR59/I=E9><=WWN?+,,L[%R*WW9R'=2G04H4I24\OM2&5>V=TG3I^
MNK5WQ9C96'LP;=Z-*<WP_O9O77D-[AS$SQ,L9B+J2PL])RKGS5:R<B@^]S]W
M1^45MQH@JZ1,R.FKR%;;QTD2YK$D++ZTLOATH\?L*7-*U VND<#W_P 85S6\
M6L6O]R2HFJ4RJG5DZ<_H^V\%![F4MW->YMRTI*5:NDJTR\TJ-K)5+(^1QT+?
MFVLON21N';+,US?6XH2,.UB74),5EY6@%Y;H[6T!M)-AV D@7\78N;MOVK"M
M7G'W-J6GI<K67(ESNO\ KET;.^L+?Q3Q&&4_S5^'N]!KNQ>3O.7S5HK-R)MI
M5R6.6PFSGMNQ<CG9LQO9.#D? 6#1C0US)4@DJE35%7,3I=<2L@#ZU []J^]C
M$8E7G"W&/OKB]Y/2KW5\F')F5/6S4Q6$P,L+&Y?G-8>S+W-KW>C6<L]R[\I4
MDTWT1YW0UUU$V:=C;E>PB7S)BJ;1(B/* 2LLN7 "P.&H%)'#M[>%[5(MUX_\
MY85RE'F?21#?VZ7NW%.S72C32B^6CY_2LJ].?)F+78^>7MG=F)S*5:6X\A D
M>%ASQ'1]HHU]=X898C#SM\ZR=.=?":^YL:\'C+=[DC)5U7DE\!VWVU29ZA%
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M3]&@'ET3^>3]&@+1J<W,F(000A%RV#W5]\^H.R@).@*;[H9;*[75V(3W2H\
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MB@% * 4 H"V;_%WRQ_).W6UX%=JD_MB@,9ZJ?-UN7\A=^E75W3M=O61PM_\
M_7WM1G#MZN(\YT%Z"@O04.@_1<-Y6Y_O<+Z;]0;BKPVOI=A:/ ?BO=$/O'1U
M0$M@C<TIU4=N-'DB(ZX\P7'E$ !D/(YB>((NXF[:?"KA0$BE(2D)2+)2+ =X
M"@/Q:$N)*%BZ5"Q!H"E'B,1@KE)L5=I/$T!7L.]0"P[U +#O4 L.]0"P[U +
M#O4 L.]0%NU"C,.%UM%EGLX\!?O4!<4!;)_&)!7_ "+!*4>%SNGUNR@+F@%
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M=#S85;2OL6CNA0X$4!4H!0"@+*)Y5Y9D.?(;=8YC?DS*+:V4<I&I*_"574/
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M\H=AH#$.ISO.Z:[D7:RO(70M/>4.!%=3=.UV]9'"W_\ ]?>U&</WJXCSJ+T
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M%U(@NZ2.'>(_9%=3=6UV]9'$WZZ8"]J,X:O5PGG:@O04%Z"AT-Z+(2J3ND*
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M/'BLHCQ6D,,-BR&FDA"$CO )L!7%E)R=6ZLD\+<81T8I)+D60J5^3]B@% *
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M"WP>0=39\([GJ'LH"QQ;C+LS)NMPS'6IUKF2"2>>H,(%_!HMRSZE 2E * 4
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M\LLN9HQT@XYYN/-TCDO/_P 4DW'%5_!0%[0"@+:2"TI,M/U@LZ!W6SV_0[:
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MA4YIUJOXRC0P2FW=O87:>%A;=V]#1 PV/;#,.(W<I0A/A42HGNDJ))[M 2=
M8_O32QM?.RC?EC'2P_IXG0&5^,/"GC6U@TW?MT^='K.?O*2CA+S>90G]EG!E
MZNP\SB] +T!O'T8OC7F/-W].W4/XH\B&MV,L7@;:KFI]Y'455R7&0N\/BCG_
M #=,_ +K:P?GPUH]9H[PV:YJ2^RSY\WJZ3S>+T O0&]O1:^-V9\W?T[=1#B?
MR(:W8RP>"=IN:GWD=5579;I8YCRKX-D>126X<K2.5)?MRT&XXJOP[* OJ 4
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M<6=2U&Y)K)@E\5C]-I3P\8\6DGN>'ZE#)?/^T.)E#V'!#P_<]Q7K']BL N:
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M +M .9+_ )A/_4_]V@++(29S81I1RDF]U).NY[U[<* O804(K04G0K3Q3_\
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M*P3^^JMN*,*H78W5\M4?2OV=1=G >/=S#SP\GY;JM67Q/K-T5#"S10"@% *
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M@*$F6S$1J=/$^Q2.TT!$2,PMY!;0V$H5P5<\2GNCUZR8*$R>N6E" GEM)'L
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ML-*2M&KQM25DHTW%#-"0G]7\%C]WG:ST":J.C(,8%[-I2UY&C-2XOEK$/27
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M]LOV'2-5P74* 4 H!0&,[H_/FRO/+W^39*@(SIW,E_Z0VRRVG6VG%04AH6
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M5!RRB#WG\3]P>;9GX!=;6$\^&M'K-+'[-<U)=3/G5>KF//0O0"] ;]]%$_\
M>&;\V_T[=1'B;R(:W8R=\&[3/4[4=:57I:Y%[B,88689DM<&-H',EM7UMC4.
M(MQ\% 2E * 4!^*2E:2A8"D*!"DD7!![0164Z&&DU1G/?4KH9(:=>S>R&N;'
M62M_#IX+;)XDL7[4_N.T?6W[!8&Z>(DTK>(='R2_\OC]I3W$'!DHMWL&JIY[
M?-J^C]WV<RT8\R['=6P^VIIYLE+C:P4J2H=H(/$&IS&2DJK*BJY0E%M25&CQ
M7Z/P* 4!E6S>GNY-[24HQ<8MP JS^1>!3';'=L?KE?N4\?4KE8_>EC"1K-][
MDBL_["0;IW%BMXSI;C2/+-^%?&_0CJS96R,-L;%#'8M)6^Y94R:L#FON =I[
MR1?Q4C@/5N356\-X7<9<TIYN1<B_USE_;GW/8W;9]W;RM^*7+)_%S+D,EKFG
M;% * 4 H!0$;C_)_A'+<J4MY[G-<]A5]+"N0W9*+]Q2;+-NZ: DJ 4 H!0"@
M% * 4 H!0%IE8JIV,FPD-L/+DL.LI9F(YL59<04A+R!;4V;V6GNB@-(P>CF]
M)?2+<FQITV'BY>:E1W,1AFGI4W%XB-$>8)98>?4MY3;O(4Z$<$ME>A*0E/$9
MJ7>6Z+[@?ZJN;ZQ.0B18TG*PLX]D.9*1E4I@P!#5C0E!+"XK^A)6I7C)2I8"
M5'2I(5+O:/37>>"5N(RV\'\%[OR,=S-[>#DV9%1!5'<:GN-2'TH=6_)*D -K
M2&D)3P[30$ETDZ63=A2\QE\K+#LK(L0L;CL:W*DY!C'8O%AWD1VI,L)=<&IY
M:C="0.  X$D#:-#!B?4_YO-S>;I'W!KI[KVNWK(XF_=@O:DNHX7U5<9YSH-5
M!0:J"AT!Z+AOD-R_>8OW;M0CBKP6^F786=P)YE[HCVG2E0 MDPSJW\VFZ/R!
MWZ5=3=6UV]9'%WYL-W59P5>K=*!%Z 7H#HKT4#_YEN?[Q$^[=J%<4>"WTOL+
M'X)\=WHCVG3U0,M$POJ[\V>Z/R!WZ5=/=6UV]9'%WWL-W59P:B#.<CHEMQ7E
MQ7'?)FWTH46U/V"N6% 6*[$'3VU;3N13I55I7U<Y1*LS:TDG1NE:<O-T^@]J
MQ>429 5!D),0E,H%IP<H@7(<X>+P^RK\^]ADRK+F])^WA[BK6+[N?)FZ>8IJ
MAS4+8;7&=2Y*2E<9!0H*=2LV24"WC GL([:_2G%INN;.?AVIII-.LLWIKFH=
M'^BG&DQ)^[&9;+D=WE0#RW4*;5;5(XV4 :A7$TE*-MIU\786-P;;E"=Y233I
M#/\ 2.F*@Y91A'6+YK]U^;WOI5T]U[5;UD<??.Q7=5GSXO5LE'"] +T!TQZ(
M/];W=][@?=2*A?$^:W]+L+"X.\5WZ/WCJ:H.6.6.6U^2#EQ!-5SH_M"K6 YR
M+KX_S8\?UJ OJ 4 H#FWKQL%S&Y([SQC7_ETY0&22@?Q,H\ X;=B7._]G_Q"
MK(X;WDKD/R\WWH^'TKF]75T%*<:[C=J[^;MKN3\?HES]$OM=*-:.[NR;JGG0
MU';E27$O3)"&@%/NI:<:UK2247(>65:4BY-SQJ2QP4%15=$J)5S*J?3R+E(-
M<WG=G5TBI2=9.GB>C*-6O#FE*M$JMU>4HG<V2\E1'2&D.I0RRJ6EL"0MF*H+
M:;4KL(24I[ESI2"2 *_?Y2&E7+3*Z<E7G?KR^U\Y^/[A=T-%43I%:5.\U'+%
M-^BB]/=BFVDBLK=^87($APLK'E4N:ME38Y2UST!MY!2+>(4@I2D>QN;6K\+
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M!07H*&]/1>-]VYGS=_3MU$.*/(AK=C+"X'VJYJ?>1U/5=%P$)O'XHY_S;,_
M+K:PGGPUH]9H[PV:YJ2^RSYZ7JZ#SF+T O0&^/17/_=V:\V_T[=1#B?R(:W8
MR?\ !6TW-3[R.KJKPMLA-Y_$_<'FV9^ 76UA//AK1ZS2Q^S7-274SYV7JYCS
MP+T O0&_/13/_>&:\V_T[=1'B;R(:W8R><&;3/4[4=957I;!![T^)VX?-DWW
MNNMK">?#6CUFECMGN:DNIGSFO5R'GT7H!>@-_>B=\<<WYL_Q#=1+B;R(:W8R
M=<';1/4[4=;U7Q:I99833CI QS+<B;I')9?_ (M1N."NSN4!>T H!0"@% *
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MJ#%E&#]9/FMW7YN>^E73W7M5O61R-\;'=U6?/&]6P4D+T O0'3OH>G\;W?\
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M0UNQDZX/VB>IVHZYJOBTRRRWEWP=(^#$M+G:1R4O_P 43<>R]:@+V@% * 4
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MK_D+.L=QU4!Z&% * 4 H#&=T?GS97GE[_)LE0#IS\WNT_,V.]ZMT!DU * 4
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MD'KVJW4O(C_P8OX!-6MP[L4>F764%QBO^3GT1^RC6FNI'4AM!KI44)' K_\
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MS *F@HN**D!Q!<<60-;CA3K<78:EDFP[*B^_K/NK-J%:T<O]="S+T$QX:O\
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M[/<U9=3/FO>KA*'%Z 7H#H7T1C_WGG?-?^(:J)\2^3#6[&3;A+:)ZO:CL"H
M6<0.]_B7N/S7-][KK:PGG0UH]9IXW9[FK+J9\UJN$H@4 H#H;T1?CIG?-?\
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MG579(]0:J"AD&Q%?]\;9\ZP??+=:>-V>YJRZC?W<OZJUKQ^TCZ)53AZ"% *
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M*$=(H'$7U92;5:DG_I.7_:F_M5?5KZ^Y?.:/]SA\UGA_:\IAEQ]4A!2VE2R
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MS&U[O2T>72]->8KS>O![QN)G?]^X:=.[HUID2^<N;F(?_;0U\I5?W(>[UO\
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ME&Y_=$^ZUN?JR7X2^M^PYW^/8?COZG\P_P!M4/Y1N?W1/NM/U9+\)?6_8/\
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M2Q68W <?@8>VU93!REH7G<FRN(F4W'8=2\F.P)#K1"G5H3J<!\1-RFZ[6ZV
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MU:9O"@% * LH?/\ +<AS92'VN8WR(Z;:F$\E%TKMW5*NL7[AH"]H!0"@% *
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MVR55EBHO0TDD_P#_ #=8Z.7,^6I5B]-,[E9N7E;SRS;[V2D192)N*YL>0VF
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M)4 Z<_-[M/S-CO>K= 9-0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * C8')^$<MRXBF'><USI"KZ9!Y#=E)O]B+(]:@)*@% * 4 H!0"@% *
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MS04-T4,&&[MWM+V]FH6)Q^+<RSJL9E<Y.CQCJEF+BFVPEJ,U_*//O/MMH25
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M*2"+@BOG<MRA+1DJ,^UNY&Y%2BZIEY7S/H* 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% 8SNC\^;*\\O?Y-DJ =.?F]VGYFQWO5N@,FH!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 1\$)&0RA3",=1=:U2CV23R
M$>./^$>U_O: D* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * T
MP>E.?:S\//Q%1VEO;E=R.=CA9M)@-3794)ZY3P?9#A18#QDJTD^**D']PMNV
MX.O@I'T/12DNAD9_MEQ7%-4\S2EZ8Z3<7TJM.A^@GMA[9W)M[=&X'<E%<^#,
MCD,E.C2T9)3D7ES)/.; @E "'-)\9=^V_?K6Q=^W<M0T7EBHJFCER*GBYC;P
M6&NVKTW)=V4I-/2R975=WD?I,BV'@\EM_"R8.4*#(=R>3FHY:RL<J;->D-\2
M!QTN"X[]:F+NQN33CFT8KV12-S!696K;C+/I2?MDWVF%3MK[I<QD9O'XU+V1
MP6\I&<Y<AY,=,V&\N0^E;;NE8OIDI1XP[4$5T88BTI.LLD[2CFK1Y%F]7PG,
MGAKS@E&-7"\YY73265Y_I? 2T_&[WC;E:WOBL-#ES\CAVL1.Q,F9RU0WF7W'
MT.)D!M0<:)=4'4I2%<$E-^ROA"=EV_=2DTHRTDTL^2F:N1Y,AL3MXA7??1BF
MY0T7%R\-&WGIE67+ZB E=.-SX;!;4Q&U4)3N;#1$Q/\ 5J)AC)827DNO,NQB
MVKRF,HCQ6E=EA['V5;,<;:G.Y*YX).NA2M<E$T_DR])J2W?=MV[<+7C@J:>E
M2F6K3C3O1]'49&O;FXD=2$YS#Q?@G$+6%YN4)W-CY-H1^6@*@\OQ'T+"+/!8
M\1%CJO8:JOV_R^A)Z4ODY,L<OSN;T<[Y#<>'N_FM."T8_*>EDGD^;3)+-EKF
M7*36PH,V'A9+L]AR([D,ED<@W"> #C+,N6XZVE0!(!*2%J'<*C6OC)QE-).M
M(Q5>>B1M8&$HVVY*FE*4J<U9-F45I&^* 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% 8SNC\^;*\\O?Y-DJ =.?F]VGYFQWO5N@,FH!0"@% 4WT*
M<9<;0K0M:5)2KO$BP- :VAX',X[-XG Y')O;@,''R);TV:^]&6I1EH*5%+!*
M5K2GQ!K[@'?-#)08WYFDQ<<\'HK+[S\:"WAI#;KDF0AZ*'A(0O7K\=5]%P4V
M!!5J[ )).^LAD7(;&(<BO*=:@.RE-(6\I*Y$>8^ZT@!0',)C)0@*/BZKJOPH
M".8WWN56,8S,HPVL2XN,Y+6RXP_+:YR5J<8;82[X^@A(.HAVQ59!4+4!,;IW
M9F\1DY4:&VSY"U\'L\U0"2TO(+?"WEK<6AO2@,I2A)M=:O&/90&)S)^=D9,Y
MS*$2)N.5BU0X43QDW6J4I7*=;6I)$A+:>8FRK=ES84!.8S>>?F>2,3YD"!&R
M!YC.7"FGVT%+27%1[(=4A*BI7M:G%W4A*O%U4!>0]P9K'X+<V0E3V\C*@91V
M.P'&>6F+'4\A"5.):45*;0A?-N;$H[MN-#!C\K>TW!NYUQG*,Y*8W*3(:="0
MW$?C,0XFIM*ENE(7J</BL:BH_6]M#)<S]]93 074NY)&1RK4^<HLNLM,(,5J
M?Y.E@JYE]82H%(0E2R+$BW:!>9B?/A[YFO*R+,6.I$&"Q*ELZFH"'F93ZUA1
M<2DEY;2$>/87MQ-@D@2VU]Q9S<$B:AY;#4>)#:4RZPTL^4//.R$"0C6K@T4L
MH4A';XQN;6H8,=Q6<W%'CQLVK)MY,MXG#+R"2S8R79$I]ET)"'-+2T@V-A[(
M>-P%J&29VYNS<>3:R4Z6Q%\D9AN26V4.MJ>8DMJ4!'6AM:E6TI\8K"%!5Q;O
M 0K74'/+9Q:&Y4*<C+Q(TM_*Q4I:C8]Q]HKY*B^Z$DN$>TAQ:5=NJ_BT!4G;
MUW4PTJ7*AL.O0W830Q\-3JM3S\!R4ZOFH40XV#:R0DC2#[)5J OFMX9+X1:Q
M/PQCWX+JTJ.Y&VK14*Y9<\E(YI1S56U)/,]A>_C6H"GTZW#D'1AL/D7PZW)Q
M#,N(I +BG'-*5/*>*U%UKBJ[86FRD$>-J!% 6F)WYN+)0,;(8FXZ7)S 0'A&
M9<+>,4J:S%]L!=U*NEQ0 7I]L3]C>P%1&]MV2860G--Q([#&L/-//1TR8O)D
MAFP;4Z-3BVPI6EXMIUC3>QH"FOJ#N=QO)3H3$3R6*V\EEB20'DA*4&.^ME*P
M]9PKNI&E("""%=\"OEMR[GQ>45>:B0G%)RJ3!;CAOX2<8AQ9;"+J62A:>:L>
M)JU!)-N\!;R]X;A=@SHLN? @1C"E2H.:NV^W)4VTF[ ##Q2E22O5XJRM2+63
M?4: D<E)?F[-VLQ$>YTAZ3C(LUORAYFZBT"XV\MOVQ)[J@>-^V@+2;NG)X49
M6"U(BXEG%MR9#<F7SI3+KD2.PH1DEQ:5'V96K3XQ'L4WU&@*S_46>B"KEB)\
M, SE"$H.%0:C0%RVEJ2%:@E2@FZNZD\.- '-V;P,[)PHB8)>QO.CJ3,=:BA0
M:82XF5I+BE@+6;)24Z-)!U]M 28W-DLA VS\%2$H5FE2$29LF-[8@18[KATM
M(<T:BXV!?64E-])-P:&"#7OS.QH<9&0D1VY^4Q\7)PG6V0W':==0Z76%K?<2
MD('+NE:U!9N0 3:ADF]K;OR^X,C'@.QFF=$1K*35A#@'D<]I*H@;*N&HKYR5
MW_FCP&H4,$0SO;<J8L.1,<AMHRR2H/!AQ+6/0F:F,7%E2SK3H6+ZM("_W/8,
ME_MS/9G)[K0Q)RK3F,1%E--,M,I2U-7&D!'E32RHJN K0M*;INDD<"* HQ-^
M3X\YV-F7HC2&I$QJ4^"/)6^6US(R6GDK(5K2E16%A*PH%.GL) I,[KW9DDP'
MXST.,S/DP\>$&,ZM3?EF-1-4_P",X+J2LE*4$:=/LN- 72]Y91[';74Y*AXE
MW-KELS9CZ%*0A41EU8Y25K2 5*;U6<5[&X[;4!&C?FY7FVG5"-'9DNQHH=2@
M-ADN0U2E/*5)=0BSJ@E+*"1XIXDJL* KJW9FY6'R4O).QH>1@H2VY@HZE+=<
MN&E>4(>0M*RVH+U(Y8M;@5$WH"A,WUN5N3(QK/DHG-R92%2%K93#0&@%1F6W
M5NI2M3HXN!12XBRO%[#0%3%[FS$'(/8K2E<[-Y)UN"'>8ZAB2R6URVR;B[:&
M2IQHC2#I([HH#UNG<63=RS<)J:S$5#S<&,SB"A?E<IO2E_FA2%@Z%DV]CHTI
M4";]@"5U%GO?![&.5&4)D."]-GH4@-PWY29"E)67G$MW460A"%K!!O?N"@+G
M,[@W1"9VUDG7F8LEV+/?GXJ.!)8F/LQN:TTV]>XU$73HU$^&U 5X>[<IY!G7
MFI</-?!V+^$XT^*A2(PD*0ZKR98"UDVT)5P.K2KQA>Q(%E)WAN&&J0@28DG(
M1G3#&)#"TOO@1.?Y6A(65!&KQ@GBGEBVK7V 74?>61SF2:Q>$E0PVZN(VY.0
MVJ0&U2($J4L"RPDJ"F6Q8G@DF_&U 0CV\LMFXF,?>EQ\:Z9V+2K$!#GE,E#B
MFW%O-J"PH-J)4$^*4Z4J"C?L OF=X[DCP&<DAIJ3%08T-&-2VZI]Q3V+1,UE
MY:U$J#A*;:3=/?50$UM7="\CEI>*E9>!DPF/%DQGH:"R2Y)YY<:LI:PK0EH*
M%O& /CT,&94 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MWSW30$G0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * QG='Y\V5YY>_R;)4 Z<_-[M/S-CO>K= 9-0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% 8SNC\^;*\\O?Y-DJ =.?F]VGYFQWO5N@,FH!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@,9W1^?-E>>7O\FR5 .G!!Z>[2(-Q\#8[C_\ 2MT!
MDU * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!C.Z"/AS97'MS+UOT-DJ ^=V/
M_J$7[TCZ5#]ES0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 6TG^/A_?5?@ET
#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>fc_centraldogma-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_centraldogma-4c.jpg
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M%!04%!04%!04%/_  !$( 5@#[@,!$0 "$0$#$0'_Q #8  $  @,  P$
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M5U"'BE#\Y:?>I2PI"+^Y";C]T:NB*JF<C\@SW2]+VG*N+)O_ -M?2D'Z$I6
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MR\7X;+9J6Y.R;BI2'Y3Q!<7Y<EQ*;D>-D@"I*K(J!0*!0?G;S. .5=LL+?\
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MD.K0C4"M"5$)7^(CJ >A_P"S'QIH-UVWGV;JNI:MN"M6,K';*P72!-\OY9X
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MZ3=VF1-BFZ+)=4O&9%E<R"VHW#<I@ K[1[ MNY5_ 'TU)%6<T?K5VS^T'?\
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M/K)JC]+M6P,?5];Q6NQ;%G&16HH4!;O4V@!2S]*E74?KKBJ7H% H% H% H%
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M6'PA<7(F-'N:>F.620@CHI+:18*'B5*]EC5A%6\<ZO(W+=\)KS""M$J4V91
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M=A^@%56!QC51VUZ7-,.O:$O8)3?9D-D=$A-Q90AL70P#_")6X/H4*DJO*H%
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M(7,F.V5(DN@6[G% #P_)2.@]@\:BMJH% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MN(#B0H)6DW2H7O8CV&@]R ?$7MU%_>*#T>CQY 0)#2'0VL.-AQ(5VK3X*%_
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M]8VF%M3$Y^%&E1DP);L%U,QHLJ4XS:ZD DW2;_7[Q03M H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H([+9W#8%$=W,S6H+<MY$6.I]00%O.
M7[4"_M-J#$P^IXO!YC,YR$I\S<ZXV]-#KJG&PIH$#RTG[H^(_P#V4$Y0*!0*
M!0*!0*!0*!0* 1<6]]!J>)A:GQEC(V'^?5%C9":I,7Y]\NN.RI!OV)4KZO\
MCZF@VR@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@U3,1-
M3Y*QF2UM4_YEF%)0UD407NQUF0RKN[%$7]H(/_&.@;2VA+;:6TW[4 )%R2;
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MNNNL:VMPYS]/K:)GEKE^FW1&I"U.(&??92">H;[I7P@_1>LEAC3N.73^"/\
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M4H% H% H('+;%)QF>PV&:Q$N:SE2ZEW(QT]T>+Y20073[.[[/M\*">H% H%
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MW3&.VL\*\8XSX1Z/M59ROPAR0T_EN0Y\:&Y'F%[*Y:-!>*S"*UE:T6=[2X$
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M'^)0._G'^9U7^DR/\2@=_./\SJO])D?XE [^<?YG5?Z3(_Q*!W\X_P SJO\
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M@4"@4"@4"@4"@4"@4"@4"@4"@@MHQ^RY!F C6<JWBGF9C3TY;C*7P[%3?O:
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M% H% H% H% H% H% H% H% H% H% H%!";9K,7;L*[A)DJ5#8=6VX7X3GDO
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MP[+<<QGR[7E>3#/W&U]!=0^WZS03E H% H% H% H% H% H% H% H% H% H%
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M*7_7CF/LY3^$_M:QW;;6[?N9O2/<R1:/KC2U?QC]BS/2"0G2<\I1LD92Y)Z
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M1V6ZI%[I%^EA[JRV?NF?-B^'?28X>''@PNV[/M]OF^+36+<?'AQ6-6)9HH%
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MJ^'K[VFNL^3=*Q[)E H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M/S&&F5N!E#BW4)273X(!)L5?1XT'NY.A-2FH3LEI$U\%3$=2TAU:4^)2@FY
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M&TNY?%,-,/OSH[3,FQC.+=0E+G=X=A)LJ]_909+CK37:'5I05J"$=Q [E'P
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M 41Y,J,&42"\V([EBATJ'8H*\+*O8W]E!ZHFPG93L%N0TN:R IZ,E:2ZA*O
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MDWO;NHJJ<CF<UFO2CH7S^1?5+QN[)@P)R7%&0PTTT^IOL<)O=LK/E_N0 !T
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MF1*ESI3;4J(X"OM6D K0IOMO='<>O<2/%V3Q6 .+]) \!@<7_J;5'%MU H%
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M8V_\$Z)R'F(NR9$3L3M$1KY9O.826N!-4QX>6M:+A0L2+E-[=+VH:O2-Z?\
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M/P/5\BK,8I'S2_,3*6M3A*UV^)-U'I0U8VQ>FOCW:L_-S6<EYJ3#R4KY_(8
MY1\8E^1W!7<I@=0+CP2L6]E#5(\@\ \>\CY/$YK*M3,;F,*P(4*=AI)@NB(D
MDI8)0#\">Y7;VV([CUH:OANWIXX]W?8GMLD'(X78I;0CY*?@YKD!<QD )[)
M2"E0*4A)-@2 +GH*&J9C\+<:1N/E\7MX%G]#'1=Z$5++BWB0KSU/=WF>;< A
MSNN+ #H+4-6N:UZ:^/\ 5X68QL2;FI>-S.+D8)Z'.R+C[#,"7V]Z&$=H"#\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tb_panels-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tb_panels-4c.jpg
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M%!04%!04%!04%/_  !$( L@#MP,!$0 "$0$#$0'_Q #=  $  @(# 0$
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MZZL-E3M:F]XAGP[Q:ERC7CMW(NH^1?)0?5GT5_\ I6'Z1E?_ )E25:GTM/\
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M);Q(A<$O*BZHO8OE2@L.8QNKF<X^?5/)!??QDW-C1BX(,,AOY2*U'W:BWO\
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M#EWG_P#*Y</AE7_Q8"\Q$_\ 9?T7T5:H]%Z<_1QP_ [BS?);[M]O<94.*])
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M -*>_P"(7NT%QZ53)CO4*P Y(=,%D+J)&2HOXL_(JU)(?7,_^8R=."\IS_\
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M<Z$36=KE H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M6\& +8V+;:%ZQ:)N+ST$BUGS82XV0NV<7LWAQAB1[R4@O#ZMM<EN0<7:J$^
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MT#V@'<7[= ]H!W%^W0/: =Q?MT#V@'<7[= ]H!W%^W0/: =Q?MT#V@'<7[=
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M!&5LM4H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MI]?S4''*<U5-JIM]]KPTU^O015RR&QV:Z6FR76<W$N]]<-BSPC0N9)<:'>:
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M4"@4"@4"@4&Q$_*+];^%*X7[F2S>W*PLQ0*!0*"LYW^9(GZ9L/ZXAT$;TO\
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M4KA?N9+-[<K"S% H% H*SG?YDB?IFP_KB'01O2_\VY#_ *FOWZP=HJ\40H%
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MOBVRH[P%54E 4<T#7U$2BLMNZ?VF MH)^XW:ZG898S[0=TFK*)AP(KL- 0E
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M*XO,3<NX235%[=90JP3.C>#S&6(JL2F( PXELGPH\M]EBX0K>'+CM31 DYR
M/J^MQ(5424AX4H53#_3_ !B1'N41Z,9,7:ZQK]-#FN>M/AK'5HDX^J*>%:]1
M/573LXK5*NUFP:S6:_S<H!R7-ODUI8J2Y\AR23$175>\.QO70&MZ[M/K<=$3
M0++1"@4"@4"@4"@4"@4"@4"@4"@4"@V(GY1?K?PI7"_<R6;VY6%F*!0*!05G
M._S)$_3-A_7$.@C>E_YMR'_4U^_6#M%7BB% H% H(>1^7<_C+5&.@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@S1?YP'U_X*"57L6H(RMEJE H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!L1/RB_6_A2N%^Y
MDLWMRL+,4"@4"@K.=_F2)^F;#^N(=!&]+_S;D/\ J:_?K!VBKQ1"@4"@4&(H
MS!*I*"*J\57C0<>%C]Q/30/"Q^XGIH'A8_<3TT#PL?N)Z:!X6/W$]- \+'[B
M>F@>%C]Q/30/"Q^XGIH'A8_<3TT#PL?N)Z:!X6/W$]- \+'[B>F@>%C]Q/30
M/"Q^XGIH'A8_<3TT#PL?N)Z:!X6/W$]- \+'[B>F@>%C]Q/30/"Q^XGIH'A8
M_<3TT#PL?N)Z:!X6/W$]- \+'[B>F@>%C]Q/30/"Q^XGIH'A8_<3TT#PL?N)
MZ:!X6/W$]- \+'[B>F@>%C]Q/30/"Q^XGIH'A8_<3TT#PL?N)Z:!X6/W$]-
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MW"ARWP;?=(UVCM#WW%>"*J<:"BGUTQN[0<O:Q25;QO\ C6_PB7R8W$@S6F3
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M>'F+-,VZ]4\L5W5:_3SIEDELO6+6K)[3?V).,W$Y;$^,L!;*(HXKBFCJ"CY
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M<+]S)9O;E868H% H%!6<[_,D3],V']<0Z"-Z7_FW(?\ 4U^_6#M%7BB% H%
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MLO#3>7%>S2JBV)G^:A(N61K=K8[:[3FJ8E^S0Q1\3)C/SVH8+S^8AI*%'N<
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M#01;X$)D*[B[45%UH)F'U)ZEY1>Y+N,0 */:BLG-M>Z"$>0Q<XD:7(=>>D2
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M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0;$3\HOUOX4KA?N9+-[<K"S% H%
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MBD*HB\.*>6@J^39K!Q7(\3QF?#D/2\PE/0H+[6Q&F3CMHX1.[E1=%1>&V@M
MMN&FH"I(GE1*!RG-N[8NW3773R>>@Y1EU4W(!*BIJBZ+V4'"M.HJ(H*BEV)I
MVT&&<ZMO@RK@^V:LQ&79!BB:$0L@IJB:\-51.%!"8'E<3J#B-JS&U17XT"[-
M*\S&D[5>!$)0T/8JCJJCY%H+ @&I;$%=_=\M!SR75+;L7=IKIIQTH"-.*2B@
M+N3M33LH"M.HNB@J+IKIIY*"&R>_+B]J"[':KC=Q.0Q%&':6%E2?^8<1OF;-
M4_%AKN,O(E!-$TX**NU=J??>2@X5IT=-05-5T3AY?-0<\A[_ '9<>'8M!PC;
MBDH;5WIVIIQH"-.JJB@$JCVIIQ36@C+_ 'ZRXK"&Y9)-;ML GFHP/O[M"?D%
MM;;%!154B7@E!(D) 2B2:$G!4H.*!0*!0*!0*!0*!0*!0*!0*!09HO\ . ^O
M_!02J]BU!&5LM4H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H-B)^47ZW\*5POW,EF]WD?B3&4/O1]5
MY/."^7_V5K"S-GMXI0*!0*"LYW^9(GZ9L/ZXAT$-TZ:-^RY*TVNTRR6_:+__
M +%WA]FBK;:V7(Y/-.KH?JD@?4X\4HB2H% H%!#R/R[G\9:HQT'S//\ I6S(
M4Z5#_99LTCO.,[_&DFO+)1UTY"]NE=%[SN]5]5P_ EN2RV[KIVQ$^A]YK_O;
M3/DHU_;B^ I[SN]5E_8-O_//V/O'[VTSY*-?VXO@*>\[O5/V#;_SS]C[Q^]M
M,^2C7]N+X"GO.[U3]@V_\\_8^\?O;3/DHU_;B^ I[SN]4_8-O_//V/O)+'OI
M12[Y?[59"QEM@;E,CPU>281J"2'1;W;>2FNF[736N5G:-UUT13?+5XOX(MP8
M+\O73.BVZZFCFBOK/HZN[?+T=D7^7+W^CIG]W.@^4^GMD;RISHCB=QE3XUCN
M>*7=+BS!DOPU=%J01H!DT0JB*J)KY?)K08;=>[P?3;#H.3W*[_-G%RN[VK*)
MD4Y"R0@13_Y)I]YK\:C.NNY47^"JBWI8\.R_JMAV+8K=)X]-)6,R93:0IDML
M9'A+@;B ;KR\Q1YO;KQ5$1/>T%4LTG)KEG*%><CBX_U2:R?C[3>NHW!^,CZ
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MH]VE5HDY?4J>[=(M@NT!^U7V!D]MM,QJW2VWHSK-RB.2F3)UUA"-M13:ZV@
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M=2;5$3@J(J(FY%I0JD\KP6UYD[%2]2YI6R.;+CUH9?Y<&249\)#2OMH.I;7
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M"X.IJ7,W[E145=:"P.=/;"Q,MERALR'@QMML\:QPY9-6:-*B1SCQS;:VEL)
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M8@KQ<XNJGD;3M^WV4&PB(B(B)HB<$1*#F@K.=_F2)^F;#^N(=!&]+_S;D/\
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MF@>SW.\/IH'L]SO#Z:![/<[P^F@QO1'&0YA*BBBIN5->"+Y?L4&3V>YWQ]-
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MM D/AJBJCA)VZJ**O#CI03% H% H% H% H% H% H% H% H% H% H% H% H%
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M:[17N<[$@LVQ@GT/U2$RW<V&G:GY1?J46C!\XW4^#9\ROMPB6:;%Q.:=J./
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M+1>(T1U#JCB3M]]@@LX3]JN8Z5P<ANC;QN[::I$61[W>:>\5$VJNB:H2Z45
MO]6XESR+%+=BX2"L]XN$^.]=9D%T(4V- @27B*$^JIN0761];1-X:[-4XT1*
M6CJKC,G&GKY<99&[;85JG7/PL20T+HWT!6&<1EW5PA>,N6 JJDA(HKQ2BN\7
MJ5:FQ:C3!?NUYD7"ZQ(]NL4"2Z^D>SRUBON.-FJJ@LEM;<=UVF:_BT772@C\
M ZI0K[B$2Z9 ^JWL+&]DUR\-&-ME+<W*D,H8#W]&.+?OJ(L!]0<>8G6./+8N
M#$#(%AA;;NY#<&WF]<1WQV5>U7:XXF@HFW1"5!5=:*\^QOK%<1>M<S,WF&K'
M)MUSD3GHT94)N2SD8VB*:[251:%LTYJ]FOK\$HCT\<MQ\CR1#E\F/B)HW?YS
MPJW$8/PPS#1'5X%RVC$G-OO==.VBJ;?>JAL0\9N]IMESC6RZ7Z);'QN-L=;D
M384R))>!832KOW$;;?$A113WR)VH1+CU4Q9Z!#E0VKE-N$UZ9%;L,:"X=V!Z
MV$@3!=C*J*'(4A0U4M%W#MW;DHK.]U*Q5IJS3Q*6]CU^2+X#(V8IG:D*X&C4
M8'7]4V$9J(:;?5)40M*# QU6Q"3=1M8+/ "N;N/E='83K=N"\,.$RL0I"\$,
MC':*Z;%70=VY=*#&/5["%9F3'7I;%MC0Y=SC7%Z(X$6?"MNGBWH1]KPLZHI<
M$517<.H\:!D?4R-9,(C9Q!L=TN$29-APHT(HIQY*MS981A?)L_6$"0MS6J>N
MJB/#=J@14/JU%B9/DMJR1F5&M4"Y6R%"EA"<Y4!NZ0HSC0W%Y%5 ,Y#RAK][
MJF[1.-$66;U L-KO,FQW=BX6V2PQ,EQWY<0VXTQJVMH[)\*YJJ.* +NT5!W)
MQ'5$H.<5Z@XWF-P2VVOQL>4]!9N\)+A#=A^*MLA4 )4?F>_!"(4+70DU35-%
M1:*I<+J]>7&L%;F6V,D^\W&5;<R!K>@V_P +/6TBXVA%J*'+)L?7U]5?LT1I
M/]8+R[=(#"W*QXY9KLM^?MUQND=^4KL2SSVH,=-H/-(AO:NNDNNFU!T2@LT#
M-[Q<,_=Q!VXVJU-Q0BO1(<N.]XR_1'HPO/2H#JO V("9$V( CI#M7?IJE!WD
MY_<X^>P[5R8J8*[<7<<E7 D/Q(W=JWG<%)#W;$:'9R%11]_KQX4$%CO5C(LE
MM5J;C6^)$RB\9$=J8C/"X;3=G6&5S;FD"&A*JQ%;+WR(I%0#S;JM '.GY#%F
MO?[$*VU[.MD&6S)G.2(+4L2%5?=4!;YWK@ &1""[>*I07O"+R]D-B"\'?;7D
M4>0:^&N-D9*-'01%-[1@;SRHX):ZHI(J=BIK15BH% H%!FB_S@/K_P %!*KV
M+4$96RU5=Z@_Y!RK]$S/Y(JPYO0EUO:OZ+-^7?XGP>V*&X $:-B2HBN%KM%%
M7M7:BKHGU$KS[X)$5GF?25W^CC:)N!09N&STGY*VUXE9:.?\M<1<1"V!JNUO
M3_PE\O8?;N'?GAXFW9O?2^)^$\=W"6W</=JR1%:UV7]SDC^G^[GCQ;#>GF29
MIDBXW!C''D1S4;F]( @&((%M)74714)%140.U5X>>M2W'-TT>*[.[*S\9GZJ
MV*4]*9^CW>GHWU?54Z=A/T?<)"/'#FRW=?#Q]427<):(FXS+1=!35-Q:: FB
M(BJJ(O8^;BM?5\V;A.PN$B(BLSNCZ5]W//1SSNB-D;:1/R+EN6WO-;V_?K\_
MSICWJ@ ZHTRTBKM::'5=H#K]GM7555:ZV^^;IK+X]QO&Y>+RSERS6Z?FB.:.
M:(_G-9F97?Z/7_5"W_U>9_=SK-PWXD.^^%?U]OU;O$^PJ[U]C5S-L3#,;,%O
M&:Y;+E#E1[E:;HR(N'%G0W$<:<Y9^J8ZIM,"X$"D/#76BPKUQQ#.KY[-NESN
M]K8R7')J3K#(APWTBFIQWHLAN4VZ^:J+S;RHG+)";7UD4NRH58K)TQGP,DM^
M6W*\!+NZ7"XW:[@U'Y3#KUPA,06VF$WDH-L-1VQ124B/35>*T*JWD/2.XP,
MCPXLP[I.QRPY/$9B,,;79SU[CGRP;U-=I"OJIV[M?)2BU;+O2[,<GLL5V^Y$
MW$ND.R-VFSI%B''V"^<5Z6LO1_>JOI&&.X#1@@@I;5W%ZJB52&-](I-CND&Z
MG<(K91K\]D+D&!#\+&'GV9;4L=H>82H@_E.8O$N.J<:4*HJ)T!@,Q;MCTA+:
M[CTYJX-0KH,,AO\ &2XJX2(DA7%:(F5=)!<Y6I!H))VJJBU6S'<-RQG+HN7Y
M9?(MQF1+.]8QCP8916W.;(9?642FZXJ&?)T($]4?)1$3(Z67H;G<+E;KS'9=
M"_\ [66 W8Q.$U->BK#DQI*(XB.,.-D2"0;##=KQVIJH52T/I[.7'LRBW:Z!
M)R/-TD+<9[3'*C,$["&"RVRSN55!EL!34SW&NJJJ:Z(*HZZ=,+T96YZQWMB+
M*;QPL2N;DJ*L@2C$@*,ED1=#:Z!"N@FI 2%Q[.(JU4Z-/CC&48X-Z37(K!;,
M>"0L?\@MLAN15>4=_K;]^[;PT[-:4*I6X=-'YT3*(J71&TR+(+=D KR=49&W
M^ U95-Z;M_@O?<--W9PXJ%62P=.'K)D4"^K<T>"&[D;I1T:V;TR.XMSQ3=N7
M3D\O9V>MV\.RA5YO=\(O_3ZPN6/'9T^X76XXP./RFXEE<F,RG8Q2O"N-/(ZC
M<5Y/$F)^()6E#0NT>):O30P67)L?3Z$_*&+*P]Z%+D@(\T7BBV]V&30EJ.B:
MNZ[M/)V<:J5:D+IC(BOVMXKJCB6_)[IE!"K.G,"Z!+#P_O\ @H>*]_Y=O9QJ
M4*JW&Z)Y MEC8_<<DCO0+1C]XQ:S$U"5MWPUV:;:;D2%YRH3K0M")""")<5X
M:Z(HM6]=>CUSGCDL%F],MVO)8=G;>WQB)]B99"9$2!4<02:=;;XBJ;A+BBJG
M"B51ECP#+KXYDUJNDD+9A\S,I-X?AOQ"6;)CQ9+$EH6'N8@HR^XT)*:@I(FH
MCVHHEJS2.AKHN0KDU)MMUNK(W*-,8O4(WH3D>XW1ZYMD -.@8.,D\0:[E%P5
MXHG!44*IO.\<ORR^G$?$6&8KECN9DKK<93M\6.W:9;"";0F*@R:D+([2U'<F
ME$A#W+HK=KDV<B3>XLFX71^YRK\Q*AF[;EE71MAEN1'C(\/XR(U'%EGG$>X5
M(ET):46K;;Z,R6\6R;'!O:;\@LEJL82ECZ\DK5$6*KRCO];F:[MO#3LXTHE6
MU;>DC-IS.5?FF;3.MDRYO7M7)\,W;I%ER%WD+#XN(&U'?QC9$WN#51X\%10J
MC&ND=[M$/#@MTV(])PR,WR[@RRY%NTTXY&X4/G\[EC%DJH@X#@%M354XJA"H
M56"^X9E658OC#%XN44K_ &UQB;?(;K)E:9[_ "#;<:=::<;)6VS<YK:;E12
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MV!V_=P-W5Y-N*?[>F.CGCOQMW_2.8]1<-P/'SRQOP\J3>A%V W$V([<7!!$
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M&W8Q19#<YCQ"HYSP+4E9)O82(H\.%!$W3H[)NEC>M+]_:*?<[D_?+S?3@?\
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MV*>?Y?.?LO\ [O[/O'[JR_*T/B\O_,4]BGG^7SG[+_[O[/O'[JR_*T/B\O\
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M<(([2,\Z0A&X"$R*OAM7WY(NJ!P725)AZ=50H% H% H% H% H% H% H% H%
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M [RTUR:(/"!WEIKDT0>$#O+37)H@\('>6FN31!X0.\M-<FB#P@=Y::Y-$'A
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M!&5LM4H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M",K9:JN]0?\ (.5?HF9_)%6'-Z$NM[5_19OR[_$^#*\^^!E H% H/4_H]?\
M5"W_ -7F?W<ZV>&_$AZOX5_7V_5N\3["KO7V-Y7](]%7H]?-$5?QT+@G'_\
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MS%/Q/*2.WL%$5.U%U152@U/FHQU3ESG)UV.^S9D>Y_M 4S2>U.A,%%!UDD!
M%%9,FC;V<L@711HB9B8C;XUUAWU^7-N%ZA6^5:!G3'A,W(LU\)#G,0  5)"
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MPK+CR39+ONQ^V,O9^6L;;)]*WGZ8Z7T9G7T@<9L^+1KABLANY7NZM*4*,O\
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M$979&,8[BKM4G$5$3;ZR4$IBO4MW))MEMK]F\#-N42]/SA20CPQI>/S0@O-
MJ G,!PS4FW/57;IJFM!YS>.J&82(LW-\7$(CT_%<7N4>SS7E=B1"N5WDQGR%
M-A"3A!M!2VIPX_>HBD72?U"N]CR&ZVOV0[<[R[=['9 MRSQ2 Q(NEO*01QS)
M@2%H%#5W<A$?%11. T$+?\]OKV36VW3V7;-=,>>O\:^0;;,4XTI L/M"(^RZ
M3::BHF)AS6]6W$7@NFJAW:ZZQ((VZ %N=F^$A64KQSW7WKHZ[=XK$C_EQCQ2
M:>-IMX'7B<)K?JNU$H+SB>:N9+D%_LDF+'MKEDD.1_9[C[BW?EMNJT$AZ,;0
M"+#Z)S&7&G#%15$5=VNA7G4C,^HTYB.[,9C)(B]11L4!BWRS9%^*RL@%C225
MD4Y0H@D1:$1Z>]UTHB?'J9.E7:W1W;/-&]6^7D=MN-EM<H'8\N598021%M'&
MA)Y'1,%8W*VH&7K:T$Q:NIL)[IQ<NH]Y"*W"M3#TJ9"M;[DIUGD A+&>1]MD
MVY(D7+-LP31>/8M%4+)>J>29/C<NT62&U;[F=PL4:1.A3)C#*P;O.2.[';EN
M1&C;DBH\MU6P71L^8!:\$(RX?E.40,CO,2=;@N.47&_/XOCL4[O+=@1(5J@M
M27N9S6D1&VA'F*\@$^\X>U=$XT%HB=4[W/O%JQ:%BP%E,FX72TW=AZ?RX4)V
MS!&?<=!X6B-UIUF2!M:-H>JHA(GK:%2O2O(LJRC&I%URQF&W)&YW*)%<A&1(
M;,.:\PB&"M@@[$!!145=_OET5=*"[T"@4&:+_. ^O_!02J]BU!&5LM57>H/^
M0<J_1,S^2*L.;T)=;VK^BS?EW^)\&5Y]\#*!0*!0>I_1Z_ZH6_\ J\S^[G6S
MPWXD/5_"OZ^WZMWB?85=Z^QJWFV5KB5LBR(\);C=;G-C6JU0>8C NRYA;0YC
MJH6P!1",RVJNT5T15T2BPI[W5/(HUS#$WL=CEF2W5JT$R$Y4@<N5!>G,S!>)
MC>K>U@P-M6T-"3AN315A16KKU2OJ3K7E 6]Y'[);LL"^8O'E*3,B58)<)EY6
MCV(CBB',<84FT5==O!5I5:/0XG4BWR0R^[*PO[)XG':?.\M'S4E+X)+@^C;:
M(G!IIQKCNXD2IPVT2BK7+K'?L<M7M3)L7"-X^S2;_9(T><CQF,-&C<AR"5D4
M;?Y;PFA!O;7UDW<$4E5HW)?5:]VB=<;!>,<;'*0?M3-DA19R.QY7MPGQ:1U\
MF@5I65BO*]ZA>J**&[7;2J4:66]9;EATWV#<;7#?R2) ]KW*-'D2S9..;KK;
M#$4@B&1R'D9-41P0 51$W+KJBI1ZO;YC=Q@1;@T#C34MEM\&WA5MT1=%#03%
M>(DFO%/(M5&S0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0;$3\HOUOX4KA?N9+-[<K"S% H% H*SG?YDB?IFP_KB'01G2X02U7P4%$
M5O(KZWO[2+2XO*JJO:NJJOW*"\T"@4'4@ TVF*$/F5-4H,#'XATHJ^\XFPO_
M &?*/V%]%!H2/R[G\9:HQT'D<CZ-_3.5(=DNL3%=>,G#5)1>^-55?)YUKK/=
MV/GGY=Y[*SXP[0LMBV)MI']+'^[1TO\ ]Q-_M1>Y4]W8^>?!Y'/]Y=H\]OV3
M]VCI?_N)O]J+W*>[L?//@\A^\NT>>W[)^[1TO_W$W^U%[E/=V/GGP>0_>7:/
M/;]D_=HZ7_[B;_:B]RGN['SSX/(?O+M'GM^RV[7]'CIQ:+G"NT-F6DR ^U*C
MJ4DB%'&30QU33BFJ5RM[/QVS$UG9\N9AS_%O'YL=V.Z;:71,3YO).QZK79/(
M-6Z6Z+>;7/LT\2*!<HST*6($H&K$EM6W$$DXBJB2Z*G905R[]-,/OC+;%QB/
M&#5H3'@4)#C9) ;=:?:]851>:TZP#C3OOA+73M6@QPNE^*PY27 RGS;HMQAW
MIZ?-FN/OO3[;'**PXXJHB*@MEM4$1!7APH-R)@.,P;ZWD<9EY+LU<YM[!PGS
M)OQUSBC#D%L7AM5H$00[!7CVT$<_TEP>1!?MSL62L63#N-L=%)3B$L:\3DN4
ME$5.*$KZ;A+M$?53A09LNP6V7P;G=6;<D[(9S5N9%')KMO0%M$AR1%>8?: R
M8?9)TS!P175>!>K0:N X+*Q^WY-[?<1R9E<Q94V.W)=F$TSX-N&@'*=$2=>(
M04W'$ 112V@.T4HB3C=/L7BA!;98?0;=8G,4BZOFNEI=1M"!=>US\4/XQ?6^
MW14/<>C.#7.*,!\)[-N*V0['-AQ9SS#,V#;$5(@RD'BX;.J[3U15UT+5.%!*
MS>GF-S7'9'_.19KEZ3)AF191M/M73PXQ"-LM%00-D>6;>FU45?/00%RZ2Q)&
M2V.?:IDFT6:V-7YYYV!,=CW$;C?Y;$HR:-$)%:50=W 7 =1T3AJ@2J=)L$"'
M[/;@/-Q4M[%I;%N4^)MLQ)9SVG@<0MZ21DFK_B-V_?QUH)"3B\@,,OF,Q+G,
MN4RYPIL:/,O<A91B[+CDR"$: .C:*J*J(/GHBMVSHQBX6!FU9 <ZZRTM4>S\
MZ1/?>2$TSR7"& 1*BLISF&W$/B2[ U71-**FK=TVQBVS&;F)3IEU:N35\.=.
MF.2'G;@Q!*W"ZXI::IR"4-B(@]BHB:4'23TRQITRE0GKC:KJLN=/2ZVV:Y'E
MB=V<%V6TAZ$BLN& 'RB%1$A14T5*#9D8':W7KC,C7&[6^Z75N S/N<*<;4MP
M+4#C;&IJ))JHNGS/5]=>*]B4&5<(LS&+0,.LS\ZPV6V #,)+1***^+((H["=
M5#4A+<JEKVEQ[:#3A]-,:M,V%,QUVX6 (;$2(4*US7&(DEBW"@1TDM+N1PA!
M.6I\"(>!*J(F@0T_I+!CW?'[GC+[\6):L@"^NV>1+=*VQVS"1XKP4?11 W7'
M]^U?534MNW6B-Z%T@P:$^V?AY<J'';N$>%:I<QU^WQHMX';,CM,%P1IQ%]ZJ
MKM[$5$X45N1NG%C9M[5JE3[O<[?%EP9\%FY7!V5X9VUN\Z.C1DF[:A(B$AD2
MFB(A*M!WNW3G&;NY<)#WBXT^XW2+?G)T24;#[5R@L!&:=9)-4#\4&PAT4215
MU3C0:5PZ2X;<9#TLTGQ9,I;FDUV'.=CG(8OC@NS8[BCQY3A@)H*:**IZJI0;
M,;ICA\1Z/(8C2$=B/VN6Q_S)Z<ZPQEBPM4[-!;70T^^7BM$=>GV(R\:=R#(+
MP$5O*<LN*W6ZLV]2.)'0 1MB.V9H*N;113<<41WNF:HB)I16['P/&HOL_DL/
M)[,O$K)(>KYKMN<_G\XU\X+XAS0%X)]B@T'NEN*&W!&.5P@O6^3<);$J%-=8
MD*EX>\1-8,TXDR\>BJ'WNU-JII0=%Z2X/['=L0Q) 6YRSP\=% E.BXW MCSD
MF+RS1=1=:=<4T<[>":]E!H91TIBWDK>[;I4@)I7FTW2^7%^6X,QUJSQ7(K9L
MN-HFU_0@551$0EUU\U$23'2O$&0:5T)DJ6+D^1(GR9CCLJ2_=8O@9#C[B^_+
MD:-M\$1M!3:B:4&6)TWQ^V38,^RRKG:78<>%#>;@3G&F9K-L 6HR2P5"1TA;
M%&U/U2(?555330-ZU8;:;5D$O*4>FSKY*9.&W)N$DI/AH;KR/G'CBJ(@-*X(
MEIQ7U1371**U&^G6--W%^Y#XO5^\-9*,191K%:NS0&*O--JGJHYO(G0UVD7'
M1*#L/3S&6[FY>6!E,7-R7<;BDEJ48$$J\1PBR7 T][^+;'E]PN*41EMF"8[;
MK1>+,^V]=X^1*2Y _=GEER)^]D8VCQJ@ZH+0"V*"B:(GGXT5KL]/+.EM&TS[
MC=[M!:F0KA%&YW!R4;#UL=1Z.C9DB%M0A3?N4E/[Y5H.9G3G%YC4H=DJ-+DW
M9S(0N,62;,R-='FA8-V.ZGO$)M-A-Z**BJHJ+K09;/T_QBQ2[7<;>R_[1M)3
MW69CTAQYY^1=^7XM^21ZJ\XYRA]8O>Z:)HG"@W<>Q>UXL$]BSG)&%/EO7!83
MSY/1X[THR=>2,))JV!N&3BAJJ;EX:4$S0*!09HO\X#Z_\%!*KV+4$96RU6I=
M+=%O%LFVB<A%"GL.19(@NTE:=':2(7D71>VN-UNJ*,6;%;EQW8[O1NB8GN2\
MU_=WZ9_T>=_:U_V*T_8['FOVMP'JW?:/W=^F?]'G?VM?]BGL=A^UN ]6[[1^
M[OTS_H\[^UK_ +%/8[#]K<!ZMWVC]W?IG_1YW]K7_8I['8?M;@/5N^T?N[],
M_P"CSO[6O^Q3V.P_:W >K=]I,XOT>PG#[RS?K(U*"XL"X#9.R%<#1T% M1VI
MKP5:R8^&MLFL-S@^PN$X7+&7'$Q=%?I<^Q?*VG?(C),;M.5VLK3>&R./S&I+
M#K1DR^Q)C&CK+[+H*A XV8H0$*]OU*"$MG3'&;:_#G:RYEUB7!;P=SF27'Y4
MB;X0X(F^:KZX@P:M@&B"*=B:T6K!*P"!9T?OF+0 EY.R5WDV]BX2G0AG)R!Y
MM^5SE07%Y:FV*HB NU-4'MH5;. ]/K7A.!P\(5&YT<671N9DWHW)>ED1R%4"
M4M (C(1!57:&@ZKI0F46'17"_ S+=**XS8DF =GC!+GOO+"MKA 11HBD6K8+
MRVT5>)J@BBEHB5*%4S?>G6,9%+N%PN33WCKBU!:.2R^XRXR=J>=D1'F"!45M
MUIQTB0QXKV+JG"J5:+_2VU/G#EI>;TU>HC1Q3O3,\VYTF*;I/(S(,4VN !DJ
MMZCJ&J[534M15>!':*"BJNU$355U5=/.M$<T"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4&Q$_*+];^%*X7[F2S>W*PLQ0*!0*"LYW^
M9(GZ9L/ZXAT$;TO_ #;D/^IK]^L':*O%$*!0*##(:)P$)O@\VNYM?JIY/K+V
M4$69\PR-$5-RJNB]J:^2J.M H% H% H% H% H% H% H% H% H% H% H% H%
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M<=45%X+]=*#H$V0(J)JAZ_?*FB^C2J--IKE'S ,D+SHNB\:@S\Y[_>G^%_\
MA0.<]_O3_"__  H'.>_WI_A?_A08GA)_;S'"7;V:KKVT&S'DN1VA9%$(1UT4
MM=>*ZU1D]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H
M.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H
M.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H
M.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H
M.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H
M.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H
M.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H.]T?3[M ]H
M.]T?3[M ]H.]T?3[M ]H.]T?3[M!D9F...B"B*(J^36H-U>R@T_%N=U/3671
M##KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0
M:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N
M3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KD\
M6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N
M=U/331!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N3Q;G=
M3TTT0:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]
M--$&N3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/33
M1!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0
M:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N
M3Q;G=3TTT0:Y/%N=U/331!KD\6YW4]--$&N3Q;G=3TTT0:Y/%N=U/331!KED
M8?)TE$D1$1->%<;K:.5MU9;%<&0H% H%!6<[_,D3],V']<0Z"-Z7_FW(?]37
M[]8.T5>*(4"@4"@AY'Y=S^,M48Z!0*!0*!0*!0<$0@).&J" (I&2\$013557
MZB)01=ORC&+M:Y-[M=ZA3;+"W>,N+#X''9Y8H9<PT70=!75=?)0;-JN]IOL%
MNYV2<Q<K:ZI"U,B.(ZR1 NA(A#PU1>"T&M?\FL&*QHTS(I[=NBS)+4"*ZZAD
MCDN0JHVTFQ"74M.&O"@VKO=;78+?,NUZF,P;;;FU?GR7238RT/WQZ:JB>;AQ
MH,T25&GQ(\^$\,B#+:!^+(;74'&710@,5\J$BZI0:$K)+#!OMMQ>9/!G(;PV
MZ];+>J$KC[<?\H0JB**;?JJE!*4"@4"@T[K=K78K=+N]YF-0K9 :61.DNDB"
MRRGWQHFJHGFX<:#-$EQ9\2/<(+PR(,MH)$60VNH.,NBA 8KY4)%U2@TFLCL+
M^0R<29G >2PXP3Y5M1"YC<5U= <5=-NBK]76@DZ!0*!0<HFJZ)0=1(21" D,
M%["%4(5^LJ<%H.:!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#-%_G ?7_@H)
M5>Q:@C*V6J4"@4"@4"@4"@QOR(\1AR5+>;CQ615QZ0\8MM-@/:1$2HB(GG6K
M$3,TC;*3,1%9FD0K0=2NGSMLGWIC)8#UKM6SVC)9>Y@L(Z:-MJ:"BEH1+M%4
M3C6U/!YXNBV;)K=NZ6I'&X)MFZ+[9BW?MW5W+.TXV\T#S)HXRZ(N-."NHD!I
MJ)(OF5%UK5F*;);D35VJ"*GY-8+7>+9C]PG"Q>KUS/9<-1,B?Y7$]"$5%-/^
MTJ5FLPWW677Q'FV[YYF&_/99?;9,^=?NCGHE:PLQ0*!0*!0*"*R+);#B5L*\
MY)-&WVL7 9*28F:(XZN@)HV)+QT\U9L.&_-=ILBLL.;/CPVZ\DZ;>=*IQ1%3
ML5$5%^HJ:I6%F*!01M]R"R8Q;3O&0SFK=:VS!LY3ZJ@(;I;1'U45=57ZE9<6
M*_+=ILBLL67+9BMU7SIA)(J*B*BHHJB*BIQ147BBI6)E*!0*!0*!0<;@W\O<
M/,TW*WJFY!5=-5'MTU\M!S0*!0*!0*!0*!0*!0*!0*!0*!0*#8B?E%^M_"E<
M+]S)9O;E868H% H%!6<[_,D3],V']<0Z"-Z7_FW(?]37[]8.T5>*(4"@4'1U
MQ&6R<+CIV(G:J^1$^O01![]Y<S3F:KNT[-:HZT'D<CZ2'3.+(=C.OS$=9,FS
M1(I>^!51?+YTKK/>./FGY=][*SX/[0OMBZ(MI/\ 4Q_O+]+_ /?S?[*7NU/>
M./FGP>5S_9O:/-;]H_>7Z7_[^;_92]VGO''S3X/*?LWM'FM^T?O+]+_]_-_L
MI>[3WCCYI\'E/V;VCS6_:/WE^E_^_F_V4O=I[QQ\T^#RG[-[1YK?M-NU_2'Z
M<7>YPK3#>EK,GOM18Z%&(15QXT =5UX)JM<K>T,=TQ%)V_+G8<_PEQ^''=DN
MBVEL3,^=R1M>JUV3R"-R-](N-7R4JZ(Q;ICFO\6.:T'Q]@T29;\;L_2Z*FUG
MJU;<;FHXB*2((/N!=E+3LU8:3[=46?IYF5VQBP].+3:KA[-L$_.;Y:;P!"VC
M;D)ITU!LR,?43LXBJ+]6B.F;YC=\J8R!FX7%+G:+)U-LT&Q;>7RFX>TBV ;:
M)O'=Y55?KT5S$>ON/K](2\1LC)V?:')?,@R8\5T9KY,B34IQMP"T1@5Y: (\
MM?ODUH+-&RKJ!D65KB4+-V\5MP89:+[XA8L4B\63*&[R>8*( DJZNHB+H'O4
M&B*[;.H%\R#(NE/4.[QQF7V/CN5/F$<.6W+.W;A%T!3L%W9N73ZNE%6CI1FO
M5W(;QC%YG^-O.)Y$RX=]=?:MK-NBDK:FT[;5CN+(Y8*FPQ>%2T75:B-[)LCS
MNY]4<UPRTYJ.*6:R66'>(9E'CNFKO+W& &\GJ@J^L][Y=---*"LN=7<RRO$L
M5=M=VN,#-95BE7NYP[.Q;F("LQ'2;&=(>GHJHT7+X,L\2U6@W;/U%ZFYY=^G
M-GM-_9L+V68R]=;M);B ZV+T.2HNNLMGHHFX(H*)NT%%7AK05YEV_P"/3>O]
MUCY*3UPLXO<Z')CQ71GOE&0FI#C3@EHD=%V( #L)/?<:HD<RZIY?'LX2,2OU
MQ;N^-8U:[O?(S,>VM65AV0T)(LCGCSGE>U1$9CHB#Y*"W8)<';S]("YWB0(@
M_<L'LTMUL. ";Y(9(/U$5>%00LWJ)U*BR^J^2L7IMW'>G$Z4U%L3L82\2KS"
M(R+KH:$+$?=S51$4B5%U72BM>!FO6.)8[W=Y3]SDV![&9EU8OMR:M0+$NS0"
M;10AA&>Z.YJHB+H*J+IK51L6?J'U!M%VZ=7:YY,UEL+.XD@Y^,QXS#2PUC1"
M?%QDFM3U0AVN*?:6OUD@U<8ZF=0'(?3O/9V5,7=C/;P%JGX2$9@&H;#SA@B1
ME!.<CK*(A.$X7&BN(]QZE9M@?4F\7/,":L-@>OMK9M[$1GGR08=4AYKR(FT
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M@Y/*S"';_!_\T4F<CZNL.2.;M5L3D&;:BWKIHA:Z45@L72/V):3M?MKQ&_$
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MZVO8E"JON]!R<M!6O]H%12MDVU\[PJ=LV\C=N9IS?O=O*TUX^^U\E*%6_GF
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M+.\<.?<2:$8C<QH&W#CJ2GOWB+H_>;5XZ$NE46>B% H% H% H% H% H% H%
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($OD1-5HK_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>pc_unique-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pc_unique-4c.jpg
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M%!04%!04%!04%/_  !$(!&H%X@,!$0 "$0$#$0'_Q #B  $  04! 0$
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MXD->>X]U]PBPDM$1OH'XQ^:WNKBOU+9HJ2$00$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$:=X7XD->>X]U]PBPD
MM$1OH'XQ^:WNKBOU+9HJ2$00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$:=X7XD->>X]U]PBPDM$1OH'XQ^:WNK
MBOU+9HJ2$00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$$:=X7XD->>X]U]PBPDM$1OH'XQ^:WNKBOU+9HJ2$00$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$$:=X7XD->>X]U]PBPDM$1OH'XQ^:WNKBOU+9HJ2$00$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M&QDU]*RU97KX8^V)'E"M$='6LIN+6&=P#72QM>6C<"X T4550$! 0$! 0$!
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MK9U1$)"722.:*EL<;07O/UH*"'K_ +VW+ZVF,5EC<I>QC_;".&)I\0?+Q>R
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MO\*#'(.LNZ3K6\O;/+:&OI3+%CVMO\6'&I9#(_@FC%=S0]S' =;G*2+[O/\
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MGH/\+$D#4M&:?;JK5F%TX^4P1Y2\AM9)F[7,9(\!S@#LJ!6GA0?H%A>5_+[
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M,5:R$>D][FSS 'ZD-B^V4D>^^-^/T?\ 6Y#Y=LD#EU4?IAHS_@_3WN;9_P!
MQ<5<*<^/C<U3_>6?T$:Y(I<COC9TI_?!_1O03[WP/^%M.^Z$G]"5('(2H[(O
M\-+G.ZA!;6[2Z>WQ,%\T#::6<PG?_H,<H.-U1T9W9>;& TE%D=(:HNV8^SO9
MQ>X^^F/# V9S&QR1R/W,J&,+2?-V&IW*2-V[QG-G1\^A[O1^"R=OELKEGPME
M]2D;/%!!#*R8N=(PEO$2P-#:UVU2!QZJ.T>Z3\6^0]V)_P##VZDJY=YK6K[/
MF7JV!X(/MM>/%=_#+,Y[3Y0X*HJ<J-76VAN8&$U+?<7M?:RNCO. %SA!<1NA
M>X ;3PA_%3IH@ZCYS<Y^7\O+K+8S"YBWR^3S5L;2UMK1_:%@FV.?+3T UM31
MVTF@IU17%*J.MNY\T.P&J6N%6F[M@1X.R>I(Y@U5A;C3NI<M@KII9-CKN:V(
M/2(WD-</ 10CP*C+\O<-HC/9A^-UMFI\#;2M'J=_'&U\(E!VMF+O1!&YV[K0
M3W;=U_EW>PBYL]=.N+=PJ)8G6KV$=?$UQ"E187/=YY3VEY:XZ?F(T9"]F9;6
MMHU]J^:265P:QH8UQ=M)IN2HZ,Y?Z+LN7VE;+2MA<27<%F97>LS!K7O=/*Z4
MDANP4XJ#Q**V9!QSWK=#3XO5-OKBUB)QF:8RWO)&C8R^MV<(XNKM(VCAZRUR
ML(YY5'3W*'O-6>(Q5KIGF"V8Q63&PV6;A:9G&)FQK;A@\XEHV![*D](KYQE!
M-L?/'E-)$)FZJLPPBM'=HU_VCF!WR%%>],\Y= :QU&-,:;R#[_(&&2X[5L,D
M<'#$1Q .E#"3MKL!'A0<+<PL#/IG7&?P=PPL=:7TPCKLK"]Y?$[Q.8YKO*N2
M,WR4U?9Z)YCX?-9-_98MSI+2^E.Z.*Y88^,TZ&.+7'P!!W/JW7& TEI6ZU5>
M7L+K*.!TED6R-<+F4MK''$03Q%YH!3Q[MJXJ_-N:5\\TD\IK)*XO>>MSC4KD
MB?\ NDZ?GO=;9/4):?4\58F'CZ.WNW@-'VC)%)&H]X[XXM0^*S_P<*L#6N5/
MQF:1]U[+^G:@_1+*?Y;>?S$OW!7%7Y?+DCHON@?\7Z@]S6_T[%)$R]Y#27OG
MY97US"SCO\$YN4@IO[.(%LX\79N<[QM"0K@]5&6U+J"[U/F),S?;+F6*WA<!
MM%+6".W;\B,(.G>Z+I'U?&9G6US'26]>,;8.(V]C#228CP.>6#QL4D6/?"PD
MY.F=1L;6V N,?._Z5YX98AY0)/82!RVS@XV]I7@J.+AWTZ:55'1.E.2/)_6=
ME'>877TP?( 7V-RVV@NXB?H7Q.<#4'95M6GH)4J,[=]V/EQCV&6_UX;6-HJY
M\[[2, >-SPE1MW)WDOHG3V9BUUI74TF?@A;<6D3VMC[#M'#LWD.9OH*[D'.?
M/_XW]4?ST'^%B5@8WD[\:6DO=.W^[0?HJN*N0>]Y@9K?4^#U*UA]5OK-UD]X
MV@36LCGT/55LHIXBK".<02""#0C:"%1W/H7O$<O\OI:TNM1Y>+$YRVA:S)6E
MPU]72QMHY\7"T\;7D<0#:N&XJ45R9S8U?::[U_F-38^-T>/NGQQV@D%'F*WB
M9"USAT%W!Q4Z*T51;\K_ (R-)>Z]C_3L03KWP<).+G36HV-)MBR?'S/Z&R B
M6,'ZX&3[52!S!'P<;>UKV51Q\-.+AKMI7I5'16E>1W*#65E'>877\I?(T%]E
M<-MH;N(GZ%\3G U&ZHJT]!*@S5YW9.6^/89;_7OJL;14OG?:1@#QN>$J-RY.
M<F-%Z<R\>NM+:DDS]N([BSA>&Q]AQD\#R',WTH1U(KF[GW\;VJ?[Q%_AXE81
M;\D/C8TI_?1]PY!WOJC_ (9S7]QNOZ%RXJ_,E<D=-]SK_,M6_P Q9?=S*2(8
MYN8.?3W,K4V-G:6@W\US#7IANW=O&1]B\*C'Z!U=<:%U?BM56T?;''S<4T%>
M'M()&F.5@/02QS@#T%!WCI[F_P M]2V++ZQU%90<3>*2UO9H[2XC/2'QRN:=
MG6*CJ*XJT/GOD<!K[E=GX=+92UR]UIV6TR%XRRE;.(V<3FDES"1Z':.W_0E4
M<3*HF3EIRWY5ZZQD(R>LI<+J45;<XVY$$3'&IHZ!\A >".BO$#79N)"1Y.ZW
MH"&/M9=;OCB.WC<;5K:>,NHI4?=)]WGEG?9]KL%K=V9N\-+!=7=M:^KRM $G
M$UKG1D@<181L-0E1U HK3>;."N-2\M]2X:T:9+N>R?);QC:7RVY$S&CPN+ $
M'YRKDCI/NG:WQ6(O\QI#*W++63*.BNL:^5P8Q\T8+)(ZG9Q.:6EHZ:%21(G>
MAUKC<1H*;2L=PQ^;SDD3/56N!DCMH9&S/D<.@$L:P5WUV;BD*XH51VUW5<!/
MB>6\N4N6ECLU>RW,((I6")K86GRN8\^)25<M<X/C1U=[J7/W951E>[]\<&E_
MYZX_PLR#] EQ401_S7YI67*O%XW)WEB_("_O!:FWCD$4C8A&Y[Y&\0():0T<
M.RM=X08K!]XSE/FXFN?F3C)R*FWR$,D+A]FT/C]AZM!5U1SPY1V.%O#=9JTS
M$4L+V'&6O]:=<![2.S( +0';CQD#K0<"R.:^1[F-X&.<2UE:\()V"IZE43KW
M3\;<W7,>ZR$;3ZK88V8SR?0\4SV,8T^$^<1XDD9_OAQO&<TO*1^#=:7+6GPM
MD83]T%('-*H_032/.CESG,/B2W/6MMD;ID$!QL[^"Y;<O 9V? 14^=L!&P[Z
MKBJ"N^!_Q3ISW/E_IBK".<%1^G^&_P HQ_\ =H?Z,+BJ#.]MA)[[0N,S4+>)
MN)OP+@CZ&*Z86<1^S#&^56!QFJB=] \I>4>N<5;7$6N)L?F71M]<Q5V+>&:.
M8 <88'N'&ROHN;79OH=B#<KCNO<O;1G:76N701@5+Y3:L;3QN<%*C+\LN1/+
MVVU):ZITQJ]^?. N@98X1"^'MPRK6E\9(V5!\U!%7>G^-63W/M?]=6!%6EO^
M)\+_ '^U_IFH/TV7%7Y@YO\ SG(_WJ;^D<N2)D[J/QH3>Y5S_20I(PG>.P,^
M$YKY>5[2+;*MAR-JX_1-E8&/]B1CPD"/--9VYTQJ#%ZBLVA]SB[F*[CC<:->
M8GAW"3U. H4'<<?>*Y4OT_[>NS'!+V?&[%&-_KPDI^+$=*$UV<7%P?544HKA
M?.9-^:S62S,C.S?D;J>[<RM>$SR.D(KTTXE42IW8/C:L/[I>?T121/?>KB?)
MRL#VC9%DK5[_ !%LC?EN"D*XA51V+R!YN:%QO+BPT_G\S;8K*8AT\3XKMW9"
M2.29\S'L)V.V/X2 :U&[<I(N>]'?6>4Y28S)8^9MQ87>2M)[:=AJR2*2WG<U
MP/40:I XQ5'?/=R^)W3O_F_\9,I*N?.]G\9MG[CVW]/<*PB%,7_F=E_/Q?=A
M!^E6I-3832.*?F]0W8LL7')'%)<.:YX:Z9XC;4,!-*G;LV#:N*HLU-R4Y3<U
MNTS^!O(K;(7%'R9#"RQ20R.=MXI8AQ,)/21PN)WE4<M<UN6%YRLSL&(NLC!D
MH;N(W%M-"#'(&!Q;26(DEAV;/.(/7O51J>G\E=X?.XS*V#BR]LKJ&X@<W?QQ
MO#ANZZ(/T[7%1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$!!&G>%^)#7GN/=?<(L)+1$;Z!^,?FM[JXK]2V:*DA$$! 0$! 0$%EF,I
M:X3$WV9O7<-GC[>6ZG<32D<+"]V_P!!^9F6R5SF<I>Y>\=Q7=_<2W4[M]9)W
ME[ODE<D33W4L![9\QILR]M8<)8RRM=U3W-(&CRL=)["2.UUQ5SUWM].>OZ-Q
M6I(F5FP]X89G4VBWO6\))/\ .,C'E5A''"H[<[K.IVYKER<++('7FG[F2WX"
M:N]7N"9HG'P5=(T?6J2J<%!2N+>"[MY;2ZC;-;3L=%-"\!S'QO!:YK@=X(-"
M@X>YO<@M0Z'R%QD].VLV4T?(3)%-"TRS6C2?Q<S15U&]$FXC?0KE5$,H""0.
M7?)W67,:[B]K;1]GA"X>L9FY8YMLQE=O!6G:NZFL\I VH.\-'Z4Q.B=.V.FL
M+&66-DSAXW4,DLCC5\CR-[GN))]@;%Q5SCWQOQ^CQT\&0^7;*PCEU4?IAHLA
MVCM/$&H.,LB"-U/5V+BKA3GP:\W-4T_M+/Z"-<D4N1Y YL:4KL_KH^2QR"?>
M^ 1[U].#I]?EV?\ T2I Y"5'Z&\F&1S\I=+12-;)$_'M8]C@'-<TEP((._PK
MBKDWG1R6R_+O+W&2QEO)=:+N7F2TNXP7^K!QKV,YVEI;N:X['#IK4#DB)$&P
M8S1FH,KI_+:J@M7,T_AF,==7TH+8W/EE;$V*,T\]Y+Q4#T1OILJ&OH.T>Z3\
M6^0]V)_\/;J2K1N\_P JLH,T_F+@[5]UCKN-C,U'"TN?!-"T,;,6C;V;F!H)
MIL<*GTDA',ZHVK07+_4?,/-PX? VSG1ES?7+YS3ZO;1$^<^1V[8-S:U=N"#
M96P=B\I?8Q[N-UE<2VSGTX>(PO+":;:5H@ZE[G4C3C=6Q ^>V>R<1X',F ^Y
M*DC,]X#D3=:SF.L](1M=J-D;69''DAGKC(QPM>QQH.U:T!M#Z30.D><B1R!D
M<;D<1=R8_*VDUE?0GAEMKB-T4K3X6O (5%J@R.!FOK;-XZ[QL,EQ?VUS%<6\
M,+2^1SX7AX#0T$DU"#].(9!-%',&N:)&AX:\<+AQ"M"#N*XJ]H,5J33F'U;A
M+O3^=MQ=8R]9P2QG800:M<T_0N:0'-/04'%7,CN[:TT7<2W>%MY-0:<J71W5
MJPON8F5V":%M75 WO8"WI\W<N540^]CXWNCD:62-)#F.%""-X(*#R@DKD#D+
MC&\VM.30L?(R69]K.(VE]([F)\574!H 7 D]"2.D.?O)"7F#%'J73(8S5EG'
MV4MNXAC+V!M2UO$=@D;4\+CL(V$[!20KC+*X?*X*]DQN9LIK"_B-)+>YC=%(
M.C<X#9U%5%F7.+0TN):VO"TG8*[Z(-LT/RUUAS"OF6FG<>^2WX@V?(R@QV<(
MZ2^4BE1]*VKCT!!WARVY?8KEMI>WT]C7=M-4SW]ZX<+[BY> '/(VT  #6MZ&
M@;S4GBKC;O'$'G%J&AK068/YG"N4(UGE60WF7I$N( ]M[$5/69V (/T3RFS&
M7I/\A+]P5Q5^7RY(Z*[H)'OPSXKM.-:0.F@G8I(Z]N+>"[MY;2Y8);:=CHIH
MW;6N8\%K@? 05%?FOK?34VC]6YC3,]2<;=20QN=O?#7BB?\ 9,+7>5<D8.&&
M6XFCMX&&2>5S8XXVBKG/<:  =9*#])M Z7BT9HW#:9B XL?;,9<.;N=<.\^9
MP^ND<XKBKUKC1V)U[IF]TSF 1;7;08YF@=I#,PUCE97I:?9%0=A0<%<P.56L
M.75]+!FK)\F,#B+;+P-+[25M=AXAZ#C](^A\8VKDC24!!V5W2;N]=HC+8ZY@
MECM[>_[>TFD8YL;V7$300QQ%'4=&2:;JJ2.?N?\ \;^J/Y^#_#1*P,9R>('-
M'21)H/;.V&WK+P @_19<5:KS$T'BN8VE[K3>4/9F2DME=M <^WN6 \$C0:5W
MEKATM)&S>@X4UKREUUH2]EM\OBIIK)KB(<G:,?-:2M&YP>T>;7Z5]'>!<D:Y
MA]-:AU!=LL<)B[J_NGGA$=O"^0@^$@4 '23L""^UMHW):$S?O>S+XW92."">
MZCA/&V)]PP2=F7;B6@BI&SJJ@N^5K'/YDZ2:P5<<M9;/%.PH._-=Z+Q.O],W
MFF<P"V"Y =#<, ,D$[-L<K*]+3T=(J-Q7%7!6ON5FL.75_+;YRQ>_'!Q%MEH
M&E]I,VNPAX]$GZ1]'+DC2T!!V=W3+N^=H/(X^ZMY8X+?(.FM)I&.:R2.XC94
M,<11U',=6G6I(YXY]FO-W5-/[1%_AXE8%OR1('-C2E33^NM^2QR#O?5) TQF
MB30"PNB2?YERXJ_,E<D=-]SK_,]6#_Y%E]W,I(D?GUR4?S(M(<[I_@BU;CXS
M$V.0AD=W;@EPB<X[&O:22QQV;2';*%J%<69C!YC3U])C<Y8SX^_B)#X+F-T;
MMAI4<0VCJ(V%5%@@Z%[I=U;RZGU)IV\8V6TRF+XY8'CB9(V&41N:X;B"V9V]
M21@>;G(#46A\A<9/3MK-E=(2$R12PM,L]JTG\7,T5=1O1)N(WT*M1#" @G[N
MF7=[;:^OH&02OQ][CY(YIFL<8F2Q/9(SC<!05 <!7K4D=G**(.0>>7=[RV/R
M=WJW0MFZ]P]V]UQ>XJW;Q3VLCJN>Z*,;71$[>%NUNZG#NM4<YO8^)[HY&EDC
M"6O8X$.!&P@@[E1\<YSW%SW%SCO)-2@EWE1R$U-KV]M[_+V\V)TBTA\]Y,TQ
MRW# ?0MVN%3Q;NT(X1X3L2H[EQ]A9XJQML9CH6VUA9Q,@MK>,4:R*-H:UH\0
M"XJ_/'F^0>:.KB#4>VET-G6)""N2,KW?_C@TO_/3_P"%F0?H$N*B#E/O<P:A
MOLE@FV^-NI=/X^VFEDOXXG/MA<7#P'-<]H(!:V)I\ZF]6$<OJ@@V;1_+[5^N
M[QEGIK%S732[ADNRTLM8ATF25WFBG56IZ 4'<_*3E?C^5VF_:R&0767O'-GR
MU^!PB24"C6,!VB-@)#:]9/31<5:YWBN6V0U_I&"YP<7;Y[!R/N+>V'ISP2-
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M0>L9H#0V&E$^*TWC+.=I!;-#9P,D!'4X,K\E!L: @(" @(" @(" @(" @("
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M2H[$TMI?#:-P=IIW 6_J^-LV\+&D\3WN.USWN^B<X[2?F+BK,(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""
M-.\+\2&O/<>Z^X1826B(WT#\8_-;W5Q7ZELT5)"((" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""-.\+\2&O/<>Z^
MX1826B(WT#\8_-;W5Q7ZELT5)"((" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(""-.\+\2&O/<>Z^X1826B(WT#\8_
M-;W5Q7ZELT5)"((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(""-.\+\2&O/<>Z^X1826B(WT#\8_-;W5Q7ZELT5)"
M((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M=?<(L)+1$;Z!^,?FM[JXK]2V:*DA$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MX2YK)0YU!6@H16GC*!9-+6RDM+6OE>YH(IYIZ:(+E 06>5_()O$/N@@]X_\
M(H/K @LQ_GI_F_F(,J@(""C#=13R/CCJ>  \1% 0:C9U[D%9 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$$:=X7XD->>X]U]PBPDM$1OH'XQ^:WNKBO
MU+9HJ2$00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M4'80=U$%D<39U):US*[PUQ 05[>TM[4$0LX2?2=O)\I05T! 0$! 0$! 0$!
M0$! 08K)6K6Q.N'N,DKI&AI=N:TNW (,J@(" @(" @(" @(" @(" @(""-.\
M+\2&O/<>Z^X1826B(WT#\8_-;W5Q7ZELT5)"((" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""VFNRR86\41FF
M+>,M!#0&UIM)0?;>Z[9[X7QF*:.A<PD'8>D$(+A 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0*@;T! 0$! 0$!!2EB,CXG T$;^,^'81\U!50$!
M0$! 0$! 0$! 0$! 0$!!3G[;LG""G:G8TNW#;O08QEN8,I;\<AEE>UYD>[I-
M#N'0$&70$! 04+W\CG_FW?*066"_(W?SA^4$&40$!!89G\A=X7-K[*"O>-;Z
ME,V@X1&Z@\0V(/F/VV4%?I @N4! 0?'-#VEKMSA0^(H/,<;8V\+:FI)).TDE
M![0$! 0$! 0$!!;Q7C)7,:&N:V3B[-QI1W#OZ:CRH+A 0$!!2N+F&V9VDSN$
M= Z2>H!!1L;]M]VG"PL$=-YWUK\Y!=H" @(" @(" @(" @(" @(""UOX)+B#
MLXZ<7$T[338"@ND! 0$! 0$! 0$! 0$! 0$! 01IWA?B0UY[CW7W"+"2T1&^
M@?C'YK>ZN*_4MFBI(1! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M]PBPDM$1OH'XQ^:WNKBOU+9HJ2$00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^0M^N=\M!D$!!@\MYV1MFG:WS=GC?M16<1&#R^R_MG#8[S=OB<BLXB" @("
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M'NON$6$EHB-] _&/S6]U<5^I;-%20B" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @I02NE#BYO#0TZ?8V]2"J@(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(.#N]5992UYNS7V3C>_&7=K:/QI-0QT$3
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M\8_-;W5Q7ZELT5)"((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(" @C3O"_$AKSW'NON$6$EHB-] _&/S6]U<5^I;-%20B" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M^>[SG&IIT)43ASTY&V_->UMLCC;F/'ZKQS'16T\P)@G@)XNRE+07-X7$N8X
MTJ=AKL"&\7R[[V>GK:/!8?)2QXJ ". MR%K)$Q@W!G:N,C6CH ;LZD$LS: Y
MF9/D/E=$:DO(LKK>])[*XEN7R QNNHY@V2:1HVM:' 4%-P""R[MO*C6'+'WQ
MC545O&,GZIZJ;>835[#MN/BH!3TVT0:1S8Y!<Q=7\U<AJ["V]H_$7$UI)"Z6
MY$;RV"&)CJM+21M84$I<\N1UKS8L[6^L+EF/U5CF.BM;F4$P30./%V,W""X
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MZY&<N<QROT9-IS-W5M=W<E_->-ELS(Z,1RQQ, )D8PUJP]""3$! 0$! 0$!
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ML?\ .#[DH,E%^*9]:/E(/: @(" @(" @I,E>Z=\3FAH: YIK4D$D>3<@JH"
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MNK0?.09) 0$!!0?9VLCS(^)I<=YZZ=8Z4%= 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$%"[F,,5(]LTAX(A]4?G(/MO;L@C:P %XWO.\D[S5!60$!
M0$!!Y<QC_2:'>,506MJ3;RNLW'S1Y\!/2P]'D07B @(" @(" @(" @(" @("
M @(" @(" @(" @C3O"_$AKSW'NON$6$EHB-] _&/S6]U<5^I;-%20B" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @UW5FN])Z'M/6]39.*R#
M@3# 27W$M/Y.)E7NV[*@4'25Z]-I,NHFF.VOH\KPZO7X-+;Q9;HM],]T;W.F
MM>]5EKPR6>A,>W'0;0W)W[6S7!'6R$5C;]F7^);=I/MVVW;FFO9&[R[_ $-!
MU_W=?=6W3V\/ZUV_Q1N\M>Y ^=U'GM3W9O\ 4.2N,E=[:27,A>&@]#&GS6CP
M- 6T8<&/#%++8MCL:3J=7FU%W%DNFZ>WU=3%KO>00$! 0$! 0$! 0$! 0$!
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M'=MZ;9WQX=<5AN*Q[*B @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M/G_U6^5!>(" @(" @(" @(" @LY_ZK<-NALBDHR?P?2N\FY!>(" @(" @("
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MN+FD&IZ?$@RZ"-.\+\2&O/<>Z^X1826B(WT#\8_-;W5Q7ZELT5)"((" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @("#&YS\B'UX^44%]!^(B^L;
M\I!C6_YZ_P"L_P!4(,L@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(-6U]K[ \O,%)F\W)5QJRRLF$=M<S4J&,!_TG;FA>W1Z/)J<G!9XYZF.
MU^OQ:/%.3)/='3,]4.%]=Z]S_,/./S6=EV"K+*R83V%M$3Z$8/7]$[>XKZ;H
M]'CTMG#9XYZ9?%^8\RRZW+QWSLZ(Z(CPWM77N8L0$! 0$! 0$! 0;URPY89K
MF9FO4[.MMAK8M=E,HYM60L/T+>ATCAZ+?*=BQ?,.86:2RL[;IW1X=#.\HY1D
MUV2D;+(^*[PZ76.8Y&<MLGIGWJ6N,M["ZAA;ZME(&,]L&/%0V6238Z0.(/$'
MFCMM*;*:)BYOJ;,OU)NF8KN_1[NQ]/S<@T>3#]*+(MFGQ1$<7?,[Y\;C;6NB
ML[H'.S8'/P\$[//M[AE3#<0DT;+$X[VGIZ0=AVKZ'I-7CU..+[)_!\DU_+\N
MCRSCR1W3T3'7!IK0>LM8. TWA;J_CKPFX8S@MP>HS2<,8\KDSZS#@^.Z(]/D
MWFEY;J=3_"LF[MZ/+.SSNPM/Z:RFCN0EWIW.-9'D[+#Y;UED;Q(QIE]8E XA
ML-&O%5H&;/;GU\7V;INL]4/JNFTE^DY7=BR4XK;,E?'Q3ZW.G=K^-?%_W:\_
MH'+;.>_RD]\>EHOVO_/1W7>AD^]+\9<'N7;?TLRZOM[^6G]J?1#O^[OYR/V(
M]-R$ULC3! 0$! 0$! 0$! 0$! 0$%UC<E?X>_M\IB[F2TR-H\2VUS$>%['CI
M!^6.E<,F.W);-MT5B7=AS7XKXOLFET;I=I\F.=-CS$M&X?+EEIK&V966$4;'
M=L:-LL(Z_IV=&\;-WSCFG*KM+=Q6[;)\W9/M?8.2<[LUMO#=LR1OCK[8]<)<
M6!;.(" @ISP1W$3H915CM]-Z"T;87#&B-EY((P* 4!('C07%K:16D99'4EQX
MGN=M)*"N@(" @(" @(" @(" @(" @(" @QU]DC;2=C&P.>!5Q.X5Z$%6TR$5
MQ&72%L;P:%I('E%4%QZQ;_RK/M@@>L6_\JS[8('K%O\ RK/M@@>L6_\ *L^V
M"!ZQ;_RK/M@@M;S)1V[6B+AD>[J-0!X:(%AD/6RZ-[0V0"HIN(07,UO#<-X9
MF!P&[H(\H06T3&V-SV312WG]#P/'17PH+Y 0$! 0$! 0$! 0$%I>.+^&TC_&
M3>D?I6#>4'N&RMK=W'%'1^[B))/R4%<.:26@@N;Z0!VBO6@^H+ QLR$[G2#B
MMH:L9T<3^DU'4@O(H8H&<$30UO4$'M 06-VQYEE(C+Q) 8VEH!\ZIV'JWH+R
M,%L;6G>  ?& @](/$L4<S."5H<T]!069BCQ\S)8APV\E(Y>GA/0:E!?D@ D[
M -Y08FZRLKFO]09Q,CVR3D>:/%5!?V<KYK6*60U>YM21L05T! 0$! 08RU_S
MB[^M'^J@9S\FC_G6_**#)H(T[POQ(:\]Q[K[A%A):(C?0/QC\UO=7%?J6S14
MD(@@(" @(" @(" @(" @(" @(" @(" @QC[B[NKR2UMI!#'$/.>6AQ)\10>;
ME^0Q[!.Z<7$=0',<P-.WQ(,HQP>QKQN< 1XB@^H" @(" @(" @(+:^M?7+=T
M(/"ZH+2=U0@MXGY6&-L1MV2<(#0\/ K3QH/MI9W'K3[Z[X1*X<+6-V@#=\Q!
MD$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&N:XUMA- Z?N-0
M9R3AAC\RWMVT[6XG<"6Q1@[R:>05)V!>O2:6_4Y(LL_PCK>#7:[%I,4Y,D[/
M/,]4.#]=:YSG,'/S9W-R;35EG:,)[&V@K41Q@_Z3M[CM7U#1Z.S38^"SQSUO
MBG,>8Y=;EF^_Q1T1#65[6,$! 0$! 0$! 0$&]<L.6&:YF9KU.SK;8:V+793*
M.;5D+#]"WH=(X>BWRG8L7S#F%FDLK.VZ=T>'0SO*.49-=DI&RR/BN\.EU/JW
M5^C.06CK;"X>V8Z_+",7BFN_"S2'8ZXN'#;PU])Y](^:WP:1IM-FYCFFZZ=G
M3/5V0^F:S6:?E&GBRV-OZ-O7VSZY<IV/-;6UCK8Z^&0=-G)#PW#)*FWEMB:F
MV,8-!%LV-'HGSAYVU;S?RW!=@^C3W?/7K[WS"SG&IMU7YCBK=YJ?+W?X[]KK
MC3^H>6O.?3]IG,G9V=S+B'&>ZL,CP/?83</G\?%0.B<!4.(X'@"HJVC="S8-
M3H<DV6S,<6Z8_2_'SP^IZ;4Z/FF*+[K;9X=\74GA_#S3WQLU36/>9T;IH.Q>
MD+3V\N8!V;)(B+?'QT% &OH2\#ZAO#U.7NTO(<V7WLL\$>66-UWW1IL'NXH^
MI,=6RWR^R*=J&,YS6YP\T8;C#V$,[L7=UBFQV%M'N:YAWL?* ^0@CTAQ@$;]
MBV+#R[1Z.8NNF*QTW3X0U'4<WYCS"V;+(GAG9,66SYYVSW[:=;<^1'*;F#IO
M7=AJ7/8=UAB(H+ECY)IH>U#I8BUH[)KW/W]86.YQS+3Y<$X[+JW5CHGKZV6^
MW^3ZO3ZF,F2SAMI/3'HK5KO>E^,N#W+MOZ69>S[>_EI_:GT0Q_W=_.1^Q'IN
M0FMD:8(" @( J30"IZAM*!X.D;P@(" @(" @(" @(+BQOKW%WMOD<=.^UO[5
M[9K:XB):]DC#4.!"X7V6WVS;=%8EVXLMV*^+[)I,;I=M\EN<-IS'QGM=DRRW
MU?8L!O+=OFMN(QL[>(=7T[?H3X"%\VYKRR=+=6W;9.[L[)?8^2<YMUUG#=LR
M6[XZ^V/7U)66#;*(" @(" @(" @(" @(" @(" @(" @(" @Q%Y:&\O'B CB:
MT=JYWHUZ!LZ:(+JTQL,$9$S6RR$U)(! \ J@K^J6O\A']J/G('JEK_(1_:CY
MR!ZI:_R$?VH^<@>J6O\ (1_:CYR!ZI:_R$?VH^<@M;S&1SM:8 V)[>@"@/CH
M@IX^V]4NGQS?CBVL9'HEO33PH,H@I7$(N(G1DT.]KNIPW%!:^V<,-OQ7!I<-
MJU\0](N'S$'FPR,MY-)%)&(PP5 VUW]-4&10$! 0$! 0$!!Y>]L;'/>:-:*D
M^ (+>S8Y_%=RBDDWHCZ5@W#YJ"Z04VQ!LKY!0<8 ( IM%=OR4%*\E<UC88OQ
M\QX6> =)\@05H8FPQ-B9Z+10(/: @(" @("#Q)&V6-T;Q5KA0H+>U<7,?:3[
M9(O,=]4P[CY0@\W\;(L=+'&T-8UH  \80>\=^0P?6H+I 0$! 0$%C-93"Z-W
M:2-9(\<+VO%6FGB\2#R^RN[I[/7)6=E&[BX(P=I'62@R""-.\+\2&O/<>Z^X
M1826B(WT#\8_-;W5Q7ZELT5)"((" @(" @(" @(" @(" @(" @(" @(,58_Y
MI>__ !TH*N:_(7?7-^6@O+?\GB^L;\I!40$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 08[.YS%Z:Q%YG<U<-M<98QF6XF=
MT ;  .ESB0UK1M)( 7=APW9;XLLBLRZ-1J+,&.<F2:6V[_#T=;@WFAS(RG,O
M43LK=\4&+MN*+$X^M6P0D[2:;#(^@+W>(;@%]0Y?H;=)CX8VS.^>O\.I\3YO
MS._79N.=EL;+8ZH]L]/X0TE9)A1 0$! 0$! 0$!!O/*_ECF.9F<]0LB;;$6I
M:_*Y(BK88W$T:T?12.H>%OE.P+&<PYA9I+*SMNG='AT,YRCE.37Y:1LMCXI\
M.ET_K/7&CN0>D[;3>G;:.3,NB)QN+K5SG.V.NKIPH:$C:?2>?-;0 ENE:729
MN8Y9R7S[O3/JM\-GI^CZ_F&GY1@C%CB.*GNV_P#RN\*ST=,Q!G*;!6/.3F)?
M9#F'E1=W/ ;EV.>]T4MZ:$<$99P\,<(%2UA!I2@IQ$;-S'-=H=/%N"VD;J]7
MXRTSD^"WFFKNNU-U9W\-:<7=3HM[/:Q7./D_><LLA'=6L_K>E[^0LL+B1S1<
M1O +C%*T4J0-SVBA\!V+OY7S.-7;28I?&_J[WFYWR2[0W1=;-<=T[.N.R?:T
M[26B]2ZXR8Q.FK%]W<;#/)Z$$+"?2ED.QH^2>@$K(:G5XM/;Q9)IZ^YB-%H,
MVKOX,5M?1';,^'8Z:TEW==$:+M!G^8=_#DIK<!\HN'"WQ<)\(>09/LR ?I5I
MFIYWGSSP88FVO5MN_#PVOH^B^V]+I;?J:B8NF.O99'M\?D9+-]Y3EEIJ'VOT
M[#-E1;C@BBL(1;6;:= ?)P;/K&$+IQ<BU.6>*^8MKUS67?G^Y]%@]W'6^GRQ
M2//3S1+2#WF^8&;D<-*:-BE96C6EMU?N'@)@$0JLE_0=/C_B9/1;Z:L/_=&K
MS1_P8?\ RO\ 1PHUUU8\W=?YM^I=0:4R;)S&R"*.WQMU'#'#'4AK0YKG;RXU
M<XG:LUH[])IK/IV9+:=MT5:US"SF&MR_4R8KZTILQW1$1Y/3,H^O<=D,;)V6
M2M)[.7Z2XB?"[9X'@+*V9+;XK;,3W,)DPY,<TOMFV>V*+9<W2(!V"J"?,-W5
M]3Y3$V62GSEG9S7D$=P;5T4LCHNU:'ACG @<0K1U-E>M:KE^XL=E\VQ;,TG>
MWO!]HY<F.VZZ^+9F*TIN3#';Z$[NFA[:]NK5UQ>R.CM;F]MX6NO+V\D:7.\Y
MY'#&.%Q:TOHUHZ7;]?F[/S3/,1-(WTF=D1[6U1;I>2Z:+IBL[(F8CWKI]F^=
ML[._?@.:VG-'<T>5TG,O 6XAR5O;.R%M?=F(9Y(H'%L\$X%0ZG"X#::.;L-"
M:^OEV?-H]5]"^=DS2G?NF/#<\7-]+I^8:+\UCBET1Q1/32-]MW=M[IW32M>0
M5O[Y.(" @(" @(" @(+_  V9R>GLK:9O#7+K3)V,@EMIV;PX;P1N+2/-<T["
M-A75EQ6Y;)LNBL2[\&>_!DC)9-+K9V>'A5WARKYEXWF9IUN1@#;?,6O#%EL>
M#4PS$;'-KM,;Z$L/C&\%?+^8Z"[29.&=ML[I\.E]MY3S3'KL7%&RZ/BCJGV3
MT?@WI8QF1 0$! 0$! 0$! 0$! 0$! 0$! 0$!!1N9^PB+Z5>?-8WK<=P0+6#
ML(@UQK(X\4CNMQWH*R @(" @(""WNXG/8)(OQ\)XX_#UCRH*D,K9XFRLW.%:
M=1Z0@J(,7-9PVU_[9.'&)2&2\6YE  UP0>;#_-;SR_=(,L@(" @(&[:4%LV_
MMG$4<[A<>%KRUP83N]*E$%R@(+.X_K,[;0?BF4?/_JM\J"\0$'PD-!<30#:3
MX$%K:@SR/O7C8_S80>A@Z?*@NT! 0$! 0$! 06EVUT3F7D8JZ+9(!]%&=_L;
MT'S(N:_'2O::M<T$'K!(0>L=^0P?6H+I 0$! 0$! 0$$:=X7XD->>X]U]PBP
MDM$1OH'XQ^:WNKBOU+9HJ2$00$! 0$! 0$! 0$! 0$! 0$! 0$! 08=LK;#)
M7$ER"V*859( 2.OH0,C>PWL(MK2LLKG#8UI%*>,!!E8FED3&'>UH!\@0>T!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0"0
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MP-R"X068_K5WQ;X+8T'4Z3K\B"\0$'B:5L,3I7^BT5*"C9Q.:QTTOX^8\3_
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MK]/BF;]EUVVG5'0^>?<O,K-7GBW'-;;(I7KGIIV;O\*(A6?:F(" @(" @("
M@(&_8@[2[N_,LZRTR=/Y:;CU'@6-C<YYJ^XLO1BEV[2YOH/\A.UR^<\[T'T,
MO';'NW^:>KUQ^#[#]M\T_-8/IWS[^/SV]$^J?%/2F=:ZVP0$! 0$! 0$%*Y_
M)IOK'?**"WQ/^7P_9?=%!>H" @(""SN.R-Y")^'L^!]..G#Q5;U]-$'K'?D<
M?5YU/%Q&GR$%T@^$AH+G&@ J3X @M;0&9[[UXIQ^;"#T1CI\J"[0$! 0>)(V
MRMX7;J@CQ@U0>T! 0$! 06<_]5N&W0V1249/X/I7>1!>(/CB&M+CN )*#78\
MA<0FD3N&($EL9V@ FM.M%9=F2MG,:YQ<'$ D<+C0^.B(]>V-KUN^T=\Y ]L;
M7K=]H[YR![8VO6[[1WSD#VQM>MWVCOG('MC:];OM'?.08NYREPZ5PA=P1 T;
MLVGPFJ*R>,>U]FSA;P\-0?"1T^5$7:"C=3>KV[Y@*EHV#PDT"#!>OSR2,,Y[
M2-K@[L]@!(\2*S\$AE87$4VT%*T/LHBH@(" @(" @(*?8L[?UC;VG!V>_9PU
MKN05$! 0:])?313R^KGLXR\G@V$5W$[>M%9JSG-S;LE(HXU#AT5&Q$5T&.?'
M(<Q'*&.[,1T+Z'AKMZ4&10$!!YDD9$QTDAHQHJX^ (+&*_GENXXC%V<$@<YA
M=Z9#1OIT(,@@C3O"_$AKSW'NON$6$EHB-] _&/S6]U<5^I;-%20B" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(/$D392PN)'9N#Q3K (^:@]H"
M @(" @(" @(" @("#Q$Y[XVN>.%YWC_\T'M 0$! 0$! 0$! 0$! 0$! 0$!
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M$! 0$! 0$! 0$! 0$! 0$! 0>'/X7,;0GC)%>@4%4'M 0$! 0$! 0$! 0$!
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MSCB-0-A!V$'PH*R @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M8@66]O&37@C82:#K)))Z2MHTFCQZ:SALCVRTG7\QS:W)QY9[HC='<UI>QC1
M0$! 0$! 0$! 0$!!V'W7=8',Z/N=+74G%>Z?E_  G:;.Y+GLW[3PO#V^ <(7
MS[[@TOT\T9(W7^F/"'UK[4UOU=-.*9VXY_=G=YZ]T43LM8;F(" @(" @(" @
M(" @(" @(""SG_JMPVZ'XJ2C)_!]*[YB"\0$! 0$! 0$! 0?"0T%SC0#:3X
M@M;0&:1]Z\4X_-A!Z(QT^5!=H" @(" @(" @IS&01N,7IC<*505$! 0$!!9C
M^JW?#N@N35O4V3I'E04'?YVW^:^>@]YK\A=]<WY:"]A_%1_6CY2#V@Q^:_(7
M?7-^6@O(/Q$?UC?E(,?C?RZ_^O\ FN091 06;_ZU="+?! 0Z3J+^@>1!>("
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MY.M!DH)#+#'*10O:'$=515!40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;MLI-N^NR>WQHW/(3D:PECKHAS26N!R8!!&P@^<LQ_6-=U?NL#_;W+?"Y\^
M;D9_:S^DQ]\G]8UW5^Z?V]RWPO\ Q5(>0/)&>:.&"=TTSW ,B9DN)SCOH '5
M*D\YUT16?_%8^W>6S-(C][\4AZ[TUI'56%BT]JNX;;XTRLGBB%P+5SG0 @4-
M14#BW>)8G29\V&_CQQ6>ZK.:[2X-1C^GE^'?OIN1P>0_(L DW= -I/MH/OEE
M_P"L:[J_=8+^WN6^%_XMXT+RET-H*\FR^F;:3UN[A$/K,TSIZ0DA]&$[ '$
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M 0$! 0$! 0$! 0$! 0>7L;(QT;Q5KA0CQH+>S>YO%:RFLL.P'Z9G04%T@("
M@(" @(""TNB9Y&V3#L=YTQ'0P='E070 : T"@&P =2#Z@(" @(" @(" @("
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M;W,+K20UDA]$_31G<?F(+I 0$! 0$&*SWY(S^<'RB@O[3\D@_FV_*""L@("
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MTUDWS=$Q'E\/&VSEOW#AUN2,<6W6W3'93P\2#N]''&SF9&YC&M=)C+9TCF@
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M03!@+PV5V^,["'=(07* @(" @(" @(" @\M8UE>$ <1XG4Z2>E!Z0$! 0$!
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M 0$! 0$'F21L4;I'FC6BI06UJ P.N;@ALT^VCC2C>@;4%TUS7"K2".L;4'U
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MGTIEV-&]QL;@M]D,(79&NT\[LEO^J'1/+-7&_%?_ *+O8P]WA<S85-]C;NV
MWF:"6,#[9H7HMS67;KHGQO-DTV7'%;K9M[XF%C4;B=J[7GH(@@(" @(" @("
M @(" @(" @(" @("!4=:+1<6UC?7IX;.UFN7=4,;Y#_H@KA=?;;OFCLQXK\G
MPQ-W=M9FWT'KF[%;73&6F!Z8[&X</D,7GG68(WWV_P"J'KCEVJG=BO\ ]%WL
M7\?*CF9(*MTEE /JK5[-_P!< NJ>9::/_LM\KT6\FUMW_P!5WD>_@DYG?NGD
MO]PY3^IZ7_LM\KE_1-;_ -5WD4)N6',B#;)I++T%:EME,\;/K6E<XYAII_\
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M"R_EA\GYR"C<Y2".(F!PDE.P#;0>$H+>RR<TD[8IZ$/V @4(**RZ((" @("
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M.*,'S8HF[FL;78!XS4DE;MAPVXK>&V-CY1JM5DU.2;[YK,^%(81=[R" @("
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MW%++!-'<6\CX;F%[98)XG%DD<C#5KV.;0AP.T$(.TN[]WB6:N]6T3KJ=L6K
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M" @(" @(/A(:"YQH *D^ (+6T!F>^]>*<?FP@]$8Z?*@NT! 0$! 0$! 0$!
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M$G2/*@O$! 0$! 0$!!9R?UJZ$.^" ATG47] \B"\0$! 0$! 0$! 0$! 0$!
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M @(" @("#1M7Z=$1?F+%OX,FMW$T;B?]H/\ 6]E>O#DZ)1IR]2" @(" @("
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M[JXK]2V:*DA$$!!Y>QLC'1O%6.%"$%E%B;>*425<X--6M-*5\/6@OT! 0$!
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MV>?<RN'F]L_Q+:=L;?Q=(:<U1I[5V,CS&F<E!E,;)L$]L\/ <-[7#>UPZ6N
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MN_';?%+HB4,:R[I.@,TR6XTG-<:9R)VLCC<;JQ+J;C#*>(5/TCQ3J6=T_/\
M/9LR4OCR3Y6+S<JQ7;;?=GS>1S]E='\XN[QFO;ZS=);6?$UAS-AQ7&,N6<51
M'<QD>;7JE:/J7+9<>HTO,+."=L]4[+H[OP8>[#J-'=Q1NZXVQXX\.]U3R:YZ
MX'FI:^U\[6XO6-M&'W>*+JLE8-AFMG':YE=[?29N/6=/YCRN_2S6/>LGI]4L
M_I-=9GV;KHZ/7"65AF1$&K:SPWKEJ,E;MK<VH/: ;WP[S]KO]E>C#?2:(CY>
MU! 0$! 0$! 0$! 0$! W;3N04>9FLO@FY6WF6A>(]5Y_^IX=M:/9),TTDI4&
MD+*R'ZJ@Z5,&/ZV6GZ-N]9<& 4%*DGI<=I)Z23UE;,X" @(" @(" @(" @(.
MNNZ3S4-S;OY69N>MQ:,?<Z;E>=K[8>=+;5.\Q>FSZ@GZ58'F6GI_R1X_:Y1+
MIV/^JW1AW03U=%U!_2/*L&Y+Q 04;F#MXBP&CQYT;NIPW% M9^WB#G"DC3PR
M-ZG#>@K(" @(" @(/CG-8TO<:-:*D^ (+6T:97.O)!1TNR,'Z&,;O9WH+M!\
M<YK&ESC1K14GP!!:VC3*YU[(*.DV1 _0QC=[.]!=H" @(" @(" @LS_5;NNZ
M"Y-#U-E_[4%U)&V5CHWBK7"A""WLY' .M9366'97Z9G04'N:Z;"]L08Z25X)
M#& $T'2:D(/L%RR=SV<+F21TXV/%"*[MU0@K(" @(" @(*%W,ZWMI)FBKF"H
M!W5W(+28WL%KZUZSQEH#C&6-#37HV;4&18[C8UV[B -/&@^H" @(""SE_K5R
M+<;88:/F\+OH6_-07B @(+.;^M7#;8?B8J/G\)^A;\U!>(""SRO^7S>)OW00
M>,D0;:( @ETD?#3IV]"#0^\+\2&O/<>Z^X1826B(WT#\8_-;W5Q7ZELT5)"(
MM[N9T;!'%^/F/!'X.L^1!4@A;!$V)FYHW]9Z2@J("#Q)*R( NKYQHT $DG?L
M 0?6/;(T/8:M<*@^ H/2 @(" @(""TFLA<SA\[RZ!H'#"-C:]9ZT%##M:ZTE
M815ID>".BE @KVCC$Y]G(:NCVQ$],9W>QN07: @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @("#S)(R)CI97!D; 7/>X@-:T"I))W (/SNYV<
MQI.96N;O*02..!L:V6%B-:>KQN-9:?32NJ_KX>$="WO0:;Z&*(G?.]\DYQK_
M ,UGF8^&W9;[?'[.I'*R#"" @(" @(" @(" @(,KIK4.2TGG\=J3#O[/(XR=
MMQ"3Z+N'8YCJ;VO:2QPZBNK+BC)9-L[I>G2ZB[!EMR6[[9=P9RZQFM],8KF5
MI[SK*_@9Z['O?&?1H^GT43P8G_.6GXXG%?.*[?#ZM]2W/BMS6;KH\/)NEJ2]
M3I$! 0$! 0$! 0$! 05;6UGOKJ&RM6\5S</$43?JG=)\ WE29B(K*Q$S-(3[
MAL5;X7&6^-MO0@;1S^E[SM<X^$G:L'??-]U99FRV+8I"_7!S8K4NHL3I+ W^
MI,[.+?%8V)T]S+O-!L#6CI<XD-:.DD!=V'#=FOBRV*S+KR9+<=LW7;H<AX/2
MNLN]+K.76>HGS8?E[92.M[(-.UL+7;8+6HH9'?[:>E =@W!JW7+GQ<KP_3L]
M[)._VSV=4-;QX[M?D^I=6+(V1^'KGQ.MM*Z1T[HG#PX+3&/BQ^-A&R.,><]W
M2^1YJY[STN<25IF?49,]\WWS66QXL5N.V+;8I$/6J-5:?T9AY\_J:_BQV*@H
M'32GTGFM&,:*N<\TV-:"5,&"_-?%ED5E<F2W';-UTTB'*6N^]_GKR66UY?XZ
M+%8]I+6Y7)M$UT\ GSFP@]FP'ZLN*W'2_;]D17+/%/5&[RM>S\WG=CBD=<^Q
M#]US1YMZFD<YVJ,W=\1)='8OECBKX&6S6M6;MT.EQ?H6QW_BQGYG49=UUWB_
M"%"#6?-;!4FBSVH[%@VUDEO SRB0$>RN4Z?39-G#9/D/J:C'MK?YY2%HWO7<
MQ\%)%%G7VVJ,8R@D9,UMM>!E?H9HAPEW\XPK&:GD6"_X:V3Y8\CUX.;9;?BI
M?'DEU=RUYOZ-YHV;Y,!<F'*V[0Z]P]U2.[AKT\()#V5^C82.NAV+3M;R_+I9
M]^-D[IC<V+3ZK'GBML[>KI;Q<6UO>02VMW$R>UF:8YH)6A\;V.%"US7 @@C>
M"L?$S$UC>]4Q5RES>[N^1TG>1\Q>37;6MSC9/7)L-;$F:W>TU,MG7TFT]. [
MQ7A^E6Y<OYO;ECZ.IVQ=LK/3V7>UKNLY=-DQDP;)MVTCU>N.E,_)/FS8<U]*
MMOSP0:BQ_#;YNR;N9,1YLK =O9R $MKN-6]%5@>9:"[29*?HS\,^'4RNCU=N
MHLK&^-Z2UBGN" 0014'804$5ZBQ1Q&3?"P?U67\+;GZDG:W[$[%D<=_%",2N
MQ! 0$! 0$! 0$! 0$&9TSB1E,B'3#^I6M);@GT33:UI\=-O@75EOX8[5<@<_
MN99YE:]N)[&8OTSA>.PPH!/!(&N_#7 '_P UP\TT] -6=T>#Z6/;OG>XRBQ>
MU! 0$! 0$! 0$! 0$%[B,ODM/Y:QSN'F]7RN-G9=6<W0V6(U%1TM/HN'2"5Q
MNMBZ)B=TC]*=#:OQW,K1.,U5C2(Q>Q!TD-:NM[N(\,L3O"QX(\(V]*T[/BG%
M?-LNR)9^#*6[PQDCN"4[';/-XO&N@7R @L;A[;*X%P3^"F\V5HW\0&QP""XM
M[J"Y!,3JD;P=A""L@(" @(/$DK(6&21W"P;R4%B^YBR#V6L)/9D\4I.PEK>@
M>-!D0 !0; -P0$%G<DW$K;-OH^G.1]*-P\J"\  %!L W! 0$! 0$! 0$!!3G
MA;/$Z)VYPV'J/04%.TF=)&62[)XCP2#PCI\J#Q>-=&6WD8J^+9(!]%&=X\F]
M!XXFOR<3VFK70$@^ N0?8/\ ,[KZR/Y2"]0$! 0$! 06F2!-C. *GAK[!04+
MR>!V,<ULC2YS&AH!!).S91!?Q B)@.PAHJ/(@]H" @(*%Q<LA8[A(=,*!K!O
M+G;!L0?;6#L(@UQK(X\4CNMQWH*R @I7,P@B,E*NW,;UN.X(,89+MCG6-HVM
MR?.N)SN#GBJ*I8Z)T.5DB>_C<UAXGGI)H4&=1'P@.!:X M.P@[00@HQV5I$\
M21PM:\;C3=XD$=]X7XD->>X]U]PBPDM$1OH'XQ^:WNKBOU+9HJ2"0 2=@&\H
MBSM0;B5UZ[T3YD /0P;SY4%X@(""G+&YY8YA ?&[B%14&H(\'6@^PQ]E$R.O
M%PBE=U4'M 0$! 0$! 08[#?DTG\Z[Y005[R-W"VXB'X:'S@/IF](]A!7BD;+
M&V1AJUPJ$'M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>))(X6.
MDE<&L;O)04X[J&5_9MXFO(J&O:YI(\%0$%= 001WI.89TKHINE\=*69K4_';
MN+#1T>/93MW>#CJ(AUASNI9GE6F^IDXIW6^GH:S]P:[Z&#@M^+)L\73[/'/4
MX=6Y/EX@(" @(" @(" @(" @()_[LG,N# YJ;E[J&0.TUJ-W#:=J?,AOWC@X
M? V<48?J@WK*P7--+-UOU+?BM]'X-O\ M[F'T[_H7S[M^[LG\?31+VH\'-I[
M*RX^2KH/QEI*?HX2=GE;Z+EC<62+[:MNR6<%U&*78ZQ 0$! 0$! 0$! 02)R
MPP?:2SZ@G;YL=;>SK]-_M'C[GV5X-7D_1A[M-9^DDU8Y[Q!S]S+QM]SLYCVW
M*ZTFD@T)I;LLCK*\A-.UNY1Q06C7 TXN#;]34G>T5V317QHL$YY_B7[+.[IG
MP];%:G'.HOC'^A;MN[>Q.V+Q>/PN.M<3B;:.SQME&V"UM81PQQQL% T!:]??
M=?=-UTUF63MMBV*1LB%CJK5&'T9IZ_U-GINPQ>.B,LSAM>X[FL8-E7O<0UHZ
M25V8,%^:^++(VRXY,EN.V;KII$.,HL'S1[TFJ),^_P#],TC;2.AM+BX+C964
M5=L<#!3MYR*=H\4%=A(% MZG+IN5X^#XKY\L]_5'4UG@S:Z[BW6='X=<NA]$
M=VSECH]D4]SCQJ#+LH77^5 G;Q=/!!^*:/L2?"M9U/.=1FV1/!'5'MWLSAY?
MAQ[:5GKE+-K:6EC"VWLH([:W9Z,4+&QL'B:T +#773=-9FK(1%%4@.!:X M.
MP@[00N*M#U;R8Y9ZTB<,SIZU;=$'AO[-@M+II/2)(>$D_75"R.GYCJ,/PW33
MJG;#RY=+BR_%;#F77W=WUSRMO6ZUY;Y"XR5CC7&XCEA'#E;-K=Y+&CAGCIZ=
M!4BM6T6V:7F^'51]/-$1,_Z9]C Y^79,$\>*9FGECVNAN1W-ZRYL:8]8F[.#
M5&-#(LS9QGS>)P/!/&#M[.2AH/H7 M.ZIUGF?+[M)DI^C.Z?5WPS&BU=NHLK
MTQO2BL0R#G;7^DW<F]>VW.S24+F::O91:Z\Q, / V"Z> ;MC!0;'D/<.A^W<
MYU-FTNH_.8)TV3XHVV3W='AT,1DP1@R_6LW3\4>OP]KH:&:*XBCG@>V2"5H?
M'(PAS7,<*@@C>"%K4Q,3267>U!@M5XKVRQ;W1MK=6M98>L@#SF^4+NQ7<-PC
M(;=J][B(" @(" @(" @("#W%%)-(R&%I?-(X,C8-Y<=@"3-!J/>*Y@1\NM%1
M\O<'.!JG4<3CD)XR0^"Q=YLKZ]!EH8H_!Q'H79HL/U;^.=UOI)<8@!H#6B@&
MP = "V%Q$! 0$! 0$! 0$! 0$!!T/W3N8@P.JKG0.3EIAM2UDL.,T;'DHV>B
M*D =M&*>%S6]:Q/,<'%9QQOM]"PZX?87#;AT#&%U#1KJ;*=!JM;=C8F-+&-:
M34M !/70(CT@Q>7MYI1')&"]K*AS1M(KTT04,=97#GND)? VE X;"?9Z$5D?
M5)?[5+\CYR(>J2_VJ7Y'SD#U27^U2_(^<@>J2_VJ7Y'SD#U27^U2_(^<@MKZ
MQG=!YDKYBTUX'4^13I06F.M9S<LD+',8PU<XBGDVHK/(BG/,V")TK]S1NZST
M!!3M(71QF27\?*>.0^$[AY$%P@(" @(" @(+.XO7LN!:6T7:SD<3JGA:T>%!
M3DOKFU+#>0-;"X\/:,=6A/6$&006=S_5YFWC?0-&3CZD[G>1!=[".L%!CV6\
M(G]5F;4"K[9X):0T[VU!&Y!>0V\-N'=DVA=M<222?&34H*J @(" @(" @I-M
MK=KN-L+ _?Q!H!]FB"J@(" @(+&-HNKUUS_L81V<?4Y_2[R;D%\@(""S9_6K
MHR;X+<EK.HR=)\B"\H!NZ=Z##V_^>3_6GY345F$00$$:=X7XD->>X]U]PBPD
MM$1OH'XQ^:WNKBOU+9HK?;MQE>RRC-#)YTI'1&-_L[D1=-:&M#6BC0* > (/
MJ @(" @(" @(" @("#RQC(Q2-H:":D-%-OD0>D%G%_5;DVYV0S5?#X'?1-^:
M@O$! 04+E[FF%K7< D?PN<*5IPD]/B0+.1\ULR1YJXU!.ZM"17Y""N@(" @(
M" @(" @(" @(" @(" @(" @(" @(""SR>RT).X/82?LP@3D'(6E-OFRGY 07
MB#XYS6-+WD-8T$N<30 #>24'YQ\XM=/YA\P<KGHY"_%QO]2Q#3N;96Y+6$#H
M[1Q=*?"Y;[HL'T<46].^>]\@YMJ_S.INNC=&R.Z/"OC:&O<Q @(" @(" @("
M @(" @(/H):0YI+7 @M<#0@C:""HL3,36':W*K6\/.G0IP^3F:-?Z=8WM)'D
M!UPP^:R?PB0#@EIN?MZ6K4=5@G2Y:Q\%WA_@^H<KUT:[!2?XEF_M[?'T_P""
MRDCDAD?#,PQS1N+)(W"CFN::$'Q+LK5Z:4>400$! 0$! 0$!!4M[>:[N(K2W
M;Q7$[VQ1-ZW/- DS$165B*S2'0.)QT.)QMMC;?\ %6\88#UGI=Y3M6"ONFZ9
MF6:LMBV*+Q<')8YK)-P^)O<HYAE]4A?*V$&CI'M:2U@\+C1H\:[,=G'=%O6E
MTTBK7^7&DGZ1TVR"^(EU#DYI<KJ&[&^;)7CNTF-178RHC9]2T+TZS/\ 5R5C
MX;=EO=&[VNG#CX+=N^=L][;EXG>@[F5IB[YS:^L^7\DTEOH+2K8LEJF2(ECK
MF^N03;VC'#I$57N(]$/^FX5L&BSQH\,Y?_LOV6]D1OGR^AC-3A_,W?3GX;=L
M]O9X=?<F;&8S'X7'VV*Q-M'9XVSC;#:VL#0R..-NP!H"P5]]U]TW73699&VV
M+8B(BD0L]4:FP^CL!?ZFST_J^*QT1FN)*5<>AK6CI<YQ#6CI)79@PWYKXLLB
MLRXY,EN.V;KII$..\USNYZ<UKZ=O+K'7^/P,;B(XL-;]M-P@GA,]VYM XUVM
M86CQK=\?+-'I;?\ FF)N_6GT0UN[6ZG43_Q1,6]GMGU,?!K'O1<OG#,92/.3
MXZ/;<,R]L;ZT+:UH]S0YS*];7 KLG3\NU'NV\,3^K-)</JZW#MFLQVQ7T;74
M?)SF]A^;>GWW]JP6><L"V++XSBX^S>X'ADC=]%&^AX3O!!!W;=1YCR^_27TG
M;;.Z?#I9[2:NS46UC?&^$D+%O:@76FA8^5VN[3G3HZ+U7#22BUUYBH 1&ZRN
MGM:^\C8VFV-Q;)(T=7%]-78M/JIU6&=-DVW?H3VQT>/H\G4Q=^GC#E^M;LB?
MBCU^W_%/((< YIJT[01M!!6NLHH7]C9Y2QN<;D(6W-A>1/M[JWD%6212M+'M
M<.H@D%<K+IMF+HV3"3$3%)W-3Y9V=[@L'+HW(RNGFTS.ZPL[AYXGRXV@?9O<
M=U1$X1'ZIA7MUMT7W_4C].*_YOTO/M\;IPVS;;PST>CH;HO [Q!%>I,;[5Y:
M:%@I;R_AH.KA>=H'B-0LCCNXK48E=B" @(" @(" @("#*W.9P_+C2=]S#U,:
M0VT=,?:U EFDD\V-D8.]\IV-ZFU=NJNKAG+?&.WQJX)U7JC+ZTU%D=4YZ3M,
MIDI3+( 3P1L&R.)E=S(V@-:MFQXXQVQ;&Z'!AUV @(" @(" @(" @(" @(*U
MI=W>/N[?(8^4P9"SE9<VD[31T<T+@]C@? 0%)B)BDC]-.7&L[7F!HG#:LM:-
M=D(&FZA'^RNH_,FCI4TX7M<!7HHM-SXIQ7S;U.<-I70H@(" @(" @(" @H7=
MRVTA,I%36C6]9*#&PWQO+J%EP UC22T-W%_16J*S*((" @(" @("#&,_SR3^
M:'^J@^YO\B'U[?FH,B-P0?) PL<)-K"#Q5ZNE!A8<J^ "(-XX6&C2=CN&NSP
M;D5DKAGK,#)H#^%;22$^'?3RHBM!,V>)LK=E=XZCTA!40$! 04W2ELL<?"2'
MU\^HH"!6E$%1 0$! 0>&2QR\79N#N$\+J&M#U(/: @MKR5[6M@B_'S'A;X!T
MN\@05HHFPQMB9Z+10(/: @MKR5S&-AB_'S'A9X.L^0(*T,38(FQ,]%HI_P!J
M#V@P]O\ YY/]:?E-09A 0$$:=X7XD->>X]U]PBPDM$1IH61L/,/FQ*\T:W*8
MLG]"V:*D*SC>&NN)1^&F/$X=3>@>0(BY0$! 0$! 0$! 0$! 0$! 04;J#MXB
MUII(T\4;NIPW(%M/V\0>11X\V1O4X;P@K("#XYK7BCP'#J(J$     4 W (/
MJ @(" @(/CB0TEK>)PW-W5*"G;RF>%DI'"7;Q6M*&B"J@(" @(" @(" @("
M@(" @(" @^.:U[2UP#FG80=H*"G%;00DF*-K"=Y H4%5!$?>.UL=&\L[^*UE
M[/+9T^U5E0^<&S F=XZ?-B#A7H<0LGRW!]7-%=UNU@^=ZO\ +Z6ZF^[W8\>_
MS>=P$!04&Y;P^2B @(" @(" @(" @(" @("#/:,U?F-":DL=3X.3@O;)]71.
M)[.:%VR2&0#>UXV'JWC: NC/AMS63;=TO;H]7?ILL9+>CSQU.UKBYP_,K2UK
MS'TB"X3,X<I9;Y8Y(A1[7@?[2/I^F;1PV4KJ-L78+YQ7^)]1LRV:K%&;'T[_
M  [&I @BHV@[EZW4^J @(" @(" @(-UY9XGUS,2Y.5M8<>VD==W;2@@>PVOL
MKQZJ^EM.MZ]-96ZO4EQ8MDA!\<QKV\+VAS=FPBHV;0@^H""TL<998WUGU.(1
MNO)WW=TX;3)/+0.<XGIH /$ %SNOFZE>B*)$1"[7!6E\P.7MGS&.'QN=G)TO
M87)O\AC&5:;V6-O#!&]X((C:7.<X#TMB]VEU<Z?BFWXIBD3U=?C=&7#&2D7;
MO2VRQL++&6D./QMM%:6-NW@@MH&-BB8T=#6M  'B7CNNFZ:S-9=T1$12%PN*
MM"M^5N%P_,"'7^EVLQ%U<P2V>?L(&!EM>PR .9)P-HUDK)&M/$!YPK7;M61G
M77WX)Q7^]$;;9Z8_!YHP6VY..W9/3V_BWU8YZ5*YMH+RWFM+J-LUK<,=%/"\
M<37QO!:YI!W@@T*L3,36-Z3%7RSM(+"T@L;9I;;6T;(86DDD,C :T5.TT 5N
MNFZ9F>DB**RXJ^!K0XN  <: NIM(&[Y:#Z@(-8UOC_6<:V]8/PMFZKC_ /+?
ML=[&PKT8+J33K1'B]J" @(" @(" @(,W@,1#>.ER62>V#"6(=+=3RN#(R(QQ
M.!<: -:!5YZEU9+Z;(WRKD+GQS>EYIZE;#C'&/1>'<Z+#04+1._T7W3VFFUX
MV1@^BSPDK.:/3?1MV_%._P!CC,HH7N00$! 0$! 0$! 0$! 0$! 0=2=SG7'J
MV1S/+R\EI#=M]ML2UQV"5E([EC1UN;P/\A6%YGBK$7QW2Y0Z_6ON0@(" @("
M @(" @M[RU;=PF,GA(-6NZB$&-@L76=U"^X(+'&C'-W<?16H16:1! 0$! 0$
M! 08N;BM<F;M['.@>SAXF"M#LW^P@\7TXR$;+:U8]SB\$N+2&@#K)09<;!1!
MY?PACB_8RAXB>KI082'%23@2M<&0N)+>+T^&NS9N16;C8V)C8V^BT #Q!$6C
MG-L;DN<>&VGVD_2R#?[*"YBFBG;Q1/#V]-$%1 0$'PM:2'$5+?1/55!]0$!
M0" 10[B@M[>(Q/G\T-8YX+ * 4#&C</$@N$%.6>& !TKPP'=7I06]F1</?>D
MUXO,C'TK!\TH+Q 0?'.#07.-&@5).X (+.S(N9'WM0X'S(0#6C!T^5!>H""F
M((6RF8, E=O?3:4%1 0$$:=X7XD->>X]U]PBPDM$1MHV)LW,+F5&UOX-N7QT
MD\FWSG>TMB&LZJ#?Y?$@DE 0$! 0$! 0$! 0$! 0$! 0$%G)_5;H3#9!/1LO
M4']!\J"\0$! 0$! 0$! 0$'F.-D3 Q@HT;@@](" @(" @(" @(" @(" @("
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M @(" @(" @(" @(" @\2Q-FC=$_:UPH4%&SE<YKH)?Q\)X7>$=#O*$%R@("
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M(,O&XOC8X[W-!/E""A>1.>QLL7X^$\<?AZQY0@K0RMGB;*ST7"OB\"#V@("
M@( (.[:@(" @(+.X_K,[;0?BF4?/_JM\J"\0$!!^>.BY8[;O#6,F:(:]NI96
MSF392X=<O:TFO5(0N0_0Y<1HO.?XJ-8^Y5S]P4'+W=5RQP+]?YP,$AQF#=>A
MAW.]6XY*>7A5D:WR*TI;<W>:EQ/K1[\C"R&?,9)LCB#=2]HQ@:XM((;Q2AQ
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MJ'<)IM%1OHHK0M/X/(0ZWN=0V6-FP5GD(9AJ2RDECDM;N^8]C;>Y@9&YP$G
MUW:24;Q-+0X%PV5'G2K-3Z(PITK/@YLM%C721X7(V4L CN;=[W/B$[9I&.AD
M8'!DAHYIIQ [>%!ELGC\I<:WTOE6VA=965GD8K^=CF<$4MV+?LQ1Q#G F)^T
M-V;.M!C,OAKN;7[\U+A+F^LX[&Q@L;N"Y; &W,-U+*\/;VK"6!KVDES7 T(I
MUA<Z@TI%JK/WUEE[2;VDGQMLR#(0R-BDAO[:XDECDA<UW&R6/C:YD@&_9UA!
MAVZ*U=EM+:IP>?N[<9Z]F@./S,;?P-T;". V]Q-"/Q;G.B#9HV[-A+=A"5&T
MXS/:CNS96U_IJ>QOGN R,CI[>6SA:&DN='*Q_')4T#!V;3M\X-HBL)A\)=VF
MM\WF+K"7/:7N09)99)MRP0>J-LHX'.?$V7H<UP#71EQJ#XB/1P=[+S M]1XW
M&3XFZ:Z6USUYVL9L\ECF1N]6+HVN)=,QY;P.+6N8WB:26D!!ORBB @((PU;#
MV.?N:"C9 R3REH!^2%D,4^ZC"+M1DL5@LCF' VT?!;UHZYDV1CQ?3'Q+A?DB
MW>K5=?\ ._0/*1DV+P/!J;7+0Z-\4;QV%L^E!V\K:A@!/XME7G:#3>NS#I<F
M?;=[MJ5HY!UKKO57,+,'-ZLOW7MT*BV@:."VMF'Z"&(;&CK/I.WDE9_%AMQ1
M2V'%KB[00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'P@.!:=Q%#Y4'Z0\B<M)FN
M4&C[Z5W%(,?';./AM'.M_P#^6M0UEO#FNCM<X2&O(H@((M[P^JO>IRHSDT;^
M"]RC!B;2FPEUY5LE#T$1"1WD00+W6N5.FM:6&H,_J[%QY.QBEAL<?'-QAK96
MM,LSAPN;MHZ,*R,IWG.3VD]*Z1QNIM'8B+&"UO/5LDV O(?%<M\Q[N)SO1>P
M-'UZ0/&@M5^WG=8UA@IG\5YIV*:V#3M/JUP\31'[9TC1X&H+#NA9*VP[]=Y:
M]=P6=AC[>ZN']44!G>X^P$D;;W3\==9W):TYGY-M;W+7;K6*0_32/]:N ">B
MKXO821J'?-N.+5NF[2OXK'22T_G9W-_U$@;]SZTA)F.06G[RUA=+>Z=@QL[1
M&TN>89(&6\@ I6E7M<?K4& [G6C;BW?J'660MWQ2$1XFQ,K2UU-DT].+Q0_)
M21&]P19]ZH%QX0=61U._\==#[Y!3[W=HQW-BY:]Y$=SB;6-Q \X%SI@:=>PH
M+_&=[+6%A;08]V"L6P11-CCDBN9N,B-H:TD%E-M$H.H.36K;KF1H:WU1D8G6
MMU+//"Z**5SFTA?P@[6MI\E02!ZA%_*2_;E ]0B_E)?MR@>H1?RDOVY0/4(O
MY27[<H+#(X][!VT1<]C6GCXC4@#;7;T(JCBI9HP^<6LKF/V-- *@;R@RL>1M
MI(G2DF/@/"]KQ1P/51$5(+J"Y![%_$1O&X^P4%9 0$! 0>7O;&TO>0UHVDE!
M1AO;:X<61/J[J((KXJH*X: YSAO=2OD0?4! 0$!!;9#\BG^L*#SC?R&#ZWYJ
M"WM_\YNOK!\IJ#)H" @H7<)FB\S9,P\<3NIP^>@]6\PN(FR#8=SF]3AO""C/
M:OEO+>Y#@&15X@=YKU(+M 0$! 01IWA?B0UY[CW7W"+"2T1&^@?C'YK>ZN*_
M4MFBI(1! 0$! 0 014;0@(" @(" @(" @H7D3I[66)GI.:>'QH,;CLA;VMN+
M:YXHI&$UJT])KT(/&0N69'LK:S!D=Q5+J$ ;*=**S3&\#&L^E 'L(CT@PE]:
M23WDGJXXS0.D&P<)/14HJ_QUHZUA(D/X1YJ0-P\"(O$! 0$&,POXF;^==\H(
M,F@(""S']:NN+?!;&C>ITG7Y$%X@(""BV5YN'PN: T-#FFM2:DC:@K(+*ZPV
M(O9.VO<?;7,PH1)-#'([9NVN!*"Y9;P1PBWCB8R "@B:T!E.J@V($=O!"288
MF1D["6-#:^P@^7%M;7D+K>[A9/ _THI6A[#XPX$(/%G86./C,-A:Q6L1-3'!
M&V)I/71H 07""R&'Q+9I;B.Q@CN9P1+.R)C975ZW 5*#Y9QQ=H]DL;#>0D R
M\(XG-I1KJ[]VQ!=S0PW$3H9XVRPO'"^-X#FN'40=A04K>PL;. VMI:Q06IJ3
M!%&UD>W?YK0!M05(X(8:]C&V/BW\#0VM/$@J(""RN\E%;$L8TS2M%7,;N:.L
MG;1!0S>0-EIS(Y4>8;>QGNAX#'"Y_P BBYX[>*Z([77DNX;9GJA^70)(!.\[
M3XROI#X=(B" @(" @(" @(" @(" @^BKG!C15[MC6C:2?  HL1,L]9Z'UMD&
M=I8::RMU&=H?#8W#Q3QAA71.HQ1ONCRP]D:'43NQW?Z9]BWR&EM48AI?E<'D
M+%C=KG7-I-"!3K+V +E;FQW;KHGQN-^CSV16ZRZ([8F&(!!W&J[GD$! 0$!
M0$&_\NN<6M^6<S68.\]8PQ=Q3X6[K):.J?.+!6L;C],PCPU7@U.AQY]\;>MF
M=!S?/I-ELUM^6?#8Z9TQS.Y5<V^"&:7WK:QEV&VN'-:V60_22;(YO+PO\"U[
M+IL^F_6M\/(WO2\RTVLV1/!?U3X;?2V"+1&;Q.?QHN(?6; W47%=P5<P-:X.
M\]IVM\NSPKJG/;=9--]'OC!=;='55,*Q+)B @(" @(" @(" @(" @(" @("
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M;W5Q7ZELT5)"((" @(*<T+9V=F\N#*^<&FE1U'P(*&,_(8OLONB@NT! 0$!
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MK6N<X,:"Y[B&M:!4DG8  -Y*DS18B9FD.B^5W=7S&H88,WK^:7"XJ2CXL3$
M+^5FP@R%P(A!ZJ%_6&K :OFT63PX]L]?0W/EWVY=?$7Y_=CY>GQ]7I[G0D6.
MY,<EK.-[V8O3[^$%D\Y:^_E V5#G<<S]QW;%@YNU&IGIN]'L;=;9I-%;^C9Z
M9]<M9O>]=REM9'1P39"]:#026]FX-/A';.C/R%Z(Y3GGHB/&\-WW#HXW73/B
MGUT7.,[T7*#)2B&?(W..XM@=>VDH9MZ"Z(2 >78N-W*\]O17QN>/GVCNFG%3
MOB66OM"<E.;ED^]MK7&9-SV[<CBGLBNF%VXN? 0ZO@D!\2ZK<^HT\TK,=DO3
M?I-'K+:TMN[8W^6'/7,[NLZATQ%-F-$32:@PT8+Y;%[0,C$T?2A@#9@!]*&N
M^I*SNEYM;?/#D]V?-^#4.8?;E^*)NPSQQU?I?CX;'/A!:2UP(<"00=A!&\$+
M.M/F)B:2^*H(" @(" 0#O0= ]W/FGKP:WPNAILF^_P!.7QE8ZVO:SOA9#!)*
M.QD)XV[6^C4M\"P7,M)B^G=DB*3'M;AR/F>><]N&Z[BMNKOZ*1,[)=:LUSIW
MVUN<-<W/JE[;2&$^L#@C>[ZE^[IZ:+5_HW4K#Z)Q16C8FN:]H>PAS7"K7#:"
M#TA=+D^H" @(" @(" @(" @(" @(" @(,!G-9Z=T^UXOKMKKE@)]4@_"S&G1
MPC=]D0NVS%==NAQFZ(0?WG^:&M-'XK3<.D+WVKM-0QW#KF\8P.NV]FV)S6QO
M-0S9)M+17J*R?+]/9?-W%%>$F7%]Q<7%Y<RWEY-)<WD[B^>YG>Z65[CM)<]Q
M)*V&(ILAQ4U00$ CBHVI'$0TD;]IH@[]U?/R7Y0Z5P=WJ+2EI)8W BL;8V^,
MM[N8O;#QUD+P":AIJXDDE:OBC-GOF+;O.YM%^'WNS_NA_P#@-I\]>G\GJ?F_
M>E*P?#[W9_W0_P#P&T^>GY/4_-^])6#X?>[/^Z'_ . VGST_)ZGYOWI*P?#[
MW9_W0_\ P&T^>GY/4_-^])6#X?>[/^Z'_P" VGST_)ZGYOWI*P?#[W9_W0__
M  &T^>GY/4_-^])6#X?>[/\ NA_^ VGST_)ZGYOWI*P?#[W9_P!T/_P&T^>G
MY/4_-^])6#X?>[/^Z'_X#:?/3\GJ?F_>DK!\/O=G_=#_ / ;3YZ?D]3\W[TE
M8/A][L_[H?\ X#:?/3\GJ?F_>DK!\/O=G_=#_P# ;3YZ?D]3\W[TE8;!HCF9
MW?M?ZGL])8'2,+<K?-F? ;G"VL4-+>-TKN)U'4\UIIL75EP:C';-TW;(_6DK
M#G+O'X3$Z?YNYBPPEG%86+X+.X]5MVB.)LLL(XRUC:!M2*T'2LMH;YNPQ,S6
M=J3O12O<@@(" @(" @(.T.YE>.DT/J"P)\VURQD ZC/;Q$_<K7>:1[\3V.4.
MDUAW(0$! 0$! 0$! 0$! 0$! 0$! 06]\QTEI,Q@JXM-!UH+:QO[1EI$Q\H8
M]C>%S7;""$%IBP+S(7=^T$VK7<,!.YSMM7#Q(K.(BA:WEG?1=O97$=S#4M[2
M%[9&\0WBK214(*Z @(" @M[N%TL8='LGC/'$?".CRH*EO,V>)LK=E=XZB-X0
M6F3SF$PC8G9G)6N.;,2(3>3QVX>6TJ&]HYM:5VT05[&_L<G:QWV-N8KRREKV
M5S;R-EB?PDM/"]A(-""-A0>+MS67%I(\AL;7N#G'8!5A J@61#GW+VFK'2DM
M<-Q\UHV(+M 0$! 0$%">:2)\8:P%CW-:YY-*<1IL'6@KH*<\+9XG1/W.&_J/
M04%.SE=(PQR_CXCP2>'J/E07" @(/CFM>.%PJ*@^4&H0?4$:=X7XD->>X]U]
MPBPDM$1OH'XQ^:WNKBOU+9HJ2$00$! 0$'B.)D+!'&WA8-P'A-4'M 0$! 0$
M! 0$! 0$!!9M_K5T7[X+<T9U.DZ3Y$%X@(" @CSG%S5Q_*C2_MK+$+O,WKC;
MXBP)H))@*N>^FT1Q@@NIUANRM4'*>$LN?W> NKC(P96=F'CD+'W$EP^QQ<3]
MA[...$'B< 17A8X_3':J)(Y><@^;NC-=X/(7^HVS::@G[;(BPO[D<4<;2X1O
MBE;&'M>X-:1MV%!T]?9"PQENZ[R5U#9VK=CI[B1L48)ZW/("@M<7J/3V<+VX
M7+662,>UXL[B*X+1NV]FYU$%OE8,;9,?>WM]%86Y-#)<O;''QFIIQ/( K1!]
MCS^ Q^(9D;W)6EGCFN,1NI[B..#M 34"1S@TFH/2@R%CD\;D[07^-O(+RQ=7
MAN;>5DT1IOH]A(V>-!9X_5&F<M=OL,5FK&^OHZ]I;6UU#-*VF^K&.)%/$@O+
MW)8[&M8_(WD%HR0T8ZXD9$'$= +R*H*%YJ# XZRCR60REG:8Z7\5=SW$44+O
MK7N<&GV4%?'Y/&Y:V;>XJ\@OK-YHVXM9631$CJ<PD(*-SG<'9W!M;S)VEO=-
MIQ02SQLD'$*BK7.!V@H+JZO+2QA-S?7$=M;M(#IIGMC8"305<X@;4%C+J+"B
MPGOX<E9R00U:9?6(NR$A%6M<_BH"4'-_*3O&ZJU]S#BQ6HG8W$:<]5N)711C
MLZO8!P<4L\CC6I^AI7J5&R]XWEY><S;+3UU@M1XVUCLS.6VE_="&VG;*6#MH
MWMX@7,X:'9N.P]!"3M!V5MHK0&!Q.6SD%ZVQMV6QRKYFM@E?YQ#8WN.UK1YC
M.GA:H-AGSV#M<?[;W.3M(<54CUZ2>-EO4$@_A"X-Z#TH,6S,X+489<XB^AO+
M-@H^^M7MGA%=S>)A(JBLK%%9XFWENKF=D<31Q2W$KA'&UHZR30#QE$4K'4VF
M\G%//C<Q8WD%L"ZYEM[F&5D31O+RQQ#1XT%Q:Y;%W\<LMC>P7<</XUT$K)0V
MM:5X":5H@LX<4)P)G.,4;R7-C J0T[MJ*RS&-C8UC!1K10#P!$4KR)TUK+%&
M 7N;0 [$$>\\"ZVY,ZI#]CQCA&ZFW:YS&'Y:]NAC_GM[V,YI--+D_9E^=ZWY
M\<$! 0$! 0$! 0$%[BL3E,Y?PXO#6<V0R4YI#:VS'2R.\C0=@Z3N"X7WVV16
MZ:0[L."_+=PV1-T]B=M,=T?7>6ACN=19&SP$;Z'U>AO;EH(KYS8RV,'_ .H5
MA<O.,=LTMB;O-X>1M6G^V,U\5R719YY]4>=MTW<QM^Q/J^LI/6 -ADQ[> GQ
M"XJ%Y8YU-=MGG_![[OM:RFS)-?V?Q;GR>[N&,Y>9&34.H[B'-Z@B>1BWLC+;
M>V8/]HUKZDRGZ;Z'HZUX]9S*[-'#;[L=+)\LY'9I+IONGCNZ.S\6G<ZN\W/8
M75UI/EN\-NK=SH,CGI&;8Y&DM?';,>/2:=AD<*?2CZ)>O0\KXHX\F[HCVL?S
M;G_TYG'@WQONZN[VN5;_ "%_EKV;(Y2ZFO<A<.+Y[JYD=+*]QZ7/>22MEMLM
MMBD12&A9<M^2[BOF9F>M;+FZA!>8K+93!WT>3PM[/C\A":QW5K(Z*04V[VD;
M/ 5UWX[;XI=%8=V'/?BNXK)F)['6');O-G,75KI3F,^.'(3$0V.? $44TAV-
M9<-%&L<=P>VC3T@;SK.NY7P1-^/=U>QO_*>?QEF,>;9=T7=??U2N^\;R+M\W
M97?,#2%L(\_;-=/F;"%M!>PM%7RM:/\ ;-&T_3CZJE>'+=?-DQCOGW9W=CLY
MYRB,ULYL<>_&_P#6_'TN. :[1N6VOFP@(" @(""7^[&P.YRX0GZ""^</'ZK(
M/FK$\U_EY\7I;)]NQ75QW3Z$VZM/%JC,U_M<H]@T6"Q?!'<^D7;U/$ZCSF#<
M#B[Z2&,;3 3VD)\;'5'L*W8[;M\$3,-[Q7-^1O#'F\?Q#8#<6AVTZS&\_*<O
M+=I>J79&3K;KB];Z7RU&VV0C9,17L9_P+QY'TKY%YKL-]N^'9%T2V $. <TU
M!V@C<0NER?4! 0$! 0$! 0$! 0$&+R6H\%B ?;+(0V[AL+'/!D^T;5WR%SMQ
MW7;H29B&F97F[C8>*/#V<EW)N$LWX&*OBVN/L!>FW2STRZYR1T-%S&NM39H.
MCGO#;6SJ_P!7M*Q-H>@N!+CY7+U6X;+>AUS=,M:<!PNZR#4])*[W%BN]N.TT
MCRWGZ0)P:[_.M8#\Q<N6_'?X=;T=$.5UFT$! 0!Z3?KF_+"#L7O>_%YI'W09
M_A)%@.6_Q+N[UN4N.EGW$0$! 0$! 0$! 0$$N=V/X[M._P SD/\ !RKP:_\
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M @(" @C3O"_$AKSW'NON$6$EHB-] _&/S6]U<5^I;-%20B" @(" @(" @("
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M5+OHCO/2?*NU'U0$'EWHGQ%48OO9?\$\N/\ ZO\ A8ERY=\=[T=$.5EFT$!
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M&P@JB:N\YJ*35.@N6F>>P-?D(9[FXX?1;+/;VTG" =NVKO84@3GW;/B5TO\
M6WG^.N$D2LH" @(*;)0]\D?"08R 2>FHKL05$! 0$! 0?'-#FEKA5I%"/ 4%
MG:2B&9V.D=62,<<5>F*NS;X-R"]0$! 01IWA?B0UY[CW7W"+"2T1&_+_ ,[F
M%S1F;^*FR>+=&[=4##6C3\D%%20B*;)FR/<P @MZ^D D;/*$%1 0$! 0$%A>
M75R939V4=9J OE/HM!06=@R2'*R122&1[6$N<:[20#T^-!FT! 0$! 0$! )
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MS6UV"MV]E/$ :(+GG7B<MRSYX2ZG9;EUM/D(M08F1]>RF(D;-)'7ZF0.81O
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MYY77; :\$]Q&^>1E1OX72%M? @F7NL?$YB_[U>_T[DD<S\BO^H+$_P!]R/\
MAKA48[*7V-R//>^N.;+IO:=N9N(LNWSR600O>R*/S/.[)M&-\S;P>CM05^?6
M;Y893.XVTY765O;XO'VSF7EW:6YMHYYI'U'I-:Y_ !3B<.G8@VOGU;,'*#DR
M]OFF+&,: !O;'8V\;1Y ?D*#HGNV?$KI?ZV\_P =<)(E90$! 0? UH<7 4<Z
ME3UT0?4! 0$! 0$%G>P.<Z.[B_'6_$6M^F:ZE1[ 07,4C9HVRL-6N%0@]H"
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M>PU'G11.;3RK!?E-3.WAEML\QT=NSCM;$<GRYYLX&\P,61LM08B]8&WEG!<
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M!1\9+' [P6FA^4OI$/AMT3$TG>\JN(@(" @(*]G9W61O+?'V,3KB^NY66]M
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M @(" @(" @(" @(""XL(#<W]I; 5,T\3 /KG@*732)(1QWP,@V[YGX^R:?\
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MIC5,;=C73XRX=39YP$T6W[&1;)R7)MNL\?AYFD?=.&MMF3JF8]<>B7**V=H
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MQ>+6W\.&[MV+#OZ+)2RY VG !%5P#MM2&@[?D+4G-DD! 0:#SJTA=:XY9Y[
M8]ADR;H6W-C&/2?/:O;,U@KTOX2P>-!R5W<>;&/Y8ZBR.)U1QV^!S(C9<7'
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MHW 4'D0?4! 0$%K>1NHVYB'X:'S@/IF](07$<C98VR,-6N%0@]("#X2 "2:
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M_<\TC826^<UQ<1MER$<PQ5BYP!,+!&V69S>HOXV-KU CI*UCG.::VV=&]O\
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M\,<#G[S'!M+</[:U/7#+YS?8VM\BP>*_BMB7T6Z*2PR[$$! 0$! 0$! 0$!
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M-KN)P&T]6U!Y/]:N^'?!;&IZG2?]B"\0$! 0$%+L:7';BFUG >L[:A!50$!
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MH':S_P O+_O'_/0.UG_EY?\ >/\ GH':S_R\O^\?\]!Y<Y[Z=I(]X!J ][G
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M'$[+:T!J*_\ S'GSY#U[-P"SNGP1ALX8\;L:0O2@@(" @(" @(" @(" @("
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M0@L[4FWE=9./FCSX">EAZ/(@O$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MW=#G$-\7E40$! 0$! 0$! 06K,A:RW'JT;N*3;M \W8*[T%T@(" @(" @("
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MZ!W$/'0CYJ#T@(" @M)\C:P.<PNXI&U\T"NWJJ@]6<19&97D&:;SWN'AW#Q
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MM]UEW!DV3#Z59?9ELB_'-;9:6""*C:#N*]"OJ @(-CTGI"\U-.9G$VV&@/\
M6KT[!YNTLCKL+J;SN:NG+EBSO<K;:HOYY<^;*:QEY9<K9?5].0AUOF,U;FAN
MNA\%N\;3&?\ :R[Y/1;YM2[V:31S$_4R;^B'=V0YM #0 !0#8 -P"S"" @("
M @(" @(" @(" @(" @(" @(" @(" @(,GI[3N;U9FK73VG+)]_F;UW#!;Q[
M /2>]QV,8T;7/=L"X7WVV6\5TT@=]<E^2&$Y3XPW$KF9+6-ZP#)9?AH&@T/8
M6X=M;$T_9/.UW0!JVJU=V:>JWJ<XA)K[&"2Y]:E'&\ -:T[A3;\U>%6/NO\
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M!]M)'2VT;WGB<0:NZZ&E4%= 0$! 0$'@2M,IBV\0%:]'_P ;4'M 0$! 0$!
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M" @(" @Q]N]K,C>AY#2[LRT'94!O0@^VK@_(W;F'B;2,<0VBM$%^@(" @("
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M?)AI<+P%PV\'9M \54%3'7;KRW$CQ1[26NINJ/\ \T%V@(" @(" @(" @("
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MJ"Z0$! 065Y^567U[ON4!_\ FD/\T[Y807J @(" @(" @(" @(" @(" @("
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M&Y6]O;VD38+6)D$#!1D430Q@'@#: +RS,SO>^(B-RJHH@(" @(" @(" @("
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MH" @M+VPBO>$N)9(ST7MWH*'M?? <(OW\/UNWY:"M9XZ*T<Z7B,DSM[W(+Q
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M-] _&/S6]U<5^I;-%20B" @(" @(" @LS_6KNF^"V.WJ=+_V(+Q 0$! 0$!
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M<H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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ML3XC.7T_"2N>VG40!\Q!<(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @("#P]SVNC#15KC1QZ0*$H/: @(" @(" @L\G/)!9O?$
M>%Y(:'=52@HW=L;:V?/%/+VL8!!<\N!V](.Q!D(W%\;'G>YH)\H0>D! 0$%.
M&43-+@TMHXM+7;Z@TZ$%1 0$! 0$! 01IWA?B0UY[CW7W"+"2T1%^@;VVCU]
MS.[=Y;<NRV.9+LJT\&'M ' C=7T?)7I14H @BHV@[BB" @(" @MI[^VMW\$C
M_/Z0!6GC0>;)ID#KM^V2;:.GA8-P07: @(" @(+#VL[-[G6L[X&O-2QNUM?
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M;/2;7PA!FT!!RSWJ_P#B[0O_ -7^GA5A'0.I.8.B=(2-@U)G;3'W+QQ-MY9
M9N$]/9MJZGAHHJ\T]JS36K+9]WIO*VV3@C($IMI&O<PG<'M])I/U005LWJ+
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M-"X/BD:'L>TU:YKA4$'J(0:WJ/F'HC24PMM1YZSQ]TX<0MI) 9^$[03&WB<
M>@T07NGM6Z9U9;ON=-Y:VR<,9 E]6E:]S"=P>T><VO1Q!!"7>]_X(P?NJ/\
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M.G:^K2MD<RN[C:#Q-K]4$'G46K]+Z2A9<:ERUKC(Y=D0N9&L>^F_@9Z3J=-
M@M-.\P]$:MF-MIS/6>0N@"[U:.4"?A J2(W4>0.DT0;,@B3GWKRSTYH;,V&)
MU!%C=8AEL^TMH;AL=]V<EPP.+&@\6UG%M'156!C>27,O2<'+?!VNI-5V8U"]
MUSZU'?WK3=E\EU*6\?:OXR2TMI7HH@T;O2?\=:$^R_Q,20CH#4?,/1&D9FVV
MH\[:8^[> 1;22 S<)W$QLXG 'K(HHK*X3/X34EBW)X#(09*P>2T7%K(V5@<-
M[3PDT<*[0=J#(H-)ON;_ "QQMX['WFJ<>RZ:>%[6RB1K7#>'.9Q-!'34H-ML
M,A896TBR&,NHKRQG'%#<V[VRQ/;NJUS204%R@^.<UK2YQ :!4D[  $&DY#G%
MROQ=TZSO-4V N&GA>V.7M@T]1=$' $>$H-EPFH<%J6S]L-/Y&WR=E7@,]K*V
M5K7@5X7<)-';=QVH+#5&J])Z8CAFU+FK;$N)XK?MI6-E=O!X6&KG#KHU!::8
MY@:#U+,ZTT[J&TR%](3(Z!LK6SNV;2(W!KB !T-0;4][8V.D>X-8T%SG'8 !
MM)*##8_6.D\KCKG+XW-V-UBK(\-Y?17$3H(30&CY [A;L(WE!B,9S9Y;9G(-
MQ6-U-83W[W<$47:\'&[J8YX#7$] :2@V/,9O$:?LG9+.7T&.Q[7-8ZZNI&Q1
M!SS1H+G$ 5*"IC,IC<U8PY/$7<-]CK@$P75L]LL3PUQ:>%S20:$$%!\RF6QF
M$L9<GF+R&PQT'#VUU<O;%$SB<&MXG.( J2 $'G$9G$YZQ9D\)>PY#'2ES8[J
MV>V6)Q82UU'-)!H10H-;R_-CEO@KUV.RFIK&&]C/#+")>U<QW4_LP[A/@<@V
M7%9C%9VRCR6%O8,A82_B[FUD;-&2-XXF$BHZ0@M[[4VG<7D[3"Y'*6MKE[^@
MLK&:9C)YN)W .!A(+JNV;$%G<:ZT?:Z@@TK/FK4:BN7<$6-;('S<1!(:X-KP
MD@5HZB#*Y3+8O"64F1S-[!86$7XRYNI&PQCP%SR!4H-=P?-'EYJ2^;C,+J.R
MNL@\TCMA)P2//4P/#>,_6U09FRU-IW)92[P>/REK=9BPJ;VPAF8^>'A<&GC8
M#5M"0-J"_NKJUL;>2[O9X[:TA:7S3S/;'&QHWESG$ #QH--@YQ\KKB]%A%JO
M'FX<[@;68-C+B:;)'49_I(-W8]LC6O8X.8X!S7--00=H((08FPU5IK*7=]88
MW+VEU>XPN&1MX9V/DMRQQ:[M0#5M""#5!@/A@Y8>V'M7[Z\=ZWQ=G^.'9<5:
M4[7\7_I(-T8]DC&R1N#XW@.:YIJ"#M!!""G=W=I86TEY?3QVMI".*:XG>V.-
MC>MSG$ #QH-)=SJY4MN/53JRP[6M.(2$QUW?C .#_20;K97MEDK6*^QUQ%=V
M4[>."Y@>V6)[3TM<TD$>)!K6?YF\O],79L,[J*RL[YOIVKI ^5E?IV,XBW[(
M!!F<%J/ ZFL_;#3V2M\G9UX3+:R-E#7?2NX35I\!VH,F@(-1SO-+EYIJ[=89
MO4EC:WS#PR6W:B25AK2CVQ\1:?KJ(,S@=3:>U1:F]T[D[;)VS2 ^2UE;+P$[
M@\--6GP.01[S^UCB,+R\U#A?;6WM]17MDUEMCG3,;=2P7,S87ED9/$06=IN'
M058&H]W#4W+_ $YR[L;.[SF-LM0Y.ZGDO+6:XBCN72&4PQ-+7$.VL:WA'A\*
M2CH511 0$! 0$%"2SM9G<4D+7..]U-J#[%:6T!XHHFM=],!M]E!60$!!&G>%
M^)#7GN/=?<(L)+1$;Z!^,?FM[JXK]2V:*DA$$'QS0]I8[T7 @^(H/,<<<+!'
M$T-8-P"##X+\;<>(?+**S:((" @("#'7UO%%'VC&_A))F%[CM)J[Y2*Y<Y9N
M]N^])J>^OO.GL+G,"W+MI'JTILV4\49H%4=:* @U?6_+_3/,*RLL?J>W?<6E
MC<MO(XXY'1<3PQS"USF4/"0[;0@^%!'6K>77=Y9B[G"WTF&P%Z6.9#=-NXX;
MN&0"@=1TE74.]KZ@JC7NZ5J:_O<+GM*7DYN+;"S0S8]Q)<&Q77:![&$_0AT?
M$!]44E&@ZVM<_D>\;J#3&FK@6-YJ1L.*N;KAJ8[.>S@EN'#:-O!&XFAVBHZ4
M'1G+_DWHKEO<>OZ?AG=EI+8VES?7$SY'2QN<QYJS9&*N8#YK0HJ&.Z3LSVN/
M_*?TMPK*,3=.T]J?O(YJQYLSAF*LW26V'M;N0Q6I,?!ZM&XU:&L?&YTN\!SR
M*UXMH="XGE'RZPN?LM4X/"0V.5LVR"WEMG.;%29A83P<197A<:$#I45O"#FS
MO@4;A-+3  R,O+CA)V_[-A^8%81L6@^26$SN,BUIS.C=J+6&>C9>W1NGO$-N
MR9H<R)D;"T5:V@/0-S: (J-^<W+GX%\IB.8_+::7&V_K/836I>Z5D,[FE[0"
MXESHI&M<U['DCHK1U 1O7/3(Q:@Y"RZDL"([?->U5\(".(QNEGBD< ZFP@5:
M=FW:.E%;AR&M.TY3:6DNG"5WJ+X2V@#>'M7M/LT4%K#R8Y(:-L:9;'6+8WEQ
M-YF;@%SMNX.E>UHI6GF@>RJ(0OKG2?+;GCIW(<L,K!<Z>RTD$&2L[*Y%U#&V
MYF[":(N:YU6T+96-<31W@ 1$H=Y70FE)]%YK74MAQ:IMV6<$-_VLHX6&YCCI
MV8?V9\U[AM:D*QG)#DYRXU%R]T_JG+X;UC.RNFEDNC<W+*O@NI&L/ R5K-@8
MWZ%$:'WE]#:6TQJ33UQ@['U6;/2WEQE7=K+)VTAFB-:2/<&[9'>C3>D"?;;E
M]RTY1VF4UUA,.;.XQUA</FD%Q<2N="QO:.8!-(]M7%@ -$5#G*#0AYVY;+<S
M>9;WY*T%R;7'X[C<R O8 \MHT@B*,.:UC0?.->*NVI&\\T^[YHW(Z8O<CI#&
MLPVI,;"^ZLW6A<R.<PCC,3V5(JX"C7"A#J;:;$JJ][MO,/(ZXT;/8YN9USF<
M#*RVDNGGBDFMY6ET+WGI>.%S">GA!-22DB!>6>D\CS"UEJ+0?K3['2#[Y^4S
M_J_FRRLLYGQPPM)J-KI:@$$"G%M+0JCH+57+O2O+WE%K:QTO:OMH+O'S2W D
MEDG+I(XBT.K(33R**BSN_<L[/F'I^+,:XD?D=.82::QP&$+W1V[9)")[B9XC
M+2272 #;MIMJ $E%GSVT%C^4&<TYKWE[Q8ISKAS76S7.?''<P@/:YO&7$MD;
MQ->PGAILW$I E'1/(O2.7T_%J+7ML[4.K-11-R&3OKB65O ^Z:)!'$(W-#0P
M.#:[]FR@H 5'/+VUN>4?>'N= V-S))IS+@QMCD=6L<EN;FW<X; 7QN_!\5-Q
M/6B.LU%1OS]^*'5'\Q#_ (F)!K7(*>^M>0T=UC(^UR4+,G)9Q4KQSLEE,;:=
M-7 !61%_=UP7+K6T^;NM=F'+ZWN;HOBM<E(29('M#G2L:XCM'N>7<>\MH-U4
ME'2FDN76C]"W&1N=+8YN/=E#$;IC7O>W\"'<(8'EW"/.)H-BBMI0<B<_I<[;
M<^, [2TG8:BN+&TM[":@/#/<S3P-/G @4XM]-F]5$PX+NY\M,=BA:9G''.96
M8<5]E;N6832S.VO<W@>. 5)I3;UDG:E50U=8Z[[NG.3%MQ-W+)HO4!C$L$KJ
MUMI).R>Q^X.? XA['4K2@KM<B-D[XG^5Z3_O%Y]Q"D#H_$_Y58_W>+[@**YD
MYN@?\S&AO_M/^-E51LG>\#!H/"O=39EV $[-]M.:?(2%4>7G)3&:]Q4',3F>
M^?*9_/,CNK>V9*ZW@M[4- MPT1%I)X TTK0"@I6I)&K]YFYRF/YJ:0OL >'.
MLLXA8/HUQ$_K4@BV.!!(<[95($IZ:[NV@+#& :ILSJ/45T#+E,K>33%TD\FU
MY91[>$5)H?2/24JJ'-5X:X[M_-'#9S3=Q-[S\S^/M)'%U8&/:VX@<?HN /:^
M)QV@D;Z$DB1>\MS!R^%QF)T7I>5\65U*7":>$\,@M:MC;&QVP@RN=2HZ 1TI
M"L]HSN[<O-/8*WL\WBH<WFGQ@W]]=<3P92/.$3:@,8#L;0<764J(AYAX&Y[N
MNOL/K#1$DL>F<L7,NL6Y[GL(B+3+;N+B26N:X.C+JEKJ]2(W/O59[)G0&#&(
MD>W YFY#KV:.H$C.R[6"-U/H7;7TZVA(&QZ/Y2\C=3:.LSAL;:Y6TD@8)<BV
M5_KO:N;YQD>QX<R2N]FRFZE$5LG,34-KRDY77%UA(FQG&6T..PL+O.:V5U(8
MBZOI< \]U?2HH(VY.\K-'9+3T.MN8;K?/:IU!6^D.1F$S8HI35E6.=1SW"CG
M%PV5X12FVHUKG!I[#\G]0Z>YD\M98['BN3;9#%V\W%"_S>.@;Q.(9(QKV/;N
M&PBA0=,3ZJT[98^QR63REKCK3(QMEM'WL\=N) ]@?1ID<VI (K115JW7VA'N
M:QFJ,2Y[B&M:+^V)))H  ).E!SIWMY+B+4>C9;05NF1W#H!0._""6(MV'8=J
ML(D[37=^T>RR.0UU;'4FK\C_ %C,9"[ED+?6)/.>V)K'- :TF@-*^+<%50WS
M(TK/W>=>8/6FB)96:?OGN;)8/>YX C+3-;/<:ET<C#5G%4@BN]H*(WWO77,%
M]RTP5[;GCM[C)P30NZV26L[FGV"D"7^7&SE]I4#=[46'^'8HKGWO2QLDU[H+
MB /"0X5ZVW<3A\D*PB0^\O9V\7*++=FP ON;$O)J3YMTQXH36FT)"LGR<^(S
M"^YUU_23)(C'ND6=MD=.ZTQ]XSM;2[?;07$=2.*.6*9KA4$$5!Z$E&HZYY<Z
M-P_/K36B\=C>QTW?^H^MV7;3/X^WED:_SW/+Q4 ;G(.H-'\L-#Z"N;F[TIB_
M4+B\8V*X?V\\W$QIX@*32/ V]2BMBR^*L,[B[S#92+M\;?Q/M[J'B<SCBD'"
MYO$PAPJ#O!0<>Y/ESHVW[Q]GH.'&\.E)>R[2P[:8UXK$S'\(7F3T]OI*HZ,B
MTSH7DIIK46I=.8OU.*.U-S=QB::4S.M6O,3*S/?2KGENSK45#')KEXWG#>Y/
MFCS-<_+-FN'6UA8N<YD),8!<2&D$1LX@R-@--AK55&W\W.0&D;C2U[G-&8]N
M&U%B(G7D'JA<R.=D XW1EE2 Z@)8YM#Q4KL2JL]W=N85_KS1#F9J4W&;PLWJ
M=S<O-7S1%H=%(\]+B*M<>DMKO*2)=4'+/*[_ *H-9_\ W3_$Q*HZ>OOR*Y_F
MG_<E17-'<Y_(M7G_ .;8?<W"LHUC6F,S6:[RN5TW@+UV,GSC8;&]O(@.-EF^
MRB?<%M?HC&PC>*[JH)HN>[3RIFP;L3!C)+>[[,MCRPGE?=-DILD-7<!V_0\'
M#X E5:#W6LQEL5G=5<M<C,9H,4Y\]NRI+8I8)_5YPRNYKR6NIUBO24E%IS1_
MZH-&?_:_\1*@VCO.:[S&(QV*T+IR1\63U(YPNI(3PR^K!S8VQ-.\=J]U"1T-
M(W%(&;T?W;>7.#PD-KG\<W-YE\8]>O9Y)0WM"/.$36.:&M!]$TXNLI54"<]=
M _!SG,+A<3=S2Z,OY9+[&X^X?VOJMSQ1QW#&EVTM([,U._IJ14V$= ]YCXG\
MM_/V7^)C4A65Y _%!I?^8F_Q,J2(S[X7^1:7_O=S_1,2$2+S&US/R^Y1,SEC
M0962UM;+&EP!#;B>, /H=AX&ASP#O(HBM+Y1<I-$2::M=4Z]%MGM59Y@O[A^
M1F$XB9<#C8WA<ZA>6D.>YPXN(TZ$1J/-/#XCDKK/3G,+EW*RUL;F9T&5Q-O+
MQPN:SA<]H;Q$\$K"X<.YKF@C;2@;1WMYH[C06G[B(\44N38]CNMKK64@^PD#
M+<R=%C6'=_Q+K>/CRF%Q5CE+*@\XB"U9VS!T^=&7;.EP"*S'=PU?[Z>6EE:S
MR<>1P+CC+@'?V40#H#XNS+6^-I21&G-.-W-3G]@= 1?A,/@PSVQ VM <!<W1
MKT5C$<7UR(ZF:UK&AC &M:*-:-@ '0%%<]=[W_@;">ZS?\-,K"+WESR.T[G=
M-XW5',:-^H-09.RMWL;-+)'!:VG9-$$,;(7,'FQ\-2>G=UDJ-=8:=BY"\Y--
MY32<TL. RKHS):/>Y]('RB*Y@)))>WA+7L+JD&G2T%$=3:PTCAM<X"XTWGF/
M?C;ET;Y!$_LY Z&1LC:.H:;6T/@45'N9Y:]WO"V3\5FK3#XNK.#BN;P07;:C
M81))+VE>G>J(X[M69]I.8.JN7N/R7MGIAHGNL9<M<'QN-K.V(2L+?-_"1O!=
MP[#PA)19=XN^R^*YSZ8OM.<+<^['0PV+R ?P\]Q<0L.W94%^SPI EOE]R"TA
MHBXQ^>F,^2UA:<4LN5EFD#3/*QS)"V($-X2'NIQ@N\-4JJ!X-.9/6'/W6&CK
M&^?C<5E[NZ&>F@X1*ZPAE$KXVDC9VCPQI\>VHJ"1->HN[5RTO].SX["8PXW,
M,A=ZCDFSS/>)PWS3('O<US2?2%-VZB55K/=-U3D;_!YO2.2E?(W!2Q260>>(
MQQ7/&'Q _2M?'Q ?5%)1A<B8^>O.;(X+.7Q@Y>Z0,C/4VR]B+B:)_8N-:CSI
M).+SANC;04)J@D/5W)/E+G=/7..Q5EC\5E&Q.]K[^TD;'(R<-/!VAXO/:3L<
M'UV;B#M16#[O&N\]G>6^;QDY=>Y[2[7Q6!D/&^2-\+G6\;B:U+7L<P?4T"2B
M/N[QA.7NN+[.76OW19?6US<\<-KDI"3)$\<3Y&-) D>7D\6\M %*521TKI+E
MSH[0UWD;S2V-;CY,IV7K36O>]E(>+A# \NX1YQ) V**YIP\>FM6]X34T'-N5
MM()KBVPUE>R&*V<Z&8,MXB:@4[+SV-J \FNTG;4=%X3E-R^T[J"'5&!PL-AE
M88I(8WP%PBX9A0D1DEH=2HXF@;"5%;J@@CO*:#TI<:+S6NIK#BU3;,M(8+_M
M91PL]9CCIV8?V9\U[AM:K Q/)/DSRVU-RZP.I<WA?6LU.9WS7)N;EG$Z&ZD8
MP\#)6MV!H'HHC7^]@Z[;J[1CK#\N$4IM=Q_"B>/@]+9OIO2!)^'[N^A/4))=
M8P2:CU1?UERV8N)YV/?<2;7F,1O8&M!/F[*]:55$^A;2ZY.]X9^A;&ZDFTWF
M:1".0U+HIH3-;N<!0%\;QV?%3:.+=5$;IWC=69FXR&G^5&G;KU*[U+(PY*ZX
MNSI;2R]C&PN!%&.<'NDZPVFXD) VO#\E^3&*PT>(FQUAD'B,,N+^[E#KJ5]/
M.?QAX+">J/A Z$5&_*^X?RPYX9/E?97QN](YAKI\:QT@D$<O8>L1D$5 <&A\
M3J>E1I.X(CI]17-7/K4^H=7:XQ/)/2UR;2._[(YB8$MXS."\,?3:8XXAVKFC
MTJ^!6$;]@>[GRJPV.CL[K#C+70:!/?7LDADD=3:0UCFM8.H-'LI561R%GI?D
M7R[S^3TU8B"SMS)?1VKY'R!]Y/P0Q-+GDNX>+@;OV!01)R3Y66G,FVNN:',T
MR9R\R=Q(VPM[A[A$61.+'2/#2VHX@6,C]!H;NW4J,QSIY%:9LM,7>L="VAPF
M?P3/77,LWOCBE@@/%(0VOF/8WSVN93=0[P0&[<D]>77,+EJ+[*N$N8L#+CLE
M(0/PKXF!S9".M['MXOJJHKGCN^Z$EYD^V.#S=Y,W0N)GBR%YC('=D;J^G:8X
M@Y[?.X6LC<30^*E:JRB3.=/(+0]AH?(ZBTG8>U.4PT7K3FQR2R13P1D=HU[9
M7/H0VK@YO2*%2HSG+1\_.#D'-@L[+ZQ?&*XQ)NYJN<9K:C[:5Q-27,K$2=Y+
M:HK"]U#4=P,7GM Y*L=_A;DW,,#]CFQRDQS,I]1(RI\+TE#O4YR[O+;3?+C$
M5DR><NVSR0,/G.:UW8P,(ZGR/)\;$@?><V8N^6/+[2W*S1\W89/*L;8&ZC/9
M/[&/@;*X.J.!T\LFUW5Q(-JTIR1Y1Z?P4.-R5I89C).C O\ (7<C9'R3$#C,
M=7?@VU]$-H:;R3M14<Z?;#R:Y]VFE-/7AET3JQD7#9]KVS8GSE\<>VI\YDK*
M G;V;J&IVHBEWG<CD,-S*T;EL,UIS%M;!]EQ-#ZS-N#V>P[Z..Q($F\O^[_I
M;2DN.U%EGW&4UQ _UNYR<D\G!ZW("9.%@(#A5QVOJ3O2JHK-M>=XKG'D<=DK
MN6+06F'2".VA=PA\<4G9#AZ ^=P+B\BH8*= 1$N9[N[<LLGB'66*Q8PN2C:3
M8Y.TDE[:*9H\QSN)YXP#2H=MZB#M2JHG[LC\I-S0UC)G9?6,VRU?%?7#J%SY
MF73&2$D 5J6[3TI*,GS"OKCFYSEAY739 V.B, /6,P&2"+MY(FM?(:D@%P<]
ML+*^CYSD$BY3DOR8R6%DPT.-L;%QC+(+^VE#;N-]*-?VA>2\@[:/J#THK4.[
M%J;*-&H^6^7N/6G::G/M?-Q<8$(D?#)&T_2->T.9]<>BB2B,]/Z9R&M>=^MM
M%P7TF/T]D,A?7&H?5N%LLMG:W;G")KB#3CD>T'V2#2BHF76/=PY;76E[JUP&
M.]J\Y#"]V/O633R.=-&TN:V0/<\.:XBCO-J.A2JL5W3-67V;T?D\!?2OF;@9
MXA9NDJ7,MKIKBV+;T-=&^G56FX!)1J.<=E^\+S?O-'LOY;/0.FW2=NV$['MM
MWB)\@!\UTDLAX8R[T&;:;^()CB[OG**.Q%B=-QO;P\)G?-<&<GZ;M!("#XDJ
MK!\YM3,Y.\K+/":1K9W4_!B<4\&LD$36%TLP.\O %.+?Q.XD%ORYY+<M\1IN
MUGU7!99K4]_$VXRES?2MG#)9AQF.,.<0.&M./TG';7< &@ZAL\=R-YQ:=RVC
M+D1Z4U(X09+&,F[6-C>U;'*-Y/"WM&RQ\1V.J*\.Q$=7J*@GO/<Q,SH_3>.P
M&G)GVN7U'+)"^[A-)8K2%H[7LR-H>\O:QKAM%21M5@5=$]VK06(TY;'56+BS
M6IY8>TO[F\K+''*\5,4;*\(:RO#Q>D[>=] J(JYBZ5FY%:@P7,/EW)+:8F\G
M?!=XUSW.MV21T?V%22713,X_-=7@+:@[J()23SYTWH[5?+&YYH"Q,F<]KK!^
M,OC+*TLMKBXC>UIC:\1G9,_>T[T@8SD1RAY>:BY?X+5>8P_K.>,T\CKOUBY9
M5]O=2-C/ R1K-@:WZ%$='22,B89)#PL;M)*BOD<T<O%P':TT<"""#OV@H/:
M@(" @(" @(""-.\+\2&O/<>Z^X1826B(WT#\8_-;W5Q7ZELT5)"((" @PF"_
M&W'B'RRBLVB" @(" @H7<!N(VL:X-(>U]3]2:H.2M8RR\F>\3%J^[B=[V\W(
M^[DE:"ZL-XWL[K<-KHY29.$;:</6JCK6RO;/)6D%_83LN;*Y8V6WN(7!\;V.
M%0YKAL((4570<Y]X75VH[W5NF^4NG;YV+;GC;G(7D;BQSA>7!MXV%S2#P-X7
M.> ?.V!6$;GA.[GRGP=DUEYB?;2X8VL]]?S2%SB!M):QS(VCQ-2JHD[JL@]\
M.MK>P>&6\ILVPO;MX8Q+<4X">L.^0$DA5MH'-[X%Z]DI#XXWO8XBIJ,3&#7P
MD$BO4G0.J+*9UQ:Q3/\ 2</.\8V*#F#ND_Y]KC_RG]+<*RB9^8G)S1?,IK9\
MU;OM\Q&SLX<K:$1W :*T:ZH+7M!.YS=G00HJ#=/76LN0W-;#<O[S+.S&CL[)
M!';0R5X6QW<I@9(QA+NR>R0><&GA<WR<-1UBHKFOOA?\/Z9_OEQ_1-5A$]:/
MOK7)Z3P=_8RMFM;BQMGQ2--008F_)!V$=!45#_>RS%G9\O;/$2/'KV2R$;H(
MOHNSMF.=(\> %S&_9*P,5S)QESANZYBL=>-++J&WQ9FC=Z3'R2,>6GPMXJ(C
M/:2U7-HCNSV.J+:-LEW88]_JS7BK.WFNG0QEPZ6ASP2.I%:GR>Y1XKF;A6\R
M>9=W<ZAR.4FF%O;RSR,C9'!(Z(\?9EKJES7<+6D-#:;$1K7.726DM'<TM"XS
M2MA#CFR26L]U!"Y[B2Z]#6.=QN<=O"0$$V]X\$\G=04&YUG7\\A2%5.[J0>3
MNFZ&NR[_ ,9,DB*N]M_GVA__ #?]+;I")SYMXVZRW+/5-A9M+[E^/G?&QNUS
MC$WM.$#I)#:**CKNH9BRO>75SB(GCU[&7\OK,7T79W(#XWD=3J.:/K2K(F34
MN8LM/:?R>;R+VQV5A;2W$KG&@(8PD-'67'S0.DFB@YX[GN+N68_56<>TMM;J
M>UM(3]"7V[9)'T\0F9[*LHM.[%\8NO?LO\6])$X<X/BNU;[EW/W!45HO=2^*
MY_NI=?<1*R,%WO\ _A/3WNB_^@<D(G32/_">"]SK3^@8HKG+5'_5MA?_ "O^
M#<JCJ914;\_?BAU1_,0_XF)!B>[-\4.)_G[W_$O5D6_,'NX:-UA<SYG#R2:>
MU#*XRNGM0'6TDQ)=QOAV4<3M)C<WK-2E1K?=^UOK"+5>>Y4ZRNG9&YPC)76M
MX]QED9ZI*V&2/M#M>P\;7,+MHW=0"4=%**Y0YU7]KB^\;HW(WTHAL[9F+DGF
M<:-9&V]EXG$]  VE5'5ZBN5N\W+'J'F)HG2&.(ERK"&R,9M<UU_/&R,&FXTC
M+O$0581DN^'#(<+I:<"L3+JZ8YW4Y\<9:/*&E('0NGKJ"^P&*O;9P?;7-G;S
M0O&T.9)$US3Y05%<O\WK^"7O,Z.CM9!+-:28J&X8T[62^L23-8[QM<PTZG*H
MSO>X@NCR]QLUT^KW98!L?TK/5IS7JW@"GA2%E-_+K_@#2WN38_X=B@YX[R=W
M;X_FYH:_NG]G:VL=K//(?H8X[YSG'R *PCJMCV2,;)&X/C> YKFFH(.T$$**
MY>[VEY'E<KH_2%A2;,R/FE[%NUP];?'#"/LW-=["L(M>\; _37,#E[J2Z#I,
M78Q6\;WTJ"<==-FD'C+7A('5,$\-U!%=6TC9K>9C9(96$.8]CQ5KFD;""#4*
M*YI[WF5MI;+3.F(#VN5FN)+WL&>=((PWL6;!M\]SG!O7PE6$3K;:2QF0T1C]
M(ZFLX[^RCL+6TN[:8<32^")C:@BA!#FU#FFH.T**YXYC\D[[E-97/,3ECGKN
MPCQQ8^[L9'_A&Q/>&>8\ "1H+ML<K34=)W&HR',[461YE=VS&ZMEAX+R*\@E
MRC(@0SB@DEM'O Z&N>YKJ=%4%3EKR#Y4ZWT/A=2$WS[NZMVB_$5T UMW'YDS
M>'@\WSP:#JHE1M?_ "K<J_I<C^=#_P -*JWK4G*O16KL5B,+J"Q?=V.#C$..
M;V\L3F-#&1[71.:75#&[U!K</=OY0P2QSQX2021N#V$WEV15IJ-AEH5:B+.]
ME-';:HT5<2DB*%D\CR-IX630D_*2$=2VUS!>6\-W:R-FM;AC98)6&K7QO <U
MP/2"#4**YM[W>4MY<?IG3,![7+7%U)>-MV>=((PSL6;!M\]SR&]?"581<]Y;
M%7./Y-Z9LGCB=C;NQM[APVT,=G+'7V0D"8.5MY!?<M]*7-LX/B.*M&5!K1\4
M+8WC9TAS2"HJ .\]>6LO,?15E'*UUU;-8^>(&I8V:Z;P5ZJ\)5A$F]YOXHLI
M_>+/_$,2%7O)SXC,+[G77]),DB..YW_E6J_[Q9_<2I*+/F;L[T6CJ[/\L_IY
M$'4RBB#EG-[.]]CJ[/Q&_P!S7*HFGG7CKG*\JM4VEHTNG]2,X:W:2VV>V9P
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M_P",F21*5U$Z>W?$P@.<!2NZH-5!\@CD;)++( TR%M&@UH&BF]!70$! 0$!
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M,P5=&\$/8\ TKPO:UU.FBBH'T/RU[P>@+B+3^&S...DFW;9I"]S9&]D7@R<
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MQVJ"%-.<M^\MI6U]ZN$U+8V^GF$LAN7O9,(HW$DF+M8'2MW^B-@.[K51D?\
MESS&,U7I'4F)RD%]=XR[CR&ILCD9)A=7EP+ALKW,:&R"G".%H+QMWDI4;AWA
M.7N<YCZ0LL/@KBUMKFWOA<R/O7/9'P=A+'0<#7&M7A14@:.QT^(TG@\3<N8^
MYL+"VM9G1DEA?#$UCBTD TJ-B#FSO+V-MD^;&B<;>M<ZSO(;:VN&L/"XQ37S
MF.H>@T.PJPC:QH/O":)B."T)J:TR>F(ZLQOMD(S=VT5?-83+$X>:* 4<6]36
M[D&1Y;\B<EBM4'F#S(RPSVK^+M;=C"Y\$,I;PB1SWAI<YHV,:&AK.BM!154D
M<P= X/F-IV;3V;:YK2X2VEW'3M;>X:"&R,KL.PD.!W@^500WA]!=X[0-K[W]
M*9[&Y33\=6V3KNG% T]396$M^L#WM'0JC-Z$Y#Y*'5#>8'-',#4.JHWMFMX&
M5=;12LIP/+G-9Q%GT#6L:UIZ]E%5;?S1P',[+^U5[RVST.(NL>Z5]S:W%1'=
M=H&AH=5DC"&@.HUS.FM5!&F9Y?=X;F-;-T]K3-8W%Z;>]CKT6@#GS!C@X59&
MT%]".(-<]K:[>@*HFS#:'T]AM&0:#CM_6-/QVKK.:&;:9F2U[5SR*><]SG.)
M;3:=E%%04SDWS8Y:9NX=RAU)#)A+QW;.Q.0(#@-WG!['Q/(V#C;P.HK4;!A\
M1WE,CJ#&^^/4&,QV(M9XKJ[MK9K#)<11/JZ,]G%6C@.$CC&]!/"@((=YN\HL
MKS(U9I3),DLSI[$/IEK2YDECFF@?,Q\C8^S8[>QI JYNU4:Z_ESSVT'VF)Y9
MZEM[[2?$XV%GDA&ZXM6.)(8#-&]M!7Z%U#OX0B+KE_R'S;-5LY@\U<LW.:DB
M<V:TM6.=)%',ST'O>YK0>S^@8QH:T[=J55+.N-'XW7FE\AI?*DLMKU@#)V"K
MXI6$/CD;7I:X TZ1LZ5! &GN5G>+T&V73VD-16+=/R/<Z*65S7QQ\>]S8YX)
M'1D[W-945Z]ZJ+K/=VK4-V<-EK;-PY35PO'7VH\ME))F]M3LNRCA#6R>8SA<
M/.H37H%&A42USAT5E.8&A;S3&&F@@O[B6WD9)=N>R("&5KS4L8\[AL\U15QH
M'2.2TMRWQ^C\A+#)D[2UFMY)8"YT!?*^1P(+FM=2CA7S4&I\A.56H>5UEF[;
M/W-G</R4MO) ;)\CP!"UX=Q=I''],*45D6?.[DSF==9/%ZOT??1V.J<4UL;1
M,YT39&Q2&6)[)&AQ;(QQ-*BAKO%-H;-RNM.;UN;]_-&^L[J-S(68V.U$8D:Y
MO'VCGF*)@/$"WI.[<%!(R""N<?)?4FI]4V',#061CLM3638FR13.,0<^W<3'
M+&\-<.( \+FO'"0!X:T;QRSM.:,5ED/A2N[.[N)71BPCM&QC@C#7"0/[.-C3
MQ&G7TJ"-<MR'UCH_4UQJODMFXL8VZJ9\-=U$0:3Q&-I+9&/97T6O:"WH<K5%
M#(\J.=G,Z6"TYF:BM,=IN%[9'X_&@.<]S>G@:UK2>ISWNX>AJ">=-:<Q&DL'
M9Z>P4 M\98L[.&/>XDDN<YQZ7.<2YQZ25%95! _-_D9FM2ZFAY@: R+,;JJ(
M1FXBD<Z$22P -CECE:#PO#0&D.'"0!M&VM%IC^67.C7)MK'FWJ6-FE(7L?=8
MBQ[-LUX(R"&2NMXXV\)(%27.\ !V@C9N27*O.<LKK4XR<UE)89>>&7'QV;Y7
MNCCA,WFO[1C:>;(VE"?&BK/X(]2?#S\*/K5E[05_)N.7UNGJ/JWH]GP>GM]/
M<@FE00ORRY1ZDT7S+U3K+*75E+B\WZYZK%;OE=.WUF[;<-XP^-K11HH:..U4
M-9<H]2:AYR:?YAV5U91X;%>I^L03/E%R[U65[W\#6QEIJ';*O"#>.9/+K#<S
M-.28'+.,$K'">POXP'26\[00' &G$T@T<VNT=1H1!#."Y?\ >7T9"-.:=U%C
MYL#%YEI/<N;*V&/HX1- ^1H'T@XFCH51''._0,^BKG2]UF<G+G-6YR:YN<WE
MI2>%[HG0-CCB:?18P.(\/@%&BCLO/83'ZEPE]@,K&9,=D8'VUPT&CN"04JT[
M:.&]IZ"N*N;\-R>Y\<MKZ[LN7>H+23 W<A>#.6!O0 ]\$T4@:^@%3&36GD51
M=ZI[MVJ]2X+U_*:@AS',>ZNHY+S)7LDL=I#91QR#U>!K(W'TW-=7@:-E !TJ
MB?7Z>M,GI5NF,_#'=VDUDRROXA7LWTC#'<)V$;15IWC?O45 ]MR:YP\M+ZY/
M*C4L%Q@+EYD.-R)#7 G8.)CV/C+@-AD86$TW*HV33^![QU_G<9>:JU#C;'!V
M=S%/>6-JQIDN(F.!?&>SB&QS:C;)3IHBLUSVY:YWF=IW'8C W%K;W-G>B[E=
M>OD8PL$3XZ QQR&M7#H02!IK&SX;3F'Q%TYC[G'V5M:3/CJ6&2")L;BVH!H2
M-E0H.:.]=88[+:HTGC<2#/K2\8ZT=:Q4+G6\TH;;AW43(Z0-\JL(Z+T/I:VT
M7I+$Z8M:.9CK=L<DC1023'SI9/LWESO*HK8$$5\]N6N<YG:<QV(P-Q:V]S:7
MHNY'7KY&,+!%)'0&..0UJX="HW_3.-GPVF\/A[IS'W6/L;:TF?'4L,D$+8W%
MM0#0D;*A019SKY1ZDYCY[3>4PEU96\&'X_66WCY6/=Q2QO' (XW@[&G>0J,_
MSFY40\U-/V]G#<MLLWCI'38ZZD!=%^$ ;)'(!MX7T;M&T$#?M!#0\1I'O,S8
M^+2^0U+C\;B(F"W?F(Z3WW8-\VD;FQM<74W.<6N^JJB,ARXY%9+EUS-NM1X^
M[@GTI)9NM(&32O?D"Z1D3G/>.R:S;(QQV.W%%7G,GE'J36/-#2^M<9=646*P
MOJ?K4-P^5L[O5KMT[^ ,C<TU:Z@JX;4$TJ"%](\H]28'G/G>8EY=63\+D_6^
MP@B?*;D>LO8YO$UT8:*!NVCRJ)H4$+\C^4>I.6N5U'?9VZLKB++]CZN+-\KW
M-[-\KCQB2-E-CQN)5%3FKR-.L,S!K71^3]H-;V_ 3= N;%.Z(<+'.='YS'M
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M8QOFL;X:<-1/:BB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(,9G/R)O\X/E%!=V/Y%;_S;?E(+/._D;?YP?**"\L/R*#^;;\I!<(""
M'^8.7Y[8#54F1T7B+3.Z/=#$QM@XL,S9&@F1Y''%('$F@X2]M -E51IN9U+W
MD=>6,NGL;I*/3%O>-,-WD9']E(V-WFN#7RO\T$;*L87=2(E'E!ROM.5NF3BQ
M,V[S%[(+C*7K1PM?(!PM8P';P,'HUVDDG96@BI!0$! 0$! 0$!!9W[&1X^9L
M;0UO#N&S>4%2P_(H/K&_*07" @(" @(" @(" @Q><E>RV9&TT$CJ.\0&Y!6M
ML=9M@CXHFO<6@N<X5))'A08_*P1V,L%Q:CLW5-0-U6T16=::@'K%41]0$!!&
MG>%^)#7GN/=?<(L)+1$;Z!^,?FM[JXK]2V:*DA$$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%O>V@O(>
MQ+^ <0=4"NY!4@B["%D(/$& -KNK1!40$! 0$! 0$!!Y?''*.&1C7MZG $?)
M0?(XHHA2)C6 [PT ?*0>T! 0$! 0$! 0$! 0$! 0$! 0$!!\(J".M!1LX76]
MM'"\@N8*$C=O05T! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 08S.?D3?YP?**"[L?R*#^;;\I!9YW\C
M;_.#Y107EA^10?S;?E(+A 0$! 0*U0$! 0$! 0$!!;7['R6<S& N>YM !O.U
M!ZLVN9:0L>.%S6 $'>" @KH" @(" @(" @("#$9_\3#]<?E(K*0_B8_K1\I$
M8G4'H0>-WS$5EV>@WQ!$>D! 01IWA?B0UY[CW7W"+"2T1&^@?C'YK>ZN*_4M
MFBI(1! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!H+^<>B8]?-Y<.N)O;
M\O$/:=E_51<.9QB'M*UXR#]+PUV5J@WY 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!!J^O=?8'EQ@QG]0F8VCYV6L45LUKYGRR D!K7.8-C6N<=NX(*/+WF/IW
MF7B;C,:=[=D%K.;6>&[8V.9KPUKP>%KWCA(=L->OJ0;<@T/37-O3&JM9Y;0N
M-AO&9G#>L>M23Q,9;GU29L#^!PD<3YSA2K14(-\0:/K7F7C]&YW3NFC8SY+-
M:CG[&UM[9S&]FWB:SM)"\BC:N^0[J06G,7G-I/EC?6>/U##>S7%]"ZXA]3BC
MD:&-=P><7R1T)*#<L#F[#4F%L,_BWE^/R,$=S;N<*.X)&UHX5-'#<X=!09%!
M%5YW@M!V>M#H5S+Z7+"^9BS/%#&;87,CQ%3C,H=1KCPN/!T%6@W_ %/J&QTG
M@,AJ/)-D?88V(SSL@:'REK:#S0XM!.WI*@Q^@]<X?F'@6ZBP4=Q%8.FDMPV[
M8V.3CBI4T8YXIMZT&S("#X2 "2: ;22@\Q2Q31MEA>V2)XXF/80YI!Z01L*#
MV@(" @((WYT<RK_E=INSSF/L8;^6YO66;HIWN8UK7122<0+>FK**C<=+9>7/
MZ9P^=GB;!/D[*WO)(6$N8QT\39"T$T) )HH,N@(" @(" @PVK<S+IW2^9S\$
M39Y\997%Y'"\EK'N@C<\-)&T T0:ER8YD7_,_3%UGLA8PV$L%Z^S;# ]SVEK
M(HW\1+MM:O(5$C* @(" @(" @(" @(" @(" @((]YR<Q+[EEI.'45A917\TE
M[%9NAG>YC0V6.1_$"T5J"P(-FT9G9M3Z3PNHKB%MO/E+.&[D@C)<QCIF!Q:"
M=M!5!G$! 011SNYLY+E59X:YQ^.@R'MG)/'()WO9P=BUA%. ;:\15$GV-PZZ
MLK:Z>T-?/$R5S1M +VAQ ]E07" @(" @("# :WU!-I72.9U);0MN)\7:274<
M$A+6/,8K0D;4&O\ )[F#>\R](NU'?V45A,+N6U$,#G/:6Q-80ZKMM3Q(-_0$
M! 0$! 0$! 0$! 0$! 0$!!XEEB@C=-,]L<3!5\CR&M ZR3L"#V""*C:"@T&Q
MYQ:)R&O9^7-M<3'/PODA[0Q4MGSP-+I(FOK7B:&NK5H&R@*#?D! 0$! 04+N
MV9=P.A>:5VAW41TH+"*#+VK!#$Z.2-OH\70/D(/DECD+YS1>2,9"TUX6;T&6
M:UK&M8T4:T  > (/J @("#Q*'&)X9Z1:0WHVT06MDPM?41F-G9,:ZHX:O%:^
M/QH+U 08+6>=FTOI/-:BMX6W$^+LYKN."0EK'NA87!I(VT-$&M<F^8=]S-TG
M+J*_LHK":.]ELVPP/<]I;$R-W$2X5J2\H)"0?'N:QKGO(:QH)<X[  -Y0:'H
M/G!HOF-DLCBM-S3NN\<WM'"XB[(30\09VL6TDM!('G!IVC8@U[-\X<IBN<F.
MY91XRWDL+TP<5^Z1XF:)HR\T:!P[**C:^8?-#2W+*ULKK4CYR[(2.CM;>UC$
MLKA'0R/HYS0&LXFUV].RJ@VC%Y*RS.-L\OCI1-C[^&.YM9@" ^*9H>PT-"*@
M]*"X9-#(]\3)&NEBIVC&D%S>(5'$!NJ@U?7_ ##TYRVP\>:U&^7L)YA;V\%L
MSM9I)"TNHT$M  #227. \M$&8T[G\9JG"6.H<-*9L9D(A-;O(+74J00X'<6D
M%I'6$&30$! 0$! 0$&(SX/81.Z \@^4(,G;N:^")S35I:*'R(,3GR#V$8VOJ
MXTZ>@(K,M!#0#O "(^H" @C3O"_$AKSW'NON$6$EHB-] _&/S6]U<5^I;-%2
M0B" @(" @(" @MK_ "%CBK*?(Y*XCM+"U89;BYF<&1L8W>7..P!!$T_>=Y2P
M7KK09"ZEC:[A-W':2F'9LJ*@/(^P5H)2PF;Q6H\5:YO"7+;S%7C2^VN6!S0]
MH):=C@"*$$4(4&FZRYV<NM"WCL9FLIVF5C_&V-G&ZXECV5H_A\UA\#G H*VB
M><6@-?W)L-/Y/_U0 N&/NF.MYW-:*DL#MCZ#:>!QITH-[)#07.-&C:2=@ ""
M*<[WC>56!OWXY^4DR$T3BR63'PNGA:X&A_">:UWV!<K09>7G7RUBTQ%J\YIK
M\')<ML3)'%,^5ER^-T@CDB:PO:>%CCYS:*#9[W56$QVF7:PN[@LP#;5E^;GL
MWEWJ\C0YKN #BVAPV4J@IZ2UA@-<8@9W35R;K&.D?")71R0GCCIQ#AD:T]/4
M@\:PUKIW0>*9FM3W1M,<^9MLV5L4DQ,LC7. X8VN.YAVT09+#Y>PSV*LLUBY
M#-CLA"RYM92US"Z*5H<T\+@"*@[B$&F:RYU\NM"WCL9FLIVF59^-L;.-UQ+'
MTT?P^:P^!S@4%71/./0&O[DV& R?_JE"X8^Z8ZWG<UHJ2P.V/H-IX'$CI09[
M5^LM/:%Q(SFIKEUIC3*RW$K8Y)CVD@):.&-KC]">A!K^I^<_+O25C87V6RH)
MR=O%>V-I!&^6YDMYV\3)#&!5C2-Q?PH/NA^<F@>8-T<=@,B1E0TO&/NXS!.Y
MK14E@=YKZ#:0UQ(&W<@WU!'6K>>7+71EY)C<IEQ/DX26S6=BQUS)&X;P\L\Q
MI'TKG5\"#YHOGCR]UYE8\'@[R=N7F:]\-I<V\D;GB-I>ZC@',V $[7(,;*[D
MP.<K()+=OPJ$ -/9W)9Q^K=L'[NPX^Q^BW^54;AJOF'I/1-YB['4=ZZUN<R]
MT6/8V&64/<QS&FIC:X-H9&^DH,!K'GIRXT1?OQ.5R;KC*Q'AN+2QC-P^(]4C
MA1C3]27<7@5&<T3S(T=S"MI)]+Y%MS+  ;FT>UT5Q$": NC> :'Z85'A4&T3
M30VT,EQ<2-BMXFNDEED<&L8QHJYSG&@  %22@B;)=Y7E-CKYUB,G-><!X7W-
MI;R20 ]-''AXAX6 A6@V"_YS<M\=A\;GI<TR3%9:5]O97$$4TU98PTN8]K&%
MS'#B%0\ [5!OB"PS69Q^GL3>9S*RF'&V$3KBZE#7/+8V"I/"T$GR!!JIYP<O
M&:5BUG-F60X&XDDAM998Y62S2PFCVQPEO:.(/4U!KN'[R7*C,7[,?[936+Y7
M<$<]] Z& N.ZL@X@T>%] K02TUS7M#V$.8X M<#4$'<05!J.M.:&A] -:W4V
M5CM[N1O'%8QATURYO7V<8) /TSJ#PH-7P/>-Y4YZ]98-RK\?/*[AB=D(701.
M)-!^$\YC?LW!6@D?,YO'8'#7>?R4A;B[*$W-Q-&QTI$+14N#6 D@#;L&Y06&
MD-9Z<UWB3F],7?KF.;,^W?(8WQ.;+&&N+2V1K7#8X'=TH+?6G,'2?+ZUM;S5
M=\;*&\D=%;<,4DSGN8WB=YL37&@&\H-AM+JWOK6"]M)!+:W,;)H)6^B^.1H<
MUP\!!J@UBZYE:/L]90:!EOG'55QP<%E'#,^G&PRCB>UA8/,'$:NW(+G6&O=)
M:#LF7NJ<G'8LEJ((3Q23RD;^")@<YU.DTH.DH-*PG>0Y4YN_CQ[<G+82RN#(
MI;Z!T,+G'=63SFM\;R K02I/<PV]M)=RNI;Q,=*]XV^8T<1.S?L4&CVO.;EU
M>:7N]91Y@,T_9W'J4MQ+#-$YUSP-D$4<;V![W%K@:-!^04&8T/KK \PL,_.Z
M==,ZP9.^U)GC,3^TC#7&@).RCAM0;*@(.:N>-R=<<W=$<L(!VMG;31WF5B&T
M$3.#WAPZV6\;G?9JPBTY/3_!YSVU=RYD:+?&Y:263&P[FCL:W-N!7_\ 5Y'#
MR!!U HKEGDO_ -1VO?\ [K^L(E4=3**Y^T%7F1SVU+KR3\+@])L]I\*[>TS'
MBC+V'I%.V?\ 9M51KO/+$VNK^>ND])W1_ 7.-$3CNX7RON2T^0M:4&S]U;4T
MM[I#(Z.OR6Y'3=VYK8G['-M[ESG!M/J96RUZJA)5+NM]2P:.TEF-37%.'&VT
MDT;';GS4X8F?9/+6^50</MPLN&MN7>M+YY?E-1Y>YR%Q,_TS':W=NQA.[TG=
MH_RKDCL/G7\5.K/[A)\L+BK4>ZS\5,/]_N_EM5D34H"#F?O/\Q=-7FGY]"X_
M(2#4UCD+=]]9MCFC;V/8/)!DX0QP_",/#Q'Y"L(V;E3SKY;Q:9TAHUV5>-0>
MJV6--MZK<!OK;FMBX./L^#TMG%Q414OY_46#TMC)<QJ&^BQV-BH'W$[J#B.Y
MK0*ESC38UH)*@C&'O.<I9KT6AR%U%$YW"+N2TE$.TTJ: O \;%:"6,?D+'+6
M4&2QES'=X^Y8)+>Y@<'QO8=Q:X;"H,1JO6^E=$63;_5.4AQT+ZB%KR72R$;Q
M'&P.>ZG3PMV((YC[T?*1TQCEO;R"$>E<R6DAC '31G$^GV*M!K'>MRUID.6N
M'NK F>WEREO+%* 0U\<EK.YO#45J00=O15(&T6'.30/+K0^DL?JG)=AE9,/8
M/CL(6F6=S?5V>=PCT6GH+R*H-MT-S<T+S#D?:Z=R/%D8FE[\?<L,%QP#>YK7
M;' 5V\!-.E09W5FK<#HG#OSVH[@VN+C>R)\S8WS$/E-&CAC:YVT^!!KNH><O
M+S3&(QN8RF6 AR]O'>8VVCC>^ZEMY15LG94XFM(Z7\(Z-Z"EHGG7R]U]?>U>
M$R+H\LX%T=C>1N@ED#14]G6K7$ 5(:ZM-M*()"01QJ[GKRUT9>R8S)Y;UC)P
MDMGM+&-UR^-PWM>YOF-<.EI=7P(*VCN=?+G7-XW&X7+"/*R?BK&\8ZVE>>IG
M&.%Y\#7$H,MS.^+G5GN1??X=Z"+^Z3\7.1]UYO\ #P*R)7U?K[2.A+5EWJG*
M16 EKV$)XI)Y:;^")@<\^$TH.E0:+C.\ORFR-VVT?DI['C/"V>[MI&0U.ZKF
M\7"/"Z@5H)9MKFWO+>*[M)F7%K,T20SQ.#XWL<*AS7-)!!'2%!@M7:ZTIH6Q
M;D-4Y.*PADJ((W5?-*YN\1QL#GNITT%!TH--T[WA^5NI,E'BK?)R65W,X,MS
M?PN@CD>XT $FUH)Z.(A6@VS"<PM*:BU!E]+XB\=<9O!E[<C;]C*P,,4G9. <
MYH:ZCMGFDJ"VT=S1T5KR^O,;IK(.N+^P8)+JVE@FMWM;Q<!-)6-K1VPTW(-P
M<YK&ESB&M:*N<=@ '24&HZ-YFZ-U_<7MMI2^??/QP8Z[?V$T3&B0N#/.D8T'
MBX74IU(-O0?'O;&USWN#6-!<YQ-  -I)*")LSWDN4^'N76K<K+D9&&CWV$#Y
MH@?!([A:[QM)"M!M.B.:.B>8;96Z9R0GNX&\<]C,UT-RQE:<7 \#B;4CSFU"
M@R.L-:Z=T'BF9K4]TZTQSYFVS96Q23$RO:YS1PQM<=S#MH@P&J>='+O1]M9S
MY?*@S7\$=W:V=O&^:X=!,WC8]S /,!!V<?"@J:'YPZ"YA7#K'3^1/MHUI?[7
MW3#!.YC=I<P.V/ Z>!QITH-[01;J+O#<K=-Y!^,N,J^]NX7%DXL(G7$<;@:$
M&0482.GA<5:"..?VOM)Z_P"4<=_I7(,O8X,M:BYAHZ.>$NBGIVD;P' 'H-*'
MH*0B9^4OQ8:1]R;/^A:HK<D&KZQYB:-T%"R75.5BLGS N@MJ.EN) #2K8HPY
MQ%=G%2GA0:)9]Y[E-=7(MY+Z[M&N-!//:2=GMZ3V?&X#[%6@TCOA.#L/I-S=
MK77%V0? 8XDA'1N'_P IL/[M#]P%%:)JWGKRTT;>R8S)9;UG)PDMGM+&-URZ
M-PWM>YOF-<.EI=7P(+C1O.KEUKF[;C<+E@S*/_%V-XQUM,_P,XQPO/@:XE!N
M69R]A@,5>YO*2&''8^%]S=2AKGEL40XG'A:"30#< @QNC]::=UYBGYK3%T;O
M',F=;.E=%)"1+&UKG#AD:T[G#;1![U;K# :'Q!SNI;DVF,$C(3*V.28]I)7A
M'#&UQZ.I!>X+-XW4F(L\[B)3/C+^,36LI:Z,N8=QX7@$>4(-1UKSFY?:"NO:
M_.Y3BR@ <ZPM&.N)V [1QAOFLKU/<"@T[5/-S0G,/EIK"RTYDN/)LQ5U(['W
M#'07!8UE2YK7[' =/ 33I5'SNI_%:[W3NON(DD3@H"#1=9<X>7NA)S99_+L&
M3 !-A;-=<W#:_3MC!#/LR$&(TKW@>6NKLM;8/'7MQ#D[QXBM(;FVD8))#N:'
M,XV@_7$*T$@9S/X736.ER^?OH<?C8:!]Q<.#&U.YHZ2X]#1M*@BQW>?Y2BZ]
M7%]=F*M/6A9R]E3KI3CI]@K02C@-18/5.-CR^GK^'(XV4EK9X'<0#AO:X;"U
MPKM:X A08K.\PM*:;U#B=+9B]=!F\VYC,= (97MD=+)V307M:6MJ[9YQ0:MJ
M7O!\L-+Y.3$7>3?=WL#C'<BQA=<,B>TT+7/%&D@[PTFBM!MN)U_H[-::DU?C
M\Q;OT] ";F]>[LFPEM*ME#Z.8[:/-<*FHIO"@T:#O+<I9\D,<,I-'&YW V^D
MMI6VQ-: \1'$!X7- 5H):AFAN(8[BWD;+!*T212QD.8]CA4.:14$$&H(4&H8
MSFIH7+WN<L;7*M9+ISC.9?<1R6\4 BD,3B9)6M:0'-(V%!J$_><Y2P7IM!D+
MF6,.X3>1VDI@V&E=H#R/$Q6@E#!Y_#:FQL.8P%[%D,9/7L[B!W$VHW@](<.E
MIVCI4&#N^9>CK'6,&@KF^<S5%QP=E:"&8M/:,,C?P@9P"K1],@VU!J."YF:-
MU)J;(Z0P]\Z?/XKMO7;8PS1AGJTHADH][ TT>X#84',W>8YBZ8UA=83&:=R$
MER_$SWL66MS'-#&UX=$UM>-K6OH6/H16GE5A'0FDN=7+C6&6MM.:>RK[G*SL
M<Z&%UK<0@B%A>[SI(VM%&@]*BL5BG<ESS?O(\;;,'-!O:^LN[*Y#0_LN*5[2
MX=B'N8?.<W:=O651N&I.86E-)YC$X+.WCK?)YM[8L;"V&642/=(V( N8UP;Y
MS@/.(4&N:NY\\M=&9*3#Y+)/N<G XLN;:QB=<&%PV%KW"C X=+>*HZ0K0;)H
MOF%I'F!927NELBV[$%!<V[FNBGA+JTXXW@$ T-#N/05!L5S<VUE;RW=Y,RWM
M(&F2:>5PCC8QHJ7.<X@  ;R4$37W>8Y2V5\;(9.>Y:UW"^[M[:1\ /31Q +A
MX6M/@5H-EO\ G#R[Q]IA;^7,LEL]0/?#BIK>.69LDD3F->UW PEA:9&@A]*5
M4&\H"#0-8\Z.76A[IV/S>7:[*,V26%HQUS,P]3^ %K#X'N!06.D>??+C6F6@
MP6*O;B++71+;6VN;>1G:.:"X@.:'-&P$^<X*T&7UIS:T%H"46FI,JV+(N:'M
ML(6/GN.%VXEL8/"#387D*#7]/]XOE9J&_CQL>3DL+F9P9"[(0N@B>XF@':5<
MUM?JR%:"4Y9&0Q/FD-(XVE[SOH&BI4&DXGG!R[S.!OM3VN99'@\;*V"[N[F.
M6W#97MXFL:V1K7.<1N#02@U>W[SG*6XOA9G(7,,;G<(O);640;=@)H"\#QL5
MH):LKVSR5I#?X^XCNK&Y8);>XA<)(Y&.%0YKFU!!4&A:OYX<M]%7LF+R^6[7
M*PGAGLK.-]Q)&[?1Y:.!I\!=5!XT?STY;ZVR#,3BLFZWRLQX;>TOHW6[Y3U,
M<:L<[ZGBKX%1E>;?Q8:N]R;S^B<H(@[O6L],Z(Y/SY75&1CQ]H[+W3(N.KI)
M7B& \,<; 7//UH5E&[8CO)\J,O?LL/;.:P=([ACGOH'0P$G=60<0:/"^@2BI
M9:YDK YI#XWBK7"A:YI&\=8*@BGE,_DP_,YX<LK=L65:1[;$1W+.%CGN 9'V
MXX6LXFGS8]F[P*B,=8_]66 _\G_AWHB6^<C^5,>*QKN:L/:6)N'#'/:RY=(V
M4-XG@.M?. <!YP.P^PHJOK/7^AM"Z0LHKN[]K<?E;"2' 1P02D=FR!O UHB:
M2P /92M*(.?^[KS5T9H/&9^/6&2DMKW(74,T1[">X=(UC' DNC8_I/2K*)WY
MA9KE1J'E_89[7)]:T;?RPRV%QV=RV3MI&O+'-$($K"6AP.[9L**W/2!T\[2^
M)?I2-L6FWVT;\8QC7, MW"K?-?YU36IXMM=^U0:UK3G/R\T'=''9S*<64: 7
MV%HQUQ,P';Y_!YK#X'N!0-%<Y^7VOKOVMP63X<J07,L+N-UO,\ 5/!Q>:^@V
MD-<3T[D&ZY')6&'L9\GE+F.SQ]JPR7%S.X,C8P=))01-+WH.4<=^ZQ&1N9&M
M.VY9:2F*E:<5" ^GV"M!*N'S&-U!C+7,X>X;=8R\8);:X8' /8=E:. (W=(4
M%\@("#Q-#'/&8I6\3';P@L!AHF_BIY6-Z@[_ +$%2#%6T,@E<72RC:'/-:%!
M?(" @((T[POQ(:\]Q[K[A%A):(C?0/QC\UO=7%?J6S14D(@@(" @(" @((.[
MU5OFY^6D;L8U[K"&_ADR[8Z_DX8\-+Z?0"4LKX:%6!=<H<KR=U-HW%Z>Q5MC
M#?,M8XLAA[R*'UI\X925SFR"LO$ZIXVUW]&Y!L_,W/P\L>5V2OL!"RT=86\=
MEB(8V@,BDF<V&,M:=GX/BXZ'J4$1\B9N46FM-Q:@U1G<5/K?+/DN+V:_FCDN
M+=KGGAC':$EKB!QO.\EVVH 51A.?V1Y<N&&UQRXS&.CUC87K!-[5R1B22/A+
MV3.8S871O8!Q4VAU#78D#:^\'S*O1RITXS%O-M/K:".>Y=&2"+/L(Y98VG>.
M)TK&GK;4=*0-^Y9<FM(Z,TS907F)M;[/SPLDRE]=PLGD,SV@O8PR \+&GS0&
MTK2IVHJ$>\_RZP>E&X[4>FH6XRTRTSK?)XVW_!VSYXFF2*5L;?-::%X-!3JW
MNJA$RZY_Z>KS_P#9ZW_H8T5C.ZU\5,/]_N_EM21:][#XL;?W6MOZ&=(%V_5\
M^A^[=B]0V9#<C%A+&"Q<0#PW%RQD3'T.P\'%QT/4@TOD3-RBTWIN/4.J<[BI
M];Y9\EQ>2Y":.2XMVN>0V,=H26N-.-Y](EVVH 1&&Y_9'EP]N'UORYS&.CUC
M87K!-[5R1B62/A+V3.8S871O8!Q4VAU#78D#=^\!F!J#D-C<\&AHR;\9><+=
MS3<1]H0*]54@7G(CE?IIVC,?J_45G%G-19J%LKKK(,;="&W9^#ABB;*'!H;&
MUM32O1N "2J.>\9I+&<N-3:9UUHNWCQ-S/,]TMO;-$4(N;1S)&2-8V@'&'%K
MP*#9NVE(1+?/OF%>:2Y:-OL-(ZVRN>=%9VDS322%D\;I)'M(W.#&EH(VAS@1
MN2%8WDER4TMA-*XW4.H,=!E-396%E[++>L;.VW9.WC9'&QX+0X-(XG4XN*NV
ME$$K6FD=+6&39F;#"V5IE8XW0LO+>WCAE[-].)I<QHJ-G2H.<[S_ *QH/L/U
M*5>A%QWP9I;9NBKB!YCGBER$D4C31S7L]5((/004@2UHGE!HO3N!@MK_ !-K
ME\S<QB7+Y3(0LNY[FYD'%*XNF#B&EQ-&CHWU-28J"LGA;7E-WE,!!ID&UQ&:
M?;5LF$EC(<B]UM+'0G:T/;VC0?1V4W!5&U]Z74V5>-/<N,-(8WY^427H:2WM
M&]HV*",T^A,A+G?6A($K:.Y3:(T=@H,-;8BTO)1&&WE]=01S3W,A'G.>YX<:
M$[F>B-P45S/S^T)B=#ZZP)TZWU/"YJ1MT[%1DB"&ZAE8Q[HV;FAS7-V=&VFR
M@%A':"BM-YM 'EAJZHK_ .DWA]B%R" N[/RWQFJ\7+JK5D?MK88JX?8X+%W1
M[6TA>0V:>7LG5:2XO;2HI6I()I2RB6>;')O2>KM*W[K#%6UAJ&S@DGQMY:1,
M@>9(FEPBDX .)CZ</G5I6H16D<@>9=Q;\H-0395QN7:*CE?;<9)+K4PNEAB)
MW['-<QO4V@Z$E&)[O&AK37]UF>:>NXFYK(W%ZZ&RCNVB2(2L:U\DI8ZK33B:
MR(;F!IH-U$B7.9_*33&N-,7MK%C+>VSL,+WXJ_@B9%*R=C:L82P"K'$<+FGH
MVC;0HJ/>[%J6;5VA\WH7/.-S#B@+:(2&KO4+YCV=EMZ&%KP.H$#< DHL.Z_<
M7&G-2:VY;9!W]9L)_6(FG95UM(;:9P'U58BDBQYRV,_-3FK=:-L7.?;Z3P-W
M>$1[?Z\^(2M'V3G0,/E02=W=-4MU'RLQC9I ;K"%^+N23N;;T=%Y!$Y@\B2J
M.N1<8UOS;UMS1N?.L;5\D./D=N N'%L9!^HMXN$_7)*-<T#G]$Z_YF9_F#S0
MRME':6CVQ:?Q62D:V+LRY_9TC>:.;$QNZE"]_$=J"2N:.4Y'ZST;D[!N:P@R
M\%M)+B+B&2%L\=S$PNC:US=O"XCA<WI!ZZ(JIW>-47FHN4-U9W\AFN,&ZXQT
M;WFKC;MA;)$"?J0_@'@:$D0[W<>7]IS"O+T:E+[K2FGWMN8L27%L$U_>C@XW
MAM"0UD.T=/F]%0;*.P\+@,)INS./P&/M\;8EYE-O:QMAC,C@ 7<+0!4@#:N*
MLB@\3316\4D\[Q'#$TOD>[8&M:*DGP (.5.2F?P&H.:6K^:&I\M98\O<Z'$Q
M7]Q%;OX;AW"TM$CFD]G#&V,GZI5%/O 9G"8O7FDN9FDLM8Y&\M'LBOH;&ZAF
M?6TD[1A>(W.-)&.?&3U"B0.JK"^MLG8VN2LGB2SO(H[BWD&YT4K0]I\H*BN8
M>2__ %':]_\ NOZPB51-O-_6'O'Y>YG-Q2=GD#%ZICC6CO6KG\&PCPLJ9/$U
M15CR*T?[S.6V)LYX^#)9!OMGD*['=M= .:T^%D88P^$((MU*?7N]MI^#>+6V
MC!\'!:3S?ZRJ+6U)Y7]Z"6W_ !6$UCZ(W-)R)XFT&[9=,+1X"@SO>@S%YDH]
M,\LL.>+):BO(Y9HQ_)M>(H6N^I=(XN^P2!K7>=PUII?#<N;.P;PVF'$]I":
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MN (%S<-9#&ZAW\+GAQ'@0:'R'GY38# >^?5^=Q<^N,O++<74F1FCDN+=G:.
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M)?Z@VY+V.)MG/CN(V4<VI'FO Z14[@DHZ$^ KE)^ZMI]M+]^E59S':0TUHW
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M+VY]KO:3A_JWJW;]KPS"7TNU9P[J;BJ)34$6:<Y-^T'-/+<R_;GUCVT]9_\
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M5.1N@<YRXT;-@,_);R7LE]-=M=:/=)'V<D<30"7L8:U8>A426H" @(" @("
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MQC\UO=7%?J6S14D(@@(" @(" @(/+&"-C6-]%HH*^!!Z0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0"0!4F@Z
MT'CMH:T[1M?&$'M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M]8<:HBUQ<DD%[-8EQ=$WBX*]!:?FA%9E$$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%EE87S63VQBKA1U!O-#M06]AD[1EK'
M%*_LY(QPD$'H\2"WR=S'?F*VM*R/XJD@$#JZ45FV-X&-9]* /8"(](" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @("#$Y#_ #2R\8^Z099 0$!
M0$! 0$&-C_SN7^:'^J@^9K\3#_.M^44&30$! 0$! 0$! 0$! 0$! 0$! 0$&
M'/%[7.ON-_K7$2'\3J;).&E*TI1!F$! 0$!!&G>%^)#7GN/=?<(L)+1$;Z!^
M,?FM[JXK]2V:*DA$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&#MO\\E\;_E(K.(C!VG^=S>
M-Z*SB((" @(" @(" @(" @(" @(" @(" @(" @(" @("#R][(Q5[@T=;C3Y:
M#T""*C:#N* @(" @(" @(" @(" @IN@@>:OB8X]9:"@],CCC_%L:WZT ?*0>
MD! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 065S9/GNX+EKP
M&PTJTC::&J"]0$! 0$! 0$!!8SVMPV[]<M2TO<W@>R2M"/ 0@\2VUY>/C%SV
M<<$;@\AA)<2/&@R* @(" @(" @(" @(" @(" @(" @L3CW&(VW;'U4FO9\(X
MJ$\5.+Q^!!?(" @(""-.\+\2&O/<>Z^X1826B(WT#\8_-;W5Q7ZELT5)"(("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(,';;,Y+7K?\I%9Q$82SVYN>G07_+16;1! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06<_9"]B,_#V?9O +Z</%5O7TT0>L=^
M1Q]7G4\7$:?(072 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(""E<3B!@(8Z1[CPL8T;2?F(*5C<RW+)3*T,?'(8R&[?1H@ND!
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M1H/._G!RLSO*+6>'P^L<3?92\Q5Q#:6=O=Q232RO;1K&,:222=P"+#H!$$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
)0$! 0$! 0?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>pc_unlocking-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pc_unlocking-4c.jpg
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M%!04%!04%!04%/_  !$( LD#MP,!$0 "$0$#$0'_Q #@  $  04! 0$
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M3(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @C.^_P B5/GG _IBF@=.?W>[
M3^9L=^*QH),@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("",[[_(E3YYP/Z8
MIH'3G]WNT_F;'?BL:"3(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @C.^_R
M)4^><#^F*:!TY_=[M/YFQWXK&@DR @(" @(" @(" @(" @(" @(" @("!V<3
MV(" @(" @(" @(" @(" @(""SOY?%8H1G*7J](2ZB(V960AQ;IKR\Y&NFJ"X
MKV(+4,=FK*R>O*T/BFB<'L<T]A:YNH(05$! 0$! 0$! 0$! 0$! U&NG>.U
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MX<ULC0=!V\#HJ4I>@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M5E;X\;20V:N7#Q(GCO:\</ICB I'Z/7LQBL73&1RMV"A1/+_ 'BW*R"/5PU
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MMEM-@$0$+"\ZEDKSQ X<%.@VZH! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M @(" @(" @(" @(" @(" @((SOO\B5/GG _IBF@=.?W>[3^9L=^*QH),@("
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MYV-QG.ULGF?.\-<!Y0U@/VP34=,5,=3QV.BQ>-@95HUHA!6KQ-#8XXVMY6M
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M @("",[[_(E3YYP/Z8IH'3G]WNT_F;'?BL:"3(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M)5QC@64N7R$O;.6CR,T;_ JXI M7R22'61[GGRN)/\*JT'A 0$! 0$! 0$!
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MSOO\B5/GG _IBF@=.?W>[3^9L=^*QH),@(" @(" @(" @(" @(" @(" @("
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M>V#[S-_JR@>V#[S-_JR@\RW@R-SQ#+JT:^DP@?&4%#'V77)WR2M]-C0&:>J
M3Q^,H,D@Q$MYT]H5',T@\0-<!ZQT/?YM4&70$! 0$! 0$&(]N=5MOKL9K#S^
MJ>T%W;IYM>*)9=$" @("",[[_(E3YYP/Z8IH'3G]WNT_F;'?BL:"3(" @("
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M8=_P'M05D! 0$%*Q+X,?,T<TCB&QM\KCV(/L$0AC#-=7=KW>5QXDH*B @("
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M@"#T@(" @(""WLM<WELQC62+74#ZYA]8?QA!7:YKVA[3JUPU!\Q0?4! 0$!
M0$!!9V;S8]61>D_O/<%=K37FLVR:<F,<YSW%SCJX]I*OZ,>9U?$! 0$! 0$!
M 08=N5P&:AR..ONJ.BJ3S5KE*W+"[A6<!XKFN(+&\=6N.A;Y5D3CR8YK:->,
M1,3&O;V,2,N++%JVTX3,3$S'9V^1CJ.U,7A73U-NYZ]AH'\UF?&PVXIXXQ(>
M9TC666R.C![>;73O5Z^YMDTG)2+=FNDQZ.&FK&Q;*F'6N*]J1SFL6B>?;I;7
M3ZE3#;;VCA+#LQ7ECMY.T7V79G(6VVYY"UH:^1DCW<H#0-"Z,#E'#4!1EW&;
M)'3/"(X=,1I'F_Q5;?9[?#:<D<;6X]5K=4SV:ZSY.[DR^+R]3,-MRTG-D@J6
MI*?C,>V6.1T36.+VN82-#SZ:=O!8^3'--->V-67BS5RZS7C$3IZE\K2^(*].
M3P[##W'T3\:IO&L*Z3I*SW%7Y+++ [)6Z'^4W_L5&.>#+89700$! 0$! 0$!
M!'MRT[S;N*SU*A\KQ8X6ZV2P[0QTUBE>8QKG0ME(8]\3HVN\)WKM) XJY28T
MF)G37M\PLA?VF0-=DWP>\';3-1YCZ"JTM^:/^(>L;6;E]PXFW4P4N VUA)+%
MF5]FHS'3W;=B$UVMCKQZ.\.-CG/=*\#F.C0%$SI6>.LSY==!2Q&V-R&.YD<E
MN.W0S&7D+\E6KP4980V'F@KAA=$2 ( S7CV]O%56O7E%8F(\_P!.8R^T\;D,
M-@X\/D973_)\TU;'3/\ #\1V-B=I5+_# ;S<G;P'G5&2T6MK';]?:,TK8("
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MMD)<&^0..JBO.OI^M7?[MO-'U-M/];XA_ K*MY1(@(" @]PSRUWB2)Q:X?\
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MVM/\*#XYCF>L-$'E 0$$I>/D_#-B[)'-#3_*?Q/\:L5^*RUEMI5@5E, 0$!
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M4'T]=4T&(J='MWT(;KGX>O>-VS@,AF(6Y1\9RT%'&QUKN/ED=H=1;9[6'O\
M0E]5V@)305#T;WY)C+KYY@_*Q81E3;<(RMCP\=8ER=FP:P>2.?P*DD< L.:2
M=.4<$T'W</2W>%*',[@HY!N*R-V;=+\IEWW[!'R5>E,V/B<UG.6M:!R_<F\T
M.I<W4]K02GH<&S2[RR&/QXQFVY[]*+#U8;$ERFT5Z$;9Q6F>&A[/%)YG1MY.
M;4 G0J8&VU*1!=XVO[3=AC(U;KS.^!O%4VG2!E\[-K)' #P:.9WPGL48H[6)
MGMQT8A7F,(" @( )!U!T(["$&A.H62WK%NK)QP93/4XA<E$$>/?8;%["((/9
MG0M#/!+'.\?G<'>)S#B-%ETBNG*&->;=7.40NV-V9*K)1R.7W3;I2\OBUYB]
M\;N1P>W4%O'1S01YPKD16.R%,]4]LKCY7WT3J[<&[CKVD/?K]-JC2O=!\7?9
MN;I!;W-8VG8?N:Q;GL>WRBI+>=,Z1U?PHO5,X:\L$G.!J--=>7AHL;+$:\%[
M',Z<4\5I=$! 0$! 0$!!D,?DWU2(I=7U_)WM^#ZBMWIJO8\LUX3R2%DC)6"2
M-P<QW$$+%F-&;$ZO2A(@(" @(""C8E=&P-C_ +:0\L8\Y[_@ XH/<4;88VQM
M[&CM/:3WGXT'M 0$! 0$! 0$%M8!B<VVWZP<LH\L9[_B[4%R""-1Q!["@("
M@((SOO\ (E3YYP/Z8IH'3G]WNT_F;'?BL:"2D@ DG0#B24%"L#*YUIWU_"('
MNC'9]'M07" @(" @\R1ME8Z-XU:X:%!2K2.+712G6:(\KSY1W.^,(*Z"V;_=
M[!9_F9R7-\TG>/C[4%R@(" @(/+WMC8Y[SHUHU)\P04JS':.GD&DLO'3[%H]
M5J#[9E=&P-CXS2'EC'G/?\ '%![BB;#&V-O8T=I[2>\GX4'M 0$%.:9D#.=Y
M^ =Y*JB-5-K1##S3OG?SO^(>0+)K71BVM,J:E2(" @(#B& .>0UKG!C2XAH+
MSV-&O:3Y$&$GW14;DK6)QM6;*Y''!LF3A@?%"VLPCF])\[V!SM#KRM^,A9,;
M>>F+6F*Q;ESX^IA3NZ]<TI$WM7[T1I'3ZYCCY$6QE?;^X1B,H*T5EMS<=Z*5
MSV\KWPGQI!#. 0'AK@UW*_F:"."SLELF+JKKIICK]G&.YKL-<.?HOI$ZY;Q_
MS<+=_FG6'C&M#*>ZFM:&,&*R/(UH#6AOMUS30#@ IO/Q8_XJ_P#+5&.-*9?X
M;_\ /=L*K_N=7_00_P"S:M3;G/GEO:_=CS0JJE4(" @(" @(" @N*4GAV&^1
MWHGXU1>-85TG25AN&OX=MLX'HS-X_P IO#^#11CG@RV(5P$! 0$'W4Z<NO#M
MT0"XD $\!V(/3897^I&YWP E-16;C[SNRO)_1(_A4=4"H,3D3V5W?'H/X2HZ
MX'H8;)'_ #'T7-^JHZX'WY$R?WG^LWZJ=<#X<-DA_F#\3F_53K@>#BLB.VN[
MXM#_  %3UP*;J%UGK5Y /+RE3U0*+HY&>NPM^$$*=1Y0$!!]!(.H.A\J YQ<
M=7'5!\0$&?VY!_;6G?Z-I^F?XE9R3V"QMS>T69)>YSO1^ <!])9%8TAK;SK.
MJBI4B @(+7(Y&AB*-C)Y6U%2QU5AELV[#VQ0QQMXESWN(  \I01NGU0V!D(6
M6*>?JRPR1R3L>TNT,44T5=[N+1P$DT;/A<%&L)Z927)9BG@Z$N1R5L4\?!R^
M+,]Q#&^(X,;KIY7. 4HC5>>--]\=_2*&J/9'J!M?$G+C)YN&K\@FL,P97N:*
MQNC6#Q"> YP>"C@G25.AU V=F<);W/C<Y5NX&BXQV\E#)XD,;FAI(+QKV!S?
MHJ=28EDLUG,3MW&R9C-VV4L9"Z)DEF74,:Z>1L,8.@/K/>UH\Y1$1JR" @("
M @(" @(+NC?EIOX>E"?79_&/.J+4BRY3)-4DAFCL1B6)W,P_2/D*Q)C1G5M$
MQK"HH5" @(" @MH/N\CK1]3BR$?:][OC/TD%R@(" @(" @(" @$ C0\0>T(+
M:OK$]U5W8WTH3Y8SW?S>Q!<H" @((SOO\B5/GG _IBF@=.?W>[3^9L=^*QH,
M[8/C/;5;ZI]*8^1@[OYQ07/9P" @(" @(""VL Q.;:;]9Z,H'?&?J=J"Y!!&
MH.H/80@IS1":,L)T/:UP[0X<0?B0?*\IECU<-)6GED;Y'#M054! 0$%M+_>)
MQ .,4>CYO.>UK?XR@N4%M!]WD=:/J<60#[7O=\9^D@N4! 04IYV5V<SN+CZK
M>\JJM=5-K:,/+*^9Y>\ZGN'< LF(T8DS,O"E @(" @I6FVW59FT)(HKQ816E
MG8Z2%LGUI>QI:7-'> 55736->7D47ZNF>F8B>S7C&OEA :N2;@\PR7J#3D^5
M.;3'9V5YLTNP-TK-:UL<4DCW:,B;'X@;Q<XK:VQ_,I_(GX>VO*?3VS$=LZZ>
M1HZ9OE9/_)CXOPWYU_R\-*VF9TBL1U:<YE=9#&X^[8L.O5(;#V[KK0\TK&N=
MX4K(>=A)&I8[3TFG@>\*W3):L1I,Q_+G[5_+BI>9ZHB?YM?;IK'FGN);N/PU
MAENY(RK0K;LLC70\H'L9:UK6L!))[&M:$BELD:1QF<<?\Q;)3%:+6GIB,T_\
MO+]ACMNYN]',\RC%8S*5[%>XR:(G(^#+<GF#6,=Z$9?'*-7/U<WN&J7STK,?
MBFLQ,?E^[$>GC",>WR7B>/16\3$ZQ\6DVM/#LC6)[>,=R<,:V-C(V#1D;6L8
M#Q/*P!HX_ %K6XC@^J$B @(" @(" @( .AU':@N\O'[7C!,T>E'I)_$Y6*\+
M:,V)UA%E?2^@$G0#4GL 07<.+OSZ%D#@#WN]$?3T5,VB!?1;<LNXS2L9YAJX
M_P 2HG) ^VZ.!Q$7CYC(QU8OOEB6.NSAYWD?PI%K6Y0(GDNKO1/!<PM;EH2O
M9VBL]]XZ_P#Y.)%>KM\]N59^I&J*7_>MZ0XX'V"&_?</5]EILC!^.=\1^DK\
M>'9IYZ1Z4:HS=]\_ QZ_)VU+<_V/M%J*#Z/(R57H\+MVV@ZD>M>^AG'D^Q;4
MJ1#N\:U)+_W8XU=CPNO;8ZF*G]\?J"__ '?"X>(?;LLR'Z4[5<CPS'WRCJ8]
M_O=]5'Z<M?$,T^QJS<?Z4Y57]MQ>4U>/^KGJM]ZQ7_YK)^&4_P!MQ>4U5(O>
M]ZI,TYZN'E .IYJTXU'D]&P%']MQ>4U9&O[Y&_6:>TX/$2^7PVV8_P"&9ZHG
MPS'WR=3+U/?1RS2/;MHUY1W^#<?$?ZT4BHGPN.RWL3U,L[WP]LW1$,CM;(0D
M$\WLUF&8 'M/IMCU^@K,^%W[+0=258OWG>C=Z&.*])D,>>QQM57/ U\]<R</
MB5B?#LT<N*>J$QQ?4OHSG'-;0W30:]_JLGL>R./\VQX9U5F<&:O.LFJ60XG%
M9&+VC&76S0'LDB>R9GT6G^-69O,<X2HR[=MMXQ2,D'DXM/U/IJJ,D"PGQ]RM
MQFA<!KIS#TA]$:JJ+1(ME4""4@?)^&#>R1S=#Y>:3M^@%8CXK+>2VE6!64UX
M@(" @A'5/;F7W)MRK'A8(KUW&93'Y<XBR\10WX\?8;,^LY[@6M+P-6%P+><-
MYN&JB559TE"=UX/J#O'+5=RXW!6,%89BG8\U[-RJRTR3Y9QMEWI5YI&\KX()
MCP?W<I]8*)U51,0PTW3;J9!2-FF^Z[+Y*MEH\T'Y9[VN>,[!9Q@C#YN2/DJ>
M,T>&!HT\CE&DIZH5[>T=_OQ>6Q]G!6[VX+^4D.8W$;[)&V:#I;$E1]"!]R%D
M7@AT,;HY&L#&@D"1P&LZ2C6$HZ;;2WEBFYZUNR(297*X?!5Y;+YV3OL9"EC3
M!:<\@GCXOUQ];M2(1:8[$(EZ6=1_\,8K'P>TUKF'V10Q=&O5R0KPLS\4Q;,X
MLCD:Q[FP\&R/U;\:C2575&OI>L]L3JGGLMNB1V-->ADV<AI,MQ>Q3V*N:IV*
ML\?//(\N]DCE+W/;'RNUC:W3E*:21,0Z,5:T(" @(" @(" @N*=R6G)SLXL/
MKL/80J;5BRNEYK*35[$5J(2Q'4'M'>#Y"L2U9B6?6T6C6%54JA 0$%O9)D+:
MK#HZ3C(1W1CM^CV(*X : UHT:!H /($'U 0$! 0$! 0$! 04+,;G-$D8^[1'
MF9Y_*WXP@JQR-EC;(PZM<-0@](" @C.^_P B5/GG _IBF@I;"9))TVVLR(Z2
M'"X\-/9_]+&@R^*BF@DECF]%Q =R'M/$\4&40$! 0$! 04K)(KRD.Y#RGTCW
M<$%ABJUF%SGR@LB<W@T]Y\NB#*(,1-3NNOF6,Z-+@1)KP 'E")7_ (5K_B!_
MJQ]5$'A6O^('^K'U4#PK7_$#_5CZJ"E:@NO@>UDP<3]:&AI(\FNJ#SBZ\]>)
MXF'+S'5K?)Y2@JSR-G(JPO!<_P#M2T@\K!V_&>Q!<@!H#6C1H&@ \@0?4!!2
MGG979S.XN/JM\JJK753:VC#R2/E>7O.I/TEDQ&C$F=7A2@0$! 0$!!XFBALP
M25;,;)ZLS>2:"5H?&]I[G-.H*F)F)UCFIM$6B8GC$HO<VA>86LP&6;1I^VP9
M$T[5<6612UPUH\%[7,=IRM #'DCSK-KN:_CKK.DQK$Z<^_\ 8UV39W_^N_3'
M5%M)KKIIW<8GUZL]B\9%BX'1MEDMV))Y+D]RSR&5]F8 /D :T-9P  :P#0<%
MC9,DWGEI&FFD=S-Q8HQQIK,SKK,SSUGM\GH7JM+P@(" @(" @(" @(/K6N<=
M&@D^0<4-&4JPO]F=#.W1KM1I]JX<5CWF-=896.)B.+ Y-VU-L5O;=RY6O1KC
M4^)<G978=/)S$$GS!5UF]YTK"XUGN#WHNDNW.>'#&QF[+. ]@@\.+7SRS^'J
M/.T.693P_-?GP1JU/N'WQ]V6^>/;."I8R(\&RVWONS >4<OA,!^%KEG4\,I'
MWIF5/4U=G>NG5G<1>+VZ;D,3^!AHN;19IY/[N(R1\)*S:;3%7E6/K1J@5JY<
MOS&Q>L26;#O6EF>Z1Y^%SB2LJ(B.2%!2" @(" "#V'5 0"0 23H!VDH" @("
M @NZ&4R>*F]HQ=V>E/\ ?:TKX7\/.P@J)K$\X2V%@?>"ZN[?+1!N6>["W@8<
MBUET$#RNF:Y_T'A8E]EAM^'U&K:6 ]\?,M:VONW;=:["=!)/CI7UI-/*&2^*
M"?Y[?B6#D\+K/W;:*NIM7;7O*=(-U1QQ9.S)A;S@ Z/*0EC>?3TM)XN=FFO>
MXMU\BP;['-3EQ\R=8;)JU\%EJS<G@;L60I@AP=5F98B>T<2 YA/'3SK$M:U>
M$PE?Y:.>U%$:[#)#ZY+>W4]G#M3',1S8^:LSR8-S7-/*X$$=H/ K)8;X@("
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MUU GL5MGY%U6>2M-*^I6,\#C'*V*S;AADY'CBTECG-YAQ&JKIS46Y(]ENC&
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M*=GP-+FN=_(7&[37#N)QSYO<]EV^:,V*N2/Q1$N'5T*Z("#=ONY9K+X>;?\
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M+&RUTXK^.W8R%:Y!:X1N],#5S#P(5A=7" @(" @(""RGL13RMI,>/2.DI[.
M[6@^4H+T  :#L0?"0T%SCHT#4D^0(*%8&0NM/&CI.$8/=&.SZ/:@N$! 01G?
M?Y$J?/.!_3%-!3Z<,'^!=LS\O)SXF@(V:\W)$VLSE&ITU\J"5(" @(" @("
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M8R9+9+=5IUEW6'#3#7II$5AEZ[Y#68^P-).75ZMKRTAR\4DA8]IC9]:[M^B
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M&MUOUF :^FQHTD:/LHQKY6@<5U.T\4ID^&_PV]DO/O$?T_EP:WQ?'7_5'O\
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M^[N<&+.]=@U2[#>E+E,-$-35':Z6!HXF+O<SZSM'H>KU7A_B77I3)/'LGO\
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M?'L9(QT<K0^)X+'L<-0YKAH01Y"%(U_LZW)LJ]#TTSA<V!ID_P '9-^IBN4
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M;Q&/<]W_ (QJQG7^<B4M1 @HQU*L,\UJ*"..S9Y?:)FL:V23PQHWG<!J[E'
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MKF.NLJ+SI".+,8H@(""([KZ>X;>6>V]F,XV.W3P'MCAB;,$=BM8?<C8P.>)
M=#'R:MT\JB8U3$H;FN@T&<S.;RES<=I\.5K96E7@?#&]]6#,U8ZSXF2%VOA0
MB/6&,-:&ZG77M5/2F+)/'TLV[-G\[GLPWY4?FGUI&P3-Y6U_9Z3:+@TL(+O$
M:W4\W9KP4Z(U83]DVY/D"':IWS:DV_CI*AP\#Z<0E;7I2 LK7)8WQ^U1&,"-
MP(9S: NYCKJT3JMZ/0C'4-O3;>9FK#HIJ&'QIF,,0(9@\E/D6.Y1Z.LAG,9
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M_P#:C]XE_H_]J![4?O$O]'_M0/:C]XE_H_\ :@>U'[Q+_1_[4#VH_>)?Z/\
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M @(" @("".YJ;Q+8C'JQ-T^,\2LK%'!CY)XL:KRT("##;L);@I2.!%FCH?\
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MWU;1:(F.4O.;TFEIK/.%)2H=Z^ZOO ;LZ7_X?MR<^0VW*:#M3J[V6362N[X
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M$! 0$! 0$! 0$&M,\?D+K#M_*/T;2W/C+&#E>>P6JC_:X 3Y7!SVCX%N,/\
M,V=Z]N.T6]$\)^QH\W\K?4MV9:S7_-7XH]FJ>K6-JB.3W'OFID+-;';)&1H1
M/Y:][Y7JU_&9H#S>$]I<WX"LZF##-8FV7IGNZ)G3TL*^;-%IBN+JCOZXC7T+
M7_%G4;__ %Z/SY2_R57_ $^W_P![_191_4;C_9_UU/\ %G48<1T]&OSY2_R4
M_I]O_O?Z+']1N/\ 9_UU5,KE=PY78F[9-PX+Y"FBQEYM>+VV*_XK#4>2[FB
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MPN;'A=R8ZY,[0-@CLQ>,2>S[F7!WTEC9-GFQ_>I,>A>IN,=^5HE)UB,@0$!
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MCK2OUK6'>2&4Z>D>Z-_'R<RYC?>#Y-O\5?BK[8\_O;K:^(4R\)^&S=*T3:"
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MNSN0>X,+AZQB=6QU:%T#W30F.&-A9(]O(Y[=&C1Q:.4D=W!!?("#XYK7-+7
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M34,N"Q_^;,=-_P"PM7XK?IVN2?)IZ^#=^!X^O?8H_>U]7'['?R\K>XB @("
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M 0$!!Y>]L;7/>=&M&I/F""E68XAUB0:22\=#]:T>J/JH*Z"+9(ZWIS]MI]
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M4-KXQV1NN#I'OC@J50X-DL6)GB..*,'M<2X=@X#CV*!A>J>X+&W]E7WX\_\
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M- ;Z^O+QU4P,ATT@RM;8&VX,T'C)QX^!L[9=1(WT!RM?KQY@W0.UXZJ!*D!
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MP*WE^ZKIS9]8;)$! 0$! 01G??Y$J?/.!_3%-!BNFURTS9FUZ_*9&#$TAX?
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MX=M]K,SBKTZ\^,S]<I:L%L1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MYYP/Z8IH'3G]WNT_F;'?BL:"3(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@C.^_P B5/GG _IBF@=.?W>[3^9L=^*QH),@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @("",[[_(E3YYP/Z8IH'3G]WNT_F;'?BL:"3(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @C.^_R)4^><#^F*:!TY_=[M/YFQWXK&@DR @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @((SOO\B5/GG _IBF@=.?W>[3^9L=^*QH),
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @("",[[_ ")4^><#^F*:!TY_=[M/
MYFQWXK&@DR @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((SOO\B5/GG _IBF
M@=.?W>[3^9L=^*QH),@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("",[[_(E
M3YYP/Z8IH'3G]WNT_F;'?BL:"3(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @C.^_R)4^><#^F*:!TX(/3W:1!U'R-CN/\ ^2QH),@(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @("",[\(&$J:G_ /G6!_3--!^=V/\ ]PJ_Z)G\"*UR@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
E@(" @(" @(" @(" @(" @(" @(" @(""VO?V+/\ 30?[5J#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>pc_strategic-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pc_strategic-4c.jpg
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M%!04%!04%!04%/_  !$(!&8%W0,!$0 "$0$#$0'_Q #?  $  04! 0$
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M?,3R9_<3"? 8?>H8GS$\F?W$PGP&'WJ&)\Q/)G]Q,)\!A]ZAB?,3R9_<3"?
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M! 0$! 01[?\ TYZ?_A/-_K+$('(GZ&="?F2Q_$M0E(2 @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((]O_IST_\
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M @(" @(" @(" @(""/;_ .G/3_\ ">;_ %EB$#D3]#.A/S)8_B6H2D) 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$$>W_TYZ?\ X3S?ZRQ"!R)^AG0GYDL?Q+4)2$@(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""/;_P"G/3_\)YO]
M98A Y$_0SH3\R6/XEJ$I"0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!!'M_].>G_P"$\W^LL0@<B?H9T)^9+'\2
MU"4A(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @CV_^G/3_ /">;_66(0.1/T,Z$_,EC^):A*0D! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!C,]J+!:7Q[
M\KJ'(0X['L(:9[AX8"X[FM&]SC3S6@E!@-,\U^7FL+[XMT[G[>[R!!++5PD@
ME>&[3P-F:PNH-ODU0;D@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @M[Z^LL9:37^1N([2QMVF2>YG>V.)C!O+G.( "#2<?SMY593(LQ=GJ>U=
M>2.$<8D$L,;GDT ;)*QK"2=WE;4&_(" @(" @(" @(" @(" @(" @(""PS&:
MQ.GL?+E<Y>PV&.@%9;FX>(V"NP"IWD] &TH-7P'.#EKJ?(LQ&$U%;7&2E/##
M;O$D#I'>U9VS&!Y\#:H-W0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 06>5RN/P>.N<OEKAMKC;-AEN;A]>%C!O)H"4&D?/KRD_>JT]S+[Q3@-
METQK32^LX+BXTODXLE#:O;'</A#@&/<*@'B#=X4#/(" @(,?G,YB=-XNXS6<
MNF66*M0TW%U)7@9VCQ&VM 3M<X!!IGSZ\I/WJM/<R^\4X#:M-:LTYK&QDR6F
M<A'DK&&4V\DT7$&ME:UKRT\0!K1S3XU S* @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @CV_^G/3_ /">;_66(0.1/T,Z$_,EC^):A*0D! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!S_ ,U^\QB]*7-QI_1D
M4>7SL!='=7LA)LK>0;"T<)!E>#OH0T=9-0IP',^HN;?,?5$KWY;4=YV3B3Z-
M;2&UMP.KLX>!IIX02I0U1V0OW/[1UU,9-_&9'$U]6J#9])ZUYA666LK'3FH<
MA;W5W/%;00BXD?$Z25X8T.B>7,=M/2U!^C,+'QQ1LDD,LC6AKY2 TN<!0NH-
M@JOE+V@(" @(" @Y![W\N5^5.GX)2\806#WV@V\!NC,X3GJX@SL:J80Y^P\F
M2ARUA+AC(,PRXB=CS#]]])#QV?!3V7%2BD?I[%VAC9VH EX1Q@;N*FVB^4O2
M @(" @A7G7SZM.7#OD]@HH[_ %=+&))!+4V]FQXJUTH:07/<-K65&SRCLH'3
M@.2M1<T.8&JIGS9K4-[,QQ)]'CE=!;MKT"*+A8/<J4-;;D+]C^T9=3-DW\0D
M<#Z]4&]Z YB<S[;4&+PVGM1WHER%U!:16]R\W=OQ3R!FV*;B;3;MI3U4'Z"2
MRQV\+YYWAD432^21VP!K14D^H%\I1#G>\WRJP_&RUO;G,3,]A86[BVO5QS]D
MT^J"5. ON4_.FVYK9+,6MEB'XZTQ<4,C99IA))*9W/&UK6@-IP>V*"5% ("
M@(" @(/CG-8TO>:-:"7$[@ @B#.]YCE3AB]EO?W&7F;[#'V[G"O5QS=DP^)Q
M4X"[Y4\Z[7FKE\M8V.(DQUIC(8IFS3S-DDD,KW-H6-: VE/;%!*J@$! 0$!
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M2'9_='^CG)_GF?\ X:V42E/J@$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MCG>-2,KD< [%]WG$Y:5@$N;U*^X8XBCC!!:S0,'J!S)#XT$4(/TLT==Q'0^
MOIGAD)Q5G-)(\T:UOHS'$DG< %\I<0<Y.;F5YE9^=D$\D.D;20LQ5@"6M>UI
MH)Y6],C]^WS!L'23](:)@M/YK4^3BP^ LI<ADYZF.W@;Q.HT5))W #I)-$%]
MJO0VK-#W4-IJK%RXV:X:7VYDX7QR!N_@DC<YA(J*@.J.E!ZT5K;/Z!SL&>T_
M<F&XC($\!),-Q%6KHI6CSFGUQO%#M0?H7I/5V*U=I.PU?9/$6.O+<W$@D</N
M+F5$K'G8*QN:YI/@7REPIS>YH9+F9J::[=*]FG;1[XL-8DD,9"#3M7-_"24X
MG'H\W<%](:':6EW?W,=G8P27-W,[@AMX6.DD>X]#6M!)/J(,CG-+:ETR^)FH
M<1>8MTXXH?3()(.,#?PEX%:=-$&(0==]S[_TWJ7_ 'Z'\2HD:YWF>;U]-DYN
M7.G;ET&/M0&YZXB-'3S/ =Z/Q#V# 1Q^V=Y)\W:@<_Z8TMGM99B'!:<LGWV2
MF!<(V4:UK&^<][W$-:T5VEQ\&\J1L6NN4.NN7=M!?ZDL&MQUP_LF7EO(V>(2
MD$ACBW:TD"HJ-O0@L>76O\SRYU+;9[%2., <UF0LJTCN;:OE1N&ZM-K7>Q=M
M0=E<\<C:9?D9G,M82=K8WUI97-M*/9137,#V'Q@J$N"5*'9_='^CG)_GF?\
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M%&"7%O,G4]MK+76=U+9L='97]R7VS9!1_8L:(V%PZ"6M!(Z%*&0Y,_2II/\
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MD$5CD"UL5Q&P@.%9/(K4B@)J>A0E"VKNZ?IC+F3(:)RC\2^4<<=G/^5V9KM
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MRAQEK)=WMP]SI&P6L#2]SG/>: 4!H*[3L&U!@D'<'=7GCEY5LC80709&ZCD
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ME*?5 (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((]O_IST_\
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M @(" @(" @(" @(" @CV_P#IST__  GF_P!98A Y$_0SH3\R6/XEJ$I"0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M! 0$! 0$! 0$! 0$!!'M_P#3GI_^$\W^LL0@<B?H9T)^9+'\2U"4A(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@CV_^G/3_P#">;_66(0.1/T,Z$_,EC^):A*0D! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 01[?_ $YZ?_A/-_K+
M$('(GZ&="?F2Q_$M0E(2 @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @((]O\ Z<]/_P )YO\ 66(0.1/T,Z$_,EC^
M):A*0D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MVHPHIBF.Q5;^9NWIZKE4U3VRQB]F.(" @(" @(" @(" @(" @(" @(" @("
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MCYS5\SFME=6SE&R/GY\6C+9M0(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @J6]Q/:S,N;65\%Q$>*.6)Q8]KATAS:$%153$QA.Y--4TSC$
MX2F/1/>7U_I@QVV:D;J/%MH#'>N+;H-^QN "XG_I ]5[-Z#E[VVCZ)[-WH^&
M"T9+Q)F;&RO_ %*>W?Z?CBZ1T-S[Y?:X[.UCO?BC,/H/B_(EL+G./1')7@?7
MH'%Q>!4[-Z-F,OMPZJ><>6*\Y'7<KF=F/15RJV>B=TI/6E6 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MSO8C26VN(W12M/A:\ A;.BNFN,:9QCL:>Y;KMSTU1-,]NQ07V\Q 0$! 0$!
M0$! 0$! 02KRYY]ZVT));V,UR<OIQCFM?C[PE[HXZ[>QD\YE!N&UO@6CSVC6
M,Q$S$=-7./?"Q:=KN8RLQ3,]='*?=/#V.\(Y&31LFB<'Q2-#V.&XM<*@A<OF
M,)P=?B8F,8>E"1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 08M^:
MC$G"V,NC!IQ5H3Z@09%DC'L:]K@6N%0? 4'KB;UA XF]80.)O6$#B;UA XF]
M808^YRS(93$QG:<)HYU:"O@WH+RWG9<1-EC\T]!W@CH054! 0$! 0$! 0$!
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MNU)MP#$=H%:$>#:B5]C&L9:-#34U/'780[I"(7B @(" @(" @(" @(" @("
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M$! 0$%.:)L\3HG[G"E>H]!04[.5TC#'+]_A/!)X>H^-!<(" @(" @(" @("
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MHV>R *H6=T^YEJMNVGA+H>1U&WFJ=FRKC'EOA)*UK9B @(" @(" @(" @("
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M4(.T$%!^4^L<*[3FK,[@'-X/BR_NK0#[&&5S&GQ@+JEBY^2W35SB)<CS%O\
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M! 0$! 0$! 0$! 01[?\ TYZ?_A/-_K+$('(GZ&="?F2Q_$M0E(2 @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(/,D<<K#'*T/8=[7 $'Q%3$X(F(G>P-_H7165!&2T[C+HG>
MZ6S@>[URRJRJ,Y?H^VNJ//+#N9'+W/NMTS_PPU>_Y"<I,B#VNF8(7'V5M+/;
MT]012-'U%FT:SFZ=U<^?"6ON:%D:]]N/-C'LEJ]_W5.65V#Z++DK!W1V-PQ[
M1XIHWGZJS:/$6:IW],^;X2U]SPMDZMW53Y_C$M6O^Y]C'@G%ZIGA/L6W-HR;
MURR2/^A9U'B>K]5N/-/REK[GA&C]-R8[XQ]\-7O^Z+K*($XW.8VZIN$PGMR?
M<LE'U5FT>);,_=15'HGX-?<\)WX^VNF?3'Q:O?\ =GYM60)AQEO? ?Y:[AV^
MH)G1E9U&O92K?5,=\3[L6ON>&\[3NIBKNJCWX-6O^3_-#&@FZTID2UN\P0.N
M1Z\/&LVC4\K7NN4^G#VM?<TC.4;[57FC'V-8OL)F<949+'75F1O](ADB_P!-
MH6;1=HK^V8GNE@5V;E'W4S'?"Q7J\1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'Z0<N<Q\?Z#TYER>*2YQ]L9CO\ NK8P
MR3_$"N/YZU^/,5T\JI=STZ]^7+6Z^=,?-LZPF>_.WO083XEYRYQ[&\,&39;9
M"(=?:PM8\^.1CUT/2+G7EJ>S&'-M:M]&:J[<)0\MPTH@( )!!!H1M!"#K/D)
MWGC;BVT9S-NRZ#R8<;J.8U+.AL=VX[V] F.[V>SRA4]2TC'&Y9COI^'P]"X:
M7K.&%N]/=5\?CZ77[7->UKV.#F. +7 U!!V@@A5!<WU 0$! 0$! 0$! 0$!
M0$! 0$! 04;BYAMFATSJ5W#>2@MH9&WUSVH/W"#S&G>7NZ2/ @OT! 0$! 0$
M! 0$! 06M\PM8+EE!+!Y0KL!;TCQH$&0MKAXC8XAYW!PI5!=(""C<74%J 97
M4+MP&TE!]@N(KEG'$ZH&PC<0@JH" @(""G-/%;L[25W"W<.LGP(/%O>0751$
MZKAO:=AH@KH" @(" @(" @(" @CV_P#IST__  GF_P!98A Y$_0SH3\R6/XE
MJ$I"0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:(/F'B>V25[O)H TL.PU.VM$2RZ($! 0$! 0$! 0$!!:9)ADLY #3AHXUV5
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M$+K)WDK3]B^=Y'U%V/)T=%BBGE3'L<)SUS\F8N5<ZJO:P"RF&(" @(" @("
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MSBZ/A+MNVA"#,HA9W0-O*V]:/)'D3@=+#T^)!> @@$&H.T% 0$! 0$! 0$!
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MR9Z:>4>6,K]D=#RN5VQ3U5<ZMOHX0DQ:9OA 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 06V0QV/RUI)892UAO;&8<,MM<1MEB</"UX(*^Z*ZJ)ZJ9F)['G<M
MTW*>FJ(F)X2AS-=USEKELHW(6IO<3;.J9["RE;V+CUM[9DCF>$ TZJ*PVO$.
M9HIZ9PJGG/RP5B]X8REROJCJICE$[/7C@SF'[O7*;#T<,"V^E'^LOII;BO\
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M!JK^T[1W:5[2IXJ[ZHEG81DNR94Q>://#N+Q^%$*E,EUP>L_ZZ!3)=<'K/\
MKH%,EUP>L_ZZ!3)=<'K/^N@4R77!ZS_KH,'>=MZ3)V_WRO1NIT4\")9K%]IZ
M&SM*[SP5]KT(A>(+>][3T67LJ\?#LIOIT_40:[!VG;,[*O:<0X:=:);4B! 0
M$! 0$! 0$! 0$&L7?:>DR]K7CXC6O5T?41+.X[M!9Q]K6NVE=_#78B%T@("
M@(" @((]O_IST_\ PGF_UEB$#D3]#.A/S)8_B6H2D) 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!I?,;6;=+8
MOT>T>/CJ]:6VHWF-FYTI'@W-ZSZA6TT_)_GKQG[8W_!HM7U'^+;PI^^K=V=O
MP[7.KWND<Y[W%SW$N<YQJ23M))*ND1@YE,S,XR\H@0$! 0$! 0$! 0$! 0$'
M2?+*V]%T3BVT\J5LDSO^LE<1]2BI&HU=68J\N#J6BT=.4H[<9]<MM6N;EQ;W
MK\@;KF1:V8/D6.,@81]G)++(?J.:NC>'*,,M,\ZI]SE?BJYU9N(_;3'MF4%*
MSJB(""0N7?)G6G,:5DV.MO0L'6DN8NP604&\1CSI'>!NSK(6ISVJ6<K&%4XU
M?MC?\FZT_1\QG)QICII_=.[S<W6W+WD3H?E_V5Y';_&V?90_&MZT.<QPZ88]
MK8_5%7?9*A9W6+^9V8]-/*/?S=)T_0\OE,)B.JO]T^Z.'M[4GK2M^(" @("
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M);H/W07!H_J;)T'QH+Q 0$! 0$! 0$! 069_*KOAWP6QJ[J=)T#Q(+Q 0$!
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M.:!YS:#A<2M5D,QF;F8JBO#"-\?MY1W\VYU++96UEJ9HWSNG]W.9[.7?R<W
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M=2JPR]7;A[6[T2CJS='9C/J='JDNH! (H14'>$! 0$! 0$! 0$! 0$! 0$!
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M'.ZJ9IG"=\/"E\B @Z:[H_-3XCSDG+C,STQ.:>9L.]YV19"FV,$[A,T;/LP
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MQ/N=%2NXKFVVR38Y[SN<=I="2?)>=K?-=T.=>=,U2+_T7-E?M^:@ZKI,V/\
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M9 ]!L_P+?606UYBXY6@VP;&]N\;@0@8_'OMGF64@O(HUHVTJ@R* @(" @("
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MU[7->*M<"' ]108:'*^C@0\/:Q,)#9*T<6]&Q$LQ&]LC&R,-6N%0? 40]("
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MK[*=_;V?%T2QC(V-CC:&1L :QC10 #8  -P"IDSBZ;$1$80]*$B @(" @("
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M7^\N;:CEOP7YIC=.V.Z?+!U#3,U_(L15.^-D]\?'>DA:ULQ 0$! 0$! 0$!
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MI49?A 0$! 0$! 0$! 0$! 0$! 0$! 06<GY5="'?! 0Z7J+^@>)!>(" @("
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MGJ]4/'->(<Q=CIMQ%N.>^KX1ZT=])))+B2YSB22234DD[22>E;E68@1(@("
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MD5+U[+]-<7(_5LGOCY>Q>?#V8ZK=5J?T[8[I^?M=/JL+4(" @(" @(" @("
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M/E-.T;]RW^0U&;L]%S[N$\^_M4_5]%C+TS=L_9^JG]O;'9SC@C1;Q5Q 0$!
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M=5,QU<O?[O7S19/'FM?ZJO[O!X5TV3RUU+=G%8B"26.-T[R]S8V#B+6 GI-
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M;3/?Y2XGS-I:X_,9&PL;D7EC:74]O;7;=TT44CF,D%/;  JZVZIJIB9C"<%
MO4Q37,4SC$2LEZ/)>X>ZL+'+X^]REHV_Q=O<PRWUBXN:V>W8\&2,EI!'$VHV
M%>=R)FF8B<)PWO6S5337$U1C$3&Q^CD^NN2_*K!6YAOL7@\;<0QW%K8V+&B>
M:.1@?&\00-,CN)I!XG-Z=I7.HR^9S-<XQ-4\Y^+ILYC+9:C?33&_"/A"ORNY
MP::YN19F334=S;MQ$T<#Q>-8R1[)V%S)0QKG4:2UX%37R5\YS(UY;IZ\/JY)
MR>>MYJ*NC]/EBX7YNZUYJ7VI,MICF'F[J27'7#X)<<P^BV1:T^1(V&/A8YKV
M4<US@:@[U>,E8R\417;IC;&_CZ5$S^9S,W)HN53LGNCT>QUGI_&W^J>ZBW'Z
MKCD;>2:=N2T3"CPRS[1]E(0=OF10O54N5Q;U#&C=U1Z_N]ZW6J*KNGX5QMZ9
M]7VS[)<!M-6@]8JK\YU+ZB! !+2'--'#:".@A!^G?*[5]WK?E[IW4S0R6XO+
M-C;UQ=0^EP$PS;J[WL<0N7YRS^&]51PB=G=P=7R5_P#-8IKYQM[^+;NTO_P,
M?NS]98C,6N0EOA;'C8UC"0'.8XDT*"PQSY&W<8CKY1HX#I;TU1+8T0(" @("
M @(" @(" @^.<UC2YQHUHJ3X @M;1KI7/O9!1TFR('HC&[U]Z"[0$! 0$! 0
M$! 0$! 0$! 0$! 06;OR6Z$FZ"X/"_J$G0?&@O$! 0$! 0$$>W_TYZ?_ (3S
M?ZRQ"!R)^AG0GYDL?Q+4);U<7L%J0)7>4=H:!4TZT%*T<+N9]X35K?N<+>D#
MI)\)07J @(" @(" @(" @(+.]^X.9>M-"SR)![9CCN]4(/=O?6]RXLC<>,;>
M%PH2/ @N4!!CO2(\=,^!^V%WW2,-VEM=XH@O89HYV"2)W$T_TH*B @(" @HW
M%U#:M#I74KYH&TE!;02,OKGM@?N, \AIWESNDCP(+]!YDD;%&Z1YHUHJ4%O9
MQNHZYE%)IO*I[5O0$%T@(" @(" @(" @HW,';Q%@-)!Y4;NIPW% M9^WB#B*
M2 \,C>IPWH*R @(.7];9;X[U3DK]KN*$S&* ]'90_<VD>J&U\:OF3M?CLTT]
MGM<EU+,?FS-=7#'".Z-C7UF-<(" @(+K&Y*_P][%DL9.;>^@KV4P#74XA0BC
M@001L*\[ENFY3--48Q+ULWJ[-<5T3A5'%)V!YV74/#!J6P$[=@-Y9>2_PET3
MC0_W7>):*_H\3MMU8=D_%:\KXEJIV7Z<?ZJ?_;\)2+C]0:0UI:FVM[BVOV/'
MW2RG:.T%1TQ2"M1ZBTMRQ?R\XS$T]L?%:+.;RN=IPIFFN.4[_1+%2<I-"RW(
MN#CW-C!J;5LT@@=X"SBW>!9$:KF(C#J\^$8L*KP_DJJL>C9RQGI]#!\V-6V-
MAB#I#%/8;RZ:V*ZCBIPVUJVE6GAV-<^G"&]52LO2\K557^6K=&[MEK]?S]%N
MU_'M_=5LG#]-/SW0A-6A1! 0$!!5MK::\N8;2V89+B=[8HHQO<]YX0/&2OFJ
MJ*8F9W0^Z*)KJBF-\['4^G<+!I["V>(@H1;Q@2/'LY3M>[QN)*H&8O3=N37/
M%UW)Y:,O:IMQPCU\647@RQ 0$! 0$! 0$%*YN;>RMIKR[E9!:6['33SR.#6,
MCC!<YSG'8  *DJ::9JG"-\HF8B,9?G_SSYNW7-#4998O?%I+&.='BK8U;VAW
M.N9&GV3_ &(/FMV;^*O2-,T^,K;V_?5O^"G9W-S?KV?;&[XHJW[!O6X:YU/R
M,[M8N66^K^9%J1"ZDN.T],*%PWMDNFGHZHO=^U50U/6<,;=F>^KX?'T+#DM.
MQ^NY'='Q^#K%C&1L;'&T,C8 UC&BC0T;  !N 5-F<5B>D! 0$! 0$$.<S.\;
MHK0+IL9CW?'^HV5:;.T>.PA?U33BH!!WM:'.ZP%O,EH]Z_\ 5/TT\Y]T-9F=
M0MVMD?5+DO7W.S7_ ##?)#ELBZTP[R>'$6/%!:\/4\ ETG_6./B5RRNFV,O]
ML8SSG?\ )7+^<NWM\[.4(\6S80@(" @(" @(" @NL=D\CA[R+(8J[FL;^$\4
M5S;2.BE:? YA!"^*Z*:XPJC&'U35-,XQ.$I_Y==ZK/XB6.QYA6PSN.V,&2A8
MR._C8-W$WR62T\/"3UJM9S0;=?U6IZ9Y</DW.7U6NG9<VQSXNL=(ZUTOKG&#
M*Z6R,5_:B@E:P\,L+B*\,L;J.8? X>HJ?F,M<L5=-<82L5J]1=C&F<6P+&>P
M@(" @^%K7"C@".H[4%H\"TN6R@4MYJ,D W-?T'QH,!K_ )=Z:YD81^%U%;\7
M#5UG>QT%S;2D4XXW$&GA:?)=TA9F4S=S+5]5$]\<)8]_+T7J<*G!7,[E5J3E
M=F/0,PSM\;<%QQN6B:1!<,'1T\#Q[)A-1X10GHN2SUO-48T[^,<E/S.5KL58
M3NX2T9KBTAS20X&H(V$$+8,1W-W=><WR^PYTSJ&>NL,5&#VKSY5[:MH!+X9&
M;&R=>QW2:<^U?3OX]?71'T5>J>7P6W3\Y^6GIJ^Z/6G-5]MA 0$! 0$! 0$%
MI>.=(6V<9H^;SR/8QC>?'N0<R]\?EYZ?A<=S%Q\5;G$\..RO"-]G,\F%Y\#)
M7%O_ %G@5HT',]-4VIW3MCO_ ,/8J?B#*]5,7HWT[)[N'K]KC%7-2! 07>*R
ME_@\I9YK%3NMLGCYH[JTN&><R6)P<T[=AVC:#O7Q71%=,TU;8EZ6[E5NJ*J9
MPF'5,&#BS^FXLKG>8[M):QYRTNK3#XJ#L,1-/$SLF12.8US@7A[6S.[5A>]U
M"'G?59N=%?33;ZZ;'&?N\N6ST+G%KKHB:KDT57]N$?;\NW;&,SQ17S=Y;VFF
M-(Z.U5:X2;35]?-N,/G\+.^22F0QSBPW,3I27%DX:YVSR:<--]5M<CFIN7*Z
M)JZHC"8GLGAYFFU')Q;MT7(IZ)G95$\XX^?RWH?6X:$0?*;:]/7TH)!Y.<T+
MWE/K*'4$4;KK$W+/1,S8L(XI;5S@[B979VD;@',Z]K:@.*U^?R<9FWT\>'>V
M>G9V<K=ZM\3OAW59:IY(<Q(;/4\ES@<G/ T=A/DFVOIEMT\+FW $D9!.[KVA
M4:JSFK&-&%4=V.$^A?Z;N5OX5_35ASPQCT[D6=X3O%:6M]+Y+16B,A'E\[EH
MGV5Y?6CA):6MK*"V:DHJU\CFDL:&$TKQ$B@!VFF:7<FY%RY'3%.W#C,M1JNJ
MVZ;<V[<]4U;-FZ(<3[M@W*ZJ(^H" @[.[ENJ_2M/Y_1L[ZR8ZX9D;1I.WL;I
MO!(!X&OC!]5ZIFOV<*Z;D<8P]"[^';^-%5N>$X^GR];J55=;'P@.!:X5!W@[
M0@LI[=EMPW5LP-=&:R-;[)AW^L@O6.:]H>TU:X5!\!0?4! 0$! 0$! 0$! 0
M6=T3<2MLV^;Y\Y'0T;AXT%X  *#8!N" @(" @(" @(" @(" @(" @(" @IS1
M-GB=$_S7"GJ>%!2LY7/8Z*7[_">"3P]1\807* @(" @((]O_ *<]/_PGF_UE
MB$#D3]#.A/S)8_B6H2VC*6D[K@S,:7L< /)%:$;-R)5\/$YD<KG&A+N$LZ06
M]?KHADT! 0$! 0$! 0$! 08_+QE]L' ^:X'AZZ[-GA066.L[CTEDCF.8QE22
MX4Z-PJB6=1 @P>3M)S<NF8PO8^E"T5I04H42N+&PF;$3)(^$N-0QI V>%$+K
MT-_^:F]<?60/0W_YJ;UQ]9 ]#?\ YJ;UQ]9 ]#?_ )J;UQ]9 ]#?_FIO7'UD
M%AD;&<<,C'/G %#7:X>LB53$VLT3GS2-+&D<+6G83MK6B(95!9S?E5R+8;88
MJ/F\)]BW^M!>(" @(" @(" @(" @LY?R6Y$XV0S49+U!WL7?U(+Q 08;5N4^
M)=-Y/)!W#)# X0G=]UD\AG^)P65E;7Y+M-/:P<_?_#EZZ^4>O='K<L*_.1"
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M,;]RKN-Q*"!ZO"VI]6BTFK7^BW%$;ZO8M'A[*?DO3<G=1[9\O8G=5)T,0$!
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MJFC\5-'75CC&.Z/AZDR7/*;)<QKR<<_]2VTNHWV_::;TWI^X$4EA"TF2Y=%
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M-TQBO5\/L06]W"Z6,.CV3QGCB/A'1XT%2WF;/$V5NRN\=1&\(*B @(" @("
M@(""S=^57?#O@MC5W49.@>)!>(" @(" @(" @(" @(" @(" @(" @(/C@' M
M<*M(H0>HH+6T<87OLGFI9Y41/3&?K(+M 0$! 01[?_3GI_\ A/-_K+$('(GZ
M&="?F2Q_$M0E(2#Q+&V6-T;Q5KA0H*%G([A=;RFLT/DD^V;T'UD%T@(" @("
M @(" @M[N9T<89%MGE/!&/"=Y\2"I!"V")L3=S1M/6>DH*B @(" @(" @("
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MI\O+<T>=IF]>IM1NWSY>6]T/8V-IC+*VQUA"VWL;.)EO;0,%&1Q1-#&- Z@
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M7#U,W+W?R6Z:N<-I6(R! 0$%I>.=(6V<9H^7SR/8QC>?'N073&M8T,:*-:*
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MZW>X=]9 ^,;7K=[AWUD#XQM>MWN'?60/C&UZW>X=]9!BKC*7+Y'")W!%M#0
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MT>M/\,K9XFRLW.%:=(/2/$JZV[V@(" @("#5.8N@L1S(TM=Z:RPX#(.UL;L
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ML</'UKVIN8431PG"?.\YH^J*F57B]! 06<_Y5<-M1MBCH^?P^U:@O$! 0$!
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MI'GBEFF=MDEE=[)[SM)\0H  O?,7Z[U<UU;Y\L'G:M4VZ8II9Q8[U$! 0$!
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M2:':L#/W:[=BJJB<)AL=-LT7<Q317&,3\)=S6O=OY)V@ CTC;/(Z9IKF<_\
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M"#Q-$V>)T3_-<*?VH*-G*Y['12_?X3PO\/4?&$%R@(" @(" @(" @(" @("
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M9N/"0:M=U%!CH++T*ZA?.0YKB6L<-@#^BOJH,P@(" @(" @ACO4VGI/)7-R
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M$! 0$! 0$! 0$!!0NY1%"0&\;Y/(8P]+G;$%O!BK>(L>^KY&T)J?)XO407Z
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M5@Y__8J[FUTG_P#+M][II45U80$! 0$! 06?_=+NFZ"Y.SJ;+_:@O$! 0$!
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MR1Y<!/2P]'B07B @(" @(" @(" @L_\ O=WUP6Q\1E_L07B @L<A8.N^%\9
MD;LH=Q""G98ML577(:]QV!N\#UT%WZ%:?@6>L$#T*T_ L]8('H5I^!9ZP0/0
MK3\"SU@@>A6GX%GK! ]"M/P+/6"!Z%:?@6>L$#T*T_ L]8('H5I^!9ZP0/0K
M3\"SU@@>A6GX%GK!!9WN*$I#[8-80*%FX'P[$%;'V)M YSW R/H-FX (+U 0
M6;ORN[#=\%L:NZC)T#Q(+Q 0$! 0$!!'M_\ 3GI_^$\W^LL0@^\B:?,SH,-
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M+[_">)OA'2WQA!6BE;-&V5AJUPJ$'M!2N+FVLX77%W,R"W8*OEE<&,:/"YQ
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MUM*(O/+32F_PH-<B$AE:V.O:5'#UU1+:D0(" @(" @((]O\ Z<]/_P )YO\
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M-SK2^(\EK,?"T^%QN''_ $0JGXAJV41W^Y</#E.VY/\ ;[W7ZJ"YB @(*5S
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MI9@YD3H>S$3@VGE/?6O$I0WW3'=3O]3Z<Q.HH]3PV[,K:0WK;<VTCC&)V!_
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M^9W.S06-;H_%XN>2&![VVUI>XZ:6>!SR7%K  UWG$GA<"I0Z!YQQ9_4?(IT
MQ]Q=:GOK;%SSXR"$BY[8S0/F'9;V\!XBYO110E@.ZGIW4.G\+J-F?Q5UBGW%
MU;N@;>1&(O#8W@EM=]*A)&U\[>3%MS0Q\-]CY66>K,<PLL[B2O930DEW82D
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M#</ <?C;.U<W=1T,#&'ZH7*\Q7UW:JN<S[76\M1T6J:>41'J9U>#($! 0$!
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M9*/<TDM%!3?5:#5\Y;ILU6XGZIX+%HV2N5WJ;DQ]%/'X.\U0W01 0$! 0$!
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M>F[<FN>+KN4R\9>U3;CA'KXLFO!EK2URN,OKBZM+*\@N+NR?V5Y!%(U\D+Z
M\,C026FAZ5Z56ZJ8B9B8B=SRHO45S--,Q,T[]N[O7:\WJ(+#*X3$YN#T;+6D
M=U%['M&^4VO2UPH6GU"O:U>KMSC3.#'OY:U?IPN4Q5"+=1<ER..XTS=5Z?0K
MH_49(!]1P\:WV7U?A<CSQ\%1S?ASC9GS3\?CZ4797$9/"7'HN6M9+2:M&B44
M#OM7;G#[4K?VKM%R,:9Q5&_E[EBKIN1-,]JQ7J\!!-?)/+]KC\AA)'>7;2"Y
MA!W\$HX7 > .:#_>57UBUA537SV+WX;S&-%5J>$XQY_+UI55?7 0$! 0$!!:
MWC',+;N(5DA\X>VC.\?UH+ACVR,:]AJUPJ#X"@](" @(""-;?GIH&YU?\AXI
MKHY[TY^,X#;N[/TF.0QD<=?-XAO4X"2E (,!K'6>GM!X5^>U+=>BV#7MB9PM
M+Y))7U+61L;M<X@$^H"3L"#%Z+U]IGF;:.R.F;ET]C92]G>12L,4K)Z!S6O8
M[HH>('<4&YH""S'Y7=\6^"V-!U.E_L07B @(" @((UU'STT#I74\VD<M-=-S
M,#X8I&16[I(^*X8R1E' [=CPIP$E*!XFB;/$Z)_FN%#]=!1LY7.8Z&7[_">%
M_A'0?&$%R@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.,^:.?^4>
MN<O?1NXK6*7T2U(VM[*V^Y@CP.(+_&NR:/EOP92BF=\QC/?.WY/S3XCSW\O4
M+E<?;$],=U.SU[_.U!;A7'2_(+6OQMAI-)WTE<AB6\=F7':^S<:4_P"K<:?:
MEHZ%S3Q+I_XKL7J8^FO?_=\_;B[AX(U?\]B<K7/U6OM[:/\ Z9V=TPF14YTE
M&?/7EK'S.T#>XJWC!S]C6^PDAH#Z3$TUBKLV2MJS?2I#O8K9Z=F_X]Z*I^V=
MD]WR:O4\G_)LS3'W1MCO^;\VI(WQ/=%*TLD82U[' AS7 T((.XA=(B<7,9C!
MY1 @(" @(" @W#0?*[6_,F\]%TKC'W$#'!MQD)?N5G#7;]TE=LK3;PMJX] 6
M'F<Y:R\8USYN+-RN2NYB<*(\_!V)RP[JFC='=EE-6EFIL^VCFLF93'PN&WR(
M37M"/;2U'V(5/SFLW;NRCZ*?7Z?@NF2T2U9^JY]=7J]'Q3ZQC(V-CC:&1L :
MUK10 #8  %H%B>D! 0$! 0$! 0$! 0$%F?RN[X=\%L:GJ=+_ &(+Q 0$! 0$
M! 0$! 06UY$YS&S1??X3Q,\(Z1XP@K0RMGB;*SS7"O\ 8@]H" @(" @(" @(
M" @I7$(N(G1DT.]KNIPW%!YM)C-%Y>R9AX)6]3A]=!70$!!'M_\ 3GI_^$\W
M^LL0@M>2SI&<G= WU2XQX.PCE&\F(0- ]S38B4E@AP#FFH.T'P%$/J @(" @
M(" @(" @(" @(" @LY_RJX;:C;%'1\_A]JU!=DAH))H!M)\""UM09Y'WKQL=
MY,(/0P=/C07: @(" @(" @I7, N(C'6CM['=3AN*#S:S&:*KQ25AX)6]3AO0
M5T%*Y@%Q$Z.M';V.ZG#<4'FUG,T57BDK#P2MZG!!70$! 0$! 0$%K>/<\MM(
MC22;SC[6,;S_ %(+AC&QL:Q@HUHH!X @@/G%CO1-5B\:*,O[>.0G[..L9'K-
M:KAI-SJLX?MGYN<>(;/1F>K]T1ZMB/5N%;$! 027R=T[Z?F)<]<,K:XT<,%=
MSKB04_PMJ?5(6CU;,=-$41OJ]BU>'LI^2[-V=U&[OGX1[DZJIN@L!K75%IHO
M2V4U+>4<RPA+XHB:=I,[R8H_[SRUJR<K8F_=IHCC/^+!SV;IRMBJ[5^F/3/"
M//+\^X]2YZ'.3:DMLA/;YR>9]S+?02.BE,LKN-YJTC82=HW+J$V+<T=$Q$T[
ML'"8S5V+LW8JF*YG'&-^U.&A^]+F\=V=EKBS&5M!1IR-J&Q7;1LVN9LCD\7!
MZJKN:T&BK;:GIGE.[X^U<\AXMNT84YB.N/W1LJ]&Z?4Z+TCS#T?KF#M=-Y2*
MYF XI;-Q[.ZC^VB?1U/"!3PJJ9G)WK$_73AV\/2O^2U++YN,;543/+CZ&T+#
M;(06F2QECEK.2RR%O'<V\@(,<K0]NT4K0K[HKJHG&F9B7G<M47*>FN(JCE*+
MLQR>L;UDDVG9S973#1]C<$R0\0]J_:YH.\5XO$M[E]7JC9<C'MA5,WX<HG&;
M$]/],[O3O]J,<WIG.:>E[++64D )HR:G%$[[5[:M/KJP6<Q;NQC1.*GYG)7L
MO.%RF8]GI93EUFOB35EC.]W#;7+O1+CH'!-0 GP!W"[Q+'S]G\EF8XQM]#+T
MC,_@S-,SNGZ9\_SP=+*CNJ" @(" @(""SM_R:=UH?O;JO@/@Z6^)!>(" @("
M#A;"_P#Y-'^*KK_BI%](=TKY2((XYT\N(^9FE(L.R]] R-M<LN;"<L[5AEX7
M1ECV!S:M+7'<=A""WY+<HQRHQ%]!<Y$9/+91\3[R:.,PP-; '!C6-<YQ]FXD
MD]/@4B3U M[N9T<89%MGE/!&/"=Y\2"I!"V")L3=S1M/6>DH*B @(" @(.%N
M=_T_Y#_>\7_PULOJ$.Z5\I$%I= P2,O6"O!Y,P'2P]/B070(< X&H.T'P(/J
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(-9Y@ZB&EM'Y7,-=PW+(3%
M:=?I$WW.,CU">(^ +9Z9E?Y.9HHX8[>Z-LM'KN?_ (62N7>,1A3_ '3LCXN*
MMZ[2_,8B&8TMJ*\TKG['/6.V6TD#GQUH)(CY+V'P.:2/JK#SF5IS-FJW5NJC
MT3PELM-S]>2S%%^C?3/ICC'GAVOBLG9YK&VN6Q\G:V5Y$V:!_3PO%:$=!&XC
MH*XK>LU6JYHJWTS@_3V6S%&8M4W;<XTUQC'G7B\62X0[U_+'Y):Q;K+%P\&!
MU,]TDX8*,AR0'%*WP=J/NHZW<?0%>]%SGY;?XY^ZCV?+=Z'/]<R?XKOY*?MK
M]OSW^ESVK K@@(" @(,QIK2FH]8Y)F(TQC)\ID'_ .JMV<0:/;/<:-8W[)Y
M7C=O46J>JN<(>]FQ<O5=-$3,NM.6/<_Q=@(<MS,N1D;P4>,)9O<VU8=AI-**
M.D/6UG"WPN"J>;URJKZ;,81SG>M^3T"FGZKTXSRC=YY=.8W&8[#6,.,Q-I#8
MXZV:&6]K;,;%$QHZ&M:  JS7757.-4XRM5%%-$=-,81"[7P^Q 0$! 0$! 0$
M! 0$!!C)\O$.-D()=N:\^;7K07MM$R&!C&'B%*EWMB=I/C05D! 0$! 0$! 0
M$! 08R2Z9CKB2.G'%)Y88W>UQW^N@OK>XCN8^TB.S<0=X*"J@(" @(" @("
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M^-HKX:%$*GI%Y_E#_M&H'I%Y_E#_ +1J!Z1>?Y0_[1J#AK$RRM[S+BV,N_\
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MX!7[*W?RVJ:NSV;'(<_E_P &8KH[9F.Z=L,*LI@B#ICE_IWY-Z:M;65G#?7
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MO4<%,/F4V6..N,3W;I+&Z:6W#-*W+Y&'>TS6;Y.$^$<5$2A?N@_^M,[^:_\
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M.6C+4S]5W?\ VQ\9]DN9UTMPX0$! 03#R#UK\3YM^EKZ2F.R[@ZU+CL9>@4
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M!=<$! 0$! 0$! 0$! 0$%M>1.>QLT7W^$\3/#UCQA!6AE;/$V5GFN%?[$'M
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M^9T^QF/OIV\XWMOD=7S64_VZOI_;.V/1\,'4O*?GQC.8UX,#?61Q>HQ$Z9C
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M6B@&P ;@$&.ET[I^:[-_-BK.2^+A(;I]O$Z;C;2CN,MK44WU09) 0$! 0$!
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M6KKXX81WSLAO=!R'\W/6[4[L<:O[8VSZ=WG=J+B[]." @(" @(" @(" @("
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M0.)WV1*ZCD<M&7LTT<>/?Q<(U3.SF\S5=X3.SNC=Y<VIK.:L0$! 0$! 0$!
M0$!!/O=FYC#!9Q^A\I+PXO-/#\<]QV17] WAV]$P ;]L&TWE5G7,E^2C\M.^
MG?W?)>/"VI_AN_QZY^FO[>RK_P"KVX.NU1751 0$! 0$! 0$! 0$! 0$!!;7
MD3G,;-%]_A/$SPCI'C""M#*V>)LK/-<*_P!B#V@(" @(" @(""TNW&5S+.,T
M=+MD(]C&-_K[D%TUK6-#6BC6B@'@"#Z@(" @(" @YMYJ<AN8.=UI>Z[T?GX_
M3;LL+8'226-Q V-C8VLCECJ" &C>6^,J4-6.A.]?(PV3\K>BW(X#+\;0@TZ^
M(2]I_6@S6A.ZM=?&<>;YE9*.\ ?VTF+M7OE,SZU^[SO#32OG!@V^V3$=/111
M01,@@8V*&)H9'&P!K6M:*  #8 !N"A+V@(" @(" @(" @(" @(" @QNH,Y8Z
M;PUYG,D_@L[.,R/IYSCN:QM?9.<0T>$K)RV7KS%VFW1OJGR]#"SV<MY2Q5>N
M3]-$8_".^9V0XIU%G;[4V:O<YD7<5U>R&1P'FL;N8QOV+6@-'@"[3E<M1E[5
M-NC=3'E/G?F+/YVYG+]=ZY]U<X]W*.Z(V,8LI@" @(" @("#H+3O/S&XS15K
M%E8IK[5%J#;"!M6ME;&!V<KY2"!4;';W<0)I0KG^:\-5W,U,T3%-N=N/+G$1
MY1@[!D/&]JSD*8NQ-=ZGZ<.>&ZJ:O;OG'@BS6',K56M'N9DKKL<;6K,=;5C@
M%-W$*U>?"XGP45HR.DY?*1]$8U?NG?\ +S*%JOB'.:A.%RK"C]E.RGY^=J"W
M"N" @(" @Z"[N6F^"#)ZKG9Y4I%A9D^U;224CP$\ \17/O%6;QFBS'#ZI]D>
M]V#P#I^%-S,U1O\ HI]M7N]$IY5$=9$! 0$! 0$! 0$! 0$! 0$%E.1:7 NM
MT,M&3> ^Q<@N(;B">O8O#J;P-_K%!50$! 0$'QSFM!<XT:-I)W(+&>ZCN@+6
MU?5TIH]P]BP;SM07K&-C8UC!1K10#P!!XN9Q;Q&2E7;F-ZW'<$'FU@,$5'FL
MKCQR.ZW'>@KH" @(" @(" @(""SG_);AMT-D,E&3^ ^Q=_4@O$! 0$!!'M_]
M.>G_ .$\W^LL0@L^3#S#R<T!>EU7,PEA&X$[71]BT #U*;$2D2VO[>Z<61DA
MXV\+A0D>!$+I 0$! 0$! 0$! 0$! 0$! 0$%I>-=&6WD8J^+SP/91G>/%O07
M3'->T/::M<*@^ H/J @(" @(" @(+-_Y5="+?!;D.DZB_H'B07B @(" @("
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MW'X>=?/!>F_R<[^6J/IL_5_Q?I^/F=5KE;OH@(" @(" @(" @(" @(" @("
M@(" @(" @(+:]M!=Q<%>%[35KD%A:V1L[N,W!!XP1&YN[CZC7P(,P@(" @("
M @(" @(""G.8Q#(9?O?">+U*(,/!B)) R1[@R-VWA]E3^A$LVUH:T-&P 4 \
M 1#Z@(""/;_Z<]/_ ,)YO]98A!1Y'1LEY4:&<RIMK;!V#8R?92&W9Q.'@KYJ
M)20B! 0$! 0$! 0$! 0$! 0$! 0$!!;W<+I8PZ/9/&>.(^$='C05()FW$396
M[*[QU$;P@J(" @(" @(+.'\JN3<'[S%5D/A/LG?U(+Q 0$! 0$! 0$! 0$!
M0$! 019S_P!:NT?R_NHK1Q;E,V3C;1S:U8V1I,SZ]%(P0.GB(*W.D97\U^,=
MU.V?=ZU9\1Y[^-E)B/NK^F/?/H<-+H[C @(" @(" @(" @(" @(" @GCN[\V
M1I?)-T7GY^'3V2E_(;B0^3:7;]E"3NCD._H:[;LJXJM:SI_Y:?RT1]5._MCX
MPNWAK6/X]?X+D_15.R?VS\)]OG=@*B.KB @(" @(" @(" @(" @("#7;NYE%
MW,8W&/RJ$-)%>'8"42R%ID)7P-+X9)'#87L;4&B(5_37_P"5F]R/KH'IK_\
M*S>Y'UT#TU_^5F]R/KH'IK_\K-[D?70/37_Y6;W(^N@QM_?W#I.!G' T >2?
M)<3X:(E=8>5SXY6N%2'!Q?TDNZ_61#)H" @(" @(" @(" @(" @(" @(" @(
M" @(" @PVJM38W2.#N<YE'4@@%(X@:/EE=YD;/"X^L-IV!9F3RE>:NQ;HWSZ
MHYM9J6HVLAEZKUS='#C,\(CO^;C/4NHLCJK-76<RC^*ZN75#!YD<8V-C8.AK
M1L'KG:NRY3*T9:U%NC='K[7YJU#/W<[?JO7)^JKU1PB.R&)66UP@(,C@,:,S
MG<9B"XL%_=P6I>-[1-(UA/BJL?,W?Q6JZ_VTS/HC%F9++QF,Q;M3.'7533_F
MF(=.<Y,[=Z.T)%9X!AM!=21XR*:'R1;VXC<:,(W$M9P-ZA4C: N8Z#EJ<UFY
MJN_5AC5MXSCQ].+NGBS.UZ?I\46/HZIBW$Q^FG"=WFC".4;8VP@S07*O4&NI
M!<1CT#!@D29.9I+7$&A;$RH+SXPT=)KL5YU+6;.3C"?JK_;'OGA[>QRG1/#6
M9U*>J/HM?OGV4QLZI]6_&<=B8).[II V1ABR%^V^IY-TY\3F\5.F,1BK:]'%
M7PJH1XIS/5C--.'+;[<?+DZ/5X!R71A%=SJY_3[.G=Y\>U VM-'Y/1&<DPN2
M+9#PB:VN&>9- XD-> =HV@@@[B.G>KYD,]1G+47*.Z8Y2Y-J^E7=.S$V;FWC
M$QQIG=/9NGSQYVO+8-.(""8^7(DT7H>_YDXRS=ELP^=V.?;M>1#;6@+)'R2M
M:.(GB:WIV M.ZJIVJX9O-4Y2NKHHPZL>-56V(B/+FZ1H&.GY"O4+=/Y;G5T8
M8[**-DS-4;]^'FFF=V+8CI_E_P U<-9YH6CM+:BRD\UI;OC;]QGNH6=H[8 U
MD@()/%Y#B014D+7_ ,G.:;=JMX_FMT1$SSBF=G?'KAN?X&FZW8IO=,Y:[<JJ
MIC#=55$8SRIJ[_IJF8F,=B!\OB[K"96]P]Z!Z78S26\W#4M+HW%I+20"0:5&
MS<KU8O4WK=-=.ZJ,?2Y/FLO7E[M5JO[J)FF?-.&SLY+)>[&$!!U]R@TI\E=&
M6C+AG!DLC^77M11S3*!P,-=HX64J/;57(=<SO\G,SA]M/TQYM\^>?4_1GA73
M/X61IBJ/KN?75Y]T>:/7BWU:%;1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M'BD=UN.]!70$! 0$$>W_ -.>G_X3S?ZRQ"!R)^AG0GYDL?Q+4)2$@(" @("
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(/,C&RL=&\5:X4(]5!;V;W
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M'PATV*<KIMGA13'IF?;,M%Y>]XBPUSK>;2]SC?B['7S2,%-([BFDDC:7/9.
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MF9ZI^FGGS[OBNVJ:[8R4=,?57^V.'?R[M_M4--3XKO#<J>#4UJV"^[5]M/-
M*=A?VX!;/;EU2*M>TT/02TU"^K\5:=FOHG9[8GA/EVOC+56]8R7^K&W=LX51
MQCS>V8VM;Y;]VN;2.KK;4N=S4=_%C)#+CK:VB=$7RT+6OE+B:<-:\+:U/304
M.7G=;_-:FBFG#JWX^YK],\,_Q;\7:J^KIW1$>WX>OGA^]KF\9)'IW3T<C),O
M#+->SQM-710.8(V\75QFM/M5D>'K56-=?#<Q/&&8HZ*+?ZL<>Z/G[G,51NZ5
M<7-! 0$! 0$&4T]J'+Z5R]MG<%<NM,E:.XHY&[B.EKAN<UPV.:=Z\;UFB]1-
M%<8Q+)RV9N9>Y%RW.%4.X.5/-K#<S,7Y'#9ZDM6@Y#%EU2*4':Q5VNC)/JM.
MP]!/.M0TZO*U<Z9W3[I[79=(UBWGZ/VUQOI]\=GL2(M4WX@(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(!( J=R#GOF[SB%R)
M]*Z2G_)S6+(Y2(_?!N=%"X>QZ'/Z=PV;3T'1-"Z<+U^-OZ:??/NAQ[Q3XKZ\
M<ME9V;JZXX_TT]G.>/#9O@A7MR<0$!!>8G'29?)VF+BEB@DO)60MFN'B.%A>
M:<3W'<!Z_5M7C>NQ:MS7,3/3&.S>R<M8JOW:;=,Q$U3$8U3A$8\Y\NR)EV5A
M=):?TII9N 9:LN<9$PNO1)$)C</(':22,H[B)INH:  #8 N-YC.WLSF/RXX5
M<-N&'*(GAY2_2N3TK+9+*?@BF*J,/JQC'JGC,QMQ^&R-D-'RW)CE_K&T&6TK
M<C'F:ICGL7">T<ZNVL1.RF[A8YM.D+>6->SF5JZ+T=6'"K95Z?C$JIF?"6FZ
MA1^7*U='5NFB>JB?-V<J9IPY&@+#5_+2Z^3.H8G9#2EW+_\ ;\K9\4T=K/(?
M-D93CCC>=YX>!KSO\IQ34[N6U"G\UJ>F[3'U4SLZH[)W3,>F8[H-#L9W1Z_X
M]^)KL5S]-=.-44U3PF/NIIGC.'3%4[]LRCCFKHZ^Y=:GAU-II[[/%WLADLY;
M>K/1;FE7PU&P-<*E@Z6U;2C58]&S]&>L39N_553&W']4<_CV[>*E^)M)N:3F
MZ<QE\:**YQIFG9T5<:>6WA'&,:<,*991O>%RK])W%C-:\.K"T0V^2C#1 6G8
MZ5S-E) -P X>+;0 <)Q9\,6XS$51/^EOFGCW8\O7AZ6?'CJ].2FW-/\ K[HK
MV8=M4QPJY8?3CMPB/I0M)))+(Z65Q?*\ESWN)+G.)J22=Y*ND1$1A#F=54U3
MC.V9>5+Y7N(Q.1SN2M\3B;=UUD+IW!! R@)(!)))(   )))H!M*\+]^BS1-=
M<X4QOEDY;+7<S=IM6J>JNK='EZYW1Q37>:C')VZL=+2V,F3TMD[&.YR./O8X
M@YD\P+)^SD I)6GEQR5'0' *ET97_P K35>BJ*+E%4Q353,[HW8QP[)CT.GW
ML_\ ^ KHRTT3<L7*(FNBJ*=DSLKPG=5CQIJQCA$Q#1M=G1%D^UR_+K)7,'QM
M%,R_QC2Y@@B< UT;C4. ?4@QGB!WUX:5WFG?RJXFC-4Q/1,85<YY^;GL].*J
MZU_ MS3=R%RJ/RQ5U4;NF-TTSQV[?I^J)Y].#0%OU1$!!]:USW!C 7/<:-:-
MI).X *)G!,1,SA#L3E9HMNBM*P6L[ ,O>TNLD[I$KAY,=>J-OD^K4]*X_K.?
M_EYB:H^VG93W<_/\'Z0\-:1&G92*:H_U*_JK[^7_  QL[\9XMV6D6@0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&*%['CY)+8@R1M=5G#[$':6[
M>I!D89F3QB6,U:[UT%1 0$! 06MW?PVA#7 N>=O"WH'A04[%[;J62[)\H>0Q
MG2UN_P"J@OD! 0$! 0$$>W_TYZ?_ (3S?ZRQ"!R)^AG0GYDL?Q+4)2$@(" @
M(" @(" @M+MQF>RR8:&3RI2.B,?7W(+IK0UH:T4:!0#P!!]0$! 0$! 0$%&Y
M@[>(LK1X\ICNIPW% M9^WB#G"DK3PR-ZG#>@K(" @(" @(" @(" @(" @("
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M@0^VD]VY!87V,E#P^W!D:10@FK@?&B5UC+22V8]TNQ\E/)WT _\ U1"_0$!
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MN!;312Q??Z$&NXLZCXT%3'Y W1='(T-D J"-Q""_0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!J/,C0>/YB:6NL!><,=U]^QUV14P73 >!_P!J:\+QTM)Z
M:+.R6;JRUV*XW<8YPU6J:?1G;$VZM^^F>4^6_L<!YC$9# Y2[PV6@=;9&QE=
M!<PNWM>PTV'<0=X(V$;0NG6[E-RF*J9QB7#;UFNS7-%<854SA*Q7H\1 0$!
M(!%#N*#J?N\<X_C*.'EYJRX#KR-G9X*]F->WB:/^[2$[WM'WLGSF[-X'%2]9
MTWHG\UN-GZHY=OQ=0\-ZW^:/X]V?JC[9Y]G?RY^V/N\!RHL]!9:'/8-T<>GL
MU*\,Q_$T26UR!QN:QF\Q$;13S/--/)KM-'U"<Q3-%?W4\><?'VM#XDTBG*UQ
M=M[**YW<I[.SV;N2'[BZNKLQ&[GDN#!$RWA,KW2%D,8HR-O$31K>AHV!;ZFF
M*=T8*C7=KKPZIF<(PC'ER=5]U+3&,BTWDM7.B;)F+J[DL63. +HK>!C'<#3T
M<;G5=UT'4J5K]^J;D6_TQ&/G=0\)92BFQ-[#ZJIPQY1LV>78V7,]XO26 UU<
MZ-REG<PVMG,+6ZS/DF&.8@$DQCR^!M=KQZU%AVM&NW+$7:9C;MP;*_XAR]G,
MS8KB8PV=7#_!JG>!Y08[*8F?F+I&!C<A STG+6]L 8KNUI5UPT-V<;!Y3B//
M;4[QMS='U&JBN+-R=D[L>$\FL\1Z-1=MSF+4?5&V</U1S[X]<.5%=G+! 0$!
M 0$!!L>C==:FT'DQE--WKK=[J">W=Y=O.T>QEC.QW@.\=!"Q,SE+>8IZ:XQ]
ML-AD=0O9.OKM58<XX3WPZ\Y:<^]+:[$6-R#FX74KJ-]#G>.QG?\ \Q(: U/L
M'4=U<6]47/:1=R_U4_53SY=[JNE^(;&;PIJ^BYRG=/=/NW]Z65I%H$! 0$!
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MU5U;(QV?"(\N+;^9?)3,\M=/X?-7MTV_=>/?!D^P81!:SD!T36N.UP<.(<1
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M 0$! 0$!!XEE;#&Z5YHUHJ4%&SB>&NGE^_S'B=X!T-\007* @(" @(" @("
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MP \$\?V\3J/;ZI%.I5+,96[8G"NG#V>ET'*9^QFJ<;545>V.^-[85BL\0$!
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M!6_)Y:JW13-V8KN1&$U8;>['?\=[FVHYRB]=K_!$V[-575%O'9$X88X;L?\
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M]B=[?$@O$! 0$! 0$!!9Q?E5R9SMAAJR'J+O9._J07B @(" @(" @(" @("
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MH.8DD63O^TQ&DO.-^YOW:Y -.&V:[>-E.T/DCHXCL7AJ&JV\O]-/U5\N7?\
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M8IIBF-T.%7KDW*YKG?5./I="]V#EOZ??2<Q,M#6SLG/ML&QXJ'W%.&6>AZ&
M\#3[8NZ6JK:[G>F/PT[Y^[NY+_X4TS&9S-<;(V4^^?=Z>2:]67/*G6>:DY<:
MIEL[K4#(V/BM)JQW#'3-+FB&:@I)PT=PM=6A&RBKV7IS5BC\UO&*>?#SQR7#
M-59+,W)RUV::J^4[]O*>>'+;@YAYP<D<ERWD^-\;(_(Z0FD#&7+P.WM7O/DL
MGX0 0=S9  "=A -*W'3=4IS/TU;*_;W?!S;6]!JR4_DH^JW/II[_ '3YMFS&
M)EO%4$! 0$! 0$! 0$! 0$! 0$%2*>> \4,KXW=;'%I^HHF(G>F*IC=*]CS^
M=B%(LI=L&ZC9Y!N]1R\YLT3^F/0]HS%V-U57IE7^5FJ=WQYD*?[W-[]?/\>U
M^V/1#[_F7_WU?YI>'ZGU+)]\S-\_H\JZF/\ 2Y(L6X_3'HA$YN].^NK_ #2W
M#EGH35/-/."P9>7$>&MBUV5R,CWO;%&:T:WB-#(ZAX6^,[ L'/9NUE*,<(ZI
MW1Y<&VTK3[^H7>G&>F/NJY?/D[?T[IW$:4P]K@L';BVQUHWAC8-KG$[7/>=[
MG..UQ.]<ZO7J[U<UUSC,NRY;+6\O;BW;C"F&47BR4=<T^9UKH:P]"L2V?4MV
MRMM ?*;"P[.UD'5[5OLCX*JQ:/I%6<KZJMEN-\\^R/>IGB3Q%1IMOHHVWJHV
M1^V/W3[HXN3[R\NLA=37U],^XO+AYDFFD/$][W&I))75K=NFBF*:8PB'Y^NW
M:[M<UUS-554XS,\5%>CR$! 0$! 0$!!]+7-\X$5VBJ@Q;URBTG;:NUE;VE^T
M28VRC=?7<)W2,B<UK6'K!>]O$/:U6CUO.U97+353]U4],=F/'T1Z5K\+:91G
ML]317MIHB:ZHYQ&$8>F8Q[,4Q<Z.961T:RRP.G2VWREW%V\MT6-=V-N'%C1&
MUP+:N+7"I\T#=4@BG:!I-&;ZKMW;33.&'.>WN];I'B[Q#=R'38R\]-=4=4U8
M?;3CA&&,8;<)[HCMB8BW2W.[66%R,<F7NWY?%.=2YMIPWM.$[W1R4!#AT GA
M\'2K3G/#^6O43%%/15PF/?'E*B:;XPSV7NQ-VJ;M'&F<,>^)WX^KVQT5F<5@
M>9&D>P+FSX[)0MGL;H-JZ*0MK'(T&A#FDT(V=+3O*YW8O7LAF<=U5$X3'/G'
M=/S=DS>5RVKY+#[J+D=5-7[9X51RF.,=],\7+&E-0Y3EKK,SR,\NSFDL<M:C
M;VD+9.&5@-1M!;Q,-?. Z%U+.Y6WJ&6P_='53/*<-GS['!-,SUW2,]U<:)FB
MN.<8_5'JV=L1PV.F]9:;Q?,S1W96DK)#/&V]PU[4M:V8L)83LKPN!X7@C8#N
MJ N9Y#-W-/S.-4;IZ:H[./R^#N6KZ?:UC(X43CC'7;JVQMPV8]DXX3L\V,0Y
M2Q&8U!H74#KJQ>ZRR]C(^"YA?M:[@=22*5H-'-)&T>,;:%=5OV+.<LX5?535
M&,>Z8< RN;S&FYGJHGHN43-,QW3MIJYQL]\;8B4F:J[P%]F,*W&8;&LLKBZB
M[/(SW'#<-'$"',B8X%I!'LGCP4Z56<EX9HM7>NY5U1$_3$;/3/P]/!>=3\<7
M,Q8_':MQ1-485S5A5WQ3&[#MJ[L.*%U=',A!=XS%Y#-7\&,Q5N^[O[EW!#!&
M*N<=Y\  &TD[ -I7C>O46J)KKG"F.+(R^7N9BY3;MTS555.$1'EZ>4;92)I3
M#9/EGS)PT>KL>P6]Q)V$5R\-DAK-Y#98I#L!C>6EW2T5ZPJ]G;]&H9*N;%6V
M(QPX[.$QVQZ5RTS*W='U2U&:HC"J<(G?&W9U4SN^F9C'C$<-L-^UEI^YU)>9
M#4ND>/&<R--R.@REG;.X9;B$L(CECIM)DB-6'>X>0=H"T&0S-.7IIM7_ *\O
M=C&F9W1/&)[JM_+>MVKY&K.5UYG*XV\WEYF*Z:=]48;*H_NH^WC,?3OAYQF<
MT[@M/Z9U+BM216F&PEA*V]TW&[AN+S(RQ\+FR,#JEQD-:N80VG$WR353>R]Z
M]>NV:[4S7<JC"YPIHB>$\L.4XSNG;L>>6SV5R^6R^9M7XIMV:)ZK,?=7<F,)
MQC';/5MQF)B/NCZ9Q09JK/-U-GKW.-L8<?Z8_M'6UO7@#J;7$G>YV]QH*G;1
M7G)Y;^/9IM]4U=/&?+T.6ZEG8SF8KO=$4=<XX1N_QG?,[,9VX,.LQK1 0$&]
M\M.6U_KS)<<O';:>M7#TZ] VN._LHJ["\C?[4;3T Z+5M6HR5&S;7.Z/?/9[
M5L\/>'[FIW<9QIM4_=5_TQV^S?RB>ML=CK'$6,&,QL#;:QMF"."",4:UH_I)
MWDG:3M*Y+=NUW:YKKG&J=\OT-E\O;L6XMVXZ::8PB(72\GN(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M(]O_ *<]/_PGF_UEB$#D3]#.A/S)8_B6H2D) 0$! 0$! 0$%"\>([:5Y;Q -
M(X3N-=B#!P7]S"YGEET;:#@.T4'0B6;O8#=6SHVFCMA;7K"(8FWQ=RZ9O;-X
M(VFKC45-.JB)93XOM_L_=N^NB#XOM_L_=N^N@?%]O]G[MWUT#XOM_L_=N^N@
M?%]O]G[MWUT'E^-@<QS6EP<00"7.(KZE4&+;BKLR<!:&MKM?4$41+/M:&M#1
MN  ]9$/J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((SYO<
MH<9S+QG;P<%GJJS8187Y%&O:-O8S4VEA.X[V':.D';Z=J-65JPG;1.^/?'EM
M5W6=&HSU&,?3<IW3[I[/8XBS.%RFGLG<X;-6K[/)6CS'/!(*$$=(.X@C:'#8
M1M"Z):NTW*8JIG&)<:OV*[-<T5QTU1P6"]7B(" @(" @  ;D$K]W;2\6I.95
MG<736NL\'&[)O8XCRI8R&0T!VFCW!_\ =6CUK,3:R\Q&^K9\5K\,92+V;BJ=
MU$=7GX>O;YDS]ZC5/Q9HZRTO!)2YSMP'3M!V^B6E)'5'49#'ZQ6@T'+]=Z:Y
MW4QZY^6*W^*\W^++1;C?<GU1\\',.B-(Y#76J,?IC&U;)>/K<7%*B"V9MEE/
MVK=W6Z@Z5<,WF:<O:FN>'KES?3<E5F[]-JGCO[(XSY<=CO\ M<2W3.F&8;2U
MK%7&VA@Q=K,XLC=)&RD8D> 3Y3MKW4KM)7,:KGY;G5<G[IVNY4VOPV>BU'VQ
MA3$^K&?;+AW*\O.;.0UC+!D<)?NU1?W3IW7H8[L.V<^O;-N&UC#&G:'!WD@+
MHEO.96FS]-4=,1N^6]R"]IFH5YKZJ*NNJ<<>'^;=\'8NOX[6UY59V#4TS+AD
M6'ECO)W"@DN&P\+7#[)TM"WPT5$RDS.9IFC9]6SNQ^#JF?BF,G7%R<8Z)Q]'
MQ?GX-C1Q;Z;5U!P?B]!KW,,K6.,0WO#26CQ[E&,)Z)PQPV/((.T&OJ*7S@^H
M" @(" @(" @(" @(" @("#;>7G+[-<QL_'A<2WL[=E),A?N%8K:"M"YVZKCN
M8RM7'J%2,'.9RC+6^JKS1S;33=-N9Z[%%&[C/"(\MT.[](Z2PNB<%;:?P4'9
M65N*N>:&2:5U.*61VRKW4V^L*  +FV8S%=^N:ZYVR[9D\G;RMJ+=N,(CUSSG
MM9Q8S-:/S*YBV&@L5Q#AN,[=-(Q]D3XC+)3:&-_Q'8.DC=Z3I=>=N<J(^Z?=
M';[%6\0:_;TRS^Z[5]M/_5/9'KW1QF.1\GD[_,W]QE,G.ZYO[IYDGF?O<X_4
M &X ; -@76[-FBU1%%$84QN?G?,9BYF+E5RY/555.,RM%[,<0$! 0$! 0;]R
MVY7Y+7UP^X?(;+ 6S^"YO*<3W/H'&.('874(J3L;7IW'0:MK%&2IPPZJYW1[
MY\MJV^'_  Y=U2J:L>BU3.%57KZ:>WV8X[=TSJW'\I^5%O'Z4+6VON$.;-<#
MTK(2='$  YX!(]@UK:JBS=U#4IGIQF.SZ:8]WIQEU:,OHVATQU=--7.KZKD\
M,>,QN_3$4XH6YQ:WT]KC)8Z[P3;@.M(I()WW$;8PYI<',X*.<>EU:@*Z:%I]
M[)T54W,/JF)C#U^YS+Q7K.6U*[159BKZ(F)F8B,>,8;9GGOP9?NZ7T4&KK^R
MD(#[NQ<8B=Y=%(QQ:/[I)\2Q/%-N9RU-4?IJ]L2V/@*]%.=KHG]5$X=\3&ST
M8SYF:[Q^GYS-B=41-+H PX^Z<-S"'.EB]UQ2>LL+PKFHPKLSO^Z/9/N;/Q_D
M*NJWF8C9AT5=F^JGTXU($5]<E=.=W?)7-UI"\L)B716%ZYML3N:R9C7E@]1Q
M<[^\N9>*+5-.9IJC?53M\VSV>QW/P'?JKR55$[J*YP[IB)P].,^=#O..."/F
M3G6V]. OA<ZGMW6\3G_XB5<-"F9R-O'M_P#5+F_BR(C5+V&[&G_T4X^MGN6/
M.$:*PU[ALM;RWUK&#-B8XR 6RO/EQ.<ZO"QQ/'4 T/%L-5@:OH7\N[3<HF*9
MW5=W/OX>CDVWAWQ7_P".L5VKE,UTQMHPY\:9Y4SOW;-NR<6A:MU/>:PSMSGK
MZ&&">XX1V4#>%H:P<+:G>XT&USOZ*!;[)92G*VHMTS,Q'-4M4U&O/YBJ_7$1
M-7"(Y;([^^?9A#"+.:L0$$DZ&NC#I')9/"111:NTM>19F&X# 99["1G83PN(
MHXQ,'E/%=Q\*K>HT8YBFBY,S:O4S1APBK?3/?.Z%TT:OIR=R[9B(S&7KB[$X
M;:J)CHJIY],;ZN_M2=F]56&7TRS55Q:_'G+[)AL6=Q!HZ\Q=Z/),D+R6[*N
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M @(" @(" @(""/;_ .G/3_\ ">;_ %EB$#D3]#.A/S)8_B6H2D) 0$! 0$!
M0$%"\E$<#AP\;G^0QGMG.V406T&)@B+'O)>]M"0?-XO609! 0$! 0$! 0$!
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MN:+JD_C_ .W5U4]M,\.WZ9Z9GO=.8[):8YFZ5>6!MYBK^/LKRU>:20R;"6/
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M+D=T\)[FL+,:X0$! 0$! 0;=IOF=K?2>)OL'ALK)'B;^&2!UK)]T;#VPHZ2
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M 0$%K>2.HVVB/W:;R0?:MZ2@KQQMBC;&P4:T4"#V@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,'JS2. UKAY<)J
M*T;<V<FUCO-EBDI021/WM<.OQ&HV+)R^9N6*^JB<)86<R5K-6YMW8QCUQVPX
MKYI<G=0<MKMT[PZ_TS,_AM,K&W8*[HY@/,?]1W1T@=!R&I6\U&&ZKC'P<?U;
M1+N1JQ^ZW.ZKW3RGVHW6V5\0$! 0$! 0>HY)(9&30O='-&X/CD82U[7--06D
M4((/2%$Q$QA+ZIJFF8F-DPV?5',35FL\7BL5J6]]/CP[I76UQ(/N[^V#0>U<
M//+0WR7$5VFM5AY?)6K%555$8=7EL;/.:KF,U;IHNSC%&/?.//N9_D3J>TTK
MS,Q-WD'B*POA)C9YG&C6&Z $;G$[ .T#02=P-5BZM8F[EJHC?&WT?)G^'<W3
ME\Y3U;JOI].[UX.B^\?H7*ZPT=;7V$A?=9'!3NNC9QCBDEMY&<$H8-Y<V@<!
MT@$#;1531<U39O3%6R*HPQ[70/$F0KS.6QHC&JB<<.<<7%G20=C@:.!V$$;P
M0NA..3$Q.$B(=F=V/2/Q%H1^H+B/AO\ 44WI )WBT@K'"/'Y;_[RH&N9C\E_
MHC=1[>+L'AC)?@RO7,?5<V^;A[Y\[1.\+RXYEZCU7+J6QQWQII^WMX[:QAL7
M=K<11M!>\OA(#B7/+CY =LHMEH^=R]JUT3/35,[<=WI^+2^)-,SF8O?DIIZJ
M(C"(C?Z.>..['@T#D/HN;4G,VRAOK=S+7 UR=_%,PM<'0$"%CFO VF0M-"-P
M*V>K9J+>6G"=M>R/?ZFD\/:?5=SL=<81;^J<><;O6G+O1:K9B-$V^FH2TWN?
MG#7@@$MM;:DDCA6M"7%C:^$JN:%E^N]-<[J(]<KEXISGX<K^.-]R?5&_W..U
M?7(A 0$! 0$! 0$&1P.!RNILO:X/"6SKO)WC^S@A9ZY+B=@:T;7..P#:O*]=
MIM4375.$0R,OE[E^Y%NW&-53NGE5RMQ/+/""VAX;G.W0:[*9*E"]PV]FRNT1
MMZ!T[SX.;ZAGZ\U7C.RF-T>7%VG2-)MY"UA&VN?NJ]T=C?EK&\835>JL3H[#
M39G+R<,4?DPPM^^32D'AC8.DFGB&T[%FY+)W,U=BW1&WV1SEJ]3U*SD+$WKL
M[(W1QJGE'EVN/]8ZPRVM<S)E\H^@VLM;5I)C@BKL8W^L])77\CD;>4M111YY
MYR_.6K:K>U&_-V[/='"F.4>_FU];!IQ 0$!!U9H>!EKR/8RY [(XS(2R#=5D
MKIW_ -!7*M1JFK5=F_KHCT=,.^:-;BWX?PKW?CNS/=,US['OD[JFVUEHH8?(
MM;->8N,8^^@D'$);9S"V)S@:U#F L=7>6GK4:[DZLIFOR4;(KGJB>4\?1.WS
MO7PIJ-&H9#\-S"JJW'15$\:<,*?3&R><Q+GGF'I"716J;O#[763ORC'RNVE]
MM(3PU/6T@L=X6KH.EYZ,WEXN<=U7?'ECYW'-=TN=.S=5G]/W4]M,[O1MB>V&
M_=W7/"SU#D-/RO BR< F@!.^>U)/"T>%CG$_:K0^*<MU6:;L?HG">Z?GAZ5M
M\!9[\>:KL3.RY3C']U/"/^&9F?[5WWC\"8<EB=21-\BZB=97! V"2$\<9/A<
MU[A_=7EX5S.-%=J>$]4>?9/L];)\?Y+INV\Q&ZJ.B>^-L>F)G_*@U7ARM+G*
M3FLS1O%IW4?:?$3Y"^&<!SWVDCCY0+-I,9.TANT&IH:E5+6]%G-?ZMK#KPW?
MN^;H?A;Q-&GXV+^/XIG&)W]$\=G[>.$;IQG"<93AD(N6^N[5DM])C<M#&VC)
MNU9VL;3M(XV.#V;]HJ%1[4YW)584Q71/=.$^;=+J=^C2]4HQKFW=B./5&,>>
M)ZJ?4P+M1\GN6\4C\:ZR9>!I;V6. N[Q]/8&0%Q&[_6/ 6?&5U+/S]?5A_5]
M-/H^$-1.H:)I%,S;Z.K=A1]=<]F.W_FJA#/,3F_F-;,?B[2/XNTZ2"ZU!#Y9
MRQP<TROH-@(J&-V [^*@*N6EZ';R<]=4]5SGPCN^/L<UU[Q3?U*)MTQ^.U^W
M?-6$[)JGUX1L[\(E&ZLBE" @(/4<<DKVQQ-+Y'D-8UHJ2X[  !TE1,Q$8R^H
MB9G"-LI=Q_)S&S7;]./U&QNOH+=MX_&BW=):1;&N$<DM"#YS:GJ/FGIJ-W7:
MXI_+^+_0F<.K'ZI[8CR[X=$L^$[55<Y?\\?RHIZNCIQIC=LJJV\XV]OVSQV?
M5\^8U1H6UU!@'NQ>H='W4C,[BK-W9L9<6P:R1[0RK7=F&![-I'9EPJ2*+69&
MFWE\W-J[]=N_$=%4\IW1Y\<)[<&[U6Y?SNGTYBS/X[N4JG\M%.R(JIB(JF,,
M8GIPQIVS'3-48S,8-8UAS+L,E9X#5^GKZ7&\PHXC:9:*W8X1& 5)#^,%CFEX
MXHV^5L=Y6UH6SR.DUVZKEB[3%5C'&G'?CV8;8V;)W=F]HM5\16[U%G-6*YMY
MN(Z;F$3AT]N/TS'5MIC;LGZML0CG4.K-1ZKFCGU!D);U\0(B:_A9&RN_AC8&
MM!--I VJQ97)6<M&%JF*<?+?O4[/ZGF<[5%5^N:YC=RCNB,(]3#+-:P0$!!]
M:USW!K07.<:-:-I)/0%$S@F(QV0GGEAR0,G8Y_6T!:S8^UPS]YZ0ZX'5_P W
M[KVJHFK^(<,;67GOJ_\ ;\?1S=9\.>#L<+^<C^VW[Z__ &^GDZ 8QL;6L8T-
M8T!K6M%  -@  5 F<=LNO1$1&$/JA(@(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((]O_ *<]/_PG
MF_UEB$#D3]#.A/S)8_B6H2D) 0$! 0$!!\<YK&ESC1K14GP!!:VC72N?>2"C
MI=D8/1&-WK[T%V@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @M[ZQL\G9S8_(V\=U8W+#'/;S-#XWL=O#FNJ"%
M]45S3,33.$P^+ENFY3--48Q.^)<I<V^[G>X0W&H=!QOO,,*R7&(%9+FW&\F+
M>9&#J\\?9;Q==.UJ+F%%[95SX3W\O8YAK/AFJUC=R\=5/&GC'=SCU][GP@@T
M.PC>%:5$$! 0$! 0$! (!%#N*#H7E9WE+C 6D&G]>1S7^.@ CM<Q#Y=S'&T4
M#9F&G: >W!XNL.55S^B1<F:[6R>7#S<G0=(\4?CIBWF,9B-U7'S\^_?WMQYG
M7/(O56C,WK*S&-R.>AMW&VEM9?1;UUU*>"(R1M+'OHYP)[1AV!8&1C.VKU-N
M>J*<>.V,./E#<:I.FYC+UWHZ:JHCA.$XSNQPPGTN7M,8"ZU3J'%Z<M*^D9.Y
MCMN,>Q8X^6\^!K0YQ]17+,7HM6ZJY_3#F>2RTYB_3;C]4^7H=V:]U!:<L>6]
M[?X]K8OBNT998>%U"WMRT0V[:=(::$CJ!7-LI9G-9B(J_5.,^V7:L_F*<CE*
MJJ=G13A3W[J?+DA/1_>ON(FQVNN<1VP%&NR6,HUWA<^"0T]P\>HK#F?#\;[5
M7FGXJADO%\;K]/GI^$_'S.BM.93!ZEQMMJO",:^WRD+71W;H3%,^)I( =Q .
MH#6@/B55O6Z[54VZOTK[8NV[U$7:-U4;\'%G/O5WRMYDY(P2<>.P_P#]JLZ&
MK3Z.3VSA39Y4I=MZ@%T'2,O^'+QCOJVSY]WJ<@\29S^1FZHC[:/ICS;_ %XH
MS6X5D0$! 0$! 0$%WC,9?YG(6V*Q=N^ZR%V\16]O$*O>]VX#^L]"^*ZZ:*9J
MJG"(>EJU7=KBBB,:IW0[?Y.\I+#EKB.WN@RYU7?,'QA>#:V-IH>PB)]@T^<?
M9G:=G"!SK4M1JS5>$;*(W1[Y\MCLVB:-1D;>,[;E6^?='9[?0DY:=8V,U!G\
M7IG%7&9S$P@LK<5)WN>X^:Q@Z7..X+)RV6N9BY%NW&,RP<]GK.3LS=NSA33Z
M^R.V7(&O-=937>9=D;VL5E%5EA8@U9#$3XJN=2KG=/J  =>TW3K>3M=-.V9^
MZ><_#D_.>MZS=U._^2O93'VT_MCXSQGW8-66U: 0$! 0$'96F,.S(<K\7A'R
M&&/(86*!\K "YHNK8!Q .RHXUQO.7YMY^NYOZ;DS_EJ^3]*:=E:;^D6[,SA%
MRS$?YZ/FP^F]#Z#Y6W;LD_,FWO9XS ^3(W<,37,>0Z@92,':VHWK,S>H9O4:
M>CHQB)Q^FF9]>UK<AH^G:)7^2;O355&&-==,=N$1LY8\7KG-HGY6:7?>6<9?
MFL.'W-H&@ETD5!VL0 WD@<3=E>)H'2HT'4/XU_IJGZ*]D]D\)\N$OKQ;H_\
M.RDUT1C<M8U4]L?JI\\;8[8B.+F;1V<.F]48G-AQ;'9W+'3\.\P./!*!ZK"X
M+I>>R_\ (L5V_P!T;._AZW#]*SO\/-V[W"BJ,?[=U7_+B["U9I/#ZVQ3,5F.
MT-FV:.Y8Z!P:_C8"!1Q#MA#B#X"N09+.W,I<ZZ-^&&U^CM4TNQJ-F+5W'IQB
MK9V>G?$S'=+5^SY/\M=KAC[*]B]M6\O@?4^Z2BI]0+:8ZEJ'[JHG_AI]U+18
M:)H_[**H_P".O_JK]SG7F1F\)J/5]]F\ V5ME=\#GB=@C)E:P,<YH!.QW#Q;
M=M25T/2LO=L9:FW=PQIY<G&O$&<L9O.UWK&/35AOC#;AA.'9.&.W:U1;97Q
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MJM4U5]=RJJ)V<XPC''#AAQC=JVJ>:K;C5\.L-&02XO)OLO1,A).(WMF<12O
M*@\&RA<37A;Y(IMVF3T;IRTV,Q,5T]6-.&.SS]OOG:T6I>)>O.QF\I$VJYHZ
M:IGIVSW;=VS"9F<>FGZ8PVQO=W5Q?74]Y=/[2YN)'S3/H&\4DA+G&C0 *D]
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M%\OL0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$!!'M_].>G_ .$\W^LL0@QW)C&"YY1Z&F@?
MP1OPEA5CMI:>P:" 1O1*2X;.WBC;'P-=P[W. ))1"IZ/;_@F>Y"!Z/;_ ()G
MN0@>CV_X)GN0@>CV_P""9[D('H]O^"9[D(+"[Q0FD[2!PCKYS:;/5%$%W9VC
M;2+@!XG$U<[PH+A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?F2Q_$M0E(2 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MP !51?XC!]1(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_P!98A Y$_0SH3\R6/XEJ$I"0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MZ&="?F2Q_$M0E(2 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MMG#<^.",/\;J<1]=:N[GLQ=^^NJ?/+?9?2\I8_V[5%/=3&/IWLRL)LQ 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9T)^9+'\2U"4A(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @CV_^G/3_P#">;_66(0.1/T,Z$_,EC^):A*0D! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 01[?_ $YZ?_A/-_K+$('(GZ&="?F2Q_$M0E(2 @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((]O\ Z<]/_P )
MYO\ 66(0.1/T,Z$_,EC^):A*0D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MFO/Y5YO](X#]I('R\UY_*O-_I' ?M) ^7FO/Y5YO](X#]I('R\UY_*O-_I'
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MFO/Y5YO](X#]I('R\UY_*O-_I' ?M) ^7FO/Y5YO](X#]I('R\UY_*O-_I'
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MFO/Y5YO](X#]I('R\UY_*O-_I' ?M) ^7FO/Y5YO](X#]I('R\UY_*O-_I'
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8C'.E:X7_ &8:PL:UP=('$O'"T@.()?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>lc_oursolutions-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_oursolutions-4c.jpg
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M%!04%!04%!04%/_  !$( ;8#M@,!$0 "$0$#$0'_Q #?  $  04! 0$
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M5^9FX2Y]D>695L981(<"% PE*)BCQHKZG9H':M&[91=1THBF1,[E?3S51(4
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MA#,""FT9I7T)D$PF$ U"(](B/3025 H% H% H% H% H% H% H% H% H% H%
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MHB!E!3U#W1O04QFV6"0PH^3(5)N1M)'G&B13JBDA(JIJ)G513,<2IW*J>Y"
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M/[MK^'0P26/>T)MU-2Z&.RAW^)Y$Z&S2+RABM$++#P"Q#+!RA$1$  O,U#W
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MCC:_#_QT,&TX+O-M]N$\6B(&2,CD;4!,Z@))%5A))   (B*"Y2F,  (7,34
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MU86F XJ^ ID"J(% KF0<I@)B*JF5U)I7X$ H\+V&AR/HLI2E*!2@ % +  <
M  HCV@4"@4"@4"@4"@4"@4$)EF'XSG,(XQW+(Q"4B')1!1NN6^D;6 Y#!8Q#
MA^:<@@8.X-!\QJR.Y#2<]T]*4>BY<N2N&F<")>UDP<4C*')S+W[44Y!:%5T6
M'X. T9/IG#\+QC 8)MCF)1J,9$MB@!4D2]8Y@"PG5./64.;\XYQ$1HQ3U H%
M H% H% H% H% H% H% H% H% H% H% H% H% H- W2VJA]R(PBI3>2LUB[KX
MSE#;ZMZP=DZR8@H7K&2$WZ1,>!@[QK"!7%,.DY_VFY=MCV<M58_$L!331SB'
M*/*3E\I3543Y1^68;M4@1YW+N'7, " AI$!R/J-FR9QS5%C'MTFC%N4$V[9
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MP,'*Y?@LA)QZKJ1C'SQ2+=IJG(1JH9DH8YE"E 0.!@(!  PA8;#\ ANM H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H-&BL>AV6ZV0Y VC%D9>2
MBV)7TJ*J@MURI'43(F"0ET 8@$"Y@->P]'?#>:!0*!0*!0*!0*!0:_E J@K
M\J3+&@,J@"A3',3M1.6K=L&GY0F^5I-PZM!L% H% H% H% H% H% H% H%!
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M !T^!P 2*<;T)=)HA0*!0*!006:94PP?$YG+Y1-59A"M%7JZ+<NM4Y4BWTD
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M_@O7J?\ ^=_O?%?_ .G_ /Y_>XG[2FY@YKF)H.,6UX[CQE&R D&Y%G5]*ZW
M.( )>60;CP 1#Y5>8\XO^'LQEX_'7A57T1RT4_\ U3_MU/LG_P ?^3>*S%7F
M-R/@M;U%GIJY+ES[/P4_[W$J\:^]% H% H% H% H% H% H% H% H% H% H%
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M"@4"@4"@4"@4"@4"@4'!O9UWNA-VI#,&D/B88R>/<I/I Y7)7/:W3X5$S*&
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M1$;M%@*FVN$'8*MDO+;YPYEI%HR,(H)KN3"9-HW,J("*:"0)MTQ,(7 E^%[
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MV7]08;Q!O#H8GX&[+^H,-X@WAT,3\#=E_4&&\0;PZ&)^!NR_J##>(-X=#$_
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M[4/_ $#"_P#=$%_C"T'0G?\ >U_ZP_\ O#519H/+AWPH%P[X4"X=\*!<.^%
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M)/JD,H*2B:A!30>B(IV$NLO"@^G("6-.PK*7.P=Q9WB153QTBF"+M P]*:I
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M*!0*!0069E8GQ*8+***HQPH%[2JW*518I.<G82%.( (WMTCT51L+C5VA76
M?6;4 =%[C>U06Z!0*!0*!0*!0*!0*!0*!00^/E9E//\ 8SJ'$9MX9X"I2E C
MH4T.81/2(W( :=)AX]-!,4"@4"@4"@4"@4"@4"@4"@AY8&8S6-"X.H5T5T[%
MB0A2B0Z@LE0."@B-R@!-0ET_G<.B@F*!0*!0*!0*!0*!0*!0*!06G6CLCKF"
M()\A7F"7B($Y9M0@ ]VW108.. V+C<*5D<ZC$(]H#514 *J9$$":#'*41 #"
M6VH &UZ"3H% H% H% H% H% H%!X(@ 7'HH- G]Q016490*95SIB)%'JEQ1
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M6(VL/?O05]H0 A5>:3EG#40^H-)BVU7 >Z%N-!XFY;+)"NDL11  N*I3 8@
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M)V$I+AJ&]@Z:HV!QJ%PJ)P #ZS:@#B #?C4%N@4"@4"@4"@4"@4"@4"@4$/
M%:E//=E6.L)IIX9T"A-'+<BFAK3)Q'40H:;&[MQX51,5 H% H% H% H% H%
MH% H(B5*U--8V9=4Z;DKEV+-(A-1%3BR5 Y3FN&D"DN8!XW'A5$DX<(-4%'+
MI4B+=(HG554,!"%*4+B)C#8   [M6(F9PCE29P< SWVHH6)54CL&:EFW9!TF
MDEA,FQ*;_4 +'5_DTAWA&O59+]/7+D;UV=R-7/\ R><SGGENU.[;^.>K^;A$
MYO3NA/J&,ZR-PT2-PY$=9F0 [UTK&'^4PUZFSY1E;7)1$^W2\S>\WS-S^K=C
MHT?S:P.4Y4*G-&?DN9TZ^V+WX?#KK>\-9X*=D-'Q=_CJVRV"'W=W+A#%%IDK
MU9,@W!)VIVDG#N65U5K7/+<M<Y;=/V1A[G+1YAF:/PW*HZ__ %8NQ87[43\R
MA&N6QY')!L!G#2R2X!W1T&'0?\@"6NAS7Z;HJC&S5A.J>3;_ ,7:6/U+<M3_
M -^G>IXJ>;VQ_P 'T%C&8XYF#/MD _3=%+;FH_)62$>X=,UC%_E#\E>/S.3N
MY>K=N4X>[:]GE<[9S-.]:JBJ/XY83U:;<*!0*!0*!06G0%%HY XB5,4%0.8
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MVA+47K(%,%AU!W!KZ'Y/9JJRE,QKGWOD_P"H:XISU6.JGW-%_$7&?G.?$_\
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M7K<.[5$M4"@4"@4"@4"@4"@4"@X5[1FZ8XO#^AT&OIR&83'M2R8V.U9&N43
M(=!U.)"]X+CPX5Z?R/R[OJ^]KCX:>N?Y//\ G&?[BWN4_BJZHUOCP     X
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MR@-4;;*;J;<0C_R9+91',WX.18G;K."%.FY "CH4N/4^67B>P<0XU!=R+<K
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MA&PT98/J/&)E7(L<BIY=@O%+235%V>->%$CEN98@'%)4H@ @<M[&"U&*6H%
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M5R"17K7MSU-DY*@%DP7:)K%05 O>.F-^[>@W(A")D*FF4")D "D(4+% H<
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MT$3&%$HHELF(GZPB0.K<W'OT$C0*!0*!084M+1T''.)65<$:L&I!4664&P
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MLF;%[0X/IECH&;G7$QU#&-J(<VHIA$!,.KIH,I[MOB,BRRJ/=LC':YH;7D1
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M#K#?C1BV.@4"@4"@XG[4/_0,+_W1!?XPM!T)W_>U_P"L/_O#519H% H% H%
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MF-WB@CWOJ0,4!_VA"NTL>4YJ[R43$=.CWM"]YAE[7XJX]_N<FR3VM$0UHXC
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MZ:M\<[(8Q^HO[.M6E[6V1%-]?C+-0G>3<J$'_P 1#5)_3-OFKG83^HYX.O\
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M0*!0*!0*!01F1>4/(,AY)531D^6'955S)D2*?F%N)S*W( :;_*H)9;1S5.6
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M!<>CB'QT#EFZW1U>GB'QT#EGX='6Z.(?'0.6?CT=7IXA\= Y9^KT=;HXA\=
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M)QG3T3V+&2O3,QA&,?W4]JV6!E#(-7()I<EX8J;<1<MP,)CW$NHHJ:B='2<
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M DAVH$P6$O;&NCEB;2 \SFZ+W#Y.J_P5/$488XSA[)[&7@KV]NX1CACRQVK
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M5TU5017.U6.%DW"=A,0W<&PW ?R5E3.$X\J51C#CD[D&=X^_.P?2)P.'634
MB>A0@]!BCIZ*[BW:M5QC$.KKN7*)PF46.>9;YT4^BGX-<GAK>IAW]>L]/,N\
MZ*?03\&KX:WJ3OZ];P<]R[SHI]!/P:>&MZE[^O6I]/LO\Z*?03\&KX:WJ3OZ
M]:D<^R_SHI]!/P:>&MZCOZ]:D<_S#SJI]!/P*OAK>H[^O6I'<#,?.JGT$_ J
M^%M:COZ];P=P<Q\ZJ?03\"GA;6H[^O6I_$+,O.JGT$O J^%M:D[^O6\_$+,O
M.RGT$O J>%M:E[^O6I'</,_.RGT$O K+PMK4G?W-;P=Q,S\[*?02\"GA;7"G
MB+FM2.XF:>=E/H)>!5\):X3Q%S6\_$7-/.ZGT$O IX2UPGB+FMY^(V:^=U/H
M)>!3PEKA/$7-:D=QLU\[J?02\"GA+7">(N:U([CYMYW4^@EX%7PEKA/$7-;P
M=R,W\\*?02\"KX2UPIXBYK4CN3F_GA7Z"7@5?"6N$\1<UO/Q)S?SPK]!+P*>
M$M<)XBYK>?B5G'GA7Z"7@4\):X3Q%S6I'<O.;?\ .%?H)>!5\'9X3Q%S6I'<
MO.?/*OT$O IX.SPGB+FMY^)F=>>5?H)>!3P=GA/$7-:G\3<Z\\J_02\"KX.S
MPIXBYK>?B=G?GE7Z"7@4\'9X3Q%S6I_$[._/2OT$O J^#L\)XBYK>?B?GGGI
M7Z"7@4\'9X3Q%S6\_%#///2OT$O IX.SPGB+FM2.Z&>^>E?H)>!5\'9X3Q%S
M6\'='/?/2OT$O J^"L\*>)N:W@[I9]Y[5^@CX%/!6>%/$W-:G\4L_P#/:OT$
M? IX*SPGB;FMX.Z>?^>U?%H^!5\%9X5\3<UJ1W4W \]J^+1\"G@K/">)N:WG
MXJ;@>?%?%H^!5\%9X4\3<UO!W5W \^*^+1\"G@K/">)N:U/XK;@^?%?%H^!3
MP-GA/$W-:G\5MP?/BOBT? J^!L\)XFYK>#NON%Y\5\6CX%/ V.%/$W-;P=V-
MP_/JOBT? J^!L<)XFYK4CNQN'Y]5\6CX%/ V.$\3<UO/Q9W#\^J^+1\"KX&Q
MPGB;FMY^+6XGGU;Q:/V=/ V.'WIXFYK4_BUN+Y^6\6C]G3P-CA]Z^)N:WGXM
M[B^?EO%H_9U? 6.'WGB;FMX.[FXOGY;Q:/V=/ 6.'WIXJ[K4CNYN-Y^6\6C]
MG5\!8X?>GBKNM3^+NX_GY;Q:/V=/ 6.'WGBKNL_%W<?S\MXM'[.G@+'#[SQ5
MW6I'=[<?S^MXM'[.KX"QP^\\5=UO/Q?W(\_K>+1^SIX"QP^\\5=UO!W?W(\_
MK>+1^SJ^ L</O3Q5W6\_&#<GS^MXM#[.G@+'#[T\5=UJ1WAW)]8%O%H?9U?3
M['#[SQ5WB4_C#N5ZP+>+0^SIZ?8X?>>*N\0.\6Y7K MXM#[.GI]CA]YXJ[Q*
M1WCW+]8%O%H?9U?3\OP^\\5=XGGXQ[E^L"WBT/LZ>GY?A]Z>+N\2G\9-S/6%
M;Q:'V=7T_+\/O3Q=WB4_C+N9ZPK>+0^SIZ?E^'WGB[O$\_&7<WUA6\6A]G5]
M.R_#[SQ=WB>#O-N;ZPK>+0^SIZ?E^'WGB[O$\_&;<[UA6\6A]G3T[+\/O3Q=
MWB>#O/N=?_J);Q:'V=/3LOP^\\7=XE/XT;G^L2WBT/LZOIV7X?>>+N\3S\:-
MS_6);Q:'V=7T[+\/O3QEWB4CO3NAZQ+>+0^SJ^G9?@]Z>,O<3S\:MT/6-;Q:
M'V=/3LOP>\\9>XG@[U;H^L:_BT/LZ>FY?@]Z>,O<3S\:]T?6-?Q2'V=/3<OP
M>]?&7N)Y^->Z/K&OXI#[.KZ;E^".M/&7N)3^-FZ7K&OXI#[.GIN7X/>>,O<3
MP=[-TO6-?Q2'V=/3<OP>]/&7N)X.]NZ?K(OXI#[.KZ;EN#WGC+W$I'>[=/UD
M7\4A]G5]-RW!'6DYV]Q//QNW4]9%_%(?9T]-RW!'6Q\;>XG@[W[J>LB_BF_V
M=/3<MP1UKXV]Q//QPW5]9%_%-_LZOIF6X(ZT\;>XG@[X;J^LJ_BF_P!G3TS+
M<$=9XV]Q*?QQW5]95_%-_LZ>F9;@CK3QM[B>#OCNMZRK^*;_ &=7TS+<$=9X
MZ]Q*1WRW7]95_%-_LJOIF6X(ZT\=?XGGXY[K^LR_BF_V5/3,MP1UIXZ_Q*?Q
MTW8]9E_%-_LJOIF6X(ZT\=?XG@[Z;L>LR_BF_P!E3TS+<$=9XZ_Q>Y2.^N[/
MK,OXIO\ 95?2\MP1U]IXZ_Q>X_'7=GUF7\4W^RIZ7EN".OM3Q]_B]RD=]MVO
M6=?Q3?[*KZ7EN".OM3Q]_B]RG\=]VO6=?Q3?[*GI>6X(Z^UCX^_Q>YX._&[=
MO^IU_%-_LJOI>5X(Z^T\??XO<I_'C=OUG7\4W^RJ^EY7@CK[4]0O\7N>#OSN
MYZT+^*;_ &5/2\KP1U]IZAF.+W//QZW<]:%_%-_LJ>E97@CK[4]0S'%[E([]
M;N^M"_BF_P!E3TK*\$=?:>H9CB]SS\>]W?6AQXIO]E67I65X(Z^UA/F.8XO<
MI'?S=[UH<>*;_95?2LKP1U]K'U',<?N4COYN]ZTN/%-_LJ>E97@CK[4GS+,<
M?N>#O[N_ZTN/%-_LJOI.5X(Z^U/4LSQ^Y2._V\'K2X\4V^RIZ3E>".OM/4LQ
MQSU//Q_W@]:7'BFWV57TG*\$=?:GJ69XYZE(^T!O#ZU./%-OLJ>DY7@CK[4G
MS/,\<]2D?:!WB]:G'BFWV591Y1E.".OM<<^:9GCGJ4^\%O$%A]*G'B6WV57T
MC*<$=?:Q]4S7'/5V/JS9#?6-W,9DAI<4V6:MD[K-@ZJ;LA XK(7[O=.GTEZ0
MN'1XSS/RJK*SO4Z:)ZNB>UZWR[S*G,QNU:*XZ^F'9*Z)W10*!0*!0*!0*!0*
M!0*"(R/'6.21YF;L-*I;F;N "YTC]\.^ ]T.[7-:NS;G&'%<MQ7&$N"S4.^@
MGZD>_)I6)Q*8.)#D'H,4>Z UWMNY%<8PZBNB:9PE'UR.-280 !$>@.FJJ9'#
MLJ!$7 Q*W( NL3W);3:]_E=ZN'O[?)BY>YKU(&X&*!@&X#Q :V'"I,( %QZ
MXC09DI$OH@[9-^0I#.T".T-)@/=%2^D1MT#PZ*PHKBO'#F95433RH\>FN1@E
M([&,AF&YG<9&K.6I1$.<4"E*82](%$PAJM\%<5=ZBB<)ERTVJJHQB$4*2H <
MPIFTIFT*&TCI*>]M(CT -PZ*Y<7&MC6:*1HBD:HIHCRBJ!Z*HI&@I&LD4#TU
M4*"F@I'HJBD:"D:HIHBFJ*:"D:H\&@I&J*1JHI&JBD:#P:"D:HIJH\'IH*:*
MIJHI&B*V[9P\<H,V:1EW;E0J+=$G$QU%! I2A^41I,Q$8SR$1,SA#H+[!\'Q
M(R3+.,B<C/'3*HO&Q"(*@W X7+K.)37X?DOWK5UU.9O7=-NF-W75SMR;-NWH
MKJTZH:-,MXE"66:X\Z6DHP-/97"B0D64N4!,&@ OU1'3T5OVYJFG&N,):M<1
M%6%.F$<8IR&%-0ADU"_*(<HD,%^^!@ :Y&+P$ECF,0B2ASE#48A2&,8I>^(
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MM!+$6->UDU"B)##Q[AJSLYBU>C&BJ*L''=LW+4Q%=,TX\G3]S&R''IO%)A>
MR)H+&8:@F9=L)R*:2K$ Y!U)B8HW*/?K.S>HNT171.-,L;MNNW5N5QA5"+&N
M9Q*1Z:"FJQ4C525LU90XI4C58RNLGSV+>MY&.<*-7[4Y5FSE$PD434(-RF*8
M.(" UC51%5,TU1C$E-4TS$Q.$P^W]B?:"9;@(HXQE*B;/-4BV24X$1D"D#B8
M@< *KW3)AT_*+PN!?GWFOE$Y>=^WIH_]/\NG:]UY9YK%_P""O17[_P"?0[O7
MG'H"@4"@4"@4"@4"@4"@4&I[@M(->"46F#\E1*_8EB@ J\T>@I0[H&MU@[W'
MN7K;RU5<5_"U[\4S3I<*KO'3K:OZ,_Y!JP2W[-U<9(_)Y0>2",H$>ARTF^CL
MWR!T:KF >(_*K0R\7,-$1AC]K=OS1CIF<<#',=C718R+GV3!JXDT#*(CSEQE
M% TB8JQ2@ ID+PZ![U6[=JC&JF9G#V;I;MQ.$51&G:B!;0,;A;>5>1W;I5=R
M\9$.)Q33Z@F %#@%[B0"]4/AKEQKJNS3$X1A$N/"FFWC,8SIAL,@QCI6;B(6
M13*HN^QU$D>X,(E%)V0#F*(6$ ZUAX5KTU54T35'-7I]CFJIBJJ*9YZ6GS\<
MTB(:"9G;<N><HG>R2HB.L"*&$$D[7X</@[E;EJN:JJIQ^'DAK5TQ333'/SI&
M.>PV6-(;&W;IQ$SK$HM(UPB(G:+";B760H@)3C8.M_EKCKIJM357$153.F=;
M.FJFN(IF<)CD7RKHP^ RS&0C&RZ[&6!FY$YU+*+@ AS1$H_*+T%MP&W'C6.$
MU7HF)G33BRQBFU,3')+(B<9BW":<)-,X]C*+,#.4BIKKJ2NHA-0+'#BF4#6N
M)!K&N]5'Q4S,QCT;OL6BW3/PU1$3A]J%!M!0T+CBCZ++*.\A#F.'*BIT^4F)
MP(!&^C@!PU7XWKGWJZZJL)PBG^-+BPIIIIQC'>_C0FW.*0:$UE#H$6B;*',U
M08LGJQT&0*.$RB)UC@(FL%^ 7XC7!%^N::(TXU8XX<OV.6;5,553HPC#EY$>
M:/P5.=8J.7+$C=RS4%9H@X.K')R9+ 0#J\#E2. B-N^%<F]>W)PB=$ZM.':P
MW;>]&,QR?9BUG*&#F.E11<QZ$;S$4U4D62AEFJA#7LJD<PB(E-WNY6U9JBJG
M1,S[>5P7*9BK3&'L0@]%<[C4C04C62*!Z:J%!304CT512-!2-44T135%-!2-
M4>#04C5%(U44C512-!X-!2-44U4>#TT%-%4U44C1&V[6*M$MQ,?,\MRA7.1.
M_1SCI'*G_P"(0K4SL3-BK!L9;#O:<6%N*W=L\\R%*0 Q'"CU5<@GX:T%1ND8
MM^DNFP!^2L\I,39IPU,;\3%RK'6E]MVD^5":G8V<2QN!:)IIR\THD5PH4M]0
M$1*(".KCQM\ =-<.;JHQIIFG?JGDCM<F7BK":HG=CGELNXRD=.[8062DD#S4
M@WD08EFEFP,UUDA%0#%.0O>$A>/P7[HUJY2*J,Q51ANQACACBY[\Q5:IJQQG
M'EY$_N!G<YBNXL1'0I6Z#5\5DI*_4D,J[YBHH@5100U !"AU-/0(C6OE<M1=
ML535CC&.'0YK]ZJBY$1SX8L='&8-MN[F#XL>FX+"1R<LQC--TS/%DM1C 2UN
MDHV[QC7[U93>KG+41C^*<)GH8Q;I[^J<.2,?M<X0S3)]RI>'QK)Y$JL-*234
MRK9))-(I U:=)#% # %C"7B/3\-=I.7MY:FJNB--,2THO5WIBFJ=$RZB_P B
MCX'-%8YYF<4QQ*/LQ<8<=D;EE;<L!TF'2(:Q$=6KHMPZ*ZFFS57:QBW5-<Z=
M_'G;U5R*;F$UQ%,?TX(+&'T7C^!Y]+P**$C'Q4SVB![0 J(A<4R(*6&PCR]=
MPOWJV+U-5R];IJQB:J?B^]Q6ZHHMUS3IB)T.,S4L_G9)U,RBA59%Z<JCA0A0
M3*)@ "\"AP#@ 5W=NB**8IIY(==75-4XSRR[INH?;=MD\.]S )1Q)-XYNHC'
MLBD[*LF10YB H<;"%S .H-0<*Z#)1?FW5%O=PQG3/*[3,]U%<37CC@Q=NLK'
M.MQ\IGI)H4K):".@6.$VH :IJD#08W=$US:A^&L\W8[BQ13$Z=[EZ6.7N=Y=
MJJF.;D1^W<XKG60S.6Y"S:.G.+1)SP$4DB!$$2B8YR% @".K0!=!1'HOPXVK
MDS=N+%%-NB9B*ZOBEAEZYNUS75A\,:(>[<91+[IH9-CF<JI2D<:.-(MUS)$(
M9FOJTARC$ -(<=1>[U?A&F;LTY6:*[7PSCA[4RUVJ_%5->F,,?8P7TW(;=;3
MX>XQ%5-F_P DYCF6FB)D.JHH0H'*0#* 8  ;V .\7AW:Y*;=.8S-R+FF*.2&
M$US9L433.FKEE+9;(K2L9LW*+HIMW+Q^1PLF@F"*8JJ&1,8X$   -8B)Q_+7
M#8HBFJ_3'-':Y;M4U1:F>>5C<.54F]SDMKC(H,\3>RC%63*B0"N'3A8"KG4.
MK>X":X)A\%992C<R_?Z9KBF<-41R,<Q5OW>Z_IF8Q]Z>>Y-&PF<.8^3S>(:X
M:Q$T>XPHS$P)IMN6%B&'2(<S4('U=%N'16O39JKLQ--NJ:YT[^/.Y9NQ3=F)
MN4[L:-W#H_C[&J8/.XI'L\FQ+&<C2QF>>2JAX3(UT2JI.8_6'(1UJ?("P:>-
MNFX7&MO,VKE4T7*Z-^F*=-.J>>7!9KHB*J*:MV9G1.N.;L>0DPKANY>1$W1?
M)-,K?LB(1V3D1(LW0.)-)%RI@4  #% O$2AQ*)36N-6Y;[[+T]Q&-$3IIYYZ
M"BON[M7>SA5,?BYEPL?FC3=; '663"&1,EU#EA)MJ! 360T&.<!T '6#4 ]W
MAT#4W[4Y:[%NF:)_JIDW;D7K>_.]JG[&;'E0A)'>+<!NV2=Y'!OUD8L5B<P&
MVH .94"CW;C<1[Q;=^L*\:Z;%J9PIJC3TK3.[-ZYSTSHV1*+@IE_N=MAFY,V
M63?N\<2![$S!TTTUTE3)G5Y>H@%#I):UODFL/<KENVZ<MF+?=QA%>B8845S?
MLUQ7..[R3]C*S7.)W!L!V[D<:[.UE7D4!7#]1!-=<6[9)(X(%%0!TD,8]SVX
MC8*PRV6HOWKL5XS$5<F.OG97[]=JU1-.&.'W<C7=_P!!H.204R@W3;.IN(2>
M/P2"Q3K:K:A[XV-IO\ 5L^53/=U4S.,4U80XL_$;],\4.2C7<.O>#58J1Z*H
MIHCP:HI&@\H*:J/!H*1JHI&LF,J:(\&@IJCP:(IH*1JL5(UDBFB*:HZQL[$/
M$X/-LP9/649)MV18&#?2BY&3=-[(B JG!900 #D3 ND.FXUT_F-R-^W;F)JB
M9WJHB,=$='M=CD:)W;ER)B)B-V)G1IG^(;=E&WK#,=WL9DY1PFXA,JAQE90\
M2H15)P]B4 (Y1;K)#8P''EW,7C:]:5C-U6<K733'Q4581O<T53HF8VMF[E8N
MYFF9GX:Z<9PYYIZ>G&-B"@L@QV:VBW7=P&+ML?!J6.YC9JNLNBX1!P)DB+%5
M$;*E #%4,40U:N@+5L7;-RC-6(KKFO'>Y>;1S=&IP6KUNK+7JJ*(IPYM?MZ=
M:Z\PC!6<R_W""*24VN)BB60,8FZIFXR+@0;$:F.!@-<%0$PAJZ1J4YF]-$6=
M[_N]YNS//A&G'8M67LQ5-W=CN=S>B.;'^/>JV[V]QZ4)CF.9W#0<8^R1DJX:
M'[6]')G!3)G43=)$( H(DX=4A^X4>[PJ9S-UT;]=JJJJ*)U1N1T:Y,KE:*XI
MINT4TS5&N=_V]&UK,>PPC&=KHG+YW&4\DFE)]]$GYRZC9%1!$PV,J5/Y0E*0
M03#H 1N-[5MU5WKN8JMT5[E.Y%7)CL^]KQ19M6*:ZZ-^=^:>N>5/3.V>%8_F
M.?R2S!>0Q3$8IG,LL;!<Z8JJR);@DHJ6Y^0F)3"/&X (7$;<=>WG;URU:C'"
MNY5-,U8:N?VRY;F3M6[ER9C&FBF*HI]N.CV:.M"X%"XIGHY-F#J#A(:-Q=BW
M(E#"]<-8A=\\4.4CAVJ8QU 3(4+"0@@!AM7/F[EW+[EN*JJIKF=.$35$1S0X
M<I;M9B:Z]VFFFB(T8_#,SSRFV6WNVN09/#+M7,:NFA%R,GEF,XR^4=-16C@*
M*)6ZA[J%(N![G)W--@'NUP59O,6[=43%7XJ8IJKC"=/+C['/1E<O<N4[LT\D
MS5315C&C###HGG1S*>@,AV'W!>0>-ML;$'\65PBQ766;JE%4IDQLL)M*A2CI
M4TC8W ;!7)5:KMYVU%5<UZ*N6(QZNIQ1=HN9*Y-%$4:8Y.3F0V%B ;$;MW&P
M<^%XWM_YY:V,Q_FV/94U[7^%?]L?<R\356?>SYFR$^<[B#;2L67%Q<&,<A7Q
MUB N1N8PC^:;K 7@ ";X:PS$13GK<T:*MVK>]G-BY,O\63KBO33O4[O/JY/M
M^]L\YA^V$1NOF>-+-HU*61:QIL.B9]TX2B%EUD2&<\Y8#B<5!N ) 8]KC_-I
MVLQF:\K;KB:L,:M^:8C>Y=&$:M;;N6<O&9KIJBG'"G=BKDG7]NI%0>VT8QCL
MNRC*(>$C)9A-%A(_'9]^LWA6(BB1P8YE$Q$ZVLAPY-SVMQN-<UW.U556Z+=5
M5433O353'Q3IP^SI<=G)VX[RNNFF)IJPBFJ?AC1$]>+%4PK$#9D]?X>T@9W%
M&T,C(S0R,DY&!@WRBFA0O:$1!18!T""28\1 W1P"L_%7>YB+DUT535,1A3&]
M7'LG1'3+CIRMJ;TS;BBNG=QG&KX:9^_H7IO$=HXS-,&E959JSPS)8M9X\19*
MNPAS/V]TR:3JE!PFW4/\H!#A;N!6-K,9JNS<IIQFNBJ(C'#>PGJQ<E[*Y6B]
M1-?PQ5$Z(_#C'7@NL=L(Z2S=\KDD+"P\%$8^I.M6\1(+#!RX$5%--<SHQCG3
M0N;ZW380  &W&I5GJJ;,11555557N_%3&]3T8<\ZCP-%5V9JIIIIIIWL(GX:
MNG'5K:=NC#X0V@866@'$$AE!UU6LW$8P^5?,#(6$Z+D@+7,F(6T'#58>%;^0
MN7IKJIKBK=PQIFN,)Z8Z77^8V[$4TU6YIWL<)BB<8]O0Y<-=RZ25!NFK#"7J
M*ZS9=-RV4,BX1.51%9,PD.0Y!N4Q3!80$!"X"%)B)C"6,3,3C#]&MEI3/I?
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MJHI&LF,J:(\&@IJCP:(IH*1JL5(UDBFB*:HE5<EF%<51PHRB88XB]-* W*F
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MNUS:[J9^#5]N/+JZ$[&[S[@1*48#1PP.\AT09L)1S'H+R!690L#<7!@U<OX
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MDWF5_P#=5O!J]_;XHVG=U:I>>BV3^97_ -U6\&KW]OBC:=W5JE2.+9/YE?\
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MA!@Y:SLF$5I.99,QT5$EN-QU%,00'@("%!1O&AF$DQVSQV0-&*&F\@1:Y(S
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MVGY-C6&@H3S7+8"7S:?F'[A/#IYV>#60<*'$,?FCPK1RT.F>X\M!=1<S93@
M%6!,;]8U!'9IG>0I8O@#&.E91":QK$6.;R MDW3@9%^DDB1JQ>'0*<=#DI'H
MJ<VQ3"4HCT#8KL4)+I.=TFKZ%=F7QW,L7)- EJ,=/FL5T$T5R )A G-0=E*;
M3\KEE[H41H4'NCN5'+Y2A)^39AZ]SA3#L31$56Z3=P9N1?Z\X%OV=)$AU+%
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M$C/)</!0V3\N5<K)N'#>89*/!:@*11(FH4$C%YIA$@#;@/&P7T=YLCFG[A.
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M:1ZH%#2  7A00T?M'AT<R;1:97R\1'O&,A$QKI^Z<-F*T4J"S8&Q%%!T$(8
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M< -0Q39=E]MRQYXKR-JCCQ3> Y!EUQ L>R<G>-R%'F:BG264%0BI1UE&UC<
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MW;EFBXC$]0IMUR(*$ Y$Q,8Q+]%Q[@B%!DOML,+DH^?BWK RK/)E&:TT3GK
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MRD7(('=++Z"%3 0-8PW*'8\9;-6ZTZ+9Y*.Q6E%E5RRX.0(BJ9-(!29=H33
26H  "04=2>H36,(WL1/T'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>fc_abcdaiassure-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_abcdaiassure-4c.jpg
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M%!04%!04%!04%/_  !$( U\%(P,!$0 "$0$#$0'_Q #H  $   <! 0
M         0(#! 4&!P@) 0$  @,! 0$              0(#! 4&!P@0  $#
M P(# @<'# \%! <##0$  @,1! 42!B$Q!T$346%Q(C(4"(&1<I+2%1>Q0E*R
M(S/3-%15%E:AP=%B@J)3D[-TE+0U-C=#<Z,D&(-$=2?APF,E1=57\/'#9-2U
M.";6XH1E1F:F"1$!  $#  4'"04&!0,$ @(#  $1 @,A,1($!4%1<:'1$Q1A
M@9&Q(C)24P;PP3,T%>%"<I*R%F*"TB,U\:+"0],D5.)CLP=S@Q?_V@ , P$
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M+%-444RRAHK511*6>!*HHCH2I1$,4531,(TJ41[I*E$A@/--HV4HC';535%
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M[GIMS%YJKUZ4-4H<F]ID4Z.Y3^NV']*5U>$_F8Z)<;C7Y2[IM];PPO<OFSZ
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MWE> X_GV]XV.2R*>?7/9YG)MN[;SF[<O#@MN63\AE[@/=#:QEH<6Q-+W&KR
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MN':%U.';Y&[WS%WNW=4\_:XO%=PG>K(FWW[>N.;L\[Q9=6MS8W,ME?026MY
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MS:-#+&+G6-]%!%=%MN:LH*@&H![0LUDS,:6.^(B="! YTXH+8M:2:BO%743
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M4@LB32MW/]Q@'\X]JB="8TR^;W1;HUENM>>R6+LLBS&18ZV];NKZ>-TX+Y)
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M>:O<7$<J\5:BE6L=1[/*97I_NK&8:$W68OL1?6MA "UIDN)K=\<;=4A#15Q
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M5%G85)SJE2A(3Q4JB"(*)5%"4[>2A*HUI*K,K*C645:IHG[NHH>2BJU%O-;
M@D<U>+E)M9[N_P#]#Z5J5_K;-/Z4<K^/R_P?M0HQ>ZG)[RS6517BBMW03222
M:96@:&>%4F9K"T1%)6XY*ZB*)$! H!RX((L+6OU/&IGV/)1)"/=R2N<Z*-VG
ML [ E8C64KJ4ZD5U @CA0JR%]98UUU%WSWZ(^0':5AOR;,T9;+*Q5=VEAZG=
MD/<'A[?N3Z=JQW7[5J]MFS*?+N8+9VH@NX:/#4'BHQ:ULFI3Q^1MV6[8IW:9
M&\!X"%;)CFM85LOBE)75QD;6%O>!VKQ!8[<<RO-\0MI<O"8R^$ESR*>(>XKQ
MBFNE2<D4T,+P))(XDU/E6TUQ0"!0>!2'$$%IH1Q!'!!-++-,*22.>WP.)(41
M$03,RD9Z2F1<'D%1=;?7%9&-$*$I@@G![*<55+5,YU$QNW\K-B;FRN)IH PN
MDC+ TZVAPIJ(/:N;FWVW'?-LQJ>DW+@>7><49;;K8B:ZZ\BP'5_#_FV[]^+Y
M2P_J-O-+<_MG-\=O6F^F##?FV[]^+Y2C]1MYI3_;6;X[>L^F##_FV[]^+Y2?
MJ%O-)_;6;X[>M!W6+#-:7?-EV: GG%V?PD_4+>:4Q],YIGW[>MT"VN6W-M#<
ML!:R>-DK6NY@/:' 'WUT[9VHB>=Y3);L73;/),QZ%76K44-02@:TH)FRTX=B
MBB:J@>'#PU4435(XEC@]HXMXA3"&3CO;=S:N>&.[6E8)LEFBZ%R*'B%C74;F
M)LL3FD5=3S3VU"M;-)5NBK$213QC4]A#?"MF)B6"8F%+6K45J%_!*%6,W'OZ
MQVC;V/KUK-<NNC(U@@+1I$5#4ZB.=5S]YRQBF-&MV^&[A=OFU%LQ&S37Y6MS
M]:\-*P-;B[P<035T79_"6K;OUL<DNM=].9I_?MZU8=<<(/\ X5>>_%\I5\;'
M,M_;N7X[>OL6MQUGPLSPYN+O  *<3%\I9+=_MCDE2[Z;S3^_;UJ)ZPX?\VW?
MOQ?*5OU"WFE7^VLWQV];;-N;CM]RXSYSM89((N]?#W<I:75CI4^:2*<5O8,L
M9;=J(<'?MSNW3+W=TQ,TB='E9;6MBC00UI0J:TH5-82B$-:4$0]*%4-:4*FM
M*%36%-!*9 E$5 ]*%4=:435'O E"J/?.TZ-1T'ZVO!10JE#^"FA5#6E"J>.8
M--#R43:1*I+Q&H?L*(3*AWBM16J'>>-30J=XE"IK)Y)0JF:USNQ1*54,8.+B
MJU30=<,9P;^PFR54G7#G>(*VRKM)"]30JIN>IHK5*Z6C7.[&@NIY!5)T$:9H
MT-O5O$4_PZ[]^/Y2Y/ZE9\,O7?VQG^.WK1^EO#_FZ[]^/Y2C]2M^&4_VSG^.
MWK!U;Q _^'7?OQ?NJ?U*WX9/[9S_ !V]9]+>(_-UW[\7[JC]2M^&3^V<_P =
MO6O,3U*QF7R=KBX;&YBENG]VR1YCTM-":FAKV+)CWZV^Z+:3I:V]< RX,5V2
M;[9BV*\K<N\73H\S5)WGC4T15'O$HFJ'>'PI1%40\I0JCWB435 R42A5 R>-
M*(J=YXTH5.\2A5#O%-$50[Q*%4KI%-"J\A/FM YE8YA>M(<YFZJXHRR-./NO
M-<YO./ZTT\/B7+CB5D?NR]7_ &QGG3MV]:G]*F*_-]U[\?[JG]3L^&4?VOG^
M9;UGTJ8G\WW7OQ_NI^J6?#)_:^?YEO6A]*>)_-]U[\?[J?JEGPR?VOG^9;UK
MG'=1L;DLA;8Z*RN8Y;J01,>\QZ6D]IH:T63'Q&V^Z+:3I:^\_3V;!BNR3?;,
M617E;=WI76H\O5#O?&E"K(X:&&[N7MF&IL;-09V$UI^PL.:9MC0RXHB9TKK-
MVMO;PQ7$+1&XOTN8WDX4Y^XL>&Z9FDKY;8B*PPO>]M?=6U1KU2B05)4T15=0
MW X<5CFUDBY="6HYK'1>J/>#PI1-4-=3P*4*LE:6X=$9I':8V\*\R2L%]VFC
M+;'*O&6\3Q5KG"O*H6.;I9**;HC&XM/N'PJ8FJLPD(HK"2O%$(ZAX$$'$%2+
M*9Y:LEL,<RI-NG,Y\E;9JKM)S?U' *-A.VMGSEYJ?>5XMHI,U2.FTCFK4158
M3WKFFE?=6:VQANO2,O3VJ9L1%ZL+IK@J;*VTCWP/)*)JB Y_)!6@@ >''GX%
M2ZY:VUD8XQ2BP3+/$)WQ-IQ2))AC;J!K@1S6>VYANM8:6T%2MF+VM-BRFMG-
MY K+%S%-JWBDFM+F*Y:W5)"\/8UW(D&O%7F(NBG.QQ,VS7F=*QF5ARMDRYB9
MW9?PDC)JYKAP(7#R8IQW4EV\>2+[:PQ^Y[V2PQ;W6LQ@N'N:V,L(!I7BLV[6
M1=?IBL,.\WS;9HFDM6Q^U,KD[?UQNB*.0DQF5QUO)[:#PKH9-ZLLFC0LW6^^
M*L3=6-Q87,EK<LT2QGSAX0>1"V+;XNBL->ZR;9I*XMLOE+.+U>UNY(H?K6-/
M!OAHJ78;+IK,+6Y;[8I$KK$9_+8[_E+5S9F3O&F*4$TD>>8//B2L>7!9?IG1
M1EQ9[[-$::LSD-IY[)3BZN[R"2<CSAYP$8')K>'+CS6MCWK'9%(B6QDW7)?-
M9F&NNL)[2\DM+ENF>(T< :CQ$+=VXNMK&IJ;$VW4EG\-'$R\MS+Z->WPTX+3
MS3.S-&YAB-J&ZU%27FE.)J>!"Y;I-+N^[-S/W1!CUNTT\"Z=E:0YUU*RN)[B
MPNVPNGDEAECB;$]K6!X=H[0:BE52VVZVM-*TW6W:UKD+MMY>/N(VED9#6M:>
M=&BG&BR8[=FVC'?=M35:.-5D42*54*<:J1%0 ")5&@E0F%=K.2I,KQ"N&T"H
MLR%ICG3-UO=I!Y#M6&[)1FMQU+JQ?;C6#J9VGP*;;ZEUE%DYM5D8F;T?_HO2
MM6O]39I_2ER!:,A*7<J"A(K0Z!0T4X_=+_>6X@,[II(J-C8*@'A[ROM4I52E
M:K=H<!Q-?"KJB @(" @E=QJT EU. "E#8,>^/U1K8J!X],'@:^-:>2)KI;5E
M*:&*R/=/N7]T:CAJIX5L8ZTTL-]*Z%Q89"&&$02NTO;R/918[\<S-87LOB(I
M*[9D[![G-<_B.%2.'N+'..Z%XR6RQV1F@GG#H#J:!Q/959\<3$:6&^8F="RH
M#V+(QH:0.Q2% @* 0$! 03Q1NGF9 WTG\BDS2*IB*S1G8\;:,:&]WK(YN/ G
MW%J3DNELQ9$+"^M!;O!8?N;JT'@*S6758[[:,8?2*SL"*A*-:<40S^.LXH[=
MCW-#Y'"I)XK4R7S,MNRV(AB,SL3:F:NYLED,<R;(RM ?,7R-)[MNEO . X >
M!:DX++KJW15T\7$=YPV;&._9B.CL:U^@6SA4?-3#0_RDGREG\%A^'UJ_K>^_
M,GT1V(_H%LW\TL_G)/E)X+#\/K3^M[[\R?1'8C^@6R_S2S^<E^4H\%A^'UGZ
MUOOS.J.Q!VP-ED$'$L((H1WDORE/@L/P^L_6]]C_ -2?1'8V*)L<,4<,0TQ1
M-:R-O@:T4 ]P!;<6Q$4AQ[KYNF9G7*?6IHBIK2A4UI0J!U5 F;(6]O!*)JJB
M0.'!5HFJG(S@2!Q/8IB43"^MLI&&Z+@EKF]OA 6*['/(R6Y(Y61AE9/&)&><
MQWHU6&8I++$U3$-(+7-JT\".RBA+6I1W4TD8/!KB MZ-,-.=$KRWQTLH$DKM
M##V=I"QW9(ADBR90R^U<!GX[>/,6++IEH7&#4Y["TO U>@6UK0<UI9,=N3WM
M+I;MO>7=J]U=LUUM9R'3K95LYACQ3 U_89)>%/X2MCW3%/[OK9K^,[['_J3Z
M([%I^@>SOS4S^<D^4LG@L/P^M3];WWYD^B.Q.-@[.J!\TL)/*DDGRE'@L/P^
MM/ZUOOS)]$=B^BZ7[1=1TF,C:T_6A\I/VRPSNV'DM];)'%]]^9U1V,]8[9Q&
M'LS88>#U2W#G2!@+G O?S-7$GC19L41CBD1H:.\YLF\7;>2:W:JK0N(<6D\C
M1;KGU-92A5#7XTH5-?C2A4+SX4HBJ&L^%*%36IH5-92A4UI0J@7 I1%4-7'F
MA5'7XT*FOQH5-?C2A5#6?"E"J)<2A5#6E"JXMY'2'N^?C5+HHO;-5UZM!QJ"
M3X5CVI9-F%":T !=&3P["KQ>I-JBV$_7&@5JJT5*Q1]HJHTRMHA3==TX-'#P
MJ8L5VE%TSG<R5>BM4FL*:*U1UJ*)-:FA5#5XDH(Q0RW;W0P-U/TDN!-!IY'F
MHNF(C26Q,SH:R-C[1[,6P>'SY/E+4\#A^'UNQ^N;]\R?1'8F.R-H<OFME?AR
M?*3P.'X?6G]<WWYD^B.Q ['VB.>+9\>3Y2>!P_#ZT?KF_?,GT1V(C8^T#_\
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M?]S8I/4RRUV<0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!2GN(
M[9@?*2&$AM1QI5!.Q[)&A['!S3R(XA!,@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @Q^9_$Q\,?4*#"V]U/:NU1.H.UIXM/E"E#-VF5@N*,D^Y2^ ^B?(
M5"5^@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @("#'YG\3'PQ]0H-?4H$%[:9
M.>VHUQ[R+[$\QY"@S=M>073:Q.\[M8>#@H2N$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$&/S/XF/ACZA0:^I0(""+7.:0YI+7#D1P*#*VF9<VC+H:F_R@Y^Z
M.U!EXY8YFA\3@YI[0H2G0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&/S/XF/ACZ
MA0:^I0(" @(*D%Q-;OUPN+3VCL/E"#-6F7BFHR?[G)X?K3^XH2R7/B$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$&/S/XF/ACZA0:^I0(" @(" @N[7(7%KP!UQ?8
M.Y>YX$&;M;^WNA1ATR=L;N?N>%0E=(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\J<4 @CF.7- H3R!X<2@ $\A5 H13Q\D @@T(H? 4! 0$&0M,M-!1DWW6/\
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MLUS7M#F$.:>1'$*$HH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MVUW!=-K$[CVL/!P]Q0E70$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MR-;/LQZ0\OA09F*:*=@?$X.:>T*$IT! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M#N?N>%0E=H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$! 0$#EQ'-!D;3+RPT9/66/P_7#]U!FH+B&X9KA<'#M':/*%"55 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M([]I=#B&NWSM7=>5<[7_ ,2L?A?M%?1.!_D<?1/KEY/B7YF_[<D.FKM.>("
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M8H]-N^]X<\5Q7VWQ_AF)]2^6!M" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M5,/L;>.+L=M7VTK#(6.]=R; S$&X<A*Z<2S9H11FU%U),[S)P=382\@MX4H
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M_A^^7@^(_3N7!6[%[=O_ '1V^;T/I_!OK/=]ZICWC_:OY_W)\_[OG]+K0(<
MYIJ#Q!'(A>2?0XFJ* @(" @(" @(" @(""G//!:P2W5U*R&VA8Z2::1P8QC&
M"KG.<:   5)*F(F9I&M6ZZ+8K.B(<JNO:3Z06MQ);G-OF,9TF2&TN7QD_O7"
M.A'C"[=O!-[F*[/7#@7?4.Y6S3;KYI[%'_J;Z0?G:?\ L5S\A6_0M[^&/3"O
M]Q[E\4_RR?\ 4WT@_.T_]BN?D)^A;W\,>F#^X]R^*?Y9/^IOI!^=I_[%<_(3
M]"WOX8],']Q[E\4_RR?]3?2#\[3_ -BN?D)^A;W\,>F#^X]R^*?Y9/\ J;Z0
M?G:?^Q7/R$_0M[^&/3!_<>Y?%/\ +)_U-](/SM/_ &*Y^0GZ%O?PQZ8/[CW+
MXI_ED_ZF^D'YVG_L5S\A/T+>_ACTP?W'N7Q3_+)_U-](/SM/_8KGY"?H6]_#
M'I@_N/<OBG^63_J;Z0?G:?\ L5S\A/T+>_ACTP?W'N7Q3_+)_P!3?2#\[3_V
M*Y^0GZ%O?PQZ8/[CW+XI_ED_ZF^D'YVG_L5S\A/T+>_ACTP?W'N7Q3_+)_U-
M](/SM/\ V*Y^0GZ%O?PQZ8/[CW+XI_ED_P"IOI!^=I_[%<_(3]"WOX8],']Q
M[E\4_P LG_4WT@_.T_\ 8KGY"?H6]_#'I@_N/<OBG^63_J;Z0?G:?^Q7/R$_
M0M[^&/3!_<>Y?%/\LG_4WT@_.T_]BN?D)^A;W\,>F#^X]R^*?Y9/^IOI!^=I
M_P"Q7/R$_0M[^&/3!_<>Y?%/\LG_ %-](/SM/_8KGY"?H6]_#'I@_N/<OBG^
M63_J;Z0?G:?^Q7/R$_0M[^&/3!_<>Y?%/\LG_4WT@_.T_P#8KGY"?H6]_#'I
M@_N/<OBG^63_ *F^D'YVG_L5S\A/T+>_ACTP?W'N7Q3_ "R?]3?2#\[3_P!B
MN?D)^A;W\,>F#^X]R^*?Y9/^IOI!^=I_[%<_(3]"WOX8],']Q[E\4_RR?]3?
M2#\[3_V*Y^0GZ%O?PQZ8/[CW+XI_ED_ZF^D'YVG_ +%<_(3]"WOX8],']Q[E
M\4_RR?\ 4WT@_.T_]BN?D)^A;W\,>F#^X]R^*?Y9/^IOI!^=I_[%<_(3]"WO
MX8],']Q[E\4_RR?]3?2#\[3_ -BN?D)^A;W\,>F#^X]R^*?Y9/\ J;Z0?G:?
M^Q7/R$_0M[^&/3!_<>Y?%/\ +)_U-](/SM/_ &*Y^0GZ%O?PQZ8/[CW+XI_E
MD_ZF^D'YVG_L5S\A/T+>_ACTP?W'N7Q3_+)_U-](/SM/_8KGY"?H6]_#'I@_
MN/<OBG^63_J;Z0?G:?\ L5S\A/T+>_ACTP?W'N7Q3_+)_P!3?2#\[3_V*Y^0
MGZ%O?PQZ8/[CW+XI_EEN6R^IFR>H#9AM7*LO)[<:I[5S7PSL83348Y6M<6U^
MN%0N?O6XYMV_$MI7T.EN?$=WWJO=75F.35/HEMJT71$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$',MT?XE??"_:"XO'/R.3HCUPZ'#?S-GVY)6N'].?R-^J5\ZX?
MKN\SUN]:H95==HB"*#5UY1VQ0*MK^-0_#;]59L'XEO2QY/=GH7V9]*'R._:7
M0XAKM\[5W7E7.U_\2L?A?M%?1.!_D<?1/KEY/B7YF_[<D.FKM.>(" @(" @(
M" @(" @Q^9_$Q\,?4*#7U*! 01+G%VHDEPI0]O#D@F,LIH-9H.(%>%4$6]]*
M=#-3R132VI\T=E!V!!99#.8K&\,KF+.R-:EMW>00.J/")'@U""G99["9,D8W
M-6%ZYQJ6VU[;S.)\C)"24&2D=<L([TO:ZNL:J@U/;Q^J@IZWBE''@=0X]OA0
M1$D@^N//4/A'M\J"5 0$! 08S<>W\3NW;^3VOG8N^P^8MWVEXP4U!K^(>RO)
M['!KV'L< @Q?1_>N2>ZYZ6;ZG!ZC;5B8)+AU0W+XH^;;9*#5Z0>VC9A4ELE:
MTJ H2ZN@XAE?9_DEP?J&.SQ-[9LOQB^_@#(G')/<Y_K6ESC)HJ.Z+6M[MPU
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MI321M<ZD>IX:7:'/&EQ8#PJ*FG#LJIB>66.^*Q$1&G[D_JK7F)D$K9'/C#Y
M 6Z'U-6&HXD"G$<%:V:5JPSII$34>S0TP/&IS'>8[4=(!Y@#EQ/:HIIJ3DI&
MRI^KN+7590Z@ X^:!V&JFJ(KS+=\;F%S:BH)%>?$> J)B&>RZ8T+C&Y*]Q<G
M?P./=C[Y$?0>!X?W5-MTVSH4S[O;O-E,D:M4\L=L>3T4=@Z<]3,A@+UN6P$U
M/1%_CI3]SD9X'@?Q7CB/?"KO>YX=^Q[-\:>?EMG[>EPMUWK>^"[Q%]D^S/\
M+?'V\\/8^S=YX?>^);D\5)21M&W=H\CO8)"/1</ ?K7<C[X7RG?]PR[GDV+_
M #3R2^\\)XO@XCA[S%.G]ZWEMGR_=/*V)<YV1 0$! 0$! 0$!!QOVH/])+_^
MMV?]*%W^ _FXZ)]3S7U)^2NZ;?6\*+Z2^3B @(" @(" @(" @(" @(" @("
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M_P#Z+@-P5M%J;;SY.2+2V5Q)M+4O-:'2-4CJ_P %/:F=>MAK==KB+::_M/\
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M! 0$! 0<;]J#_22__K=G_2A=_@/YN.B?4\U]2?DKNFWUO"B^DODX@(" @("
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MW>&W9MK6G2Y+F_\ ]9BT[NM3L.X]8IRH,O%W5?=UT6NWF^(@0$! 0$! 0$!
M0$! 0$! 0$&@Y=S&=?>F9DY2X;<D</'_ &C3:/=_%1+MR@:'U=CS4FSICAYW
M0:)H'7(B:]T[V=ZT-;'HY4<6N=^]%%,(ENE@V]996[,C(R6_;&T7,L(+8W2
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MF_2#KAU%W&P!]E@;#$[1M9QQ#IF]YDKIH^ Z9C7>-:KHN@(@0$'G[>O5O>F
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MK^UOZQ+_ '>5<GB_Y2_H^^';X'^=Q],^J7T'7RU]B$! 0$! 0$! 0$! 0$!
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MV[3Y=#>WK@>];O9MW6UMC7333[VD8/ YG<N2BP^ L9LCDYZF.VMVZW4'-Q[
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MI0J:H8MW1/.9.#.P;FSL65FS5A98ZXOY63.GD;;7HNWO>USRQE&_<XVQ!K>
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MW[2Z'$-=OG:NZ\JYVO\ XE8_"_:*^B<#_(X^B?7+R?$OS-_VY(=-7:<\0$!
M0$! 0$! 0$!!C\S^)CX8^H4&OJ4" @ EI#FDAP-01P((0:#F.G=]9YRXWGTQ
MS VENZY)?DK1\1GP.6?X;VT86ELG9W\&E_'C5!<P]<<IM@"VZM[.R.WW-J'9
M_$1OSF"D#>;Q-:M=-%7[&6+AX>");)BNNG1O,L:^PWWA#J&H,GOH;:2GC9.Y
MCA[H4"IDNMW1[$QF2^WU@F@#5ICR%O.\@>!D3WN/N!!J\W7O](@;?I-M+*[P
MF?P9EYX78?!QU.G6^\O6L+@/2I%&ZHY<PI%A:=.\QN7*VNZ.L64AW)E[&07&
M(VW9,?#MS&2T])L4AU7<K36DMQR[&H.BN<Y[B]Y+G.-23Q)*(00$! 0$!!K>
M\]ZXO9-C:S7<$V2S.4E-I@-OV(UWV1NZ5[N(?6L;SDE=YK!S\"#%X?HYD]YS
MQ;AZXW,68G:[OL=LBT+AM_&@C@V2.O\ SDP^NEFJVOHMI0HEV.VMK:RMX[6S
MA9;VL+0R*")HCC8T<@UK0 !Y% JH"##[EVIMK>.,DPVZ<5:Y?%R^E;7D396@
M]CFZA5KAV.;0A!Q_([<WAT6:<CM^6\W?TFMQJO=NW#G76;P\(XNFL)WDON(&
M#BZWE)< /-=X)&^8C+8K/XJSSN#O(\AALA$)[*]@-8Y(SV\>((/!S3Q:>!1"
M\0$! 0$! 0:?NSISB=S9.'=%A>W6VM^6D?=6>Z\26LN^[X?<KF-X,=S%P]"8
M'Q$(+:VW[UBV?_R^\-I,WMC(ZTW!L][6798WMFQ=T]CPX_\ LI7-\ 1*[9[3
M'2B !N=N\GMVX(!=;9G#Y&U>T^ GN',KY'((N]IKH[+YF*S%WF;@^C;XO%9*
M[D)I6GF6]/?*4%K-U1ZG[K:(>G^P9\+:3#S=P[V>,="P<M3+"%TES*>-0#H\
M:"7 ]-8+?.0[SWME9MY[[@#O5,I?,;%98\/IJ;CK)M8X1P^^.U2'PHAO))))
M)J3Q)/$DE 0$! 0<FZZ9$Q8K&8IM?^:G?.ZGV-NW30^4R5]Q>U^E<-<M^3X8
MIZ?^CY?]?[ULX,6'X[IN_EBG_EU/%6[LI-<;CO\ 0ZL$+FVXC> YGW(4=P/[
MZJ]#O=VUEGR:&7Z=P1BW#''QUN],TCJAA>^MW#SXC&3S,3N'Q756M%ST,V]"
MM!907'W07(@@!\^:=C@T>*K=53X@%6J-,3J7<KS P6=K/$UH\UTSWTE(/,5I
MYK?WH]U6ABNYZ351%F'3=U#-;^<#&-4C2*^%I X^(JRDW\E+O0&R@CJ)KV)I
M::%C6R/</XH'[*M%9U(VIB*TT>A4C980-%QIEN!72W660L<>7 ><XT4UF4;,
M_;[49D;R=;X<XC&V45D*A_K4=?6=5*<)34@>(+8B8G77[GG\G#IG+-W)7S_;
MR-<DD:]O>/U/F?QD>YVHEVKG[WA412'7OB9C[?:%+QTX+)%S6G%$ZU:9A 9-
MWS999 7/'$N:?WQ(YE+9B=$HOLF*3#*8_%&6Q^=;^=MMB+>33K=YSYI:@NBA
M9]>ZE"XGS6CF>Q4[S32-:+[=F:4K-/-'29C.W>5#W%@AQYEU,MP=57M  +CS
M<0W@*\!R "R61$4:>Q%L3,:;IUS/W<T,2"T@T%2>SL 677T,5OLQ7E9W'9\-
M$4.4!GCA!;!>1AKKN$'AI&L:9&<?O<G"G(A8KK.6%HMC32D5U_XNSIU+B\QT
M.IU]=2:\5=N)L\ACHP;=LSJ'1)$2#&:5JS@:^C4)%W)&N-=5*3HB='-&O_K]
MJ,5#9W,ME+>PM<Z&%VF<L(.EO.KFUKI\=*+)-^FB+;(FRNFJKCL9D<HYPL+=
M\P9]\D TQ1CPOD<0UONE3-\0P7;-OO,H+7"8^)T63RSKJ5_!UIBVB4-<*<'7
M$NEGQ Y5K=.J%)NF=,1-/+]OV'SWB[4&&PQ%N\,<'-DO9)+QY<!0&GF,X#LT
MT4;,SIJM%DS[-UWH9;']1-PV =92N@?B'-H^QMHHK?NVN.HNA<UIT/!X]H\(
M6&[#9KY5O#UK$33[OMRJ]WFMRNA=E<1G)\IBF>?-&6M;/;./(3Q-' #LD;YG
MDY*8BV-$Q26O=;9=2V;8KU>:?M"&*W3F)[H^N7%M=6;BZ..2]MH)#0 $ZM#=
M0J.5"K;,3%>;F1DP1;?LQKG1VNF8C>5CG,3#C+FW=:3VP+VMM6<6PUJ'4-:C
MW5J>&G'DF^)K7G<S>+HNLMQ3$Q$3,QLQIBFG3'EAA>I>VQ/M#'9RWNV2,QSI
M8P[T2^"X.MHH>((/!1BS3.>ZV8I,TZF]NEL6X+=F=J*S2>:/MH<6+7S$10G4
M\-+] !<7'F0  >SCY%MS=2)JZUEL;4;/,LV2W!CN+>-[1%(&OE!TBHC-10GC
M45[%ANB-;<Q73,S'*LW"GD6I?K=7%6BD+B2WDCN(S1\#VRL(Y@L.H?46OM3$
MUYFU.&,ELV3^_$V^F*/:_L[9UL6\8H6NI;YJR>UC3VN:T3M/ETM=[ZW/J3%&
M7<XOC]V8GS3H^^'SCZ+S3N_$IQ3^_;=;Y[=/W2]6+Y>^[B @(" @(.-^U!_I
M)?\ ];L_Z4+O\!_-QT3ZGFOJ3\E=TV^MX47TE\G$!!%O![2>0<"?<*(G4]S[
M]W%T*ZH82WQ&X-X6K+&WN&WD1MKMEO+WK&/8*ZVN-*//"B^;[IAWW=;YNLQS
M68IJJ^M[[FW#?+(LR9+:1-?>B/MK:CC>I'L_=%\==-V('YO-W#0V5UOWDLTQ
M;Z+9+F5H8QE>R/RZ2MZ_<M_WZZ.]]FV/MJC[_2YUG$.&\/MF,/M73S5FO^:=
M'H]#B&%ZRYZTZL-ZHY5@N9YI'1WMC$=+!8O9W?<Q5Y=VVA97FX5=S*]%EX99
M.Z]Q;HYI\O.\KAXQDMWSQ%VFNN/\/-'1ZW;=V6'LX]8+MN[+K=+<+F9HV-NS
MW[+*601MTM$L5RP@N: &ZF=@YE>>W>[B&YQW<6;5O)HKZ)AZG>K.&;_/>SDV
M+N73%LSTQ=#A75##].MKYK%,Z99I^:AAB[R_FE?WNFYCEU,H]L<;"".QM>2]
M)N&3>,MEW?V[/-T>F7E.)8MVW?);X>_;IKY=/HB/^CTKN+>'0KK-M*P_2K/1
M8WU=[;OU9]P+2]MI]!:^.CVG4.-#I:0>87D<.[;[N66>[MVN356)>XS;UP_B
M&&.\OBWEI6DQ+G?1SJYL:?8L_2CJ<X0XBDL%G=RAYMY+69YD$<CV5=&]CC5C
M^5*<06\>KQ/AV:,_B,&OECR_?7E<3@_%,%V[^&WC1'EYITZ^2DZO-S)<ATO]
MF?&PW%\[?LDL?=O-M;,O(;@M>6G35L$+I' 'LYI9O_$;IB.ZZICUS1-_#>%6
M5N[[S;5L^J*L9[.O6O$;"@N]I;N>Z#!7<_K5ED&L=(VWG>T,D;(UM7:'AK2"
MT>::U'&HS<:X7?O$QDQ^]$4F.>.UK< XQ9NT3BRS2V9K$\T]G[>=L&\-B>S/
M/9Y?<&+W1%:WLT%Q-98ZUOF.MVW3F.+-, C?*!K(\P&G92BU=VWOB,3;9=96
M*Q69C33IK1N[WN/"IMNOMR1$TFD1=%*]&F?-U+;V8^JFT]KX7*;/W9>Q8P7%
MT;^SN;GA;R=[$R*2-S^32.[!&K@:J_'=PRY;[<F.-JD4FFOG^]C^G.(X,-EV
M+).S6=J)G5JB/N289_1_IQUOP=_M;/1.VR;"]?D+M]QZU!#<RB1K(VO:WAPI
M0$D^-3EC>]YW*Z,EGM5BFBFC0MAG<=TWZV<5\;.S-=-8C7R_M6'4+JYB\-UV
MQW4#:EU%FL3;V,-M>-@<0V6)_>-FC!<!1P!#F]E:+)N?#KK]QG#DC9F9F8^Y
MAW_BMF+B%N;'.W;%L1-//5O.[A[/'62\Q^[<INH8J]MXFPWENZ9EE-+ PEPB
MECF:3J:7$:XSRX5/"G.W?Q^Y6SCMLVHGS^K[W3WF.&[_ '6Y;LFS,:->S7IB
M?7'8TOK]UJVYN+;L'3O8![W!0F+UV]8QT<+H[4#NK>%KP'%H(!<XBGFBE5T.
M$<+R8\DYLWO<D=.N9<SC?&,63'&#![NBL\FC5$=O11GNL7478^?Z*6.W<-G+
M:\S<+<8'V41<9!W#6A_-H'F]JUN&[EFQ[Y-]ULQ;[6EN\6W_ '?)N.Q;?$W>
MSH0]F?J+L?9^R,EC]S9RVQM]-E9;B.WG+@\Q&W@:'\&D4):X>XG'-RS9LULV
M6S=&S]\L?TYOV#!N]UN2^+9VN7^&UY:?Q<\CC5SB/?7M'S^-4/2^V=J^S+N7
M:V%;E,Y'CMPP6<,>4E%R^PD?<AM9"YLX+#YU?.:.(7D,^\<2Q9;MFW:MK--%
M='FTO>[ONW"LV&S:NBVZ+8KIV=/+KT-ER?5KI-T?V3<[6Z77(RF6F$K[<P.=
M-&VZF:&^L7$[@&NH /-94G2&T:.*T\?#MZWW-&3/&S'W<T1VMS-Q3<]PP3CW
M:=J[R:8K/+,\O1'DU0TSV>>MV!V?BI]D;U>8,1),^>PR+F.EB89Z=Y#,UH)#
M2[SFNH>9KPHNAQGA63-=&7%INY8^^'-X#QG'@LG#FT171/)IY/O]-5UOG8/L
MWPX;-YS ;HCCRK[6XFQ6,M[]DT NM!=&QL08Z2A=04+J!8]TWOB,WVV7V:*Q
M6:<GJ9=]W+AD67Y++XVJ32V+HI7DT:V?V]U6Z:]6.G46Q>J%_P#,^9BBBCEN
MI7=TV26V T7,,Q:6->:><U].)( (6MFX?O.Z;QWN"-JWFZ>2FMM[OQ/==^W;
MN=XNV;J:9G1J_>B=5?)TZ*+BTZA=(>@^SKS#[%R8W+N&[<Z8%CQ/WMR6Z6NG
MEC#8V1LIZ#37W22JW;GO?$,T79;=BV/5Y(UU7MW[<N&8)LPW=Y=.GGK/EF-%
M&%]FSJ3M+;.!W!^F.>M[')Y')F[I<%P?)KB;J?P:10NJL_&]QRY;[.[MF8BV
MC6^G^(8<>*_O;XBZZZNGHAY]Q.Y+G;6\X-U8HMDGQ^0=>6X=4,D:)2=)[=+V
MDM/B*]3DP1EPSCNY8H\=CWJ<.\][9R75^W2]/;DRWL_==;2QR^?SGZ/[@M81
M"3+*RSN8V$ZS$\S-='(T.)+2WP\Q4A>.P8]_W"9MLMV[9\\=.C3#W6\9>&\2
MMBZ^_8NCRQ;/1IT2XIU7VKTEVS8XV+IYN.3.99TT@R0?(V=HA+1H<UT<;&"C
MA2E2>*]#P_>-ZRW3WUFQ')]JO+\4W7<\-EO<9)ONKIY='FBCEJ[3SH@(.D=
MO]7]K?UB7^[RKD\7_*7]'WP[? _SN/IGU2^@Z^6OL0@(" @(" @(" @(" @(
M" @(" @(" @YENC_ !*^^%^T%Q>.?D<G1'KAT.&_F;/MR2M</Z<_D;]4KYUP
M_7=YGK=ZU0RJZ[1$$4&KKRCMB@5;7\:A^&WZJS8/Q+>ECR>[/0OLSZ4/D=^T
MNAQ#7;YVKNO*N=K_ .)6/POVBOHG _R./HGUR\GQ+\S?]N2'35VG/$! 0$!
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M*%W^ _FXZ)]3S7U)^2NZ;?6\*+Z2^3B @(" @(" @(" @(" @(" @(" @("
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MY\X06E/5K"!KN#FOGK</H>7!WF?Q5,UY6&;-'O5_[>KE27&6R\K6QR7+VQO
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M'W_BN+==$^U=S1]_,[W#>"YM\]J/9L^*?NCE^VEZVV5T$Z;;*9%+#BVY7*L
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M5;0RR- GG%'4X%P%$%.]W-+;Q82";=^;@Z6.WQ<X["[C%S<-N[C .QQ,[/6
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M5IS<Z-MKM71JP,^*Q]N!7U_($-'A#Y6Q_M+TFXSL;K-W\4ODOU+'?<6BS_\
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MX/ZO^KY!N]-\^H(F-,=[7S6:?_%[K7R9]^$! 0$! 0<;]J#_ $DO_P"MV?\
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MXF;3B\"U[7:@?4+0@24/+OGN0=$@@M[2VALK.&.VLK9@CMK6!C8H8F#DUC&
M-:/$ B%1 0$! 0$!!H&Z\UN#<NY?HGZ?W1L,\Z".[W;N5@#OF3&3^@R*O WE
MR >Z'UC//\8)=0V;LO;FPL%!M[;%FVTL(:ND<?/FGF=Q?-/(?.DD>>+GNX^X
MH&?0$! 08[.X'#;GQ-W@MP6,.1P]]&8KJSN&A\;V'Q'D1S!'$'B.*#C.*ERO
M2C<V-Z<;FO)<CLW-O-OL#<=T[7/#.T%PQ%[(?2=I'_*RN](#1Q(X2.C\1P/
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M=]LRRW;G[./[W;Y*\B93E1D[P%]@W:[:Q63SVQZGP[?8IO&2.:Z[UL,MAIB
M@("#I'0+_5_:W]8E_N\JY/%_RE_1]\.WP/\ .X^F?5+Z#KY:^Q" @(" @("
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MW3:V4,=O".W1$T-%?'P7R7-ENRWS?=KNFOI?=]VP6X,5N.SW;(B(\R[6)L"
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M?.N9<[AO!-RRQ=M8XFE.?M=]Z&Y._P SMK;>3RD[KF_N!*9IWT#G%LLK16@
MX  +N[I=,XHF?+ZWS;CN#'@W[)CQQLVQ,4C_ "P[NMIQ! 0$! 0$! 0$! 0$
M&/S/XF/ACZA0:^I0(-$/_P"L7M3O*:!L_+=S7^4^<K;53QZ42Z%OG8UMONPA
MQMYF,KB;:-SC*,/<BU[]KVZ2R;4QX>WMH0MW<]\NW:[:MMMNG_%%:=#G;_N%
MF^8^[ONNMMY=F:5\DZ)K#23[/6$=(9)MX;KGU%[I&39*-[7]ZT-D#P;?B'M:
M&O\ "."Z%_&;[K9MG'CI,4]V>WDY'+Q_3^*S)&2,F3:B:^]&O17]WEI$3SPT
MB^Z6V&#O[VRWMG]T6F+GE>^QS&,NR_&OBD8(],\7<RNBDTM#7ZJM<!PX<$P<
M9RXK;;8MLG9BE9C3HU<JN\_3V[Y[[[KKKXVYF9B)C9TQ$3HF)UQ&GR:-3&3[
MPRVQ<E*1GH]X;?C[W(6N<%;>X@OY6L@C=DAYK90UOF1'6T5]*G +>LWG!O%F
MS%LQ?-+=F(K6V--+9_=K.FZ7.S[AO&[Y-N+XV*S=MW33VYI;%U\:[]FW19;%
M(F:5IH=>Z8Y!EQ!?;AW%<QMW-FO5[J?66LC98OK'9-C/(-?1Q;6CG$UIQ"XF
M\[EDQSHBNO5II,:X\NSRSJ=_<N*8<]M:TT1/M:)FV[1;=3DVZ>S$Z?)#H@O;
M-U--Q$=6G31[37O*Z*<?KJ&GA6CW=W-+J1ELGECT\^KTIHKFVG-()F2G2'T8
MX.\QU0'<#R-#Q2ZRZW7%%K<EMVJ8E55%W%<GI_ZE+CNZZCL.+UFGHT&9?W5?
M=UJ1O2($! 0$! 0$! 0$! 0$! 0$!!H.6T_3YTT[ST1AMQ]SX.]K::OXJ)=N
M4#'9&\G#VXZPI\X3-U![A5D4=:&1WAY4:./G4KPJ4%2U@M,7 V-TC1(_SI9I
M" ^60\7.))_8Y <!P43*8MF=2>6?&S-T3RP2,[6O<QPX&O(^,)M1SK=W=S2M
MAA;:.C\?-+9\ 0V%]8C332K'ZFTHT#@!PKX5-5$*YVUI5L.0C XD'U>;@.=#
M5AY?O>)[ $%6#+123-MIX)K6X>[0QDK#I<X:O1>VK3P83SY>5!?H.+;D_P#U
MD<%HIJ.R\IWM.>CYPMM-?%J4C>40(" @E<UKVECP'-<*$'B""IB:(F(F*2\F
M=7.GD5G=7^WYFEN+OVF?&3@$F,:JLH23YT3A0\:D<3Z2^M;AO-O$=TI=[VJ[
MIY_/KZGY]XCNN7@/$HOQ^Y7:LUTFV==D]'NSYKN5Y'O[.XQ][<8Z_;W-_;/,
M<H^L<1R=X@1Q!Y47FLEEUETVW:X?9MVWG'O&*W+CFMM\5CLZ8U2MG:XZ!XI7
MEX#Y#VJE6<$E$J*C9#X*A6B2BI%(]AUQN+7\N':I@5A<1O:[OHP".;HSH=[W
M(J:ITL[MS$X+(7<S<WE'XS'B"1T%S)$0'7 ;5C">(H3S(6?'9;-:SH:&]Y<M
MEMO=V[5TSU,='81T>6R^MN97A;N8UE/#K>03[C52+8Z6SM3T=*&F9@!BQ\8!
M^S/?.]VK@ E)Y(36WEN3M.2-/-AMP>;G-A8T>6M2IB;NCT(F+->OTI!<2MHZ
MXN;4M/-O=LF=[S6_MI6>68(B.2)^W2J?..)AXOQC+RH(:]Q?:MKX0V)QK3QE
M5FZWF^Y&Q?/[U.M?X\665T0B[-HVOXO.T-MP?$Z,?;-]U;&/9OG[FEO-U^.V
M9B*S37]ON2;EQ+L7.]KY&7$>KS+R(ZX9>VK7\CXTSVQ;I4W#-=DMC:UL"YS1
M'$ZI+B"'5I04-!2G'WUI\D.I33*I$XM<(W/TQR$"3P4!KQ5HUJ732)F-;,9.
MUL;"[C9B[WUJ/NV/,S0YA;(6@D4/'S3P6UEMMLF-F7)W/-ERVSWMM-/VUMEV
M_<2W)%;J2V$H/?/:Y_'2-7$,()U&E/+5=S#DV[(F-;S'$,?=W71?%8UQS-HV
ME@,=DLV^PO[A]DR]N'1V[XV][5^L-8T < '5=YW8J7W39;,TJT\U\9(MV=7J
MY-7WM6WSG9,QN?*W4;RVS$Y@M8P?-;!;_<HFCQ!K5S;,DVVO0V;E92*QJUM<
MCN8HF%SZ.)< 6"K9 T \0ZE #R/:L7>3&ET/#Q?;2B>YR<LE'0/<(])JQNK[
MG6H+ XFI%.U3=O%]T*8N'XL<ZF+DN 1SXUX#PK5VG3BQ9RSE8;KF:VU933#B
M2>"Q3++;&EZ&Z.=/[^.&TL88-6X\])'JC/.-A]!CCV!C27O/9Q\"]=NF.W<]
MWG+DT:*ST<D?;E?&..;[?Q??[<&#3;;.S9Y9_>NZ/_&'T+VQM^SVM@;' V/&
M"SC##)2ADD/%[SXW.)<OE>^;S=O.6[)=KNG_ *1YGV_AVXV;EN]F"S59'IGE
MGSSI9=:CHB @(" @("#C?M0?Z27_ /6[/^E"[_ ?S<=$^IYKZD_)7=-OK>%%
M])?)Q 0$! 05K2[N;"Z@OK*5T%[:R,GMIV&CF2Q.#F.!\((JJW6Q=$Q.J5[+
MYLNBZW1,:7T2Z4]1+#J7M"TSL!8S)Q@09>S:>,%VP><*?8/]-A^Q/A!7RKB&
MY7;KEFR=7)//'VUOL_#=^MWO#%\:^6.:?MJ;NN<Z8@\Z>TM_BVW/ZO=?;QKS
M_%M=KQ?U%^)BZ+O_ !</7GWEWI[V<O\ (5U_XI=?:1+U?#/PIZ?NA[CZ>_*S
M_'=ZW75U7I!!Q/VD>I\6R]IOVWC)@-S[AB?#&&GS[>R=5DLQ\!<*QQ^.I'HK
MT7!-PG/EV[H]BSKGDC[Y_:\QQ_B4;MAG';/MWQZ(Y9^Z/V/#@X"@Y+Z,^4B
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M^>" @(" @(.D= O]7]K?UB7^[RKD\7_*7]'WP[? _P [CZ9]4OH.OEK[$("
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M! 0$! 0$!!QOVH/])+_^MV?]*%W^ _FXZ)]3S7U)^2NZ;?6\*+Z2^3B @("
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M$MNZI??<7\&?[9BI8Y'!]5_F^]Z;]GK_ "9M7X,W]/,O0[G^#'G];Y)]2_\
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M[=C=O9R&3-1U$N$O&OL,HPMI6MK<MCD-*CT0Y!MA!:2TBA' @\""@(" @("
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M>%%])?)Q 0$! 0$! 0$!!#2/ $35%$" @(" @(" @(""% >81( !R""*($!
M0$! 0$! 0=(Z!?ZO[6_K$O\ =Y5R>+_E+^C[X=O@?YW'TSZI?0=?+7V(0$!
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MCD<'U7^;[WIOV>O\F;5^#-_3S+T.Y_@QY_6^2?4O_)9>F/Z8>@EMO.B @("
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MO3?L]?Y,VK\&;^GF7H=S_!CS^M\D^I?^2R],?TP]!+;>=$! 0$! 0$! 0$!
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M%L=,ZE#*0[YZ;--[D9KC?&PXA6ZO1$W]),;'7[Z]D+6LOX6CB_2QD[1Q'>+
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M][TW[/7^3-J_!F_IYEZ'<_P8\_K?)/J7_DLO3'],/02VWG1 0$! 0$! 0$!
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M40O$!!6M[6>Z=IB;4#FX\&CRE!F[3%06]'R?=9?"?1'D"A*_0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$'GWVA?\F;J^##_ $\*U-\_!GS>MZ+Z:_Y+%TS_ $R\
MQ=+OOV4_W</VSEYZ]]<XOJL\[HJH\\('8?(?J(//;O2/E*SP^@0@I2RFV_\
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MESCR XE!EK3#<GW9_P"S'[9099C&1M#&-#6CD!P"A*9 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(" @(,A:8J:>CY?N47C](^0(,U;VL%LW3"VGA=S)\I4)5D! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+BVLI[H_<VT9VO/!H09NTQL%M1Q'>2_9N[/(.Q0E>H" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M !>FB(MB(CD?GB^^;[ING7,U;JI5$! 0$! 0$! 0$! 08_,_B8^&/J%!KZE
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M3^R@@@!I<0UH)<>0'$H,K:8=[Z/NCH;_ "8](^7P(,Q%%'"T,B:&M'8%"4Z
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M" @(" @("#'YG\3'PQ]0H-?4H$! 0$! 018Q\C@QC2YQY <2@RUIAN3[L_\
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M&<M,9!;4<[[I+]D>0\@4)7J @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @Q^9_$Q\
M,?4*#7U*!!-'%),\,B:7//8$&8M,,UM'W1U._DQR]TH,JUK6-#6@-:.  X!0
ME% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&/S/XF/ACZA0:_SX#FI0R-IB)9J
M/G^YQ^#ZX_N(,U!;PV[=$+0T=I[3Y2H2JH" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(""UR%L^ZA;%&0#J!)/8!5!"UQ]O:^<!KE^S=S]SP(+M 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&B;BWGNK$YBYQ^-VM<9*
MRAT=U>QMF+7ZXVN--$;AP)+>?8NGAW7%?9$W7Q;/-H<[-O.2R^8MLF8Y]+%_
M2+OC]2+OXEQ^!6;P6#YL=7:P^,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y
M<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3Q
MF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ
M[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?
M-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>
M"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/
MP*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_
M$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J
M1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=
M\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#
MZ1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+G
MK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S
M?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:
M>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL
M=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6
M#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!
M3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXE
MQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+
MOXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC
M]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2
M+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?
M8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y
M<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3Q
MF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ
M[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?
M-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>
M"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/
MP*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_
M$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J
M1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=
M\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#
MZ1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+G
MK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S
M?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:
M>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL
M=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6
M#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!
M3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXE
MQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+
MOXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC
M]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2
M+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?
M8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y
M<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3Q
MF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ
M[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?
M-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>
M"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/
MP*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_
M$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J
M1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=
M\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#
MZ1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+G
MK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S
M?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:
M>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL
M=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6
M#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!
M3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXE
MQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+
MOXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC
M]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2
M+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?
M8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y
M<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3Q
MF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ
M[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?
M-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>
M"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/
MP*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_
M$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J
M1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=
M\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#
MZ1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+G
MK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S
M?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL=7:
M>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6#YL
M=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!3P6
M#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXEQ^!
M3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+OXE
MQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC]2+
MOXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2+OC
M]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?8?2
M+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y<]?
M8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[#Z1=\?J1=_$N/P*>"P?-CJ[3QF;Y
M<]?8?2+OC]2+OXEQ^!3P6#YL=7:>,S?+GK[&T?I%G/S)+_@OSIR?^/?D?H>G
8_&\2TNYL^+][9\WQ-SOK_A_=KY_A?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>bc_caris-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_caris-4c.jpg
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M%!04%!04%!04%/_  !$( LP#M ,!$0 "$0$#$0'_Q #5  $  @(# 0$
M        !P@&"0,$!0(! 0$  @,! 0$             !@<!!0@"! ,0   %
M @($!PL'"08$! 4$ P ! @,$$042!A,'-P@ALG.S%'1U,4%QL2(R-+05-B=1
MTB.4-18784)R,R0E)E88@<%2@M-5T6*2DY%#4U2AHL2%.&.#A$:C1+41 0
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M
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MF+A):1I7(Z,3;R6ZDG$;;B4JH1F15IWP&4
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MZXE)-G0JZ'-P(?02"6OS32APSQ=Q)C QC=/S.W:,X7>R2G-'$ND$Y!5/@TT
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M>+SE<)]TS&1Z&L_+6J^RLV^3JXS,Y>M(:FKA%DI/2H41$:74JT3183X2--.
M_P#X!)4/.$[->ZUF.'=7#D3K#)B04/N'B6J/TJ,MDS,^^DE&CP)(8$)9-M&:
MLUSSR5E@U+7>5(5)C8R;96F+B<2MU1_FMU-7A^4Z#(LC9<A9XU*:H<_/N2([
MEWE-,NPWK:MU:FF_U3RZK;;-*D(6I9&7<I48%:LG,90F7YMG/4V9!L3B5:27
M 0EUY+O!A-1*)1X>[4TI4?Y!D7!U$ZN<DY8D73,^3,QIS' N++49I9I03T8D
MJ4M:'#29'57D'12$'Y(Q%E-8P
M                         (5UA[P]LU=9X5E:X6EV=";BLO/RHKB2>;>>
M-2L&C61)46#"KSR[HSP$5:Y]>>KK6%E-=HMECE/7U2FU1+C-:995$PK)2\*D
M..*/$DC3AX$\->\##']URP3[IK*3=&4*]F6J)(5.=X<'[2VIAMLS^51J-1%_
MRG\@S$1??LON93S9+R[F!IU*;;+-B6EJB'5L)57&V:R,O+0>)!F5.$C 2$Q8
MMW)Z.3Z\TY@CN&5>BNQ&U.E^0S;:4BO@4 DRSY3R79M0V>,QY*FSIL"^Q=&O
MVDEI#R#@.K;IA:*A8C6:N$^Y08$3[N6V/+G_ /,]2?&8C-=[[WTL79?_ -0Z
M,0&7:D<RV3*.H"[WW,4<YEF9N+[4N&E*'%/(D]'9P$APR2JN/A(S[@"*M8-H
MU"S+1*O^0<P2H-WX%-9<?C/N-K4I1$:4K6@M&1$9G4W%EP4&1ZVZA-O#6L:1
M!A*6=JDP'EW-HC/1T:-.B69=S$2U$DC^11_*,1$/V[WHB=?;YXAD66WQ8CRH
M64IZ4F<=IV<PXJG 2W4L*25?RDVK_P !B P[=WUOV'($>?ER]Q)3KEVF,+AO
MQ$H<+2+(F32LEK10BX#J5>^$1CN\KMAOG)PO5&AF M%JBM<2^:CK'9IZ<<*X
M6UZ+(3\K;RW4*_\ @8PRI-CN^KW-=QB>9<[:J=:W^Z1&3K;D1PR_(:5F:?[!
MEA-FZ1E'IN8;KG.2BK%J9*%"49<'297"M23^5#983_3&(CI[WGO[9NR$>LOA
M 9UJ6B/7#=QS+!C)-<B2W>&FD$53-:XU$D1?E,P%9]7N9V,FYULN9Y3"Y,:V
MR"=>9;H3BFS2:%8:F18B)52J8R+\Y3S7E[6ME*1<8,=\['/Z1;WV)B$MK6BF
MC<(R0M9442OE'EE0^ZQKSJLSY<[='7AN-I=E0VW5%Y[$EI;1+IP?K&7<1>$>
MF$J;IV4CNF<9V;'VZQ+%'-J.HR__ -N81H*GZ+9.5_2(8B+E##*BV\_M;G]4
MA\T0]089]=__ ,0+;^FW_P#]18P,/W4MJ+G9<KG&1F(ZV])M7D]1B<4P@+([
MN6QS+G_\SUU\8BR]36YK+;U6Y>B7U4,K@Y)FM1"B&X;2E(4A:UJ)6%5#(D=\
MA@1K+WJ-6-WL[\6\6"X2=,@TNVU]B,\PY4NX:E.TI^4T_P!@SP850BV^1F7,
M*+=881I?N<K1P("#->#3+\A&(^$R21\*C[Q5,9%DM[BV28]FR2ZI1NM0^EQ'
MGS+NN*;8-)F?RJ)M1C$!BV[MK>L&0F9V6[W%E.+N\UA<.1%2A:2<<HR:7"6M
M%"+@.I5[X1$=:XI]TN.L_-+MW4HY+-QD1FDJK1,=A9MLDFOYNC))E_XC(R76
M5,U*M9(LEJU=,+>S&IUJ1<[@\AXGDMI96E;;JG:)Q*6I)X6BPEA\%0R3=ILJ
MLQVG6/8$&27+G:6X;:CX");Z9"$F?@,QB(B+*]ZN&KW.T"\/Q%=/L4S]J@N_
M1KJTHT.M&=#PJIB36G 8R)+U\ZZ;%K0A66W6"%)CL05N29+LPD(7I7$DDD)2
MVM9&1%6JC,(#T-WVP2,T9%UI6"'PS9T&(W%29T)3Q)E*;29]ZJB(AB(A>QLV
M-F^-QLXIG,6I"EM3B@DVF8TLB,BHEXL/DJ\Y)T/N]\9$DNV'=Q;8TR<UW]UR
ME>CHAH)SP56TE%?\P"VFJ/*UBRGD:WQ,N27YEIGI*Z1WY> GC3,0EQ.(FR))
M430AY91-O@^[>6NO/<R,P8>5N<?_ -R_^W?_ %01$R:\H%RN6JC,\6TI4N7T
M9#IH055*99>0Z\1$7_Z:5#$&5.]26?;5JZSRU?;U'6_;7H[L)]QI)+<9)XTJ
M)U*3I6AHH??PF?@'IA\:WCU:2LQ>UM6LQQR#/Q.S;><9R.S&>.AGH3<))X55
M/R,-$&7 =#(B#YU-V/+^:M8]I@9MG)9@K<)XFGZJ*9(;,C;C&H^ M(?=Q>=3
M"7E*(!L+'EE3;>\]_;-V0CUE\9@PRS5=_P#B]FWD;QZN0"$]16UO*O6U<TL9
MB-A(\LJ);Q&KV=D_/<Z\ML*/+^8'ES8<E)>0F0Z>-YE1]Y1+,U)+_"9?(=/4
M&&5ZI-Y=&4+%&ROG""_.@0$DU;Y\,T*?0P7FM+0XI)*)/<29**B>"G ,<!,&
M5-X[)N<\VVW*=F@ST.W$W4IERT---H4VTMTBHEQ:CQ8,/A,.#*FV;9\VZYVN
M\W,:W>EO7%[VAWW4$ETTJ0DE<!8"+"DNX5"(989QK@FZG#MUCMNJR/B>:QNW
M*>:7TK4E24DA"U2*&I5:J.A4+O )$W:]F^L;D5>J/#$1"6JC:;E#M>%SZ1D3
M[OC>AY/Y2X<6.,0&*ZE<NR\UZG=95AMZ#<GR3C+BM%W7'8Z3?0@ORJ-!)+P@
M(HU<YRD:NLZV_,Q1CD%"6MN5$4>!2VG4*:<21GW%$2JE^4N$9%N[7KZU?:Q'
MV\E6SIS-QS R_#;T["4(:4XPLSQJ)P_DH6&O",,J7KM3=BS*JSYN8DL-091Q
M[JS%P)DI2VK"O1&X1I,Z<*:\!C+"246'=Q5')\\UW]#AE7HRH:#<+\AF31H_
M^8!(MRRIE3+^[5F.[90ES)EKO[D.6E=Q)I+Z=#.:9P&37DE0TJ[YC P+=;VK
MQ^HR^*0S$7'SEF&V95RO=,P7IDY%KA,FJ5'2E*U.(69(P$E9DD\1JPT,Z#RR
MIOGRU[O]VM,W,&2+]*M%ZPFZSEYZ,^XTXZ9UT:#-%&Z_+I5)+Y!Z8-UZ;=V-
M:D2);U+]GRXLDKJVDSP&PVTI2%*+N<#N B/\M.^$1>4>60
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M)JQR?JYC.L99A&W(D$12ISZM+)=)/"1*6=*$7^%)$G\@PRS
M
M                !C^>,K,9VRG=LK2'NCHN;!M)D8-)HW",EH7AJFN%22.E
M2 8-JVW?\G:NY:+OB<O.8&_U,^6E*4,F94,V6DU))G_B,U*^0R&>(ED8
M               09FO=;R5F2[3+U'N5PMTR>\Y)DH);<AHW7E&M:B)Q.(JF
M9_GC/$=:Q;IN0;;*1)N\Z=>$-F1]%6I$=A5#[B]$6,R\"R#B)T@0(5KA,6ZV
MQVXL"*A+4>,RDD-MH25"2E)<!$0P.P
M
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M)E.H9:37N54LR(!TK%FS+&9TN+R[>(=T)FFF*&^V\I%>YB)!F::]ZH#V
M '5<N=N9G,6MZ8PW<Y*%.1H:W$)?<0WYRD-F>)1)[YD7  Q?-&M7(639Y6J_
MW=+-RP:9R(PR_+=;:I7&XF.VX:"IP^53@ 9/;+E!O-NBW:V/%(MTUI#\5])&
M1+:<+$E1$HB/A(^^0#M*4E*34HR2E)5,SX"(B[Y@.O;[C;[M$;GVN6S.@NUT
M4F,XEYI6$S2>%:#,CH94[H#L@.M<;A"M,"3=+B\4>!#;4_)?57"VTV6)2CH1
M\!$53 ?<25&G16)L)U$B');0]'?;,E(<:<22DJ2HN R,CJ1@.8
M
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MJWN5!MI*,U*3;WJ2(Z3,^$S23BD^ B&1)@P
M
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MD!W]4)>T)N>LTH*L*\9@D(@.EPI=C0$)C)=2??2I25T\ "3A@
M
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M[$9'Y7" [&7[%;<L66#E^SLZ"VV]I+$=ONGA3W5*/@JI1U4H^^9F8#T@
M
M
M
M
M
M
M
M
M
M
M !CF>,[V+5YEV3FC,1R"MD7]842.[+=X$J6?D-)50B2E2E*51*2+A,@&.9FU
MV9*RL5N.:4^6<ZW(OTA,"(Y*5!LRS)/3IB4<+;*3.AGPGP*H1DDZ&>#[FZZL
MC6_,Z\MRWI+;+3Y07LP&PKV*W<%Q>FIAJF5P:8V/I,)<'"1&>(R(#@_<OZY<
MHYD90<!JX-SGID*%'MLB(MJ6Z5T9.5&?2BI_0J82M\UF984(7B(C30#@D(&
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M)7<,&'J
M
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M$2:$@BPT01J$4Q P
M
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M/_E/QMU:_P"\']6D_P"F'T_Z[\']TO\ ,^L-+_-_MG_RGXVZM?\ >#^K2?\
M3#Z?]=^#^Z7^9]8:7^;_ &S_ .5FEHNT"^VV/=[6[IH$I.-AW"I&))&9=Q1$
M9<)=\AIJ]">C/&2>'":':DOI?54_4TI:M./&6;LC_P#V[H_!]0
M
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MU$6'O@.W#S#8+C'@2[?=(DN+=#4FV/L/MNMR5(2I2B94E1DLTDA1GAK0B/Y
M'I
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M,'E]@
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MAQA"+\IJU.$>$9H<;7S[1M__ +MG_N(_XC/^E/\ PC\'G_J*?XH?&![1M_\
M[MG_ +B/^(?Z4_\ "/P/^HI_BA\8'M&W_P#NV?\ N(_XA_I3_P (_ _ZBG^*
M'Q@>T;?_ .[9_P"XC_B'^E/_  C\#_J*7XH?&#LC\G[@  PAG6_JZ?S!*RPU
M?$*N\0Y:'$Z%\F%NVY&DELM2-'HG76$>4ZTVM2TE6I<!T,\'3@:\=65S@3;A
M#N[BR@.Q8[T-<&:U.6[<*G%)J*XPEYW3$1FV;;9D9$?R'0<&2V;.>6LQ/0V+
M'/1/5.MS=YC+92M39P'UX&G35AHG&HE$E*C)1X5<'DG0P]X
M
M                                 ?*_,5X#&8,1[% %GY:O"8OB#DZ/
M:^:C+!4 J S35(?Q'R]U@^;6-/K62J67I)MGW*CBNBN>*=='L9UB>X>9>S97
M-*&RTS-TL<O-I=<]OK_IS\HJ15%T.9BH!4 J EC=X/\ C]?9[_';$6W-E.J%
MZ>[']PC@FYRK5BKE[(JW@]GRNNQ_$L2C;6<Z8H+O;V[KEO51J+24,5 *@%0%
MA]V3T;,OZ</Q/" ;L[U+J^5;O_;_ +M>V3YD^""+65BWDC_B^U]FHY]X65M;
M+S8[H*3W[G*?Z?S3(9J)@K@J 5 *@+GZI-G&7NKGSBQ3VM9VI;<Z/VS[;1PW
MQ9H-,DBG.MXZ:Q[_ ,LWS+8N'0\E3LCSBYOW3[G6MAX8,(J-VBY4 J 5 7XC
M>C,_H)\1"A9^]%UI3[L+'*/+] !6YG5QF:)GV(Y8H=[1JWR7=;KF9BU3UV]*
M)5SD,OFB/:M&>G4VX[(<7CEN(2DE8>_4C+L94ROF#/<[,>:]9F7;]ES.BUQ9
MMJDPEPR;MT:TK>.)#M[B77E/.J)YU4A3S24.*<-))(B(!ULOY#UBY2O>7D6.
M-<(,665H?)B*^PY;83#4IPKC"N2G%&X]HH&B;C*21XI!N+30U&8"R0,   Q3
M67G9K5SD6]YV>A.7%-H8)Y,)D\*G%K6EM!&HR/ C$LC6NAX4U53@ 1F6O#-T
M?+V?C59;1><U9"C1[E,7:;DH[0];I<9Z5I4.K:-S&TEA:5-8*J/"9&1*X#/!
MV[CKRG0;GEIMR# CVVX6ZQW2ZHE27&YCC5_<<:6JWMD@R<1 )I3\I2NXW_A[
MIC@SS(&>8F=84ITGXB+DPZI:[5'?2[*BPWE&<4Y2",S0ZMLB4M/YJJH[J3!A
MF
M                                      #Y7YBO 8S!B/8U_+\]7A,7
MQ!R?'M?(,   S75'M'R]U@^;6-/K63J67I)MKW*CBNBN@*>=',9UB^X69>S9
M7-*&RTS-TL<O-I=<R%?].;E%2 7.YG    2SN[^_Z^SW^.V(MN;*=4+T]V/[
MA'!-SE6L%7KU15O";/5==C^)8E&VLYTQ07>WMW7+>J>+14.    L1NQ^C9E_
M3A^)\0#=?>I=7RK=_P"W_=KVR?,GT05:JL.\I[X6OLU'/O"R=K9>;'=!2F_,
MY3_3^:9# F"N    %T-4>SC+W5SYQ8I[6LY4MN=';:]MHX;XLU&G213?6^=-
M9%_Y9OF6Q<.AY*G9'G%SANF'_P!G6MAX8,(Q#=HQP,0' Q <#$!P7ZC>C,_H
M)\1"A9^]%UE3[L+'*/+]&+/:R,B1W7&'K_#0\THT.(-SA2I)T,C\!C:2Z5ZN
M:'&%.;A'_!H9]P:?+&,L:TD(P_Q?'XFZO_YBA?\ <'K_ &CUGY<WP>?J+3?S
MY/B?B;J__F*%_P!P/]H]9^7-\#ZBTW\^3XGXFZO_ .8H7_<#_:/6?ES? ^HM
M-_/D^+EBZQ,CS9+,.+?HCLJ0M+3#27*J6XLR2E)?E,SH/$^E^JDEC--3FA"'
M[>Q^E/7O05)H22UI8S31X0AQ[8Q9.-8W@ Z-ZA2+E9[A;XCS4>5+C/,,OR&"
MELH6Z@TDIQA2DDXDC.JD&HL1<%0$;Y?U&6:PY)SCEA$TEWC/$1^'>;RQ#CPF
MDI=B*ALICPXQ(:;:80LS0V7"9FHU*,S!GBR*3J]C2LLY:RL]+Q0[$F$Q*?-A
M!O3(L)M"5,8C_5H?4VC3$GSD$:.XH&'D:O\ 5!%R)F&5?4W5RX$F-(MUHCJ9
M0R<>%,N#MR=2ZM)F;[FF=HE9DFB2[E34HS*2P8  !$^NV+F9Y.7)<7ICN0(4
MB4]G:):9Z+3<%Q^CJ*,XF2Y(BT9:=\MY)/),RH?"1&0,P5XA9SSO>\CW._9J
MS5=+/=<IY*CYDR?AFG'<F.2+A-1'F2T))*92EMLQHRB=2I"L9GAJY4&69Y@N
MNL+)+EVNF994Z.JZV^X2;P]&N!O*=@NS&'42(45PZ05PF'/9Z35AQ.NI6>(D
M&H&$_:N\VHS99YA*MR[5/L,^18KC!4]TM#<F#A(]'(HG2H-*DF2S21UJ2B(R
M,&&7
M                                ^5^8KP&,P[6(]C7ZOSU>$Q?$.QRA
M'M?(RP  #-=4>TC+W63YM8TVM9.I9>DFVO<J.*Z*Z(IYT:QG6+[A9E[-E\TH
M;+3,W2QR\VEUS(5_TYN45'Q=#F@   !+.[MM <[/D<=H17<V4ZH7IYLCW"."
M;G*M:*O7JBG>%V>JZ['\2Q*-M9SIB@N]O;NN6]4\6DH@   !8C=C]&S-^G#\
M3XK_ '9WJ75\JW-@=VO;)\R?A!5JJP;RGOA:^S4<^\+*VMEYL=T%*;\SE/\
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MB<%:U.O<H ^T7*W.-O/-S&%LQW51Y#B7$&EMY!DE3:S(Z)41G0TGPU =H
M
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M22HJ\(/+)P
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M*D*21H77&DR*AUX#J7?J ^@
M                                          ?*_,5X#&8=K$>QKW69
MXU>$Q>\.QRI&'[7Y4P8X%3 X%3 X,VU0G\2<N]9/FUC3ZSDZEEZ1[;]RHXKH
MKJBGW13&-8WN#F;LR7S*AL=,S5+'+S:;6\A7_3FY*-U,7.YKX%3 X%3 X%3
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M\[(]NZYKDJ"+IVK-O#RI+&=(*67G&TG;6C-*%*25=._WB,67M>26/I9N,/\
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M9JE0+;&M<F/='#N+=[C.+945L=M4E4)Q#JT+-*](^A2&3;KC2E2NXDP89T
M
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M/4/U)/%!>44JZ;8'KGV9W_\ 08]9:&\T+.T_M\,46W5[76LE\4JFU1;KG8J
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M)!@
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MI]O^IKTY:DOW>$T/X_\ @AGK-W^A]+6FHSPG^])'A'A+^SFZ']0>0O\ !/\
M^PC_ %!]'TQZO_T_'_P?)]=:=_"?^F'^8_J#R%_@G_\ 81_J!],>K_\ 3\?_
M  /KK3OX3_TP_P Q_4'D+_!/_P"PC_4#Z8]7_P"GX_\ @?76G?PG_IA_F?J=
MX'(:U)02)]5&1%] GO\ _P"X,1VSZN'X?C_X$-\Z?&/#A/\ TP_FE019/@
M
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MHVZ.%?R@%?R@.6,?[2SP_GI\9#Q/W8OTI]Z%J_(H9UF
M                                                   ^5^8KP&,P
M8CV->:_/5X3%ZP<KQ[7R,L   S?4_M*R[UD^;6-/K.3J67I%MOW&CBNBNR*@
M=$,8UC^X&9^S)?,J&QTS-4\4O-IM;R%;].;DHL+F<W    )=W<=H3G9\CCM"
M+;ERG5"].ME9^.";G!;,5BO!$V\5LZ5UZ/XEB3[;S?3%"-Z>W]<MZI M!1@
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M[K$
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M"U?T4.ZP
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MC(>9^[%^E/O0M7_%$.K@
M                           'ROS%> QF#$>QKO7YZO"8O2#EJ/:^1E@
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MK8F'#;(\  #EB^DL_II\9#S/W8OTI]Z%K8"*(=6@
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MM]E8N"#:;M\>8JUJN#)%&JETE3&TN2E.X,*4K:;_ #3,@GD&
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MRU ?/W)RG]Y6\X%:(Q9E:9*.W<211PFTI-"> O)Q)0I2$KIB)!FDCPF9 /?
M
M?*_,5X#&8,1[&NM9^6KPF+S@Y=CVOFHRP5 *@,XU.G\3,N=9/FEC3ZSDZEEZ
M0[<]QHXKHKP"HG0;%M9.S[-'9<OF5#8Z;FJ>*7FT^M9&M@FY*(5%R.<RH!4
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M<4ZKO84I46,R\VI8J5(&&01I+,R,S+C+QQY"$NLKH98D+(E).AT/A(P'*
M#PLSYSRIDR.Q*S5>(MI:E.:&(4EPD+>=X/(:1PJ695X221T >0]K=U91\QGE
M%_--O:S*F0F$=L6\27^DK,DI:H?YQF?< =ZVZQ,CWB$NXVN_PY<)N8U;%.M.
MDHNF2%)2TT1%PFIPUI-%/.(ZEP<(#)@
M    !\K\Q7@,9@Q'L:Z5GY:O"8O.#EZ/:_*@P5 *@,XU.'\3<N=9/FEC4:SD
MZEEZ0[=]QI8KHKPBHG03%M96S[-'9<OF5#8Z;FJ>*7FT^M9&M@FY*'U%QN="
MH!4 J F#=L/XB.=G2..T(QN3*=4+TWV9GXX)N<%N162[$1[Q^SA77HWB6)-M
MS-],4*WED.J6]4*HLY2)4 J 5 62W5_1<T<I"XKX@>ZN]3ZKEJ[%[M:V3YEA
MQ!UG*J[S_OG:>RT>L/"QMKY>;%=!3F]\W)@^:9"%1+E?E0"H!4!>#4YLRRYU
M8^=6*BUG.5+;G06W?;J6&^+.1J$A4EUT'\3\Q<LWS#8MS1<G3LCSBY]W+[E5
MMAX8,#J-RCA4 J 5 ;$(OHK')HXI"C)^]%U%3[L+',/+VH!F?WEO/7I7/*%V
M^E\F3##DYE]=F*F.;G%Y0^E\0  ,BR![]99[5A>L('P:AEJF";E%M=(SM']2
M3Q07R%,.DF :[=EV8>38]::&[T/.T_M\,49W1[;5LE\4JE51;;GXJ 5 *@)U
MW8/>6]]11SR1#=T^3)BN6/L7,5,%ZSXKM<"O>])Z+ECE)O%8$YVKWJG3>J_?
MG=HVS_*K@)ZJ<   !;G=SV<IZ](\2!6&Y,WTP7CLSV_KFN2T(PFZJN\O[]6_
MLMKUA\65MC+38X\I5*[XSLGZ</%,ABHEJ %0"H!4!=[5+LWRYU1/&4*>U?.5
M+71.WO;J.%F8U*0*2:V-H^8^MJXJ1<.CY.G8YSW%[C6Q,-J-LCY4 J Y8I_M
M+/*)\9#S/W8OTI]Z%K80**=4.*5Z,]^@KQ&/4G>@_.IW8V*"8C%\N3N!B,#@
M8C X&(P.#--4I_$;+_6#YM8T^M9*I9>DFV8?_9T<5T5S!3CI$ =6XVVWWB!)
MM=VBM3K;,;4S+AR4)=9=:65%(6A1&2B,NZ1@,4/5#JR/+A92/*\#[O%)Z>4/
M14I,IATY+KCTF'R<>+%A\FM. ![D7*>6H,6T085JC1X-A5I+-%9;2VS%7HUM
M8FT)HDE87%E6E?*/Y0'S8<GY7RN_/DY>M,:VOW1TWY[D9LD&ZX:E*X:=PL2U
M*PEP8E*.E5& ]L   $*:_,O7:[W/(5U)JZOY1L=RERKXC+S72KHR^N&MN%*9
M9P.FK1.&K$I*%*1BQ)[E2,P>)&M>LG/64LA:O\[6^8;-SD.W3.URG,MH<.Q6
MR4;L*#+-KZ,I,RD=+Z&U5)*7*EW0'%K!U:YAA7"[?<TIEU*/#O%\AV^0PT<)
M#ETFM3G[<A24H.2<N6RE[1N*HAMO1]QP@$HZJ9V:KA8)SN:%2WFT7*2W8I=S
MC)@W"1:DDC0NR6$I;P+-1N)+Z-!J025&FI@PSH   %:M=5@SLQK(G9MLC>85
M35Y83;\D2\ML-2FF;TW)==4Q-TC;NB:=4IE3CADA"VTJ2I7DD0,P9>K+F8M8
M>?8$;.MO7%RYD^T).4M"5LQKEF6\Q%,/N1E'Y[41A;J$KX#2X[\J0&"2M7V8
MLG7%,^RNWF7:+/.MEKEWIF S)N)1XD!V*B5#B):-+B8K*FXNET2U&IU]PB\A
M- L#D63F:9DRPRLY,)C9J>@QUWAA!$DD2E-D:R-*3,DG7SDD="/@+@!AD
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M@O'9GM_7-<EH1A-E4]YCWZM_937K#XLK;&6FQQY2J6WQG9/TX>*9# EB
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M #J?]<O\S[VY5_WVW_6V/GA_T7J/RYOZ8_R/]T]'^=3_ *Y?YGWMRK_OMO\
MK;'SP_Z+U'Y<W],?Y'^Z>C_.I_UR_P S[VY5_P!]M_UMCYX?]%ZC\N;^F/\
M(_W3T?YU/^N7^;U&'V)3*)$9U#T=TB4VZVHEH4D^X9**I&0^6:6,L>$8<(P?
M?)/+/+":6,(PC^^'8Y!Y>P                              ?*_,5X#&
M8,1[&N=9^6KPF+S@Y@CVOFH,%0"H#.=39_$[+?63YI8U&LY.I9>D&W?<*6*Z
M*\8J)T"Q;67L]S1V7+YE0V.FYJGBEYM1K.1K8)N2AE1<;G4J 5 *@)AW:S^(
MKG9TCCM",;DRG5"]-]F9^.";G!;L5DNI$6\ALW5UZ-XEB3;<S?3%"MXY#JEO
M5 J+.4F5 *@%0%E-U;T7-/*0N*^('NKO4^JY:FQ>[6MD^98@0=9JJ>]"?\:6
MGLM'K#PL;;&7FQ704]O?-R8/FF0?42Y7Y4 J 5 7CU-[,<M]6/G5BHM9SE2V
MYT#MWV^EAOBSD:A(%(]=.U#,7+-\PV+;T7)T[+XN?]R^XU;8>&# JC=(X5 *
M@%0&Q.+Z*QR:.*0HR?O1=04^["QS#R]M?N:/>6\]>E<\H79Z7R9,,.3F?UV8
MJ8YN<7E#Z7Q   R/5_[]Y9[5A>L('P:AEJF";E%M=(SM']23Q07T%,ND$?Z[
MMEN8>3C^M-#=Z'G:?V^&*,[G]MJV2^*52FHMI0!4 J 5 3MNO^\M\ZBCGDB'
M;H\F3%<L;8V8J8+UH!7:WU>MZ;T7*_*3>*P)QM7O5.F]6&^^[1MG^56X3Y5
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M$1F>.@#M,W2V24Q%1YK#J;@@W8!MNH44ALDDHU-4,\:2(R.J:\ #M@
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MB#[L?X'WY?XFF9_]1/\ U$'W8_P/OR_Q-,S_ .HG_J(/NQ_@S]^7^+['EZ
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MJ53I#7?/_&0_&M"'^G-9%]/I8Q_UI,4.:]XHIU:
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M-SC*^RV[9;7L#:+;&E1[85Q3'))J)TG9$<U3#<4C!A6ANN)("9P8
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MOW1W,JFV4/QH<1QIB8[-1/N,1<@Y-V,G4IT"I276DZ%/FZ/AX"2!%+(,
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M]=6S,A''-R@F$1=-U1-Y0_B*WV='X[HLW;>4ZHW*5WGGX8)><4/5$G0@J 5
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M(-O>X4L5T5YA4:_D9;P.RN\<I$]::&_T#.R=7ABBFZ_;:ELOB@I;46HHO@5
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M3Q0;"!3KH)'6O?9-F3DX_K3(W6BYRG]OABCNX_;ZMD/%!1:HM91A4 J 5 6
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MI5^(NW@MFLSK,7G"$CV[G(61Y(9O'VZ;%+S5!J+441P*@<"H' J!P?=?H?\
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M9.G9?%1NX<_5MAR@CT;A'P   &RR)Z(QR:.*0I*;MBZ/D[L+',/+VURYK/\
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MSA"1[=SD+(\D-WA[=-BEYJ?5%IJ)*@%0"H#DK]#_ )O[AC][U^YL/%%.I@
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M%)S]L714G=A8YAY>VN#-A_Q3?.T)?/+%R^F\J3##DY\]9Y\^*;F\>H^A\A4
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M @VY^VGU7+)V;W:MLOS+,"%K"5 WLO?JS]DH]9?%A;:\B;%=!5>[\S)@^:9
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MSPS_ &MCE$<8AYG[(O4G>A:V8BE'1;AF>B/\FOBF/4O;!XG[L;&M&HNUSD5
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M!?*-M?NR+,O)QO6V1N=%SDGV^&*/[AR%2R'B@H946HI4J 5 *@+#;I/O5?\
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MYKI@MW:N2ZHW)G$<2U3G>OVAVWL=GUF0+$VWEIL4>4%4[NS<N"'BF00)2A8
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MG.D)#M_-PLCR1/=>0FMEYJ65%GJ6*@%0"H#DK]!_G_N'G][U^YLI%(NDP
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M=R^5)BN3G:'GU,-ZW @*SU9M[[T3*/*3^+'$TVQVU.F]7N\>[2ZOE59$X5P
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M\_\ <,?O>OW-F(I)T:    ^7/U:O ?B&8,1[&K]S]8KPGXQ=,'/D>U\C+
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MC<6:Z87K9VKD^J-R;1&DN4KWI]IS?9D;G'18^W<KU1N5-NK.=,+T)5$E1$J
M5 *@-AVJ39CE/LR-S9"I-2S53%%>6D9.EA@S,:YM6N[6H?Q*S;VM-Y]0MS3L
MM3PR\E%ZK#_YE7'-S8C4;!J^!4#@5 X._8C_ 'W;>M,<XD?E6[DUD7[T(?\
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M"EYNV+H"3NP<X\O;6EFX_P"*[[VC+Y]8N+TWE288<E#>K\^?%-S>-4?2^4J
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MU$YTA(- S<+(\D6W1D9K9>:D-19BGBH!4 J Y*_0?Y_[AC][U^YLY%*.B
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M?:!GZ?V^&*_0JU<R']YK9//ZU$YTA(- S<+(\D7W/D9K9>:CM19:H2H!4 J
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MTX  .>%Z9'Y5'&(>9NR+W)WH-HXIA?;@F>AR.37Q3'J7M@\3]V+5S47.H0J
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M9GLM_=S%$>:M<Z--6REATE+3'=2X:2,U4(S)-!^'J-P25*4TGW(_^:$8=O\
M&#Z?3;9J4JLD\9X1^[-"/9']T5HQ#$]8IK+RE)SUDB[94B240Y%Q2RE$EU)K
M0C1/MNG5*3(^$D4'W>A]1#T]:6I&''[O\FOU'TL?4^GFI0CPC-P_;]L(JX?T
M>9A_F>%]7=^<)9]2T_P1^*$_2=3\R'PB?T>9A_F>%]7=^<'U+3_!'XGTG4_,
MA\(G]'F8?YGA?5W?G!]2T_P1^)])U/S(?")_1YF'^9X7U=WYP?4M/\$?B?2=
M3\R'PBD[4IJ.NFJN]7*Z3KO'N+4Z*49+;+2VU)43A+J9J,^#@&GU359?5R2R
MPEC#A'BWVCZ-/Z&I----";[T.";!'4H1+KOU0W'6NU9&H%S8MQ6I4E3FG;6Y
MCZ031%3"94IHSKX1O-*U*7T<9N,L9OO</^'%'=9TJ;UT)(2S0E^[Q_X\/Y(?
M_H\S#_,\+ZN[\X;[ZEI_@C\4;^DZGYD/A$_H\S#_ #/"^KN_.#ZEI_@C\3Z3
MJ?F0^$3^CS,/\SPOJ[OS@^I:?X(_$^DZGYD/A$_H\S#_ #/"^KN_.#ZEI_@C
M\3Z3J?F0^$4^ZH-7\S5KE#[M39K<]XI3TDGV4*;3A=)-"HHS.I81&-2]9#U5
M7[\(</V<$OTKT,WHZ'^G&/WOVQBST:QMT%:Y]0MUUHYHBW^#>(]O9CP6X1LO
M-+<4:D.NN&JJ3(J&3A$))IFKR^DI1DC+&/&/'_A!$]7T2?UM:$\)H2\)>'_&
M/\T=?T>9A_F>%]7=^<-M]2T_P1^+2_2=3\R'PB?T>9A_F>%]7=^<'U+3_!'X
MGTG4_,A\(G]'F8?YGA?5W?G!]2T_P1^)])U/S(?")_1YF'^9X7U=WYP?4M/\
M$?B?2=3\R'PBLOD'+3^3\G6?+$F0B4_;&"87(;2:$+,E&=2(S,R[HB'K*\*U
M::I"'#[T4Y]#Z>/IZ$M.,>/W8<&1CY'VJSY]W8+YG#.-XS,QF")&9N<A3Z&%
ML.*4@C(B(C,E4,^ 2_TFO24:,M.,D8_=A_%!O7;;J>HKS5(3PA]Z/'LBQW^C
MS,/\SPOJ[OSA]?U+3_!'XOB^DZGYD/A$_H\S#_,\+ZN[\X/J6G^"/Q/I.I^9
M#X1/Z/,P_P SPOJ[OS@^I:?X(_$^DZGYD/A%]L[H&8FG6W2S-"JA1*+]G=/N
M'7_$0Q'<E.,.Y'XP>H;4JPCQ_P!2'PBMN(,L1QOMF\PZT1T-Q"DD9][$5!F$
M>$6)H<8<%2?Z/,P_S/"^KN_.$Y^I:?X(_%77TG4_,A\(G]'F8?YGA?5W?G!]
M2T_P1^)])U/S(?")_1YF'^9X7U=WYP?4M/\ !'XGTG4_,A\(G]'F8?YGA?5W
M?G!]2T_P1^)])U/S(?"+)=7V['>\F9SL^:)%_BRF+:\;RX[;+B5+(T*30C,Z
M%W1\GK-=DKT9J<)(P^]#^+[O0;<J>GKRU(SPC]V/\%E1$$X8;K4R5)UA9(N&
M5(DMN$_,6PI,AU)K0G0/(=.I),CX230;#3_50]-6A4C#CPX\FLU/T<?5^GFI
M0CPC'A_PCQ5W_H\S#_,\+ZN[\X2KZEI_@C\4,^DZGYD/A$_H\S#_ #/"^KN_
M.#ZEI_@C\3Z3J?F0^$3^CS,/\SPOJ[OS@^I:?X(_$^DZGYD/A$_H\S#_ #/"
M^KN_.#ZEI_@C\3Z3J?F0^$4J:DM2ESU4W"[39]U8N*+DRTRA##:VS0;2U*J9
MJ,^[4:75-4E]9++"$L8?=BD&CZ//Z&::,TT)OO0@F81])D5:[=4]PUK0+1#@
M7)FW';7GGG%/MJ<QZ5*4D183*E*#=:5J,OHYIHQA&;[R/ZSI<WKI982S0E^[
M&*&OZ/,P_P SPOJ[OSA(/J6G^"/Q1GZ3J?F0^$3^CS,/\SPOJ[OS@^I:?X(_
M$^DZGYD/A$_H\S#_ #/"^KN_.#ZEI_@C\3Z3J?F0^$3^CS,/\SPOJ[OS@^I:
M?X(_$^DZGYD/A%/6IW5Y,U9927ER=.:GO*F.RR?90IM))=0A.&BC,ZD:!&=2
M];#U57[\(</V<$NTGT$WHZ/^G&/WOVQCR2 -6W"!-<.[]=]9F;4YCA7J/ 93
M$:B:!YI:U5:4M1G5)D7#B$FTW6)/2TON1EC']O%$=6T*?UE;_4A/"7]D(=C
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M?B?2=3\R'PB^OZ/\Q8,'WFA4K7T=WY/T@^I*?X(_%GZ4J_F0^$5N!!5B@
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M@'R3B#-1$HJH\\JEP5*O#\G  ^@    'RMQMO#I%DG$9)3B,BJH^X15[X#Z
M     'X9D1&9F1$7=,^X _0 !^*6E!56HDE6E3.G"8 E25U-)DHB.AT.O"7>
M ?H   /PU$5*F15.A5[Y@/T      ?)N-I6EM2R)Q=<"3,B,Z<)T+O@/H
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M%@MNN75U;KA!@%>SE-VC)\=V(IGI,.);T,(9NBH2F6'R-^,LC;-*"<7A4IS
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M]-@,
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M"(UJ))&9)*ITJ9\!%_: ^4R&%NN1T.H4^T23=:)1&M!+X4XB[I5[U0'(
M  /AYYF.VIY]Q+32?.<6HDI+PF?  ^R,C*I<)'W#       !\N.-M)QNK2A%
M2+$HR(JJ.A%4_E,P'T       #XTS6E)C2)TYIQDU4L> CIBIW:5[X#[
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M 0P<5;2KBX\23<<6K"E*T$I*4M$9F:JJ5W* RS.Q-.LV2V,OH-M]N(PAUM7
MI*TMI(R/\I&##T     '3NKS$>VRWY49R9';:6IV(RT<AQU)%PH2V5<1J[E
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M7&O;.>G+@A+C[KDF(S":7$2Y'1:]$29*DR3X6EI6IQ1D1EB/ 5%$? 92"#
M     ,9L=G:^\%VS N B$M1G;X)$TEIQ;#:L;KRL/=TKO<K^:A)]\P&3
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M(JGI%DE*3/O(K^< R8
M
M
M
M
M
M
M
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ME&(B/$8#\7FR]M.S&+,PR[H2NEP?<N$AQWZ."ZTE+31(26$EDX=.$R;IW%5
M<;FLJYID39S=F>=R]"-YIU9-.)4E3+!.Z93YF;6C-7T9IIB+SN$N !Z,"\7V
MW77,;^951W2MMJB3DQ[:MQ3>&LM2_HW>%*ST>$E?GD1=RE '4<SGF:+T:/(B
MVYZ9=D0W[:;#SFB:;F2FXZB?.AFK 3I+0M-"<,C31/= >[;KG/O=ANS4Q?0K
MG"<E0'Y,$Z$3C)<#K.E)6&I&1D2B.A_*##SG)LZ9EC*$=<]V.N]=#9G3T*)#
MZB5#6^HDK(BPJ=4@DXDE7AX*'0&73M4ZZ*N.5T.721(8*;=[:X9J;-N8S$)X
MFG7<**J6G1)\I)D5:G3A =ZPNW.+G>[VJ8]+3"7&*5!:F/)E)D$3IDX\T:?U
M*4&M+>B/N\!EWP8>;"S[?5PX-SN3$"-!O+<GV>3"W93C#T<S)&E)!$;I.4(L
M+2242S)'E5J#+J)SCF:YID.K2S%MT2WWHKE&2EV-,5(MRVDH<969JT-4N$=%
MXC3^7@ =AW6'?6SN<J-95/6B"B:VTZZEUHC=@H/"MR0=48''$FWA2G$G@/AX
M2 =I_,><?;,*R?NYJ4U<X[,]Q*7G&G8,F&^_A;(S)27$J:/RC\D^ ^"ID ]"
MTYO>>M%XF7M3%MN5K6HI,)UMY)Q267T*7.%6EQ?FN,^2Y^:5> &'D1\[9KG-
MKB18$-FY1#N!RW)NGCH-$%,9QO"QY2TFZF27GK\FE?*J1 R^9N:[]=TV^=;D
MQH=C*Z6B))2X\XB:I4I4=Y9)--$&FCR48#+RTU.I<! /9NF=';7>'[+(CM-R
M"=9>CNN.X&U6S1*<DR55*I:'1.)5WJFC_$##%I><KM<''$OFMCV?TM1G&T]O
M*4P]:GY#2B2]B6@TJ0>%2B[M%$7>!EZ4O,]X??LUV6[&A96.XR&%&IUQ$O##
MB2L1OU\@TFMHU*;[J2(E<)\!!P,9VS1*NL&*:8\=F)/>9O"7(LAER1%]GG,0
M;+3JL;:BH9?2=TR+P .:U9]S+=6XI%:41%WDF%6B5+;>8BHTZ7'C:<-1U=6E
MI&(C;PDH^#@[H#GM&8[O"R[,D2S:EWM^_2K5')3JU1$/.S5,-U69&HFTE3R.
MZ1^07#P@/QS-^;.F2K&Q%MIW>VHE.S9:W'RBK0PVP\V3:"(U$I27Z+)2O(I7
MRL1$ [N8,ZR8&6X-\MC2%RI<([I[.6T[(=5&;92ZLB-FA(IC2DW5^21F7 =2
M(&''&SE>'[HVXJ+%38'KDFT-X7%JEFMR,E]+QG0D$FIF@T<)T\K%^:#),O\
M?47M^RV%IA<R3.D-](N3SBV6DQH,9_R&VTDJBC=PX25P<*N&N$&'F2\W7Z_6
MINY6U,>WVEN9:8\XE.N%-QRGXRW-$:2))IHZ2$I,OI>'N5*IE^Q-8699<-R>
MW9$MQ971O9CLO21&$JES&XR$.O*)1+,T.$Z1MI[QI[Y& _)V?\SPKC)RVBUM
MS<P0$.29#D)I]^,\P24*:0A*3Q-N+TA)5C49(IBX<1$ [CV>[Q%>D7"5 818
M8TMRWK82M2Y^D;A]*Q'W&RHHE-J1P_XL7> >7,S9FFTWDWIR(\E^;!@(M\*W
MF](:0Y.DO$;CC524O EOST4TG<\D!W7<[YL2T:SM<6,JWV]=TNC<M3S3SK;,
MEUG"RW0S;TJ&C<0;AG2I),NZ8#UK/=\U.6S,LR2U&N4J#.FLV:)%)3"EM,*,
MFVW%.'0U]ZI< ,/%;UB7J4\Q&M5M.Z/1D,KNI,19#2M*_(<9-@D.*JPMI+:E
M+TQGP\'Y09>I S)?8.4)M\O2H<V:W.D181QL4=@T'.5$8TBG,5"(S+$HOS>'
MN@P\F;/S+=\R6G+-S5"2B'/)RZ=%7);;DM'&5)8)!)62DK0I!FI"U*2?DJ[A
MT!ED,I+_ -\X96R?+<=22G;Q$4YC@,PU-&ELC0942ZMPDJ10\5"77R08>':K
MU<KE=7G[TJ3%MEZ<N-NM;K,M#28R("UE53*4D:5J2PMS3&M2DGY-$E0&7GFS
MF,\MMWUB9<9-@7)D7-UGIW1[@FV(9)#&!Q:3Q$I*52%-J6GA418N"@#+;K?;
MPJ19+=EE$1;EVBR):95R6X6!N.EDTEHD46M2],5?*+#W>'N PQU>L:Z3&X;E
MO980W<&78_E-O.HB7%,1Z0G22"HVM'T7ZM)8S2HE<%: RXV<Z7^$U;V'VBFY
MBNL6W&XXPAY^(A3C$B0XM$5%%E5+=.!?E&=> D@.^C/&9%GTEVUL0XD%NVKN
ML60M?3-)<7%-J2A)%A1H_)66.N(CIY)\(#CL6:\UH]E(S$40XDV7+CN7:.P^
M;!K1-5&8CF1&>B6K@PN.>0L_)\[NAZ^:;:4B\V%93Y\8I<M49]J),>CM+;1%
MD.D1H0HBKB2DZEP\ ,,9@9UOV7["F9<&4W.&X5SZ 27'')JG(DU331.*54E$
MI*B\WA13\[O&7JW#,V;2R/?KDF,W;K[;JI@RI4=UJ,\5$*)PF'%&X1%B-%#/
MA452X 'U+S3<;/<W6Y))1!;GQV+S<G-+(C1])$CK(D-HHIE#BEF1+6:D)5PJ
M\[@#GL6<[E.N<:TW.(W%N+TF2U*AX7&W(B&FC<9(S75+VD(C,G6_(47<X2,@
M8>=:]8=[O$V"B!9U/PUE!Z<ME#CJ?V])+-;;Y&3:4LI4E1XR\LJTIP5,O5NV
M:[M#G7!V(Q$79K+(BQ;BVZXHICJI:6U59(O)3A)Y&$E$>D.J2P\!@P\G+]RO
M-GRM&F2E1I>9<P71<9,DW'^B:5;CB$K63JE*(DH:H2&Z$9T25*U!E]R<X7UY
M%PM3T>.A^W1;HY=)45]QLE=!2U@Z*JAFA2R?(U&JNB4DR\KN@.=>;;P\AF1H
M8R;%<'YEN82EYQJY-KB1I#AN&9I-.)2HZO((JH29*,SH9 %NS=>L<%:HT<[&
M<J#:E*6\X[.6N9#8?)TU&E*?)6[A,C*JB+%4O- =1R?F!&?;JS&7#<DR'6K?
M9U2%R21'8;AM2Y&D:2LD+4I2BP8")7=,U84T >WEC,]WS!<%1W(T9B+#CI.<
MXVXIXW)2GY#!DP=$D;1''-1+/A5BI0C28,,$>S7?W,M7*SINCJ+S/>EW6!<D
MJ23S%G2\^\[@\D_U&A..DS+\]L&6:65!WMF9F67<9136)$E#4%M];;$-,=2D
MH:6RVHDK4:<+BS<(ZXN#R: P\"PLWB9:,MM7)RYPO:S["I#QW1R0[(04!]XS
M2M!U:2:R)2DII7P R]5J_P [+UKS>;#Z[VQEY9>SW)CI8U.K92XN,X^E)F>C
M6HO*,C4DE4.ID _#SCF:!<9$>ZQ8*X=NFL0IKD53VE=3-:)UM;2%5))HQ$E2
M5&>/A,C3W 'P>=\PL%;428MO6_F-IMVQZ%UQ2&%/+01%*,R\I!)=29+;IC46
M B*J3 >5'SEFVVO7*W=%1=;STZX/*3%3(EL)8A-Q4)9;2D\32G%.D?E*-+9U
M\ZI /?@YAF6^U7R\R:NL1;N12FY#AUBPUE'TQ$95(M E:E&7<\DP8=5C6-*D
MNNQ>BLQ9*-._5:G'\,)U26[:[HFDXUJE*<226T<-24DN$@9?5ISY=)LFV-SH
MK<*&])D6Z;,6R\:#G,R- VR1$9FPIPC2M.FJ1F>"N+NA]3LSYI@WV]1&TPI,
M/IULMUH;63C2V5S6TJ=6\HJDLDU-24IH9]RI .(L[R)UV7;*:6 MR'(M]PB$
M]$2X@[DS$<1B<Q:5)&XDS-!$E153WZ@.%&L+,;-L9N<VV17#NK!.V>)#6ZZZ
MAPY345*'C-)8ZZ="ZH(NX:>'@,!\S,WYMFVNXPH\./;KM#@S)LAZ<3T0G([>
M)#2V45-;>(R.JEF>"G</$0#VTWN]*A9>M5EZ,N[7"V].7*N2G%-X&&V25P-T
M4M:E.IJ>+@*I\/ 1F'FP\^WR>:+FU B-6)@[:F8A3RW)2U7(TH,VC2E*,+:U
MI-)G72)_P\ ,O?NSTMC.&74-2W41)3<YN1"(TZ!PT-I6E:BPXL23+@\JE*\
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)2G#W:@/? ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>lc_significant-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_significant-4c.jpg
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M%!04%!04%!04%/_  !$( F@#M@,!$0 "$0$#$0'_Q #?  $  @(# 0$
M        !@<%" $#! () 0$!  (# 0$              00% @,&!P@0   &
M 0," @,*!@T&" H)!0 ! @,$!081$@<A$S$(02(446&1,M+3E!46%W%"(U56
M5X%2,W2TU)6U=I8W&#ARLK,D5'6AP=%#<S0E-O"Q8H+B4Y/C9#62HL)CPT2$
MQ(4FHV5&)Q$!  $# 0,'"08$!@(" @,   $1 @,$(1(%,4&AT5,5%E%QD2)2
MDJ(3!F&!L<$R%.%"<C/P@B.3-#7QLF)#PB2#)0?_V@ , P$  A$#$0 _ -_@
M !7W(7-?'G&:RBY+9_\ :JDDM-5$0<B7L5U)2D)T)!'Z#<4G7T *\JO.)QC:
M6+5>=?<QCD.):9=7&9<2:EF22(TM/K5U,_0DP&P@   (ER7G]=QGA\W+[.,[
M,8B&VVB+'T);CKZR;06Y71):GJ:C]'NGH0#R\4\F5G*^)HRFLB/022^Y#DQ'
MS)1MOM$E1DE9:$M)I6DR5H7N>@!-P !&<]SNAXXQM_*<C4Z5<PXTSLCI)QY;
MCRB2E*$FI)&?BH^O@1@(IQQS]@7*-V_C^-^V-V3$94PTS64LI6TA:$*VFEQ>
MID:T]/<_  M$            !46>>9#CKCO(I>+7I6#EO"2VI]$6,2T%WFDO
M(T6MQ!'JE9> #"U?F[X>L7T,2'["L2L]O>F1#-M.ONG'6\9%^P NJIMZN^KH
M]O2S&9]9*3OCRXRTN-+3X=%),RZ'T/W# >T  8E.48VNW1CZ+>&N]<)9HK42
M&U2C)HM5GVB4:M$Z=>@#+     ,3:Y1C5$XTQ=7$*O??4A##,J0VRXXMP]J$
MH0I1&HU'T(B(!E@   4??>:SB[';ZQQVP19G.JY;T&4MJ*A37=CN&VLTF;I&
M:2,CZZ +I5-BHAG8*>24%+1R#?U]3M$G?OU]S3J IG'/-/QCE.05V-5C=G]8
M6DEN'%4[%0EKN.JVI-1DZ9D6OO ,WR/S]@7%URW09)[<NS=CHF);AL$ZGM.*
M6A)[E+06NJ#Z (Q5^;WA^PDHCR';*M2M1)[\R(1MIU])]AQTR+_S0%D9=R?B
M&&8DQF]E*5*QV4II$65 3[23OM"34@T[3(C(R+QU 5:7G(XD-WMFQ<$G_P!:
M<1K;_P #YG_P +-P/EO .24K+$[AN3,:3O>KW4J8EH3[O:<(C4DO2I&J?? 3
M8!36+>8K&\IY2E\81ZR6Q)9>E18MBX:3;>?@$M3I&V75"=&UFE1F>OI(M0%R
M@   I#)O-7QABMY8X].;M'["KDNPY?L\5!H)YA9H7H;CK>I:EXZ=0&0PSS,<
M4YM9L4T.>_6V<I1-Q6+1GV<G7%'H2$N)4MO<9]"(UEJ?0NH#'\S^8ICA_(H.
M/O8ZNW.;"3/*0F648D[G7&MFTV7-=.WKKKZ0%UL.]]AM[3;W$)7M\=-Q:Z .
MP           $9SK/\7XXHU9!E<SV6%O)EE"4FX\\\HC,FVT%U4K0C/W"+J9
MD0"L<2\V'%^57;%&M,^F>EN)9AR;)II$=:UGM21K:=<V:GTU41)]TP%Z (MR
M!G]%QKCJ\GR),A5:AYN.HHC9.N;WC,D^JI22TZ=>H"I_[XW$?_JK?Z(W\^ M
M+CGDC'N4:%W(L93(37LREPEE+;)ISNM(0X>A)4LC+1Q/74!+P       8F'E
M&-V-HY25]O#EV[+1OO08\AMU]#25$@UJ0A1FDMRB+4P%89[YBL<P'D*!@$ZK
MERG9'L_M<]DTDACVM6B-J#+<YH1D:M-/>U/H N4                  0?D
MOE;%^*8$&QRA,I3%@\J/'*&TEU6]"=YFHE+1H6@#XXSY;Q+EB+82\6.215CC
M;4IJ8VEIPN\DU(41)6O5)[5%X^@!C>2N=\%XKM(E-DQRW+"9']K;;A,I>VLF
MM39&O<M&FY25:?@ 2C \YI.1<:CY5CY/)K)*W6VRE()MTE,K-M6J24HO$NG4
M!)0    %-9[YBL<P'D*!@$ZKERG9'L_M<]DTDACVM6B-J#+<YH1D:M-/>U/H
M M"[R;',;9]HR&VAU3&FXES9#<<C+PZ=Q1:_L ,HA:7$)6@]R%$2DF7@9'U(
MP'(   *?Y>\P=!Q%=U5%95<JQD6#)2WUQU(0EF,;BFR46_XZS-"O4U+P\>H"
MVX[[<J.U*9,S9?0EQLS(TGM61*+4CZET,!V@    *GY!\PV \:9">,Y&W8*L
M4LMR3.+'0ZUL>UV^LIQ!Z]/< 1;^^-Q'_P"JM_HC?SX"R.,^6,7Y7A3Y^+HE
M)8KG4,2/;&DLJ-;B=Q;=JUZEH G(   (YGN5IP?#KC+51#G)J8YR#B$YV3<T
M,BTWFE6WQ\=I@*DHO,Y'NN-,IY&+&5L-8S(B1SKSFI6;_MCK;6I.=@MFWN:Z
M;#UT 7\ CV=Y*6'89?91L)Q=3!?E,MJ^*MUM!FVD]/0I>A& TN\N?&L7F?,+
M_+N07'+6)7J;?E-.+4DY<Z6I:D]Q2=#V()M1FA.GBDOBZD*-PD\4\9MKANLX
MC4L/5[K<B&\Q#99<;=942T*);:4JZ*+7J?7TB"ON3.1.;ZW+9.,<:X.W:0H[
M#+WUS*)Q;+G>29F1'W&&TJ2HC3MWJ/IKZ0$8XY\R.7/<@,<:<L8^S374MU,5
MB1&2XR;<EQ.YI+K;BW-4NZD2%H5IU+H9'J0>GD;S+V/'/++V'6==%7BD5##K
M\QM+JYQH>C$[HDMY(W&L]I=--/$!&V?,'EV3<9YYD^2XI6N4\!=2W554V.^N
M+)CV+[C;G=4XK1[:2$*(T$DM>NG@ E7'W.573\$R\_L:"%50ZR<Y6U]%2H]G
M9=<,FS0E)*W$DU*6I2U=>A&>AGT 1>CYY\QF31&LIH, ASL2D.FTP;+4A:U$
MA9MJ,ED_N5M41I4LFMI:'[ABC:]&_8GNZ=S0M^W7;NTZZ:^@0:D^=')'YDC%
M..Z\S<DR'%6<B.D^JEK,XT4M/?,W@$'FU[' GF5HRC)*+0N%!)74]AQ)T<HD
ME9Z^))=)U9?Y(HVTY=Y.KN)\/=R:;'.;)<=1$KH*5=OO27"4HB-6A[4DE"E*
M/0_#W3$%*8MS9YC<D.LO8N!PI.(6TAMEB0RU(U2TMWM&X:B?6HDI,]5+-K;T
MU 2;F?S#VF$9;%X[P6F;N<OD$P3AR=ZFD/2].RRAMM2%+6HC2KXY$6I>/70,
MWQ7G'-5S:6M=R=B<>EC08)RHT]A#K:77]R22V1FZ\VKIO4K:LC+ITZ@([P!Y
M@\FY<RJQH;FK@P8L.O5.0[#[W<-Q+[31)/N+46FCAF ZLL\Q&3X_SDQQ9&JH
M#M0[8UD YKG>]I[=@AA2U=%DG5/=/;ZOH =/(7F:L>.^6IN&VM9%=Q2"EIQR
M6R3JIRB>AI?))%O)&XW%$@NFFG4P'&$>9FTD8GEN<<@U**RJK7(3>.PHK3K;
MDQR:3YDTEU\S2X?Y,E&I)$24ZJT\" 1=SS&<^+IOO!8P6&CCXCU[RFWUGVMV
MS=W2>2K37IW"9V"C8KB_D:HY2Q"+E52VJ/O4J/-A.*):X\IK3>V:BT(RT-*D
MJT+5)D>A'T$&G_-,:-,\UD:',91(B2+*@:D1W4DMMQM;<5*D+2?0TJ(]#(4;
M/9]Y?N-LTHI<&-0PJ>X-I7U?9US#<1QI\D^H:R92DEHU^,E1'T\-#T,H-=_)
MUF-E3YE<8)/>--/+BO3"8<5ZC$R&I)+46IZ))39JW^[M3[@HG%EYDN0\VR.?
M1\&XHW<P:S4WK.8E;G=02C23A))QA+:5F7J$M1J4770NI%!DL$\R62Y36Y/C
M\[&TQ^4Z&(_)AU#:7NW,=BJ)#K),F?=2Z@SZMDI1F6NG@8#6CC[+LYI.6YV3
M8[CAVF8//6"WJ,F7W#;7(4LWD]ML^X7;,S+J?3TBC;'D/S#2./,1QI4^E[W)
M.0PF)2\>/N-(BJ<(B6;J3U<+\IJA"/C*,CZEH((*]YC^9,!LJY_EO"6(>.V:
MOR:XK;C$A*2TW;#6^\DUI(]>VO:H_=(46ORQS[C'&F.5EO&1]=6-^R4FCALK
M[:'(ZDI63[BS(S2WHI.GJZJ/H7@9E!6>%<X>87+;BEEHP6.G#K:9'85/3"FD
MAN,\Z25/D\;QD:4I/<:]FWH H;EO*,PMN94W=U0G79!$DQ40*M33R#?1%>_U
M<]BSW'W="^+X^@4;/2O,'DV(\7O9CR)BJJK*I%FY64]$:7HG>0EE#I/K[^Y9
M((S61F1=3(B+QU$&$PSF'S&9#/HK&5@D-6'7TF.AN<RR^GM19"TI[YJ*0XHD
M$D]^];>AEX -G0'YD75&K*LAY/N6B-;]2]+MDZ'_ ,VNT0RYJ7IT2]N_8%&Q
MD_E1?]T*/9$\97,F.G%-VOK=Q*C869GX[CBH4O\ "8@H:DQW[#<G<6K6?Y:Q
M^H;F01GU3[=*)1$>OAHC;T%$U\X/;^^*L[NG:^J(6_=\7;[3(UU]X!*?,S;<
M$S<*CL8<JF?RTI+1PG*)#!&A@M>[WEQR).S3H25'KNT,B\0&'R*FOJ3R?54:
M_;<8<>N&Y4*,\1I6W$?6ZMO4C\-QFIPO>4(++\LF X/DG#L21?XY6V4J1*F(
M>DRHC+KZDH=-*?RBDFKH70M#Z */YSPTN".5*J[P)Y<&*^A%K5M[E*]G>;<4
MAUG4S,U-GH711]4J-)Z^FC?2DLV[JFKKAI.QJPBL2T)\=$OMI<(O_K"#6GCO
MELKOS#6.+)Q&C@RGYEI"E7\6.I%DZW7I>-)K<W'J:S:3OZ=?V" >6?YM,CIL
MZR3$I>-,67U?*FUE*S7$][3(F,R.RP2]RE^JHB/=L1NUTT(!X<?\V.<U.;,X
M]REC;%5 ?>;:D(0Q(ARX:'C(DN*0^M>]!$9*/H1F74O< ;>@-!:.)43O-O/B
MWS,614KO[CVAF>EM496UN2I.\G?5/11$:=?3H*/GS5P^-8&6U+?'Z(3%EV'#
MO6:GMIC(62D]CU6?42Z9;]Q%UTVZ@/GS5'9G=X*=UN^N3Q2"=CO^/[5W'N[N
M]_?KJ VAY0SKD[%48_5\<8@61RK2,M;DMPG%LQU,$V6UQ*#;).XED:5+=3KX
M$(*J9\S'*.!Y/"IN9\4CUU=--*E/Q$.-.MLJ5M-U!]U]MTD'\9*3(_?%%B<[
M\_M<3HK:RE@-VV26S1RHZ75&49F-NVI<7LT4O>HC)*4F7@9F?AK!YN,L^Y_M
M\NA4W(F%QZN@EM//N6C+3S1M;&S4A)GWGD;E*-*=B]JM-3] "$3?-AE%7G&2
MX<YB[-I)@RIE90L5Q/'(D3&9/9:[I&I>J302C43:-QJT(M"ZD&*HO-_EU%D,
MVIY3QEN*VRES6-"9>B36'R0:VT+;DN*W)6>U.OJZ$>[J704=<OS9\H8WD,1>
M9X6U68]-)+[4!UF3'FJB*/3N-.O*)*S(O_NR(_> 7WR9R!F%%C=);\:8V>52
M+UQ"6-"<4AIIYDWFW5H;(CVJ(NIFM)%Z3ZB"D[/S&\X\=64)SE+"HD:EG+,D
M%'2XRX:4F6\FW2??;W)(]=JBU_  VJIK:#?U$"\K'.[764=J9$=TT-3+Z"6@
MS+T'H?@ U;\[M//>K<3O4/).MB.RXCT8UD2B=D);6A:4:ZJ+1I1*,OB]/= 5
M_E=A*\S5[A^-\?8R=9&HH3<>UL5-)0Q&[Y(WI4I'0F&>VKLD9DI9FK1)&*-Q
MJOD+!I5_]B(-_'EY/$-<=VO)9JD=R*D^X2NFFY))/=U$%:>;O^QN5_O"%_GF
M I[@NW\NT/C]ACDENI5DY2I!N'.AN/O]DU%V]5I:66FGAU%%C9US'C'%&!TM
MYPQ654K';FQDM.I0R]'8[S3:26HD)[1[O5(C,_00@L!KDZW<X*/E0X<8KDJI
M=E[$7<]F[B3,MOQM^WI^V_9 0;CWS"91F/&N=9K,JX$>?BK)/0X[7>[+I]I;
MADYN6:OQ?Q3(!"ZKS:\AY+2O0\8PI-IF+;CCSOL;,F3#8@(0C:M33:C<4LUF
MK7UDI(MOB9]*)OP#YCYO)UR_B.5U[$'($,KDPY,/>AA]+1EW&U-N*6I*TD>X
MO6,C(C\-.L'AY3\TS]!E+N#\;TJ,@O8[IQ)$ETG76CED>U3+++!DMU23]51[
MB]8C(B/Q =U%RKYB7,<R:??8"TFTJX\5VJB(AS6URURI2&EI)!.KW]MHUK5M
M,C3H6H#6?@K+L[PW)[*QP''#R2U>@+8DPDLOR#:CF\TLW-K!DHM%)2GKTZBB
M^N5>89&/\M8_4S,,HY]JAFM6S9V$=:Y\5R:9&M*%[B-/;4H]G3U3Z^(@GG./
MF*A<5S&,:I8";G+Y#:7E,+4I,>,VX>B.YL]92UZ=&TF73J9EJ6H5P]YFN8<#
ML8"N5L(9B4]EJMCL-/0Y';3IOV&ZZZA2D$HC-M6U7AJ9:@+'YCYXDX1A.,YM
MA3$.VKLB<T:5,)TB[2F3<29$A2#)1&6BB5X'T 5=?>;#DR33Q\CQ/#4-8S'2
MRU9W,V-*?BJFFE/=0AQI:$-HWGM3N4I1]-=#/047'Q[S[1Y=QA:\A6T<Z]W'
M4N)NX+1]S\HV@EH[)JTU)W4B02O!6I&?3<<%4U?F)YZS@IM]Q]@<29B\%U3+
MB#0]*>W$1+V&M+S.]9)4DS)MOT^ HVBQN;:66/55A=Q$P+>7$8?G04[M&'W6
MR4MOUM#]0SVGJ(*EY.Y#YLJLK=QCC7"&[6*U'9D?7,HG%LJ[Q*U21]QAM*DF
MDRVFXH_3IU 1+C_S)9@7($;C?EO'V::VF/(B,28R7&3;D/$792XVXMTE)=,R
M)*T+TZEXEU(,KS!YB;K%<U9XUX\I6KG+%]EM]<G>IM+\E)+;90VVI!J5M4E1
MJ-9$6OX= E7$&8\Q9#9VE9RABK%$U!8;<CS6$.-I?<<4:=J3-QY"M"2HU;5]
M.G3J F').2Y!B.'S[[&*5607$8V4LU;>_>OO.I:-1);2I2MN[<:2+P](#7:_
MYX\R&$L-Y%F&"P(F-+<2VO\ )/%MW_%)3B)+IMF?@1K1IKZ &QO'F<U?(^(5
MV7U*%,QYR5$Y&<,C6R^THT.-J,O':HCT/TEH?I :Z^>&22:O#(>O5V1/=T_Z
M)#"?_M@,#Y?=W&G/UQQXXLRAV\)*&4J5KJZB.B>PK7T_DE.$7X11!N5UN<F9
M]R?ENXW*C$8[<:&LE&2"-F6S!;))^XLS>= 7QY;<OIL1\O<C)+]_L55-,FG(
M61$I1[EH-*$ETU6M3A)27I,R$$3:\S/-69JL;3CC!V'\<JS-4A;C,B:Z2"(U
M$2EMNLI-9I+=L;29E[X"U>"_,!6\O)E5,V&FJRN"WWW8B%FXP_'W$DW&3/0R
MVF9$I"O#4M#/KH%4U'F^S&=,LJ-.),V>1J7[/0PJQ,A?<?2LR<-TMZUFE*"W
M$2$ZGZ="ZD&2XU\TV53L\CX-R;1QZQ^=)3 0[':?B/19;IDEM#S3ZW#-*E&2
M=?5,M=>I ._F/ELL8YLJ*!>)4=I)CG *'=3XZG)S!2UEKL<)1;=IF9HZ=#Z@
M*6\T=_E%YR0\UDE,=2Q5]^!3.FVZW[9 :DN]N1JX>BMVOBCU11LUA_-635V"
M9!E_+F-KQF)2'';K8Z&'V79IO),DH;3(5ZRC5M+4CT+74^A&8@K1OS+\X9-%
ML,IPS!XJ\-JU+.4ZMJ1+4A#9;U$IU#K1*-*3)2MC?JEU/H MSA_GJNY7H+5Q
M$1-;E=,PI^77*6;C*T;3V.MJT)1H-1:*+Q3T\=2,PIFO\YN2RZ6Q;7CT-[+'
M76&:*+%3(4R9*)PWG'DFM2E;=$$A"%$9ZGKX=:/KE'G*UK:_ YV38717%Q.J
MTVRSM8;AN191R'&S2TE:MR$Z-I/0S/4^OH(!8/-7F#R'BVZQN%#K(4NOMX+<
MZ8M_O&Z@S<-*R;V+26FWXNOI$%?Y)YL>4*^1%R"'A;<#!)SBBJW[./*)<MHM
M3(TR$K0WN-);M$)41>ZHNHHOE'.&*%Q(WRX^EQJK<:_^7ZDJ0<TG#9.,GP(S
M[A&6[33;Z_0A!1=+YI>7;9<K*X^#-3./:YPBLEPV9*W&&BT4O_6=^PUI2>JC
M[6TBZF1%U%%A<"\^WW+V3W5585D.!6U\8Y45;'=[ZMSQ(22]RU)^*?73TB"T
MLAXPX^RRR.WR3'85G9FA+1RI+1+7L1KM3K[A:@-)^"<4QO(>=;#'[NKCSJ1'
MUGVX#R=S*>RLR1H6OXI="%%Y<D\KX5Y>Y2L-XUQB(YE-CVY,V*R2FXS)K+:U
MW2;]9;BB^*VDT]#UUZEK!&G/,WRY@=I!3RUA+42IL2-QGV9MV)([9:$KMFZZ
MZA2D:EJVK:KPU,M0%V9_S?B.#8%!SM*CM(]TA"J&(R>Q<I3J.X6IJ(^VE)?N
MAFGU?#3<9$ HA7F6YW33%GIX1#+ #7M]J-B3MV&OMZ][O>&[U.YV]N[IXBB?
MY'RI2<M>73,;^J:5$EQX:X]G6NJ):X[Y&A6FXB+<A1'JA>A:^\9&10:_8+_A
MAY4_WA4?PR,*/T%$$6Y)QI_,,!R/&8ID4RR@/L1=QZ)]HV&;6IGX%O).H#3?
MRN\H5'&.2WF+YJLZJ#;&V@Y4A*DE%G0E+0:'BTU02B6I*E'\522UT+4RHW.3
MR!@BUQ&F\FJG'9[K;$%MN;'6M]UY1)0AM*5F:C49D1:"#4W+,_Y Y?YLE<7U
M63N8?CL>=*K6NRM3"E>P;R<4X;:FUNK<4V>QLUDGP+W3.BOKK&HN'^8/'\?B
M9 [DBH5O3ID6;RMSG?-]DUMF9+7U1KIINZ>'B0"2<\QH\SS/Q8<MI+T61+HV
MGV5EJE;;B6$J29>DC(]# ;"^:Y*4<(VZ$))*$R(!)21:$1%);(B(A!6?"6+8
MIF?EML<?S">W55LJ[>*/9..(9[$S:P3*DFX9),S4>W:?QB,R].HHKJ\8Y5\K
MUG7'2Y5&L*"R6MZ-%9=-Z(\3>W?WHCA^H:B47KMG^!>I -Z,7NBR3&J;(B9.
M.5M!C3RCJZJ;]J:2[L,]"\-V@@T1S*3EG+/F-L%X&I"[BNF&BD><-'9:12ET
M=U<)2=#6V:RW$9&:A1X^=L0YM@QZO)N6I+$]O>=="EL'',T&HE/$A1,-M^.B
MC+77T@-E),3$^=^!<95EUPU4R9B6$1[1UQM!HNHJ7(ZR(G%))>\TN_D]=32?
M3KH8@U_L;+ECRO9!6UC&1Q[?'Y&Z2Q6-/F_#>92HMY+87ZS"E;OC(TU/P4K0
MQ1<','"U/RO>,Y?A^11:7/SAQ),VIEO$A9I-HE1W%=LS=9622).[89'M+P,C
M,X(]Y>^6N09>;V'$V93OKQ)-36(\UQQ,AUB3!)1*+VA.O=:625%N4:NNAD>G
MC1!?*%?5&.\F6;%[,:KE3:MZ+'5)6EI"GT2&7#;W*,B)6U"C+7W '7F=S57W
MFT@V5++;G5Z\@I&D2F%$MI2V/96G-JBZ&1+0I.I=#TZ /3S5&CS?-9&AS&DO
MQ)%E0,OLN%N0MMQN*E25$?B1D>A@+.\[,.<K$<7DL)/ZJCSWFY))+U4NN,_D
M==/#HAPB$$&P[".4LZP*(S4\MUQ8S(@)A2*1Z4Z@XS':)I45YOM^KL3ZGN&7
M4C,C(Q1>OEPXRG\:8W:Q95U NXUG,*1&?JW%.L)-I'966XR(MVY.AZ>&@@UX
MYD6VUYLH3CJTM-(M,?4MQQ1(0E)(BF9J4HR(B(O$S%&TW(W-F"8#C\NQ<N(<
MZX)I?U;517T/OOOZ:((TMF9I1NTW+5T(O=/H(-3?+UA&17M7R+FD9A:S1CUG
M65KVAD;UG.9W&39EXJ2DNNG@:TBC \%5^9W*[2JPS/XN'35*:=<A2GUQE3"(
ME))39I0HE&C70TZZ]0%W\8<%Y;2<OP\ZO<UJ;NSC'(DVC,5];LYU+\=<?<I)
MH3TU6G4S_P#&(*VX?M:VB\S]N_=RVJ]E5A=Q^]*6EILG5N.D25*49$1F9:%J
M?CT\11\^99<]KGBNN&;--?$E,5<NEO"-2V6&4F1%(2ILE&:4.)4YZA'[P"39
M)PUR=FE(P>3<N4EOCZ'"EQW),Y:XQ.;%))PE;-OQ5'UU](" ^8;%[/"KW!:B
M\,IT6MQR#"*0SN)A[V1][NH;49$?3>7CUT,@&\6.<@X#?5-=-HKRO.#,2TU"
MCD^TTXE2]$H9[1J)25D9DGMZ:Z]-!!I]YD)#4#S&U<Z8OL1&2J'W'E?%2TVZ
M1J5^ MIBC9+F'%,!Y>Q"+6S,DA0G3E?]A6[<AEQOVWM&9M?'(G-R.JD$HE>!
M^@0:P+R;E;RPY5 QV1>L7>.K2F256T^<F*Y$4O11(0X1+CN'H>FW0M>OK%J*
M-]T.$MM+NAI2I)*T46AD1EKU(0:,>62D8S7(^2J^3H;5S2RH:EGUT]N?Z*]W
M4C+<0HK'%2O,G52<(.-&TP]DIRI!Z^NVZXVB*]J7N-H;6KX0%H^9!EBFY_Q=
M45!,QX\6G6RA&NB4,2EH21>YH2- 'E\X3:7>8JQI?Q%U$-*M.AZ')D$8#U^8
M;@^GX?B46;X$_*89*:F,^V^LGS9DDDWF'4*-)&7[FHE$K4M= $QY@S9WD+RL
M4F4RC2=C*FQ&K'81)+VN.IUET]I?%W*1O(O<,02WROY1C5%PM".ZN8-=VI4U
MQTI4EEDT([Q]5$M1&6H"AN<LM3SORU54&"(5.B,)14UKY)41/NK<4X\_H9:I
M:3KXF7Q4&KP%&^=17-4]3 J&#W,0([,5M1]#-#"";(_@(0:/\/?XM9_^]<A_
MS90H^>-TH7YP99+22B*]R R)1:Z&3<PR/KZ2 >CSK(0GDBC6E)$M5(WN47B>
MDN3IK^ !O!",SA1C,]3-I&IG_DD(/SUF8;"Y!\S-YA]C)=B0[.]MD.28Y)4Z
MCM=]Y.A+Z=301'[PHV@P3RK<:859L73WM5]9Q5D[&.Q6@X[;B3U2M++:$$9D
M?4MYJ]WQ$%%>=?\ M%HO]R-_PN0*)/Y@>6LV1G%3Q3BEL>-PEMP&IMHEPXZU
MO3R3HI3Y>LVRVE:==FGXVNO0!4G/_'_W>6=)62\PD97=R8[K]@4DS-4;5221
MM)3KJB)SUO$_Q=0&QG*7#N-\JT>))1D$:ESR+3QRA-27$F4J'L2>BV]Q+T2L
MST6@CTU,C(^FD%<\3<F<G<>\M0^(\OM2OZQR2W6.H[WMI,+>02FG&)!^OM3N
M3N0OP+4MJ5%TH\7%"$GYO;O<1*-%KD)I,^NA_P"L%J7[!@.OS&-MGYD:))H2
M:7/J?N$9$9*UD:>M[O0M $S\\*$'5X8X:2[A2)Z25IU(C0P9EK[^A ,'RSS%
MEV$<=<;8;B<M58_8XQ6SI]HW^[]I3"&VVVEG\3JA1K47K>&AEUU""\Y\;2L%
MQW'Y]YGCV5Y#<.&\N(MU;S*63;W&\TIQUQ2D[C))+,BW:^ #<;@K^Q_#-?S8
MQ_XC$&J^63JK-/-0NHY3D&UB<&<Y7QXS[ALQT,LLJ..@U:EL0\YL4L]>N_Q(
MO"CIRZOO?*UR0Q?838M3\5N"6IFN<?)?<CEU./)0E6[U-VK3WI_#N(!/_*)B
M$^WL\BYCO7$NS+1U^)#,E$I2GGW2?ENJ26NW56U*=>NF[T::P3KS=_V-RO\
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M3$ZSLF<1()Q70U1J^4VA!F?I/N]X_P!D!&:=,^P\I5^U")2FZW*6WIQ)U/\
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MIZZ%J9Z$ S?(W'&-\H8ZO',E;7V"63\64PHD2([Z2,B<;49*+70S29*(R,C
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MN/(]I9+J<D>C2)<EQ;'M#:H;K;J";,F23H9MEKN28"Z
M
M
M       >2TJJV[KY%5<1&9]9*3VY,22A+K3B===%)41D?4M0%=H\NW"J)7M9
M8A$-W77:IR0IK_V9NFC_ .J L># @UD1FOK8S4.#'22&(L="6FFT%X)2A!$1
M%^ @'H
M
M
M
M
M                                   8Z_?>BT5I)CK-N0S$D.-.%IJE
M:&E&DRU]PR&1I[8NRVQ/)-T?BQ-9?-F"^ZV:3%MTQZ&G'WO\E?I%)^!OY ^M
M=RZ/LXZ7P'Q)Q'MKNCJ/O?Y*_2*3\#?R!.Y='V<=)XDXEVUW1U'WO\E?I%)^
M!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?9QTGB3B7;7='4?>_R5^D4
MGX&_D!W+H^SCI/$G$NVNZ.H^]_DK](I/P-_(#N71]G'2>).)=M=T=1][_)7Z
M12?@;^0'<NC[..D\2<2[:[HZC[W^2OTBD_ W\@.Y='V<=)XDXEVUW1U'WO\
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M+LAY6FY:U)(S,]-"'R[B..W'J<EML4B+IH^Y\'S7Y='BOOFMUUL3,I&->VP
M            IKS 99D>*PZ)W'K!R N2[(2^;1)/>2$MFG7<1^&ICUWTYH\.
MHNOC);%U(BG2^?\ UCQ'4:2S%.&^;-Z;JT^Y1GWO\E?I%)^!OY ]GW+H^SCI
M?-O$G$NVNZ.H^]_DK](I/P-_(#N71]G'2>).)=M=T=1][_)7Z12?@;^0'<NC
M[..D\2<2[:[HZC[W^2OTBD_ W\@.Y='V<=)XDXEVUW1U'WO\E?I%)^!OY =R
MZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?9QTGB3B7;7='4?>_P E?I%)^!OY
M =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?9QTGB3B7;7='4?>_R5^D4GX&
M_D!W+H^SCI/$G$NVNZ.H^]_DK](I/P-_(#N71]G'2>).)=M=T=1][_)7Z12?
M@;^0'<NC[..D\2<2[:[HZC[W^2OTBD_ W\@.Y='V<=)XDXEVUW1U'WO\E?I%
M)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?9QTGB3B7;7='4?>_P E
M?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?9QTGB3B7;7='4?>_
MR5^D4GX&_D!W+H^SCI/$G$NVNZ.H^]_DK](I/P-_(#N71]G'2>).)=M=T=1]
M[_)7Z12?@;^0'<NC[..D\2<2[:[HZC[W^2OTBD_ W\@.Y='V<=)XDXEVUW1U
M'WO\E?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?9QTGB3B7;7=
M'4?>_P E?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?9QTGB3B7
M;7='4?>_R5^D4GX&_D!W+H^SCI/$G$NVNZ.H^]_DK](I/P-_(#N71]G'2>).
M)=M=T=1][_)7Z12?@;^0'<NC[..D\2<2[:[HZC[W^2OTBD_ W\@.Y='V<=)X
MDXEVUW1U'WO\E?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?9QT
MGB3B7;7='4?>_P E?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R [ET?
M9QTGB3B7;7='4?>_R5^D4GX&_D!W+H^SCI/$G$NVNZ.H^]_DK](I/P-_(#N7
M1]G'2>).)=M=T=1][_)7Z12?@;^0'<NC[..D\2<2[:[HZC[W^2OTBD_ W\@.
MY='V<=)XDXEVUW1U'WO\E?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\#?R
M [ET?9QTGB3B7;7='4?>_P E?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*_2*3\
M#?R [ET?9QTGB3B7;7='4?>_R5^D4GX&_D!W+H^SCI/$G$NVNZ.H^]_DK](I
M/P-_(#N71]G'2>).)=M=T=1][_)7Z12?@;^0'<NC[..D\2<2[:[HZC[W^2OT
MBD_ W\@.Y='V<=)XDXEVUW1U'WO\E?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O?Y*
M_2*3\#?R [ET?9QTGB3B7;7='4?>_P E?I%)^!OY =RZ/LXZ3Q)Q+MKNCJ/O
M?Y*_2*3\#?R [ET?9QTGB3B7;7='4?>_R5^D4GX&_D!W+H^SCI/$G$NVNZ.H
M^]_DK](I/P-_(#N71]G'2>).)=M=T=1][_)7Z12?@;^0'<NC[..D\2<2[:[H
MZG)<O<DF1G]HI/0O<;]TO_(#N;1]G'2OB3B/;7='4W7'QY^B&*R;_NW<?O&3
M_H5#)TO]ZS^J/Q86O_XV3^B[\):##[B_,(              ,];X5D]#40+Z
MVKU1ZFS)"H4K>VM*R=;[J-20I1I,T]=%$0P<.NP9LEV.RZMUO+&WFV-GJ.&:
MG!ALS9+*69*;LUC;6*QR3LV>4K<+R>XHIN2UT!3])7&LIDLG&TD@VD$XOU5*
M)1Z)41^J1AEUV#%EMQ774ONY(V\^PP<+U.?!=GQV5QV5WIK&RD5G96O)/D=$
MW&+NNHJ[))<;MT]JIQ$%_>@S6;)FE6J",U)ZD>FI#GCU>*_+=BMGUK.6/.ZL
MFAS8\%N>ZVEE\S%L[-M/LY?2Q RV"S#6+W;^-OY:W'(Z&-(*&])WH(R>423T
MV:[M/63UT]/X1B7:O%&:,,SZ\Q6GV,ZS09KM/=J(M_T[;MV9K'+LYN7GCFYV
M'&6P0  9[%<1M,OD3XU6ME#E=#=L'S?4I!&RR:242=J5:J]8M-?A&#J]99IH
MMF^OK71;L\LMEP_AV36WW68YBMELWS7R6T\^W:\%)26F1V<>FI8YRK*5N[#!
M*2@U;$&M759I26B4F?4QWY\]F"R;[YI;#'TNERZG+&+%&]?=R1LYHKS[.1)+
M?B;D&C@/6=C2K*#'(U2'6'6)/;2DM5&I++BU$1%U,]-"](U^'C&DRWQ9;?MG
MDK$Q^,0VVI^GN(:?'.3)BF+;>68FVZGNS,^?R(8-N\^ ,SC.*WN7SW*S'XQ2
MIC+"Y3C9K0WHTV9$9ZK-)>*DD1>^,35:S%IK8NR32)FC8:'A^?6Y)QX;=ZZ(
MF[EB-D>>GEAAAEM>SUSB-I1T=)?S%LJ@WZ'7(26U*4XDF#22NX1I(B^,6FAF
M,'!K+,V6_';6N.E?O\C9:KAV33X<66^8IFB9MIR^K3E]/VL",YK0!(,1P^US
M6?)KJA;"'XD5R<Z<E9MI[32DI,B,DJZZK(8&MUN/2V1=?6DSN[/M;7AO#,NO
MR3CQS$3;;-VW9LBGV3Y6,IZBQO[*/45#!R;&4HT1V"4E)J,B-1]5F1%T(_$Q
MDYLUF&R;[YI;'*P]-ILFIR1BQQO77<D?^4PF<+<G08ZI3U XMM!:J2P]'D.?
ML-M.*6?[!#4V<<T5\TC)'WQ,=,Q1O<GTQQ.RV;IPS2/)-MT^BVZ9Z$;I,4OL
MA78-U40W7*IA<J<A:T-*;::/171PTZF7[4NHV&?68L,6S?/ZYI'/R^9J=+P[
M4:F;XQVUG'$S=R12(\]/1RL,,QKP                      ;Q\9?V>XU_
MN^/_ )A#XQQ7_EY/ZI?I#@7_ %^'^BW\$K&L;L             4#YH/_E^-
M_P#32O\ ,:'N?I3]>3S6_F^7_7O]O#Y[OR:WCZ"^2
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MN+\P@              V3S-LKC'+O"'5$IVEQVKO*MLR_<SA)4F1I^%&B?\
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M(]4*,B\#-)EJ7NCV6CU'[C#;DI3>A\WXEH_VFIOPUKN3,?=S=###,:\
M        ;Q\9?V>XU_N^/_F$/C'%?^7D_JE^D.!?]?A_HM_!*QK&[
M      % ^:#_ .7XW_TTK_,:'N?I3]>3S6_F^7_7O]O#Y[OR:WCZ"^2
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M^[=Q^\9/^A4,G2_WK/ZH_%A:_P#XV3^B[\):##[B_,(             ?A\
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M6QLB(I,S/VS1MM+&'#H=7?9ANPV763%;YFMUTUB+8CR1,^>:[9V-?![Q\I
M                      ?2?!7X/^,A)6'Z&#X,_53%9-_W;N/WC)_T*ADZ
M7^]9_5'XL+7_ /&R?T7?A+08?<7YA
M                                     ;Q\9?V>XU_N^/\ YA#XQQ7_
M )>3^J7Z0X%_U^'^BW\$K&L;L             4#YH/_ )?C?_32O\QH>Y^E
M/UY/-;^;Y?\ 7O\ ;P^>[\FMX^@OD@
M        /1 L)]7*;G5DIV'-:U[4F.XIIU.XC2>BD&1EJ1Z#KR8[<EN[?$71
M/-.UVXLM^*Z+[+IMNCDF)I,??#W7&4Y)D"4(O+:78--GN;;DO+<0E6FFI),]
M"/3TZ#IPZ3#A_MV1;YH9.IU^HU.S+DNOC[;IF/0Q(RF"
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M^W\-O4>$>&=G/O7=:R1YYZX            ][T@&I'X
M
M
M                    *,\WDB3$X)O9$-]R-(3,IR2\PM33A$JTC),B4@R,
MM2/0P%Y)+1)%[@#D!P9Z$9^X ^=_3P\?0(.4JW>CIIJ%=M!]"C@ST$J/DG-2
M,]/#Q(!]$>I;O>UT%'SW"]SK[@@=PNN@HX[G73;\ D#Z2K=X> 0"EDD]-.H#
MDCU+44?/<+W/3H(/HST+44?/<+3P$*N242C,O<%!2MOHU <D>I:@.0
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MK='W1=,0F25$HM1ALYR
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MF&Y#*TN,.I2XTX@]4J0LM4J(_<,C'1,3$TEW1-8K#M!0
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M%I/P-*BT,OV2 5I6^7?A2HLXMU6877QK6&\F5'F()SNI>0K<E6XU]=#ZD1]
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M>>^RVEYUMA>]26UJ4A*C+W#4E1?L!?@R8]M]LP8]1CR32RZ)F&<'4[@
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MU&/+7<FM$@W)]TAU.\U+W1*AJ7ND*.0'&Y/ND!0U+QU+0"CG4C\#
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M74CZC<V7Q?%8Y)?.-5I<NFR3BRVS;=;RQ++#FQ@
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M*U7@?M<SJ7OO&0WO#_[/WOF/UIMXG=/V6_@N<;%XL
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MKJGJR>DUL+6G:LM%&DTJ2?@9&1D8V&.^,EN]'(\EK-+DTN6<62*76\K,CFQ
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MO%&^NR1$:-:4H;/V?<@BT3ZNNFGB0UM^+A\X[:S;N[:;?2V%F7B47W4B[?\
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MP7*3A*/I^#Q&RH\4[!
M                            #\# 4Q2_XHLJ_HA5_P -? 7.
M      /+)@0Y1'[3'9?T(R+NMI7T/Q+UB/Q$I$N=N2ZWDF8\S4SE/B[%:KE'
M&JFGIGFZ:X=AJM&H_?4RGVF6IIPB46XFRV>_T'GM5I[;<UL6QLFGXOK?!..:
MG)P_+?DR1OXXG=K2NRVL>?:MP_+7Q+U,JA[0O_BGNI^]ZPV?['#Y'D/%_$Z?
MW(]V$1I.!^.YO(>5T4JH?^IJR-6N5_Y9XD]R2AQ3VB]?6ZI3Z>@QK-'C^9=;
M39%&XU'U/KK='AR6Y(W[IOWMD<TQ1%/,)Q'@V 8G7VF,07(TZ1/3'<<6\X[J
MV;:U&6BC,O%)#HUVFLQ61-L<[=_2G'-7KM3=9FNWK8MKR1Y87'Y=O[(L>_\
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M2_?OFZD16:[.1[!R=8
M                           'X& IBD_Q197_ $0J_P"&O@+G
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MKI^V-D4ANP/3/AP
M                         !^!@*8I/\465?T0J_X:^ N<
M       % ^;5EYS *UYMM2VF+-M3ZR+4D)4VXDC5[FI]!JN)1,XX\[Z#]#7V
MQK;HF=LV33TPJ_B?S"2\3K*+"7:5I^K:?..Y.;>44C22Z:MQ(,MNJ37X:^ P
M=/KIQQ%E-CU?'?I2W5Y,FIMR3%\Q6E(IZL>7[FYJ-VTMQZJTZF/1OB;D
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M(FVR8F9\GZHV+Q&Q>(
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MFZ>I[4D1#S6NB(S;/L?;_I:^Z_A-\W3,S7)R_P!+=<>F?#C4@   -2
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MVOG+DC(_ P'(
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M7F%RW'<7]K^KG,6K)3ASY;TYTW53'D]''U*42="^+KH"-D0
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M9&.V)B8K#!R678YW;HF)CFG8](K@
M                      #$Y*UD+]'/9Q61'AY MA95TN:A3T9M\_BJ<;09
M*4DO21&"PHBXE>8S'"9+(^4./ZE3Y&;/M\-V)W"3IN-'>?3J1:]= 2DK*XCM
M<JM*>8YEF58_ELU$DTLS<7+2*TWL29-N_E'/7UZ^/@"K",$=)1(Z'%O(:2E]
MPB)QTDD2UDGP)2M-3T]\!SV4D>XD$2C/51ET/4O29^D5'PF%%;<<=:80VZ\>
MKJVTI0I9_P#E&1$9_LCBKT>!:>\**9I/\465?T0J_P"&O@+G
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MOSUNF7GGF5KXCT^<NVCPHR#=D2'8*$MH0GQ4HS1T(AQNS:J(K-?1_!V8^%<
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MBOI*]QZ?\)> #[$
M    !PHM4F7ND USYKFT>#Y&K+:SF"5A.83FVF_LPXCZ_@329:-+>E.V2GDJ
M41%JZUH"I]P=F?(><XFNVY'Q@\;M6I"F8A[7&"G1221IE%&>U=8)>O[FX>I
MBSP     _ P%,4G^*+*OZ(5?\-? 7.
M            (1S%_9;EO^[)'^:,?4_VKO,W? O^PP_UV_BIOR=?_*,I_?,7
M_1K&MX9_-]WYO;?7_P#=Q>:[\8;-C=/EP     X4HD^)@."5JK3WM0'T
M  */Y28S>TA3(M[1X/816[R&>%1LGE/(C2$=MS<IY"TFGVLE:=EM&I&6[W &
M7PR7Y@DWD"'F-'B4#$4I6F0JFE35RFR2@^V3+;J$HTUT(_<(!;):Z=?$
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M+O=EEF'DO)W(42TZ$9+3U(R46I&0[&+R;':
M                      #$Y,YD35%8.8HS$D9$EA9UC%BM;<-<C\4GEMD:
MB1[NTM052-I&Y01R#.ML&QKCR9EA5]>5W-F2Y'UVR\<<B4VKM-J6AC74F#/3
M>CJ8$K4X_E<E2:^0KDV#40;8GC**W0O/R&#CDDNJSD)2HEZZ]"Z )@"    !
M^!@*8I/\465?T0J_X:^ N<
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M!K/4R0A]9)27O$70AO=#,SABKY7]666V\3R;L4B:?A"TQFO*
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M6[^R&D_RY/\ IUCNT/\ 9AJ_J[_L\G^7_P!86P,]Y$
M                            '"M=IZ>.A@*'L7N7\-Y2RNWQ/ W<OP_(
MV*Y\G5W42!V9\1CLN$RT]NT;46F_=U-1:ET Y%G8+?9=?P'Y.8XDK$)[;QMQ
MX*I\>S-UHDD?<[D<B)/4]-I]0$K     #\# 4Q2?XHLJ_HA5_P -? 7.
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M @  .-2 <GX *8I/\465?T0J_P"&O@+G
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M9M.MFLC-)FE7H5H>AD,O#GLRQ6V6@XEPG4Z"^+<]M)NY.=+B/4=[4@
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MMI<JND-2V4N%,?/8:VE*22M.NFH"^@
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M;BHM?';BLJ<.:_JLT-)21JTZ:Z +X
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M .#+7TZ &GOB4')^!BBF*3_%%E7]$*O^&O@+G
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M-2?,/%XWL\]CP&)665F4N/T;&47&)&VF!&-V07U2NS*1^34ZE9[F-OKI3U\
M%S\,0L,H8F28ABJ9RK&AN'VLFF7"S>L)UC(0A\YCKQF?<)Y*DFE73H6FA +0
M     #\# 4Q2?XHLK_HA5_PU\!<X
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M<41&I6H"R      _ P%,4G^*+*_Z(5?\-? 7.
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M0@2T5     _ P%,4G^*+*OZ(5?\ #7P%S@
M                                 X,21K]FOENO<KM,P=KN1[&AQW.'
MVI5S0,0(DALW&F6F?5></>6I-),Q27OXEQO+["7%RA'+]EEV+07I5?(J955$
MAMO/1%*C+)3B")PMBTZZEXZ"%%Y%KIU\11R     HCSA_P!@E_\ OVF_G6*
MO8@'(
M                 "/9QC#6:8E=XF^^N*Q=PGX#DIHB4MHI"#1O2E6A&:==
M=#!6O.1</Y3@[E/EU[SG;Q9$!#.-U<LJ>$O8W8NMM(9-"===ZTM^L?AH O;C
MW&,IQ:NDP\JR^3F4QU\W69\R*Q#6RWH2>T2(_0R(R,]3Z@53$$    #\# 4Q
M2?XHLJ_HA5_PU\!<X
M                 "&<CY\U@%7"DM5K]W>7$QJIH:2*I#;DN?()1H0;CGJ-
MH(D*4MQ71*2U!59<0<B4U308E51L;D4C.77]] DQW)R; H5K'>??<2;I(3W4
M/+0LD&DB)/O@B_R/4M?#W@'(    "B/.)_8)?_OVF_G6* O8@'(
M
M   #@_ P&N_-?)5-+N6\%>Q27?U%+<8^>26[4YNN:KIL^2A<!*$J2M<E6OY1
MQ"-"2GQ/J MK#\W9RBZRNC.$Y!GXK9?5LE#BDN)>;<90^S(0:2+0G$K^*?5.
M@"7@    !^!@*8I/\465?T0J_P"&O@+G
M                                 5SS#C4+)*NC;+(48OE$&WC2\1M7
M4H=1];I):6V%,K,NZAU"EI4V1D9EU] "C^&\;8A<GL85G7(U)=Y5ALFRNJS#
MZ",[&05A:J6Y)?D//='5LI>42([9ZMD>JO ();:IT)):> #A*MWAH9>\(.2/
M44-2UTUZ^X Y 41YQ/[!+_\ ?M-_.T4$E>R>I:@KD
M                                                     !PKJD^F
MO0^@#5_FOCN7/M<HR?#<[I:%+*Z:XSVKOFCD18S]/^5@R24R9+:-Q""2ILR_
M*I\.H+187E[8Q^7BT[+ZG*V\VM\JGN3\AR%EE45M4UM"62CMQED2V&V$)2A#
M;A;M/6/Q!%O&9%U,]" -Q::Z]/= <@/DU=#/4M"Z>(&USZ %,TG^*+*_Z(5?
M\-? 7.
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M&M]A,;&LHA3E65;'*SL:=Z+5[HUHPHU'*4>TD*V'L/\ &U+W0&XY> #D
M
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M&5%O83E;*-29CRMR6G#U-!D?QO= ;(
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M+TU7JZ\:EF6[XNI]"""9JJSSA:IX#R DF9$<RE(RU/\ .T45%[%X=0'(
M
M        #Y7H2%&?AH>H#4'F7CF?=YUDN=9-B\O):/'+K%YL5DFERTN8RS'=
M*S9A,:Z+4EU?<?0DM5: 4JL;RPU5565F7NXC02*#CBPNUR\29GQUQ);S"F&R
MD+-MW1SLD\2B8[G79T 7+DM! RK'[3&K5'<J[B'(KYJ"\39E-FVO34CZZ'T
M4)!X8Y5MX&'<=9U;TS_&F#SH<UJ= 3(3;6K5/K[ Q(;<_)-$G1!O&A1[MO0(
M59=O@]OGD7-<2Y*5#L>/[ER.BD@0#>C2T1&TI<<3)=29'O[R4J2:#\ 172O*
MY3QN5L8S6NL+ Z"EARFY4>5;V#\Q<M;B%L&A:EG^2+:?<;W;5>DC$5L0:2UW
M?C$6FI=!44W2F9^:+*B,]23A]61:]="]M?,!<P
M                                      "J.=<BNZ:KQFHIK?[.%E5[
M$H)N2$E"G(,>4EQ1FSW-4)==4@FD+61DDU:^.@+"KN-LWRR/]UV/R<FF75C-
MR/)ZVQ:GN(?ESJJN5(0E]\R+7\@:$:*+0M>@#:=):)($-"\-"T <@   HCSB
M?V"7_P"_:;^=HH)*]B\ 5R
M                                   X5\57X# :G<L9CF[_ "+<1ZS*
MYE! PJXQ.+"QVN4VP5DQ>O(]HD3%J(UN-GJ;24H,DEIUZF"K?XFR>RR+)N2H
MSMBJWH:;(%0J:<>AH1K&:7(BH6DB)28[IFCWO#4$6F XT+W '.A>X XT+W"
M<GX& IBD_P 465?T0J_X:^ N<
M                         S(O$!7?+%O4,LXYB5Y2,7];FMLS0RH<LR["
M&7&W'ENF1D>JD$WZA%H>O@9 JE.)9^(89R/IAO'=718+DEM8XE4Y+&DNR+5V
M;4DIQQ3C;VXDQ75MN)23:]=R=5^@"6UR3U21@CD    !1'G$_L$O_P!^TW\[
M1025[)ZD"N0
M                       '"_BJ_ 8#6/F:QXVRAS.%9E@<3([/C]VHJZ%Q
MY]3$B=/OB2MMC>T:5I;0M:?$U?C&GJ"K$X)MU%3VN"3<<K\6NL(EIK)U72+-
MZK-,AI,EEZ.M:4K/>A?K]PMV[74Q":+9%0    /P,!3%)_BBRK^B%7_#7P%S
M@
MX,!1W*UFWEE'<U%WQMDURS06\--0]4J1&F/O;%K38P'4/(4E#/Q%*/\ ;%T$
M6C!\>+JYMW@V--<0Y5BM3B)RW:.=8]HJ^.](94EQR0:7EK<6O<K12M3WJ,Q1
ML:GXI CD    !1'G$_L$O_W[3?SM%!)7LGPZ> *Y
M                                                     8?*+>51
M4<^VAUDFY?AQUOMU4 DJER5)+HTT2S21J/T:F"PUZSANE/D>!FS_  SEM[>L
MLUUDN77K05>Y,99,X_M+!R$H<D0]ZFR,T^J>OCT 69PXMB<639">(W.(VM[:
M*FV3&0F@Y,ASM(0E;6Q:R2RA)$A"?0"56B     'X& IBD_Q195_1"K_ (:^
M N<
M  '!@* N*C)^9^2,KQ=&7VN*<?X3[' 6QCCJ8<VRM)K'M+ZGY*DK4EME"D(2
MVDO6,S/4!V451E'#7)6+8JK+K3+<!S1,V&W&R-U$N=66$%CVEM;,E*4*6TZ@
ME-J;670]#(_$%7VGP]P$<@    *(\XG]@E_^_:;^=8H"]B <@
M
M (]G&2-8AB-]E#K1/_4M?)L$L'T[BH[1K2C7T;C(BU 4IC_!V7YO15N:9ORG
MEL7,+:,W8JCT$UNNK*]4ILG$L1XQ-+(TMDHD&:S,UZ:GX@43GA+(LELZ_(,6
MS68BTRK"K9^CDW"6R85/BI0AV+*<;3JE+CC2RWDGIN+7T@2M,     /P,!3%
M)_BCRO\ HA5_PU\!<X
M                  "B\@\O5M99=?Y7C7)N28D61R&YL^LJ#83&[[3"(^\M
MZ#/4TMEJ(KMQ?R_VM1F%'EN1\EY'ERJ!QY^!77"F%1TNR&5,*7ZB$GJ25'Z1
M25W$6A: CD    !1'G#_ +!+_P#?M-_.L4$E>R>I:@KD
M                                                        !@<S
MQB+F>+7.*377&(EU#?@//LZ=QM$A!H-2=>FI:ZD IB/Y<,VBQV8L?G+-&H["
M$M,MI7&)*4((DI(B[?H(A%JL+BGBW[LH]T4C(K'*+6^F%86%M;]LY"W$-)92
MG5LDEH24%Z!188(    'X& IBD_Q1Y7_ $0J_P"&O@+G
M                                                      %$></^
MP2__ '[3?SK% 7L7@ Y
M                                          _ P%,4G^*+*_Z(5?\
M#7P%S@
M          ,#>9CBN+''^TUW!IBF*-$3ZQE,Q>ZHM-203JDZZ:]= J,R3R7&
MNZ@R-)D1D9&6AD?@9&73P 1V?R'@=7:)H[/)ZJ'=*4395\B=';D[S\$FVI9*
M(S]!&!"3$ HGSB?V"7_[]IOYUB@+V(!R
M                                                  ,!!S/$[.ZD
M8[6WL"9?1-?:JN/+9=EM;#T5O:2HU%M/XW3IZ05EY<N- CNS)CR&(C*36\^Z
MI+;;:$EJ:E*49$1$7B9F"486CSK#,H=D1\9R&NN9$4MTEFOELR5H3KIN4EM2
MC(M>FO@ D/H_8 4S2_XH\K_HA5_PU\!<X
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M8-ISV1M!+,W#));=?5W=? 0;?EX .0
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M+IU 4UQ7;YA=^8?+)F<8PC$[E.*UC;=:W/:M"6R4Q_1TWF4I2DS/5.S37IJ
MV+
M       5;EG#KEQE4W-,3RBSPW(+F(W6Y"_6I8>;G18^XFC-N0E1-OMI4:6W
MV_620%'NK.*8&.4V'XYB-I94%#B$@I"841\C*R29*-;4Y2R,W$K6HW%^'K&
MC4W@:T<SV[Y&J,_MZO(;QI$1:BCP)B8D)LR4F+$.2RLVFMQ;E$D_6/JK4!;-
M-"E5U?%AS9CEC+8:0V_8/I0AV0M):&XI+9$DC/Q,DD1 *8\XG]@E_P#OVF_G
M:*!*]B\ '(
M                          #RV$&+9PY%?.93(A2VG(\F.OXCC3R30M"O
M>41Z *>I/+S"K7\>A6>36UYA&'26Y^)8E.-CV>))8U)A3SZ$$[)2QN/L)=/U
M.GB F,W K2;'S&,>67+1981)BN-NMDJF23/:45?JD]F[XQFK7UNH*C7'O"]S
MQNQ3T]1G%F]B=.2DHH%PZUIEY*C4I7>=:92ZI2EJ-:E[MRC\3!%O>@!3-)_B
MBRK^B%7_  U\!<X
M                         HCSB?V"7_[]IOYUB@+V(!R
M
M         !^!@*8I/\465?T0J_X:^ N<
M                                          41YQ/[!+_]^TW\ZQ0%
M[$ Y
M                           _ P%,4G^*+*OZ(5?\-? 7.
M                                                           *
M(\X?]@E_^_:;^=8H)*]B\ 5R
M                                              !^!@*8I/\ %%E7
M]$*O^&O@+G
M                    %$><3^P2_P#W[3?SM% E>Q> #D
M
M        #\# 4Q2?XHLJ_HA5_P -? 7.
M                                          *(\XG]@E_^_:;^=HH)
M*]D]"T!7(
M                               'X& IBD_Q195_1"K_ (:^ N<
M
M     41YQ/[!+_\ ?M-_.L4!>Q .0
M                                                   /P,!3%)_B
MBRK^B%7_  U\!<X
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MX U]X U]X U]X U]X U]X U]X U]X U]X U]X U]X U]X U]X!R"@
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M/SX"VL.@9168[#A9G;M7N2-I5[=:1XR833RC49I-+*342=$Z%X@,\
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M)QTJU%(*V:6Z1$CO^KV]NGCU 3?[+>9O]8>.?R$O^, 'V6\S?ZP\<_D)?\8
M/LMYF_UAXY_(2_XP ?9;S-_K#QS^0E_Q@ ^RWF;_ %AXY_(2_P", 'V6\S?Z
MP\<_D)?\8 /LMYF_UAXY_(2_XP Y+%O,T9Z'R'CNGITHEZ_P@!"N*[SS(\IX
M:SF,7-<>KFGI4V'[(JE6Z:3@27(QJW=\OC=O=IZ-0@33[+>9O]8>._R$O^,
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M]EO,W^L/'/Y"7_& #[+>9O\ 6'CG\A+_ (P ATFY\R4;E.!Q<>:X\<F=2/Y
M5E]2KT2F/)1'[7;[_74U;MVOH 3'[+>9O]8>._R$O^, 'V6\S?ZP\<_D)?\
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MBU/T"H]*%H<22VU$I"B(TJ2>I&1EJ1D9"CZ
M?*DDLM#\#Z&7CX@*[H>".*\8R-.5T6/-1+=EQYZ'HX\Y&B/2M>\Y%CK6IIE2
M]3U-M!>]H DE7@^,TUG?W%; 0S8Y0ZV_?NF:G"EN,M=E.]"S4DB)'JZ)(B,!
M',3X+XNP>[+(<8H40[9M#C,)U;KTA$-E]6YUN(V\M:&$K]/:273IX= %B@ #
M@Q)$;K:K#8^4W-G6>Q%F4]N.F]=96A4UQF*1I8)])*-1)02M$ZD0*DHJ
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MEN09EJ7I(!PFVK%V*ZA,Z.JU;03JX!.H.0EL_P 8V]=Q%U\= 'M(R/P/4
M                 !KE'HJ7DSS,\@5.<P&;JGPZBIXE%634]Z*T=PAU^4\3
M2M4]U1D2>YIN(BZ& D'E@>E,X3D&-/2G9<'$\IN<>J')"U.NIKH3Y*8:-:S-
M2NV3FPC,_ M %V@     #"93BN.9E6?4>4P$6=4MUMY4)[=VU.,JW(-1),M2
M(_0?3W0%$<;UE#:<_P!KDO$]>S5<;T-4Y09'-KTDQ5VU[WD+0W&:1HVX<1!*
M)Q])?&/;U\05"?LC8\)QKG-^2>-:3(<5BW\NXG9-&E%(NXD.=,)3+_8=:(ED
MSN3JA+FNG4O P2$_EU=+R7YE'ZC*F&[O%<:Q"+84M5+3W8*I=M)4ER6;*O56
MOMI)!&I)[2\.H#*>6AU=>UR-@S!N*H</R^QK*!+JU.$Q 63;Z(R%+,SVM&M1
M)+7IJ O4   '!^ "E>>^.,GSN;A$V@IZS((^/6<B;95%T^J/$?:=BJ902MJ'
M-QI4>I$:055V2YXWC7"W+>+4F*M<=<A8PB$U<0*EQ#D935XZTPU.BOH2@U$I
MI2NII)2#("J293@N,<3Y;PM;8#!132I-NUBUJ<35'UC73HCBU>U]?RRDK;)P
MEN:J)7I"B(QC>'8[RAQOS3GV81$3,O>N,B8@7#QJ.36,T2#1!1%<U)3*63;)
M?J:;OQM1%YVP/"616F6<1X3DETM3MK8TL)^:\KXSKYM));A^^LRW?LBHGP
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M=3$57[N)4U;Y3*;F.&T;?*;!P,K/+B4KZT=L9=BWWB=?,]RT+0XIHVE>IM]
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M1;=4),E&DU:Z=2 9GH Y
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M4IT-UMQ:'$Z%U\2"$F&S!&DNFOI,!]
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M42# L@Y%NGIB,ZQ&/CC#:$K@R8MHU9H=-1F2VE$A*32I&G4_BGZ 3D3H
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M^'0A!YJCR]8!4JRMQ]$ZZ>S>$U6Y0];S5RG)K3)+(G%*T2:7-%_&1H1:%H1
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MSU,$3WC_ #6GY%Q&JS2A[A55LP3K3;Z=CS2TJ4VZTXGT+;6E2%>^704JDP
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MT)):F1=0&N7EFSW%);G*-7274"RR"?F5_9U%6U(1WI<;:VIMUM/B;:].BRZ
M*-3,Q=/$\3+TY2J1RM]H43ON97I]2_72K#14(J,B)2-J=7">UV[O7]((_0UE
M2ULMK=1VW5)(UMZZ[5&74M?3H8*^P     !5W/N6XSC?%^5Q,AM8E6_;4UG%
MJT2WDM*E2/9%_DVB5U4KUBZ%[H#'\(9]A4CAC&IL>_KWH6/45:U?2$2$&B X
MB*C<F0>OY,RT/4E"*AGENS_"K/+N4ZNLOX$NSN,SL)]7$9D(4[)A^SLGWV4D
M?KMZ)/UD].@J-E     '!EJ :$6NA%U\0&M/F^S#%J_$Z"AL+B'%O/M+06/U
M>\\A$CV)F:7<?V&>O;3H>JO 2JO5RYE./'E7#O,<*Q8L>.J:XL8-K=Q%E(AQ
MRM8IQFI"UHU(FTNHV+7X)U%*/=@-O!S[S%Y?FV+.(GX?38U"QA=Y'43D.59J
MEKF.(8<3ZKA-(425J29D1F"+_         :Q<SO5=ASQBM-FN0.8!C<6AE3:
M;+H+R:V=,LG'NV] ^LED:6FT-$3IM'\<_P!@!F_*M-:>Q[+*JJ--AB-7D4UC
M'<K-LVW[MES1QV3(6?\ UAU*S-"I'_.:%IX 4;!$                   #
M@]/2 @&?99Q/@R(TWD";5P7)ZC1$*:PA^2^I!>ML;2A;JR27B9)T+T@KWLYI
MQ]&P(LT;M:^/QX<<WTV1DEB#[,I1H/U3(BZJU3MVZF?334"'7QQEW'&6U#SW
M&T^OE5,1TVY3%:VF,3#ZR)6CC&Q"D&HNI&I):^@!-00      %9S<]X+1<2:
MN??8W]=JD^SRHKSD,Y'M6[;L61^L:]W31774"J7W,+%8L1^RR)B B%#:-Z3+
MG-LDTRPT6IJ4MQ.B4I+W3T()(>C'GJ"94Q9^,.17:.4CO1'X';]F<0L]=Z#:
M]4R,_20@RHH     .%*))&HST(O$P& +-L35EIX(5Q%5F!1?K Z5+A'**+J1
M=Q2"\"ZEX@J-9CRUQ/@=XBNRW)(-9?O-)4<=25.R41U*U3W>RA:FVS/J7<T2
M?B")_&?:DM(D,+2XPZE+C3B3U2I"R(TF1^X9& [@     !P9Z%J P]=D^-7,
MFTA5=O#FRZ5WV:Y8COMNKB/$6O;?2DS-M6A>"@&(H,@XSRR]E2L7LZ6ZR."V
M2)<JO=BRYC+2O5(E.M&I9)]'B%1+R+0B(O N@#D      0G-N7..N.9<:#FM
M_'J9DUM3\6,XEUUU;2#VJ62&4+/:1]-3 9BMS'%KC&TY?674.3BZV%RBN&WD
M^QDPV1FM:G3/:DDZ'NW&6GI!4>PGE;B_D2WD1<*OXEO;Q6"=D%'0M#IQM^TE
M$IQ"=[>X^AI,R 3\$                                 '6\TVZTMMU
M*5MK2:5H61*2:3]!D?30!55'R9P)=94C%Z*ZH9&4]Y;45IAII*ER&?C(8?[9
M-N+3I\5M9F"U9C)\YXDK\BK,2RZYISRA]YHZJIGFT]*2^^9=LT(4E2D*7TVG
MTU] 5(6 DO=/4_?!'(      Q61S:*MIY=ADTB+%H8K:G9\B>:"BH:3U,W#<
M]73\((A6!Y_PYG4V0W@%G5SK:"V2G6X;)1I:(ZST):4K;0LVS/IN21I]\%J^
M&^1N%5\B*QINZI3Y&-WV3:2&O:S?V]8_M.S0W=/^:[F_T: ++06B"(O @'T
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M7N+41%[X*E]9]7.0(KE4IE=:MM*H:HFSV<V%%J@VNWZIH,C(RV] 1[?
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M7&W$V.XCD+J';B&A]Z6TTON,Q5RWW)'LS2M3U0SW.T7HZ=.@(LT
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MJ&I)Z;2/H QW'6!U'&N&4^%4REO0:9@HS4E\D$^Z2=?6<-"4D:NOCH E(
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M2)792A/J^!:$ SX
M
M
M
M
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M#*HZDI4<BLD(DM)4:DJ]0U((E$773P,O$!%+CAFEGWDK(ZBVL:&UD6#-VW[
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M,D[7#941H4M#C3NXCU(@5,EYA3HS!6#J[WUXFK.]/\F?8]C)_P!F_=/#?O\
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M7$Z))3;:%+ZH2E24J-)GH"LN7-=#;PW6:J-95TBTKIT[$;2QA&Q#M"AQUO\
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M+G,1F[&RB5=6B_L;2#$4] 8JGH3DYF0I[4D[74-J2VDM5*5TTTU,A1XW.?\
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M;!N)*RVLQYW(G8)*J)B#G%'G1V'UF>IEHXV3NPDFM)DA1F!1=8(
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DJ+-O24Z<B3 97'C*2;JS:)+;BW%%HV:$JU4>JB,P1E0 !__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>lc_colorectal-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_colorectal-4c.jpg
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M%!04%!04%!04%/_  !$( A$#N@,!$0 "$0$#$0'_Q #+  $  @,! 0$!
M        !@<$!0@# 0() 0$!  (# 0$              0($ P4&!P@0   %
M @,"" H'!@('!@,)   ! @,$!081$@<A$S'2%)065@@805&1(I+3U%475V$R
MDW2T%3=Q@=%"(U2Q,U)B<[,D=39RLD/D)36A@R93PS1$9$6%M3@1 0 ! @0"
M!@8(!0,% 0     ! @,1D5($%!42DA-3!18A46%QL=$Q08&A,M(S!N$B<K(U
M8J(T\,%"(W-#_]H # ,!  (1 Q$ /P#OX
M                                         !1&L/:BM;2^N(LVDTN3
M=E]+R9J/ 5D2RITLR$.N$EP]XHC)1-H;4>'#AB6)<'S2?7'4B^+N1:]XZ65&
MTH[T9V8W5I2GTLI0U@1)-+\9HE*4:B+S5X_0!@O@$1S4"X)=IV+<ET4]IM^=
M1J9+J$9E_-NENQF5.)2O*9'E,T[<# 0/LW:L5[66P)%V7%#AP9S53?@(9IY.
MI:-IEIEPE&3JW#S8N'CYV +*WP0      $!;UCL=_4U6D<:3(>O1IM3LF.F.
MX3#*4L%)\]U1)2>+:DF67-PX J? @ Y[T;U[NG4;6"^-/:O3J?%I%L'-*%)B
M)>*2YR2<F*G>&XZM)XI/$\J2V@LPM[42[T6#8]>O-<7EQ42&Y,*'O-SO3;+8
MC/E7EQ/9CE,$55V?NTS#URJU8HKE _(*A3([<UALY?+-^RI9MN&7]%G+D4:/
M'CF!9A&M0>V- LK5"5IS#M<ZJQ"EQZ?)K'+R823[Q(-PB:Y.Y_E&LTGBO::3
MX ,$M[07:'=T0EV_3HMM'<,RX$R#9+E?)2;5'4T@DX$RZ:S4;I>("(1"G=KZ
M=1;FIUN:OZ>5&Q6ZJI*8U1?=6ZT25*R9U(<89,T),RSJ0:LOB P2/77M)SM(
M+NHMF4FT5W-5*Y%;DQ3;EFPHW'I"V$,H;0P\I:C-&S RX2("(16/VR9-NU:)
M3-7M.*O9+$PSW4YS>/)R\!KW3K#"E)3B6;=FH_H\ +@Z@I]0@U:!%JE,D-RZ
M=-:1(B2F5$MMUEU)+0M*BV&2B,C(P8LD
M
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M4G.S_:9U(U&HBF)BFOZW)DS7B;_<1?5^C "5W @
M
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M+A/:#%G
M                (C:.J%A7Y4:G2;2K354J-&5EJ;#:'4&R9K4WM-Q"2/SD
M*+S3,!+@
M
M                                             !Q;V+_U1U<^\(_&
MR@92[2!B
M
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M'QMTJZSQ?([Q Y9N=$G--KK@^-NE76>+Y'>('+-SHDYIM=<'QMTJZSQ?([Q
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M-4]*GHQ,S@W]GN[=^F.C5TIB(Q2X:3>         %)Z<$?>)UN/P$S:A8_\
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MW'4.:/<0.(M:HS@X>[IG*3HG=/N.H<T>X@<1:U1G!P]W3.4G1.Z?<=0YH]Q
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M/'X1M;G<=M5$X881$9-3;;?L:9C''&9G-(AJML
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M="
M
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MHQG^7_RICT815G]RP1N/.
M
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M_;"Q1N/-
M
M                         #BWL7_JCJY]X1^-E REVD#$
M   !_-:]/^L;A_YG-_$+'B;WXZO?+]/>'?\ %M?T4_VP[DT(_22U_N[G^_<'
MJME^C2^#?N;_ "5[WQ_;"Q1N/-
M
M                                           #BWL7_JCJY]X1^-E
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MQ/$C\ X+EWHU4TX?B=IM=A-^Q=NQ5AV,4SAZ^E."2CG=6
M
M                                                   #BWL7_JCJ
MY]X1^-E REVD#$               !_-J^F'HU[7&P^@VWD5.:2T*+ R/?K'
MB;T87*O?+].>&515M+4Q]'0I_MAY0[RN^G16X5/N"I1(3)968S$Q]II!&9G@
ME"%D1;3\ 1=KB,(JG-G<\/VURJ:J[5%4S]<TTS/P>_3^^^M%7Y_)]8+V]S5.
M<N/E>S[FWU*?D=/[[ZT5?G\GU@=O<U3G)RO9]S;ZE/R8\N\+MGFP<ZO5&2<5
MU,F*;TQ]S=/HQRN(S+/*LL=BBVC&;M<_3,YN2C8;:C'HVZ(Z483A3$8QZI]'
MT/K]XW=*?C2I-?J+TJ&I2XC[DQ];C*UEE4IM1K,TF9;#-(3=KF<>E.93X?MJ
M:9IBW1$5?3'1CT^_T>E[]/[[ZT5?G\GU@R[>YJG.7'RO9]S;ZE/R.G]]]:*O
MS^3ZP.WN:ISDY7L^YM]2GY'3^^^M%7Y_)]8';W-4YR<KV?<V^I3\F._>%VRI
M$:7)KU1>E0E*7#?<EOK<94LLJC;4I9FDS+8>48S=KF<<9]'M<E.PVU-,TQ;H
MB*OICHQZ??Z/2S&=1;_CNH?:NFK$XV9*29SI"BQ+QD:S(_V&,HOW(_\ *<W#
M5X3LJHPFS;ZE/R=VZ4W+4+OT]H-PU;*=2EL**2M!$DEN,NK9->!8$1JR9C(M
MFT>LVUR;EJ*I^E\!\<V=&TWMRU1^&F?1]L1.'V8ID-ET@
M
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M?,0[@[/_ .D%L_[.1^+>'J=C^C3_ -?6^$?NG_)W??3_ &TK+&\\N
M
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MI_R=WWT_VTK+&\\N
M
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M\V[]_P"NKG_YM/\ Q+@\5?\ U*O?/Q?ISPO_ (=G_P"=']L.V>S_ /I!;/\
MLY'XMX>GV/Z-/_7UOA?[I_R=WWT_VTK+&\\N
M
M                              "!:STRB5;3>LQ+BBU:52".*^\BW6R>
MJJ%1Y;+J'8Z3)6)MK2EQ>P_,)6P%A5SUM6/K=6*U7-,]3WZ0FYXC,"^J% 0P
M<J8Q&;4P1N,2DI?BN[L]RIPD8&DL,.'$.@*-2(%OT>GT&E-;BETN,S!A,XFK
M)'C-I:;3B>)G@E)%M!&<     XM[%_ZHZN?>$?C90,I=I Q
M                '\V[]_ZZN?\ YM/_ !+@\5?_ %*O?/Q?ISPO_AV?_G1_
M;#MGL_\ Z06S_LY'XMX>GV/Z-/\ U];X7^Z?\G=]]/\ ;2LL;SRX
M
M                                              -+=MP.6M;\VNLT
MJ=7'HI()JE4IK?S'UNN);2EM!FDMAJS*,S\U)&?@ 4'<&E&H>MTYJKW50J+I
MI'0XV]'J,$OS"\2)I6)$<UDVFF247@(UF6)D"NC:=#.GT^) .0[*.*RVP<J2
MK>/N[I))SN*P+,M6&*C\)@C)     <6]B_\ 5'5S[PC\;*!E+M(&(
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M&HD.I0HR+':9$.:UN+=R<*9Q==O?!]YLZ8JO6YIB?K]$QG&*5C8=0
M                                                   "L-2X)T"D
MW7>%7O>MT*@2(L%D_P L:*0=*W,A!+D1VTLNK/>8Y7CR*P1F/P8D5$+:T^>O
M.G%5K3UYN2L4]6!<HA2J>\E*C_E626,4J_U58& O6GQ7(4"+">DN3'H[+;+D
MQ_+OGE-I))N+RDDLRC+,K B+$$9(    #BWL7_JCJY]X1^-E REVD#$
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M[]_B_P"*AUGB7Z/VP]O^R_\ (Q_34Y=T8_52U/O[?^!CH=I^M3[WU?\ </\
MCKW],OZ%#V+\X@
M            K;7ZFSZMH_=4"DHJ;E5<C-J@-T-M;U05);?;6TE"&U)4:#6D
MB=RGCN\P+",P^T3.."PNIZ2:@,U+=(.8S'H1O,H?REG2VXIY!K22L<JC26)>
M @,%SP)7+X,:=N'8W*6FWN324;M]O>))61Q&)Y5IQP46.PP1D     .+>Q?^
MJ.KGWA'XV4#*7:0,0
M                                         !2_:C_2MW[_ !?\5#K/
M$OT?MA[?]E_Y&/Z:G+NC'ZJ6I]_;_P #'0[3]:GWOJ_[A_QU[^F7]"A[%^<0
M                                                          :>
MZH5Q5&@3(=J55JB7 Z2"AU1^,4YMDTN)4LS84I!*S()22\[89X^ !2=[4GM*
M6C:-:NF)J13*J[1HCL]=/.WV(YNLQDFXZ27-\O!1(2HTEE\X\"V8X@OH7;:M
M4:KEKT2M,2_S!FI0(LQN>37)^4)D,H<)W=8GDSDK-DQ/+C@"-N     XM[%_
MZHZN?>$?C90,I=I Q
M                                          %+]J/]*W?O\7_%0ZSQ
M+]'[8>W_ &7_ )&/Z:G+NC'ZJ6I]_;_P,=#M/UJ?>^K_ +A_QU[^F7]"A[%^
M<0
M0^[9]*KS[^FD*Z'J!><^&FHL+IIH_,68;4A)*>1O$+02%*0;1FHO">&T!S_=
M-.TX9N;X87]KW<LB7,-$:H4)R0VPPXE\B,H\F2S$W;9.)/!2%N)Q2?T@R=34
MVG0:/3HE)IC"8U-@,MQ8<9'U&V&$$AM"<? E)$1 Q90    #BWL7_JCJY]X1
M^-E REVD#$
M                                   4OVH_TK=^_P 7_%0ZSQ+]'[8>
MW_9?^1C^FIR[HQ^JEJ??V_\  QT.T_6I][ZO^X?\=>_IE_0H>Q?G$
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MM3=6GF5I=9<?;6VX@R4A253)1D:3+89&7 8,I=J Q
M
M      %+]J/]*W?O\7_%0ZSQ+]'[8>W_ &7_ )&/Z:G+NC'ZJ6I]_;_P,=#M
M/UJ?>^K_ +A_QU[^F7]"A[%^<0
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M1H*F(K)N&1K-MF5)0G,9$18X%MV 2[<!B
M                                                          *7
M[4?Z5N_?XO\ BH=9XE^C]L/;_LO_ ",?TU.0[$N)BTKOH]RR6%R6*9(3(6PV
M9)6LDD>PC/9X1YVS<[.N*O4^R>)[2=UMJ[,3A-<88NEN][;G5N;]LT.[YK3I
ME\P\AW^]IRD[WMN=6YOVS0<UITR>0[_>TY2=[VW.K<W[9H.:TZ9/(=_O:<I.
M][;G5N;]LT'-:=,GD._WM.4G>]MSJW-^V:#FM.F3R'?[VG*3O>VYU;F_;-!S
M6G3)Y#O][3E)WO;<ZMS?MF@YK3ID\AW^]IRD[WMN=6YOVS0<UITR>0[_ 'M.
M4G>]MSJW-^V:#FM.F3R'?[VG*3O>VYU;F_;-!S6G3)Y#O][3E)WO;<ZMS?MF
M@YK3ID\AW^]IRD[WMN=6YOVS0<UITR>0[_>TY2=[VW.K<W[9H.:TZ9/(=_O:
M<I.][;G5N;]LT'-:=,GD._WM.4G>]MSJW-^V:#FM.F3R'?[VG*3O>VYU;F_;
M-!S6G3)Y#O\ >TY2=[VW.K<W[9H.:TZ9/(=_O:<I.][;G5N;]LT'-:=,GD._
MWM.4G>]MSJW-^V:#FM.F3R'?[VG*3O>VYU;F_;-!S6G3)Y#O][3E)WO;<ZMS
M?MF@YK3ID\AW^]IRD[WMN=6YOVS0<UITR>0[_>TY2=[VW.K<W[9H.:TZ9/(=
M_O:<I.][;G5N;]LT'-:=,GD._P![3E)WO;<ZMS?MF@YK3ID\AW^]IRD[WMN=
M6YOVS0<UITR>0[_>TY2=[VW.K<W[9H.:TZ9/(=_O:<I.][;G5N;]LT'-:=,G
MD._WM.4G>]MSJW-^V:#FM.F3R'?[VG*3O>VYU;F_;-!S6G3)Y#O][3E)WO;<
MZMS?MF@YK3ID\AW^]IRD[WMN=6YOVS0<UITR>0[_ 'M.4G>]MSJW-^V:#FM.
MF3R'?[VG*3O>VYU;F_;-!S6G3)Y#O][3E)WO;<ZMS?MF@YK3ID\AW^]IRD[W
MMN=6YOVS0<UITR>0[_>TY2=[VW.K<W[9H.:TZ9/(=_O:<I.][;G5N;]LT'-:
M=,GD._WM.4M!>_:=H5U6E6+<C4*9&?J49<=M]3S9I0I? 9X%C@.&]XC371-.
M$^EV'AO[-O;7<T7IN4S%$XX82M;1+52!J#3':3#@/PW+>B0F7W7W$K)TUH4C
M$L-O_A&>WQCL-GN8NQA$?AB'D?W'X)7L+D7*JHJ[6JJ8PCZ/K_[K7'8/(@
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MDH0DB)*4D6!$1%P$0#B_L7_JCJY]X1^-E REVD#$
M
M     0W5*Q2U%LR;;29!19;BD/PY"R,T)?95F3G(MN518I/#@QQV\ UMS9[6
MB:7=^"^)\OW5-[#I1]$Q[)]3E-79>U5)1D3$%1$>!**6G _I+%)&//\ +;WL
MS?6X_>GAWKJZKYW7]5?[>%SM/\ Y;>]F:^<_#O75U3NOZJ_V\+G:?X!RV][,
MSSGX=ZZNJ=U_57^WA<[3_ .6WO9F><_#O75U3NOZJ_V\+G:?X!RV][,SSGX=
MZZNJ=U_57^WA<[3_  #EM[V9GG/P[UU=4[K^JO\ ;PN=I_@'+;WLS/.?AWKJ
MZIW7]5?[>%SM/\ Y;>]F9YS\.]=75.Z_JK_;PN=I_@'+;WLS/.?AWKJZIW7]
M5?[>%SM/\ Y;>]F9YS\.]=75.Z_JK_;PN=I_@'+;WLS/.?AWKJZIW7]5?[>%
MSM/\ Y;>]F9YS\.]=75.Z_JK_;PN=I_@'+;WLS/.?AWKJZIW7]5?[>%SM/\
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M>A+:+!M3#B"4V:2+# C298 Q90    #BWL7_ *HZN?>$?C90,I=I Q
M
M
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MEIALH9)1EB>TR1B#%N     '%O8O_5'5S[PC\;*!E+M(&(
M
M
M             "N->[9D7AI#=-MPZ9)J\Z=':3#@05M-/KDMR&G&5$IXTHRM
MK2EQQ)GYR$F1;3(%A&8&KNKR8,8JGHO5SJ)-(Y8<:H4\F3>))9S;)3N;+FQR
MX[< %R4^0_+@19<J,N%)?9;=>ANFE3C*UI)2FU&@S29I,\IFD\/$",D    !
MQ;V+_P!4=7/O"/QLH&4NT@8@
M
M                                                   *2IMPTBB=
MH>^BKE7C4Z,N@T/DZ9LE$="E;R5FR$ZI)'X,< 5^.S]J?1ZAI)09EXWA#D7$
MMRHE+>J4]@I2B149*6L^=9'L;)&79]7 "5VM.M/M(?86EUEU)+;<09*2I*BQ
M(R,MAD9<!@C]@    .+>Q?\ JCJY]X1^-E REVD#$
M
M
M        !#[DTITVO"I'6;IM:FU>JFVEDYDR,AYW=MXY4YE$9X%B8"N[2T\T
M)NZN7;0H^FM)C.VG4$4R0\Y$8-+ZULI>SH))8D6"\-H*NZ'$BT^)'@0641X4
M5M#$:.V1);;::224(21;"))$1$0(]@    '%O8O_ %1U<^\(_&R@92[2!B
M
M
M                          TMVW70['MRH75<<CDM&IK9.2'22:U&:E$A
M"$)+:I:UJ2A"2X5&1 *@LS4.V:5 U3OB#9]?I54ILABLW11JEN45!Q*X:'"<
M;9-XT-X,)SF@UX[/'L!5VTJIPZU2X-9ISF]I]1CM2XCO!G9?03B%?O2HC!&8
M     XM[%_ZHZN?>$?C90,I=I Q
M
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M^D56.U,@O*0ILUL/I):%&E9$HL2/@,L0''_8O_5'5S[PC\;*!E+M(&(
M
M
M                      "KNT053^$==53%2D);<@N5-=.-:9::8W.87-4T
M;9DK$F"<-6'\N(+"D;NE6GJY*U$U%.K2RT_TYH+,6Q:K#DR8,9-=-AV0Y(CY
M5M&M]M9LL$2MBL2+ ]@*FVO%6N"3V2WJG6,S-=J-*H)UPT_TS2[,D0RE%@7
M1FM23+Q&"1]+==IN.S3],J1)I[26I=%N&@R**EM)%NGVIB&V]WA]7!"E)+#P
M 0N\$<>WOJ_IS?=7N63?5?8IU-M=NI0;-L^4T\XN15FF76/S.8@FU-YB49IB
M(49Y"Q6>"C!E@]Z)>VK59T9TXC=G!42M3*+3VZ;>33J8Z3C2F8L8VFL9RF2,
MRQ<S;O']H"-]A=527?>IJZPDD5=7)SJ"$Y2(I)R9.](LGF[%8\&P"7;X,0
M
M
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MVD#$
M
M                               !#]4[>MJY[$JU+N^I.4>WTI9FRZLR
MZW'=B\@?;E(=2XXE:4FE;2>%)[-@"A[CZ!:D,WOJ+8^I53MVTY$6+"U,9BTA
MV04V*B.;;;S:9#)/-&<=>53K2%%NRQPP(S!72EMP*32K=I%+H&'Y%"A1HU+R
MJSIY(RTE#."CX2R$G:"-H     XM[%_ZHZN?>$?C90,I=I Q
M
M
M                5YKA:E7O/36K46A1FY]42["GL4N0HD,S?RZ8S+5%6I6P
MB>)HT%FV8F6.P%A0KM_5BN5;5JD4.PKE<N+4*/!IM)ITZF+B,Q#.E% ><FON
M'NFVFEFH\<QDK L#P/$BNHK-H+EK6?;]L.O\I=HM-ATU<G;_ %%0V$,FO;M\
M[+B#%NP    '%O8O_5'5S[PC\;*!E+M(&(
M
M
M "M-?;@K-L:6U:JT*>JDS"?I\9RKMDE2H<:7/88??(E$9>8TM6WP</@!85A?
M-QW/>%T7R[9U\RZ);.E-OLU!N135LNQYU:=8>E_\6XI*TO-(:92EQOQGX#Q(
MPOVRJW)N:S;=N2:P4696*9"J$B,6.#3LN.AY2"QV^::L 1O0    '%O8O_5'
M5S[PC\;*!E+M(&(
M
M                                          ""757+M_\ J:DQK Z2
M4J/!C'3VW)T1IFKKEKW<F,:)!96TM(/,HW<266)$0*J6.B\(=K3+)A=FMN+:
MM07O9U+8N"D,LON9DJQ<R&1J/%">$^ B+@V .BJ4;BJ9"4]#*G/&PT;E/)2%
ME'5D+%HE-^:>0_-Q3LV; 1E@    .+>Q?^J.KGWA'XV4#*7:0,0
M
M
M                  %,W_4KQOC49G2*T*V]:])A4M-;NVX8*4JG[N2\IF-#
MBK5CNEKR+<4YA]7##PDHJ-W58EZZ(T*7J+9%]7#<L6A)Y=7[9NJ:FIQYM/:\
MZ3N7%-H4PZE&9PEIQQ-.&&&PPZ!IT^-5:?$JD)6>'-9;DQUF6&+3R"6D\/I(
MP1D@    .+>Q?^J.KGWA'XV4#*7:0,0
M
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MMI2RD1ZX:36W&DI5YAHD$DR94C;G+!18;0%B@@
M
M                         #BWL7_JCJY]X1^-E REU_<>'1ZK8\'(I/\
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M"/H
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M+?/*1)2DL%8[ 5;P(
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M=6A%_P#>@)9$EQ9\5B=!?;E0I+:7HTEA:7&G&G")25H6DS)25$>)&1X& ]@
M    !\4I*$FM9DE"2,U*,\"(BX3,P$28U6TODSDTN->M!>J2S)*(C=4AJ>-1
M\!$@G3,S^@!+@    $>I5]6C6G:\S3JLPZJUWUQ+@4K,TB&\T1J63BW"2G!)
M)/%1'ALX0&ZAS(=1BLSZ?(;EP9*"=CR6%I=:<;46*5(6DS)1&7 9& ]P
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MX#(P'T
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M6?DJV*6FDOFTSC^QDVT_N E;@(
M
M       .+>Q?^J.KGWA'XV4#*78]4BN3J9-A-*)+LEAUE"E8Y24X@TD9X>#:
M,[=71JB?5+BN4]*F8]<.3B[*%\X;:O22/_MR?4#VG/[.FK[OF\/Y>OZJ?O\
MD^]U"^??%)].3Z@.?V=-7W?,\O7]5/W_ ".ZA?/OBD^G)]0'/[.FK[OF>7K^
MJG[_ )'=0OGWQ2?3D^H#G]G35]WS/+U_53]_R.ZA?/OBD^G)]0'/[.FK[OF>
M7K^JG[_D]X797O>+-C255>E&EEUMQ1$N3C@A1&>']$O$,:O'K,Q,=&K[OFSH
M_;]Z*HGI4_?\G6@\4]PH_64C^+VA^!&9%6*IB9%P?\"0+"']J"T*C:R*OJ_:
ML93[-6HLRU[^IS1%C(I\Y@V(\PB_TXSAMYE<.0D\"4J AKK@A5*W[-[.^K"8
M4BI4"QJ=%1<4:*VIYUF'4Z;'95+)I)9C)G)BK#;P>#$P5LM6KZMG7INU]--*
MY?2*=*K,"JUFI1&G>34JFQ%*6MYYU:4DAP_JH1]8]I;#-)&1TG5O_:YWW=W_
M +A@CD+LWZ\Z)V1HY0+8O.O,0;BA+G'+BN0);RTD]->=1BMJ.M*L4+2?UOH!
ME,+.UQ<A7-IM;>L]CK.<Y9<V)=5*?9;4VN12TJ),MHDN)0I*%,GG42B+ZF )
M#QTCMN9?-E:B:AR"5$K.K#L_\L<?(TNQZ,TRY!IJ%D6.!I1BYBGA)1 *@T^B
MZ)T6TX]LZJW/<5EWS0VU0JY09=8J41K,VI2=Y&0T>[6RX7G))K$OVE@9E3F]
MJ':MN*[.=+L7>JM%%QMR*2MTW5N*CS"*02E&\1++,;IG@HB,N# L 1+.T3CT
MMT5P(S+IK",\",_!] $-3?5T4/3CM2TN\+UE?E-KU.S':3#JSK;BHQSFJ@<A
M32EH2>!DV6/[R\8'U+_K2TN4"HN(/,A<-Y23+PD;2C($<X]E72?36LZ.VI=E
M9M*F3[D6<PW*A,BH?=4IF>^AM1DZ2BQ2E*22K#P$"RDG:#273K1$B3BE-VM;
M"+$BP2G#]@$-1VE[;:1>-AZB5]%458-$*?3[EF4)U]F;3T3D))J5C&_J;HE$
M:7C3_+LVXD0$/WIW1NSI6K^HDRT+NJ-SWA242)]*9DU2H5%#"%-[IY1D]BA&
M*5D1DHR,]FP\ &GT=U&M30J+<^F&J<M= K=-K,ZH4Z3(8?<;JE/EK);3\=32
M%[Q9\&0O.X"+$\Q)$M/94V74K)[3=4F4V52G:@Y4IK=/G-FU+;9DTYYUHG6]
MII6:%),T^ SP!2;!J]*TI[/FJ$2G2*M2+%1'D5^!#;-Z0B#-CMMKDI;X5;G)
MC^_'8G$R#H"T=;]*[[JD6BVE<L>J5:8PN4S#90\3I--$1K-PE-IW9ECP.8&"
M8*MT*NN@6QJ%J=IS<$S\MO*LWE4JG2::^VM"Y4.4V3C3K*C3E41H:4OAX,/&
M!*K]/[?TML6-4+$UCN.OV?>%&FR\IE5JA3Z;4(;CRG&94/<&36"DJ(E$7G9M
MI[3,B*EUXVA:]O:;V%J'I#'F7#9-L74B[*BUC(D2I$52S:DR$)D$EQ1H4V1E
MB7!BO@Q,!C=HS6BQM1],FJ;I_)>N#)4*74*O*BQGTL4Z+RA*4*DK<;22%N.*
M2VAOZW">&! 1#KT&*CM L:50]1+)DENZC;=SUA"F3^NJ)//E<9[#ARN(</+^
MP%E'M"+&HVH_9+HEEW V?(*G'J#6\)/]1AY-1DJ:>1C_ #-K(EI\!X8'L,"?
MI:#L_P!1N=G6:[:;?D53-RVK:\*BU2:6\<Y<5/DJW4Q..*E;YA3:O&H]N&)@
MLK9@=HG3"H6%&U%E29D"TYE071S?EPGU&V^@E&9NI92[E;,B_P SZNW \%;
M3!5]Q7)9VINLNG4W1)*:A<5%J'*;LN6F,+8B,T(TX.QI3^1"7#=+$FTF9X'B
M18&H!NH=PTG0W6Z^G;Z?_*K.U!*'5Z#7G4+Y&4Z(TIN5%<<21DEPS4;B25_*
M7C,B ;/1;>7AJ-J'K<3+D6TJXF%2K6D2FU1U2H%-:P>EDEPDJ)IQ9$ILS(MF
M./ !+9]F-E3]@U:ZB2I$:\+DK5PQ$K2:%<GERC;;/ ]I9DM9B^@P)70"
M
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MK?U&F&$DA"$XXG@22(@&8
M
M   .+>Q?^J.KGWA'XV4#*7:0,7,5*M*XKJ[0FL_1^\JA:/)%6T4DJ:S%>Y2;
ME+Q2;G*6W,,F4\,N'UMH*];3H-7MO7V\*;6[CF73-.QFG2J50;89>2A4QPB:
M),=*$Y2PS8Y<<3,!5])I=\P.S%;-QUNXRJFD+6X5<EFP8:8$]5)7/4TXA%00
MMQ:\%F2UIR-YD8IS8<)77$&RK59OI%\P9#J:XJC-TEF"W)_X,J<ETG$+1'+8
M6TB(E%L_>#%EW;8M#O<X#=P;Y^! 4^LJ<ES+%?7(87')3R,#SJ:):E-'B61?
MG%M(L V]%IB*)2(-'1)D340&&HR9<YPWY3J64$@EO.F1&M9D6*E'M,]H#.
M
M
M                           <6]B_]4=7/O"/QLH&4NT@8M'2[0MVC7%7
MKKIL/<U^YN2?G<O>.+W_ .7M&Q'\Q2C0G(@S+S$ECX<3 ?@[+MI5S3+P.%_]
M13Z>FCRYF\=\^"A9N$UDS9"\XS/,2<WT@,6)IS9L*Q5::QZ82;*5%=@'3%.O
M++D\@U&M.\4LW,3-9F2L^8CX# >5*TRLVB7-%O"G05MW!#H[5N,2E2'W,*:P
MI*D-FE:U$I1&E/GJ(U'XP$N
M
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M7'=@I;)"'C<./NEL;TT$V1)<RJV;=I 2ZG!
M
M                                                           '
M%O8O_5'5S[PC\;*!E+M(&+F.WM1K?T\UWUG?NEB;'I$Z30B*M1H4B=&;>9II
M8,/<E;=6A2R7F:Q3E5@HL2/ C*VMDZ=R=2:5JC6*VBJVM0M1:HR_2&&E*@5
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M=+Z?+F731:]!J<RXSILJG(I-.BJ-<A+S\IEDS-U/FICD9YSX> L0Z6!
M
M
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M-B:[(DWF[ >DQ'$H2W'.G1SCIW9EM/.1XGF 3$
M
M
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M[F^JWSCF^C-]K Q.YOJM\XYOHS?:P,3N;ZK?..;Z,WVL#$[F^JWSCF^C-]K
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MTJ!3F+@>Q_,945EA$Q>\42CWRT$2SS*(C/,>TP&Y
M >#4V&^\Y'8D-.OL_P":TA:5+1_VB(\2_> QJW H51ISD>XXL2722-*WFJ@V
MV['Q2>*34ETC3L/@,P&1 C08<*/%IC+3%.:;2F*S&2E#*6B+S20E!$DDX<&&
MP!^BF1#DG")]LYB4YU1R6G>DD_":<<< 'L                   #X1D? >
M.&P\/& TZ:3:A7"JJ)@T[I7D\^:33'YAN\N3:YAO,N7S>'@V -LZ\TPVIY]Q
M+3*"Q6XLR2E)>,S/80 R\S(:2_'<2ZRLL4.-J)25%XR,L2,!^P
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M"Q6XXHDI27C,SV$ -.M/MI>86EUE99D.(,E)41^$C+88#]@
M   /RM:&TFMQ1(0G:I2CP(B^DS ?H!BJ>IT_E%.4XQ),DFW+B&:'/,66!I<1
MMV&1X8*(!BP:9;EJ0%LTR'"HE,S[UQN,TU#8WBB).8R02$YC(B+$!LTJ2M*5
MH42D*(C2HCQ(R/@,C >29<5<A<-#[:I;:26XP2TFXE)\!FG'$B,![
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MEIJ$"+/0DTHE,MOI2?"1.))1%_\ $&+)
M 1'5&RBU%T]N*RM\F.[6(:V([Z\30W(3@XRI6&)Y2<2DU8> !3UP0-6M6;9H
MVE=RV0Y;T1,FGJO"Y'YL5Z"Y&ICJ'E\B0RM3BU/J:+(2DEDQP5XP5T>"
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M49=UD29*/$_$ Z5IT!BET^)3(I&46$RW&8(^$FV4$A/_ ,"!&2
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MBP:4VG*:MIEAB Z789;C,MQV4Y&6DI;;27 24E@1>0@1Z
M
M
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M1F7"$IT\O*%J%9%"O2 C=QZS$;DJ8QS;I[ZKK6.S'=N)4C'Z 1)@
M
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MT^^K;AW)36)4-J21I>@U!A<67'?;/*XRZVX1&2D*(RQ+%)\*3,MH,4@
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M#1&FU"1(9_<;:TJ+]H$K?!
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M):%8'@>"DF9'M(!]>?9CMF](<2TRG#,XXHDI+$\"Q,\"VF> #T
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M                      !YI?84\N.EU!R&R)2VB41K2E7 9IX2(\-@#T
M                    %;Z[?IO4?]M%_P!^@=9XG^A/V?%Z7]M?\ZGW5?!R
M0/'/KX     O;LT?^XW#_L8W_?<'?^#_ (JOL>"_=_X+7OJ_[+<U&MAZZK9D
M06;@JUNFRER0J70GVXLEPD-++=J<6TZ9(/'$\F56)%@HAZ5\X0KLQOQXG9[L
MV3(6W'BLP7W7GEF3;:$)DO*4M2CP(B(L349@LJAU[GUO5+3*OZBJ4_3M-J'(
MIR;+@GBTY6'WJE'C.520@R(RCY'%HB-JVJ(S=418I(%AV #$
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MWW"JU3?K=P2J'1IU=J\E1'RB?)=D*<-I!$1-,IP)MEHMB$)(@6710(
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MM5>=K-UU'$C.35YY[R0K$B(C2@\&D&1%BE)'@"RGP(
M   *KK]ZZU4>LU*GTK3%JXJ63A_DM7BUN)#0MI1%E*2S)(G$*2?UC1F(_ 7C
M*V&BUAU:P+/>AW"^P]<M:J,VO5HH>)16YE1<WBVF<VW(@B2GZ3Q,"5B @
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MYT=-3D4]#C<-W?R(ZVT/&DUI(X[C9F2LI<("LK+[.MLVIK+5;KAV\B+;,2%
M5;+Y3I#JVZ@C>E),T+>4H_-4G_,Q3XO""XK_  0
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M8D!@MJ#.AU.%&J5/?1)@3&D2(LEHR4VXRZDEH6DRX24DR,C!&0
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M-=LGHC);KS\J*J14XL^:\Q&AK5,)#<3,E+)-F6=:EXF>4LOA =/ @
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MC.3B2;/%67;@"NAP0                  'Q2DH2:UF24)(S4HSP(B+A,S
M4-(F+U\O^WW: C'2?3^K%6';A/ZE7KT(E-L-03_F8CJ6HW'MJ5GYJ?\ 2,JW
M;OBW;,H;S%DU&)2[@4I!LS*A'5+CI01^>1MH6@\3+@/'9X@1679X4W$9O:WZ
MFPHK^IE>=7>52WW*&:A.EMH=3*9/(WNVE(P)#&0MT18;3V@LKJ!
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M)PU1E2IBR<<>Q:CMN9C5B?U\-I[ 7%9P(
M
M
:                               #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>lc_plasmabuffy-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_plasmabuffy-4c.jpg
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M%!04%!04%!04%/_  !$( E\#M@,!$0 "$0$#$0'_Q #D  $  @(# 0$
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M[?AH#;= ?%*"05*("0+DGH !0&"VSO3:N\FY;NU<JQEF(+H8E/15%;:7"G4
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M([3;6@NI66EH+;;1TE;:FE(6GH>H-NT"T<F'EB-FYTIGDS;^QMKA2/8S,Q#
M?> 0G5XRY23;S]0\PGIW4!P]W/F'/<B#/[;W8[&F9[;KB0G+0=(8F,+4MO6
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M VA'RS!S^,D,!V1)2&TE8;66U%-T>://3UZU(+P.3^0N6=SYZ+L3=>+V-LS
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M3Z':#U[S(-F;-WWS)B^?,?Q;OK<43+0EQGI$H0XC#+:[PW'VP%AEM8*5 7J
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MI&JI!G(-_P#UJY$V-O9P%[&W_P!-:J =>]@?_61LTV-A!;Z__D9E =G.P/\
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M=MJ YI2E/HI OVV%J ZG(<1YU+[T=MQY'H.+0E2D_$2+B@.U24JZ* 4/A%Z
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M/A_1_P!)7RTJ![/A_1_TE?+2H'L^']'_ $E?+2H'L^']'_25\M*@>SX?T?\
M25\M*@>SX?T?])7RTJ#HB0HSB7"M%]+BTCSE=@/3L-*D'?[/A_1_TE?+2I(]
MGP_H_P"DKY:5 ]GP_H_Z2OEI4#V?#^C_ *2OEI4#V?#^C_I*^6E0/9\/Z/\
MI*^6E0/9\/Z/^DKY:5!T1(<9Q#A6BY#BTCSE#H#T[#2I!W^SX?T?])7RTJ2/
M9\/Z/^DKY:5 ]GP_H_Z2OEI4#V?#^C_I*^6E0/9\/Z/^DKY:5 ]GP_H_Z2OE
MI4#V?#^C_I*^6E0=$2%&<0X5HN0XM(\Y0Z ].PTJ0=_L^']'_25\M*DCV?#^
MC_I*^6E0/9\/Z/\ I*^6E0/9\/Z/^DKY:5 ]GP_H_P"DKY:5 ]GP_H_Z2OEI
M4#V?#^C_ *2OEI4'1$AQG$+*T7(<6D><H= >G8:5!W^SX?T?])7RTJ![/A_1
M_P!)7RTJ![/A_1_TE?+2H'L^']'_ $E?+2H'L^']'_25\M*@>SX?T?\ 25\M
M*@>SX?T?])7RTJ#HAPXSC:E+1<AQ:1YRAT!Z=AI4@[_9\/Z/^DKY:5)'L^']
M'_25\M*@>SX?T?\ 25\M*@>SX?T?])7RTJ![/A_1_P!)7RTJ![/A_1_TE?+2
MH/''O5Y3.JWS V_+84SMR'&0_A E!5ZP_(&E]>KJ5+! ;T7Z#K;K75[1""M.
M2]YO'Z#9Z6*RM\S8WNX\-9_:$B9O#=6B+(R4-,2)B4J*G6V5K2Z5OD6"5]$@
M(ZVZWZU@;EK874H0Q2?'V%C475/!&TM^QF6%;4+2=).XL??J3V!WRGX:T9A%
MYJ"10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * IO(7H[7_S%COREU*(9<J@DUWS?MN;N/CK)KPS87N7!J9S^ .G4KVAB
M74RVDIMU_.>&6C\"C0&ILOO"#O/*;BY83E)&(VYM7;<3$;>RL-A,N2SF-RAI
MZ28[:CI6^$+BQT ]BU$&I!%R&;WCM!_?<&*]F\-':V%D<W!BYG*C+2T9&*I2
M42TJ"W2PKKYR0O2H]@&DW$%E@S,MM#/\6IE[IR<V!G<7G\WN*3DWO'2ZZUCH
MCR5%%@$-LDJ4AM%DBYH28;:&5W$UN/C;-PYNXI&*W7,?;F9C/9!KP\O&=Q\B
M4VMO%-K<3'3="5MZ V4(%E WH00\'/W/%V3L#D5W<^7E[DRN[H^&FHD2UK@+
MQL[)O0U,*B_HR$-V*5Z?$UB^JW2A)L7@S!MXK*\DNMSITOQ-T2VBF;(5(2-"
M&U:@%#HHZK$^0 =U&#I9Q>X6]W;WW%Q+E\7DY,R>TQNK;N>8?9#62BQ&6P&I
M;2=:4*8\)6E3;B.MTGJ: J>S\A"W.=A\=[?;E[*V>\UN.1E\+ FN"29N#FHB
MN0F)B%:_5DNOK=!:4FZ4I'0730&;VEF]PP>3\'LU6X9F3PL5W=,90E.(>==;
M@JQZXZ7W+:EKC^L+;"R=1'I7/6@*W^\F\MQIVEA/WIR$!O/;XW1@YTV&IKQS
MC8:9RFF$**"$Z RE*%CSD=O4T!8L? W'NYG>6:1O>9MZ7M/++PFW'7'P<?%8
MQ*&@IS(-K*1(5))47E.JOH4G04GSB!7,UNC?FX9N^<KA4[F.X<!DY..VF,6F
M,G L^S4HLF6AYYL.>L+U>.MT>8@C04Z;D#TIC)$B5C8<J8SZO+?8:=?8U!?A
MN+0%*1J3T-B;7%0"50"@% * 4 H!0"@% * 4 H!0"@% * 4 H"+!]![ZY?W:
ME@E5 % * 4 H!0"@(L'T'OKE_=J6"54 4 H!0"@% * BP/T;OUJ_NU()50!0
M"@% * 4 H"+!_1N_6N?E5()50!0"@% * 4 H"+ _1N?6N?E5()50!0"@% *
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MVG_F*!]QVB(9<Z@D4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MH0>OX2JK=R*=*E"MR:K0SV2WEM?$*Q:<CE&(XS16,6XI1+;_ (;?C**5@%(
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M'L7(_B)^>*=] =S(>Q<C^(GYXIWT!W,A[%R/XB?GBG?0'<R'L7(_B)^>*=]
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M?W: DT H!0"@% * 4!%A>B]]<Y]VI!*J * 4 H!0"@% 18/HO_7.?=J6"54
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M ^*P6$6M3B\;%4M1*E*+#9)46O ))T]OA?F_YOF]E ?58;#K2$JQ\921',$
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M)% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MZB[&:21Z6KGS!(T/L?\ KG/NU()-0!0"@% <5H0XDH<2%(/:E0N.G7L- <J
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MW5N+&V2NVL]:-\$94-.Y1S5-XJDNI44B,XH ]"--C_+6F,4^>MO?LKG]'Y:
M>MO?LKG]'Y: >MO?LKG]'Y: >MO?LKG]'Y: >MO?LKG]'Y: >MO?LKG]'Y:
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M]VHWMF<7X^:CNC4 XM,=Y4<_FEO- Z5J186\MNMZSK>MNV[?=Q>!=5V2CE7
MV+6"6A0"@% * 4 H"+C_ - KZQ?Y1H"50"@% * 4 H!0$6!^A7]8O\HU+!5N
M0^W:?^8H'W':(AESJ"10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4!KKFG;60W+M&.C&8IG/2L9DH64&#FR&XL&8B*[J6W)6Z%)T $
MK%TGSDIZ5(*ML1YK(9_&RH?$^ Q$8N.$9['3</)<C^&"E:D"*CQ%$*(0K1V:
MNM ;NJ * 4!3>0O1VO\ YBQWY2ZE$,N502* 4 H!0"@% * 4 H!0"@% * 4
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MIH!XLCZ#^FF@'BR/H/Z:: JW(>_H_'6UI&Z<GCWY<:.ZRR6(RD:R7UA -U$
M $];UE:;3N_<R)T+EN#G*B,%Q9S/C>55Y5O%8B7!<Q(9+OK*FBE8D:K6+:C8
MC1V&KVKT4M/2K3J5W;+MTJ;$;DNN:M#!.E10KSD]H[:UY8.7BR/H/Z:: %V3
M8Z8_7NNL6H#AXL[]G3_6?>J0/%G?LZ?ZS[U /%G?LZ?ZS[U /%G?LZ?ZS[U
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MQ<)Q9=<;8205K/34I1)4HV\IJY=O3NNLW5DRFY.K9DH?8_\ 7+^[5DI)- *
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M"@([\Z%%=9CR9+3+\DZ8[3BTH6XH=R 2"H]>ZJE%O%(FA\A]C_USGW:@@DU
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M;C3^";]!5-^=UNEQNJZ2)N3=)&?DS8D2-(FRGT,Q(B%N2GEJ 0VAM.I163T
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M9=S,Y_(.!U:/!;AQ5N,Q&FK6*$-:B+'\(JN5=];6SIK=J.6*]IE0MQBJ(K3
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MLAMC-8W(*4[C\JEM2BU(4"AUEULE*DDI(5;JD]M2#T@>T_'4 4 H!0"@% *
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M.NI3H*B191U%:EF_96T;RT27Z$>7MTHD0DLO.-N.H:6MID O.)25(0%&P*U
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M7*6$G](4@W4 :NW=3;M249NC?RQ*Y7(Q=&7C:ONU\@YV+[4SR4;9Q*!XKHE
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M>E ?%)0M)0XA#C9();<2E:+CL.E0(Z4!\*&U%*EM-K4C]&I:$J*/YI()'V*
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M*-U&QJ08;;FS-_,[U@[GW#(V7*DH26)4_'X9;.87&""$M-2EOK4E(-NG46J
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M$HR5E-KOL,M5SIQR/E+STIB7_A)9:\^@S>$X/9DX-#V=FR(6?>NHLLAM;4<
MV"5#KK)'4G57.[I_=*Y;UCCI+4+NGC]9N2<\.,<.RD\,4ZT+L-)6.+HR^X3&
MP^,]LOM14R\G#BK>G/K9;09*K@$@I20" !V]PKS3==5<\4[A&5QV[$YJ-J*E
M)Y%B\4\O%UX85=*,R8Q5F.&)YEG2D3Y\N>VTEAN4^X^AE'HH2ZLJ"1;R7K[
MTEAV+,+;>9PC&-7SHJ5\YII.KJ3ML2,3$W'BY6>;\7#,R$+F(*=8T"_4I_"
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MNQ,7'1&;==]->GM4;=!<DFW=7.WKKNS<WQ9@3EF;9@MU[+D9"6<EB=)?>/\
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MK5II-\>C&A5*]"+XE<W!MK=&V&(L'.L+8@!:S%2V^W*BMON?I&PMA;C:'2$
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M[A]J..;A3J\YL9R=WW.*YGK78N3VKE]IXR?LI++>V76O^!9CMAA#8"B%(+8
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M,#OK?6Y<[G-XS=Y9K;.19;VZ[-D*@I0RY!96XZ,6UX*$E+KKK6I31M:U[B]
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MG4M+J74V<"F5(&HK/Q6KJKVCMZ>UWEMM2CSZ?\393M*W'-%XH]+; XTVGQK
MD0-KQEM^N+#LR5(<+TAY200G4L]R0;)  %<]J-5<ONLWP,&Y<E-XEOK%+8H"
M+!]%_P"N<^[4L$JH H!0"@% * A9?$8S/8R5ALS%;FXN:V6I45X:D+0>X_=!
M[C5<)RA)2BZ-$IM.J*]L/C_:&PHLR-M3&I@B2\?672M;SKOADA(4MPE5D@V2
M.ZKU_4W+S3FZT*IW)3XLMU8Q0* 4 H!0"@% 1H?8_P#7.?=J02:@"@% * 4
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MZQ?Y1H"50"@% * 4 H!0$6!^A7]8O\HU+!5N0^W:?^8H'W':(AESJ"10"@%
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MK@-CTZW3W =]>3>(?$]^]J.ZTLI1C###C*5:>CDES,[1Z",89KB3;]2-=3^
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MC5&0U0DU20* 4!%@^B_]<Y]VI8)50!0"@% * 4 H"-#['_KG/NU+!)J * 4
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M,N'VDN:6"^[S6)Y;XYU.Z:&W;G"3C!MUFN3Y*O*N/EZ<#EP;Q9NZ+GL9O3(
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M/*:U&R>/;VJOQTU^*C<=<5[KDJU5.*PZV5ZCQGN=J/>+NY1Z,K]ID9ON@85
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M!0"@% * 4 H"-#['_KG/NU()-0!0"@% * 4 H"+C_P! KZQ?Y1H"50"@% *
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M.U*!T->/[WX6U^HW-WK<EDFTU+-C"E,*<</JT]1=T>X68:=0:Q6%*<3?H%@
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M?*5NS6,HXT:I5=*^52YJM!<M)2EBF67D*,]&=Q3#;*O9++!9:<)U(2ZBP"5
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MJ6"34 4 H!0"@% * C0^Q_ZYS[M2"34 4 H!0"@% * BX_\ 0*^L7^4: E4
MH!0"@% * 4!%@?H5_6+_ "C4L%6Y#[=I_P"8H'W':(AESJ"2.J?$0HH4ZD*2
M2".O0B@./M&%],G^6@'M&%],G^6@'M&%],G^6@'M&%],G^6@'M&%],G^6@'M
M&%],G^6@'M&%],G^6@'M&%],G^6@'M&%],G^6@'M&%],G^6@'M&%],G^6@'M
M&%],G^6@'M&%],G^6@'M&%],G^6@'M&%],G^6@'M&%],G^6@'M&%],G^6@'M
M&%],G^6@'M&%],G^6@'M&%],G^6@.QJ5'?)2TX%*':!VT!W4 H!0"@% * 4
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M"P)[*U=O77X696+;RPFZRIA*5."<N.7JX%Z5J#DIO%KAT+S&>A;;SN8#+S*
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M::=CI$-+<8J+:4M.%>HW425*^Q4:S7N])./9IZ3J;M]SX84)G)7+V,XODX[
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MDZML[2*HDCFE"47TI";DDV%KD]IJDJ/M 8MW)0\3$DS)SGALI?6+V))43T
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M*UE_33LOM<.D\TWOPWJ]JE^\6:#X37NOV/J?FJ7^L4Y<BP?1?^N<^[4L$JH
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MV%V9*<GD4*/@GP?V:8UHN!U[HW,W-S;T[ N/1F%V)<Z-N%SL4I)3U -KCO\
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MQN12%X^8Q+0H:DJ8=0Z"D&UQI)Z7J9VIP]Y->5%-N["XJQDI>1U)=6RZ* 4
MH!0$:'V/_7+^[0'')Y.#AL=*RV3?3&Q\)I;\E]9LE#;8U$G[%2DVZ(OV+$[]
MR-NVLTI.B76SR7BX>;]Y_D5W)Y3Q87'6"5I;922/S9-TM)/9XSUM3BAZ*?\
M=OOI-:.W1>_(]QU%RSX4V]6[=):F[SZ^G_+'A%<WYSUKC<; P\"/B\7';B8^
M(VEJ-&:2$H0A(L  *T+;;JSPV_?G>F[EQN4I.K;XMG3G(DF?B9<.&YX<EYLI
M;5>W7R7'9<=*U6ZZ:[J-)<M6GEG*-$_ET\"K3SC"Y&4E5)E:V-M_+XA^4_/3
MX#+B A+&H*U*!OK\TD=!TKB_"&RZS0SN2OK)&2HHUK5U][#T><V>Y:JW=24<
M7TEUKT@T@H"+"]%[ZYS[M2"54 4 H!0"@% :"Y^X7.X65\@;-0J-O+&@2)+<
M>Z%RT,><%ITV(?;M=*AU4!;M":VFBU>3L3QB_5^@].\'^)_AG\'J>U8G@J_5
MKR_R/FN7'I+#P'RJUR-MQR/D%)1NK&$)R2!8>,E71,A('<JUE#N5\!%6=9IN
MYGAP? U'BSPZ]JU%88V;F,>KIB_)RZO.;<K!.(% * 4 H!0"@(T/L?\ KG/N
MU+!)J * 4 H!0'GOWA^4LE#6QQ=LA2W=U9C0U/5'ZNM,R.B&$$=CCM^I_!1_
M.!&UT.GBZW)^[$]3\&;!;FGK]516;=7&O!M<9/[L?6_(73A;B*!QA@4JDI;D
M;KG(2K*34^<$=X8:)_ 3WG\(]?(!CZO4N]*O+D<]XH\1W-UO]FJLP]R/^Y];
M]2P-CP^Q_P"N<^[6&<:,ACX.5@R,;DX[<O'RFU,R8SR0MMQM8L4J2>A!JEI-
M497;N2A)2BZ-<&8/:/'^S=AM2&=I8AG&)EJUR5MZEN+(O8%;BE*TB_1-["K=
MNU"'NHR]5K[^J:=V3E3@66KI@B@% ?" 001<'H0: P.!V/L_:\V9D=NX2'C)
MT\_\6_%92VM8)U6N!T3?KI%A5J%J$75*AF7];?O14;DW)1X59E<?^@5]8O\
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M,;IV=/S623-AR$);<0EMU#I5YFF_5-@;_%5'B/PI=W#5J_;E%52B\W*G->S
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MDD%*JFS>5Q51&Y[;<T-W)-UJJIKF7>KYJA0"@(L+T7OKG/NU()50!0"@% *
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M]W=4CJ?"VY/0[C;N5[,GEEY)8>IT?F,![KVZE[@XU;Q<E97+V_(7!NJUS'4
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MLUVU9W#3WKB_X[D9)UI3ZK\V63JF>1MO;FS4W9L79T=;36.:E/.!(4EE:UN
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M\V_?5Y[%/3VE?C-.<*2I3#IP?/Z3'TOB&WN>L_Z]VWEOOND\<U9=G&-,./\
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M'C(]<B?3(^<*4!T19,=(>U.I%W5J%R.H)Z&@)'K<7Z9'SA44 ];B_3(^<*4
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M/5M:0\2% 18'Z%?UB_RC4L%6Y#[=I_YB@?<=HB&7.H)% * 4 H!0"@% * 4
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M %K$7Y)-?0SM;]WG#@_G9.YW!_[O;ZT=/]][_LI_V<N445O^YESZNG2_U?\
MXF9QO VP(S@7DH&\YR1VMIQR6$G[25'^6J);G=:PHC O_P!R-=)4A;A#TOZ2
MP*XAX=4 /W(W8+#K9F6+_#Z?W*U]Z_>N\9M>3 T=SQONL^-ST12.'\&^&#U.
MQMUW\OA3/UE:QZ.#=6WZ3!_-&O\ M+]5#^#?#'_D;=?]3,_64^"MC\T:_P"T
MOU4/X-\,?^1MU_U,S]93X*V1^:-?]I?JH?P;X8_\C;K_ *F9^LI\%;'YHU_V
ME^JB%C^,.!LHJ8G';2W-,5 DKA30RW+5X,EL)4ME?G]%)"@2/AI\%;ZQ^:-?
M]I?JHF_P;X8_\C;K_J9GZRGP5LG\T:_[2_51R3PQPPJ__P"8^ZA;RM2Q_P#K
M*?!6R/S1K_M+]5'+^"O#'_DG=/\ 5R_UE/@K?R8_-&O^TOU4/X*\,?\ DG=/
M]7+_ %E/@K?R8_-&O^TOU4/X*\,?^2=T_P!7+_64^"M_)C\T:_[2_50_@KPQ
M_P"2=T_U<O\ 64^"M_)C\T:_[2_50_@KPQ_Y)W3_ %<O]93X*W\F/S1K_M+]
M5$'&<6<"Y<2U8S:NY)HA278,OP42U>#*8(#C*_/Z*1?K3X*WU^D+Q1K_ +2_
M51._@KPQ_P"2=T_U<O\ 64^"MC\T:_[2_50_@KPQ_P"2=T_U<O\ 64^"M_)C
M\T:_[2_50_@KPQ_Y)W3_ %<O]93X*W\F/S1K_M+]5#^"O#'_ ))W3_5R_P!9
M3X*W\F/S1K_M+]5 <+<,#MV1N@_&W,_64^"MC\T:_P"TOU4??X+\+_\ D?='
M9;]',^W^DJ?@K8_-&O\ M+]5>P#A?A<?_P##[H/QMS/UE1\%;'YHU_VE^JB#
MC.+.!<LF4K&[4W'-$.2["E%I$M7A26#I<95^<%E()ZU/P5L?FC7_ &E^JB=_
M!;A?_P C[H^/PYGZRH^"MC\T:_[2_51U2N%.(7(C[,+:&Z8<MUM2&I:6)+A;
M61YJ]"UE*M)[B*S-+'X:>:#_ $F9I/&.X:>ZIIIKFLJQ70:0:VCC./MRIB\J
M[8FS=L3%%N+/3X\![0E7Z5M-TA1MZ32S?X>PG;ZC1V=<L\<)KCU_+DSUMZF.
M_:7OM#<5N]'WHR2]$O\ ;-?X;FPW&WN][C@-Y';^UL]E(!)2)43UMQ)4#U"K
M.]"+]A K03V^,'22HSR36;UNVCNNU>[$ER<5Z5ABNLR!X9X6)'_YB[F%C>P;
MF]?@_2U1\';,+\SZ_P"TOU5[!_!CA:UOW%W,.A%_#F]_?^EI\';'YGU_VE^J
MO8<QPYPMH"/W"W(2+^>6INHW%NOYW[-/@[9'YFU]??\ PKV$'$\9\"91B0,=
ML[/SQ"F.Q93J&YJE-R8YTN,+LZ+%!Z*%JGX*W\F1^9M>W7/^%>PR".'^%4>)
M?C_<:O$3I&IJ<=/PI_/=#3X.W\F'XFU_V_PQ]A\=X>X5<5J&P-QM]+:4-30.
MRU^KIZT^#M_)A>)M>OK_ (8^P^GA[A4Z?_S W&-)"NC4WK86L?SW8>^GP=OY
M,?F;7_;_  Q]A\'#W"H45?N!N,W456+4VPOW?I>P=U1\';^3)_,VO^W^%>P^
M#AWA8)2G]P=R'3J&HM3;G5Y?SO=W4^#MC\S:_P"W^%>PU5R(>"XC:L'QYM23
M.W9)5ZI=YZ64Q74G3YC8=7XKI5TT]GW*VFFV:W/M366/EXGI?AS0;EJHK4:R
M?=65VJ-13DNO#LQZ^/SEBXWX0PD3'O2>3-MYV?DI *&L=$BOI8CH[-1<:4DK
M6?@.D?#63K-0KD>ZAA#JPK^@T_B+QQ*Y+N-#V;<>,J>]Y$^$?6_(6C%\;\!Y
M:+*:QNR\[-]2EN0Y;S+<TN,R8UDN,+/B@!23Z0M6C^#M='K.*7B77UKG_#'V
M$]?$/"JR@_P^W$G3JZ)9G '5Y?SW=W4^#M]'K"\2Z]?7_#'V'(<1\*:RO^'F
MX.J4IT^#.MYHM?\ 3=I[33X.WT>LC\RZ_P"W^&/L/HXEX4"PK^'6?-NFDLSK
M'_\ C4^#M='K'YDU_P!O\,?8<D\4<*)5J_AQGCU!TEB?;I?_ -_WWI\':Z/6
MR/S'K_XGX8^PZ_X1<*^&6_X>;AN=7G^#.U#4;_3=W=3X.WT>LJ_,NOK7/^&/
ML.U7%/"BB3_#?.BZ BP8G@"WX0_/^E3X.UT>ME/YCU_\3\,?8<E<5\)J(/\
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M#X:2?1'93B.!G=N;AQ^Z</'SF+#H@R=?A>L-J9</AK*#=*K'M2:@DRM * 4
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MH9=9O9B2E*2I24*42VI-U=E027/.;.V=^_O+,3V' $:'LN$\Q'$=L--N/(R
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MT!EZ 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MKIJ2>Q2% 7LI"@4J'<16JN6W;DXOBCS#7Z&[HK\K%U4E!T?M74UBC+5;,$4
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MQ:7']J/GCBSU36C/&A0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M +X<G?\ Q3G_ ,PJMOJ_^&WY/8>J>)O_ *30^3_:C=M:D\J% * 4 H!0"@%
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M9-CSFFE>&ZN(\V^E"_Q5%M2K'XZ X-Y?#/3?9C.4A.9/]B1*97(^+PPLJO\
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M6B]B0*D'5L_9VVHO(7+_ !JG'MN[#3C&<FW@WKKCHD-V<;(!-_,/HGMZ#R5
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M00@!(NI94I1L.U1)-:1NKJ>-W+DKDW*7&3J^7'J6!W5!;% * 4 H!0$+*_\
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MZ8XIJ5&<ZH<;+J24*'>#;J* O^X<?!Q'O+[!=PT1F"]/Q4Y,D1FTLH=* ZA
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M/?6R]FLX]N8SNV8[#=G+<4VN,&C;6A !"R?(2*@&"F<E[PS.;SF+XNVG'W'
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M H!0"@% * 4 H!0"@% * 4 H!0"@.B7+BP(SLR:\B/%925O/.J"$(2GM))L
M*E*N"+EJU.Y)0@G*3X)8MFD,]RSN;?>67LSAJ"Y+E$E$O.*39IML^:5H*NB$
M@_\ M'/]U)Z&MM;T<;<<]YT70>J[=X4TVWVEJ]UDHKZMOFWT.G%_=CYWQ-B<
M8< X/9;Z=P[E>_>+>BU>*N?(U.,LN'K=I+ERI0^E7YWD":L:C6RFLL>S$TN^
M^+[VMCW%A=S86&58-KKIP7W5ATU-Q5KC@10"@% * 4 H!0$+*_\ (N?[OY0H
M"N5)!%R6,QV9Q\G$9>*W.Q4ULLS(;P*FG6E=2E0!%P;4!]QV/@8?'Q<3B8S<
M/%P6A'APVA9IIE/8A(-_-%^PT!5V>)N+H[V0D,[/QB'LJTN/D%>"3XC+I"EM
MBZO,2HBY"+4!F?W4VQ[1Q>7]D1O:N#8]3PLS2KQ8D:UO":.KHFQMUO0'='V]
M@8>=E;HB8YAG<DYM#$W*H!$AYIL@I0LWM8:1;IW4!PQ6V-MX/VD,-B8L).9=
M5(RZ6D73+><!"EO)65!14%&_2W6@,/A>+>-=N9?V]@=J8V!F02IN8TU=;:E=
M26PLJ""3UND4!FD;=P#6>>W4WC6$[FD,)AOY< ^LKC(L T57MI%AW4!E$J4E
M04DV4DW!':"* P^#VKMC;#L]_;>(BXE[*.^LY)R(@MJD/7)UKZGK=1/3RT!B
MWN,.-Y.;?W))VIC7LY*"Q(FK9NI9=24K5IOI"E D%03?[- 3&]C[,:1A&V\%
M$2C;1*MN@)5_P!4;DL>=TN>O6] 3)FW,!D,SCMQS\:Q)S^("DXK).))?C)<O
MJ#9! %[F_2@,*YQ9QH[EI>=>VEC',O.2XF7)4S<K#P(<.F^E*E@G4I(!H">U
MLG9S+F$>9P<1#VV4EO;K@2K5 0>T,>=T'QWH"6[MW /YUC=+V-87N6*RJ+&R
MQ!]9;CKOJ;2;VTFY[J QCW'6P9&=D;G?VY!<W!,;=9ESRV=;R)*"TZ%I!"3K
M0=*C:Y% <-M\:\>[.FN9+:VVH.*R+B2V9;""74MJ[4(4M2M*3_LVH#/9+&8S
M-0'\5F8;.0Q<H!,B')0'&E@&XN#WCN(ZB@*YAN*^--O1LC#PNU<?$BY=KU?*
MLAM2TR6-6H-N!:C=(4-0MV&@&,XKXTPJ8J<5M3'15090R$1U#:O%;F)&E+H<
M*M6I(Z"YL/)0&17LK9[@S@7@XBAN8WW%=*O^/-[_ )_SNO7R6H#E-V=M+);=
M8VCD<'#E;6BH2U%Q#S>J.RAL62&P3J3:_0@T!'VKQ_L?8RY#NS\#$P[TM(;E
MO1DJUNMI-PA96572#W4!!9XEXMC29\QC9^+1)RC3D>>L,W\1E[](@ FR OOT
M6H"UX^%"QL6+CH#28F.AH0Q%CLW"6F6Q9*47)("1V4!H;<6 WOFY&5./X:P^
M-WIDTOPSO)4N,N.AA\J0IY)M<.*0;DVN%7[:D&TL#Q]@L=Q[B>.\[%CYW%08
MK;$MN4WK9?>!*UN!)ZI\Y1TD6-J@'+;W&/'>TO6SMK;4+&KR#"X<YQE*M;T5
MP64RI2E$Z#W@4!E8>U]MX[;ZMIP,5'C;74TY'5B&TD1BR_<N(*22;+N;]: Z
M)&R]H2]M-[,E8.(]M%D(#6$6E1BI#:BM%DZK^:HDCK0'?E-L;;S@QB<SBH\]
M.%=1(Q ?22(KS:4I0MJQ%BD)2!>_90'2=F;15)S<Q6$B&7N5'A;A>*%:I[=K
M:7_.ZCXK4!Q&R-FI:PC(P40-;:.K;J-*K0%$WNQYW3KUZWH"7*V]@9V;A;EF
MXUA_<.,0MG'9-8)D1VW+ZTH(( !N;].^@,+N/BWC;=^1]L;GVM R>5("7)KK
M92ZX!V!PH4G7\:NM 63'X^!B8$;%8N,W"QD)M+$.&P-+3+2/10@=P% 2: 4
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H * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>fc_miprofile02-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_miprofile02-4c.jpg
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M%!04%!04%!04%/_  !$( ^($)P,!$0 "$0$#$0'_Q #/  $  @,! 0$!
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M/_\ EDU)'Z@J*\54%%(EL*<55>"4$,,QB7'$9"?&)U5LC8O I7\UD6]!-H%
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MC'S([ILN6MK;)1*R^2Z6H#S[\@^9(<)UQ>DS)2+\ZT%WLS#X+/;AB8O<6:#
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M;LSL&0BH_&R$MIQ"Z=0/&B_[*#O/Z<<C'Q_B[@^TD@A*&3% EX(CCK!Z$_\
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M4<%=C*A.D**@I856Y>:BJO +G=C^.FZ2G[=R4S$[P>B#C\O"85Z*TG"Y/&G
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M"@F9;<^WL&U'?R^18B,2A,XSCAV%P6@YA:%2Z+U>*6Z?)05H>(FS3CR)'>:
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M.E1$?C/3R?>:^4?:./R@B7B7MX21%%<-F$5%XHJ*_CZ#@,['?VE)QNP7B_\
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M\='9N7R_)TV\M!I\+UQRRM]+BN7V+\32O[G@WSNRQ>=;R?WFK5;]*]!] H%
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MG8N6UZ[9#^>@W06N1#9:]4$H)% H% H% H% H% H% H% H% H% H% H% H%
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M^4Q3T#,DXU$GE'ERV6"4F&04E!YMXA)MUU%L5R2Z51W.$_\ N?N__P .PO\
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M6_LS2PC;T$ZJ+=?*M!S6=8D9#PIW_'GY*?)'"YC(QX1N2WB<Y#)-B#;AZKN
MFI>J=Z#[7B,2SAHQ169$J2!&KBN3I+LMU%5$2R&\1$@\.B]J@XS%1I&_,MGY
M^4GS(^&Q>0>P^+QD&2[#&\-!%Z2Z;! 9F3JD@(I:0$4X755H.;W!N#<>"VGX
M@X <H^_E-KI#>PV9,D24L:>@.,@\0IUC;,7&R*W7"U^*JJT?4L'ANY8SC9SI
M60DR'%?DRICI.D3A(B+H%5TMAPZK;:(*5!QV+>B1]V>)ST^9W?"!,<4B?K1E
M6&TQHZG$,N J*<;KT4%1 S,?';OVR&W7,\>)S+ST*<>6&6Y!DCV1Z2V\TY-7
M4+J$RGH"B&*KYDJBXVU"=\0(DG=.8R4X(,J3*8P^-@RGH+4:+$?..!ER" C>
M-6U<(C)4&Z"*);B%/O;.CL7>&%FB#T]UC;\Z)'-]3<36LJ$G/F/()*VRVB:W
MWB3@GG7A0?1-LXR=C,8(Y3)N9?)R263+FFMFE<=LJBPVBJC;(]  GDXJJDJJ
ML'+P&9&^MP;@>GY"7'P&"F+AX&,@ONPD<?:9;=?D/N,D)FNIQ ;'5I%!O95+
MA1QN^1R [2\0=G97(2IL?!18N2Q,XGR&4<6:CHHQ),-/-Y9M'Z=]0Z=5U2]!
M]CQ&*:P\58C,B5)!35SF3I#LMVY(B6UO$16X<$O:H/G6U=MEG<_O=Z=D9C6(
M:SKK;&/A/N0T5]8<57'G7&" S7T4 =6D;7LJKPH@9'>&>VO!S^TNWR)N3AY7
M&8O#Y@F>US!B9H1-"-M/[YZ.*/(*VZ]@4D5=5PDQY,S&YO!/;88W1(YTMN'G
M&,NU,<BNPWT(3DF4I-+;C1(!ZF]-QN.E45+!,VSBI>[Y>ZW,UF<CV2!G)T'%
MQHDMV(C -HV6K4RHD1(1+H0E413H3IH*QW>6?'9>'QKLN2[FYV;F;=E96#'Y
MTTHV->DH[(:: 23G&U&M?2J"1*=N%J";C793&Y<5&P#6Y.YLDC\3.M99N:K3
M8\@S;EMR)2ZFG$,4!=!6+7>UQ1:"BQ.W&XOAQNS+PLMF(TW'2-R.12:R<H11
MR+*E*V:BAZ2*XHI*2=9;JO30667PP9K=OAS*F3\@,C(8Z:3YQYK\>Q!#9)2!
M&R'0I*774;:O+0?7&6D99;9$B(6Q0$)PE,U04M<B6ZJOG5:@SH% H% H% H%
M H% H% H% H% H%!S6[?Y'D?V!U4=&'H#\R5%94"@4'QK'>'7@SN><D7 957
M\WAXSL$G(&0U2183(),N8W5'!;D(HHI"0HA$"]-JJ.@Q_A!L.'%[FA%)Y<05
M V4ED3@<['.XU%)+W158=.U_TNMY*6-^'\+-I[0?=R6'DRL7&;="6X /@#(
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MVAMOF#<F;:M:<>BW'YN-!XSF<3(>8CL363?E 3L9M#34X +92%.E4H)U H%
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MF9S+[*R'WXYO<_'RGA;>!L"3EZ;&O2NL4X>6@MW9!)O;',OXJ*N\',!,=;R
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M(I&=^"II64NML>#F*VEF'LQBI:(^],66XZ[%9=DDTZZ_)=CD\YJ5 5^03@*
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MDM?EZ4X63ILE+*7&&Q*XMIY7I"RYD@A-^0H"WJY8"V"((\$1!%/RW6HJRH%
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M9*BLJ!01I49Z0HJU+=C(-[HT@+JOY]8E01^[I?WI)^JS_AU0[NE_>DGZK/\
MAT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'
M0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (=
M[NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#N
MZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I
M?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_
M>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z
M2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)
M^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZ
MK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL
M_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_
M (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\
MAT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'
M0.[I?WI)^JS_ (= [NE_>DGZK/\ AT#NZ7]Z2?JL_P"'0.[I?WI)^JS_ (=
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M9X22FIVW,C/8 FV)><S$AIMP5;<$'ISICJ!411545%LM!WM H% H% H% H%
MH% H% H% H% H% H% H% H% H%!S6[?Y'D?V!U4=&'H#\R5%94"@P=9:?#EO
MMBXW="T&B$-Q5"1;+YE2Z58F8Z),6P<BQ7C)QUAMQPFR9(R 256CXD"JJ>BO
ME3HJQE,>).,2A-;<V\S&>A,XB$W#D:5D1PC-"TYHXCK%!L5O)>MD\_),W.4W
M'M:XX>.(J,8J?8VN87#NP Q;N/C'C&[*W")EM6!TK=+-J.E++QZ*QCESC+=<
MWYWJL\>$X[:BO)N:@06!;%F*TV+):VD!L10"TZ+C9."Z>KP\G"I.>4]991C$
M>",]M_ R4?&1BXCHRG$?DHY':)'71140SN*ZB1%X*O&LHYLXJLIT]K">+";N
M(U]B<TTTPT## "TRV* VV"((B(I9$1$X(B)6N9F9N6R(K2&L8,(6 C#&:2,V
M2.-LH H F):T)!M9%0NM?S\:N_*[O5-L55/3B17.=S&&S[2/+D:@%>8"(J:3
MNG62RJEEI&4Q6O0G&)^+&-CX$(0&'%9CBV",MHRV+:"VBJJ FE$L**JK:KEG
MEEUFS'&(Z0VM,M,!RV&Q:;15) !$$;DJDJV3SJMUK&9F>JQ$0UE#ADRY'*.V
MK#I*;K2@*@9$NI5)+6557BMZNZ;NTVQ54V$RR;H/&V)/-(2-N*B*0H=M2(O2
ME[)>I<U2U""Q@,%%=>?C8N(R]($@?<;CM 3@GQ)#5!151?+?IK9/-G,5.4Z>
MUKCBPB;B(U]C;+Q&)GBP$Z!'DA%75&%YD'$:5$M<$)%T]'DJ8\F>-U,Q;++C
MQRJXB:54C9V(EYM,K*8:?BI"[ F-=9;./P?YZ.:214U77S5NCN<XPVQ.MW=Z
M]*:9[?&<]T^55X=;9Y?;#66#'X]7DC;>B&+DC$LM +<CDJ)--D7Z+8D-U 1Z
MW0JVNBSCYYPN:O*?'R\_B<G!&=1=8QX>?E\%T\PS):)B0V+S)\#;<%"%?+Q1
M;HM<\3,3<.B8B>KUYEF0VK3[8NM+95 Q0A516Z<%X<%2](F8Z$Q$]4)O X-H
M90-8R( S;I-$6&T1Y%557F6'K\57TJV3S9S7JG3IKT:XXL(O2->NG5D.%PXP
M"Q0X^,F+/B<)&6TCK==7%O3I7CQZ*GZN>[=<WYWJOZ>&W;45Y>#8UC,:S"7&
MLPV&\<0D!0P: 6%$_2101--EOQX5)Y,IRW3,WYK&&,1MJ*\FN)A<- !&X..C
M16Q<1X089;;%'432AH@BG61%M>KERYY=9F?BF/'ACTB((N&P\)XI$+'QHT@R
M5PW666VS(RO<E(1155;K=?EIERYY14S,_$QX\<9N(B&<?%XV*2G%AL,&3I2"
M)IH 57G$TDXJBB=8D6RETK4GDRGK,K&&,=(ABUA\1'FN9)C'QFLB[=79@,MB
M^6KIU&B:EO;CQJSRYSCMF9KR2./&)W1$7YMRPX:L%%6.VL8E4B94!Y:J1:U5
M1M;B7'YZQW3=WJRVQ54U-8C%,37,DS!CMY%VZ.S : 7S1;7U&B:EO9.E:RGD
MRG';,S7DD<>,3NB(OS3*ULR@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%-NK^1O\ [2/_ *ANK F,^@Y\Q4$V
MH% H% H-+\6+)0ADL-O"8$T:. )HK9VU"MT6XK9+I0:X&,QN*8[+BX;$&,I*
M:LQF@9;U+TKI!$2ZT&B9M_ Y&2,W(8N'+F B($A^.TZZB#Q2Q$*JEJ"3,@0<
MA&*'/C-2HAVUQWVQ=;6W1<2146@U1<1B8,4X,&!'C0G+\R,RR#;1:NFX"B(M
M_FH)3K++[:LO-BXRMKMF*$*V6Z<%X<%2@SH*]_ X.5-')R<9$>R(Z=,QQALW
MTT^C8U%2X>3C09Y'$8G+@#>6@1Y[;:ZFPE,@^(DO"Z(:+9:"04:,;'929 HJ
M"@(RHHK>D>A--K62U!DXTT\.AX!<"Z%I-$)+BJ$BV7S*ETH(CV$PTF<WE)&.
MBNY-FRM3'&6R?!1Z-+BBI);Y%H)?):YO/Y8\_3HYMDUZ+WTWZ;7\E!%[FQ'>
M/>_=\;O:VGM_);[1IMIMS+:K6X=-!O.'$=BK!<CMG"(>648@%6E#HTJ"I:WR
M6H(^/PN&Q(.-XK'1H+;O]Z$9EMD2_P") %+T$QMMMEL6F@1MH$00 401$4X(
MB(G0B4%?#V_@<?)*; Q4.+,.^N0Q'::=75TW(115OY:#;+PV'GR69D['QI4R
M-_R\A]EMQQNRWZA$BJ/'CPH)8--M:D; 00B4RTHB7(N*JMO*M!E0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0<UNW^1Y']@=5'1AZ _,E165 H*_)H
M]]DK,AQCI14;T<?GU"59XQ;'*:5_^<^/?_=>Q6S9##=)_G/CW_W7L4V0;I/\
MY\>_^Z]BFR#=)_G/CW_W7L4V0;I/\Y\>_P#NO8IL@W2?YSX]_P#=>Q39!ND_
MSGQ[_P"Z]BFR#=)_G/CW_P!U[%-D&Z3_ #GQ[_[KV*;(-TG^<^/?_=>Q39!N
MD_SGQ[_[KV*;(-TG^<^/?_=>Q39!ND_SGQ[_ .Z]BFR#=)_G/CW_ -U[%-D&
MZ3_.?'O_ +KV*;(-TG^<^/?_ '7L4V0;I/\ .?'O_NO8IL@W2?YSX]_]U[%-
MD&Z3_.?'O_NO8IL@W2?YSX]_]U[%-D&Z3_.?'O\ [KV*;(-TG^<^/?\ W7L4
MV0;I/\Y\>_\ NO8IL@W2?YSX]_\ =>Q39!ND_P Y\>_^Z]BFR#=)_G/CW_W7
ML4V0;I/\Y\>_^Z]BFR#=)_G/CW_W7L4V0;I/\Y\>_P#NO8IL@W2?YSX]_P#=
M>Q39!ND_SGQ[_P"Z]BFR#=)_G/CW_P!U[%-D&Z3_ #GQ[_[KV*;(-TG^<^/?
M_=>Q39!ND_SGQ[_[KV*;(-TG^<^/?_=>Q39!ND_SGQ[_ .Z]BFR#=)_G/CW_
M -U[%-D&Z3_.?'O_ +KV*;(-TG^<^/?_ '7L4V0;I/\ .?'O_NO8IL@W2?YS
MX]_]U[%-D&Z3_.?'O_NO8IL@W2?YSX]_]U[%-D&Z3_.?'O\ [KV*;(-TG^<^
M/?\ W7L4V0;I/\Y\>_\ NO8IL@W2?YSX]_\ =>Q39!ND_P Y\>_^Z]BFR#=)
M_G/CW_W7L4V0;I/\Y\>_^Z]BFR#=)_G/CW_W7L4V0;I/\Y\>_P#NO8IL@W2?
MYSX]_P#=>Q39!ND_SGQ[_P"Z]BFR#=)_G/CW_P!U[%-D&Z3_ #GQ[_[KV*;(
M-TG^<^/?_=>Q39!ND_SGQ[_[KV*;(-TG^<^/?_=>Q39!ND_SGQ[_ .Z]BFR#
M=)_G/CW_ -U[%-D&Z3_.?'O_ +KV*;(-TG^<^/?_ '7L4V0;I/\ .?'O_NO8
MIL@W2?YSX]_]U[%-D&Z3_.?'O_NO8IL@W2?YSX]_]U[%-D&Z3_.?'O\ [KV*
M;(-TG^<^/?\ W7L4V0;I/\Y\>_\ NO8IL@W2ML?S.S)S72>.Z]<[7Z?]U$2M
M645+9$I58J4%-NK^1O\ [2/_ *ANK F,^@Y\Q4$VH% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!S6
M[?Y'D?V!U4=&'H#\R5%94"@@Y+T6_G6MF##)\U\3=XY_:+&(3;L4)<W).31)
MHHQS7%2%#.2(@T#K2V(A03+5U1NJ(M>QV';<?-.6^:C&O&NN5=:EXOU+N^7@
MQQ_3BYRW>$Y=,9RTB)CR5$;QDC)$DONP#RK[*.3'&<830-,XV) BS)3PNR#'
MG<M9%@1$$S]5+5OR^F3<1>V)T]7CE.66,14=+KW0YH^KXQC,[=TQKZ:TQC#'
M+*;F8W5NTZ3/DDR_&3&QG)9-8#(2L?%68J3VW8P"XSBU9[6X+9FAIH!]LQ%4
MN=U1.*5AC],RFO7C$S6FO]5[8^-2VY_5L<9GT93$;M?3TQK=/6]+CWMZ^+V$
M7(2L9%Q[\Z4U*B0X*Q7F39F=OD'$;-MPE$1076U$T5>KY[HJ5C_IN>V,IF(B
MIF;B=*B_P9S]4XXRG&(F:G&(JM=V4XQ]\:JC#>-3#F$?D92 <K,1<B6)=;B*
MVRT4QQZ233(HJDJ(,=C63MM)%U1NM[;^7Z7,9Q&,UC..[7RJ+G_FGHY^'ZO$
MX3NB\HRVZ>=Y5'_+%S/3R=GMG>D;=<^?$@8R9&C8YJ*;\N8@-?;36 D"QR;\
MQ#$#ZZDEKI\J5Y_/VL\.,3.43.5Z1[)J[Z/1[;O(Y\LHC&8C&M9TUF(RJNO2
M=735R.\H% H%!P'BCOC,;)CXES#M,F<Y9Y2"=C.S5$($,I*6::<;5!)1LXY?
MJ!<O)7I_3^TPYYRW7IM\:ZY5UU^$>,O&^J=[GVV.,X5ZMW6)G\N,Y=(F/+6?
M"-4-OQDA$$UL<!/G2\;&4YBXRTJ.LUEIEQ]D#1.#8\[JO%P(1);<..R?IDZ>
MN(C*=-VDUK4^_3I[881]6CU1LRRG&-=NL;HC&9B)_P"+2?&I2,CXK8\,?.7&
MQE+(- VU%?1QJ3$[3*Q+N5:+4"_:-B+6@U'I7HX5CA]/RW1NG3XQ-1G&$^Z=
M6?)]3QVY;8UZ1.DQ<\<\D=.L:4AXOQ;DKBRR&<P1LLM3XN*/(M2&6X0F_#9D
MF](<-=+ W=1!0N"J0C>Z+6?)].C=MPR\)RJIOK,5'GT_BPP^J5C.6>-1&48W
M<;=<8RN9\(U^^(?4"11)17I1;>:O&>X\JA0*!0*!0*#D=XY;=&*RFV8V#DP6
M8><R"8N0,R*<AP#5IU]70(701$TMZ-*ITK>]=W;<?%GCG.<3>&.[2:\H\GF]
MWR\N&?'&$XUGEMFXOPF=-8\J<EA/&IL<,#NY\:ZF9>7_ ""Q>6$><CN1>@-Z
M>L2LZ2;Z_,3BEU3S5W<OTOUUQSZ?&^L>F,OCU\'G\'U?_P =\F/JO2NF7KG"
M/=TUOX+5?&#&E%F26\),;[$Q"<<:F.M1'3DY$5-J*VV=S)W2!K81XHE^A:T?
MZ;E<1NC69Z7.F/7+W.G_ %7"IG;E%1CUJ)O+IC_O>P'QBQ3[S/8L)/DPGQ@(
MW*$V!59.8B++AQT;4M2D=N41)U1+Y*O^FY1&N41/J\^F,UE/\?<QCZMA-5AE
M4[==.N>.[&.OCT\K27O%'%R=CYS>F&8-8F.Y,>"[*3[.1.E-LJ+>@.NJ,N/B
MVZB<5(20>BL([#*.?'BRG7+K7A$7^,1<?!G/U/#+M\^;"-,:B+\<IB*]NDS4
M^VT3#>++$O&;?=G8YUZ?E6I@S'X:($9)V.)QLXT<750W'WB;U,Q^!J*HO&L^
M7Z?..6=3IC57UK+QGRB/'+HQX?J<9883EC-Y1E==-V.DQ%ZS,UZ<>M,HWC#B
M'V84E<7)[,;<=[-.-/,.]UA.EK"81X=0FXXKJ6=;;'4W^EQX5)^FYQ,QNB]=
MND^JHW37PZ3/5(^K83&,[9UV[NGHW9;8W:W=]8C6/%XYXK-(WB<N<%8&W,H&
M1>A/S7&1*6Q!90P<0T-4CZC72@N"1%=$X58^GS>6-WECMNKTF9_^7P9?ZGC6
M.=;<,HRF)FM8B.O7T_'56R_&:0^T3V*PQ1X:8Q<@Y*ED#CS$EK)IC76"CZ@U
M#JO8[HO%%MP5*VX_3(B:RRN=U5'C&W==M$_5IG\N%1MNYZQ,9[)C;_%;EXNX
MDI7(8PTYP9C_ &? ES(Z=X:<@.,,DN5V4%\D3[:UQZWR5H_TW.KG*-(]77T^
MG=\=/)N_U;"ZVY:S6/3U>O9/CIZI\:T=;MK/,;GP<7.QF'(H25>;.*\HDXT]
M&>..Z"D"J)6-LK$/!4XUP\_#/%G.$S=?QBX>EV_/'-QQG$5=Z>4Q-3]\+6M+
MH*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#YSXD[]W!M#)P8N%B,RHY8
M]_*3N<PX^B-QY3#!*XXVX'(9$'2,WM)V5$ZMJ];L>TX^;&9SF8UC&-:ZQ,^6
MLZ=-'B?4>]Y>#/&,(B8VSE.DSTRQCK?IBIF9RJ:\F+/BYCFY4B)(B/36XDYY
MC(3XR-M-1(AY(L;%<4#-2>UN)UN7QT]:R>C2?IN51,3$7&D3XSMW3[M/-,?J
MN%S$Q,UE4S%:1OG#&>NNOE[ZCH\B>,F-DNM<S SXT U8-R>X]%Y;465-/&A(
M(=:$HI)!1(435IZ_15R^F91'YXF==*GK&.ZO^7[]#'ZOA,_DRB+C7TZ1.4X1
M/7^Z/EJRB^+^/RA]@Q6)D/9=V2]$8%'F"CV;AK.&1S244)HFD4NKTVX7NBU,
MOIN6&N64;:OI-_FVU7G;/'ZIAG.W&)F9G;'2OR[[ORI6X7QPQTO;N%R$G'29
M^1GB3;R0A >8]#99.:;3-R-$;-X0;;+K.=*=6RKMY?I66/)EC$Q$1Y^V9VW/
MMK6?!S]O]9QSXL,IQF9R\O9$;JCKI,U$=9]VJ]R'B'(/:V2W'AL8;+,',1\-
M'>GJ!!)U3PAR#!MLM0H-UT:[+?R<*YL.RC]6,,LNN,Y:>'IW0ZN3OYGBGDPQ
MJLXPU\?7&,SI/ROY).8\2,=C-SY+:T7%3LE,Q;2G).*(JG.6*4QMI$7CUVQM
MS%L.LA'Y:PX^RRRXL>2<HQC+S]^V_GX>39R=_CCRY<<8Y93CUKSV[J^7CTN8
MA6,>-&VIF1AP<;CY^0;F&"MR(XB0E%)QE@GVQ341H#KO+(4X]0U\E;I^E\F.
M,SE,8UY^>LU\HOXPT8_5^++*,<(RROQCRN(F?A,U/NE(V#NC>VYF\7/R>.B?
MA^5&E%)RL9=*]LCRWF!;%NZV'2V/'S^6L>\[?AXMT8S.Z)C2?*8B678]SS\T
M8Y98X[9C*\H_NC*8JO=#OJ\Q[!06D#_ET^=?]M:,^K9CT2:P9%!3;J_D;_[2
M/_J&ZL"8SZ#GS%03:@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'-;M_D>1_8'51T8>@/S)45E0*"
M#D?1;^=:V8,,G.YK;F!W(RS'W!C6<DQ'-76 D(JH!D.@E2RITCP7SI77Q<W)
MQ3>$SC;EYN#CYHK/&,H]K1+V=M*> MS<#!?:%])B-FP.GM MBUKLED] !!4]
M%1%$5.%9X]SRX],YC2NOAU_%AGVG#G^;#&=;Z>-5^&GN;G=M;<?YO/Q$1SM"
MR5?U-(NM9RBLE2\_.T!S//I2L8Y^2.F4Z5]W3Y>#*>WXIN\8UOP_N_-\_%IC
M;-VC#?*3$P4)F2;P2E=!E$)'VG%= T\B*)JIC;@A*JUEEW/+E%3E-57PZ?@Q
MQ[3AQFXPQZWT\8FX^_7WL7]E;/DM*P]@81-J/+LC6E4'G%)LA"J*EG3-Q%1;
MH1+YUI'=<T3<9S]HK\-">TX9BMF/R]N[\=?>LH>-Q^/)XX$1N,<CE]H-M+$Y
MR&T9;UJJJI: % &_D2M66>676;K^.K=CQXXW45?7\/P2JP;"@4"@4$67C,=/
M<8>GPV93L;FI&-X$-6TD-JTZ@WZ-8*H%YTX5GCGEC<1,Q?\ #6&O+CQRF)RB
M)KI\=)^[15KLC9]G4'!Q6Q>8"(\+0FT),-((@*H!"G50 %"]*PHEZW?NN;^Z
M>MM,=IPQTPB-*T]G^R/DS+9>SRD-2EV_ [0PPD-EQ&!%0C"!-(VB)9-* 9!_
MPJJ5/W7-5;YJ[Z^)^TX+B=F-Q%=/#I7RT8O[)V=)<YC^!AN$IL.$A-KH(H@(
MVRI!?26@404U(O!$OT58[KFCIG/C]_4R[3ARZX1X>'ET^2^55555>*KTJM<K
MJ>50H% H% H%EH-$B#$EG&=EQP?<A.]IAFX.I67]*AS \Q:25+^9:RC*8NIZ
MZ3[6&6&.4Q,Q=:Q[)5I[/VFY'6(>"A+&5I8_+1I$1&E>63I%4XC]LJNW3CKX
MUMCN>6[W3?\ A7X:>YH_:<-5LQKW>W=_U:^_4>V?M21%.'(PD5V,YV?F 8*2
MDL)-+"J2KJNV*J(K>]E5/+2.YY8FXRF]?OZ_-<NUX<HJ<8GI]W3Y>"!$\.]J
MP,W*W%"A SEGFV&H3O+ PQZ18_9FEB-DFD;#QL5^-;<N]Y<L(PF=-;_S7-SN
M:,.PX<.2>3&/5-5_EJ-L;?+1.P^TL'A<)CMOL1NU0<6ZDN,<M$<=6:CA/=J)
M41$YJN$1W1+(O1T)6OD[C/DSG.9J<M-/+I7NINXNUX^/CQXZN,====;O=[[U
M_ ?V=M.3+6>_@XCDPC=>-Y6UN3TA-+CBI>VLD_3MJ\RU([GEB*C*:_EX>Y9[
M7AF;G&+N_C/6??[7C.R]HQG,<\Q@80/8@B/&N(RFM@S+61(2\5)3Z]SNNKCT
MU9[KEF)B<Y]77VI':<,3C.S&\>FG3Q_'7WL/P-LM6Y#2[>@JU*-UQYM6;@IR
M$TNJ(WL.M.G2B>?IJ_N^:XG?.G\.B?M."IC9C4WX>?7YLUV7M!6F6%P$)6(X
M.M,-JUU1!\T=<'IXH1BAKJOUN/34_=<US.^=?X+^UX:B-D5%^'GK/SG7WMC>
MU-L,S)609PL-N=-?:ERI LHAN2&'.<VXOF(7/M.%NOUEXU)[CEF(B<IJ(J/=
MT_#3W+':\,3,QA%S-SIXQ-W\]??JL(<&'CHXP\?&"+$$C,6&1T@ANFKAJB><
MC)27Y5K5EG.4WE-RW888X16,5'\]6^L690*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0566VQMW/28DO-XJ/D9,&_9')(:^6BDAJEKV5-0H6DD5+I6[CY^
M3CB8PRG&)ZTY^7M^+EF)SQC*8Z6Q/:>UW9D7(.86&4Z$^Y+B2%936W)?<YIN
M)_O*Y]IQ_2ZR<:L=QRQ$QNFIBI]W3\-/<D]KPS,3.$7$W&GC,W?SU]^KT-J;
M7;:1@,)"%A ;:1KDBH<ME]90!9;II%XE=1/66]/W'+=[I^?LK\-/<1VO#$5L
MQ^7E.Z/OU][7 V=M+%J"XW!0XI-D1@3;5B%7&E8*RJJKQ;56_P#AX=%7/N>7
M/\V4S]K_ !U3#M.'"MN$17L]E?AI[M&#FR=G.\M2P,)"95A6C!OEF/9&^2S8
M@4530VB-IQ]%$1;V2K'=<T?USX_?K/WZI^SX-/1CI7AY14?=I[DR1M[ R\9(
MPDK&1W<-+<*1*@$VBL./..<XG"'RDI]>_K<:UX\W)CE&<93NCQ^[\&S+@X\L
M)PG&)QG68K3K?XZM,#:FV<7,C9#&8F/#G0VNSQI#"$!@UUDT\"ZR)J*VJ]K\
M*RS[CDSB<<LIF)3#MN+"8RQQB)B*^#P-I;693'"QAHC X<R<Q2,-\KLQ&YS2
MY>A4LA'UU%>"EQM2>XY9N\IG=U]OA^"8]KPX[:PB-O2HJO'3XZK"# @XN*W
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MXN255$,M1)U!MUE2@MNU1E:YZ/!R=*N<S4FG0/25[VLGE6@A1)^0DY65'*&
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M1,93-5X3CYQ/F^0_CW?G_J;(^^3V:\K]]R^;P?W_ '?_ -N7RP_[3\>[\_\
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MWG#S9SRQ..%=)\<O/\=7Z1KXM]\^>[SQ+&Z-WX_;,DE&-*V_FP?(>*BDHX;
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M@4"@B3LIC<6+9Y&6S%%TM#2O&(:R1+J@W5+K;CPH-3F<PS4AR*[/8"0R!.O
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M4 E1!34A*2\.I?A5HM>)O'(/,!)[3#@+)E]B*-) E<QXIS+.2?M!NIZ$$1L
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MSX+TIV"U):.8RB$]'$Q5P!7H4A1;I02*!0*!0*!0*!0*!04VZOY&_P#M(_\
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MN2RWC'PFXW(HK9269;4A9+;G6!0*QK91(+*/!:#I\>Q*C0V6)LHITH!L[+,
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M*47'09'TNL1HW^CP2Z7\ME%I)[TA-2D@.Q7PGJO"+IU.J" )D8H-]0]:PJ/
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MYU%MS&]2<DFUV,S4R,8\=$Y;UFT154^8HH*<"^?AYZ46W#OG&.MD^RR\407
M:*4H*+3:DHH2N%:P(.KI6E%I4K<K<!]\IK!L0HT L@\I)=X=+BAITBJIT)?I
MHJ,]OG&10)9<>0R\-EY1!92"^E7!NJ*K:'8%*W2J4I+9L[AFS(V7>B1;.X]
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MYDJ*RH% H(#&$Q4;E]GB@TK1JZTH7321)9;<>"+;T>B@][FQ/V:)"9$6D,0
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MEY09=<>BDZ\X\U&AJ;R":]8@,5"R)H6B/H.7R4L,A)1J>ZQDV"C]TXT!^QE
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MH!8VH7K*-GRUZOFTV^<,X^X<[%:SIS8ZOR<2R'-(DY49#;BD\KPK;43;BH/
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MFU H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MY0_F#JI0:'MN860 A(C<W2 M(1N.D>@5)4124M2^F275>@E3H6@%MO!G?7"
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M4"@4%I _Y=/G7_;6C/JV8]$FL&104VZOY&_^TC_ZANK F,^@Y\Q4$VH% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MT"@<$Z>% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M0M0#!<F/-O<LDOU$:4K*B^CQH+YC8&_-V;"VZUMW&[2@0H79)N*SD%]X)XO
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M43CSE4$_V]%!LF1MZ1XCJLG*D29 JX*BXW]C)%UQ6Q$4T_9J/+0D5;6XKY:
MD'<$<WC-)YQU<?[6XTX!R[.R"=%(Q%_]-$4.'D1%1*#8<+>8L.OR)DA'W&G&
MW19Y;@@(L-JV3;8H*JXKFI"5"\]N%J"3+QV??G0<M'1V/)8@L@Y'%X" WE?
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MF4S$1TZZQ7SZ&7<<<1$S/7II-_+JRD[QVS%@PLD>1;<B9%%* 4=#D$^*)=5
M&1,U04])4'AY:8]MRSE.-:X]?"OFD]SQQC&5Z9=*UOY- [PQH'D'I+K8XZ)V
M3E.,\U^07;&D<%'&!:U@JW32G6NG'A67[;+2(ZS?NT]MG[C'69Z17MG7V4A3
M?$G;429@([;QR6-P*\D:4RVZ8!R!55UH(*J+J30HK917IK9CV/),9STV5][3
MGWW'CEA'7?=:3X+=C=FW9.67!L3P/)(1MHV@GH)QI+F N*.@C%/2 24DXW3@
MM:)[?DC#?,:.B.XXYRVQ.JF?\0<0_F\-AL)+9EO3YKD60BBXEVF6'G#-@U1
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MRU-%U%RD55NLL+I>R\Q/+T^6FAJ#E(HII&6"#TV0T1/]M-#5ZF6CIT3!3_\
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M#9D:R5PVB,5-"!$--6G3PJ"=+RVX<]N3([>VW(9Q<+!BPF3RC["RG')<EOG
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M,^@Y\Q4$VH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M^K:$-G!4#$V[C<5XHM!4^$V:W5F-OMNY^(BL\Z?HR9S$D/.&W/>!&E;1H+"
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M+<0Z6@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@YK=O\
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MH];HZ.-!IG;XV?C6XCTW.0F6)S8OQ75?!0-@ELCJ$BJB-JOZ:]7Y:"VEY&!
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MXVTX0BBCP15(DOYJ"K3+2W(:R,?F9#^1D8Z:YEF4TFL-]ME5$A:(;-$V[U!
MDZWE1;7H+C 9O+.Y&1C<JZV$Z&L2-)1U%;:>(P?/G1K)9>:(@6F_5L2>2@W9
MS(9""_F59DN R$2&ZVNA"2/S'G&WG L-UL":EU7M;S4$%<E)?VY)88S#8.,2
M%%B?(D PX_!!W2A(\@DB*>DFQ<T*BVO05\[.[B@O-3 )P<7(CQGB&0\ JTSI
M!40_LU4#,T,"-;H5TLB6JCZ'&>[3&9D:";YP"YRS2Q#K1%LJ>=+\:Q5MH% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H*;=7\C?\ VD?_ %#=6!,9]!SYBH)M0*!0*!00LOB8&=Q<
MS#91KG8Z>R<>4UJ(-33B:22XJBI=%\BT&G,[>Q&X,>.,RT9'XK9MO,=8@<:>
M96[;C3@*A@8KT$)(M!$Q6U(>+[0I3LC/*2TK!E/G/R-+9=* BDB"J^LB:OEH
M-.(V1AL1/:R:.3)\Z,!M07LE*>FK%;=LABSS2+3J0412])42U[4&Z#M#$8W*
MY#*P5D,+E%<<G01?<[$;[R"CCW(5=*.$@IJ(;7Z>E5H,XNTL#";P+<>+H#;0
M*UADUFO) F%C*G$NM]FNGK7H)LC#X^7E(.:?:U9'&MOM0WM1)H"7HYJ61;+J
MY8]*>2@^>Y:+MKO'*$UM/.NY!^01R<=%"0QC<E(%;"ZXH.I%5#444C<5+IZ:
M+T51UNPMOR-K[0Q6$F*"S8[9'*1K^Z%]]PGG!#@G5$C41X)P2H+.)A,;!R>2
MS$5G1D,MR.WNZB7F=E#EM\%6R6%;<$H&*PF-PO;>[6>3WA+=R$OK$6N3(MK/
MK*MKV3@G"@K?P-M?\.Q]K+!1<-$<1^(UK<1QEY'%=%QMU"Y@&)DJH0DBI\U!
MOPFV8V$><D!/R$YYP.7JR$QZ4@A=%L(F6E%54Z;7^6@CQMD8.(N7;9[2F/S0
MOC-QBR'5AHLM5)\FFE*S9.*1*2A;BJT$^1MW$2MNGM5]C5@SB=W%&UDEXW+Y
M6C4BZO1X7O>@CYO:>&SJ1#E ZQ.QZ$F/R$1YR-+80T03$'6U0M)(B:A6XK9+
MIP2@V8+;.)VZ,E<>V9RYI"Y/G27#D2I!@.D5==<4B+2G 4O8?(B4%.GAEM-$
M*,K4A<(2D28!93RXH2-=2Z8NK0B7550+:47H2@L<ALS 9+%X_$OL&#.(1M,5
M(9=<9E12:;Y8DT^!(:+IX+UNM^E>@V8/:>(P#\B;%1Z1E)8B$O)S7G)4MP&[
MZ 5QU55 &_ !L/EM>@U_@G;*[=_"AP!/!(9NC&(W-0NN/%(4P<U:Q-'"4A(2
M117HM0:\1LK#8G(!EU.5D<LTV3$>=DY+LUYEERVH&E=)4!"MUE%+EY56@YG<
M,?;!9K).R=N9_M[ND)9XIJ4W'R8B"(.LHSHM'9.I=Y17A9>JE!8[4V0PWL]<
M-N" U'[=.<R[^+CG]E%<*8DMAD2:THO)T-BNGJJHKY*"YS6S\/FYH95Q9$',
M-M]G3)8]]R))5C5KY1FVJ:P0E54$T6RJMK76@]<VE <Q#>'69D1%MWM 31G2
M$F<WC<E>UZE1454TKU?DH)&!VYB]NLOMX\7"?EN<^;,DN'(DR'D% 0W77%4B
M5!%!3R(B61$H->=VKB-PG&D31=9R,+6D+)0W3BRV4=1$- =:42TDB)J%;BO"
MZ<$H-8;/PIX65@,BC^6Q\Y=4OO)]V6XX2:=*ZW"51TZ14=%M*I=./&@TXO8^
M%QF09RAN2\CD(J&,%_)RGII1A<322,\TB0%5.JI)UE3A>U!;0</C\=+R,Z&U
MRY65>&3./42\QUMH&!6RJJ)8&Q3AYJ"M=V;A2ASH<?M$),C-/*2'X<EZ.]VQ
MRR$X)@2*E]*=7T?DH-;&Q=NM8G*8AYEV6UFQ4,Q)E/./2I2*'*3F/$6OJAU1
M1%1!3HH,LSLS%YMY'9,K(,-DTD:1'ASI$9AYD;]1P&S1.A52XV*R]-!GE-FX
M+*8_'X[E.06\0HKB7L>Z<-^)H;5FS)M*BBBMDK:CT**]%!YE]FX;,NQ)CZR(
M^6@M+'C9:)(<CS49)44@)UM44Q)1NHG=+\>F@]+9^'?P3^W9Y2<ACY1B[)*;
M)>?>,P,#%5<(M2(B@/ ;)\E!8Y;#X_-QFXF2:YS#3[$L!U$-GHKHO-%<51>!
MBBVH(61VKB\CFHFX2*1&R\0$8[1$?<8YT<3YB,O""V<;U<=))Y5\ZT%W0*!0
M*!0*!0*#FMV_R/(_L#JHZ,/0'YDJ*RH% H% H% H% H%!RCV]X[.2R./6-J[
MO%PB4'FR=7D\NZFUZ0"O,1 )>GY*M):9D,^YCG93$#'++CXQL7L@0."TK8'<
MK-@J=<D%%-4N/SWX4&L]R<T@<+'JY@7GUB!/4Q6[B*HH2M*G]VIIH0M5[_HV
MXT&W%[ADSS8:E8XHAS8RS(!<T76W01!51541%$TUCP5+>95M00AWB^R+)Y+&
M+'![)CB$)I\7D$UUHKA]4+ A"@^?K4H1Y7B%&8%QP8:\H)DF&)//M,\T8@@2
MFUJ]-34[-AP4K4HM>97-8_&NM]O%$9;9=F/OFB*C#+.E-2I9555(D%$'CTT5
MJC[OV_)5] E$/9D)7^:RZUH4#$#%=8)UA(Q0AZ4U)2AN'/8A,HF- B[4Z#[A
MO"V7)3L9"#B&[;2A#J3TEJ"E/?T$6I;K\%X>RXU,PP*Z55X",Q!L>/!PD1LK
M+^L3Y:M(F1=XP)3SD)6C;R&EI&8YHNAQU^,$D&^;IY8DJ$HHBEQM>E"Q@3\?
ME(:/16D<LTTXL=11%%#!' #CU;V7S\%J*J7]ZPV1PY.1"$LR($#9FV)IJ(0T
M BK]J:$:7 /)QJTCJ:BE H% H% H% H% H% H% H% H% H% H% H% H% H%
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M5E0*!0*!0*!0*!01'(;IF1I,>!"6Z /+LGR)<%6@Q["]\<_^[]B@=A>^.?\
MW?L4#L+WQS_[OV*!V%[XY_\ =^Q0.PO?'/\ [OV*!V%[XY_]W[% ["]\<_\
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M_P"[]B@=A>^.?_=^Q0266R:;T$Z3JW5=9VU<?^%$2@V4"@IMU?R-_P#:1_\
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M-;M_D>1_8'51T8>@/S)45E0*#E?$3_RN?_?L7T?^(QZ[>R_]OPR_Z9<?>?\
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M>GCQ93C,9Y;K]E.$A9$\A"V_M_*R0:_"ZRI>XI)*6D.XB6/&(^C4CAZ'[>5
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MY=<1$14-E12@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@IMU?R-_\
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M2(]_@MF=H\B+*BLNML-2'<>\VRT"HVTF/Y-P&ZW5"Y7"_1>M$]S<Q,ZUN_\
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M6G'GJ(BNF[_Y-L\-S,WUV_<KXNQW(_8;S4+L;T1Y?L[:NRORGE3TN&KM-O\
MX?EK=EW=WIUO[XQC^#7';56O2ONF9_BB93P].7+.>!19;CSLI'8\P7A:[/,=
M1VR*RX*ZA5++>Z$B^2U9\?>5%:QTZ5UC3Q89]I<WI/7KY2N=P;29S88IIMY(
MC./<0'V@&X/021$<C6NFD34 X^337/P]Q/'N\;^Z?-NY>#?MUJOOCR_!32=@
MSYV0R,N7/:+M+<EEI[0X;Q!*<;<%'-;B@(M(WH$6Q2Z<5XUT8]YCCC$1'2ON
MO\?:TSVLY93,SUO[Z_"DC<NR)N:<G%'FM"QD3+G1WP<5L4*,W'%RS3@:S#EJ
MHB?4ZR^5$6L>#NL<*N/R_P YG[_FRYNVG.ZGK_*EB.UC&.+':D73/A3[Z.E(
M33#2CT_I<F]_)>M,]QK=>$Q\YG^;9^AIU\8GY5_)71=G91CN9OM,82Q+SBID
M&A>"64974<%K@: J.)U'!.X_I"E[6W9=SC.[2?5X:5=?P\&N.WRC;K'I\?&O
M+X^+M:\YW% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H%!3;J_D;_[2/_J&ZL"8SZ#GS%03
M:@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4'-;M_D>1_8'51T8>@/S)45E0*!0:)<R+ 8*5,>%A@/
M2,ULGR(GG5?(B5ECC.4U#'+*,8N546=F/]:!C35E>A^6:1D7S*@6(U1?E%*W
M_HQ'6?EJU?J3/2/GHQ3*9P+*42*\GJ-OF!7^<V[4_3P\Y^1OS\H^:1%S\9U\
M(<UIR!,<72TW(1-#A>9MP54#^9%O\E8Y<,Q%QK#*.6+J=)6U:&TH*>1/RK;[
M@--QU:$E0%(C0K?+9*V1A;"<FKO+,?JHWUG/HJ[#<=Y9C]5&^LY]%-AN.\LQ
M^JC?6<^BFPW'>68_51OK.?138;CO+,?JHWUG/HIL-QWEF/U4;ZSGT4V&X[RS
M'ZJ-]9SZ*;#<=Y9C]5&^LY]%-AN.\LQ^JC?6<^BFPW'>68_51OK.?138;CO+
M,?JHWUG/HIL-QWEF/U4;ZSGT4V&X[RS'ZJ-]9SZ*;#<=Y9C]5&^LY]%-AN.\
MLQ^JC?6<^BFPW'>68_51OK.?138;CO+,?JHWUG/HIL-QWEF/U4;ZSGT4V&X[
MRS'ZJ-]9SZ*;#<=Y9C]5&^LY]%-AN.\LQ^JC?6<^BFPW'>68_51OK.?138;C
MO+,?JHWUG/HIL-QWEF/U4;ZSGT4V&X[RS'ZJ-]9SZ*;#<=Y9C]5&^LY]%-AN
M.\LQ^JC?6<^BFPW'>68_51OK.?138;CO+,?JHWUG/HIL-QWEF/U4;ZSGT4V&
MX[RS'ZJ-]9SZ*;#<=Y9C]5&^LY]%-AN.\LQ^JC?6<^BFPW'>68_51OK.?138
M;CO+,?JHWUG/HIL-QWEF/U4;ZSGT4V&X[RS'ZJ-]9SZ*;#<=Y9C]5&^LY]%-
MAN.\LQ^JC?6<^BFPW'>68_51OK.?138;CO+,?JHWUG/HIL-QWEF/U4;ZSGT4
MV&X[RS'ZJ-]9SZ*;#<=Y9C]5&^LY]%-AN.\LQ^JC?6<^BFPW'>68_51OK.?1
M38;CO+,?JHWUG/HIL-QWEF/U4;ZSGT4V&X[RS'ZJ-]9SZ*;#<=Y9C]5&^LY]
M%-AN.\LQ^JC?6<^BFPW'>68_51OK.?138;CO+,?JHWUG/HIL-QWEF/U4;ZSG
MT4V&X[RS'ZJ-]9SZ*;#<=Y9C]5&^LY]%-AN.\LQ^JC?6<^BFPW'>68_51OK.
M?138;CO+,?JHWUG/HIL-QWEF/U4;ZSGT4V&X[RS'ZJ-]9SZ*;#<=Y9C]5&^L
MY]%-AN.\LQ^JC?6<^BFPW'>68_51OK.?138;EI!>D/QT<DB NW5%1M54;(O#
MIXUA,4RB;2:Q4H*;=7\C?_:1_P#4-U8$QGT'/F*@Y'QFRV3P7AEN'+8>4Y"R
M45ELH\IE40P57VQ6RJB]**J5!P>P]H[^SF)VYNB9XI32&<S$R#^*5AHD5'$%
MTF%/FW6Z+IOI_)5%AX?[NR\OQ=\0\-F<N1X?&&RF.B2'!%MK42WT(MJ#W(;M
MS)?U%8/;4+*F>VI&'<D/P&C$V#>09/6)$OQZ@KT^2@XO8;'B#XAL[NRR^(61
MPSV%R,B+#!>6L(0;N:*ZBVZJ="^9*(^G^!.]LYOW8+.8W$@EDV)+T,Y0 C8R
M!9051U!%$1/2TKIX7%:*Y&3N7?OBUOC-[6V1F?PQL[;+J1LEF66T=ER9*$0J
M+:JJ634!Z=))P34JKJ0:#N]J[;ROA\UE<INO?$K-X461<0LJ@@,5&]2N&KBD
M2JBI;AP_+4$;#^.WAEF\JQB(>7('Y9\J"])COQX\AQ"TZ6W7 $56ZVXVXT%C
MN/Q;V#M/)3<1GLJD3)0&FGW8RM.D9B_;EBUI%>82W]$+VXJMD1:"H/\ J!\*
M@P;.=[[0F'W#9"(#+I3$-M$(]3*#J$41476O5^6K0O9'BALB-M2+O8\HA[:F
M. PQ,;;</[5Q5%!(!%2%4451=0I;RU!4QO'3PPE[A#;;&;$ICKG(8DJVXD-Q
MZ^G0#ZCH7CPU7TKY%H)V[O%O9.R<@N)S<I_O(6DDNQXT5^0K;!71'#( 44'@
MOZ5!S_B'XVX+;WAXWN_:TMC(RLI]G@T<;>)AQT'!1U'$%!4% %)=)J/%+510
MYWQ3PF[?#&%FXF]7]IRH\J"QE\I%Q\AW_.&P3KD<6].K0JHI(0JJ=5$5;+00
M=R[U8VK_ %!,R<]FG8FV8^ YSS1N.<DW2$T'2P-T)PEM9!&ZT1]'P'BEL[?^
M*S([6R).3H,9TGXKH''D@.E40T$T152_Z0]"]-JBN)\!=X1L9X.GN7>67(8L
M>=)1^?.=-XD2X((HI*1*JJMA$;KYJLCO]I^*VRMYY$\/AIK@Y46^T!#F,.Q'
M76%Z'&T>$=8^7J\;<:@L]I[YVMOAF9(VMD0R#,!Y8TH@$QTN)Q14UB-Q).(D
MG!?)0=#0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0<UNW^1Y
M']@=5'1AZ _,E165 H-,J4Q"C.RY):&& 5QPE\@BEUK+'&<IJ$RF(BY<]'9D
M3I 9/(@JS5XPXI<1B-KT(B='-5.)GY.A+(E=<S&,;<>GC[?\/)S1$S.Z>OX?
MXI#;C;X*\PZ#S>I05QHQ<'6G2BJ*JE_DK"8K26<3?1F(D2Z115)>A$XK45X_
M#Y[#C$J/S8QI]HVX*J*HGE^14\B]*4C*IN)U2<;BI,3,>B2AP\QTG@<$CQTE
MQ;F8!Z;3B^4PNBH7Z0\>E%IR8Q,;H^/\S#*8G;/P7M<S>II']^Y_Q+71CT:I
MZOGDOQ8Q$3/YG;Q8]\G\.,Q7'^>P@$6.CA)=4P4M;+2B:(#S@Z"+J]->KC].
MSRX\<[CU5X3_ %34>^?9&KQ\OJG'CRY<=3>-^7],1E/NBITRG2]%TYX@[)9=
MG,/YR*T]C&Q>R $IJC(JH"O70=)J). )HVI**DFJU<\=GS3$3&,^KI]OAXNF
M>_[>)RB<X]/7V?:XORN+8Q/$78\\9)0LVT^L-CM4D&VI"N RCG*(M'*U+I-4
M$T1%4%5-2)5R[+GQJ\>LUX?S_P!IAWW!E=91-1?CTZ>7A/7R\47)^)VT("0T
MC3VL@Y,=@"J,&H@S&R;@@W)<<,=" B%JLJHMK^9:SX^QYLKN*K=\\?!KY?J/
M#A$3$W<X_+*:B?<G?C[9.L&USD82<BK/'7S 3LR-D_K52!$15:%74!5U*'61
M%2M7[/F_MGK7QZ?CI[VW]]P?WQTOX5?X:^[5<XS)0,SCX^5Q;Z2<=+'F1I H
M0BX%U34B&@K:Z<.''YJT9X9893CE%3#IX^3'DQC+&;B>B56#84"@4"@4'([U
M\0(&QWH;<V"[,"3'DSG39?CL<J+")L751)!AS'/M$T- NHO)QKN[7L\NXB:F
M(J8CI,ZSTZ=.G5YO>]_CVU;HF;B<M)B*C&KZS%]>D:MKGB3L)EOFNY^.#?:%
MAJI"\FE\4U&))R^"-HOVI+U6_P!-4K&.QYYTC">E^'VU\//P9Y?4.WQBYSCK
M7Q\?EX^$>+6QXF[%>"2XYEQBA$GO8EU9+;@7D1E3F$%A*[2715=6PI?K6NE9
M3V'/%>F[B,M/*?X^QC'U'MYB9W5MRG'7SCK\(\^GFR8\1MI$['B3\BQC\C+?
M=CQXAN<Y2Y4HX:&KC0J B3@:4U$EBX=-2>RY:F8B9B(Z_"_P91W_  W&,Y1&
M4S.G_%M\/;I[]&>0WFL;)Y7'X[#2<FUM]I'<[.!YF.S'(V%DBT".KJ=/0B$:
M EAU)Y>%3#MKQQRRRC'?^6-9O6K]D69=WZ\L<<9RV?FG2(C2ZUZS7EYM&-\3
MME9#;S&Y',HW#A'V=N6+PNJL1^4T+PMO*+?52Q<'%L!>1:RY.PYL>2<-MSK7
MMB)K3^75AQ?4N#/BCEW;8TN_"XNI_GT3#W]LIN3DH;F=BA)PX/'DP-3'DI%)
M >34HZ2("(1404BNJ<.-8?L^:L9VS655[;Z-G[[M[RC?'HN_977Y>+%GQ"V.
M_P!DY6=C*LYTF(PDCH%S0<%HA-#!%;L9"%W=*:ETWO2>SYXOTSI]OCIY+'?<
M$UZX]73YU\-9K7QT=*J*BJBI94X*E<CM*!0*"HW3N!G:FWYFX)$9R8W$5@$B
ML$ ...2GPCMHA&J"G6<2ZKY*W]OPSS<D81-7>ONB_P"#E[KN(X..>28F:K2/
M;,1'7VRYLO%7#1,Q"P&<Q\K$921-+&SFY!,N-PGN4VZR;CC9*A-/HZ @X/0O
MI6KK_P!/SRPG/"8RBKBKUZW\8KHX_P#4^/'.,,XG&=VV;K2=)BZ\,KBI^;=C
M/$["9/([;Q@PY4=_<L59;#CVCEQR57499>5/TWN0[H1/5K'D[#/#'/*XF,)K
MW]+F/9%Q:\?U/CSRX\:F)Y(N+\.M1/MFIKW2FSMYDQ.S$;'8:1DH6W@,LWD@
M>9889>",LGD-HXNITT#3KTI8=2=/&M>/;7CC.648SG^6-9O6K]C?EW=991CC
M.48?FG2KJZ]LU7S:,=XG[)G[?C[C<RK<."ZK#4E'A=O%D26A=%IY4;L/ TLX
MM@+R+66?8<V/).&VYU^,1XQ_+JU\?U+M\N*.6<MN,UU\)F+J?+KUZ)CF_P#9
M+4G)Q'<[&;DX873R@%S$Y*1C1MU+J%B(#(1404BN2<.*5A'9\TQC.V:RZ>V^
MC9/?]O$Y1OCT7N]E=?D\;\0=D.I#4,Y'_P ^Z<>,A(Z"JZVX+)":$"*W9PA;
MNYI34NF]Z3V?-%^F=/\ ;\=-=%_>\&GKCU=/G7PUFM?'1TBHJ*J*EE3@J5QN
MTJA0*!0*!0<IE-_8[$Y2=A7X,D\C$E8N'':#3:7WRA*TXTOD%OEN\RZ?H+7;
MQ]GEGC&43%3&4^[;UOWZ5[WG<G?889SA,3<3A'OW])CW5-^Z7K_B1LEN$DQG
M,,R%<.4Q%CIS&W79,$$<>943!%;(4(5)31$%"15X4CLN:ZG&8Z?*>D^WX+_J
M';U<9Q/6*\;QZQ\/'R;!\0=GC'5^9E681M06,K*:=UKRHLE&])H:!I<'4Z Z
MFU)+JE8SV?-=1C,ZSC\8_#IXLH[[@JYRB/3&7PFM?;&L:PRQ>_=IYO.0MO8J
M>LK(9",],CD#+J,Z(SJLN 1$(J+@D)7 D3H^5+N3M.7CPG/**B)KYZ_)>/O>
M'DY(X\9N9B9Z3X34_'V?X*G!>*VW,O$/(SM.'@'+2!"*1):DOO22<<;1M6(V
MMQHEY1**."ETXI6_E^G\F$[8]4U<Z54>^=)Z^#GX?J7%GCNGTQ>V+F-9N8JH
MUCIXK%SQ)V"U%=FEN",L5AY(SC@HZ:ZR$G$41%M2,%$"-' 10TBJZK)6F.QY
MYFMDW\/M?LZML_4>VC'=OBOM/RK6^E:VF!O3:+@"X.;B\HNATC40MV3MUU(D
M1$3L_P!M?U?EX5A/:\O3;/VG;_U:-O[SAJ]\5_\ UW?].ON0W/$K8+,6/->S
M\=N-),VVC,7A5"9( /6*MZF]*N!=7$%+$B]"UG'8\\S,1A-Q[OM/3P:Y^H=O
M&.Z<XB/]G7RZQU\TL=[;1*>_C$S#';(SIQGT5'$;%]ILW7&^=HY:F MFI")J
MJ:53IK#]KR[8RVS4Z_#W=?%LCN^&<IQW1<37QC68OI<5-K>%,BY&%&R,%U'X
M,QH)$5\;H+C+HH0&ET1;$BW2Z5HRQG&9QGK#HPSC/&,L9N)BX;ZQ9E!2Y_=&
M-VV_BVLG=MC)N2067=$:CA"BN2W'';\=.AM>BNCAX,N6,MO]-:>=S6CEY^YP
MX9QW=,KU\(K&<IOX0K \3MBO2,7'CY87^]WY$:,^#;B,MN1&A?<YY&(\L=!B
M0D265%OZ/&MT]ASQ&4SC^6(GYZ:>;1'U'MYG&(RO?,Q'PBYORTU]L:]&UOQ'
MV&ZVPZ&?C*$DW&V$LZADK#8O&NA6]2"C9"YJ5-*BJ*BVK&>RYXOT3I_L_'1E
M'U#MYJLXUZ?"+_"8GW:O8WB-L26TT]&ST=P'Y 0V407D(GW 1T$05;0K$"ZQ
M.VE1NM[(M,NRY\9J<9Z7X+CWW!E%QG'6OCU_#7RIJ#Q,V.]/Q^-B95)<G)R3
MAQUC-.N +K;7.17%THJ 8JBMFB*)]*+9%5+/8\\8SE.-1C%Z_+_;Y,<?J/;Y
M98XXY7.4UI[K^^.GGX:-,SQ3V5&6*VQ/68_-[>$<&@,!1_%LH^\T^3HCR5TD
M-E,?+=>'&LL>PYINXJ(V_P#RFHF/-AE]2[>)B(RN9W?/&+F)\OBE->(NRB5&
MY&9C1I8P0R<B.9$7*8)D'R3F".@B #$R$"4M/6M:L)[+FZQC,Q=?&Z;([_@N
MISB)K=\*OW=)OW:K?"Y[#;CA%D,%-"=#;>.,ZXVABH/M6UMF)B)"271;*G0J
M+6CEX<^*=N<5-7\'1P\_'S1.6$[HB:^,>"QK4WE H% H%!:0/^73YU_VUHSZ
MMF/1)K!D4%-NK^1O_M(_^H;JP)C/H.?,5!PGCXMO"'=%_P!0U_J6J0/E'AMB
M/Z<X&-VKG9F1B,[TCM0I;VN=(0@R(H!K=O7H14<_1TVHC# ^'6T_$/QK\2(N
MZHIRFH+S3L9&WG&=)&NDK\M4OT)TT$G#[)VYL'^I7 83;$<XV/<P[TDVW'3>
M57C;DBJHIJJ] #PH.9V#X8Q?$#;_ (BN#/GQ<K'R4L(3,5]0BNF@D8"\S94-
M"+JKY;=%!]O_ *?=S,[F\,,6XVPQ&?QI.8Z2Q$ 6FD<874A:!X(I@8&7G)56
MDJ^=^'>X\?X.>(6\-F[Y<[LAYJ:N2PN6?14C.M$1VU.="7$AX]"$)"JWHBX\
M>]S8C>OA=F(VR<M'S"XUZ'*S+4!U'U&'K+K%H5;HAB)+YD&ZT@4/C-N78>Y?
M"7;N"VD]&GYB6]!;P&+AJ)RV"$=!"K8=8%1%Y:HMKDM!;X"$I?U,.CE1"1D8
M>VF#)TD0U&4C;#9F*KT*J$:7\RT&[P8Q>+7Q3\76^QL* 3FV!%6Q5$:?=E*Z
M"(J60344U#T+:@^0\$_IIR[0+]FUNQ0;%%N@CRFE1$_/0=WXQ[D\/=P>$.WL
M!M5^)/S+SD%K!8V#I.4P2"@F*M#UFU5%T*))=25.F@NLKOO<LK?N1V-+W?$V
M1C=MXZ*<_*O,,.R\@]R&S<T+*ZJ"BN*HH-UMQLM^ ?/MK(K_ /3'X@!'(I+3
M>90F2TV7EHY!)20?T>%R7S4'1>+V=P>;_IXVT6&G,3.R/XJ-+1@Q(FI 07-3
M;B)Q$D\J+QH+'<^5V[A?ZF,/DMSNLQ\<SAFN7*DHG)9D$+J-F1+P#BMD)>A5
M2@\&=B-S_P!061S>RC;E8B#M^0&X)\2RQGGR:<%/M!ZI*NII+WXZ%]6@^91V
M\@/@ELZ>VZC&%@[I=<RD@V>U,L$NA&G76>.L!Z]Q7TKZ?+5'U_#8:7NG?^TM
MQ9#Q0PN?R6*)YV!"Q\=AF4]',%5YO[%W5;2B\"3JIJ^6H/I/AGFO#;,Q<L?A
MPW':BM32[R2,PL=#D$ET<LHC<21.JJ<*BNZH% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H.:W;_(\C^P.JCHP] ?F2HK*@4%)GUYS^.QR_P!T
M\\3[R+Z)!$'F(*IYE/171PZ1.7VU:.368C[:/CO]3$[/P_#12PQN-Q)$YIG-
MOLJJ&D0Q+2)*G% -S2A>?@GEKW_H>/'EW/JZQ'I]_P#L?-__ *+/DQ[3T=)F
MLO=K^,U^#X'_ $\Y'=T3Q"CQ=J-),:D,/+E8#SQ,1#C@"V-TQ$]*@:CH+3?5
MP\JU]-]9PX<NWF>32IBIZS?L?(?0>3GQ[F(XM;B=T3-17MTGI/33KIXOT#O/
M<>Z<QLW<C.1PD#'XB#,;QF5EMY-TG!1N3'5P@3DM]54<1.)CY:^8[7@XL.;"
M<<IRRF-T1M]D^V7V7=\_-GP9QGACCC$[9G?/2XO^F//SAOSN$\-<5D-MR=J]
MW,Y9=PXQILH4SF/$T;ZHX.D7BNBCZ26Z*QX>7N<\<XY-VW9EUCV>YGS\/:\>
M6$\>V,OU,>DZ]??Y/H^6U!"*6W_?P3"6S_Q,K<D^904D6O(X^M>>CV\^E^6K
MJ1)"%"%;B271?.BUQ.I3R/[]S_B6NC'HU3U<#DO"C;N6R.5GSIDX@RSDN0Y$
M;)EL&GY\88;K@.(VKA?9#U ,E 5XZ5KU./ZCR88XQ$1Z:UUZ1-QXUU^+Q^7Z
M7Q<F64Y3E6=Z:=<L=LSTOIX3->Q@]X0[6?YS;LF>4,E>*'#YH<J&<MYJ1))A
M>7JN\;(J2&I(**2#:]6/J7+%:1>ESYU$Q%^Z)/\ 2N*YURK6HO\ +NF,LJTO
MU3'C?LINR?A9M[*'S3FY".\DF;- V76]*.Y*6W->0@)M1-M7&Q1 -%33TWK'
MC^H<F&E8SI$?\L;8^-3U9<GTWCRUO*)O*=)_NRC*?"IBXZ3X-#'@YLMG$NX)
MQ)<G%/KCNTQWWA5'0Q*FK($H@/5+67,M:_DM64_4N:<M^D3ZO#^[K_@QQ^D\
M$8;-9CT>/]G3_%C_ -']LF]*>DS9\LIT)<?,*63#[IIV4H0/BZ;6H'@85 U#
MP+2BJG3>_P"I<M1$1$5-Q5QX[JJ^EL?])XINYRG=C4W4_P!.W==:9;=/;\[[
MN,P$6,Q$:55:CM-L-J7$E%H4!+KY[)QKS,IN9GS>OC%1$>3;49% H% H%!49
M#;6'RN=Q.X<BPDF=A6WVH#3H@XP*R5 B<42%5UBH)H(52W&M^'/GAAEAC-1E
M5_!S<G;89\F/)E%SA=?&M??HH9OAA@ID%N ,_(Q6Q7) \XP\WS'XN;>Y\R*Y
MJ;5.69(EE1-8VZ:Z<>_SQRNL9_+\)PBL9Z]?N<F?TWCRQVWE'Y_+6,YO+&=.
MD_/VM$OPEVW+?%_M4QL6IDF='CER7V&TG(VDEA&WFR0FG%: D0KJ*IP6U98_
M4>2(JHZ1'C$Z=)T\8M,OIG%,W<]9GPF/56['6.DU?L\--&PO"?:I-RFD=FBW
M+!&W!1T+((Y-<LB"G+X6?73_ ,'#IXU/]1Y=.FG_ &[/P^]/]+X=>NOM_P _
MZG_5]RTR&RX4[*Y+*L9&=CN^VD9SD&(;?99B"TK F0N-FH&C:Z5)M4U(B7K3
MAW66.&.,Q$[?RS/6/'\?-TY]ICEGEG&4X[X]4159:5XQI->5.>R7@MM+*,HP
M[,R337(C1' ;?;47&(</L((0FT0ZN6FK7:XG=1M>NK#ZIRX3=8]9GIXSEN\_
M/[G%R?1^'.*O*(J(Z]8C';K<>7WZPWYGPHP.0AR48)\YY.Y"9$1^0K3(R\H;
M#IFIMMD8HV<=LFK(NE>E"2L>+ZCR8S%U7IB=/#&X^^YMGR_2^+*)J[]4QKXY
M3$]:N*G&)CR5^"\'(,=UG,[BFE,W*4J1+R!M"V_%?"1*24+)I(:N7+-+HZ(
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M95 LB6#2V-D6_P ]<')RSG&,3_3&V/=U_B]/CX<>.<IC^N=T^^HC^"PK4WE
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MP.$P(2&\)CX^/;EO%)DC%:%I''C](R042ZK06- H% H% H% H% H% H% H%
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MH6%@&C[C\I14U!LS1I- @*F;AH(@**JT&N)/WX<B.<["XYJ"\8"^VUD'7)+
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M5E,N.,O"XR) ! 8$BBJ"1)PZ47C66'/GC%1.C'+AQRUGJS+;^)<9>9?85Y)
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M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!04VZOY&_^TC_ZANK
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M)B)@2$!(BB2+=%1>A46@]H% H% H% H% H% H% H% H% H% H% H% H% H%
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M51A1QNHDMF6TZP$IBO >D2521?(2JO34W9><_-=F/E#R1C<9+DMS9D"-)FM
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M17]4]?9'E_-WX>N;\(^]TE<CI*#A7-M9AS+Y',S0"1&R[<B#-@,V;?&&V/\
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M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0<UNW^1Y']@=5'1AZ _,E165
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M)8[1R_\ ,J"NW6ZMHJ#;R=*JM!MH%!3;J_D;_P"TC_ZANK F,^@Y\Q4$VH%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M*Z9!),W2U:BY*HJC^B*C?SJE^-+&;&W-V,]A3OUPF %%FB!7(W>8JH0*8*B
M(631:RT&;FW-Q#*F''RK[<5]R2\TTT]94-XE(;JX!V&RH.D?1TW3IH-36UMR
MA(5X<LK26D.*@.NJAR'7"<;54)%7EAKMR[VI8\9Q6Y<A"SD*6\0#)1AN"_)<
M(DY[7]XX(6N &5E$45:#-[;>ZE;=C!EE<:-EL8[CKAD3,A!'F.&BC9T2). +
M9!_+P"/^%-V)(F/,9@HR3%151MU2/FBV#:N$1@O5+1P!/0OP6]+&R7M;="]Y
M#"RB7FFV++CSKI\MAK6B HJBHJDA6->E?R7I8\F8?=02(6.QDMQEEF.V!R0-
M08!MIE&U:0%1=1F::D<Z11?DH-_X<W"@\R3G7T%"4E57U"P$:+9= "ET!--_
MRT$=G:6Z6')S\?,C'>D)S(ZM:N6,HR%3<<#2B&B]>PKPXTL;GL3NML<;&9R#
MKCR)+)^0Y(01%U>7R541!%=!+&NA?(O%>B@UAM+/R90RLGDB,Q>5UM6GG Y;
M8<Y6Q1$2U[N^ETZ4T\:6,&\#NK&PVKSB=%F[LQN(1BKZ'UG&FPTIH(G%5SFH
MM^.FUJ#W&[=WF49E<GFW4?0%(@1VPH2M$C8JH@BJK9J.M;V/I5*"?CL/N:'C
MI4:1+"1/-O2Q)%PVVA0CN0HV(II)$5;.)T\+IPH*[';2W1!(W3RRJ])=!V:3
M!J"'IU^B)BHBMR$R5$Z]M*T&;NU]UO<EN1EN<RPT%_M7!)R0B$BN$J#T==;C
MZ*I9+4L;@V[NU4'5FB V630=+A(+LI=.AXATV$$1%3DI<;\>-!(=P&X9(0!<
MR1,K'YR2";=-'G )5)I"<0;JJ+IUVLBVX<*#3D-KY[(2&ICN09YX1&X+K6DD
M!T%TN/J2C94UN B61/1^>U!HR&S\KD')3L5YG%M3 90H[*JO*<A*AQS A$4N
MAD9$FGBFFEB\P>.RD%QU)),,0DTHS%C@BW4002,C5$)=2IJ2]U\ZK15XJVXK
MT5 145+IT4"@4"@IMU?R-_\ :1_]0W5@3&?0<^8J";4"@U2)$>)'=ERG08BL
M 3KSSA(  V":B(B6R(B(EU5:RQQG*:C698Y91C$S,U$.?VMX@[-WJY*9VQEV
M<@]#_P"8:!# Q%5LA(+@BJC?](;I77W/8\_;Q$\F,XVX>T^H]OW4S'%G&4QU
M^TNEKB>@X3=,Z7,WIA=HO9)["X:?#DS!DQ7!8D39<=QL4B-NJEQT@2ND@=<D
MZ%TH5!T,&)#VEBI;T[+27\<PKDMZ9E9"/*PT@W).:2(N@42_65?GH(>-WW@L
MGD(V.09<-Z>A%BW)\1^(U,0!UER"=$454%-6E;%IXVM0;,IO7$8S(.XEMJ7D
M\I'$')<3&1G9AL YQ!75;11!23B(DNI4XHEJ"9%W)B9DV%C6G' GSX9Y*/&>
M9=9<[,V;;9J0N"*@J$X**)6+Y*#>F:QRYH]O(ZJY<(HSRCZ2_P"6-PFD+5;3
MZ0JEKWH*?$[_ -KYMF1,QTHSQ42,LN7E7&G&8+0BB$8&^X(@C@(MS"]Q_2M0
M>8W?V!R<Z+!$9<0LC=<4_.B/Q6)E@5S[ W1%%72BD@K8E'BB*E!T<F3'AQWI
M<MT&(L<"=??=) ;!L$4B(B6R(B(EU5:#F\=X@;?R4R'$!)<4<EPQ,J;$?BQI
MBZ5.S+CHBBJHHI"*V4DXBBI093M^8&'/EXAE)60S,$T"7CH$9V3(;$FP=0R$
M!L@*+@V*]E7@EU14H+"+NG;\S +NAF>TF!%MQUR:XJM V+*J+G,1Q!4"!142
M$D145+*EZ")BMXX_,36H<:#DF@D"IQ9DF!)CQG1$=5T<<!--TXCKTW\EZ""U
MXF[1D1)>1CR)#V+Q[#DG(3VXL@H\<6CT&#AH'!P>)*WZ2"FI4M0=!F<YC,#B
MGLUE'N5CF=&IT!)U55TQ;;01;0B)2(A$4%.*K05.0W[M^#D).';61/S<0T!_
M%P([LB2**TV]K41&R!I<'KJJ"J]5%U):@KL[XB8YC8F8W;M_F378#,ML6.S/
MD;$Z,T9<N6R@BXT@$B<S6@V1;WLJ+0>O;I'*8;$3VY\S;YNY''1W3DXUP5E'
M(,4[,(2 N@/*6GFCZ/GH+?,[PQ&&G#BE"3/S!-)(7'8Z.Y+D PI:4=<1M%0!
M545!4U34OHWM0>-;VVT]MZ3NAN;?$05,)QJVX+L=QHD%QMYI11P#!5ZPD**G
M3T4$:/XA;;D3XD+7(98R+O9L9DGXSS4"7(5%5&V7R% (B05T>0_T%*@ZF@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'-;M_D>1_8'51T8>@/S)45E0*
M"/.;D/0I+,1SDRG&C!AWU'"%4$NA>A>/10<N&#W<V:ZLN3P=8113T()*B<IW
M@*J6CH,%X'T_)51!FXS>JO,1(TUT$><$A<%U2&,P(JCJ..$W]J1DNH.JBAT)
MT4$B1M[=G:7^R9+0RIH<60CQ\Q ;32+;PJ"H=T5;EJO>U!L9V[N3GOO2IR/N
M+"DQ6'772X+))H@30((**V@$*N)Q+@JI08MX+=\7"P<9CIS$1V*Z5GU4G%[.
MED!#1103)4U*:V1-=E&R<*" [LW<KS1-A,!K7D.\&M;[CG*!2ZP&NC[4E3T2
M6VGH^6EB6FW-W,1R8AY/ED38-L/$\9DT0-BV9GJ!5=4T'JZO0Z>-!(+;^YCR
M49'<@#N&BR4=%MTS-TV0,'&T-5'^\$D+K7XC9%H-&2VWNS(!*C=Z(,5S7V8'
M%UV7FZT5ZPHA):R(@HED'SJJT&Q[;^Z)$9R/(R3CRF@D!B^4?0X#J&7]V-R%
MQ$ZMUZG1Q2@)M[=#SD=)^264R$EA]T5-6@16'Q=,D$ 76)B.E&R6P+093,1O
M-X!:C9$&'.:X3\I'357&SNB((*"BW852UKV)+T'KN$W8A/-LY1591U%C.<TE
M-(J+_=$BC97%]+FWO^C\M!JRN.W<QAHD6'.>D9<B<$I(%I1'C=$FW7%T:>6
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M@[V'*,!.<!(CQM\]&[. (-!J<,2TII4R$105]8E3HH,>P;Z VU[8+HGJ-SK
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M!?M )=5_1H(\L=\8^\AUWM )$ 4-E *2<YQ-2@(H&CEH:6ZP^CY:"RC,;U"
MO:W@=G$+#A"*MBG,YIHZTBHB:0Y:-];B5[]-!7)C]^($2.#I($40(WG9(F;S
MX*7%Q4%+MKJZPV2XHG&]!,FPMTS\*,(C=#(MNH3KH&VRCC3C9IHNBEJ0%(=7
M1>W"@Q2%OMITX[4MOL;9 $5XT;-TF;@AJZJV37Z6E1'HZ>*T&PHV]"Q@D;C9
M907C-1'0(H'*)+"JJJ*A&O!2XBB]%TH)4C\7N3):1@;CQ5A",8E,7529<%NB
M$*<$133BEELBT%;W=O),E!=10*'%=>-XE=1")IS4.@!Z%-;H>L^"<11.A4#:
M[ W4_F8\R65\?"*6\C8&.@W2 ACJ+8I<A$>E#6^OBG"@U01WVZPR_*(Q8*,V
M3D=%CA,60=E<ZRCH&R^BGD&Z+QM0:67?$%Z:XR#K6J/&<62:@*12FK_= TI"
MAZ=/$N/I>6@E.1M[*TK6I'T)$15,FVNJ8&BHNA25="Z5NB]=?5M>@S88WRK@
MFZ\(-M"!*TJM*CK^MM'>*#=&M&OECZ5^E>B@VPXN[(^2L3JN8XI;SFIYP'$2
M.XZX2BJ:4*Z"K8M(/H\=5Z"NBXWQ A1V83$MLF6H@H#SJ@XZDOEKJ0[Z45M"
ML@=*^5;I02'XV_6AY,5X)"&2HC[IM@38BZ0C=!!-6II455Z4-.B@C.8W?:A"
M:9=0NQJV?,DNB:DC;6E-2@B*3BDIJ:EU5ZMDX4&#Y;[.4$%I4)Q4=<;1W0K(
M- @JPD@P%+NZT+5RUTJ/DH)SL3=TJ?CA)M6\8PZR]*)U\%=(@-"*W*1$MQ)-
M/0J6^:@P*-OYJ*1"^,F4;9)H4F6T!PF5)"%4!+Z74%$15]&]!7/,[\QJ2$CJ
M*RIKH'$%M4=^W,D5U7-:**,BA%9$5%2J+0XV^TD,16WQ['=!D3R)I7>6:-*:
MH&A!0Q7F(/"UJ@]%=YL@ /FBS79*1VB% <8[(9$G,)$%%1UL$UDJ]4EZJ=-!
MG-:WR_E)2PR;C8QL#*(BD!JX^(JC:'<;HV2HBFB<>FRT$%W"[NDL3S<>=;D2
M7HY((2 %% &"!U!L-D;4R0D%>LJ>6]!*6-OB,R4*.ZCC:*(L2R5HG1:;:*^I
M"0=1&:C;S(GYP\S3V]@DP.P1U"":QVIR,.-NN]=4YB@K@H@Z>LBFJ=''@M!H
MC?\ 4.0KO7;9<;D.@X3H@C1M-MW:Y(Z=5E/@9%T^3A30> N_W9<N.TI,M-K'
M[*Z_R21&#OS4)1&QO);@H]1.'EO0>E"W[S&QCD#+,4%5I.<A"Z_9P1)Q+75N
MQ(I!ZR(MZ"5D(.[)>.CPR<4U-HN<8&#+@N\U%!'%2]Q1NZ*H+=2XT$=8.^VV
M6R!QIQU'S)65($%M@"L"-K;B:@I?WETU6OT4&[LF\7\PV_I!J!%;=[+SGD,U
M>)DVP5SEHET5="DGD6]KT&:,[U,FQ U:$B:YAN&P>EI5%7DL(\7+ZN6J=5!\
MEZ"(4#?CJLG+<;D+'=;>1MLQ9UII)%12'H(5);IITEP\U B0M]MISI;BN2'"
M,GT!UNXHH@@ PA)I!$4$5S5>_'2O&@FLQ-YE =;FOM.3709-##1H;?&0NM&Q
ML-P1I!44->*]/2M!X^UO<V8BL&VRJ,MC+:4@<+FZSUFA*@W72@+:]NE.-!J)
MK?O(L!CV[EJG,4FN1VA+HIJ%M7*4;:!3K(7I72@].%OL3Y;,Y%90)!(Z:,JY
MS U)&%4T(EBZJN+0>E#WT<[D]L!O&"^ "^*-J^<1"5"4M261VW&Z!:WRT$,8
M&_SGLS7' ;=1DF)6DP-JZNH0$RWU>@13FZUX] T$B)C-U*F5>EJ13W&HKL,B
M>%&EEQ+D0"((B@TX7#C==*K>@U% WRCCL9H@[O%HC1''1(W9*JI64K7$+KT)
M_LH$F%O^9#FCVA(SAN<N*RTXV))',B(R5W22HXB:1!>CSITT'48GO- DIDTZ
MW/-8QJ0J1,K91N@\!5/1Z5O:_EM458T"@4"@IMU?R-_]I'_U#=6!,9]!SYBH
M)M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*#FMV_R/(_L#JHZ,/0'YDJ*RH%!HF+*2(^L% *:C9+
M'%Q; KENJA*GDO0<@;6]H_;)L$G'BE6%MB4C DTH,(B.:054_O$TJ*+94X_+
M51FCWB )1N:RVH$#A3^7RE4-1=5&+KQ(12R:UL5^-J#Q&]^@3[3,A";(W"CN
MOM-$>DWE6RZ2$1TMJFC@O&Z+Y*#$/QZ+B-QU%ML%Y:I(;;=!23B+B$!H2@2K
M8D7K"G&@S$=[,1);[#:NY&1,9)L7U:T@R#38N(@BMD%20T%;ZOTEH)+@;PD!
MC^4:1W$=<":^HM*:L<P5$Q;55%%(4Z.LHT%<#7B"YD6ICBMQT)A&98H@.LMN
MJYJ%600T4AM;F$:W3]&@W1&_$ &FV'7P4FT;$G'&VB,Q0%U$I(2#J4TM;3;1
M94XWIH/78_B B,@$D'"4T0WU!D5;%-(J2"BHA*J$:V7@BHE!D1>(+DP&11IF
M$ 'S)%F2,S;0^79%6R<SJ:^'5\E-!F'XV9Q<415'<HJOE(UHTH<TG$)H%7A]
MB@J2:AZ_ ?EH($N1O>.^Q!(N8_+<;1$; %0FN39\G%1?LT$M.A07YZ"Q;_&7
M=LJ)(L[E'&6W8KXBVVV#NNSK=Q*W52RA?IXT&"1-Y06($:&\"L-LL#,<= 'G
M5?)7"=/@0WXZ-71P553C01(DSQ DP0?;;'FF!* OMMM+VE"6PF.KA'TI="3[
M35\E!O5OQ 9?-&7VW6S$#%7VVU'G<AI%;1&R'2VI(YQXJA6_1H,XR[LBXN>#
M#+KV5<FD]'<E*TB=G=6XHJ"JCPTZ2$;:;WZ:#-AK>LAN5'R3C:"Y%>1L61$5
MYIZD!$<$NJHJJ>1;IQZ;T$&#'\0HNH'5:!IY]3)Q;2" +:432IITDB7TK9!O
M^E02\8YNT,8]'*Q.0>1' TTD\XG5)Y45S@1MHJ@BJNDU2]!I=#?T%AX<:@S#
M>-^0PLE6A5M5?<(&BLJ7$FR%;WZJI;HX4$E"WNDP6'+=W(VV#LL!95]7]*(I
M""KIT*2W)%XC;A>@BM->(11DCN/-ZA! U&#>LQ2.5B)P21$,G4L>D>"64?+3
M09MN[^(U<2S;!:B%AYIE701#5%#4!Z5) L39="DJH7"@S4=Z1<?"8ABI/J[)
M<F29"-.&C+CSBAU$(4UH"BJ()6\E!Y/B[U4GYF/THZ^S$!8;K@*T+H@XKI:A
MLJ6+0*Z;73R4$;&%O"?DW<FT\2Q&4",T#X-MM.JKC7-6PK?2%W-!)95M9:"4
MPWOF+)EJB,N1@<=?C1^!<]#<(M"ND5V_2ZB6MI2W30>-1-[ON/+,D-H^$:4R
MP;*<II'S5OEFG6)211%;*0W K]-!FWC<[VMMS'*_"Q@NPR=AR#1QP^6Z:R"U
MJX2HBBHWMZ5![.<W\CB-06V5%'2;1XN6J$PE[.**JEBZR*@]'5X]--!AIWZL
ML(K>AF'K/G3%Y3AJ.LB$@%5LBDBZ21;VMPZ:#9C_ ,;--O#)TO2#9D&".\M&
MFY!&I-")"MR#2NE$6VFW%5H,"D;R8@9"1(UK9R&WC ;:9.4K+CH(\9BA:.9I
M(N'HHB(OGH-3B;_>)A-0M<M\7'="-()QA)>6*W55UEPYZ>BB>@O10>/,^(3\
M,_\ ,BV^J-!9IMELAN1J\2*2G=11!0/(2+Q2@W1&MXNY2&,MI Q3!$Z:ZQ$U
M/[9!OI+BBB07#R*E!B [_9!M7WA? M/:5:;81X$Y39%RA54%2YBN#U^&E+]/
M2&#[OB"X",!'95PC3FNW &^68V(12^I%;7BAZNOYDH+!P<_+Q8M2 =22+[9S
M@%6VN8PA?:-,$!7M9.JI*BJG"Z+00) [V67_ /JEE(F,C@O8X[Y-FIGRC$4>
M6ZEHOI/@NI"X75+T&DI^]DR#,$#5VPF[*5MAH5&+I'EDFLE3M"EJ31?0MK\*
M#:/X]!6G)(W>=)=?948(&P!PB0%1POTP01U_HJJKT(B4&# ;^YYR92KI(K\H
M.2O+8$7!U-I=$5XKBND^I\U!-B?CP6I)RN03[@R$C-6;0&U!6T86XK=2,=:G
M?@A?)01&X6]5[?.0U*6\Y'&"+Q-CHC-":JI@"H*&I*BF*+:@VNCOM'"810=Y
M3P=F>5&P!Y@;*9/:%11._HB":53I\M!'AQM^@<EL7^5'D2.9'>>!IU]&7'0Y
MBFB'H A"_+%$4?/QH/'V?$ XKL6W,>E/N<US4T MQ2;1M!:4;$A);F7]9;=%
M!(=F[S.1E!QS.MEE\V(O.!L!0!!M6S!56YW+6)ZK<.*=%!&AQ-^Q *23RO27
M.0U*;<Y1(@ZG5><9Z$4@%0%M%LA?I4&)Y'?I36X3*!SA$W)2<ILA;BZA1HD6
MZ(L@DOJ"^CIM02R#?H.L&X;;[2\XY!-"VV;::B !:!2L2J%C1'%5-72M!+R)
M[Q=R,-C%HC.,(6DF2W4:)U$54(C$5X(72*CQ3RI05+L+?4\9CLJ[4HH),M--
M.-ML)([0)-J!(6I55L>NI<$6Z)PH/4B^(#;4F,BMHU(=?('-2.F@N F@5531
M1Z^NZBMA'3;RT&X)FZV\=&;!3)1F-P$>99!QXV6F7%<>)'504NXB J^8;IZ2
M4&MV-OW)N$,H^PLZFA 8RM$B*I,FX2J7%4#0>CSZK*BT&<F;O>$T;\Y1;C-*
MXC[C#;3A\A%(6"9%5ZSQJ@\P2ZB(O5H,H1>(<@6G9)M,6;5QQE&012/EHK8*
M1$MM2W1SA<5Z%M303();P:Q<GGMH678TE%CJK:QW0$EL".W4M1#P)2Z%Z.%!
M%=_'YNR10&RC,V*.**V!/&*M]74B]45L9(MOD6]!J-OQ$D1GB-P65YK8,@TC
M(N=G0S(W%5=2<S2@#IZ.*_D:";+D;V3'"D&.#F1[0ZB..JV $P)=34%^K=%7
MH*]Q_P!Z@T2(^]G\?D&)#UWQ6,L18P-MNJ(/-DX0DIZ%)00K@26OPO:@+)\0
M$<-0CM$  G*$N6G,<0U1-9(O4$@5".R+8DL/3>F@\98WO(E8U9QHK+3_ #GN
M4(,@H(TZ)"]UB);.*&C1P(>*\4H-L1=]G*;<D* PVT;5QHA90G'"= 7DN*K9
ML0UJTJ=9?TJ",L3?D8YDF$^DA\G$:;;E\KEJSSGR4QTVLH-DV@=%U]*@ZW&=
MM[ QWB:.3=/VQH'*NO\ PZBLMNGC45+H% H%!3;J_D;_ .TC_P"H;JP)C/H.
M?,5!-J!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0<UNW^1Y']@=5'1AZ _,E165 H-$PI01'SA +L
MP6R6.V:Z1)Q$72BKY$5:#C0E[X[8^Z#1\@F@%A7F4T*(*XKCA-BXJB[Q%!!/
M3X+YZJ) 3]]$XKI0VA:'G.%$T7=^S%"::YNM 7F)Z1"G5/AT4$>=*W\Y&FM"
MTVVIBX#"QFE)\"(55E14C0"U=!K?J+QZ*#W/.;T?D/1,5'<&.PT!,O"8MJY(
M1/14]7$"OQX72U!DW(W[VP7"%A&7B;!PB:=5MI!5Q5%&]6I;JNDG$X:4%?/0
M9WWM%DRNS\MQAZ69"]);)Q0:)QU 1!:.Z@@BT/!+HA*7%:#2WG-ZK(FQ@@(]
M(:!I&@)KEMC)=L1#S.9UF41#1'.GY*#:$W?PMJ^;#+J)RQY+;*MF@FAJZ?VC
MB7)K2B"*60[]-!N7(;GD0<EV-M'I,(VFX9Z>4KYJ0N%K%233H%=!C?BMZ#5D
MAWJ_";99>)I\2=:-YAML5<U V31J*FJB@EK3@7DX]-!F^[O5]C+L& -*VP\&
M.5@51YTQ6S3J&IZ$(K+=M>CAQH-$J3O.:P4 &#81Y]GES0;$3[$B?:DXBG87
M%+AI3]'CT] ;,5*W1'A2HACVJ3"::)R0HHKIOR20W!0=2"I,AJ6R%8KBG#C0
M92,GO-O6D6$KY*0H"N-"V"(CB:;_ &EUYC=U/@G++A0;TF;H##118;*3F&C)
MF9SV1;5P]"J)(J*(("*J7+R]"<:".])W=DG";::<QS2RFEAN<H54HPN-\PGO
MM.JJ)K1 _23\U![(_&DB3"=:,HJ<AIU]E&VS91\&Y*."2ZD)=1*RB)>R=*=%
M!LQ62W4[E0>S$5R+BS!&PC V!KVAWEJJ.&*DJ"VNI$-.J2=/%*"+C"WO%&-$
M=!73<>U3)+P"6EEQVZN(J&B*:)U-")9!1"H-CR[W8FS941>U(V9A%AOB ,&V
M;_474)(J:&UO>URZ%H)9.[P<;@BT;2$07E/=G4;J;XAZ#CB**@TI&O3<D\U!
M5'FMZ'+C-'CRCJ:$KPB*.$  TJ.$ H>D^OH4$)?TE3BJ4&UV9O=LVY\Q B,-
M(\<EIL1<:T@)*V)7(BZUD4B'BE[=%!NRDK>DC'M!"8[/*EQ=2\L1)67'E)3$
MC(TL;(:-'"QE>@DY&7N:%SV<9%)]6>0W"'0)-FV@HI&;BFA754(%3R<"XT$=
MS([V70#,8!0BLX^;*Z0%#)-: AZB0^II'TA&ZEY*"8$W<:8J4Y(9-<DR:"TC
M#(Z'>NO6 3-2T6X*A=:R7\J4&G+%N%X<:[&%X7N6A90(NH!Y2VYB-<U4Z_3I
M14U=%E3C01<8WO:)/B%+)9D!]Q>>)J@FR)ZM-_\ @;THOK'\JWH,TRFY8.)?
M>R#:M$R;5WT;YI T8DI((*=W#$D%%6]E0N'0M!IBY#Q E, Z;##"N-D:@C)*
M8$H"K?$G$%4*ZJ2=(DFGY:#R<>_$<8<8;YI@I+U4%MNQGIL8(YUM(@A]*>DJ
M4%A#E[M;R:L9-&AQH.(RR\#!FY(%21$<702BWQZ1+]'K4%9):W9-<=7&O3(+
M3SRI&20*$K)"X*.$Y=>LVXUK4$2^DK6ZU!,QY;L&!.CY5M?LT5&Y#9.$\2*/
MV:-HVJ*NGJZUN*]/EH("1=^.(!M/NLS&0+G-O*!,N/*2(TH**6TBU?6G0IKQ
MXHE!:Q9>Z5DXPWHBMQW6V0FM>F2*I.H1:E*PJ(H!E>ZK?2G&@B-2=\M-"KK-
MFC=>;<TMBZ\RR'$'117/M"-5TZ>%DX^3B$>*]XB-M1N:#>N.TX!QR#4KKG)L
MRKKJDJ*BJFLN6MT/J]%-!-![?3FFZLB&I/M!CJBDVI,C?2;B*)()NFJ><+='
M2&IB9OD!?DOP^HC@@D4$$S4'!5"=$B.R(VJ(NBW&ZIYJ#R/+WZ\4!V8R,=IR
M8*3&F&P50C-Z4OUS)51U2)5MQ%$_.&4B7OMXI#;40!$4=(>@+NBOV30'KXMD
MEE)Q4NBW2U!#AY?>V1FR#A-H4-A'!1XVM FZVTCG*$5<LJ*Y]GS/-^>@NW\E
MFE. 3<=XX+[1N2^2PH2!)-2H-G%TBBIP3CJO;R4%*$;>,@&U8?EQU4B>$7U3
M2D?1]FP2^DK@O>D?E!/,M!-"5O0(44WHMYC)/C)0;'SD$VM*B.I$%3NYH5>J
M*)?HH,\B_NPLBCD9IP(\=UU"!L1(%CDW8'$ZWVIWX\OA9?[0TKDM^M,&\< '
M'73=!EH!'[(6M"LF?VERYR70T3T%7Y+J&#:;ZBQX\F,*ORTB1FW84HA)LGS>
M=YIDXA(J*V"BO!.MP2@W)*WV*$^C;4@&QU-L@QRB>0 ;)$57'+@1J1BMTL.F
M@UMSM\JZX\XPHL$J TVC(*J")N:25-:+J.X"?&PBFI$H-$+-[ZF0&I0P14W1
M-5'EZ+2A)11FQ'?D62_/Z?DH) RM\HP8N, 72T$=L"1^W*+0?/(]'3I(UZ47
M@E!O.7N>3BE9076<FQ)#M#K;(HCL4B5%Y8FJJG#@O'4G3YJ#2Q(WQ%8&/(;Y
MS<=B,)2A:%Q]QTP4G%T<Q$72:""_(2EY*#1.W#N^&P!RX21R%M!<5IKG\R:3
MBZ&FAYB*K:AZ3GDM^8)<-[>4#%@T\WVZ6UV8A4Q1''4<0N:TI:U%-"H/VI>2
M_"]!BS*WV^[8VVX\8="*XK JX1&I<VPJ[P%NP\M?TT6ZT$B',WH['5R9'89E
M&_&0HS8$7):);O6<(T%SJVLJ=!*MTH(C.1W\]UEBLQFE?0!)YHC-&EU$A$#9
MWZ=(';H3K)029<W>P2IG98K#C(O:(S.DD7LZ+Q<YBD@D2CQ0/6X+PXT$.7E]
MZ1VT?5D0C_8B2)&)V0I.O"VZ@")Z;MW3EZEZZ76@R;E[W%QQQ]HU C/T&@+E
M,J@<K0"&.LB4>OJ6X:EZ41*"5!F;T23"[RBM\I\T*6VR"?8W(Q4$-35%$$03
M4E2Y7LE!I69OIEIQYR.#RD!Z6FVA10(D<45_O%U:%%M+?I:EH,F<IO"3C9#K
M4=@9C#S492TD8]"$^X@(MRT*7+THO2)+=>%!J.;OKFO*41-(@@1E9%$1S42)
MJL9J@'TKU^ BB<;EP#I<(Y-<Q<5,CK7(-M $IQP!;4WA!-9((\$12OT5%6%
MH% H%!3;J_D;_P"TC_ZANK F,^@Y\Q4$VH% H% H.9W#N;(XS-XO;V'Q89'(
MY-B7*0GI*1&6FH2LB5RY;JJJJ\-D0:!@-V/9++2]NYK&GA]PQ&AEI%5X)++\
M-PU;%YET$'4B$.DT(1(5MPLJ+0=-0*"AW%GWL+.V[$:8%X<UDN[G2(E%6P[+
M(D:QLG%;LHEOEH+Z@JH6?AY.%D)N,!V5W<_*AN,B&APY,(B;< ->E%ZPJ(K>
MR^>@EXR8YD,=$G/178+LED'CAR$%'F2,4)0-!4DU#>RV6@E4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'-;M_D>1_8'51T8
M>@/S)45E0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!04VZOY&_\ M(_^H;JP)C/H.?,5!-J!046]"SX;3S)[635N(8CRXU+(J\[2
MMM*%P4O5OPO:]=7:1QSS8_J?DN+]SC[V>6.#/]+\]3M][X5_3E,\5I.XLNFZ
MBR3NW>22O'E^=<9W,'2C2O\ 61=.O6(\//QM7U7U[#LXXL?TMN^_Z:_+[:?&
M?_F\^^RY<_U=VROZK_-[+^-OTE7Q;[]\\W:68'Q(VHN#;BNS>[,S<9SCC37+
MYD"ZHK0&NJ]N%K4'-S,_E\,.^]WYQH&]_8'&M0H4%@5<@M0I1$<9UDR02>1U
MU/M5-!5%;T:41-14:9>+F0(+,[:VW]R%OJ*;+@YB<X%IIB8\X)=Y1 K;HZD4
M=%@X:$32E$=-NMC:.<SLJ >)R>X,]%; )"XUYUH("D*&VB.F^PRTZ2+K306O
MH5>&FBJ/%9>?G=M>$V3RCA/9!W,:)#QVUF3$'(-:CMPUKHN5N%[T'T(,OD,C
M+<Q,S;<]B ]S&'9SCL/D\NQ)J^RDJZB$G18+\?)4'#>'VV<+C,1NK)P6#9G1
M<IGHK#R/OEI:;D."*6(U2Z(*=:U_EJB(T$S,X?P@Q[V1ELMY.)_^LW67W&WI
M#0XE73 S1=77(4U%?5TV5%XT$Y=H8R/O]O9\5Z4QL^;B'<K,P827NSN2XTAN
M.)74E,0(7KN-@2"9"*DBV6X1)F;F>'L+Q%Q^%,W(.#C8^9@(SY'([*_E -GE
MBKI$JMBZVC@@JV34J<$Z C2L9,Q\6/.VGM[<B[VBNQS7+3W0M.TN!SPF*LH@
M4'0U<-%@6R@@V2@^L;BCY:7@,I%P,@8F;?B/MXZ4?HMR3;)&S7@O05EZ%^9:
M@^=[=Q.U\I S&U(\7([8WM*QJMY%B9)D'+2_428T]S2;D(+W'GMK=5X%IOIJ
MCUW<F0WAM';>WU<.'N3/2UQFX$8-67HR8@U7*J)!Q#4K2M O_P"E%:"3#V]%
MW5OG>\7<+S\W"PI&/"%B%>=;BMN.8]DG'5$"'42\$2_ >E$NJK053>=S>+V[
MD=L0L@\CZ;K#:N*RCQ*_)C0I?)>U*;JDIFTVX;;1'?B@7OY0[[$[#VSA9S64
M@QG4RC:$A3'94EYUU3'22NJ;BHXJ]/71>/%*@Z2@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4'-;M_D>1_8'51T8>@/S)45E0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!04VZOY&_^TC_ .H;JP)C
M/H.?,5!-J!0*!0*"EF;?&7NC%;E60H'C(LR&D;2BHXDXF"4E*_#3R.BW&]!"
MR^RH&:S4S)3W"<@9/$.8+)8U4L#S).JX!ZT5"$@UNBEO6OP5*#5C,)O?'#%@
M'N./-QD8@3M4J"19)U@%_NW'1?%M344LKO*X].F]!I3:.=QV3R[^W<VW!QN=
MDI.FL/1$DOL25:!IPX[BN"*<P6QX.@:"7%.'5H-6*\.F,5AMIX9K(N.-;5G'
M.:=-M%.0A-R6T ^MP5$D74DZ5'HXT';T')8K:61Q+^<BLY)MS;^9?ESAC&PO
M:F),]=3J(ZCB"3>M2,45O5QM>R4&,'8H0F]E-I/(_P &LDP"JVB=JU0EAW+K
M=3IU\+^:@M#VZ)[O8W9VE4-G&O8OLFA-*H\^T_S-=[W3EZ;6\M!"D['QV0R&
MZ)&3<65 W3#BP)<%1T(#<4'@51-%O<N=>_#2J<*##&8;>\#LL)[<4:;C8QAJ
MDR()+D7F07T''!?%M35."NHUQZ=-Z#HY[4M^$^S DI#FF"BQ*)M'D;->@E;5
M10D3S72@YJ)@<@QF0W=N_+1GW<7#?BPPC,=BB1VI!-N2'G"<==(B-&6^DT$$
M3@G&]!3[!QD+);EW%O\ @"8X;*N"SA4*X@X(@"2YC8^09+C3=BMUT;0^@DJC
MJ\3MX<7G,_FDD*Z6=>C/$PHH*,]EC!'LA(JZM6C54%0YX>P)..W#CIDQXASN
M3[Y9DL69?A20%CDDR::NLT<<7!)4^145.D)^)Q^\X\F.F9S<.;!8$A<Y, H\
MB0JC82,ED& *B\5T!Q^3HH.BH% H% H% H% H% H% H% H% H% H% H% H%
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M*!0*!0*!0*!0<UNW^1Y']@=5'1AZ _,E165 H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H%!3;J_D;_P"TC_ZANK F,^@Y\Q4$VH%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MNO!50:#LJBE H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H*;=7\C?_ &D?_4-U8$QGT'/F*@FU H% H% H% H% H% H% H% H% H%
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J*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tb_technical-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tb_technical-4c.jpg
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M%!04%!04%!04%/_  !$( ^$$9P,!$0 "$0$#$0'_Q #4  $  @(# 0$
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MP[5%/B2IH/OVF+XN38]TUR$A$#NEND2W&PUVBX\$4C%-55=$)52D",^R=_\
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M$3;-4^ M"%%_R5J2KSK]H"ZPKQU;R*3 ,78[1L15<!445<C1VVG.*? 8D/\
M-5A%[Z2P)#70'J;<7!5(TH"995>Q288125/I$2H//\1$*6P))J*N BHO8J*2
M51^HHHB"B(B(B(B(B<$1*Q5]H*[G_P#R'E'^$3_^&<H/S5K)'Z=X_P#^PVO_
M '2/_P"$-8J\A_:Y_P#J%:O\(:_XF15A$U]CO_W;*_\ =X?^>[214/M3?_59
M[_<(G_V%5@6'[/L21/Z8]5(41%64_!1MI![5(HLE$1-/A[*DCSJ [S$-4'<J
M)N+@B:^E:HV_"^S3U*N45J=;5MDR"^F]B5'G-NM."O80D**BHM-1-XO]F[J3
M;,KLLN:,%MF',C2Y"!+ G189> C(11-5T1/Z:FHK7VD?_K#?_P#JP_\ A&JH
MW?\ 9";!,*OKJ"B.%=-I'Z5$8[2HG\VY:DB%^UEG=W@N6S!;<^<:!-C+.NBM
MJHJ^!.$VVTJI]XB@1$/IX?!2!J+HSTB/JO<[@R[<DMMNM0-'*,01U\U?4T 0
M%5%-.X6I+V<."ZU15^H6.0,0S2\8U;)93H=L>1@))[=Y$@"IHNSAJ)*0_P U
M!Z$Z6_\ [K^8_P#5NO\ PP5!Y51=%1?@JC])RS''(N%#F#D]DK ,-)*2MZ;3
M'9J@)\)JO=V=N[AIK6*OS;=-''3<0=J$2D@IV)JNNE9(]T6_ G,G^SS;<0E!
MI<'[.R_$0^"A+04D,Z_!WM!+XM:BO&6(7Y_#<OM-_5LN;:9C;S['R346ST<;
MXZ:*H[AJHZH<.=F.5-0HR*5POD] #7BO,EN]J_R*6JT'Z3VBV1;+:H-G@CLA
MV]AJ+''X&V00!_Z$K%7?*DLPHSTR26R/';)UXU^]!M%(E_F1*"H6S.^F>?6Y
M6(]VMMTAR!3FV^63:'HOH.._H7](T'G#[1?3WIAC$"+>,3DLP+Y(D(V[98SR
M.MN,J*J3HMZDK>U43L[JZ]FM6$:RZ*NRV>JV)G"4D>6>V!;>WE&BB[_-L4M?
MBJC!ZIPY,'J1E<>7JKR766YN+M4772<!?YQ)%H)K$.B&:9U:&[SC;MNE1CU1
MQKQ@(^R2$H[76]-05=-41>U-%H)US[,/5)K;S6K>&\D -TP$U(NQ$U3BJTU$
M_P#:'LDS&\'Z8V"X[?'VZ#(C2>6NX$=;;C(2(OI1%]-2!%_92_\ JBY_A<K_
M #VJLC5&7Q)$#*[Y"EHJ28]PE-.H7;O!XD6@NN+=!LYS*SL7S'CMTN"^**NV
M8',;)>T'!TU T](K02Y_9AZI-J N-6\"<7:VA3 12+371-4XKHE-1A?:"L<^
MP9A:H,]-3;L5L:$T55$EC,^'/1?3WVRI N_V3<PL-EN5]QVZR&X<V[)&=@.O
M$@ Z4?F(36XM$W?E$44]/&I(]=$\R)@V3@HXYKRP540BT35=$].B5%>1/M@?
M\TX[\'E[G_C+5A'3]DBZVV!D]_B3934>1+A-+&!TT#F<IU=R"I*FJHA(NGP?
MR4D6W[7KK3^.8L\R8N-'+D*!@J$*IRAXHJ<%I U?]E[_ .K,/_<Y?_AU9%#Z
MEP9%NZAY3$E#M>&Z3#777B+CQ."O'T*)(M!ZV^RQ=(4SI>W;V'!69;9DAN6U
MJF\><7- E3MT)"X+\2_!4E7F#KA=(5XZK9/.MYBY%\2+ N NHD49H&35%3@O
M>!>-5&R>F\"3'^S9U!GNBHL3'B2/KV$C(LB1)_.NG\U0:(Q[_P!_M7^^1_\
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M]>WL>N@6Z*\3<F5(C.LM-L/M&R2[W4%-$0]=$H-\_:)Z47/J)98%SQT!>O\
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M?Q4H'D=G^I,_BI0/([/]29_%2@>1V?ZDS^*E \CL_P!29_%2@>1V?ZDS^*E
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MZZ3\)<NXW6:,>?;9IBTUIS1;336/C#NL.49C,A].^EN%S6;-+DXQ$O%UOKS
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MP7K&/72:Q/'\73Z-N\NXQWMETUB\QP^&C9]>,]TH% H% H% H% H% H% H%
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M[?.V&2^TVELE]-+?HCKYNC5Z?J6*F^WM,>/76O#)/5RZZZ?QVO1@B("@ B"
MHB"*)HB(G8B)7R;[5]H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M%2@^T"@4"@4'0_!A2C!R5&:?-I=6R< 345^)21=*RB]HZ)86I6W3$2[ZQ9E
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M;Y$Z8L-@6V[-&;;:1XFWS=>)&]2[F@ZBI%WJ"TCU6A2\>L%QM-IE2\AR60_
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M:<=LF*DZSS<T:7BVO;,]/_!LK'<5M-[^T#DD;*X[%ZEVNRVQS60".,E+&/&
MGN66J*7%=N[736O(S;B^/84G',UBUK=VL\'N;?;4R>I9(RQ%YK2O3T:Z5XZ-
M=9[E;6:85E-YDS[%CS87(V(N)-0&"O,EX7@57GGB)'0<74B,P#1=%15[:];:
M;><&:E8B]_R_KYIY8X=$1T:/%WVZC<8,EYFF/\W"G+'//'IF>F)^,0N5T/%X
MO5CI[>,P"$%LN>+MN3IUQ;:5B1,5HT0W3<3:1_(3<7Q?%7GXXRSM<M<>NM<G
M"(ZH^#T\LX:[S!?+II;%QFVFDSIU_%7,N"YN1.NB6SF$(W>UG<A8UYO@1<?5
MSLX[4T3=Z-NNO#6NO;S6)VO-Y;:?/@XMU%YKO.7STU_Z>.JS9G*Z?7*Y]+X_
M2<H3F1MW6*<?RI YS-L =7DE<KO(B:(IH[QTW_Y5<>UKN*USSN->7EG]7FZM
M/]/@[MW;;7OMXVNG/S1^GIBO7S:?U^+LP?%L6OMQZU3KM:XL^2W=+@RT^^V+
MA--_ES_)J2+L7<FNX=%U1/@J;K<9<==M%;3$<M?Z+LMMARVW=K5BT\UNG\>C
ML5_'[3'N_2WIQ>UR>U6;)[#YJ[:(N1&UX"6QXDP,21U?^[VBB$B+M_F14ZLV
M2:;K-3DM:E^77DZ8X?U<F#%&3:8+_<K2].?EB^G+,:_'L;TZ,Y;[YX)$O'E3
M%G)'GXYQH0[(AFVXNYUA/P#)5_[6O%>VOF_4]O\ 8SS7FFW".GI^4OJO2-U_
MD;>+\L4XS&D='SA?Z\M[!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!08L*V6VV\[RZ&Q$\2X
MKTCP[0-<QTNTSV(FXE]*KQK.V2UM.:9G1KICI37EB(U[%-ZG]/0S7$+Y9K,W
M#@WZ\C&!VY.M[2,8S[3NCKC8J9)M;T'MTX5Z&PWGV,M;6UFM=>'SB7F^I;#_
M ",%Z4TBU]./RF)X]?4G+#B%BLR1IP6N"&0A&:8EW5F,V$ATFVT;)5=04-47
M3TKV5S9MS>^L<T\NO"->'<ZL&UQX]+<M>?2(FVD:]_2J-@Z3QV,KS:\Y3'MU
MZM&32HLN#"D,)(Y*QA=15,7@44)=Z:;:[LWJ$SBQ5QS:MJ1,3.NFNNG8\[!Z
M7$9LM\L5O7),3$3&NFFO:V ]9;-(BQX,BW1G840A.+&<9;)IHV^ $ **H*CK
MP5$X5Y<9;Q,S$SK/Q>Q.&DQ%9K&D=$:=#L8MMNC2Y$^-#89G2]OBI3;8 Z[L
M30>8:(BEIZ-5J3>TQ$3,Z0L8ZQ:;1$:STSVH^'A^)VZ<Y=+?8;=$N3R$CLQB
M(PV^2&FA(IB"$NJ=O'C6VVYRVKRS:TQV:RTTVF&EN:M*Q/;$1J1<.Q*".V%8
M;=&'GC,T9B,-IXD/DN]T$[Z:\"[4I;<Y;=-[3PTZ9Z.PKM,->BE8XZ]$=/;\
MV2]C]AD75F^OVN([>XR*,>Y&PV4IL5115!=4=Z)HJIP7TUA&:\5FD6GEGJUX
M=S9.#'-XO-8YHZ]./>Y-V*R,VX[0S;8K=I<UYD &&QCEN75=6T':NJ]O"DY;
MS;FFTZ]NO$C#CBO)%8Y>S3AW.%IQZP6&,<.QVN);8CJZNL0V&X[9*OI(6Q%%
M[?35R9LF2=;VFT_&=4Q8,>*-*5BL?"(AR"Q61NVE9F[;%"T'KOMXL-I&7<NY
M=6D':NJ\>RI.6\VYN:>;MUX]ZQAQQ7DY8Y>S3AW,UIIIAH&& %IAH4!ML$00
M$!31!%$X(B)V)6N9F9UEMB(B-(<ZBE H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H.+C8
M.@33HH;1HHF!(BB0JFBHJ+VHM6)T28UX2Z8,"#;(P0K;%9APV]>7'CMBTT.Y
M=5T$$1$U5=:RO>UYUM.LL:4K2-*Q$1\&'[MX[M(/*(6PI"32'PS6BRDUT>5-
MO]IQ^7\KXZS^_D\T]&G3/1V?)K_Q\7ECIUZ(Z>WY_%RE8]89URC7B;:XDF[P
M_P#9)[S#;DAG354Y;A"I#V^A:5S9*UFL6F*STQKP+8,=K1>:Q-HZ)TXQ^+%F
MX9B%SGI=;CC]MF7--%2;(AL.OZIV=\P4N'\M9TW.:M>6M[1'9K+"^TP7MS6I
M6;=LUC5)-VVW,S7;DU$9;N+XBV_,!L!?< --HD:)N5$TX(JUIF]IKRS,Z1U-
MT8ZQ:;1$:SU];!/$\5=F2K@[8[><^:"MS91165=> N*BX:AJ2+Z4):V1N,L1
M$<TZ1T<9X-4[7#-IM-*ZSTSI''YNRXXUCMX8C1;M:(4Z+#5%ALRH[3S;.U$1
M.6)BJ#HB(G"I3/DI,S6TQ,].DLLFWQ9(B+5BT1T:Q$Z,EFUVV,[*?CPV&7YR
MH4UUMH -]41417%1$4^"_?5A.2TQ$3,\.CX,XQTB9F(C6>GX_-B6O%L9L<AZ
M79;+!MTN1KSWX<9EAQS5=5W$V(JO'X:V9-QER1I:TVB.V9EKQ;;%CF9I2M9G
MLB(9;%JM<592Q84=A9Q*Y-5MH YYEP4G-J)O5=>*E6$Y+3IK,\.CX-E<5*ZZ
M1$:]/#I^:.EX9A\^)'@3L?MLF#$55BQGH;#C32DNXN6! J#JO%=$K;7=9JS,
MQ>T3/QEIMM,%JQ6U*S$=$<L<$Q'CQXC#<:*T#$9H4!IEH4 !%.Q!$=$1*YYM
M,SK/2Z*UBL:1&D.RHR*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"BR^I:-2[ZU;\9O%V@XY
M(6%=9L%N,YH^,=N20LL$^+SVT'@UY;:JJ\!1:"<M^76J[O67RAN3/MU^A%<X
M%WCQW#MZ1T1LA1U[1$;-Q'$5L"XEH7P4$]0*!0*!05ZS96U>,GR7&0BFRYC9
MP@<DD0J#_CHZ2$443BFU%VKK06&@4"@K5LSJPW;,+U@\4G4O=B9CR)6\$%EP
M)*:JC)ZKO5K4$=X)M4Q^&@LM H*YGF6M8+B=RRM^(<YJW"T116B$#/FO UP(
MN":;]:"QT"@C6[P#E]D6%(<P7(\9J8L\XYC!-'C,.6#Z]TG1V:F"<4147TT$
ME005SR>/;\@M&,LQW)ETNHOR"!I1TC0HJ)S)#JJO =YMM"B<2(N'!"5 S+#>
M O\ 9XEY;AS+>$P.8,.Y1SAS&^*IHZRYH0%P[%H)&@^$6T5+X$5?Z*"$PS)&
M\QQ.RY6S&.&U>8;,X(KA(9MH^"&@D0\%5-?103E! Y7D[6*Q+?*=C'*2X7.!
M:1!LA!0*XR CHXN[M0%/<J=JT&;;+P%TD7*,$.9%6V2?"&Y+CFPV^O+!SF1R
M+@ZUW]N\>&Y%3T4$C0*!0*!08=WN(VBUS;J<>1,"$PY(*+!:*3*=1H5+8RT'
M>,RTT$4XJM!WQ7TE1F90MN-(\V+B-/"K;HH:(NTQ7B))KQ1>R@QVKO;7KM)L
M34@2NT-AF7)BHB[@8E$X#1JNFFA$RXB<?O5H,V@4"@4"@4"@4&//G1+7!E7.
MX.C'@0F7),I\]=K;+(J9DNGH045:#[#EQKA$CSX;B.Q)38/QW4UT-MP4(237
M1>*+K08U[O=JQNU2KY?)00K3"#F2I3FNQL-4'5=$5>U4H.$Z]-P+M:K04*:^
M=V)\0EQHSCT2/X9OFJLEX4VLH?R6]_RBX)QH).@4"@@L@R>/CDRS-3X[BV^[
MRQMRW -%:C2GTTCBZGRD%X_R0DG!#447Y6M!.T"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@IEIZ@%?WFI%AQZXW#&G9!1 O[:Q6XYJ#BMD\VVZ^#QL(2+^4%O
MCVBA#QH,VS9Y8+YE=_PN*3K5^QU65ELOARQ>:D-BXCL<M5Y@"I<LU3Y)\%[4
MU#$NG4FP6B]R['+9E\^#(M$69)!H5CM%?W'68ID:FBH',:V&NG=4A^'@$QE6
M36_$+(_?;D#SL=HV& CQ01R0\_*>".RTV"J.XC<<$436@F:!0*!00,O+K7"R
M%[&7@>\P9M9WPS04Y/A6G>2J;E)._N]&G9Z:#YA>963/<;A918'#*!-'7DOC
MRY##@\#:>;U78X"\"37XTU146@@4ZKVB5;<=G6>UW"Y2,I?EQK3 :!AIY2MZ
M.J\3I// V HC1*B[^/#A167%ZBP@O<+'<CM5PQNZ7(E:MA7$&BB2GT$C5EJ5
M&=>:YNT5)&S(2)$7:BZ+1'2WU%>G3[Q"L>+7:[!9)IVR7*86"TT4IIMMTA;\
M1*:)41'![RBB:T$]"R>%,R&3C')?9NT2!%N<@7!'EBU--YL WB1(IB3)[D3A
MV:*M!-4"@4"@QY\Z%:X4FY7&0W%M\-HY$J2\2 TTRT*D9F2\$$43556@J$?/
M[E<F&[E9L.O,VQNKJU-)(D-UUM2T1UN-*D-/;%3O)O "5.P:"1M.=V&\Y=?L
M(C$ZU?\ 'ACN2FGPY8/,R6Q<1V.6J\P 4T;<5/D'P7M%5#/A9' G9'=L79%U
M+C9H\*7+,A1&5;N*OHT@%JJJJ>'/=P33A084'.+%<<SNN"1R=\]M$9B;)W!H
MR3<C[UL]>\3:$VKB:=WF!\-!9*!0*!05W*\N8Q8K3'6WR[I<+W+6!;X<%&=Y
M.BP[))2)]QH!%&V3752^*@R[%>+A=DD+/L<RRJRHHVDXXI\U"1=5#PS[VFW3
MCNT^*@EZ#HFRD@PY$TFG7QC-&\K,<%=>-&Q4MK8#Q(ETT$4[5H.NU7 ;M;(5
MT"/(B!-8:DC%FM%'E-(\"&@/-'W@<'70@7BB\*#+H% H*]D686S&Y]IMDL'7
MIEV6430,CNY4:!'*1(D.? V"( <.*F8)IQH*Y%ZN02M]FOUVL%UL^+WY8O@+
MY*&*Y&!+AM2,LE(\AUQA'", 0G VH1(A*-%T;$HA0*!0*!0*!0*!0*!0*# O
M5YM>/6N5>KU)"':H0<R5*<UV &J)JNB*O:M!GT"@4"@4"@4"@4"@4"@4"@4"
M@4&DK=:^H5SG]3V,)OMOM"NY"38++ANOOHZMJ@;B%\7D$-4TVJK)[%XZ%V45
M@67,F[5"Q&X8[$DV_'[3A>2.GC+CZN#XO'WX$=6W"%51TVS!UL7M-20E+[Z@
MD"Q*0YTM]_UR.X)U#\G]X!R5)CB,)*Y'C>3X;7P_@=WY/D<O3E>G?WZ#EC[3
MG4[,)DC(9<YJP'C./70<;8E/QXPS+HDLW#)62;-5!&Q$1W(FO>5-R#H$1&L4
MZ=TXS')9V1W>1DV+2+[&QR[E,<!V(U8'GVXNX 46WB,6A\0;P$KW%#X4%CNM
MSL6<':HCELNU[R@[1$GRX5FGO0(ML2<',;=<=\3';!XUW<I>\[M#5$0>*A4+
M/>,CSNV=&[=>+Q.C-WT+VQDJQ)!1GYK5M8-M&W7&%'0B-L2<-O:ORMBCNH%P
MNDJT]3\JPNWR9-@LE]F6&US<K;[_ (,%MB S$9=,E()4E4Y3;[B*+>J<5=($
M4)Z>4J_9WD./3+->;UB^)M6ZVVRWVRX!%:1]^*$IR1)-R9'?==VFV#9$1"*"
MJIWR5:# *+G$V5T_P[*9]UM4:==+]#DZS@2Y3K''B.NQ!EO1#5$>44;0W /?
MW57<A%K0;IG3+5B&.2)\DE8LMCA&\X1$3A!&AM*2]XU4B5!'TJJK1&@K3*ON
M*Q\)S6]X[=+9<@N<IW-+C)6&U"\/ESH\_>@2''%&/(\'M_)IH#7'3CH5>6;*
MF8=5,WM5^N$Y_';7$LIQ+(U+>CQ4D2FI"N/+R3 E54 -!W;=4W:*6BH$5:,A
M@'BDO%LMDW6^RH>3W''[)$B/N^;7-J"X3C8.N-.,J8M,K^6<=<$5$-SBZKQ"
MFY/.N;."=7<2E1Y<&UV8[+(M5NN$H9[\5JX$R9M"\+CNK6]M2 %<+9JJ)W=J
M(&RIV6RNG>49JQ>G7YMGD6Q<LQQMTC/0XZ!$FP6C-5T_++&<;!.&LA=*"M72
MRWW&(MEG=2_.,AQ&/9A*^3;;-D*[;+V<AR3,F/,QC;>=807$!DV5-8X-*B!H
M6Y GKQ*R:_Y%F%IP:]JV])PVTR<;?)XG(@294BY(D@%[Z(3H VG-02[!70MN
ME!,=,)N."[<[)"M]SL.410CO7NQ7J2_+?'F;Q"0TXX\^VZVX0N#SV#T,A[VA
M)I09-@4I/5?,WI()S8-NLL2$:IQ2,ZLM\]/B)Q5U_P"JGP4&M\=D7W*8'1BV
MW&_7$8=XM-TDY!RI+@/W!([,<@!YY"0T3<6JD*H>FJ(J(2T&?D-[NG2X\^M&
M-3'%M\6TV:Y6)FXNG+:MDR[S)%M<4">4C5@5:;D<LCVH6Y$T0N ;(LO3^R6!
M]FZMR;C.OC+9 _<YT^2\Y*4@455]OF(R7;J(HT@A]Z@Z)1&N.EDV<TQT:M[4
MET+=)PVX.R8@FJ,N.L>5(V9AV$0(X>U5[-R_#169F>69#C]WZDO6N>K3T:WX
MS&M/B%5V-#D7>7*AE)%HN[W5(7"X:%L37A0=>?8!;\:BXE<+3<KDDD,GQ\+H
M4V:_-2Y(4]D-TD7S(>8A:.";8BHJFB=WNT&)D%VR)^R9JQ$ODV#*'/+5:H4Y
MIQ3=B1)16H'&V4/44'1UQ=BIMU)55*"QOVD<&ZC89&L$R8D#)?,85\ARY3\Q
MN0Y&AE+:E?ES/:^A-*)&.F\27=KH.@0=FL;^8]+W>I-QO=P8S6[6^3=X-SA3
M'F6[8A@3C,9B.)HSRV1$0<$P+F$A*:JJ\ V5TZF2KCT^Q.X3GED39=FMS\E\
ME4B<==BMD9*JJJJJJJKJJT1I"S/9'!Z687>4NEVN^7Y[,AVJYW)J6J2V[?LD
MRR9A#(=%AD^4PK2.\#524]RGI15OA6/-HEUFQ<&M5SQJUW.S7%AYR^3F)\2-
M>=HK;Y;(>)EN[E(G$?1.Z2(*JFY.(1#=V@6?I_GL!AB\XQU-M^,3)MQB7*?(
MER#-F*Z@W"+)YIM/)S=45]G:>[1#$%VI02&4\^V7QO*.H#5RG]._+8!0+I:Y
M,EH;+*:0RE/S68KK;I"YJ!>)1#1L1420!U(@DK5CEC>ZW9+=M\E3:L]EGMN#
M/EHQS')%PU50%Y&R;T 50%103CHG%:"MS[M&"9CV;8/!O@09U_M\63DLV::P
M[C N4OPS@^%DOF;C!([NCF+ ;= )M=G:%BL.,!FN19\61W6YR85OO:P;/ 9F
MR(C4%$@1'E=95@P+F*;A*)$O<^]1-2U"$Q7(LCSBT=/,7NMW?8"YQ[S)O]QC
MFL:;<&L>EA";9%UK:K:ODX+T@FMI:"HBJ(2T$WG5N7#(5CQK"V[HR&5W@(LX
M($TSE!%CQ9$MX(CDU] 8-U&-A$!BNU2(>^B+09F%VR_VG,M+78[K9\(EP'O,
M8EWG,3&FKDTZTL=R,B2I+HJZ!O(\FJ NT%^5KJ'W)[>_D75NTXW,N,UG&BQV
M=.GVJ+(<CM2W6IL5IKF*T0DB"CA:[53=V+W=44(G&,)8R"YYGC]WO5X?M>.7
M)+?C0!<)#+UO:?A1YN\'FS0W'&W'R%IQ]34 $0[-=0Z\,RO(+_*Z03+C.=)V
M[62[NW< )6VI4B,W# 77&QT%2U4C3AW=RZ4'9U"YUSN/4ZRS9,@K0SAD6:Q$
M!]UEL)"%<U5P>60JBERP0_0:"B%JG"@[V(V(6#IYBECEM76?(OS4,X=D@39C
MDR;(&&)."A'(#:P )O<0G :33CQ5$4->Y>$N5TVZL8O=H\^';\=>@2K+ F3R
MDR(K<UADU95]ET^8RA*:@VX9[==O8(Z!L[)"/#LPP.VV=^<EH-+](F0%ER)*
MR58@\X!-7W'"/:2:@A+H*]E!&X_A[^6].X><7#(I[.=WJW#>8V01YCS3%O<E
MMI);99CH?(\,RBBV39MES!15/4B5:# QV5<.I^56)W(ITIBQW#![7>9^/PWW
M8T1^?,D/(KA*V:'L%$7:*%WDV[M=J4'?X/,W[!F>&XQ.E7#W;R&*W$9>EDS/
M?LCK,2>_;FYQEO ]KSC3+SA[MNT5-/EH'R_R\0N/1+.8M@;G6PK0Q)<F6FZ'
M(2?;[G';;E,@22''5#4D:<;5LU;7=N!5UH-TQC<<CLN/#L>,!)P/P25$54_F
M6B.V@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@U$XUD/1*WH]%=9O72>(^G,AO(
M35VLT24\*?D74U"5'9(U7EF(.@WP0SVHBE1#]@O-POV=Y+B@B6:XMD03K.R2
MB S&G;/ &5;W35.#<D!VHJ\ =1MS[V@^6Z/;NK%PZD>7$3<')L=L!6]YX=CD
M>3I<>6K@HJJ#L=\$WAVB8:+02%IO[G5*Z]/&'VMC5MA+EF1L$"B(7*.IP(S'
M_8E))<T7TL)0;EHA0*!0:IR3_P"JES__ #%E_P#&T56\*5[IY9<$S5I57#\K
MLUBM^7-ZKMB7(X;#$*Z<>""?<B2EX<.4:\ -:#%P0#:;Z,M."H.!/R<3 N"H
M2-3D5%H+_P!<-A]/GV&U3S9^XVENQHBHCJW-;C'6/RO3N0TW</O47T:T(0>#
ML9J[>.H!8[/M<:![TRT5N?#D27N9X2)N7>U*9':OH3;_ #T%@M6[_P"9LAWJ
MBG[N6?<J)HFOB[AKHBZT&P:(4"@4&N^M"M)B<$9VQ+"=]L87Y7=$:\O*Y,(Y
MS-?O%7:A_P"3KKPHL-B41HR9C]YN>29[D&*;??7%K]&N%D;-1 )8N66",JWN
MFJ<&I3:;-5X X@.=H45*87F-EN.5YMGR.''Q]S'+#<7C?':ZPW&6ZK(;>!-5
M%QD@,'0[1(52@I%MG7G'H&)=0[OC5TMUR&\R+IEERD+&2&-NR@T:?14"2;NV
M.G@U3\GP1CBB<:#TM1"@4"@UKU32Z%?NG264XS=T6_/\@YP..1T_](G[MPM$
M!*NGR="[>VBL/,IN;6TL)&\7",V_,RV!&<\F&1%;=AG&DJ;3R.NN*0D0HJIK
MIP2@E\IE7E.H^+VRV3CB#,LU_)&U52CK):6"C+CC2*B'RU-=-?A7X:"E8S+:
ML%FO5EOK-UL_5AO'Y;\Z3,FR)4>YE&:3FSH+W,)D]KA 6@@VZTAH*@(Z4&3C
M2SL^G8WC=_N4HK%;L/M%YN$-N0ZP_=)UU1QKF2'FR%PVFDCDJBA(A.'J>NU*
M"#Z@7#(<)M^=8?8+W-;A-0;%=[!.-TY$JU%<;JL%Y@7G"(S;_)(XR#A+IJ8<
M0T1 NEVL;6!Y5A=PL4Z>JWRZ'9[\Q+F/2VIS;\&3(%]P7B-!>;<CB0FT@]U2
M#Y*HB!@8PJ8]FR1>HC5P:S"Y7&>%@R-93YV:XQW5==CQ&P!WE,N-QTT2,\TF
MI-D8$:KNH,RW(F43LZZ@.ZG;F8DO&<<).Q8<#?XY\.\HKSY:$&OI%@%H*/&#
M,IO37IQ9,N:@!TUN[-A@W.3:E?.X"+@1_! \CZ" ,O/(VR^XVJD.[@FBJ0A*
ML'<LYNF5W"\6?(;@,.[SK/8I%DN+$%BWLVTUC<U@%F,%X@G!-TW'0+T"G<31
M0DN<_?[=8,?SBS76\=28]J:?O-JM$Y8L:(3AJ 29#S$B/'!UU6C)O:1%W3V)
MM15H(*VS<ER['NEEFNMZN,)RZ7*]VN_O,2.5-E1+4U/;1IUYC:G,/PP<QUO1
M==Q J*NM!9[-9&I?5#(H4^YS0Q?#8=A>LUH6:^W$:?Y+^Y]Y=Z$YH+0=UTE%
M5U(D(M%0*Y(NC,>Z8CF.$0;XQ;+O?H<*5?[E-,HMT@7-PV]5BR9!N$T6\7([
MG)#;W=O<544)_%\7'.+EG;V27:Z/A!R*7 LC+$Z1%&W-MQXYH;'),%YF]PB$
MCW(/!!1$UW!#89D%]ZF1<!Q^_P!PD-0Y%BF7F_NQ#6*[=78$IJWMMFXSL(&U
M4R>?%I1W$H#\C5%#ADMTN72R_P";^03YLNV6W#6[M9K/-D.2X\.:Y,D,[@YI
M*2MJH@6AEW4%414'@@2$.P97;;CCLS'[/D87MF?%;R.[7BXPWF+A;W"1N8<I
MD9KH;@!5=91AI-A"@AH"JBA'):)USPOJ+F4^^W-S(+'=,D=QJ0$MYINVA:GW
MU8;:: T Q56_RB.B6\5V+W$1*#-*%+L-IZ=9Y&NLY[)KY<;1'R%]^2\XQ/8O
M8[7FSC*?) 6R<0V$;!.7M01[JEJ&,PMSSB?E%RN]HR.?R+O<+3895DN,> S;
MF;:Z41'(X+,97GD8$Z9O-EJJH/R$1%#)M47+<HS;'<>Z@RY<,_<Y)F1V.'*5
MJ/)N0309WN%%)$3@I*0M$B%NVJJB.BA 9Y$_<+JWA<J5,F6?%Y$*18R?EOD^
MPU.BL/K'5U#0W&FS,^6CJEH)(/':-!>,ZQF9:5L:PK?=;[T^A)-6_P!CM\^2
MY<B??1LH\G\J\CLEMG:Z*QQ=UU,3$24-*#8&)W&QW;&K7<,9F+/L#\9M;?,)
MQQXW&43:BF;RJXI)IH7,[^NN[CK1$Q0*!0*!0*!0*!0*!0*!0*!049_IN?CK
MY)MF47>TP\BD^.N4."40=)"QVHQ$R\<<WFM09#Y)\%XHJ4&?;.GF,6658Y%J
MC%%8QZVRK-;H0GNC^%G''<=YB&A$9J4<5WD6JZDI:JNM!!#T=M:6GW36^74L
M W:IBRO-^'2/NU\'S^7XE8FG=Y'.TV=S79W:+JM\+&K=;\AN62QU<2?=(L.%
M(;4DY M6]7R:V B)HOY<]W'X*(P6,&LT?'+[BX.2%MV0NW-^<:N(KPE>3<<?
MY9;=!1%=+9JBZ<.V@B Z70X$]9V.WNXV0I,&':[J,4F#\6Q;05IAPB=:-6WA
M!5!76MJJ/QH*H'=8^E6,8Z&)-VTI0M86DX+,!O(:*-R%1=1Y5'4]$+NKKK\.
MM!F2NG>,7%W*RND<Y\;,FX[5ZAR"U94(K'APY:"@D"[4W;D+5"[R*BT&!_\
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M,R(S)>TE5:"6H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H%!&^3CV^-F?3E0/)Q^NS/IRH'DX_79GTY4#R<?KLSZ<J!Y./UV9].5 \
MG'Z[,^G*@>3C]=F?3E0/)Q^NS/IRH'DX_79GTY4#R<?KLSZ<J!Y./UV9].5
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M/N:[6QU[273LK;CPWR:\L3.D:_@TY<^/%ISS%=9TC7M2-:FXH% H% H% H%
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M4_F^G1W([(>F.373,L_OL98J0<EQLK-;=[I(:2E;;!.8B NT=17BBK6W#O\
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M(2KN5*#HNV4YU'L>4V"RY#XB;9\ELUDL.6/LLN;EN#T7F190MB+;BL&[R7S
M4786B_E!*@L&4=1I]QZ+Y!E=E,K-E-J;.'<HFH.O6ZZQ7@:D,%JBB6U5U E3
M0VR$TX$E!/\ 52[7UBS0L:Q*;Y=F&4RQMEHG[0<6+M;.2_)5LT5"%MED]>':
MH_#03&!9.F98?9\D5KD29K">-C:*G(FLJK,EGCQ_)O ;?\U$6.@4"@B<HC7:
M9C=WBV&2L.^O0Y 6R4.W5J6K9<D^^BCP/3M32@UOE.;Y'?\ I5CD["I*0\RR
M]J-X!UM ,F'6XQSI:(VXA(NT([C*HJ?*)/3I14M=\VEWJV]//=E](LO-9L&8
MNNA&%J88\RF)Q14[S;:1U7T*YPXT%;Z?]685LPCQ61!=K@S;9MS"^7\8[LJ)
M"$;E)1$?>5=RBPT@<Q6Q-&@TW:(BZ!<KQE*VS,)+;%QF7 (^/+<@Q6#!;D<W
M67RQEMOIM,C_ .[Y*'MV][MHB/P_JQ&N/3R!F>5PI=H<=BP">1R(XV,N9< #
M8W ;$G7'M[AH#:)J1:I15BQW.K9D%TD6(H<ZT7V.P$WRVZQ_#/.1#5!1YI4(
MP,$)=A[2U N!(FJ:D5;.9QR.H=EQNX9-)QRP.V6X7 RB2FH!.RV),1H-77!5
M500=/N(OQK15<>R;)'L/N!MWM^Y6N%F%FMU@R=M$C.W"V.3X*/"1,H .B#CC
MT4GFQ0'4!5^%5#8MXZB6FUW:78X4"Y7VZVYL'KI'L\597A!='>V+I*0"CACW
MA:$E<4>.W11U(^O]2\0;QNW91%F'/@7AWPMG8ALNNS)<KOHL=J/M1SFBK9\P
M3$>7M+?M02T#ML>?62\SYUH?;DV:]VY@9LJV79KPKZ0C4A22"[B;<9W"0J8&
M2"J:%IPH-<]3>K$6;T]GR\?;O%M9GK%"QY*D9V-$DDY+80.2^*[Q%X27E&X(
M XG8JZIJ5L[.<G7#\6N%_;BK.EL(VS!@BNQ9$V6Z$>,UNX[4-UP!4M."+K1$
M&Q@%^G,-RLBS2\%?3%"D%:76X$!MS77:Q'Y9IL'Y*<Y7"5/E*M%9]YZ@VJS7
M-^Q1H5ROUV@,!)N4>T15EG%:=1>6KRHH"AN()$#8ZF2)J@Z::D0[F3LWS/NG
M\S'[F4G&KS9KY,%&3(8\CEE;>49@NG>#>:(A)N%5)."ZT5%=/L_&V]-L)\W\
MQO\ DUZA..M1HP%,G/A'+\L\9&0H@!O 2,S3B0CVJB4%^@9?9)]RA6-7'(F0
MS[=YRW9Y;9LRPABX#1$X*HJ"HF8@0[M=:(Z<BS2UX[-AVDV)5ROMP$W8MIMK
M/B)1,,J(N/$FHB#0*8BIN$*:JB)JJZ4%$S;JI&N6 9A(P^5+MN2X^$)J>,F*
M3$J"_.=!.60/@H\Q&U5>"$/%%1514HJ<N&#Y;:H3T[#,PN3M^9%7(\*_.-S[
M;*,$549>3E@ZV+B]U7&3$A[="TVJ%&N/6*[+>\9S"VBZF%.8R=]R:QJ".O,Q
MBF,1WY D([E<@J1&X*<#;$]$W;:&C8-]R":&?X% MDY"L=Z9NSTH&MCC4D6(
MS+C!(>B\$4E(5%>.M$5S.<ZO=ISJ(];9HLX=B:P!S1A1%4=]XGEBLJ1D*J/A
M$09)[%^2::\**V[1%8R;/;%BMRMUEG#)DWN\ ^Y:;;"8.0_*\*K?-$$'@B@C
MB&2DJ"@ZJJT$(UUAQ^4DABW6J]3[Q;U-+S98MO-R?;U#BB26]405<'O,H)$K
MH]YM"2BZ([+,@+*;KTWB8S?I$;&,M=FR'IUK,67I$9FW.2F=KA@1 FY$4D1$
M+T+05O*<CRK$(O4+'K;D4FYQ++C[%T@WI\&7I]JFR''6^0ZX("#RD I(;%P=
MZ)\I5$@H+A;LUND_"<KCW$AA9]B4:7%O#;6FB26HQ.QYC0DG]C(#:^WJFB:J
M"]X"H.,_++M"Z062[-R.9EE^@6J#;GR04([K=P:9!W;IM78;BO$FFFT5]%!+
M],+Y<+SBPQ;Y(25DMADR+%?9""@*],MSBM*^HHB(/B 0)"(B:(CB:41<J!0*
M!0*!0*!0*!0*!0*!0*#273KJO'@X,V[>&+U>RMDBX#?+U'BO3F8J!/D=UUS7
M>:LM;5,61-0'37X**RL^A2FV<?R+',SO(PLGOMKC)X68R<18%T=37PZ*R6@J
M"]PD7A\-!U]1;G?^F<7'ELMZN%R;&X2;Q>1N+C<E^1:;;#-R5& E =J;/RH[
M4W;Q^.@MW4W(KC!PTF\3E"&2Y%I;L<E@B.@$B2T;OB$UU%199!Q_CP[G&B*?
M.O\ *O:],(URR:58[5?[!+N=RE1Y+,%U^4TQ )O<Z0+V<]Q5 --5X]B45:.F
M%XNUR<R2$_<RR#&K9/"/CV2."VARV58 GFU<9$&WO#NJ37. >]IM74A)5#8-
M$*!0*#7'3/.H4_$FW\FO\0KR,^[,/>)?89=$(]TE,M"0:CIM; !3AV)156CY
MQD4J$W+CW=7F7>HZV1IYM&C [3SE%&!(15%'3AN3O?'0;PHC46#YU>[IGLD[
MG-%W#\N2>N%L;11&EQY](K^TD%"+Q8DLH-R_)%=.%%7O.<G<Q'&I5XC1?'W-
M38AVNW[N7XB?->"-&:4N.T2<<'>6BZ#JNBZ41#,8'D,MEN5?\VNY7M4W/%:B
M8@P&S7CM9CDT[J ]B<XG"7TK14I?LUMF.SHEBY$V\9!)9*2%LMK*2)216EV%
M(=X@#8;M!13(=Q<!1=%T(P'^K&&1K);;\_(?"-=9IVB-&\,\LP;HVCFZ$Y'0
M5<%]":)OEJ.N[XN-!G8_G=HO]PFV8X\RT7R RW,?MEU9\,^L-Y5$) :$0&WN
M$@51-=I)H6G#4(=OK#BAM,7,F+BSBLIX(T;*G8AA:#)XQ;:/G*NX67#(0!\@
M1HM45#VJBT5T,]2YW_R->\0=Q^Z.6VVQ(3K$MB"1"KL@Y:..$YS-%:)&!%I4
M#52WIZ*"PNY_C#6$-]0O%$YC+T5F:R^VV9NF$A1%L!:1-RN$1BWR]-V_N]M$
M1DGJK81N5SLUIM]TOEULKI,7>+:X9/%&(0%P=Y&H#WQ+5L1)2+CHE%9;O4O$
MDQRVY-#DNW&'>75BVB+#8<=FRI0[][ 1U%#1P.4YS1-!Y>PM^W:M$9N,YC;,
MG=N$-AB5 N]J, N-KN+*QY3*/(JM.;=2$FW$$MA@1"NBIKJ*H@6&@4"@4&J<
M:S2[GU>R7';I,YV/3C6/CK)H I'FVF+%<F,BHBA%S0EB\F]?O#TX)17V_P"8
M7DNL&.6*VS%8Q:WN' R%D!!4DW.YP)$J(R2D*JB,MQN:NQ4_M0UH.K&RE9W?
M,@&[97<K3D5CNTF*F-6YYN&D2!'=1(KAM&V:OC):VO<X]0+F;!TVZ4%HLUWN
M<GJ9EME?DD=J@6RQR(454%!;=EN7!'B1435=Z,MZZK][PHBY4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&H,;P#'<GR'J(_DMN?D@
M]D6SD//RV8<A@+; 4=T<7 9='<BIN("1>Q>RBNW+#NUAZ@.W+%[0LV9:\$NR
MVB VT21W93$N*4>,B@B"BDHH(@BHNG905:'/A7C+NFTRW9-><MG^9'+O4DVC
M9M43FV><VG-C@T 17"</8VT:[Q[R%QXJ$MC-QM-GS>U6OI=>7;GC-XF3EO\
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MSEOH3BNAS%%#W&GRA6@L(67'XC^$3L4F3;["N>9/7.?<Y:N2C*2EIEQ3<4E
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MBC1O,LLJV.U$U%$91=5X\:">H% H% H% H% H% H% H% H% H% H% H% H%
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M-R/5GOF4#S>+^;D>K/?,H'F\7\W(]6>^90/-XOYN1ZL]\R@>;Q?S<CU9[YE
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MLM$ .N"!N+M;$B1%)?@1%[:Y8B9=DVB'/5$5$5>*]B5%8[UPAL0G[@3PE$C
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M]*?%30U<4?9)TF!<%7P1"-M"131%[%5.U-::3IJ:QKH[*BE H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MPV#^0)LFCWIH0JBZHNX(#I9;9%EL^>7*;EDF/$8OM_;>E3 @A'8<%_4IIJC
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M;I#=DNM]MLJ\9+<HX"X;,>W.M1' A@\A@A/ONIM)Q"Y;:+P4M%0,;.)V18W
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MDV:\_?KQ^3IZ=:#('%MN>.YMXO5'+0W9O \OLY<DY'-YF[T[]NW;\>M!6O\
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M_ J41SH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MFPE[AQXE7T*VR^;H)Z"8%?@H+9TKN<S.\@>S.ZHOC,?M3&+OM]@MWI#YUY1
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M#0/VEYF47+K+TQP&TY3=L=LV2(<>X+9Y;D4EWOH._0"1")$X)NUTHL(V\/\
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M,A1-Z.#NU41H*_AJJ,;H&2(I*EJN"[4[5TM8\$H*YC^/Y/G>!CDBX7%N67Y
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MY]RNN07&V"0VER]S"F##5P%;,V@T >80$H*Z:$YMU3=HI:A.6K%[198]UBP
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MY9-&T:(32M[=NE!B6OI=88%[MV2SYMROF1VDG?+KG=9:R'6&GV"8<: 1$&T
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M)MX0,?Y"%*#!7*XB9L&#<AWQYVHKTDKN\CDA(&-L[=V_<6O9II03] H% H%
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MQVW$;1=P\"7714731:&C.RWK/TUPFRVG(+]?6TME_%3L;D1MV:4T4$2561C
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MS98 C0O2 31QQ 3@*$2*6U.RA*"LZ9=T:R'JU;\DZ?7++K?F,R9=H610A9*
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M(NLJ#@FVA@0.)Z4)"330KM#I!&/#<LQ*XWR9<'<NF.729=7A:1]J:XVPB$V
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M)-DHHVB[51.7\/IH:L[).AD#(L:Z=XV[>GV&^GLFW2XTD60(Y96MH6A0TU1
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MLZ ((Y'>T0E! T!=W#5:"N8[]G6+8K1F3CN6W2=U S:,46Y9H[M"8T.F@HP
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MWP%$;;787%->/>5:)*J76;@%C^T'U#=^T7;DF,W2-$:P)R?">N,,[>@D)M1
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M'$D03@S([9N\LD<U!QLD#1%%57CKJFFBET1=IZS?:)S'"<OS+&0QZ+;\&G7
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M-A>BBR]4X#9,I@]-;7:,PN3MSR]V JW:;)42+Q<D2,PU!$11:4^6.B?)&C%
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M_%UTX]F7GZ"-_>:>W-QYJ]\^![IVOEOW1^X_BZZ<>S+S]!&_O-/;FX\U>^?
M]T[7RW[H_<?Q==./9EY^@C?WFGMS<>:O?/@>Z=KY;]T?N/XNNG'LR\_01O[S
M3VYN/-7OGP/=.U\M^Z/W'\773CV9>?H(W]YI[<W'FKWSX'NG:^6_='[C^+KI
MQ[,O/T$;^\T]N;CS5[Y\#W3M?+?NC]Q_%UTX]F7GZ"-_>:>W-QYJ]\^![IVO
MEOW1^X_BZZ<>S+S]!&_O-/;FX\U>^? ]T[7RW[H_<^I]KGIPO_\ C+S]!&]'
M_P"4T]N;CS5[Y\#W3M?+?NC]SQI-_P!LD?Z4_P#.6OOZ]$/S2_ZI?(<.9<)+
M4*!'=ES'EVLQV )UTR[=!$4557^2EK16-9G2"E+7GEK$S,]4.\;/=BNS=A\$
M^-Z=>"*%O-L@D*^X2"+>PD14)55$1%K'[M.3GUCETUUZM&?V;\\8])YIG33K
MUEUW&WSK1/D6NYQSB7&*9-28SJ;7&W![15*M+UO6+5G6)3)BMCM-;1I,=+&K
M-J*!0-4[/3165,MERMP1G+A#?B-S6ADPR?:-I'F"^2XVI(FX%]!)PK"N2MM=
M)B=.$_!LOBO2(FT3&O&-8Z8^#%K-J*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M"=@?\HWW_>[;_P#9)KFO_P!VORM_]7?B_P#U[_\ 57_[(+MX)VK72X&3/M\^
MU2C@W2*]"FMHBN1I+9,NBA(A#J!HBIJBZI6-+UO&M9UCX-F3':EN6T3$]D\'
MV;;+E;?#^8PWX?C&0E1/$-FUSH[FNQUO<B;@+1="3@M2MZVUY9B=)TGY]A?'
M:FG-$QK&L:]<3U_+XL6LVME0+9<KJ\<>UPWYTAMLWW&HS9O&+3::F:H"*J"*
M=J^BL+Y*TC6TQ'S;<>*^2=*Q-I^$:L35%[%K-K?:(YL,/27FXT9LWI+QBVRR
MV*F9F:Z"(BFJJJJNB(E29B(UGH95K-IB(C693&0X=E&*3(MOR*UOV^=-;%Z+
M'=1%<< B4$T057CN333MK1AW.+-$VI:)B'5N-GFP6BN2LQ,]#G+P?-K?#6X3
M\:NL6 *:E*>@R&V41/2ID")4KN\-IY8O69^<+;8[BL<UL=HCMFLZ?R0-=+B%
M5$XKV4"@4#LXK094.V7*X-R7;?#?EM0FED3#8;-P66$717'%%%VBFOREX5A;
M)6NFLQ&O1\6VF*]XF:Q,Z<9TCH^?8Q:S:B@4"@:\=/30?0 W#%ML5-PU00 4
M4B(E[$1$XJM)G18B9G2';*ARX+RQIT=V+(%$567P)HT1>Q=IHBUC6T6C6)UA
MG?':DZ6B8GXN;ENN++9.O0WVVAXDX;1B*(O#BJHB)4C)69TB896PWK&LQ,0X
MG"FM16ISD9X(+ZJ+$HFR%EPA[4$U3:JIZ=%JQ>LSIKQ8SCM%8M,3I/7U.!QY
M#;+4AQHPCO;D9=(50#V+H6TE31=%7CIV58M$SHDTM$1,QPEW6ZVW*[RV[?:8
M;\^>[P:BQ6S>=+3X !%5:QODK2-;3$1\66/%?)/+2)M/9$:NZ[V&^8_)&'?K
M9*M<LAW@Q-8<CN*"\-R"X@JJ?'6./-3)&M+1:/A.JY<&3%.EZS6?C$Q_-'UM
M:2@4&5*MMQ@QHLR;#?C1)P$Y"D/-DVV^ KM(FR)$0D1>"J-85R5M,Q$Q,QT_
M!MMBO6(F8F(MT<.GY=I%MMQG,2I4*&_)BP01V:^RV;C;#9+M0G"%%045>&I4
MMDK68B9B)GH^)7%>T3-8F8KT\.CY]C%K-J93MLN3$"/='X;[5LED;<6:;9BP
MZ;7 Q!Q4VDH^G1>%81DK-IK$QK'5UMLXKQ6+3$\L]$Z<)_%BUFU% H% H% H
M% H%!/XQ_99!_@\C_P 5FN7<=-/^J/ZO2V71D_Z)_G" KJ>:F;7B&67R(Y/L
MEAN-R@M*J.2H<1Y]H5'M13 53A7/DW.+'.EK5K/QF(=6/:9LD<U*6M';%9G^
M4(;L71>U.U*Z'*4"@YLLNR'FX\=LG7W21MIIM%(S,ET$11.*JJ\$1*DS$1K+
M*M9M.D<9E+VW$,JO%Z<QRVV:7(OS.[Q%N1DA?:V*B$K@DB;$15352TK1?<XJ
M4Y[6CE[73BV>;)D^W6L\W9IQ_'L_%PR3%LAQ"XI:<FM[MMN*MH\+#VFI-$I"
MABHJJ**J))JB^BK@W&/-7FI/-";G:Y=O;DR1RRP(,"==);5OMD5V;/?7:Q%C
M@3KIEIKH( BJJZ)Z*VWO6D:VG2/BTTQVO;EK$S,]4<9=#@&TX33HJ#H*HFV2
M:$)"NBHJ+Q146LHG5C,3$Z2^48E H% H% H% H% H% H% H% H% H% H)J^?
M^WXY_AI?\=*K1B_5?Y__ %JZLWZ,?_3/_P"=V+:[%?+Z;K=DMDNYFPB$\,)A
MR0H"2Z(I(V):(J_#663-3'^NT5^<Z,,6WR9=>2LVT[(F?Y)%,"SE3:!<:N@*
M^X##2N0WVQ5UTD !W&""BD2HB:KVUJ_S,'GKWPZ(V&YX?[=N/#],]:'N%OFV
MJ=(MER8.+<(CA,R8SJ:&VX"Z$))\*5T4O6]8M6=8ER9,=L=IK:-)AC5DUE H
M)&XV&\VB+;YMS@NQ(EU:\1;7G1T%]E-.^"^E.*5JIFI>9BLZS7I^#HR[?)CK
M6UHTBT:Q\4=6USLNV6NXWJX1[5:8QS+E*+EQHK2;G'#T5=!3^1*PR9*XZS:T
MZ1#=BPWRWBE(UF75+BR8$I^#,:)B9%<-F0P::&#K9*)"2>A45-%K*MHM$3'1
M+"])I::VX3'!EW&PWFT1;?.N<%V+#NK7B+:\Z.@OLIIWP7TIQ2M=,U+S,5G6
M:]/P;<NWR8ZUM:-(M&L?%FQ<*RR;CLG+HUHD'C4/_:+GM064T) 7:I*BEH2Z
M+M1=*UVW6*N2,<VCFGJ;:;'/;%.6*SR1UH&NEQ%!*VC%\FR$3.P66?=0;7:X
M4&*])02TUT56Q+1=*TY-QCQ_KM%?G,0Z<6US98UI2UOE$S_)@2X<RWR7(<^.
M[$F,KM=CO@33H+VZ$)HBI6RMHM&L3K#3>EJ3RVC28ZI=-9,'8PP]*?;C1FR>
MDO&+;++8J9F9KH(B*:JJJJZ(B5)F(C6>AE6LVG2(UF7*9#EVZ6[ N##D6='-
M6WXSX$VZV8]HD!(BHJ? M2MHM&L3K$K>EJ3,6B8F.UV/6RY1H,6YR(;[-MFJ
M8PICC1BP\3*Z.(V:IM+:O MJ\*D9*S::Q,:QTQV+.*\5BTQ.D]$Z<)^4L6LV
MME7*V7*SRR@7>&_;YP()'%E-DPZB&*$*J!HB\475*PIDK>-:S$Q\&W)BOCGE
MM$UGLF-&+6;44"@4"@4"@4'(/E+_ "%_]BTE8=LW_;)'^E/_ #EK&O1#*_ZI
M;7Z"V:[++RK,[/#?FW/&[0^-H:BMJZZMTN $PPH@G%=H\Q5T]%>'ZOEKI3%:
M8B+VC77RQQG^CZ3T+#?7)EI&ML=9Y>O\UN$?U6K.;+<QZJ]*\TND1Z'/R<[,
MMU8DMJTZ%S@O,,R$(%T5.ZK:I7%M,M?\7/BK.L4Y]/\ IF)F/ZN_?8;?YFWS
M6C2<G)S?]436)_HG;@Q@I6[KC-R2W39#T6\QQN,B(; O<EV7HP,0G0+EJB_V
MV[5"3LKFI;/S;:*3$:UG377R\=>WX.S-&WY=U.6MOU5UF-/-^7EU[)_5VJCC
M/12 _8[!=;I8;_>_>9/$(]:'&&F;7!=<VLDXK@DKSJCH9)W11*[L_JEHO:M;
M4KR>;7\T]?RCJZW!M?1:3CI:U;V^YQ_+,?EB>CICC/7U0Z4Z1X-C-JRB[9S<
MKB3>+7]+6K=N%K?.BN,B;(@)IHVZ2N"1DIZ"*$G;HM9_^2SY;4KBK7_<IKQU
MX3KQ^<?@UQZ1M\-<E\UK:8[\NE=/S1I$Q\IX\>/1P^+CTSZ68WF\" ,O'\@8
M:N!O-%DZRX<>"TYO<Y*,,/")/B@H*.;55=V[3LIOO4,F"TZ6I.G]NDS/QUF.
MCX?@>F^EXMSCCFI>.;7\^M8CIX:1,<>'3\==$A!M&"V3HIDT/(($Z3/MF1+;
M;G,A'&!UR6PJBVK#CC1*+&B"I 6J[M=.VM5\N?)O*328TM36(G7H^/'I;\6#
M;XMADK>+3-<G+:8TUUCHTUCH^?7JZI/3!O))V$1;GD%Q.R-8<.1WA^6X,DX4
M)E$W,PPVB@AN(1%"W;4X\=$2LHW\XHR36E>;[G)&G#6>VS5/IL99PQ:]N7[7
M/;6=>6O97A^'PCY:*Q)Q# ,GPJ]9=@B72WOXP_%&[6VZNM2%?A3'.4V\T;0#
MM-%W*8KJG#^GLIN<^+-7'EY9^YKI,:QI,<=)<.7:[7+M[Y</-$XM.:)TG6)X
M:QIU]O4NSO2#I*UU(E])1GWQ<DD-JY;[F7AUB1G%C))!IP$%"=5012(^ZG8*
M(BZE7G1ZENYV\;C2G+'3''6>.GX?Q+T__%;*-S.UYK\\]$\-(X<VG1QX>'">
M+SU(8.+(>BNZ<UAPVCV\4W-DHKI_.E?55G6-7QEZ36TUGJ==5@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@G8'_*-]_P![MO\ ]DFN:_\ W:_*W_U=^+_]>_\ U5_^
MR$;_ +1O_K#_ /:E=+S[=$MK_:8_^L=]_P!#!_X1NO#]#_\ U*_C_.7TG_L/
M_P"];_\ C_\ C"V%TQM62Y#B=GO]^NSL*1@S=\&2^Z$@HC@CJC30JVGY .U&
M_E+V;JXO\ZV*F2U*5UC+->S7XS\?C]'H4].KN+XJY+WTG!%^F)T^$</T_#I^
M*#7#NC3V#L]28SV0#8[?.*T7&TN>&67,DJ FT8.IW&142WGP+\%-%[R]'^5N
MXS3AF*<TQS1/'2(Z^'7\.CM^#1_A;&V&-Q$WY:SRS7AK,],<>B/CT]D:=*:M
MW3.WV3J.[ QF^W6!8[OB;V0VJ3'>&/-1AX>$=\D%4(%4=53:B]G'5-:Y[[ZU
M]O$Y*UFU<G).O&-8ZX=.+TVE-W-<5[UK;%SQI.DZ3U3_ !V=<:H[(VL :Z X
M;)\NGA<)+DX8LAHXP$MQ;W(X4DN7N-G?KRQ1=R!HBK6W!.>=_DC6-(Y>W]/P
MX]/;U:M>XKMX],QS,6U_-QCE_5QUUX?IUZ.O3K4_#<-QQS#[MU$S5R65@MTM
MJV0K;;2!N1,G.BCBBKKB$C8 *HJKM55X_!Q[]UNLD9:X<6G-:-9F>B(_J\K9
M;/%.&VXS3/)68K$5Z9GIZ^K3^.''9?3W"\)MN==/<VL:W"3C>2')"VPY)LK(
M@W>%JA"^2 B.-:(>S:B%JB*J_#X^\W6:V#+BOI%J::S&NDUGL[)[7O;#98*;
MC#FQ\TTR<VFNG"T=O;'3IIV=+6.0R[3,ZM#)LWC^45Y;605S>!^0LI)GY0A)
ML11 UTV(O%/AKV<-;QM-+:?IZNC31X>>V.=_$TYOUQKS:=/-\.I<.IW4;.,3
MZVWR19+U-!J)-91NW*^X<1P$:;_)$RI*"B6JIII\:<:X-ALL.;9UB]8XQTZ<
M>GM>AZGZAN,&_M-+3PF/RZSIT1PT6?+>CMGO'4C-[G"MDV3:+.W;Y!8W9>6U
M*?N%S:0U; W$(&VQTYKJZ<$+NI7'M_4KTV^.LS$3;F_-;HB*_P YZH^KT-SZ
M3CR[O+:(F8IR_EKIQM;J^77/SX,W!NE^-XIU/PN;/M-P8C9-$N!V^R7<H[SL
M&? :)7ADH@;76U;+<P2:$BZ*M:]UO\F;;9(BT?DFNMJZ\8GHT[)UZ66T].P[
M?>8IFMH^Y%]*VT_+:O3KVQI^GKZ-5$QOIICN9.Y'E-CM-]GXY:7FXL:P,NQU
MN4J<Z2DYJ^@;&V0315T!2X]M>EGWV3!%,=[4BUN/-QY8CY:\9EYFV],P[B;Y
M:5O-*Z1R_EYIMU\>B(C\9^*1F]!;>F10'7'9]AQ%VRR<AO,>X(V]<X#=O)!?
M83EH@&I*0JV2I\G55153CJIZO;[<Z:7OS12NGZ9YNB?%LR^ATC+$S,TQ\DWM
MKQM7EZ8X<.N-/]$1T]+I1<>J&*QK19[P,0I2M*W<9,62#K^H>'<<!&D1!T0U
M=!%[=NWL77?O/\JNVO-K5UTZHF.'7U]SGV$;.^\QQ2MM/^;EG6>J>CYZ_AHE
MW+58;GD?5E[&)MYLL:V6NXOW&.$EEL)4L)3B&THM-HGA531$;^5VINTX5HC+
M>F/!&2*VFUJZ<)X1IT\9_5\71;!CR9-S..UZQ6MIF-8C6W-.L<(_1\.GIXHD
M\%Z98H>-8]G#UV?R;(XL:9,E6YQEJ):PG*B,"H&!DZ2+_:<>SY-;_P#+W.;G
MOBBO+29B-==;:=/R^'U:/\#:8/MX\TWY\D1,Z::5UZ.W7X_1W+TBQ7&[=FLW
M-[A/,L/ND:$(VL6D6;'E A-H@NHJ-F>\54E)4!->!<*Q_P#)9<ML<8HC_<K,
M_FUX3'RZ?Z_!E_XC#AIEMFM;_:M$?ETXQ/1T]$\>WA\5:ZF8;C5CMN+99ASL
MI<=RJ,\\Q#N"B<F.]%,0=%3!$0AU+A_)79L-SDR6OCR:<V.8XQT3KT//]3V>
M'%7'EQ3/+DB9TGIC3I_FM/2_I9CV;VNVC/L%_:\P5QE_*$E0XUO;?W'R_#L/
M"AOCH@H>TB+7=IV5Q;_U#)@O.EJ</[=)F?QF.CX?@]+TSTO%N<<<U+\?[]:Q
M'X1/3\?CJE++9\#L?1_,(>20)\J;:KZW;KQ,@G&;><?9>46O#..M$H-:(.\2
MU7773MK1ERY\F[QS28B+4UB)U[.O2>ET8<&WQ;'+7)%IFM^6TQRZ\)X<NL='
MS^*M]!S825E3-MD1XF?OVDVL0D2R!L1D$7Y5&C=[HO*.U 7X-?1K79ZO$Z4Y
MHF<?-^?3LZM?AVO/]"FNN2*S$99K^37MZ].K7L_'JU6O,;1>1Z48_.ZK2VW\
MDM>4MP?&D^W<)C5L=;5QYB0XP3FXA45<VJ2DB;4].E<.VR4_RKQMXTK;'KII
MRQS:\)C73Y/2W>*\;3'.[F)M7)IYIY=.,3,:_/Y:.[J-=\DSRRY9D.#]0%OV
M(L+SKOBRQW(3\6"X7!!1T=7 ';J1(J>GT\*QV6/'M[TIEQ<MYZ+:ZZS^'0V;
M_-EW6+)?!FYZ1TUTY=(_'I9%]>:RTLCMUJOL*1AN3PK5"PJQK+0D@.1>2X\\
M485,H@0FFGS?,A%%3X=:QQ1.'DM:LQ>DVF]M/U:ZZ1K_ '3:9CE7/,9N>M+U
MG'DBD8Z\WZ=.76=/[(I$3-N$1/XJ1FV&R[ZR$BRSXC4"RV5+A8,4,C2>F.,J
MJK--4;1GG2%4I;C6_F;3UTX(E>CM=S&.=+1.MK:6MU<_EZ==(_3$Z:<'D[W:
M3DKK28TI3FK3K^WY]=(KS6_7,:\W'\&-T9RZP6*+E&/W:[/8O/R.,PQ;<MB@
M3CD(F#(R!=G?$'=4U(5333M3@J9^I[?)DFEZUB\4F=:3U_\ !K]'W6/'&3':
MTXYR1$1>.KC_ %_#YQTQ+N]),WR/.K+8LIR!R_623!?GV[((KYW$7K=&[YMQ
ME>7^T4C$=JKHBDB\4K1'J.'%@M?'3DM$Q$UF.72T]NG5X.N?2MQFW%*9<G/2
M8FT6B>;6L=FO7QCOZV3>>BUM\G@WUFRWO&&VKQ!M=Q@7EYAXWX4YT6DD,.-@
M.UQ%)$,%%137AV<<,7JEN>:3:M_RS:)KKPF.J>/0VY_1:<E;Q6^/\U:S%ICC
M$SIK'#I^'0R%Z4=+9F69'TUM,Z\KEMM9DR8-TD\A(/,CCS/#DV([B1!5$)SN
M[EUT1$TUQ_\ (;F,5,]HKR6F(F(UUX]?^BQZ5L[9;[:LW^Y6)F+3II\O'H\:
M];^G>,M=+86;OV^[9%*G!+6>_9GV 8LYQU46AD-$!N%N^4X2Z(@]GH5>J^]R
M3NIQ1-:1&FG-$ZVUZ=..GR<>+T[#&SC-,6O,\VLUF-*:=&L3&OSZM.^;CA5A
MLS-XZ..9%*N=ZCW>)*.WVV2^T]!AR@<'38TXVNC*CKJ*+NW(/'0=*X-UFO--
MQR16LUF-9B.,QIVZ]/\ J]/:;:D9-M.2;7BU;:1,Q,1,:=6G1]=8CL0CUJL-
MR3JU,Q:9>K1#M<57)\ I3*,S)2S7T,7 ::%%81$1 #Y2:KWE1=*Z(R7I]B,D
M5M-IX3I/".6.V>GM<TX,=YW,X[7K%8XQK&DSS6UZ(_3V=?3QXN@>CN.7#.<4
MB6N9+'I_D5H6_2+@\XV4B.Q';(I+:N(V@H0$@#KLX;OBK/\ \GDKAO-HC[E+
M<NG'2=>CK_KU-$>CX[9\<5FWVKTY^:>76.WJTX<.KK2&/6;'AMW2ZZ39=WN&
M,7+(YL>#89,AIV-'096V,O*)O:J$NBR$["U+:B:\=6;+DYL]8BL7K2-;1$ZS
MPX\=?_C^#?M\&.*;>\VO:ELDQ%9F-(_-^7AII_U?CHY7C#>G^;]9<GQ"$-QM
MEX<"X^"4GHZ13O$?O@  +7=84$)=JENX=M3%NL^#9TR3RVC\NO3KRS^/2N?9
M[;=;Z^*)M6VEM/TZ<\?#3]/3/3JUW<<-M-GZ6VG+;BY('*+]<I,>W1$(!CC
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M+>UR6E$P0$-4)"H-N40H% H% H% H% H% H% H% H% H% H% H% H%!#SO\
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MKB[G.)29=T:=;R?%2,WWH3Y,P;G!:54(N2^2ML/M@FY4!Y6R1/\ O"H*]?\
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MWVX3:B<EQ$0WGG"5QUTD'1$4S(C5$X)K03- H% H% H% H% H% H% H% H%
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MAHHZ%WM:(L- H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M=JKJ>QQU--=""U=0T.RWW#LX:W(W;KBEFNJH2 /EU^4(VIZ]J!*2*Y_(BT%
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MB2Y)":N$2CM4S(=QKMXJJT%LH% H% H% H% H% H% H% H% H% H% H% H%
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M)%E%EYED:9D>)+(44[5X=%<1UD6N>3VJ<$;05'4UX:D*=I)03% H% H% H%
MH% H(7(/EV?_ !%G_,<JB:J!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*")LO^U7K_?U_X=B@EJ!01E]OL+'H'CYK<AX2,668\-AV5(==<X"
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MMP?4V_GT#RW(O;@^IM_/H'EN1>W!]3;^?0/+<B]N#ZFW\^@>6Y%[<'U-OY]
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M$Z&Z+\.2V#T=X%U VW!0A(5]**BZI0=U H% H% H% H% H% H% H% H% H%
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MC.76Z/E*DI& E,6054$0;W*I*("FY>):Z)H'9DV'6;*5AR)ROQ;I;5<*VW:
M^<2;&5X4%Q&W6U1=IHB(8%J!:)JFJ)H&%-Z=V2Y6:):;A*N,F1;Y"S;?>7)C
MJW2/*42#FM2$5"%=I$"BG<4545%154H(F^=.XL'",TB64)%WR?(K5+B/3;D_
MXF7+-8SK;#)..J@"V*N*(@*"";E735252LBR]+;!;SM3S[MPDQ;/R7K39)DQ
MV1;H+[+: V3+1JNJM)JC7,(T#[W1430B8E8+B\^!>+9-A>(A7V8ERN#9N.(J
MRQ%H1=;,20FB#D-D!-D*B2;DT6@ZK=A$>WQ9T5R]WJ<DYKD*[+N+YNLC\+)
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M_;Q>JL4#RN_^WB]58H'E=_\ ;Q>JL4#RN_\ MXO56*!Y7?\ V\7JK% \KO\
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M]58H'E=_]O%ZJQ0/*[_[>+U5B@>5W_V\7JK% \KO_MXO56*!Y7?_ &\7JK%
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M1-5!\$A)-PJBHOI3BE!#9%E%OQIN(,EM^7<+B]X:VVR$WSI<EU!4R0 511!
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MXX)*#H(<>-R3 NT51I6U!?Y%HJ7RCI[AL/+NG\"):FH\25*FQ;DTUW$N$=J
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M>:\UJ;0\MS:9AW@$MW#36@MV-X%D-IR^UWUFW6#'[;%BOP;E&L:O[ID<A16
M,"99#5IP=PFNI(BD*<"6@[>G=FAW.+YPX\\+-LR3(G[($>0XS&<9?F262WM
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M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H(>=_S':/\
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MADMPR1?W[DV[U>)1TVZZZ>F@L- H% H% H% H% H% H% H% H% H% H% H%
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MNHMH1J2H"*NJ *H*?!06"@4"@4"@4"@4"@4"@4"@4"@4"@A<@^79_P#$6?\
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MX+=MLT-F!;VM>7&C-BTVBDNI+H*)Q55U5>U5XK09E H% H% H% H% H% H%
MH% H% H% H% H%!"Y!\NS_XBS_F.51-5 H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H%!$V;_:KU_OR_P##L4$M0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!01*X_%557Q<_C\$V3^LH'N]%^MS_7I/ZR@>[T7Z
MW/\ 7I/ZR@>[T7ZW/]>D_K*![O1?K<_UZ3^LH'N]%^MS_7I/ZR@>[T7ZW/\
M7I/ZR@>[T7ZW/]>D_K*![O1?K<_UZ3^LH'N]%^MS_7I/ZR@>[T7ZW/\ 7I/Z
MR@>[T7ZW/]>D_K*![O1?K<_UZ3^LH'N]%^MS_7I/ZR@>[T7ZW/\ 7I/ZR@>[
MT7ZW/]>D_K*![O1?K<_UZ3^LH'N]%^MS_7I/ZR@>[T7ZW/\ 7I/ZR@>[T7ZW
M/]>D_K*![O1?K<_UZ3^LH'N]%^MS_7I/ZR@>[T7ZW/\ 7I/ZR@>[T7ZW/]>D
M_K*![O1?K<_UZ3^LH'N]%^MS_7I/ZR@>[T7ZW/\ 7I/ZR@>[T7ZW/]>D_K*!
M[O1?K<_UZ3^LH'N]%^MS_7I/ZR@>[T7ZW/\ 7I/ZR@ZRQ>WFZV^;\TGVD(6G
M%FR=PH>FY$7F>G1-:#L]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE
M]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6
MY_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?
MUE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>
MB_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^
MO2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64
M#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+]
M;G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])
M_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=
MZ+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?
MZ])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE!UNXO;WU;5Y^:XK1HZUNFR5VN#J
MB$GY3M35:#L]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z
M])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90
M/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOU
MN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG
M]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]W
MHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_
MKTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE
M ]WHOUN?Z])_64'6WC%O:)PFGYH$\7,=49LE%(]$'<OY3MT1$H.SW>B_6Y_K
MTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE
M]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6
MY_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?
MUE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>
MB_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^
MO2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64
M#W>B_6Y_KTG]90/=Z+];G^O2?UE ]WHOUN?Z])_64#W>B_6Y_KTG]902U H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H*
M[A65MYC9%NGA2M\R/+F6ZX6YPP=<CR[?(..Z!$'!>(;A7TBJ+0,6RQG*AO,B
M/%<C6^UW23:(\MTAVRR@J+3SK:)V +_,937M4%6@L5!&G=9 WYFS#;9)Q'8K
MDHKP/+\&VXVX#:,$N_?S"0E)- TT%>-!(H0JJBBHI#VIZ4UH"D@Z:JB:KHFO
MPK01-_R6U8TEL6Z&8>;7"/:87+;)S65+54;0MJ+M'NKJ2\$H)>@UGB?43.,O
MMMLOUOPAMJPW11<:DO7AE'@CD:BKA-"PO%$3=LW_ !:T5LS5/Z>RB/B$*JHH
MJ;D[4]*:T!51%1%715X)\=!]H%!\W#NVZINTUT].E 541-571.SC\=!]H/B$
M):[51=%T73T+\%!]H(+,,F9Q&P2;TY'.;($FH\"W-*@NRYLIP6(\<%75$5QP
MQ'7[WM7@E!47>J<^)E?N?)L2'.;G6RV.RVI7Y!7;G;9<\C!":0MK91>5QXKN
MW<--**MN%Y3$S7%;5E,)HX[-R81TXKNBN,/"J@\R:IPW-."39:>E*(I47J[<
MKZY9VL1QA;H=Z"[3(92)S<$"M]HF-0PD(I-FJI(5U'&Q1. <5HNB;DYMD-IB
MV0[_ (V,*?>KR%G&*S/"2+33D9U])"N"T*+Q:4.7I\>OHHCIQ7J0=]DXRU<K
M9Y6UEUE:O-E-7D>UD"V#DJ&?='OM X#@$B:.#OX)L74J_41\W#HJZIHG:OP:
M4'U%14U3BB]BT'Q"%5445-R=J>E-:#ZJHG:O;P2@^;AW;=4W::Z>G2@*2(J(
MJHBKV)\.E 4A'35435=$U]*T'V@^(J$B**ZHO8J4$;CE_MV4V&W9):",K7=(
M[<N&3H$T:M.CN%5 M%151>Q:"214)$(5147L5.*4$:W?[<[D4G%P(UNT2%'N
M;P["Y:1Y;KS+:H?8I*4=SN]J:?'01N&90]E$:[OR(X12MMYN5G;$#4^8%ND$
MR+BZHFA$@[E3T4%E5=.*]E!\145$5%U1>**E!]541-5X(G:M 145$5%U1>**
ME U1=41>*=M!\14)$(5147L5.*4#5-=->*\43^2@*J"BJ2Z(G%57LH/M!%WS
M(+;CS,1^Y&8MS9L6V,<L"<59,YT66D5![$4B34EX)0<G+I("^L69+;).*]%=
ME'=Q1OP;9MF (P2J>_F&A*0Z!IH*\:"1U37;KWNW3TZ4'U51$5571$XJJT#M
MXI0?%5!12)=$3M5>"4$+F&2Q<.Q>[91,;)^/:HKDI6&U1#=($[K8JO!%,M!1
M5X)K0<<7+,CB.N9F-M;F&0DPS:E?(&P4=2 S>^60KPW"(HOP)03FJ:Z:\4XJ
MGIT6@:IKMU[W;IZ=* JHG%5T3LX_'0?:!0?%5$5$5415[$^&@^JJ(BJJZ(G%
M56@=O%.R@^;DXHG$AXJ*=M!'8_=)-ZLT2Z2[9*LTF2"FY;)_+24RJ$J;7.4;
M@:KIKP)>V@D45"345U3X4H&J:[=>]VZ>G2@^T#5-=->/;I0?$5%[%UTX</A2
M@(0JJBBHI)VIZ4UH"JB:(JZ*O!/C7MH*Y@^3/99CWG4J.$1Q)MQAJT!J8H-O
MG/Q!+543B2-(2IZ%72@LG;Q3LH(RW7^W72YWBTQ"-9EC>9C7!" A!'9$=N4"
M"2\"_)NBJJG\E!%]/,J?S7"K)E,J,$.3=8R23BMFK@@NY4T0E055.'P4%F54
M'M5$U71-?A6@B[YD-MQY+<MR(Q\TG,6N)RP)S63*54;0MOR1X+J2\$H)6@^*
M0HJ"JIN7L3TKI0-4UVZ\>W3TZ4'U51$U7@E U1--?3V4"@4'P2$DW"J**]BI
MQ2@*J"FI*B)\*\*#[0?$)"3<*HJ+V*G%*!JFJIKQ3BJ>GC0%)!TU5$U71-?A
M6@B'[Z<6[RH$FW2FK9$@)<7+XJ-^"54,Q)A-#YG,$1YB]S;M5..O"@K6$W[J
M#E(VS)IT.U0,.N['C(T%#D.79J,^VAQB<-$Y*F:*BN B)LUT0BTXE7Q20=-5
M1-5T37X5HC[0*#YN'=MU3=IKIZ=*#ZJHG%5T2@C;-=)%U8E/2K;)M:QY4B*#
M<SEH3K<<U 7PY9FG+<1-P:Z+IVHE!(HJ*B*BZHO%%2@:IKIKQ3BJ?RT$;%O]
MNEWZXXVR1K=+5'B2Y@J!("-3R?%E1->!*JQW-43L]/;0?+U=I5J6W)&M4NZ^
M/FLPGEA\K_56GD)2DO<TP_)-[>]LW%Q305H)-51.U=/1Q^%:#[015NR&VW2[
M7FR1"-9UA<89N"$!" G*8"2""2\"[ABJZ=G90173C+7\XPJSY3+C!"DW-HW3
MBM&K@!L=-O@1(*K\GX*"TJJ"BJ2Z(G:J]E!]H/BDB*B*J(J]B>E=* I"BH*J
MB$78GI72@^JJ(FJ\$3M6@^;AT0M4VKIHOHX]E!]H/B*B]BZZ<.'PI05KI_E$
MC,\4B9%)C!#>DO3&BCMFK@BD26]&14)41>\C:$O#TT%E0D)-PJBHO8J<4H"J
MB<571.SC\*\* JHB*JKHB<55:#[0?$)"UT5%T71=/A2@^T#LXKV4'Q%14147
M5%XHJ4!"15445-4[4]*:T!2$>)*B)V<?A6@$0BBD2H@IVJO!*#[05F^Y2]:<
MHQ.P,QP>8R.1-8?D*:H3*0X;DE%%$14)24-JZJFE!FY7DD+$<=N&13Q-V/!;
MW#':3<Z^\9(VRRVGI-UPA;#_ "B2@SK:[/<ML5^[LMQ+D;(',CM.<UIIU113
M 7%0=R"O#=HFO;092JB::JB:KHFOI6@^T"@B\;R"VY78H.16@C.V7%I'XI.@
M31JV2JB*H%HJ=GIH),2$DW"J**^E.*4$5C.1VS+;%#R*S$9VR>).1C= FC41
M-055 M%3B*]M!*H0KKHJ+HNBZ>A:".O]S*S6.Z75L!=>@0Y$L&27:AJPV1HB
MJFJHBJFFM!!^^$G_ .+_ '_\('C/(//? [UY?,\'XKE;]-=NO=W:?S4%$O\
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M,Y3%LRSI9&3[L5F;)C?E"0DW&8, IDO%2U6@])6NV0++;X]JM; QK?$!&HS
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MN+$7@O%MY:#9/46XV"%CO@\@@NW9F[R6+;"LT=='ILQX]S;(JIMBB=Q3-3-
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>bc_novelcircul-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_novelcircul-4c.jpg
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M%!04%!04%!04%/_  !$( ;\#M@,!$0 "$0$#$0'_Q #<  $  04! 0$
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M^CX[D<.YR)TF(B<A<!EAQH-...-@$NOM'FU;/#3Q4!T3&K_#RG'K7DMN0XW
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M+B5QY24:Z%73=2DJ2->*DZCU: ^2/32_ZH6G_@<?^]RJD'UMLW_TGPG_ ()
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M86HG0?;5I"$_ZY30'0<KR_'<(L;N29-,$*S,*;0Y)#;CVBGE!"/):2M1U)\
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MI'.R\D+0KE6$J&H/81K0&=0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MD\>.BV@/YM2#$]$B\S(6[#5C;<4+??H,N+-9!(2KHM*?0K3LYDE! /@"CXZ
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MU/+J#KQX0#Y2V]N^ WS.)^3[X3I<V*Z%RE--H=<5+F.+'!Q3.BDMI&IY4Z>
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M^D^$_P#!(']W14 @/I/[2W#<G$XMSQYGKY-CRG'H\5/OY,5X#K-([-5@H2M
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M:=-: KZ7NVZ;/%Q7)L=A=/&;;"387&V=5(C-M+4[&U))/*KJ+3S$]H&IU4*
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MO7X@?Y?I4!-8&!X=:\<E8C;;+%B8W-2XB9;F$=-MT/I"'"OET*BI( *B==*
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M%AM=B95SLVN)'A-KTTU3&:2V#IZO+4 V- * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% <^R/8[:?+)CUQO>+1'9\A16_)8ZD1QQ:N)4L
MQUM\RB>TGB: ]<7V6VMPV8W<,>QB)'N#)"F9;O/*>;4/JD+D*<*3ZJ=* GE
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% 0-6R^UR[\<G5C44WY4OO(SM7><RRYUNKISZ:\_E=E 3R@% * 4 H!0
M"@% * 4 H!0"@% ><B/'EQW8DMI#\5]"FGF'4A;:VUC125)5J""#H0: YC</
M1QV4N3YD/XE&;<)YB(SLF*W\AAU"0/4 H"5XGMU@^#)<&)V*):W'1R.OLHU?
M6D?4J=65+(]0JH"3T H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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ME* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M:V#5% * 4 H!0$OC?B[7Q$^T*Y<MK.M'8CUJI84 H!0"@% * 4 H!0"@% *
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M5.A[#7OVG=@XJ3C7I6WR'-X_HW[;&29=Z=N]_D.+ZC[EQG*)<5P&JNBELG@
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M-*BAY0[S9[C)E0K?<(TN9!5TYL=AYMUUA>I'*ZE"B4'@>"@*51+31G4(% *
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M5WD=W)WCR3#[O>I]DOL&\1+"^TF9C<6S376VV%*0'$RKLAPL,OZ*44I*=-=
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M%E)(!/'MH#TY4_!'L5 /*2 &P0 #KX*D&)J: ]XO%:M>/#P^O0&ME'_?+?\
MTX^N% 3NH)% * 4 H!0&A@_K7=O[/&_VJD&^J * 4 H!0$2MX\TN]YMRM!]O
M$QH>-$E()(]90-98["C-K5B!0"@(MDVW&#Y@_P">Y!9FGKF!HFY,*7$FC0
MEY@H4K0#AS:UNV-;?LJD)8;MJ[F:&HY?I[[K.*KOV/O1"G/1KVQ><4X_WLZE
M:RXMIRX*4DK/:HZHU).FFNM;ZYWJ5LR]QS7R#22=6I/_ %'/-YMIL1P)O&,@
MQN&JW6%<M5JR)PDSEI9FCE#X3(*TA:4=4)5H.57*1H0*ZW+.8W=0YPFZRIFC
MT;.C#R>2IP^<<IL:=0G!985RS_JP?3C78J^6G4="3=K= ZF96.$V[CV.ZXMM
MA:&2GIW"[2-(SLE*N'.DJ3T$KYS]K0ZOPUR^'*7^*;]*?IW7[,5BE]NS:XHZ
MZO0C_F@DX0_QV8JGI2>#?_BG7U5)])D1<5:N4Z)MO*<%SM-D4B_;ASG$@BYW
MR9]M8C+UTU3S?;UI*3HVEI%5EJ,L7?7HN7HVU[,%M?V+KJS)'39Y*P_2C#T[
MK]N;Q2_\G^7*CIUO@0K3 C6RWM"/;X3:68S/,I00T@>2GF622 /&:XTYN<G*
M6+9WK=N-N*C%425$4PY'4@RKD1IWC*=?1_1I(;1])&M:SVF=$A4E*TE"P%)4
M-%)/$$'P&H),%JQV1F.N&S;8K<1U06ZPAAM+:E#B"I(3H2/'0%9UFL]S4A=R
MM\:8ML:-JD,MNE([= 5@Z4!E)890R(Z&TI8">0-!(".7LTY>S2@+$PH:(OF*
M([28(1T_-@A(:Y"-.7DTTT]32@*-6^ PXV\S%9;>:;##3B&TI4ED'4(20-0G
M7ZGLH"Y42(N2B:IAM4QM);;D%"2ZE![4A6FH!\5 ?ERO[HOUS[=?:$? WM*=
MM25.HO;U70[FP=RX=L9C2(49$$6OJK4RME+*F2"O0'ZKF'#@0*XJY5'PSL.5
M:NM?+4]#/G<GJXZA1IE5*5ZJ&!9MU;E;+]F-_EPFYTC,XDR'-:4XI"&A.5S:
MHX*U"!Y*4GP5FN<OC*%N"=.&XM>0UK7-91N79R6;C*2:K[7W;*'OCVZ$./BL
M7"<WQMC+,=MKJG[2E<EV!*BJ7J5(2\R"2V23Y)'ATUT"=*WN7MW7=M3=N3VX
M)I^1])>QS5*SP;]M78)UCBXM>5='TW4R5;T7A[/;'FKUMC)AXXR8EGL$=2F8
MK$;I*:"$JXG7RM2K3P :: "J_"H*Q*UF=9NLI=+=:EOC4WJ87LJRVU2,%@DJ
M-&AL&X-WQK-)6:6MEKK379*I=O>!<C.QYBRIQA8X$IX]OC -;5[10NV5:D]E
M*/IJNDTK',IV=2[\4O2;JNBCZ#-RC+,!O%L<CX_@#%@NSRDK<N2+C*DA!"@I
M0:96$H0%<4Z<= >%4T^FOVY5G=<XKHRI>?:7U>LTUV#4+.23Z<\GYMAI<.R^
M]X-?XV1X^\&I\;F24.#F:=:6-%MN)U&J5>OJ#H1H0#6SJM-#46W">QFCH]9<
MTMU7+;Q7<^I]7TVG06]Y[%:9;U_Q+ +;9LRD!SGO!?=DM-+>!"UQXJ@E#2M"
M>PZ>/4:BN4^57)I0N792MK^FB7>]K.Y\;M6Y.Y:L1A<?]56Z=D<$O)YR+8;N
M+<<3GY#<G8XNDS(X$F!,>D.*2L*F*"UO%0!YE:\2/#6]JM#&]&$4\JA)->3H
M.9HN93T\[DVLSN1DG7\W2>NW>X0P=%XM\ZTM7W'K_'3%NEM==5'*TM\W(I+B
M0HI(YU>#Z8J-;H?$96I9)0=4]OF)Y=S+PN>,H*<+BI)5IY_*S86+<VW6Z!<<
M8O.+1KU@DR<Y<H=C>D/-.P7%ZA(8EC5P )T221J>/9S*UQWN7RG*-R-QQN)4
M<J+TNV.SZ=AET_-86X2M3MJ=IR<E%R=8]DMNS#K\KK9:=Q;+C6>VW,\3Q5FT
MP[:RZTFT>>/2 ZIYMULN+?=!5S:.> :>2*FYH9W=/*U<N9G+^JB6[H788[7,
MK=G5POVK>507JYF]JDJYGC_5YC$Q+<*1B=RR.Y,P&Y*LBA2X#C:W%(#*9B^<
MJ20#S<O9H>VLNIT*O1A%NF1I]M#'I.9O3W+DU%/B1E'LS$- T 'BKIG%945!
M!=4E2M""HJ074*EPJ2"M""X4(*BA!<*D@J*$'7MEMGY&>3DWN]MJ9Q&(ORNU
M*ICJ#Q:0>WD'_J+'Q1QU*?.<XYLM+')#]Q_]O7]R^C]?_'^0O6SXEQ4M1_[G
MN75O?D75]CQX[$1AJ+%:2S&80EIEEM(2A"$#E2E*1P  &@%?,Y2<FV\6S[/&
M*BE&*HD>E5+"@(8KWQ]>NL<=EJDI6DI4 I*AH0>((- <SQ?9_P#0J[I<Q?*+
MI Q%,E<P8G_N[L)*W=2IMM:VBZAKF)5R)7VUCC"CP>!EE<S+%8[SP3L;9DX0
MU@_>LOS-J\B_"5RM=4O"29/3TY=.7F.G9K4<-9:$\5YLU.@W>2;96W(LJ;RU
M4U^).%GF8_(;9".1Z)-!/E<R2=6UGG3ZM6E"KJ4C.BIUF%>=FL=OVU\#;"X/
MOK@VN/'8@7-/*F6T[$2$H>20.4*TU2>'$$BH=M..4E7&I9C*QK:ZVX[DL/)C
M/D3I=NL,3&8#;X;Y&8L3E*EIY4CRW%)U4?H=E2H4=>H2N-JG74SK)@$"P9OD
M6:0);R59,W&%PMGD^;=>(GII>3H-0HIX*X\:E1HV]Y#G6*6X@]U]'BVW&)D%
ME8RB[0<5O\M=S=L3!CEAN>ZXAU3G.MI3BT<R KI*7RZ^/2L;M;57 R*]L=%5
M&]RK:5S,KBI%\RBXNX@X]&E.XNEN*F,7(?(4!+W1ZZ4%2 M20YQ)/&K2A7:\
M"L;F78L=YO\ </!;?N+BTG&+A)>A(><9?8G12$R&'X[B7$+;)! .J=/6-6G'
M,J%(2RNIH9&R^,O7_#;ZV\^P,,BMPHD)LI2Q(;C)TCEX<O$LK)<1I]4:KPU5
M/<7XCHUO+)^T;[=\NEYP_+;IBK=\>,N\6^$F*_&=E* 2M]M,IEWI.+ '.I!X
MZ4R8X.@XF%&DZ%U\V<M=]N&4W&5=)8>RJS-6&7H&OM;3((ZJ?)]^=>.O"CA6
MO6%<:2ZF;+(]LK3DN!P<%FRY+3-M:AB#<62E,EN1;DI#+VA24$ZIU(*=#4N"
M<:%8S:EF-/:]GY%OO%SR5_,;O,R6ZVCN9^Z."*E;02]UD.L(0R$-\O8$<I3V
MDZJ)-1DQK7$L[F%**AML+VW3B]ZN6476]2\BRJZLM1)-SF(88TBQ]2VVAJ,V
MV@:$ZDD$FIC&CKM964ZJE*(XWN+88<2]YC;\5M&;)N.0A?G5DMC!:L%SFOL\
MOG)E\JNFV2K[?HZV5<NA&G;AFL72N/<;$'@JTP[R8VW8VZ(M.$2VLGEX]E.+
MV1%G=>M[<9]!ZB4EX?[PVX#Y0T!JZM[,:-&-W55X539)[%L]8[,U?I4FXS[Q
MD^1PW+?<LBN;J7IGFZTJ2&V@E"6VT)UU"$H X#7705902KO91W&Z;D4O.S6.
MW[:^!MA<'WUP;7'CL0+FGE3+:=B)"4/)('*%::I/#B"11VTXY0KC4LQDX[M;
M;;!DUNR=4^1.E6FP1L9MS+_(&VH\<I*G0$I'VQPI',?H=E2H4=>H2N-JG74S
M[1@$"RYW?\Y@RG4.Y''C,W&W:($<O0QR(?&@UY^7R3QJ5&C;WD.58I;B$7;T
M>;9<X^36AC)[M!Q;)I3MSE6*.ICH)N#ZD+6[U%-*=4@J0#TBOE\?95':VJN#
M,BO-4=%5$UL^WT*SYG=\T;F/.S+O!AVYV,L(#2$04E*5)T&NJM>.IJZC1U,;
MG5)$0C; 6BWXUC]GM5_N,"]XO(F2;+D3!9$MOO%Q3C[:T%!;6VOFT*2G_3K3
MA))8["[O-MNFTD6#[6P<(R"]Y*U=IUUNN0-147-^X+0XMQV(%CJ:I2D#F"M.
M1("4@ ) JT84=2LKF9)4V%4[6VY(SX"X2 <^24S2 WK&UBF)JSY/$\IYO+UX
MTR;>L<39U'F-J;8(N!11<)')@)08*B&]9'3C>;#J^3XN/DZ<:9-G4,[Q_,8S
M&S-D;V_R+;UZ=(?MN12IDU^2H-AUIR:X'?(T3R^0I(*=14<-96B7=>92W&VQ
MG;R+CF12\E%PD39\ZV6^TR.L$!*A;4J2'?) \I?,2KP>*K1C1U*RG54(8?1Q
MQ9J!F%HMURFP;/F4J))FPF>F$,-17UR%,,'EU2VXI9YAX!P'AK'PECUF3C/!
M[B;9UMY;,WM=JMZY#EL>L<^+=+5,B!'48>AD\H3S CE()21624<R,<)N+J3"
MKF,5!(H!0"@% * 4 H!0"@% * E\;\7:^(GVA7+EM9UH[$>M5+"@% * B%]_
M6)C^@'MKJ2#,C_<4_1H#TJ >,K[D/C5(,2@/>)[]7Q?]- :V5^.6_P#IQ]<*
M G=02* 4 H!0"@-#!_6N[?V>-_M5(-]4 4 H!0"@(QDS9MTR'D2 >BU_NEPT
M_)W3Y*S\1?MU:+*LS@00"#J#Q!'8164J5H!0"@% :G)\<MN7X[<L8NZ2;?<V
M2RXL<5-K]\VZG^<VH!0]:L]B]*S<5R.V/TIY37U.GC?M2MRV27T?DVG$,:NU
MWPN8BQYTA$C*,%@=WX!8V4%"+P_/<+#4QE7DA9Y.1@@:EM/44H<VM>BO6X7U
MFM80NNMR7LI8N+W=+ZW1;#R]B[/3O)>QG966W'VV\%);\*1ZEF;Z3L^'XVO%
MK$W;I4@3+Q(=<GWRX::>=7*4>9]W@$^3KHA TX(2D5P-3?XT\R5(K"*W16Q?
M3I/2:/3\"WE;S2>,GOD]K^Q=5#(OS[WF[=KAG_W"YJ\W8_FI/W1P^HE.IK4;
MH;A)X<5F#$8AL#1F.A+38_FH&@K"9#WH!0"@% * 4 H#\LU_=%^N?;K[0CX&
M]I05)4N%"!4D%PH074*E14@N%""HH074*@5(+J%2ZA!45(+J%2M205%0"ZI*
ME:$%14@NH5+A4D%:$%PH05%""X5)!U#9[:2;N)<O/IX7&Q2$L"9)'DJ?6./1
M:/C/U2OJ1ZI%<'FW-8Z2&6.-Q[%NZW],3U'(>1RU\\TL+4=KW]2^W<?:,"!"
MM<)BW6YA$:#%0EJ/':'*A"$C0 "OE]RY*<G*3JV?:[5J-J"A!4BMB,FJ&04
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MVUEC'8C-K$9Q0"@% 0Q7OCZ]=8X[*4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MAP85O9#$%AN.R/J&TA(^CIVU4DR* 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4!$+[^L3'] /;74D&9'^XI^C0'I4 \97W(?&J08E >\3WZ
MOB_Z: ULK\<M_P#3CZX4!.Z@D4 H!0"@% :&#^M=V_L\;_:J0;ZH H!0"@%
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M;&[WNWIQO#\TE<UV6K2UW1T@><%1^XNG@.I\!7U79[[3F\ISKDRMKBV5Z/\
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M6^*KLCL'LX?#5VJ/T*RI4*-FYJQ H!0"@% * \9,9B9'<BRD!QAT<JT*["*
MQ\?G2(,LXY<7"ZI*2Y;)2^UUA/:A1^&CZ8K%)4+IDFJI(H!0"@% * 4 H#\L
MU_=%^N?;K[0CX&]I05)4VJ,;R-:0I%FGJ2H I4(KQ!!["#R5AX]OVEWHV?!W
MW_1+N9KE(4VM2%I*5I)2I*AH01P((/8169.IJM-8,"I*EU"I45(+A0@J*$&3
M$@S9[I8@1G93X!46F&U.KY1P)T0"=.-5E.,563H7MVIW'2*;?46)9>4\(Z6U
M&05=,,A)*RO73EY>W77AI4U5*]!3*ZY:8F8FS7A4]JU)M\DW1[0,P>BYYPLG
MLY6^7F.NG@%4XL,N:JIOK@9/#W<^3*\SZ*.O<8KC;C+BVG4*;=;44.-K!2I*
MDG0@@\00:R)IXHP2BXNCVE!5BI=0J5J2#T9:<?=;9907'G5!#;:1JI2E'0 #
MQDFJMI*K)2;=%BS-N]GNE@N+MIO41R#<F.4O17ARN)ZB0M.H]5)!JEJ["[%2
M@ZIF2_8G9FX3662VKSF%64URHJ074*EPJ2"M""X4(*BA!<*D@]&7G8[S;[#B
MFGVE!;3J"4K2M)U"DD<00>PU#2:H]A*DXNJP:/L'9+>-K-8B,<R%U+>614?:
MW3HE,UI XK3_ /N >_2.WWPX:A/S;G/*'II<2VO\;_[?PW=W;]B_CO/UK(\*
MZ_\ *O\ N6_MWKRKIIV6O,'M!0"@(8KWQ]>NL<=E* 5) J"10"@% * 4 H!0
M"@% * 4 H!0"@% * 4 J2!4$B@% * 4 UU[*D@5!(H!0"@% *$"A(J2!4 4)
M% * 4 H!0"@% * E\;\7:^(GVA7+EM9UH[$>M5+"@% * Y_G/^()_H$_7&N!
M_(/]E/\ T_W(ZG*_]S'R_48=M'^Y-^NKVZ\7I/VEY3T5_P!=F5I6V8#!NP_W
M5/QQX?4-<_7?M^4VM-Z_D-+IZ_LFN(=$V-G'V]WM]X/#ZM=/E_KR[#3U7JKM
M++/_ (FQ_3-_75Z/^+?N7>Q?6SD<[]6'E^PZY7O3S H!0"@% * T,']:[M_9
MXW^U4@WU0!0"@% * B^1+[SND*P@ZQFQY]<!X%(0=&D'U"KB?6J\459L*R%1
M0"@% 5"%DA(2>97$#QB@-1D5[-AL\ZYQX3EWF0F3)%HB+0);S:2.8H2HZGE'
ME<!QTX:FL]FUQ)J+>5/I>PU]1>X4'))R:Z%M^GT1RW+\NSB)BTS</!,EAWW$
M;TA+=JMLN/TKA#E2U".TB&MD'J.(=(U9>2>P@UV=-I[,KJLW8.,X[6GZ+2Q>
M:NQ-=*.!K-5?C9=^S-3A+8J>DF\%EIM:ET-=!URTLW2/:8#%\D)EWMN,TFYR
MD)2VEV4$#JJ"4 ) *M>P5P[CBYMP5(UP75T'HK*FH14W65%5[WTF/?8KKT,2
MHG"X0%"5$5_/;XE/K*&H(K$U4RDCM\UJY08\]C[E(;2XD>+F&NA]4=E83(9-
M * 4 H!0"@% ?EFO[HOUS[=?:$? WM+%>]/K5)"VGV!N/#W<E2L><P7(VK3:
M.XX0>C.W%B&I4GRRI?(YQ.J2D<WJ5X/12TB4^+#,\[_I;P/IW,(:V4H.Q-1C
MD72ECC^!QC']O+?-QP;@Y\_>),:[SI#$&%8(R9DZ4MI2NO)6XY]K2@. CCQ4
M>RO07M;*-S@V5%.*57)T2W*FW8>4TW+HW+7B+[G+.W102<GO==FTW+6Q4%>7
M+QH762IJ[6%5_P 3?5'#+TA03KYM(:7Q2M/AT\'B/ 87S>7"SY5Z,\L\=G6G
MN-A<AB[SMYGZ4,\'2G^F2?3O^S81J/M<7MH7]R53"FXM/E;=JT20NW(>3%6^
M/JM0\HCQ:"MQ\PIJU8IA3;^:E:=QSH\JKH7J*XUV?EKEK^KS&^.R,=S([1CC
M-T>0\BP(R3+9"F0[YBTI():9:;\MQS7@$]IU!\8K6^+-6Y3RKU\D,=O6WT(V
MWR./%A;S-/AY[F%:=22Q;ZC R/;:Q+PRX9IAJKRS'L;K#-WM^11417U-R2$(
M?84WY*D\Q *.)'A\&N6QK[G&5J[E>:M'!UV=#K]9@U7*[? =ZUGCD:S*XJ/'
M8U3#;T>7MR<_VRPW ;7U)>0R)%^N4&+-L-K0RDG1PIZJY*@-$H]^EO0ZZI\-
M5T6OO:F>$$HQ;4G7NI]I;F7*]-I(5=QN<E%QC3OS=6VG9TF9Z/-R>L%RS/)V
M %+L^-RI"4GL)0ZTZ!Q\?3-4YW!7(V[;_JN+ZG]Y;^.3=J=V\OZ+<OK3^PDT
MO&K?:M[KMG*4![&8-J<S^+U#H'BZT5M '70$RB2D:^"M*-^4]%&SLFY<)]6_
M_M.A/2PM\QE?6,(Q=Y=>&'ESXKL,_*&;GD>^.W\IBY/6:Z7JP19?>$1*%.LN
M+9DJ4$I7JG16A2H$::$UCT[C:T-Y.*DHS:H^G&)GU6:]S.PU)PE*VG5=&$]Y
M"+/MQ;[U^F>8Y7.NMPMMDNKT.0S:&6Y%VDO*=)7(<#AY4)XA2CQU\KLTX].[
MKY6^%:MJ,7**?I.D5AL.-:Y7&Z[UZZY2C";7H).;==N."7X[*8Z["=O,>S.[
MY')@S;BYB6/1Q,#3$=M=ZEH5P"&V0HH!U2K56I\'#CPS:O77+$()J.>;IM]!
M=KVFKH>66M5<N2BY<*VJTHL\NI+9Y>S#'#QLF!V+-<U=LN(S)\;'(<1<^YR[
MK'1Y[%9C_=4]%A1ZB@2E*0-"2>SA5[NMN:>QGNJ+FW1*+P==F+V&.QRZUJM4
M[=ER4(K-)R2S*FW!;>A=IGY!MO87,/N67X>N\LMV)QANZP,@B)C.N-R5<B'X
MZF_)(YNU!X@<2>SFQ6.87.-&U=RO/7*X.NSH=?K^BS:OE5KP\KUG.N&UF5R-
M-N"<:8;=J\NZNV7MQ@N&7*P6/+L@G1LZG&),4B+&;=MT%3C@*&I)*DK))'+S
M(/#MTTTUP>/OZB,YVH)VU58OTI=:Z.\V_A>ETERW;O3DKTJ/!++'JET]W:U0
MU7I#?]8,A^+!_N3%;/(_]E#_ %?W,YO\D_\ 87?]/]D3F-=P\V5%2"ZA4N%2
M05H07"A!44(+A4D%10@R(<R5;Y;$Z"\N/,C+2ZP^THI6AQ!U2I)'$$&J3@II
MQDJIE[=R5N2E%T:Q3/LS9S=Z)N#;Q;+JI$?+8B-9#0T2F2A/#K-#Q_#2.P]G
M#L^9<WY3+22S1QMOS=3^P^T\@Y['70R3PNQV_FZU]J.JUYX]8* ABO?'UZZQ
MQV4-20?..V.*9'N#A\[)EYWD=OR?O&XQ8LEN>MV&A,62M#05$<"FE)  YAH"
M?&*UH1<E6KJ;=R2C*E%0D.WF]LRXVG#[=E4(O9-?;E<K#)EQ.1,82K1J5NE)
M*2 XG0Z)';KV"K0N52KM*3M4;IL1*)F\F.6NY9M"NL:3&CX0F#Y[*"4N"2NY
MHU9;80A14I:E:( (&JC5N(E7J**VVE3I/?%MS57K)/T1R''I^+Y"]$-SM\:>
MJ.\B5#2L(4I#D9UU(<02.=I6BAKZ]2IU=&J"4**J=41M&YN7C>FX86NQ2',;
MBPXZ]4F,DM(=>*57!Q:G 2SH"D(3Y>H.J>RJYWGI3 MD62M<?I@7*](&S):3
M?U8_=$[<+E>9)S4I9$'G+G1#O3ZG6Z'/Y/5Z>FM.*MM,-XX+V55=Q,=P=PK9
MMW9X%[N,61.ASI\:VI3!2'70J7S<JPC4%?%.G*G4G7A5Y2RJI2$')T(4-_%J
MD7*RIP:_',+:!)>L ;8+@MZDA0E*>#I:"3[WD"ROFX 'B13B=%'4R<+IJJ&W
M?WMQ]^PXS=,=M\V^W7+VW';%8XB6TREIC_=U.J<6EMI+1X+4I>FO9K4\145.
MDKPG5UPH83^_V.0,9N]^N]LG6V=CD^);<BLLE+?G4-4UQ*&W24+4A;9!YTJ0
MH\P'"HXBI4E6FW3>93F\:U-6^+!Q*[2,FO3DE=GQ]88C27($3EUF/*?<0AAI
M7, D.J"BHZ:5.?JQ(X?6J(D.-Y_%RO&;E?+1;I2KK:7),.?C[O2;FM7&&G5<
M4ZKZ?,21RJY^4A0.M64JJI64*.C.78;OS?&MO9^8YM8I2VXL\0V)3'FS;;ZY
M$XQ0RV@.<P4QP#BE\"0=":Q1NO+5HS2LK-1,Z?>]PX-CS.!ACL)YV9/MLNZM
MR4% :2W"]\@ZD'F/@X5E<J.AA4*JI XOI*6)Z'8KU)QF]QL9O^D>%>#&2XVJ
MXJYN6*AM"BXLJ4@H2L)Y2KLX D8^*MM'0R<!XJJJC>VC>^PO1,I=RFVSL6G8
MBTU*NL"XH0IWS62GF9<;+*EI7SD<O*D^^X597%C7"A5VGA3&I?CV\;5RO=IL
MF0XS=<77D:%N8Y(N:6"U+Z:.H6U=!UPLN\OE=-S0_1X44ZNC5*B5NB;3K0K@
M&\L#<%]1@62?!M+"'DS;Q-#;4-J8R\&A%2OG^V.%)#AY-4@'3774!&YFZ!.T
MX])M<TW+M^*OVFU6Z!)R/)+\IT6BT6PME;J(XU==6XXM+;;:![Y2E?Z=)E.G
M65C!OJ2.685N*Q:\VW<S#)TW&VVNWILJ7+/,U<D1I"V5-=!II"UH*G7.7D+1
MY5Z@ZUBC*CDV9I0K&*1.&]YO-3=X>28M<K#>[=:)&11+=*7%=,V!$'VSI.L.
MN(#J3ISMK(4G4'LUTR<3>C'P]SKC0C5[W6M676G'KOYKDECL,G(;-%M%TA.-
M04W%Z7U-4K#A*EQ$*3RN^2.?@4ZBJ.=4MNTNK;3:P;H2AS>ZPQL1RK*)L"5'
M>Q&XNV>?:E<ADN2D.(;;#6AT4'2XGD/AJ_$5&]Q3A.J6\LNV\Z;?(N+<+%;I
M=8N.M-.Y=,AF-T[:IQD/K:'4>09#C2#S.)8"N7QZ\*.YU; K?7MV'M<MY;<J
M\PK#B-EN&639,!F\RE6P,H:C6Z4 6G%KD.-)*UI/,AH'F4*<3&B52.&Z5;H:
MGT<;I(NN#7>XR'9+W4R"[*:$PKZR&@\.1"DN$E'*.'+X*K9>'E+WU22[#"B^
MDM8GK=;,@E8Q>HV*SGE07KV6$.LLS@I:0P$-+6XYJI'+S-I*>8Z#4ZZ.,MM,
M!P'6E54D^-;MHOTR_6:7C-UM62V2(+DFQR4L&5*AN ]-3)0Z6^92AR<JEC17
MA[=+*=:JF)25NE'54/"W;O2I%VF8S=,3GVO+$0'KI:K0Y(@OJG-,$!3;;C#Z
MT(=U(\API[:*>-*8DNWA6N!&-N][[J[ML<MSVUR5N![S:%-A-L\MTER);C#4
M6%'2X5\Z2E+1ZF@U!5S::FJ0N>C5EYVEFI$D$C>Z/:;=D2\FQN?9<AQVWIO+
MUD><C/.2+>XYT@\R\PZMM0"O)6.8%)X5?B4K5;"BM5I1U3-9/W(MN33L)N1C
MY%98,_($1+%TEH@MW-M<4N!Z2RO52HIU.B>"CVU5SK3;M+*%*['@;RX;ON6*
M_P *W9+BMRL]CN=P3:+??'W8;C:Y+BU-M*6PR^MY#3BD^2XI&G$:Z59W*/%%
M5;JL'4U^T4N5(SC==N1(=>:CWUMN.VXXI:6T&,E7*@*)"1J>P5$-LNTFYZL>
MPTUIW9Q_#;-DE\?.0W>&,T?L4E$]QJ:\Q(=TU$-#>A\V3IHVUQ7Q[*JII)O'
M:6=MR:6&PD$'>^&Z<FAWC&[G9+[CEK<OW=,[H!Z3;FP?MC:FW%H!U'*H%7 G
MM[=+<3;5;"G"V4=4S&A;_6R0Y8I\O&KQ;\/R)UB);<FDM-)BF5*'VM*T!PNH
M;4KR4NJ0$GM'D^53B[,,&2[+QQ55T&Y8W>M;UASN_=VR4,X%,FP9[)+?.^NW
MH#BE-:*(T4#Y/-I4Y\&]Q7ANJ6\B<G>/+).X.*VVRX[*DXY?+*BZB*DQ0\Z)
M(97U0XMT<J(X<Y7$\"3[WF%5XCS*B,G#65MO%,F.,[HJR_(7[?8L=G2,9CRY
M-N=R<N14Q1*A@]0=$N]?DYAR)7T^)/BXU=3J\%@8Y6\JQ>.XZ#5S&* 4 H"7
MQOQ=KXB?:%<N6UG6CL1ZU4L* 4 H#G^<_P"(I_H$_7&N!_(/]E/_ $_W(ZG*
M_P#<Q\OU&';?Q)OUU>W7B])^TO*>BO\ KLRJVS 8-V_%4_''M&N?KOV_*;.F
M]?R&FKB'1-C9_N[OQ![==/E_K2[#4U7JKM/.T?XFQ_3-_75Z/^+?N7>Q?6SD
M<[]6'E^PZY7O3S H!0"@% * T,']:[M_9XW^U4@WU0!0"@% * B5L/G5SO-Q
M)UYY1BMGQ(BI".'KG4UECL*,VM6( !) '$G@!0&OM%\LU_$I5DG,S_,9"X<T
M,*U4S):/*IM:2 4D$>$<?!66Y:G;IF5*JJ[#%;O0N5RNM'1]3.62]Y<<PC</
M-;=EM[7)M([M?L4..DS.BX&2B6PGIZI00L!2DJ4/9KM1Y9<OZ>W*W&C]+,WA
M7'T6>>ES:WIM5=C=GZ/HY4L:8>DL-GE.27#?*Q3<*SK%7^]7YE^N\ZX6&<2D
M"/&><;=CH6HN\Z.52#S(0"-#7<ARJ<;UJXLJ4(I26]XUZ#SDN=0E9O6Y9VYS
MDX/<L,JVUZ-AGGTAHTW/[#EMDQR7.O$>SNV2= 2M*5R5N*0Z@M])#AT2X%'W
MNNAK%\&<;$K<YI1S9D]W1]1L/GL9:B%VW;;ED<6M_2J4KTG2MM=O;Y)ODC.L
MR@(L,9^8;M:,(CN+7$C7!;725/>;42D/E/O4@>23KHDZ"N1K=9!05JT\[IE<
M^EKV4]QW=!H9RN.]=CDJ\T;?0I4IF?1F^F!V6N >D% 8N(*Z46=;>.D"8ZVV
M#\VYHZGZXUBEM+HD55)/*5*BP8SLR:\W&B,(+C\AY0;;;0D:J4I2B  !VDT!
MHHF?8/.@-76+D=M<MKRU-LRO.V4M+6V>502I2@"030&V<NMK9AHN+TZ.W;W-
M.26MU"65<W9HLGE.OKT!ZR9D2&EM<N0W'0ZM+32G5I0%.+]ZE)41JH^ 4!;+
MN$" &S/E,Q0ZKIM%]Q+?.L_4IYB-3Z@H#)H#\LU_=%^N?;K[0CX&]I:1J"!X
MJD@Z5O1EU@S2^V.?C[RWXT&R1+?(4ZTIHB0PMTJ2 KM "AQKD<KTT[$)*:Q<
MV_(Z'<YUK+>HNQE;=4H16[%-DIP?<NTOX!;\$NN6W/!+A99#SL"]VUMV1'?C
MR%J=4U(:84E94%*/+X.SU:TM7H9K4.]&W&ZI)5BZ)IK#!O W]%S&V]*K$KDK
M,H-M256G5UQ2QZ32G/$V#=''<D9R^X9C;;.XV'KK-9=8<Z#RE(DMM-.K4KE+
M:B1KIJ3IIPK9\'Q-+.#MJVY=":V]%6EO-1Z_A:RW<5UW8QIBTU@\)43>XDB=
MQ]NVMP!;64.C:@V%[''#TW.KTY#BIBW0WIS!77/+KIV<:U?!:EZ?,_WL^?N]
M&GZ3=^(:1:K*E_@X;M].Q^DVEMKFP\YB67>B)$W<RC+;AYT,=R5MZV&1#T:F
MQH8Y41GVAX'$);3J->&I/$BKW>5MZ2%N-,T*2QV-]*?4ZF*SSJ,==<NRKDN5
MCAM2V1EVI)&OS[((;N//Q+9NQ>,N\[4A*K+*BRH[/1"N8]9QYSE44D CE3Q(
MK-H[,E<3EIXVZ?U)Q?=1&OK]1!VFHZF=VK]5QDL.MM_8:_>7+K%F5\LDZP/+
M?C0;+$M\A3C:FB)#"W2H *[0 H<:S\KTURQ;DIK%S;\CH:W/-9:U-V$K;JE"
M*W8IL\=OLHLF.XWG<.Y/+;N5\M0M]K;0VI86M:E%84H#1/@[:G6Z>=V[:<5A
M"565Y;J[5FS?C-TE.-(^<WMXW2M5PV;@8BVVLYGR,VFY3%(X*L\)Y;["$N:^
M ]-/+\:M:URZ<=8[G_UXR2_,U1_:;=[FUN7+XVE^[A%NG]$6W''N\YNV]S,/
M.>[9Y*[*=$3';(U;KVL,.%3<AJ.XC1(TU6.=?:G6M=Z"]P+]M+UYMQQZ*K[C
M9AS/3^)TUUO]NVHSP>U1??BS3X=?L?A9)><H8S^7B4UZZ/OHC-V]Z8S-@*<Z
MC?.$*Y>8\RAR.IT'CK8U5FY*U&V[*N+*OZDJ/Z=*-;1ZFS&_.\K[M-S;ID<L
MT:U6SRX-'J]D^(9#N3?\OM>32=O4NK:5:I,>$Y(#XY.60IY$90*2XI(7RD*"
MN8\W&H6GO6]-"U*"O;:UDE3=2N[9]1#U6GNZRY>A=>G55EI%NOM547TM5ZZX
MXD@=WJQJ+N@<ABHDO6>99$V&^7B,TF'-D/\ -SF>VTG3E6"$A/-Q"1P[ *U5
MRF[+2Y'3,IYXQ>*2]FN[:;CYW8CKN*JN,K>24DLK;]NF_8L=B1&LXOT%S'WX
M]LW7O&5&2IL=RRXLMEKI!85H\X\YRJ*= ?)3Q(K=T=F2N)RT\;=/ZDX^9)'-
MU]^#M-1U4[M?Z6I[.MR=/,;K),KVJSBY6K<.^7*?!R2(U&3=L;C12X9C\4@I
M+4@J#;:">!))/+]2#6MI]-J]/&5B$4X.N6;>Q/>MK-W5:W0ZJ<-3.4HSBEF@
MHUS-;I;%Y>CH3(3N]DMIS#<.[Y%8W%/6N8(H8<6A3:CT8S32M4JT(\I)KJ\K
MT\[&FC;GM5?K;.!SK4V]3K)W+;K&66GDC%?6B$5U#BE14@NH5+A4D%:$%PH0
M5%""X5)!44(*T(,RV7.?9KA'NEKD+BW"(L.QY#9T4A8__6A!X$<#5+EN-R+C
M)53,MF].S-3@\LH[&?:NTFZL#<:T]*1R1LGA('>$(< L=G6:!.I03VCZD\#X
M"?EO->5RT<ZK&#V/['U_6?;^1<[AS"W1X7(^LOM75]7=7H]<,]*0Q7OCZ]=8
MX[*5)!\_87B^^V'X[,PZR6VQQ$R)LV4UD,J<\\6DS7U.<PBH8\I: K@"O0GM
MK7BII4P-J<K<G5U,FX[*W[%[!@:\$>CW3(<*G2+A)1<UJCHN+EQ21*65I"^1
M1*M4:ZZ#P\.)VVDJ=!"NIMYMC,"3LMG64IW#=RA^VQ+CEJ[+<+<J(IUV*Q*M
M',0PZE24J4C0)2IP:%6I4$C0"HX;=:])*NQ5*=!)-LMO9=DR,7:[8'9,>D18
MSC35TMMQD37G'G"D*"&W64!#:D\VNJRKLJ\(T>RA2<ZJE6S,O>$9:C=E>66A
MF).QG(+2U8KZA]Y<>3%::>6LNLZ(4%ZI7H$\.-'%YJ] 4EDH]J=2'':O=-W!
M4;(NFUIP=#B6%Y8EY9G*M:7^N&A#+7*'^ 1S]3DT]7C5<DJ9>@OQ(YL^-=QT
M/='"+KD]DQBUX\&AW-?K5<G@^X4:1+>LJ7RD)5JK3305><6TJ&.W-)MO<5A8
M;?&-V,DS!8:[FN=EB6Z(0X>KYQ'<<4KF3IP&B^W6IRO,WU$9ED2ZSGF,;2;A
M8;8<"O=J;M\K,<1CW.!<;,](6B)+AW&4MX=*0&B4.)U2K53>G:/!QQQA))/I
M1EE<C)M/8RV_;/;@9)8<PO%R,!&:YC<;/(<MK+RS#B0+*ZDM-=938*W"G4K5
MR $]E0[;:>]B-V*:70B2[M[5W+*<GL^:6FW6^_+M\1VVS\>NKST1M^.XX'4.
M,OLA7(ZA>OOT%)2?'5YPJZ[2ENY1-;"6[88JG%K ^RK'(&,S)LER1(M]LD.3
M&B2 E*UNN(;*ED#RM$Z5:"HME"ER57MJ<J&SNX4C;C)=M'N[F&6;@J[8O>$O
M.+\X=,XS0B2UT]6QIH@D$\?'IQQ<.65Q,_%CF4C>LX7NID.>6C.,LC6F"W&L
MURM2[= ?==6T[) Y%J<6@!74/@3[P#M435LLFZO<4S14:*NTQVMJ<Q;VQVQQ
M,"+WMBE[MUQN_P!N5TQ&ANO+66E<GE*T6G0$#UZC(\J6XGB+-)[T9>:[.WK-
M;_N!UY#,.SY19[9"MTL**W$3+:^9"2MO0>1SA.NAXBIE;S-]9$+BBEU,]X>(
M[FYCDF)7#<"-:[3;<-=5, MLAR6[<9_1+2'$A;389:3J5<IYE'L]43EDVJ]!
M&:,4\O29^VFUB;=MNG"]P[="N8,^9-<B*TE1R'I2WVSY:1J0%>*D(4C1B=RL
MJQ,?*=L[O8;YBV5[40+<TO&F9D!6-ODPXCT2X*ZBRTMM"@VX'-5^]T5K] G!
MIIQZ!&:::ETD7D[+9UE(W#=RB1;8EQRQ=DN%M7%4Z]%9E6?F(8=2I*%J; Y4
M*7P*M2H)' 53AMUKTEU=BJ4Z"^W;3WMRTY)'."6+'+S+L<^VP+I!N<B6MV5,
M;Z82$.L)Z;*@3S$J4H<.!J<CH\$@[BJL6\3=9!MEE5RVYVTQB.F-WIBUQL<N
M[A3I#0:MC92]TE<GE'73E! UJ7!N*6XK&:4I/>>60[.WNY[LLWV&_'1M_<I%
MOO.1P5$]9RZ65+B8W(G30H62T7/'R\:2MMRKT"-Q*%.DTF0[*7B-E^1W>)BU
MFS.SY)*5<&A<YLBW2H4AY 2ZA?3;=0ZR2.9( "N)!JKMXMTK4LKJHE5JAO&=
MOL\P;,7,BV[M]G>M5[M<"V7.S2Y#T=J ];T%MI;"T-+*V0E2M4<H4:ME<75%
M7.,HTE4DVS>%9%@^+7.T9*Y'?N<J[W">'XA5TG&Y;@6E82H:HU.IY-3IXZM;
MBXK$K=DI.J(-"VCS1C9?&\'=3$&06N^,7.6E#ZBP([=R7+/*LH!)Y%#ARCC5
M,CR)=9DXD<[ET4-SF^V>:W[+\MO>/SFK8+SBC5BMMP#JTO-S&Y9>4"$)U2A:
M"4\Z3J.T"K2@VVUN*0FE%)]#--@&TF2V3.L;RA['+)C=JMUMFV^;#M<A<B4X
M^Z$<K[SJVD=0K*3IJ2I/A4K7A6,&FG2A:=Q.+56S7Q=E,\E;:N[<W-%L1^C=
MU3=L6GJ>><8N!$E]Y34UI*$J;0I#O(2@D\=1V<8X;RT+<6.;-O/9>T%[G8EE
MT"'@]DQ>_P!TM2K7!EQ+D]-<>ZKJ5N)6IQA ;:/(E0'$ZTX;H\$B.(DUBVB;
M91@60W9W;!<1+!_12<Q)NW.X4Z(;BEE1;\GRB%'@.%9)1;IU&.,TLW6<M;V)
MW!<:C-7"V627?H.01KM/S1Z0Z]=KK&1,ZW* IK[1R(Y0I'.4GE  ^JK#PY=6
MW:9^+'KV;#L6W>&WK&LHSZ[70,B)D=U1.MO265J+*6$MGG&@Y3J.SC6>,6FW
MO-><DTEN1SM[9S-UV6Y04IA^<2MPD98S]O5IW8E:5:D\G!SA[SZ=8N&Z>6IF
MXL:^2AL]U<0O#-^S7/W@S^C7[O[A9N;J'SCSHK6][SET".7ZKF[?!4W(NK?4
M5MR5%'IJ:/'<4W)W"V^P+%[BW:HN#16K1<WKVP^ZY,E0XB&WF6$QBVE+;AT2
M%KZBD^$?!J%&4HI=!9RC&3?29MYVOW28.X^,XZ+2]C.>R)=R[TF.NIDQG)K(
M0ZQT4H(45%(2A7. D>5Q][4N$L4MC(4X^BW6J-NG;_/++>=MLDL\:#,E8_9&
M\>OT%^0ML-H<2P''F7 V>?E+:N! UX?0G+)--="*YXM23Z74U<S#\ILN=2=S
M/T?@XU$LR9\V\R;)-D27[^REI?097"2RA 65:*4H\RN;LXU#BT\U*?:64DUE
MK6OF.OX&]D\G#[/+S,-HR>3&0_<F66^DAIU[R^ER\RM"V"$'CQ(K+&M,=I@G
M2KIL)%5BHH!0$OC?B[7Q$^T*Y<MK.M'8CUJI84 H!0'/\Y_Q%/\ 0)^N-<#^
M0?[*?^G^Y'4Y7_N8^7ZC#MOXDWZZO;KQ>D_:7E/17_79E5MF P;M^*I^./:-
M<_7?M^4V=-Z_D--7$.B;&S_=W?B#VZZ?+_6EV&IJO57:>=H_Q-C^F;^NKT?\
M6_<N]B^MG(YWZL/+]AURO>GF#3R;Z_'D.,)M$U]+9T#K2$E"O5!*APH#Q_2.
M1_D=P^]H^SJ2!^D<C_([A][1]G0#](Y'^1W#[VC[.@'Z1R/\CN'WM'V= :Z/
M<IK-YFW)5FG%F2TRVA(;3S M<VNOE>KPH#8_I'(_R.X?>T?9T _2.1_D=P^]
MH^SH!^D<C_([A][1]G0#](Y'^1W#[VC[.@'Z1R/\CN'WM'V= :O&%<]M6X4E
M"W),A:TJ]\%%U6H/JUE6PHS=5((_?<XQ/&+I M&17)%LE7-*EPWI*5(BJ*5<
MO*I_3IH4>.@616U:TMV[%R@LRCMW]QJ7M99LR4;DLN;979W[$<[R3%8N;[CR
MV,-GO8^[%A(1G616IWD,M$Q/-'A)0/(6\4#J*?\ J$D:ZG05U+-]V-.G<2G5
M^A&713;+LZCCW].M1J6K3<&E_DE'IKLC_P!5,<W0J&\M>P>T=K82TG'$374^
M^D3GWGW%'QD<Z4CZ"16O<YOJIOUZ=B1LVN2:.WLA7M;?X&V9VEVO8(*,0M9T
M[.=CG[?C$U@?,=2__LEWFPN6:1?_ %1[B26NRV.QI*+':H=K01H1!CM1]1V\
M2VD&M6Y=G<]>3EVNIN6K%NTJ0BHKJ21G5B,PH!0&)CO"\7T#LZD<_1+7&L<M
MI9&GW5W ?V_L,*1;8*;ED-[N$:RV."XOIM+FRR>0NK'$( 22?&=!PUU%"QR+
MT@?WL1ME;P,OG6);;LN$F4FT,RVBJ.IU!Z:2\XKB'0CB>U&OAH#39= AV#=7
M"H>8X?&R@Q\:E^<V#%[6F3#YO.7NFMB)(7V(3IS$G77LH".FRPKALA<932TQ
M<0R/-8J[9867>L[:XCD@,K97K]S=T.I;'8-#KY52#;9'>[FBP6/:S)E*?R7
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ME+S=?;N[^WW'\7Y1=O7EJ*N$(/:MLGN[/:[NSZZKYN?8B&*]\?7KK''92@%
M* 4 H!0"@% >,>7$F!Q41]M]+2RTX6E!82XGM2="="/"* ]J 4 H!0"@% *
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MQ[.KK9ZGD/(I:^>:>%J.U[^I?:^@^SH,&';(;%OM["(T&,A+4=AH<J$(2-
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MDUCLVTV;**E3RRG/,1R_ ;#;+A GL9OC<-JV6^2PMHVYV.VI *G0H\_-TT<
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MI.@':30&JM;1R&ZHNA'_ ++;E$0M>Q^2.!='\U'8GU:QR99(EU4+"@% * 4
MH!0"@/RS7]T7ZY]NOM"/@;VE!4E2X4(%207"A!=0J5%2"X4(*BA!=0J!4@NH
M5+J$%14@NH5*U)!45 +JDJ5H05%2"ZA4N%205H07"A!44(+A4D$XVQVUNVX]
M[$.+K'M$8I5<[B1JEIL]B4Z\"XK3R4_1/ 5RN9<QAH[=7C)[%O\ P.YR?E%S
MF%W*L(+UI;OQ?0?;^/8_:<6M$:QV2.F-;XJ>5M [2?"I1^J4H\5$]M?*K]^=
M^;G-U;/N.ETMO36U;MJD8_3O-G6 VA0"@(8KWQ]>NL<=E* 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MKUYX]8* 4 H"&*]\?7KK''92@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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ME* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H"7QOQ=KXB?:%<N6UG6CL1ZU4L* 4 H#G^<_XB
MG^@3]<:X'\@_V4_]/]R.IRO_ ',?+]1AVW\2;]=7MUXO2?M+RGHK_KLRJVS
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M%I0<:*TA7*L=BDZ]A&O;0%KD2*\VEIYAMQI*@M*%H2I(6#J% $::@\=: ]J
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M)3B6NIUE,)7Y)=#>FM1Q5MIAO)X+V55=QM[YNW'BY),QC'<>N>3R;4RS(O\
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MO,T+2KB^BI-[WN1D=EML.X?H)=) 7$\]N:1)M[0AI"E ME3LE(<=T3S<C>O
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ME%NG25SQDEFVHV.V.V=RQ[:-[;K*'4*DRDW./)D15:@M7!UXA:=0-"4N:Z>
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M464$?4-?^HX?42FM9LVT2J+&:AQF8C">5EA"6VT^)*!H*PF0]: 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MAX9;QW CY\_)_EIXCJ'AEO'<"/GS\G^6GB.H>&6\=P(^?/R?Y:>(ZAX9;QW
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M:3X?YQXUC;J72)!5210"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M^6;/MR\P^<K_ +N/G*_Q893_ )#;_EO?94^6;/MR\Q'SE?\ =Q\Y7^*_*?\
M(;?\M[[*GRQ9]N7F(^<[_NX^<?Q7Y1_D,#Y;WV5/EBS[<O,/G._[N/G*_P 5
MN4?Y# ^6]]E3Y8L^W+S$?.=_W<?.5_BMRC_(8'RWOLJGY8L^W+S#YTO^[CYS
MLFTV[EMW*@NLNH1!R2(.:7;PK5*FB= ZT3Q4GL"O"D]O @GS/-.53T<JKTH/
M8_L9['DG/(<P@T_1N1VQZMZZOJ[CI-<0]** 4 H!0&B-]?!(Z2/9-;OAUO-'
MQ#W%._G_ )I'TZ>'6\>(>X=_/_-(^G3PZWCQ#W#OY_YI'TZ>'6\>(>X=_/\
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M!\!!\!% 68]<9+,A>/W1PN3&$]2'*5P,B..&I_GI[%>S6)JA=,D=5)% * 4
MH!0"@% ?EFO[HOUS[=?:$? WM+3P23ZE20CN>Y.V*;KGN-XK@=MC0Y<_'(]Q
M<CI5T6W'DEY3BR5:^40D#Z%>;T.OR6)W+S;2FU]1ZWF7+.+JH6K$5&MM/=[1
M$KILMG%IQR7DKZ(;[%LT-X@19;;\V"#^4-(UY2/JD@DIXDC@:W[?-+$[B@JK
M-L;5%+L9S+W)=1;M.XZ/+ZR3JX]J,7%]JLHR>S'(PY!LV-]0L-7>]2D08KKH
MU!2VI>I5Q!3J!IKJ->!K)?YA:M3R8RENBJLP:;E=V];XK<80V9IO*OI_\&T3
MC\ZV;8Y47K':9K5OO+<)_*$2 Y,8=:+8+<<)X+:5K[X'0A2N!T'+@=Z,M3;]
M*2K&N6F#V[>LVEII0T5WT(2RSIGKZ2I39U/[>[,QK9C,"[C]YF=W1ESGX\N#
M8YLQEJY2XJ7$K4IN.YP4.4:\I.NG@JE_FEFDXK,Z)IR2>5/K9?2\EO*5N<LJ
MS--0<EFDNJ+VX&QW3PJYY+O=D=@Q6"R@1VX\AU*2W%B1HS<-@N.N*/*A" 3Q
M/A)\)-8^7ZN-K10G<;QJM[;S/ MS713O\QN6[26%'T))98U?81#(=LLAQYFW
M3?.(%VLMTDI@P[S:929<(RE?^DIQ(!2KXP\!T[*Z%CF%NZVJ.,HJKC)4=-YS
M-1RJ[:RNL9QFZ*476-=U21(]'S<54J5;EHM[-U8"EQK<[-:1)F-H'%<=!XE&
MO#F5RC6M3XUIZ*7I9=]'1=IN_+FKJX^CF6Q9E679^-#,VXV=9RW$,JOMQD-Q
M[I;D^;VJ,[+;C)9E(4M+IFI4DJ; (3R<Q&O&L>NYH[-ZW"*JI;<*U71EWF;E
MG)5J+%R<W24<(JM*/IS=*Z/.1BS;9W.[N3T+O=BMC-OENV]4BXW-EAMZ0SIJ
M&??*6DZCE7IRGP'MK?N\PC"GH3EF5<(MT3WG*L\KG<S5G;@HR<:RFE5K=O[2
M;[.X7/QW>Z)C&76]HR&HTI:F'0B0PXA4<J0X@G5*DGP'Z' ZBN9S35QNZ%W+
M4L*KJZ3L<ET,K',5:O154GMQ6S:OIU;SE=KLLK(<FBV"WA*9=RFIB,$C1"5.
MN\O,=.Q*==3ZE=ZY=5JTYRV153R]JP[UY6X[9-+O?U'4LEN6W>W%Y>P['\0C
MY1<[:>A=;S>%NN%V2$CJ):8;(" @\-?'X].8\+3V]3JX*[.X[:ELC'H715GI
MM3>T>AN.Q;LJZX^M*>-7TT713Z;*N"=U3L_R]4+$L?1;'9@2MNTLK4&(Z&FT
MAQQ3CVG*@D%9*NS70>"NMQ8Z6S6[/-3IZ7CU=QP>#+6ZEQLPRYOZ5L6"KB^C
MI\I[9)MS>\:M;=]\[M]YL:WA%<N5FEHFL,R2.;I.E(!2K3U-/5XBHT^OMW9Y
M*2A*E:25&UO1.KY7<L6^(I1N0K3-"69)[F;6^[+YQC425.O342-'CO1X[)5)
M1S2G)*FTCS=/:L(+J><Z #CVZ&L%GFUBZTH5;:;V;*5V]M,#9U'(-58C*4TD
MDTECZU:>KV5QV&:K8/<-"YT9;,,7*&A3S=M\Z09DIE':Y':'%2-?)!/+J> K
M&N=Z;!XT?33!=39F?\;U:S+T<T<<N;&2WQ6[MH:VZ[19E9\;?R:2W%<BPBD7
M2''D(>F0N?33SAI/O#Q',G4J3X0.-9[7-+%RZK:K5[&UA+L9J7^1ZFU9=UT:
MCZR3K*/_ %+Z4Z2<WZV,N6/9-$&TPYDV<' Y$>2EEJ8OJQPE#ZTC4@]FJM?H
MUR[%QY]563273MIA+8=O5VH\/0Y81DY=#P4L8;?IWD5E[;Y9EF39;W'9HD-Z
MRS$HFVB*^E++!DN*2E+*G"E)0GE4I1U2E(\ '"NA#F%FQ:MYY-YUA)K;1=)Q
MY\IU&IOWN'",7;EC%/95O97"F'4EN6PU66[:Y'AULA7N<N)-LDY?19N-MD)E
M1P\ 26U*3IY7DJ]3@>-;.EYC:OS<%52CT25'3>:FNY1>TD(W).,H2P4HNJKN
M\S-E"V<S"9&85U+?'O$QGSJ#CTF8TU=9#!25!:(ZO& 3HH@UAGS:S%OUG%.C
MDHO*GVFQ#D&HE%8P4Y*J@Y)3:ZH^3IH0):%M.*:=24.H)2M"@0I*DG0@@]A!
MKKIIXH\[)-.CV@58J5%"#?X?E]YPB^Q[]9'>20UY+K*M2T^R2"IIP#35*M/H
M'B.(%:>KTEO4VW":P^I[T;^@U]W1WE=MO%=S6YGW'@>=67<"Q-7JT+Y5C1$V
M$H@NQWM-2A7C'P5?5#Z('RG7:*YI;F2?D>]'W3EG,K6NLJY;\JZ8O=]SZ23U
MH'5% 0Q7OCZ]=8X[*5)!\XM[W[EQ\1?W+EV^QR<4BW-RV/V5@R6;JL-R_->9
MAQ:UMN.$Z$-\@X>&M;B2IFPH;?"CFRXU.ZP,LQZY*N;<6X,J?LF@O#)6 Y$4
MI!<T>'U/D@GCXJSU1K.+1:C,,7<QO],!=HPQ<ME[O9;B41NF%<G-SJT&G-P]
M>F94KT#*ZTZ3!M&Y&!WZSW"_V?((4RT6I*G+E*:>24QT(25E3@[4CE!.I%0I
M)JM27"2=&BZV[BX)>+V,<M>0P)E\+0?$%F0VMTME(7J #Q/*0K0<=.-%)-TJ
M'"256CR8W/V]DY&<18R6WN9('%1S;DR$%WKH)"FM-=.<$$%'OO4IGC6E2<DJ
M5I@1/'-T2G-,ZM67W&)!LUGNMNM-B6XD,E3LV.7>FI940I2C[WLJBGBZEW;]
M%-$UOV?89C$M4'(+Y$MTQ$;S];,AU*%)BEP-!T@]B2L\H)\/"KN26TQJ#>Q$
M5O6\&*W+'KP[@&68^]D$",)2'+E)5YBRV'FVE./EC581JL)&GU1%5=Q4P:+J
MVZXIT-_<-RL(L+#HR/(K=!EQ&HSLY"GTH"?/$DME*5$*(7RJ*>'8*LYI;654
M)/8C/N&;XA:L?:RNX7N%'QQ]*%Q[FM]'F[H=XHZ:@=%%7@"=:ER252%%MTIB
M7V',\4RAQ;..WB)='&V&93B8CJ7N5F1S=-2N4G3FY5=OBHI)[ XM;48UXW#P
M;'[S'QZ]Y# @7N4 IF#(D-MND*UY20HCE"M/)YM-?!4.23HV%"354CSN&Y.!
M6JP0\HN.0P8U@N/"!.<>2&WSQX-^%78=>44<DE6H4)-TIB9+N=X8S#MMQ>OT
M%%OO"7%VR6J0V&'TLMEU90X3RGE2DD\:G,MXRO<78]FV(Y7;9%WQR]1+E;8B
ME(E28[R5(:*!S'J'7R=!Y7E>#C123V!Q:P:,?&]Q<%S"7(@XOD,"ZS(O%YB*
M^AQ83KIS  ZJ3K]4GA4*2>QB4)1VHQHFZFW$Z=!MD3*+:]/N25KA1T26RMQ+
M:E)5H-?&A0T/;H=*9X[R7;EN/,;C8Q?L?R"XX7D-IG2K-'>6[(=D<T*.ZAM2
MD+D*:U4&=4ZJ6GZD'2F9-.C&1IJJ+8^X=AL>&63(LZR"T1'+A':4J;%?(@2'
MU("EF(73SK0>U/ G2HS)*K8R-R:2-VO+\8;QL9@NZQTXP6DOBZEP>;]):@D*
MY^S0D@5;,J5Z"N5UITFJ3NIMNKO7ERFV$6, W50E-%+&IY?*/-I[[R>'U7#M
MX5&>.\MPY;C*<W#P=K&D9BYD$%.+NGE;NA?0&%+)*>0*UXJU!'+VZTS*E:X$
M9)5I3$T>0[RX/9\$E9];KE'O-K:7YO&;B/HYGY9U*8Z2>QP@$\I&NE0[B2J6
M5N3E0SH^ZV .8HQF4F_P8UB=4&3*6^GIB3H"IE)X<RT^)(UJ<ZI6I'#E6E#9
M(SO#7(-MN;=]A*MUX4INV2P^@LOK;0IQ02O735*4**N/#0ZU.9;R,CV4-#;<
M_9N>5K,6_6%[!S8N^6>1]P70!#Y;<DK"M&A$ '+SZZA7J552J]N!9PHMCK4V
M-FW)PK+6+BG$+_"NLV RMUUJ,ZEQ:  =%%.NI3K]4.%2I)[&0X26U&GV=S>Y
MY9M/:<VRIUKSZ0S*D3766^DT$,/NI!"=5::(0->-5MRK&K)N1I*B/3%-Q65;
M>1-PL^F0K';[J53(8<5T4,P9*RJ&VI2U'G=4URJ7R]JB=!H*F,O1JQ*'I95B
M8V9[P6&VX)?\GPRXV^^7*SP&;DB,A[JMEF0YR(4OI*! .BN&H.HJ)7%1M$QM
MMR2>!'KMN)NO@MDBYIF%LLUYPQ89=N;EC\ZCSH3$CE <Z<A3J74H*AS<JDGU
M .(JY2BJO864(R=%6IZRM[Y%MW;&'3X;!PB2W 9CWYHJYVIUT:4[&#VJN4-N
M\BD(/*/*TX]M.)25.@*U6%>DE.+YW<+UG>>8Q.8CL6O$U6X1)2"L.N)FQE/N
M%WF)2.4CARZ<.VKQE636XI*-(I[R,;4;R7G.LGF6>^6V-;[?.A*O6)/LJ<ZD
MJV(EN12IT+)'/JE"M$Z<#5(7')XE[EI155Y269!GG<^;1; I<:/8X-IEW[*+
MA)*AYM%0M+,8)(4 DK7U5$J!\ELZ5=RHZ&-0K&O71&8C=';IR5/A(RBVF5;(
M_GD]OSIK[5' !+BCS:: *3KXM1K4YX[QPY;B-;A;OP[-MA*W"P.1!O[;<B/%
M847%+C%;\A#"@LM$*!3SZZ=M5E.D:HM"W665X&"QN%N#C>9V_"LXBVB:[>[?
M/G6JYV;SEE"';<WU5MR&7U.*"2#P6%\3PT\49I)T9.2+554P]L=[[GFF'7J=
M?+<Q;,QM5M5>6(*.?S:3 >94Y'?;YE%125(+;@YO)(]45$+E4]Y-RUE:IL-A
M,W8O;6SV.9M%@Q7LPRCNV):K:HN)BKN%S<2A*/?<_* 5*]]KPJ7-Y4^ED*VL
M[70CS:W6OTO:$[C,0XPNUD?6,HM*0M2 W;Y)9G-LJ*P4K#:5.ME6O@![:9WE
MJ.&L^4ZY&D-2X[4J.H+8>0EQI8[%)6-01ZX-93">E 2^-^+M?$3[0KERVLZT
M=B/6JEA0"@% ?/WI3?J1<OB0_P"]IK3UG[3/5?Q7_P!E;[)?VLX'@GZK0OC/
M?UBJ\]+:?0^8_OR\GU$CJISR([C_ *O-_P!I1]:JK1VG6Y5^]Y#E%9CU9.]K
M_P#$;A_9Q]>*QSVG!YOZD>TZ5Z+GZR7SXT/^M<KIZ#UGV'D/YM^U9[9?5$^V
MJ[!\N% * 4 H!0&A@_K7=O[/&_VJD&^J * 4 H!0$8R59N,Z'CR#]H7_ +Y<
M=/"PVK1"#ZBU^U5HHJV9V@' #0#L%92I6@% * J$J) "22>(&G&@-9D-Y:QN
MPS\ADQ),Z-;FR\[%@H#LE24Z<W(@E.O*/*5QX)&M9K-IW9J":3>_88+]Y6K;
MFTY9>A;3F>9YKG]AQZ?G>+R[5DV"7)E+EE<0DQ;A"<E:-1^4$*1("75 *;4
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M$:$1V1R,Z_&42H>H:[>AMT@Y>T?+OY?K5?UBMQV6E3RO%_8O(?3E= \4* 4
MH!0"@% * 4 H!0"@(K<$FVY.A\\(MX:#2CX!*CCR=?C(X#UJO%E6;*LA4BV4
M[:X?GDIE_)X;TM]EDQHX1*D,-H225!1;96@*()UU5K6[I]=>TZ_QNGD7VG/U
M7+K&J_=6;RM?4S@WHO7=['\LRC;FZ_:I;O,ZRVK742[:M33R /&I"M?]2O2\
M^MJY:A>CL^R6SZ=9Y+^-W7:O7-//;]L<'].H^HJ\:>]% * 4 H#"NL]-MM[\
MP\5H3HT@<2IQ7!*0/#J30&SQ^W*M5GBPG.+Z4<[Y\;KA*U_^(FL!D-E0"@%
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MX%(5P4-/$=:Y&5/8?1+O+[-WTHX5Z5L/')<PE9$TS%,=,6(TKJ%M*BM2EZ:
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M^39_6=SV1P[!,2;=1;K_ &O(,RDH4J4_!E,R%-QTJ'D-(2HJ".*>=6G$Z:^
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B]/IIZ6G2T')RZ<O+IPTT\%4+%U * 4 H!0"@% * 4!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>fc_miprofile-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_miprofile-4c.jpg
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M%!04%!04%!04%/_  !$(!80$)@,!$0 "$0$#$0'_Q #A  $  @(# 0$
M        ! 4#!@$"!P@) 0$!  ,! 0$!             0(#! 4&!P@0  $#
M P(# P4(# H(!0$ $P(! P0 $042!B$3!S$B%$%1D3(587'14B.3519"DM(S
M4[,T5'24-0CP@:&QP7*R8],88H)SHR1U%S?A0^.T-E;"1,0EHD65M29V@V2$
M9:5&)W<X$0$  0," @4(!P8& P "  <  1$" Q($(3%!46$3!7&!D=$B,E(4
MH;'!X9(5%O!"8G(S!O&"LM(C-*+"4W,D%^+R0V.#P__:  P# 0 "$0,1 #\
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MC,S83P2(D@!=8?:)#;-LTN)"27145%NBI45FH% H% H% H% H% H% H% H%
MH% H*+.[TVCMD2+/YN%CE'M;D/M@ZOO-WU+_ !)07$62Q-C,S(IH[&D-B\RX
MG83;B(0JE_.BT&6@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@^-NI703JCN/?NX<YB<.V]C9TUQ^*ZLN*"DV78NDW$)/X
MTJU1YEO/I)OO8&.8RNZ<<$.#(>2*TX,AA]5=("-$LT9*G %XU1I-!Z?B_P!W
MSJMF<9"S&/PS;L#(,-RHKBRXH*3+X(8+I)U%2Z*G!4I4>V_NZ])]]=/]T97(
M[JQP0X4J!X=EP9##ZJ[SFSM9HR5. KQ6I(E=4/W9XN\-QR=R[;R[6+E9 U=R
M$*2VILD^7K. 0+<5)>)"J+WKK=.RE1M_1OHKB^EH2ISDU,IN.<",O2T#EMM,
M(J%RVQN2V4D12)5XV3@E%>KU!'ESH6/:Y\^2U%8O;F/F+87]\E1*"%%W1MJ<
MXC,+,P9+JKI1MF4RX2KYK"2K06M H(&0S>%Q-O:F1BP;I=/$OMLW3S]\DH.8
M.;PV46V,R,6:J)=4C/-O+;_4):"=0=>8'QD]*4'*$)>JJ+[RT!50>)*B)[M!
MQS&_C)Z4H.R*B\4[*!00I^9Q&*1%RF0C0D)+BLEYMFZ)YM:I0<P,MBLJ*GC)
MT>:(^L49T'D2_GT*M!,H% H/@3]XK_O%N3WXG_LV:RA&J=/]FO[_ -V0-J1I
M80GIW-49+HJ8CR6C=7NC95N@6H/6MT?NH;NPF)?R>&RL;-.1@)UR$+1QWS$$
M551I%4T(O,-TOY.-2H^?ZH^O/W2-V3,C@LSM*8X3C6'<:DX_4M]#,M3UMIYA
M$PU>^:U)'TA45ADRHL)DI$Q]N/''UG7C%L$]\B5$H(,3<NW,@\D:!EX4J0JV
M1IB2TX=_-I$E6@M* JHB77@E!UYC?QD]*4':Z6OY//05:;EVX4CP@YB"LI5T
MHPDEI7-7FTZKWH+2@4"@@3\YA<4MLIDHL)52Z))?;96WG[Y)0=H&8Q.512Q<
M^/-$>)+&>!Y$1?/H5:";0%5$2ZK9//0=>8W\9/2E!R1@ *X9(("BD1*MD1$X
MJJK008&<PN4<<9QF2BS7FDNZW&?;>($[.\@$JI_'0>'_ +U^7R>,V?A_9<]^
M&K^05N0D9XVE<!&372>A4NETO9:L(^,R(C)2-5(B6ZDO%55:H_3+:AA]5\(F
MI+^ B^5/P(5BJYH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H%!\^?O>?_  +#?\W#_P!L_5@?&U5'Z1=,O^W&T?\ DV/_
M /;-UBK:J#\W^IIFG4?=R(2V]LY#RK^<N5DCTK]T\B+J;*1254]DR>U?[YBI
M(^A^N'53_IAMAM^  .[BRIDQBVW.(!H1%<>)/*@:A2WE(D\EZ*^%L]N3/;HG
MGD]PY%_(S3555V0:G:_D%.P4_P!$41*J*RRI952WE2@^WOW6H^33IJ60R4M^
M2,V:\L('W#<!J.P@M:6T)5TIK$[VJ2K7/WC.MN5VO,38VT)"Q,HK0/9;)-_?
M61=2X,M+]B:C8R+M1%2W&]D(^2),J5.D')F/.293JZG'G2)QPB7RJ1*JJM4=
M6G7HSHO,&3+[:W!P%4#%4\J*EE2@_2G8D&=C=F8"%DY#LK)-0(Z3'Y!DXZ3Z
MMHIZB)55;$JIQK%7YS[A,TS^534OY9(\J_A2K)'OG[H!$6Z-Q:E5?^ :[5_O
MDJ2-\_>Y54Z?XE4547VNWV+;_P"UI%(5\:\QSXR^E:J/T=Z6<>FFT%7BOL:!
M_P"W"L5>+]?^O<_;TY[8^R7T9R;2(F7RP6(F2-+\EF]T0T1>^?V/8G>O:Q"/
ME-UW)YF:3KQOY#(R%53,U-]]PNU555U$JU0@9')X6<$[&2GH&1CE=M]@R9=
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M"\X5_C$TJHJ-E[(S>_LL>$V]X<LD+1/@Q(>!A7!!40D#7;42(NJR>2Z^2@]
M_P L'5O\PB?KC7PTJ'^6#JW^81/UQKX:5'T=G,%,VS^[M.P&104GX_;SC$H0
M)"%'1976B*G:B+PO45\'54?9O[I&0B/; R>-;<19L3*..OLW[PMOLM(V5O,2
MMFB>\M21U_>TST*)L;'[?5P5R62G \#-^\C$8#4SMYM1 /\ '2!\:51]>Y_
M2T_=,B1$!4?8@1,BH6X\LY0R%5?> ]50?(54?;W[J^5C3>EXP&S19&,G2&7V
M[]Y$=5'A54\RH?!?<6I*M+_?#RD;D;6PHDBR]<J8X%^(MV!L%5/])=5OZM(1
M\J]O!*H^^]Z0'<5T GXQ]%%^'MQN.Z*]J&U' "3TI45\"54?;/[J'_;!_P#Y
MK)_%,U)5[G4'SK^]]?ZG8!?)[37C_P#P[E6$?'M4?I;L>9&R&S-OS8;@NQWL
M=$(#%45/O(HJ</*B\%3SUBJ_H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M$L,I]I=0,!?UDNB*XO8@\.U4I(^KNL?_ &LW;_RU_P#LUBK\ZZR1]L_NH?\
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M&M+CS 154;^ZE!/H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M%3?M6?\ %H'M=_Z*F_:L_P"+0/:[_P!%3?M6?\6@>UW_ **F_:L_XM ]KO\
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M]E\*[@Y2278Z1G5)4<!O2J.!K$5T][3Q3UA6H-UH% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!!R3FF))3^Y=_
MD!:!A?V/C_T9G\6-!.H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M"@4"@4"@4"@4"@4"@4"@TKJ!TZ;WY[.=3/9/ S,6KJQW\4_R-7/0$+6EKK9
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M_P 7I^X_5N\ZK/1/^X_S0=3_ (N,_5C_ ,6GZ?VO\7I^X_5N\ZK/1/\ N/\
M-!U/^+C/U8_\6GZ?VO\ %Z?N/U;O.JST3_N/\T'4_P"+C/U8_P#%I^G]K_%Z
M?N/U;O.JST3_ +C_ #0=3_BXS]6/_%I^G]K_ !>G[C]6[SJL]$_[C_-!U/\
MBXS]6/\ Q:?I_:_Q>G[C]6[SJL]$_P"X_P T'4_XN,_5C_Q:?I_:_P 7I^X_
M5N\ZK/1/^X_S0=3_ (N,_5C_ ,6GZ?VO\7I^X_5N\ZK/1/\ N/\ -!U/^+C/
MU8_\6GZ?VO\ %Z?N/U;O.JST3_N/\T'4_P"+C/U8_P#%I^G]K_%Z?N/U;O.J
MST3_ +C_ #0=3_BXS]6/_%I^G]K_ !>G[C]6[SJL]$_[C_-!U/\ BXS]6/\
MQ:?I_:_Q>G[C]6[SJL]$_P"X_P T'4_XN,_5C_Q:?I_:_P 7I^X_5N\ZK/1/
M^Y883]Z?>\?)L.YZ%"G8F]I,>,V3#^E?LFS4R34GF)++[G;6K-_;N";9T3,7
M=O%T;?\ N[/%\=Y;;-O32L3]<OJ+:6\=N[WQ+>9VW,&7%*R.AZKK+BI=6W07
MB))YE]]+IQKXG<[7)M[]-\4GZ_(_1]KN\6YLUXKM4?5V2OJY764"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@U_+?_*-N^]._%#73C_IW^9IN]^WSKXBT^2_FKE;G
MCFX<SO'JIE)NU^GLU<'LV Z43/;Q%%5Z0^"V<C8^UKZ.PW46U^"+\;VL6/%M
MK8R98U7W>[9U=4W>IXF;)FW5TX\4Z+(X77]?7%OK4&1V_P#N]]#FF%W%';R6
MXG?E6_&)[2R3ZKVGRE[@(J]BD@I[]=./+O\ ?<+)I;V>S;#ER8=AL.-\1-W;
M[5RJ_P P?3/AXGIQ-;Q9*B+(+&QE'3Y]/9_+71^49XY9HK_-+1^<8.G#=$?R
MPMX&P.A76*$N<V"[[%SD8E<27B%*%-BO+V*Y'6R61>Q41$7R%7+?NMYM)TY8
MU6ST7<8EOLVFQWD:L/LW==OLS'F;/L[=&\-J9V+T^ZH.MS'YB*.V-W,IRV,B
MK8W6-(1> 241+I?U_=7UN//AQ9;.]P\/BLZNV/X?J=NWSYL.2,.?C7W;^OLG
MJGI[?K]9"]N/;7EO8=J!04NYOR&-^FQ/QXT$P?R8_>_I2B)U%*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*#P/\ >P_^$8;_ )J/_MGJ^I_MS^O=_+]L/A_[
MP_ZUG\__ *R^1*^_?E3;]B].LWU +)#AW6&/9K0N$4DB%'7G=7*8;THMW#T%
MI1?-7G[S?6;;3JB9U=7TSY'M>&^$Y-]JT3$:8Z>F9Y0K]F[4E[TW SM^)(:A
M/NMOO%(E:^6V$9LG3U( D5["ODK;NMS&#'KF*\N7:T>'["[=YNZB=//GV+',
M]/WX."=W1A,Q W'M^,Z$>=*QRNBY%<=X-\YE\&S$37@)6LJUIQ;Z+LG=WVS9
M=/*O3Y)AU;KPF<>*<V.^W)9'"9CG'EB4Z!TR"5A<)EIVZ<3B'MQ XYB84]9
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M3-VXW:F&S4+*KE7&68V3C<U(R&^6E$-# 311^R336'S>G#=DOMFW3T32K?\
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M_1F?Q8U!.H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MQ_Z,S^+&H)U!T>!PVB!ISE.*EA<LA:5\]EX+00?!93Z37YAN@>"RGTFOS#=
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M6@Y3)8\C%H93*N&?* $,5(G-.O2B7XKIX\/)05Y;JP@0"R)R$!H!(R;+@Z@
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MR41(;FI5%>\@)<53[+MO16JM]+]AP,RJ9[<8S-RZF<M+"64)IPAB3XD[F\E
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MLMK+73N=GFV\Q&2V;:N7:;_!NHF<5T74YMAKC=S5F\W.3J%/PCSXCAH^$BY
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MT=0E:8 STZ515+3I3SWH(TGJ3LF,RS)++ [%>8;E^)CMNR&6HSM]#KQM 8M
MME[SBC06.6W3A,*D59C[AE-$CB-Q&'IAN@""I$(QP<72B$G'LH.(&[MM93V7
MX#),OKF0?<QB"JHKR1+(\@HJ)8F[]\%L2<>'!:"<YE,>SDH^'<D"F3E-.R&(
MW%3)EA0%P^"<$17!2Z^>@K<GO3;.(F.8V;.3VHWH5<>RV[(E$CHD8Z660,R1
M4 EN(K;RT$B#N?;^1P[FX(F19+#,HXLB69<H&>0JHXCO,TJVH6[R&B*GEH(6
M+WYM7,3&,?"G$DN6!.PFY##\7Q( .I585]L$=LG'Y-5X<>R@J=I=2\3N?+Y;
M$(2A(BY!R'CT%B2B.L-1VG5,R-M! M1&FE53L3ST&+-[G#!=28C.3R!Q\(Y@
MGS2)WC%R8LYAMM0:!"(W-*DB(**MKT&QX[=VWLICYN3AS$6-C=29$76W&7HQ
M-CK)'67!%P%T]ZQ#Q3LH(L3?^U)GBT"<3)PHIY%]N5'D17%A->N^ /M@1MCY
M2!%\GG2@N'LQBX^(///2FQPS<=9IS;W:2,@<SF73['3QH*?)[^VIB'59F3B5
MX&1EOML,2)),1W$U"X^C+9JT*HE[N::#8(TF--C,S(;P2(D@!=8?:)#;<;--
M0D)#=%146Z*E!YGL7J3@XNR,*>Y,NX_DVX;3F6FDV])%DG+JBRGF@(&E5.WF
M$-D[:HWK+;HP6$C1960F"@3E08 ,B<AV02CKLRVRAFYW>/<%>'&H,</=^VYV
M'E9YG(M#BH).!/??NPL8V?7!X'4$FR&Z=TT1>*>=*#'B-Z[;SDLX$"623@9\
M4D:2P_$=./?3S6QD VIA=412"Z)=/.E!"7J9L:S1IEVSBN\I%G VZ<-LG[<L
M79 @K32KJ3@X8JGEH-LH-9:Z@;3D2PAQ9QR5-](@R8\:0]$60I('+\2VV3-]
M2V]>@XR/4+:.*E2HDS(=^ J#D'6F7WV(I$ET20\TV3;2VXKK)+>6@FY/=VVL
M.$9S(Y-AD)K2R(2H6OQ#8J"790$+F*O,"R!=5OPH&*W;M[-,37X4T1'&?M)N
M2!Q'8R*',17FY MF J/>0B%$5$6R\*"IE;XPN5P66D87+^SW8D(I@Y29"D(P
MTRHJHR$%X&T=;2U^X7&@LLANO"X$(,;+3>;DIC6MAB*PZ_(?0!36X## N&@)
M?BMK)>UZ#7=I[LC9?=6\9S>61_;,.-C'HYN.:(\9%:?5]50]/+6XW<0[*EN-
MJ"^Q.^=KYN<UCL?.4IDALGXC;S+\;Q#0(BD;!/ ".BETNK:KY^R@[0=\;4R;
MSS,#)M/^&CG+E/"A\AAELE$E=>44;;5%%>Z9(5DO:W&@ZXG?.U\W.:QV/G*4
MR0V3\1MYE^,DAH$12-@G@!'12Z75M5\_90=)?4#:,*<] D9)$<C.I'EOBT\Y
M%CO$J(C;T@ 5ILKJET,TMY;4$;I=.G9+I_@9^3D.2Y[\;4_)>+6X9:R2ZKY>
M%!MU H% H% H% H% H*G,?DDK_8N_P!@JHD87]CX_P#1F?Q8U!.H*C=6*?SN
MU\WA(Q $G)P)4)DW;\L3D,FV*E9%6R*7&R4'BSG2+J,W 0]O/XG;60>;QD5Y
MC'/26P'V2RX(S%<;:!#><,])@K5N4(CJO6546^"Z6[XPN?Q;K&:Y&VH63R$V
M1#CRGR-U)>0<F XO. DL;)I&=9[!TZ@+O+4J,>4Z2;QSV==?S&7![#CFHV54
M2F3"64Q'R;<QD>0B($8HL<2CM\E;.JNH[*E*B%D>BNZY6^L_N:')Q\:/DIJR
MF73(W'"9=+&*8<M&4Y9V@$AFKAH:*(H(\514<SNB&YLB[#/)Y,,B\]"2+EY<
MF=-(]89MG)7;%45%0F )D/55HD'3YT5'I.P]O;@V['D1<]+6>2"#<:84R1)(
MF@>?)L5:?%$!6VC;!3$E)RUR[$ND;A44H% H% H% H% H%!!S>.:R^&R.)?C
MM2V)\5Z*[%DJ2,.@\V0*#BC==!(MBMQM0>$'TGZF.Y3&8MO,+#Q^/A*F/RX3
M'W?9:!D!<898&P>+>;C"K7,DMHA"5EO9;VJ+.%T?WRQ%B,S\ZUD5#QGB6'Y4
MM&!ER&6FV\BT@"B\Y"%PC8=4@NXI"2+2I1U;Z(;K FYGUE4<JR@JS("1-1L7
M&'L:4<N5S.79IN/+!!T67G\;I>E2CH[T4WQ)@2(\G=1%-ODWX\CQ,M!7(/M
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M"J6WO#'.O+':CRBD$I^'9Y5C?%HB R;123@*@M]5EI0J!NS")$7*M YX!PQ
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M,S(> 2/EB2JJB:@!&(N(*DB+:@UO#=1)F9<W5!GP<IC(\*1)9B9)(.@8<=F
MV_J=4B-.:A$1"BC9;APXU1>1MZ8O'8;;[(O3<_E,G 9EQ&H\?7/DQ^6WJE.M
MCH%H54QU*2B.I=*<>%0=UZD[6:PXYJ8\]"CC-#%2V9+#C<B+--$5&GV[*HJJ
M**HO%%0A5%5%2@S8_?>,FY(,1(A9#&9&2TX_CV,C&*.LL&$NXC%U5%,4LJME
MI.RWTVO8*7I_U R&Z)V7A9#%3F/#Y.9&B2#AJPPU'805!MXU,K.\5O0<Y?J!
M.Q74!K;:8C(2\6F->DN+%AJ\;DA'F!$VSUI=L1<(3X<"M06\[?N,BSY6.@P<
MCF7\>J!D2Q<4I+<=Q40N69W%%<TDA*V&HD3M3BE!>8?,XS<&,CYC#21EXV4*
MDP^%T1;*HDBH2(HD)(HD)(BBJ*BI>@HI6_\ &-RI4;&8_)9M(+A,3I&+BK(8
M:?;5$-K6JBAF%^\+>I17@O'A0:L]DECS]_OOY>7BF S&%:9E1P1]UKQ,6 "-
MBVX)(*.&YI/N\-2K5&TSNH&&BY2?@HD:;E,YC2 9N/Q\<GG6@=9%X'"55$$$
MD)$&Y7(KHB+9:@C9#=.)S&.VYD\=F96.C3<RQ$$68_RKSX*Z+D&2V\"DTBD!
M"YP$A4>V@E3M^XR--EP,= R.;?QQ*WD%Q499#;#J"A\HC4@%7+$BJ *1)Y42
M@R9;>L;$6(\/EY+ L#*D/QH+C@,MFFJQWTJI"G$@;0B3S4%6]DV<EU"VE+QT
MKGXJ=@\I*9-LUY+H$Y )L[=B]TN"JGEH&\]\3MM;EVWB8V-FS(F1=?\ &E%B
MK(4P"*\X#;1(8_*(8(1);U+T%B&_L,]EV]OQV)KN<7PRR8(1C5R*U+;1P79"
MKW0 ;Z252];@B+:@@X'=+,3:.%FL'EMV>/%PF9S<-/$NBADNIX11IMM$OI'5
M:_N\:"JW7N:%N'"[:R.'>>:1-TXJ',8-#C2&7FY2"['?;X*BIV$*\%3CQ146
MJ-F;WOCY.9/$0(.0G S)\!*R4:,KD%F2GK@;MT]1>!D(J(KP5;WJ"HZIY%K$
MQMKY"3**)"8W#!.6\AD \E >NA:.)(JV33QNMN%!:8_?F,F9.-B9D'(XB3/U
M)C3R<4HS4D@124&RNJ(>D5+EGI)4[$X+0<3M_8S%S28R<#(P\<$@89YI^(08
M\73)&PNXJZD C5 1S1HNOK6XT&3(;WQ\++/8:- R&4EQ%:'(%CHRR&XJR+*"
M.E=.\HDAJ(:B0>*I94H.<OO;'8S(/8J-#G9C)16Q>G1L7'6248'$50YJW$4(
MT15$+J:IQTVM0<2-_;;;Q.-R\5]S(-YE5#$1(31O2Y)@A$8@S9"16T$N9KTH
M%N]9:#7(>YF<YU1Q,5D)<&1&PV1*;BIH''=#5)B(TZH74#$K'H,").U+WX51
MN&?W/C-N^%:EH](R$\B#'XV&V3\N03::CT-C]B"<3,E01\J\4J"OB[^P;\;+
M.R@E8Z9@XQSLEC9K!,RPB@)ES1#BC@+H)$)LB2Z6[>%!';ZE[>=.*\C,T<'.
M<;8B;@.*8XUQQ]4%NSJ\4$R) %PA0%+L+BE!.W[N"5M;:.7S<&,[)FQ(K[D8
M6FE?0'1:(@-P44?DQ5$4UOV4$7!;YB3X^&:R,2; R.6/PT9N9&)CG/!%*4X0
MI<K!I K*J]O"@NY6<Q\/+P\&^1)D)[$F5&! 515J&K:.JI)P14YH63RT&L,=
M6-JR8L?*,A-+;KZM@>?6,8XYAQQ=.EUU;:=)=PSTJ %P(DXV";$ZA825D(<$
MV)L2/DW%8Q.3EQC9A3'4%3$&G"\IB)$WK0=:)W;T&3);ZQL'(2<7"A3\S-@H
MGM ,7&60,92%#$'#51'6HKJY8JIVXVXI<.LKJ-M*+B<;FRF$YCLL\46";3+I
MN')!#56%;0=:.Z@)OEJ.K7W;7H(F^L@]-Z6[@R3+,G'ONXF4ZVR^GAY3)<HK
M:D$ET$G];A08X_4O;[$2+)?:G#@"1II-RE&-,6JF@B)J\O>1LB72CJAH\NJW
M&@G-9W&P,_NIZ?FW4B8F/"?FQ)( U$@MFVX6MMQ!12YB"I'<ELJ<*#I%ZB8=
MZ3#9FPLCBHV1<%C'3\C#<C1GWG%LV"$7$"<^P1T04NQ./"@J]LYZ%A WWE,W
M,)J#%W&ZV).*;JIKB0Q!IH$U$JD96!L$NI+P2ZT%UC=]8R;DHV(FPLAAITY"
M7'AE(RQQDJ J9"V:*0ZQ%-2MDJ';C;@M@QR>H.'9F2HT6)D,C&Q[JQ\ED8$4
MY$2,Z"V< S'B1-_^8C0GI[%XHJ4$C ;ZVWN:0Q&P\DGBEQ',A$-6S!MZ,S)*
M*9@1(B+I,4NG;8A7RT%G'SF/E9J;@8YD>0QS+#\Q$%>6VDI3Y8J79J5 4M/F
MLOE2@L:!0*!0*!0*!0*!05.8_))7^Q=_L%5$C"_L?'_HS/XL:@G4&&7&;FQ'
MX;RJC,ALV7%%;%I<%16R^1;+04S>TH4:;*R./D2(DV68N.N-D)#][%HD0"%1
M1"04)>'KIJ\][42<=M^)C)0RF2)5;CC#8%4%-+(JA65434:W2]S5;76W:M06
MU H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H*7<WY#&_38GX\:"8/Y,?O?TI1$ZBE!3[JVSB]X[
M?G;;S($>.G@@.\LM)BHDA@8K9;$)"A)=+<.-=.VW%^#)&2SG:Y=WM;-SBNQ7
M^[<U#ICT:V[TO=FS,=)?GY*<*-'*DZ1T,"NK0 @B(EU1%)5O>R=E>AXCXMEW
MD1%T1;$=$=;R_"_!<6PFZZV9NNNZ9ZGH]>,]YYUE,+!W7OG=.#F+>.[MF'CW
MU2RD'CI$U=27["30A#[MJ"!L&5,WKEVLMFN_(VE 7;\P2%+>WG%1,B:+Y; T
MR@KYG"JBHV1N*7/Q&V=LMY]K 8R%MZ-.?F#R5E2U%UZ*0-'($FP!CD(KI:2*
MYCZOE"LQTF-]39\X9RRL;&Z@,/.9200I=A,E'^6=)$$4'BBZK(EN/91&^,Y/
M&XGJCD).8DM--9[%PF=O3W"%&3\$[(\3&!U5MS-3H.:+W)%_T5M%9-T38$_>
M&P5B2&90-9:<V:M&+J"\&*DJHK95L2(M[=J4&7<AB/4W8HZD0SC9M$2]E44:
MC*J>ZET1:"%O;)8K$]2-A3<P8,1^1FF6ICUD::=="*@ZC7@&I$44)?*MO+01
M-\Y^*NZ<//P38Y?)[3A9?,Y%J*:&3<98)MML&HZK%(=5O0/:NA2MW:HH,]/.
M8UL*=D-V!F,ID\[B93>.A)';@HVXXI*38 *O: OI$W'5NMD7BMJ(O8<F,S&Z
MKP7GFVYWC);_ (8C%'>4YB(Z@>A5OI)!*R]G!?,M%:[L]IYK*XE9>X7L .7V
MK@4PC[015:DA$9/GLBY*9=3F 3PN: 5%43U66RV(L-RX+&8QW&Y=K..9R=E=
MV;?;R#[YQE$78;FEL$",VV(EI5+W2Z\**V_?JH.8V&5T$_K"(B78MBQLY%1%
M]U.VH(W31]AN7O* XX(3AW+D'"C$2(ZC;HM&!:5XV(50D7RI09,A)CPNK>*=
MF/!':D[>GLQS=) %QT)D0R 5)4N2#WE1/)QH(G3C,8O"X7)8+-S6(6X,1D<B
M[FQE&$<R\3+=DA*76J:FW6W (7.SR=HJE!+Z8B4C%Y_,10)C%YS-3LEAE,5'
M7%>T CZ 5E07G -X;IQ0T7RT$7I=F\'C=CP<+.E,8[+X%M8F>AR70:=9F-DO
M.<<0B3@Z:JZ)]A(5[T&L;G<!4ZB+J2WUBVPM[I:R^RK>FJ-UV>C?UVZA$*#S
M%R./0R1$U*B8J+9%7MX7X5!H*.-).<%"%$3J<(HB*G UAB2I[ZJMZHV_IAE\
M7B=L.X',368>X,+)FCG6)3B-.HZY)<>607,5%)MX31T7/55"[;HMH,;NY2S.
M8W",[<X[<P> <:8"/&6.DN0#L=M\91./B[\FYS-#*-!WM*]Y5[J4:YTS-"?Z
M9=ZZ_5O+HE_6LDF$G%/(OG3R4&Z;V>9B;NV#,E. Q$#)36C?=) ;1Q[&R1;%
M2*R(IKP%/*O"H,>T58/J+U!=:4",BPZ$8JBJH>!N/%/)Q54]^J-,V'N":Y@=
MF;2C95O P9&&>R;N546C=D<J0K2QXZOHK8J"%S'"425$TV3M6B*YB7#?;F'$
MR9Y2+_U%PX-3WR!3>5&X8JJ* @)#=-(D(V)$X7[:*W#*2&]EY3VQM/,LS(&6
MS#;&4VF1MOJ<R=(!J0Y"(5YC;PD2O.M%J!;&M@6ZT$[JU*AP(FU)V0X0HVY<
M<\^:IJ0!!'5UJB<; O?5?(B7\E0<[\R>(SC6W<'BI3,[,S<OC9T!(I@\;4>%
M)"0_*[JK9L6@,=?8JD@]I4&B[QW*YN+I?G=QY?<:P2EC)CP]KQ!8%6S:>Y21
MGT,#?<=33=ZR@@W5;(*7JC;MYOM[3=S.]MLYQAG*M"RYF]MR' =CY!YIH0;;
M$457&93C: VV0<#L&H"[:"#MR-(:W#NW%RMU2L!E7,L]DDQZ#"1'H<IMM6'V
MUDL.$8H HR5B5!(%'A0=\5&Q6T-[XB9(RRS<#EX63#'YJ2XT3*Y6;."9(;UL
MB#0*\B7!$1+\LDXK0699G$Y/K)C(V.?;D2(.#R(2W6K& DY)AJ+2F-T4T05)
M0O<45%7M2@SY.9%PG56%D<T8QL?E,*N-Q4YY4%D9K4I7WF%-> F\"MD"+;7R
MUMQ2H-:ZE38.<R&8/#.A(' ;4SX9Z8RJ&T"3F&^1%-P;HIJK1NZ%]5!NOK)>
MBYZA<IOHCD+((-!B(ZA:R".D6]-O(EO)0;1U ;<=V'NEIH5-T\1D! !2Y$2Q
MG$1$1.U5J#4,IE<8VSTTW"LQDL)$E U*G 8FRTLW&/,LD9HMA$C(0U+PN2>>
MJ)F2S.+R'5?;\&#+;D2(6(S"RD:)#%M73A:04ANFNPJ2CVHEE7@J5!11D9']
MVA4%!%KZLN*J(B(/&.JK[G%:HV;?RM!M[;1EI01SN 4>SA_QK*</XJ@Q;!R^
M)P[6X,)EY+./SL'+9*;DADF#!.LS))OLRTU*EVS:($0NQ-*C]C5&I8Y8D[-8
M;,QF$'#9O>TK(8<C2PO-!AG65D@B\=+KK1N OE3O>6@]!ZI_]MMV(J7OBIB:
M?/=DDM_'V5!5YW=>TY'326L>4Q)CSL:YCX>,:LK[TA]A60B"PG?1Q2) 5O3<
M?+:RT&@2H,^$NY8\\2G'@V]ER=PQFTY[CT;'W<E=U.)61LG+?9(-4;SU,SV!
MSNQG\1B)D?*Y/<8M1<!&B.@\;TAQP2;=#0JV%E4YQN=@(-U6H-8??8AY+(9V
M<*'@,/OTY&7*R$,<3Q+3#<ASS T\X!$OV*=[[&J-MWYE,5FSVW@,2^S/SLG+
M8_(PAC&#Q1X\)\7WI9:55!;1M""Z\"4T%.VH,'3S<VWMO[.8PV;G,8O,X0GH
MN7@R7!;D))%TR-Q 5=1H\I<UL@1=>KA=:#5-NVQO3/:._HS),)MN;/DS65 D
M<'#S9K[4P5;'RM H/J/D5JU4>D[!A/CB9&>G"J9/<<IS+2$);J#3J($9J_;\
MG'!H;>>]0;70*!0*!0*!0*!0*"IS'Y)*_P!B[_8*J)&%_8^/_1F?Q8U!.H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H%!2[F_(8WZ;$_'C03!_)C][^E*(G44H% H%!T%
MED73?%L1><01<<1$0B0+Z45>U;76U ;9::U\IL0YA*9Z40=1KVDMNU5\]!!E
M8#!3F68\W%Q),>,JE':>CM. V1=J@)"J"J^6U!*<@PGF7XST9IR/)NDEDP$@
M=0A05UBJ6*Z)9;^2@CG@L(YC@Q#F-BGB6[<N 3#:QQLMTLVHZ4XKYJ#M#P^)
MQ[;;./@1HK+)JXTVPR#0@9#I4A041$54X*J>2@DDPR;K;YMB3S6I&G%%%(4.
MR%I7M2]N-!KV:VV]EMTX/+GR7,5 B9*)/C/(I*ZD](Z"B"HJ)#\D6I"]R@N<
M=B<7B&BCXF#'@,&6LVHK0, I6M=4!$15LE!CB8'!P"=.#C(D4WS%Q\F&&VU<
M,"UB1*(I=4+O(J^6@R.XC%/S4R3T&.YD1;5@9AM 3Z-%=%!#5-6E;KPO:@2\
M3BI\0<?/@QY4 -.B*^T#C(Z$L-@)%%+)V<*#B+AL/!CA$A8^-&BMN(^##++;
M;8NIV&@BB(A);M[:"4XRRZK9.MB9-%K:4D15$[*FH;]BV54O01_9>,3(+EDA
M,>U5#E+.Y0>(Y?Q>9;5I]R] GXO&906PR<)B:#)HZR,EH'D!Q.PA0T6Q)YTH
M,4_!8/*NM/Y3&1)K[*69=DL-O&"7OW5,55./FH+"@K9VW=OY20,O)XF'-E@B
M"+\F.T\X@IV(A&*K;C02RA0SYB'':)'2 W;@*ZR;MH4N'%1TI95[+)09 99;
M-QQML0<>5"=,41"-41!125.VR(B<:#'X*%>_AVK\WQ%] _?K6YG9ZUOLNV@B
MY';^!R[H/Y;%Q)[S::6W)4=IXA&][(IBJHG&@[/83"R)4><_CHKLV(@C$DFP
MV3K0@MQ1LU&XHB\4LM!);AQ&B VF&P-I"%LA 444<5")$5$X(2I=?/0=)V/@
M92,<+)169D,[*<>0V+S1**W2XFBHME2@[L1(L:_AF&V=2")<L!"XMII%%LB<
M!3@GFH(TO!82?&:ASL;%DPV"UL1WF&W&P+SB)"J(O'R4&=($ 401BLH(D!BB
M-C9#:1! DX=HHB(*^2@CLX'!QYYY6/C(C64<4E<G-L-C()2]95<0=2W\O&@G
M&TVXH*X FK9:VU)$725E2Z7[%LJI00L?@\)B7'7<5C8L%UZW..*PVR1VXIJ4
M!2_\=!PF!P:3'LBF,B)D)(J$B5R&^<X))I5#/3J)%3@MUH!X'!.9 <LYC(AY
M4+:9Q,-K(32EDLXHZN"=G&@[9+"8;,(VF7QT6>C-U:24RV_H5;7T\P5M>WDH
M.QXC%.8_V2<&.6*TH'@2:!8^E%NB<M4TV1>/90<P\7C,<VVSCX3$1EG4C+;#
M0-"".*BEI041$U*B7MVT&29!A9&,</(1FI<1RW,CO@+K966Z7$T5%LJ4&.+B
ML9!AKCH4)B-CR0D*(RT#;*H? D4!1!X^7A09G(\=YA8SK0.1B32K)BA HIY%
M%4M:@RT%>S@L''AOX^/C(C4"4I%*BML-BRZ1\"4P0=)*MN-TH,D+$8G'-MM8
M^#'B--:N4##0-"/,MJTH*);59+^>@S>$BI&\$C#?@]/+\/H'E:.S3IM:WN4'
M9QAAX1!UL'  A,!(4)$(%N*HB]BHJ<*"'D<%A,N;;F6QL6>XS=&3E,-OD"+Q
M72IBMOXJ"83#!JT1M 2LKJ95115 K*-Q\RV54X4'+K3;S9-/ +C1I8P-$(51
M?(J+P6@AA@\(WD%R[>-BCEBOJGBPVDA;II6[B#JXIP[:"6+#(.N/ V(O.Z4=
M<040B0. ZE[5M?A00X6!P>-DNS<=C(D28]?G2([#;3IZENNH@%%6Z\>-!+&-
M'%'1%H!%]5)Y$%$0R)$%5+AQ541$XT$7'8/"X?F+B,;%@*[;F^%8;8UV[-7+
M%+VOY:#6LHSN]_(NG'VYAI$MHC3$9R3((N0VJJH*XUX?F(27NHMN67XR4$4]
MDY0,+B-C1Y +M5IM"W!D3)4F355Q7'6 ;%-("^:DKIZ^ *H"G'4@;ZB(B(B)
M9$X(B4'- H% H% H% H% H*G,?DDK_8N_P!@JHD87]CX_P#1F?Q8U!.H,<B.
MU*9..^.MEQ+&-U2Z>^EEH*6+B=K3N8D+E25:6SO)?)S2J^0M)K;LK*ZRZWG%
M$BZ)Y2D?5K"?FO\ O'/NJQ4^K6$_-?\ >.?=4'3V#M[G>&Y0^(T\SD\T]>B]
MM6G7>U^%ZM)I4J[_ %:PGYK_ +QS[JH'U:PGYK_O'/NJ NV\&*76-9$[55QS
M[JA5T>P&WX[1/2&1:9!+FX;IB(IYU53LE6(F9I!,T=_JUA/S7_>.?=5!""'L
MUQP6FWHQNDND0&5<E+S(B.=M;)QWQT2QUQUI;6W\ ^V#S+ N,N(A X#ID)"O
M%%14.RHM83$QPEE$U=OJUA/S7_>.?=5 ^K6$_-?]XY]U0/JUA/S7_>.?=4#Z
MM83\U_WCGW5!P>W<"V.MR.@ EKD3KB)Q6R<5*K!5S]6L)^:_[QS[JH'U:PGY
MK_O'/NJ!]6L)^:_[QS[J@+MO!I:\:U^"?*.=OVU"I]6L)^:_[QS[J@?5O!WM
MX;CVVYCE[?;4*GU:PGYK_O'/NJ!]6L)^:_[QS[J@?5K"?FO^\<^ZH'U:PGYK
M_O'/NJ!]6L)^:_[QS[J@?5K"?FO^\<^ZH'U:PGYK_O'/NJ!]6L)^:_[QS[J@
M?5K"?FO^\<^ZH'U:PGYK_O'/NJ!]6L)^:_[QS[J@?5K"?FO^\<^ZH'U:PGYK
M_O'/NJ!]6L)^:_[QS[J@?5K"?FO^\<^ZH'U:PGYK_O'/NJ!]6L)^:_[QS[J@
M?5K"?FO^\<^ZH'U:PGYK_O'/NJ!]6L)^:_[QS[J@?5K"?FO^\<^ZH'U:PGYK
M_O'/NJ!]6L)^:_[QS[J@?5K"?FO^\<^ZH'U:PGYK_O'/NJ!]6L)^:_[QS[J@
M?5K"?FO^\<^ZH'U:PGYK_O'/NJ!]6L)^:_[QS[J@?5K"?FO^\<^ZH'U:PGYK
M_O'/NJ#(Q@<3&>"0Q'TO-K<"UFME]Y25*"RH%!2[F_(8WZ;$_'C03!_)C][^
ME*(G44H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MC-!X,5")I 4Y0DFE4#AW45$MPK*;[IKQY\TTQZ$./MG;\7Q/A\<PV,Q-,EM
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MIIN3"0H<4F'5)TD13YQGW>YQ2Q)6JS?XXFZ:3QG[&[)X;DNMMBMO"*?2@_\
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MFOF-"5D[Y$2#Y45*<3@]8A2AG0V)@-N-!(;%T6W@5MP4-+HA"O$5\Z+58L]
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M++.P(L(6<CB[]XWA Q)-.CO*I*"B>I+(G9\8KT:H% H% H% H% H% H% H%
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M@4"@4%3F/R25_L7?[!51(PO['Q_Z,S^+&H)U!P7JK[RU826OUTN4J!0*!0*
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M1L5CY64F*21(3+DA]6P)T^6T*D6D 12);)V(EZ#)$E,SHC$V/J5B2V#S6L2
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M]B[_ &"JB1A?V/C_ -&9_%C4$Z@ZGZA>\M6$E0(J6KI<I=*!=*!=*!=*!=*
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M,AF4RXCK;VIUID>X8 8CI[4XT%-N3;'43>.W)&V<K,Q4!IT!Y\^'XAPY1LN
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MN.X*DKS<J$[%01MP[7+K?R5!28S;^_<#BF]J8N= <PL44BXW-2.:N0CPD[H
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M/8?Q"@3OC0<%64!N^M2*]ATV75?U;+>@AX3>&V-QR'HN$RC$V2P/,<9;+O\
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M/EE-24U5#)"(N)>55H&/V;M_&%CG(\=QQ[$J\N,>DR'Y3C"201MP0-YPUTJ
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MG@O<>6:") BD?>]7MH4;5M7=N,WA"?FXQM]H([J,NM2F^4XBFT#X%:Z]TVW
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M% H% H% H% H% H% H*G,?DDK_8N_P!@JHD87]CX_P#1F?Q8U!.H%! K:TE
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MI,CP]OSFW9[-CC$X<V(JM ZG R!$N>E50;I?C15E,T_]7<.BV4DV]DK>=/\
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M&VQ(C$40SMK)$2Y6X)=?+:@PPX$'',^&Q\9J)'NI<IAL6@U%VKI!$2ZT&9
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M8/Y,?O?TI1$ZBE H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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ME*(G44H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M?Q8U!.H%!J.ZF,T^Q$'"&X#J/W>5HD%5'05D*Y#PU6NO&W;I7LK:TJ L?O\
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MQLB+0H(C2JND=.L5"QKZ*#UT$- %#+4:(B$2):Z^5;>2H.U H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M92)X_'/0=6CQ,=QG7;5;F(0WMPO:]2&4M=':LHWW)+N1<;?=1L55A3$ ;$1
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M3VG@_P"]3[5::C3VG@_[U/M5IJ-/:>#_ +U/M5IJ-/:>#_O4^U6FHT]IX/\
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M=5M6FR\$*W>3L7RT%Y0*#J^TW(9)AX4-ET"!P"XH0E=%1??2@KGMNX.0IJ_
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M H% H% H% H% H% H% H% H% H% H% H% H%!4YC\DE?[%W^P542,+^Q\?\
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MSU];;EU2W"UJHMLC,?Q4[#[2Q$=,_N=6)$UN?F'11(L4#%LWG70;4E)2=%L
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MO^+0-&X/P\/YEW_%H&C<'X>'\R[_ (M T;@_#P_F7?\ %H&C</D?A7_V+O\
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MV#:*!0*!0*!0*!0*!0*!0*!0*!0*"MF?M?&>](_L#065 H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M'N\"1$1%3CP5$1.*4U0:99&-OMQGSD,11;>-54B%4XW]R]J:H-,I7@I7X/\
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MM\:9[)K]-(7=:FXH% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MH*?,=0I^$R\N"]BQE,-&VC",N6-6G&B)%(E111TG!1ODEI5$77J5*4*NY]3
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M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"MF?M?&>](_L#065 H% H% H%
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M9()-J/JD*+VU!0XWICD#R^)R>\]V3=UM;==63@H4IB+%:;E<LF1DR/#@//?
M") (K"*DI(.JRI1IO3_I#N"3MG&P-Y9:;$P3&9FYF1LU0C$T;[67?EQ-4@$(
M_#DJ-2.3J];M6W=H-J+H]&5W*M)G)28?(;CA[OC0.6UJBY*++;F/(+MM1-/.
M-IW2]3C9:#$_T7CORI6/7<,Y.G\[*%G9NS^6P3!S7)'C#;20H<T8QOISC81?
M654U("Z:";(Z1XN3M[-;=<R4E8^:W&FZGGK-ZVWQGLST9'A;EZF4"Z\;+YZ"
M0UTX>>ZA1^H&;SCN1D8L)C&"A#&CQ!C,3[(XVZZR*.2!%!1&T<6P^LJ*7% W
MRH% H%! S?[%R/Z*_P#BRH,\'\AC?[)O^RE!(H% H% H% H% H% H% H% H%
M H% H% H*7<WY#&_38GX\:"8/Y,?O?TI1$ZBE H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H*V9^U\9[TC^P-!94"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@@9O]BY']%?_%E09X/Y#&_V3?\ 92@D
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%+N;\AC?IL3\>-!,'\F/WOZ4HB=12
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%
M;,_:^,]Z1_8&@LJ##((A0=*JE[]E96L;F#6Y\9?365&%9-;GQE]-*%9-;GQE
M]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE
M]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE
M]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE
M]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE
M]-*%9-;GQE]-*%9-;GQE]-*%9-;GQE]-*%9.8Y\9?35H5EV<,T-40E1.'E]R
MI$$S+KK<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,
MOII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,
MOII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,
MOII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,
MOII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,OII0K)K<^,
MOII0K)S'/C+Z:M"LIB=B5J;4'-_L7(VM?PK_ &]GWLJ"CQ.X,C(Q O.P%B&4
M,W8:*CCBJ;#2*J&F@>U5N/'BB>>JC$UN;+,F3!1%F1D#6WDR XXF)6N?*027
M2VJZ3MQ7@HC:]*#+]9,J"B)PELBJANJ#O*1"XB1J(*J7M811%7BBK:E!(C[@
MRIDRDG%&TKS9O(T*D3B6 B%LK@B(7=L2WLBJB)>]!U9W)D2;>D.X]/",MN$C
MPDX*.$#1.ZAUMBJ!W>7=>.KR6H(B[KRSQLLQH(*IH).2;/JUI54[S=VA4D5"
MLBK;O(M^'&E"KE-S[@>A.R&,/RW&T1$!]7%)"(T"Q" *O<XDY9>SU;TH).0W
M/-A..BUCRD$V8 #0H[J<$ANI(2-J*(M^[Y[+V4H.OUGR00I$F1BR!]B0U'1@
M5,U+6MBO8.'G$K66Z=G&E!R&?S#DZ'#<@)'1YP"<)4<.[3B$6D5T(B$"(G,U
M61+\+T$9K=6;%ELI>+1%)MPE=;YVC4WW5L*MZK(7;Y=/&E!DB[DS[X\PL2.A
M%,B!"=1Q &Y(*(K=E-13AQ1%54[*4!=RYUR.;[6*%L1<!O4X3A6YCEE4A!NZ
M(V*+K]VUKI2@F2,YE(\I[5C=4!H]',$C5U1U*BGI1NVE$%26R]EJ"*NX\M(5
MY8T%&V19D&TIB\1F3;2&U;N(B*2JMQ7CV4&-K<V:DL2Q#'H#T>(K[4@4<5MY
MQ$145L" 34%55'BFI%3L[+AQ]<,CS" <0Z\( A*K2.7<*ZI\D)-IJ0N"BJVL
ME[IPXJ#)'W+EGW;EC^6VW&<?-L>8:F2:-!B6A$0"NMD]?@O=I09ASV9=BOOA
MCP!4;,HQFKJB9M:54E% 0D T*X?9<.R@XAY[,K-B0)>/0AD=\I@*0M\M5)$%
M-0^NB#J).RR\.-!LU12@I=S?D,;]-B?CQH)@_DQ^]_2E$3J*4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@K9G[7QGO2/[
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MIN#<F#8^L<US.(\R3Q162PK;B,H"%I]9/55%MV)6,,Y3-HY#9,R5TIS\LO\
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M03!_)C][^E*(G44H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MF<5\ENQ:J-0#K'DWGH$)IO%BLB9,A+ED.6]"?6"W',N0#;2NH2$\31HXB()
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M6L+D>LV!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*([N>NO\
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MIY]N4R;$?\H=%P5!NP(YWU1;#W20N/D6]!G$A,4,%0@)+B2<45%\J4'- H%
MH% H% H% H% H% H% H%$3D[$K4WH.;_ &+D?T5_\65!G@_D,;_9-_V4H)%
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M;T7>OJE^@^&^+8=[;[/"_IMZ?-UPWZO+>P44H% H% H% H% H% H% H% H%
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M'R!^]>J?7W$IY?9#7_N9%?H']N?]>[^;[(?E/]W_ /:L_DC_ %7/!Z^H?$%
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M@W#8)F.WRB+F P31FCJ]WO=V^HJ(M-VX.;@XNUH.V 1&,:4R/CD?17FV\@[
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MY3((YCL;-RY8EV9<VVXN)@L<M&6E14Y(2'F-)F-KZK7]6@CIC<%D7%7V:,+
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MY:"KQ@8UN?EPAND[-*2#N10[KH>-AI!%%5$2W+$%LE!:4$27CH\V3"E/J6N
MZ3[ H5@5PVC9N2>6PN%;W:"70*!0*!0<+=45$6R^>@K\/AHN%8=:8-U]^0XK
M\N7)/F/O.DB)J,K(G!$011$1!%$1$1*"QH% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H*V9^U\9[TC^P-!94$67&\0H
M]]!TW[>/;6=LT876U1O9O]\GH_\ &L]?8PT=I[-_OD]'_C37V&CM/9O]\GH_
M\::^PT=I[-_OD]'_ (TU]AH[3V;_ 'R>C_QIK[#1VGLW^^3T?^--?8:.T]F_
MWR>C_P ::^PT=I[-_OD]'_C37V&CM/9O]\GH_P#&FOL-':>S?[Y/1_XTU]AH
M[3V;_?)Z/_&FOL-':>S?[Y/1_P"--?8:.T]F_P!\GH_\::^PT=I[-_OD]'_C
M37V&CM/9O]\GH_\ &FOL-':>S?[Y/1_XTU]AH[3V;_?)Z/\ QIK[#1VGLW^^
M3T?^--?8:.T]F_WR>C_QIK[#1VGLW^^3T?\ C37V&CM/9O\ ?)Z/_&FOL-':
M>S?[Y/1_XTU]AH[3V;_?)Z/_ !IK[#1VGLW^^3T?^--?8:.T]F_WR>C_ ,::
M^PT=I[-_OD]'_C37V&CM/9O]\GH_\::^PT=I[-_OD]'_ (TU]AH[3V;_ 'R>
MC_QIK[#1VGLW^^3T?^--?8:.T]F_WR>C_P ::^PT=KLY -0;$7!L-^*\+W6]
M2+R;&/V<Y^$#^6KK30>SG/P@?RTUF@]G.?A _EIK-![.<_"!_+36:#V<Y^$#
M^6FLT'LYS\('\M-9H/9SOX0/Y::X-$GLYW\('I7X*:S1)[.=_"!Z5^"FLT2>
MSG?P@>E?@IK-$GLYW\('I7X*:S1)[.=_"!Z5^"FLT2>SG?P@>E?@IK-$GLYW
M\('I7X*:S1)[.=_"!Z5^"FLT2>SG?P@>E?@IK-$GLYW\('I7X*:S1)[.=_"!
MZ5^"FLT2>SG?P@>E?@IK-$GLYW\('I7X*:S1)[.=_"!Z5^"FLT2>SG?P@>E?
M@IK-$GLYW\('I7X*:S1)[.=_"!Z5^"FLT2>SG?P@>E?@IK-$GLYW\('I7X*:
MS1)[.=_"!Z5^"FLT2>SG?P@>E?@IK-$GLYW\('I7X*:S1)[.=_"!Z5^"FLT2
M>SG?P@>E?@IK31*T%+"B>9*TNA!SG[%R7Z*_^+*@F,_>F_ZJ?S4'>@T_>F.^
ML,[%;;4D%MX9<XW$XDTY%;0&'4XHJ*#KP&/NC0:U"S,[/YF.BOKCLE.Y."GR
M6D3FQWH+#TN:RVI707#,@$5XV"Y)Q1*HYE,/9G)L;8]M2W<<QG46'*;?M(((
M4194AHG!3OBR_H%%7B)+I5>[03=\2'(&:3+LOR$=V]BCD-BCRC&5Z8^##9R!
M1.\ H!D?%.ZE0=,]+R^V'I$/'9J1D,C(Q;Y2/%J#B,37GFF(;X@(H@:W733E
MIW2$>"=V@NY_CL:N$VHSE)!2LN[(\3F'E I'+8;5YP6^Z@"9^J"(-@"ZHG=H
M*7<#<R!DQ@XZ6X[(B0VX\67+-'WADYR>VPG>-%OI!D[73@E4<G(S#K/MSVT\
M"R-P#!P<1E02+X1)8Q3!P$3Y34+;QW5>%TTVM09L+-G;HFN0BRCT: 0/912C
MD#,EQE^8^Q&;$A&Z-@W'N2IWE4A2]N"P0<G/G2L:W-]NRH3LK*-X3;L5AQ$(
ME9EI%<=?[BDX9<MQP]7=$?)>ZK18MR9C>U<UEL=)T3,QEG1AR4M<4=EA :)%
M)+>H JE02<KD,OE<KN"!MN8KCV)A1&7(;3@-KXJ0Z3S@"X8D@.JP(H"EP%31
M5H* ,AG]T(</:LB6W!BQ(CD&:_+;9<1Z<TKZ/2Q43<<$$(4%M$TG8D55[4H]
M18+6R!<P7NZEW0MI)4X*J65?+4&2@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@K9G[7QGO2/[ T%E00W_
M +Z7\7\U;(Y-5W-TLE5B62@62@62@62@62@62@62@62@62@62@62@62@62@6
M2@62@62@62@62@62@62@62@62@62@62@62@62@62@62@62@62@R']Z:_CJ1S
M9SR8[)58%DH%DH%DH%DH%DH.R_>Q_K+_ $4Z670ZV2C$LE LE LE LE LE L
ME LE LE LE LE LE LE LE LE LE LE LE LE LE LE LE LE LE!.3L2M3>
M@YS]BY+]%?\ Q94$QG[TW_53^:@[T&/P\=9"2U:#Q2 K2/:4UHVJH2CJ[;*J
M(MJ"%+P.%G1WXLO'QW8\EU)+X*V*:WT1$1U51$778435V\*#GV%AN3"CI 8%
MG&N(]  0$48<&]B;M;2O%;V[:"4<.(XKY.,-FLD$:D*0(O,;'4B =TXBFHN"
M^=:"% V[@L8PL:!CH\=A7 >( ;&RN-*B@2\.*@J)I^+Y*#/DL5C<Q&\'E(K<
MN,A(: Z.K28]A"O:BI?M2@ZM8;$,BT+4%@48Y2,V;&X^'NC5EM]AJ+3YKK09
M1QV/!IA@(C(L1CYL=M&Q06W./>!+61>\O%//00Y6V=O31BA)QD=P82:8J<L4
MY8<%TC9$L*JB7'LH.X;>P3<Y[)!CHZ3WS%UV1RQUJX*HJ%>W!;HBW3MLE!G<
MQ6,=QY8DXC*XPQ5LHF@49426ZII1+=O&@AGM;;IP5QI8R/X$B$S91M$0B!-*
M$5N)+;A=>V@RN[?P;\N-/=Q[!3(8B$9[EHA +?$!2UN KQ%/L?)02H,&%C(K
M4''1VXL)E-+,=D4;;!%6]A$;(G%:"10*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05LS]KXSWI']@:"RH(
MCWWTOXOYJV1R:KN:DW/NC ;,PDG<>YY[>-PD/1XB8]J415TQ;!+"BJJJ1(G!
M*J*J7U,V/#G3\6YE@<R>,QJ9N;"CM/27V\>2B@NZ&0,EOK&P"BFMTX4*-J%P
M#MI+B0H:"O M*^6R\: A@JZ4)%)4U(E^-O/0.:W92UCI%=)+=+(O99:"&SF<
M3(R4O#L3F'<K ;:>G0@<$GF&Y&KEDX"+<4/06G5VVH*#=/4O9NS'GF-PY'PK
ML?&/9QY!:<=TP([K3!.7;$NUQX $?6)5X)0B%C%WCMN7D/9(9 &\FLI^ U#D
M(4=YZ1$:!YX61=05=0 ,5(V]0^[06.1RF/Q.-F9?(R CXS'LNR9LDU[C3,<5
M-PR5/((BJK0,9DX.8QT/+8UY'\?D&&Y<-]$5$<8>%# T0D1;*)(O%*#I+S6(
MQ[T2-.G,1Y$]Y8L%IUP0-Y\0)Q6VT5;D2")$J)Y$O01=S;HPFS\%/W)GY/AL
M3C01R6\(DZ0H1((H@-H1*I$2(B(EUO0=<YNS!;<;8=S,@HS<@)+H'RG7 $(4
M<Y+Q.&V)"V@MMDMS5+KP2ZJB4%?B^H^S,LU$>CY,60G# *'XQMV(CQ9=E9$5
MMI7Q!#<-M%)0!5(?LD2A1M-TNB7XKV)0:I$ZF;%G9+%8B+FF7<AG#FMX=D4/
M_BEQA$,E6UTV404#35?26E=*K0HJG.N'2P,7%S+>XFY,"<^_%A%#8DRW'G(B
MBCZMM,-&X8-ZQUN"*@ETXT*2V%O?&U7<HF&;R399%9YX?E()V]H-Q/'%'U:=
M.M&/E+7]SMX4*-@H% H% H% H% H% H% H,A_>FOXZD<V4\FO9_=>.V_*Q^/
M?:D2\GE%=\%!AM*\\81T%77+71$$-8ZE5?*EKU6+O#WAM:>#YQ<S#<"-,/&/
M+S@'3-:)1)GO*G?147A00!Z@[;*!G9R/EJVZLY,A#[OBM.-54>,&M6I1X=TN
M%^%!>Q,KCIKB,1Y+92^4#YQ=8\\&W40A4P1;C=%\M!,H%!V7[V/]9?Z*B]#K
M50H% H% H% H% H% H% H% H% H% H% H% HB<G8E:F]!SG[%R7Z*_\ BRH)
MC/WIO^JG\U!WH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MQ4]%*E#0'Q4]%*E#0'Q4]%*E#0'Q4]%*E'.D52VE+)V):HM'&@/BIZ*M4H:
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M% H% H%! SG[%R7Z*_\ BRH)C/WIO^JG\U!WH% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M5$)7E&0G<OP02+BG"E!!9ZDYZ:P])A8=H&'Y;4#'.RG%: 'W)R0M#^G45_\
MS>Z/"VGM5%I0JLMS9/)8C<6(FSY1K@=+#,B+ >!MT)KSJ@CCC!(IOLN*H@B
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M253!S0"IJLM[HMJ4&ZQG3?CLO.-DR;@"9,GZP*2(JBONIV5%1<Y^Q<E^BO\
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MOKK 4$@5_4;>A$1$5$\E;<UD7=Y=/5;,>2:?8TX,DV1BMMX5NOB[MF(NF?\
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MRH)C/WIO^JG\U!WH% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MBZN9QLO!?XZ#:JBE H%! SG[%R7Z*_\ BRH)C/WIO^JG\U!WH% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MNH2>&#5I16@5>]Q)22@]%J*4"@4"@4"@4"@4"@@9S]BY+]%?_%E03&?O3?\
M53^:@[T"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@K9G[7QGO2/[ T%E0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#A1$K:D1;+=+\>*4'- H% H% H%
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M']@:"RH(4N8Y'<0 $511OQOYZV6VUAKNNF)8/:;_ ,0/Y?AK+1##O)/:;_Q
M_E^&FB#O)/:;_P 0/Y?AIH@[R3VF_P#$#^7X::(.\D]IO_$#^7X::(.\D]IO
M_$#^7X::(.\D]IO_ ! _E^&FB#O)/:;_ ,0/Y?AIH@[R3VF_\0/Y?AIH@[R3
MVF_\0/Y?AIH@[R3VF_\ $#^7X::(.\D]IO\ Q _E^&FB#O)/:;_Q _E^&FB#
MO)/:;_Q _E^&FB#O)/:;_P 0/Y?AIH@[R3VF_P#$#^7X::(.\D]IO_$#^7X:
M:(.\D]IO_$#^7X::(.\D]IO_ ! _E^&FB#O)/:;_ ,0/Y?AIH@[R3VF_\0/Y
M?AIH@[R3VF_\0/Y?AIH@[R3VF_\ $#^7X::(.\D]IO\ Q _E^&FB#O)/:;_Q
M _E^&FB#O)/:;_Q _E^&FB#O)/:;_P 0/Y?AIH@[R3VF_P#$#^7X::(.\D]I
MO_$#^7X::(.\D]IO_$#^7X::(.\D]IO_ ! _E^&FB#O)/:;_ ,0/Y?AIH@[R
M3VF_\0/Y?AIH@[R3VF_\0/Y?AIH@[R3VF_\ $#^7X::(.\D]IO\ Q _E^&FB
M#O)/:;_Q _E^&FB#O)/:;_Q _E^&FB#O)=VI[IJ=Q'N@1):_:G\=2;(6+Y=/
M:;_Q _E^&KHA.\D]IO\ Q _E^&FB#O)/:;_Q _E^&FB#O)/:;_Q _E^&FB#O
M)/:;_P 0/Y?AIH@[R3VF_P#$#^7X::(.\D]IO_$#^7X::(.\D]IO_$#^7X::
M(.\D]IO_ ! _E^&FB#O)/:;_ ,0/Y?AIH@[R3VF_\0/Y?AIH@[R3VF_\0/Y?
MAIH@[R3VF_\ $#^7X::(.\D]IO\ Q _E^&FB#O)/:;_Q _E^&FB#O)/:;_Q
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MEXC#L \F;PQ/JS'E..J*8^2KW I*-:7CY=D%%1%3BEZ4>ET0H% H% H% H%
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MF7T4"R^9?1034[$K4W(.<_8N2_17_P 65!,9^]-_U4_FH.] H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H*V9^U\9[TC^P-!94"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@@9S]BY+]%?\ Q94$QG[TW_53^:@[T"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@K9G[7QGO2/[(T%E0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*"!G/V+DOT5_\65!,9^]-_U4_FH.] H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M8E H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M'I;_ !946:P$J$^W)BNIJ;?9(7&R3SB0JJ+7FW6S;-)BDNZ)KR9JQ4H% H%
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M H% H% H% H% H% H% H% H% H% H."]5?>H*3!?D<?^HE5%Y44H% H% H%
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M[HOSTZ+;9CT2C])L?E5W!N3!XA).QG7]H,$QC)<US)<Z=,U(WF6S4S $#@)
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M0YE!BP7[*8_U_P 85!8T"@4"@4"@4"@4"@4"@4"@PJPA2ADKVB"@/\:WH,U
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MJ.OG;=;Y:=*)NGIVT&[-T>S7XF V=AY+(!-R;SO);6:TCS$<-(O/.N**DM@
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M>R\,V^2=IJB9[WO-?&>.F9IY/,B9#I[@\;)WB0D4O%L89O.[4E(XJ:XLF0V
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MY(?-7'W2)QUPEN1&2W557SJJU@\^ZZ;IF9FLRQT8E H% H% H% H% H% H%
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M%!#F4&+!?LIC_7_&%06- H% H% H% H% H% H% H% H% H% H% H% H% H%
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M H% H% H% H%!P7JK[U!28+\CC_U$JHO*BE H% H% H% H% H% H% H% H%
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M_P#]*SRW?ZI>NUX;Z H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M-G,["PF2E0X)9EX,WF6CY\QN*#++,QY 3F/7X<$ !1+)[B4&>+U)CY9[;\?
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MG? B)"T(2W7A=$U)2@BN]4&L6W,=W+B7,8C$&1DXH-R8TPWF8:@CP$C1_)N
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M;*81U%[4YS''02"NI0U+\6Z+06S^\,PV]%P\;;QR=TNQRG2\<,IH6(T9'%:
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M,P<:;(G."JOMOM.@WCWR1J2C)6!Q%43$%U#P6Q72@MLCN3<T;J+C]NQ,8#^
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M-B=[6LI 2=M^%!)>=".RX^ZMFVA(S5./=%+K0:X_O[:C&/#(NSDY90HF61E
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M88]Y6D;DQ2N1\VRFXIIJTDBAI3309I1Y^5A]^[F^L4]F;MW(SRPL=D@"*TU
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M<&Q[UUO<51%M1-VEE]P;QS>UGLCEGX\-=N,9>;"AD#3<F>DKEZG#!.+=D+4
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M"@4"@4"@4!>Q:"DR7KQ_TAG\8E5%W45!R^9Q>!@GDLO)")";405P[K<W"00
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M#*&9"(6U6&R72Z\:"[Q&\-MYYR,SB<@$EV8P[+C@(F*DU&=1A[@0I8FW"0'
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MG7.DR@!:;#/(N2O^$<(T$SY1ZM*J*ZDT+QH(NZ(&X-W.[DFQMORF8$K&XF%
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M I3B!*>#%/9(&VL@YCT0>4LH6N[S$76-[(1"@D2(2K03\%^1Q_ZB4%Y44H%
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- H% H% H% H% H/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>fc_companion-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_companion-4c.jpg
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M%!04%!04%/_  !$( C4#M@,!$0 "$0$#$0'_Q #1  $  04! 0$
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M/!++6AUTX6M*HMI.6/2MO2=&5BW<O:QRBI.,53D\U[.A%C@87$8S9G0C-8^
MS%S$O/Q>]SVFT"0\CTA=:..(FHD6R)Z2\$X)PK8E=G.[J8R;:4'1;MAKJQ;M
MV-+*"2D[D:O>ZO''^L,-AY8G-=*\-/ZN,;ZA,O9>=F,HUCN=$*0X^VANHC,9
MQ )&W$<(26Q"O$2OPX97+6JG&P[3\U1C7&FY8M;U3GWE5J]H[<M2KRK)SG3"
MM<=D7N=:<-SW8?8F4S&W</L'9N[WHVV&SP;\I=P3\0&9FF+TIQ6L<R#S3B J
M-<O4"HJ\42W8BQ*W"Y.[<MIS\Y+*IY5L7G.CXU,XW9VH6;-UJWYC>9PSO&3\
MQ56'FTJN9<*V3;,"/D]I]*\-E62E8XMYS(CL20"HG)4VE)LPXZ45574/NK6Q
M?FXW;\HX/JTZ])1I[:EI]/"2JNMI1\Z_IF4;YQN/PN[NLN-P\1N!CG-KQ)!1
M(P(TPKRDSZ: "(*+Q7L3PK[M:>EG*Y:T\I.KSO%]TW]5;C;NZF,%E3MIT6RN
M']=))Q<G ;>W?LK<74M@2V<_LG'1-OSI3!2(,><++2O 0H)(CA#KXJGYR?@Q
MNQG<M786'YZNR<DG1M5?>V&%B5NU<LW+_P#&[,5%O%9J+OTK_6S%9V,;?V0V
MX$%R/L;.]16'MMX^0!-WQKK;X&H"ME%LT441/<7RUN0FU>>/_I&R\S_Y8=\U
M)VU*Q'#_ ,YZA95_Q:>SDH;9QV*QFW_O*2H&"A,XR#)VMK?BQ&Q88(Q>1$70
M"(**B"/8G@KB3N2N=G*4VY/K-KYCO6K4+7:;C!**ZK8L%Z7 MN<W?MK97WB)
MF6W5/3&XYW:[49M\FW745XW@)!1&@->P27L\%76M-<O]GJ-M5?65W>,HU&KM
M:;M)SNO*NJIL;W\E>!9,Y)D[_P AOSJA!@R(VSL=M&7@\/+E-E'.<XX)*;H-
MDEU;'6?'XOANB;%J*T\;5AM.;N*32W<G@[YKWI/4RO:F*:MJU*,6_P"[?7FQ
M?>Y4K7)W"T,'9^U<I*B[>PQ;/B/-9H\.UEY^2<?!$*#'YP&@HBDJ:>W4B^-+
M71LO-<N13G+K'YN=Q4?^3H42O^;:M2:A%VEYV13E+_@JU_WYRV[:D0X6U>C^
MXMXQW)G3S#R<RQE4)HY#,:6X^YW8W@%"N*+ITI9?55+>!;K\7*[J(6\+DE"F
MZJIC0U]/-1L::[=QM1<\V]5J\O?I0IRDS;^0#KCD-JQ>ZX"5CL8]";1@HJ$)
MNM*3HM$B*(N%=P?12Z+>R4A&Y#X97'62<JXUW/?R;#)SM7/BY6UYC4&L*<,:
M<NTSC);>P6W=P=!9F#QS..E2UY<M^,VC;CHN1627FD*7)5)PE52X\5KG0O3N
M0U2FVTME>=[.@Z<K%NU=TCA%1;6[F6WCM>WE,':=VCC^F&ZMD[LQ9/=9)4^2
MG=G(;CV3E37GA)A]AY&U56[:ENAHEM7#T_2Z+5V6IA=MR_\ !);_ #4MZ:X_
MUNPY2=B&EN6KL:ZAM_VUDY;FG39MY\</.QNF])$;9F7AYT,K$RG4UG$X?&[D
MV7EX#D])SJ,LI_TKJ@J(2\%/EEZR+QNMJITT7?BXY7&TY3<9QE2F+VKRE^JF
MM/-3S*5Y1A&<)1<LS>7T7X<N_EP,LQ4C 8C[PF97<.-;Q<W<>,QY[>9>C(=\
MBXV"NHVX *@N(:&)'PN2+=:TKBN3T$<DLRA*6;'=5]ZFXZ-IV[?:,L\<LKD8
MY<-]%7'G-;[;[E"V3TMS^Z(#L_IWB\KF/K]H6B?9;DNN(D9U]M+Z@%?&*\$)
M/SK+UK^:5Z_"VZ7)1CEYM]/ZX<#B6,L=-IYW%FM1<\^]8O"JW_[K?1](XO([
M7WCLG-%T\-EW'269T)LX<988+-..J+8"!NY>D/I:>-?)SA=LWH]=6J<7BZX5
M/M;5VUJ+$NHV/,L%3&G<-)P"FXC;'1WJSCH+V4P>V8K^.ST6*',>8 E..;PM
MIVZ5UW[.*#QXWKZ"5)7-1IY/+*;3C7?OIX.^?,Q;5K3:F"S1MIJ5-OJU\/>Y
MS/\ ='5+8.]]A[PQ.U<LN0R0X";,<8[M(9T--B@EJ)T!'4BDGHHM<VQH+]B_
M;E<C19TMJ\1U-1VGIM3I[L+4JOJY/8UAW48C$ZK[<D]&X&P=K=XS^^9^#'"#
MB(<9\E:=?:Y+A..$ @@@A+Q15][C6]+L^Y'6.]<I"VIYJMK=B<Z':5JYH5I[
M=9W)0RY4GO5'C2F']88F/[ZVI/:A;>V'LQMR3U"VGMJ2N[9L1Q4%,<\UJ."J
MBB\PS5P^6/B7_%Z.SI-1'-*[<PMW)K(GQ];DV8_U75UVGFX1LVL;MNV^L:X4
M]&E/.K7!>7#-LAE=L[EP/1:'L=I(L$]P17X< ?E8S.*:)98'P15(%7TR7UKZ
MOSJY\+=RU/4.[B\C5>.;T?ZW;#I7+EJ_;TL;."ZR+2WTAZ7/3>]^W>7[JVNK
MJ-T@)$6RYF8J<.ST6:U>S_E]1^E>,W>TOFM/^J7B-3XS;> F=$.JN;EXN.]F
M6,U-1B>XTA2&T9<8($ U34*(IEZMKW6]TKMW+]R.LL14GE<%ANWG M:>U/1Z
MF4HIR5R5'O5,N_NOI+XSD]N[<Z@[?W-U59YVW,CL[&LX'(3(SDV,W(%EM7P4
M!!RSA7-?5OZ7^*M=V[EVQ.WIWYRN2S).CI5T\70;"NVK-^%W4KS96HY9--X[
M]SQV\U>4PP!BCTWRB18;D*%_,:,L:"ZV3;C+*MJH 0+=1415$MX.RM]U^(C5
MU?4O'CB:$,OP[HJ+XC!4V8=XV! S.R-E]3NH"]7XX,Y3*SDD83)9&$<]A[$\
M4::946W+:1TH5D\&GM&N9.U>OZ:U\,\(KSDI4\[EQ7+X3I6[UC3:F\]4O.E+
MS6XN2<=R6&Y43Z-QA/53<OVB8W]#R#\;"3H,U A;9CX8')TYIDVU&?(GDVI@
MB@FK6)IZ/#L5$+H:"QU75-)R37I9\%_Q4>?^N'.[2U'7==%M0<9>@H8RHUYS
ME3@NBFU-5S?!/X#"==,+.W3'::#<.V\8&'E/QN:DC,.FPB&AH!6>4A5.8O%/
M"O&N?=5RYHI*V_0G*N.R./>Y#IP=NWVC"5Q4SVXT=-LVX]_E,(Q451V'MS+9
MB([,V)B=[3Y&ZHX-D\ M_HQ:==;%%4FP]-"X>&WAKH7)?^\XQ=+DK2R]_!<N
MPY\8KJ(2FJVXW9.>%>Z^18UZ"^Y][!9S,]2-R[ CH.R$V@Y#R<V,P4>#)RO,
M$@Y0J((I"*<20? OM<=:RIVX687G_P"G652;JU$V;SA<N7[EE?\ GU33:PBY
M?[>/B2YN!PN%PW0'*8;&L0LI+R.-[U+8!&WGN\@T;O--.):U5;ZE\/#A6$+L
MYSU49-M*,J+A2M";EF%NUHYP2C)RMU:WUI7I&T,IB-M]4(>%V)-B[PPV?R\M
M^?$?Q[C>8PSI+I>D=Z< 2T!9>)=HWLG'5346YW=,Y74[<H15/.\V?!4,]-=C
M:U:C9:NQG-MK+YT-S=7_ %38JNITDO!51%NGCKY(^T% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0!.Q?)^6@.6"]8O*M=0XY30"@,UZ4_P <8_XD
MC]0=47_09?I_31T97+.J<7?>>_J>7[OB^<Z]&^W_ )7VF>0?=?SOLQ\9IFOH
MCY$4 H#]']I_PM@_W?$_4A7C^I_EE^I^$_06C_@A^F/@-9?>>_I@7[PB^8Z[
M7V_\U[+/G/NOY+VH^,XMKT8\@% * 4 H!0"@% * 4 H!0"@% * 4 H!0%3?K
MCY4\]&2MI^F;?J#Y$\U>,,_1:V$>=\F/QOR5E$AD&K#$4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@"*J+=."IV+0"Z(1.((HX:6-Q!%#)$\9(EUH#
M[J](CLG,)-).636HIX%+M5* ^</9'W>"<?+PX_AH#Z!(!B6D5TJBHFE+);Q<
M.'X* Q39>QV-F/[A?;G+D%W!EG<WI<9$$C./7] ;D6I4OZ_"MW5:IWU!4IDC
MEYSGZ31K3N>-<\G+FJ96I*MM2(5BUBI(A*A>TE^Q?=2M(Z!\545551&Z\572
M-[KX>SM]V@'#V17QJHHJKY>'&@"V(5 A$FR[0(44>'%/15+4!](E-5([$J^T
MB+[U^R@/G#Q)?QV2_O\ ;0%)-M&HDXTV9#Q$C 35/(I(JU-611%9$1K<_2]Q
M>*6\5NRH)/B+9172-Q55!=*>BJI9=/#AP\5 6#=6%W'F6(P[8W,>UYK!F;CS
M<-B:R^)CIT.M.V2R=J*GAK:T]VW!OK(=8N=KOFGJK-VY&EJYU;XY5+O,@;(V
M(&SW<ODYV5?W#N?/NMNYC,S !M748%0:;;9&XMM@B\!\B=B(B6:K5]<HQ45"
M$/1BN7E*M'HNH<I2DYSG3-)[Z;*+<OZW(R[A[(^YZ*</)PX?@K1.B?=2ZD.R
M<P4TBY9-:#XD+M1* ^(MB$](\P$5 -113%"[40K72@"V+2I(A*%]"DB*HZNW
M2J\4O[E $6UT1!0211(4%-*HO:BI:U  LV@HV(@(>H("@BEN/!$1$IM!:\#M
M[%;8&<W@VSC,9"8[DGH^M3:"1(LKG*%?DP)4U:$X7[*NO7I7:9L:*G<7'B46
M;$+-<F&9N7=>VG#F+H.D$(0  $UU&@@(H2^-;)Q_#5)>?&Q!D2%AL&1+UD:
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M%+O96GN**<?15%B]A%GM_5VG)J2\]U>"VEHW+OW=^\9+$G<^4=R7=CYK$=U
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M4+<74?JAF!<:VMTPFQC[&9FXYL;',)_B)MHGW5\FE%H"Z;)V+N>'N"1OC?\
MGURVZ9$=84;'P4./A\?%(T,FV6E6[ADHCJ==]+APLE ;#J0* 4 H!0"@% *
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M515K(@]Z 4 H!0"@% * 4 H!0"@(\Z;&QL*3D9A\N'#:<D2'/9::%3)?P(E
M:/=#J'UUB8.<6'A;4Z?I/A9W'SY3QR<X\S$=1YDFV0$6V%=1/SC)4 JC:3L)
MTS#]2>F&X-V[LVOB\=NW;N?EKFLC%<?.#F6.2P#9,M&HN-O"@M_HA72J=GAH
M#:FV-Q8W=VW<7N?#FKF+RT9N7%(DTEH=%"L2> D[%3QU)!=J 4 H!0"@% *
M4 H#&=S=0]B[-(6]T[A@8I\[:&)+X \M^RS=]7'R4!80Z\='#=1E=Z8MITNP
M7WD85;__ +1!J*HFC/7*];>E&'!M7]UP)+SR*K$6 YW^0Y;P U&1PU7\%*HB
MA;6>ML.:VDC%[)W=.A?.F\.;863PH+QMFO\ Z:5!7!Z_=-'Y"0LO/D;:G$?+
M"-N&(_BU(O$)O@+:_@.E430N4_K7TCQAHW-WKAP<7L$9C3B\?< BI5"@Q_6K
MI-DYC<"'N_&K,=^29=?1@B^+S=-Z51!G0D)B)@2$!(A"0K=%1>**BI4@JH!0
M!.Q?)^6@.6"]8O*M=0XY30"@,UZ4_P <8_XDC]0=47_09?I_31T97+.J<7?>
M>_J>7[OB^<Z]&^W_ )7VF>0?=?SOLQ\9IFOHCY$4 H#]']I_PM@_W?$_4A7C
M^I_EE^I^$_06C_@A^F/@-9?>>_I@7[PB^8Z[7V_\U[+/G/NOY+VH^,XMKT8\
M@% * 4 H#-NENR\?OS<4K#9*2]%88Q\F<+D;2IJ;&FPKK14LNJN9VCJY::VI
M12=9)8\IWNQ>S[>MO.$VTE%O#DH8[C]M[BRR1%QN(F2^_JX,)6&''$>)GY1
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M@.G^\=I,R,IL?#PMR8IYW#[@@E C*K.1@KRW;*H743X. OLDE$29K_+#IO\
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MYG,WFG!*7*98/T@BL@VC#&KM3QU"#.BZR(% $[%\GY: Y8+UB\JUU#CE- *
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M.PY.T7LSF<UF7=P;LW$\T]ELHZT$9O3&#ELLL,@JHVTVBEI2ZK=55: S6@%
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M0_3'P&LOO/?TP+]X1?,==K[?^:]EGSGW7\E[4?&<6UZ,>0"@% * 4 [.*]E
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M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%J 4 H!0"@% * 4 H!0"@%
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M6GQ77P4!-+#X\F9#"MKRY3XRWO2*ZO 0$A7OPXMCPH".FW,8A2!LZL.5S.?
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M0DET6@$';N)Q[P2(S1=X!QY_FFX9D3LE!1TR4E6ZEI3R>"@+K0"@"=B^3\M
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M)K+30DT++^IAO0I*I*3:J^BZK(J66A![Y/(YS%N1,>;Z2I>05TT?CQ%/D-L
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M !F7FI#0JJKH*4WK<%+]B:D4K?XJ$E[H!0"@% * 4 H!0"@% * 4 H!0"@%
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M1YWR8_&_)642&0:L,10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0!.Q?)^6
M@.6"]8O*M=0XY30"@,UZ4_QQC_B2/U!U1?\ 09?I_31T97+.J<7?>>_J>7[O
MB^<Z]&^W_E?:9Y!]U_.^S'QF/;"SVPF=K9_:>_3R3,/*RH4QAS$BV3A+$1Q%
M$U<NFFY)PTULZVSJ'=A<LY6XIKSN6A5V7JM*M-.SJ'**DT_-Y#+-S;AZ";GC
MXAK(S]T*&"QS6)@"@,:.6Q=1,T)%36M[$J6X(G#A6A8L:^RY.*M^?+,]N\ZV
MIU'9>H4%*=SS(J*[F_9MXFC^/A[:^H/@6?H]M/\ A;!_N^)^I"O']3_++]3\
M)^@='_!#],? 8+U_VYG-T[ 7%;?A.3\@LV.[R&M.K0"'<O25."72NGV-?MV=
M1FFZ*C.+]Q::[J-)DMQS2S+ Y9_DEU5_VQ*]]K_GK[CZMI/\B/-/H.N_Q/O>
M4?R2ZJ_[8E>^U_ST^K:3_(A]!UW^)][RC^2757_;$KWVO^>GU;2?Y$/H.N_Q
M/O>4?R2ZJ_[8E>^U_P ]/JVD_P B'T'7?XGWO*/Y)=5?]L2O?:_YZ?5M)_D0
M^@Z[_$^]Y1_)+JK_ +8E>^U_ST^K:3_(A]!UW^)][RC^2757_;$KWVO^>GU;
M2?Y$/H.N_P 3[WE'\DNJO^V)7OM?\]/JVD_R(?0==_B?>\H_DEU5_P!L2O?:
M_P">GU;2?Y$/H.N_Q/O>4?R2ZJ_[8E>^U_ST^K:3_(A]!UW^)][RC^2757_;
M$KWVO^>GU;2?Y$/H.N_Q/O>4?R2ZJ_[8E>^U_P ]/JVD_P B'T'7?XGWO*/Y
M)=5?]L2O?:_YZ?5M)_D0^@Z[_$^]Y1_)+JK_ +8E>^U_ST^K:3_(A]!UW^)]
M[RC^2757_;$KWVO^>GU;2?Y$/H.N_P 3[WE'\DNJO^V)7OM?\]/JVD_R(?0=
M=_B?>\H_DEU5_P!L2O?:_P">GU;2?Y$/H.N_Q/O>4?R2ZJ_[8E>^U_ST^K:3
M_(A]!UW^)][RGT>B?51"1?LQ*X*GA:_YZ?5M)_D7?"["UW^)][RG>H(J *+V
MHB5Y:SV]'C+ W % 2ZHM3%AD/N[_ +"U95&-!W=_V%I5"@[N_P"PM*H4'=W_
M &%I5"@[N_["TJA0=W?]A:50H.[O^PM*H4'=W_86E4*#N[_L+2J%!W=_V%I5
M"@[N_P"PM*H4'=W_ &%I5"@[N_["TJA0=W?]A:50H.[O^PM*H4'=W_86E4*#
MN[_L+2J%!W=_V%I5"@[N_P"PM*H4'=W_ &%I5"@[N_["TJA0=W?]A:50H.[O
M^PM*H4'=W_86E4*#N[_L+2J%!W=_V%I5"@[N_P"PM*H4'=W_ &%I5"@[N_["
MTJA0=W?]A:50H.[O^PM*H4'=W_86E4*#N[_L+2J%!W=_V%I5"@[N_P"PM*H4
M'=W_ &%I5"@[N_["TJA0=W?]A:50H.[O^PM*H4'=W_86E4*#N[_L+2J%!W=_
MV%I5"@[N_P"PM*H4'=W_ &%I5"@[N_["TJA0=W?]A:50H.[O^PM*H4'=W_86
ME4*#N[_L+2J%!W=_V%I5"@[N_P"PM*H4'=W_ &%I5"@[N_["TJA0=W?]A:50
MH.[O^PM*H4'=W_86E4*#N[_L+2J%!W=_V%I5"@[N_P"PM*H4'=W_ &%I5"@[
MN_["TJA0=W?]A:50H.[O^PM*H4'=W_86E4*#N[_L+2J%!W=_V%I5"@[N_P"P
MM*H4'=W_ &%I5"@[N_["TJA0=W?]A:50H.[O^PM*H4'=W_86E4*#N[_L+2J%
M!W=_V%I5"@[N_P"PM*H4'=W_ &%I5"@[N_["TJA0=W?]A:50H.[O^PM*H4'=
MW_86E4*#N[_L+2J%!W=_V%I5"@[N_P"PM*H4'=W_ &%I5"@[N_["TJA0=W?]
MA:50H?4CO<?06E4*'*9>L7E6NJ<8IH!0&:]*?XXQ_P 21^H.J+_H,OT_IHZ,
MKEG5.+OO/?U/+]WQ?.=>C?;_ ,K[3/(/NOYWV8^,M_3?:CF\.G>]<3C0AKGS
MDXQ8+LQQM@A 2,G=#A\1NB<;=M9Z_4]1J;4I5RTE6G>+>R-'\5HKT(TS.4:5
MZ3:>-Z8EC>I&WMQ=WP[>V8&&"/DV@>CJA3DA.MF7)M8U5TA])>WMKASU^;33
MMUEG<JK;LS+?S'U$.RLFLMW4H*$84DL-M'NWXG*R=E?=GDA^C^T_X6P?[OB?
MJ0KQ_4_RR_4_"?H+1_P0_3'P%XK7-L4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M.M*FG_VT:<!4]+QJO"EIVJO.I4W4IY";ROY5U;C7?F3[U&C[D0W.6-CCB7H
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MJFOO/UBT\[?LT:.2XW;PWO>HLNUCUBEW*>-$ZA7W3JG%<<R;\#0RX;H*-'3
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MNAT6GD@WU\+MJYS/5[?3[:-VL^R63N5\% E?ZK%QS\SR]%:]\10W0F(>&<]
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M7TQ\$S]']I_PM@_W?$_4A7C^I_EE^I^$_0.C_@A^F/@+Q6N;8H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4!R 7K%Y5KMG#*: 4!FO2G^.,?\21^H.J+_ *#+]/Z:.C*Y9U3B[[SW
M]3R_=\7SG7HWV_\ *^TSR#[K^=]F/C+3T>P?4C./9%O9&9>P6(8Y;F;GM$2H
M-D)01&@0C=.R%I$4\JI5W:EW36TNMCGE_:O]=B([!LZR[F5B?5P_N?\ IM;-
MH9O=75/!XY_"['PVZ,I(<10F;JST=XG5LEE6)%44!H>VQ$-_/7#LZ?2W)*=Z
M5N*W0BU_V>\^IU.KUMN#AIX7)O?.:_\ ICX,.G:<O\/!7W!Y4S]']I_PM@_W
M?$_4A7C^I_EE^I^$_0.C_@A^F/@,!^\+G,SM[IZN1P4Y['3DG1V^\1C5L]!(
M=QNG&RVKJ]B687=1EFE)4>TX?W)J+EG29K<G%YEBCE#^;/4O_=>3^DN?#7W?
MTW3?XX]!YA]8UO\ EGTC^;/4O_=>3^DN?#3Z;IO\<>@?6-;_ )9](_FSU+_W
M7D_I+GPT^FZ;_''H'UC6_P"6?2/YL]2_]UY/Z2Y\-/INF_QQZ!]8UO\ EGTC
M^;/4O_=>3^DN?#3Z;IO\<>@?6-;_ )9](_FSU+_W7D_I+GPT^FZ;_''H'UC6
M_P"6?2/YL]2_]UY/Z2Y\-/INF_QQZ!]8UO\ EGTC^;/4O_=>3^DN?#3Z;IO\
M<>@?6-;_ )9](_FSU+_W7D_I+GPT^FZ;_''H'UC6_P"6?2/YL]2_]UY/Z2Y\
M-/INF_QQZ!]8UO\ EGTC^;/4O_=>3^DN?#3Z;IO\<>@?6-;_ )9](_FSU+_W
M7D_I+GPT^FZ;_''H'UC6_P"6?2/YL]2_]UY/Z2Y\-/INF_QQZ!]8UO\ EGTC
M^;/4O_=>3^DN?#3Z;IO\<>@?6-;_ )9](_FSU+_W7D_I+GPT^FZ;_''H'UC6
M_P"6?2/YL]2_]UY/Z2Y\-/INF_QQZ!]8UO\ EGTC^;/4O_=>3^DN?#3Z;IO\
M<>@?6-;_ )9](_FSU+_W7D_I+GPT^FZ;_''H'UC6_P"6?2?1ZL=2U(4^U>3X
MJG_]2?PU'TW3?XX] 7;&M_RSZ3] @55 57MLE>4L]U6P\9AD "H*J+?P>2IB
M&0N>][9>_5E$8U'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]
MLO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'
M/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*
M(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME
M[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5)4-PS(M9*MD2U
MZPDB42ZP,BW//.BZ:(:HB+P2]6I*A@V>?/>]LO?J:(5'/>]LO?I1"HY[WME[
M]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[W
MME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"H
MY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I
M1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]LO?I1"HY[WME[]*(5'/>]L
MO?I1"HY[WME[]*(5+FVJJV"KQ542Z_@JIF91)(A9(A6RI;BGEI':0RW\][VR
M]^K:(QJ.>][9>_2B%1SWO;+WZ40J.>][9>_2B%1SWO;+WZ40J.>][9>_2B%1
MSWO;+WZ40J.>][9>_2B%1SWO;+WZ40J.>][9>_2B%1SWO;+WZ40J.>][9>_2
MB%1SWO;+WZ40J.>][9>_2B%1SWO;+WZ40J.>][9>_2B%1SWO;+WZ40J.>][9
M>_2B%1SWO;+WZ40J.>][9>_2B%1SWO;+WZ40J.>][9>_2B%1SWO;+WZ40J.>
M][9>_2B%1SWO;+WZ40J.>][9>_2B%1SWO;+WZ40J?4?>X^FOOTHA4Y4+UB\J
MUU3C%- * S7I3_'&/^)(_4'5%_T&7Z?TT=&5RSJG%WWGOZGE^[XOG.O1OM_Y
M7VF>0?=?SOLQ\9KS:0;[DR'(6QURBR'=)/M8DW@OIOI5Q6E1$MQLI+76U+TZ
M5;V7VJ>,XVACK)O+I\_+E;733QFTPV/U-Q4!,KU"ZAN[3QA+R^7)R;\J49*.
MI6Q::<LI:5XCJ5?<KA/6:6<LMBRKCY(I+IH?5P[.UMN.?4ZEVH_KDWS;:=]F
MBN%ULED\%Z^I/@&?H]M/^%L'^[XGZD*\?U/\LOU/PGZ!T?\ !#],? :R^\]_
M3 OWA%\QUVOM_P":]EGSGW7\E[4?&<6UZ,>0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H"IOUQ\J>>C)6T_3-OU!\B>:O&&?HM;"/.^3'XWY*RB0R#5AB* 4 H
M!0"@% * 4 H!0&.Y7>V!P>YL/M3*N.1<AG@<7%2'&R2(\\RJ7CH]ZO.5%U"'
M:J4!D5 * 4 H!0"@% * 4 H!0"@% * 4!+@^L?D2L)&2)M5F1:Y'RQ^6KEL,
M&>=20* 4 H!0"@% * 4 H!0'FV^P\3@-.@X;):'A$D)0.R%I)$[%LJ+9: ]*
M 4 H!0"@% * 4 H!0"@% * 4 H"ZM?)A\5/-5++$42OD#_!YZF.TAEMJTP%
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M_"?H'1_P0_3'P&LOO/?TP+]X1?,==K[?^:]EGSGW7\E[4?&<6UZ,>0"@% *
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M'8T"0B5Z6X)&+::46RJ@$MULE :'ZT;EW)C=Y9&)-SV=VWB(^';D;+^S\4I
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MW!=A"TE%9K6Q\8O^U][H+@G6XXC>:CX/:.(Q$;<$:1'RHQD<YCKDD=/,U^!
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MOJ7:;;\[,GO3Y"^?W#=>I5^,4O-47':I(A9WJ:4[;DC:>VL#!VM@9[HR,HS
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MGZ!T?\$/TQ\!K+[SW],"_>$7S'7:^W_FO99\Y]U_)>U'QG%M>C'D H!0"@%
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M13WZE&+-D-[FVV]9&<S!<NMDT262X^+@52"Y@8."AMDA@27$A6Z*GN*E 54
MH!0"@% * 4 H!0"@+JU\F'Q4\U4LL11*^0/\'GJ8[2&6VK3 4 H!0"@% * 4
M H!0&#XSI#T[P^Z3WCCL*VUG%<=D-%S'2CLR)%T==98(E:;-S4NH@!%6HH"S
M]6FLOALKM'J3C(+N4B;2DRTS<"*"NREQF28Y+SS+:>N3*B!J*<5&]&$:KVYO
M(MLXU<-L#JSM!=GQC=>QD7.L.)D8C+SA.DR]H?:NC9&HHI BV[:@DNH=5-WN
M(2AU7Z>$@)J/2T^MA\:VE\$I44 =5-X&A*'5?IX: FH[-/JB)XUM*X)2HH8_
MC(T;>DP=F[=S+>\=P;@W%"W/OW=>,9)K#8]C%DT;;#)*I"KA(PVV (9%Q4BH
M#?6[>DO3_?&58S.Y<.,O(,@+#C@NNLI(8 E(6I M&(O BJJH+B*E94(,S;;;
M:;!IH$;:;1! !1!$1%+(B(G!$1* JH!0"@% * 4 H!0"@"=B^3\M <KGP4E\
MM=0XYF4?!9XLK@,!$SSS1YJ $Z.JN/"VR)"9<O2)\;(%KI:J7.-&Z;&7J,JI
M)[48H_DY\T.3*G/R6Q*Z-NO&X.H>%[$JU=1(I<F]YEO2G^.,?\21^H.J+_H,
MNT_IHZ,KEG5.+OO/?U/+]WQ?.=>C?;_ROM,\@^Z_G?9CXS3-?1'R(H!0'Z/[
M3_A;!_N^)^I"O']3_++]3\)^@M'_  0_3'P&LOO/?TP+]X1?,==K[?\ FO99
M\Y]U_)>U'QG%M>C'D H!0"@% * 4 H#+>GN^YFP,R]DV8C>0QLR.<'+8Y_@V
M_$=5-0ZK+I6_8MK>!>VN?KM''4P46\K3JGP9VNR>T9Z.XY)9HR5)+D-BM]/>
MG>\H^W-X[2"7B<#DL]'P6:PDH]7+5XD54C/75;+<03BOK>!4M7'>MU%ASM7*
M2E&#E&2Y.*/IEV9H]4K=^U6$)3491?+P?+@MN_<U0R[.Y/93&2W+M'=&Y, &
MTV6I,'&[<8QKD>7CI+/HLF#XM75Q%'TUU*A+V<*Y]F%YQA<MPGGP;EFJI+?A
M78=J_/3J5RS=N0ZNC2AEHXTV4?'^D8INS<:;0Z9;$+#XJ"F;S^%>BS,L^P+C
MP1PTII;3L0R4]2FJ*OHI6_IK'7ZF[FD\L)U2KO./KM;\)H['5QCFN0IFIBEA
MLZ>\93'P."W)N?:'5UR&TWM8,#)R6?:;!L6!G8H5 A4$33Q-SL\.BM&5ZY:M
M7--7S\Z4>-)?UWSIQL6K]ZUK:>8K;E+92L?]_P#J6+&0,=O?IKA963CLQG-Q
M[[!B8^RV#;C<:21JK($B(HBB6 4[$X5LSG+3ZF2BV\EG#G6\U81AJ]'!S276
MWL>9MX>)%DZD;TRL;=>5Z7XZ' PFT6Y+>(;AM0V4=1@E 4D<TA4]9(6I"1>S
MWZV=#I8.S'42;E.F:M7MX4-+M'7W(ZEZ2,8PM54/16QTQ-DY9_9>S=U%LS*Y
M[ P.G\1@(TS:<G'.%,<1V.B\\Y:-J2ND1:D,3M;_ !<:X]M7K]KK8QF[C=5-
M2PV[*5V'T%SX?37>IE.$;*5.K<<=FURX\OCQ,7V%,Q>0VO'VATTR^,Q^^(LF
M<LR+EX33_P!=LH9DRH/.@5K-B*Z41+>%$1+KO:R,XW7=OQD[;4:973)QP7*<
MWLZY;E95G2SC&Y%RJI1KUFVF-.&.&SF.?I3+\:4_'E K<IEPVWVRM<70)1,5
MMPX*BI7UL&G%-;#SB]&49M2VIX\YYM^N/E3SUDRM;3],V_4'R)YJ\89^BUL(
M\[Y,?C?DK*)#(-6&(H!0"@% * 4 H!0"@% * 4 H#7_7&!(R72/=\6(*F_\
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MFZ/M],F"?7.39^1F,J.2AHZH8A'B-#0HT5;\KEI^C&Q<1];C625"&S9U20*
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M1S4:7*:MW2.W<4%)2;=,..RCJB^2=FR7Y2OME#Q&/D3GL7""3*)W7+C*#;@
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M4JK&N&]4XKP%,;M9N%'A3'<Z\'R;SYF<QB=O0QR&<F-PH)NMQ@?<52$GWCT
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MRY41Q20'!NA672J+VHG8M9V[DK<E*+HT5W+<;D7&2JF2VD1AIMEC]&RT(@V
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MAJLM&LK*FI;%Q+CV^6@&L^'I+P2R<?!0#426L2^CZO'L\E %(E+4JKJ\=^-
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M1A0#$?25L8XMDX=B7UCU6'P(E"#T=PI.0L3$Y]EQCL=TCT_*=W!15+7X7[:
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MRW&X%3VWLF@3H,2<VUC<HNJ7J:4GVR,!;=Y2ZM/IH-TU)Z*JJ\>R@)'V=_\
MKI>/20@A)FA, D#@  \VXC=K\>#>F]"",F'S$3*OY6$D8'ICC3,@&!(&R81U
M"-]X2*QNBVB@*IX^-TLB 9-0D4 H!0"@% * NK7R8?%3S52RQ%$KY _P>>IC
MM(9;:M,!0"@% * 4 H"U[CQKV7PLN!&,0E.")QR<OHYK1BX"%;CI4A1%MX*
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M@MS,E*1U\H<*4$;ZE>&";R-M("?(&*IRC%S42HHIX%XIV >Y15A,SWG8/_\
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M 4!=6ODP^*GFJEEB*)7R!_@\]3':0RVU:8"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% $[%\GY: Y8+UB\JUU#CE- * S7I3_'&/\ B2/U
M!U1?]!E^G]-'1E<LZIQ=]Y[^IY?N^+YSKT;[?^5]IGD'W7\[[,?&:9KZ(^1%
M * _1_:?\+8/]WQ/U(5X_J?Y9?J?A/T%H_X(?ICX#67WGOZ8%^\(OF.NU]O_
M #7LL^<^Z_DO:CXSBVO1CR 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 5-^N/E
M3ST9*VGZ9M^H/D3S5XPS]%K81YWR8_&_)642&0:L,10"@% * 4 H!0"@% *
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M%^+X*9B:'))>L7E6NP<0IH!0&:]*?XXQ_P 21^H.J+_H,OT_IHZ,KEG5% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@.0"]8O*M=LX930"@,UZ4_QQC_B2/U!U1?\
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M_N&S"QK[L+:RQCEHEL7FHS_<>V4QN"@2<)LW"RL>[@V)DW)RG0;E@^;*DX0
MKPJJHB(0V!;K7$TVISW)*=V:>=I);*5PW'V.MT/568NUIK4H]4I2DZ)UICA6
MO+L-;=/8$+*[UP&-R+0RX$J2C<AEWB+@*!+8D\J7KO=H7)6]/.471I'Q?8=J
M%[6VH36:,GBGOP9F>^]OQH>U966FX+'8O*M97NF)=PB\R.<456Z3$!QQL55$
MX75"5>%DXUR=!J)2O*$9RE%QK+/MK_QP3/I>V-%"WI9796H0FKF6'5[,M?\
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M.C*Y9U10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M * Y +UB\JUVSAE- * S7I3_ !QC_B2/U!U1?]!E^G]-'1E<LZHH!0"@% *
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M;;L\-:.K[6OZF.65$N3?SG6[-^W-+H;G60K*6YRHZ<V",\KCGTHH!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@.0"]8O*M=LX930"@,UZ4_QQC_B2/U!U
M1?\ 09?I_31T97+.J* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MX_XT]ZF5"H[X_P"-/>IE0J.^/^-/>IE0J.^/^-/>IE0J.^/^-/>IE0J.^/\
MC3WJ94*COC_C3WJ94*COC_C3WJ94*A);W'BGO4RH5.42]8O*M=8XQ30"@,UZ
M4_QQC_B2/U!U1?\ 09?I_31T97+.J<K=?_X_+_LH_G.O1.P/E?:9XM]X?/\
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M;:+H/T"M=;<:;423<#%Q'41QC9W5#9N.:SN!QL/(1&XKPS(*PYR$SI;)L6U
M=3"B3!7 A05N2=@@SB5U!V)A]R1-CR<U$B;C?%L(F)U:3L:+RPX)I%20?0%5
M15\"5-07_(M*] DMC&;F&K3FB*\B*VX>E; 6I%2Q=BT!SK]V[=O4[(9[([3W
M-'>';^&B:"CRXZL.8V2+FEJ,!D(D8:-0AJU>B"*A>/%5)9TI61 H!0"@% *
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M6B1<SD;K Q[[[;<A^RV_1MD2$7%/ E2#1GWC>G'4S>&4Q67V8XY)QN-B._\
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M-QV=PS7I.W(RQF69#&$2P1D=< 1,R=05?_275-:)4(,V/4@4 H!0"@% * 4
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M^M14&R,1,F9#%PYV0@.8N;(9!V1CGC;=<CF:75LC:4@51[+BMJD$V@% * 4
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MR +SSCHM_)BX9&@_%0E6WX*E12V)$2N3E12DW395MA'GT:%A'G$8 M8-(9(
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M]MH"M-DB<LS<;5/<J*T)+ANGJ5]WC>3 Q-UK'S<=OBT4G%3']/A] ^[W3_\
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MJ2NWE@WAA&4L*[$VU'FP)<)O)\ED<_.1,CE,Q$6;!<=%48B0P.3Q%"T-H2\
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M5#,EM.]P]0?(E>.,_32V$>=\F/QOR5E$AD&K#$4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H"7!]8_(E82,D3:K,BUR/EC\M7+88,\ZD@4
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M1>L (*J/;JXT!.DY%S-;BQ,9AUQK%M..(^ $H\]\HA&0E9>(-B8W_P 9?X:
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M H!0"@% * 4 H"ZM?)A\5/-5++$42OD#_!YZF.TAEMJTP% * 4 H!0"@% *
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."@% * ^IV+Y/RT!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tb_micancer-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tb_micancer-4c.jpg
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M%!04%!04%!04%/_  !$( E\#M@,!$0 "$0$#$0'_Q #%  $  @,! 0$!
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M^C0W_:<TI_PT'9QI,:8P$F(\$B,XEVWFB0P)/6A"JHM!MH% H% H/+=W>?\
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MBRQ5!^7?9&SMJ3,M(Q.[86YMP260!YO'DG+8BB=[VU$I*1:;DMK=%)'JN?\
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MRV1.'N[./;?AD%V)[<0IK?,O]5P0,21%3H)$7Z:#T)_RU\F&>6B>:J/..D(
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M5J0.<\C,%+W+Y4>9^$@"ISI3,?LS2=)NM-NN "?22CI_MH/*?++<D39V_P#
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M45&._)YB&G1++;IDR647K-Q8H1B5/H(W'K?=ID>_9_:F#W1@'-M[@C)D,6X
M@0O*O,U EA<0TLHFG3J&U17@65_)[A7I!.87<\F'&5546948)1"B^C6#C-[?
MLU<HZ7R\_+3A]B;C@[H//RY^1QZD; -M-QF55P";)#2[I*FDEX(24RK[O_\
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MR6ZY&?D0WLB39%&;8 Q#E- UP)215N@7JY'?P?+N-"\LR\M4GN'%* _C?$%
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M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'A)2RQOYBMUY%H!-V+M!9
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M?+=XXQ/3Z_I^]8O>7OF%M7+[9WQLQF'/S43 1,!N'!27N4#R1VPN3+RHB<"
M>*V^JG3=4K*.9Q]U+ZMLS%9O-JVB/?WAM/ Y.B^O=IB+6C7%+5F>^/:6&[]I
M>9&YLSM+>V1VSCLH_B1E,S]G29H%% G27E2 =,5 BTJ.NXK902R+Z+QN1Q]5
M-FJM[5\L8O$=?K'^/=.5Q>5NV:]UM=;37.=<VZ?2<]O_ ,1L1Y0[U<PGFAC<
MPWC8,O>"1GL6F/->Q@ZUS#5K2H"0B*J(:M/'BMJ[V?):8OHM7RF-><Y[^G5Q
MJ^*WSKY%;^-9VXQCMZ]&<K8WF9N3:&QL7E\7#@93:&9@&0MRA<!['0&1#G73
M58U5/J7J5Y?&U;=MJVF8V5MZ?\IGLMN%R]VC36]8K;5>OKWK6._W^BT#:_F7
MY>[MW1D]C8N#N'!;KD^(JQ+E=C>ASG-2N$5TL;:D2K8>-K)PMQPG?QN3JI7;
M::6UQCI&<Q_JWCC<KB[MEM-:[*[9\NLXFMO_ #"B#R3W;!P.THH/QYV88W2.
MZ=RNHYRVA,U!#1G4**5A!/0EUKTS\IJM?9.)BOX_"O\ N\L?#[JZ]<9B;1M_
M)?\ V=[F=FYV;YS[;WM';:7 8S&2(<IPG+.H\]SM.ENW%.N/&]?,U<FE>'?5
M/\UK1,?N?6W<39;G:]T8\*UF)_>](KY+[90*!0*!0*!0*!0*!0*!0*!0*!0*
M!0>&P]N^;6T=\[WS>V<'CLC#W3)9>BR9D[DBRD<7$%3;%-17YG%$MT=-?H[;
MN+NT:J[+6K.N/2.^7Y6G'YNCD;;ZZ5M&R8Q,V[8SZ?M5+7D;NK$[4VQB8LB-
M.RL;=+6Y\V8ER8[:((@0,(HHJHB GH2Z^BU;S\KJOMO:8F(G7X5]_P!KSQ\-
MNUZ==8F)M&W\EO2/V.@#:_F7Y>[MW1D]C8N#N'!;KD^(JQ+E=C>ASG-2N$5T
ML;:D2K8>-K)PMQ\L[^-R=5*[;32VN,=(SF/]7KCC<KB[MEM-:[*[9\NLXFMO
M_,*(O)+=D/:VV<>V_'G9P-TANG<;J'RF4,D031K4**2(@IZ$NMZ]/]TU6VWG
M$Q7\?A7_ '>7^S[JZ==<Q-OR_DO_ +.\G;,SK_G=C-]-@TNWXN$/'/&KEG4?
M)UXT1 MQ2QCQO7S:<JD<*VK_ )3?/[.CZU^)LGGUW_\ "*>/[<R\^W#Y.;ZR
M<+S";B=F!<]G8V7@12?5 FQ(YO*3#RHB:+ZP-+KTI;ATU]33\EHI;3G/\%)K
M/3M,XZP^/O\ B>1>N_&/X[Q:(S_-$9Z3[+3 >7N]G/,; [RF[=P^VL)!QTK'
MKB,8\)N,:VG! G%!L -2(N&C@(]/&L=W,TQQ[ZHO:]IM$YF._7[M]' Y$\JF
MZ:4UUBLQXUGMTGOT_P O1,VGY:;JP_D1E?+^:VPFXI;,]M@!>0FKR550N=K)
MTUGR.=JOSJ[HSXQ-?W->+\=NU_'6T3CSF+>ONK,!Y3;O\OY&T=R[*C1ARC4%
MO';UPG:.6Q,1$U*^)DBIS4)5X^O3;AJOMN^1U<F-E-LSC.:6QUCZ?;_'L\^C
MXO=Q9U;-,1Y>/CLKGI;Z_?\ Q[H#'E%GMGY#*PH.Q<!O?"3I;LS&S\B;4>;$
M!^W\%Y70/6 6X:/I7TV36?D=>ZM9G;?5:(Q,1UB?K&&5?BMG'M:*Z:;JVF9B
M;8B8SZ3GOAV>/V!G(WFEMO=K6/AX[ X[;@XN5#B.(C<>61NN$VR""-VQ4^!6
M2OGWYE)XM]>9FTW\LSZQT[_5]/7P=D<O7MBL5K77XS$>D]>D?1ZS7PWZ$H%
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M[>Z_#LOG<9N56H;..8\6@RQU(#V*0;.&2*I==EQ%%Q$]! MNM0<Y+WWNIAF
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M1H9?X1Z:#&=M>/CMAY3:VW(ZH)X^:Q#CDXJJ3TEMQ>)N+PU&=^*V2_H2@O\
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M@4"@4&)@#@J!BA O2))=/]"T&5 H% H% H% H% H% H% H% H% H% H% H%
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M3<.KP^$+%.YEQ7^;XM..<B:=/+0V&F='2M_Y5[_30<]"V7FL"SB7]OY-E<E
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M1)QNW6420TZ++00\7O\ EEE\5"R<O"R6LPX4<(^)E]IDQ)"MFZ N<51P%$%
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M!OH5T%%"5$M=$5;VO0<EO<\B_MB!C)AQ8^_I$IDMO-P2-\1G,FBH\(N")<L
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MIBA)I?C.*TX"H2(O A7]/2G"@JWM\8 (N/E1BD3DRJ.ECV8<9YYUT(RHCIH
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M@4"@4"@4"@4"@4"@4"@4"@4"@4&;/\T/VD_OJ3V6%K6+LH% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MQR3$%=!4(45P ^JJ7M0<D]G)H;3WQ,P&=DSMO1$;'#9AQT77FG^*2VVWUN1
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M5<7VMYQ,F&:QD A<>CMY.8LYI&-6@7.2:JV:(J7UJ0WM90^GAMQ<\][AC/\
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M_*L_AC[*!V"#\JS^&/LH'8(/RK/X8^R@=@@_*L_AC[*!V"#\JS^&/LH,FL?
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M:Y,Q58-M7"$^HEU5 M77>4]''Q,KFLQM3:F+3<60?@0O,1S;^$W T^0S'L2
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M^NFH52J/3L'EXV?PT#-0_P#LT]AN0V*JBD/,%%42M^L*]5?IJ"PH% H% H%
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M*N'/\5;A-YDQ#M@XHX2SU55TZ%?1 *.CBCZ4-4U7H(&ZLCE]KP=T[>3+RY#
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M(/P-L8N!-<YXN0F6VP08@GH(">0S=)UM1TJNI41*#HM_9#/.XI<'BI!Q<RS
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M=?%@$#G2'">>-4Z2,RXD2KQ5:@DT"@4"@4"@IZW9E H% H% H% H% H% H%
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ME#RY V,1XH^V;I6]ZE!Z34"@IZW9E H% H% H% H% H% H% H% H% H% H%
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M!*;Y3B$@D!"2(B*)B7#BG%"6@XS<FV,GB\?"9/+.RLGEMUP<@60;8$5CN$
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M=N.CC2MNMEJ5&TU"2Z2X?5XJH4.Z,&Q#VW V/C9KSV\,A+2;!R2")26Y:O\
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M'B>,^=C_ (H>V@>)XSYV/^*'MH'B>,^=C_BA[:!XGC/G8_XH>V@>)XSYV/\
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M/%L5\]'_ !0]M \6Q7ST?\4/;0/%L5\]'_%#VT#Q;%?/1_Q0]M \6Q7ST?\
M%#VT#Q;%?/1_Q0]M \6Q7ST?\4/;0/%L5\]'_%#VT#Q;%?/1_P 4/;0/%L5\
M]'_%#VT#Q;%?/1_Q0]M \6Q7ST?\4/;0/%L5\]'_ !0]M \6Q7ST?\4/;0/%
ML5\]'_%#VT#Q;%?/1_Q0]M \6Q7ST?\ %#VT#Q;%?/1_Q0]M \6Q7ST?\4/;
M0/%L5\]'_%#VT#Q;%?/1_P 4/;0/%L5\]'_%#VT#Q;%?/1_Q0]M \6Q7ST?\
M4/;0/%L5\]'_ !0]M \6Q7ST?\4/;0/%L5\]'_%#VT#Q;%?/1_Q0]M \6Q7S
MT?\ %#VT#Q;%?/1_Q0]M \6Q7ST?\4/;0/%L5\]'_%#VT#Q;%?/1_P 4/;0/
M%L5\]'_%#VT#Q;%?/1_Q0]M \6Q7ST?\4/;0/%L5\]'_ !0]M \6Q7ST?\4/
M;0/%L5\]'_%#VT#Q;%?/1_Q0]M \6Q7ST?\ %#VT#Q;%?/1_Q0]M \6Q7ST?
M\4/;0/%L5\]'_%#VT#Q;%?/1_P 4/;0/%L5\]'_%#VT#Q;%?/1_Q0]M \6Q7
MST?\4/;0/%L5\]'_ !0]M \6Q7ST?\4/;0/%L5\]'_%#VT#Q;%?/1_Q0]M \
M6Q7ST?\ %#VT#Q;%?/1_Q0]M \6Q7ST?\4/;0/%L5\]'_%#VT#Q;%?/1_P 4
M/;0/%L3>_;H]_7S0]M \6Q7ST?\ %#VT#Q;%?/1_Q0]M \6Q7ST?\4/;0/%L
M5\]'_%#VT#Q;%?/1_P 4/;0/%L5\]'_%#VT#Q;%?/1_Q0]M! Y+/NP^ZGLK=
MF^<EGW8?=3V4#DL^[#[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW8?=3V4#DL^[#
M[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW8?=3V4#DL
M^[#[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW8?=3V4
M#DL^[#[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW8?=
M3V4#DL^[#[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW8?=3V4#DL^[#[J>R@<EGW
M8?=3V4&;3+/-#^&'UD_53U_HJ3V(6O(8]V'W4K%H<AGW8_=2@<AGW8_=2@<A
MGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2
M@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8
M_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<A
MGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2
M@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8
M_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<A
MGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2
M@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8
M_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<A
MGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2
M@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8
M_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<A
MGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@<AGW8_=2@JZW9E!YG/\Y<9BO-=
MKROR6.<CA(:8[/GE=%8ZRY0$;3!-Z;BIZ"024K*7#TU,]1?8O?+>3\PMP[!2
M 33F AP9Q9!7$(7DGH=A1O2BCIT=.I;U1U#4J*^ZZRP^VZ\RMGFP,2(%]1(B
MW3^V@^=MA]3_ %EK^*:M-]<>LXG!13CQ5/50;Z#R?&^;^>W/,E/[)V/+SFU(
M4\L8]G%FQHBN.-.(T\XS'=76;;97NJJET3@E3(]1<FPVD-79+0(V2-N*1B.D
MRZ!6Z\%6_!*HS5]E'DC*Z':%'F(SJ37HO;5IZ;7]-!B<N(W("(;[8RG$NVP1
MBCA(GI056ZT'EVX?-C*8?>&]-LL8R.\SM?;']1QGW'3$GGU4D1HT0501ZOUD
MXU,CKMJ[O;R^P,7OC.<G&,RL:WDY]C4F&!5OF'UB1%413TVJCC,1YO[NW7&'
M.;,\N9^3VFZXB1<I+FQ<<[)94D'G,QW;DH?K=94NG14RKU9R7%:>;C.OMA)>
MNK3)&*&=NG2*K=;?151Y-NKSARNW]Q>8.%8Q<=]K9N!8SL5TW3$I#CZ*JMFB
M(J"*:>E*F5PZ7)>89X7RF7S-FX]'W&<.UF'\:R[H%2<:%PFQ<(5X(I<%4?[*
MJ.IPN5#+X''9T@[,W/AL35:,D7E"^T+FE2X(NF]KT$M9446VWE?;1IU41IQ3
M'22ET(*WLMZ#X<R&V*DY(:$4<Y*J1BB(ZOZG%?K?1TT&;[[$5HGY3H,L!]9Q
MPD $OPXJMDH /,N$0-N"9@B*8B2*J(272Z)T73HH/.,[YLOANJ3LC8FVY.[]
MQ8X!/,DR^U#@0%<34V#\EZZ<PDXZ!%5J9'6;>SV3FX1,GNS$?TO-%UQIV%)E
M,R!1 +2)H\VJ J'TCZ?75%VK[ BV9.@@NJ@M$I(B&I<405OQOZ+4!I]A_7R'
M0=5LE;<T$A:33I%;="IZJ#!)D0I"PQ?;66*:B80Q5Q$]:C>]!]"5%=?<BM/M
MG)91%=9$Q5P$7HU"BW2@!*BN$ @^V1.*2-B)BJDK?UD1$7CI]/JH-U!FS_-#
M]I/[ZD]EA:UB[*#F)6XLT_GI^$P&-C2_"VHYS)$N4<9.;*0R%L!!AV]A%"55
M5/K)0)&Y\@>0\!P^,&?G([3;F6+G<J!")X-0@;Z@I$9=(@#2EIL1:44;A]R.
M?SN&PCTW(XR.>562Q#@1(TLB:D.2W6V6[N&R"A8CZW46R)>@UY/<6XL'AYV5
MRN(C$;/(:@Q8<PW2?D27A8 "5R.V@)J,>/6_10;\5N').9Y[;6=@-1,B,5)\
M5^(^LF.\PCG*-+FVT8&!*-T4;*BW1>E$"[DSH4,FAF26HY/ERV$=,04S7]4=
M2I=?H2@W(XV1DV)(K@64Q1454U=%T]%Z#2]/@QHZS)$IIF(*V)]QP0;1;Z;*
M2JB=/"@VB\R8 X#@DV[96C14420DNFE?3=*#7%FPYS9.PI#4EH25LC9,7!0Q
MZ1515>*>J@J=V[D7:N&?R_ATG)"P)N.,Q=":6VP4S,S<(1$4$5]-U7@B+0;,
M]N ,,$1IB,Y/RN2<5G'8]E1$W3$%<)2(U00 !12,UZ/I5410PP&X3R[\['3H
M+F,S6-5M9<)TA=%6GT)6G6G0ZI@>DDOP5"$D5.%!:R9T*&30RY+4<GRY; NF
M(*9K^J.I4NOT)056WL\N4P2YG)"W"0'YC+MSLV Q)3L="4CM:Z-HJWZ%H/F<
MW F/@XZ=C^5,9GSX4)'$.[?+F/BR1B0W151"NE!:O3H49]F-(DM-29"JD=EP
MQ$W%3I0!544O[*"N7=.$'<!;8.4 Y86 DJV1@B*+IJV()<KJ:JE]-NBU!)@Y
M%UW'G.RL;POEF\CC;SS3B"VTX0"XIMDH(ABB':]TO9>-Z"4S+BR(XRX[[;L4
M^(/MF)-EQMP)%5%X\*#XQ-AR77F8TAIYZ,2!(;;,3)LEZ$-$55%>'IH 38;D
MIR$W(:.:RB$['$Q5T!+BBD"+=$7Z:#Y+GP<> N3Y345LRT 3[@MHI+Z$4E2Z
MT&UQYED5-YP6Q$2,B-4%$$4N2K?T)Z:#&/)C3&0DQ'@?CN)=MYHD,"2]N!"J
MHM!2Y'<K+$[#Q<<;$T)^17'3"!U"5BT5]_H"_6NR@V*W307] H% H% H% H%
M H% H% H% H% H%!4;GS1[>PDG*M15FR&U::CQ$/EJZ](=!EL-2H5KF:<;+0
M0G=P93#0I>3W5#C0X$<0Y789#LU]YYPT &@:5AI5(R41!!NI$MK4'V%D]X2S
M8D/8*-#@.FB.,/SE6:VTJ_7(&V3:U(G'0CJ_M4$=O<6X,ED,I'P.+B2(.+E=
MA.5*F&P3CP--N.:0".[9!5S1Q+BJ+01LGO#-QG<](QV'9FXC;BB$YQ9?*D.D
M,<)+R, K2@JM@X/UW!U+=.%!=RLEEI$*%/VY$C38TII'U*7(<B*C9B)-J*"R
M[>Z+QO:U!!VGN+-;AAP,I/QT2!C\E%&5%%N84B1_$$205!6&TX(O65"6@Z17
M6A/ED8HXJ(J"JI>RK9.'Z:".YE<8U$&>[-8""2V&43H(TJW5+(:K;I3UT&YV
M5&8CE+?>;:BB.LGS)!;0?6I*MK?300W,F\LW&M0HO;,=.1TGLBT\RC; M@A
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M,?N3.X:' (#44/#Q)@ UI7@2"^9/.+ZQ.@OHV,P3N_Y^'R\.*C$+&Q2VSC7
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MBXW&;B=A!M?*Y]7)D&$AM8YEQ8A*S',7"7J/21%P@6P*XJ#;K<0N(,+;N/\
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MWLK*;G9/%1)DQH4!M^0PVZ:"BZD2Y(JV1>*)Z%H)TF+%F-HS,8;D,H8.(VZ
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M\I=5S2I*8]9$]%7J)'E!O3)[G\I\1O7=DALIST>3)R$AIM&6T!AUQ+H WM8
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MGP1QUML")M%5%1$*RJJ*B(MEH/CV]]K,P,=DO$!=AY="\+-D''ED& J2MMB
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M/"AE<DY@$T2"16ZI*/IJ"JW9D,@[F<OC,D]EHL-N*VNWX>':)"R#AM&KMWQ
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MHS'R#/>5^%0.T9CY!GO*_"H':,Q\@SWE?A4#M&8^09[ROPJ!VC,?(,]Y7X5
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M9+\G;>4V^#/+..N5%@4DM/(I";2L.NIP1.LA65+I51U- H% H% H% H% H%
MH% H%!FS_-#]I/[ZD]EA:UB[*#SS;.XII[[SN.G2B>QV1D/AB6C*XL/XD&&W
MV03T:Q<%VWK0UJCY"SF8R'F#/<BR#+$+"G8_%03(@C.3<4ZQSWB2W2KCY,ZD
M] +4&6P7<?E.SRI>7R![TBMJ6=Q4R2ZT;;YII<$H2JC:-"9?PB;#3:RH1=*A
M?;$ERYVVVY$U\Y$A9>0!77%U%I;G/@"7]0B*"GT)04K&\<?B-Z[I@9_+)'CM
M>'E C/DN@!<CJIJ"(G#42<?IH)6T,^.>W/NLX<]9N(CG "$B$JM-J4;4X@(J
M):ZJBK0=I0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0<?OW<+.V/ <K-FE!Q+>0<\1,;JCC(P)1HWI%%(U(Q#2 I=2M0<]N"
M5N,-BY[><_(.P)<Z.R4"%$>3E8^ KH*BH;=T)\P)2==%51. AP'45%M"C;?S
M47*8[:VYIRY5V,0#)[=)E%&+4B@Z(/F0\"1+^M+CT+4$>!N/,;O?Q.$9U8S(
M0'.?O/D%QCN0W-"1 +CPDN#K%;W6.BK^N-!\S&!%G>&W\<UE<L$+(MY%R6R.
M3EH)$P+1!;^)<413+@-JHKY#N$9W-N/'[EW)*QD'$QL>&,5S*NQ# '&3(W$7
MF"KIJ2<2/6J]'T4%AMS)[A=E[,9S$B1S94++%*%\.SN2 8=8&,Z^TB)I<5HD
M,ALEB)>"=%07F7FS&-X8F*R^817,7E'G6$7J$ZRY#1LE3TJ.LK?I6@I-L;8<
MR^SL+E&\[EXF=F0(LIS(I.>?O(<:$U(F7U-DA4EXAR[6X4&US<^7E;# W5!G
M=DR26WT6,I("9%))0G'FKHJH(Z#D)>]A3CT4&6.GYQ[9$N CLF1N#"/EB<C(
M:%%FNA%=$2?;0^"NO1E%X?\ $7"@^>73FXS[2.6>.3%$44GS1U&5?4ULD=7Q
M%Q40+<W4EM?1Z:"8_E3/<^;GR''1Q&TX(KV8"T@[*D-%(=,N*(2@T@""%P36
M2^J@PC^8;3D:!F9&'FQ-J9)8XQ<T]RD%%EJ@M&\RAJXVV2D(H9#Z4NB)QH)6
M0WFXQ)G!B\+,R\/$DH967%5I!;,0UF#(&8D\X"?7$$X?52Y=6@^2=[M'D&\5
M@<=(S4YZ"QEF>03;+"PY)&(&KKQ"**NA=(]*_HNJ!":\RH;\1C--XF:.US>&
M))R[HMM)'D$ZD<A-DCYB@V[_  W'!11$D6UQ12H(,?/9.'OS=V/QV/E9F0*8
MUY(S;H-,1VBCJBJIOF("1JBV >*VNMDXU1;/>8F+'&8Z?%A3),G)S'<4QC!
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MM:Q=E H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H.4WF SY6W-ON\8F3R0E,;5$4'&(+#LOEDB]*$;0(J>E+T&I
MG*;GW!/R;F!>B0<7B9)P&QELF^Y,DQ[<Y2(3#E-H2\L;(1*J*7185#E]AYG+
MN;:VOMC!HQ%R<F')R&2DR4)\(D<)1-J+8"H<PR<-1!5)!L)$OH%:+F;NS<^%
MC9['SHS$S-8EJ++ARX[3JLOP);RLE(..!&XA1]#A.M@2ZD1--M5D@B;AEYG(
M[:P4S%[CAS!?S6/$<E$C%RG6SE-B(J(2+=4KH::NLG55!JBUW1F\I@F8S9[A
MQL3(<@C1I^&\Z4I\/3RVGB-MGH0E%"5/7Z%@C1]V[@W#*VU&P3<:&QG,1XU+
MDR1-\HXB<=%; $)O6I\Y115MIMJ6_P!50J(3S#(M"]"C3.;OB6VVLH-:L.*K
MZH\UQ32X-K(7J5:HFR-V;R7&[EW)';@AC=LS)S08XQ-79\?'JJN7>UV9-111
M;ZA)JXEP6R06\;+[H@9["Q<T421 W +X W%;-HX<AEE9 CK(RYH$ FBEI%=2
M(O0MD"L=WQ)Q^Z,?C7,O RK&0G+CGX,..Z!Q3(35M4?YC@$0J&ET"LOI2UM*
MA$VJUNZ0]NU<%(A08[&>GK'28R<E93W45=>AQOE-HO4ZNHE^M]"T=!C/,7 R
M,9BY>5-<;/R+>I8) XZH.BZK#@:VP5%1'1(47A=./"H/C64W1N"=DW, _$@X
MS$R3@-#+9-]R9)CVYRD0N!RFD)>6-D(E5%+HL*A41?,3(Q-M83>FX6&6-O3&
MW&LTK"&;D*6KJ@P0K<M;1FG(7A?60%]758-<]W<DK/;-DSVH\/<,AG-.QXJZ
MC9C$Y&%6&G50KFH)I1T@LBE?3PM06L3>LS*XW:A8]AMO+YY_ESXSR':,W"0O
M$."674V8*R-_UR&@E[(;2 6X, VO^J8G*.A";1+"W'ELM3!;'Z )\A1/0EDH
M.KH% H% H% H% H% H% H% H% H% H% H% H*>MV90*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!09L_S0_:3^^I/986M8NR@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'.;QA3WHD
M'+8EHI&2PDQO(-10TZWVD$V7V14E1$(F73T?XK4$,-N[@QTV<_MG(QXN,S+Z
MS94>;'-UV+(=!$=<847!1=:HA*#B6$[KT+IH(4#8&0P&/P98#* F=PD=Z$4B
M8US&)T60YS2!\0)"$M:"8F!=4K\%$E2@LX.WL]#7*9D\C'D[KR2, +CC!I!8
MCQE)0CMMBYKTW-Q5-3U*17M9$% KQV+/7&9 RF1VMP3\I'SNIE@A@-RXBLJ(
M<K7J431E.:>I")24N'!*#>>VMSM9B3FL=DH<>;EXD:+E"=CF^L<XJ&B'#53'
MJKS%7ENW34FKTJBAOV]LX\$]A'%F]H3#X<L*MPTDZJFR2.JMULMF>*>M:#4&
MR'!Y/^O(O*W [N'^7TB[S/X/UO1S/K?1T4&Y=G&NW-RX'MB:MP.Y%X9'+_D^
M(ZK)IU=;1J]:7H+"?@2FS\#-21RTPSCSA @\7>=%<C61;]6VO5Z>B@YB!L+.
ML1<#B)66C>"[:F,2H01XJMO2@CH2#VDE<TH::M2DVG7/K+TVH)<;:VZ\-(RZ
MX#,Q1BYJ<_/<&;%-TX9R$1%5C0Z*'T(6ESAJ^CA0=+@<+$V[AX>%A*91X;>A
M''5U..$JJ1N&O"Y&2J1?2M!Q.2F0]JY;,MX[=$'%QYCB3LAC9C*R)3$AX$UN
MPQ$Q(^:B(O+T&FNZITJ- VIL5Z1MG;./W(2NXK'0S-W"R6T4WI<E2TN2E5;*
M3;9KU-/\PE+I$;!;0MI2X#^!F9',=J8VRDX&GWPLZY$D-H#7.<4K*;0"B&Y;
MKVU+956@@;(@QY&7W!O6$KIX*<X?@3"@J7 T YDAD>E1E/ )#?ZVE"3@24%[
MLR!.C8^7DLJT4?)YN8[DI$4U0B8%U!;9954X*0,MMB5N&J]J#HZ!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*"GK=F4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4&;/\T/VD_OJ3V6%K6+LH% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H,
M5; B$R%%,+Z25$54OTV6@RH/A"A(HDB**I947BBHM!]Z."=% H% H% H% H%
M H% H% H% H% H% H% H% H%!RZXEN__ &N7W@_;6[,\);^;E]X/VT#PEOYN
M7W@_;0/"6_FY?>#]M \);^;E]X/VT#PEOYN7W@_;0/"6_FY?>#]M \);^;E]
MX/VT#PEOYN7W@_;0/"6_FY?>#]M \);^;E]X/VT#PEOYN7W@_;0/"6_FY?>#
M]M \);^;E]X/VT#PEOYN7W@_;0/"6_FY?>#]M \);^;E]X/VT#PEOYN7W@_;
M0/"6_FY?>#]M \);^;E]X/VT#PEOYN7W@_;0/"6_FY?>#]M \);^;E]X/VT#
MPEOYN7W@_;0/"6_FY?>#]M \);^;E]X/VT#PEOYN7W@_;0/"6_FY?>#]M \)
M;^;E]X/VT#PEOYN7W@_;09-8AM7 19<OZR=$AQ/3^FI/8A:>#-_.3.\N>VL6
MAX,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:!X,W\Y,[RY[:
M!X,W\Y,[RY[:!X,W\Y,[RY[:#36[,H.*W%YN>6^T\L]@MQ;ACP,NP#;CT1P7
M2,0>34"KH DLJ?34R.EP><Q.Y<1$SV"E#-Q$\.;$EMH2"XVJJET0D1?1Z4JB
MPH.>S&],#@MQ8+:V0<='+[C)\<6 -&;9+&#6>LQ2P<.C5TT'0T"@4"@TG+BM
M/M17'VPE/H2L,$8HX:!Q+2*K=;>FU!]DR&(D=Z7)-&XT<"=><+H$ 342K^A$
MH*_;FX\)N["0]Q[<F#/PL\5.)+ 2 3$24%X&@DEB%4XI00]V[TP.R8V/EY]U
MQIG)SF,5$5IHWE65*54;14!%LBJGUEX)074N7$Q\5Z;/?;BPHXJX_(>-&V@
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MC$EBK9$1IMQ.CU^FJ)FRUR1;PWFN6!@)^O&ZQB$9LZ>RK:RN")7]?"H.[H%
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M;G;DAKCN7=.5RE=YU[6OJNG3?HH+.@4"@4"@4"@4"@4%/6[,H% H% H% H%
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M^TG]]2>RPM:Q=E H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H.+WKR96<VMALJ5MN9&3(&8T2J+,B4TSKBQW5NE
MQ)4,]"\#($1;]"A$W?BL%CO \5V=G&;;R^6;:S:1A&,T\79W5CM/<M$30Z\#
M39?:X O K4%9N>'CL!N!^/MEIJ(4S Y1[/0(U@91F.V*19!LC81/6I-B5D4Q
M4DXZ.K1!=VM@V=N>7KK3"MR9S\"+DI0&HR)L>5#,WFI3B=9T'" 5(36W53T4
M&[=,*%A(WF/CL4VD#'.[<:R!QXZ:&FY)A,9-YML>J)*#+>K2G%11>F@GYO";
M7PV+VYE=M(TWF5R$!O#SF#U/SDE/ D@'74N3X.,*X;BFJ]&OI%%H*-Z(SD6E
M@23/LLC?SX/@!J',#EN*K9*BWTE:Q#Z4X=%!<Y.1AMC[IS;K$08^"+;JY#(8
MV*(M-.O,2%9$D!-("2@6@CX<+:EL/ -.+Q98_?F-QTO'8C',9;#S1EX?&ZC0
MX[#D?E]H$A '$!3,!/EI>Y)T4$' P,;"\M]HOP(K$9R3EL3VER. -DX09!$3
M6H(BDJ<4XT%WA<1M?<7]62]U-,SLBUD9D3(K/LA0H3!+V8&R*RLMJQH>0PTW
M4E.]^-!3[4ACN7(;1/<G,R(A@9K[0S+JDEL)L<(S[X%P<)6E$T4TZ24NF@['
M9,=C'3MTX:"/)Q<#*)V***KRV!DPXTAP&TZ!!7'#)!3@FKAPJ#E<I$YV5S'E
M@>KLFY,@F15-9(?A$II79VA1XBG/;)N_H5Y*HUP)4S<?,')*A2MF8>;#R!":
MW\6?0XZDOH5>0RKB?0\E!(P6%PLW,[%>G8^+)?+:QFCK[3;AJ;"X_0MR1550
MU+9?1>@U8[;.#RN'W_,R,49,Q<KE>7)<XNL<D!4%8+I:42%#N%EU<>F@ZM93
M\WRN6;+<5V3(P'.?=+I)QR%J(E_2JWJ"RVI_Z/PGI_\ #(O^SA0<_P"6N&E-
M[4VUD"S<]UE<?'/L!K&[-8V4L/580](WZO\ $OPXT%%B\=-B;>QV]\$T3V6P
M\O*MSH;:7*=BCR4@GV$3A=QNW.8_QCIZ#*J$-U@]CX[>.+=20QB,[-R[,EI$
M7F8V1D)#<A45>A%CO$:IZ%'CT4&K-MI,V%NO=CBB1Y^<P[%<2Z?^'1)34>):
M_H(05Y/^DH-V<;E-[BW/N6+<GMLSL3,0!1-11@B*,P+KT7CR#+]I$H,FWTES
ML1O8C$V\WN5IK'."JJ*XQJ'*AQE&_H=4C?2W3S*#1+QFZ]Y1MT9K!#!*/E'P
M:P<I^0\+P#@W%[,8( $*"LH7'1ZR70N-!V4:%@M^XG&[D('&CF11128=)MQ&
MW$NXPXH].DKBOI%;V5.-02]RPPB;)S,'&-HT+.+E-16FT7JZ8YH*)Z:#E9;H
MCD_+M[% CB>&SS@M7LA(D!I6TO\ 3PH*';6V<_GMNX7-0/!6\DXY'R+FX$64
M[DNUH8K)1PB1%4BL;+C)%I'ZED042J+7$[9P>;A[\DY:*,R2>6R++;SO6..#
M33:CV<NEI4)-=PLNKK=-J#&/FCVPQM_?&0,GXV>P,>-E25117<E'C]IB%=>D
MWM3S*>LE!/50;&,:K(XK9[V+@97=3L61G<K*RXH<9IR8^G:%$$$E<)7#4$M9
M! 4NO%$4*G&P<5E=L;%\19A9)IC<,O'QWE1)+"Q62R#;;;1OZB)I$;! U*M]
M(]-!]W>V#+'F9&CDL9H6,(RWR5Y:M HH"<NWU%1/JVZ*(ZN;@\3M_>&TGL+%
M" Y+<FP9BL)H[0QV1V0B/6_F*CC8FA'<D6_'K+45QF/B8S(->7,+,$BP'\AG
M@5IPU%M]S7(T,GQZPDJ7T+P)11./15'9XZ+B\+Y@Y"#AQ"+BW<0,S-PF10(C
M4E'D!AU13J@;C7-U6MJ$$5>BH+/RX%\=B;>1_P"MV%E6[]*,J-VD_L#30=10
M*"GK=F4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&;/\T/VD_OJ
M3V6%K6+LH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H%!%R&-Q^6B.0,G&:F0G;<QA\$<!;+=%L2+Q14NB^A:"#%
MVKMR'C'\.QC(_A<K_M44P1T'>")_$UZM7!$^M098W;&W\1%DP\=CF&(\Q-,P
M4!%5X;*-G"*ZFEE5$U+T4$Q<9CB:B,%%:5F 0'";4$TLDT*@"@ENJHBJHEO1
M0?'\9CI)ON2(K3KDIH8\DC!%5QD%)1 E7I%%,K(OK6@A0=J;;QF0/*P,7&CY
M ]7\=MM$(=?UM'H#5^MIMJ]-!*3#8D514A,(J25GHJ-C_P!K)%17NCZZHJ];
MIH-CV,QTA\Y,B(R[(=8*(XX8"1%'-;DT2JG$%7I'HH(.*VIMO!D)XG%QXCH*
M2@ZV"<Q$-+*B$MUM9+:;VH,XVV<!#5]8V.8:21(&<\(@FE939:Q=0>A"0NM=
M$^MQZ:#5D]H[8S4P)^5Q,:9,!$'FNMB2D(_5$_MBE^ G=$]%!:=CB]J"=R0[
M8#9, _I3F(T9"1 A=.E5$5M]% 9B18[K[S#(-O2C1V28"B$X8@+:$2ITJ@B(
M\?0E!BL""LX<HL9I<D#11AEZ!YR,&2&3:':^E2%"4>BZ4&(8W'-=LY<1H/$"
M5R=I 4YYJV+2DY9.LN@1&Z^A+4$:5MS!36X#4K'LN-XL@/&IH0>SJVB"/+5+
M**61$LG"U!):QT!EJ2RS&:!F8;CLH!!$%UQ[@9&B)Q4O2J]-!F$.(W#''@P
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M^Q([L_\ #H'B4?[$CNS_ ,.@>)1_L2.[/_#H'B4?[$CNS_PZ!XE'^Q([L_\
M#H'B4?[$CNS_ ,.@>)1_L2.[/_#H'B4?[$CNS_PZ!XE'^Q([L_\ #H'B4?[$
MCNS_ ,.@>)1_L2.[/_#H'B4?[$CNS_PZ!XE'^Q([L_\ #H'B4?[$CNS_ ,.@
M>)1_L2.[/_#H'B4?[$CNS_PZ#-K)1^:'4D?63_\ 9G_7_P!'4GL0M?$XWV)'
M=9'PZQ:'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<
M;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX=
M\3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?
M#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CN
MLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8
MD=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<
M;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX=
M\3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?
M#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CN
MLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8
MD=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<
M;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX=
M\3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?
M#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CN
MLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8
MD=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<
M;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX=
M\3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?#H'B<;[$CNLCX= \3C?8D=UD?
.#H'B<;[$CNTCX=!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tb_micancerseek-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tb_micancerseek-4c.jpg
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M%!04%!04%!04%/_  !$( M<#M@,!$0 "$0$#$0'_Q #/  $  @(# 0$
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M_)>/$U*WF)R:$9,I<C&;!52T(:]>4=1L%VMWD@OZGV1_UG]62/2*BM.?N?\
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M F]+.@]!_O"()+/#I0[#AO.Q>EQ=Z[M_Y5(&L_*WREY+YN5;D5;*A2Q.#;;
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MN+K*$7GR:_<CCN+8"MQ+FT$YU*#=WCLG6%I2&'748Y0=V?0.P2'7IHVG353
MW#A_W%>7&?SV,X[AY;EB]E)QK0F]=XH@,V?3>\A"^COT]5G3"O&7F!F\GR/G
M&;R><E-[9W9HB$]7>&**1P&(6]#1BVUF^95%Y\VL-Y,X+C6$J>75_P 5S\LK
M27[[322D]9HG;^(+[8XR(W9V%@8FT?5!>/V??_E#EW^[4_\ UYE)'G3'?_EB
MI_O,?_.,J/8?[N/^'.,_[Y@_[-94A6JOVLT?%,]RS&;MGON"FK;_ ).^E -?
M[M4E&F82R'$N21'8@[O*X.Z)25Y?\L].5G<"_P#.'1U1[7QG[F?*B]CX;5O)
M34+LC#WF/EK3G*!OIJV^,"C=M7[=RF%>3/./!6^/>9O)J5H"%I[TUZN1=AP7
M#><"9_3T/1_G9V51/X3@/D]E\=#<L>998RR0"4]&WBS&2(W;J.YI7$]'](NZ
M#<'D)Y;<*H\CN\KXER\N1AC(3I3Q>X24Q$[(ZL3%(;N3:"_8/]Z@\J8[_P#+
M%3_>8_\ G&5'Z?K%778GBJUY;,Y,$$(%)*;]C #:N_\ <S(-&83]U?EOE*[C
MG*]W$3/J,D4D/O4+L_R%%J[].W4&5P/.WG;R+RZY-R6"_P"7F/>G7[EVR,PP
M^ZPSSN6K$$/31V;ZQ:-N^3IJ]18N.\2SF0_;?R3(QQ&]2+,19.M$S/Z\-2-H
M;$HMZ1'<^K_^[?Y$&L.(8WBN5R;T^6YJ7 4"#6+(157NBTNK>K( &),+MKZP
MZ_V>E!L.UY;^2]2+O3\UADUTT"'$S2D^OS#(^G]Z"6_<%Y<V.#8#@\$$Y9#&
M4*MC&G?V=V+SE.=H=18B8=[2'M]9_JNI H/!^,^7G(:T@\IYC)QG)@;M'%)0
M*S7DCT;0FE"1MKZZZL3-\SNJ+[Q_R?\ *O-\DQ^ POF5XCEK1N<-:+%RL)M
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M!_\ C&M/5%VDD-]=NYR?:+^A0>=H2R'$N21'8@[O*X.Z)25Y?\L].5G<"_\
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M1F]UC[1+7[:91MGS4\MJOFCQ^M@+>0DQT=:V%UIHHQE<G".2/:[$[=/XFO\
M<HJO>5/D70\K,S=S%3,S9$KM7W0H980B$6[P9-VHD3Z^KHJ.[S)\A.&>8ULL
MO,\N)Y 3,TN0IL+]]M9A;OHR;0G9FT8F<2^?1DR-9P?LYJM-K9Y?(=?7ZD=
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MD5.] [1V:Y%IJ\9Z.VCZ-J),XO\ )T90:-L_LZIE/NI\NDCK:] FHC)(S?\
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M#0>];.Z[S1W?79N+3M^TZBK @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M68JDHM)#6@;ZHE7@D::7=]>4S9M.U!M50$! 0$! 0$! 0$! 0$! 0$! 0$!
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MJ6LE/;>Y/'CKEJ#(7L4.SW>:W58-AN[BYLS]W&YBQ:$XM_K;@LR @(" @("
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M.V,T4NA&X,VK1;?XG>_5<.K.@L4S08;F7)"SV<O8$<K/7NXVU$T T[->.G%
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MU: ZV/KP0-6JUAG<7F,1(Y#(SV"VXCZ-T9FU?4+&@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M07M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MHVG1FZZA94! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[&#R1@;/#6B'(]V3&+V!%F-V<69NK]>C:*"50$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MNS_Y3$"]"#%Q/$[\/*\7D<A4BDQM/C<&,(Y'"1QNQSB;BP]?\K?6;H@S;O%
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MW<93R$^1C:"WE<A:R156)I.X&P3;8W(=1<F$6<MO3<[Z:]J"Q(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#6OFISW.<=M8'
MB/#H(;',^43E#1.UJ]>M!$S/+/(S=7VL_1OF=^NFC]?V_B4V1?9MF8IKCKCQ
MGX.)[GSMFJ::M,1.S9/3/A$><L>#CWFAQFM>Y!F.>^-0UJ%V>?&EC*\$7?C
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MD+9(XCO,+=^=<2"%S].P3(G9O[2=09" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MQ+5FCJ3-7M&!##.0=Z,9NVC$X:CNT?KIKU043 \DR.)X5R?,YBW)E;& N9<
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MQ1S SL$@L8L3.):$VK:L_5G7'F,3AW8G,9<U%$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M><]PW=G=G?\ V8?5)F^9]=?C\;7KT4O_ ./NOF9^Y/EZ5_Q;7)Y>S;R;Z_\
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M5]JD4S-L>=IS/XRDEXO<0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV_/T?0+@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @^.^C.^FNGH9!K;E5F#ED5 ,%B;L/,J]NM)1
MO6:4M4\>(3,4IRSR"(]V43&SQB9=XS[='U5&5A\P7#2S6(S&.N%*>1O9'%RT
M:LML;T-^8[0B!1"[-*#F\1#(X_59]=KZJ#!XYQ_.8[*\,ER%%X9!CY!<R(0_
MQ(:<F5LQV@@<QZ:CO<.G1W%].BHL/':5V#FG,[<]>2*I;EQSU)S%V"5HZ8@;
M@_IVET?YU!0N.!F\3A^,XKDD63QG&0JW9+ T8YVL'D7O%W<-AZXE* /$3D##
MM8W?J_1F>CG2PV3J\7]Y\*NUX*/,6S#TYA.:XV-:TQ=[IJ9R.P%O?1R+35NK
MMH@E.8<?RO+,GFRQ%<WAO\<H^X3V .&&6Q7ORV6KFYLSBYLPL3$VK,75D%TP
M_+*N8E@JMC\C3OR"Y6*UNG-%[N0MKMDEVO%UT]5P,F+T*#%YY3MW<;C(Z<$E
MB2/,XF>08A<G&*&[$<AOI_E$6<B?Y$$=FS+ >8-3E%V">3"6<1)BY+-:&2RT
M%@+(SAWHQ"1L,C.3"6W3<VCZ:L@KTE/-9.ER*ZV'MUGO\KPMVI7FCTF.G6/&
MB4[CZ!9H3(F?J+-UZJBY92I<DY]QR['!(=*O0RL<]@1=XXSE.FX"1>ARV%I\
MNCJ"I9O"9M\_G<Y6QTUJ+&YW$9>*NP^O<K5L>$$_N^YV8SCWD0MKU(-O:J)J
MY?+F7(..Q8>I:'&X>X64R.4LP2U C*.O-7"L#3@!'(92^OM;009]7U=F4'#@
MTUGB7EECY<KC;OO-1Y6FQ]>N<MS^/=-A=H1]9^AL;_ZO5!?T! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00/-<S;X]Q+-9R
M@('=H5);%<9F<H^\ 7<=S,[.[:_.@B9LGR;C63PL>8NU\OB<U;;'$4=9ZEFO
M8DB.2(Q89)!.-^[(39]''5BU=F=!#5N2<UDXG<YV-RE-6I%?GEPAURB$JN/L
M2QD(66D)VD>.)W$B!QW=K,RHDLQSJU3Y+AZ=*$#X^05BSUB1G[Z!\N;P4&'U
MF8=90?O-S=!=E!=7MU6M#1>>-KIQO,%9S'O7B%V%S8-=7%G=F=]/2@KM_+YJ
M_P BFXWQXZ];W"M%:R>1M 4^PK12-!#'$)QZD31$1DY:".FC.[] AHN=9BR%
M#"C5@J<IL96QA+DTN\Z$4E*![1RQ]1(^]AVG#&[L_K=7]5]0F^-YK*V<QFN.
MYEZ\]S#^ZR#>IB4<<L5P#(1.,B-XY1[MW(=[MM(7;MT08_*<GRC 4<EFVN8P
M,33 I8HI:M@YR9FT&/<-@6<S)V$=!ZN[((>SS+E=:GDK<U6G%/QBG3LY^KH9
M-///$T]F."3?ZC11OZA$Q;BZ/HW546RME[.0Y#:QU,!\+QD;!?LDS[BNS,)A
M"'H]2-]\G_+%OE4$T@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M#%O9+'8N%K&3N04H")@&6S($(.3L[LS.;LVO3L0<7RV*;'^+/>KMBMN_W[O0
M]WVN^W7O-=NFO3M0<J.2QV4A>QC+<-VNQ.#RUI F!C;M'<#NVK:]B#N&> IC
MK#*#V(Q$Y(6)G,1-W87<>UF?:^C_ #.@P+G)..X^<ZM_+TJMJ-F>2">S%%(+
M$VK:B1,[:MU09P6*\LA11R@<HB,A ),Y,$FNTG9NNA;7T?TZ(/I3PC,%<I!&
M>1B*.)R9C(0TW.S=KLVYM?[4'$;=0K)TAGC*Y&+&==C%Y1!^PG'75F^=!Q"_
M1EMR4([,1WH18Y:PR"\H"_8Y SZLSZ^ED"6_1KV(:D]F**W8U[B Y!&233MV
MB[ZO_<@Q[V=PF+E&#)Y*K2G,=X1V9XX3<-=-S,9,[MJW:@RJMNK>KQVZ4\=F
MK*VL4\)C)&3:Z:B0N[.@[D! 0$! 0$! 0$! 0$! 0$! 05'S3=F\N>3ZOHWA
MUCKV:>H_5!F8[B-*M?K9>[=NY;(5!)J4N0F:1J_>#L,HPC&,&(A?:YN.[35M
M='=!3>"<4QV9XE%9S-^W9Q)7<C++B9)A#'_PLC.[,8"(D0,X[G S<7]+.RHZ
MJ/%LWSCCV:RXY:.A4YD<EJ."6@$LL=81:&B32O(+](XXYAZ>J1/H@M?$\]A>
M0PXG(W(ZT7,Y:,T<\)"#78VK3-!< ?\ /W8V T?T:Z*#IY97QV'R']4-R,>.
M7I:[5;?>C'/%;@@(C!NX/0BE!Y"V/'ZWK:.Q=&04@<0PP8O'<ODGJX+EN6O9
MC(6,@[0VFFB&)L?6EF!Q:M)($>_2-Q(=G="_RT6'C&1PG%,IR2M7R<3\&IM6
MLR9.U,QA6R-R4XY*Q6C=WEZ=R[;S(@W,.NFUF"9S+MR/E^/XX#[L;A.[S69T
M?H4^KM1@+1_MB=AV=O\ V8?:4&)SC"4H1LY*&25[F:*K1DPX$ PY*S$3^[A(
M[MN$6Z]\X$VL0OKT9!4LO3'$/R"K-=E_JC&>X2<<(2**6Q:MNTDLT<;/H;V+
M)2A*VA>HS#]5F5&Z5 0$%:H<SKY66,L5C+]W%2V'JAEXHXVJN0DX$8[Y!D*-
MB9V>00=ODU;J@S<9R?$9?+Y;!5)2\3PLD<=V&07%])08Q,'?ZP]=NK=A,[.@
MQI>:8.#,E@ICD"Z%R#&D3@_=-8MUCM1-NU[" '%G^UH/I09^8SE'!A3*ZYN5
M^W!CZD<0N9G/8+06T;T,S$9/Z!9W022 @((^QF:=;,4<'+O]^R$-BQ7T'4-E
M1XFDW%Z'_BCI\J"005V_R^"IF+&#JXR_D[U2"&U:]SCC>.,++R#&SE++&SD7
M=%T'5!D8/E&+S\MJI6[ZMDZ.WW[&W(BKVH6DUV$0%V@>C[3!R%^NC]'032"+
MP&<AY!1EO01'"$5NY2<)-'=RHV9*Q%ZKOT)XW)OF02B @(*];Y=4#(SXC%TK
M>8R%5V&Z%$ >*N9"QB$LTIQQL;B[/L8G+1V=VT=D'7)S;%U;.$I96O:QES/S
M3UJ,-N,1=IJ[:[9" S$=_P#[/UGW=G:@E;^9IXZ]C,=9W^\9>:2O4VCN'?%"
M<Y;G]#;8R_O08^6Y-B<+D\1B<A(4=O-S'7HZ"[AOC#?ZY?Y6?H(_*3LR"80$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0:]Y?>!N<8.-L5:S#XG'W\D5.F$,A]Y.\=:)W::2,>K=\S=4%4
M$J?AF(G[AWK\DY.68EP6-@*=ZT>.@<C@*'0?X@S5P>QH+,TI%V]KT63 Y3%#
M<Y'YE]WX1QN"FU.Q5,6AL22XR28IIK,&C/'*+EW( 7KNS=>CBR# X1;A/FT.
M1GOU;.:Y'BK-K*059XYW@EK68B@@+8[Z-##/W;/Z78G]*#,X7>IWK65LSX.W
M>;,9F[+'E2K0G6[B*3W6)^\(]S@P0#_E03&>$<)SGCO(!9@JY4)>.Y ]79MQ
MZV:3Z-\D@21M_P#%4%6Y'F;+7^1<IH.;6QL5.%<>EA#O)@EFG![LL0&["Y]X
M>QM?5W0MNZ:JC)\5BX+B\A3;CG@F6DQ=^[B\B\H9 [EBE 4YA9G9N\>;_P!I
MH>YB9BT+IH@[,OQS&\;X3A,Q1A9L[B+.-M>)C_UFQ-:L116WED^L;6!ED8V)
M]'U^9M R,1QG%\JXWR')9:)I\CF[F2'WR5F>>O'3LRUJHQ'VQ]R,0D.W30]2
M[7=T$-Q[+R7<]CLOD,/8S=W(<0PEBP4$->0@DDEM$3EWQQZ;G=WT%!M?&F$E
M&"0*AT (=6IR" ''K_E<8R(6?^QU!E(" @(" @(" @(" @(" @(" @XF 2"X
M2"Q 3:$)-JSM\[.@Y(.+11B#QB M&^NH,S,/K=7Z?/J@^B(@+"+,(BV@BW1F
M9O0R#K:M7&5IQB!IF8A:1A9BT-]Q-KIKU=M70<9:5*>>&U/7BEM5]>XF,!*2
M/=IKL)VU;71M=$'*Q7KVX3K6H@GKR-I)%*+&!-\CB6K.@ZPQ^/CJ-0CJPA1'
MZM48Q:)M'W= 9M.WKV(.]@ 2(Q%F,]',F;1WT;1M7]/1 **,R S 2.-W*,G9
MG<7=G%W9_1T?1!P.M7DEBL21 <\.[N92%G,-S:%M=VU;5NW1!VH" @UX;9/R
MMH XR!D> UYQC>.34+^.AM3,+;3ZC/#&1_5=A,0])Z=0B6QN2?(\HY1@(WFY
M#@,]+)%5%]'NT)*%)[-)_1_$9M\6O9*(OV;E1BM&W,6Y[D^/&\D\XX7,X"9A
M]9[%6H%B#1BZL[G'W9-VMU9T$]%?DYWR"ED,-(T-;#X9LC2EE9R$,IFX7&N\
M@=A=S QN3?\ O4'9Y?RQ4[3X;,QY"GS8:82Y**]:EM07.[<0DM5C<RB(=[MK
ML$"#<S$(]%!L% 05#+_\2.+?]W9C_P!>D@HE./*-Y3MS^;,WYN5U()<A#<*Q
M)W6RO.3M7*#=W91D ]V>X7)_K:ZZ:47K#/KYC<H?Y<;AW_\ 3NJ""\Q<N>!Y
M##G,7W;Y;%\=S5JT&FKE SUVKM)V>KW_ %'5_0>GI5'"IC.2T[N&LXNEFO$Q
MM0#G;N3N025K=0WV6"DA:R8"0,^^)H8VT=MK='=D&%4J9J?C$,N.AL7\16Y#
MG3S>+HS>ZW+-5[]P1[H]\>NPW8RCWCO[-?0X;$XI=Q60P-2QA9IIL?H<8>]E
M*5D"B,@.*7O]9&.,F<"$^K.VB@F4!!2_*DG/A=:2;KDCM7RRKNS-(][WR9I]
M_P#K,;.W7T:(,'G>*JYWEW%L)?W/2OU,S!-L?:8L\,#B8%_E,"9B FZB3,Z"
M+JY7*7,_Q+"\@=BY+Q_*V*F2F9F ;,<F+MO7N +=@3@VKZ=!D8P_RJC#Y%XA
MR?)<MM4,7?M3U0AQ/'+]086BCMXR1K9GK+,#_P#6V&,W8>R)!+9G(W.1X_C_
M "L:EW(\-GI22Y3%XB:2*[%:D[MPD<8CC.887&2,HP+<Q>LPEIT"_8:W0OXF
MC=Q=GWS&SP1R5;3D4CRQ$+.).1>L[NW;NZZ]J@SD! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!3[6,Y=6Y1E
M<UBXL?9BO5:E2F=N::(JXU7F,V, B/<Q'*[MM)NSJ@Z\#PBSB,KC;]JU%<]T
MAR,UJ?8\4DV4RUB.::5@9W$080< '5W9G]/:@XCPJ[)E+#69X7X]9S!9R>J+
M'WDQA7@"&(VZ#M&:,IB[==H-]I!)Y;C9SYC#9G%-!7L8LK7>,0[6D"S6.-F]
M1O1)W9/KZ&?TH,SBN%?CO&\7A#(9):-:.&>4-6$YF%N\-M>NA'N)!PY9AK&>
MP%O'TI1KY-N[L8VS(VH17:L@SUS)F9WVM( [M/1J@BI.%2/PVG@*]D8<Q1DA
MR%?($+R@V3BF]Z*4A=V=PDE<M[:Z[2=M=4'5/QS-\IOU9N61U:F,H068AHTI
MCG>Q8N0%5DE*0XX]@#$9L :.^I:N_31PQH.,<LM4</QK,SU'P>'FK26+\)&5
MG(18\QDK 41#MB=RC IWWEKIH+,Q= Y3<;Y=2@S>"P=BJV'S4]BS6OSD;6<<
M^0)SM",0CME]<SDA]<='?0NC=0[(^,9W!9V.]QH*4V+CP]+#15[TTT4L;4))
MB%]T<4C$SC*S>CJR"VX\LB50"RL<,5[KW@53.6)FU?30C '?IV^J@RD! 0$!
M 0$! 0$! 0$! 0$! 007-,M;P7$\SF*!1C=I5)9JY3BYQ-((ZBYB+L[BS]K,
MZ",CY?8M<*S69"$:O(<)6MAD:$FIC7R%.%Y'!^K.49>K(#Z^M&0OZ4$9'GN4
M9S/XK"4;\.,CL<?AS5F=JS6#.Q+*,;BS&;,(-J[Z=OSH%CFF?K<?R]0@J2<R
MIY,./XXQ8VIV;EH(I8)7#5R!FCF8Y@W/MV%H_8@LN#Y3CLGQ:GR>Y/%1JRQ,
M]L[!M#'#.)=U+&1&[,VV5G#J_:@^\LS\G'\=#)4B"?*9"U!C<9#,3A$5JT>T
M7D(6=V &W&6C:Z#HW5!!7N59CAUPH>6209#'ST+N1JW*4)5Y DQL??30'&4D
MC.Q1ONC/>WU28F['0?9,YS+"QXK,\@"F>+R-FM5R&/K@82XY[IM%"33E([3,
M,A@$NH#V[AZ-HX6O,9>C@<99R^2D[JE4#?(3,Y$_701 6ZD9$["(MU(G9FZH
M*3C.<\@RN+ 3I04<Y=SL^#AB)WE"M'")S.<FA>O($49:B),+GT[$&7!R_+2X
M^7&"$$G+&RDV$KN(NU>1X=)2M/'N<A ("[PQW?6]5GZL@O+=G7J_RH" [:L[
M?*@JW]$0SO6BRN7R.5QU64+$5"Y+&4121&TD;S.$8'*P$PD(R$[:LVNJ"8QF
M%IXF?)V:KF\F6MO>M=X6YFF>&.'U.C:#MB'I\NJ#&PG%<1QZ_E\ABP.*3-SC
M:MQ.6L0RB&UWC'3U6)]2)OM.[H.."XGBN.8Z[C<0\L$%Z>Q:,]^LD9V7[(RT
M]40;08V_RLS(..*XM#C\B.7MY"YELG%7>E6L7CC?N:YD)&(#$$8[I' ',W'<
M6UNJ">0$$=8PM.UFJ&>D<_?L=#9K5V$M(W"X\3R;ATZO_!'3Y.J"-#A.&CX<
M?!A*?P62O)4(GD_C]W*[D7KZ=OK=NB!;XDTV9LYRAEKN-M78(*MP*SP%')'5
M>1XW9IHI-I-WI=10=N,XAA<=!?C.,\A/EA[O*W+YO8GM1[7!@D(NFQA)V&,6
M8&U?1NKH.O$\3+#%6BK9K(R8RETK8Z:6*6-@VN(QE(4?>F MIM8I'?IVN@^1
M\1CJ4PIXG*7L:(V[=XC@.(W.2_-)-*)M+&8N+%(^SIJ/3J@DL)A:7'\<&-H;
MRB$Y)I9IC>2:6><REEED-_K&9DY$_P _R()% 05N?AU5LG9R^'OV\-=O$TE]
MJ1QO!8E86#O)(9@D#?M%FWBS$^C:N^B#NAXI4"]B<E:N6[N0P[6VK6+,@D1^
M_,+2=XP (OHPLPZ,VB#GD.*XC)<AQ'*)P,,QAFG"M+$6P3CL1E&02M_G%MVX
M&?ZI=6[7U#*P6%I\=Q5?#T'D*M78G8YB[R4SD,I#,RZ:D1D1$_RN@B?Z+CKP
MG6Q68R.,JR36YSAJR0[-;\O?2,'>1'LT-R<-NCCN?^X)O%8NCA<;5Q.,B:"A
M2B&"O$SN^T ;1M7?5W?Y7?JZ#,0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$%1\TNGEUR9__ .WS_P#J.@K_ )EXV?"T<MR_',_N5[%6
M,=RFN N3E7[B1J]QA'JYUR+:?RQ$_P!@51@8[%%E.:X*K[];QY1<.K$4E&1H
MC+_I(LXD3B6K?V=4$@7'?>.65L%Q>WX94XM$>2NV2!KAS93+[P8IN^?4Y&B:
M0R-R=_XC>A!QQQXKB=GE'&N=W*MG"3.'(0LWXHXZI1W9FCG HR9XV8+(L?\
M;*S]J"[<HQ.-S&'D@REEZ,-<X[<60 QB.K/6-I(YA,V<6<2;_,VCMJSZL[J"
MB8W%1\VY-'8N927D> Q%.[3GOL 04)YLC&,!PPC"S-(XQL;RRB3LSFPCIZS-
M1T2T"S5[#\0QG);'(\;C[E6Y=<>Y*&M4Q\K2@%NS"/\ &E,XP (W=B+J9L^W
M5!8\Q3R'+,M1RG'LEC;F)P<TP%1LC+* Y: ]CR&41LSE VYA!V]4WW=K#I!
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MK@F7)11 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:<\W8*N4\Q/+# 7 ::K>L97WB)^QXVJ
M"#_Z#==_VZ9IQ]]X\8BO\WS7NM8OR>/KGPM-_P#Z6L^'GD>3CB."Y!C.?RQH
M9XLP,@ZPG;%Y*E$6U[7C G(?[%V.3%=7=MK_ /SS3'R\;?FX?$FV[MT6_P#\
M]=G=\^M:_DBJV5RN3XKY1\5:D.4X_?JY&6;$37O"Z^0M5)Y8PBEGT?I'HQ,'
M^9WT^1>UM=:;>1LSVVB:]<=TUB8CK$?'U\FO7;>^GC:L=U+1;Z>[MBTQ,QB9
M^'IYI#E_&^4\:\KO,2OEL5'@N,6I<18PF$BR#9(*ECWN(;# ?UA&3Z^C]&Z,
MR\N-OU;>5IFMN^\=W=;M[<QB<?D]N5Q]VGB;XM7LI,TFM>[NQ/=&?S\4_P T
MJ8GFN>M<=Q_&:F2SO'<%4/+9O,9*Q2J4XSKC,'<10N^I,)[GDT;1^C]%K<6U
M]&N+S>:UO><5K6)F>N.LS_)M\RM.1LG777%K:Z1W6M:8BO3/2(_FK%*UDN6<
M;\CJ^5R5MI+M[*XZU;@G.*P=4)P@V/(+L_\ LF[O7MT6Y:M=.SDS6(Z16<8Z
M9QG^?5HTM;?JXD6M/6UZS,3UQG'\NBQ1Q3>5O//,? <$[ZOBJ_$Y<W3QQ2'.
M$-Z/NV:4.]<G?:QD75WU[/D6I,QR]&F^WK,[.V9\.C=B)X7(WTT9BL:N^(\<
M6Z=>J"S'&\!QWR:P7FQ@<C8'S(FDIVO&O>Y99[=RQ(S3US$C<28/69QV_P"3
MKVEKLZ]^S;S+<>\1]KK';B,1$>$_QZM3;Q]>K@TY5+3]Z>V>[,YF9\8_CT6N
M'AF*\PO.7S#Q7*_>BQT5'%6"QD5F6*!K4E&)FD(0)F(HM2V:ZCU?5G6E/*MQ
MN'IMKQG-NN/+NG^;H1Q*<OG;Z[<X[:3C,XSVQU_#R:^AP,5SR ?S/M7[\W-<
M'9B@P^2.W*[U:\%R.L$,0;MH@PDY=FN[TZ=%U)W37G_8B(^W>.L8CK.)G,N/
M&B+>V_U,S;[E)CMG,](BT1B%TY_%CN>Y[D%:GQJG=SW'<16FSG(<KDK-2&J4
ME;OP]UAA=VW#U??HS;F];IIKS^'-N/2DS>8K>T]M:UB<]<=9ET^=%>5LO$:X
MFVND=UK6F(CIGZ8AM?R-RE_,^5'&<ADYSLW3KR1G/([D9#!/)$&YWZN^T&;5
M^U</W776G*O%8Q&?YQ$OH?9MEMG#UVM.9Q_*9AL)<MV! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!!$W^,X+)YG&<AO4QFS.&[UL9:<C9X?>!V2:"Q,+[FZ>LSKWIOO2EJ1/T
MV\?P:]^-KOLKLM&;4SB?3/BX4^)\<Q]S,9"GCHH;N?<7S$PZ[K&T2%MW7Y"+
MLT[5;<C9:*UF>E/#X)3BZJ6M:*QF_P"[XHJ;ROX#8XU7X?8P4$O':AG+4IF\
MA=R<A$9%'(Y=X+NY%]4O2O:.?OC9.R+3W3XS_'1KS[;QIU1JFD=D>$>GX^+&
MI>4'EQC\#?XU5P4887)G%)D*Y33F\QURW1N4A2.?JOU;0EG;W+D6O%YM]5?#
MPZ9>=/:N+37.N*?3;&>L]<>'GESS/E+Y><@RE;,Y?!PV;]:,(!-SE$9(H69@
M"8!-AE869F_B,71M%-7N/(UUFM;8B?XZ>GX,MWM?&VWB]Z1,QT\_U]?Q9-7R
MTX-2CPD-7#QQQ\<FELX06.5VK36#:20AU-]=Q,SZ%JRPMSM]NZ9M^^,6\.N&
M=?;N/6*1%?\ ;F9KX],^*2#BG'H^16.6#0#^H;5;W"Q==S<CK:B_=N+EMTU$
M?\NJ\IY&S[<:\_3$YQ\7O'%U1MG;CZYC&?@KF/\ )CRQQ>:#D%'CM>+(Q2=_
M VZ4J\4NK/OC@(WB M6;1Q#IHVBV[^Y\F].R;SC]?S\6EK]HXE-GW*TC/XXC
MY1X++4XO@:&<R7):E(8LYEPCCR-QB-RF" 6 &=G)Q;1F9O59EIVY&RU(I,_3
M7PANTXVNNRVR(^JWC/KA&AY<<)BXK+P@,1&/%IC[V7'=Y+L(VD&77=OW_7%G
M^LO:>;NG;]WN^OUZ?)XQ[?QXT_9[?HGRZ_-A9?RA\N<]EXLYEL##9R,4<<+F
M1RL$L<(B$;31B;!+M$19N\%^QOD9>FOW+D:Z=E;3$?QX>GX/+;[5Q=M^^U(F
M?Q_6//\ %9,!@,1Q?$U\%@:K4L34W^[UA(C8.\,I"T<W)^I$[]76INW7VWF]
MYS,MW1HIII%*1BL>227B]Q 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 01G]08?XEONG^% _J##_$M]T_PH']08?XEONG
M^% _J##_ !+?=/\ "@?U!A_B6^Z?X4#^H,/\2WW3_"@?U!A_B6^Z?X4#^H,/
M\2WW3_"@?U!A_B6^Z?X4#^H,/\2WW3_"@?U!A_B6^Z?X4#^H,/\ $M]T_P *
M!_4&'^);[I_A0/Z@P_Q+?=/\*!_4&'^);[I_A0/Z@P_Q+?=/\*!_4&'^);[I
M_A0/Z@P_Q+?=/\*!_4&'^);[I_A0/Z@P_P 2WW3_  H']08?XEONG^% _J##
M_$M]T_PH']08?XEONG^% _J##_$M]T_PH']08?XEONG^% _J##_$M]T_PH']
M08?XEONG^% _J##_ !+?=/\ "@?U!A_B6^Z?X4#^H,/\2WW3_"@?U!A_B6^Z
M?X4#^H,/\2WW3_"@?U!A_B6^Z?X4#^H,/\2WW3_"@?U!A_B6^Z?X4#^H,/\
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MF])$+$9?9';]ID$L@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M1MM];J@W"H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @UUSB[1?
MF.!KWL;:R]?&4K^4EH5*WOKO(?=UH7*-_F*;:_RH*N#8_P #Q#. 1<?Y/R8<
MG7PM6,[@04*</?%"4,8EHY35F.:,1VQR&X^AU19>,6\-#>Y!S[' .(X0-,8Y
M!V-7&>>@<Q6+10:,43@W\+UQ$RV]6T85!B<+LR2<V#+W+,19+D^*FM7*L4P3
M/![G9C]V@=A?H\4-C:[Z>L>]U1]XJ7'<Q?R]K*X.3)VLKF;G<9&;%E/7:O7/
MW2+_ *049#L88&T?=IU03V8$<%SS 9H&:.EFH)./W7UV@TH,5JD^W^T9XV_Y
M;,H*SR//SPY3D/*Z1O[Q1DJ\/X](,96'&Y<FC*Y*$/\ G(2.,&'_ #%#H_14
M=\65QG"*.4;P.UC>2'C+V0IY/)G%<GR)48>]-I;$<DC]YT8RB=V;378VC/H#
M)<;I<8XGAN35F?\ JC'6,=8NY9G=[-TKEB**V,YOJ\@2C*?J%ZHOMVLVUD&1
MC^+T.88//9S*:S9K)6\@&.R!:C/0BH69:]1JQMUBV=TTC[--QN[EKJ@A,7E*
M&7S^/S6?P<F=LY#B6&M'W5$+?=RS2VC-]";U-SOT9NW^Y!>LWFAP7#FLX*C[
ME>M,%/"8R2(:[M=N'W4(E%T9F8RWFWV6=U!0+=O_ ,/N06./8B1HK,F&P>.#
M,3Q.=6HTER^$EVV[:-J4LFHB[^O(75V'<34;7X_@*'&\<..H,9,Y%-:M3%OL
M6;,K[I)YC_S2&74G_N;1F9E!*(" @(" @(" @(" @(" @(.B[2J9&I-0OP!9
MI6 >.>"46,# NCB3/T=G0=_9T;L08M;&T*=-\?4K1P47[S6O&+"'\8B,^C?:
M(B=_G=!VU:U>E6AIU(A@J5P&&"&-F$ CC9A$19NC,S-HS(,.O@,+4O#DJU""
M&^ 3Q!8 &$V"W-[Q,S.WVY/7+Y2ZH.&5XW@L[/5L9BA%>DI.15FG;O %RTU?
M8_JN_3TL@[LKAL7G*ON67J1VZS&,@A*VNV0/JF+]HDVO0A?5!A?T?Q=\1/@2
MQ5<\1:,9K54P8QFE$QD8Y'+5S)B 7U)W?HWR(.]^.8(LR_(3H1'FMK -V1M\
M@,([6V;M6'ITU'1!F6:-.Y)6FM0C+)3D[^J1MKW<NP@WM\^TB;7YT&-;P.%O
M9"OE;E&&?(U=.XLF#.8[7W#U].U_6'7ZK]6T=!(H" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @I5JMRVES#*9C'XFMD*UNG3I4)Y+GNW<C 4TDC
M2#W1EHYRZ^KKJS(.KCW"\AC,OC+V0E@L/5BRERY/#NC8LKF+,<LCQQENTB &
M,!U+7KUZZH.+<+R,V1N4K/<?TQ>S4F;N1L[N<X#!!W4!@XZ;2G I).O5A9O\
MSZ!(Y'B<4.<PN<P%.I5FQY6QM" #!WL5BL8BSN ]?XHQ]OHU?T()'B&&/CW&
M,3A9G%[-.M&%D@?42L.VZ4F=V;HYN3H.',,/;S?'[-7&E&&8A**[BI)O]F-Z
MG(,\#F[,[L+F#">C?5=T$1+PNU_1E+#UIXPY#1GBRT5N;=+"65"?WN0CTT)X
MY)",2?ZS"73J@ZK>"SG,KU0N2T8\1B*,-L"K0V6M36)[U8ZA.QB L$81R2::
M^L1.W0=.H8T&#YGD<=B.*9J&M'C,9/5/(9B.9Y"OP8XPEA$('%GC*4XP>7<6
M@LQ,.[5G8.<F'YIBZV:X]@XJTV/RMBU8QN6EF[LJ#9$REF&2%@=Y'CD.0XMA
M>LSL);=-7HY0X'/<8ST-G 8Z+)XF+"4,-$TMMJTP/CY)W9R9XC8F(9!ZL_;K
MT4&?%2SF<Y)B\AFZ#4,?AH);$5<9QL#)DK+E"):LPZM%!NZN+=9>GU4&07&G
MM\FSUW)10V<%F,53QIUC]9S[B2V\PF+MIM<9Q9NORH.[B6-S6%HRX7*SM=J4
M).ZQ&0(W.S+1T9XQL:LW\6/_ &;GJ^]F8G]9W9!8$! 0$! 0$! 0$! 0$! 0
M$$/RK,R\>XWE,W!"-B>A6DGB@D/NP,P;5A(]'VL[]K^A!@Q\OAM<,O<JJ0.T
M]"K:ELXZ9]LD-ND!][7ET9]"$P<7?3YVZ:((I^7<BR>8QF%P=6E%/;PT6<L3
M73E(&:608^Z 8F9^FNNYW_N0<YN>7*_',M;GQ;#RK%7&Q#8<9F*.QD9^[>L,
M,KL+O',,T9LY"SBSOJWJN@L^!S%;D&%HYJF__1[T(3"VNKBY-ZP/\XOJ+_.R
M#IY'GHN/8YKA0E:M3S14Z%*,A [%NR;1Q1L1NPCJ[ZD3]!%G?T((8N8W,)=D
MI<SJ041*E9R52[2F.S <5$6.Q$3''&8R ),;>J[&.NFCB[(.N/E^>JOB[^=P
MH4<'F9X:L)!.\MNI);]6#WJ/NQ%F,W$'[LRV$3,^K:NP6++S9R((0P=2O9GD
M)VEDMS%!%$+-KKH$<A$[]C,VG]J"N0\YN2T3@+&,')@RS\?>DTS'6][:)K/>
MM,PL3P]P_>_4W_Y=-4'='S64\1-(5%GY%%D2P@XT9'>.2\+ZZA)MU[KNW[]R
M<=1#75M606]M=.O;Z4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MT35'L1--WCZ:#LW;MSZ]FB"20$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MK]W_ $[*^WN0TU]^C^9!#R6/!?,^]G8Q<:+V<;QN\PCJ 06ZG>UBT;1AVV"
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M^B"20$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$T#L3312%/JX[A8P9PWMTU;5E1D28O,P5N?\?;&SRR9WWZ_B[P=W[K(UFC%
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M',5BN\Q_((J%?&7 (>XJ15(@KF,VXMP]TP=['M8MSEIVJC9Z@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(" @(" @("#XQ"6NCL^CZ/IZ'0?4! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9;_!D#NP^RW^#('=A]EO\&0.[#[+?X,@=V'V6_P9 [L/LM_@R!W8?9;_  9
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MOH0=Y6( FCKG((V)6(HHG)F,A#3<[-VNS;FU_M9!V(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\MGE[R4M&+3'SOM)F(7]7L=GZ.S^ED%5OV#XS@^4<!OD_N!8;(7>)SR.[[Z
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MY&_SNN)R=]MVRVRWC:7T'%X]>/JKKKX5C^/S32UVT(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+&+A%W]@M7&,7=W8!9A =7U?35^KH)I 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M&T<2'=!ZQ2[2;5GG,F].UE1<<SR6"C):QDF$R60D:-ABBKTRFKV>\'Z@RO\
MPF[=I=Z0LW]B@J&&X_F."0\2REFK+D1HXR;"YJ*FQ69JT4TD=B!X@%MTD<!
M\+[6W;78M.CJBR\3KW[>;Y!RJ[5EHP91ZM7&U+0-'8]UH ;=[(&KN'>22R.(
M%ZS#H[LSOHT'9QVC>K<KYC;L0'%4NV:1TYBTVRC'1BC-QZ^@A<7^=!4>.XO/
M\9BP7(9<59LA7;,X_*8^+:5N&&]DGM0V(XM?7;^&+&(ONVDQ,S[7942^ OV\
MKYF92[-CY\?5'"4XJHVF89Y!][LN\AQL[O&SNSL EZSLSOT4&39*YQ?FN2S4
MU"U>PF>JU(RM4HBM25;5#O1V'#&SGW<@R,XF+/H3%NTU9T%>L83/96;(<G+%
MS5BR^>P,E;'2,/O(8_%6(V*Q,+$["Y:F;CKJ(,.OK:LU%YYQ4M7^%\BHT82L
M7;.,N0UX(]-\DAP&(B.NG5W?1E!$MRO*%BX:/'N/Y"QFNX&.'Q"M)0IQRB+-
MNGEFVOL'M?NV(GTT9!B<=XG:XUR+CE.(3LT<=@;M6UDMK"!W)[564G=M7T>0
MFD-F]""-'B^3XUSG&RT*<MKB-5LMDJ;5V9WIR7(@>:F(:MZLDK=[!\CD0=C"
MJ,K$>6E#+<5FCY.-J+,\@&:[FHXK=F*,+5_4R'N@E:/6)G&-O5T]1D%NXE8S
M%GCF./D$!U\W'%W%\)--2G@=XBD;;TVR./>#_JDR@FD! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$'3-4JV'8K$$<I"V@N8"3LS_)JR#K\-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP
M^A \-QWP<'LP^A \-QWP<'LP^A \-QWP<'LP^A!E(" @(" @(" @(" @(" @
M(" @(" @(" @(""-R^)DRH0-#D;>-EKF\@2TC 7+47':8R!(!CUUT(>U!TX/
MCE+!'<LQ2SW,CD#&2]D+DG>SR]VVT!U9A$0!G?: "(MJ[Z:NZ"80$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$5C,Y#E
M<AE*=2(GKXN4:LMQW'NSM;=\D8,SZOW;$#$_9N?;VBZ"5004_+L/7Y)4XH3S
MEE;C2;'&"1ZXO%%WSB4SLP;G#UF%G=T'S,\KJ8F^&)AIV\IEB@>V=+'QC))'
M69W'O#<S 18B9Q!G+<;L^UGT?0,_#9C'Y_&5LQBY>^HVA<HR<2 F<7<2$A)F
M(2$F<2$FU9V=G09Q/HSO\C:H*]Q_EL6?HX*X&/M0MG*97@)HWE@KL# ^R:8?
M5$RW^HW^;1].Q!E\ISP<8X]D,_) 5H*$3S%7 F C9G9M&<NC=J"70$! 08N.
MR5+*UO?,?,T];O)8.\%G9N\KRE#(/5F^J8$/]R"+R_)_"K$M>/#Y/(M!&TUB
M6C6:2,1?7H+F8/(73ZD3$7S(.NUS3"14L3<HE)E"SHL>'K41:2:S'L:0C%C<
M&$!%V<RD(6'HS]79D'5#SK$6,>-R"&T=PKA8OPCN=MYKP \A0E&3L+.,;=ZY
M.>S9ZV[1V09 \OQ)X6#-B,W=V)VI1TWCVV_?'F> H'C)VT,38F)M=&9G?73J
M@GT&+CLE2RM;WS'S-/6[R6#O!9V;O*\I0R#U9OJF!#_<@RD! 0$! 0$! 01-
M3.A;Y%D^/- 0'C*]2T5AR9Q-KKS,PLW:VWN>O]J"605S'\OKWKV,IS4+F.\8
MKRSX][\3UY"DK$[2P'$7KA(P:2"Q-ZPZNWU706- 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_L0;@4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M*G,5,J]J IAF8?5V-N?4M>SH@O0Z[1U[=&U0?4! 0$! 0$! 0$! 0$! 0$!
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3]BQ^EL?EH'B=;[%C]+8_+0?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ph_cancercate-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ph_cancercate-4c.jpg
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M%!04%!04%!04%/_  !$( 28$9@,!$0 "$0$#$0'_Q "U  $  @,! 0$
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M)7G, Q*\Y@&)7G, Q*\Y@&)7G, Q*\Y@&)7G, Q*\Y@&)7G, Q*\Y@&)7G,
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M4_\ \-I3_P# 5_O(9-#[Z_W;/<?9I_XO-#6Q@
M                                    +^+I5V5&M[QW*''D75)K@0WE
M.)<<H>&F(DFDC,]A;1FJUXB9^$_V]K53[:9B)ZHB:NR%(^R[&D.Q9"#;DLK4
MVZV?:2T'11?X#1$Q,8PS3$Q.$]K77R^2M*^2OFJ*AW_LIM /(9T.A'0SILKY
MJ@+&=:E0;7:[HMY*T7-+RDM$1D;9,JPG4^PZCE37U533DZUZ?3335C]RN^PR
M,C[:&6V@ZN16M/M[#\]/, $==I;2[*^2O[0"O8?D/L/R'3S
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M8 ]+J?\ ^&TI_P#@*_WD,FA]]?[MGN/LT_\ %YH:V,
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M^*>IDW9,TF32I'Z?$J*2#BI3T?2XD;34G;BQ5KMJ&CTX?_I\?WQ7W'7U8?\
MU?#L[,'9JQ:VH5W8<@SG[8LFSM\A28WPZ,1&64N.ILL1$=229=I^4<]",9IG
M&,?GVXS^[I[F<*:HPG#Y=G3&6#YP/J/D
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MR            #[ 'I=3_P#PVE/_ ,!7^\ADT/OK_=L]Q]FG_B\T-;&
M                                                       S4SH1
MF9D781G4B_8(%3I2IT\U=G< $I1)P$I1(,ZF@C,DU\].P J=*5.G;2NRO[
ME*(B(E*(DF9I(E&1$9]ID5=@#![2PF9FGR$>TB_80"1K<,R-2U&:=B3-1F9?
MLJ>P,#&6*GMVG0^TJGM_;YP"JB3@)2LOMP5/#7]G8 8E821B5EEV(J>$OV%V
M ,"@
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MHN)L*6\;1$;?3N$HJ%7;4]@Y5>[F:HJP[':CV44T54]7W8>#T(P/HL
M       ,@,     ,@,                          #>__ $H_\G^8JM B
M
M
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M *D 5( J0!4@"I %2 *D 5( J0!4@"I %2 ;WS+*C_R?YBJT5(1"I %2 *D
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M/<1P@&:>XCA ,T]Q'" 9I[B.$ S3W$<(!FGN(X0#-/<1P@&:>XCA ,T]Q'"
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M5\Y&()
M
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MV/OL$:&G\DD.(=)"C4:#4AQ.).(Z*K0Q%78@
M
M                                      ":?57^S_,@$
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M:W%K69J6M1G52E&9F ZQ
M
M                       $T^JO]G^9 ,Y1[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@$W&S-+98D["IM,!#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>3Q$ 91[R>(@#*/>
M3Q$ 91[R>(@$DMG1?B3M+>+SD K:$ 4( H0!0@"A %" *$ 4( H0!0@"A %"
M *$ 4( H0!0@"A %" *$ 4( H0!0@"A %" *$ 4( H0!0@"A %" *$ 4( H0
M!0@"A %" *$ WOD65'_D_P Q5:*$(A0@"A %" *$ 4( H0!0@"A %" *$ 4(
M H0!0@"A %" *$ 4( H0!0@"A %" *$ 4( H0!0@"A %" *$ 4( H0!0@"A
M%" *$ 4( H0!0@"A %" *$ 4( H0!0@"A %" *$ 4( H0!0@"A %" *$ 4(
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MJ#/U?L 2$
M
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M)F52[1@;E;IU%WLQM:<E6:,S;&TJ5$NMF23,!6'R2(RCQLNJ+RD;B5'_ !$
MQ;+9(+5>KI,V*9VNYM6MIA;I$;4A+45UM]-/*18L*OV@/(W'0QM-W21;;?+=
MM]O=AQ8L!UU;\N;#8=;.9DFXJN64?%&C-XMJ<SRN"CUNB(+T&V7#%#<ML"7<
MY<NTVUY.4Y'A/8,"3:_\(E+);A-[,)*["[!)'I!
M
M                                          &QOU'?Y2_W) 0 8
M       &0&  !6W.Q0;NXT]*<ELO,H4VER%+?AFIM9D:D+R5I)1&9>4J^8R%
M'5;[?!M4&/;+9'1$M\5!-1HS140A!;:%_B=3,]IGM,!T"       ,@,
M                -[_]*/\ R?YBJT"(
M
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MA71LZ4V^+R5(00   E)-2T)41K;IF((R-2:]F(BVE7[0   9(C,Z$53\Q ,
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M\QD9"UT543A5&$I37%48Q.,.@>'H 9-)D1&9&1'V?: R:5%0C(R,^S8 QV;
M&
M
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M*AAUM?J1<6&KJ;AP[PY$LTR[M.08\R*TU)@()2HSJI!4-#F(LMS$E1X552&
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MAQJ4J6EQ4>:IHGS(R>?6ZQ#S=B3<-2\1Y9F*/K&G+O'N\!PF8B[>];7UVV7
M<,E&P_%))&@EIV*3A-*D*+M29""W$
M
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M=A%VF M!
M
M           $T^JO]G^9 ,8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?
M< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]Q@&!>Z?< 8%[I
M]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I
M]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I
M]P!@7NGW &!>Z?< 8%[I]P!@7NGW -CB%FAKPGL3MV ->!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7NGW &!>Z?< 8%[I]P!@7
MNGW ))0O"OPGV>;[2 <G4/\ -5W@,=0_S5=X!U#_ #5=X!U#_-5W@'4/\U7>
M =0_S5=X!U#_ #5=X!U#_-5W@'4/\U7> =0_S5=X!U#_ #5=X!U#_-5W@'4/
M\U7> =0_S5=X!U#_ #5=X!U#_-5W@'4/\U7> =0_S5=X!U#_ #5=X!U#_-5W
M@'4/\U7> =0_S5=X!U#_ #5=X!U#_-5W@'4/\U7> =0_S5=X!U#_ #5=X!U#
M_-5W@'4/\U7> =0_S5=X!U#_ #5=X!U#_-5W@'4/\U7> =0_S5=X!U#_ #5=
MX!U#_-5W@'4/\U7> W///$VP9.*(U(J9D?:=15:>H?YJN\1#J'^:KO .H?YJ
MN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^
M:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA
M_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .
MH?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P
M#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN
M\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:
MKO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_
MFJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H
M?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#
MJ'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\
M ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:K
MO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\ ZA_F
MJ[P#J'^:KO .H?YJN\ ZA_FJ[P#J'^:KO .H?YJN\!L0^\:'#-Q5221EM_U$
M T ,          "2$FM:4%VJ,B*OV@*6!J6!<=,JU4PTZFWH8E23:62<[!"4
MXE94(Z5,VE8=OF%%A!F,S[?$N37X<>:RS(92X9)429""<0D]OK4/L(!T[#6I
MHE)-U%#<;Q%C02NPU)K5-?)4044K5=L;MAW2 ?Q!I%R9L[C;2B2I,AR8F$L]
MM:I0LZ_ZB+8*+WPJ,R;4EPB4:,2#)1&I)T,ME=I'VD(*^^75NR6*ZWU3?5-6
MIAZ0\PTM)*4IA.(V\6TDJ_F[!1NCS#D29,<XLAA$9##G5OH)$9XGT&L\E>(\
M672CE2+"9EV@.6\7MJSMVMTVCE-W6X1+8RMI:22DYJE)2[7:2DIP]A=H"=XO
M42R1V79*'GWY3J8T&%%1FR9+ZB-1-M(J1'1*34I2C)*4D9J,B 8MEPN<UQUN
MX65ZTDA)+;==D1I*'"/M*K"U&E22VGB*E/* L4&3I)4THG$.%5M:#):5%_I,
MJD?^ @P;C26R=4ZVEE1DE+JEI)"E'V$2C.AF?F(!ICR52)<R)TLAHXBVT$^\
M@DLR,QLG*L*)1FLDUP*J145L%&]!I<2E32B<0HS)*FS):3,CH9$::D9D>P0$
MFE:34A25I2HT*4A1*)*R[4F9&=#+RD8 >$LRJDED[7ZJ+\,J5JO;X=FWQ ,*
M4A"#=6M*6222S=4HB;PGV*Q&=*'YZ@)&1EL/_P"J@,            WO_P!*
M/_)_F*K0(@ KKY<7+5;79S;9.+;[$*,R(_\ $AVT=.*ZHARU:^BF9<^E+T[J
M&P1+P^TEAV3F8FD&:DE@<4C89TW1[]SHQI:DT1..#Q[?5G5TXJF,,5R,S0BI
MUEMUEAQU"'Y&+IVEK2E;A-D1K-"3.JB21^*G9Y1130=5VJ=(OL?!)B(TZ2%W
M"1,84PVIEQI;Q/-5,U*;PMJ\1I*M-FP!RQ=<VE^!<+A*CR[<5OC,3E1I;:4O
MO1)E>F<92A:B4;JDY9(J2DK\*B# >D0:E(0I:#:6I)*4TJF)!F532JE2J78=
M!!D
M
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MHD(9)U2EDVFM$54?AI3PT$D>S$           ;W_ .E'_D_S%5H$0 46L?\
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M2_JX5*6WF?Q8>TQ)'I1
M
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MT))"$I+L2E)4(B+S$ R
M
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M5CG^R8!TK'/]DP#I6.?[)@'2L<_V3 .E8Y_LF =*QS_9, Z5CG^R8!TK'/\
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M8Y_LF =*QS_9, Z5CG^R8!TK'/\ 9,!-$9DDK(GJU*AGA[-I&(J((
M       #-#I7R><!@       &?M\@#   S0R[0&                  !M<
M]1K^4!J
M
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M6 W+MLLYL8C4PJ0HC2X;K)X'"=2I*#2X2B/&DTE0_((.T0
M
M                                                !-/JK_9_F0"
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MB;:X]R?N64F?=[@_='X\=1K;8-]*$):)9DG&:4MIQ*PD1J,Z +P0
M
M                                                      !-/JK_
M &?YD @                                                 VN^H
MU_* U
M
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M(W2[@# C=+N ,"-TNX P(W2[@$@
M
M
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MLB5A41U*I .T   ')(N<**N&V\Z6.>]TT0DD:\;N!;AD6$CI1+:C,SV; '6
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M,R?FG%:PJ/$3"24LZD5"H1EV@.L
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M=4I*E+4MXZI;+PDBE2,S,Q1&2D[C?)9-+S"N&HH%O6E?\3%DC%,</]F:E?\
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M(ZMU#AM2+B^:_"A"4D@U(CD9D6RE*$(/=
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M X9"=#G!N>8MTH:KI^+@ZNJ;OF[>DPEBS,VM>G_CQ5VX@',@OTW^#7M*5?\
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M",^G,\-,7AKZNT!B2G0IM6E2U**SDB+\.0SU/P@TFY_RV/++I_7IAS#[:?8
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MZY>*O4>'LQ;<(#W@
&    #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>fc_discovery-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_discovery-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$#@VAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@.2XQ+6,P,#(@-SDN9C,U-&5F8S<P+" R,#(S+S$Q+S Y+3$R.C U
M.C4S(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.GAM
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/2)X;7 N9&ED.F1B,#8Q-C0P+3-B9C,M-#0S92UB,V1B
M+3)B868V9F$U8C$R,"(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#I&13 W
M,40Q-#$W1C,Q,48P03,P-3DU.30U.#,X0C-#02(@>&UP34TZ26YS=&%N8V5)
M1#TB>&UP+FEI9#I&13 W,40Q,S$W1C,Q,48P03,P-3DU.30U.#,X0C-#02(@
M>&UP.D-R96%T;W)4;V]L/2)!9&]B92!);&QU<W1R871O<B R."XS("A-86-I
M;G1O<V@I(CX@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240]
M(GAM<"YI:60Z96$V93@Q.#@M83(Q,RTT,V1E+3AD,C(M.#<U-34R.3@X-C(Q
M(B!S=%)E9CID;V-U;65N=$E$/2)X;7 N9&ED.F5A-F4X,3@X+6$R,3,M-#-D
M92TX9#(R+3@W-34U,CDX.#8R,2(O/B \+W)D9CI$97-C<FEP=&EO;CX@/"]R
M9&8Z4D1&/B \+W@Z>&UP;65T83X@/#]X<&%C:V5T(&5N9#TB<B(_/O_N  Y!
M9&]B90!DP     '_VP"$  0# P,# P0# P0&! ,$!@<%! 0%!P@&!@<&!@@*
M" D)"0D("@H,# P,# H,# T-# P1$1$1$104%!04%!04%!0!! 4%" <(#PH*
M#Q0.#@X4%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%/_  !$(!&8%W0,!$0 "$0$#$0'_Q #L  $  04! 0$
M        !P$#! 4&" () 0$  @,! 0$              04#! 8"!P@0  $$
M 0(# @4*$ D+ @($#P$  @,$!1$&(1(',1-!42(4"&%Q,E+2%196%S>!D:'1
M0I(CD[.45765U5<8L;+3=+0UM39V8G*"HC-3<^,D-%3!U$,XX6.#PT0E)O#"
MHV2DQ$5EA?&$)Q$  @$#  0("P4%!P0" @$%  $"$0,$(3$2!4%187&1L1,&
M@:'!T2(R4G)3%!7PLC,T%N%"8H*B\9+2XB-S-<)CDR1#@[,E-J,'1%0F_]H
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MW_:6(0#H3\S.Q/S)1_ M0,D) $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M $ 0! 1[?^?/;_\ A/-_VEB$ Z$_,SL3\R4?P+4#)"0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M,[$_,E'\"U R0D 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M CV_\^>W_P#">;_M+$(!T)^9G8GYDH_@6H&2$@" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M]1U"JR]" ( @" ("/;_SY[?_ ,)YO^TL0@'0GYF=B?F2C^!:@9(2 ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MG5K..'8KDYLJ$(*A""J$! $ 0! >T^F_]PMN?S"#^(%\7WK^;N^\S].=W_\
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MPYW@^HMG)WY9M3V(ISER&MB=W+]Z&W-JW%\>OH_:8^_/1YWELG$/W%6GKY_
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MF*BH/0F$QD.$PV.PU?3N,=6AJ1:<!R01B,?4"@DSD 0! $ 0! $ 0! $ 0!
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M/556)<<MU33_ '=I>7RE[F6HPWU;:_>HWSZ5Y#G/2N<X=1Z&A('O-!P!(_\
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MF6_IK%AWK_Q=K^3[IFW!_P WD<]W_P#(:'*$CTDF:$C7,U=="1]A'XENVO\
MB/Y)>4K\G_\ D"_W(]2+OI.$C?6-T)'_ .*8N /_ .TV%Y[L?EI>^_NQ//?=
M?^]'_;C]Z9V&U/\ Y:<C_-,C^'D57E_\Q'GAU(Z+=_\ _'I>[<^](C?;FTNC
M][!T;F>WC/0S$T?-<ILCU;%)J1RC[D[P#QJ^R<O/A<DK=I2BM3K^TY/#W?NF
MY9C*[D2C-K2J:G_=.XZ2;:V53ZIO=M7*'.4*6&?:CM2MY'QW)9Q"X-'*SLB/
M;I]FJC>^3D2PO]6.PW.E..-*]?47W=_#PX;T_P#7GVL8VG*KUJ6THZ-"_=?C
M(UZS9K(9CJ)FFW9'&+'S&E3A<3RQPPZ#R1X.8ZO/JE=#N6Q"WB0V?WE5\[^U
M#D^\V5<O9]S:U0>REQ)>?7X29L!8FW=Z.^1]_G.GDJ4KHCL2G5SCCRZ6!Q/A
MY2QK=?#HN3R(K'WM'L]%91_JT,[S%F\ON_-WO2<83T^Y5QZ*)>#2?.T\G>PW
MHWOR6-E,%Z&M=[F=A(<PON2LYFD<0X!VH/@*G+M1N;WV9*J;C]U$;NO3L]WG
M.#I)1G1\7IR72<+Z-^4R#-\VZ/G#W5+M*66S$YQ+7RQO86O()]D-2-?5*N>\
MMJ'RRE33&2IX]!SG<J_/YV4:NDHMOG36GG\YHNM&<R\W4W)N-R5IQ4L4>.Y'
MN;W 9&QX,>A\D\WE$CPK=W)8MK"CH7IIUY=+UE9WHR;LMY3K)_Z;6S_#H3T<
M6G3SDG^D"_S_ *;;:RM@ W);-=SG@::=_4D>\#U"6A<[W=6QF7(+51^*2.Q[
MXR[3=UFX];E'QPDV?74WY@-N?S;$?T<)NO\ Y6YSW/O'G?7_  %GW;7W49G4
M*[9V'T5PU#;CS5-EM2C)8A):\-GA?/-(TCL=(YIU/^45BW;;CE[QG*[IIM2H
M^1I)>#R&QOJ]+=NY[<+#V=K9C5:-<7*3YY->-GE\.<.;1Q\K@[CVCMXKZ/0^
M,'I#;&;V1U/Z<X_8&8R7O+EZ$<$#8N\;$9)*K>2.2/FT;*'#BZ,\>;7Q-<OG
M^58R<#,ED0CMQE5\=*ZT^*G ^+PH^N8&7A;VW?##NS[*<%%:Z5<51-<$J\,=
M=?Y9$6=1NE6<Z>.AGLS,OX2Q(8J]Z(%FDFA/))&2>1Q )&CB"!VKI=V;WM9M
M4ELR6M>9\)Q&^^[U_=C4I-3A)T4EHT\37 ]?"^<Y##8C(9[*U,-BXC-D+LC8
MH(Q[8^$GP-:/*<? .*M;]Z%F#G-T444.-C7,B[&U;592=%]N)<+X%I)AR/2O
MI]M 1GJ1N^?W[LM[]U:@PN?J[M.ICF>02#H][6:KE;6]LO)_*V5L+167]J7@
M53O;W=[=^$E\_D/M)::07^63>FOI-1J=9UY?2M]+L!=IROM5GVZ;ZEN;4S/A
MDJ2D.<2 =7#0NX=JK.[RE'.N1DJ.DJI:J[2+KOC.$]UV)P;E%SA1O6T[<G5\
M^ALR+>4OX?T=:U[&3NK7!1K1-GC.CVMFL,C?RGP$M<1J.(\"QPM0N[X<9JJV
MGXHMFS>R+ECN[&=M[,MB"JM>F23\3\QP?HY92]#O*UBVS.\PMTY99H"3R&6)
M[.5^GM@"1KXBKOO/:B\93II4EIYZG+]QK\XYDK:?HR@VUP535&8NZMG93=/6
MC-83;H;!/WS;<MC4L9 TQ1ODE<6\?9O\'$N*S8>=#'W;"Y=TJE*<>ET70N@U
MMY;JN9F^KEFQ2+KM5U;.B+<O[SZ6;^ML;I;L7/TH,SN^Y)NBI/#(R*C'R!DW
M,TM#^6.;EUU&H,@.BT);PSLRU)PLQ[-I^MQ=*ZBUM[HW5N[(A&[D2[:,DZ17
M#P5]&5/[VHR/2;AC%K;5@- F>RY&]_A+6.A+1] N*\=U)/9NK@]'RF3_ /N!
M%;5A\+4_%L^<VOI)_P!W,#_.G_@EJ]UOQKG-Y3?[^?E;7O?])3,S_*9T);E'
M.[W,81@FL$GRN_H#EF+CXWPN,FGJA38C\AO78U1N:%S2U=$M!XRY_5MP]IKN
M6M+T\,-$J\\'M4Y46+4[=@^C_6@86MR6XH@T$#V1R0,CB?6KCEU\>BRPC\YO
M=M^K:?W='WM)@NS6[N[L8JFU?73VFE__ -/17CH8?3#=>S\WL*;IKN2Y[TS.
M[V-E@R"!LT<TIE!;*?)#VN/*6/X.&GLM2!EWOAY-G+67:6VM&BE:45-7%RK5
MR:#7[O;RP\C=[W?D2[)Z=-=G:3EM:)<:>C9>AJFO2ER/4+H[EMDTCFJ=MN4V
M_P S0^=K>[EB[PZ,+V:N!:20T.:[M\ 5ONS?EO+EV<EL3XN!\WF.>WYW5O;O
MAVT9*Y:X]35=55IT:E5/7P(D7/?_ "X5_P":4?Z7&N>QO^:?O2^ZSL<[_P#C
M,?=M_?B8FR=P[,WOTZ@Z=YW(>\^0A:V$:O;")3'+WD;XW/U8XDZ<S#Q)UT\!
M6;/Q<G$S7E6X[<7IXZ:*.M-/,S5W3GX.\=V+ OS[*2HN"-:2K&C>AUT56MNM
M.!D>]0NE&:V#''=?89D<)+)W;;<;3&YDA&H$D9+N770Z$.(];@N@W9OJUFMQ
MILS7!YF<=OWNQ?W8E-M7+;T;25*/E6FG)I9P 70'(E4(" ( @" ]I]-_[A;<
M_F$'\0+XOO7\W=]YGZ<[O_\ '6/<CU'4*K+T( @" ( @(]O_ #Y[?_PGF_[2
MQ" ="?F9V)^9*/X%J!DA( @" ( @" (")_20PTV8Z39=T#>>7'/@OAH[>2&0
M-D/T&.<[Z"E \%J2#TWZ)6]Z5&SE=BWY6PS9"07\5S'023,9R31C7[(L:QS1
MXFN4,'K%02$!R?4K?%7IYL[(;GL,$TT#1'2K$Z=]:E/+&PGQ:^4[_)!0'Y^;
MKWCN/>V5DS&Y+\EVV\GNVN.D432?81,'DL:/$/H\5Z(-OLWI/O[?L)M[;Q#Y
M\>UQ8Z]*]E>OS-[0U\KF\Q'AY-=$!SVXL!D=KYN[M_+-:S)8^0PV6QN$C \
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MU:UGCO5EV;\[;MR4J)ZG4^.A75_#[,K7MH;P83MC(O=-%9##,V"21H9*R6,
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M>+TUX//H+^/Z@=*ZO3#<VT-M9".E2ITK^/Q@O2%MJ_)-5<XS\KFM/W220M'
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M7!371\33TQ>KFHJ[7;.UNCG3/+C=]W>U?-R5.9V,J0.BF>Q[VEH<65W2.>\
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MY_(2M+:=J^R.N3P#G01#G(]3RVC7U%#!Z,4$A $ 0! $ 0! $ 0! $ 0! $
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MR5+U=Q9/6G88Y&.'@<UP!!4PG&<5*+JF>+EN=N3C-.+7 ]#+(60QE4("D%5
M"$%0@"D@J$!4(050@J$!5" $!5209N)Q=[-Y*KB,9%W^0NR-@K0\S6<TCSH!
MS/(:/HE8[MV-J#G)T2UF:Q8G>N*W!5E)T2_M-ANG9^XME7XL9N6F*5V>$68H
MA+%-K$YSF!VL3G@<6GAKJL&+EVLF.U;=4G3A769\W OX<^SO1V9-5I5/1I7
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MAT\#=!H"51;]N-2MXT-$:+S+HH=)W:M)PN95S3)MZ?ZF_#7Q$2_O#=3?A/\
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M%CXEV-NTFG2KTUUZNKQG6^B;N3S+=.7VO,_2'+56VJ[2?_CTW:$ >JR1Q/\
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M_!7O=N_=8]&9CW;)W%RM)YKCFMT':?-F\!]-1WD?_L6^;RGON8O_ %+OO?\
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MD,.ZD_TY<]R[_P!1YN7T8^+GI'%@GT;)-!_^"VOZ=(OG5[_FO#'[B/L>)_\
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M?OPG].L^_'[DCSBOHQ\5" ( @" ]I]-_[A;<_F$'\0+XOO7\W=]YGZ<[O_\
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MR=Z]TFFO;IS$Z:Z+Q&$8ZDD9;EV=SUFWSNI6>]>M-;':LRSL9Q8V61SP#V<
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M" ( @/:?3?\ N%MS^80?Q OB^]?S=WWF?ISN_P#\=8]R/4=0JLO0@" ( @"
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M ( @" ( @/S3Z@?W^W3^=\A_29%]>P_P(>['J/A^?^8N>_+K9SJVS1" ^D(
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MF$'\0+XOO7\W=]YGZ<[O_P#'6/<CU'4*K+T( @" ( @(]O\ SY[?_P )YO\
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MWT:=Q[\WECLUN+=V8FR%!DK*..BD9$QHD8WO)G^0QI/!S /HJ&23PH 0! $
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M_P!PMN?S"#^(%\7WK^;N^\S].=W_ /CK'N1ZCJ%5EZ$ 0! $ 0$>W_GSV_\
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M6">SN[C*[9[P\/G5G[K*#X^5SN7U@O))VB ( @" ( @" ( @" ( @" ( @"
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M@*05" JI(*J" @ 0'T%)!5""H0%0A!5" $!520$ 0'T%)!500%(/H=B$,JA
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MO9N'\W,_#M4,$E=>>A4W4%[-T;7=''NF"(0V*LI$<=R)GL/+/!LC== 7<"-
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M\HL@C=]% 8'1K:OPQZD8'$R,YZ4<XN7@1JWS>I]U<'>H\M#/]) ?HBO)(0!
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M!H=W?S5[[<)!_5 :]2=Y#_\ K61_I,BZ; _+6_<CU(XO>'YJ[_N3^\SU'N[
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M'^3A_-]YG)=X_P#D+O\ +]R)+NX^'HF5=/\ PJ']-B7/6/\ EWSR^ZSK\O\
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M[(3(!IWDGLI)"/&]Y<\^NO))O$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! ?FGU
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MKD_+K'VVK:KHYW72];UZM1S06^504D%0@*A""J$%0@*H0 @*J2"H0!" @/I
M54GD( @/I" %(*J""H0!205" JA!5" I!4("JD@JH(" ! ?04D%4(*A 5"$%
M4( 0%5) 0! ?04D%5! 4@^AV(0RJ$ *054$%0I!4(054D%4(" ^QV*2"H0@J
M$(*H0$ 0! $![3Z;_P!PMN?S"#^(%\7WK^;N^\S].=W_ /CK'N1ZCJ%5EZ$
M0! $ 0$>W_GSV_\ X3S?]I8A .A/S,[$_,E'\"U R0D 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0'DGTM;&X\?
MN#%,BR=MFV\I3<#CFS/;6-BN\B0]V"&G5KX^U2B#S2I!ZW]&KHW:PI;U"W16
M,.1FC+<'2E&CX8I1HZP\'B'/:>5@\#22>T:0P>E5!(0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $!^:?4#^_VZ?SOD/Z3(OKV'^!#W8]1\/S_ ,Q<]^76SG5MFB$!
M](0 @*H0$ "D'T$(*H05" *2 @/I00 I!5" @*J2"H4 JI(" ! ?00@JA "
MJA 4@JH(*A2"J$!2"J$! 54 J$(*J2"H0!" I!4("J$%4("D%0@*A""J@@*0
M50%0A!5" $!5""H4@JA 4@JH 0@J$ 4D%0@*A""J$%0@*H0 @*J2"H0!" @/
MI 54GD( @/I" %(*J""H0!205" JA!5" I!4("JD@JH(" ! ?04D%4(*A 5"
M$%4( 0%5) 0! ?04D%5! 4@^AV(0RJ$ *054$%0I!4(054D%4(" ^QV*2"H0
M@J$(*H0$ 0! $![3Z;_W"VY_,(/X@7Q?>OYN[[S/TYW?_P".L>Y'J.H567H0
M! $ 0! 1[?\ GSV__A/-_P!I8A .A/S,[$_,E'\"U R0D 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0$:]8^D[.
MJ^+QE%N0&,LXZRZ86G0]_K#(PMD8&A[.)(8==? I!J]A>CIL+9-F+)SLDSN9
MA/-%9OAIBC>.QT<+1R@CP%_,1X"$J"7E " ( @" ( @" ( @" ( @" ( @"
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MN@?))U+^*]_[T5/U7$^)'I'T/.^%+H*_))U+^*]_[T5'U7$^)'I(^AYWPI=
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M /B[=^]E/J^'\2/2/T[O+X$^@?)EO_XNW?O93ZOA_$CTC].[R^!/H'R9;_\
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MB?F2C^!:@9(2 ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$
M\XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]
MN$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \
MXA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N
M$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ \XA]N$ $\1( >-3V("X@" (
M @" ( @" ( @" ( @" ( @(]O_/GM_\ PGF_[2Q" ="?F9V)^9*/X%J!DA(
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M 0! $ 0! $ 0! $ 0! $ 0! 5!T((\" VH.H!'8>*$E4 0! $ 0! $ 0! $
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M $ 0! $ 0! $ 0! $ 0! $ 0! $!ESN::T;002.74 \>Q"3$0@( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MMJE*TX:,I[>^[$\IXRKM)M5X*K6B2%2E\$ 0! $ 0! $ 0! $ 0! $ 0! $
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M,E $ 0! $ 0! $ 0! $ 0! $ 0$>W_GSV_\ X3S?]I8A .A/S,[$_,E'\"U
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M@;708+MF5JFUPI/6GH?,8*RF$( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M1V*UQ,N.3;VXII<I29^!/#N=G-INE='V1S2W"O" 'L*!'Z$=-OF\VI^:*/\
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M=&,/:=.Q<)O'#AC348RVZJI]+W7G7,NVY3@[;3I1_P!B.Z546X0! $ 0! $
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M]5(_>9ZW#@X!P.K3Q!'$$%?/SZ@% " ( @" ( @" N0.Y9F'U=/I\$!LT)"
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MXMYF.':TZ:@^$+-%U29KSCLR:JG3BU%I>CR$ 0! $ 0! $ 0! $ 0! $ 0!
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M 0! $ 0! $ 0! $ 0! $!'M_Y\]O_P"$\W_:6(0#H3\S.Q/S)1_ M0,D) $
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MCSQ<XZ?0[!P6+)RKF1/:N.K,N)AVL6&Q:5%]M9O%JFX$ 0! $ 0! $ 0! $
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MIOE.Y566X0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&RK.YH6^IP^DA)=0! $
M0! $ 0! $ 0! $ 0! 1[?^?/;_\ A/-_VEB$ Z$_,SL3\R4?P+4#)"0! $ 0
M! $ 0'GWTN/[BXG\[0_T>PNH[N?F)>[Y4<;WL_*Q]]?=D>.U]!/EPX>'L\)]
M1 ;+)05)\N<?MZS8R./,C:^+DM1B&9XD(T'=A[PS5[CP#O56"W)J&U-*+X:&
MU=A&5W8M-R6J-=#^U3]%]F;;K;0VKB-LU0!'C:T<#G-['RZ:RO\ ]-Y<X^NO
MDV5?=Z[*X_WG_8?;L3'CCV8VX_NK^U^%Z3B<CU9NYZ]8P'27$_";*5WF&YFI
MRZ#!4Y!VB2<:&5P_W<7$^ JPAN^-N*GD2V%[/[[\'!X2ON;QE<DX8T=N2UR?
MJ1YWP\R+N'Z00W<A%N3J;DG[QW)&>>"&PP1XFF[MTK4QY/#LYY.8GMT!7FYO
M%QCL6%V<?ZGSOS'JUNU2EVE^7:RY?5CS1\KXC,WKU+VIAY7[2KTW;KW/988V
M[4QL3;<CFD:'SC@8X8Q]D9?!QT(7C%PKL_\ 4;[.*_?>CHX6^8R96?:@^R2[
M2;_<6GIX$M/#P'!;5Z9=6=LB]N3;%W&[:EMR">/I]K-<Q 9IY37S.>3'*X_9
M5P&^#V/ 661G8MVD)J4Z?_)H4NCA7/UE5CX&7:K<MN-NNGL]+CTUT/W>H[G;
MG5S&VLE'MC>]&79V\G<&8[(N'FUD]G-4MC[E*TG@!J':\ "JZ]NZ2CMVGVD.
M-:USK6BSL;RC*79W4[5SBEJ?NRU,D951;A $ 0! 1QUUVHW=W3+-5&,Y[V/C
M]]*)\(FI@O('JNCYV?Z2MMTY'8Y,7P/T7X?VT*7?6*LC$FN&*VESKSJJ\)X0
MQ?O7*RY'EKMBK7%:2:FRO&)FRW6#[BR4%[0UAU<#)Q+?%Q7TVYM*CBD].GFX
M?[#X_94'M*;:T.E.&2U5\>DUZS&L$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M=M[%=FKI773@KRTUF,O9C" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M,:X0 ]A0(_0CIM\WFU/S11_H[%\DS_S-SWI=9]QW9^4M>Y'[J.G6B6(0! $
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MT>PNH[N?F)>[Y4<;WL_*Q]]?=D>.U]!/EQN=J6,K6W#0=@Y*\65E>ZM6DNB
MUFFPQT1,GG(,8&CCQ<.';VK7R%!VWMUIKT5KHT\&DV\.5Q7H]FTI:E6E-.C]
M[1PG1]'KXP/5C:\TSVM#<@*4CVN#F?\ 4AU8D.!((U?V@Z:+3WG#M,6:7LUZ
M-)O[FN=EFVV_:IT^CP<Y^A2^5'VD( @/B6**>)\,S&R0R-+)(W@.:YKAH00>
M!!"E-IU1#5=#(5WKZ/F+O0RS[(?#CRYYG?MVZUTF(DE.OE0\A$M.3C_M*[AX
MN71=!B[XE%TNZ?XEZWAX)<S.=RMS1DJVJ1_A?J^#A@^6/01'>-C'9FMANI>W
M)\I>@!;3;;F-/<+8FZ-_Z#*P.CCR,;=3RQ2D2^ *\A24'*Q-13UTTP_F@],.
M=:"AG6-Q1OP<FM5=$^#U9JBN+2]#TZ>0EK8VP.B&\@W*8]]C<=JB_P"[8_.7
M+5B>G*W@634[#P 0?)\MA:? 2J/*S,VSZ+I!/ABEIYI(OL7#P<CTE6;CP2E)
MTX-,7Y43;'''#&R*)@CBC :QC0&M:UHT  '  !<^W72SHDJ'TH)(NWWT\VK1
M?9WYB\S\ =R0 OFW!5<R*K,>WEN5WZ13M)\!',3X3V*XQ,R[*EJ4>UC[+U^!
MZT4N9A6E6]&78S]I:OYD]#,3HYU:R6_+F2V]FZD?OEBX8[,&8JLF@J9"I*XL
M9/'#8:V1@=IKQX'P:+)O+=\<=*<7HEHHZ-Q?%5:#'NO>4LERA):8Z:JJ4D]3
M2>DEJ22.&-\TK@R*-I>]YX -:-23ZRI$JZ"];H?FY4L9'/;X%_%20192[DGW
M:<EUT3*[93,Z=ID,_P!SY>'$/X'LXKZY)1MV*2K11HZ5KJIP:3X=&4[V5M0:
M4I2JJTXZ\.@T^0MV,A?MW[98ZW:FDGL&-K(XS)(\N<6MC :T:G@&C3Q+9A%1
MBDM21I7)RG-REK;K]J:#&7LQA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! =!MS>^ZMHULC3V[D74:V68V/(QM9&\2L:U[0#WC7$:"1WL=.U
M:E_$M7FG-5<=1O8N=?QE)6Y;.UKU<O'SLIC][;IQ6VKNS\?D70[:R+G27: 9
M&YLCGA@<>9S2\:AC>QW@2>):G<5R2]*.IBUGW[=J5J,J0EK6CS5X#58[(7,1
MD*F5QTI@R%&9EFI. "631.#F. <"#H1X0MB<%.+C+2FJ,U+=R5N2E%T<6FN=
M:3,W)N;.[ORC\UN.X;^3D8R)]AS&,)9&-&C2-K1P]98K&/;LQV8*B,^3EW<F
M>W<>U+P>0Z; =:.J&V*;,?B-QSMI1-#(H;+(K@8T=@:;#)" /  5IWMUXMU[
M4H*OA750W[.^LRU'9C<=/ _O)FCW7OC=>^+4-S=63DR,]=KF5^=L<;(VOT+@
MUD;6M&N@UX+9Q\2UCIJW'9J:F7GW\IIW9;5.;R4.?6V:(0 ]A0(_0CIM\WFU
M/S11_H[%\DS_ ,S<]Z76?<=V?E+7N1^ZCIUHEB$ 0! $ 0! $ 0! $ 0! $
M0&DW%L[:^[8HXMQXJOD1%_LGS,^Z,U[0U[=' 'Q K:L95VPZVY.)J9&)9R%2
MY%2YS78/IEL';DYLX? 5(+):6=\]IG>&NX$!TI>1J.!T6:]O#(NJDYMK[<1A
ML;MQK#K;MQ3/O#]-]B[?R,>6PF#K4,C$'".Q ',< \:.'LM"#XBHNY]^['9G
M-M'JSN_'LRVH047R'4K0-\Y/*],=@9O(3Y7+;?J6\C9<'6+$C#S/<T!H)T('
M8 K"WO#(MQ48S:2*^[NW&NR<YVXN3X:'5AC&L$;6@1@<H:!P '#33Q+0J6!Q
MK.DO3>/*#,LVW4%\2=\'<KNZ$FO-S"+F[L<?\E6+WGD[&QMNGVX=95K=6(I]
MIV<=KF\FHV>+V+M#"Y>;/XG#UZ>8L=YWUN)I:]W?.YG^'3RCQ[%AN9EZY!0E
M)N*X#8MX5BW-W(02D];YRWA>GVR]NY(YC"86M1R9:]IM1 A_+*=7#B3VJ;N;
M?NQV9R;1%G!L6I[<(*,N-%,9T^V5ALN<_B\)6JYDF1QN1M(DYI]>\.I)]EJ=
M4N9M^Y#8E)N/%S"W@V+<^TC!*7'PZ3ZW+L+9V\'Q3;DP\%^>$<L<[PYDH;V\
MO/&6N(]0G1,?-O6-%N31&3@6,BG:P4J&/-TQV!8QE7#3;>INQ=)[Y:U;D(:V
M24 /=P()<0!J7$E>UO#(4W-3=6>7N[&<%!VX[*U*AG9?9FU<]B*V"R^*@MXJ
MFUC*=>0'[BV-H8WNW AS=&C3@5BM9=VW-SC)J3U\IEO8=F[!6YQ3BM2XN8U<
M'2GIU6QDF(BV[4][YI&32QN:Y[GR1Z\I<]SB\Z:G0<VBS2WEDN6TYNIKQW7B
MQ@X*W'9?(=!1P.%QN'9M^E1ABPC&.A;0Y0^'NY"2YI:[4$$N.H*U)WISGMMO
M:XS=A8A"&PDMGBX#187I=L#;N6CSF$P<%/*0\_<V&.D/)WC2QW*USRT:M<1P
M"V[N\<B[#8G-N)IV=V8MF>W""C+C,G#=/ME;=R1S&$PM:CDRU[3:B!#^64ZO
M'$GM6.[FW[L=F<FT9;.#8M3VX049<:+NY-B[0W<8W[DP]?(2Q#ECFD:6RM;X
MA(PM=IZFJBQF7K'X<G$9.#8R/Q8*7.4VYL39^T722;<P]>A-*.62=C2Z8M\1
MD>7.T]35+^9>O_B2<AC8-C'_  H*/,6\ST^V5N+)#,9O"UKV3#6-%J4$OY8C
MJP<".Q3:S;]J.S"32%[!L79[<X*4N-FPW!MG ;JJ1T-Q4(LC3BD$\<,X):V5
MH+0X:$<='$+%8R+EE[4'LLRW\:U?CLW(J2UZ2]A<)B=NXZ/$X2I'1QL)<8JT
M0(8TO<7.TU)[2=5YNWIW9;4W5GJS9A:BH02C%<",]83,$ 0! $ 0! $ 0! $
M 0! $ 0'T7O(Y2XEH[ >Q ?* ( @" ( @*@Z C0$'P. =_"@*N>Y^G,=0.P>
M >L$!7O'^/4Z::^'3Q:]J C7=72O*;Q=DL;F-^9GX%Y>8RWMM0Q4XV&%P =6
M9:[KOFPG33EUU]52"1*E6&I5@Q]&$14ZL;(:\+!J&11-#&-![=   H!?<98^
M#AIKPX@<0.S7QZ:H#Y#W#30]GL3X1KVZ'P?00#G<"2.&HT(T&A'JCL0'T[O&
M$!XTX< 0- /4'@0%M 5+B3J>WP:</X$!4N)U[./;H $ #W @@Z%O81P0%.;A
MH  /$ !V>+0(#Z[Q_C\>F@ TU[=/$@*![@ !V Z@$:Z'QC7L* <QXZ\0[V0/
M$'UP>U :;=V'R6Y-OW,+C,W8V]>MAK&YFFQDEF*/F!D# \::O;JP.^QUU"D#
M:NU\+LO;U#;&WX3#BL<PLB#W<\LCG$N?+*\\722.)<]WA)4 VZ (#@9/GLK_
M .%IO[0B5@ORK]]?=9I/\RO<?WD=\J\W0@" ("H)&NGAX( "0"/ >T$:H#Z:
M7N?JT:N\0 /U-$ <V1@Y7MT':-1KQ]1 4#W \P.A\8 " %[CIQT#>( X >L
M@/IQD#1S#0/X]@'-ZIT[?HH"@D>/#QTTUT&NGBU\7J(#BLIT\KYW?N-WMG,K
M9NTL$P/P.VBUC*%6_P I:^X[3RI)"#Y =P9VJ0=F>/$]J@'T'N!U&@=IIS
M.T]<#5 ?/,>)[2>TGC_"@*AS@-!V ZC7CH?&-?"@--NC$97/8YE3$9^WMO(1
MS1SLR5&.":1PCUUCD9.US',=KY0TUX=JD&CV9T[K[4R^7W1D<Q=W)O#.,B@R
M&:R BB(K5R3'!## UL<<8)UT XH#LU " ( @" ( @*H#:M/,T.\8U0DJ@" (
M @" ( @" ( @" ( @(]O_/GM_P#PGF_[2Q" ="?F9V)^9*/X%J!DA( @" (
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M,Y&Z;EN6W:;E3EI-:>"7[RX-F7!PE_9O7^_CW28SJ#7DLQTCR7<O7J/K7J9
MU)R6-T+X@/#+!SQ+SD[HC+TK+I74JU3]V7#S/2,7?,HJEY-[.N6RU):*^G#6
MN>-5P&]WEZ0>"QU:9NRQ#F9(O)GS=E[H,+6>6\P:Z8 NGDT(/<UVN<?4*UL;
M<\Y-=K6/\/[S\' N5FUE;ZMQB^RI*FN7[B\/[SY(U9PN)V%U(ZKY"'/[DM35
MJ+7<]?+9BNUG(W74>]F(=Y$6HTTL6N9Y&C@-58W,O'Q([$$F^*+^]/A]V/,5
MUK#R<R6W-M+CDN7]RWP>]+3J9/&S.GNVMBPS##0R2Y&YRG(9>[(ZS?M.;V&6
M9W$Z>U: T> +G,G,N9#]+4M26A+F1TN+A6\=>CI;UR>F3YW]D:/KGNMNT>F6
M;N-D#+M^+WLHCPF:X"PZ>JUG._\ T5L[IQ^VR8K@7I/P?MT&GOK*6/B3E72U
MLKG?F57X#P;B_>B-MQV8JV;$)K214G59&Q".\X?<72E['!T8T/,P:./@*^FW
M-O1LM+3IKQ<-.4^/67;])S3>ATI[7!7D,!9C7" ( @" ( @" ( @" ( @" (
M @" ( @" S*N)RMV%UBE0LV:[?930P22,&G^4UI"Q2NPBZ-I&>&/=FJQBVN1
M'Q2Q^0R5D4\=4FMW"'$5Z\;Y9=&#5QY&@G@.U>ISC!5DTD>+=J=R6S%.3Y-)
MC+V8P@" ( @" ( @" ( @" ( @" ( >PH$?H1TV^;S:GYHH_T=B^29_YFY[T
MNL^X[L_*6O<C]U'3K1+$( @" ( @" ( @" ( @" ( @" ( @" ( @+%J]1HL
M$EZW!4C.NCK$K(0=.W0O(UT4@N0306X6V*DL=BNXZ-EA>V5A/BYF$A0"D%BM
M:B$]2>.Q 26B6%[96$M):X<S21J"-"@+B ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @(4S]:]U3ZP9GIYDLK<QVP]G
MXZI;O8[&3OIS9*]?\IO?31EL@BC X-:>*DDW&0EV[T0JT,%LS$7<QG]Y9#N,
M-@IK\LC'3QQ>7(Z>TZ3N8(VCF?IKJ? A!AW.MF3P>,WG6W1M=N-WOL[%MSCL
M5'<%BA>I2'E;+!::P. #CRO#H]04),O#]8,S)NK:^+W+M&3 X#>K3\%\HZVR
MS.^9D(GY+,#&@1\[>+/*/#37P@"#F=K=1L;M7$VK&&P,P9F^H-G;UR.WDI;9
M;--R\]J-TC3RMX<(!P'C0'=;AZJT-K;SS^W,S4[K"[>VZ=SW,NV3FD<QLO=&
M%L.FFIU'*>;M0'.MZR[OJ':MC<.Q!BL7O3(5:6&L^^#9Y(H;>CM;<;8QR2\A
MYVM:7-/$$@H"[O+K3?V'N7S#<&&QHV_Y]%1UK9F*?.]S.\,9<./;&"(N/,YO
M/S!J U]'??4&'K;N["Y&O [:.&I5I[51UT-BQ^-)E>,A&!#S2RRM;JZ$D<G9
MS% 7\3U\\^LX'(W\)5I;,W-=BQV+N-RD,V6A?;<65IKE%K1W<<KM.QY<S4<R
M4!NMF=4<QOG=62QV'P52/:^)O6\9D;D^1:W,0RTG%AF?CQ&2(GO :W5^NAU0
M$F* $ 0! $ 0' R?/97_ ,+3?VA$K!?E7[Z^ZS2?YE>X_O([Y5YNA $ 0! $
M!#6\CD>HW5MG2<Y6WB-G8?#,SNX(\=,ZI;R,MB7DA@[^,A[8FZ:N#"-5))LL
MA%L_H)B)+>V\9D,EDMS7JF,Q>!-Z:TZS>=J(VQNM/>(6 $NE<$(/JOU7S>.R
M.7VSOC;,>$W;2PUK<.*@K7?/:&0JTP3(QLW=L<R1A #@6=G$(#5X;KGF+<FS
M<MF=F28O9&]9(*6,S?GK)IV7;#26NDKAHY8'$<K'%W,1Y1 [$!IW]3\=L6WU
M-S.,P$L]NKNW&XG("SD99([,M]K(^_C:Z,B ,#_]FW4'QCAH!(VZ.H];:F_\
M=LZ_4'O9:PN1S]S,=X0ZO%C-"YHBY=':CP\P0'#V>N^ZJ>W<5O.YL UMJ;CO
M4:6!LRY%GG/=WIA&V6Y V/6/F9J^,,<[Q.TUU0&UZB]9,GTWR\XRN$QDFW:L
MD;7@9J$9V>O)RAUB#'\FI8S7BTOU(&J US=[=19^NLN!H5:]G:@Q$%J*A+>;
M! W'S3L#LH?N)<9P"6^;D^QX\W% 4?Z0L38XMR#"UOD\DOMQPR!R</OSW;[/
MFHN^]W+J*_/QT+^\Y/+TT2@.@PO5',;FW_E-IX#!4Y,-@,@[%YJY;R3:^3:8
MV![[,-'NR7PC4!I+@7=H0$F* $ 0! $ 0! $ 0! ;&L[FA;ZG#Z2$EY $ 0!
M $ 0! $ 0! $ 0! 1[?^?/;_ /A/-_VEB$ Z$_,SL3\R4?P+4#)"0! $ 0!
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M4"/T(Z;?-YM3\T4?Z.Q?),_\S<]Z76?<=V?E+7N1^ZCIUHEB$ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0$,]8,/B<]U2Z0XK-TH,CC+%G*MGIVHVRPR 0-<
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M_"TW]H1*P7Y5^^ONLTG^97N/[R.^5>;H0! $ 0! 1SOKIQFLONC&=0MAYJ+
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MRIIV?6I1^KRZZ<M#7[!ZE= ^G&7DS6VZNZ66IX'59X['FLD3V.<UWE,$[=7
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MX;,2=]N2QS9#<%@.Y^?(V]'R^5X>3@S7U$!VR@! $ 0! $ 0! $ 0! $ 0!
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M:A%/T4J5?M:V^3EKH/-6UNK>:VGC=U8O'T:LU;=AE-M]CO#)$)F2,/)R.:.
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MQ?),_P#,W/>EUGW'=GY2U[D?NHZ=:)8A $ 0! $ 0! $ 0! $ 0! $ 0! $
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M! $ 0! $ 0! $ 0! $!]NED>T,<=6CL&GB0'P@" ( @" ( @" ( @" ( @"
M( @" YJSO_:M7<M7:4E]KLU:<8Q#'Y;8Y WF:R1PX-<[[%IX_45A'=]^5EWM
MGT%]M!5SWIC1R%CN2[27!Q<-'Q-\!TJKRT" ( @" ( @" (#@9/GLK_X6F_M
M")6"_*OWU]UFD_S*]Q_>1WRKS=" ( @" ( @" ( @" ( @" ( @" ( @" (
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M:M:YQ:#ZP7BUC6K7J14>9&6_F7KWXDY2YVV:9;!J! $ 0#L[4 !UXCL0! $
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M=6]BQM4\@Y_8_<PYO%[E )24 ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M3;33KZ"6I:=-:Z=6KQER.CMJ2_B*[LQ-%0LPQNS-U],N-.=Q=WC(XFR$S-:
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MI/U.'G_9^Z4^X=\._+Y>3=R4%IN+U7R>#4I?O4;YY87,G8A $ 0! $ 0! $
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ME2M7KEHTNJ_>Y.#0D3PSF+&EXT?H.8<.WZ"Z%:M)1O654D! $ 0! $ 0! $
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MZ7&FI?;B(JM[YVMAM@[IVEM_866Q-+--C9;GO69)H(+,;AW;R)(_)<"!XB2
MKJ&)=G?A<G=C)QU45&UTG/W<VS:QKEJ%B<5+7M-M)\#T_;40HNE.*" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" Z?&]0-TXC:61V/0MLCVWE9'2W
M:QAC<]SY QKB)'-+AJ(V]A6E<P[4[JNR7I1U?;PEC9WA>M6)68OT9NKT+D\Q
MS"W2N" ( @" ( @" ( >* [3?'53>G4**I5W'>YL?2#>YHP QP&5C>7OGC4E
M\A&OE./#4\NFJKL3=]G&;<%I?#Y.8ML_>M_,25QZ(\"U<_/]E2K.+5B5(0!
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MP(#@0.>R+"MM.+VHRU/[:FN%%O9N.:TJC6M?;6N)^4Z-:IG" ( @" XO<_\
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M71%KP.9@!T/'L*]69SA-.%-K@KRZ")QC)4EJX388C-8C,4*61IRQ/@R,7?U
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M[-X/,[UE!)W* ( @" (#F)OG2I?X6G_M-JW%^5?^XONFF_S*]Q_>1TZTS<"
M( @.=W/N7WHTHTQS9-X#BYPU;$UW8=/LG'P! <QN3;U7<&-9%D;4S-]2S,EC
MBB/,]KCH&,>QN@8UK!KKKS,*D&RZ<YC$Y7=EG%;L@G;O2C)I2FO2:F9M=@:/
M)&C>\:!S>'F!Y@A!-B$! $!IMV8)VY]N9' -LFF<A"8?.0SO.0.(U\G5NNO9
MVK;Q+_87HW*5V76AI9V-\S8G:KL[:I76<KMWIQ9P>ZL9FGW(Y\=B,)%AJD(8
MYLO>L(+Y3Q( <2X_15ED[R5VQ*%*2G<<WYNHJ<3<[L9,+FU6-NTK:7-^]X=)
M(:HCHP@" ( @" ( @" ( @" ( @" (#[B=RR,=ZH0&T0D( @" ( @" ( @"
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M_P# 8MC*_&G[SZS!B_A0YEU$?9_I1-D]R2Y#'6Q1Q%L.L6HNZYWQV>(+86\
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MZK^.0_73Z]B<;Z&/TSF<2Z1^[AU7_)U7\<A^NGU[$XWT,?IG,XETC]W#JO\
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M=9*XW%/ICYC'3)XX=#\X\XZF_P#D8'\7N?RZ5QN*?3'S"F3QPZ'YQYQU-_\
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M<W)P]BM58L%*J+R[O[)N6':E1UUMJK?DT<>OE.8ZLO\ A+U#VMLT'6K7TMW
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M0_'?^0GZ3_[O]/\ F'Z]?P/Z_P#(/WE9/BT/QW_D)^D_^[_3_F'Z]?P/Z_\
M(/WE9/BT/QW_ )"?I/\ [O\ 3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_P"[_3_F
M'Z]?P/Z_\@_>5D^+0_'?^0GZ3_[O]/\ F'Z]?P/Z_P#(/WE9/BT/QW_D)^D_
M^[_3_F'Z]?P/Z_\ (/WE9/BT/QW_ )"?I/\ [O\ 3_F'Z]?P/Z_\@_>5D^+0
M_'?^0GZ3_P"[_3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_[O]/\ F'Z]?P/Z_P#(
M/WE9/BT/QW_D)^D_^[_3_F'Z]?P/Z_\ (/WE9/BT/QW_ )"?I/\ [O\ 3_F'
MZ]?P/Z_\@_>5D^+0_'?^0GZ3_P"[_3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_[O
M]/\ F'Z]?P/Z_P#(/WE9/BT/QW_D)^D_^[_3_F'Z]?P/Z_\ (/WE9/BT/QW_
M )"?I/\ [O\ 3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_P"[_3_F'Z]?P/Z_\@_>
M5D^+0_'?^0GZ3_[O]/\ F'Z]?P/Z_P#(/WE9/BT/QW_D)^D_^[_3_F'Z]?P/
MZ_\ (/WE9/BT/QW_ )"?I/\ [O\ 3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_P"[
M_3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_[O]/\ F'Z]?P/Z_P#(/WE9/BT/QW_D
M)^D_^[_3_F'Z]?P/Z_\ (/WE9/BT/QW_ )"?I/\ [O\ 3_F'Z]?P/Z_\@_>5
MD^+0_'?^0GZ3_P"[_3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_[O]/\ F'Z]?P/Z
M_P#(/WE9/BT/QW_D)^D_^[_3_F'Z]?P/Z_\ (/WE9/BT/QW_ )"?I/\ [O\
M3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_P"[_3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ
M3_[O]/\ F'Z]?P/Z_P#(/WE9/BT/QW_D)^D_^[_3_F'Z]?P/Z_\ (/WE9/BT
M/QW_ )"?I/\ [O\ 3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_P"[_3_F'Z]?P/Z_
M\@_>5D^+0_'?^0GZ3_[O]/\ F'Z]?P/Z_P#(/WE9/BT/QW_D)^D_^[_3_F'Z
M]?P/Z_\ (/WE9/BT/QW_ )"?I/\ [O\ 3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3
M_P"[_3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_[O]/\ F'Z]?P/Z_P#(/WE9/BT/
MQW_D)^D_^[_3_F'Z]?P/Z_\ (/WE9/BT/QW_ )"?I/\ [O\ 3_F'Z]?P/Z_\
M@_>5D^+0_'?^0GZ3_P"[_3_F'Z]?P/Z_\@_>5D^+0_'?^0GZ3_[O]/\ F'Z]
M?P/Z_P#(/WE9/BT/QW_D)^D_^[_3_F'Z]?P/Z_\ (/WE9/BT/QW_ )"?I/\
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MD#GNZ4[+=(]TCSAZA<][B]Q/)VESB23ZI0'9J $ 0! $ 0! $ 0! $ 0! $
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M ( @" ( @" ( @" ( @" VL;N9C7>,!"3Z0! $ 0! $ 0! $ 0$>W_GSV_\
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MZ?:_B_\ )/\ Q'P_I#L6,:R.R31ZN:R8_P#XE1]0N_P_W8^8GZ?:_B_\D_\
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M\:;7C,193 $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M/E\YD:67I=S3@#B#W3H^Y>'\K6<SN#^8<?H>) =RA 0! $ 0! $ 0! $ 0!
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MA77#\1Q3<J1Y>+7PT)E95S\%2ELP4I:-6K:>BOHU>AOPFK6R:80! $ 0! $
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M%\5WE^:N^_+K9^E-S?D;'^W#[J.A5>6P0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M&T0D( @" ( @" ( @" CV_\ /GM__">;_M+$(!T)^9G8GYDH_@6H&2$@" (
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MYN?/Y"KW1^3M\QC]:_\ L-F>IN_"?AG+WNOUKG^W/J,>]O5M?[L.LDY4Y=!
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MXIX:2.K&?^IN/F;W<?J#1OE./M0A%#LD(" ( @" ( @" ( @" ( @" ( @"
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M6/A(-RT![$'CR-U[7GZG:I()TQV-I8FG%0Q\38:T0T:QOU23X2?"2AY,I $
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MU<11AQ''P(#.]1 5 T0@( @" ( @" ( @" (#85':P@>U)'_ *H27T 0! $
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MOSE @" ]K;#_ +D;<_-E/\ Q?%=Y?FKOORZV?I3<WY&Q_MP^ZCH57EL$ 0!
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MSL[;$.V<6V%VC\C/I)=F'A?IP:/\EO8/I^%2>6="A 0! $ 0! $ 0! $ 0!
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M%9%::7>U5TN.H. \EED\W^DS0?P(#$P]+V/! =O1@$40.G$H#+'$^L@*H0$
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M],B!=6<,$ 0'M;8?]R-N?FRG^ 8OBN\OS5WWY=;/TIN;\C8_VX?=1T*KRV"
M( @" ( @" ( @" ( @" ( @" ( @" (#BM]8C$0UI-QSX5F3GB#6V_NTD#A"
MWAS^1P=RZ\>'9ZR$HCOW[VG\5&?CLZ$CW[VG\5&?CLZ >_>T_BHS\=G0'/;^
MRNW)]D;@BJ;=;4LNI2".P+<LG(=1QY7<"M[=_P"9M^\5^\ORMSW66>G&5V[7
MV'@(;NWFW;+:WW2R;4L?.>\?QY6\ O6\OS5SG\AYW9^5M^ZCI_?O:?Q49^.S
MJO+(>_>T_BHS\=G0#W[VG\5&?CLZ [W8>)PMZ)FXH<$S&O:YS:3S/+.7-TY7
M/ ?P''4 H0SO$(" ( @" ( @" ( @" ( @" ( @" ( @" (#+G<TUHV@@D<N
MH!X]B$F(A 0! $ 0! $ 0! $ 0! $ 0! $!P&[>J5':^6&(%1UN5G=/L2QR,
MY8XWN/."!QYPT:AI[=0N:WAOVWBW>SIM/173T^$Z/ W)/*M=IM;*TTT:WP>#
ME+N^,/:ZC[#%;"6&T&7^YM-?>:^,&%A[P!P&I;KHT]G8NTW+O"W;N1OM-Q:T
M<>DXCO!NNYD6)XRDHRKI>M:'7@Y2.NF52')=4IK./D;;P^V<5#C8+T6KH7R,
MC9$2QW80YW>D>,<5U&])N&$E+1*[-RIPZV_,<9N6"N[RE*V]JW8MQMJ2U-T6
MI_WB<[>6Q=#7SZ[!6T[>^E9'_&(7 W,BU;]>2CSM(^G6[%RYZL6^9,XK=O4>
M"G!!#MF:&W/8#G.N B6*-K3RZ  \7$CZ"]6KT+L=J#4EQHB[9G:ELS3B^)FH
MV=F+.Z]R0MW&_P [=2@DEH1AC60B0D-<][!P+N4Z-/@XK*8SYW=T99+=.XM@
MVO>3.L<9/-F.,=9[CQ/(6C6,GQ:%A\00\G-5NI&8VY;&&ZD8F6E<!Y6Y&!@Y
M9-.',6 \CQ_E1.^@E":G?8K,8G.Q"?#7H;S/"(7:R#_.8='#Z(4$F;V<"@*(
M#F)OG2I?X6G_ +3:MQ?E7_N+[IIO\RO<?WD=.M,W"J P\GE<7A(38S%V&C$.
M([]X:X_YK.+C] (#@;G4S(YVV<-TYQ,V1ON\DWIH]6,\',(SP:![:5VGJ(14
MZ#:G1ETEX;CZB6_?K,O(?YDYQDKL/:!(XZ=YI[4 ,'B*D@EUK&L8UC&AK&@-
M:UHT  X  #L0$37Z5[IEFAD<3&ZYB;X+9Q(TZ, ?S<G,SL(!U:YP]1"24,=D
MZ&6K-N8VPRS6<2T21G4:CM!\1]0H092 ("U8L1U8732G1K?!VDGP #PDH#D\
MF]\]@2S\9M.7D'8S0Z\NOAT\/JH2:+%[;AH9R_G&6II9<@-'UWG[FS4@\/"=
M-/)U[%6V-WQM9$[ZDV[G!P<?AY.(L[^\)7<>%AQ25OA6M_;AXS,S$.['7<5\
M'7P,H"37*B?EU+-1[;CR\NOL>.JC,66YP[!K9KZ=:?:E.+2,-XBA<[=/:IZ%
M/MKKQZ*'6Q,!=Y/L=>&O;HK,K%J+M_'-R&/EJ'V;M'Q$^"1AU;]9 :[$4BT@
M.;RD<' ^ CM" W^F@T'@[$!]#L0@( @" ( @" ( @" ( @" ^F.Y7M=XB"@-
MJA(0! $ 0! $ 0! 1[?^?/;_ /A/-_VEB$ Z$_,SL3\R4?P+4#)"0! $ 0!
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M.-NENFTEHKJ\1^9;,K<KJ=_:<6_2V:;7@KH, Z:\.SP+.:H0! $ 0! $ 0!
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MCR$ 0! $ 0! <%)\]E?_  M-_:$2L%^5?OK[K-)_F5[CZT=ZJ\W0@" ( @"
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M#>WAD6LRU8=/2BMK1PZ:TZ#D,;=6)D;NR,F*DG"<MC3^[Z+5=>G3I,;I)L3
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M4AHU<M:LD?=I875.[:Z*,@N#GD^2#V(":FM:UH:T - T '  !#R50! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0&98_[6/_ $?X$),-" @" ( @" ( @" (
M @" ( @" ( @" X*STEVW9SAS+I+# YW?OKMD<=;7>=YWI>XD\>SE[%SLMP8
M\KW:Z>;EK6M6=%#?U^-GLZ+BK3]VE*4\IWJZ(YT( @" ( @" (#@9/GLK_X6
MF_M")6"_*OWU]UFD_P RO<?WD=\J\W0@" ( @" ( @(OZU05ZNV<?)!"R-TN
M<HRS%C0TO?J[RG$#B> XE='N23E>DF__ (Y'+=XDHX\6E_\ +#K,KI_#!;SN
M]VSQ-EC&8YVLD:' .87:'0Z\01J%\UW2HSNY%57_ %/+(^H[VE*%G'HZ?Z?F
M)&73G+A :^Y6#9._8.#N#_7\:$GU7C[$!FCAP0! $ 'A0@J@" ( @" ( @"
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MN'HX..IQ79QM1DKBG&YZ.SP+C>TFJZJ;-#5]O$]JV33" ( @" ( @" ( @"
M( @" ( @" ( @" VNVMOWMU9REM_&NC9=O/+(GS$MC'*TO)<0''0!I[ M7*R
M8X]IW):H\1O8.%<S+\;-NFU+575Q\I+6PNDG53;6[J%\-;B\?!.QUZVVU$Z*
M6LQP,C#&QSG.YFZ@!S!Q\([5RV\=\8-_'E'UI-:%LNJ? Z_M.XW1W=WIBYD9
MTV(IK:EM*CC72J)MNJU571K.XVQE\1F^OV=M89[)H(L-YO/:B(<R6:*6NUS@
MX=O+PCU_R5395FY:W5!3T-SJEQ)J7]OA.DP<FS?W]=E:HTK5&UPM.&G_ *?
M<]L1U+=.V]_=-!994SMS(6[=(2NY6R\SFZ ::D\KX1WF@UY7>%;^\%+'O6,J
ME81C%/D^R>CE15;JV,NQEX-=FY*<I1KHKJ\.AQ]+1J?"9O1'IYGME;INVMS&
MO3N6:4E>GCQ-'-/+&)HGOF C<[1C2UK>/A=X%AW]O*UE6(JU624DVZ-):'HT
M\)L=U=RW\'*E._2,G%QC&J;:K%N6AO0J)>'@X=9TR!.T>K.@UUCM@>K]PLK9
MWI^8Q.>/7$T=T+_TMX<T_NS-+Z,_]^,E^:9?Z376YWI_*Q]]?=D5_<;\_/\
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M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 9EC_M8_\ 1_@0DPT(" ( @" ( @"
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MKQ\2_*2R+KM2_<=*JO+S<ZYR3\)GNGG2B#)YG';B?N[>-V UJSFQO9&UFH<
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M" ( @" ( @" ( @" ( @" ( @" ( @" X&3Y[*_^%IO[0B5@ORK]]?=9I/\
M,KW']Y'?*O-T( @" ( @" ( @" ( @" $:]J IQ'JA"0@" #M]1""J ( @"
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M >UMA_W(VY^;*?X!B^*[R_-7??EUL_2FYOR-C_;A]U'0JO+8( @" ( @" (
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M;)IA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M*;X.#EH6,ZW>N3MQKM0UEKE[KO8UFW>G39NJL:/FU])SZWRJ" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#VML
M/^Y&W/S93_ ,7Q7>7YJ[[\NMGZ4W-^1L?[</NHZ%5Y;! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $!@9RFW(8:_2<WF[^"1@'^46G3ZJ \XL)+07>RTX
M^NH/8<>5I=XAK]) >A=ITO>_;>+J^%M=CG?YT@YS]4J3RS<(0$ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0&98_[6/\ T?X$),-" @" ( @,>U0Q]\-;
M?IP6VL]@+$,<W+KXN=IT4@OQQQPQ-@@C9# SV$430Q@]9K0 H!:./HR23O-*
M!\ML 6G&&-SI@WB.\/+J_33[+5 ?4M"L^7SF>G$^QW9@[^2%CI.Z=VQ\SFZ\
MIU]CKH@*,JU8WMECKQ,E8P0LD9&UKVQ#L8"!J&CVO8I!]3006(S#9B9/"[3F
MBE8V1AT.HU:X$<% *35JMAT+K%>*9U=XDKF6-DAC>.QS.8'E/JA2#Y%*B"PM
MJ0 QO=+&1%&.25^I<]NC>#CKQ<.* Y3=>U-_9R_YQMK>4>#QCHA":DF)AORP
M2:.#YZT[GM<R1P=]D"!IP0&PV7LO$;&VC1V9C>>WC:C'B:6X&R269IG&2668
M:<I<]Y)TT0&[@ITJL!K5:L,%9P(=!#$R.,APT(+6@ ZCQA ?=:K!6B;5I0,@
MKL!#((&-CC:#Q.C&  ?20""&"M&V*K$R"%NI;'"QL; 2=3H&@#B5 +;*-"(L
M=%3KQNB<Y\19#&TL?)[)S=&C0N\)':I!<9#!%))-'#&R:;3OI&L:UTF@T'.0
M-7</;* 6H<=CJXB;7I5X6P%SH!%#&P1N?[(LY6CE+O"1VJ05;0H,?!(RG7;)
M5YO-7B&,.BYSJ[NR&ZMU/$\J K:J4[S&QWJT-N.-W/&RQ&R8-?XP'@Z'U0H!
M<GBAM0R5[43)ZTH#9()6-DC<!Q +' @@>L@-3N'%Y2W@[U7:ENO@MQ2UVUL=
MEW563"LUI&@[L <S0.;E;KH#Q4@Q-B;*QG3_ &U7VWBY9;7+)+;OY&R=;%R]
M9=WD]B4CAS/<>SP#0(#HU .!D^>RO_A:;^T(E8+\J_?7W6:3_,KW']Y'?*O-
MT( @" J 2= -2>P! ?7=2^T=](H#X0%)ZK)X71VH&S5W:<T<K ^,^+4.!!0%
MJI3IT(G0T*L-2%QU?'7B9"TD>,, U0'S+A<;+$VM-C:LE>$]Y'"^O$Z-A)U+
MFM+= 3XPI!S.5V W-=1L!OZ2V.ZP6-O8J3$&#O&6&9#3RB_FT:&Z>QY#J@.N
MC@94BCKPPMKUXP6Q01L$<;6GM : !I]!0"Q5HT:)<:-2"H7GF>:\4<)<?&2Q
MHU0'R,;C&OGD;1K-?:!%IP@B!E![1(0WR@?\I2"ZVM69(R9D$39HV=U'*(VA
M[(_:-<!J&_Y(X("C*M2.%]:.O"RM+S=[ V-@B>7\7<S .4Z^'4* *U6K3B$%
M.O%6@'$101MB9J?#RL " NH @" ( @" ( @" ( @" ( @" (#+I.\IS?&-?I
M(#,0D( @" ( @" CV_\ /GM__">;_M+$(!T)^9G8GYDH_@6H&2$@" ( @" (
M @(2])C^Z.-_.,7X"==?W6_,R]Q]<3Y]WZ_)0_W%]V9Y>7TL^*A $ 0! 3WL
MS#W,[T'O8ZC>KXZ>3*EPM7)S5A :Z(D&0:Z:]@"X?.O1M;TC*47);&I*KX>
M^H;KQIY&XYPC*,&[FN3V5^[PECJ'%DMJ])<9M7,RR9^U<M-LQ9MFLU&JUO,6
MPQ6'<7/(#N74>Q+O  %[W:X9&?*]!=FHJFSJE+E<>+RT,6^HW,/=4,>ZW>E.
M55/7"'\,9:VZ5IR.7 J&9U0VO=WENK8FW:#A%-;Q3>>=X);%%&.=[R!VZ-'
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M9"TDC[+31 2A5EEGJP3SP.JSRQLDEJO(<^%[F@NC<6Z@EI/*2."@%U $ 0!
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MN$E':HZ<9=7L\! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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ML" D-0 @" X&3Y[*_P#A:;^T(E8+\J_?7W6:3_,KW']Y'?*O-T( @" ("/\
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M=;\S+W'UQ/GW?K\E#_<7W9GEY?2SXJ$ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M>UMA_P!R-N?FRG^ 8OBN\OS5WWY=;/TIN;\C8_VX?=1T*KRV" ( @" ( @"
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M$??AE-V.;/S.T\V?*V8MY=>7V30==-5E[26QL<%:^$Q]G':VN&E/ ;%8C($
M0! $ 0! $ 0! $ 0 @.!:X!S2-"TC4$'M!![4!JL9M?:V$LR7L+@L=C+TVHF
MM4ZD,$K@>T%[&@\5(-JH!JLEM;:V9M1W\S@<=DK\.@AM7*D,\S WL >]I/#P
M*0;4     -  : -  .   [ % " ( @" ( @" ( @" ( @" ( @" (#:0NYHF
M'U/X$)/M $ 0! $ 0$>W_GSV_P#X3S?]I8A .A/S,[$_,E'\"U R0D 0! $
M0! $!"7I,?W1QOYQB_ 3KK^ZWYF7N/KB?/N_7Y*'^XONS/+R^EGQ4( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MR/:&..K1V#3Q(#X0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 95
M)WE.;XQK]) 9J$A $ 0! $!'M_Y\]O\ ^$\W_:6(0#H3\S.Q/S)1_ M0,D)
M$ 0! $ 0! 8-W_:-_P W_P!4(,9 $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 93
M;;6M#>[UT &OK(2?7GC/]W_ @,:1_.\O TU\"$'P@,B&PV)G(6<WAU0DN>>,
M_P!W_ @+$THE<'!O+H--$(+2 O03"$.U;S:_^B O>>,_W?\  A):GG$H #>7
M0ZH06$!<AD$3^8CFX::(#(\\9_N_X$)/B6RV2,L#-"?#]% 8R$'TQW(]KB-=
M#KH@,KSQG^[_ ($)*&VT@CN^T:>! 8B$! 9GGC/]W_ A(\\9_N_JA 8KCS.+
MNS4ZH0?* R8[36,:PLU(&FJ$GWYXS_=_P(#&E>)'EX&@/@]9"#X0%^&PV)G*
M6<W'75"2[YXS_=_P("S/,)2"&\NB$%E 7H)A$22WFU0%[SQG^[_@0DM36&RL
MY0SEXZZH"PA!]Q/$;P\C4#P>N@,GSQG^[_@0D^)+37L<P,T)&FJ QD(/IIY7
M!W;H=4!E>>,_W?U0A(\\9_N_X$!AH0$!EBVT #N^P:>!"2OGC/\ =_P(#%>[
MG>YP&FIUT0@^4!DQ66QQAA9J1X?HH2??GC/]W_ @,>:02OY@.7AIHA!;0%^"
M<1 @MYM3J@+OGC/]W_ A)9GF$P;HWET_]4(+* NPRB)Q<6\VHTT0%_SQG^[_
M ($)+<UALK.0,Y?#J@,="#[C?R/#R-=/ @,GSQG^[_@0D^76VN:6]WIJ"-?7
M0&*A!4<""@,OSQG^[^J$)'GC/]W]4(#$/$D^,H040&4RTUK&M+-=!IJA)]>>
M,_W?\" QI']X\O TU\"$'P@,B&PV)G(6<W$G7UT)+GGC/]W_  ("Q-*)7 AO
M+H-$(+2 O03"'FU;S:Z?40%[SQG^[_@0DM3SB5H ;RZ'5""P@+D,@B?SD<W#
M31 9'GC/]W_ A)\2V6R,+ S0GPH#&0@^F.Y'M=IKH==$!E>>,_W?\"$E#<:0
M1W?;ZR Q$(" RQ<;I_L_JA"2OGC/]W_ @,5YYG.=V:DG3UT(/E 9,=IK&!A9
MKIX4)/OSQG^[_@0&/*\2/+P--?!ZR$%M 7X;#8FEI;S:G75"2[YXS_=_P("S
M/,)2W1O+HA!90%V"41$DMYM>" O^>,_W?\"$EN:PV5G*&<O'75 8Z$'W$\1O
M#R-0->" R?/&?[O^!"3YDM->QS S34::\$!BH05:=' ^(ZH#+\\9_N_JA"1Y
MXS_=_P " PT(,BF"9=?  =4!GH2$ 0! $ 0$>W_GSV__ (3S?]I8A .A/S,[
M$_,E'\"U R0D 0! $ 0! $!PW4V_>QV+K38^P^M,Z=C'/CTU+2UY(X@^)6^Z
M[4+EUJ2JJ>8HM]7KEJRG"3B]I:O"1C\*-R_E:Q_J>Y72?)6/81R'U'*^)+Q>
M8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*
M-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^
M5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?
MZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y
M3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK
M'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA
M]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*
M^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO
M%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'
MPHW+^5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<
MOY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:
MQ_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I
M[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^
M2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q[
M"'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4
M<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB
M2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>
M8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*
M-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^
M5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?
MZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y
M3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK
M'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*^)+Q>8?"C<OY6L?ZGN4^2L>PA
M]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO%YA\*-R_E:Q_J>Y3Y*Q["'U'*
M^)+Q>8?"C<OY6L?ZGN4^2L>PA]1ROB2\7F'PHW+^5K'^I[E/DK'L(?4<KXDO
M%YBCMT;EY3_^-K'9_D>Y185CV%XR'O'*I^)+Q>8F/"RRSX>A-,\R325XG2/=
MVN<6 DG3QKC,B*C=DEJJSZ'BR<K,&]+<5U&<M<V0@" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M" @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M/\"'NQZC8K6-L( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" NOG<^,1D#E;IH1V\$!:0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M'Q-!=_ @#@YA#9&N8X]@>"T_5T1:0]&O040! $!5K7/<UC!S/>0UK1VESCH
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MGA<W0^#0Z'356=S=E^W95YKT?'I*FUO;&N9#L1EZ:\FM> [=59;! $ 0! $
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M37AKJK/Z9?[#MJ>CKY:<94_5<?YCY>OI\VBO%4[=59;! $ 0! $ 0! $ 0!
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M,JMX[SM8,5*XG23IH_M1N,#N?'9_;-7=E<25\7:KFV!.T"1D3=2>8,+AJ /
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MYFMT]CKV$]HXK6GF6Y[5N+J]EOQ5-RW@7K;C=DJ)3BN7UJ=!LNIT4MC=E:O
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M( (250! $ 0! $ 0$>W_ )\]O_X3S?\ :6(0#H3\S.Q/S)1_ M0,D) $ 0!
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M;2U^4U,;?L_F%8R+?9REJT\>KIU:.$FQ<R=:1QU>ZEW>FF/Q=VECXL@Z_/)
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M*;\*-PM8V@@" ( @" ( @" ( @" ( @" NO@<R-LA((=IH/7XH"T@" ( @"
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M:'MU'@.AXK3G!PDXO6G0WX34XJ2U-5,A>#V$ 0! $ 0! $ 0! $ 0! $ 0!
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M)6CC++5)P=J\1O:\-/*'.=H.UG#0'1:T]VV<?+C&:VK=S57@?VZS:M;VR,O
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MC.GTD),I $ 0! $ 0! $!'M_Y\]O_P"$\W_:6(0#H3\S.Q/S)1_ M0,D) $
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MMS<OU' _55O]=R_:70BB_36![#_O2\YVVV]D;3V@Q[=MXFOCWR#EEFC;S3/
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MH274 0! $ 0! $ 0$>W_ )\]O_X3S?\ :6(0#H3\S.Q/S)1_ M0,D) $ 0!
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M@N>>QK07$_0'%!R%.():00X=H(T(]<% $ 0%'>Q/K%2B'J)VP']1XW^;0_Q
MN!ROQI^\^L^H8?X$/=CU&Q6L;80! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!@W\)ALJYC\ICJMY\8+8W68(Y
MBUKN) +VG0%987IP]637,S%.U"?K13YT9D<<<,;(86-CBC:&1QL :UK6C0
M<  %C;;=69$J:$?%JM7NUIJ=N-LU6Q&Z&>)_%KXY 6N:1XB#HIC)Q::UHB45
M)-/4S&Q&%Q& I,QN$HPX^A'[&O68V-FO9J0!Q)\)/%>[MV=V6U-N3Y3Q:LPM
M1V8)17$C.6(RA $ 0! 7'0O8P/<!RG33CXT!;0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0&OKX#!5;?OA5Q=2"_JYWG45>)DVLFO,>=K0[5
MVO'CQ6:5ZY);+DVN*IA5FVI;2BJ\=#8+"9@@" ( @" ( @" ( @" ( @" (
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M $ 0! $ 0! $ 0! $ 0! $!F6/\ M8_]'^!"3#0@( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M/T[G=L=K%/(XM;&?*];B.'%5]C>%NY1:F^ WKV#.W5ZTC:JR*\( @" ( @"
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M-_FT/\0+@<K\:?O/K/J&'^!#W8]1L5K&V$ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0&!?Q-:[&=&B.P&\L<P'%O'7L!"TLC#A=7%
M+@9N6,J=M\:XC7X'*Q=^_!6)8VWZ[>=D#I!YPZ/F(YC&3S:#Q]BU-WWWIM2U
MQZ>@V\W&>RKT4]F7#3T:\^HWZN"H" ( @" ( @" ( @" ( @" ( @" ( @"
MLV[,=.M-:F<UD<+'/<Y[@QH#1KQ<[0#URO%R:A%R>I'NW!SDHKA.4Z>[MRV[
MJ-N[DL<VE#'*&5)8RXQRL(.NA=VEI&A(X*GW3GW,N$I3CLI/1R_V%QO; M8D
MXQA+:;6GD_M.Q5V4@0! $ 0! $ 0! $ 0! $ 0! $ 0! $!FTFZ,<[QG3Z2$
MF4@" ( @" ( @" ("/;_ ,^>W_\ ">;_ +2Q" ="?F9V)^9*/X%J!DA( @"
M( @" ("/>K/]3U?YS'_%>KO<_P",_=\QSF__ ,!>\NID2+JSAP@" ( @,BM;
M=6=,[NHYS-"^#_J&][R!XTYF:G@]OV)\"\3AM4TM4=='VU&6%QQKH3JJ:=/A
M7+Q'VV*C*VC#%*^&S(XLO36-!7CYGZ,<TMU=RAO%^JBLEM-JJX*:_MQ$J,'L
MI.C?K-^JN)^<^3C97LN6H>2:MCW-9-98X :/<6,<P'1Q#B/ /73M56*>ARX"
M.Q;4I*C4-;Y]"IPZ2ZQF<BDKP1.N,EML#ZD3'RATK'=A8T'B#IX%Y;M--O9T
M:]6CG/:5Y-).59:M+TKD+;SDYX)K,LEF6M YL=B1\DCF,>XZ-:[4\"2-%Z6P
MFDJ)O5J/#[247)N32UZ7HYS[9B'QVZ]6Y+#0%N)MAEF9P,0B>TN:7&/F(+M-
M-.W7M4.\G%N*<J.E$>ECM349-0VE6KU4X*TXRS_T7F0/W7WS[[B#R^;^;\OV
MW/S?0T7KTMK@V:>&OF/'H;'#M5\%.NM?$5MVG7+4UHQQUS,=705V]W"- !HU
M@/9PU]=(0V8I:Z<>L7+CG)RHE7@6A=!CKV8P@" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @*.]B?6*E$/43M@/ZCQ
MO\VA_B!<#E?C3]Y]9]0P_P "'NQZC8K6-L( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ^
MBQ[0'.:0T]A0'R@" ( @" ( @" ( @" ( @" ( @" C;*]/<1C^HD?4Z'SE^
M4<SDFB<\>:M=W0K\^@',#W9TTUY=>*H<NV[-Y7HJO'Q+@.SQM]WKN[7N][*A
M70Z>EKVJ<7K>$P][7]W09MF6Q,MDX6..-]62NTO@!'LQ*UHXZGVW@5W"<9Q4
MHNJ9R$H.#H]9V6T=W4]T4]1I#DX0/.JNNNFO#G9XV'Q^#L*]G@Z-" @" ( @
M" J@&A0%$ 0! $ 0! $ 0&CK[OV_:S#L%!;#[[26@ 'NW/;Q<QK]-"X:=B$T
M,K,;@PV K^=9>XRK!SMBYG:D\[]2T:-!/$ ^!:N1EVK$=JY+96HV<?$NWY;-
MN+D]9%6X=WY?J,^?;&SZ;I,<Q_)DY9.['>P%[0Q[2X^0W5I=[;L7(9F?=WA6
MSCQ]']YZ-.E4YCK\3 M;N2O9$O2_=UZ'32N7J)3V]@*.V<3#A\<9'5H2YP=*
M[G>YSW%Q).@':? %UV)B0QK2MPU+C.1R\J>3<=R=*OB-HMLU @" ( @" ( @
M" ( @" ( @" ( @" (#95V\L+?5X_30DNH @" ( @" ( @" CV_\^>W_ /">
M;_M+$(!T)^9G8GYDH_@6H&2$@" ( @" ( @(]ZL_U/5_G,?\5ZN]S_C/W?,<
MYO\ _ 7O+J9$BZLX<( @" ( @" :#@?%V*07&S3L>R1DKVR1?[)X>X.8!V!I
MUU;]!>7%-4H>E*2::;JM7)S<1\\[]'-YW<KSS/;S'1Q'A(["?5*FB(JSYT [
M%) 4 ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MQ'BHO'6I])Q]P8UN%+BVY<+J_%0E#IMO:;=^.L,R#&,RM!S66#'P9(R0$L>
M=="=""/&NPW+O-YEM[7K1U^'A.2WQNU8EQ;'JRU<G(=LN@*$( @" ( @" (
M@" ( @" ( @,RQ_VL?\ H_P(28:$! $ 0! $ 0! $ 0! $ 0! $ 0! 1)NW<
M^X\7NF2M<=R8;F9W=4M'<RU3R\SN;37FUUX@^25CN6XSBXR54S)";@U*.M'<
M''Y*H'V</.)*\H;W,0(<.1W$$<Q+3ZZII8M^RV[3T<7]N@M8Y-FZDKJT\?\
M81;N>23![REGPCA7NQ]R\M@',T696#O(PT=H<=-6^JKJ%=E;6NFDJI4JZ:B7
M<%GH,K&*L[XHLY!&QV0H,>'NA>X<0?6/;XNPKV>#<(0$!HMQ;SVSM2+O,[D8
MJTA&K*^O/._AKY,;=7'7QZ:(",[?73(Y:=U38FVK&1DUT;8LAW+][BUT_P!*
M0(#"?+UUSHUL9&M@X'<0R/NF/;]H)7_3<A)9=L#?5SCD]]V7N\4;K#@/H%[
MH!\#I;G(_*AWI>;(>TGOM->WP3>-"2Z-I]4\?H[%[W?/R^QBL/FT.GC[P2-4
MD%]F\>MFW-797%5\[4;[*2!K7.#1X=:Y!^G&@-_@>O.U<A**F>@GP-T'1WG
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M/*Z9SQ7YNWB">>3UWGZ"@4.\ACBK0BM5C9!6;P;#"T1QC3_): $)/I $ 0!
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M ( @" ( @" ( @" ( @" ( @" ("[ WFF8/5U^EQ0&R0D( @" ( @" ( @"
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M_P =ZS;H_!?/YC7W[^87NKK9Q*N#GP@" ( @" ( @" ( @" ( @" ( @" (
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M2XN[-P]7:=.:IGK9-8( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MK1P  "'D^D 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&33;K(7>(?PH#.0D(
M@" ( @" ( @" CV_\^>W_P#">;_M+$(!T)^9G8GYDH_@6H&2$@" ( @" ( @
M(]ZL_P!3U?YS'_%>KO<_XS]WS'.;_P#P%[RZF1(NK.'" ( @-QMS<=[;5UUJ
MHULL,S0RU5>=&2,'9QXZ.&O K5RL6-^-'H:U/B-[#S)XT]J.E/6N/]IMI<OT
M^F>;1V_:9.[4NJQS!D',?%H\ ?0"U59RUH[14XZ:>HW99& WM=E*O%71UF%-
MN*O+M&GMIL$@GK6A9=.2WNRULCGZ =NNCM%ECC-9#NUT-4IX#7EF1>+&Q1UC
M*M>#74W$^_*4V[ZFY13F$%>H^JZ EG>%SW$\P.NFG%:L=WR6.[555RK4WI[U
MA++C?V711<::*FFP>X8,1NB7<$D$DD#W6'"!I;SCS@ZCB=!P\*V\C&=RPK:>
MG1XC0Q<R-G)=YIM/:T<.DNQ;FJLPVX\4ZM(YV<FEEB?JWEC;)V!_'4Z>'1>7
MBR=RW.OX:1[6;#L;UMI_ZK;YJ\9E,W7ALIB:N+W9CY;4M%O)5O57ADO*   >
M+=#H-#V@]JQ/#N6[CG9DEM:TS,L^S=M1MY$')QU2CK\@H[GV_#0R>W[.-L?!
MN\\2P1QR V(W!K>;F<2-=7,#@=>'8ES$NN4;BDMN/0Q:SK"A.S*$NREI6GTE
MJ\JJ6LENC%V=NU]OX['24X:EJ*Q$72"3F9&[F)>3QYW:DGP+U:Q)QO.Y*2DV
MFOMR'B]G6I8ZLP@XJ,DUIKH3KIY68F[]P0;ERK,C7@?78V!L)9*6EQ+7..OD
MZC3BLV%C.Q;V6ZZ:F'>.7')NJ<4UHII- MTK0@" ( @" ( @" ( @" ( @"
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MJ?(;E;YHA $ 0! $ 0! $ 0! $ 0! 5T/B* H@" ( @" ( @" ( @" ( @"
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M%C@?)8?"/I>H)J=[##%7B9! QL<,;0V.-@ :UHX  !"#[0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $!G4FZ,<[QG^!"3)0! $ 0! $ 0! $ 0$>W_GSV_\
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M0&8@" ( @" ( @" H][(V/EE>(XHVE\DCCHUK1VDGQ! :2O&_<,\>1M,+<'
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M$%$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0%0-2 .TH#:@:  =@X(250! $
M0! $ 0! $ 0$>W_GSV__ (3S?]I8A .A/S,[$_,E'\"U R0D 0! $ 0! $!K
M<G7@L.:RQ$R5@&H;(T.&O'CH5ZC)QU.AXE",M#53 ]Z\;_X<'WIGUED[:?M/
MI,?86_970A[UXW_PX/O3/K)VT_:?2.PM^RNA#WKQO_AP?>F?63MI^T^D=A;]
ME="'O7C?_#@^],^LG;3]I](["W[*Z$/>O&_^'!]Z9]9.VG[3Z1V%OV5T(>]>
M-_\ #@^],^LG;3]I](["W[*Z$/>O&_\ AP?>F?63MI^T^D=A;]E="'O7C?\
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M-_\ #@^],^LG;3]I](["W[*Z$/>O&_\ AP?>F?63MI^T^D=A;]E="'O7C?\
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M/Q'S%3O/\)<Y&"Z(YP( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @*.]B?64D,F7"?U
M-C_YO%_$"X[(_$ESL[+'_#CS(SU@,X0! $ 0! $ 0! $ 0! $ 0'(;^W5+MR
MC#!38Q^0O%S6&0<S&1M'E.+?#V@ (2B(L9D*=3)QW<E1ANU#('3URWE8 3J7
M,:W1O#MY2-$)/143HW1,=#IW1:"S3@.4CAI]!#R?2 ( @.?W5G9,16CAK-:Z
MW9Y@TO&K6L:.)(\/;H A*. I6J]>ZRS<K1V*_,#+$1RM )XEH&@X>+L0DEYA
M8YC7,TY" 6Z=FA[$/)5 $ 0! $!RV<R;YYI*3&M[B(\KRX:N+QXM>S1<UGY;
ME)VTM"ZSH,+&48J;ULKMR:!MHPOB;W[FDQS_ &6@[6G_ .A3NR<=O9:T\#(W
MA"6QM)Z.(ZA=(4 0! $! _5+?,^2R-K;%6&$8VD_NIY98Q)*^=OLBPN]@&GR
M06\3QXZ<%\XW_O9W)RL12V8ZW337R'T/<>[(VX1O2;VI*JH]%.7CJ7>C.2Q3
M,S)C+&/B&5DB>^ID@"92UO%\9U) X<06Z:^%>^[-^UVC@XK;X)</-_8>.\5F
MX[2FI/93TQX.1_VDYKZ(?/P@" ( @" ( @" ( @" ( @" (#,L?]K'_H_P "
M$F&A 0! $ 0! $ 0! $ 0! $ 0! $ 0&!G21@\F1P/FECC_]DY 0OT6_N3KX
M3<EU^TC1DHD)02$ 0! $!5O:/70'&S.+YI7NXN<]Q/TRI!\H @" WN <3!.P
M]C7@CZ(X_P "@&V0! $ 0! $!P6/\CT@*_+_ /$QWE?1JD_^BDADY(0$ 0!
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MVKDJI:(\/%5\GVY\'>+*DK:M*+HWIEP<R)P7T(X ( @" ( @" ( @" ( @"
M( @" ^B]Y'*7$M'8#V(#Y0! $ 0! $ 0! $ 0! $ 0! $ 0! 8^0@-K'VZHX
MF>&2(#_/86_^J @SHK)_^2]VH?95;S@X>+GC;[DJ&2B1D)" ( @" J#H=?$@
M.4R-<UKDL>GD.//&?&UW%2#&0! 40'28: PT@]PT?.[GT_R>QJ@&P0! $ 0!
M $!P6W@;G7RW(SBVE0<UY'@(AC9Q^BY203DA 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $!4#4@>,Z(#; :#0=@0D( @" ( @" ( @" ( @(]O\ SY[?_P )YO\
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MN2[-M:ZFNHND9>K.B_VG>- T\()T(^DM#';5V+CKJ;M])VY5U4.[7:G)! $
M0$"=:[%U^YZE:?44HJHDJ-^Q+GO<)'>OP ]9?->]$Y_,*+]79T>7[<A]%[MP
M@L>4EZSEI\AR&T;%RKNK#RX\D6S;BC:&_9,D<&O:=/ 6DZJBW9.<,F#AKVEU
MEUO"$)8UQ3U;+_9XSU4OLY\@" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @*H" .G;/>;>6\]KN.@BL.L0CQADKAP_T)&E02B24)
M" ( @" (#&NTHKT08\\LC>,<@XEI/\(* YZQCKE8GGB+F>"1GE-/TE(++(9I
M#RLB>YWB#2@-K1PKRX2WARL'$0:ZD_YVG8/44 WB H@" ( @" ^F-YWM;XR!
MKZZ X7HX#F-];TW0.,+G^;1'_B2EW#_1B:I()M0@( @" ( @" ( @" ( @"
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MEQ'!=CN3=DL.VW/UI>*AR.^MY1R[B4/5CXZ\)W*Z(Y\( @" ( @" ( @" (
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MD;0UH^@ A!>0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&=3;I&7>,_P(29* (
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M4,=>SP$!1WL3ZRDADRX3^IL?_-XOX@7'9'XDN=G98_X<>9&>L!G" ( @" (
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MC6]C3H23J@),K68+E:"[5>):EF-D]>4:@/BE:'-< =#Q!UXJ 7$ 0! $ 0!
M$ 0! $ 0! $ 0! 9$L+&0LD;KS.TUX^,(#'0! $ 0! $ 0! $ 0! $ 0! $
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MN!SM3SZGR91J.?F.FG8@.SP>=Q^X:#+^/?S,/DR1NX/C>.UKAX"$(-D@" (
M@" ( @" ( @" ( @" ( @" ( @+U9O-,WU./TD!L4)" ( @" ( @" ( @" (
M @(]O_/GM_\ PGF_[2Q" ="?F9V)^9*/X%J!DA( @" ( @" (#A.IW]5UO\
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MC;N=V;T^D%V;=&!SMJM8Q?G,W&+WKCCEE<UQ>.9Q:6LT\"$D\*" @" ( @"
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M-*T%<VXQI54>G^TQ%D,80! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M!U+@!P<2.&A7EIMJC_:2FDG5?L,N.;([>R39:\S8KT&AYXGB6-S7@.Y26\'
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M" ( @*.]B?64D,F7"?U-C_YO%_$"X[(_$ESL[+'_  X\R,]8#.$ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M 0! ;2%O+$P>I_"A)]H @" ( @" ( @" ( @" ( @(]O_/GM_P#PGF_[2Q"
M="?F9V)^9*/X%J!DA( @" ( @" (#A.IW]5UO^.S^*]6N[/Q'S%3O/\ "7.1
M@NB.<" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ("CO8GUE)#)EPG]38_\ F\7\0+CL
MC\27.SLL?\./,C/6 SA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&98_[6/\ T?X$),-"
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @/I@YG-;XR @-JA(0! $ 0! $ 0! $ 0!
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M4V/_ )O%_$"X[(_$ESL[+'_#CS(SU@,X0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!D2S
M,?"V,:\S=-=>S@-$!CH @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M'>Q/K*2&3+A/ZFQ_\WB_B!<=D?B2YV=EC_AQYD9ZP&<( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" S+'_ &L?^C_ A)AH0$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MG]I]4(!YM/[3ZH0#S:?VGU0@*MK3<PU;PUX\1V(#8(2$ 0! $ 0! $ 0! $
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MH3\S.Q/S)1_ M0,D) $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0$>W_GSV_\ X3S?]I8A .A/S,[$_,E'\"U
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M_P"?/;_^$\W_ &EB$ Z$_,SL3\R4?P+4#)"0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M_2. _62 ?#S?G[*\W^D<!^LD ^'F_/V5YO\ 2. _62 ?#S?G[*\W^D<!^LD
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MS?Z1P'ZR0#X>;\_97F_TC@/UD@'P\WY^RO-_I' ?K) /AYOS]E>;_2. _62
M?#S?G[*\W^D<!^LD ^'F_/V5YO\ 2. _62 ?#S?G[*\W^D<!^LD ^'F_/V5Y
MO](X#]9(!\/-^?LKS?Z1P'ZR0#X>;\_97F_TC@/UD@'P\WY^RO-_I' ?K) /
MAYOS]E>;_2. _62 ?#S?G[*\W^D<!^LD ^'F_/V5YO\ 2. _62 ?#S?G[*\W
M^D<!^LD ^'F_/V5YO](X#]9(!\/-^?LKS?Z1P'ZR0#X>;\_97F_TC@/UD@'P
M\WY^RO-_I' ?K) /AYOS]E>;_2. _62 ?#S?G[*\W^D<!^LD ^'F_/V5YO\
M2. _62 ?#S?G[*\W^D<!^LD ^'F_/V5YO](X#]9(!\/-^?LKS?Z1P'ZR0#X>
M;\_97F_TC@/UD@'P\WY^RO-_I' ?K) /AYOS]E>;_2. _62 ?#S?G[*\W^D<
M!^LD ^'F_/V5YO\ 2. _62 ?#S?G[*\W^D<!^LD ^'F_/V5YO](X#]9(!\/-
M^?LKS?Z1P'ZR0#X>;\_97F_TC@/UD@'P\WY^RO-_I' ?K) /AYOS]E>;_2.
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M_2. _62 ?#S?G[*\W^D<!^LD ^'F_/V5YO\ 2. _62 ?#S?G[*\W^D<!^LD
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37^[#6%C6N#I XEXY6D!Q D__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ph_powerofbigdata-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ph_powerofbigdata-4c.jpg
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M%!04%!04%!04%/_  !$( 18#M@,!$0 "$0$#$0'_Q "_  $   <! 0
M         0(#! 4&!PD( 0$! 0$! 0$!             0(#! 4&!Q   0($
M P0""0T. P4%!@<! 0(# !$$!2$2!C%!$P=1(F%QT3(4=947"(%"TB.3LQ55
M5C=7& F1H;'!DK+35'2TU-4VEE(D-6)R,Q8X\$,E92?Q@J)S129C@Z,T1&24
M=A$! 0 " @(" @(" P " P    $1 B$#,1)!!"(346$R!7&!%)$CH<%"_]H
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M^>4:CV44R>=#F%\L;YY1J/90,H'FAS#W:QOGE&H]E$,HCFAS#WZQOGE&H]E
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MA_UJV?M3'OJ8#V]K_FW3XL8][1$JSR\O/3C_ .H[4O[-;_W-N+4^'SH=T!"
M0" 0" 0" 0$8(C%$#!4(@0" 0" 0" 0"*$ B! (! !M@-BT'_6^FO&E'[^B
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MO/3C_P"H[4O[-;_W-N+4^'SH=T!" 0" 0" 0" 0" 10@$0(! (! (! (!%"
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M! (! (!%" V+0?\ 7.G/&E'[^B(/=KUGJ?B@/+;[0OY\*7Q-2_GN0'R9 (!
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M?.7J?Q0GWX07X3_:-?.5I7Q2OW\P1\8& @(":0VQ%C*VJRU5U4[X(G.IK+-
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M11[=\C_FET6?_*J<?_#$GA/EXRZ]_KC4_C>O_>5P5KL4(!$" 0" 0" 0"*$
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M#4MH:\)273E<=;K%^UEI"NL<RC/$8)B2M;=7#!.6>N8M;-V*4N4#JE(SI5F
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M>V<,)*2"4D$SZPVXB E'5GAUAL/1 3*>=6H*6LK4, 5$DR&[&"HR5PRO=/;
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M>N'/>YK5LO4G'5S?9/V<OSEZG\4)]^$%^%3[1OYR]*^*5^_F#+XS;0IQ65)
M5M .$Y0&1MU]NMG2X+97.TH?!2\VV2!]S9$P88YQ:U*4IPA2UDJ4O:23C%@I
MP5,(&%>E?\&>0Z-HB-1?5#O'J6W0D+XAQ!.,QOB'AM.F: )JF'ZI16B96DK3
M)"0K"6$<]MLO/V;+G72*.EK&Q1I#I6U-XR4""G#">8#$SVQK1G6,5RZTQ4ZK
MUI:[#2TZE.NJ*U-!4E*#:2HD$QGOW]=<O;US+ W@<&[7)I((2BH?:.]<@L@
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M3M+0@OW=IPM)J S4)"@EUIIHR5AV4B/3.W,?/WZ_6UKM91FHJE&C;4XTXM7
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MUZSU/Q0'EM]H7\^%+XFI?SW(#Y,@$ @)BM1,R9GI@J[I:2IK$GP=LN*1,K&
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MYE:WA3S,N.1,($MLHFUXX:UG+8[-2-5"+Q5BI4VBEDIAXC,%*6H9BXG:9)V
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M>WTQGVGR_KW^N[)W],QM)MAKNN[ZW3TZK?2.)36OI+-P2A(,VA@8F'YW_?\
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M77T_&Q?-/H9M;09:J:=("@^YGS-/.I&=!(.$DIQ*4Q,.&WM%U8=87ZSN.U-
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M1/$)J*AL9RE.V9!W88F.>]Q'/LN-:[/7A5CNH;HE)-MHU$O4JP$AYL8I64#
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M9U*?"'G'FFN"Q/$92$-$F>4F1Z<(1*L\AVD2&T=.,:9F,\I0-\"(S&Z$7/\
M"$XJ$0"9P6U""$!L6@_ZXTV?_-*/W]$![M>L]3\4!Y;?:%_/A2^)J7\]R ^3
M(! (!!5W1U'@I+H4>)E4$ 82)WDQ!4H:@LU;#J3Q%I5G*5@8K/23NA5BZJKF
MZ\_4+N"35%W%&9Q8#:QO2)]&&,6,VK-+"BA4UY79D<!29'[_ &(JS6U7K*&G
MI4TBTU;;Q?;XCB$)F6ESEE4!L,L8S%VBWI:=VHJ@PW(E4B21A(;XTQEL%/\
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M6XJ2^6ZGMM:6J>K;KJ924J;JV3U"%)"BF72DF1A+EJQB%;<-D:90@I$" 0"
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M-LJ[HRW=JMRDMJBKPNJ:2"Z!BK,E)[($"*-2]3\=Q,UOTJ%E+"U=52FYDI)
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M^M6O]J8]]3 >WU?\VZ?%C'O:(E6>7EYZ<?\ U':E_9K?^YMQ:GP^=#N@(0"
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M4_%%<GEM]H7\^%+XFI?SW(#Y,@I!" 0" F1*8)W$&"544L2(2,LS,R@N>/"
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MR1*70<1]V4=L5@D-L00G ,("8I 3,GK'8D?C@N4% )P!F=\MD$E2P" 0" 0
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MF]8N5%XJE)8N[[P!2TE(3)* D=8R)![6V.>DNM>SN[-.Z9OELVCZC1U?1?\
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M]7>[:XOF+7(3.?XX]3"M2ONT[R'F%9'4DE*NV)1!24HJ,U8G&9Z23."IPU,
M[SLAD2D98"6*(00@$ @$ @$ BA 549=JA,#$)Z3T01G;5J>HM-JJJ"E8;6Z\
MH*15K/MC0EBE*=X[,=NOMNHHVZKJ+AJ&WUM8X7:ARL8*U*.,@X@"0CGOO[57
MME6_-JWXLI_>T1SK4\O+WTXO^H[4O[-;_P!S;BUF>'SG ("*24J"@9$$$';
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M"DJ/51@)9B90258G;V8(A (! (! (! (! 1@I,C">!VP"9Z8J(0"($4(!$"
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MM%H[_FNN1658;J6A3-("44[2E MA8!P*A'V/I;<)M'S$1[49[9Q]+#E5*($
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M'FBZ27"NG:<2F1PRDSBIP^;SRO\ 0_D)<]:Z>_\ ^W+G_"P$/-?Z('TZUO\
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MT4!RO]$&8ESUKI[I:<N<_P!V@)ARP]$//U>>E?FZ!IVYS_=8'"!Y7^B#,_\
MKI7?VY<_X:'(AYK_ $0/IUKO[<N?\- /-?Z('TZUW]N7/^&@'FO]$#Z=:[^W
M+G_#0#S7^B!].M=_;ES_ (: >:_T0/IUKO[<N?\ #0#S7^B!].M;_;ES_AH!
MYK_1 ^G6M_MRY_PT \U_H@?3K7?VY<_X: >:_P!$#Z=:[^W+G_#0#S7^B!].
MM=_;ES_AH#,:7Y:>B4SJ2SO6_G=75-P;KJ9=+3?\O7) =>2ZDH05&G 2%&0G
+N@UEZH^L]2#+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>bc_carispoanet-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_carispoanet-4c.jpg
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M%!04%!04%!04%/_  !$( LD#M@,!$0 "$0$#$0'_Q #<  $  00# 0
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M'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP
M\Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(
M]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5
MX#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'Z
MP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q
M<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&
MK5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#
M'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP
M\Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(
M]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5
MX#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'Z
MP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q
M<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&
MK5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#
M'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP
M\Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(
M]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5
MX#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'Z
MP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q
M<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&
MK5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#
M'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP \Q<(]&K5X#'ZP
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M_
M
M                                    !8,A^=\4\JN_1<\ P7ZD8UY*
M@^+H 7\
M
M                                          %@R'YWQ3RJ[]%SP#!?
MJ1C7DJ#XN@!?P
M
M                                                6#(?G?%/*KOT
M7/ ,%^I&->2H/BZ %_
M
M                                                     !8,A^=\
M4\JN_1<\ P7ZD8UY*@^+H 7\
M
M                                                           %
M@R'YWQ3RJ[]%SP#!?J1C7DJ#XN@!?P
M
M
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M=M"-6RHA*\@
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M",R4&XQ
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MP@$\=T^-8GC.$6QC#W$RK9,:1+5<J$3DMUU):G7.:1_<Z#]Q33S!Q2S8
M
M            !HV5RAI3,N3?&,2>?W4P+T6-SLN[L:2\B5QZ8JI"86@U*C)>
M4EO7QFHZU)/,!-%Z3OF=O&>EAN'V9BXV^%<%6N\WR?<H]N0E^.I)2FX499+?
MEK8)5%Z4I1J+3JYH%&V 0          "P9#\[XIY5=^BYX!@OU(QKR5!\70
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M
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MUOR'H4=QQ:SX5*4I!F9]$P%W@P85LB-0+=';B06$Z&(S"$MM(3SDI21$1>H
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MZ5)6DZI41DBI&1E4C(!D@
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M^L>1/@/F.K>7;X0MY&!F9$60P:GL+XY(?+]8\B? GYAJWEV^%E(^!]X
ML&0_.^*>57?HN> 8+]2,:\E0?%T +^
M
M                                             "#=\3_?5R[Z?[8H
M6K@Q_KMR0IS'Q?\ 9=EGE4&D=U'1ZTTA0]::0H>M-(4/6FD*'K32%#UII"AZ
MTTA0]:[8R?TAG\-/3(<;HX)<K<7AA.X5,N@     6#(?G?%/*KOT7/ ,%^I&
M->2H/BZ %_
M
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MC7DJ#XN@!?P
M
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M) .,2 ^ZT\\$OI*(^ P'T
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M)!F::MJ--2KMVT"B%Q0K40XI<@2
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MPZ)!"T3'C34ZCLAQE5V3;:(1_P#Q)Z0X2YJ\0
M                             ,9M[M%R$\Z2_P!L4.SN."_QU5+UAPER
M=XA(                                                   ")V^T
MO]1[I^!%\7;%A;&[+;]_+*L=NW4UR[[N2&OJ#,L'I% -(H!I% -(H!I% -(H
M!I% -(H!I)@[JOL]L/>Y]L4*VVGVF_*M79/9,/)G9B,:RH  /,?)B_S)>._I
M/;E"XL#V=N2.11.L^UN\Z>5:J#O?.4 * % "@!0 H 4 =\,OTR/V1'PB'&[B
MERLYT/484POP     6#(?G?%/*KOT7/ ,%^I&->2H/BZ %_   !UO'U(F$+!
M<%4)0[+7"5SL?S/!["CI#KGC=D+@(
M                     &(P5'W1*+]Y?[88[>XX=UDD4ZD0ZY<H50A(
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M@'18+_:,HLT/(+!*3-L\]'&PY:"4E+C=3+41+(CILYI +D
M #$(/ZS*[Y?[88[NXZ^ZR6)P$.N7.%4.*0
M                         $4M]7VC73\"-XNV+&V+'_);]_+*HMXKJ:]?
MT>K#7]!FJ-<TB@4-(H%#2*!0TB@4-(H%#2*!0TB@4-(H%#22]W6?9]8>]S[8
MH5EM3M5^5<VQ.Q8>3/+,!C&:  !YDY-]9+QW])[<H7'@>SMR1R*'UGVMWG3R
MK4.Y\X         [X?ZY'[(CX1#C=Q2YV<Z'J(*87Z     +!D/SOBGE5WZ+
MG@&"_4C&O)4'Q= "_@   ZGO<^R)A#'[CP*';:X2NMC^9X/84=(=4\;LA<!
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M&D0E+G$9K-QQ2QSX\=^)'DP(KK4669JD-(6RDR0X:MIJ(MAF?"(%Y
M    !B$']9E=\O\ ;#'=W'7W62Q. AURYPJAQ2
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MLRN^7^V&.[N.ONLEB<!#KESA5#BD
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M)A#'[CP*';:X2NMC^9X/84=(=4\;LA<!
M      /BE)26I1DDN>>PMH#XEQM:EH0M*EMF1.)(R,TF95*I<S8 Y      "
MBO"[JU:9[EB99D7M$=U5M8E+4W'7*)!\4EU:2,TH-5-1D5: (H%B&7Q+'EL'
M-HLUB8C(X=XA.KBRLGCWFYG9OCF%QX[;5(RWUZD&DT(;51O8;=3E"46(*GKQ
M.Q*NMM19[F=OB',M+:B6B(_Q*=;"5$9U)M54$=3X!"5Z     8A!_697?+_;
M#'=W'7W62Q. AURYPJAQ2
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MX"                                  :,Y0V+[R,E9MCF+PFKG9+4_
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M"_4C&O)4'Q= "_@   ZGO<^R)A#'[CP*';:X2NMC^9X/84=(=4\;LA<!
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MO65O$Y"$@#$(/ZS*[Y?[88[NXZ^ZR6)P$.N7.%4.*0
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MX_9$?"(<;N*7.SG0]/12ST$     +!D/SOBGE5WZ+G@&"_4C&O)4'Q= "_@
M  ZGO<^R)A#'[CP*';:X2NMC^9X/84=(=4\;LA<!
M   #JE/*CQGI"&5R%M(4M,=G3QCAI(S)"-1I3J5P%51%T0&M'=^>,0L,O&8W
M2#.BHLLQ=L?MC269DA^6AI+^B*N,ZXR\7%JUJ4ARB"2O5328D;'M\UJY0(MQ
M8(R8ELMR&B5L42'4DLJ\.VAB!4@   TORDSIB5J\HI[0Z-QW5[1?YN>%<;^]
MCP__ /)^FY&/6+)4G0U@4-8%#6!1)CDU'7&;QW^7:4"N-ZO;V>;GE=6X4?\
M+B>?^F&[!IBR0!Y[NJ^-7^$?3%[Q/ \H6QP0X:A-7*AJ"I0U!4H$K:0511Z$
M-?BT?@ETA1$\;U;'$YB$@#$(/ZS*[Y?[88[NXZ^ZR6)P$.N7.%4.*0
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M+6?:W^=/*M=!W/F* % "@!0 H 4 * .^&7Z7'[(CX1#C=Q2YV<Z'IX*6>@P
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MZICB<Q"0!B$']9E=\O\ ;#'=W'7W62Q. AURYPJAQ2
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MT3:_%H_!+I"BYXWJ2.)S$) &(0?UF5WR_P!L,=W<=?=9+$X"'7+G"J'%(
M                              BWO[+_ #ZKO./TUC?=A]F^^5=;?G_J
MZ,-84&=:[I% -(H!I% -(H!I% -(H!I% -(H!I);;F/LVLO\3XTZ*\VOVJ_[
MN2%F[%['9]_6EGHQ#-/BC,DF9%4R*M.> M42Y277E(4WK(R,R2@J&5/5,!"#
ME)*->^&^U2::-PBV]YM"S=A]CM^_K2J/>+MU_1ZL-3T&<:Z4 * % "@!0 H
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M0QQ.8A( Q"#^LRN^7^V&.[N.ONLEB<!#KESA5#BD
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MRD!YMY*7^8[OW[)[:H7+@>SMR1R//^L^VO\ .GE6N@[WSE "@!0 H 4 * %
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M+?X)=(4A/&]*QQ.8A( Q"#^LRN^7^V&.[N.ONLEB<!#KESA5#BD
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MC'$YB$@#$(/ZS*[Y?[88[NXZ^ZR6)P$.N7.%4.*0
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MLB/A$.-W%+G9SHRO304H]$@    "P9#\[XIY5=^BYX!@OU(QKR5!\70 OX
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MO1T<3F(2 ,0@_K,KOE_MACN[CK[K)8G 0ZY<X50XI
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MP/3(4B](@#0/*R.F%67RHGQ=T;9NU[>[S<\-(WO[+9Y_Z;D1-0L%5-#4!0U
M4-0%$M>26=<3OWE%/:$#0-YO;6>;G6IN?V:_S\T)"#46\@#S)EJ_2Y'97/A&
M+KMXH>=[XX9=6H<G"AJ H:@*&K:7JD!1Z<,_B6_P4](4G/&]%1Q.8A( Q"#^
MLRN^7^V&.[N.ONLEB<!#KESA5#BD
M 1:W^5\_E=YQ^FL69N['_)TI4%OS=,;2Z%N=K#;SQLM&A:<FWGA0TY-O/"AI
MR;>>%#3DV\\*&G)MYX4-.3;SPH:<FWGA0TY-O/"AIREON7^S:R_Q/C3HJK;O
M;;_NZL/1>Z$UV5A=+KW,]&#;>II)&TI,M)>X*CI%S6SX?8X0%01D9$9'4CVD
M9 (*\I O]7KWV.%XHT+.V%V.W[^65.[R=OOZ/5AJB@SK6R@!0 H 4 * % "@
M!0!Z [COLGQ;O4^VK%5;7[7B9<RZ]A]APLF>6P1B6;  !YMY(7^8KOW[)[:H
M7-J_L[<D<CSUK7MK_.GE6R@[WS% "@!0 H 4 * % '=#+]+8[(CX1#C?Q2YV
M<Z,KTQ%*/18     L&0_.^*>57?HN> 8+]2,:\E0?%T +^   #J>]S[(F$,?
MN/ H=MKA*ZV/YG@]A1TAU3QNR%P$  \U5N=6K\(^F+PJ\T1;P./&!5.B<8%3
M1.,"IHN2'.K3^$73"J)MX'I4*/>EP!$[E9*TY3C_ )/<[<8W_=GV5_G9E7[Y
M1_MP_-GE1]XP;?57^B<8%31.,"IHG&!4T4LN2<K5BE^\HI[0@5_O-[:SS<ZU
MMSH_YK_/S0D"-1;T /,J6K]+D=E<^$8NNWBAYVOCAEU:QR<*&L"AK H^H7U:
M/PBZ8(F."7IR*2>C0!'[E;'3";)Y53XN\-KW:]O=YN>&E;W=EL\_]-R(6H6"
MJNAJ H:@*&H"B7')'.N)7_RDGM"!H&\OMK/-SK2W1[/?YV:$AAJ3=P!YBS%?
MIDGLKGPS%TV\4//=\?BET:AS<*&H"AJ H:MI>J0@H]/F?Q+?X*>D*5GC>AHX
MG,0D 8A!_697?+_;#'=W'7W62Q. AURYPJAQ2                    U9O
M\1G3V(VV-@;5V7+>O$,KRO'G6F+FBT()QR2<=;ZDH)9DE*$UKM,ME 3#4%XS
MA^-NJLR\5R?+I<5[+2LN61;DX@\Y;5I^.MT-*6R+C4'H<-+75:*T46VA+9G)
MOR.[Y%BU^5<KM*N<2!?9L&T,WE6J_1(+!I2AFY]2DR?KJ51=5:3*I\PB);F!
M   *>5,:B)2;E3-7N4EP[ ')N7'=03B7$D1\Q1D1EZI .7'L?E$>^( X]C\H
MCWQ (P;^B)6>:B,C)4)@R,CKLJLOZ!9N[D_\G2G,\_[]Q,;2RV6YVL=(V57]
M32!4T@5-(%32!4T@5-(%32!4T@52UW,[-V]F_B?&7156W>VW_=U8>D-SOI.%
MTNO<SP8)N#XJNDZ%4Z'0CX %G@+N"73;TF:$D9&ERI)+G4.A@E"SE&Z_YO7S
M61$?%PJ4YW<C0L[878[/OZTJ;WD[??T>K#50SS6P          >@&X[[)\7[
MU/MJQ5.U^UXF7,NS8?8<+)GEL$8EFP!Q6XALB-:M)*,DET3/@(!YNY$I*LAN
MRD'J0<V3I5SRXU6T7/J_LK<D<CSUK<4QK_.GE6T=[Y0        !W0_UMCLB
M/A$.-_%+G9SHRO3 4F]&     "P9#\[XIY5=^BYX!@OU(QKR5!\70 OX   .
MI[W/LB80Q^X\"AVVN$KK8_F>#V%'2'5/&[(7 0 #S)6[U:_PCZ8NUYPBW@<>
M-$IT3C0-$XT#1<D.]6C\(NF(1-O ]-A23T> (D<K=6G*L>+_ /Y[O;S&_;L^
MRO\ .S*SWPC_ &X>2>5'G7T1M]6@T-?1"I0U]$*E#7T0J42XY)"M6)7_ ,I)
M[0@5_O+[:SS<ZT]T(IJ]_G9H2%&I-W 'F),5^F2>RN?#,73;Q0\^7Q^*73K'
M-UT-8%#6!1]0OJT?A)Z8A$QP2]0!2CT0 (^<KDZ819/*J?%WAM>[?M[O-SPT
MO>WLUGG_ *;D/M0L!5U#4!0U 4-0%$N^2(=<2R#RDGM"!H.\OMK/-SK0W2[/
M?YV:$B1J3=0!Y@3%?IDGLSGPS%T6<4//^)'XI=&H<W"AJ H:@*&K:7JETP*/
M4)C\2W^"GI"E9XWH*.)V"$@#$(/ZS*[Y?[88[NXZ^ZR6)P$.N7.%4.*0
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M!0 H 4 * % "@!0!/KDY?8WCG\9XZ^*PVWVR_P"[JPM[=_L.'TNM+:8PK8
M 08Y1WVNWOL<+Q1H6?L+L=O2ZTJ:WE[??DMZL-54&>:T4 * % "@!0 H 4 *
M )^;D/LIQ?O4^VK%4;7[7B9<R[MA=APLF>6P!B6<4SOZ0\4?A:;HM[HGPI3_
M $@*D!YP9&7^8;MW[)[:H71J_LK<D<CSOK7MK_.GE6R@[WS% "@!0 H 4 *
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M;-NEQE2V)9FN039H6TA1$@EZR<2:#(C*H4%SB[UK5+N6-,HM=P18<O0QYOY
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M1G%LS&X9.S.8M41$&%:56MMMF,VII*)"HJDO?$K?4GJEZ5*)'Q9=36H;($
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M24)HAO9I(D'U(#:(@    8A!_697?+_;#'=W'7W62Q. AURYPJAQ2
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MZT1HR:4+3;?C''W2(R0X^ZXC46D]*EF9'0^>0[.XX]UDL4J$0ZI<X50A(
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M;2TVEM'N4E0AB6<<P !YQY']8;MW[([:H73J_LK<D<CSIK7MK_.GE6P=[Y@
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MP\;+;G;P&FK.  !"3E2E_JDKR=%Z:Q9&[_9>E*IMZ.V=&,[2M!L;5"@!0 H
M4 * % "@!0!/'DZI4>Z''7%Z:D4Q+9)YB>['JUZ)F53%7;:C_LO^[JPN3=Z:
MZAA]+K2VH,*V   $'>47]K=Z['#\4:%H;![';TNM*E]YOJ%^2WJPU6,\U@
M        $\]Q_P 9NMQEY1)(RBJ0@D\PB=61\T]IF53%3;7C_LQ,N9>>PI_X
M,+)GEL,8IG   ><N1E_F&[=^2.VJ%TZO[*W)'(\YZU[:_P Z>5;*#O?,4 *
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MINM/X\2/LC.JG_Z';/J<&[^Z[DAH'0-^4M4T 5- %30!4T 5- %30!4T 5-
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M"YP!0N< 4+G %"YP!0N< 4+G %"YP!0N< 4+G %"YP!0N< 4+G %"YP!0N<
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M@*&# DL:S6X;6JFQ-#K3F[2,!6<0]^TK]A'M '$/?M*_81[0!Q#W[2OV$>T
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MO>& =UE^1>]X8#@Y.)#:E\2[U)&>U!D7KF Z[?/<EJ6AQ!$:2J1IX*<X!7@
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M        R(RH>TC 4BD(AN)>;2265T0\DMA%7W*O9V& JP
M                 ?#,B(S,Z$6TS 4\=/&J5*67N]C1'S&RX/9X0%2
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M0@UN?CG#U.= ^87K%L =P  L&0_.^*>57?HN> X82XEK!<<<6=$IM,$S\&0
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M>^P.P863/+.)#7'-FDCHLC)3:N<HN QB&>=1.-3&C:-1(?IM17JD+2?#ZQD
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MKYF^!%?\HDMO7!4U^.3J4(83H02-)430J[3"1M 0./&-Z^*UEQE*Z*EJISZ
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ML.MGI6>P]JR ;1W48Y=,2W>V/';TA#=S@-.(D(:63B"-3RUE11;#V*(0EF0
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M !YWY"7]_P!U[\D=M4+KU?V5N2.1YLUOVU_G7<JVT'>^4H 4 * % "@!0 H
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M.DD-,6"  "&?*:^TU7>$;IK%E[N]DZ4J<WM[=T;<[3=!LC3R@!0 H 4 * %
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MH:Y@  1NY7/S9BW9YGP&AN>['.Q,D9U>[Y<S"RW9D6*#>U:% "@!0 H 4 *
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MLL8-LP  (5\H+[5;SV.'XJT+3V!V*SI=:5&[U?4<3);U8:QH,^U0H 4 * %
M"@!0 H 4 3@W.I)[=KC#9*)33<8UN:3J6KC%F23]3F]$5'MCMF)E7]N]]/PL
MF>6PAB6?  !YZ9#\_P!U[\D=M4+MU?V5N2.1YHUOV]_G7<JVCO?*
M .Z)^M,=D1\(APOYLNS#YT97HN*.>G75(:-QOJ-CJ#U-G_6+^@^ !]9=)YM+
MA%2O"D^$C+89'Z@#L  %@R'YWQ3RJ[]%SP#!=F$XT1\/R5!\70 OX
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M  6#(?G?%/*KOT7/ =6!N$6(6%@U&O3;(2FEJ*AK:4PC29EMVEP& R0
M       !P>=2RVIQ6TD\PN$SYA%ZH#J;(HS"WGS^,.JW3Z/.+U. @'V,VI*5
M.NE1YT]2RYQ<Q/K$ [P     !3)_1Y!H_L7S-2.@YS2]?A 5("F9^(=5&/W!
MU6QZG-3ZQ@*D      4S7Z0\<@_Q;=4,]$_NE?T *D!3/?'NIC%[@J+?]3F)
M]<_^ "I   !A^]/[/K]WN7;$C*;+[59E87;<TU+$R9X1"H+-HI?UA0*'K"@4
M/6% H>L9/9<6M,FSQ;[DEX<M$"XSCMEL*/'[I<6\C8MQRID26TF=-G5#'8VL
MWVXDX>'9IS;;I75FG!WH^UE]5U/#Q,*W%QL2<.V^[0LI%9F>_/>A9KU:)5AO
M,^QSC2J7;WE,.K;KH72AI6FNVBDF1[1]>!B6XN';B6\5T5?!K.'=J^-?A7\Z
MR:9>[7[X4-!W4?/ZPH%#UA0*'K&?[E4D>\:U&9;21*,O!G"&%VU'_)=]W+#8
M]W;HG7K.EU92E9^(>5&/W"JK9]3[I/K&*X6^J0 !J?E)?8_?.R0O&VAG=A=L
MM^_DEKF\?8;^CUH01H+.4^4 * % "@!0 H 4 * ).<CPJ3,O[' ^%(&E[S<6
M'TLS?]T.=B]']25#C:74*;654J*AD-(6(ZHSBC2IITZO-'I4?/+F*]<@'> C
MCRM"K;<7[/+^ T-TW7YV)DC.KO?3F866[,BY0;XK&I0"I0"I0"I0"I0"I0"I
M0"I0"J4?)+*EMRCL\3X#HT/>CG8>2<RSMR^9BY;<Z1PTM8@  (<<I;[2U=X1
MNFL69N[V3I2IC>[MW1MSM/4&RM-* % &SMV%RNMH:1,:S.W63'D2R7>+--4M
MQQY@B03AE%XE9/:T%H2255J7W/",#M+#LQ)I.%=??3\-T=R>Y^*O!2?_ -+:
M]BX^+@QI1CV8>'%WXK+JUF."OX=&=*L<'!PY%\Q3)K/&8R1>$W2W8Y=9M].8
MRU?4FF&JQMFI;+;:30ZVEQ"U541%KI0D*'R:UJU]TX?KK;L2V+*?@X]/NSW)
MI_#OOOU#7,.V,7X>^S"ONQ=+\?!;ZJ*S;'%,5B9RTXI:ZW@2\?N&:7F=BVM5
MCD2#=CK<UU6I22-U9$YU1)4YK4DE;=)E49O4+,6S MMQ>=$<.;^#6=JXN#B:
MU??@\R9K&>>'AX9K+&J#[F+* % $WMP7V3V#^+\<>%5;=[;?]W5A>>['T[#Z
M76N;*&#;,  "%O*!^U2\=CB>*M"U-@=BLZ76E1>]?U'$R6]6&LJ#/M4* % "
M@!0 H 4 * % $Y=S7V8XWWL?;5BH]L=LQ,N9?^[WT_"\W/+.AB&P   \]L@^
M?[KWY([:H7;J_LK<D<CS/K?M[_.NY5N'>^0         =L91)DLJ4=$DM)F?
M0(R'&[BESLFET3+T30M#B=2%$I//+:*->H'(!P=;2\VIM7 HN$N$CYA^L X1
MG5.(-+GXYL]#A=$N;ZAEM =P"P9#\[XIY5=^BYX"GPY"O,?&'VRJZU:X)D7W
MR3C-ZD^N0#)4+2XA*T'5*BJ1] P'(           %-^L2.>S'/UC<_\ :7_$
M 7^D2":_LF:*<Z*_N2];A 5(       .M]HGFS16BN%"N:2BVD8#Y'=-UNJB
MHXDS2XGG*+A =5P43<?CONVU$I!ESZT]@!U1+EQZ5<8VHE)/[A)J*A^H J.Z
MV_O'/S:O: 8M"WJ[N[CDKF'0,C@R<I94M#EI:>2N22VJZT:2^Z30]2>$N: ^
M0MZN[JY9([A]OR2#)RAE;C3MI:>2J23C%2<1H+;J1I/4GA*FT!>YES42U,(2
M:4F5%*,C2O;PT(^@ NB$I0A*4%1)$1)+H *6?-.&E!I3J4LSI7@*@#E;U$Y'
MX[[MQ1J69\^M-G0(!5    P_>G]GU^[W+MB1E=D]KLRYF!W@FFH8L_9GA$*I
M"TJ*&]<5(*'KBI!0]<5(*'KF=8'DD2S0G47B]-1[0Q+3*;LJX!3Y3CJ2(S<C
M*<2:&35[DU&>SAX1AMH:K=BW1H63-TQ32TM&,EW=N;1L;:>'J^'/K<6+;(NK
M&'H:=TSW[.Y;7BR\/!+%L@O#N07ZY7U]!-.7&0M_BB.NA!T2A->:9)(B,QDM
M7P(P<*W#C^F*,%KFO3K.L7XT\&G=6G>CBB/ MU2'?1\GKBI!0]<5(*'KFP-R
MOVC6O\"3XNX,'MR/^2[[N6&T[KXE=HV1]EW5E**XKXJ/QI%U:%)-!ES#Z/0Y
M@K1=SJAW!QYLS<94I1'2K95+_B8"H[J/\@[[TO; :LY1CIN;H+[\4XFCD+:I
M)4VRVN';P#.;"[99TNK+7-XX_P""_H]:$%](L]3E32!4T@5-(%32!4T@5-(%
M32!4T@52;Y'Y4EY=V.!\*0-,WFXL/I9E@;G\[%Z/ZDJ!HZQE/((VE)E)*NCJ
M72+FMGP^QP@.Y*T+*J%$HN>1U 1TY6?S;B_9Y?P&ANFZ_.Q,D9U=;Z\S"RW9
MD7:#?%8% "@!0 H 4 * % "@"47),^;<H[/$^ Z-#WHYV'DG,L_<KF8N6W.D
M:-+6*  "'/*5^TI7>$;IK%F[N=DZ4J7WO[?T;<[3]!LK32@!0 H 4 * % "@
M!0!-S<%]D]@_B_''A5.W>VW_ '=6%Z;L?3L/I=:YLH8-LP  (7\H#[5+QV.)
MXJT+4V!V*SI=:5%;U_4L3);U8:R&P-4          !.3<W]F.-]['VU8J+;'
M;,3+F>@-W?I^%YN>6<C$-@  !Y\9!\_77OR1VU0NW5_96Y(Y'F;6_;W^==RK
M:/H?(         .;*#<=;06PU*25?5,<;II"8BLT>A4!HH_&,&=7",E'SC29
M4(R]@47#U)*L$H %IN4A^-)2IGJ=22)2J5)5#X/6 5J'Y*D)4<8ZF1&?5)+I
M@+'?W7SNN+&;!D971TTEK3M/Y,G%T@'=@OU(QKR5!\70 NS?Z.^;']DY5;70
M/A4G^D@%2          .F0ZIM%&]KRSTME_6/F^H7" I)$Q%N2B.A.M>FIF9
MTX>:?JF JHB4E'0I)ZM9:U*/A-2MIF8#O         6^9)*#()Q):C=3\8C@
M+J> Z\_F *MM;<IA*]-6W"VI5T@')IEIE.EI)(3PT(!S 1DR?(-WF\3>MC&'
M8M,LUJMV%7]F^7R_)>B0WI-V2I?%6V"G4E;ZWW5&<E2"-.RFHU[ 2I]Y%YM:
M][.[^X-7FQ9)C"LH9:MN,V$V6[W&N3K:FW)DAUI3JGFF7M:WT4;+JDDO49 )
M/KCL.+)Q;9*6G@49;00[ '!UIMY.EU)+3PT,!TQ_B5JBG[E/5,GST'S/6,!4
M@   P[>KLW>W^G[.7;$C+['[7AY<S6MYIILS&G^W/"'NI0MG1>;_ %\FI0:)
MZ^34H-$]?)J4&B>ODU*#1/7R:E!HGKY-2@T3U\FI0:)Z^34H-$]?+86Y(U'O
M'M5?O)7B[@P.WHIJ=_1ZT-QW.Q9NVIAQ]E_4E+ R)1&E1$:3X2/:0JUZ$?$(
M0VG2A))3SB*A .0#5/*/V[H;WV2%XVT,[L+MEO2Y):UO+V"_H]:$%M(L]3E3
M2!4T@5-(%32!4T@5-(%32!4T@529Y(!4EY=V.!\*0-+WGXL/I9E@[G<[%Z/Z
MDIAHZQW1-_572J:3,J%3A,SX"]?@ 4UMA/136ITR+41$22.O!S0&@^5C\VXO
MV>7\!H;INOS\3)&=7.^O,PLMV9%^@WQ5Y0 H 4 * % "@!0 H E!R3OFW*.S
MQ/@.C0]Z.?AY)S+0W*YF+EMSI&#2UC   AWRE"_U*5WA&Z:Q9N[G9.E*EM[^
MW]&W.T_0;*TPH 4 * % "@!0 H 4 3;W!_918/XOQMX53MWMM_W=6%Z[K_3L
M/I=:YLD8-LX  (8;_P O]4[QV.)XJT+5V!V*SI=:5$[U_4L3);U8:RH,^U0H
M 4 * % "@!0 H 4 3@W,J7_+3'6W$Z'$QC,BV;4&XLTF5#/F"HML3_V8F7,]
M [NQ/R[!R9Y9X,0V   'GSD'S]=._)';5"[M7]E;DCD>9=;]O?YUW*MP[WR
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MN@9 .\        !1N,(FO'QJ?B&>I2?!J6?#MYQ *M"$H22$%1*2H1%S@'T
M 8HC=ANU:FM7)O#;&BXL.$^S,3;(9/H>2K62TK)K42B46HE$=:[0%;;\(PNT
MWA_(;7CEL@W^2:CDW2-"CLRW#<VK-;R$$M6JO55/: OP   .F2VI:2<:_'-'
MJ;Z//3ZY .;;B76TN)]RHJ]'U# <P !A^],J[OK\7[N7;$C+['[9AY<S6-Z?
MI>/YN>$0>+%N/,FD<6!I'%@:1Q8&D<6!I'%@:1Q8&D<6!I'%@:38.Y1%-XUK
M/^I)\7<& V_V*_H]:&Z;ES_[7#R7]2Y*T56]'   U5RCMNZ*]]DA>-M#.["[
M9;TNK+6MY>P7Y;>M"#%!:"F:E *E *E *E *E *E *E *E *I,<D,J2\M['
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M H 4 * % "@!0 H FUN$^RFP_P 7XV\*JV[VV_[NK"]MU_IN'TNO<V0,$V<
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M-TUBSMW.R=*5*;X=OZ-N=J$;*TP          $V-POV4V'^+\;>%4[=[;?\
M=U87MNO]-P^EUKFR!@FT   AEO\ OM2O'8XGBK0M78'8K.EUI41O9]2Q,EO5
MAK,; U,          $X-SGV98YWL?;%BH=L=LQ,N9Z"W=^G87FYY9"W/7'E*
MC(15@EFE**=453Y@Q#8EP[J/\@[[TO;!#Z4HS,BXATJ\TTE[8" >0E2_W4C+
M@F2"V\/XU0N[5N'"L\V.1YDUR*8^)YUW*MH^A\8         [HOZTQV1/PB'
M&_FR[,/G1E>AXHMZC=,ELW&ZH.CK9ZVU'P5+G] ^ !QC36)6QM75D55(/A+V
MP%0  +!D/SOBGE5WZ+G@+9@L)US&L?E)<-3/<$527%5):R)E.TRZ(#,@
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M *E *E *E *E *E *I(\DLJ2\K['!^%(&D[T<6'TLRR-RN=C9+?U).C15F@
M CSRJOF[&>SR_@-#=MUN?B9+<ZM=^/9X.6[,C+0;ZJHH 4 * % "@!0 H 4
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M0*FD"II J:0*FD"JYXVG_,5H[]C=M2.C6/9W9)Y'TZK/^ZSSHY7I.*9>@P
M8%OK^RS)N]2[:@9;8_:\/+F8';_8,7)GA S2+:454T@5-(%32!4T@5-(%32!
M4T@5-(%6TN3N5-[-E[',\4=& V]V._H]:&T;KS_["S)=U93>%7+K  !K#E!?
M95>>R0_&FAG]@=MLZ75EJN]7T[$RV]:$*Z"TU&U* 5* 5* 5* 5* 5* 5* 5
M* 52,Y*14E95V.#\)\:1O3S</I9EE[C\[&R6?J27&B+1  !'WE3?-V-=FE_
M:&[;K<_$R6YU9[]>SP<MV9&F@W]4Y0 H 4 * % "@!0 H DMR6?F[)>S1/@.
MC0-Z>?AY+LRV-Q?9XV6W.D$-)68  "(O*,^T97>,;IK%H;M]DZ4J.WS^H="W
M.U+0;,TDH 4 * % "@!0 H 4 3/W%?9;8OXKQMX5/M[MM_1ZL+]W4^F872Z]
MS8HP+:@  0ZW\E_J?=^QQ/%FQ:^[_8K.EUI4%O=]3Q,EO5AK:@V!J)0 H 4
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MH  (C\HLJ[Q5=XQ^FL6ANWV3I2HW?/ZAT+<[4U!LS2*E *E *E *E *E *E
M*E *E *IF[B_LML7\5XV\*GV]VV_H]6%_P"ZGTS"Z77N;$&!;4  "'>_DO\
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M]22@T-:@  (_\J/YOQOLTKX#0W?=7GXF2W.K'?OV>#ENS(V#?U3
M  DGR7/F_).S1?@.C0-ZN?AY+LRV=Q/9XV6W.D -(6<  ")/*)+_ %$5WC'Z
M:Q:&[?9.E*C-]/J'0MSM34&SM'J4 J4 J4 J4 J4 J4 J4 J4 JF7N,^RZQ?
MQ7C;PJ;;W;;^CU8>@-U/IF%TNO<V(,"VL  $.]_'VGW?L<3Q9L6ON_V*SI=:
M5 [W?4\3);U8:W&PM0          !-;=#]FV.]['VQ8I_;/;,3+F>BMV_IN#
MYN>6;##MC  ! :_?/MS[[?[8H7CJ_LK<D<CRWKGM[_.NY5O'>^0
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M!4H8%2A@5=L4C[I9[(GID.-_-ESPY_%&5Z!BB'JP     6#(?G?%/*KOT7/
M,%^I&->2H/BZ %_     #*NPP'G+D;:2R&[D@C)'=LG21GJ,BXU5*GS1=&KQ
M_JMR1R/.NN75Q[_.NY5LT#Z'R5- %30!5F-WPJU0<%MN86V]?*3LJ;\G38J8
MRV&X[Y1TR%();AU6:"42342229\'!4\9A:W?=K%V#=9HTC2B:UK%:?<S.-J.
M';J=NL68FE6[1NC1F*3HZ5*SQTR4[WVU5LW;IDX-<\MN%Q*).CQN[[9:202W
M9$-+Z(ZGUGJ+0A3BC2WLZK2H^ =>)K]-8MPK;:Q,TF[O32M/MFG'E=^#LK2U
M2_&ONT;HC2MM[LVUBW2X^"*\$9)[C!- R[7ZF@"IH JY-HZM/JETQ$IB>%Z4
MM^X3ZA=(4C+TG'$Y"$@#BOW"O4/I"8XT3Q/.%:.K5ZI],7C'$\R3/"XZ 14T
M 5- %78IU];*(RW5JC-*4MMDU&:$J734:4UH1G0JB-&*U[KE-\S$17@C.[9<
MZ?/)E,Z6]*3'034<GW%.$VVDB(D()1GI21$1$1#C;AVVUT8B*N=^-??$1=,S
M%L4BL\4=Z/L4V@<W54T 5- %5RQY/]_VKOR/VU(Z-8]E=DGD?5JD_P"ZSSK>
M5Z("E'I,  &#;Y/LQR3O8NVH&7V/VS#RYFO[Q?3L7S<\(.:1;KS]4T@5-(%3
M2!4T@5-(%32!4T@5-(%6S=P!4WIV?L<OQ5T8#;_8K^CUH;7NI/\ [+#R7=64
MSQ52]@  :TW^?9==^R1/&FQL&[_;;.EU9:EO;]-Q,MO6A#:@M90M2@%2@%2@
M%2@%2@%2@%2@%2@%4A.2T5)64=CA?"?&C;U<W"Z69:&X?.QLEGZDD!H2UP
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M>4 * % "@!0 H 4 * )H;I/LXQ[O<^V+%/;:[9B9<ST=NS]-P?-SRS089L@
M (&7XO[\N??;_;%"\]7]E;YL<CROKGM[_.NY5OH.]\A0 H 4 * % "@!0!VQ
M2_26?PT],AQOYLN>'SHRI_"AWK      6#(?G?%/*KOT7/ ,%^I&->2H/BZ
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MII"A4TA0J:0H5-(4*IA;D?LQLG\5XTZ*DV_VZ_H]6'H;=+Z7A=+KW-@C -M
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MSQO5<<3D(2 .*_<*]0Q,<:)XGGVM'5J]4Q>\<3RE,\+CH$HJ: *F@"IH J:
M*F@"IH J: *KA84?W[;.^V.V)'SZQ[*[S9Y'UZG/^^SSK>5/@4<]2   PK>Y
MMW;Y#WN7;$#,;%[9AY<S6]Y?IN-YN>$+M(N%YRJ:0*FD"II J:0*FD"II J:
M0*FD"K8VXE--YMI['*\6<&O[P]BOZ/6AN&Z$_P#L\/)=U93 %3/0(  -<[]-
MN[.[?AQ?&6QL.[W;;.EU9:?OA]+Q,MO6A$'2+9H\^5-(4*FD*%32%"II"A4T
MA0J:0H5-(4*FD*%6_>3(5).2_@0^F\-$WLYN%TOTK6_^?\['R6?J2'&@+=
M!H?E,;8&.]FE?!;&\[I\_$R6YU5__0/9X.6[DM1UH+"4_4H!4H!4H!4H!4H!
M4H!4H!4H!5(KDS[(&1=FB_!<%>[V<_#R79EP?_/_ &>-EMY+F^!HRU   12Y
M01?Z@J[RC]-8M/=KL?2E0N^_U'H6YVJZ= ;0T0IT "G0 *=  IT "G0 *=
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M15I4JC2]Y]8PL6,/0NBZFEQ3$]Y9NXNJ8^!=C>MLNLK%E-*V8KSN^WJ-&6H
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MB,JD=15FW,2W$UR^ZV8F.#ACS87SNM@WX6S<*R^V;;HTN"8I//N[C.!A&T@
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MQ3RJ[]%SP'S!2+S)QLR(BK:X)G39M..@!D    /AH2HR-22,RX#,JT ?0
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M0ZR9)X3UI,T[*;=H#Y;KI;;O&*;:9C$^&HS2F1%=0^T:D[#(E(,RJ0"K
M       !P>>9CM+?D.):8:2:W'7#)*$I253,S/81$0"G@W2V7.(5PMLUB9 .
MM)4=U#K)Z>'JT&:=G-V@.$2]6>?!7=(-PC2K:WJUS&'FW&$\7[JKB5&DM/-V
M[ '9;[E;KM%3-M4MF=#69DB1&<0\T9I.AT4@S(Z .<2;#GL]T09#4IC4I'&L
M+2XC4@Z**J3,JD>PP'>           "BN%XM-I)D[K/C02D+XJ.<IY#/&.']
MRC69:CZ! .5PNELM+!2;K-8@QE+2TEZ4ZAE!N+]RDE+,BJ=-A .-PO%IM),G
M=9\:"4A?%1SE/(9XQP_N4:S+4?0( N%XM-I)D[K/C02D+XJ.<IY#/&.']RC6
M9:CZ! *T            !13KQ:+6Y':N<^-"=EKXN*B2\AE3J_O4$LRU'MX"
M ?;A=K7:4M+NDZ/!0^X3+"I+J&26ZK@0DUF55'S"+: ^3KQ:+6Y':N<^-"=E
MKXN*B2\AE3J_O4$LRU'MX" ?)UZLUL>8CW*XQH<B4K1&:D/-M+=4>RB$K41J
M/H$ K@            %$F\6A=Q79T3XRKNVCC%P">0<E*/OC:KJ(MO#0!].[
M6M-Q39U3HY79;?')@&Z@I)M%]V3==6G9PTH ^)O%H7<5V=$^,J[MHXQ< GD'
M)2C[XVJZB+;PT =LB?!B/1X\J2TP_+4:(K3KB4+=66TTH)1D:C+G$ J
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M,.ALV[%#L=HGW"V04)9AQKJM3C:-+39$AM3C!:E:2+5PF"&]P0
M#'<ZMN&W3%I[.\!J*[B+)(EW),]6B*28JTO)4X9F1&25((Z'L/@V@(DWNT%!
MW<;P\QL-N7B>Z;/KYCL2!:VM4'BK&V^B-,N'$I-),-SC42=.E)FW[HJ&0.3/
MV\6W<V3?!O Q&9;;=!W2^;%IO636PTHCVJ/<XDM1L+6VC2A!J:;):BH6NE5$
M=00N&YS=Y9,E:WAWI%E59-TN>O0TX_B[9NV\G8<)LVW)Q-,J;4PB8JAI0G09
MH+JBH9 2O7)4C1XFZU^+$:2S&9OUZ;991L2A")KB4I*M=A$1$!+=X(
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MGB.\')[;D,.?"RR/#L-G>M<U#,:P14/&:D)4TDG9<MXTO+2WJ4E"4I^Y!*=
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M&-6G<INLL>4'F5JQF+&R'C')#<A)NJ::>>]VXS'4LV6EJYJFVTF":L]!
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MVD":L[O6,6'(I%JE7J$B7(LDM-RM2UJ67$2VTJ0EPB2HB,R)1^ZJ0(7<
M      6#(?G?%/*KOT7/ ,%^I&->2H/BZ %_
M
M
M           !8,A^=\4\JN_1<\ P7ZD8UY*@^+H 7\
M
M
M                 %@R'YWQ3RJ[]%SP#!?J1C7DJ#XN@!?P
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M"JH@&0@ #'\OS.PX-;HUUR%Y;,.7,C6UE3;:G3.3,7Q;1&2",R(SX3Y@#(
M  4-YO-KQVTS;[>Y2(5IM[*Y,V6[4D-M-E52CI4]A<PMH#IQS(['EMEB9%C<
MUNXV2>DUQ)K-=#B4J-"J5(C*BDFDR,MAD HXN9V&9F,_!&'EGD5MALW*6P;:
MB;3&DK-"#)PRTF=2X !_,[#'S.)@3KRRR2; <NT=@FUFV<1EPFE*-RFDCU'[
MFM0&0 ,?N&9V&V999\)EO+3D%]8E2K<R3:U(6U"(E.FI9%I30E%2O" R
M                                             !8,A^=\4\JN_1<\
M P7ZD8UY*@^+H 7\
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MFE;%ID:'"+^HMQ*@3#1Z+O*WAL8EO(R*.^U(PB\89AK;LE>E2;K'ED_>7]/
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M^[LV[+O FYWW18KM,E.7">FXJCNR6$&:VS+:TE[29\29]1IV$0"6H.(
M                                          "P9#\[XIY5=^BYX!@O
MU(QKR5!\70 OX
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M8\<MEL?96\ZR["A1XZT.222EY25-H29&X24DLR]T1%7@ 7X
M                                   !8,A^=\4\JN_1<\ P7ZD8UY*@
M^+H 7\
M
M                                         %@R'YWQ3RJ[]%SP#!?J
M1C7DJ#XN@!?P
M
M                                               6#(?G?%/*KOT7
M/ ,%^I&->2H/BZ %_
M
M                                                    !8,A^=\4
M\JN_1<\ P7ZD8UY*@^+( 7\
M
M                                                          %@
MR'YWQ/RJ[]%3P$&;9\VPN]VO@$#DJA
M
M
1     "EE_CH'?"NT.B1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>lg_datacliniclogo-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_datacliniclogo-4c.jpg
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M%!04%!04%!04%/_  !$(!!L#M@,!$0 "$0$#$0'_Q #F  $  @(# 0$
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M)2#^*\VE_P!!*,%-\V_]J^U_^O%_XHT!]5_;!_V20/\ UN9_Z5:C*:\^\?\
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MC1\FWFE)%0A541?P]"2]TJD-DP/N@VR-%%F;K^$G212RRCC&V1+\R%LT&_\
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M]E0$-$\'^)H3B.LZK#(A6Z(^CD@?Z1=,T7^J@+S#A0\?&;AP([46(TG%J.P
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MOF"_,2>4U%?Q2@+I0'C+B1I\5^#-:%^');-F0PXG(#:<%1(21?5%1;+0%/\
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@.HF!WXDBV];*B_Z% =J 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MRA)0OQT-X:DZP;Y5HJ-_Q)=%2^BMT_'XI^-<QZQS0"@% * 4 H!0"@% * 4
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M<*/D8LIH@^DF KC!N)U#D***]"1%NA(J?!: JK.L17(NNQIZQXS^&C!$<QD
MC<C-D(HB "&JE9$2WN6]0$1Y#A3Y4.?E\)/"$UK&+F25>6.$@FY(MD2)&,^C
M+O!"$G N2)9$]:%1^?GBO[=_(7G+.PLP41(^H.3.[G]AGE=2;!U'S8;;15-Q
MTA5/5+>Y+JE4B/U6BQH\2.U%B,A'C,@+;+#8H   "@B(B-D1$1$1$2@/:@%
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M#V%;Q\+%C@<A.P[4?%HZD-4BO+9P$>(S3FI<BY&JW^-9)4P-,YN;<I.K9K[
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MU1?TYR?**Q9N]1W7Z:PYI5EA&*YRE@BM^,F9^L/9'QMF912YN*%O(8V:=_\
M&(4WJY:__DG^8K^U*Z_4G&]IW$%13\+7*2_]R^9YWH\9[;5M+CU.%)1D_P 4
M9?\ ME6O6B-WIC4G_). '= A%B2PTQ&TR/%&5?1]I1X\NG*W+^BMVT=U;2;M
M5U:X_3G2C.;U".WEO[:W&EQ=N?U4I75'GQ,?6@T\/)D&+XU)D\4<"6NTM8XE
M+'"EQ2*JVN'>4N2=.O&L[WG/:-[BNK4M%?JZ>FB1AMOTRWT8[2FG1+S%'Z>&
MG+PZFZ]-#MEO'VCM>3\#B0U^"F.DXK(/R(R,HC9NMN-<25/FG);?MI:WE_\
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MR_)N&P08.6UB\SA)[;L:8X:LH$1Y$!X0(!54.R H?BEJGI^[5B3<EJC)9>W
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M1$Y4J2A('(8:5L7#0#>+@T)+92*RK9$^/1+T!ZT H!0"@% * 4 H!0"@% *
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M1C,C"RTLY[FEY2?JN*DNI9PXD Q0'7/@KI HMD2?NC^*T%3:]4@H!0"@% *
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MHFO;[+Y"9HH>BJJ@*W_"FN5-/#,.*K7B2U8F0H!0"@/"3"AS./U;#;_"ZAW
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MLG1/Z*&1V:CL,*JLMBWRZEQ2UU7U5?FOXU0>M * 4 H!0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M5%^:5$P=ZH% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * ZF2C:WQH"E9[RGK.#RGZ"RLG-[$/5
MS#86.<^4V/S<0/8W^QPT6NF&WG)5^E<W@<%W?6[<M&,I<HJK[>"[:$>]YAQV
M/07M@UO8<'CKIW,C-QI%&;1?BX4<W2%/Q4:S_2MX1E%OE4UOU",<9PG%<W'[
M*]Y=\5EX&;AL9+%2F9N-DCS8EQC1UHQ5/@0JJ?MKEE%Q=&J,]"%R,TI1::)"
ML3,4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#@B0>JU&P<(8JMDI4':J!0"@%
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MG=<+T>3P$LC6WC_[@<[K?V]8/>\KA'-AC8@W,-EY@S6XSXDRZ+48N#C9JXI
M8(2HM^E^O6NF]M(O<.*=*XHBEAB?0&0V?8?Y4A;'K&O_ *U,FL,2UQ9S6H)
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M>SNP9*9E$%CN@V])DRD$5(WGB0455+D1$M=5CZ7UGP_[DBH;M16"48TZB?\
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M*75!0541_M$MD^-NS967.ZI?AB261J'=/'V3\;?9D[A,T!-9N5.BY/(QU3_
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M=;>O2O2W]V4+BIE3#!&J$:KI/H71?$/C[Q[E)N:U. Y%R>2:[,R2_+DRW'0
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M^"W)<E.OC)!&Q5+*R;HB0H@]4Z(O6LE>N:M2CDJ?(QT*E*])><1IHXO<<YN
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MF2V0"KR*V?,G151M8?AZ4"9A[]I>TYW9=:S.$B,!"PT2/];%66+9N$Q-CO\
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M)77^KN\_@>A_D;_/W'/_ '4_"O\ S+(_RZ5_PE/U=WG\!_DK_/W#_NI^%?\
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M:_C(V&PT5N%BX0(U$BLCQ!L$^"?M6ZJJ]57JM8&U&?0"@% * 4 H!0"@% *
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MR\KW47ZEHT+B'"]^MQZ$EAX]*QH95.,CA<NYE)$V(7\"1,B$^R1V18\= 57
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 LE * 4 H!:@%DH!9* 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% <73YT!S0"@% * 4 H!0"@% <73YI0"Z?.@
M'(?FE <T H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@<P^=4E1W ^="G:@% * 4 H!0"@% * 4 H!0"@% * 4!U(Q'\RV^- <=UO\
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M962Z\JH2&)+P<(>GX5HN)-5/9],N2A>E:=:.*:SX9YUYKB?3J*B^E<Y]*<T
MH!0"@% =>X"?&I5%H.X']I*I!W _M)0#N!_:2@'<#^TE2J+0YYC\Z50H.0_.
ME10Z]UO^TG6E40YYC\Z5+0Y147T6E2'-4"@% * 4 H!0"@% * X5;(JT!\Q9
M_P"\:#@-ARFNN:?(DR,9,?@*ZW-;1'38=)KD(]I53DJ=$O7FSWNF36G)\_N/
MLMO^V97;4;CN):HIY<UUGCDOO'/#&#68\=Y+'NN(I-!+D?3D8HME44=CBJHB
M].E1[UK./O\ N,[?[95SZ+REU*O_ %&ZO&_DR#O^BL;Y)CC@\>\;P&W)?$Q;
M1AU6N1.J@#U5/E7=9N>9&M*'S._V;VEYVF]5*>]%A3;=762W#3-0?JWFDD-,
M_4M<S97BJ&*<NHJA"J*GK>MAP'JFRZZO)1RT-4$%>)4D-JB-"IBIK[ORHK3B
M*7I<"_LK5!RYL6!905=R<5M"5M!4WVQ15>1%;1%5;>]%]G]KX4!CO[AJT:.Y
M+?S4$(K1(VZZLAOB)DBJ@JO+H2HG1/6H6AT;W74'7.TWG8!.]TH_!)#?+N@/
M(@MR]43K04/7&[=K&8-6\5F(<PT<['!A]MPNZE_99%O?VET_!?E0$S5(* 4
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M7=>C0T-VJJ2]YOL>H5E2>1]C?SQJ?QSD#\/\8#_3KY73+DSV=<>8_GC4T_\
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MBP##JVO>YL);XK6MJJ9VV;T(7[<U)9M/&/XNI)Y]!]V@ED5/E7$?<G:@% *
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M2R=$Z5YJ.MGH:*HJB>OPK(AIP?%$C->2<QN6U"!X5EYMS%1$/GWNRV*";J?
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M6T:FNFVET;;$3101;+8"K&&"53U/5K$I77*";3@X-\*UJE7BZ_(OQZOA-?\
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M"^;1.*G'N+=.G50/M?6X3N,U[$XR0B#(A0XT9T!+D@FRT($B+\;*E R4H04
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M9Q@9;Q;I>*P.&:V?<7LWWMHU]N1GH RA:PLPV6I[[Y(HR>X)V^E46B-!3XU
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M+GV.9= < UY-7Z%?C\D7X?\ </H\=U"556,OJIPY21]7Z3ZA*S)23I*+[_\
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MML5[B*B!VA$53K:]U6M_GR_.NYFORX\O>>;7C* TY'>#7LSWXSC3S#GZO$Y
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M4 0 3T%*M0. ?V4^=0#@'5+=%]: < _LI0'"--IZ"GRH#LB(B63TH#F@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MBY/)&FT^[7PV272;.]+_ /$7:RTL\?\ S6U_-[F>L7[J_$TXR;@NY.4X"*9
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M9J7-1$;E:M.^\F=VMB+TTQHC.PYJ/]1XUP-M(MT1?G7G'4<T H!0"@% * 4
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M=HV*VQS5/(.*8=PN0E/3])S;ZFPC9S"5V3C2?;(" A<4G&1(K&)=/<EJ]_\
M47I6_,LR\224X]64J=*P?4?/?I[,+OEW8K2VY0;Z<7&O.N*^XV]KNGZKJ, \
M7KF+8QT)PE-]MH>KI*EE)PBN1K;I<U6O'O;B=Z6J<G)_#[#VK.WMV5IA%17M
MWFMMTTCPOI@IFI&JQ9><E/<L/@H_<,IT\OR U#0NVO6W(NWQ%.JUZ6WW6ZO^
M!3>GC+DOYL_>>;N=MM+"UN"<JX1YRZ%E[B[>-=;G:UKG:S*B>QY.0]E<X;?^
M"^NF%S,&[=.#:<6AMTL-<>[OQNW/#]$4HQZE\^+ZSMV=AVK?B^J3<I=;^2R7
M0BX5QG8* 4 H!0"@/FG[@-CS&J^1L%E\(_V90XI0<;7JT\W]2:J#@^BBO]:>
MJ5S[C;V[\'"XJQ?M5<4^H\^_=G:N*4,Z&L_/V2R>Z:KIV[0H1#K;7U4><YZK
M%R+AB*MG9$]BH'L.UE_;6[]N[-;.%RTYZW*6I5I73TI455T+%9XU,=[>=Y0G
M2B2:?0_L-M^&\1A\[]MD;&;!,_3\,X4ER9,0A#M@Q-5Z_(T5$Z@B5Z&ZFXWV
MU[8&W;I>0JG=W.^$MCW/*9AG)2H&1VC%OZY,F*P['@2@D\01T'' X]VR((GZ
M*EKUS*[)12Y.HC=M2DVGGAUEFV/6\=I^A96'N>VY*;IQ8U,.L<V8PN,MD@M-
MDUV&A(G$1+>ZZ>JK5\[Q:DE6ILFHP@]3=*'I'\<8?)XQ[8LKLF0S;,S7Y&)@
MS748:2-BY[2*Z;8,- A.$(CU._I\ZOG/"B2QKVE\M/%NN'N.FHZII6=Q,C/:
M#EY$''Y/$K@,DL, 95XHP=L)#C:@BA*;%2XG;JA>GI6+NR>:K1U+!0DM47FC
M'UW2?$L3%X;R%J7# P<*+_++ G8*1& #BOMR.YZH2I>]N7-$5.M66XG)-2Q3
M)!0HI+"A5<-D?&.=SC3&5W',964Y"FX77I>981A&V\F/;=X2D8;5]PAL@*ZJ
M_LO5\YI8)+)]QIA.W)K%XX*IGYA_QAJ&63!L9G)8C/8O"CK61=QT4S^HB*P@
ML&[VVU#O-7YMN)94553JG2L7=;Q?.OMUF3G;A+35UH=L7BO"6MX? ^0]=9>P
M;&#FC #)QXS@291*RK1L2&S%2,'$7D1(B>Y+I5GN)RJI.M20C9A%22TTP-AZ
M]Y<T;9<HSAL=DC#)/W^GCRV'8JNV]4;5T115_"]ZT\#=&]&4J)EZ147T6]#>
M<T H!0"@% * 4!Y?31^ZCRMBKR(HBZJ>]!7U1"]42I0'H@H*63THE0'-4'"H
MBI9?2@*ON'C_ %7>3Q);+ 28N%E).QZ\S#@\/SX*G(5LEQ7Y5OM7[EJNATU*
MC,)04LRT)>R7]?C6A&9S0"@% * 4 H!0"@% 4>7YA\:0-W:\;S=BC1]X?,&F
M<*ZC@OF;P<VT15#BO(>J>ZA:&%#\H^,-^SV4\<8+9X\[9XPOLY#'PT)QYE(Q
MH#RJ1MDW["]JJMTOTJ9.H*SL7@G/9C-Q<MCMX+',8PB<Q,4\1!D*R3K?;<5P
M_P"&CW+K;N O'X?.N^WN(1@XN%:YXLYY6FW6M#+VKP!B=O@8>+E<W*65CI#3
M\J0VTPRD@$1$? 08%KM]VW15(^'R6L;.ZE:;:2Q]EW&<K:DD=MU\(R]H@GB<
M=M3F+P\EOA/C.8Z'*<=5"0A4'A%@VK6_<7K4L;A6Y:G&K73[5).W7!.AKE?L
MT87_ /;9_P#9]#__ '5>E_EG^1>W8<[VJ?$NFAS]+A;\_P".9V]!L'DW!C]4
M_C&<>QC4;B]L.(JC3"@1")H1<7N77JE>1<N*3\*HNMLZXQIGB;BR^6Q^ Q,O
M-9=Y(V,Q[)R9D@D(A;9:'D9J@HJV%$NO2M)D1>D[UJGD7!CLNF9-O+X,W7&&
MYK(N""N,K8TLX(+T7\* L5 * TK]TB+_ )L&5+_BPYS#K*^7:^L"]_PO:N[9
M?W.QF$LB^^1LCD<1IF8RF)DNP\E&9Y1I4>$N4=;)7!2XQ!5%=6R^E_Q^%<=J
M*<E7[#-O ^-]<W_R)%\B[GDV-ARC>4GMXH,G*#37)#[Z,M$#2.Q$<O%01)4%
M55>[Z_"O<N68>7%:>?XO:ISIXL^H_N&5M/!>Z*[^5<85N2W]ZD''K\^5J\K:
M5\V-.9O9=M-1U-1P*2+]],=#1V_KR^G"]_Z:U7?KEUL1R1JB5$\08+.F[D<]
M,DYK'9B6^WDWB>E!C\QFF4C.,H^VRK+9DA#P;-?8:(O1:VIWI*B6#7>D8TBB
MR8/PGK&NIB_T7)9B">,BICT5F:0%)A ^4AMB0H@G,6S</@0\31"5.5JPENI7
M$ZT=>CL+H2/=KP[KC+\20F1R92(;V5ELF4@5)7<\*C+4K-I=%O[/[*U?U$FJ
M="_].0T+@>4#PEIL!MB.T].<@ D!)D)V1RC3CQ%DB'*'@G<)O@">U10N \D6
MU'N9MUXX\,JYT&A4H=9OC74<#K$.'DLS/C8#7,D6RA,E2Q'M21=.0JN.*VEV
MT-PRX_,O7TK'S9N3<5C)4]NDKBJ493->\?\ A_94?T_"YC,=]S$"V4)UQ^.^
MN&^N^J9(/J(XJH(^7L/J2HMEO6^5Z]&DFEG[Z&.F+-DYOQQ SN73-.9K+PIQ
M8],-)2#)1EN1%0R<LZ"MFBFJF7O&Q67I:N:%YQ6FBSKEQ,G'B0<'Q/HWZW-D
M8;)S8F=Q\AAV\*4*NXXD@C%;9;%0) ;.,@(H&A<A02]>M9O<7&L<4_?C]I%"
M*>!V9\#Z/%DQW\<Y/A#%/'O,L1Y)(T,G$D1L/J)"5W+N&IW6Q<E54OUK+]5<
M>=./#F1VT26%\0:]@9F"G0IV1)W77<B_C@>?%QOEF#4Y/<3@G)"55MZ6J2OR
MDFGQI[LBJ"3J8LSPGK<YC)M/9/+"YE,NSL9R6Y0B^QE(P\ >CFC7\-4%!%;?
M 42JMQ/#+!:>P:49 >'M<"!E\.L[)'@<R$D9.'*6OT39S?<\ZRV@IP,C574Z
MJ(FJJ(I6/GSJI857'JR&B-&N!UF^&-9R?U?ZG.RDQ,A CX[)=V6MY7T1J[&D
M.J(BJOLF7)LTLB=/:M57YJE.#;7;F30C.C^,X#.8P>?D9K+S\M@$E##?FRA>
M0TG"(.HZ/;%%11 41!XHEK^MZP=QZ7%))2^1=.*?(CHWA?7(LMJ:.2RIO,NY
M62'<DB2=[.BH2S7^&G547V?V5K:]Q-\N'_IR,5;14&?"VQXG969.N9N1CXF/
M;QT+#9))*.FUC\> @3,J*XP2/&0JX D#@)Q)+]4ZYO<J2HUG6O6%"F1O445$
M_P!!/E7$E0VG:J0J_D7_ *A;9_T-/_Y,Y3B<^X_M3ZG\#\UM%BQY6S8H9<),
MI';>;>/$7(3G]M45(@* DO-Y?8/3X]>G6M\LC\RV,%*\JJJ7#GT=I]",QGBQ
M\F!'$\HS*89/<(H17W,GH^/A2B,(T,Y!\QX(1HVVGN'@3H\@M6C,^NBJ*B5<
M%J_-;2KAGW+AB\4:K\MZ^3"8?:,4VT[I&01_':WFA$&961CX\U%'Y306_B=5
M#NJ(DZ@\S%"6ML6>#ZI8^F:IHR3XNG/[>)].?9XG_P"ZN3_TS*3^IIFL)9GT
MGH/_ (_:R1FS_"#7E?,Z3+UV6[Y(W"$;.88.'+=;R&).[9.$9$K*QTLH\NG&
MRVM6!]$7Z=XB\=9+8<=MDW LN;'B6FX^,R"&\#L9ED% 0:X.(@"@JJ61.OQJ
MBI#/?;OX6?QK>(=T^$6/9G%EF6N3_LG&*";HDCG)%-!'FB+8K)R1;4!4,UJ7
MVSZQ(U@'M>A<=MV-"UX\:W(<CEGDN/>16#X-*"AQ0NB#ULGK4*7(_#OAK,%L
M^&<P$*6>8DL2]KA]UXU?E(JR&3DCW/S>[F-_P_"A*D[A/&.BZUL+^V83#-Q-
MBDQVX4G(";QNN1FA &VRYF2*(H H/3I:JB-LQME\?>,_+,7&Y//8N'G6HJJ]
MB<HR9MOM754)6948P<$55.J"=EH4\7_"GBR5J4C1I>L0W]7EO#*DPG$<,W9(
M+='C?(U>)Q/1#5SE;I>U!4C2^W3PF;,V,NF0$CY)F-&R#8]T1?:A*A,HXB.>
MY144+DO4E1%556@)QOQ-XZ;S#V?3 1SR\G'_ *+)DO*X]W<;VT:^F<%PR$F^
M*(G$D_NT%3 PO@KQ'KVNY?4L1J&.CZYGO_DQ 5M71D\5N/,G"(K O4$0O8O4
M;+05/%K[?_#C&$QFN1]1AM8;#RRR6.C KP]N:5OXZD+B&3B(B()F2JB=$LE!
M4V0(H(H*>B)9*$.: +Z+0&E/*>KL[QM</4'Q12?US+/PW"_W.8,B+VC_ *"2
MR_A6ZTZ1KTKYGV'H^[>SVTKZX7;:?3'3/4BO:9Y%R^R^.(.BLO=CR$Y+75Y*
M>K\>.T/\::2?_2V!(>7_ )2U64%&5>&9W^H>F6]OO9;AXV-/FKE)O*/;+A^4
MPM%RF'\=;EYCR2,=O"ZW$CN!%9Z$K4,#0 %5O[BLB7^:WK/0[BBEFV<_K]Z4
M_3MM<FZMZV^MF/(\F^8V_$37GIO)X\L>1_6.Z4L).P.,*0L9!29S[RN^AJ7I
MU].E="LVO-\K&O/IZCX#5.E>DD\KY7W_ #ODSQ]K>E2\?C];W3!EFA67'*0^
MUR8<,D->0\U;4;MB/%"+H2VK%;>"MRE)5<68^9*36G)_>=M/\@^39F8\J>/\
MYFHDC/:;'27B-C:@ V*@0*=G(J&@*JBB6]WM55_-5N;>VE":6$LT6-R3JN**
M_P"']ZW#7O!^0\Q[3L)9O%M#D9+F#<B@+[DYR4K8*LWFI(*FJ)Q1NPBO3TK+
M<682O*W%4>&/8+<I*-6ZD]K7D#S3,S>J27,3D<IB,VXVFQQ7L,&-@XYB4@DC
MT27WC<<%GDO^%OS%+^U5K7.S949+!-98Y]G291G/#["L^(L5N,CSUY7;@[''
MA/QI\1S+N?IH/),:YFJ "$\G9]MQY7+Y_"M^X<%8A55PYFJ"EYCQ]JLL<3S+
ML&#WWR\FTK'>UW1834J##@,HRZ\1JG:[CQ<C(U0A;55]J>J):M3VJE"%,Y&Q
M7'J9@9+R=Y@POB?&>=7\C!F8V2;4J?IJ01;CM8Z4\K+:-S$-7E<'V$I%TN7I
M9.N2L6Y7';54^=2.Y+3JKFS/V/R;Y0S'E+6M.\?S<9 Q&T:TN?Q:Y&,;IB3S
M)D*OD*JJD"C<$"P_VN58QL6U;<I5\+H/,DY471\SK+\H>2CV8_' /2'<WK..
MC/;5GM=Q(94WLG+'D#33#QM@TR(+<C5.1$ED04J*Q;TZWDWA5T#N.M%PY&U_
M$>P;OL&G,2_(6&+"[*T\]'>;,.SWVFU3MR.UR/M]Q%ZARZ$BVZ6KEOQC&5(.
MJ-T&VL2^5I,Q0"@% * K)>0])#+/X-S-QF\I&5P9##A*';5I.1\B)$%+(GSJ
M5+1D)GMS\5YO%E#SF5@9##9!KF4=P5D-.-@X+=["*V43(4OT5%M6<+DK<E*+
MHT:[EF-V+C-:D^#*.V'BZ$<G'X3R9F<)"CJHN0&LBZL=I.:!Q:*6TXJ6)4&P
M&M=SW\I8RA"3YZ?C2E3ACZ?&*I&4XK^9_.M">UESPQK648R4//L3]FRA$PWF
MLI+*;.=XN=I0[SJKVQY^RP\45>E:;V[N78Z6TH_EBJ+W?,VV=C;M2UI-R_-)
MZGWOX(OD?<-7?:GO,91@@QC0/Y!;JG8:<15$C14NB*B*M<F1VT9/"2$*$*W$
MDNB_@M4AS0"@% * 4!\I_=&JIN>&X^OZ4MOE?Z@[5*59Y6\^I=1LV)I^)'QX
MFEO")8R1BRCR5.UB<=:)PG5NB+<7%YC\K)7PEO?R_P FKL'^)1Y5C6E.''''
M ^@6WC';:.@U%KB(GVTZ@$TB+ +L #G%;O;Z%)CJ%SM^ZI(*K7Z/O/[LCY]?
MV(URJLN53ZAE?RT&-B?6_0#A@-GZ!7^S]*AWLRK2E[;_ -CC_17(>FZ&I/+&
MT8M[>\#K>7BR\CKN%1<MFH<".4LG)+HJ$5IP$Z<415-;^MZ''?FO,2>2Q^P]
M/$.Q-2-,V;351]LM>"4F,":VK$DL7)$S84VRZHHW45_HI6I-O):'#\N75P*M
MH:3/&VKZUY%@H;NHYJ*$?<H07)674<-MJ<"?AT%Q/]/H-5JMN,9K)Y_:8K_'
M_,WX_P#U!;ZF6P7SA=>"QUF/*"G;]Q5];T)_\4*_3JQ[\/O/HR>NN)%A'D5A
M)"%UI<84GM(RCW^XJPI=.7]CA_10]-T-18_^>$\L^05TK]-0[X[Z[]61]1_P
M"\.WV?\ 77O3$Y%J\R6BG#.IG^6CV)K0<&]G6XSVR!G<<;K,%3",XX+IJV *
M[U3DED55^-&+^I05<ZHC,I/V/R)Y"U_3]CQ#&J/81X-@YN24DS)+;*J*-Q'
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MCQ#F<=E]7?D9YEW%Z:HL8<VXI-Y&1CP!QMN++=1[MJ+0FB(H-IS444J$J3F
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M9BA<=?&)'3BVCKYJXX2)ULI$JDOXK5!+T(* 4 H!0"@% * 4 H!0"@% * 4
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#@ELEZ,%&RGF'QUALF
MYB,AGH[<YDE;>$4<<!LT]1,P$A1?AZ]/C6Z.WNR55$[8;*]..I1="XPIT7(Q
MFID%YN1#?%#9?:)#;,%]%$ANBI6G%/$Y))IT9DT,10"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!48,1W)0FGECD\*/(HH0?$5<_)R^7+X7JT93+H04 H!0"@% * 4
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MA24D31?5\T;$W+-*K:(WR*]O6N*_;C%)KBWEB=,)-MIF[JY3:* 4 H!0"@%
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MPJ2VO;'AMIQC>8P$YG)8IY21F9&+FT:@2B2(OX*EJ2A.#TS5&8-4)6H8B@%
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M,XEC P&< "-X-MAL,: H0BD801&^*'[D3C:W+K6U'B3G*<G*3JWF2]4P% *
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M)V3QRILT8XDEE]P&8S;W?:5L.@NAS"X\[JMOA\::NA$)8=<B *M@])%LD5"
M3%!5%]45$&UE^--70B'/\NQE+DLB4I(2FA*XBKS5+*5^/JJ=+_*FKJ!GP,>U
M $A;-P^2W5750BZ(B)U1$Z(B5C6H,R@% 4S.'NKTUXL1&5(I,NQ&0)P002(P
M_P 85;]5X\NVGP^-5$9U:<\@LQV8S<6.O:;X]]USF1V5!'DG._*R<B7XJM7
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% $2U * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!AS,I
MQZ<ITAJ,"JB"3S@-H2KULBDJ76C:69G"$IND4V^A5.8V2AS&^[#>"0TJJB.,
MF+@+9;+8A54Z+18X\"2BXNC5'TX'JD@%ZVM?TH8G*O@GSH!]0%T3KU2Z_@E
M<+(;O9+WH!]0"CR1%Z^B525/0"0QY)4*=J 4 H!0"@% * 4!$YW9L#K,19^P
M9!C&PD)&T?E."T)&7H(W7JJ_)*04IND55AX*K,R+D8DZ,W,A.A)B/"CC#[)"
MXVX!)="$A545%3XI4;HZ/@#RQN8QV8AM9'&/A*@/BILR6EY-F**HJJ+^U%2K
M*L71YE6)DMRV'N?:<%SMJ0'P)"L8_F%;+T5/BE2N-!0\8N4@SB?&&^$@HKI1
MY*-$)]I\$12;.RK8T14547YT;IGA4AX1=@Q,W(Y'$19(NY+$HPN1C)?FRDH5
M-KE=+>\454LM9.,DDVL'D#(F9*%CXKLZ<^$:$P"N/R'B%MML!]2(B5$1$_&H
MJMT68Z3V;?;=0%!;B:<@5/145+WJ5!ZU0* 4 H!0"@"]*C!JK:ON+\2Z9LAZ
MIG<WPS#"HDP8[+LEN,1(BH+QM"2(5EZBEU3XUU6]M<N*L4:YW(PS9L7"9S$[
M'C(V9P<MN=BI@(Y&EL$A-F*_+Y*B]%1>J+T6N>47%T:HS*,E)561(5#(XNGS
MH BHOHMZ YH!0"@.+HGJM <T H!0'"DB>JVH#F@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% <*MJC 1;U0<T H!0"@.$(56R+=: <AO:_7Y4H2IS0HH!0"
M@% * Z\PN@\DNOHE =J 4 H!0"@% * 4!T<541+7NJ_"HW0&BM^^ZG0=&R\_
M7QCS\MG,<ZL>6PPV++#;H?F%7752ZI_>BJ5ZNW]*O7HJ54DSDO;N%MT>9KJ9
M][AM/D#.DF ):XOS^#B+:_5$8Z5Z$?1)-?6NXY9^H1BZ-&7C?O=Q!J 9C4I3
M"*OO<B2VW[#?X"X#=_ZZQGZ'<X27P*O4(<4;^\;^4-5\IXF1E]5>>-F(ZD>4
MS):5EUIQ10T14ZHMT7U$EKQMQM;EB5)G?;NQN*L2+R/G'QKB<U-P&2S11<CC
M9 Q,AW8LD6([SBV!''NUVQ$E_*2EQ7YTCL[THJ45@^HCOP4M+-B-N@8H2$BB
M2<A5%1445]%NE<M3<=E,$15541$]::D6@(TLO%4Y6NB4JB%"?\Q^/X^Q?RLY
MF+Y?ZT,2J!'?..F0=6PQE?%M6D=5?W>==/Z6[IUTPI7AES-3O03T\2X8W,XK
M+M/NXR8S,"*^Y$E&P8N(W)87BXV7%5L0+^9/A6B47'/#B;$ZY',S,XJ!,A8^
M;,9CS<D9M8^.X8BX^XV"N&+8KU)1%.2V^%$FTVLEF&Z&8A@J7Y):U_Z%K&I3
MLBHOI5 H!0"@(_)YW"85H'LQDHN/:<51;.6^VP)$GJB*X0W5*PE.,<6Z&ZU9
MN772$7)]"J><C9==BN=J3EH;+JB)H#DAH"XFEQ6RDG14ZI6J6YM1=)3BGUHS
MAM;TU6,)-=3/2'G<+D2)N!D8LIP$N0,/-NDB7M=4%56U6W?MW'2,E+J:9C<V
M]VVJSBXKI31GH2+Z+>MYH.: 4 H!0"@% * 4 H!0"@-;^8VFSP.*7M"^ZF?P
MMFBX^Y5FMIQN5T2Z=+UHO9+K/HO0'2]<Q_\ AN_\C*.K[L-K:,WBC/ 2YNSX
M?'2\)&)&RC$T^S'=,E#VJLIMSG<$LH\5NI7K15^)K#&E/;F>Y"W&;L6KB5Q1
ML79J;X^&4DO_ /&U3OX%ZG),F>3V,*WDI<7%_HGZ@4:,\K;9/MS0!57HJ^X5
MXK;X5T2J[M*X4^9\[:4(>G.YI3GYNFK7!P;^)56LSFV-;Q$_]8EC,R^Q/Z_)
MF/.=T&(CT]X$,1).(N(+0LMG\%+K=:T:WI3KFZ'MSVEB6XG'0J0LJZDN,E"+
MISI5N37)8$WN$J/@<9LD3$YJ<UGH^#DSFH9.NN<.SU"6#AHJ70O85BZ_*MUQ
MI)JN-*GE^F6G?NV7.W%VY78P;22SSCAT8Y&-L<W,1=+F9)N5D8<XG\0+7.2+
MCA Z^P#Q,\;V%Q'"$D5?S)\*P;:MUQX&W:V[,]VH-0E&EW@^"E1/JI6IB1\A
MM<W#SGL++>R,9C/.HWA'WTCY5R!$;[4F+W50>+@O?Q0$EOV[(I>ZK633:QQY
MXFZ5K;6[D(W8J#=I>-1U6]<G6,Z<8Z?#*F4L:8&R=(R<+,:Q GX^1)E1C1P$
M<G(HRQ-MP@-MY%1%0VR%0+]E;H--51X&_L3LWY0FE%K\OTXJJ<>AK%=98*S.
M 4 H!0"@% * 4!JGS*U@XR8'/3<TYKV>Q+TES!918+F3A]UYKMO,R6 ;-%%P
M%L/43O\ D6_2NO:.5912U*5*XT[GT&,TL.@UU,W/;I&9U9!A3-5S*)@3D807
M)GTK\>8\(RA8AMM*PC8"1=Q9!\P].BCU[(6;:C)5U+Q8X<,L<^[,TRG)T>3P
M^\Q(4SR ]K63V%W*9QO+X&#@7\9#$G&V'I$J:\,GNQT"SRJV@H:*G0?ZZV3C
M8U*-(TDY5[E3J(G*G'(O_B8<;KF0\@L2YL]9T+-9&9+B3"?<!N$X?=:D )!8
ME=&Z\@NI6KBW=9J%*4TI8<^1MA@WUE'AYA"ES<ID,EE\%XRS^?S>0#.8IN3&
M=D2NU%;BJ9@TKHM$@O*W[;&X-EO9*ZYQ6E))2N1C%4?;7Y5-<4]3Y59X8:-O
M:%G]PR3V5@[=$8U$B99[C+4Q3/M/+*8%.+I]DOXH>@*J]$K9-V?#!4<:S[.5
M'PQR(M6>-</CB3V%Q68R\[5V=FDY3+X?:7=B9V7%9(W7X0LXV2;L%$:5$1JR
MMAQM;FG1;HM<TY0BI.-$XZ=+6>*\77\BQ3>?3]Q8_"&7R,V5GX&0R,S/E!-I
M5V-QR2L&2;I.KQ;CR@!8SS8\4=:;Y!^6U:-W"*TN*44_PX57;Q3X/,V6ZXIX
MFY$)"2XK=/FE<-38$(56R*BK2H.:H% * 4!%;/E2P6N9?."B$N,A29O%4547
MZ=DG+*B=5_+52JT@?D_C)+^;RYY3)O&]-R+Y2ICYKR-QV02N&2JOK=5K[;:0
M5#Y/UR].-N*54I/$^[_MAS Q<'*U%3(FV"6="L-Q;;=MW!)4]%4O<B5Y'K-C
M%75QP9C^W=RZ2L/\.,>I\^FO \];\E;C-\LY76]VV1=7>:GRF,!I#N*!&,KC
MFVE[+T?*'U)TU]_$5]4L@]>GDSMQ4*I5PSY=A]:GB>&N^=<@NE:]C</B\UN&
MR9'!S\].G.+#CRXN/CRGHPR'4%4;,^X'%MMOJJ"GQI*SBZT2K05,;3/N SN+
MTC684O Y#<]I>U5=MRN09>C1Q^B:E/,NFX3O'W"+?1$3W+9$ZUE.PM3HZ*M
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MV2MJ/HJ.(*HO3UH6A /?=7X6<TO-;OAM@'*8_"DC#\=J/*!]9;P.'':4"9Y
MCRMD(ND/!/WE2I4$WX-\X:SYSU--AP8+$R491;S.(+N.%"><4E;;5XFFA<Y
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MHNOGU&N<G517$BMIW*3X?Q#<23D2V<D"1/5<K*X90HC*(O:;&+&/G;W?Q74
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MDMW%4[?V;4=]UKTU)0RLK]O.KYL)K62R$PV)F!QFN((*V!-#AG4?CR0+BO\
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MA)^[0$MDO..J8S/3<(8//GCCD1'Y#"L.&4V'&*4ZP#'=1[\H*(N*"-J?MO\
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M*]E[&W*XHXQ3U>*JDG189>]'F?JYJWJ^IX84<6L:<?<;^B/OR(C#TB.45]T
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M-<AZ ]'%1NV?KT2U91:4LN#S1&JDONK&RZ5N'D[/:KE\Q-SN(US#2&/J'$E
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'"HBI9: "*"EDJ('-4"@% * 4
MH!0"@% * 4 H!0"@'K0'@U"BQU<*.T#).EW'2;% 4S7]XE1.J_BM1JI:GFSB
M\=';5IB*RVT1<U;!L!%3O?DJ"*)>Z>M45/9([0FK@BB.JB(3B(G)41;HBKZJ
MG6HU4AXLXO'1A4(T5ED%/NJC38 G<_M>U$]WX^M4'=N##9><DLL-MR7K=YX
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M 4 H!0"@% * 4!U4E141$O>@"%=;?W/C0':@% * 4 H!0"@% * 4 H!0"@%
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M=%ESQ.'];%3TRI'K>=<L#<'="]K]?E7GU.\[IU2]4"@% * 4 H!0"@% * 4
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M&<%FD;SY)/Y'U1K'GK3MIQ&1V-(N4PVK8V-]6_G<O!*+!(>2!Q:=0S[AJJ]
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MKME*6B,52F6'B[>*,/+LWFXZW)UKVP?5^&1,9"+HV%W"7LTN;V=Q7%,XV;-
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M;!LDQO&X."*'-G2.C30DJ BDJ7]5)$_IKF2;=$9'Q[OOVW>+/+V#R'E7[?\
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M,8F.ZC7)6[DJ\R^/PK+4J+H#S/+)^&@FY&!,')HRQ&BX^%)CHPB]QN**M25
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"U * 4 H!:@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MZ3Y^WC$)-SK'E#"K]5I^9E,3'WFK&6/DJ0J]&E"/5M0)%X*J<2&UJT_M[?\
MDVO\9N/#N+"<5J_^6"^FY!_BJOJXQE5/A7EW=A3O1W<,82IE^'HET\N#+)FM
M[T[/[)Y/UJ;DOIM8W/(,3L7L;+1O-L28)J;1.M"B.$RXA*)*(J0^J(M>U;VM
MZ$+-Q1\5M.L>OYDO;NS.=RTWA*F/55D7K^:Q.@:WG(63V+%;$Q+B3(N)P&/B
M)*4Y4UKMC*>E2(P$T#7YT 3Y*OP3K6V];GN;D7&$H4:JV^7!)/$YK,X;:U*,
MYIIX))88]F8\C>7,E_,G;U')Q)6#9Q^-8;>/'0WR5QF"RVZBG)8)Q50T).J_
MLZ5ELO3H^56ZFI-R_$^;Y/D:]]OVKJ5N551<%RZ463'[/ VSSKXJR,.4$N0Q
MC\)$R9-M]@6Y[+9]YM XBB<57T%./RKF=EVMG>36%9TZN!U0O1N;JVTZO3&O
M6;>WO#['$V?R63. /,R=A#&O80G( 92#(CPH:MNQ'S(Q^F1'/?=2%?WAZUX=
MBY;E"U66E0U:L:/%X27,]*[;FI7**KG33555$LF0(8[S"YCL@^X6;:W$HV7*
M0S$:?&*0.L6AM@\;_9XB7'Z=&&^XA(2%\ZWN6VU+".CP<M6?BX5_FK@8*.XH
M\]?BZLL.[AQ,_,8'R? S$1F.F9/3GX^$D[%WCE3>4A67DE>QMP7E3N=OO@R2
M?.UNE80N[=P;>G6G+3DN*IT=52SMWE-4KHI&N;Y\,^61ZX+#>0TE9![+.[%D
M&<7K1R,-!<EKCGW,B4J0C(D*.N6=1M11ON\EM:Z*72L+ERS1:5!-SQ=*X45>
MRN=#9;MW*NKEA'"N'%]? BHV"W_(Y/#-R,3EWL,QGM6S##<MF3V(WTJ/C/<4
MYKAN(2*0=PELA?F042M\KMF,9.L=6FY'"F-::<L*9T.?R[LFE1M5@U7A1^+,
M^K6' =:[C9(;9*JB8JA"J+\45*^91[Y3]>_[1MQ_]3PO_BRZZY_V8=<OD<\?
M[LNJ/S,+RAL6K8IC"8';<-^MP-IRC.'9C. VZT#[W4#-'/@B_$>M9;2W<DY3
MA+2[<=1AN9P2C&:U*;H4M_>/%>+RFR>,/Y5 &='A.;"D 6&1BO%!:&011QOU
M>03NBE^/7I77^FW$XPO:_P"X]-<:JKIB<_GV8N5M1_MINB7))_,S,_Y(U3N:
MME\9J#VQ;GNV*,L;!:%EN5^E=KONMO/N+Q0415]B7NM86MI=\<93T0M2Q>.=
M:5ZRRW-MZ9QCJE<6'5F1N0\C:#B],UKR!!T"9,P..;?6(]'B,-N80F'!:-LT
M<,5;N2^WA=%]:V6]K>G=E:=Q)NE<7XN/M4D[\(PC-0<DN5,'EQ9[9/:]#^AP
MWE/9O'CT7,SLK%P^-=GQHRY!2?#DS)Y<E16T1+"2KR2W2I"Q>;E8A<JDG)T;
MT]*$IVZQNSMTDW18*N53$\C;7H\?=6\+M'B:9L.>GF4;$Y H421]>,8$,NP;
MI\E0!+Y=*SV=BZ[.J%[1%9JK5*FO=3M^:E*UJD\G2/S+0>X:;%VO(XUS6B8S
MVNZLF5<?)MI'&\8J76$"HMT5+V4?RUR+;W7;34O#.Y3CGS.UW(ZG6.*C7[B*
MD>8=;T70]?V?$Z9D1TW)1AEM+CVF!CPED.\1:<3F*"1F73CTZUOAL)WKTH.:
MUI\:XT1HGNE9MJ2@]/13"O:3>=\T)KN#P&4R6HYEO);%-/'0L$H,I/1X;J-Q
M[G&QV]ONK7:V7F3DHSC2"JY8T,Y[IQC%N$JR=*85^)==3V*5LN)#)3<+-P$@
MW#;_ $_)B 2$0/0E0")+%\.M<=Z"A*BDI=*.JU-SC5IQZ&3U:38* 4 H"E>1
M_*&J^,<(>8V61P(^0P8#2H4N4Z/[K0+\$_>)?:/QK?9V\[TM,3EW.ZM[>.J;
M^\^!?*WF;:/*^45[+.?28%@[X[!,DJQV43T,UZ=UU4]2+I\D1*^JVNSC96&?
M,^&WOJ,[\L<N7+IZ7[C7"J/K>NX\=LN/CC4H6T9HY.:(VM2P;*Y/8Y ="^E;
M)!!EM?\ RDAQ19!/FM_A7-?N25(Q^J6"^;[#MV]F#_J3PA!5E\EVO L.>V"3
ML.7FYF6 -NRW$(([5A;99 4!ID$^ - @@"?)*]6S85N"BN"]GVGRNYWTKUR5
MR6<G7Y)=BP7O(WN*?L%%YET"W55+X(B)\UZ5NHEB<ZN:\#Z)S$$,0N-UYE;M
MX3'Q81?^L*'=?7]O<-:X-A*L'-YSDWV9+W'T?J<--U6XY6XQCVYOWF7KNWYS
M5GD/&/7B*J*[!>N3)_L3]U?Q&FZV-G<+Q9\^)=EZE?VC\#\/Y7EV<C=VI^1L
M%LHI&!5AY?U. ^J"1+;KVR]#3]E?'[OTZ[M\7XH\U\S]!V'J]G=/2O#/\KS[
M.?87)"Y>B=*\T]L[4 H!0"@-1_<CJF3V[Q/F,;B05V8SPE RGJ?97E9*C.+>
MVG<L2BO:F)\B?;GN,34,^\]LF^N:GKL*2V_+UUUAY]O).(A(0J@H2-$"B/(N
M-UK%9GSWIEWRZZIZ4OPLK?EV?+V_=H^.PVY/^08CR*.&=[3K"1N^X7^+"T:(
MB<10>1HG5/6HS3ZA)WKJ49:ZY=!^A_C3"2-=T+7\-+3C*B0V6WD_OD%+UFC[
M"U'1",>22*+]N96PV]"?11W7.71?5%5QOHM2)P[#Z9_SR*^UE]I9\C0-8P.9
M7&8K9=BV<,B@QVGCO B,NB;9&BV)"54^7QLM.)'*2FHQ=%*4J]BX&+'WS>V<
M#BFG\ZKTF)Y#72,E/6,P+\[&H^K8F=AXMNH/J0)UJ5?O-:W%Q06/X]+Z56G>
M92^0MMPVN[=KF8RSLC?-5RTATY:-L@;V#98+(LO]H0X\#C@K162Z&OK>CK0S
M5^24HR?BB_\ TY_# ]SS'F(<,QN428+>"FX&5D<DY+.'(;8DK#63#>@M *%;
ME_#)MQ50A7EZU:M&=;SBI)X-=W%-?88O\Q^2</J^J;]F\OD<]J6=@Q)NS1<-
M#CC-Q0NPQ,7F$!%-QI72N_T541+^G2F1I5VZK<+CK)22JDE557#HYE6\E[SL
MT_"Y?&XW;UR>N2=&+8(V1Q[+<0GY*91J&I*8BAHAMDHF'2RW2I4T;N_-QDE+
MP^6Y576;-S&;SGC[;M'D97-OO^.LQ'/$Y#ZD642-E>SW8KKC@@*\'1$F^/HA
M(BUD\SOE.5N<6WX6J=3+SX^>SDS76,GGGW'Y63<=G, X@(L>(^:E'9]B)?BW
MQ557K=>M#JLN3BF^);*IM% * 4 H#3GG+P) \PM8^8SD5Q&PXQ":8EJWWFG(
M[A<E;<#D*]"]PDB].OSJ'E^H>GQW45C1HTE_W(,ZO5=OB*J__<;G_"53Q/\
M^/R_[GN^\Y_[D&>_]\(G^1N?\)0?_P >?Y_=]YL3QG]INI:PWD"WQ(VVRY)-
MI#4VG&68[3:+=$'GU(E7JOR2I0]+:^D6[:>OQM]%#!\E?:1B-FRL25HLB%J>
M.9C*S*AC'<=[SRFI=R_<3]U4&E#'=>D1N/\ IM0PQPS]Y2/^X_G?_>^)_D;G
M_"53S_\ ^//_ +GN^\RL=]D$U)K'ZMMK)XQ#193<:(0O&VBW41(G%1%7TO\
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M)QGNXZ3H-&C0J/?<Z$-U7VULVMNS&XW&57B2Y<N.*K'V[S['\7HG^;C3K?\
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M9O5)RYLSBJ*A+5B44 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% <$0@*D2H(IU55Z(B4!RBHJ73JB^E * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'%T
M7HBT!S0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@(+.[EJ^L/,L;#F86+=DHI1PF/@R3B"J(JBA*E[7K7*<8Y
MNAV[?8[C<)NU"4Z9Z4W\"4Q^0@Y6&SD,;(;EP9 (XQ(9)#;,%]"$DZ*BUFFF
MJHYKEN5N3C-.+6:>9"Y7?=,P62_2<UGX$#)*@JD.3(!IZSGY5XDJ+U^%:Y78
M1>+.NSZ?N;L-<+<I1YI-K#,L/<"R+>UTNE_E6TX#E"$ORJB_LH#F@% * 4 H
M!0"@.%)$]5]>E2H.:H% <(0EU%;I^%2H.:H% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4!$[(\V.#R0\D5SZ9Q> ]2L2**=$Z]5H#(Q$R
M-.QT=Z(XCC2 (*J72Q"B(J*BV5%2A69U""@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 4KR+Y*Q/CJ%%<F19&3S&4=^DPF#Q
MX=V;-DJGY 'X"-TY&O1+UJG<43)*IKQ/*/G&(?UTWQI$D8X.92,7C\N#V5:;
M1;)85'@XXG[P!UKB6^M:W#5EEX6J\^[J-KLR23-JZ/N^ \@Z[&V;7'U>Q\A3
M;('!5MYEYHN+C+H+U%P%Z$G]*=*]!/F:2QUD04 H!0"@% * Z.$8VX#R5?FM
MJH-3-_<?XWF2Y$'"ED\W(BGVI"8S&RI" :*J6)> HE^*V^=JT^;%Y8GLKT?<
M43EIC7G)'5[[D/'<.,D[*,YC&XY?_MV9BI33"7+CU- 6W7IUIYJXF2]&OR=(
MN+?)21=C\@ZJSIX;[(R -:DXR$H<DH.<>RZ2 !<$#GU542W&];4TU5'D7+4K
M<W"2Q1ZX7>-?V#-Y37<6^;V5PR-ED05AX&VT>3DTJ.F" :&/N%0);CUH84,$
MO*&FM9#*8N5/6'+PS\>'DUE,O,,M/S206![Q@C9=R]T(2M;JJVH*';"^3=-V
M'-L:_A<A]9DI$1O(MBVT]V_I7A4VS4U!!3D*71+T%#C)>3]+Q&6RV%R&0[,[
M!QVY>516GE!AI_AVT4T!4(SYAP ;DJJB>M!0QX_EW0I4_$XMO*\<AFE((4=Q
MA]LT=!TF%:=0FT[3B."H<'.*W2@H>4?S'H,R/BY43(FZUFYCF.Q7&-(Y2)+/
M!30![=^(H8^];)4J*,Y_SR>/5;R!MY573QLD8+[#4>0X\Y),W&Q!AL6U)ZY-
M.#=M%3VK\$I449DQ/*FB3YHXR#F6962<98DLQ61=-QQF6RY(9($0/<A T?IZ
M$G%;$J)5)1DOJ>VX3=<2&=UYXY&*=,VVGW&78ZD31<3L#P@5D)%2]O6A6J$Y
M0@H!0"@% * 4 H!0"@% * 4 H!0"@% :R\ZXZ _XSVB;(C-/2V()*P\XV)N-
MW,47@1(JC_17%O$O*?MR/I/VW.2]0M)-I.6..>9A^/\ :,1IGA'7=@SKW8QD
M/%LD\:)<R555! !_>(B5!1*6)J%E2>21M]4V=W=>K7+-I5E*;_UZD16LSM@W
ME<CN^S8'&8K!R\>ZYKD&2PU(RCG:]X27''!541!_**(B=4_!5Q@Y7$YR22IA
MSZS=N[=C9RCMK5R<[BFO,:;4%SBESKQZ.ZJ>)O\ .EN>A/[ACMXE_P P-2WX
M[6-R+3,K'O\ 9$"0#N"&'/E;DA=*T[;S;EO4I8])Z_KJ]/V6\\B5A>71/5%R
M4E5YYT?50VOX=S>T;'I</.;;8<M-?EGV$:^G[++;Q-@WPLB].*]2ZUV[>4I0
MK+-GRGKFWV^WW<K5AUA%1QK6KHG7WFPJZ#Q!0"@% * 4 H#1WF[:]@>V#%^+
M,#+<PK&<Q\G*YW/QB_QYO&0W6F#C0NBH#[Y.H/>+_!A<D12M7#N[RM0<GT=K
M>2ZC?:AK=#0><+[<M7RLG 9_)0\;EX2B$F"_DLR3K7($,4)1>)%7B2*O6O*@
M]Y.*DE&CZCI_I+#$]M?B> =RF.8?4<HW+S*,N2 _2\KEFIS -6N^R;KO!#;5
M4(;HO7U14K&Y/=VEJFHZ5G@C*,;4L%6I]'>#]QV7.1<_JFVO!D\[I\J/!+/M
M"C*9*-*CC)CON-(EFW^V:"\(W'FEQZ+7N6+BG%-<4GV,X;D=+H;7Y=414M>N
MBI@=JI!0"@% * 4 H"GY_P AXK6=RU[3LO'?8<VE'V\-E50?HCG1Q[BQ#/E<
M'3#W-HHV.RHBWH6A.X?/XK/!(<Q,MF8W%><B2#8-#0'V5L8+;T5+UC&2EDZF
M^_MKMEI7(N.I*2KQ3R?42=9'.* 4 H!0"@% * 4 H!0"@% * 4 H!0$;G<JW
MAL5*R)V56 50!?WC+H*?TJM 0NC1)*X]S-9(%7*9(U<-X^I*S_N:)_9'XHB4
M?04M2(B75$1+]5M\5J$"DB+9?6J!S'K^'KZT!V145$5/1?2@% * 4 H!0"@.
M%5$ZK0!%1;V^'1: YH!0"@% * 4!%[!L>$U7&EE]AFA QH$+9R7;\$)Q;"GM
M15ZK6ZS9G=EI@JLTWK\+,=<WI7,P]9W?5-Q^I76,HSDDAJ"2>SR]G=15"_)$
M];+6=_;7;-/,BXU->WW5J_7RY*5.0V;=]4TU(J[1E&<8DU32*KW+^(K5E*W%
M%].25;&UNWZ^7%RH3<;NSMZ>9)1KS,O [+@MHQH9C 30GXUPR;"2TA<5,%L2
M>Y$7HM:KUJ=F6F:HS99OPO1UP>I<R/V?R#ING<!V3,1X+SB7;CF2F\26^#8(
M1=?G:MNWVEZ__;BY&O<;RQ8_N342(P7F7QKL4P,?C=@C_6NKQ:8?YQR)?D*N
M(**OX7K?=],W-I:I0=#GL^J[6]+3":;+-L&SX'5<>65V&<WC\<+@LE(>0N*.
M'^5.B*O6N2S9G>EI@JL[+]^W9CKN/2N9CZSNFK[BW)=UC)M9)N&0MR29Y6 C
M15%%Y(GJB5G?VUVS3S(Z:F%C=6KZ;MR4J9D]7,=0H!0"@% * 4 J,&A-E)"^
MXM&\N;:.#J#AZN+BH/\ %^I5)B@JK93[?K\>/X5Y7J$?!)T^SH^?:=-ATDNL
MGT>=%W@X=D11%I!NJKR6X(EKK^-Z^(C-IM-\NWQ>$]QQ5",\,&RGD7RX&+M^
MC#EH2N<+]I,L49?KD!+JB*A<>2)\:^_V^O2M6#9\_.E73(W?7<:A0"@% * 4
M H#H?YPO^-5$/@W1L]GM?U/9,\_K\N5K,7(#$2><UF/'=-'W1XM-OCR+BI\E
M%I"1$156O.LR:CD?HVYMPNW80U+4U6E*O)<>!:<_L&W9O7-O8QVN2)I8B%'D
M2G(V3CNI]/.:%\'@0!1PQ[7N7@/X?.MMR4G%JGO.2W:M6[EMN:6INGAXK"G)
M8X&QL),\>1_ 'CMOR8/>P$L(3$:.0O.-NS3%Q&Q<%E4513W+[NETO6R,E&";
M/"W>VN7]Y=5M5:;?8;#*1X_\6Y?$XI>4');<Y%P^.%4>D=\L<T+##9$O)!0
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M?=H((,;)MO3V1>@/CPX,S6V2<3CQXO G(5Y(MQ"1#R9N>M;AF-VV#8)+_C/
M;[D]/V. 8@K$/&RH,4\?*51;YHC$IU6S7DJD+@].E4&1CL_Y2F>3\3A,Q/S2
MLY777-OE83&28<<H"R,RC3#1+) 5)IF,H-N-W4E+DM0I!->0O*^0W/-Z_K&U
MG%SCVQ;=A,.WG6VEPS[6-9$H$6.[PZ2P<-"LJ^YODJH7&U"$SA=YV+:=J\>:
MM%S&QZZ>4RNRXC=,/D'X[V1A3\3BV):1@E"T0.-H1(ZT\">X'/AZ(!%Z]Y)\
ME:WJN/\ )LC,2MEQ9[)F-.RN#G&SQ4W,@<+#RF2 &U%6G1;:D>Y>8&I6Y#0&
MS2WO;]2B;'K;#S.P9[Q]A8^?V?(9ATF7,B4L'Y!M0T9 1;;$8Y@+ABJ(JB*I
MT(J# Q8WD[*^1]!\D2RA+CL3C<9D$QAB$AN3=,<W+:)QZ_;%T4>3DV'N$AOZ
M4*57P+L&>W4<5H4_.3\- P>BZQEV$C.H.0RDS/12>E3RD.HX9 R=F^*7'F5R
M^"4H2I!ZMY9\G!M\B#G<T<V/*E[)XZP\U&VV,?*VO$.-N8Z:H"%F_J6G"9<!
M"4$=9(D^*502D7RCY)V+21SV%R3L7R#'QRZL[A7&$=B_SCC3?<R+ILB!'[6X
MXBB6XIWQO4*?0?C7>,=Y(T7!;MBQ5J/F(HO.1BZFQ(%5;?8+^^:=$VR_$:IB
M6J@% * T_P#<PMO%<LK7M,A?^F2O>]"7_P"6NI_ ^<_<;ILI/IC_ ,R*3]I]
MO_GL1$_?A?W <2O0_<?_ ,?5+XG!^VLKO6O^4[_=G9 U!52]W9J?UBS5_;G_
M ,G4OF8_N9I>55<7\CT\<[?_ "+]N[^P-HCDYJ5+9Q[9]4*4\^H-HOX(J\E_
M96OU#:_J?4?+X4C7JIB9^G;K]+Z9YG%.277J:1J'0M%V#R]L\YV1.)"%$E9G
M,R1[AH3JV0 1%2YEUXC>R"E>_O=Y;V%I)+H45\3YW8[.YZA>DV^F4FL57@O;
M!=9>=H^V+88APQUC(MYB+(<%N2LP4BN1K_[K[55"$?BB>ZO,L?N*W)/S(Z:<
ML:]!ZVY_;EQ44):D\ZX-=*IR+=YCP,S6?!D+ Y#*/9F5"FPFSR$A$0S]Y*@I
MZKQ%/:/)56WJM>?Z3>5W?N<8J":>"/0]7L.UZ>K<I.;4HXOK/+[3?_D;MG2W
M^.QT_J:*MO[B^JW_ "OXFO\ ;+K&[_/\CZ+KY,^Q% * 4!5I/D'5XNWL:$]+
M,=LE,_51\?\ 3R"YQO174<0%;X(J64E/HO2KHEIU)8%Z#QD>3-.B9/,XB9DD
MBS==CI-S:R&GF68L8T50<-XQ1NQHB\>)+R^%7RYM)I9Y$P,7#^6M*S>4QF&A
MRWVY^; W<(,N%+B!-;:!73)@WV@$K G*U[VK*5J:3=,O=UD4D=,YY@T77I62
MBY+(FI87BN;=B1)4UF"AIR'ZAR.V8@MENHJMT^*)2%FY))TS]_424DCIO_CC
M">4<?C)Q3'<?F\4XD_6MBQZHDF&ZX'YP5>A@:6Y@70D^2USRC5-/C@S.O$H[
M'C?S?+-R!-WG$0X!W;7,XO%JSENU:RJ/)>V#A?VA]/A7FQ]/M0:<51KVP-[W
M$I)ILGL3D/%W@YC%>.67WX,N6CLJ(RL67-E9%ZW.0^3K+1]UW]YSK[4MT1$2
MO75F<_$L:=78<[DD7##^1M+SN*E9S&YN(>)@N=G(2G7/IDBNHJ#PD"_VR:)5
M5+(XB7^%65N<71H)IEG D,4)/1>M8(':J!0"@% * \W+HHDG6WPJD/D/2-MF
M:D]G?%.4;A?68*;D"^BFM*CKC3A*X,MAQ444Y(ZBAR5%MZ5S1?X.1]ON=O&]
MIW$:^)1RYY4:Y8%EW7RB>@X][!S($*%EIPE+6,"66>!,B+<=L6A4A,U2R$J]
M%].E92N**./;;!7Y:TVXK#J=<V1WFC7I^J_;YHD.<TXI:YDL5(S'$>1,"HN$
M?*W]DC0+_.M5Y-6UUFWT^]&[OKK7XU*G3BO]3-\L;EKWD#R+XFQV@Y:/FLHQ
M/DY'_$B[R,-JR"MN.JET&RC=4+JENJ5C<DI2C3'$U;';W+%B\[L7&+26/'/[
M2*^WS9O%>M>/<WA-^D8_&;;'F34VV+F0#ZI]5.PW%P5)T;>W@-UY7Z=:6I14
M6I9\3=ZK8W-V_&5E-PHM.G)?81TS :SY,\YIC\!E96,TZ7I;$B >$+Z)7(S*
MHC;5N-Q;$NJA9.HV6JHJ<VEE0VV[L]OLZSBI35S'5CCSZRFZ5O>\!'TG)0LC
M*R>8Q^$VH8+#CANH^4 '585P%54<5I%Y#ROT%$^%:HSE58\SMW.UL5N)I*+E
M;KWJI?/&KGCO$X3!>4<EY%RF2W1['SLEF,*F3YN3WVV#<>C%&6Y)VK+Q1;<K
M(M;;;26K55GG;R-^<Y6(VHJ%4HRTY8X.O3Q*5K.=S>&V_0<_JS\R(FTR'FOH
M9VQ!FW)K+PJC:2HZ ':+DJ)U^/R5*TQE1IQXGH7[4)VKD;E'H5:J&FG4^) 3
M\]B3\89G-9#=-B9\X/276LSB%=D@/9&0B$#K:(@@T(6+GR11/VHE2OA;J]1T
MQM26X4(VX>2E@\.6:Z?EB;#9/#[UM6U8[RIN\_6&M9QT'^5X3<Y80(P4,36:
M/+_#&2\25$]Q<OZME5)O4Z4/+>NS:A*Q;4];>ITKQRZ%P*?N+^2\I:'X'QOD
M(WIT7-;;)Q#TP[MR)>.(>R#RJO7G;HA?&W6]=%F3<<3PO5K-NUN91MJBPPY/
MD>.T?;]Y,AZIMD+RCFG,IXU\3XJ>YX^1"0%GO2&B<9==LJK:,-@(27HJ<17C
M6X\BI6(>7SVS2M>TW..2_P"7<-I6*F:S C;$SJC*N2&4)[(=Z1[9!@:J/!%]
MMOPJE+6UF=EW+/\ BGQ_YSW=W%:5*P<R>69Q>6;:C9F8P^X$8G<@R7!3%L1O
M[KW1?0BH0I./RZX[.;0NL;3-RT![R9KL)O/?5$,C(0^W(%$>>;4>ZA(B"I+T
M.UZ%-G>-DU+R!D,EOWESRAE-:\G0-L<@MX8,M^FA"9:E"VQ""(?^YNHO%3MT
MOU7HM0%)PN2V79]LU/7Y.SYB UE?)6S8R5(A3G6Y 0T;:3LMD1%Q1$51'HO&
M]TJ@XSNR;EXZQ/DCQM@MARSFEXS=\7A79\B>H3(N,G,O&XU]:XB]A'S 0)U4
MLEOQ6H#>7VQM[3BO(&T82));3QS]#'DLX)W98NSRL?D2)$YHZRJF+;X<ELO2
MZ?LH1GU75,10!>B4!K9[R?*8FY9AS&MI&Q6Q1]?<>[I*I,O1@DG(XH'J(FB=
MOX_.A:'HYYEU-UEB=CWR>QR.$DQQQB2TZ,?Z$L@#K;:M<C0V15P;VN*+\4M0
M4,V1Y<T2-)9B.9)5>?,0:0&73NABB@?M%?82KP$O3ET^"T%#!E^9]/7'/2\7
M))]]()95@)#$B.!0D+B+ZJK2FC1+>QH"^G[*"AE,^7=147?K2DPC;DY&$"/Q
MG$[SN'M]1VN*%=.OL1?<7P2_2@H2>=\A:QKLKZ+)2#&4(M*\#;1N=DI2'].#
MJBE@)Y6R%M"7JJ5!0\,#)'R-HH3\W!2/ V.(XJX]5)22')14!#4Q&QJ"HJV2
MR+Z4:JFGD;;-V=FY&<'246FGTHT-MGB+R9C-:@:S@!C9^!KDU<GJ^61](V1B
MHA*9QW&7$X.W+BHJ*^J?+I7D7-M=45&..EU3XGZ1L?7MA<W$KUVMMWHZ+D:5
MA+AJ3S737AWF)G9&7\B&YNOCUU,=Y'_37,'NFIN<6IQ,F/$S8!WBI*B)[;=;
M<?0DLN-QNZ]4,)4I*)MVL;6P7Z?=+5M]:N6;JQC7@I4R_P!>!LSQON.J:GK$
M#4L+A,^$R&*([CI&*D),)\U4G#,T'M*I%?KSXHE=EB<(144GW8GS/JVTW.YO
MROW)VFI?B5Q::<$OQ>ZIN5HU<;!Q14%(4)0+U2Z7LO[*[CY([T H!0"@% *
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M!3I54HHUO;;IQT:EIK6FN.?/,Q,=L7@O#2H<S#XDH,K'=Y<>\Q@LDV;"R?\
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M)#>.;=DLE,%E\T;=:3FK'>&Z$5KT!9= \H^.DAZ1J&*DR87\R8@I^JQ\HO\
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MM D[3 V]_'..9+$JRYB8I27_ --B/Q6NPRZS"Y]@#;;3B)"WT_;UH*E*\/\
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M'X=>M26ZNMIZ&J9?3]H5N*XKWF/JWCYK47X:XV=LKV,@(K<'#S<JDF"VWQX
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M2TF''Q[9(:1VK+T%21%5512*R76N);FY<P<=*[,6;G"*R9?U5$]5M5,3F@%
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M)4JZ5-TK%N4_*AJUITKAI=/JPS2Y'D/F?'/@XU#Q4V9DX@27\G"BN1GTCL1
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M"@% * 4!4O*&L3MU\=;3J.,FICLCG,7+Q\682J@-NR&B 5-1NJ JK8[=>-Z
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M+^A.GKR[>QY;<I8R9]/ZYZ\]["&WLIPV]I)1B\W19RZLDNW,VM76?)B@% *
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MJ:4#GBE-*%3A0%?5*M$#GBB>E* *(JEE3I2B!S5 H!0"@% * 4 H!0"@% *
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MW0FSLG(#$D^/K0M2OIX/U%J/%2'+RT+,QI,B<NR1Y[HYA^1-;!J03\@N7-'
M; 5%1LB /&UJ4)4EM1\5ZGI&0_4L W);?%B3%:23)=D@VS-DI,>$.ZJJG-^[
MJW7\Q%\Z4%2'=\$:5]&SCH+V4Q<(8GZ9-9QT]Z.D^!W7'48EVOW!%7G4%>A(
M)D-[5*%J9<SPSJ$F<LAHIT/%NNQI$S78<MQC#RGX0@#+CT4>BJ@M-(2"J(?
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M30M+2-](F!A)'^M3+"VC 6'(I_\ ;(]+B[\W$]R_.@+%0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M2\0P818:MHCZFVZV[W>:>T@7U%05"142O.O[>=ETD;5)2R+S7.44 H!0"@%
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M.2_]*]0%X\,X_P"R%WQ?K3GDQ[%CO91B7-"^_D =1[O'QY(RO!%X<?2H"/\
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M:_.M<[<9+$[MIOKNVE6#^[I7)FJ_\S.9)<1A7HN+7 X,CEQ9S$9V/.%]'.X
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MD5',?3_P+05.1)"2XK=*%.: 4!HG9?(^>ULW?%NAXX<MY6DN3W\9$?,&8L>
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M5))4\3K_ *<@HKN,C7/&D/58+>,Q6=RXX&'S3%8UV0+C<-'$)$$"(.9BW?\
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M1XSS<>;(C  &+)?1R9$=%$R=)7!_@BI^T>*E:@,'1?*N:VS%9LWXD)G+P,7
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MZU=1%N&X2DH_2Z<<>E='(CX_EK'$1G(T,FVCEME'CH[D%D)BNZ2O.NHBJ@N
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M(3(."BNI()%1M1OU1;VH2AX#YM\?OFS#A294[-2$FHWA8D*1(G*YBS$)37
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M5TZJ2WH*G. \9XW 3(4YB6Z\_CE082*#+(HR+#D<0/M *F7%Q5(RZDMJ(-F
MUX=P<<A&/+>&,K8#(;)MDS<<::)D7.Z0*8>TO<(K8E1*"IFY3QE R+:@,YYI
M2C18;@F#,AHVH;3C0<FW05.5G%)"2RB75*"IRWXPP;+>/ )$LRQT\<F#CSG<
M-TD:;:5IU5'WMEV6S)%ZJ0I5H2IZ87QKAL+*D/-FK\-UN0PS"<;:$0:FFKCP
MDX((XY=55!YE[1Z4!B_YL$<@)BI>PY)_&Q8KL+$,H8-%%:>1!52-L45XA$4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@.G=%4NG7X5CJP*.Z/
M_@I4'>LB"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MFD(6U,4<*_$+I=;>MD_"@,:'DF9;9.$VY%L\<<1DCVB,FR5+@BKU$K7%?BE
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MD2Z7Z=*X-CZQMMZVK,M3CG@U\3IW&RO6*>8J5)!K(QWGWXS)BX]&5!? 212
MB'DB$GPNBUZ,+\)RE&+3<<&N5<JG+*$HI-K!Y$2&[:X[DDQ+4M')Q._3B "2
MBKGI;E:WK7CQ]>V<K_D*59UTY//K.U^GWU;\QQ\-*E=R?F_QQAM[9\:Y3*E&
MW&0]'CL0"8>42<F"A,HCJ H>Y"3]ZOIHV)N&JF!YCFDZ&1Y#\Q>/O%?Z>F\9
M7]./*(ZL(!9=?(T8X\ULT)6MR3UK&U9G<^E5*Y)$EL7D74-5TY-]S>02/JQ-
M1WVYJ 9\VYG'LJ("BDO+FG2U2%N4YZ5F5M)5*-+^Z+PQ QN,S$S..L8O,H\N
M,E'"E<'DBN]EWC_#_=+HMZW+:W&VJ9&OS%TFTI&:Q\7%NYI]X1Q+,<IKDN]V
MTC "NJYTO=.*<JY55NG$VFK8WW0^&)F&G[!&SKAX;&.QX\Z7]'*06WIO/LA9
M6D55)&S7HGPKJ_2W:I4S-?F(V)J6X8+>->@[3K+ZS,'D4,HDE0-I31MPFB]C
MB"26(53JE<TXN$M+6)G%U52L:WYQ\;[;N,G0L#E"D[3#*0$J$L=YM *&7%U.
MX8(*\5^2]:W2L3C'4U@8J:;-BUH,Q0"@/-YWM(BVOZ_%$M;KZK5!KC+>5H!2
MEB8%ME]L30'<O.D)%QXJ1( D)(A&Z-[W(10?CR5*YI7\:+O>1Z]OTR;CJG5=
M$567W/VH5[&>9LD[(09D&%*3N$V3$!XFW_8ME)$=Y"0].GN'E=*U0ORXI/J.
MV[Z5"E8RDE3\27=@;1U_:<5LD?O8PR7@O;D,.)P?8=1+J#K:]15/ZE^"JE=<
M)*2JCPKUB=J5)+/+DUS1 YWR/%P?D;7O'\F 9'L,9Z1&R7<06A=80U[2BJ75
M50/6_P 4K5*]IN*%,^)VV?3I7=K/<)K^FU6/'&F/O]Q":KYNPFT^2LWXYCPS
M8D8A'NUD"<$FY!13%MT1%$NEE)5]5Z"M:[>Y4[CARK[CJW7HMW;[2&Y;PG3"
MF*U8IL]M/\V:ULF'R.>RILZ[B8>1?QD25D933;<M6.%S;4N/]M+BE[5;>YC*
M.I^%&&[]'O6;D;<4[DG'4U%-Z>AF3N'E-K6)6+&)CDR^-R<67-2?'EL  !#:
M5Q$%"55<0[>H>E+FXT<*JE<S7M/37?4JRT.+2HT^+IV$;X]\TQM_SS6#CX9V
M"3F':SG?-T7?:ZX@(U9!1;];\JEG<^;+32F%3?ZAZ/+:6_,<E+QZ,O>86>\Z
M2!V;(ZSHNHY#<).%7M9>3#)&H[+UU16T)1+D265/AUO:]JDMU23C&+E3,VV?
M1?Z4;MZ[&RI_2I9M<RP:1YCU3<-8D;&^XN":QKRP\NSEC",L62*7X$9J(K=/
M3^JR+6RWN(SCJR.3>>DW]O>5I+S')5CIQJBS1]TU65CFLO'S,%W%ONC':FA*
M95@GS_*VA\K<U^ ^M;/,C2M53K."6UO1FX.$E)*M-+K3F%W7410E7/8U$%7$
M+_'6.BL(A.)^?U!%]_\ 9^-/-AS7>7])?_)+_:^.7>=X.W:UD\4><QV6AR<,
MW?NSVI#11V^-K\W$+B-K];K62G%JJ:H8SVUZ$_+E"2E^6F/<5;;_ "_K6OZ1
MD-XPK\?9(..<9:<;Q\ELT4GW1:2YCS0;7OU3K6FY?C&#DO%0]':>D7[VXC8F
MG;E)-K4GP53(T+R.QO.8V7%-8XX1:V_'CFZ;@N(\LD"-%1$1./'C2S?\QM4I
M0U[WTY[6$)-I^8GV4+Y70>4<*ETH#2\_?\_X_=VO6<L99G/]P)GCX'U'NY)O
M+N]EF(J)956+)7@XM^79L=K5T*VIT:RXFMRI4D<9Y"=T["CC\]$S>PIKXHQM
M.WA&'Z092V)\P0E;<<::(EY*TVJ "?&RUCHU.JXY(NJF9EEN?Z-OFYOYO(JW
MJN'PV+R -K[FVR>.1W"!!2Y$YQ$41/5;(E-%8JF;;#E1OE0DL?Y&9RD[]$GX
M;(Z]E9D1Z;B&LNT#22VF!0CX*V;EG6[B1LE8Q%;_ #K!P:Q6*XF2*/X,W+8'
M8V,US=\@[E96PX]-@UK,2D03?:OQF0B6PH3D4U0QM=5:-%_=K=N+2JW%9.C^
M7>:[<VZ5,[QYY+E,>-]2DYAN=L>X9_ZQ(T2( '*D?2R71)PU)0!MML>"$9DB
M=4]5J7+=)NF2,U+ MF,\J:_DG<=$6+-A9"?D'\*[$F,]DXF188*3V)*\E05=
M;'DR0J0G\%K7Y;]U2:T=/\[NH?1[C-[KR,Z-(*)GD4$0^\((2(RE_P")S)>V
M/I<T5*>5*J7YBN22;Y$/K_D&!&\@;SCMGSL?&PHRX@\3C\G(9BFR$F +KR"+
MA(O4U]WKUK)VWIBTN9%+%G3"^0HA;?Y%R!Y9,IJ6#BX9Z&$!4F@!R&GU>%E&
M.:D;A(/M^=J2MND>;J-6+)8/*\2.,Y,YKV7PTF+CI&:CQI;+2N2H,-$5[L]M
MTQ5X$(5-DE0DNE8NWRQ,JDM*\A:]%#6W%<-P-K17<20(B)],,99;C[JDJ(#3
M;27,E]+I\ZBA+'H%41./\MXB=,Q@.XC*0<-GGDBX#/2XZ-09CQHI-(GN5QM'
MD2[!.MBCGP^%9.V\>:S,=:,25YJPS29MZ%@LSD8&LRY4+8IT:,*L1"@K9XD(
MW![J"BH:HU=4#JJ)Z55:>%<*Y#4NXP-IWH<7Y)U$W,V$+3<ACI$N3W#0(SW(
M55DU)4Z7N-J]3:[3S=K<:@Y3325#YKU#U![??V8RN*%MQDY5I1\L3I$WIO.>
M8(..P><;G:P6(>=>CQG!./\ 5-DON)4]%1+5E/9NULW.<'&>I+'D8V_4U>]3
MC"U<4[?EMTBZ^*OV$] \NZS-GQHK<>>WC)KZPH.?>C$WBY$I"44;;?7U4E14
M%5&RUS2]-NQBW5:DJN-?$EU'7;]<L3N**4M,G2-S3X)2Y*73PX,],]Y6PFNS
MI<6;C<HY#QJ@.4RC$,SA1B=X\4)Q52_YDZBBUC8V$[T4XN-9?2JXNAGNO6+6
MWG)2C/3#ZI*/AC7+KSX5(G,[5D87E+&1F)+\C73P$G)NXZ*'=60;:DHJV")R
M(U1$XHGK6ZWMHRVK;5)ZU&O+K-%_>SAOXQ3;M^5*=$JUH^'%OH*;'\F;-EO%
M&T9$WID?/XYXC8RBQQCM(R<D0!H#%.*N *V,;73XUZ4_3[4-W;A@XRX5KV]1
MXEKUB_=].O7/$IPKBXTPK@EP;7%9KB;"U7R9ALMDX.ON19\?)2XB/0I4V,4=
MF:C0(KI,D=B6RHOJ*7KR+^PG;@YIQ:3Q2==/6?1;3U>U>N1M-3C*2K%RCI4J
M9Z:XX=*Z<C8(KR1%M;\*\T]PZN6Z(J71>E1LI&:S)?F8&#)E.*[(<;NXX7JJ
MW5+]*SDJ,A+5B#4?GJ1MNL:]C_(VJSI?8TZ:SD=DP<8OX>2P0DB36R'BOO:;
M570+Y"2=;UG!5=&1X$_O?D%C"Z 6SZ[;)S<NW'CZHPTM_KIV501A"'HJBJFC
MA?W@JM1+&@K@5O#>7O&^B8MC5=FWI,SL&&;"/G<N8R)@?6KU=5^0PR335C54
MX&2<!LA>E-+;R%:&1Y#V3(QMV\3?H63-O#Y[+R6IHQ7!.--BECW'F^2I="&X
MB8**U8)48;>!9=I\L^/M*R"8K9,VU%R2M?4'#:;?EO-LWZ..A&;=5L%^!.61
M?A6*BV6I8XF>PT_$-Y^'/C2,(ZS]4&2:> HJL(BDKG=1>/!$154KU 137D#4
M'L [M(Y1H-?9<;9<GO"XRV)O$ -_X0!6Q$X""2)9;W]*E2T,R=MFO8S(/XJ=
MD&6,C&A_JDB,96<"#W%:[ZC;J"&G%53T6J*'5S;M?;SI:S]:!9P&D?=A@ADK
M8**G_$)!4 511202)"4>J):@H1X>2M*<Q09L<H*XIUYJ,S)[+Z"Z](ZMBTBM
M\G.:(O%0146I4498<7E,?FL?'RN*DMS,?*'N,26"0VS&]NBI\E2RI\%Z52&7
M0"@-?>5(7EE_#E)\3Y2#$R["$9P<A'%U)*(-T%MTUXMETLG,>*_%4K=9<*^-
M8&,ZTP/E73?O$WK#9US ^68(2<:+Q0\C(BL_0Y*"8EP-> J@EP7\PV0ODM>I
M<V$7&L&<,=TU*DC<_DQO&XF'!7=$7>/&.5MD,($TE<DQ<NPVKT44D-H*N,R$
M50'GZ7ZW3U\J$I1>&#.V5'GD>N[^1<AX6TQC==]R$C+;MF?X6,UF.?TV-:=4
M$/MB I?@P*IW'"4B5>B>M9V;#NRHL$N)C<N*W&K-1^,O,?W->:MK?AZM.QN)
MP\54=R4HH+;D*&T:KP#DXAN.&5EX AW6UULB*M>A>V]FS'&K?O.:U=G<;Y'V
M?CX\IK'M1\F^DZ8+:!*D]I&1=/C8B1NY(*+_ &;K7CUJ=Q1L#J&5Q.NYS#26
MT?9CM3L=K;:'<BQS_)QM#NJ()7/M_#V@E!4AGM6.-"DY'/PEB#!U>)%;R#CX
M#V,E%:= C$D(N)"AH@N6J@BAP>4FXO)XPL$^SLV6AXQ^.B.QEC<,:XR)D)MN
M+P,D]Z\OS_#TIA4M>)8W]4R99!_(MXI4D#M$;*QW^;?<2 C;8O&*\KI?B2$W
M\?E0$7D]4V=W"SL9$P7)79<Z9!?5]M'&"6>$ED00CL'-M"7FGN$O;T1: NN]
M8')Y^!B9V'04RV$R$;+Q8<@N#;Y,"2&R9)RX*0F2"75$*WPJ$.V;F[!,QACC
M]?*0XC0NO19;P,\W!,/X0J!^ZR<BNJH)6X_&H6I5,7J&6'(X=O)8CGA8$W.$
MZT2LJTD+(C=@49$E2RJMNVB>S]E9$/+6=8VR)#;Q.;Q7U '$CCB9YNLNKB94
M5' 2Z$5^BJ+H&W>_HOI4>9<*'4=0R\K!XYJ9K[C>;BRL6UEWUE@Z,R/ =4G7
M0LXET)%4O<B&O+C5XD-KP(,/&PV8,!D8T-@4!E@$XB IZ(B?"H#(H#A51*E0
M?%?C[8\[XUW=<Q)=:E^.?->=RQ@U,+BSCMH9R$ED&E5.B#-::%!4O4A1.B#=
M?*]1G>=MJPH7)+.$N,>/4^O Z]O&&I:VXKFN9/\ W)2L@[H>SZE@HDO 9!S!
M3LSL)1S)Z..*B J"WP'H/U3P]J]^C8N+7RWI=CR=PKKL7=LW)1TP>JU)R6;2
MR4:9X1JUFSU-Q/7#2IQN*E:M4DJ?$OFJ9>)B_&V&VZ:(M0L=@(4S)SL2:<D8
M;A X02(SJHA7%%3IZK7G*W*YNY3MI:E/3*=AK+52EZU/!\=37*N)N<E&THR>
M%*I7/^B:R-4^/7<]XT\Q:]LV25'&?-<!\L]B^2@,'88AG+BQFQ-![:C$<&.V
M!?F,22_I7U,=W9C9IL%&YY,O%;C@U'*2BN#XKA*E.*9Y;M2<OZU5J6$G[J\U
M\":W;9/\TOFF9Y0S6OS<OXUV7!!AHV<QD<I;V GM.&Y);<CI[V@>54,U2RKT
MMRXJE;MK#;/;7%MVOZSFZ/!ZVL8M<&N*X&-R5Q7(^9G"G<CW\BN8?S/X0S#_
M (9E0,UEW\?";RTN.O;?FMP'P=3&/D? Q-P>X@ Y;HMDZ%7E[?7M8;:S>2A"
MS!2N-_3JIIA%/B]3;IT(Z+E+DKDXXN<J17&F;?=AVDOK/G#Q3Y3D-:)M;1ZE
M.8!EO_-UG8APWC>805  4@%MQ&S#^$VU8_:B\46NK?;>Y.Z[VXGY=BUXE&&K
M5/#.=,:8OPJIA8N1A'3;CJN2XNGA_E7S*0&S8W7ON@\A9&9!?E#)P>%"(7Z=
M(D=I.*<5)B*!JB<41 YVO7E[J,9[6T],,)RT>>O+C%8TTVUG1?0GP\3Q.FSX
M;DE662KHQ;Y^)Y=)LS$KIWE2'L[;FNY3-A.+]%SHS8/Z*W)1EE%;)6W$%Q4;
M%W^";B73U'T2N>Y;OV[T)R\W>3IJCI\%F/++VIFC9&4)P<?!9CDZ^*;*)IF9
M\G02=^UF;)<@[#C&T%O<!5$?32"Z#+;=%5'ZP47Z$.(]'%Y_N*M?6[>YN-4)
M34+5MQ\4:^)7'PJGI:Z<V>3<C;HTM4I5P?"GQ/JG6]?P>JX*!KFM0FL;@L8R
M,>#"8'BVVV/PZ]555ZD1=2555555KVCD)6@% ='%MQL5E5?]#K48-3AL43;Y
MF8S6:D$UHN ) :@@I)]6XO\ NCW'J2>G!OTZI>OF?U$-RYSN/^E;X?F?3S]N
MFO!&[YDI2;\$.'/I?R1YXS9M"VZ:.#;QIX28ZML;.906'4<%/;Q-JRB7R0KH
MM:K.[VF[EY:CHEP:HGV-?Z"%ZU<>FE'P+-H&SS\B_DM:S9HYF\$ZK+DA.GU#
M"*HBXJ)T0O[5>IZ?NY7'*U/ZX<>? V[>ZY5C+ZHNG7TEBG?]8<3_ +U+_P!!
MNO7.O@:3^YZ _B&M-\HP _Q[5,NPCZHG58T@Q7W+_90@M_KJIBS3N_3LIMNU
M;?YRP$A7,;HV4Q,?%*%R;<CM%8W!5?@A<25/[^A3;/CV3'\F_<)L7D*(:R-?
MUG&Q<;B7%5+(_,:0CM_6[04*5EI.T1O/_D$M6TV'NDHFX:2(<] 4([:--V<'
MGTN2^V@-]^,&\Y.U>>[LNJ1-(R\E]V.L+&@V'-E&T1MY5;]2N1(E_2U"GSJ&
M"W/PIA,G@=R\>8[=/'AR'9,G-LH)R%9<5$Y$ZG(FT2R?G!++?W6H0^H]>_DK
MR#J&%R\;%19FO2&&WL;%F1FG!8$1[?%&S0A$@LH>VH4T?]N.MZYE-@\FCDL/
M!F#"SW"$,B,TZC (;UA:0Q7@B<4Z#0A].(B(ED]*H.: 4!B9&#'R45V%+#N1
M7QX.M]4Y#\KIUKGW%B%ZVX358RS1G;G*$E*+HT:JVC"OZ3DXFPZ^"LQ+]LFR
MN0 :I916ZW433\>BU^7^L>GS](OPW6U5(\LZ/D^AKVR/KMCN5O;<K-YUEG7F
MOM168^6V#"D[EA(P7-MNI]0=[.W+J8_WPJO2OF;6]WFU<KV*_4*2J^-7BUTI
MY/[3UI[>Q>I;_P"TTZ<NA]9L;3M'Q^.AP\CE6;YE"20*D9(K/]D>*+:Z>JW^
M-?HOH?[?M6+<+EY5O-ZL_IY+KYGR_J'J<[DI0@_Z>77[<#Y8^];#NZQY#T?R
M;!%&U<0&7G Z$LG%OB^V2_M ^*?ZFOU#824H2C[8GS%V-'4JGW;Y:7Y'\L,8
MG -%(CZ_K@Y P1?]Q=9+)/.?T,D']5;MG%0A5\7]QKO-O+@<>3O)"YS[3O&N
M$0U.;(G.0I:K^94P0D IZ^BH\RM+5FE^3Z/B9-^&A??/?B/]+^UO23CM%]?I
M+49^<EDNC>6%/K/QZ/F"_P!%<^WO)WY?Q?(SG'PIF1F_+RR/LHB2_J%_7)K3
M>GN$*\21QDU;._Q6\9OK_JJL;/\ ^3[_ &[2.7@-9Y72EU7[-869D-H&1VK8
MXN2-5Z%],(/,QQ7\.(*:?ZJNB,]6XIP2H8Z:0/K+[5[KX TFW_DI5_\ +GZ\
MK=_W9>W WPR/FO[>/_SN]I^7?S__ "A:]/=?V%V'-9S?MQ9]^5X9V"@"]$5:
M UOY2RZMPHV")_Z:+/%U_)R%4DM!C(/-M>"*J=XS%N]K6NBUHO/AWGJ^G6_$
MYTJU117.3_\ :L33LC$Y7"E$RC,J&U)D0VI8,91B,\S$:?[Q,W)]/\*0M@-[
M=+H V1$1>*CCRQYGT7F0NK3XFDVJQK65-/VM^\D=F<V8W<?CYD^"\Q*@M2WG
M"@069D<W&W'#^F4$0K,J"<RNBC=/6LIXTR]QS[>%M:I)2JFUFZ-8+Q5_-4E,
M#.GZ=G\?S5"9A,11GR1!&OJ<7D%$@>=1$]QM..>T1L@\2LEBK*,M#71\&:[T
M%?MRI^)NBK],H\%T-=^'(]ON865@8&I^1X "[D-3RP.*A=$)J0E^*JG7BI-B
MB_MJ[VJ49K@_;X&7[:TW9W=O)X78>]?ZFGIV-ROCOQUHOEZ&TAYV:_E"RKOY
M5<;SK3B,*2]55!$5)/Q*N!P<+<9K-U]Y]3"[#=[N_LY/P14-/_ U7["-8UXM
M:R^B0\_(Q,3$S-:^NAN;+'.7BOJISANO"H@H\7;$/N)>G3^]K'2X.-:9<<L3
M=+<*_;ON&MS5RC\MTG2."_X3Q;BPH!ZG"QV>;S^+8+9TB2&(ST5AF\-"-ME'
MTY&'+W(2=.OSO6$E@L:_49J;GYTI0<)?TJU:;?BS=.@V+]N!C_/\2ZWOID1;
M)ZK:0'I75L?[G_"_BCPOW'_XK_\ N?P)/Q/N>M>*<UO.F^0)8X/,%F7LG'DR
M <[<F*ZB<% Q%;]$Y#\^73K>MFWN1M.49\S1ZKL[N_MV;NW6N*@HNG!K@R W
MK?=7\A9[1MAR&,?A>*X^;F1\@]/90(LN1Q;()!B%U(53HO/X(2?.L+MV-R46
MU2-6=>PV%[:6[UN,E+<2A%Q475I8U77]Q2-T:UV9,WH-(01\<2,M@VF5CHH1
M/KB0T<[%^B=%=_+\/PM7->:\3C]-5\/]3U=F[L?(\_\ O*-S/.G\7N[>DVOY
M!\;Z)B?*'BO4H.%C,Z_+>R#LV"**H/FVVUQ5U255._ >5_6NV]:A&["*6!X'
MI_J&XN;+<W93;FE&CY8O[36>_P"++$S/(V(UUAN'J,'8\,YE8C0&49B,;3RB
M1--V7M=S\R)^"?*N.[%IS2RJOF>]L;L9QV\[C<KDK<]+XMX5Q?&AB[5'PK.+
MW2;AMBPLM9N,A?6875X,B+CN 36$;=,G+MBX*_NHO*Z_MJ2Q4FFLE@J\T9[2
M4W<M1G;FJ2E25R2<OH>%%C1F^?M],5W#R?9>JS\=9/C_ (!VN_9_5/VYGR/K
MW]G;_P LOD;\KTCY 4!KG=,)+R'DWQME68!R8.)>S)S9@AS"+W\>K;:D2_EY
ME[1_&MT))0DNKXF$E5HU3NF(V+8\7MT'8M>V/8-U-V:U@X+*.,:]$B-FOTKT
M8Q<!DU5E!(N?)PW+AQK?;DHM4:2PKS,9)T?,LFYZ1LVRO[Y%QT!TBR.$U]<<
MXX2Q@DR,9).2Y'%W]PU04&_[JDE80N)*/0W[S)IXGOK&'Q$[:,;D<7J^U?4P
M8\U\\ELTB6VWCW9+!,J#;,EPT?==1>!=NXB/NY>E8RDTFJKLXA1Q,C"Z'G9G
MAK4(S#)8O?M799R.%^I'@;4]CERCO=45&WVR)EU+_E*_PI*:\QO@PHX+H*'K
M^CYO&:UX^SNQX+.C$C8S(8O.8O#NO,Y+'.RYZRF72;CD+CS:V4#0?1.)VK=*
MXFY)-<.HQ4715+._J;YZ5L.PZEJV5C9Z#D8.?P8YV2Z]DLK)PG!10V72(V1,
M!<CM@1(1"J+9+I6N,_$DWA2F'"I7%T="+'QGM,>7I&+&$X_B-EC1U\@F8HG9
M>Q\PLTG>5+JI..NG%0OPM6?F1Q?++MP^\QI*J]YL?7]3:E>2?(63SV$:?@S7
M<0N+ES([;H.BS $'>T1HMT$TXE;XUIE+P1H^?Q-B6+*MG,'M^ RWDZ=H^+>@
M)-9UX(+^/CM=TX[/=&>4)LN+;C[;1%Q%?WK?&U9)Q>FO21IXT/'3L RODW#Y
MC$ZWGFL,.+R43)[%L??*1-DNE'(1<;DFIB-D*QJV DMT1.E)S\#Q5>@B6)CZ
MCXTV9Z1LVO9=AR-BM=Q.0U32ILK^(V^QF#<?64GQ3MMJQ'6WP!4K*=Q*C6+;
M3?8$GBN!@ZMJ\96-8P62U':W]DQC\%O),S9TL,)&<QG&\L)!.$RZV*AS8!NZ
ME^6R4G/%T:I[RI<_:A;\-@,XUH?E."]CI 3LGE-G>Q4<@L<AN6!(P32?%'+^
MWYUA)IRB^20QHS!;T_(3MJ\:EE<(<G$0, ,7*_4-";+$@8R(@.H71"0DM;YU
MZMG<1AM;L5*DG)4YM'S6]V<KOJ%B;AJA&,JO@FU@9TG1W6/+34C#X<<?KSN
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M)%7TX*MT2WR5:4(3V*RC&7AA.C X#+G5ON@H*0JB$)#ZHHDBHJ*E 9M * 4
MH!0&'E)J8Z"].5AZ4D<"=^FC KK[G 57BV"6Y$MK(E1E1\OZIXSS.]^ F_'N
MX:;)Q6:,)C939I-QYT:<4QV5&E-\57D@*X"W0NON&OC=\]S:WGF6=G&ZU_\
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M[B,$Y69[B3;JGN'@NZ*QY)'IV]W"K2FH+HMK[RDXS7]HB?<Z]M+>B2F]:75
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M<;JN.#&8QM1:1>;KQKR<<<5.I$O_ ,%J^PVNUAMX*$>_F>I;MQA'3'([SO\
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MBH+"N.%5SKGU8KH-J>/- EXDV,QFVQ:DL(J8W' 0D$9#'@;KBA[2>,4X]%5
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MC<Q)?045*QV%K5>MMPNUAFYOPQ_EP]QEZA=T;>ZE<LZ9O",(^*6.;Y&[FD5
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M66L)04LT9*361DZSIVNZ;B@P>K8UC$XAM3,8L4>(JXXMR,E6ZD2_$B55J*-
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
@ * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>bc_publications-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_publications-4c.jpg
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M%!04%!04%!04%/_  !$(!&8%WP,!$0 "$0$#$0'_Q #G  $  @(# 0$
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M%3Z&-H_T&P7Y-MO:P5/H8VC_ $&P7Y-MO:P5/H8VC_0;!?DVV]K!4^AC:/\
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M%3Z&-H_T&P7Y-MO:P5/H8VC_ $&P7Y-MO:P5/H8VC_0;!?DVV]K!4^AC:/\
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M8?$UD!( 8
M
M
M                                             TO<WWEQ'ZQZ=^.+
M4,PP]"_/G<WX7L/B:R D ,
M
M
M                                                          :7
MN;[RXC]8]._'%J&88>A?GSN;\+V'Q-9 2 &
M
M
M
M           -+W-]Y<1^L>G?CBU#,,/0OSYW-^%[#XFL@) #
M
M
M
M                        &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@
M!@
M
M
M                                     #2]S?>7$?K'IWXXM0S##T+\
M^=S?A>P^)K("0 P
M
M
M                                                  !I>YOO+B/U
MCT[\<6H9AAZ%^?.YOPO8?$UD!( 8
M
M
M
M    TO<WWEQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D ,
M
M
M
M                 :7N;[RXC]8]._'%J&88>A?GSN;\+V'Q-9 2 &
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MMDBE8J.:YCTJCD5.E%13#+L
M
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MJ(G=,L/T6V_T_<Z4T3@=.WLB27F.LXH;ES5YF]:C:O1J]UJ*JHGF'Y9;(
M      BG>K>.7:>#$I;XEN3N<OXQU;I)NICB\6ZNO,B,<KJ]9T53H,BN.>[4
M.Z.722.QGM,-"_@B64".D1O_ %YUE6OFMH9HPN?IBXGN]-8:ZNI%FN9[&UEF
ME=3F?(^%KG.6E.*JM3\LH0[5.A<_J;"X;/X.VEODPCKAM[:0-621(;E(UZUK
M$XJC5BHZG&BUZ$4S#"I^ TKJ+4^4BPV"QT]YD)7HSJHV+1BJM%61R\&-3NN<
MJ(AD?H]I;$2:?TSAL%++U\N,L;:R?,G0]UO$V-7)7OJT_++U@
M
M
M          &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@         46[
M2>N)]5;A76'BE5</IQ76-M$B^"MRE/&'JGJN=.K\YB'ZAA$EC97>3O;;'6$+
MKB^NY66]M SBY\LKD:QJ>:JK0"\&V?9XT=H['V]SJ"S@SNIG-:^YN+IB36T+
MU2JLAB>G+1J_;N;S+T\.A,592F_3^!DA\7DQ=FZ!."1.MXE9Q\Q6T,# PNAM
M(:;R=UE\!AK7&9"]C2&YDM&)"U[&NYD3D91B<>-4:!'&Z?:&P^V^7ETW#B+G
M)YV)C)'H]R6UJC96H]JI(J/<[@O'E93N5J9H(6R':UW#N'K[GX[%V4/<18II
MG^BYTJ)_W11A\QO:TW$MI47(V.,OH/MF=5+ _P!!S9%1/Y*B@L%M7O?IG<]'
M6,,;L7J.)G62XN=Z/YV)TNAD1$YT3N^"CD[U.(9;?KG/W6E='YK4=E"RXNL7
M:R74<,JJC'+&E:*K>/08%7_XO]6?H]COY<_\XS1A)>5[1V/P6W6 U/?V++C5
M.H(99;;#V[U;$Q(97Q++(]R*K65;PX5<M43H5449:;M=VAM>:WW(Q&GLG%80
MXC(R3-EAMX7M>UL<$DK>5[I'+6K$Z11AD:[[3NI=*:PS6FK?!V%Q;8RZDMHY
M97S<[VL7@KJ*B5%!D;;]I;4>M=;8?2UWA;&VM<C(^.2:%TJO:C(GO\%'.5/M
M106%S^H,/I?$76=SUTRRQ=FWGGGDZ$JM$1$2JN<Y5HUJ<57@AAE6'5?:[R+K
MF2#1>$ACLVJK8[S**Z21Z>J2*)S$;YRO<9HPU6#M7;GQ2\\L6+G97C&^VD:E
M.]5DK5_TF:"=]DMZ\ANK<9&PO\(RPGQL+)I;RWE5\#EE=RM9R/3F:JT<J>$[
MH,,IC,#7-P/F%JGX(R'^&D _-8_3"V/8[:WW,U6ZB<R3V=%IQ])-W3$B0M_M
M#Z<U#M]F\Q>6D4>9Q%L^]LLBUB-G1T*<RQJ]**YKT3EY5X=WI1!#*AAEA;/L
MNYN\Q^VNL)F(DK,5/+>VT3U7E63Q5'*U53H15C3H,2-8_B_U9^CV._ES_P X
M4$L[';S9C=6\S-ME,;;6#,9%!)&ZV=(Y7+,YZ*B\ZKT<H9;%O1N)D=LM)P:A
MQEG#?3RWT5FZ*Y5[6(R2.5ZN3DHM:L1# @3^+_5GZ/8[^7/_ #C-&%D-K=87
MFO=#8O5=_;QVEU?]?SP0*Y8V]3<20I17<>*,J89?G5>?[Y<??'^N4_3"4-@]
M<X+;O4>:U)GGNZAF)E@MK:).::>X?<0.;&Q."<4:Y555HB()&U9OM;:YN[IZ
MX+&8_&V-5ZMDS9+J:E>',_G8U?08AB@][1G:XOO'(K77>*A6RD5&NR.,1['Q
M(J^F="]S^=$[O*Y%[R+T"@M)CLC8Y>PM\GC+AEUC[N-LUM<1+S,?&]*HJ*89
M?G_OK^UO57E;?8F'ZA@V*_:WI7RMWL3Q(MKOANIE-K,7B;_%V%O?/R%Q)!(V
MY<]J-1C.9%3D5##*$T[7VJT5533N.15Z?#G_ )PHPL]H34-QJS1V%U)=PLM[
MG)VK+F2&)55C5?W&\W&AAEYVX6Z.DMM;%ESJ&Y5;R=%6SQMNB274U.ZUJJB(
MVOVSE1/1X 5SSO:\U3<2O;IS!V5A;5\!]XZ2ZFY>XO@.B:B^@IFC#Q;;M7[G
M0RH^>'%W,=:K&^VD:E.]5DK5,T%E,)N@B[3V^YVJ;!]K$Z%;BXL[!%G<C%N%
MAC5B.5OIDY7+5:(B\5X'Y90EGNV!E9)'LTQIVW@A3@R;(ROF>OFK'#U:)YW.
MIFC#55[5NZ*R<_)BT;]S2U?R^RU_TF:#=]']KI9;J*UUQAHX+9ZHU^1QBO5(
MZ]UT$BO54[_*^O>13%!96+,65]A?=S$SQWEC+;K=6L\;N:.1G*KFJBIW%,,J
M%;J;P9;=9,4F4QUM8>Y/C'5+;.D=S^,]77FYU7HZM*4/TPC@"PN&[5NJ;"SQ
M^(AP&/?';10VC'N?,BJV-K8T5:.[M#%!,^^>\&7VI7!>Y>.MK],KXUUOC+I&
M\GBW4TY>14Z>L6M0RA].U]JM*TT[CD5>GPY_YPHPM7IG*39S3>'S5Q&V*?)6
M-M>2Q1JJL8^XA;(K6JO%41742IAEIVYF].D=LFMMLB]]_GI6\\.)M519>5>A
MTKEX1M7N5XKW$4R*]9?M;Z[NI5]Q\5CL=;U\%)6RW4J)YKU?&U?Y HPX8GM;
M:_M9FKEL;C<C;?;M8R6VE5/,>U[FI_(44%A]LMZ=);FL6VQ[G6&?B9SSXBY5
M.LY4Z71/3A(U.[3BG=1##+9]=9^ZTKH_-:CLH67%UB[62ZC@E548Y8TK15;Q
MZ *O_P 7^K/T>QW\N?\ G&:,)"N>T[A<9H'#9^]LV76KLO'.],':249"D,\D
M*/F>[F5C7<E6I17+W.'$4$3W/:QW*EN5EM[7%V]O7P;?J)7I3N(YRS57T*&:
M"6MI^TK8:UREOIK55G'B<Y=JD=E<P.5;2>5>B.CU5T;W+Z1%<Y'+PK6B+BC*
M?# @[<_M)Z>T1?3X# VON[GK95CNE23J[2WD3@K'/1'*][?MFMZ.A75JAF@A
M>Y[5^YTTRR008NWBKPB9;2.2G>57RJIFC#8]*=K+5EQD;3'9K3]GD5NI60,\
M0=):S*Z5R-;1)'2M5:KT>"8H+;&&0
M
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M)AD
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MK8!^0           :7N;[RXC]8]._'%J&88>A?GSN;\+V'Q-9 2 &
M  !^96JL7-A-39G#SM5LMA>W%LY%_P#E2N;7T:5/TP]_:+5<&B]Q<%G[Q_)C
MXIU@O7KT-@N6.A>]?,8C^?T /T48]DC&R1N1\;T1S'M6J*B\45%3I13\LN0
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M',]G:8D>SVQ__P#3?_ZC_P#I1 JR9'Z9Z0^:>!^#K3V!A^65<NV/_P#Z;_\
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MLUI<QLF@F8M6OCD:CFN1>\J+4_++N
M
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M,8.34D&-L)-5S0P3);SXE%L5=%:L5$<V;D=&G,_A7B#P+JA^0
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M^66[
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M1TCL)N7JN\BB7#3XBP<J==?Y-CK5C&5XJC'HCWKWD:WZ@J,G4/9\W)QF<O\
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ML1&L8U*-1J<$1$3H1##+D
M
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M'H7Y\[F_"]A\360$@!@
M
M
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M*@*@*@*@*@*@*IL[."?^MYOO^*Q^R$9W_P"SLYTH[O\ M+^98LAJ:
M &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@
M
M
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M^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@
M
M
M                              ^*B*BHJ51>"HH'7;VMM9Q]3:0QP0U5
MW5Q-1C:KTK1J(@'3)B\9->QY*6R@DR,2<L5VZ)CIF)WFO5.9/04#+5$5*+T
M=-O:VMG'U5I#'!%57<D348VJ]*T:B)4#&;@\*R^7*,QMJW)JJJMZD$:3JJ]*
M]9R\W^D#/         5=[0'S\9Y!!Z^0G6X^S_:GS(!O[M/V8\Z*SO(^
M      $V=G#W[S?DL7LA&=_^SLYTI[O>TOYEBB&IL        :7N;[RXC]8]
M._'%J&88>A?GSN;\+V'Q-9 2 &
M
M
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MIT(KVHJHGU2'7Q2Z83.R[:MB>5WGX?L   *N]H!/\]L\@@]?(3K<?9_M3YD
MW]VG[,>=%E#OH\4 4 4 4 4 4 4 4 4 FOLX^_>;\EB]D(QO_P!G9SI5W=]I
M?S+%$-38        TO<WWEQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D ,
M   !\1S75Y51:<%IQ ^@                             .$TT-O#)<7$
MC8H(FK)++(J-8UC4JKG*O!$1.*JH&%BL]@\\R23!Y.TR<<*HV9]G/'<-8KDJ
MB.6-SJ*J=\#T                  !\1S7*J(J*J=-% ^@
M
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MGJRXR>0LM$8J9MPW&Q7,T5N[E6EK;JQCT8M4;UDW"BT6OID,L+4F&0
M%=MZ[.]VPUKA=Y]-L<D%Q,W'ZGLXUHRX:YO!7)T5>QJMJO!'M8[I,L+ 8^_M
M,K86N3L)$FL;V&.YMI6]#XIFH]CD\]%,,LD
M
M                     !JNY?S!U#Y%)]8W]W]HLYW/WCV:_F4T+)5@
M       "].)]ZK'R>+UB%5Y?3GGE;6+T(YH9AYO4   *O=H#Y]L\@@]?(3O<
M?9_M3YE>[_[3]F/.BP[R.@         !-?9Q]^\WY+%[(1C?_L[.=+.[GM+^
M:.E8DAJ<        &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@
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M+&ZHQ5Q;\RQW2W:0NY'R>$B*Q?2]+5JG'I%!8776M</M_IN[U+FW+XM;T9#
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M>8@D2\8
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MAK_J,RPL,89
M                                                         -5W
M+^8.H?(Y/K&_N_M%G.YV\NS7\RFA92KP           7IQ/O58^3Q>L0JK+Z
M<\\K<Q>A'-#,/-Z@  !5[?\ ^?;/((/7R$[W'V?[4^97G>#M/V8\Z+#OHX
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M<RLY'Y:[N;]$7@O)5(&KZ*153S#,B9#
M
M                  :IN7\P=0^1R'0W?VBSG<[>79LG54U+)5:
M  "].)]ZK'R>+UB%59?3GGE;V+T+>:&8>;U   "K^_\ \^V>00>OD)WN/L_V
MI\RO.\':?LQYT6'?1RH"H"H"H"H"H"H"H"H"J:NSE[]YOR6+V0C&_P#V=G.E
MO=OVE_-'2L20Q.0       #2]S?>7$?K'IWXXM0S##T+\^=S?A>P^)K("0 P
M         ("[1VF,G928/=O3;.;,:5FC\=:U%576C9>LC<ZG%6L>KD>GJ7JJ
M\$4S VO*Z.T'OY@\#JF^GNI;!L#GVD-M.D;8GS*WKF2(C7?TC7,Y'><!)MO;
MPVEO%:VS$CMX&-BAC;T-8Q$:U$\Q$0P.T"/]1;.:.U+J^VUQ>I=0:@M76\D<
M]K-U35DM'(Z-RIRK54HB><@&U:ATYI_5>/?AM1V,.1L9/#6WG2JHJ<$>Q4HY
MKDKZ9JHH$=6/9KVDL;Y+WW(EN$:O,RVN+F:2!%[E6\R*Y/,<JH9J(@U&_'ZW
M[36GL7IU&2XO3\EE;?V=$\79'BE=<RM8C?!:QBUCX<*IP#"W$G5JQR2\JQN3
ME<CJ<JHO"BU[YAE%F:[.FT^:OG9!^'=92R.5TL=C-);PN55K_5HJM;_V$0S4
M1QVA<?HG;K;:VT1I>SAQ]WF+R&=]O$JNFD@M4<Y99GN5SW(CN5K>=>ZM.A1#
M"9=H,+/@=L-,XJ[8L=RVQ9+-&J4<QURJSJU4[BIUE%\TPRZ] ;1Z1VVN[V\T
MVETDV08R*X\9FZU.6-RN2B<J46J@;V!$VK^SIMKJZ\ER3K2;$9"=5?--C)&P
MM>]5JKG1O8]E55>*M:E3-1XN,[*.V=C*V6]FR621%JL4]PR.-?,7J(XW?]X5
M$W00PV=M';PIU=O;L;'&BJJ\K&)1.*JJ\$3NF!&VI.S_ +6ZGOY,G=X=;2]F
M<KYY+"5]LV1RK55=&U>2JKQ54:BJ9J-&WCP&W^TVTV5P^G+"&QR6H5ALH5YG
M27<Z,E9+(KGO5SU8UK5_V4543NAAN/9RPL^&VFP_C3%9+D'3W_(J47JYY%ZM
M?^TQK7)YXEEYNI.S!MKJ#)R9.W\<PSYGK)-;8Z2-MNKG+5>5DL<G)7O-HU.X
M@J/;M=A-N++2M[I*VL98[/)+"Z_O>MK>RK;R)(RLJHJ(B*GI6M1/,%1NNEM-
M8[2& LM-XA95QU@US+?KW]9)RN>Y]%=1*T5W#S# C_7?9YT#KO+2YVY\:Q>5
MN%1UW-CWL8R9R<.9[)&/;S+W5;2O2M5,U&YZ$T/A]O-/1:;P<D\MC'(^;K+M
M[9)5?*M755K6)3S$:8&EZO[.FVNKKR7).M)L1D)U5\TV,D;"U[U6JN=&]CV5
M55XJUJ5,U'BXSLH[9V,K9;V;)9)$6JQ3W#(XU\Q>HCC=_P!X5$WV\$5K!%:P
M-Y((6-CB;55HQB41*K55X)W3 Q\MC+;-8J^P][S>)Y"WEM+CJW<C^JG8L;N5
MR="T=P4#1++8S;NTTC/HJ2PDN\--=/OT6YE5UQ%<OC9$KXY&HU6KRL1.'HU,
MC4+7LG;:07OC,UUE+JV1:I927$38_.5T<+'T\YR+YHJ)GPV%Q.GL;;X?"6<=
MCC+5O+!;0MY6-3I5>^JJO%57BJ\5,#P]Q->X?;O3-UG\K(U96M<RPLU6C[FY
M5/ C:G32O%R_:MJH$*]E70LL-OD]R,G D4V45]IB6(WE:D"/YIY&IT(UST1C
M>]RN[BF9865,,@'7/"RX@EMY*]7*QT;Z+1>5R46B^B!I6WVT^D]M)+^7327*
M.R38FW/C,O6I2!7JWE\%M/3J!O($2ZN[.6VFK+R7(K:SX>_G57S28R1L+'O5
M:JY8GLD8BKW>5J5,U'CXOLI;96,K9;V7)9-$6JQ7%PR.-?,7J(XW?]X5$M9W
M2V!U+@I=-YNS;=X>5C8W6[U=5$9Z56O1>9'-IP<BU,"(8>R?MI%?>-27.4FM
M*\R6+[B)(_.5S(FOI_VJ^:9J-QR>R.@<C?X'(,M);!VG&QLQ<%E)U,+$AF6=
MJN:J.YE5ZJKG*M5[I@>UKW;S3VY&+M\1J1)UM+6X2ZB\6DZIW6(QT?%:+5*/
M4#V<!A+'3>$L,!C>?Q#'0LMK;K7<[^KC2B<SJ)50(+W]REWKG46!V5TS(C[Z
M]N&7F=E9X3;>%B*K$DHOVK5=,YJ\>#*>F,PPGG#XJRP6*L<+CF=788^".UMF
M=*I'"U&-JO=6B<5,,LT
M
M     !JFY?S!U#Y'(=#=_:+.=SMY=FR=538LE5@           +T8GWJL?)X
MO6(55E].>>5OXO0MYH9AYO4   *O[_\ S[9Y!!Z^0GFX^S_:GS*Z[P]I^S'G
M18=]'           FKLY>_>;\EB]D(OW@]G9SI;W;]I?S1TK$D,3L
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M,;)Y$6G!\B(CG>E3I7N(!F@
M
M          &J[E_,'4/D<GUCH;N[39SN;O/LN3JJ:EE*K           !>C$
M^]5CY/%ZQ"J<OISSRN'#Z%O-#,/-Z@  !5_?_P"?;/((/7R$\W'V?[4^97/>
M'M7V8\Z+3OHV          $U=G+W[S?DL?LA%^\'L[.=+^[7M+^:.E8@AB=@
M       &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@
M
M
M                                     &J[E_,'4/D<GUCH;N[39SN;
MO/LN3JJ:EE*K           !>C$^]5CY/%ZQ"J<OISSRN'#Z%O-#,/-Z@  !
M5_?_ .?;/((/7R$\W%V?[4^97'>+M7V8\Z+20(V          $U=G+W[S?DL
M7LA%^\'L[.=+^[7M+^:.E8@A:>        &E[F^\N(_6/3OQQ:AF&'H7Y\[F
M_"]A\360$@!@
M
M
M    &J[E_,+4'D<GUCH;N[39SN;O/LN3JRIL66JH           %Y\3[U6/D
M\7K$*HR^G//*XL/H6\T,P\WJ   %8-_OGVSR"#U\A/-Q=G^U/F5OWB[5]F/.
MBP[Z-          !-79S]^LWY+%[(1?O![.SG3#NS[2_FCI6((8GH
M!I>YOO+B/UCT[\<6H9AAZ%^?.YOPO8?$UD!( 8
M
M
M                              !JNY?S"U!Y')]8Z&[NTV<[F[S[+DZJ
MFU"RU4% % % % % % % % % % +SXGWJL?)XO6(51E].>>5R8?0MYH9AYO4
M  *P;_?/IGD$'KY">[B[/]J?,K?O%VK[,>=%IWT9          ":NSG[]9KR
M6/V0B_>#V=G.F'=GVE_-'2L.0M/@       #2]S?>7$?K'IWXXM0S##T+\^=
MS?A>P^)K("0 P
M
M
M     #5=ROF%J#R.3ZQT-W=ILYW,WIV7)U5-BS%4            O/B?>NQ\
MGB]8A4^7TYYY7+A]"WFAF'F]0   K!O]\^F>00>OD)[N+L_VI\RMN\<_[7V8
M\Z+3OHS4!4!4!4!4!4!4!4!4!5-/9S]^LUY+'[(1?O![.SG3#NQ[6_FCI6((
M6GX       !I>YOO+B/UCT[\<6H9AAZ%^?.YOPO8?$UD!( 8
M
M
M                                        !JNY7S"U!Y')]8Z&[NTV
M<[F;T[+DZLJ;EEJF           !>;$^]=CY/%ZQ"J,OISSRN?#Z%O-#,/-Z
M@  !6#?[Y],\@@]?(3W<79_M3YE:=X^U?9CSHM) C(          35V<_?K-
M>2Q>R$6[P>SLYTQ[K^UOYHZ5AR%K         -+W-]Y<1^L>G?CBU#,,/0OS
MYW-^%[#XFL@) #
M
M
M       -5W*^86H/(Y/K'0W=VFSG<S>G9<G5E3BA9BI2@"@"@"@"@"@"@"@"
M@"@%Y<3[UV/D\7K$*GR^G//*Z,/H6\T,P\WJ   %8=_?GTSR"#U\A/=Q=G^U
M/F5IWD[5]F/.BT[Z,          !-/9T]^LUY+'[(1?O![.SG3+NO[6_FCI6
M'(6L         TO<WWEQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D ,
M
M
M                                           U7<KYA:@\CD.AN[M-
MG.YF].RY.K*G!9BI            7EQ/O78^3Q>L0JC+Z<\\KIP^A;S0S#R>
MH   5AW]^?3/((/7R$^W%V;[4^96?>3M7V8\Z+20(P          $T]G/WZS
M7DL?LA%N\/L[.=,NZ_M;^:.E8<A2P0       #2]S?>7$?K'IWXXM0S##T+\
M^=S?A>P^)K("0 P
M
M
M       #5=ROF%J#R.3ZQT-W=ILYW+WKV3)U94X+-5$           "\N)]Z
M['R>+UB%39?3GGE=>'V=O-#,/-[   !6'?WY],\A@]?(3[<79OM3YE9=Y>U_
M9CSHM) BX          33V=/?K->2Q^R$6[P^SLYTS[K>UOYHZ5AR%+"
M    -+W-]Y<1^L>G?CBU#,,/0OSYW-^%[#XFL@) #
M
M
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M7Y\[F_"]A\360$@!@
M
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MN7O7LF3JRIR6:J            %Y,3[UV/D\7K$*GR^G//*[</L[>:&8>3V
M  "L._OSZ9Y#!Z^0G^X>S?:GS*P[S=K^S'G1<2!%@          FCLZ>_6:\
MEC]D(MWA]G9SIIW5]KDYHZ5AR$K$        -+W-]Y<1^L>G?CBU#,,/0OSY
MW-^%[#XFL@) #
M
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M'G1:2!%0          FGLZ>_6:\EC]D(KWA]G9SIKW4]KDZL=*PQ"EB@
M   &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@
M
M
M                                 &J[EN:S0.H7N5$:VRE557O(E3H[
MM[3CZT.5O>::/+/);*G19JGJ@*@*@*@*@*@*@*@*@*@*KQXKWKL?)XO6(5-E
M].>>5X8?9V\T,P\GL   %8M_/GTSR&#U\A/MP]F^U/F5;WG[7]F/.BXD**@
M        !-'9U]^LUY+'[(17O#[.SG3;NI[7)U8Z5AB%+&        -+W-]Y
M<1^L>G?CBU#,,/0OSYW-^%[#XFL@) #
M
M
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M,PP]"_/G<WX7L/B:R D ,
M
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MO)"B@          3/V=??K->2Q^R$5[Q>SLYTX[I^UR=6.E88A*QP
M#2]S?>7$?K'IWXXM0S##T+\^=S?A>P^)K("0 P
M
M
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MOSYW-^%[#XFL@) #
M
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M.E88A"R0       #2]S?>7$?K'IWXXM0S##T+\^=S?A>P^)K("0 P
M
M
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MX7L/B:R D ,
M
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MJX;:IQBCH^?S?4M_U@9@%8]_/GRSR&#U\A8&X.S?:GS*G[U=L^S'G1<2)$@
M         FCLZ^_6:\EC]D(IWB]G9S^9.NZ/M<G5CI6%(0LL        TO<W
MWEQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D ,
M
M
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MPO8?$UD!( 8
M
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M?@\KN:/>6FU<?VKXF>3BGR2V@TG2
M
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M5JL=LW764B/''QN3BWYHLM\669*W732."[XF^G+=L
M
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MMQ=>'Z"E3KV
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MYCU]]UEMLV[,5X:),.*D8
M                                                           !
MA9C)V^$Q%_F;NOBF.MIKR>G3U=O&LCJ>@T#\_-*ZGQFM8\UO5N?H+/[E3+<3
M.N.J:K<!@\?&M6PP-<[^F<QOA2)R\C&\KG+S*YP?I(.]V\&#U-IO;/06W$V0
MQ^A-71=9?0X"VKE5QUD_Q5F,MH&+1)'/8^)65Y:M;Q6/FJ(AL6T.I=M='ZIN
MM 83;.[V^W0FQ4_N$[,(DTV38V-9D8MRKE6KW0\RIZ158J5JWE#",-K(-A]0
M;/:SRF[U]8KNE=7&1?E[O,RHS-17/*JP+:L>J2*J.XTC;Q?5KJHE RL5V1=2
M9?4VQF"GS4S[FZL);G'17,JJY[[>VE5(JJO3R,5(T\QH8E.08       4TW%
M^?6H?+Y_7J6;N_L]G5A46\^U9.M+63?<X          +.=G[YCW'PC-[%"03
M?W:(ZL=,K'[N=EGK3T0E4CR3@'"5S&QO=)_5HB\WG :#K[&O706H9N;E:^QF
MY&+Q=Q]+53H[L[5CGZT./OOL&:.6RZ%4TX(B=XM-1D 9 -JTSH:[U!CKC/Y#
M(6^!TM:OZJ;+WO0^1%HK(653F5.BM:5X)53FZK7VX;XQVVSDR3_#'G=?0[KO
MU..<U]\8<-LTV[O#/U8X.:O+P15YV3Q6'9J"UP^F\LN9L;I]O S(+$L/]//)
MR.:C%I5&U1?-/?%ER3BF_+9L3%9I6O!#5SX,,:BW%@R>MMNFV-JE/G7328][
MC;;F-NM%X2XO+"]W A9E+-'))9OM.5W6(WF1BJCUZ>!S,.\M1EB+K<$[,^':
M=S4;DT>"ZZR_5Q%UO@FV'A:)T?;:KM,ODLIEO<'%X6."2ZNWQ=<VL_-X*I5M
M*4-W7:R=/=9;9;ZRZ^M(K3B<S=6[K=;;DOOO]3;BBVLTKQ\_(Q]3X/36&9:N
MT_J>/43YW/;<,CAZE8&M;5'+Q6O,O _>ESYLLSZS'ZNG%PUJ\]=I=-@BWU.>
M,TS/#2(X/'P>1KQO.:  +Q8KWKLO)XO6(5!E].>>7T'@]G;S1T,L\GNP[?\
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M\I=. E0
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M%0%0%0%0%0%0%4T=G7WZS7DL?LA$^\GL[.>>A8'<R?[V3JQTK"D%6F
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MIOVEZ4^$[;V1"R=Y=FR=65.[G[;BZ\/T%*G7L
M
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MOE1W3]VM)@R6Y+=JMLUCA^1+1P4I
M
M      :;K?<G!Z"FLX<O;W4SKUKWQ+:LC>B)&K47FYY&>J.EH]WY-3$S;,<'
M*YNLWACTLQ%\3P\C5/XB=%_W')_@H/;S?_(L_+;\/Q.?^?8.2[X/C/XB=%_W
M')_@H/;Q^19^6WX?B/S[!R7?!\9_$3HO^XY/\%![>/R+/RV_#\1^?8.2[X/C
M/XB=%_W')_@H/;Q^19^6WX?B/S[!R7?!\9_$3HO^XY/\%![>/R+/RV_#\1^?
M8.2[X/C/XB=%_P!QR?X*#V\?D6?EM^'XC\^P<EWP?&?Q$Z+_ +CD_P %![>/
MR+/RV_#\1^?8.2[X/C/XB=%_W')_@H/;Q^19^6WX?B/S[!R7?!\9_$3HO^XY
M/\%![>/R+/RV_#\1^?8.2[X/C/XB=%_W')_@H/;Q^19^6WX?B/S[!R7?!\;W
M=([O:;UEF&83&6M[%=/C?*C[B.)L?+&E5XLE<O\ H-75;KRZ>S;NF*>*OQ-K
M2[UQ:B_8MB:^/_E(!R'8   "FNXGSZU#Y?/Z]2S]W]FLZL*=WI/^WDZTM9-]
MS:@*@*@*@*@*@*@*@*@*K-]G[YCW'PC-[%"0+?W:(ZL=,K+[M=EGK3T0E4CR
M4L-O]JNE?TP6RT;WG2=U?0 S -6W)^8>H/(Y#I;L[5CZSC;[[#EZLJ=EIJ'
M          !>'%>]=CY/%ZQ"G\OIW<\OHK3^RMYHZ&8>3W .N>%L\3HG]#DZ
M>\O<4#KM)G21K'+_ %\2\DB>;W%]$"M>_GSY9Y#!Z^0L3N_V;[4^93??#MT=
M2WIE%U21H74J"I4%2H*E05*@J5!4J"I4%2H*IH[.OOUFO)8_9")=Y/9V<\]"
MP^Y7MLG5CI6%(*M4        TO<WWEQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D
M,              -&UOM-I3<+(VN1U*MW*ZSB6"WMX9UBA:CG*YSN5$KS.X(
MJUZ$0Z>DWEETULVXZ</B<77[GP:V^+LM9V8I$5I#/T7MUI'0$5U'IBQ6U=>J
MQ;J5\DDTC^KKRIS2.6B)5>"=\\M5KLVIF/636G$]]#NS3Z.)C%;3:X^&O2VH
MT73 ,:\E<UC88OZ^9>5GF)W5]! .Z&)L$38F>E:E/^D#F       !B7C71JV
M\C2KX?3HGVT:]*>AT@93'->U'M6K7)5%\Q0/H
M
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M7#CP69+;]JZ[CCD_XXG.TFNU&759,5^/9LLXKN7A^&O'P<3?SE.Z
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M7)&BHJ]_H3@JG+TFBC59YMM^;9%9K/@M^-V]?O&[0Z:VZ^-K)-(B(\-WQ?\
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M20HK8G7",3K%8BU5&JZM/,(UDV=J=GBKP<R9XHOBR-OTJ16G%7PLL\WJ
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M]6.E88@BV@       #2]S?>7$?K'IWXXM0S##T+\^=S?A>P^)K("0 P
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MN_WNB'3[O=@Q\T_>EI5S_P#=59_!:_X60Z5OZ5/6\\.-=^NQU/\ QERU'_\
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M\"KS<DC55CVHO"J(YJHBTXH1O5Z><&6[',UV93#0:J-5@LRQ%-J/^7OFJW@
M                                                 !Y4EFS(7,LC
M5Y(V49SHE>9R=/U.@#/MK:.UCZN/SU5>E5 [@   !7SM(I_;]/+W4ANJ>BZ*
MOUB8=W_1OYX\Z$]Y/3Q\T^9!Q*41          "3-A_V@0^2W'K4.'OKLT\\
M._N'M4<TK4$"6*   %-]Q/GUJ'RZ?UZEH;O[-9U84OO7M>7K2UDWW+
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MQV12VV*0SSR>X
M  !C7DKF,;%%_7S+RL\SOKZ" =T,38(FQ,]*U*?](',     *^]I#_?]/_>;
MGUT9,.[_ *-_/'G0GO)Z6/FGS(-)4AX          29L/^T"'R6X]:AP]]]F
MGGA(-P]JCFE:@@*Q@   ION)\^M0^73^O4M#=_9L?5A2N]9_V\O6EK1T'+J
MJ J J J J J J J JLSV?_F1<?",WL4) =_]HCJQTRM'NOV2>O/1"5".I:
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MHZ9[&HUSU1*(KE1./#OGZFZ9X)?F+8B9F(XW:?E^@
M                                                           !
M\54:BJJT1.*J!BVJ+/(^]>G!W@PHO<8G=]$#+      !7WM(?[]I_P"\W/KH
MR8=W_1OYX\Z$=Y?2Q\T^9!Q*T/J J J J J J J J J JDS8?]H$/DMQZU#A
M;[[-//"0;@G_ &HYI6G("L<   *;[B?/K4/ET_KU+1W=V;'U84GO:?\ <R]:
M6M'0<NH"H"H"H"H"H"H"H"H"JS.P'S(N/A&;V*$@&_\ M$=6.F5I]UNR3UYZ
M+4J$=2T  :MN3\P]0>1R?6.ENSM6/K.'O[L&;JRIT6N^>P           7BQ
M7O78^3Q>L0IO-Z=W/+Z8TWLK>K'0S#R;    5AW]^?3/((/7R%C]W>R_:GS*
M0[ZS_OQU+>F46DE0:H"H"H"H"H"H"H"H"H"J:>SI[]9KR6/V0B'>;V=G//0L
MKN)/]_+U8Z5AR!+>        -+W-]Y<1^L>G?CBU#,,/0OSYW-^%[#XFL@)
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MIN7E[ZH,FYK]B;\5UN2(^CQL8N\6+UD8\UEV&9XMJ.#W? E&[59I&63."/\
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M+YZ&<F.['=-MT4F'YQ9;,MD7V36V>*66>;U
M                          &)=JLSV63%IS^%,J=R-/L@92(C41K4HU$H
MB)WD ^@      K]VC_\ ?M/_ 'FY]=&3'N_Z-_/'G0;O-Z6/FGS(.)4AP
M       27L1^T"'R6X]:AP]]]FGGA(=P=JCFE:<@"R0   ION)\^M0^73^O4
MM+=W9L?5A26]NV9>M+6CH.4          %F=@/F1<?",WL4) -_]HCJQTRM3
MNKV2>O/1:E0CB7  #5MR?F'J#R.3ZQTMU]JQ]:'#W]V#-U94Y+9?/(
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M0Z++FR8JYK-BZL\%:O?-5O
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MEN9SG7                                    /BN:E*JB5Z*@?0
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MMJJ>JJ"4CA@      !7[M'?[]I_[S<^NC)CW>]&_GCSH)WG]+'S3YD'DK0P
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ME>*JJKPZ$TMY:[\5DVHBEL12(='<^[/P.&;9G:NNFMT^-OIRW;
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M0%0%0%0%0%0%0%0%5F=@/F1<?",WL4)7_>#M,=6.F5L=T^QSUYZ+4J$<3$
M:KN5\PM0>1R?6.GNOM6/K0X/>#]/S=25-RVGSB           "\V)]Z['R>+
MUB%+YO3NYY?4FF]E9U8Z&8>38   "KO: ^?C/((/7R%E]V^R_:GS*$[]?J,=
M2WIN162= *@*@*@*@*@*@*@*@*@*IL[.'OWF_)8O9"&]Z/96<\]"T?\ KZ?]
MC+U8Z4_0?V:=UHO]4^KX/_:;Z!7ZZ68       !I>YOO+B/UCT[\<6H9AAZ%
M^?.YOPO8?$UD!O4UU;P*C99$:Y>A.E?] 8=-HBSR/O7=#O A3O,1>GT5 S
M            84RI9W"7/1!-1DWF.3H<!D0W$-PBK"]'4Z>_]10.T#XYK7M5
MCDJUR45/,4#!ANH[3FM;E]%C6D;EJM6+T='> SFN:]J.8J.:O%%3H ^@
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MG9NI*FY;CYM           !>;$^]=CY/%ZQ"E<WM+N>7U1IO8V=6.AF'DV0
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M>*6..1[T5K'JG*B^9TJ&'I@8;_[5=)%TP6ZHZ3O*_N)Z &8
M##B_LMRL"\(9JOB[R.[K0,P
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MJ)7I#+V@P
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M_P#7O:,W5CI6)*_76ZYX6SQ.B?T.3I[R]Q0.NTF=(Q8Y?Z^)>21/K+Z(&0
M   &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!ATW,'7Q*Q%H]/"C=WG)T
M* M9^OB1SDI(U>61O><G2!W           #&O)7M:V&+^OF7E9YB=UWH(!W0
MQ-AC;$STK4H@',             &-<V-O=.1\B*CTX<S5HJIYH'79(EN^2R5
M**U>>-WJF._UIT 9H             ,*\:ES)'9HE?\ XDCO4M3O>:H'9;6-
MO:JKHT57KPYG+5: 9(
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MHRYEZIS.K<OI>-47ZP&>    -+W-]Y<1^L>G?CBU#,,/0OSYW-^%[#XFL@)
M# !AR_V6Y2X3^IFHR;S'?:N_U 9@         !\54:BN<M$3BJ^8@&+:(LTC
M[UZ>G\&%%[D:=WT0,L               !C7D3E:V>)/Z>%>9J=].ZGHH!W1
M2MFC;*Q:M<E4 Y@          #A-*V")TK_2M2O_ $ =-G$YC'32_P!?,O,_
MS.\GH(!D@
M           QKR5S6M@B_KYEY6^8G==Z" =T4388VQ,X-:E$ Y@   #2MV_V
M=9[[S'[-&=/=?:K.?S2Y6]NR7\WGA3\L96(          <F4YF]ZJ"2)7R9Z
M5OG(5/*XH?3#(  @#M&_[]@/O5SZZ,F?=WT;^>/.KSO9Z>/FN\R$"6(,
M      $E;%?/^'R6X]:APM^=FGGA)N[7;(ZLK2%>K6 .,DC8HW2/6C6I50,>
MSC=1US*E)IO"IZEO<0"H6XGSYU#Y=/Z]2UMV]FQ]6% [ZG_>R]>[I:R=%QZ@
M*@*@*@*@*@*@*@*@*K(;%0.?H2Y?$O\ 3LR4TD?GI#"E/10KWO#VF.K'3*X.
MYW8KNO/W;4LP3-GB;*WH<G%.\O=0C2;.P !JNY?S!U#Y'(=3=7:\?6A'N\?Z
M;GZDJ:EO/F(           %Z,3[U6/D\7K$*3S>TNYY?6NE]C9U8Z&8>+9
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M^+O(_NM S           !AO_ +5=)'TP6ZHY_>63N)Z &8
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MW-NV54H[BCD3HJ@89 &J[E_,'4/D<AU-U=KQ]:$>[Q_IN?J2IJ6\^8@
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M)&WON7H Y6T"6\21UJ[I>[ON7I4#M
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M=<KQABJR#S5^V=_J S
M          #KGF;!$Z5W&G0G?7N(!BPX^%6I+<L1]PY5>_II5>-*=' #.
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M(5+*Z8<C#(  @#M&?[]@/O5SZZ,FG=ST;^>/.KCO?Z>+FN\R$27($
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MK;2^QLZL=#,/%L@  !6'?WY],\@@]?(69W;[+]J?,H#OY^I1U+>FY%I)U>@
M        !-/9T]^LUY+'[(0WO1[*SGGH6K_UYVC-U8Z5@KB9MO$Z5W&GI4[Z
MKT(5\NQQM(711UDXS2+SRKYJ]ST .\ !USS-@B=*[[5."=]>X@'3;6K49UEP
MUK[AZ\[W*B+15[B><!E  -+W-]Y<1^L>G?CBU#,,/0OSYW-^%[#XFL@) #
M  =3+:WC>LC(VM>O=1 .T      '5XM;]9UO5-ZSIYJ=T#M
M       !TW:QI;2K*E8^5:IW0/(@RT\:L;(B/C2B+ZJG?J&7J^/6?W9OU0P>
M/6?W9OU0'CUG]V;]4!X]9_=F_5 >/6?W9OU0'CUG]V;]4#R9\M/+SL8B,B<B
MHGJJ+YH9>S;+&MO$L24CY4Y4##M
M                   ,/_>[OOP6R^@Z7_W0,P    5U[2VG-UM99/3&!TQI
M+Y4[=6<T>5U)CF9*VQCLA/#(O5VDCYGHY(FHG.[E:O,KNXK44,PB[06I]SG]
MK7*WMUM]'89N\P]E8YO"-REL]F,Q*R6+'7K9F)R2\C6L5(6>$O-3N!GP-YW:
MV)V:CTWJS<[&9^YP.I%6]RR:AM<J]S'9-5?+U?+SJU5=)X"1QT=QHWB&*MCV
MJWH;@^SG@MQ]WL@Z&X2*>%MQ*E;S()!/)%;]7&M%DED8Q./VWIW*C:J"C7]I
ML7E]P]Q'=H#7T]M8922W6TT'I%MS%+/:8N1CE=+(U%YEEDC>Y>BOA.541.5&
MA9UCVR,;(Q:M<E47SPPY 8EVBPO9>L2O)X,R)W8U[OH 92*CD1S5JBI5%\Q0
M/H  !I>[7[.\[]YC]FC.INKM5G/YI<??/8\G-YX5"X%D*JJ< 5. *G %3@"I
MP!4X J< 5. *G %7UE.=OGH8DB5[F>D;YR%2RNR'(PR  ( [1G^_8#[U<^NC
M)KW<]&_GCSJW[X>GBYKO,A$ER 5 5 5 5 5 5 5 5 5 523L8U%U_ O>MKCU
MM#@;][+//"4]V(KKHYKEF+;^S3.LW?U:U? O^SW6^@5VMYF  .BYB61K7L_K
MHEYXU\[I3T4,2S"G6X#D?KC4"M141;Z5:+TU<O,O^E2VMV372X^K#YVW[&SO
M#-'UY^'A:X=)Q*@*@*@*@*@*@*@*@*@*K,=GUC4T3<.IX7NA,E?,ZN-W^LKK
MO%VJ.K'G75W+G_0F.2^[HB4KD93EQDD;%&Z1ZT:U*J!B6]JR9JW%TQ'2RKS(
MCN/*WN)]0#PMR41- Z@1.")9243T#J;J[7CZT(]WC_3<_4E3@M]\P
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MSD151O*Y*KYZH!YC<M=I)SN5%97BRB(E/,[H9>\U4<B.3H5*IZ(8?0
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MA&;V*$KKO%VF.K'3*Z^Y789Z]W1:E4C*=L.;^U7*6Z?U,5'S>:OVK?\ 6!F
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MS$##Z           /CFM>U6.2K7)14\Q0/)FQ3(46:-5D1BH[JE[K4Z4JGF
M>K&]DD;9&+5CDJ@'(
M  QKR5S8TBCXS3+R,3S^E?00#Y!C[6!6N:RLC43PEJO'OTZ ,H      &'/C
MK:5'N8SDF7BCDK3F[].@#MM9UGB17)25J\LC>\Y.D#O
M   !AV_]IG=>._JVU9 GF=UWH@9@           Z+J!9HO 6DS%YXG=YR?9
MYPR++$UZIRN5/";WE[IBH[#(QKR)SV-FB_KX5YF>;WT]% .Z&5L\396>E<E?
M^@#F  TO=K]G>=^]1^S1G4W5VJSG\TN-OKL>3F\\*AEDJDJ J J J J J J
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MM97+S2.[[EZ0.X#5=ROF%J#R.0ZFZNUX^M"/=X_TW/U)4Y+??+X
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M[[1FZL=*PI7R[@#$O'.>K;.-:/F].J?:QITKZ/0!E,8UC48Q*-:E$3S$ ^@
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M_P"N^T9NK'2L(5\NYQD>V-CI'K1K4JJ^<!CV;'.YKJ5*2S<43U+.X@&4
M &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360&Z2_VJY2W3^IAH^;S7?:M_P!8
M89@                  PW_ -ENDDZ(+A>5_>23N+Z(&8
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MG1/]*Y*?]('39RN>QT4O]?"O*_S>\OHH!D@
M              !AR_VJY2!.,,-'R]Y7?:M S             *E>"] &';*
MMO,ZS=Z3B^!?]E>EOH 9@       '!LT3I'1-D:Z5G%[$5%<B+WT[@',
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MS*YC^]3I^K4#KQN0FFFZB9>?F15:ZB(J*G'N >L!C>/VG6=5UJ<U:=VE?/Z
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M)YP4B  &F;L_L\SOWJ/V:,ZNZ>U6<_FEP]^]AR<T=,*BEFJ7J J J J J J
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MU>G^;,]\(W?L[RTM)[&SJQT*>UL_W\G6NZ7C4-IIU* J4!4H"I0%2@*E 5*
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M;144-HJ*&T5%#:*BAM%10VDF;$._S_"B<*VMPB^=1.!'>\$?ZD\\)MW,N_\
MHQU;EI2M5Z   !3/<5/\]ZA\OG]>I<&Z^RX^K#Y>[P_J.?KW=+6:'3<$H H
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MBJ"AM%4%#:*H*&T504-HJ@H;15!0VDF;$+_S A\EN/6H1SO#V2>>$W[ES_\
M1CJW+3E9KZ   "FFXOSZU#Y?/Z]2X-U]EQ]6'R]WA_4<_7NZ6LT.FX!0!0!0
M!0!0!0!0!0!0"S?9^^8]Q\(S>Q0E:]Y>U1U8Z97YW!_3KO\ )=]VU*Q%EB,:
M\B<YC9HOZ^%>9GFIW4]% .Z&5L\396>E<E?^@#6MQ_F+G_(Y#J;J[7CZT(YW
ME_3,_4E4"A;[Y;* * * * * * * * * * 7<Q7O79?>(O6(4EF]I=SR^O=)[
M&SJV]#+/%M   !23M7)_S1C^"[7V28L7N]V7[4^95G>CMGV8\Z#J$D1,H H
MH H H H H H H!8SLBHUN?U1,Q'+=,L;=8Z>E5B3*KVJG?6C:$/[RU]79SST
M)UW2F/69(\4+>QR-EC;(Q:M<E4(,L5S        TO<WWEQ'ZQZ=^.+4,PP]"
M_/G<WX7L/B:R D ,                      '3<P=?$K$6CT\*-W><G0H"
MUGZ^)'.2DC5Y9&]YR=('<           ,-O]JNU?TP6ZT;YLG=7T ,P
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MK;T,L\6T   %)>U;^U"/X+MO9)BQN[W9?M3YE5]Z.V?9CSH.)(B8
M  61['_SDU)Y##[,1#O+[.SGGH3CNE[7)U8Z5KHO[+<K;K_4S5?#YCOMF_ZR
M"+(9@       &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@
M             >)>7C[>\E\6\&M$DKQ17)W0R]&PNUNX5<]*/:O*ZG0OFAAE
M         ,>[E=&Q(XOZ^5>2/S.^OH =D$+8(FQ,Z&IT]]>ZH'8
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MO3IKWZ!EZ?7P_=&_RD#!U\/W1O\ *0!U\/W1O\I '7P_=&_RD =?#]T;_*0
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M2>0P^S$1[R^SLYYZ$Y[H^UR=6.E;@@:RF')_9;I)NB"=4;)WD?W%]$#,
M  !I>YOO+B/UCT[\<6H9AAZ%^?.YOPO8?$UD!( 8
M  ,>\E<QB11?U\R\D?F=]?0 [(8FP1-B9Z5J4\_OJ!V         -9NIYI9G
MK(Y:HJIR]Q$Z*4#+W;![Y+2)STHM*=[@BT0,,D             'BYF1_7QL
MZ&M;5J^:O!?K!EVX>:5_61/57,:B*BKQHJ]P,/5 XO56L<YJ5<B*J)WU UE;
MF=TG6K([K*UK4,O;CN;QT;'+:JY51%KSM2O#IHO0&'/QB\_NB_A&@/&+S^Z+
M^$: \8O/[HOX1H#QB\_NB_A&@/&+S^Z+^$:!XEU<7$D[W2*K7-541E?2T[G
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MA%14146J+Q14 QIK"UG<KWL\-?MD547SP/EE([D=;R?UT'@.\UOVJ^B@&4
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M^G7?Y+ONVI3(LL8  :/O)^RW5?P=-]8Z>Z^U8^M#D;X['EZLOSRH6PI(H H
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ME 5* JE/L_L:NN9W*E53'34\Q>MBX_Z2/;_[/'6CHE*N[,_[<]2>F%G"!+,
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M@   I;VID_YFQ_!EM[)*6/W=[+]J?,J7O7VS[,>="="2H@4 4 4 4 4 4 4
M4 4 L7V1OG'J/R*'V4B'>;V=G//0GG<_VV3JQTK9D"6:  ,:\B<YC9HOZ^%>
M9GFIW4]% .Z&5L\396>E<E?^@#F   :7N;[RXC]8]._'%J&88.D)4AUON'(C
MDZF3,V44K.ZQZ8:PHZG>=W^_7O 2$&                    ,.3^U720)Q
MA@H^7O*[[5H&6YS6-5[EHUJ55?,0#%M&K*YUY(E'2\(T7[6-.CZO2!E@
M    ,:\B<]C98OZ^%>=GF]]/10#MAE;/$V5GI7)7SO, [ ,:\B<]C98OZ^%>
M>/S>^GHH!VPRMGB;*STKDKYWF =@        #$NW.E>RRC6BR>%*J=R-.GZO
M0!E-:C6HUJ4:B41/,0#Z 541%55HB<54##M46XE=>N3P5\"!%[C$[OH@9@
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M!:P=1$C%6LB^%([ON7I4#IN56XF;9M])Z>=4]2G0GH@9B(B)1."(
M   ,-G]ENECZ(+A>9G>23NIZ(&8  PV?V6Z6/H@N%YF=Y).ZGH@9@
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M*SKQAAJR+O*[[9P&1/,V")TKNAJ<$[Z]Q .NTA='&KY>,\J\\B^:O0GH 9
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MIU]5^L0[O/[.SGGH3_N;/]W)U8Z5K,<C8XGV].66)RI(G?KT.]%"!+.9@
M U>Y?(ZXD=)PDYEKYE R]>UGOW6\:]2CTIP>YU%5 P[NMO\ ^[M_E_\ 0!J&
MY#[AV"QBRQHQ[=0Z=6)J.KS+[L6O!5[@9=.A?GSN;\+V'Q-9 ;^J(Y%14JB\
M%0,,6U58)'V3UX-\*%5[K%[GH 98               #&O)'(UMO$O\ 33+R
MM7O-[J^@@':QD=O$V-*-8U*)7@!C_P"]W2(G&WMUJJ]QTG_0!F
M    PYO[+<-N4X0R49/YB_:N_P!0&6US7>E5%ITT6H'7/!'<QK%(G@KW4Z47
MOH!C6V,AMI.MYE>Y/2UX(@&<     '&1C9&.C>E6N2BH!@QXB".5'JYSFHM4
M8M/]('H  ,6[L8KNBN56O;P1R=[O*!TV4+;.>2V7BLB(^.3U2)TIZ 'H
M      &A;S_LVS7_ );_ !41U]T=JL]_HEQ=]]CO][[T*DEB*PJ J J J J
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M$IYP8<9(HY4Y96(]$Z$5*@8K$2SN>J3A;S\8^\UZ=*>B!F@
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MDQ)W$QELB?A)2R>[G9?M3YE/][I_W8ZD=,H8H2=#*E 5* J4!4H"I0%2@*E
M5* J4!587LG)34.H?(H?92'=Y_96<\]"P.YGMLG5CI6K( M, PX_[+=+#T03
MJKH^\C^ZGH@9@     :7N;[RXC]8]._'%J&88.DYDM]:[AW"N_H'9FSBF91?
M!>W"V"HY.XJ*B^?_ * -\@N8+E%6%_-3I3H5/04,.X
M  &'/_9;AMTG"*2C)_,7[5W^H#,           &&O]KNZ=,%LM5[SI?^@#,
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M[1/S@P_D;O97$][M>ROZWF5#WXG_ &,?5\Z&B6J[V@&T V@&T V@&T V@&T
MV@&TE7L_K_GBX2O'W.F6GF=;"1KO%V:.M'1*<]RIKKKH_P#X=WWK5FBNET@
M !2;5Z?YLSWPC=^SO+GT79\?5MZ(?*F]NVYO\E_WI>-0W'+* * * * * * *
M * * 6CV$^83?+)_K,*Q[Q]K^S#Z![B_IOV[O,D\C2?  #3-UW-;M[G7/<C6
MI%'5SE1$3^F9W5.SN7MF/G\THKWKB9W7FB.2/O0J1U]M_>(?PC/LELUA\T>I
MOY#K[;^\0_A&?9%8/4W\AU]M_>(?PC/LBL'J;^0Z^V_O$/X1GV16#U-_(=?;
M?WB'\(S[(K!ZF_D.OMO[Q#^$9]D5@]3?R'7VW]XA_",^R*P>IOY#K[;^\0_A
M&?9%8/4W\AU]M_>(?PC/LBL'J;^0Z^V_O$/X1GV16#U-_(^LGMN=O]HAZ4_^
M(S[)B9AF,-]>)>AGI&^<A1\OK^.)],,@ "J';!]]-*?>+SU\).>[/HY.>/.K
MGO=Z>+FN\RL]"8H$4 4 4 4 4 4 4 4 4 F;LO)_S6MO(;OUJ$>W_P!EGGA*
M>[';8ZMR\)6RV@   _//=M/^9NK/A.Y]D4MO=O9<?5A1F]Y_W,O6EIE#HN34
MH"I0%2@*E 5* J4!4H"I0%2@*KG=E1*;:W7PM<>P6Y7/>/M,=6.F5L]T^QSU
MYZ+4XD93   :5N]^S+5/P?+]8Z>ZNUX^M#C;[[#EZLJ!4+<4.4 4 4 4 4 4
M 4 4 4 *G#AT@?HWB$O_ ')Q_5K#R>+04JCJ_P!6TI7+Z=W/+Z+P4]7;S1T,
MVF2[\'U'_9/)[%,EWX/J/^R!A9-+[J$696+$CO"ZOF]"M>X&6-B>L\;;R5Y*
M+UG>I3[(%6.T]^TF/X-MO7REE=W.R_:GS*<[W=MCJ1TRABA)D-* * * * *
M* * * * 6$[)_P X=0^10^RD.[S^RLYYZ%@]R_;9.K'2M40!:8!C7S6+;/<]
M>7D\)KDZ4<G10#$M\PCWMCF9RUHG.B]WS@/4    &E[F^\N(_6/3OQQ:AF'C
M8-CY-6Z_E8J]6S,VD2QTX<_N/8.YD[ZJCD1?. W/$03),LRM5L:-5*KPJJ@>
MT&                    .,C&RL=&]*M<E%3SP,>S>Y$=:RK66'@B^J9W%
MR@        '1=S.BCI'QFD7DB3_:7N^@!RMX6V\38DXT],[OJO2H':
M    48SC43-9)$3AXU/3\(XM/#[.WFA4V:?[EW/+ H>KQJ4!4H"I0%2@*E 5
M<7Q1RMY)&(]G3RN1%3ZBF8F8XGYNB+HI,5ARHB<$3@G08?JI0%2@*K6['2Q-
MVYQZJ]J(LUU2JHGI9WHOUB ;Y[5=S1T+#W)-=+;/CNZ4B]?!]T9_*0XSN'7P
M?=&?RD =?#]T;_*0".-YLBDFWV<AB3P6I!22O=9<1N^IPH=G<O;+/?Z)1SO+
MP;MRSR1$_P#ZA5TLE3M0%0%6=B\+FLXZ5N$QMSD5@2LZVT:O:S_K.X(B^96I
MXY<V/%3;NBVO*V,&GS:B9]59=?3CI'%[_%[W&P4\)6M8BO>]R1QL8BN<Y[EH
MC6HE5557N(>S6VX\'#6:>_R<[V,EI+5>&L_=#+X.\LK#@CKF:*C&UZ.>BJK?
M^U0U<6KP9;MFR^VZ>1OY]#JL%FWDQ76V\L^#GI,T]]TXO3VH,ZV5V#Q=SD66
MZHV=ULSG1CG)5$=Q3BJ'[RZC%BIMW1;7E?C!I,^>LXK+KZ<=/ X93!YO!211
M9O'7&.EG1SH&7+.17M8J(Y6\5Z*H9Q9\>6)FRZ+J<C\Y]/FP3$9;)LF>*OA8
M![-:H"K(L/\ ?K7[['ZY#\9/1GF>N*?GQSPO*5 ^@    KIVBU_S!A_(W>RN
M)_W9C^U?UO,ISOW=34XNIYT,U)=16^V5%#;*BAME10VRHH;944-LJ*&V5%#;
M*BAME10VTH;"M<NM;I\:TE9CIGM;W'*V6).7T>;_ $$7[R1_JQUXZ)3[N-=$
MZ^[_ !S]ZU9Z&5DT;96+5KDJA72[7,   I1J_P"=F>^$;OV=Y<VB[/CZMO1#
MY3WMVW-_DO\ O2\8W7*          "T6POS";Y9/_P"R5CWC[7]F'T%W$_3?
MMW>9)Q&D_  $;[^I7:#5*+_=XO\ $Q'7W1VNSG\TN)OSL63FCIA^?/5M[R?4
M+2HIW:DZMO>3Z@H;4G5M[R?4%#:DZMO>3Z@H;4G5M[R?4%#:DZMO>3Z@H;4G
M5M[R?4%#:DZMO>3Z@H;4G5M[R?4%#:DZMO>3Z@H;4N4<;>L;P3I3N>:8F"+I
MJ_4J/^K;YR?6*8E?D<3D89  %4NV E<GI3[Q>>OA)SW9]')SQYU<=[_3Q<UW
MF5HH3) :E 5* J4!4H"I0%2@*E 5* J4!5,O9@3_ )JV_D5WZU"/=X.R3SPE
M7=CML=6Y=\K5;8   ?GMNTG_ #-U7\)W/LBEM[L[+CZL*+WQVW+UY:90Z3D5
M* J4!4H"I0%2@*E 5* J4!4H"JYG95_9M=?"UQ[!;E<]X^TQU8Z96UW2['/7
MGHM3@1A,0 !I6[O[,M4^02_6.GNKM>/K0XN^^PY>K*@E"W%#% % % % % %
M% % % % /TAPGO+CO)8/8VE*YO:7<\OHS3^RMYHZ&>>3W "HBI1>*+TH!Q:Q
MC$HQJ-3O(E *=]IW]I,?P;;>OE+*[N=E^U/F4YWO[='4MZ90S0DR&% % % %
M % % % % % +!]E'YPZA\BA]E(=WG]E9SST+"[E^VR=6.E:D@"U #&OTC=:2
MI(O*VE:^:B\/]('F6^)G<]CIJ,CX.7CQ\X,O<#    :7N;[RXC]8]._'%J&8
M8FB6I<:UW#NJUACS%HR%M?MO<:PYG4\WO_8##?P
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M6H9AB:$54UKN1"G]7#E;".-O>;[CV2_755 W\,
M'"9_5Q/?2O*U74[]$ UR.\N(E18Y%1J=#*^#TUI0,O;;?U:B^+S<41>#*I]<
M,/OCW_TT_P#(_P"D!X]_]-/_ "/^D!X]_P#33_R/^D!X]_\ 33_R/^D!X]_]
M-/\ R/\ I \:XO;F9[U5[FL6J<B<$1.BBAE[=B_K+2)W+R\*43H\%:?Z@PR
M          !1S.)_ZUDO*I_9'%JX?9V\T*;SS_<NYYZ6!0]GAM% ;10&T4!M
M% ;10&T4!M% ;10&T4!M+6['_L[Q_P!^N?9G%?;Y[5=S1T+-W#V2WGGI2*<5
MW@ !HF\G[.,S_P"6_P 3$=G<O:[/?^[*-=Y9_P#GY/L_>M5-+-HI':!0V@4-
MIOVT6H<+IG4>1OL[=MLK2?'26\4KVN<CI72,<C?!15Z$4XF^--DSX;;<<;4Q
M=7WJ)/W:UV'2ZF^_-=%ELV4B9Y:O-VOU18:,U7'F,M$YUA)#-:S21ISR0I*Y
M')(UJ=/I:.IQH;&]=)=JL&Q9QUB>>G@:/=_>&/0:KUN7T9BZV?#LUFM:=/A;
M;I?(:%VWR65U+8ZJ=J&>\ADALL5;PR,DE61_6(ZY<_A5%2G,M.ZOF'+U6+4Z
MVRW%=B]7%L\-TS'!X/FI!H,^@W7DR9[=1ZZ;XF+;(B:S6:_.\?@K-/"U'!:<
MT3E\5#<Y?6+,'EG22+?X^2T=)&UBO<K4A<BHBU;3O][N'5U&IU..^8LP[=O!
M2=KI<#1Z+19\479-3&&^L[=DV\%*SP6\7@YV9N'JO#YR+!Z>TTDK]/:;MUM[
M:[N$5LEQ(YK6*Y$5*HU&M2E:55>BAX[NT>3%-^3+3;R368CP-C?6\L.HC%@P
M5]5@BD73_%-*>2(\/AEI!V*([M H;3(L/]^M?OL?KD//)Z,\SUPW?/MYX7E*
M=?1P   5R[1OSAP_D;O97%A=V/8W];S*2_[![3BZG_DA>A,%7E % % % % %
M % % % )7[/GSYN/@Z;V6$B_>7LL=:.B5A]POU"[_'=]ZU8^7$V\DJR(YS4<
MM7-2E*^85JOIFL8V-C8V)1C4HB <@ %+=7U75F>55JJY&[557[^\N?0]GQ]6
MWHA\H;WG_>S_ .2_[TO&H;CE% % % % % % % % % +/;$?,1/+)_K-*R[Q]
MK^S#Z$[A_IGV[O,DTC*P  !'._7[(]4?>(O\1$=?<_:[.?S2X>_>PY.:.F'Y
M_P!"U%,5* J4!4H"I0%2@*E 5* J4!4H"KE&G](WST^N8DB>%^H4?]6WSD^L
M4M+Z"CB<C#(  JKVO/?/2OWB\]?$3KNSZ.3GCSJV[X^GBYKO,K70F2OR@"@"
M@"@"@"@"@"@"@$R=F-/^:EOY%=^M0CO>#LD\\)7W6[='5N7:*U6\   'Y];L
M)_S+U7\)W/LBEN;L[+CZL*'WQVW+UYZ6G4.DY%2@*E 5* J4!4H"I0%2@*E
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M<GVO+]L&5M=N-6)KO0>G-8=6D,F9Q]O>30MJK8YI&)UK&UXT:_F1 _+9P
M    */9SWZR7E4_LCBU\/L[>:%*:B?[MW//2P#V>&T V@&T V@&T V@&T V@
M&T VEK-D/V=X_P"^W/LSBO-]=JNYHZ%I=W^QV\\]*1#BI   -$WE_9QF?_+?
MXF([6Y>V6>_]V48[T33=V3[/WK53*EG447M%10VBHH;144-HJ*&T5%#:*BAM
M%10VBHH;144-IDV"_P!NM?OL?KD/QDCYL\SUPW?/MYX7E*:?2P   5S[1GS@
MP_D;O97%A=U_8W];S*1_["[5BZG_ )(9H3%5Q0!0!0!0!0!0!0!0!0"5NS[\
M^+CX.F]EA(MWE[+'6CHE8G<']1N_QW?>M6<*U7V   %+M6I_FO._"%W[.\N?
M1=GQ]6WHA\G;WG_>S?Y+_O2\>AN.74H"I0%2@*E 5* J4!4H"I0%2@*K.[$\
M-")Y9/\ 6:5EWC[7]F'T+W#_ $S[=WF281E8   CK?C]DFI_O$7^(B.ON?M=
MG/YI<+?W8<G-'3"@5"U%+5* J4!4H"I0%2@*E 5* J4!4H"KE&G](WST^N)9
MB>%^GT?]6WSD^L4K+Z$CB<C#(  JOVNDKD]*_>+SU\1.N['HY.>/.K7OCZ>+
MFN\RME"9J^J4!4H"I0%2@*E 5* J4!4H"I0%4Q]F1/\ FG;^177K4([W@[)/
M/"5]UNW1U;EV"M%P   !^?F["?\ ,O57PG<^R*6[NSLN/JPH;?/;<O7EIU#I
M.04 4 4 4 4 4 4 4 4 N/V6OV;W7PM<>PP%;]Y.U1U8Z96[W1[%/7GHM3:1
MA,P !I>[?[--4>02_6.INKM>/K0XN_.PY>K*A1;J@0 !NF@\5I?.7#8M6ZPD
MTW%931+CX4AEFZSK'*Z162M7D@5%:WPG)TK7N'+UV3+BBN+%ZRL37AB.;@X[
MG;W9BP9KHC/FG%%LQL\$SQ\=)XK.*.&?,W#>+(7TF[>+OM5V7B&%MO$VVLL+
MTNUGQD,ZO6='MHCW/J]>7N<$\U>9NG';^"NMQ3M73M5\%+J<70[>_<U_YE9=
MGMV;(V:4X:V1=Z7//#P>]XY];*Z8TOO+G,[FM$ZHN?E7*U;MN$R$"P,DBC:V
M-&1R(ZB(B42O'S4IQ-?%J<V[\=EF;'&QQ;437RPV]1H=+O?+DR:?+/K9X=FZ
MVE8B*4B?^6!M1;PY?;;66G=0J["Z3EEBN)M4U:UD-W&L?+;N8Y466O*U>1G?
MIP5S3VWI=./58LF/Y^3AC8Y8X>'Q<\^:6ON2(S:#/BR?V\4S$^L\$7<%+?'X
M."/@K#MW1QSL'M3I+!:?G;G='1W#[I^I6.:J+>R+-2!L2*JQ-1'/6BJO'@M%
M3C^=V9/6ZS)?DC8R4IL?5X.&OA\#][ZQ>IW=AQXI]9BB9GUGUOG<%/!QS[_C
M0>2M P !^C>$]YL=Y+#[&TI/-[2[GE](Z?V5O-'0SCR>X   4][37[1X_@VW
M]?*67W;[+]J?,IKOAVZ.I;TRAJA)T** >OIK,PZ?S,&5N,7:YB&)'M?C[]BR
M6[TD8K%JG?1%JU>XO$UM3AG+CFV+ILGECC;FCU%N#+%]UEN2(_ANXO=R>/A;
MS=[P1V>&O\/HC2]CI;W5CZG(7MNYT]R^)45%:Q[T;RU153NTK5*+Q.19NB;L
MEM^;)=DV>*)X(2#+W@BW%=CTV*W#M\%TQPS3Q32*>;P4GA>5IC<EV(T[)HW4
M&%MM1Z4=-XU%8W+Y()8)EZ70S1K5E:KW.ZO'BM=G4[N]9E]=COG'?2E8X8F/
M'$\;3T>^/58?P^;'&7%6M)K$Q/U;HXO#Y>/C?-1;GY;*Q8;'X.S@T[@]/3MO
M,1C['F>C+ECN9LTCY*K(]%5>*IW5KTC3[LLLFZZ^9R79(I=,\G)%.*#5[ZR9
M8LLQVQBLQ3M66V^">69GCFOA\?"]]^]%E-E6:KN=%8R;7,2-Y,RLDZ1=8QO*
MV1;9%Y5>G<=S53O]!IQN>Z+/51EN]5]'@KS;7(Z$]XK+LGKYP63F^G6ZG/L<
M5?'6OC1GE\K?YW*7>9RDJSY&^E=/<RJB)S/>M5HB<$1.A$3@B<#O8L5N*R++
M8I$11%L^>_-DNR7S6ZZ:RPJ'J\"@%@>RI\X-0>1Q>RD-[T>RLYYZ%B=R?;9.
MK'2M,5^M9AP?VJX==+_4QU9!YJ_;._U 9@      -+W-]Y<1^L>G?CBU#,,/
M0OSYW-^%[#XFL@) #            ,+(M;,QELB5EE=X'^RB=+OJ <;3&1VT
MG6J]9'IZ7A1$J!G@    !PEB9-&Z*1*L<E% \I^-;9JVY5RRQ,<BO92BHWO^
M;0,O714<B.1:HO%%3O!A]        J]J%4_CFTFG?TM*G_<OPSX$C[C;L;&:
M6U+\F=RY[.',I9-NHUO\=)>1K;2N>WD;(V&5*U:J\@%=]LM!+N++OG?[;8N7
M#[7:JQKK#2UK,Q;6WNLE$G/&^)CJ(V-)&O\ ,8V5&]Q40RZ?IIP*]E_Z'TAN
MOI:ZCY*?)3Q6;QSKNOY.?EY.CJNYZ;G\&G=!3A6VVFTK=:(VTTKI2_HF0Q>-
MMX+U&JCFI<\B.E1%3I1'JY$4/RW(       "C^<]^LCY5/[(XMG![.WFA1VH
MN_NW=:>E@4/9X;10&T4!M% ;10&T4!M% ;10&T4!M% ;2U>R'[.[#[[<^S.*
M[WUVJ[FCH6MW>G_2MY[NE(AQ$B  &A[R_LXS/_EO\3$=O<G;+/?^[*+=ZOTW
M+]G[]JIA:"@]H!M -H!M -H!M -H!M -H!M,BP_WZU^_1^N0\\GHSS/;#=_<
MMYX7G*8?3X   5U[17S@P_D;O95+"[K^QOZWF4A_V'VK%U/_ "0S0F*K2@"@
M"@"@"@"@"@"@"@$J]G[Y\7'P=-[+"1;O+V6.M'1*Q>X/ZC=_CN^]:LV5JOP
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MH]E9SST+$[D^VR]6.E9J\>Y4;:Q+26;A7U+.ZI7ZUV1&QL3&QL2C6I1$ Y
M     TO<WWEQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D ,          !\<Y&M5S
MEHU$JJ^8@&+:-65[[V1*+)PB1>Y&G1]7I RP       /BHCD5KDJB\%3S% Q
M;15AD?9/7TGA0JO=C7N>@!E@       =*VEJZX;>.@C6[:WD;.K&]8C5[B.I
M6G$#IO\ $XK*M:S*6-O>L8M6-N8F3(U>^B/1: 93&,B8V.-J,C8B-8QJ(C4:
MG!$1$Z$0#']S,;X_[J>)P>Z:MZOQWJF=?R='+UE.:GF5 R@        %(,W[
M]9'RJ?V1Q;6"/[=O-'0HC4W?W;^M/2P3VHU]H%#:!0VGS@O0*,;1P%#:?10V
MGRJ51*I5>A.Z9H;?@?3%&=H%#:!0VEJMD?V>6'WVY]F<5UOOM5W-'0MONYV&
MWGNZ4AG$20  :%O.M-MLU_Y;_%1'<W'VRSW_ +LHEWNFFZ\OV?OVJD\Q:='S
MSZPYA0]8<PH>L.84/6',*'K#F%#UAS"AZPYA0]8<PH>L.84/6,BP=_;K7[]'
MZY#\9(^;/,]L&3^Y;SQTKUE)OJT   *[=HE*Z@Q'D;O97%A=U_8W];S*/_[#
M[5BZG_DAOE)BJVIR@J<H*G*"IR@J<H*G*"IR@J<H*G*"J5.S^E-;W'P=-[+"
M1;O+V6.M'1*Q>X'ZC=_CN^]:LR5JOT   /S6W 3_ #[JGX7R'^)D+>T?L+.K
M;T*-U\_[.3KW=,M=H;;2J4!4H"I0%2@*E 5* J4!4H"I0%5W^ROPVK;\(W7U
MF%<=X.U?9A:O=CL?VI\R;".I4  ([WV_9-J;[Q%_B(CK[G[9CY_-+@[_ .P9
M>:.F%"*%K*2J4!4H"I0%2@*E 5* J4!4H"I0%7*-/#;YZ?7,2S$\+]-X_2-\
MY/K%*2^B8XG(PR  *M=K9/\ U+2WWB\]?$3ONQZ.3GCSJR[Y^GBYKO,KA0FB
MO"@"@"@"@"@"@"@"@"@$P=F=/^:-OY%=>M0CG>'LD\\);W5[='5N74*S7&
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M:25&NZ]W#P$145.^:6KMSS9_:NBWCK/AI3P.ENZ_2^M_V+9OKLQ;;'%,S/\
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M[.3KW=,M<Y?,-QHU.7S 5.7S 5.7S 5.7S 5.7S 5.7S 5.7S 5.7S 5.7S
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M^L>G?CBU#,,/0OSYW-^%[#XFL@) #          PW?VJZ1G3!;K5W>=)W$]
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M\.'_ /B;-/K(@$G17EP^)CEMGN541>9%1$7S4##GXW<?W1_U4 >-W']T?]5
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MBF*/U%]2@9VB@-I+W9X^=>2^#G>SQ$9[P>PMZWFE,>ZLUU-_4\\+($%66
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M9V&>O/1:F8BR<  #3MU_V<:F\AE^L=3=7:\?6AP]_=@S=65%J%P/G@H H H
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MU2>I3Z@H;1U2>I3Z@H;3,Q42>ZEEX*?[Q%Z]#\9(^;/,],5WSXYX?J 4ROL
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MY7(A)11!-L%#;!0VTF7;F_P_8=G,G/[L*O+5*TZV?N$?LC_ZM_4\T)?-W_\
MSN+_ "?^=SMTK%\L]L+_ $%CI(DU-CKY,E86<SVQ>,PN?SJC'.HE4J]J]Y:5
MZ3\:N?PVMMU%T3ZNZW9F>2?=1Z[NG\=NR_1XYCUUEVW;;,TVHVJ\'PQXII6E
M67F[RVV^T;IC2&3C@R><AR7NSF,6R1',8R-[WMB>YO,B5>K//Y5[AY8,<ZS4
M9<UM;;)MV+;J<W#Y*MC5Y[=V:/!ILE,F2+_67V1/@K,TKUMGGI/@>[H'7N$U
M;N''=R:8CQ^<N()G/R[KM\ST;&Q&\B,5$;14X&GO#=^33:2GK-JR)CYNS1TM
MS;ZPZ[7UG!%F2;9^?MUG@IP<2'=4WF/O]07USB\<S%6G6OC6TCD65JR1O<CY
M.9R)Q>O&G<)5I,=]F*V+[MN:<?%[WO(%O+48\FIONQV>KBLQ2)KPQ,UN]]Y!
MM4<[;!0VTO=GGYUY+X.=[/$1?O'["WK>:4[[FW5U5_4_\K5CR K9   "C^;3
M_P!:R/E4_LCB[-/[*WFCH?)6MG_8R=:[IE@4/=IU* J4!4H"I0%2@*E 5* J
M4!4H"JU>R'[.\?\ ?;GV9Q5O>#MEW-;T/HKN3^E6<]_WI2(1Y-P !%W:)2NS
MVHD\C_QL!V]R=LL]_P"[*/=XNP9/L_>A0WD+04W4Y 5.0%3D!4Y 5.0%3D!4
MY 5.0%3D!5EXIG_J=E]_B]>AYY/1GF>F*?GQSP_3@IA] @  !4SM9I75. ^#
MW^S.+ [L^QOZWF5;WQG^_CZOG5\Y27(%4Y05.4%3E!4Y05.4%3E!4Y05.4%3
ME!5-W992FY%U\$W'LT!&.\?98ZT=$IGW1G_<GJ3TVKD%<+<   #\\]=-_P [
MZE^%;[_$O+ET79\?5MZ(?/&\9_VLO7N^]+P.4VVA4Y05;'HUFBVY&6;6Z7LM
MA#&CK6RQR,1]S.KT1&/D<J<C:+553CYM>G2U?K]F(P[-9\-W@AT=!=I8OF[4
M[4VQ'!%OAG@X*UX/=P\NQ[X:6P6D==RX;3MHECC6VEO*D"222T?(CN9>:5SG
M<:=\T=S:G)J-/MY)K-9Y/,ZG>+1X=)JO5XHV;=F)XYGIF7NZ2R.UNJ,WBM-6
M6V#ILA?2,@=-[LW=$1$K+*K41.#&HYZ^8AJZK'J\&.[)=J."W_\ AV^]'F;>
MARZ'4YK,-NEX;IB/;7^_/O167E:I^BS";GY.V9A;BYTABF.M68^TN9&]??PH
MB/5\DKE>D?/S,7E=W.9.' V--&LRZ2V=N(R7<-9CBMGQ1P5I\37U<[OPZZZW
M8NG%9P4BZ>&Z..LW<,16L<$^")C@X'MR8;;S<+;_ %+J+3>GG:5SVEFQ3R,9
M=275O<0R<RHURR(G%48_H:BUIQ5%H:D9=3I-3CQY+_66Y*QQ4F)]U&_ZG1:_
M29<N+'ZF_#$3Z4W1,</+S3X..G#*%N4E"$5.4%3E!5<GLSI3;-OE]S]9A6G>
M+M?V87+W1[#]J[S)B(TF(  T#>S]ENH_O$7L\9V=R]LQ\_FE'>\?Z=EYH^]"
MCE"V5"% % % % % % % % % .4:>&WST^N)XF8XWZ/1^D;YR?6*.GC?3<<3D
M89  %9NU2E<CIG[Q=^OB)]W6]#)SV^=57?GVF'FN\RO7*356E3E!4Y05.4%3
ME!4Y05.4%3E!4Y05.4%4L]G)*;EV_D=SZU"-]XNR3SPF7=#]0CJW+BE8+N
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M.E9LKU;P       !I>YOO+B/UCT[\<6H9AAZ%^?.YOPO8?$UD!( 8
M ,.W_LT[K1?ZMU7P+YG=;Z &8!B2HMM<I<-3^BEHR9$[B]QWV0,L
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M/V^7JQTK,%>+@        -+W-]Y<1^L>G?CBU#,,/0OSYW-^%[#XFL@) #
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M &,?4\Z".4F2N:G*"IR@J<H*G*"IR@J<H*G*"IR@J<H*ID[-"4W!N?@N?V:
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M:D\AE^L=7=/:\?6AP>\'Z=FZDJ1T0N1\WE$ 40!1 %$ 40!1 %$ 40!1 %$
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MFGBV0   JGVB?G_'\'P>OE+0[L]D^U/F45WW_4(ZEO3<B6A*D#* * * * *
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M%6+Z   "DFY2?Y_U)\(7'KU+FW5V3'U8?-6_OU#/U[NEJM#IN$4 4 4 4 4
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M6I;(FL   :EN?^S[47D4OUCJ[H[9CZT.!WA_3LW4E2NA<SYJ* * * * * *
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MD<]**J)W%[Q!=[ZNS4ZF<EE:3$<?,M7N]N_+H=%;ARTVHF[BX8X9JW Y"1
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MI^QMX\MG\T_TG\/6O/5V'X=_M8_<^D^MY/E/V-O'EL_FG^D_AZUYZNP_#O\
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M1$7OT5'+Z-.X@$F,GB>QKVO3E<E4X]\,.761^K;]5 '61^K;]5 '61^K;]5
M'61^K;]5 '61^K3ZJ >=<Y=L4JQQ,Y^7@YRK1*^8!D8[D=;]:B\TDBJZ5R]/
M-WO0 RP
M
M
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MR20HO13HJGF@HLECI[FYQ]I<WMOXI>30QR7%HKD>L4KVHKH^9."\JK2H89(
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M.\&B5T;?ZH8YVF[^"]CR%K/,VBK;R.C2C9$JC>#E\)6^"B.1043N&
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MG0*C+F1.E%?3P/5<[E3P>15,N79JN\4SLDY>29S.HM;?/^ZE:4149*]>?_\
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M:U+A-7;7:6SVG,=[D86>Q9#:8JO.EJEHJVSH6N6BN:QT:M:Y4JY./=#\RWD
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M6LIWXU]2#P+9!@        TO<WWEQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D ,
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M9^QEO<WJ_)-Y+_4F9G\:OI&*J*K4=1J-151*T3F6B55:(&:I1#
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M^?.YOPO8?$UD!( 8
M
M
M                                                    TO<WWEQ'
MZQZ=^.+4,PP]"_/G<WX7L/B:R D ,
M
M
M
M     :7N;[RXC]8]._'%J&88>A?GSN;\+V'Q-9 2 &
M
M
M
M                  -+W-]Y<1^L>G?CBU#,,/0OSYW-^%[#XFL@) #
M                                         >?GKB:TP63N[=_5SP6D
M\L3THJM>R-SD7CWE0]]/;%V6V)XIF.EJZR^ZS!?=;-)BVZGD4Z^F[<?_ (_+
M^#A]K+6_)M%_ZX\L_&H/]Q;T_P#=/DM^(^F[<?\ X_+^#A]K'Y-HO_7'EGXS
M]Q;T_P#=/DM^(^F[<?\ X_+^#A]K'Y-HO_7'EGXS]Q;T_P#=/DM^(^F[<?\
MX_+^#A]K'Y-HO_7'EGXS]Q;T_P#=/DM^)<?#3RW.'Q]S,[GFFMH9)'KPJY\:
M*J\.^JE49[8MR71'%$ROW373=ALF>.;8Z&<>+9
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M'NCO[7ZS>$8\V6;[=FZ:4CS0GP@"[
M
M        #2]S?>7$?K'IWXXM0S##T+\^=S?A>P^)K("0 P
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M.*=93AQZ S1O5O<07=O%=6TC9;:=C9896+5KV/3F:Y%[J*BU##L
M                                     &E[F^\N(_6/3OQQ:AF&'H7Y
M\[F_"]A\360$@!@
M/&U=PTIG5_\ X^[]@>;&F]K9UHZ6KJ_87]6[H?FMUI<=5![)UHJ;)UHJ;)UH
MJ;+]+M-?-S#^16WL32F\_M+N>>E?VF]E9U8Z'J'@V%3.W-'<38K;R*TF\7NY
M,ZK8+A4YDCD<QJ-?3N\J\:!^H;/9=F_5VJ=4X?4^]VX$NLH<!,ESC,);V<5A
M9=:U4<CI$C5&N15:WF1(T5U**ZG ,50OM"NY^I=;;GY7#:9TMJ74L^9GM\ZF
MJ9'NO+>%))&-@BCX\L"<JLZ/M4;T-2AEYFY&B-RMHNSU?:7U(EO9XS/:S@G2
MRQ]S)/:08^6VDE6!SU3F9%UT,:IYK:]*\0WO5.T>^6M++2<N&TEHG3RZ9N[7
M(X',8"ZECE;!$B*QC7T<CHG>!)7BJJU%3I6H=6F]!Z4U]VRMQ[35M@S*XS&6
MD>0AQURG/;/NDBLX&NEC7P7HULK^5')2JU!X$U7%AVF;/4+K33S]$6^@;>[2
M+&V\C,BV^CQ4<G+&Q48WJTD2)$3P?!KY@80!I31>K-:]HO>2RTEK6\T7>P3O
MD?=64+9NOYI>5K9$5[%1&KQ\%:AEY>A<Q=Z5V9WXTU!9+!NY@)70:BU V:6>
MZR$$UT^WEFZR15>G5-ZY>9M$\)'^F55 RM-[:;I;@[#8G2VG-':*?IK(6D,]
MKG67$GNJVY:Y'OFDD3FY9^9',D;W.+.C@!LVXN!U!M+J[8W=O4,S$R=E'9:2
MUU?1O5\3JQ+$LSWJB<ZK$^=7.<G2QOF =^W6.=K>7?[?6[5)K?)VV7P&FYNE
M%Q]G;.17M[Z.9';M14[K7 0I=7V49V9=L,/!U2X')ZKO4RS+J1UO92/AFK!%
M<R,5%;$J.D<[CPY>;I:@9\*<\OM3OKJC5FA=2MTMH_3+])Y""ZAO=/SR0/DL
M4?&KX'(C:/CY&K1O>543@Y:F&DZPREUL_J7?_0>.7EFUM#976F;1G@NDES<Z
MPS-@3N<K;J5O#[F@'D:D@O=K-*;G]G'%W#I;S+9;3S=-,D7^DN6YAD2W/)YE
M861KYZ@;!K3"ZCPO:+T9M_I_&8?,-TGI>UM=)XO4DCHL=*]D3DEN&L1:/G<]
MKU\U65Z6H![]SM]O1I#*[D[M9#$X;3<5_H[)VMQ9:9GD5CKV.%'17+8E3A(W
MDYU>G>5>ERU#-V3T5M/>]DZ]R>2QV-NI;BQRD^H,C<LB6XBO+=TO5HZ545\:
MQ-2-8D14[CDXNJHGC;7V'?V',^%[[ZT08EI66TPFY':/WQTPU$>ZXT9'C+7F
M]*V[=%CY87+7U,K47T RUO8/-7F\.L=J-/WS9'6>TF(O;O+LE:K6^.LG6TLF
M<>ES(VV[T[W*Y 2P]JMQ,%M=L/N3-J+"PZBM5U=)CK7!W;6NM9[F>&-S4F1[
M7HC&I;N>O@KZ6G3Q0,;>7&[DXO)[5ZPUG!I?"Y&ZS-N_$6&F;9T%W;L22&5$
MEF<JI(UE6\&JK6N7@O$$-WQVE=.ZM[<NLK34V-@RMG88J"_MK6[8DL"7,=GC
MXV/=&ZK7<K97<O,BT7CTH@/ ^:$Q%EI;M=;I:7TO:ML,)<:<DG3%VK49!UTL
M%A/X$;:(W^DE?RHB43F5$X \#+['V3QUMV<=9.N;N&%ME?926\61Z-2&-V/@
M5'OKT-5&K1?,7O EI>T>U&4WB[)MSI;"9%F/RUMJ>?)6C9U<VWN'P6\;.HF5
MJ*J-5)%<B\JT<UO 'A;78[K:EQN!W-T!E=%8[1^\>G=,7%XW*8&."*&>QMV,
MJ]BQ55CF,FZ^-$>YO3P8J44-R[*&W^UN1V7P^69AL9F<QD%F7/W=Y;PW=QXW
M'.].JDZUKE8C&HWD9PX4?]M53$M"Q.A],:^[:VO\=JZQ9E,7CK"')18^X\.V
MDN8[:P@8LL:\'HULSZ-=PJ&? ]?"VUO9=M75]E9Q-@L[;2C(;>"-$;''%'8V
M+6L:U."(B)1$!X'C=B'0>WNI-O=39/4.(Q^8S;\B_'W27\4=RZ+'>+12,:UL
MB+U;7O=*JN;3F5O^SP$M'T-96#]F>T-B+**/(:)P=^LVDYYD2X;'(Z2:)987
MN1:.6!D%7M6M// FK1>TN-W([)N*TY@G6F$SN?Q=LLV6AA8U9YK.ZZYD=T^)
M.=[5<SE=6JM7C152BF/"Z-D]89/0^XF&V0W+T1B<+K1N*6/3VI<-%#2\LH&.
M>J2.:BN1)&VSE<[F2KV<6(M 2M2&             (2[1U?<O!4_O$_K&DR[
ML33)DYH5;_V!CF_#AI]*[HA7JCR?;4*;_#7%'C:@_#7%'C:@_#7),V(1WT@0
MUZ/%;CUJ$<[PW1.DGGA.>Y.&ZW>43/T;EIBLE^@%,-=Y_6VLNU>MSM[IR'5L
MFV>/2%EC<7<=C;,NKAJ];,LDKD17M?.C$;WXZ]RH?KP/NQ.9U1HCM,ZKTIK;
M!QZ7NMPK9V9BP\-PR[@;>1K)<(Z.5CE:J.3QKHZ%X=P$\3K[*&DM$:BU_NU=
MZAQECE<Y:962*SAOXX[A8K6:XN>M<R*1%3PE1K7/IYG"JU$O*VWT'::IU]V@
M=JM#9#W,T/D+=L%O<6RJ^VM[YMQ6.-.5:=77KXE1%XQI0#:=J<WD]K-9:7V-
MW<T)A8[V^M)K#3>K,9##+XS"]KF/;/5O,Y):=7([P%5:<[%15<!S[*.G]-S[
MD[SK-BK%]SB-2)[E<]O$K[-C;J_1.HJVL2)RM1.2G0@)>%V1]!Z+SV0U]K#5
M.-AR>1P6:<F,EO&]='9HQ[[ATL+%JB2*Y&KSTYDY4I3C42Q\AJ/5.]FWNXFK
MM(Z9TAIC;"U3)K=W.3LTFS5[<LA6YDGYHT1C)W=8U[7KQ;(J4<^E0-!S.7NK
M_L^[#8#4%]+%H7(YW(0:EN.=6-9;6F22.)KGIW&0R3.:B]'*GJ4 OKBMO-N\
M=910X?3.(ALEM5M(UAL[=6OM)4:KHU<C%YV/HU755>;I6H?E6CL8Z;P64TKK
MJ:2UMXLQ#G+NVM,I'%$E_9Q3VK8ZPRJWGCHCG<M*)T^:'ZEX&G;;/]E'(8?3
MNXVD\+J7;[(YEJXG6EI#&N1M[IZHYDCFR(Y_,Q&\[6]*4=R2.H@.-<.SUCI7
M(:BO-(V.8M+G4V.CZ^_Q4,K7W,$:\GA2,:JJW^L;T]\/RJOVHK+.Y'M ;26.
MF,FW#:@G8]F.RCXFW#;>=;CP7K&]%:Y$[RH'ZAN^+V U3CL_<;M;AZOFUWN#
MA+"Y=IFU\59:V-O<MB>L2MB:JHY4<M6HUK$YEK15HH8JU'L=Z2V^U5M3GLUJ
M2QLLYJ#)Y*[CU+=Y-C+F=(U8US6O?*BN:US7.DYJ\7*JUX<#,H^VBVWS&[NR
M^Y&W>F<NZWP%AJ5EUI.XN7/6UG=$UZNAD<B*J,<SJ9/!1:/5'4Z:A*NU6L4D
MU3E=DMTMO,-AM;VV&YF7F-MK:2RR%E;(V1C'L:UW#HE:G,K>9%\%CD1%,-.[
M+UO#C^S3KG5^"Q]M)KK%/S;L9DFPQNOHGLQD+XVLDY5>G%55&UX^B&9XVM[1
MZ*W*UKL9+A=+:0T;EL'GDO8K[-9"XE7-)>K*]J2RN2O)-%X#HD]2C7?;<0X[
MI:!S6.C[-VVFX4J29+QJ\PF66SF<Y/$)\C:01QQRT:O"V<UG1PZ )LWI[.MS
MD;/2&0V?L,397.B[N6_@TG>0M9C+YTSH7.<]O!JR5A:UW6>G;]LBIQ,1+9.S
MIN;C]>6NI\++I2VT=K+35^EOJC%V,<;+=]T_GA25%C:E75MWQN1RN5.5/"5*
M E%FYF,N>T=OCJ'9C+YCY/X'16.\=PT$<<;KF[RLT,2I._G3F6)B3\6,<E6(
MBI15JAGB:%:ZTU_IC2=KV6<%B':6W?3-6UDF7PB^+0W..<U9G7SIXG->LCFM
M8KWT\*+BM%16@6IWZMELM@=96;II+EUO@Y(5N)G<TLBQL:WG>Y>ESJ55>^&(
M5[VEV3W/W/V9TWC<GN9)C=K[^%[OD[96$27'4LN9.:)UPBL<Y%>U7>&KD_V5
M#-3?S;G2]ENAL5MA:P20Z11%Q<ELR1S9)+62ZB25'2-HM9:NYW)15YE!#CO7
M@I\)V@-MM!Z,T[@VZ>L\?+?:?T]E/[)A)\I</N$E=*D=.:5>IAY&K7F>C4X\
MU%$-UTAM+O"[>^RW(U!A\!I7$W&,NL1J"/35S(QUQ')!+U<O(YJUD23J>->B
M-%Z4##1,)8Y[LG7V.P^X>E<+JC;7)9ICL=K.W@C7)6UT^CXWN;(CG<[&Q]8U
ME.'*[DD7@&>-UZ;?N3G>T1NS=X/ Z<U#J:QO/$X(=4RO;+;XJ.22*%;.)J\6
M.C;%UCJ<*M]6M0^Y[;'<#;?8O>V75UIC<7A]0SXS)8K#X>=\MI:S.R#>O;&Q
MR)R,Y5B:U*]#43N 9FJMM-!VG8HM=0VV!M(]0IC<;EO==(F^.K>75S V5[IZ
M<ZHYLCF\JKRHVB(G!*#PO"W-MK"^T9V9<ODK:WFOK^3'6^3O9XXU?<6\*63&
MLGD<E7M1JKP>JIQ4":MYM86.F-6Z*VCV^T5@<CK?*I/=X1^7MXX\7C(IED;)
M*QD;47FDZN17=6J+X/0Y7(@8A&.W."SF&[761T]JY<+<WF5T]*F>L\':]1C)
M62Q1R=7)!(G%R\C'NYD\+@O=#/@;!V-,'I^>]W&O)<9929'&:CD2PG=!$L]M
M&Y)6HD3E;S1MHBHG+3N@E!&+R&8Q_9HW03$O?'%=ZNMK7*OC56JEE(U%5%5.
MAKY$C8[OHM.Z&5@=VM![26'9.;?8S'X^*"UQ=A=X/+Q1QMNI;Z98J.ZU$YGO
MF5SDD15Z%7O<#'A17F[&36VI.S-C]=1.OV93%V\>0BN%<JW-LEPG5=8J\7=9
M&UBNKZ:OF@2!NGIG3^BNU7M#=Z1QEMA),DO57K,?$RVBD;SO@6L<2-;58WJQ
M5IQ2G>!X&#KK2&KNS_J[6VZ%UIK$;B;8:HO6W>;]TFQNR-DVYG=_1HLK7(C4
M?-U?@M>UR<O,C: 6ZTKG<;JC3.'U'AFN9B<M96]]91O:D;FP7$39&-5J<$5$
M6BH@?EZX                                              TO<WWE
MQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D ,
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M&.D5O<I3@"J2-M=M=-[4Z;72VE?&/<M;B6\_MDO7R=;,C4=X5&\/!3A0,.K
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M/2:KL9,EF]4OB6VCS.=NUOKF*%W!61KRL:VJ>#7EYJ<*T5:BJ50P
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M;XZPA9;6-I$RWM;>)J,CCAB:C&,:U."-:B(B(&'>
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MU=R1-1J57A5:(1N^Z;KIF?"E5ED66Q;'@BC(/R_8
M                                   #5]9Z#PVNH+2WS,EQ&RS>^2+Q
M9[6*JO1$7FYF/[QO:36Y--,S93AY7/UN@QZJ(B^O!R-0_A\T/_><C^'B]I.E
M^>ZCDM\D_&Y?[>TWUO+'Q'\/FA_[SD?P\7M(_/=1R6^2?C/V]IOK>6/B/X?-
M#_WG(_AXO:1^>ZCDM\D_&?M[3?6\L?$]O2NTFF='Y=F:Q4UX^[9&^)&W$L;X
M^61*+P;&U?\ 2:NIWIEU%FQ=$4\7_+;TNZ<.FR;=E:^/_AOAR79
M
M                              -+W-]Y<1^L>G?CBU#,,/0OSYW-^%[#
MXFL@) #
M
M
M                                           &E[F^\N(_6/3OQQ:A
MF&'H7Y\[F_"]A\360$@!@                           !Q9(R1O-&Y'M
MXI5JHJ53@O0!R
M
M
M                   &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@
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MQDB<\CH8(TBF=$U?%VHYC)(VUY74\) )$
M
M
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M$*VT;U5RJG+$KY.6C:)Z9>^!G
M
M
M                &E[F^\N(_6/3OQQ:AF&'H7Y\[F_"]A\360$@!@
M
M
M
M                             #2]S?>7$?K'IWXXM0S##T+\^=S?A>P^
M)K("0 P
M
M
M                                          !I>YOO+B/UCT[\<6H9
MAAZ%^?.YOPO8?$UD!( 8
M
M
M                                                        TO<W
MWEQ'ZQZ=^.+4,PP]"_/G<WX7L/B:R D ,
M
M
M
M         :7N;[RXC]8]._'%J&8:EA=09S#[A;D08O2>1U!#)E+![[K'W&-A
M9&[W'LDY'-OKNV=S<*U:U6\>FH&T_+?5_P"[7._CF _.@8/EOJ_]VN=_',!^
M= 'RWU?^[7._CF _.@#Y;ZO_ ':YW\<P'YT ?+?5_P"[7._CF _.@#Y;ZO\
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MYW\<P'YT ?+?5_[M<[^.8#\Z /EOJ_\ =KG?QS ?G0!\M]7_ +M<[^.8#\Z
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M= 'RWU?^[7._CF _.@#Y;ZO_ ':YW\<P'YT ?+?5_P"[7._CF _.@#Y;ZO\
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MYW\<P'YT ?+?5_[M<[^.8#\Z /EOJ_\ =KG?QS ?G0!\M]7_ +M<[^.8#\Z
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M= 'RWU?^[7._CF _.@#Y;ZO_ ':YW\<P'YT ?+?5_P"[7._CF _.@#Y;ZO\
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,5$:CE3F<UM50R__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>tb_molecular-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tb_molecular-4c.jpg
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M%!04%!04%!04%/_  !$( E@#M ,!$0 "$0$#$0'_Q #8  $  @,! 0$!
M        !08#! <"" $) 0$  @,! 0$              04" P0&!P@0  $$
M 0,# 00%!P8("@@""P(! P0% !$2!B$3!S%!42(483*3%0AQ@=%"(U06D:%2
MTC,7L6)R)+15=3>"DJ*R0U-SLW0VP<)C-)0E-1B#XT16.,-DA';A\:,G$0$
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MBY+#2PX_8Q[*$JZ*]%<%T4+W%M5=%^A>N!)8&-]]B*P[*E.@S&9 G'GG"0
M 34B(ET1$1$U55P*6_YC\6QU47.6UJJ/KVWQ<_YF[7 VJKREXYNGQBUG)ZYZ
M2:Z-LK(!MPE]PB:BJK^3 M$R7&@1'YTUT6(<5LWI#QKH -MBI$2K[D1-<#FW
M$//GCOFO(4XS429#=@[N2&<IGLM2%!%)4;+<JHNB*J(:#K^7)H.GY 8# 8#
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M*8D/RF1"NHE71%1?H7?B!V_P[_\ LW+_ .!N?^]DY"7ROXF_WG<0_P!K0_\
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MU]J9*%R_$QQ>;1>39MLZV7W;? W+AO:?"I-M@TZ&OIN$AU5/<0^_$#H_CO\
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M*^'+%=0D-QF^Z*I_1-44D_,N8I>?)?\ NZY9_L>?_HYX'PUX2_WK\4_\</\
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M]FQTV:_QT?Q$5S)WUP/($@]MNE$-:TQ^6</4G-_U=J*:CL_M-%U]F4]L9/\
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M4Z]VVOW.#E^KLTF#-I\ML^)-=E-^RE/-O5F0J)^&N&FO5>7.:?\ P*YV6_\
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MUU?$<=>BQ&6'7^K[C38@3BZJOQ**(J]57US";[IV3,[&RW';;,S$1%2)7P(
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M$;R&OD6U!:U<-Y(\N=#D1F'U4D1MQYH@$M1^)-%77IUP-R(T;$5AAPM[C38
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M*BHNBHJ*BH0KU1>BYYW+BNQ7S9=%)AZG#FLS61?9-;;MR0S4W& P& P& P&
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MW7UU?<9;!LC755U)11%7JJ^N9W7W7;)F986X[;9K$1%6SF#,P& P& P& P&
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MN4#)\@W[R_L$8C#[A!37^4U_]&:)U-\K;'R/3V[ZW>>GL1SG*^2.KJ5BZ/T
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M/7WHGR76:._2Y)LN\WE??]#K<>KQ1DLG9*XYQ.\P& P& P& P& P& P& P&
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MVI]3T],TQ$1LCVIR6W1MB*Q3I3NW-F <21/;8" CI ]L>DP2/MFVBJF[MF)
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MB6;*.]I5U)IU%476B_QFS0@+Z4SXWJ,%V')-EV^'Z,T^>W-CB^W=,)_.=T&
MP& P& P& P&!#V=Q(@W5'6-,(XS:NR&WWEW:M(Q'-Y%31%3JH[>N!,8# 8#
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M\9]2\OX9C-;'?T]7H>^^C.<?N,7@7S\5N[ITZWT_GAWT@P& P& P& P& P&
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M<D_ZUK[(<4#^\#DG_6M?9#B@?W@<D_ZUK[(<4#^\#DG_ %K7V0XH']X')/\
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MYM5'^35,LL7Q8J/$<P_\&OB^.VV[[7T3P>S*XX?26)]77X;*NJO7]H(()_\
M*1<^.ZS'X>:^WLF7Z,TV3Q,5MW;$)_.1TF P& P& P& P-63+;8EP(IM[W)A
MN@T?3X%::5Q5Z]>J)ITPAM828# 8# 8# 8# KO/;(JCAE[8-KHZU#>1E?<Z8
M* ?\I4SLT6/Q,]EO;,.75Y/#PW7=D2^>>4Z5/"VH )M4A8BZ>GL12_YJY]AS
M?#CH_.G+?_/KIOG^]=]CF65KVY@,#\5$7HO5,)6+CMU2U[)QK>M24BFIMR$$
M3-$5$^%4+3ITZ9T8LEMNRZ*J?7:3/ENB[%?P[-VZ$W_$W"/]4%]@W_6S=XN+
ML5?^WZ__ -G_ '2E>+^5X_!K=;/C,9Q8,O8%M3.HC3#XMZ['6S%2[;P:JB%H
MJ*G1<KM9@QYXV;)>@Y7=JM/6W+,7V]^WI['3GZ#Q)YV:<G4,C[CYF2*X^V(B
MW)(]-55Z/J@OC[W&EW>]?9E-%^;3;+MMO3KZO.]#-N/-NW].FQ25XS=^+VON
MKE,90KC>-8M]'U=KW.XO02-$U:+_ !7$3/0Z+78[XX:TEXGG?)\]]_BV?%%.
MK?LZ=[/P7Q50<QDWW->56J1.,5]@XPXP!HRCBMMMFI.2"70&UWHGP_$OT97:
M[4W69.&V-LO0<IP1.FLF[JC[TKRKSAQKC]8O#O%45(%>FK;EVPUL%I"Z&<9H
MM"<<5/1UU?I^G.3#H[K[N++/3IU++-J>"V8QQ$SZ(Z>5S)CD/!V&092K<<0$
MT[CK0&X2^TB)2ZJOJJYZ2,F*(I1X:_0Z^^Z;IR1%>R9I['ISD_#$!5:IE-S]
M459;%%_/JNF3.7'_  L;>7:ZNW+L[Y4F0XC\AV0C8M(X9&+0?5!"77:/T)G%
M,UFKT]EO#;%M:TC?VL>0R,!@3G#Y2Q.202_5>4F"_P#Q!Z?SHF;\$TOA5\UQ
M\>EO\FWT.Y^/Y/R/D-Z/Z-VU8JK[E>ANII_R'2R@^J,5<=M_9*X^@M1-,F/S
M]/6[-GSQ]:,!@,!@,"W\.Y<528UU@2E6&OP&O5627V_Y*^U/SY$P.J"0F*&"
MH0$B*)(NJ*B^BHN8I?N P(V[I8EY"*'*31?K,NHGQ-G[%3_TI[<#C-I62ZB:
MY!F#M=#T)/JD*^A"OM1<S0T\!@,!@,"B^87E:X!9-)]:2Y%CI^1V4T)?S:Y<
M<GLXM79Y_8I^<Y/#T>28['!_)L@FH%>R(HJ./D2HJ:Z=L%T_YV?2>9S2VV/*
M^/\ T79749+NRSVW0YNANNJA$OUEV;R].OL55]V4E7U*C,+T<(AQ%8 I'>0T
MF:EN0!145M$UT425===-<SB6J;)XHFNRF[WO"F2JB;MHJNY$_53\V9VTV;47
M;IB7Z)_"2[E157XDU]4Q$[6,QL9%=%35>V*B@Z(B_#Z>WX53KF56N8\C<84(
M@MRGVQ5X4U885-=VOZ[FNN@I[$_6_)BM=D,>%Y"2^;C[CX@X[)#MJX^.NW71
M44/Z*Z(B"OL3-D3$--]G7MV=-O:UFN^IJ#6[>XFS0=54D7]7IZZYMAS7;)I6
ME4D$2/%%%MW-NG_Z&SM5]=.J;BT5&^OOU+Z,1?,[(:;L5L;9Z?:RAR>WBLNP
MJEQ:Z$^"M.1HVJ*X)*FN\OK&JZ)U5?R:9E$1&_:Y<VGC)/%,3,QU_P!FRFR-
MB4A)'GPR&ZC*Q-Z(S9J*-ZZZ='Q)4WIIZ&/Q>_=F471&Z7%ELOMNB(VQ#2E4
MLF'';<62RS&DJH"]',WF7A#ZRZMB2+HOJ/L]R9KXZ[9=L71-W#;7BZXW3ZV>
MM-(DQA]V\%M#;4$?07B)&4Z;5T35!7^BN3XE?PL)QSU=6^*M=IEL70?8M6_B
M<[33"@_WDZZZB(@JCN7^CD1DFWJ,F+BBDQZ)B8HZ/PNUJB>61;+'G2Q%>T_'
M=0)*FB:)WD-&]Z)[>FOY<B^9FWX)X?-[%%JL'Q4NMXK:;J^BL]<=L)^35,\G
MCO5%K%-N)(,CK[1@5=98E%T%4T^(4+T< NBI[>FN:\M\4BZWYHZNV.O[G)HK
M,F"Z8FZMEW_;,[J>3M<1Y-QV=QJW>I[38W+8^L0+O;(23<) 2>HDB]%_-DQ=
M;EMK&Z7I\%TVSMA7T>^7EQ9 *J$TZV>OTB:+E?=-+HGRP]%=;QX,EL]=EWZ9
M?0=8Z4;G'%) ]-94B.7Y'XKB:?RHF6GU!9Q:2[IUOGGT1DFW6S';#O.?*'W@
MP& P& P& P&!KSWV8L"5*D-]V.PRXZ\UHB[P 5(AT7IU1-.N$,S9(3;9BF@D
M D*>Y"%%1/S)@>L),!@,!@,!@,!@<'MW5D\[Y6^7ZK\6./Y&HH?^DL^J_3UG
M#I+?+]LOA/UQDF[6Q'9'V.$S75>FRGE]7'G"_E-<Z+IK,K/#;PX[8[(CV,&8
MMI@,!@,"R<2O*ZN2RIKX'7..7C(QYRQ]%?8<:/N,R&T71")LO4=>HJJ9KOMF
M=L;X3%*MLN&42JKS/.*8H&OPN.#+"1M^ECLJ2+]&N1XD_P ,^K[3S>W[&O8_
MPA2L-_PW96-CR-ET'6K@!2OBL;%U7M NYXB]Q*H:8B+KOFB*>EE$S&V-G3IV
M+-_>+QKF;81_+%,Y,LP%&VN8TRMQ[=$1-$^9;)$9E:?TBVG_ (V<7[6_%MPS
M2/X9^7S=<>SR+/\ =V98IFC;_%&_S]4M<_'G"IZ][CWDJG^57KVKMB962@3W
M$(M/ JI_B&NN91J<D?-CGS4F/;'L83I<=VVS)'GK'NEDL;+B7".)VW%N*VR<
MCY'R-&H]W>,-.1X$: PXCWRT7NH+CA.N"*N.$(IH.B)[<BRW)FR1??'#;;NC
MKKVSW=2;[L>&R;++N*Z[?/53LCO]SFV6*K,!@,!@,#HWC5Q2A3V?8#PDG_##
M_P#MECI9V2\;]06_^2R?)[W<_#SI'P2&P7_Z*_,CI^0)3FG\V?+.<V<.KO\
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M*KZ@,-/R'@C,MJ;QEM%L45255]FB=<V6Q,S2&G+DMQV3?=-(9W6W6'/EGM-
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M(=L1:)M3(8N[M1TUW)T5L!-/\K/F//-5XNJGLMV/MOT[H_VVBLMZZ5ET[^[
M_P#6:?8K_7RAJ]%0_NP/_6:?8K_7Q4H?W8'_ *S3[%?Z^*E#^[ _]9I]BO\
M7Q4H?W8'_K-/L5_KXJ42='P&)5S$F3'TF&WHK#:AL 2_I*FI:JGLR*BXY"3
M8# 8# 8# 8# 8# ^>/Q1<5(8=/Y)AAJ5,?W==[4ZK73#1 <7Z&7M/S&JYZWZ
M;UGA9IQSNN]O3V/#_5_+/W6EX[8^*SI]WG?&WE>D5HX_)(X:MFB1IRC[%_Z(
MU_YO\F>LYM@I3)'=/N>0^BN9?-I+I_O6?YH]_FES13;5=4<Z^O5/;^;//5?4
M*-B,[#VN?-$;GPKVD#X?C^E5US.V;>MKOB_9PT\K\U)T=&U16Q378G33\J>W
M\N1$LIACW:KZ:?1D#.$YP%W%H>G1%+U1/H)-%S*+Z,9LK%&1)(.FADR9HG1
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M>QWBU$D1U 1-Q+KO5-5ZZY$64ZT39%*0AZVXCTMD[,JVGP8<AR8?;=>%7?\
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MEM]OW/K?TIRC]GI^*[Y[^G3[WT'GE'M3 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MH7JF?5N5\UQZNRD[+NN'PGZ@^G,N@R>+A^3?LZNGJ[G'^3<*?K5.;5"3]?\
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MLA3+>FL)$A6I=<X^Y#9U%.Z3S!-&FBIJNT24OAP); 8# 8# 8# 8# 8# 8'
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MHOH1;B3V%GA]=SG/J=E>&WLA]2Y;R#2Z*/@MK/:Z]E&]"8# 8# 8# 8# 8#
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M -]H@$OA5%Z*NO3 VXC)1XK#!EN-IL (O>HBB*O7 S8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8$/9U$B==4=FT^C;-4[(<
M?97=JZC\<V11-%TZ*6[K@3& P& P& P& P& P& P& P& P& P& P& P& P&
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M\-^6NRR;?^ZOV*[-KK<>IQX)B:Y(NF)ZHX:?:E\Y%B8# 8# 8# 8# 8# 8#
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MY"X3%CB@,,0K1IH$]! &F!1/S(F76F_H<W?C_P SR^M_Y32_ES>RQ>LI7IS
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MA<.0Y UYH2"J22:)&EW%T30M.JX&W$1X8K R%UD(V".KZ_&@IN]/IP,V P&
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M(I$O7V(B:K@8Z^P@VT&-:5DEN9736@D1);!(XTZRZ*$!@0ZH0DBHJ*F!LX#
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MVA8B1P%IEEM-H  )H@HB>B(F97WW7W3==-9EABQVX[(LLBEML4B(ZH9LP;#
M8# 8$19W+D"YI*L&$<"V=D-..ZJG:1B.;R+HB+KJHZ=53 E\!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"K<,L)L^1R@9
MCY/C#NY$:*A_]&P+#!""?0BDN6FOQ6V1BX8IQ8XF>^MVU0\ISY,MVHB^:\.:
MZV/)'#9L];GO&?Q&TW)JZODLTLEBQDWB4<JL)Q">:9=C2Y3$QO0$[K;PQ#!M
M!1-3W"B_#UJU_1ZIO/,VXXK"Y)'XRU*D<AFQZWB-576K$U^5*D,N2'&II"T
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MT1$T%5AN_%E=?4?!Z&?*1Z%PR;"G*#T=MX)J0(;L-&W -=HH7=W^W14_/A"
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MR0/**-N(0@J_LR+3VZ:I@2>!$0>44%G/9K:V<$Q^3$6QCN1T-Z,Y%%WLJ8R
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M!@,!@>!9: W'0;$77=%=-$1")131-R^W1.F93=,Q3L8Q9$3,Q&V=[WF+(P&
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MER'!<!IX&C3H;PDXW^R3XOB3"%0=_$?P-N2Y";@7K\Q"FL1V&:F09R)=4O\
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M+S8G')/JZ?%NP58K'P!QZX@38=M>VTR3<3F++D%BX4/YN>[#%L(PJX,5.PC
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M)LJZ!+N*6=)D]J9 <?.$QN$>\3K!-FFB]2V@JE\.!+8# 8# 8# 8# 8# 8#
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M3L.V@V:6U;76,BP?8GQQ8(DN8KKALQ&V20VHW81%5Q=J]%PAS"WL^827N?\
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MRUC&N@NIHOU%5-$+TP(*_P#(7&N.G3)*D)(9NK1:1J3&-IQEB4+#T@N^:FB
M(BR6[U5%TZ8'YS3R-Q+@%95W7)IORU1;SX]9%G *N,"],$S;-PQZ UH"JKB_
M"F!MQ.;<<ER;R,4P8J\=FMUEF[+5([0R7F&I ")N*B%J#P:?2NF!@YMSWC_
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M1Y4N;9M(+D2&Q";[A%),2U#>FJ-H@JI$BHF!J<>\F\3Y/R&RXY52M\FN9KY
M224!CRV[5ER0S\J6_5Q4!HE--J:8%A*[I01TCL8HBQVU>57VT0.\2@WN^+IO
M)-HZ^J]$P-:DY-6WTNY@0^XW.H9JUUC'?#MF+O:;? Q35=6W&W0,"]J+[T7
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MN(]]YG,!Y7![!-JK6Q"30G%Z^SVX%%X;X.YCQ6\XO96%557:U-+251R_O>?
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M1*+KCJQVNX([VV1UT'1<)JQ<]\#W'&N(\BNZ:%!:5IOFI.QJIMSYE^LO$_\
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MRZO..VS*IQ61RE_DDB6Z6@R8=GQ]RO$&=NY>['E=5$]J(.TD5?3 @6OP^>0
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MOQG)DHHHI>MHW8=MGN[&UD(FKB@B+NZII@JQKX/\?K&)H8\YN<KL.2-LW8S
ML@D5T983#H24=1Q"1A5:+K\8_6UP56FVX?0WT:FBV[!RVZ";%M*PG'G5<"9
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M[(6U;0T%#;*.8M(HZ?%HXHK]'K@3& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P*?Y$_P#IU-_MVI_TL,M^5_/?_+R?IEYS
MGW^EB_G8?UPIWG^AM>1->/X-371;-X.51W76;*,Y,KA;2OG"IRFVTU[:*2)J
MNB;E3*AZ2'#.7>'K_C,FYKHT,N05]'QZG=E2V:XRGHT5W-ER6N/NJ9C$<C-N
M?L0_:*(H*>Y<)JU+BA4N/>8XK4$G.16%C?2(D$>-2F[-Z"[<-/H\ESMVO-&R
MBEV$ZD/^3@6WD=-&M^4.7?BRC>KN G)XL%BC58_!A3K9F_CO#)8C$RVJI&C"
MYWWQ#:J*@JJ[<(6WQ%2<#?BCP[R#Q1N5Y<-R:[RB7<4SDKYUY7S,Y(V#L<F7
M&'4VJRB.Z;=!1-4TP*YQWB\3C?X28+<JF&FD3$KBY>*QOE)3L)+=L992OA$R
MTBJYN5S_ */7V8.MFEM<W#S ]Y>B<;E.5,2^_A",XCK@OE1I&*%TB(UM6(MB
M:2OF.YKM37;MZX%?J7_)]W>)R:ML+UWR!6\-L'IZVE0D:''OH]E!DOU$=5C@
M!MN@V;(HBFNW:8EJJZ$MSEWD7S,Q2P[J"Q?0[^Y*;R6B@+"1R(U!&8TS%IWF
M&(KQN2%BBK[O==:$-Y+N)43:$K9<J\]0;";;T9V%K*EVW,:J!Q^3 ;&"S#K&
M7WZMX"%D'%(C 1 W'%%Y%0$Z]<(:_(.8\_;AT(\0Y5;.<>D,2W97*KNOD,OC
MR,"91N')CQZMT@9%%,Q8[(@XNX.[\*)@>_F^=<A\F<8:Y:=L[>4W-'BETC-<
M8\?AU+<&4U"EL2^SJ7=0MVXWE52(A(1V)@3]$M!QWF7,7.?<9E6GDZ3=S['B
MMB56=@Y*K&PWUS=?-5DV6%:;1&MAN!M<U4OK:X%#B^1O+#O&[N6=C<LUK<FH
MGUD=Z%(6VE#*C22FU+$Q*S:D@'6FT0_E>WO_ &2&@KKA*=9<\B0>6W5)47?(
MX$_D'-:U9JR(02@B<<L*=72>9<<CFP)H\VL8R$R%I0'X=?K$*ORODGE;FM9S
MRKA!R6)3.5;L\*]UEQ+*#/J;J,VK(2&HK ?MHI&]V&2=^!$7>JJ6I*SO\DYE
M L;)"FW%+X[G7LUQ[EE33@Y;/J-+6G7]QL8BDHOND[O>6.2D8"RI G3"&6MY
M5YY>/[ZO';&%85+W#1>X^S :6%)6XVM6O<)6%<78!(X2-FB,.:_F#2\@<1N9
MGE;FW)3IU=H(EMPLY,]N"\=R,=M01QVIEBB]M&BV_-( JJM[_B'"6&'R_P W
M/5')9M[R4:.U8';;4SD&<;L20ECM;;AN-UKC;+3T9%:%X2E>HN^JK@>YW+/(
M4)N\O6(MM3]^7QIU*XH"-7MHVM&A/0_G&(#R%*1]!^)UM!73M:M:JF!IRKGG
M?$6>;4D69RH+ZUY9828=@;1/1H,9V%\S 4NW"DJX,DT[(LL?!O#:2MIKO"?I
M>6>;+*SK[ZRE6<5INRX9"?H1K0;AG'OJZ+][N&I,J[^P=<,D5'-K)BJ%JFJ8
M0C(]%R25^'ASC$C[RN^4PN81X\^!?QWI M*W?MN(CB"T)/1B94'W#$C'0RT)
M$3:)*P1>(>3/'EPM#Q.P,AF0+_F#U35PFX]&Y<ME&&%5L]Y#6-',E4C071)Q
M=Z_!JNA"MO\ ./*G\.3Y-=R&Y<K0A5$JTGVM4Y"G)R W75L:>%VH!*SW&Q':
MXK#P,.;1W_'JA+,=]S"CL^;RGG.61)?(Y?''8;<IL@2M@S*YKNR77&(4I$[4
M@2B.@P&[=MZ#JIH$0UR+S2+?\:"MW_'EGP>&,6N.":0CG1;5]B>?R_9VC(9B
M;98-?6,SZ"2;6\"ZS6^=<F\*R?GYK_+ZH>0Q7;"+7-RTLYG%&9+)RX6KL> X
M^]M[B*H-CW&_@ZEKJ0U.?\UAUO&8R>!JV;0[QL);<FLI7Z^&_9P&&C:ANQ5K
M#-YYU/A!"1MO02W&NW:@;R<G\SA:N\A@E/EFO*)='#XM*BMLUAUSM%\ZT\;J
M,(\B#,06Q>5W:G4%P*U:<T\EGQ;C3U3R:Y;<G))7F]O:5ST5RJOABM$Q#1EB
MM>)N,CQ.:H+3@FH("NHA?$$S=2.=6+%G,YA9..VT#E?%J_AE:,48T$IQE72)
M,N,9MB^:&+DL=#-4!K>)=== [3S[^WXA_P#U#$_[B1EQRW=F_E7>VUYKG?S:
M;^?9^F]<LIWI# C>0A9N4%JW2JHW!PY UQ"HBJ25:)&E13^%/CTZKTP-R(CR
M16$D]9"-@CJKHOQ[4W>G3UP,V P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P&!#6C=T=U1'7DJ53;LA;=$($16UCFC6J%U7]IM^
MK_@P)G 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8&I85D&T;9:GLH\W'?:E,HJDFUY@D-LOA5/0DUS;BS7XYF;9I6)CS3O<
M^?3X\T1%\5BV8NCOMFL3Z6WFIT& P& P,;S+,EER/(;%Z.\)-NM."A@8&FA"
M0KJBHJ+HJ+@>P &P%ML4$!1!$131$1.B(B)@?N P& P& P& P& P& P& P&
MP& P& P& P& P&!B=C1WS9<?:!QR.?<8(Q0E;-14-PJOHNTE35/8JX&"?5P+
M,HA3F4>*#("9$55)-DAL2$3314UT0E]>F;L>:_'7AFG%%)[G-FTV/-P\<5X+
MHNM\ET5I/K;F:728$=R!;,:&T*E15N4AR%KD1!5?FD:+M:(?P_7T^MT]^!MQ
M%>6*PLG_ -X[8=[T^OM3=Z=/7 S8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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@<!HON7 :+[EP&B^Y<!HON7 :+[EP/W1=OHNNONP/_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
